PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Da Costa, CR; Johnstone, AP				Da Costa, CR; Johnstone, AP			Production of the thyrotrophin receptor extracellular domain as a glycosylphosphatidylinositol-anchored membrane protein and its interaction with thyrotrophin and autoantibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEIN; HUMAN TSH RECEPTOR; CHO CELLS; SIGNAL-TRANSDUCTION; EXPRESSION SYSTEM; GRAVES-DISEASE; CYCLIC-AMP; BINDING; REGION; LOOP	The thyrotrophin (TSH) receptor (TSHR) is synthesized as a single polypeptide with a predicted large extracellular domain (ECD), a seven-transmembrane pass region and a C-terminal intracellular tail. It is a common target for production of autoantibodies. To investigate whether the ECD is solely responsible for ligand interaction, we directed the expression of this domain in isolation on the cell surface by means of a glycosylphosphatidylinositol (GPI) anchor sequence. Immunoblotting detected TSHR material of M-r 70,000 expressed at high levels. In immunoprecipitation studies, the GPI-anchored ECD was recognized by experimental and pathological antibodies. The molecule was detected on the cell surface by flow cytofluorimetry at up to 10-fold higher amounts than the highest expressing full-length receptor alone. Radioligand binding studies confirmed this and showed that the recombinant molecule bound TSH with high affinity similar to full-length receptor; however, studies with human autoimmune sera indicated differences in the degree of inhibition when compared with full-length receptor. The existence of the GPI anchor was confirmed by cleavage with a GPI-specific phospholipase C and biosynthetic labeling with [H-3]ethanolamine. TSHR material was also present inside the cell in both soluble and membrane-bound forms. Thus, the recombinant GPI-anchored ECD is the smallest known fragment of the TSHR that retains high-affinity TSH binding and is expressed at high levels on the cell surface as well as internally; this approach may well be useful for other membrane proteins.	St George Hosp, Sch Med, Dept Cellular & Mol Sci, Div Immunol, London SW17 0RE, England	St Georges University London	Johnstone, AP (corresponding author), St George Hosp, Sch Med, Dept Cellular & Mol Sci, Div Immunol, Cranmer Terrace, London SW17 0RE, England.	sggf600@sghms.ac.uk		Da Costa, Clive/0000-0002-0435-6747				BANGS JD, 1986, J CELL BIOL, V103, P255, DOI 10.1083/jcb.103.1.255; BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; Bobovnikova Y, 1997, ENDOCRINOLOGY, V138, P588, DOI 10.1210/en.138.2.588; BOOTHROYD JC, 1981, NUCLEIC ACIDS RES, V9, P4735, DOI 10.1093/nar/9.18.4735; CHAZENBALK GD, 1995, J BIOL CHEM, V270, P1543, DOI 10.1074/jbc.270.4.1543; Chazenbalk GD, 1997, J BIOL CHEM, V272, P18959, DOI 10.1074/jbc.272.30.18959; CLASSON BJ, 1992, INT IMMUNOL, V4, P215, DOI 10.1093/intimm/4.2.215; COSTAGLIOLA S, 1994, J MOL ENDOCRINOL, V13, P11, DOI 10.1677/jme.0.0130011; COYNE KE, 1993, J BIOL CHEM, V268, P6689; HARAGUCHI K, 1994, LIFE SCI, V55, P961, DOI 10.1016/0024-3205(94)00542-7; HARFST E, 1992, MOL CELL ENDOCRINOL, V83, P117, DOI 10.1016/0303-7207(92)90152-V; HARFST E, 1994, MOL CELL ENDOCRINOL, V102, P77, DOI 10.1016/0303-7207(94)90100-7; HARFST E, 1992, J MOL ENDOCRINOL, V9, P227, DOI 10.1677/jme.0.0090227; HARFST E, 1992, ANAL BIOCHEM, V207, P80, DOI 10.1016/0003-2697(92)90504-Z; HUANG GC, 1992, J MOL ENDOCRINOL, V8, P137, DOI 10.1677/jme.0.0080137; HUANG GC, 1993, J MOL ENDOCRINOL, V10, P127, DOI 10.1677/jme.0.0100127; JOHNSTONE AP, 1994, MOL CELL ENDOCRINOL, V105, pR1, DOI 10.1016/0303-7207(94)90175-9; KANESHIGE M, 1995, HORM METAB RES, V27, P267, DOI 10.1055/s-2007-979956; KOSUGI S, 1993, MOL ENDOCRINOL, V7, P1009, DOI 10.1210/me.7.8.1009; KOSUGI S, 1994, FEBS LETT, V349, P89, DOI 10.1016/0014-5793(94)00646-6; KOSUGI S, 1994, BIOCHEM BIOPH RES CO, V199, P1497, DOI 10.1006/bbrc.1994.1400; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIBERT F, 1989, BIOCHEM BIOPH RES CO, V165, P1250, DOI 10.1016/0006-291X(89)92736-8; LIBERT F, 1991, J CLIN ENDOCR METAB, V73, P857, DOI 10.1210/jcem-73-4-857; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MISRAHI M, 1990, BIOCHEM BIOPH RES CO, V166, P394, DOI 10.1016/0006-291X(90)91958-U; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; PERRET J, 1990, BIOCHEM BIOPH RES CO, V171, P1044, DOI 10.1016/0006-291X(90)90789-P; Rapoport B, 1996, J CLIN ENDOCR METAB, V81, P2525, DOI 10.1210/jc.81.7.2525; SEETHARAMAIAH GS, 1993, AUTOIMMUNITY, V14, P315, DOI 10.3109/08916939309079234; SEETHARAMAIAH GS, 1994, ENDOCRINOLOGY, V134, P549, DOI 10.1210/en.134.2.549; SHI YF, 1993, THYROID, V3, P129, DOI 10.1089/thy.1993.3.129; TAKAI O, 1991, BIOCHEM BIOPH RES CO, V179, P319, DOI 10.1016/0006-291X(91)91372-J; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; VANSANDE J, 1992, MOL CELL ENDOCRINOL, V88, pR1; Vlase H, 1997, ENDOCRINOLOGY, V138, P1658, DOI 10.1210/en.138.4.1658	39	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11874	11880		10.1074/jbc.273.19.11874	http://dx.doi.org/10.1074/jbc.273.19.11874			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565613	hybrid			2022-12-27	WOS:000073536700067
J	Houston, ME; Chao, H; Hodges, RS; Sykes, BD; Kay, CM; Sonnichsen, FD; Loewen, MC; Davies, PL				Houston, ME; Chao, H; Hodges, RS; Sykes, BD; Kay, CM; Sonnichsen, FD; Loewen, MC; Davies, PL			Binding of an oligopeptide to a specific plane of ice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIFREEZE POLYPEPTIDE; WINTER FLOUNDER; ALPHA-HELICES; MECHANISM; PROTEIN; STABILIZATION; PEPTIDES; FORM; GLU	The alpha-helical antifreeze protein (AFP) from winter flounder inhibits ice growth by binding to a specific set of pyramidal surface planes that are not otherwise macroscopically expressed. The 37-residue AFP contains three Il-amino acid repeats that make a stereo-specific fit to the ice lattice along the (01-12) direction of the {20-21} and equivalent binding planes. When the AFP was shortened to delete two of the three 11-amino acid ice-binding repeats, the resulting 15-residue peptide and its variants were less helical and showed no antifreeze activity. However, when the helicity of the peptide was reinforced by an internal lactam bridge between Glu-7 and Lys-11, the minimized AFP was able to stably express the pyramidal plane {20-21} on the surface of growing ice crystals. This dynamic shaping of the ice surface by a single ice-binding repeat provides evidence that AFP adsorption to the ice lattice is not an "all-or-nothing" interaction. Instead, a partial interaction can help develop the binding site on ice to which the remainder of the AFP (or other AFP molecules) can orient and bind.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Prot Engn Network Ctr Excellence, Edmonton, AB T6G 2S2, Canada; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Queens University - Canada; University of Alberta; University of Alberta; Case Western Reserve University	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca	Sönnichsen, Frank D/D-8408-2011	Sönnichsen, Frank D/0000-0002-4539-3755				CHAKRABARTTY A, 1991, EUR J BIOCHEM, V202, P1057, DOI 10.1111/j.1432-1033.1991.tb16470.x; Chao H, 1996, PROTEIN SCI, V5, P1150; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CHOU KC, 1992, J MOL BIOL, V223, P509, DOI 10.1016/0022-2836(92)90666-8; DAVIES PL, 1990, FASEB J, V4, P2460, DOI 10.1096/fasebj.4.8.2185972; DELUCA CI, 1996, BIOPHYS J, V71, P2345; DOIG AJ, 1994, BIOCHEMISTRY-US, V33, P3396, DOI 10.1021/bi00177a033; Gronwald W, 1996, BIOCHEMISTRY-US, V35, P16698, DOI 10.1021/bi961934w; Houston ME, 1996, BIOCHEMISTRY-US, V35, P10041, DOI 10.1021/bi952757m; HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P80; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; MADURA JD, 1994, J AM CHEM SOC, V116, P417, DOI 10.1021/ja00080a066; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MERUTKA G, 1993, BIOCHEMISTRY-US, V32, P13089, DOI 10.1021/bi00211a019; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; WEN D, 1992, J BIOL CHEM, V63, P1659; WEN DY, 1992, J BIOL CHEM, V267, P14102; WILSON PW, 1993, CRYO-LETT, V14, P31; YANG DSC, 1988, NATURE, V333, P232, DOI 10.1038/333232a0	20	67	70	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11714	11718		10.1074/jbc.273.19.11714	http://dx.doi.org/10.1074/jbc.273.19.11714			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565593	hybrid			2022-12-27	WOS:000073536700047
J	Wei, LH; Berman, Y; Castano, EM; Cadene, M; Beavis, RC; Devi, L; Levy, E				Wei, LH; Berman, Y; Castano, EM; Cadene, M; Beavis, RC; Devi, L; Levy, E			Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN GAMMA-TRACE; CYSTEINE PROTEINASES; CEREBROSPINAL-FLUID; BRAIN HEMORRHAGE; FIBRIL FORMATION; CATHEPSIN-B; IN-VITRO; ANGIOPATHY; MACROPHAGES	A cystatin C variant with L68Q substitution and a truncation of 10 NH2-terminal residues is the major constituent of the amyloid deposited in the cerebral vasculature of patients with the Icelandic form of hereditary cerebral hemorrhage with amyloidosis (HCHWA-I). Variant and wild type cystatin C production, processing, secretion, and clearance were studied in human cell lines stably overexpressing the cystatin C genes. Immunoblot and mass spectrometry analyses demonstrated monomeric cystatin C in cell homogenates and culture media. While cystatin C formed concentration-dependent dimers, the HCHWA-I variant dimerized at lower concentrations than the wild type protein. Amino-terminal sequence analysis revealed that the variant and normal proteins produced and secreted are the full-length cystatin C, Pulse-chase experiments demonstrated similar levels of normal and variant cystatin C production and secretion. However, the secreted variant cystatin C exhibited an increased susceptibility to a serine protease in conditioned media and in human cerebrospinal fluid, explaining its depletion from the cerebrospinal fluid of HCHWA-I patients. Thus, the amino acid substitution may induce unstable cystatin C with intact inhibitory activity and predisposition to self-aggregation and amyloid fibril formation.	NYU, Med Ctr, Dept Pharmacol, New York, NY 10016 USA; NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA	New York University; New York University	Levy, E (corresponding author), NYU, Med Ctr, Dept Pharmacol, 550 1st Ave, New York, NY 10016 USA.	levye01@mcrcr.med.nyu.edu		Cadene, Martine/0000-0003-4936-2662	NATIONAL INSTITUTE ON AGING [R01AG013705] Funding Source: NIH RePORTER; NIA NIH HHS [AG13705] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; ABRAHAMSON M, 1990, BIOCHEM J, V268, P287, DOI 10.1042/bj2680287; Arnason A., 1935, ACTA PSYCHIATR NEU S, P1; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BARRETT AJ, 1984, BIOCHEM BIOPH RES CO, V120, P631, DOI 10.1016/0006-291X(84)91302-0; Beavis RC, 1996, J AM SOC MASS SPECTR, V7, P107, DOI 10.1016/1044-0305(95)00592-7; BENEDIKZ E, 1990, VIRCHOWS ARCH A, V417, P325, DOI 10.1007/BF01605784; BOBEK LA, 1992, CRIT REV ORAL BIOL M, V3, P307, DOI 10.1177/10454411920030040101; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BURNETT D, 1995, ARCH BIOCHEM BIOPHYS, V317, P305, DOI 10.1006/abbi.1995.1167; Busca R, 1996, J BIOL CHEM, V271, P2139, DOI 10.1074/jbc.271.4.2139; CHAPMAN HA, 1990, AM REV RESPIR DIS, V141, P698, DOI 10.1164/ajrccm/141.3.698; COHEN DH, 1983, J EXP MED, V158, P623, DOI 10.1084/jem.158.2.623; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; CORTICCHIATO O, 1992, INT J CANCER, V52, P645; DELEMOSCHIARANDINI C, 1992, EUR J CELL BIOL, V58, P187; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Emilsson V, 1996, AMYLOID, V3, P110, DOI 10.3109/13506129609014362; GHISO J, 1986, BIOCHEM BIOPH RES CO, V136, P548, DOI 10.1016/0006-291X(86)90475-4; GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974; GLENNER GG, 1971, SCIENCE, V174, P712, DOI 10.1126/science.174.4010.712; GRAFFAGNINO C, 1995, STROKE, V26, P2190, DOI 10.1161/01.STR.26.11.2190; GRUBB A, 1984, NEW ENGL J MED, V311, P1547, DOI 10.1056/NEJM198412133112406; GRUBB A, 1982, P NATL ACAD SCI-BIOL, V79, P3024, DOI 10.1073/pnas.79.9.3024; GUDMUNDSSON G, 1972, BRAIN, V95, P387, DOI 10.1093/brain/95.2.387; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; HOCHWALD GM, 1967, P SOC EXP BIOL MED, V124, P961; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; JOHANSEN TE, 1990, BIOCHEM BIOPH RES CO, V172, P1384, DOI 10.1016/0006-291X(90)91603-P; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; LAVIE G, 1978, J EXP MED, V148, P1020, DOI 10.1084/jem.148.4.1020; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; LOFBERG H, 1979, SCAND J CLIN LAB INV, V39, P619, DOI 10.3109/00365517909108866; LOFBERG H, 1987, STROKE, V18, P431, DOI 10.1161/01.STR.18.2.431; MAURY CPJ, 1995, LAB INVEST, V72, P4; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Nakamura K, 1997, ANGIOLOGY, V48, P551, DOI 10.1177/000331979704800611; NAKAYAMA S, 1991, CLIN NEUROL TOKYO, V31, P454; Olafsson I, 1996, BRAIN PATHOL, V6, P121, DOI 10.1111/j.1750-3639.1996.tb00795.x; OLAFSSON I, 1990, SCAND J CLIN LAB INV, V50, P85, DOI 10.3109/00365519009091569; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; PALSDOTTIR A, 1988, LANCET, V2, P603; POPOVIC T, 1990, BIOL CHEM H-S, V371, P575, DOI 10.1515/bchm3.1990.371.2.575; ROKITA H, 1987, J IMMUNOL, V139, P3849; SHIMODE K, 1991, STROKE, V22, P860, DOI 10.1161/01.STR.22.7.860; SHIRAHAMA T, 1975, AM J PATHOL, V81, P101; SHIRAHAMA T, 1990, LAB INVEST, V62, P61; TAKAHASHI M, 1989, VIRCHOWS ARCH A, V415, P411, DOI 10.1007/BF00747742; THORSTEINSSON L, 1992, J NEUROL SCI, V108, P121, DOI 10.1016/0022-510X(92)90042-J; TU GF, 1992, AM J PHYSIOL, V263, pR195, DOI 10.1152/ajpregu.1992.263.1.R195; WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5; ZUCKERFRANKLIN D, 1987, LAB INVEST, V57, P176	53	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11806	11814		10.1074/jbc.273.19.11806	http://dx.doi.org/10.1074/jbc.273.19.11806			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565605	hybrid			2022-12-27	WOS:000073536700059
J	Ben Mamoun, C; Sullivan, DJ; Banerjee, R; Goldberg, DE				Ben Mamoun, C; Sullivan, DJ; Banerjee, R; Goldberg, DE			Identification and characterization of an unusual double serine/threonine protein phosphatase 2C in the malaria parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE THREONINE PHOSPHATASES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; KINASE; CELL; ACTIVATION; DIVISION; GROWTH; SYSTEM	We have cloned a gene from Plasmodium falciparum with homology to the Mg2+-dependent serine/threonine protein phosphatase 2C (PP2C) family. The predicted coding region is 920 amino acids long, twice the size of other members of this family. We show that this protein can be divided into two halves (Pf2C-1 and Pf2C-2), each a complete phosphatase unit with homology to other phosphatases of this class. To study the function of this PP2C, we have tested the ability of different constructs to complement conditional null mutants of yeast. Our results show that expression of the full-length protein, the first half alone, the second half alone, or a hybrid with the N terminus of the first half and the C terminus of the second half was able to complement the heat shock response defect of a Schizosaccharomyces pombe strain with a PP2C (PTC1) deletion. Recombinant P. falciparum PP2C expressed in Escherichia coli was active in dephosphorylating P-32-labeled casein in an Mg2+- or Mn2+-dependent reaction. Each half alone was also active in recombinant form. Using the two-hybrid system, we have shown that the two halves can interact. Gel filtration assay of P. falciparum protein extracts suggests that full length PfPP2C is a dimer, and phosphatase activity competition experiments indicate that dimerization of PfPP2C is required for its optimal activity. This unusual phosphatase molecule appears to be composed of four catalytic units on two polypeptide chains.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, POB 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	goldberg@borcim.wustl.edu			NIAID NIH HHS [AI-31615] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI031615] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; Butler D, 1997, NATURE, V386, P535, DOI 10.1038/42306; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Degols G, 1996, MOL CELL BIOL, V16, P2870; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; DURFEE T, 1993, GENE DEV, V9, P2117; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Gaits F, 1997, J BIOL CHEM, V272, P17873, DOI 10.1074/jbc.272.28.17873; HARPER JW, 1993, CELL, V75, P805; INGEBRITSEN TS, 1983, SCIENCE, V221, P331, DOI 10.1126/science.6306765; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MANIATIS T, 1982, MOL CLONINGS LAB MAN; MCGOWAN CH, 1988, METHOD ENZYMOL, V194, P795; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Mitchison JM, 1970, METHOD CELL PHYSIOL, V4, P131; MOORE F, 1991, EUR J BIOCHEM, V199, P691, DOI 10.1111/j.1432-1033.1991.tb16172.x; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; ROBINSON MK, 1994, MOL CELL BIOL, V14, P3634, DOI 10.1128/MCB.14.6.3634; SHIOZAKI K, 1995, EMBO J, V14, P492, DOI 10.1002/j.1460-2075.1995.tb07025.x; SHIOZAKI K, 1994, MOL CELL BIOL, V14, P3742, DOI 10.1128/MCB.14.6.3742; TAMURA S, 1989, P NATL ACAD SCI USA, V86, P1796, DOI 10.1073/pnas.86.6.1796; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017	34	36	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11241	11247		10.1074/jbc.273.18.11241	http://dx.doi.org/10.1074/jbc.273.18.11241			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556615	hybrid			2022-12-27	WOS:000073395200067
J	Grilley, MM; Stock, SD; Dickson, RC; Lester, RL; Takemoto, JY				Grilley, MM; Stock, SD; Dickson, RC; Lester, RL; Takemoto, JY			Syringomycin action gene SYR2 is essential for sphingolipid 4-hydroxylation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE; SYRINGAE PV SYRINGAE; PSEUDOMONAS-SYRINGAE; SERINE PALMITOYLTRANSFERASE; GROWTH-INHIBITION; MUTANT STRAINS; BIOSYNTHESIS; CERAMIDE; RECEPTORS; LIPODEPSIPEPTIDES	The Saccharomyces cerevisiae gene SYR2, necessary for growth inhibition by the cyclic lipodepsipeptide syringomycin E, is shown to be required for 4-hydroxylation of long chain bases in sphingolipid biosynthesis, Four Lines of support for this conclusion are presented: (a) the predicted Syr2p shows sequence similarity to diiron-binding membrane enzymes involved in oxygen-dependent modifications of hydrocarbon substrates, (b) yeast strains carrying a disrupted SYR2 allele produced sphingoid long chain bases lacking the 4-hydroxyl group present in wild type strains, (c) 4-hydroxylase activity was increased in microsomes prepared from a SYR2 overexpression strain, and (d) the syringomycin E resistance phenotype of a syr2 mutant strain was suppressed when grown under conditions in which exogenous 4-hydroxysphingoid long chain bases were incorporated into sphingolipids, The syr2 strain produced wild type levels of sphingolipids, substantial levels of hydroxylated very long chain fatty acids, and the full complement of normal yeast sphingolipid head groups. These results show that the SYR2 gene is required for the 4-hydroxylation reaction of sphingolipid long chain bases, that this hydroxylation is not essential for growth, and that the 4-hydroxyl group of sphingolipids is necessary for syringomycin E action on yeast.	Utah State Univ, Dept Biol, Logan, UT 84322 USA; Univ Kentucky, Dept Biochem, Lexington, KY 40536 USA; Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	Utah System of Higher Education; Utah State University; University of Kentucky; University of Kentucky	Takemoto, JY (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	takemoto@cc.usu.edu	Takemoto, Jon/A-5309-2011	Takemoto, Jon/0000-0001-9919-9168	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041302] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADETUYI FC, 1995, FEMS MICROBIOL LETT, V131, P63, DOI 10.1111/j.1574-6968.1995.tb07755.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bard M, 1996, P NATL ACAD SCI USA, V93, P186, DOI 10.1073/pnas.93.1.186; BIDWAI AP, 1987, P NATL ACAD SCI USA, V84, P6755, DOI 10.1073/pnas.84.19.6755; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; Cliften P, 1996, MICROBIOL-SGM, V142, P477, DOI 10.1099/13500872-142-3-477; DESFARGES L, 1993, YEAST, V9, P267, DOI 10.1002/yea.320090306; DICKSON RC, 1990, MOL CELL BIOL, V10, P2176, DOI 10.1128/MCB.10.5.2176; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Ella KM, 1997, ARCH BIOCHEM BIOPHYS, V340, P101, DOI 10.1006/abbi.1997.9897; Feigin AM, 1997, BBA-BIOMEMBRANES, V1324, P102, DOI 10.1016/S0005-2736(96)00214-3; Feigin AM, 1996, J MEMBRANE BIOL, V149, P41, DOI 10.1007/s002329900005; FEWSTER ME, 1969, J CHROMATOGR, V43, P120, DOI 10.1016/S0021-9673(00)99173-8; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; FISHMAN PH, 1993, ADV LIPID RES, V25, P165; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GROSS DC, 1991, ANNU REV PHYTOPATHOL, V29, P247, DOI 10.1146/annurev.py.29.090191.001335; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hakomori S, 1996, CANCER RES, V56, P5309; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HECHTBERGER P, 1994, NATO ASI SERIES H, V82, P23; HRABAK EM, 1993, MOL PLANT MICROBE IN, V6, P368, DOI 10.1094/MPMI-6-368; HUTCHISON ML, 1995, MOL PLANT MICROBE IN, V8, P610, DOI 10.1094/MPMI-8-0610; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; JULMANOP C, 1993, J GEN MICROBIOL, V139, P2323, DOI 10.1099/00221287-139-10-2323; JUNGALWALA FB, 1983, J LIPID RES, V24, P1380; KAISER C, 1994, METHODS YEAST GENETI, P73; KATO R, 1991, METHOD ENZYMOL, V206, P183; KULMACZ RJ, 1978, J AM CHEM SOC, V100, P3963, DOI 10.1021/ja00480a070; LEI Z, 1987, PHYTOPATHOLOGY, V77, P297, DOI 10.1094/Phyto-77-297; LESTER RL, 1993, ADV LIPID RES, V26, P253; LESTER RL, 1993, J BIOL CHEM, V268, P845; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; LINGWOOD CA, 1993, ADV LIPID RES, V25, P189; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; MERRILL AH, 1992, METHOD ENZYMOL, V209, P427; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; PINTO WJ, 1992, J BACTERIOL, V174, P2575, DOI 10.1128/jb.174.8.2575-2581.1992; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; SKIPSKI VP, 1969, METHOD ENZYMOL, V14, P545; Skrzypek M, 1997, J BACTERIOL, V179, P1513, DOI 10.1128/jb.179.5.1513-1520.1997; SMITH SW, 1974, J BIOL CHEM, V249, P3395; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; TAGUCHI N, 1994, MICROBIOL-SGM, V140, P353, DOI 10.1099/13500872-140-2-353; TAKEMOTO JY, 1993, FEMS MICROBIOL LETT, V114, P339, DOI 10.1111/j.1574-6968.1993.tb06595.x; TAKEMOTO JY, 1992, BACTERIAL PHYTOTOXIN, P247; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; ZWEERINK MM, 1992, J BIOL CHEM, V267, P25032	58	113	118	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11062	11068		10.1074/jbc.273.18.11062	http://dx.doi.org/10.1074/jbc.273.18.11062			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556590	hybrid			2022-12-27	WOS:000073395200042
J	Weiler, S; Gruschus, JM; Tsao, DHH; Yu, L; Wang, LH; Nirenberg, M; Ferretti, JA				Weiler, S; Gruschus, JM; Tsao, DHH; Yu, L; Wang, LH; Nirenberg, M; Ferretti, JA			Site-directed mutations in the vnd/NK-2 homeodomain - Basis of variations in structure and sequence-specific DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE SOLUTION STRUCTURE; CENTRAL-NERVOUS-SYSTEM; NK-2 HOMEOBOX GENE; CRYSTAL-STRUCTURE; ANTENNAPEDIA HOMEODOMAIN; DROSOPHILA-MELANOGASTER; FUNCTIONAL SPECIFICITY; TRANSCRIPTION FACTORS; RECOGNITION CODE; COMPLEX	Secondary structures, DNA binding properties, and thermal denaturation behavior of six site-directed mutant homeodomains encoded by the vnd/NK-2 gene from Drosophila melanogaster are described. Three single site H52R, Y54M, and T56W mutations, two double site H52R/T56W and Y54M/T56W mutations, and one triple site H52R/Y54M/T56W mutation were investigated. These positions were chosen based on their variability across homeodomains displaying differences in secondary structure and DNA binding specificity. Multidimensional NMR, electrophoretic mobility shift assays, and circular dichroism spectropolarimetry studies were carried out on recombinant 80-amino acid residue proteins containing the homeodomain, Position 56, but more importantly position 56 in combination with position 52, plays an important role in determining the length of the recognition helix. The H52R mutation alone does not affect the length of this helix but does increase the thermal stability. introduction of site mutations at positions 52 and 56 in vnd/NK-2 does not modify their high affinity binding to the 18-base pair DNA fragment containing the vnd/NK-2 consensus binding sequence, CAAGTG, Site mutations involving position 54 (Y54M, Y54M/T56W, and H52R/Y54M/T56W) all show a decrease of 1 order of magnitude in their binding affinity. The roles in structure and sequence specificity of individual atom-atom interactions are described.	NHLBI, Biophys Chem Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Lab Biochem Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ferretti, JA (corresponding author), NHLBI, Biophys Chem Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	jafer@helix.nih.gov						AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; ANDREW DJ, 1994, EMBO J, V13, P1132, DOI 10.1002/j.1460-2075.1994.tb06362.x; BILLETER M, 1990, J MOL BIOL, V214, P183, DOI 10.1016/0022-2836(90)90155-F; BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661; Boncinelli E, 1997, CURR OPIN GENET DEV, V7, P331, DOI 10.1016/S0959-437X(97)80146-3; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; DAMANTE G, 1994, FEBS LETT, V354, P293, DOI 10.1016/0014-5793(94)01145-1; DRAGANESCU A, 1995, J MOL BIOL, V250, P595, DOI 10.1006/jmbi.1995.0401; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; FRASCH M, 1988, GENE DEV, V2, P1824, DOI 10.1101/gad.2.12b.1824; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Gruschus JM, 1997, BIOCHEMISTRY-US, V36, P5372, DOI 10.1021/bi9620060; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; HEBERLEIN U, 1994, MECH DEVELOP, V48, P35, DOI 10.1016/0925-4773(94)90004-3; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirsch JA, 1995, EMBO J, V14, P6280, DOI 10.1002/j.1460-2075.1995.tb00318.x; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x; KIM YS, 1989, P NATL ACAD SCI USA, V86, P7716, DOI 10.1073/pnas.86.20.7716; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; LAUGHON A, 1991, BIOCHEMISTRY-US, V30, P11357, DOI 10.1021/bi00112a001; LI T, 1995, SCIENCE, V270, P262, DOI 10.1126/science.270.5234.262; LIN L, 1992, GENE DEV, V6, P1071, DOI 10.1101/gad.6.6.1071; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; MELLERICK DM, 1995, DEV BIOL, V171, P306, DOI 10.1006/dbio.1995.1283; NIRENBERG M, 1995, ANN NY ACAD SCI, V758, P224, DOI 10.1111/j.1749-6632.1995.tb24830.x; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; PERCIVALSMITH A, 1990, EMBO J, V9, P3967, DOI 10.1002/j.1460-2075.1990.tb07617.x; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; QIAN YQ, 1994, J MOL BIOL, V238, P333, DOI 10.1006/jmbi.1994.1296; Reecy JM, 1997, DEV BIOL, V188, P295, DOI 10.1006/dbio.1997.8641; SCHIER AF, 1992, NATURE, V356, P804, DOI 10.1038/356804a0; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SKEATH JB, 1994, DEVELOPMENT, V120, P1517; SUZUKI M, 1994, STRUCTURE, V2, P317, DOI 10.1016/S0969-2126(00)00033-2; SUZUKI M, 1995, PROTEIN ENG, V8, P319, DOI 10.1093/protein/8.4.319; TSAO DHH, 1995, J MOL BIOL, V251, P297, DOI 10.1006/jmbi.1995.0435; TSAO DHH, 1994, BIOCHEMISTRY-US, V33, P15053, DOI 10.1021/bi00254a014; WAKIMOTO BT, 1984, DEV BIOL, V102, P147, DOI 10.1016/0012-1606(84)90182-9; Weiler S., 1996, Biophysical Journal, V70, pA342; WHITE K, 1980, DEV BIOL, V80, P332, DOI 10.1016/0012-1606(80)90409-1; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Wuthrich K, 1986, NMR PROTEINS NUCL AC; ZENG WL, 1993, DEVELOPMENT, V118, P339	52	39	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10994	11000		10.1074/jbc.273.18.10994	http://dx.doi.org/10.1074/jbc.273.18.10994			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556579	hybrid			2022-12-27	WOS:000073395200031
J	Advani, RJ; Bae, HR; Bock, JB; Chao, DS; Doung, YC; Prekeris, R; Yoo, JS; Scheller, RH				Advani, RJ; Bae, HR; Bock, JB; Chao, DS; Doung, YC; Prekeris, R; Yoo, JS; Scheller, RH			Seven novel mammalian SNARE proteins localize to distinct membrane compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR TRANSPORT; SYNTAXIN FAMILY; TRAFFICKING; RECEPTORS; SUBSTRATE; VESICLES; FUSION; YEAST	Soluble N-ethylmaleimide-sensitive factor-attachment protein receptor (SNARE) proteins of the vesicle-associated membrane protein (VAMP) and syntaxin families play a central role in vesicular trafficking through the formation of complexes between proteins present on vesicle and target membranes. Formation of these complexes is proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers, In order to further understand the molecular mechanisms that organize membrane compartments, we have characterized seven new mammalian proteins of the VAMP and syntaxin families. The proteins are broadly expressed; however, syntaxin 13 is enriched in brain and VAMP 8 in kidney. The seven novel SNAREs localize in distinct patterns overlapping with Golgi, endosomal or lysosomal markers. Our studies support the hypothesis that evolutionary radiation of these two gene families gave rise to sets of proteins whose differential expression and combinatorial associations define and organize the membrane compartments of cells.	Stanford Univ, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Scheller, RH (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA.	scheller@cmgm.stanford.edu		Chao, Daniel/0000-0002-3544-5283				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; BANFIELD DK, 1994, J CELL BIOL, V127, P357, DOI 10.1083/jcb.127.2.357; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; Bock JB, 1996, J BIOL CHEM, V271, P17961, DOI 10.1074/jbc.271.30.17961; Bock JB, 1997, NATURE, V387, P133, DOI 10.1038/387133a0; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hay JC, 1996, J BIOL CHEM, V271, P5671, DOI 10.1074/jbc.271.10.5671; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; HESS DT, 1992, J NEUROSCI, V12, P4634; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Lupas A, 1996, METHOD ENZYMOL, V266, P513; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; MOLLARD GF, 1997, J CELL BIOL, V137, P1511; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHELLER RH, 1995, NEURON, V14, P893; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Wang H, 1997, GENE, V199, P39, DOI 10.1016/S0378-1119(97)00343-0	25	213	224	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10317	10324		10.1074/jbc.273.17.10317	http://dx.doi.org/10.1074/jbc.273.17.10317			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553086	hybrid			2022-12-27	WOS:000073224200035
J	Chong, SR; Williams, KS; Wotkowicz, C; Xu, MQ				Chong, SR; Williams, KS; Wotkowicz, C; Xu, MQ			Modulation of protein splicing of the Saccharomyces cerevisiae vacuolar membrane ATPase intein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PI-SCEI ENDONUCLEASE; BRANCHED INTERMEDIATE; BINDING; PRODUCT; GENE; MECHANISM; SELECTION; SEQUENCE; SUBUNIT; INTRONS	Protein splicing of the Saccharomyces cerevisiae vacuolar membrane ATPase intein involves four highly coordinated reactions that result in precise cleavage and formation of peptide bonds. In this study, we investigated the roles of the last N-extein residue (-1 residue) and the intein penultimate residue in modulating splicing reactions. Most of the 20 amino acid substitutions at the -1 position had no effect on overall protein splicing but could lead to significant accumulation of thioester intermediates when splicing was blocked by mutation. A subset of -1 substitutions attenuated the initiation of protein splicing and enabled us to demonstrate in vitro splicing of a mesophilic intein containing all wild-type catalytic residues. Substitutions involving the intein penultimate residue allowed modulation of the branch resolution and C-terminal cleavage reaction. Our data suggest that the N-S acyl rearrangement, which initiates splicing, may also serve as the rate-limiting step. Through appropriate amino acid substitutions, we were able to modulate splicing reactions in vitro by change in pH or temperature or addition of thiol reagents. Both insertion and deletion were tolerated in the central region of the intein although splicing or structure of the intein may have been affected.	New England Biolabs Inc, Beverly, MA 01915 USA		Chong, SR (corresponding author), New England Biolabs Inc, 32 Tozer Rd, Beverly, MA 01915 USA.		Wood, David W/B-2992-2012	Chong, shaorong/0000-0002-6525-3389				Ando, 1967, METHOD ENZYMOL, V11, P263; ARMSTRONG J, 1983, NUCLEIC ACIDS RES, V11, P7145, DOI 10.1093/nar/11.20.7145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS JE, 1989, NUCLEIC ACIDS RES, V17, P979, DOI 10.1093/nar/17.3.979; BRUICE TC, 1966, BIOORGANIC MECH, V1, P266; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Chong SR, 1997, J BIOL CHEM, V272, P15587, DOI 10.1074/jbc.272.25.15587; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; COOPER AA, 1993, EMBO J, V12, P2575, DOI 10.1002/j.1460-2075.1993.tb05913.x; DAVIS EO, 1994, EMBO J, V13, P699, DOI 10.1002/j.1460-2075.1994.tb06309.x; DAVIS EO, 1992, CELL, V71, P201, DOI 10.1016/0092-8674(92)90349-H; DORNER LF, 1994, NUCLEIC ACIDS RES, V22, P1068, DOI 10.1093/nar/22.6.1068; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; Gimble FS, 1996, J MOL BIOL, V263, P163, DOI 10.1006/jmbi.1996.0567; GIMBLE FS, 1995, J BIOL CHEM, V270, P5849, DOI 10.1074/jbc.270.11.5849; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; GUAN C, 1988, GENE, V67, P21; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; HIRATA R, 1992, BIOCHEM BIOPH RES CO, V188, P40, DOI 10.1016/0006-291X(92)92347-Z; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; MIDGLEY CA, 1985, EMBO J, V4, P2695, DOI 10.1002/j.1460-2075.1985.tb03989.x; Nogami S, 1997, GENETICS, V147, P73; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; SHUB DA, 1992, CELL, V71, P183, DOI 10.1016/0092-8674(92)90345-D; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; XU MQ, 1994, EMBO J, V13, P5517, DOI 10.1002/j.1460-2075.1994.tb06888.x; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	35	142	160	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10567	10577		10.1074/jbc.273.17.10567	http://dx.doi.org/10.1074/jbc.273.17.10567			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553117	hybrid			2022-12-27	WOS:000073224200066
J	Hoffmeyer, A; Avots, A; Flory, E; Weber, CK; Serfling, E; Rapp, UR				Hoffmeyer, A; Avots, A; Flory, E; Weber, CK; Serfling, E; Rapp, UR			The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK/SAPK-activating pathways in T lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; OXIDASE SUBUNIT-IV; PROTEIN-KINASE; TRANSCRIPTION FACTORS; BINDING-PROTEIN; C-JUN; GENE-TRANSCRIPTION; E4TF1 SUBUNITS; ETS; CELLS	T cell activation leads via multiple intracellular signaling pathways to rapid induction of interleukin-a (IL-2) expression, which can be mimicked by costimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA) and ionomycin. We have identified a distal IL-2 enhancer regulated by the Raf-MEK-ERK signaling pathway, which can be induced by TPA/ionomycin treatment. It contains a dyad symmetry element (DSE) controlled by the Ets-like transcription factor GA-binding protein (GABP), a target of activated ERK. TPA/ionomycin treatment of T cells stimulates both mitogen-activated ERK, as well as the stress-activated mitogen-activated protein kinase family members JNK/SAPK and p38. In this study, we investigated the contribution of the stress-activated pathways to the induction of the distal IL-2 enhancer. We show that JNK- but not p38-activating pathways regulate the DSE activity. Furthermore, the JNK/SAPK signaling pathway cooperates with the Raf-MEK-ERK cascade in TPA/ionomycin-induced DSE activity. In T cells, overexpression of SPRK/MLK3, an activator of JNR/SAPK, strongly induces DSE-dependent transcription and dominant negative kinases of SEK and SAPK impair TPA/ionomycin-induced DSE activity. Blocking both ERK and JNK/SAPK pathways abolishes the DSE induction. The inducibility of the DSE is strongly dependent on the Ets-core motifs, which are bound by GABP. Both subunits of GABP are phosphorylated upon JNK activation in vivo and three different isoforms of JNK/SAPK, but not p38, in vitro. Our data suggest that GABP is targeted by signaling events from both ERK and JNK/SAPK pathways. GABP therefore is a candidate for signal integration and regulation of IL-2 transcription in T lymphocytes.	Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, MSZ, D-97078 Wurzburg, Germany; Univ Wurzburg, Inst Pathol, D-97080 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Rapp, UR (corresponding author), Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, MSZ, Versbacher Str 5, D-97078 Wurzburg, Germany.	rappur@rzbox.uni-wuerzburg.de	Serfling, Edgar/X-7212-2019					ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Avots A, 1997, MOL CELL BIOL, V17, P4381, DOI 10.1128/MCB.17.8.4381; BACHMAN NJ, 1995, GENE, V162, P313, DOI 10.1016/0378-1119(95)00329-5; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CARTER RS, 1994, J BIOL CHEM, V269, P4381; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DORN P, 1990, J VIROL, V64, P1616, DOI 10.1128/JVI.64.4.1616-1624.1990; DOUVILLE P, 1995, VIROLOGY, V207, P107, DOI 10.1006/viro.1995.1056; Faris M, 1996, J BIOL CHEM, V271, P27366, DOI 10.1074/jbc.271.44.27366; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Flory E, 1996, J VIROL, V70, P2260, DOI 10.1128/JVI.70.4.2260-2268.1996; Galley Y, 1997, P NATL ACAD SCI USA, V94, P5119, DOI 10.1073/pnas.94.10.5119; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; GUNTHER CV, 1994, MOL CELL BIOL, V14, P7569, DOI 10.1128/MCB.14.11.7569; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Janknecht R, 1996, ONCOGENE, V13, P1745; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Kharbanda S, 1995, J BIOL CHEM, V270, P30278, DOI 10.1074/jbc.270.51.30278; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Ludwig S, 1996, MOL CELL BIOL, V16, P6687; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; OHagan RC, 1996, ONCOGENE, V13, P1323; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Ouyang LH, 1996, J BIOL CHEM, V271, P10425, DOI 10.1074/jbc.271.18.10425; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; RAPP UR, 1994, FOS JUN FAMILY TRANS; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SAWADA J, 1994, EMBO J, V13, P1396, DOI 10.1002/j.1460-2075.1994.tb06393.x; Seko Y, 1997, BIOCHEM BIOPH RES CO, V239, P840, DOI 10.1006/bbrc.1997.7570; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; SGOURAS DN, 1995, EMBO J, V14, P4781, DOI 10.1002/j.1460-2075.1995.tb00160.x; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; WATANABE H, 1993, MOL CELL BIOL, V13, P1385, DOI 10.1128/MCB.13.3.1385; WHITEHURST CE, 1995, J BIOL CHEM, V270, P5594, DOI 10.1074/jbc.270.10.5594; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106	58	56	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10112	10119		10.1074/jbc.273.17.10112	http://dx.doi.org/10.1074/jbc.273.17.10112			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553058	hybrid			2022-12-27	WOS:000073224200007
J	Resnicoff, M; Valentinis, B; Herbert, D; Abraham, D; Friesen, PD; Alnemri, ES; Baserga, R				Resnicoff, M; Valentinis, B; Herbert, D; Abraham, D; Friesen, PD; Alnemri, ES; Baserga, R			The baculovirus anti-apoptotic p35 protein promotes transformation of mouse embryo fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; PROGRAMMED CELL-DEATH; FACTOR RECEPTOR; CAENORHABDITIS-ELEGANS; INSECT CELLS; TUMOR-CELLS; TUMORIGENESIS; INHIBITION; GENE; EXPRESSION	The baculovirus p35 protein is a potent inhibitor of programmed cell death induced by a variety of stimuli in insects, nematodes, and mammalian cell lines. The broad ability of p35 in preventing apoptosis has led us to investigate its effect on mouse embryo fibroblasts in vitro and in vivo. For this purpose, we have used R- cells (3T3-like fibroblasts derived from mouse embryos with a targeted disruption of the insulin-like growth factor I receptor (IGF-IR) genes) and R508 cells (derived from R- and with 15 x 10(3) IGF-IRs per cell), Both cell lines grow normally in monolayer, but they do not form colonies in soft agar, and they are non-tumorigenic in nude mice. We show here that, in addition to its anti-apoptotic effect, p35 causes transformation of R508 cells, as evidenced by the following: 1) decreased growth factor requirements, 2) ability to form foci in monolayer and colonies in soft agar, and 3) ability to form tumors in nude mice. Since R- cells stably transfected with p35 do not transform, our observations suggest that in addition to its effect as an inhibitor of apoptosis, the baculovirus p35 protein has transforming potential that requires the presence of the IGF-IR. The possibility that these two properties could be separated was confirmed by demonstrating that R508 cells expressing another anti-apoptotic protein, Bcl-2, could not form tumors in nude mice.	Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA	Jefferson University; University of Wisconsin System; University of Wisconsin Madison	Resnicoff, M (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Bluemle Life Sci Bldg,Rm 606,233 S 10th St, Philadelphia, PA 19107 USA.		Alnemri, Emad S/B-4526-2010	Herbert, De'Broski/0000-0002-2449-5365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033694] Funding Source: NIH RePORTER; NIA NIH HHS [AG 00378] Funding Source: Medline; NIGMS NIH HHS [GM 33694] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baserga R, 1997, VITAM HORM, V53, P65, DOI 10.1016/S0083-6729(08)60704-9; BEIDLER DR, 1995, J BIOL CHEM, V270, P16526, DOI 10.1074/jbc.270.28.16526; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; CARTIER JL, 1994, J VIROL, V68, P7728, DOI 10.1128/JVI.68.12.7728-7737.1994; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; DAmbrosio C, 1997, CANCER RES, V57, P3264; DAmbrosio C, 1996, CANCER RES, V56, P4013; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; HAY BA, 1994, DEVELOPMENT, V120, P2121; HERSHBERGER PA, 1994, J VIROL, V68, P3467, DOI 10.1128/JVI.68.6.3467-3477.1994; JUNG JK, 1997, ONCOGENE, V14, P1207; Jung YK, 1996, J BIOL CHEM, V271, P5112; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; KORSMEYER SJ, 1992, BLOOD, V80, P879; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; MARTINOU I, 1995, J CELL BIOL, V128, P201, DOI 10.1083/jcb.128.1.201; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; MORRIONE A, 1995, J VIROL, V69, P5300, DOI 10.1128/JVI.69.9.5300-5303.1995; Nunez Gabriel, 1994, Trends in Cell Biology, V4, P399, DOI 10.1016/0962-8924(94)90053-1; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Parrizas M, 1997, J BIOL CHEM, V272, P154; PORCU P, 1992, MOL CELL BIOL, V12, P5069, DOI 10.1128/MCB.12.11.5069; PRAGER D, 1994, P NATL ACAD SCI USA, V91, P2181, DOI 10.1073/pnas.91.6.2181; Prisco M, 1997, MOL CELL BIOL, V17, P1084, DOI 10.1128/MCB.17.3.1084; RABIZADEH S, 1993, J NEUROCHEM, V61, P2318, DOI 10.1111/j.1471-4159.1993.tb07477.x; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; RESNICOFF M, 1994, CANCER RES, V54, P2218; RESNICOFF M, 1994, CANCER RES, V54, P4848; RESNICOFF M, 1995, CANCER RES, V55, P3739; RESNICOFF M, 1995, CANCER RES, V55, P2463; Robertson NM, 1997, CANCER RES, V57, P43; Rubini M, 1997, EXP CELL RES, V230, P284, DOI 10.1006/excr.1996.3430; SELL C, 1995, CANCER RES, V55, P303; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Singleton JR, 1996, CANCER RES, V56, P4522; Singleton JR, 1996, J BIOL CHEM, V271, P31791, DOI 10.1074/jbc.271.50.31791; SUGIMOTO A, 1994, EMBO J, V13, P2023, DOI 10.1002/j.1460-2075.1994.tb06475.x; Valentinis B, 1997, MOL CELL BIOL, V17, P3744, DOI 10.1128/MCB.17.7.3744; VARA JA, 1986, NUCLEIC ACIDS RES, V14, P4617, DOI 10.1093/nar/14.11.4617; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; Wu YL, 1996, J CELL PHYSIOL, V168, P499, DOI 10.1002/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0	48	15	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10376	10380		10.1074/jbc.273.17.10376	http://dx.doi.org/10.1074/jbc.273.17.10376			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553094	Green Published, hybrid			2022-12-27	WOS:000073224200043
J	Vega, FV; Vidal, A; Hellman, U; Wernstedt, C; Dominguez, F				Vega, FV; Vidal, A; Hellman, U; Wernstedt, C; Dominguez, F			Prothymosin alpha stimulates Ca2+-dependent phosphorylation of elongation factor 2 in cellular extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MR 100,000 SUBSTRATE; FACTOR-II; MESSENGER-RNA; RAT THYMUS; C-MYC; CELLS; EXPRESSION; GENE; CALMODULIN	Prothymosin alpha (PTA) stimulates in a dose-dependent manner the phosphorylation of a 105-kDa protein (p105) in cell extracts from different cell types. Protein sequencing and immunological analysis indicated that this protein is elongation factor 2 (EF-2), We propose that calcium/calmodulin-dependent protein kinase III is responsible for the PTA-dependent EF-2 phosphorylation based on the following lines of evidence: (a) Ca2+ is required for the effect; (b) calmodulin enhances the reaction, and calmodulin inhibitors block the phosphorylation; and (c) no phosphorylation is seen in cell extracts depleted of calmodulin-binding proteins. To obtain a strong phosphorylated EF-2 band, we found it necessary to add PTA to cytosolic extracts from synchronized dividing cells in various phases of the cell cycle except in mitosis. Since PTA is a nuclear protein everywhere in the cell cycle except in mitosis, when it is found in the cytoplasm, we hypothesize that, if PTA activates EF-2 phosphorylation in vivo, as present data suggest, its presence in the cytoplasm during mitosis could explain why EF-2 phosphorylation is mainly restricted to that phase of the cell cycle. Moreover, other bands in addition to EF-2 were phosphorylated in a calmodulin-and PTA-dependent manner, and several of them (in a range between 50 and 60 kDa) have similar M-r, to those that conform to the holoenzyme calcium/calmodulin dependent protein kinase II, suggesting that PTA could have a more general function modulating the activity of various Ca2+/CaM-dependent enzymes along the cell cycle.	Univ Santiago, Fac Med, Dept Fisiol, Labs Neurociencia Ramon Dominguez, Santiago 15705, Spain; Fac Vet, Dept Fisiol, Lugo, Spain; INGO, Unidad Med Mol, Santiago De Compostela 15705, Spain; Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Ludwig Institute for Cancer Research	Dominguez, F (corresponding author), Univ Santiago, Fac Med, Dept Fisiol, Labs Neurociencia Ramon Dominguez, Santiago 15705, Spain.		Vidal, Anxo/B-5010-2015	Vidal, Anxo/0000-0002-0866-4202				ALVAREZ CV, 1993, J MOL ENDOCRINOL, V11, P249, DOI 10.1677/jme.0.0110249; BAGAGLIO DM, 1993, CANCER RES, V53, P2260; BARCIA MG, 1993, J BIOL CHEM, V268, P4704; BRADY MJ, 1990, J NEUROCHEM, V54, P1034, DOI 10.1111/j.1471-4159.1990.tb02354.x; CELIS JE, 1990, P NATL ACAD SCI USA, V87, P4231, DOI 10.1073/pnas.87.11.4231; CONTEAS CN, 1990, P NATL ACAD SCI USA, V87, P3269, DOI 10.1073/pnas.87.9.3269; Desbarats L, 1996, GENE DEV, V10, P447, DOI 10.1101/gad.10.4.447; DOMINGUEZ F, 1993, EUR J CANCER, V29A, P893, DOI 10.1016/S0959-8049(05)80433-2; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; ESCHENFELDT WH, 1986, P NATL ACAD SCI USA, V83, P9403, DOI 10.1073/pnas.83.24.9403; FRAGA M, 1993, VIRCHOWS ARCH A, V423, P449, DOI 10.1007/BF01606534; GALLEGO R, 1992, ACTA ANAT, V143, P219; GARCIACABALLERO T, 1994, ANAT RECORD, V239, P88, DOI 10.1002/ar.1092390110; GAUBATZ S, 1994, MOL CELL BIOL, V14, P3853, DOI 10.1128/MCB.14.6.3853; GOMEZMARQUEZ J, 1989, J BIOL CHEM, V264, P8451; GOMEZMARQUEZ J, 1988, FEBS LETT, V226, P217, DOI 10.1016/0014-5793(88)81425-X; GOODALL GJ, 1986, P NATL ACAD SCI USA, V83, P8926, DOI 10.1073/pnas.83.23.8926; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; HARITOS AA, 1985, P NATL ACAD SCI USA, V82, P343, DOI 10.1073/pnas.82.2.343; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Lutz W, 1996, ONCOGENE, V13, P803; MANROW RE, 1991, J BIOL CHEM, V266, P3916; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; MOL PC, 1995, MOL CELL BIOL, V15, P6999; MORI M, 1993, ONCOGENE, V8, P2821; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; NAIRN AC, 1994, SEMIN CANCER BIOL, V5, P295; ROSON E, 1990, HISTOCHEMISTRY, V94, P597; ROSON E, 1990, J HISTOCHEM CYTOCHEM, V38, P1889, DOI 10.1177/38.12.2254650; ROSON E, 1993, HISTOCHEM J, V25, P497, DOI 10.1007/BF00159285; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sburlati A R, 1990, Protein Expr Purif, V1, P184, DOI 10.1016/1046-5928(90)90014-P; SBURLATI AR, 1991, P NATL ACAD SCI USA, V88, P253, DOI 10.1073/pnas.88.1.253; SBURLATI AR, 1993, BIOCHEMISTRY-US, V32, P4587, DOI 10.1021/bi00068a015; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TSITSILONI OE, 1993, P NATL ACAD SCI USA, V90, P9504, DOI 10.1073/pnas.90.20.9504; Vareli K, 1996, EUR J BIOCHEM, V238, P799, DOI 10.1111/j.1432-1033.1996.0799w.x; ZALVIDE JB, 1992, J BIOL CHEM, V267, P8692	39	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10147	10152		10.1074/jbc.273.17.10147	http://dx.doi.org/10.1074/jbc.273.17.10147			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553062	hybrid			2022-12-27	WOS:000073224200011
J	Yaich, L; Ooi, J; Park, M; Borg, JP; Landry, C; Bodmer, R; Margolis, B				Yaich, L; Ooi, J; Park, M; Borg, JP; Landry, C; Bodmer, R; Margolis, B			Functional analysis of the Numb phosphotyrosine-binding domain using site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL FATES; INSULIN-RECEPTOR; DROSOPHILA; SHC; PROTEIN; NOTCH; DISTINCT; EXPRESSION; GENE	The Numb protein is involved in cell fate determination during Drosophila neural development. Numb has a protein domain homologous to the phosphotyrosine-binding domain (PTB) in the adaptor protein She. In She, this domain interacts with specific phosphotyrosine containing motifs on receptor tyrosine kinases and other signaling molecules. Residues N-terminal to the phosphotyrosine are also crucial for phosphopeptide binding to the She PTB domain. Several amino acid residues in She have been implicated by site-directed mutagenesis to be critical for She binding to receptor tyrosine kinases, We have generated homologous mutations in Numb to test whether, in vivo, these changes affect Numb function during Drosophila sensory organ development, Two independent amino acid changes that interfere with She binding to phosphotyrosine residues do not affect Numb activity in vivo, In contrast, a mutation shown to abrogate the ability of the She PTB domain to bind residues upstream of the phosphotyrosine virtually eliminates Numb function. Similar results were observed in vitro by examining the binding of the Numb PTB domain to proteins from Schneider S2 cells. Our data confirm the importance of the PTB domain for Numb function but strongly suggest that the Numb PTB domain is not involved in phosphotyrosine-dependent interactions.	Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med & Biol Chem, Ann Arbor, MI 48109 USA; NYU, Med Ctr, Dept Pharmacol, New York, NY 10016 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University	Bodmer, R (corresponding author), Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA.	rolf@umich.edu	Borg, Jean-Paul/AAX-8096-2020	Borg, Jean-Paul/0000-0001-8418-3382; Yaich, Lauren/0000-0001-6998-5141	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029119] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29119] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; Blaikie PA, 1997, J BIOL CHEM, V272, P20671, DOI 10.1074/jbc.272.33.20671; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Borg JP, 1996, MOL CELL BIOL, V16, P6229; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; CamposOrtega JA, 1996, NEURON, V17, P1, DOI 10.1016/S0896-6273(00)80274-3; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; DIKIC I, 1995, J BIOL CHEM, V270, P15125, DOI 10.1074/jbc.270.25.15125; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; GREIG S, 1993, NATURE, V362, P630, DOI 10.1038/362630a0; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Gustafson K, 1996, GENOME, V39, P174, DOI 10.1139/g96-023; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Isakoff SJ, 1996, J BIOL CHEM, V271, P3959; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; Li SC, 1997, P NATL ACAD SCI USA, V94, P7204, DOI 10.1073/pnas.94.14.7204; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Margolis B, 1996, J LAB CLIN MED, V128, P235, DOI 10.1016/S0022-2143(96)90022-0; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RON D, 1992, BIOTECHNIQUES, V13, P866; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3489; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VANGEER P, 1996, P NATL ACAD SCI USA, V93, P963; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Vervoort M, 1997, CURR OPIN NEUROBIOL, V7, P21, DOI 10.1016/S0959-4388(97)80116-X; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yajnik V, 1996, J BIOL CHEM, V271, P1813, DOI 10.1074/jbc.271.4.1813; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	41	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10381	10388		10.1074/jbc.273.17.10381	http://dx.doi.org/10.1074/jbc.273.17.10381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553095	hybrid			2022-12-27	WOS:000073224200044
J	Yamagata, K; Murayama, K; Okabe, M; Toshimori, K; Nakanishi, T; Kashiwabara, S; Baba, T				Yamagata, K; Murayama, K; Okabe, M; Toshimori, K; Nakanishi, T; Kashiwabara, S; Baba, T			Acrosin accelerates the dispersal of sperm acrosomal proteins during acrosome reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG SPERM; MOUSE SPERM; ZONA-PELLUCIDA; MONOCLONAL-ANTIBODY; HYALURONIDASE; LOCALIZATION; SPERMATOZOA; ACTIVATION; MATURATION; PROTEASE	Using homologous recombination, we have previously produced male mice carrying a disruptive mutation (Acr(-/-)) in the acrosin gene. Although Acr(-/-)mouse sperm lacking the acrosin protease activity still penetrated the zona pellucida and fertilized the egg, the mutant sperm exhibited a delay in penetration of the zona pellucida solely at the early stages after insemination. To further elucidate the role of acrosin in fertilization, we have examined the involvement of acrosin in the acrosome reaction of sperm using the Acr(-/-)mutant mice. When the ability of sperm to adhere (attach) and bind to the zona pellucida of cumulus-free eggs was assessed in vitro, no significant difference was observed among Acr(+/+), Acr(+/-), and Acr(-/-)mouse sperm. Immunocytochemical analysis demonstrated that the release of several acrosomal proteins from the acrosome of Acr(-/-)mouse sperm was significantly delayed during the calcium ionophore-and solubilized zona pellucida-induced acrosome reaction, despite normal membrane vesiculation. These data indicate that the delayed sperm penetration of the zona pellucida in the Acr(-/-)mouse results from the altered rate of protein dispersal from the acrosome and provide the first evidence that the major role of acrosin is to accelerate the dispersal of acrosomal components during acrosome reaction.	Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan; Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058572, Japan; Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Miyazaki Med Coll, Dept Anat, Miyazaki 8891692, Japan	University of Tsukuba; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University; University of Miyazaki	Baba, T (corresponding author), Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan.	acroman@sakura.cc.tsukuba.ac.jp	Okabe, Masaru/B-6917-2015	Okabe, Masaru/0000-0002-0803-9044				Adham IM, 1997, MOL REPROD DEV, V46, P370, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;370::AID-MRD16&gt;3.0.CO;2-2; BABA T, 1989, J BIOL CHEM, V264, P11920; BABA T, 1994, J BIOL CHEM, V269, P31845; CHENG A, 1994, J CELL BIOL, V125, P867, DOI 10.1083/jcb.125.4.867; DEVRIES JWA, 1985, EUR J CELL BIOL, V37, P81; DICARLANTONIO G, 1988, GAMETE RES, V21, P425, DOI 10.1002/mrd.1120210410; ENDO Y, 1988, DEV BIOL, V129, P12, DOI 10.1016/0012-1606(88)90157-1; Foster JA, 1997, J BIOL CHEM, V272, P12714, DOI 10.1074/jbc.272.19.12714; FRASER LR, 1982, J REPROD FERTIL, V65, P185, DOI 10.1530/jrf.0.0650185; GREEN DPL, 1978, J CELL SCI, V32, P137; GREEN DPL, 1978, J CELL SCI, V32, P153; HARDY DM, 1991, BIOCHEM J, V275, P759, DOI 10.1042/bj2750759; HEDRICK JL, 1989, BIOCATALYSIS AGR BIO, P215; HSU SM, 1982, J HISTOCHEM CYTOCHEM, V30, P1079, DOI 10.1177/30.10.6182185; HUANG TTF, 1985, BIOL REPROD, V32, P451, DOI 10.1095/biolreprod32.2.451; Hunnicutt CR, 1996, BIOL REPROD, V55, P80, DOI 10.1095/biolreprod55.1.80; Hunnicutt GR, 1996, BIOL REPROD, V54, P1343, DOI 10.1095/biolreprod54.6.1343; KAWAI Y, 1989, J REPROD IMMUNOL, V16, P71, DOI 10.1016/0165-0378(89)90007-7; KLEMM U, 1991, HUM GENET, V87, P635; MEIZEL S, 1976, J EXP ZOOL, V195, P137, DOI 10.1002/jez.1401950113; NOLAND TD, 1994, J BIOL CHEM, V269, P32607; NOLAND TD, 1989, J BIOL CHEM, V264, P13586; OKABE M, 1986, J REPROD IMMUNOL, V9, P67, DOI 10.1016/0165-0378(86)90026-4; OLSON GE, 1987, GAMETE RES, V17, P77, DOI 10.1002/mrd.1120170109; TALBOT P, 1985, J HISTOCHEM CYTOCHEM, V33, P1169, DOI 10.1177/33.11.4056380; TOSHIMORI K, 1995, MOL REPROD DEV, V42, P72, DOI 10.1002/mrd.1080420110; TOYADA Y, 1971, JPN J ANIMAL REPROD, V16, P147; WESTBROOKCASE VA, 1994, BIOL REPROD, V51, P1, DOI 10.1095/biolreprod51.1.1; Yanagimachi R., 1994, P189	29	146	150	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10470	10474		10.1074/jbc.273.17.10470	http://dx.doi.org/10.1074/jbc.273.17.10470			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553106	hybrid			2022-12-27	WOS:000073224200055
J	Darboux, I; Lingueglia, E; Champigny, G; Coscoy, S; Barbry, P; Lazdunski, M				Darboux, I; Lingueglia, E; Champigny, G; Coscoy, S; Barbry, P; Lazdunski, M			dGNaC1, a gonad-specific amiloride-sensitive Na+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; CAENORHABDITIS-ELEGANS; HOMOLOGOUS SUBUNITS; DROSOPHILA; TRANSPORT; FERTILIZATION; CLONING; EGGS; GENE; ELECTROPHORESIS	Amiloride-sensitive sodium channels have been implicated in reproductive and early developmental processes of several species. These include the fast block of polyspermy in Xenopus oocytes that follows the sperm binding to the egg or blastocoel expansion in mammalian embryo. We have now identified a gene called dGNaC1 that is specifically expressed in the gonads and early embryo in Drosophila melanogaster. The corresponding protein belongs to the superfamily of cationic channels blocked by amiloride that includes Caenorhabditis elegans degenerins, the Helix aspersa FMRF-amide ionotropic receptor (FaNaC), the mammalian epithelial Na+ channel (ENaC), and acid-sensing ionic channels (ASIC, DRASIC, and MDEG). Expression of dGNaC1 in Xenopus oocytes generates a constitutive current that does not discriminate between Na+ and Li+, but is selective for Na+ over K+. This current is blocked by amiloride (IC50 = 24 mu M), benzamil (IC50 = 2 mu M), and ethylisopropyl amiloride (IC50 = 49 mu M). These properties are clearly different from those obtained after expression of the previously cloned members of this family, including ENaC and the human alpha ENaC-like subunit, delta NaC. Interestingly, the pharmacology of dGNaC1 is not very different from that found for the Na+ channel characterized in rabbit preimplantation embryos. We postulate that this channel may participate in gametogenesis and early embryonic development in Drosophila.	CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lazdunski, M (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, 660 Route Lucioles, F-06560 Valbonne, France.		Barbry, Pascal/O-5021-2016; LINGUEGLIA, Eric/F-5509-2013	Barbry, Pascal/0000-0001-9632-6483; LINGUEGLIA, Eric/0000-0003-3902-3405; Coscoy, Sylvie/0000-0003-3963-3609; Darboux, Isabelle/0000-0003-4990-8856				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Barbry P, 1997, AM J PHYSIOL-GASTR L, V273, pG571, DOI 10.1152/ajpgi.1997.273.3.G571; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Benos D J, 1985, Soc Gen Physiol Ser, V39, P211; BIGGERS JD, 1988, AM J PHYSIOL, V255, pC419, DOI 10.1152/ajpcell.1988.255.4.C419; BOHRMANN J, 1987, DEVELOPMENT, V101, P279; CAMERON IL, 1982, EXP CELL RES, V139, P455, DOI 10.1016/0014-4827(82)90279-8; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORNELL JC, 1984, COMP BIOCHEM PHYS A, V78, P463, DOI 10.1016/0300-9629(84)90579-6; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; DARBOUX I, 1998, IN PRESS BIOCH BIOPH; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Epel D, 1980, Ann N Y Acad Sci, V339, P74, DOI 10.1111/j.1749-6632.1980.tb15970.x; EPEL D, 1990, CELL DIFFER DEV, V29, P1, DOI 10.1016/0922-3371(90)90019-S; Foe Victoria E., 1993, P149; Fuller Margaret T., 1993, P71; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Jeunemaitre X, 1997, J HYPERTENS, V15, P1091, DOI 10.1097/00004872-199715100-00007; King R. C., 1970, OVARIAN DEV DROSOPHI; KUPITZ Y, 1993, SCIENCE, V261, P484, DOI 10.1126/science.8392753; LAFLEUR GJ, 1991, J EXP ZOOL, V258, P126, DOI 10.1002/jez.1402580114; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; LINGUEGLIA E, 1994, J BIOL CHEM, V269, P13736; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; MAHOWALD AP, 1983, DEV BIOL, V98, P437, DOI 10.1016/0012-1606(83)90373-1; MANEJWALA FM, 1989, DEV BIOL, V133, P210, DOI 10.1016/0012-1606(89)90312-6; MCCAIG CD, 1982, DEV BIOL, V90, P335, DOI 10.1016/0012-1606(82)90382-7; NOSELLI S, 1992, GENE, V118, P273, DOI 10.1016/0378-1119(92)90199-Y; OVERALL R, 1985, DEV BIOL, V108, P102, DOI 10.1016/0012-1606(85)90013-2; POWERS RD, 1977, NATURE, V270, P603, DOI 10.1038/270603a0; RENARD S, 1994, J BIOL CHEM, V269, P12981; ROBINSON DH, 1991, DEV BIOL, V147, P313, DOI 10.1016/0012-1606(91)90289-F; SHEN SS, 1985, J CELL BIOL, V101, P420, DOI 10.1083/jcb.101.2.420; SHI R, 1994, DEV BIOL, V165, P105, DOI 10.1006/dbio.1994.1238; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Spradling Allan C., 1993, P1; Tates A.D., 1971, CYTODIFFERENTIATION; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALDMANN R, 1995, J BIOL CHEM, V270, P11735, DOI 10.1074/jbc.270.20.11735; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; WEBER WM, 1993, J COMP PHYSIOL B, V163, P153; WOODRUFF RI, 1980, NATURE, V286, P84, DOI 10.1038/286084a0	53	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9424	9429		10.1074/jbc.273.16.9424	http://dx.doi.org/10.1074/jbc.273.16.9424			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545267	hybrid			2022-12-27	WOS:000073128800013
J	Pohl, M; Wank, SA				Pohl, M; Wank, SA			Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard - Relationship to vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide and glucagon-like peptide 1 and evidence against the existence of mammalian homologues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIN-RELEASING PEPTIDE; GILA MONSTER VENOM; AMINO-ACID-SEQUENCES; GUINEA-PIG PANCREAS; THYROID C-CELLS; PROLINE ENDOPEPTIDASE; AMPHIBIAN BOMBESIN; DISPERSED ACINI; NEUROMEDIN-B; RAT	Helodermin and exendin-4, two peptides isolated from the salivary gland of the Gila monster, Heloderma suspectum, are approximately 50% homologous to vasoactive intestinal peptide (VIP) and glucagon-like peptide-1 (GLP-1), respectively, and interact with the mammalian receptors for VIP and GLP-1 with equal or higher affinity and efficacy, Immunohistochemical studies suggested the presence of helodermin-like peptides in mammals. To determine whether helodermin and exendin-4 are present in mammals and their evolutionary relationship to VIP and GLP-1, their cDNAs were first cloned from Gila monster salivary gland. Northern blots and reverse transcription-polymerase chain reaction of multiple Gila monster tissues identified similar to 500-base pair transcripts only from salivary gland. Both helodermin and exendin-4 full-length cDNAs were similar to 500 base pairs long, and they encoded precursor proteins containing the entire amino acid sequence of helodermin and exendin-4, as well as a 44- or 45-amino acid N-terminal extension peptide, respectively, having similar to 60% homology, The size and structural organization of these cDNAs indicated that they were closely related to one another but markedly different from known cDNAs for the VIP/GLP-1 peptide family previously identified in both lower and higher evolved species. Cloning of the Gila monster VIP/peptide histidine isoleucine, pituitary adenylate cyclase activating polypeptide, and glucagon/GLP-1 cDNAs and Southern blotting of Gila monster DNA demonstrate the coexistence of separate genes for these peptides and suggests, along with the restricted salivary gland expression, that helodermin and exendin-4 coevolved to serve a separate specialized function. Probing of a variety of rat and human tissues on Northern blots, human and rat Southern blots, and genomic and cDNA libraries with either helodermin-or exendin-4-specific cDNAs failed to identify evidence for mammalian homologues, These data indicate that helodermin and exendin-4 are not the precursors to VIP and GLP-1 and that they belong to a separate peptide family encoded by separate genes. Furthermore, the existence of as yet undiscovered mammalian homologues to helodermin and exendin-4 seems unlikely.	NIDDK, Digest Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wank, SA (corresponding author), NIDDK, Digest Dis Branch, NIH, Bldg 10,Rm 9C-103, Bethesda, MD 20892 USA.							ANDREWS PC, 1980, BIOCHEMISTRY-US, V19, P5494, DOI 10.1021/bi00565a005; BERTACCINI G, 1976, PHARMACOL REV, V28, P127; BJARTELL A, 1989, REGUL PEPTIDES, V26, P27, DOI 10.1016/0167-0115(89)90101-8; Chen YQE, 1997, J BIOL CHEM, V272, P4108, DOI 10.1074/jbc.272.7.4108; DIMALINE R, 1988, ANN NY ACAD SCI, V527, P621; DRUCKER DJ, 1988, J BIOL CHEM, V263, P13475; ENG J, 1992, J BIOL CHEM, V267, P7402; FEHMANN HC, 1994, PEPTIDES, V15, P453, DOI 10.1016/0196-9781(94)90204-6; FEURLE GE, 1992, J BIOL CHEM, V267, P22305; GOKE R, 1993, J BIOL CHEM, V268, P19650; GOURLET P, 1991, BIOCHIM BIOPHYS ACTA, V1066, P245, DOI 10.1016/0005-2736(91)90193-C; GRUNDITZ T, 1989, P NATL ACAD SCI USA, V86, P1357, DOI 10.1073/pnas.86.4.1357; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; HEINRICH G, 1984, ENDOCRINOLOGY, V115, P2176, DOI 10.1210/endo-115-6-2176; HOSHINO M, 1984, FEBS LETT, V178, P233, DOI 10.1016/0014-5793(84)80607-9; IRWIN DM, 1995, MOL ENDOCRINOL, V9, P267, DOI 10.1210/me.9.3.267; IWASAKI S, 1995, J BIOL CHEM, V270, P6997, DOI 10.1074/jbc.270.12.6997; KARN RC, 1993, BIOCHEM GENET, V31, P307, DOI 10.1007/BF00553173; KIMURA C, 1990, BIOCHEM BIOPH RES CO, V166, P81, DOI 10.1016/0006-291X(90)91914-E; KOHAN DE, 1993, AM J PHYSIOL, V265, pF670, DOI 10.1152/ajprenal.1993.265.5.F670; KRANE IM, 1988, J BIOL CHEM, V263, P13317; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; MCFARLIN DR, 1995, GENE, V154, P211, DOI 10.1016/0378-1119(94)00856-N; MCRORY JE, 1995, MOL CELL ENDOCRINOL, V108, P169, DOI 10.1016/0303-7207(94)03467-8; MINAMINO N, 1983, BIOCHEM BIOPH RES CO, V114, P541, DOI 10.1016/0006-291X(83)90814-8; Moro O, 1997, J BIOL CHEM, V272, P966, DOI 10.1074/jbc.272.2.966; NAGALLA SR, 1992, J BIOL CHEM, V267, P6916; NISHIZAWA M, 1985, FEBS LETT, V183, P55, DOI 10.1016/0014-5793(85)80953-4; OGI K, 1990, BIOCHEM BIOPH RES CO, V173, P1271, DOI 10.1016/S0006-291X(05)80924-6; PARKER DS, 1984, J BIOL CHEM, V259, P1751; Raufman JP, 1996, REGUL PEPTIDES, V61, P1, DOI 10.1016/0167-0115(96)00135-8; RAUFMAN JP, 1982, AM J PHYSIOL, V242, pG470, DOI 10.1152/ajpgi.1982.242.5.G470; ROBBERECHT P, 1985, FEBS LETT, V190, P142, DOI 10.1016/0014-5793(85)80445-2; ROBBERECHT P, 1985, BIOCHEM BIOPH RES CO, V130, P333, DOI 10.1016/0006-291X(85)90422-X; SCHEPP W, 1994, EUR J PHARM-MOLEC PH, V269, P183, DOI 10.1016/0922-4106(94)90085-X; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; Shima K, 1996, REGUL PEPTIDES, V63, P99; SPINDEL ER, 1990, P NATL ACAD SCI USA, V87, P9813, DOI 10.1073/pnas.87.24.9813; TAKASAKI C, 1992, BIOCHEM BIOPH RES CO, V189, P1527, DOI 10.1016/0006-291X(92)90249-K; TAYLOR WL, 1980, BIOCHEM BIOPH RES CO, V94, P9, DOI 10.1016/S0006-291X(80)80179-3; TSUTSUMI Y, 1990, REGUL PEPTIDES, V31, P11, DOI 10.1016/0167-0115(90)90191-X; VANDERMEEERS A, 1987, EUR J BIOCHEM, V164, P321, DOI 10.1111/j.1432-1033.1987.tb11061.x; WANG YX, 1993, PEPTIDES, V14, P573, DOI 10.1016/0196-9781(93)90147-9; WILLIAMS DL, 1991, BIOCHEM BIOPH RES CO, V175, P556, DOI 10.1016/0006-291X(91)91601-8	45	56	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9778	9784		10.1074/jbc.273.16.9778	http://dx.doi.org/10.1074/jbc.273.16.9778			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545315	hybrid			2022-12-27	WOS:000073128800061
J	Vestner, B; Bustin, M; Gruss, C				Vestner, B; Bustin, M; Gruss, C			Stimulation of replication efficiency of a chromatin template by chromosomal protein HMG-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN VIRUS-40 DNA; HISTONE ACETYLATION; T-ANTIGEN; MULTIPLE FUNCTIONS; NUCLEOSOMAL DNA; XENOPUS EGGS; TRANSCRIPTION; COMPLEX; INVITRO; CELLS	The effect of chromosomal protein HMG-17 on the replication of a chromatin template was studied with minichromosomes containing the SV40 origin of replication. The minichromosomes were assembled from M13 DNA in Xenopus egg extracts in either the absence or presence of HMG-17. Structural data show that HMG-17 was efficiently incorporated into the chromatin and induced an extended chromatin structure. Using an in vitro SV40 replication system, we find that minichromosomes containing HMG-17 replicate with higher efficiency than minichromosomes deficient of HMG-17. The replicational potential of chromatin was enhanced only when HMG-17 was incorporated into the template during, but not after, chromatin assembly. HMG-17 stimulated replication only from a chromatin template, but not from protein-free DNA. Thus, HMG-17 protein enhances the rate of replication of a chromatin template by unfolding the higher order chromatin structure and increasing the accessibility of target sequences to components of the replication machinery.	Univ Konstanz, Div Biol, D-78457 Konstanz, Germany; NCI, Mol Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	University of Konstanz; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gruss, C (corresponding author), Univ Konstanz, Div Biol, Univ Str 10, D-78457 Konstanz, Germany.		Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242				Alexiadis V, 1997, CHROMOSOMA, V105, P324; ALMOUZNI G, 1988, EMBO J, V7, P665, DOI 10.1002/j.1460-2075.1988.tb02861.x; ALMOUZNI G, 1990, NUCLEIC ACIDS RES, V18, P5767, DOI 10.1093/nar/18.19.5767; ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; ALMOUZNI G, 1988, EMBO J, V7, P4355, DOI 10.1002/j.1460-2075.1988.tb03334.x; BUSTIN M, 1991, NUCLEIC ACIDS RES, V19, P3115, DOI 10.1093/nar/19.11.3115; BUSTIN M, 1995, SEMIN CELL BIOL, V6, P247, DOI 10.1006/scel.1995.0033; BUSTIN M, 1990, J BIOL CHEM, V265, P20077; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CHENG LH, 1989, CELL, V59, P541, DOI 10.1016/0092-8674(89)90037-8; CRIPPA MP, 1993, EMBO J, V12, P3855, DOI 10.1002/j.1460-2075.1993.tb06064.x; CSORDAS A, 1990, BIOCHEM J, V265, P23, DOI 10.1042/bj2650023; DAVIE JR, 1994, J CELL BIOCHEM, V55, P98, DOI 10.1002/jcb.240550112; Depamphilis Melvin L., 1993, Trends in Cell Biology, V3, P161, DOI 10.1016/0962-8924(93)90137-P; DING HF, 1994, SCIENCE, V265, P796, DOI 10.1126/science.8047885; DRUCKMANN S, 1986, EXP CELL RES, V166, P486, DOI 10.1016/0014-4827(86)90493-3; FELSENFELD G, 1996, CELL, V86, P16; GRAZIANO V, 1990, J MOL BIOL, V214, P897, DOI 10.1016/0022-2836(90)90344-L; GRUNSTEIN M, 1990, TRENDS GENET, V6, P395, DOI 10.1016/0168-9525(90)90299-L; GRUSS C, 1993, EMBO J, V12, P4533, DOI 10.1002/j.1460-2075.1993.tb06142.x; Gruss Claudia, 1996, V52, P337; Halmer L, 1997, MOL CELL BIOL, V17, P2624, DOI 10.1128/MCB.17.5.2624; Halmer L, 1996, NUCLEIC ACIDS RES, V24, P1420, DOI 10.1093/nar/24.8.1420; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; KRUDE T, 1991, MOL CELL BIOL, V11, P6257, DOI 10.1128/MCB.11.12.6257; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANFORD RE, 1988, VIROLOGY, V167, P72, DOI 10.1016/0042-6822(88)90055-4; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LOIDL P, 1994, CHROMOSOMA, V103, P441; MADRIAN JK, 1980, SCIENCE, V209, P1534; Maniatis T., 1982, MOL CLONING LAB MANU; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; PARANJAPE SM, 1995, GENE DEV, V9, P1978, DOI 10.1101/gad.9.16.1978; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; POSTNIKOV YV, 1991, NUCLEIC ACIDS RES, V19, P717, DOI 10.1093/nar/19.4.717; Quintini G, 1996, MOL CELL BIOL, V16, P2888; SIMANIS V, 1985, VIROLOGY, V144, P88, DOI 10.1016/0042-6822(85)90308-3; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; SVAREN J, 1993, CURR OPIN GENET DEV, V3, P219, DOI 10.1016/0959-437X(93)90026-L; Svaren J, 1996, CURR OPIN GENET DEV, V6, P164, DOI 10.1016/S0959-437X(96)80046-3; TRIESCHMANN L, 1995, EMBO J, V14, P1478, DOI 10.1002/j.1460-2075.1995.tb07134.x; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; TURNER BM, 1991, J CELL SCI, V99, P13; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; van Holde K.E., 1988, CHROMATIN; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; VOLLENWEIDER HJ, 1975, P NATL ACAD SCI USA, V72, P83, DOI 10.1073/pnas.72.1.83; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; WEISBROD S, 1979, P NATL ACAD SCI USA, V76, P630, DOI 10.1073/pnas.76.2.630; WEISBROD S, 1980, CELL, V19, P289, DOI 10.1016/0092-8674(80)90410-9; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Wolffe A., 1995, CHROMATIN STRUCTURE; WOLFFE AP, 1994, CURR OPIN GENET DEV, V4, P245, DOI 10.1016/S0959-437X(05)80051-6; WORKMAN JL, 1993, TRENDS BIOCHEM SCI, V18, P90, DOI 10.1016/0968-0004(93)90160-O; YAMAGUCHI M, 1986, P NATL ACAD SCI USA, V83, P1646, DOI 10.1073/pnas.83.6.1646	57	47	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9409	9414		10.1074/jbc.273.16.9409	http://dx.doi.org/10.1074/jbc.273.16.9409			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545265	hybrid			2022-12-27	WOS:000073128800011
J	Yoshida, H; Watanabe, A; Ihara, Y				Yoshida, H; Watanabe, A; Ihara, Y			Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; MICROTUBULE-ASSOCIATED PROTEIN; NEUROPIL THREADS; TAU-IMMUNOREACTIVITY; SENILE PLAQUES; PHOSPHORYLATION; GROWTH; BRAIN; UNC-33; FETAL	Intraneuronal accumulation of paired helical filaments (PHF) is considered to be closely related to the neuronal loss observed in brains of patients affected with Alzheimer's disease. The central issue is whether PHF formation itself causes or accelerates the neuronal perikaryal and neuritic degeneration or whether they are simply the consequence of preceding degeneration. We sought to address the issue in part by characterizing the PHF-associated molecules and thus raised a number of monoclonal antibodies to neurofibrillary tangles, One monoclonal antibody, 3F4, strongly reacted with neurofibrillary tangles and some plaque neurites but few neuropil threads. This monoclonal antibody labeled a 65-kDa protein, but not tau or ubiquitin, on a Western blot of human brain extract and immunoprecipitated the same protein. The peptides released from the purified 65-kDa protein had the same sequences as those of a newly identified protein, human collapsin response mediator protein-a. Incorporation into neurofibrillary tangles may deplete soluble, cytosolic human collapsin response mediator protein-2 and lead to abnormal neuritic and/or axonal outgrowth of the tangle-bearing neuron, thus accelerating the neuritic degeneration in Alzheimer's disease.	Univ Tokyo, Fac Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Ihara, Y (corresponding author), Univ Tokyo, Fac Med, Dept Neuropathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yihara@m.u-tokyo.ac.jp						ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; BENZING WC, 1993, J COMP NEUROL, V334, P176, DOI 10.1002/cne.903340203; BRAAK H, 1988, NEUROPATH APPL NEURO, V14, P39, DOI 10.1111/j.1365-2990.1988.tb00864.x; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Byk T, 1996, J NEUROSCI, V16, P688; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; DESAI C, 1988, NATURE, V336, P683; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; GOEDERT M, 1991, NEUROSCI LETT, V126, P149, DOI 10.1016/0304-3940(91)90541-Z; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; HASEGAWA M, 1990, NEURON, V4, P909, DOI 10.1016/0896-6273(90)90144-5; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; IHARA Y, 1983, NATURE, V304, P727, DOI 10.1038/304727a0; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; IHARA Y, 1990, GERONTOLOGY S1, V35, P15; IWATSUBO T, 1992, AM J PATHOL, V140, P277; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; KSIEZAKREDING H, 1994, NEUROBIOL AGING, V15, P11, DOI 10.1016/0197-4580(94)90140-6; KSIEZAKREDING H, 1994, BRAIN RES, V649, P185, DOI 10.1016/0006-8993(94)91063-4; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEUBA G, 1994, NEUROBIOL AGING, V15, P29, DOI 10.1016/0197-4580(94)90142-2; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P404, DOI 10.1097/00005072-199207000-00003; MASLIAH E, 1993, AM J PATHOL, V142, P871; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; MINTURN JE, 1995, J NEUROSCI, V15, P6757; MIRRA SS, 1991, NEUROLOGY, V42, P1681; MORISHIMAKAWASHIMA M, 1991, BRAIN RES, V554, P316, DOI 10.1016/0006-8993(91)90208-D; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; PERRY G, 1991, J NEUROSCI, V11, P1748; POLLOCK NJ, 1988, J HISTOCHEM CYTOCHEM, V36, P1117, DOI 10.1177/36.9.2841371; PROBST A, 1983, BRAIN RES, V268, P249, DOI 10.1016/0006-8993(83)90490-0; SATOYOSHITAKE R, 1989, NEURON, V3, P229, DOI 10.1016/0896-6273(89)90036-6; SHIN RW, 1992, AM J PATHOL, V140, P937; SHIN RW, 1991, LAB INVEST, V64, P693; TIERNEY MC, 1988, NEUROLOGY, V38, P356; Wang LH, 1996, J NEUROSCI, V16, P6197; WATANABE A, 1993, J BIOL CHEM, V268, P25712; YAMAGUCHI H, 1990, ACTA NEUROPATHOL, V80, P368, DOI 10.1007/BF00307689; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	46	146	150	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9761	9768		10.1074/jbc.273.16.9761	http://dx.doi.org/10.1074/jbc.273.16.9761			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545313	hybrid			2022-12-27	WOS:000073128800059
J	Dao, V; Modrich, P				Dao, V; Modrich, P			Mismatch-, MutS-, MutL-, and helicase II-dependent unwinding from the single-strand break of an incised heteroduplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCT; NUCLEAR EXTRACTS; TUMOR-CELLS; REPAIR; DNA; PROTEIN; HETERODIMER; INITIATION; BINDING	Escherichia coli MutS, MutL, and DNA helicase II are sufficient to initiate mismatch-dependent unwinding of an incised heteroduplex (Yamaguchi, M., Dao, V., and Modrich, P. (1998) J. Biol. Chem., 273, 9197-9201). We have studied unwinding of 6.4-kilobase circular G-T heteroduplexes that contain a single-strand incision, 808 base pairs 5' to the mismatch or 1023 base pairs 3' to the mispair as viewed along the shorter path between the two DNA sites. Unwinding of both substrates in the presence of MutS, MutL, DNA helicase II, and single-stranded DNA binding protein was mismatch-dependent and initiated at the single-strand break. Although unwinding occurred in both directions from the strand break, it was biased toward the shorter path linking the strand break and the mispair. MutS and MutL are thus sufficient to coordinate mismatch recognition to the orientation-dependent activation of helicase II unwinding at a single-strand break located a kilobase from the mispair.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Modrich, P (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	modrich@biochem.duke.edu		Modrich, Paul/0000-0001-8708-9885	NIGMS NIH HHS [GM23719] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023719, R01GM023719] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; AU KG, 1992, J BIOL CHEM, V267, P12142; COOPER DL, 1993, J BIOL CHEM, V268, P11823; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Eshleman James R., 1995, Current Opinion in Oncology, V7, P83; FANG WH, 1993, J BIOL CHEM, V268, P11838; FRITZSCHE E, 1987, NUCLEIC ACIDS RES, V15, P5517, DOI 10.1093/nar/15.14.5517; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; HAYATSU H, 1967, BIOCHEM BIOPH RES CO, V29, P556, DOI 10.1016/0006-291X(67)90521-9; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LAHUE RS, 1987, P NATL ACAD SCI USA, V84, P1482, DOI 10.1073/pnas.84.6.1482; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1986, J BIOL CHEM, V261, P169; MESELSON M, 1988, RECOMBINATION GENETI, P91; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nicolaides NC, 1998, MOL CELL BIOL, V18, P1635, DOI 10.1128/MCB.18.3.1635; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PARDI A, 1982, BIOCHEMISTRY-US, V21, P6567, DOI 10.1021/bi00268a038; PATEL DJ, 1982, SCIENCE, V216, P581, DOI 10.1126/science.6280281; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; YAMAGUCHI M, 1997, THESIS DUKE U	34	112	115	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9202	9207		10.1074/jbc.273.15.9202	http://dx.doi.org/10.1074/jbc.273.15.9202			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535911	hybrid			2022-12-27	WOS:000072990800088
J	Howell, GM; Humphrey, LE; Awwad, RA; Wang, DG; Koterba, A; Periyasamy, B; Yang, JH; Li, WH; Willson, JKV; Ziober, BL; Coleman, K; Carboni, J; Lynch, M; Brattain, MG				Howell, GM; Humphrey, LE; Awwad, RA; Wang, DG; Koterba, A; Periyasamy, B; Yang, JH; Li, WH; Willson, JKV; Ziober, BL; Coleman, K; Carboni, J; Lynch, M; Brattain, MG			Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA-CELLS; FACTOR-RECEPTOR; C-MYC; AUTOCRINE; EXPRESSION; GENE; TRANSCRIPTION; PROLIFERATION; REQUIRES; PROMOTER	Autocrine transforming growth factor alpha (TGF alpha) is an important positive growth effector in malignant cells and plays a significant role in generating the growth factor-independent phenotype associated with malignant progression. However, the molecular mechanisms by which TGF alpha confers a growth advantage in progression is poorly understood. The highly tumorigenic cell line HCT116 up-regulates TGF alpha mRNA expression during growth arrest, whereas the poorly tumorigenic growth factor-dependent FET cell line down-regulates TGF alpha mRNA expression as it becomes quiescent. We have identified a 25-bp sequence at -201 to -225 within the TGF alpha promoter which mediates the differential regulation of TGF alpha expression during quiescence establishment in these two cell lines. This same sequence confers TGF alpha promoter responsiveness to exogenous growth factor or autocrine TGF alpha. The abberant upregulation of TGF alpha mRNA in quiescent HCT116 cells may allow them to return to the dividing state under more stringent conditions (nutrient replenishment alone) then quiescent FET cells (requires nutrients and growth factors). Antisense TGF alpha approaches showed that the dysregulated TGF alpha expression in quiescent HCT116 cells is a function of the strong TGF alpha autocrine loop (not inhibited by blocking antibodies) in these cells.	Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43699 USA; Bristol Myers Squibb, Dept Mol Genet, Oncol Drug Discovery, Princeton, NJ 08543 USA; Case Western Reserve Univ, Ireland Canc Ctr, Dept Med, Cleveland, OH 44106 USA; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA	Bristol-Myers Squibb; Case Western Reserve University; University of California System; University of California San Francisco	Howell, GM (corresponding author), Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43699 USA.	howellg@uthscso.edu			NCI NIH HHS [CA34432, CA54807] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034432, R01CA054807] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANKLESARIA P, 1990, P NATL ACAD SCI USA, V87, P3289, DOI 10.1073/pnas.87.9.3289; Berkowitz EA, 1996, ONCOGENE, V12, P1991; BOYD DD, 1988, CANCER RES, V48, P2469; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1992, ADV CANCER RES, V58, P27, DOI 10.1016/S0065-230X(08)60289-4; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; DERYNCK R, 1987, CANCER RES, V47, P707; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HOWELL GM, 1995, J CELL PHYSIOL, V162, P256, DOI 10.1002/jcp.1041620211; Kudlow J E, 1990, Semin Cancer Biol, V1, P293; LYNCH MJ, 1993, CANCER RES, V53, P4041; Maniatis T, 1982, MOL CLONING LABORATO; MARKOWITZ SD, 1990, J CLIN INVEST, V86, P356, DOI 10.1172/JCI114709; Mulder K. M., 1989, CELL MOL BIOL COLON, P45; MULDER KM, 1991, CANCER RES, V51, P2256; MULDER KM, 1989, MOL ENDOCRINOL, V3, P1215, DOI 10.1210/mend-3-8-1215; PITTELKOW MR, 1993, CELL GROWTH DIFFER, V4, P513; RAJA RH, 1991, MOL ENDOCRINOL, V5, P514, DOI 10.1210/mend-5-4-514; SAEKI T, 1991, MOL ENDOCRINOL, V5, P1955, DOI 10.1210/mend-5-12-1955; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SIZELAND AM, 1991, MOL CELL BIOL, V11, P4005, DOI 10.1128/MCB.11.8.4005; SIZELAND AM, 1992, MOL BIOL CELL, V3, P1235, DOI 10.1091/mbc.3.11.1235; SPORN MB, 1985, CANCER SURV, V4, P627; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; Todaro G J, 1990, Semin Cancer Biol, V1, P257; WATKINS LF, 1988, CANCER LETT, V40, P59, DOI 10.1016/0304-3835(88)90262-5; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3; ZIOBER BL, 1993, J BIOL CHEM, V268, P691	33	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9214	9223		10.1074/jbc.273.15.9214	http://dx.doi.org/10.1074/jbc.273.15.9214			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535913	hybrid			2022-12-27	WOS:000072990800090
J	Janecki, AJ; Montrose, MH; Zimniak, P; Zweibaum, A; Tse, CM; Khurana, S; Donowitz, M				Janecki, AJ; Montrose, MH; Zimniak, P; Zweibaum, A; Tse, CM; Khurana, S; Donowitz, M			Subcellular redistribution is involved in acute regulation of the brush border Na+/H+ exchanger isoform 3 in human colon adenocarcinoma cell line Caco-2 - Protein kinase C-mediated inhibition of the exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT MOSAIC PATTERNS; PARATHYROID-HORMONE; PLASMA-MEMBRANE; ILEAL ABSORPTION; NHE3; ENDOCYTOSIS; EXPRESSION; LOCALIZATION; TRAFFICKING; AMILORIDE	Na+/H+ exchanger isoform 3 (NHE3), an epithelial brush border isoform of the Na+/H+ exchanger gene family, plays an important role in reabsorption of Na+ in the small intestine, the colon, and the kidney. In several cell types, phorbol 12-myristate 13-acetate (PMA) acutely inhibits NHE3 activity by changes in V-max, but the mechanism of this inhibition is unknown. We investigated the role of subcellular redistribution of NHE3 in the PMA-induced inhibition of endogenous brush border NHE3 in a model human colon adenocarcinoma cell line, Caco-2. Subcellular localization of NHE3 was examined by confocal morphometric analysis complemented with cell surface biotinylation and compared with NHE3 activity evaluated by fluorometric measurement of intracellular pH. PMA inhibited NHE3 activity by 28% (p < 0.01), which was associated with a decrease of the ratio of the brush border/subapical cytoplasmic compartment of NHE3 from similar to 4.3 to similar to 2.4. This translocation resulted in 10-15% of the total cell NHE3 being shifted from the brush border pool to the cytoplasmic pool. These effects were mediated by protein kinase C, since they were blocked by the protein kinase C inhibitor H7. We conclude that inhibition of NHE3 by protein kinase C in Caco-2 cells involves redistribution of the exchanger from brush border into a subapical cytoplasmic compartment, and that this mechanism contributes similar to 50% to the overall protein kinase C-induced inhibition of the exchanger.	Johns Hopkins Univ, Sch Med, Div Gastroenterol, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Gastroenterol, Dept Physiol, Baltimore, MD 21205 USA; Univ Arkansas Med Sci, Dept Med, Little Rock, AR 72205 USA; INSERM, U178, Unite Rech Differenciat Cellulaire Instestinale, F-94807 Villejuif, France	Johns Hopkins University; Johns Hopkins University; University of Arkansas System; University of Arkansas Medical Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm)	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Div Gastroenterol, Dept Med, 918 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@welchlink.welch.jhu.edu		Khurana, Seema/0000-0002-6884-810X	NIDDK NIH HHS [R01DK266523, P01DK44484, R29DK43778] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043778, P01DK044484] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azarani A, 1996, J BIOL CHEM, V271, P14931, DOI 10.1074/jbc.271.25.14931; AZARANI A, 1995, J BIOL CHEM, V270, P20004, DOI 10.1074/jbc.270.34.20004; Beron J, 1997, MOL BIOL CELL, V8, P387, DOI 10.1091/mbc.8.3.387; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; BIEMESDERFER D, 1995, J AM SOC NEPHROL, V6, P372; BRANT SR, 1995, AM J PHYSIOL-CELL PH, V269, pC198, DOI 10.1152/ajpcell.1995.269.1.C198; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; CHANTRET I, 1994, J CELL SCI, V107, P213; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Dauterive R, 1996, J BIOL CHEM, V271, P11414, DOI 10.1074/jbc.271.19.11414; DONOWITZ M, 1996, MOL BIOL MEMBRANE TR, P259; FORTE TM, 1977, GASTROENTEROLOGY, V73, P941; HELMLEKOLB C, 1993, PFLUG ARCH EUR J PHY, V425, P34, DOI 10.1007/BF00374501; HELMLEKOLB C, 1990, PFLUG ARCH EUR J PHY, V416, P615, DOI 10.1007/BF00370605; HENSLEY CB, 1990, KIDNEY INT, V37, P707, DOI 10.1038/ki.1990.37; HENSLEY CB, 1989, AM J PHYSIOL, V257, pC637, DOI 10.1152/ajpcell.1989.257.4.C637; HOLM PK, 1995, EXP CELL RES, V217, P157, DOI 10.1006/excr.1995.1075; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Janecki A, 1997, FASEB J, V11, P2971; Janecki AJ, 1997, GASTROENTEROLOGY, V112, pA372; KANDASAMY RK, 1995, J BIOL CHEM, V270, P29209, DOI 10.1074/jbc.270.49.29209; KATSURA T, 1995, P NATL ACAD SCI USA, V92, P7212, DOI 10.1073/pnas.92.16.7212; KEMPSON SA, 1995, AM J PHYSIOL-RENAL, V268, pF784, DOI 10.1152/ajprenal.1995.268.4.F784; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Loo DDF, 1996, FEBS LETT, V392, P250, DOI 10.1016/0014-5793(96)00823-X; Lostao MP, 1995, FEBS LETT, V377, P181, DOI 10.1016/0014-5793(95)01339-3; Maher MM, 1996, DIGEST DIS SCI, V41, P651, DOI 10.1007/BF02213119; MONTROSE MH, 1987, J MEMBRANE BIOL, V97, P63, DOI 10.1007/BF01869615; Noel J, 1996, J CELL SCI, V109, P929; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; SHURETY W, 1995, BIOCHEM SOC T, V23, pS184, DOI 10.1042/bst023184s; Silviani V, 1996, PFLUG ARCH EUR J PHY, V432, P791, DOI 10.1007/s004240050200; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; TSE CM, 1994, BIOCHEMISTRY-US, V33, P12954, DOI 10.1021/bi00248a003; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; Vachon PH, 1996, J CELL PHYSIOL, V166, P198, DOI 10.1002/(SICI)1097-4652(199601)166:1<198::AID-JCP21>3.0.CO;2-A; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; WATSON AJM, 1991, AM J PHYSIOL, V261, pG229, DOI 10.1152/ajpgi.1991.261.2.G229; WATSON AJM, 1994, BBA-BIOMEMBRANES, V1193, P316, DOI 10.1016/0005-2736(94)90168-6; WORMMEESTER L, 1998, IN PRESS AM J PHYSL; YANG J, 1993, J BIOL CHEM, V268, P4600; YEO CJ, 1994, SURGERY, V116, P388; Yip JW, 1997, J BIOL CHEM, V272, P18473, DOI 10.1074/jbc.272.29.18473; Zhang YB, 1996, AM J PHYSIOL-RENAL, V270, pF1004, DOI 10.1152/ajprenal.1996.270.6.F1004	45	140	140	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8790	8798		10.1074/jbc.273.15.8790	http://dx.doi.org/10.1074/jbc.273.15.8790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535857	hybrid			2022-12-27	WOS:000072990800034
J	Krambovitis, E; Hatzidakis, G; Barlos, K				Krambovitis, E; Hatzidakis, G; Barlos, K			Preparation of MUC-1 oligomers using an improved convergent solid-phase peptide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHIC EPITHELIAL MUCIN; TANDEM REPEATS; BREAST-CANCER; PROTEIN CORE; ANTIBODY; EPITOPE; CARCINOMAS; FRAGMENTS; SEQUENCE; RESINS	The sequentially repeating nature of the core mucin polypeptide chain MUC-1 on the surface of malignant cells makes it an excellent target for cancer immunotherapy. We describe a reliable and efficient method of synthesizing oligomers, up to five tandem repeats and oligomer heterotope derivatives with a 15-amino acid epitope from tetanus toxin using an improved convergent solid-phase peptide synthesis. The different oligomers were easily distinguishable by reverse-phase high pressure liquid chromatography, but they were poorly fixed and migrated with the same migration rate, irrespective of size, in electrophoretic studies. In contrast, the oligomer heterotopes exhibited size-dependent electrophoretic behavior but in high pressure liquid chromatography chromatograms the different heterotopes were eluted simultaneously in two peaks representing the L-and D-enantiomers of the derivatives. The oligomer heterotopes were recognized as antigens in Western blotting with a murine monoclonal antibody against the epitope APDTR, In enzyme immunoassay studies with the same antibody an increasing reactivity was observed against the larger oligomers and confirmed by inhibition assays as the MUC-1 pentamer was the most efficient inhibitor. These results support the suggestion that the pentamer attains a structure closer to the native conformation and is more immunogenic. In conclusion, large composite peptides can be reliably synthesized with the convergent solid-phase peptide strategy offering an attractive option to vaccine designing and development.	Inst Mol Biol & Biotechnol, Dept Appl Biochem & Immunol, GR-71110 Iraklion, Greece; Univ Patras, Dept Chem, GR-26010 Patras, Greece	University of Patras	Krambovitis, E (corresponding author), Inst Mol Biol & Biotechnol, Dept Appl Biochem & Immunol, POB 1527, GR-71110 Iraklion, Greece.	Krambo@nefeli.imbb.forth.gr						BARLOS K, 1991, ANGEW CHEM INT EDIT, V30, P590, DOI 10.1002/anie.199105901; BARLOS K, 1989, TETRAHEDRON LETT, V30, P3947, DOI 10.1016/S0040-4039(00)99291-8; BARLOS K, 1991, INT J PEPT PROT RES, V37, P513; BARLOS K, 1989, TETRAHEDRON LETT, V30, P3943, DOI 10.1016/S0040-4039(00)99290-6; BARLOS K, 1991, INT J PEPT PROT RES, V38, P555; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BURCHELL J, 1989, INT J CANCER, V44, P691, DOI 10.1002/ijc.2910440423; DEVINE PL, 1992, BIOESSAYS, V14, P619, DOI 10.1002/bies.950140909; FINN OJ, 1995, IMMUNOL REV, V145, P61, DOI 10.1111/j.1600-065X.1995.tb00077.x; FONTENOT JD, 1993, CANCER RES, V53, P5386; FRANK G, 1974, EUR J BIOCHEM, V44, P317; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; Goydos JS, 1996, J SURG RES, V63, P298, DOI 10.1006/jsre.1996.0264; HAREUVENI M, 1990, EUR J BIOCHEM, V189, P475, DOI 10.1111/j.1432-1033.1990.tb15512.x; HATZIDAKIS G, 1993, J REPROD FERTIL, V97, P557, DOI 10.1530/jrf.0.0970557; HUNG CH, 1977, J BIOL CHEM, V252, P3995; KOTERA Y, 1994, CANCER RES, V54, P2856; KOVARIK A, 1987, FOLIA BIOL-PRAGUE, V33, P253; KRAMBOVITIS E, 1992, FEMS MICROBIOL IMMUN, V89, P129; LLOYDWILLIAMS P, 1993, TETRAHEDRON, V49, P11065, DOI 10.1016/S0040-4020(01)81800-7; NOELKEN ME, 1981, ANAL BIOCHEM, V110, P131, DOI 10.1016/0003-2697(81)90123-8; NOKIHARA K, 1995, SHIMADZU REV, V52, P1; PRICE MR, 1990, MOL IMMUNOL, V27, P795, DOI 10.1016/0161-5890(90)90089-I; RAMAGE R, 1987, TETRAHEDRON LETT, V28, P2287, DOI 10.1016/S0040-4039(00)96103-3; TAYLORPAPADIMITRIOU J, 1993, ANN NY ACAD SCI, V690, P69; TAYLORPAPADIMITRIOU J, 1991, INT J CANCER, V49, P1, DOI 10.1002/ijc.2910490102; XING PX, 1992, MOL IMMUNOL, V29, P641; XING PX, 1995, INT J ONCOL, V6, P1283	29	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10874	10879		10.1074/jbc.273.18.10874	http://dx.doi.org/10.1074/jbc.273.18.10874			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556562	hybrid			2022-12-27	WOS:000073395200014
J	Yan, ZH; Karam, WG; Staudinger, JL; Medvedev, A; Ghanayem, BI; Jetten, AM				Yan, ZH; Karam, WG; Staudinger, JL; Medvedev, A; Ghanayem, BI; Jetten, AM			Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; RESPONSIVE ELEMENT UPSTREAM; RAT HYDRATASE-DEHYDROGENASE; HORMONE-RECEPTOR; THYROID-HORMONE; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTOR; LIPID-METABOLISM; ACID RECEPTORS; CO-REPRESSOR	Recently, Re reported the cloning of the nuclear orphan receptor TAK1. In this study, we characterized the sequence requirements for optimal TAK1 binding and analyzed the repression of the peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling pathway by TAK1. Site selection analysis showed that TAK1 has the greatest affinity for direct repeat-1 response elements (RE) containing AGGTCAAAGGTCA (TAK1-RE) to which it binds as a homodimer, TAK1 is a very weak inducer of TAK1-RE-dependent transcriptional activation. We observed that TAK1, as PPAR alpha; is expressed within rat hepatocytes and is able to bind the peroxisome proliferator response elements (PPREs) present in the promoter of the PPAR alpha target genes rat enoyl-CoA hydratase (HD) and peroxisomal fatty acyl-CoA oxidase (ACOX). TAK1 is unable to induce PPRE-dependent transcriptional activation and represses PPAR alpha-mediated transactivation through these elements in a dose-dependent manner. Two-hybrid analysis showed that TAK1 does not form heterodimers with either PPAR alpha or retinoid X receptor (RXR alpha), indicating that this repression does not involve a mechanism by which TAK1 titrates out PPAR alpha or RXR alpha from PPAR.RXR complexes. Further studies demonstrated that the PPAR alpha Ligand 8(S)-hydroxyeicosatetraenoic acid strongly promotes the interaction of PPAR alpha with the co-activator RIP-140 but decreases the interaction of PPAR alpha with the corepressor SMRT. In contrast, TAK1 interacts with RIP-140 but not with SMRT and competes with PPAR alpha for RIP-140 binding. These observations indicated that the antagonistic effects of TAK1 on PPAR alpha.RXR alpha transactivation act at least at two levels in the PPAR alpha signaling pathway: competition of TAK1 with PPAR alpha.RXR for binding to PPREs as well as to common co-activators, such as RIP-140. Our results suggest an important role for TAK1 in modulating PPAR alpha-controlled gene expression in hepatocytes.	NIEHS, Cell Biol Sect, Pulm Pathobiol Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Lab Pharmacol & Chem, NIH, Res Triangle Pk, NC 27709 USA; Glaxo Wellcome Res & Dev Ltd, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); GlaxoSmithKline	Jetten, AM (corresponding author), NIEHS, Cell Biol Sect, Pulm Pathobiol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.		Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445; Medvedev, Alexander/0000-0001-6983-1687				Adachi H, 1996, MOL CELL DIFFER, V4, P365; BAES M, 1995, BIOCHEM BIOPH RES CO, V215, P338, DOI 10.1006/bbrc.1995.2471; BOCOS C, 1995, J STEROID BIOCHEM, V53, P467, DOI 10.1016/0960-0760(95)00093-F; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; CHANG C, 1996, P NATL ACAD SCI USA, V91, P6040; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHU RY, 1995, P NATL ACAD SCI USA, V92, P11593, DOI 10.1073/pnas.92.25.11593; CHU RY, 1995, J BIOL CHEM, V270, P29636; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; DE LUCA LM, 1991, FASEB J, V5, P2924; DESVERGNE B, 1995, INDUCIBLE GENE EXPRE, V1, P142; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Gonzalez FJ, 1997, BIOCHIMIE, V79, P139, DOI 10.1016/S0300-9084(97)81506-4; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; HANSTEIN B, 1996, P NATL ACAD SCI USA, V91, P10009; HIROSE T, 1995, BIOCHEM BIOPH RES CO, V211, P83, DOI 10.1006/bbrc.1995.1781; HIROSE T, 1994, MOL ENDOCRINOL, V8, P1667, DOI 10.1210/me.8.12.1667; HIROSE T, 1995, GENE, V163, P239, DOI 10.1016/0378-1119(95)00414-2; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JOW L, 1995, J BIOL CHEM, V270, P3836, DOI 10.1074/jbc.270.8.3836; Joyeux A, 1997, MOL ENDOCRINOL, V11, P193, DOI 10.1210/me.11.2.193; KADOWAKI Y, 1992, BIOCHEM BIOPH RES CO, V183, P492, DOI 10.1016/0006-291X(92)90509-J; KADOWAKI Y, 1995, P NATL ACAD SCI USA, V92, P4432, DOI 10.1073/pnas.92.10.4432; KAMEI Y, 1996, CELL, V85, P1; Karam WG, 1997, CARCINOGENESIS, V18, P2077, DOI 10.1093/carcin/18.11.2077; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KELLER H, 1993, TRENDS ENDOCRIN MET, V4, P291, DOI 10.1016/1043-2760(93)90048-J; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; LEE HJ, 1995, J BIOL CHEM, V270, P30129; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051; ONATE SA, 1995, SCIENCE, V270, P1354; PALMER CNA, 1994, J BIOL CHEM, V269, P18083; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; QUI Y, 1994, TRENDS ENDOCRIN MET, V5, P234; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; RIBEIRO RCJ, 1995, ANNU REV MED, V46, P443, DOI 10.1146/annurev.med.46.1.443; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Varanasi U, 1996, J BIOL CHEM, V271, P2147, DOI 10.1074/jbc.271.4.2147; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Yan ZH, 1997, J BIOL CHEM, V272, P10565; Yoshikawa T, 1996, ENDOCRINOLOGY, V137, P1562, DOI 10.1210/en.137.5.1562; Yoshikawa T, 1996, GENOMICS, V35, P361, DOI 10.1006/geno.1996.0368; Young WJ, 1997, J BIOL CHEM, V272, P3109, DOI 10.1074/jbc.272.5.3109; ZHANG BW, 1993, J BIOL CHEM, V268, P12939; ZHANG BW, 1992, P NATL ACAD SCI USA, V89, P7541, DOI 10.1073/pnas.89.16.7541; ZHU YJ, 1993, J BIOL CHEM, V268, P26817; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	75	59	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10948	10957		10.1074/jbc.273.18.10948	http://dx.doi.org/10.1074/jbc.273.18.10948			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556573	hybrid			2022-12-27	WOS:000073395200025
J	Llorca, O; Smyth, MG; Marco, S; Carrascosa, JL; Willison, KR; Valpuesta, JM				Llorca, O; Smyth, MG; Marco, S; Carrascosa, JL; Willison, KR; Valpuesta, JM			ATP binding induces large conformational changes in the apical and equatorial domains of the eukaryotic chaperonin containing TCP-1 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROEL-GROES COMPLEXES; CYTOPLASMIC CHAPERONIN; BETA-ACTIN; PROTEIN; SUBSTRATE; ICE	The chaperonin-containing TCP-I complex (CCT) is a heteromeric particle composed of eight different subunits arranged in two back-to-back 8-fold pseudo-symmetric rings. The structural and functional implications of nucleotide binding to the CCT complex was addressed by electron microscopy and image processing. Whereas ADP binding to CCT does not reveal major conformational differences when compared with nucleotide-free CCT, ATP binding induces large conformational changes in the apical and equatorial domains, shifting the latter domains up to 40 degrees (with respect to the interring plane) compared with 10 degrees for nucleotide-free CCT or ADP-CCT. This equatorial ATP-induced shift has no counterpart in GroEL, its prokaryotic homologue, which suggests differences in the folding mechanism for CCT.	Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; Inst Canc Res, Chester Beatty Labs, CRC, Ctr Cell & Mol Biol, London SW3 6JB, England	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Valpuesta, JM (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain.	jmv@cnb.uam.es	Llorca, Oscar/P-2784-2019; marco, SERGIO/E-4875-2017; Valpuesta, José M/T-1977-2017; Llorca, Oscar/K-1144-2014; Valpuesta, Jose M/AAA-6002-2019; marco garrido, sergio/F-5876-2013	Llorca, Oscar/0000-0001-5705-0699; Valpuesta, José M/0000-0001-7468-8053; Llorca, Oscar/0000-0001-5705-0699; 				BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; DELAFRAGA LG, 1995, ULTRAMICROSCOPY, V60, P385, DOI 10.1016/0304-3991(95)00080-1; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Fenton WA, 1997, PROTEIN SCI, V6, P743; FRANK J, 1996, 3 DIMENSIONAL ELECT, P126; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x; Hoenger A, 1996, J STRUCT BIOL, V117, P99, DOI 10.1006/jsbi.1996.0075; HYNES G, 1995, FEBS LETT, V358, P129, DOI 10.1016/0014-5793(94)01408-S; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; KUBOTA H, 1995, EUR J BIOCHEM, V230, P3, DOI 10.1111/j.1432-1033.1995.0003i.x; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LEWIS VA, 1992, NATURE, V358, P252; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; LIOU A, 1998, IN PRESS BIOL CHEM H, V379; LIOU AKF, 1997, EMBO J, V16, P4316; LLORCA O, 1994, FEBS LETT, V345, P181, DOI 10.1016/0014-5793(94)00432-3; Llorca O, 1997, J STRUCT BIOL, V118, P31, DOI 10.1006/jsbi.1996.3832; MARABINI R, 1994, BIOPHYS J, V66, P1804, DOI 10.1016/S0006-3495(94)80974-9; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; MARCO S, 1994, BIOPHYS J, V67, P364, DOI 10.1016/S0006-3495(94)80489-8; MARCO S, 1996, ULTRAMICROSCOPY, V66, P55; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; Nitsch M, 1997, J MOL BIOL, V267, P142, DOI 10.1006/jmbi.1996.0849; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PHIPPS BM, 1993, NATURE, V361, P475, DOI 10.1038/361475a0; QUAITERANDAL E, 1995, J BIOL CHEM, V48, P28818; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7; WALDMANN T, 1995, EUR J BIOCHEM, V227, P848, DOI 10.1111/j.1432-1033.1995.tb20210.x; Willison KR, 1994, BIOL HEAT SHOCK PROT, P299; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1996, J MOL BIOL, V255, P356, DOI 10.1006/jmbi.1996.0028	37	52	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10091	10094		10.1074/jbc.273.17.10091	http://dx.doi.org/10.1074/jbc.273.17.10091			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553054	hybrid			2022-12-27	WOS:000073224200003
J	Nantel, A; Mohammad-Ali, K; Sherk, J; Posner, BI; Thomas, DY				Nantel, A; Mohammad-Ali, K; Sherk, J; Posner, BI; Thomas, DY			Interaction of the Grb10 adapter protein with the Raf1 and MEK1 kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-DEPENDENT MANNER; RECEPTOR TYROSINE KINASE; SIGNAL-REGULATED KINASES; SH2 DOMAIN; PHOSPHORYLATION SITES; PHEROMONE RESPONSE; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; INSULIN-RECEPTOR; IN-VITRO	Grb10 and its close homologues Grb7 and Grb14, belong to a family of adapter proteins characterized by a proline-rich region, a central PH domain, and a carboxyl-terminal Src homology 2 (SH2) domain. Their interaction with a variety of activated tyrosine kinase receptors is well documented, but their actual function remains a mystery. The Grb10 SH2 domain was isolated from a two-hybrid screen using the MEK1 kinase as a bait. We show that this unusual SH2 domain interacts, in a phosphotyrosine-independent manner, with both the Raf1 and MEK1 kinases. Mutation of the MEK1 Thr-386 residue, which is phosphorylated by mitogen-activated protein kinase in vitro, reduces binding to Grb10 in a two-hybrid assay. Interaction of Grb10 with Raf1 is constitutive, while interaction between Grb10 and MEK1 needs insulin treatment of the cells and follows mitogen-activated protein kinase activation. Random mutagenesis of the SH2 domain demonstrated that the Arg-beta B5 and Asp-EF2 residues are necessary for binding to the epidermal growth factor and insulin receptors as well as to the two kinases. In addition, we show that a mutation in Ser-beta B7 affects binding only to the receptors, while a mutation in Thr-beta CB abrogates binding only to MEK1. Finally, transfection of Grb10 genes with specific mutations in their SH2 domains induces apoptosis in HTC-IR and COS-7 cells. These effects can be competed by coexpression of the wild type protein, suggesting that these mutants act by sequestering necessary signaling components.	Natl Res Council Canada, Biotechnol Res Inst, Eukaryot Genet Grp, Montreal, PQ H4P 2R2, Canada; McGill Univ, Dept Expt Med, Montreal, PQ H3A 2B2, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 2B2, Canada	National Research Council Canada; McGill University; McGill University; McGill University	Nantel, A (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, Eukaryot Genet Grp, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	andre.nantel@bri.nrc.ca	Posner, Barry/B-6733-2008; Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X				ACSADI G, 1994, HUM MOL GENET, V3, P579, DOI 10.1093/hmg/3.4.579; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; BRUNET A, 1994, FEBS LETT, V346, P299, DOI 10.1016/0014-5793(94)00475-7; CHAREST DL, 1993, MOL CELL BIOL, V13, P4679, DOI 10.1128/MCB.13.8.4679; CHOI KY, 1994, CELL, V78, P499; CLEGHON V, 1994, J BIOL CHEM, V269, P17749; Daly RJ, 1996, J BIOL CHEM, V271, P12502, DOI 10.1074/jbc.271.21.12502; DECHERT U, 1994, J BIOL CHEM, V269, P5602; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; FATH I, 1994, SCIENCE, V264, P971, DOI 10.1126/science.8178156; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Frantz JD, 1997, J BIOL CHEM, V272, P2659, DOI 10.1074/jbc.272.5.2659; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; GOLEMIS EA, 1994, CURRENT PROTOCOLS MO; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Janes PW, 1997, J BIOL CHEM, V272, P8490, DOI 10.1074/jbc.272.13.8490; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; LAMARCHE N, 1990, J GEN VIROL, V71, P1785, DOI 10.1099/0022-1317-71-8-1785; Laviola L, 1997, J CLIN INVEST, V99, P830, DOI 10.1172/JCI119246; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; LEE RM, 1992, J BIOL CHEM, V267, P1088; LEEUW T, 1995, SCIENCE, V270, P1210, DOI 10.1126/science.270.5239.1210; Li X, 1995, CELL PROLIFERAT, V28, P571, DOI 10.1111/j.1365-2184.1995.tb00045.x; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; MULLER AJ, 1992, MOL CELL BIOL, V12, P5087, DOI 10.1128/MCB.12.11.5087; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; ONeill TJ, 1996, J BIOL CHEM, V271, P22506, DOI 10.1074/jbc.271.37.22506; OOI J, 1995, ONCOGENE, V10, P1621; OSBORNE MA, 1995, BIO-TECHNOL, V13, P1474, DOI 10.1038/nbt1295-1474; Pandey A, 1996, J BIOL CHEM, V271, P10607, DOI 10.1074/jbc.271.18.10607; Parrizas M, 1997, J BIOL CHEM, V272, P154; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Pogulis R J, 1996, Methods Mol Biol, V57, P167; Raffel GD, 1996, J BIOL CHEM, V271, P4640; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SBRACCIA P, 1990, J BIOL CHEM, V265, P4902; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Tanaka S, 1997, CANCER RES, V57, P28; UEKI K, 1994, J BIOL CHEM, V269, P15756; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; YOAKIM M, 1994, MOL CELL BIOL, V14, P5929, DOI 10.1128/MCB.14.9.5929; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; ZHANG XF, 1995, METHOD ENZYMOL, V255, P323; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; ZHENG CF, 1993, J BIOL CHEM, V268, P23933	71	92	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10475	10484		10.1074/jbc.273.17.10475	http://dx.doi.org/10.1074/jbc.273.17.10475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553107	hybrid			2022-12-27	WOS:000073224200056
J	Ruud, KA; Kuhlow, C; Goss, DJ; Browning, KS				Ruud, KA; Kuhlow, C; Goss, DJ; Browning, KS			Identification and characterization of a novel cap-binding protein from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC INITIATION FACTOR-4E; GLOBIN MESSENGER-RNA; WHEAT-GERM; ISOZYME FORM; ELONGATION-FACTORS; ANALOGS; PURIFICATION; EXPRESSION; SUBUNITS; COMPLEX	Cap-binding proteins specifically bind to the 7-methyl guanosine (m(7)G) functional group at the 5' end of eukaryotic mRNAs. A novel Arabidopsis thaliana protein has been identified that has sequence similarity to cap-binding proteins but is clearly a different form of the protein. The most obvious primary sequence difference is the substitution of two of the eight conserved tryptophan residues with other aromatic amino acids in the novel protein. Analogous forms of this novel protein appear to be present in other higher eukaryotes but not in yeast. Analysis of the native and recombinant forms of the novel protein by retention on m(7)GTP-Sepharose indicate that it is a functional cap-binding protein. Measurements of the dissociation constant for this protein indicate that it binds m(7)GTP 5-20-fold tighter than eukaryotic initiation factor (eIF)(iso)4E. The novel protein also supports the initiation of translation of capped mRNA in vitro. Biochemical analysis and yeast two-hybrid data indicate that it interacts with eIF(iso)4G to form a complex. Based on these observations, this protein appears to be able to function as a cap-binding protein and is given the designation of novel cap-binding protein (nCBP).	Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; City University of New York (CUNY) System; Hunter College (CUNY)	Browning, KS (corresponding author), Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.							ALTMANN M, 1988, J BIOL CHEM, V263, P17229; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; ETCHISON D, 1987, MOL CELL BIOCHEM, V76, P15; FLETCHER L, 1990, J BIOL CHEM, V265, P19582; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; LAX SR, 1986, METHOD ENZYMOL, V118, P109; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Merrick WC., 1996, TRANSLATION CONTROL, P31; Metz AM, 1996, J BIOL CHEM, V271, P31033, DOI 10.1074/jbc.271.49.31033; Morino S, 1996, EUR J BIOCHEM, V239, P597, DOI 10.1111/j.1432-1033.1996.0597u.x; Morley SJ, 1997, RNA, V3, P1085; MTSUO H, 1997, NAT STRUCT BIOL, V4, P717; NEWMAN T, 1994, PLANT PHYSIOL, V106, P1241, DOI 10.1104/pp.106.4.1241; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; RHOADS RE, 1993, PROG NUCLEIC ACID RE, V46, P183, DOI 10.1016/S0079-6603(08)61022-3; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; SHA M, 1995, J BIOL CHEM, V270, P29904; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; TEMELES GL, 1994, MOL REPROD DEV, V37, P121, DOI 10.1002/mrd.1080370202; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454; WEBSTER C, 1991, J BIOL CHEM, V266, P23341	30	70	74	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10325	10330		10.1074/jbc.273.17.10325	http://dx.doi.org/10.1074/jbc.273.17.10325			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553087	hybrid			2022-12-27	WOS:000073224200036
J	White, JR; Lee, JM; Young, PR; Hertzberg, RP; Jurewicz, AJ; Chaikin, MA; Widdowson, K; Foley, JJ; Martin, LD; Griswold, DE; Sarau, HM				White, JR; Lee, JM; Young, PR; Hertzberg, RP; Jurewicz, AJ; Chaikin, MA; Widdowson, K; Foley, JJ; Martin, LD; Griswold, DE; Sarau, HM			Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; HYPAQUE-FICOLL METHOD; IL-8 RECEPTOR-A; POLYMORPHONUCLEAR LEUKOCYTES; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; N-TERMINUS; RABBITS; EXPRESSION; ADHESION	Interleukin-8 (IL-8) and closely related Glu-Leu-Arg (ELR) containing CXC chemokines, including growth-related oncogene (GRO)alpha, GRO beta, GRO gamma,; and epithelial cell-derived neutrophil-activating peptide-78 (ENA-78), are potent neutrophil chemotactic and activating peptides, which are proposed to be major mediators of inflammation. IL-8 activates neutrophils by binding to two distinct seven-transmembrane (7-TMR) G-protein coupled receptors CXCR1 (IL-8RA) and CXCR2 (IL-8RB), while GRO alpha, GRO beta, GRO gamma, and ENA-78 bind to and activate only CXCR2. A chemical lead, which selectively inhibited CXCR2 was discovered by high throughput screening and chemically optimized. SE 225002 (N-(2-hydroxy-4-nitrophenyl)-N'-(2-bromophenyl)urea) is the first reported potent and selective non-peptide inhibitor of a chemokine receptor. It is an antagonist of I-125-IL-8 binding to CXCR2 with an IC50,, = 22 nM. SE 225002 showed >150-fold selectivity over CXCR1 and four other 7-TMRs tested. In vitro, SE 225002 potently inhibited human and rabbit neutrophil chemotaxis induced by both IL-8 and GRO alpha. In vivo, SE 225002 selectively blocked IL-8-induced neutrophil margination in rabbits. The present findings suggest that CXCR2 is responsible for neutrophil chemotaxis and margination induced by IL-8. This selective antagonist will be a useful tool compound to define the role of CXCR2 in inflammatory diseases where neutrophils play a major role.	SmithKline Beecham Pharmaceut, Dept Mol Immunol, King Of Prussia, PA 19406 USA; SmithKline Beecham Pharmaceut, Dept Biomol Discovery, King Of Prussia, PA 19406 USA; SmithKline Beecham Pharmaceut, Dept Pulm Pharmacol, King Of Prussia, PA 19406 USA; SmithKline Beecham Pharmaceut, Dept Med Chem, King Of Prussia, PA 19406 USA; SmithKline Beecham Pharmaceut, Dept Immunopharmacol, King Of Prussia, PA 19406 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	White, JR (corresponding author), SmithKline Beecham Pharmaceut, Dept Mol Immunol, 709 Swedeland Rd, King Of Prussia, PA 19406 USA.	john_r_white@sbphrd.com		White, John R/0000-0003-2998-1626				ALT XE, 1992, LIFE SCI, V50, pPL101; Babi LFS, 1996, EUR J IMMUNOL, V26, P2056, DOI 10.1002/eji.1830260914; Berkhout TA, 1997, J BIOL CHEM, V272, P16404, DOI 10.1074/jbc.272.26.16404; BIGNOLD LP, 1987, J IMMUNOL METHODS, V96, P29, DOI 10.1016/0022-1759(87)90363-2; BOEHM JC, 1993, J MED CHEM, V36, P3333, DOI 10.1021/jm00074a014; BROADDUS VC, 1994, J IMMUNOL, V152, P2960; BROOKS DP, 1992, N-S ARCH PHARMACOL, V345, P673, DOI 10.1007/BF00164582; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; CHUNTHARAPAI A, 1994, J IMMUNOL, V153, P5682; CLOZEL M, 1993, NATURE, V365, P759, DOI 10.1038/365759a0; DETMERS PA, 1990, J EXP MED, V171, P1155, DOI 10.1084/jem.171.4.1155; DOERSCHUK CM, 1992, AM J RESP CELL MOL, V7, P140, DOI 10.1165/ajrcmb/7.2.140; FERRANTE A, 1982, J IMMUNOL METHODS, V48, P81, DOI 10.1016/0022-1759(82)90212-5; Grau GE, 1996, LAB INVEST, V74, P761; GRISWOLD DE, 1991, J PHARMACOL METHOD, V25, P319, DOI 10.1016/0160-5402(91)90031-Y; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; HAY DWP, 1991, PULM PHARMACOL THER, V4, P177, DOI 10.1016/0952-0600(91)90009-R; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Jones SA, 1997, J BIOL CHEM, V272, P16166, DOI 10.1074/jbc.272.26.16166; Khair OA, 1996, EUR RESPIR J, V9, P1913, DOI 10.1183/09031936.96.09091913; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; LANE TA, 1981, BLOOD, V58, P228; LANZA TJ, 1992, J MED CHEM, V35, P252, DOI 10.1021/jm00080a008; LARSEN CG, 1995, J IMMUNOL, V155, P2151; Laterveer L, 1996, BLOOD, V87, P781, DOI 10.1182/blood.V87.2.781.bloodjournal872781; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; Motosugi H, 1996, AM J PATHOL, V149, P963; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; MULLIGAN MS, 1991, J CLIN INVEST, V88, P1396, DOI 10.1172/JCI115446; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nakamura H, 1997, INT ARCH ALLERGY IMM, V112, P157, DOI 10.1159/000237448; Quan JM, 1996, BIOCHEM BIOPH RES CO, V219, P405, DOI 10.1006/bbrc.1996.0246; ROLLINS TE, 1988, J BIOL CHEM, V263, P520; Rot A, 1996, J LEUKOCYTE BIOL, V59, P39, DOI 10.1002/jlb.59.1.39; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; SUZUKI H, 1994, J BIOL CHEM, V269, P18263; VEDDER NB, 1988, J CLIN INVEST, V81, P939, DOI 10.1172/JCI113407; WIDDOWSON KL, 1998, IN PRESS PEPTIDES ES; XU LL, 1995, J LEUKOCYTE BIOL, V57, P335, DOI 10.1002/jlb.57.2.335	41	344	368	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10095	10098		10.1074/jbc.273.17.10095	http://dx.doi.org/10.1074/jbc.273.17.10095			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553055	hybrid			2022-12-27	WOS:000073224200004
J	Hu, T; Chang, S; Hsieh, TS				Hu, T; Chang, S; Hsieh, TS			Identifying Lys(359) as a critical residue for the ATP dependent reactions of Drosophila DNA topoisomerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC TOPOISOMERASE; CLEAVAGE SITES; 2-GATE MECHANISM; ANTITUMOR DRUGS; PROTEIN CLAMP; STRANDED-DNA; B-SUBUNIT; ENZYME; GYRASE; YEAST	Substituting Lys(359) With either Gin or Glu in the highly conserved QTK-loop in the DNA gyrase B protein homologous domain of Drosophila topoisomerase II inactivates its catalytic activities. Although strand passage and DNA dependent ATPase activities are affected in these mutant proteins, their DNA cleavage activity is comparable with the wild-type enzyme and can be stimulated to the same level by topoisomerase-targeting anticancer drugs. The sequence specificity in the DNA cleavage reaction remains unaltered for the mutant proteins. We have used both glass fiber filter binding assay and CsCl density gradient ultracentrifugation to monitor the formation of a salt-stable, protein-clamp complex. Both Gin and Glu mutant proteins can form a clamp complex in the presence of 5'-adenylyl-beta,gamma-imidodiphosphate, albeit with a lower efficiency than the wild-type enzyme. However, the mutant proteins can form a stable complex either in the presence of ATP or in the absence of any cofactors, These results are in an interesting contrast with the wild-type enzyme, which cannot form a stable complex under similar conditions. Our data suggest that Lys(359) is critical for the catalytic activity of topoisomerase II and may have an important function in the ATP signaling process.	Duke Univ, Med Ctr, Dept Biochem, DUMC, Durham, NC 27710 USA	Duke University	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, DUMC, Box 3711, Durham, NC 27710 USA.		Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012		NIGMS NIH HHS [GM29006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BOROS I, 1984, GENE, V30, P257, DOI 10.1016/0378-1119(84)90130-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Caron P R, 1994, Adv Pharmacol, V29B, P271; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; CHEN GL, 1984, J BIOL CHEM, V259, P3560; CORBETT AH, 1993, J BIOL CHEM, V268, P14394; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21335; DEPEW RE, 1978, J BIOL CHEM, V253, P511; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; HORABIN JI, 1993, MOL CELL BIOL, V13, P1408, DOI 10.1128/MCB.13.3.1408; HSIEH TS, 1983, METHOD ENZYMOL, V100, P161; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; JACKSON AP, 1993, P NATL ACAD SCI USA, V90, P11232, DOI 10.1073/pnas.90.23.11232; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MP, 1989, J BIOL CHEM, V264, P21779; LEE MP, 1994, J MOL BIOL, V235, P436, DOI 10.1006/jmbi.1994.1004; LEE MP, 1989, J BIOL CHEM, V264, P13510; LINDSLEY JE, 1993, NATURE, V361, P749, DOI 10.1038/361749a0; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; MIZUUCHI K, 1978, P NATL ACAD SCI USA, V75, P5960, DOI 10.1073/pnas.75.12.5960; MULLER MT, 1988, BIOCHEMISTRY-US, V27, P8369, DOI 10.1021/bi00422a012; NELSON EM, 1984, P NATL ACAD SCI-BIOL, V81, P1361, DOI 10.1073/pnas.81.5.1361; ODea MH, 1996, J BIOL CHEM, V271, P9723, DOI 10.1074/jbc.271.16.9723; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; OSHEROFF N, 1983, J BIOL CHEM, V258, P9536; RICHARDSON DC, 1994, TRENDS BIOCHEM SCI, V19, P135, DOI 10.1016/0968-0004(94)90207-0; RIOU JF, 1986, BIOCHEM BIOPH RES CO, V137, P154, DOI 10.1016/0006-291X(86)91189-7; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Rybenkov VV, 1997, SCIENCE, V277, P690, DOI 10.1126/science.277.5326.690; SANDER M, 1983, J BIOL CHEM, V258, P8421; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; TAMURA JK, 1990, J BIOL CHEM, V265, P21342; TANABE K, 1991, CANCER RES, V51, P4903; THOMAS CA, 1979, ANAL BIOCHEM, V93, P158, DOI 10.1016/S0003-2697(79)80130-X; UDVARDY A, 1985, CELL, V40, P933, DOI 10.1016/0092-8674(85)90353-8; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; WYCKOFF E, 1988, P NATL ACAD SCI USA, V85, P6272, DOI 10.1073/pnas.85.17.6272; YANAGIDA M, 1987, NUCLEIC ACIDS MOL BI, V1, P196; YANG L, 1985, CELL, V41, P127, DOI 10.1016/0092-8674(85)90067-4; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014	51	28	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9586	9592		10.1074/jbc.273.16.9586	http://dx.doi.org/10.1074/jbc.273.16.9586			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545289	hybrid			2022-12-27	WOS:000073128800035
J	Inanami, O; Johnson, JL; McAdara, JK; El Benna, J; Faust, LRP; Newburger, PE; Babior, BM				Inanami, O; Johnson, JL; McAdara, JK; El Benna, J; Faust, LRP; Newburger, PE; Babior, BM			Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47(PHOX) on serine 303 or 304	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; PROTEIN-KINASE-C; CHRONIC GRANULOMATOUS-DISEASE; CELL-FREE SYSTEM; HUMAN-NEUTROPHILS; OKADAIC ACID; SUPEROXIDE PRODUCTION; COMPONENT P47(PHOX); PHAGOCYTE OXIDASE; TRANSLOCATION	The leukocyte NADPH oxidase is an enzyme in phagocytes and B lymphocytes that when activated catalyzes the production of O-2((.) over bar) from oxygen and NADPH, During oxidase activation, serine residues in the C-terminal quarter of the oxidase component p47(PHOX) become extensively phosphorylated, the protein acquiring as many as 9 phosphate residues. In a study of 11 p47(PHOX) mutants, each containing an alanine instead of a serine at a single potential phosphorylation site, we found that all but S379A corrected the defect in O-2((.) over bar) production in Epstein-Barr virus (EBV)-transformed p47(PHOX)-deficient B cells (Faust, L. P., El Benna, J., Babior, B. M., and Chanock, S. J. (1995) J. Clin. Invest. 96, 1499-1505). In particular, O-2((.) over bar) production was restored to these cells by the mutants S303A and S304A. Therefore, apart from serine 379, whose state of phosphorylation in the activated oxidase is unclear, no single potential phosphorylation site appeared to be essential for oxidase activation. We now report that the double mutant p47(PHOX) S303A/S304A was almost completely inactive when ex pressed in EBV-transformed p47(PHOX)-deficient B cells, even though it was expressed in normal amounts in the transfected cells and was able to translocate to the plasma membrane when the cells were stimulated, In contrast, the double mutant p47(PHOX) S303E/S304E was able to support high levels of O-2((.) over bar) production by EBV-transformed p47(PHOX)-deficient B cells. The surprising discovery that the double mutant S303K/S304K was also able to support considerable O-2((.) over bar) production suggests either that the effect of phosphorylation is related to the increase in hydrophilicity around serines 303 and 304 or that activation involves the formation of a metal bridge between the phosphorylated serines and another region of the protein.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01655 USA; CHU X Bichat, INSERM, U294, Paris, France	Scripps Research Institute; University of Massachusetts System; University of Massachusetts Worcester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Inanami, O (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.		Inanami, Osamu/A-5197-2012	Inanami, Osamu/0000-0001-7895-3918; McAdara, Jeanne/0000-0002-6364-0123; Newburger, Peter/0000-0002-8615-673X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033346, R21AI128479, R01AI028479, R37AI024227, R01AI024227] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-33346, AI-28479, AI-24227] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARAI M, 1993, BIOCHEM PHARMACOL, V46, P1487, DOI 10.1016/0006-2952(93)90116-E; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; DING JB, 1992, J BIOL CHEM, V267, P6442; DJERDJOURI B, 1995, EUR J PHARM-MOLEC PH, V288, P193, DOI 10.1016/0922-4106(95)90194-9; ElBenna J, 1995, BLOOD CELL MOL DIS, V21, P201, DOI 10.1006/bcmd.1995.0023; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; GARCIA RC, 1992, BIOCHEM J, V286, P687, DOI 10.1042/bj2860687; HAYAKAWA T, 1986, J BIOL CHEM, V261, P9109; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HEYWORTH PG, 1995, BIOCHEM J, V311, P81, DOI 10.1042/bj3110081; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; NAKANISHI A, 1992, J BIOL CHEM, V267, P19072; OHTSUKA T, 1986, BIOCHIM BIOPHYS ACTA, V888, P332, DOI 10.1016/0167-4889(86)90233-8; PARK JW, 1995, BIOCHEM BIOPH RES CO, V211, P410, DOI 10.1006/bbrc.1995.1829; PARK JW, 1992, J BIOL CHEM, V267, P17327; Park JW, 1997, J BIOL CHEM, V272, P11035; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; STEINBECK MJ, 1991, J BIOL CHEM, V266, P16336; SUZUKI K, 1995, BBA-MOL CELL RES, V1266, P261, DOI 10.1016/0167-4889(95)00029-R; THRASHER A, 1992, BLOOD, V80, P1125; TWOMEY B, 1990, BRIT J PHARMACOL, V100, P819, DOI 10.1111/j.1476-5381.1990.tb14098.x	26	150	151	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9539	9543		10.1074/jbc.273.16.9539	http://dx.doi.org/10.1074/jbc.273.16.9539			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545283	hybrid			2022-12-27	WOS:000073128800029
J	Jackson, JG; White, MF; Yee, D				Jackson, JG; White, MF; Yee, D			Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; IGF-I; TYROSINE PHOSPHORYLATION; GLUCOSE-TRANSPORT; IRS-1; EXPRESSION; KINASE; PROTEINS; LINE; SHC	Because insulin-like growth factor-I (IGF-I), insulin, and interleukin-4 (IL-4) have known biological effects in breast cancer cells and signal through insulin receptor substrate (IRS) adaptor proteins, we examined the expression and function of IRS-1 and IRS-2 in breast tumors and cell lines. IRS-1 and IRS-2 were expressed by cell lines and primary breast tumor specimens. IGF-I, insulin, and IL-4 treatment of MCF-7 and ZR-75, and IGF-I treatment of T47-D breast cancer cells, resulted in much greater tyrosine phosphorylation of IRS-1 compared with IRS-2. Furthermore, IGF-I stimulated greater tyrosine phosphorylation of IRS-1 than either insulin or IL-4. IGF-I treatment also enhanced association of the p85 regulatory subunit of phosphatidylinositol S-kinase with IRS-1 and stimulated increased enzymatic activity compared with IL-4 and insulin in all three cell lines. Similarly, mitogen-activated protein kinase activity was greater in IGF-I-stimulated cells. To determine the functional significance of the activation of these pathways, we inhibited activation of phosphatidylinositol 3-kinase with wortmannin and mitogen-activated protein kinase with PD098059. Both compounds inhibited IGF-stimulated growth, suggesting that both pathways contributed to the mitogenic response to IGF-I. We conclude that IRS-1, and not IRS-2, is the predominant signaling molecule activated by IGF-I, insulin, and IL-4. Furthermore, enhanced tyrosine phosphorylation of IRS-1 by IGF-I, compared with either insulin or IL-4, is associated with greater activation of mitogenic downstream signaling pathways resulting in enhanced cell growth.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Med Oncol, San Antonio, TX 78284 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA	University of Texas System; University of Texas Health San Antonio; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Yee, D (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Med Oncol, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.	doug@oncology.uthscsa.edu		Jackson, James Griffith/0000-0002-2640-6442; Yee, Douglas/0000-0002-3387-4009	NATIONAL CANCER INSTITUTE [P01CA030195, P30CA054174, K04CA001670] Funding Source: NIH RePORTER; NCI NIH HHS [KO4 CA 01670, P30 CA 54174, P01 CA 30195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BATES P, 1995, BRIT J CANCER, V72, P1189, DOI 10.1038/bjc.1995.484; BEITNERJOHNSON D, 1995, J BIOL CHEM, V270, P5187, DOI 10.1074/jbc.270.10.5187; Blais Y, 1996, MOL CELL ENDOCRINOL, V121, P11, DOI 10.1016/0303-7207(96)03843-9; Blakesley VA, 1996, ENDOCRINOLOGY, V137, P410, DOI 10.1210/en.137.2.410; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; CHOUDHURY GG, 1994, KIDNEY INT, V46, P37, DOI 10.1038/ki.1994.242; CLEVELAND DW, 1983, METHOD ENZYMOL, V96, P222; Coligan J.E., 1997, CURRENT PROTOCOLS PR; COSTANTINO A, 1993, MOL ENDOCRINOL, V7, P1667, DOI 10.1210/me.7.12.1667; CULLEN KJ, 1990, CANCER RES, V50, P48; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; ENGEL LW, 1978, CANCER RES, V38, P3352; FLIER JS, 1986, P NATL ACAD SCI USA, V83, P664, DOI 10.1073/pnas.83.3.664; Harada S, 1996, J BIOL CHEM, V271, P30222, DOI 10.1074/jbc.271.47.30222; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; KOTANIDES H, 1995, J BIOL CHEM, V270, P19481, DOI 10.1074/jbc.270.33.19481; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMMERS R, 1989, EMBO J, V8, P1369, DOI 10.1002/j.1460-2075.1989.tb03517.x; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Lee AV, 1995, BIOMED PHARMACOTHER, V49, P415, DOI 10.1016/0753-3322(96)82678-3; Li SW, 1996, J BIOL CHEM, V271, P12254, DOI 10.1074/jbc.271.21.12254; MCGUIRE WL, 1992, J NATL CANCER I, V84, P1336, DOI 10.1093/jnci/84.17.1336; MYAL Y, 1984, CANCER RES, V44, P5486; Myers MG, 1996, MOL CELL BIOL, V16, P4147; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; OKADA T, 1994, J BIOL CHEM, V269, P3568; ONeill TJ, 1996, J BIOL CHEM, V271, P22506, DOI 10.1074/jbc.271.37.22506; OSBORNE CK, 1976, P NATL ACAD SCI USA, V73, P4536, DOI 10.1073/pnas.73.12.4536; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PRUETT W, 1995, MOL CELL BIOL, V15, P1778; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; Rocha RL, 1997, CLIN CANCER RES, V3, P103; SEPPLORENZINO L, 1994, CELL GROWTH DIFFER, V5, P1077; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; Surmacz E, 1995, CLIN CANCER RES, V1, P1429; TARTAREDECKERT S, 1995, J BIOL CHEM, V270, P23456, DOI 10.1074/jbc.270.40.23456; TOI M, 1992, CANCER RES, V52, P275; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; YANO H, 1993, J BIOL CHEM, V268, P25846; YEE D, 1989, J BIOL CHEM, V264, P21439; YEE D, 1988, CANCER RES, V48, P6691; Yenush L, 1997, BIOESSAYS, V19, P491, DOI 10.1002/bies.950190608	50	154	158	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9994	10003		10.1074/jbc.273.16.9994	http://dx.doi.org/10.1074/jbc.273.16.9994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545345	hybrid, Green Submitted			2022-12-27	WOS:000073128800091
J	Shimizu, T; Cao, CX; Shao, RG; Pommier, Y				Shimizu, T; Cao, CX; Shao, RG; Pommier, Y			Lamin B phosphorylation by protein kinase C alpha and proteolysis during apoptosis in human leukemia HL60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II INHIBITORS; ISOLATED THYMOCYTE NUCLEI; DNA FRAGMENTATION; HL-60 CELLS; POLY(ADP-RIBOSE) POLYMERASE; ICE/CED-3 PROTEASE; ACTIVATION; DEGRADATION; INDUCTION; DEATH	Protein phosphorylation plays an important role in signal transduction, but its involvement in apoptosis still remains unclear. In this report, the p53-null human leukemia HL60 cells were used to investigate phosphorylation and degradation of lamin B during apoptosis. We found that lamin B was phosphorylated within I h after addition of the DNA topoisomerase I inhibitor, camptothecin, and that lamin B phosphorylation preceded lamin B degradation and DNA fragmentation. Using a cell-free system we also found that cytosol from camptothecin-treated cells induced lamin B phosphorylation and degradation in isolated nuclei from untreated HL60 cells. Lamin B phosphorylation was prevented by the protein kinase C (PKC) inhibitor 7-hydroxystaurosporine (UCN-01) but not by the Cdc2 inhibitor, flavopiridol. Phosphorylation of lamin B was inhibited by immunodepletion of PKC alpha from activated cytosol and was restored by addition of purified PKC alpha. PKC alpha activity also increased rapidly as lamin B was phosphorylated after initiation of the apoptotic response in HL60 cells. These data suggest that lamin B is phosphorylated by PKC alpha and proteolyzed before DNA fragmentation in HL60 cells undergoing apoptosis.	NCI, Mol Pharmacol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Div Basic Sci, NIH, Bldg 37,Rm 5D02, Bethesda, MD 20892 USA.							Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; BERTRAND R, 1995, DRUG DEVELOP RES, V34, P138, DOI 10.1002/ddr.430340206; BERTRAND R, 1993, EXP CELL RES, V207, P388, DOI 10.1006/excr.1993.1206; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Carlson BA, 1996, CANCER RES, V56, P2973; Chinnaiyan AM, 1996, CURR BIOL, V6, P555; CLAWSON GA, 1992, CELL GROWTH DIFFER, V3, P827; Collas P, 1997, J BIOL CHEM, V272, P21274, DOI 10.1074/jbc.272.34.21274; deAzevedo WF, 1996, P NATL ACAD SCI USA, V93, P2735, DOI 10.1073/pnas.93.7.2735; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Dubrez L, 1996, EMBO J, V15, P5504, DOI 10.1002/j.1460-2075.1996.tb00935.x; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; FIELDS AP, 1988, J BIOL CHEM, V263, P8253; Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GJERTSEN BT, 1995, BBA-MOL CELL RES, V1269, P187, DOI 10.1016/0167-4889(95)00117-B; HOCEVAR BA, 1993, J BIOL CHEM, V268, P7575; KAUFMANN SH, 1989, CANCER RES, V49, P5870; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Mandal M, 1996, J BIOL CHEM, V271, P30354, DOI 10.1074/jbc.271.48.30354; McConkey DJ, 1996, J BIOL CHEM, V271, P22398, DOI 10.1074/jbc.271.37.22398; McKeon F, 1991, CURR OPIN CELL BIOL, V3, P82, DOI 10.1016/0955-0674(91)90169-Y; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; NEAMATI N, 1995, J IMMUNOL, V154, P3788; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nigg E A, 1992, Semin Cell Biol, V3, P245, DOI 10.1016/1043-4682(92)90026-R; Nigg E A, 1991, Semin Cell Biol, V2, P261; OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827; POMMIER Y, 1996, SEMIN ONCOL, V23, P1; Pommier Yves, 1997, P153; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; SEYNAEVE CM, 1994, MOL PHARMACOL, V45, P1207; Shao RG, 1996, EXP CELL RES, V227, P190, DOI 10.1006/excr.1996.0266; Shao RG, 1997, J BIOL CHEM, V272, P31321, DOI 10.1074/jbc.272.50.31321; Shao RG, 1997, EXP CELL RES, V234, P388, DOI 10.1006/excr.1997.3650; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SHIMIZU T, 1995, CANCER RES, V55, P228; Shimizu T, 1997, LEUKEMIA, V11, P1238, DOI 10.1038/sj.leu.2400734; Shimizu T, 1996, EXP CELL RES, V226, P292, DOI 10.1006/excr.1996.0230; SOLARY E, 1993, BLOOD, V81, P1359; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; TAKAHASHI I, 1987, J ANTIBIOT, V40, P1782, DOI 10.7164/antibiotics.40.1782; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; UCKER DS, 1992, J IMMUNOL, V149, P1583; Whyte M, 1996, TRENDS CELL BIOL, V6, P245, DOI 10.1016/0962-8924(96)20025-X; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V233, P96, DOI 10.1006/bbrc.1997.6411	46	86	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8669	8674		10.1074/jbc.273.15.8669	http://dx.doi.org/10.1074/jbc.273.15.8669			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535842	hybrid			2022-12-27	WOS:000072990800019
J	Warn-Cramer, BJ; Cottrell, GT; Burt, JM; Lau, AF				Warn-Cramer, BJ; Cottrell, GT; Burt, JM; Lau, AF			Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMED-CELLS; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; POSSIBLE INVOLVEMENT; RETROVIRAL VECTORS; GENE-TRANSFER; INHIBITION; FIBROBLASTS; CHANNEL; CASCADE	Activation of the Ras/Raf/mitogen-activated protein kinase kinase/mitogen-activated protein (MAP) kinase signaling cascade is initiated by activation of growth factor receptors and regulates many cellular events, including cell cycle control, Our previous studies suggested that the connexin-43 gap junction protein may be a target of activated MAP kinase and that MAP kinase may regulate connexin 43 function, We identified the sites of MAP kinase phosphorylation in in vitro studies as the consensus MAP kinase recognition sites in the cytoplasmic carboxyl tail of connexin-43, Ser(255), Ser(279), and Ser(282). In this study, we demonstrate that activation of MAP kinase by ligand-induced activation of the epidermal growth factor (EGF) or lysophosphatidic acid receptors or by pervanadate-induced inhibition of tyrosine phosphatases results in increased phosphorylation on connexin-43, EGF and lysophosphatidic acid-induced phosphorylation on connexin-43 and the down-regulation of gap junctional communication in EGF-treated cells were blocked by a specific mitogen-activated protein kinase kinase inhibitor (PD98059) that prevented activation of MAP kinase, These studies confirm that connexin-43 is a MAP kinase substrate in vivo and that phosphorylation on Ser(255), Ser(279), and/or Ser(282) initiates the down-regulation of gap junctional communication, Studies with connexin-43 mutants suggest that MAP kinase phosphorylation at one or more of the tandem Ser(279)/Ser(282) sites is sufficient to disrupt gap junctional intercellular communication.	Canc Res Ctr Hawaii, Mol Carcinogenesis Sect, Honolulu, HI 96813 USA; Univ Hawaii Manoa, Sch Med, Dept Genet & Mol Biol, Honolulu, HI 96813 USA; Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Arizona	Warn-Cramer, BJ (corresponding author), Canc Res Ctr Hawaii, Mol Carcinogenesis Sect, 1236 Lauhala St, Honolulu, HI 96813 USA.	bwcramer@crch.hawaii.edu			NCI NIH HHS [CA 52098] Funding Source: Medline; NHLBI NIH HHS [HL 303470] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA052098] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHN NG, 1993, MOL CELL BIOCHEM, V128, P201, DOI 10.1007/BF01076771; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BERTHOUD VM, 1992, EUR J CELL BIOL, V57, P40; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; CHEN SC, 1995, CELL GROWTH DIFFER, V6, P681; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; CROW DS, 1992, ONCOGENE, V7, P999; DAHL G, 1992, BIOPHYS J, V62, P172, DOI 10.1016/S0006-3495(92)81803-9; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DOTTO GP, 1989, ONCOGENE, V4, P637; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ELFOULY MH, 1989, MOL CARCINOGEN, V2, P131, DOI 10.1002/mc.2940020305; FILSON AJ, 1990, CELL GROWTH DIFFER, V1, P661; GHOSHROY S, 1995, J MEMBRANE BIOL, V146, P15; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; HII CST, 1994, BIOCHEM J, V303, P475, DOI 10.1042/bj3030475; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; HOLTZWAGENBLATT A, 1993, CRIT REV ONCOGENESIS, V4, P541; HUSOY T, 1993, CARCINOGENESIS, V14, P2257, DOI 10.1093/carcin/14.11.2257; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KANEMITSU MY, 1993, MOL BIOL CELL, V4, P837, DOI 10.1091/mbc.4.8.837; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; KURATA WE, 1994, ONCOGENE, V9, P329; LAU AF, 1992, MOL BIOL CELL, V3, P865, DOI 10.1091/mbc.3.8.865; LIU SG, 1993, BIOPHYS J, V64, P1422, DOI 10.1016/S0006-3495(93)81508-X; Loewenstein W R, 1992, Semin Cell Biol, V3, P59; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; MALARKEY K, 1995, BIOCHEM J, V309, P361, DOI 10.1042/bj3090361; Martyn KD, 1997, CELL GROWTH DIFFER, V8, P1015; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; MESNIL M, 1993, MOL CARCINOGEN, V7, P14, DOI 10.1002/mc.2940070103; MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179; MIKALSEN O, 1997, INT GAP JUNCT C KEY, P78; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Musil Linda S., 1994, P173; OH SY, 1991, BIOCHIM BIOPHYS ACTA, V1094, P243, DOI 10.1016/0167-4889(91)90016-Q; PAGE E, 1986, HEART CARDIOVASCULAR, P573; REYNHOUT JK, 1992, EXP CELL RES, V198, P337, DOI 10.1016/0014-4827(92)90388-O; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SPRAY DC, 1995, ANN REV PHYSL, V47, P281; SWENSON KI, 1990, CELL REGUL, V1, P989, DOI 10.1091/mbc.1.13.989; TURIN L, 1977, NATURE, V270, P56, DOI 10.1038/270056a0; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; WARNCRAMER BJ, 1997, P 1997 INT GAP JUNCT, P276; YAMASAKI H, 1990, CARCINOGENESIS, V11, P1051, DOI 10.1093/carcin/11.7.1051; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Zhao ZZ, 1996, J BIOL CHEM, V271, P22251, DOI 10.1074/jbc.271.36.22251; ZHU DG, 1992, P NATL ACAD SCI USA, V89, P10218, DOI 10.1073/pnas.89.21.10218	56	285	291	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9188	9196		10.1074/jbc.273.15.9188	http://dx.doi.org/10.1074/jbc.273.15.9188			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535909	hybrid			2022-12-27	WOS:000072990800086
J	Abeliovich, H; Grote, E; Novick, P; Ferro-Novick, S				Abeliovich, H; Grote, E; Novick, P; Ferro-Novick, S			Tlg2p, a yeast syntaxin homolog that resides on the Golgi and endocytic structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSPORT VESICLES; NEUROTRANSMITTER RELEASE; PREVACUOLAR COMPARTMENT; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; SECRETORY PATHWAY; VACUOLAR; COMPLEX	Intracellular membrane fusion events in eukaryotic cells are thought to be mediated by protein-protein interactions between soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex proteins. We have identified and analyzed a new yeast syntaxin homolog, Tlg2p. Tlg2p is unique among known syntaxin family proteins in possessing a sizeable hydrophilic domain of 63 amino acids that is C-terminal to the membrane spanning region and nonessential for Tlg2p function. Tlg2p resides on the endosome and late Golgi by co-localization with an endocytic intermediate and co-fractionation with markers for both endosomes and late Golgi. Cells depleted for Tlg2p missort a portion of carboxypeptidase Y and are defective in endocytosis. In addition, we report that Tlg2p forms a SEC18-dependent SNARE complex with Snc2p, a vesicle SNARE known to function in Golgi to plasma membrane trafficking. Based on these findings we propose that Tlg2p is a t-SNARE that functions in transport from the endosome to the late Golgi and on the endocytic pathway.	Yale Univ, Boyer Ctr Mol Med, Dept Cell Biol, Sch Med,Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Ferro-Novick, S (corresponding author), Yale Univ, Boyer Ctr Mol Med, Dept Cell Biol, Sch Med,Howard Hughes Med Inst, 295 Congress Ave,Rm 254B, New Haven, CT 06510 USA.	susan_ferronovick@quickmail.yale.edu			NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NCI NIH HHS [CA46128] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Bryant NJ, 1997, J CELL BIOL, V136, P287, DOI 10.1083/jcb.136.2.287; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; COUVE A, 1994, J BIOL CHEM, V269, P23391; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; DULIC V, 1991, METHOD ENZYMOL, V194, P679; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Givan SA, 1997, MOL BIOL CELL, V8, P1317, DOI 10.1091/mbc.8.7.1317; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hicke L, 1997, MOL BIOL CELL, V8, P13, DOI 10.1091/mbc.8.1.13; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; LIAN JP, 1993, CELL, V73, P735, DOI 10.1016/0092-8674(93)90253-M; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Pfeffer SR, 1996, ANNU REV CELL DEV BI, V12, P441, DOI 10.1146/annurev.cellbio.12.1.441; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; ROBERTS C J, 1991, P644; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Sherman F, 1979, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Vallejo Abbe N., 1995, P603; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; VIDA TA, 1993, J CELL BIOL, V121, P1245, DOI 10.1083/jcb.121.6.1245; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046	47	95	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11719	11727		10.1074/jbc.273.19.11719	http://dx.doi.org/10.1074/jbc.273.19.11719			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565594	hybrid			2022-12-27	WOS:000073536700048
J	Asano, K; Niimi, T; Yokoyama, S; Mizobuchi, K				Asano, K; Niimi, T; Yokoyama, S; Mizobuchi, K			Structural basis for binding of the plasmid ColIb-P9 antisense Inc RNA to its target RNA with the 5 '-rUUGGCG-3 ' motif in the loop sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPZ GENE-EXPRESSION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MESSENGER-RNA; DNA; REPLICATION; CLONING; SYSTEM; VITRO	The sequence 5'-rUUGGCG-3' is conserved within the loop regions of antisense RNAs or their targets involved in replication of various prokaryotic plasmids, In IncI alpha plasmid ColIb-P9, the partially base paired al-nucleotide loop of a stem-loop called structure I within RepZ mRNA contains this hexanucleotide sequence, and comprises the target site for the antisense Inc RNA. In this report, we find that the base pairing interaction at the 5'-rGGC-3' sequence in the hexanucleotide motif is important for interaction between Inc RNA and structure I. In addition, the 21-base loop domain of structure I is folded tighter than predicted, with the hexanucleotide sequence at the top. The second U residue in the sequence is favored for Inc RNA binding in a base-specific manner. On the other hand, the upper domain of the Inc RNA stem-loop is loosely structured, and maintaining the loop sequence single-stranded is important for the intermolecular interaction. Based on these results, we propose that a structural feature in the loop I domain, conferred probably by the conserved 5'-rUUGGCG-3' sequence, favors binding to a complementary, single-stranded RNA. This model also explains how the RepZ mRNA pseudoknot, described in the accompanying paper (Asano, I,, and Mizobuchi, K. (1998) J. Biol. Chem. 273, 11815-11825) is formed specifically with structure I. A possible conformation adopted by the 5'-rUUGGCG-3' loop sequence is discussed.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 113, Japan; Univ Electrocommun, Dept Appl Phys & Chem, Chofu, Tokyo 182, Japan	University of Tokyo; University of Electro-Communications - Japan	Asano, K (corresponding author), NICHD, Lab Eukaryot Gene Regulat, NIH, Bethesda, MD 20892 USA.		Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338				ASANO K, 1991, J BIOL CHEM, V266, P3774; ASANO K, 1991, J BIOL CHEM, V266, P24549; Asano K, 1998, J BIOL CHEM, V273, P11815, DOI 10.1074/jbc.273.19.11815; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; COHEN SN, 1995, CELL, V80, P829, DOI 10.1016/0092-8674(95)90284-8; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3; HAMA C, 1990, J BACTERIOL, V172, P1983, DOI 10.1128/jb.172.4.1983-1991.1990; HJALT TAH, 1995, NUCLEIC ACIDS RES, V23, P580, DOI 10.1093/nar/23.4.580; JAEGER JA, 1993, BIOCHEMISTRY-US, V32, P12522, DOI 10.1021/bi00097a032; Kato A, 1994, DNA Res, V1, P201, DOI 10.1093/dnares/1.5.201; KITTLE JD, 1989, J MOL BIOL, V210, P561, DOI 10.1016/0022-2836(89)90132-0; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P448; Malmgren C, 1997, J BIOL CHEM, V272, P12508, DOI 10.1074/jbc.272.19.12508; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Miller J.H., 1972, EXPT MOL GENETICS; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; MURRAY NE, 1974, NATURE, V251, P476, DOI 10.1038/251476a0; Sambrook J., 2002, MOL CLONING LAB MANU; SHIBA K, 1990, J BACTERIOL, V172, P1992, DOI 10.1128/jb.172.4.1992-1997.1990; SIEMERING KR, 1994, J BACTERIOL, V176, P2677, DOI 10.1128/JB.176.9.2677-2688.1994; SIEMERING KR, 1993, J BACTERIOL, V175, P2895, DOI 10.1128/JB.175.10.2895-2906.1993; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; SUGIYAMA T, 1993, NUCLEIC ACIDS RES, V21, P5972, DOI 10.1093/nar/21.25.5972; SUSSMAN JL, 1978, J MOL BIOL, V123, P607, DOI 10.1016/0022-2836(78)90209-7; TOMIZAWA J, 1984, CELL, V38, P861, DOI 10.1016/0092-8674(84)90281-2; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wilson IW, 1997, J BACTERIOL, V179, P742, DOI 10.1128/jb.179.3.742-753.1997	33	39	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11826	11838		10.1074/jbc.273.19.11826	http://dx.doi.org/10.1074/jbc.273.19.11826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565607	hybrid			2022-12-27	WOS:000073536700061
J	Malanga, M; Pleschke, JM; Kleczkowska, HE; Althaus, FR				Malanga, M; Pleschke, JM; Kleczkowska, HE; Althaus, FR			Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE; POLYMERASE; ACTIVATION; ENDS; SITE	DNA strand breaks are potential interaction sites for the nuclear enzyme poly(ADP ribose) polymerase (PARP; E.C. 2.4.2.30) and the tumor suppressor protein p53. Both proteins bind and respond to DNA breaks and both play a role in DNA damage signaling. A temporary colocalization and complex formation between these proteins has been demonstrated in mammalian cells. Here we show that free and poly(ADP-ribose) polymerase-bound ADP-ribose polymers target three domains in p53 protein for strong noncovalent interactions. The polymer binding sites could be mapped to two amino acid sequences in the sequence-specific core DNA binding domain of p53 (amino acid positions 153-178 and 231-253) and another one in the oligomerization domain (amino acids 326-348). In mobility shift experiments, poly(ADP-ribose) effectively prevented and reversed p53 binding to the palindromic p53 consensus sequence. Additionally, poly(ADP-ribose) also interfered with the DNA single strand end binding of p53. The results suggest that ADP-ribose polymers could play a role in regulating the DNA binding properties of p53.	Univ Zurich, Tierspital, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Zurich	Althaus, FR (corresponding author), Univ Zurich, Tierspital, Inst Pharmacol & Toxicol, Winterthurerstr 260, CH-8057 Zurich, Switzerland.	fra@vetpharm.unizh.ch						Agarwal ML, 1997, ONCOGENE, V15, P1035, DOI 10.1038/sj.onc.1201274; BAKALKIN G, 1995, NUCLEIC ACIDS RES, V23, P362, DOI 10.1093/nar/23.3.362; BAKALKIN G, 1994, P NATL ACAD SCI USA, V91, P413, DOI 10.1073/pnas.91.1.413; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; CHEN XB, 1993, GENE DEV, V7, P1837, DOI 10.1101/gad.7.10.1837; COX LS, 1995, BIOESSAYS, V17, P501, DOI 10.1002/bies.950170606; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; FRIEDMAN P, 1993, P NATL ACAD SCI USA, V93, P3319; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAEMMLI U, 1970, NATURE, V227, P620; Li XQ, 1996, J BIOL CHEM, V271, P4447; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; MALANGA M, 1995, ANAL BIOCHEM, V228, P245, DOI 10.1006/abio.1995.1346; NIEWOLIK D, 1995, ONCOGENE, V10, P881; PANZETER PL, 1993, J BIOL CHEM, V268, P17662; PANZETER PL, 1992, BIOCHEM, V31, P1380; REALINI CA, 1992, J BIOL CHEM, V267, P18858; RUPPERT JM, 1993, MOL CELL BIOL, V13, P3811, DOI 10.1128/MCB.13.6.3811; Selivanova G, 1996, NUCLEIC ACIDS RES, V24, P3560, DOI 10.1093/nar/24.18.3560; TAKENAKA I, 1995, J BIOL CHEM, V270, P5405, DOI 10.1074/jbc.270.10.5405; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; WANG Y, 1993, GENE DEV, V7, P2575, DOI 10.1101/gad.7.12b.2575; WesierskaGadek J, 1996, J CELL BIOCHEM, V62, P90, DOI 10.1002/(SICI)1097-4644(199607)62:1<90::AID-JCB10>3.0.CO;2-J; WHITACRE CM, 1995, CANCER RES, V55, P3697	28	195	201	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11839	11843		10.1074/jbc.273.19.11839	http://dx.doi.org/10.1074/jbc.273.19.11839			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565608	hybrid			2022-12-27	WOS:000073536700062
J	Murray, NR; Fields, AP				Murray, NR; Fields, AP			Phosphatidylglycerol is a physiologic activator of nuclear protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PROLIFERATION; PHOSPHOLIPASE-C; LEUKEMIA-CELLS; DIFFERENTIATION; IDENTIFICATION; MEMBRANES; ISOTYPES	A major mechanism by which protein kinase C (PKC) function is regulated is through the selective targeting and activation of individual PKC isotypes at distinct subcellular locations. PHC beta(II), is selectively activated at the nucleus during G(2), phase of cell cycle where it is required for entry into mitosis. Selective nuclear activation of PKC beta(II), is conferred by molecular determinants within the carboxyl-terminal catalytic domain of the kinase (Walker, S. D., Murray, N. R., Burns, D. J., and Fields, A. P. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 9156-9160). We previously described a lipid-like PRC activator in nuclear membranes, termed nuclear membrane activation factor (NMAF), that potently stimulates PRC beta(II), activity through interactions involving this domain (Murray, N. R., Burns, D. J., and Fields, AP. (1994) J. Biol. Chem. 269, 21385-21390). We have now identified NMAF as phosphatidylglycerol (PG), based on several lines of evidence. First, NMAF cofractionates with PG as a single peak of activity through multiple chromatographic separations and exhibits phospholipase sensitivity identical to that of PG. Second, purified PG, but not other phospholipids, exhibits dose-dependent NMAF activity. Third, defined molecular species of PG exhibit different abilities to stimulate PKC beta(II), activity. 1,2-Dioleoyl-PG possesses significantly higher activity than other PG species, suggesting that both fatty acid side chain composition and the glycerol head group are important determinants for activity. Fourth, in vitro binding studies demonstrate that PG binds to the carboxyl-terminal region of PKC beta(II),, the same region we previously implicated in NMAF-mediated activation of PKC beta(II),. Taken together, our results indicate that specific molecular species of nuclear PG function to physiologically regulate PKC beta(II), activity at the nucleus.	Univ Texas, Med Branch, Sealy Ctr Oncol & Hematol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Pharmacol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Fields, AP (corresponding author), Univ Texas, Med Branch, Sealy Ctr Oncol & Hematol, Med Res Bldg,Rm 9-104,301 Univ Blvd, Galveston, TX 77555 USA.				NCI NIH HHS [CA56869] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA056869] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7961, DOI 10.1021/bi00246a013; Bell R M, 1986, Methods Enzymol, V124, P353; BHAMIDIPATI SP, 1993, J BIOL CHEM, V268, P2431; CLEMENS MJ, 1992, J CELL SCI, V103, P881; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARILOVA NJ, 1992, BIOCHIM BIOPHYS ACTA, V1105, P328; GOSS VL, 1994, J BIOL CHEM, V269, P19074; HOCEVAR BA, 1991, J BIOL CHEM, V266, P28; HOCEVAR BA, 1992, J CELL SCI, V101, P671; HOCEVAR BA, 1993, J BIOL CHEM, V268, P7545; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; JONES GW, 1994, CLIN CHEM, V40, P418; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Murray NR, 1997, J BIOL CHEM, V272, P27521, DOI 10.1074/jbc.272.44.27521; MURRAY NR, 1994, J BIOL CHEM, V269, P21385; MURRAY NR, 1993, J BIOL CHEM, V268, P15847; MURRAY NR, 1997, PROTEIN KINASE C; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4668; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12742, DOI 10.1021/bi00166a005; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; TAGUCHI R, 1987, J BIOCHEM-TOKYO, V102, P803, DOI 10.1093/oxfordjournals.jbchem.a122119; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; VINSON JA, 1977, J CHROMATOGR, V135, P226, DOI 10.1016/S0021-9673(00)86325-6; WALKER SD, 1995, P NATL ACAD SCI USA, V92, P9156, DOI 10.1073/pnas.92.20.9156	30	67	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11514	11520		10.1074/jbc.273.19.11514	http://dx.doi.org/10.1074/jbc.273.19.11514			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565565	hybrid			2022-12-27	WOS:000073536700019
J	Plesofsky-Vig, N; Brambl, R				Plesofsky-Vig, N; Brambl, R			Characterization of an 88-kDa heat shock protein of Neurospora crassa that interacts with hsp30	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; ALPHA-CRYSTALLIN; NUCLEOTIDE-SEQUENCE; CHAPERONE ACTIVITY; HUMAN HSP70; GENE; EXPRESSION; CLONING; IDENTIFICATION; SUBFAMILY	The small heat shock protein of Neurospora crassa, Hsp30, when employed in affinity chromatography, bound two cellular proteins that were identified as Hsp70 and Hsp88. Both Hsp70 and Hsp88 bound to Hsp30 in preference to other proteins, but binding of Hsp88 was more selective for Hsp30, and a direct interaction was observed, Transcripts for Hsp88, a newly characterized protein, are present at normal temperature, but they are strongly induced by heat shock. Its cDNA sequence predicts a protein with homology to mammalian Hsp110 family proteins, which are distantly related to Hsp70 Hsp88 and its homologues show greater similarity to Hsp70 in its N-terminal ATPase domain than in the C-terminal peptide-binding domain, and its ATP-binding motifs are conserved. Nevertheless, the N-terminal domain of Hsp88 land related proteins) is consistently more hydrophobic and more basic than that of Hsp70 proteins. Within the C-terminal domain, the sequence corresponding to the DnaK alpha subdomain is conserved in the HspB8/Hsp110 family proteins, whereas the DnaK beta subdomain sequence is not conserved. The interaction between Hsp70 and Hsp30 may reflect their cooperation as cochaperones for denatured proteins, whereas Hsp88 and Hsp30 may form a complex that interacts with potential substrates.	Univ Minnesota, BioSci Ctr 220, Dept Genet & Cell Biol, St Paul, MN 55108 USA; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; Univ Minnesota, Inst Plant Mol Genet, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Plesofsky-Vig, N (corresponding author), Univ Minnesota, BioSci Ctr 220, Dept Genet & Cell Biol, 1445 Gortner Ave, St Paul, MN 55108 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019398] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-19398] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BRAMBL R, 1975, BIOCHIM BIOPHYS ACTA, V396, P175, DOI 10.1016/0005-2728(75)90032-8; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FATHALLAH DM, 1993, J IMMUNOL, V151, P810; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FRACELLA F, 1993, EXP MYCOL, V17, P362, DOI 10.1006/emyc.1993.1035; Frohman Michael A., 1994, P14; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HOPF N, 1992, PLANT MOL BIOL, V19, P623, DOI 10.1007/BF00026788; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; INGOLIA TD, 1980, CELL, V21, P669, DOI 10.1016/0092-8674(80)90430-4; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; KAPOOR M, 1995, J BACTERIOL, V177, P212, DOI 10.1128/jb.177.1.212-221.1995; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Kojima R, 1996, J BIOL CHEM, V271, P12327, DOI 10.1074/jbc.271.21.12327; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LEEYOON D, 1995, J BIOL CHEM, V270, P15725, DOI 10.1074/jbc.270.26.15725; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; MORIMOTO RI, 1986, J BIOL CHEM, V261, P2692; MUKAI H, 1993, GENE, V132, P57; ORBACH MJ, 1990, J BIOL CHEM, V265, P10981; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; PLESOFSKYVIG N, 1995, P NATL ACAD SCI USA, V92, P5032, DOI 10.1073/pnas.92.11.5032; PLESOFSKYVIG N, 1990, J BIOL CHEM, V265, P15432; PLESOFSKYVIG N, 1992, J MOL EVOL, V35, P537, DOI 10.1007/BF00160214; RAVE N, 1979, NUCLEIC ACIDS RES, V6, P3559, DOI 10.1093/nar/6.11.3559; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sambrook J., 2002, MOL CLONING LAB MANU; SLATER MR, 1989, NUCLEIC ACIDS RES, V17, P805, DOI 10.1093/nar/17.2.805; Storozhenko S, 1996, FEBS LETT, V390, P113, DOI 10.1016/0014-5793(96)00640-0; VASSILEV AO, 1992, BIOCHIM BIOPHYS ACTA, V1156, P1, DOI 10.1016/0304-4165(92)90087-B; WANG KY, 1994, J BIOL CHEM, V269, P13601; WELCH WJ, 1985, MOL CELL BIOL, V5, P1229, DOI 10.1128/MCB.5.6.1229; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YASUDA K, 1995, J BIOL CHEM, V270, P29718, DOI 10.1074/jbc.270.50.29718; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	44	20	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11335	11341		10.1074/jbc.273.18.11335	http://dx.doi.org/10.1074/jbc.273.18.11335			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556627	hybrid			2022-12-27	WOS:000073395200079
J	Wang, TF; Guidotti, G				Wang, TF; Guidotti, G			Golgi localization and functional expression of human uridine diphosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANOSINE DIPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; RAT-LIVER; NUCLEOSIDE-DIPHOSPHATASE; APPARATUS; VESICLES; PROTEIN; GALACTOSYLTRANSFERASE; SIALYLTRANSFERASE; GLYCOSYLATION	A full-length E(ecto)-ATPase (Plesner, L. (1995) Inf. Rev. Cytol, 158, 141-214) cDNA was cloned from a human brain cDNA library; it encodes a 610-amino acid protein that contains two putative transmembrane domains. Heterologous expression of this protein in COS-7 cells caused a significant increase in intracellular membrane-bound nucleoside phosphatase activity. The activity was highest with UDP as substrate and was stimulated by divalent cations in the following order: Ca2+ much greater than Mg2+ > Mn2+. The results of immunofluorescence staining indicate that this protein is located in the Golgi apparatus. UDP hydrolysis was increased in the presence of Triton X-100 or alamethicin, an ionophore that facilitates movement of UDP across the membrane, suggesting that the active site of this UDPase is on the luminal side of the Golgi apparatus. This is the first identification of a mammalian Golgi luminal UDPase gene. Computer-aided sequence analysis of the E-ATPase superfamily indicates that the human UDPase is highly similar to two hypothetical proteins of the nematode Caenorhabditis elegans and to an unidentified 71.9-kDa yeast protein and is less related 60 the previously identified yeast Golgi GDPase.	Harvard Univ, Dept Cell & Mol Biol, Cambridge, MA 02138 USA	Harvard University	Guidotti, G (corresponding author), Harvard Univ, Dept Cell & Mol Biol, 7 Divin Ave, Cambridge, MA 02138 USA.		Wang, Ting-Fang/ABI-3818-2020	Wang, Ting-Fang/0000-0001-6306-9505	NHLBI NIH HHS [HL08893] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307; ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; Abeijon C, 1997, TRENDS BIOCHEM SCI, V22, P203, DOI 10.1016/S0968-0004(97)01053-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BERMUDES D, 1994, J BIOL CHEM, V269, P29252; BERNINSONE P, 1994, J BIOL CHEM, V269, P207; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; BRANDAN E, 1982, BIOCHEMISTRY-US, V21, P4640, DOI 10.1021/bi00262a019; Chadwick BP, 1997, MAMM GENOME, V8, P668, DOI 10.1007/s003359900534; Coppi MV, 1997, ARCH BIOCHEM BIOPHYS, V346, P312, DOI 10.1006/abbi.1997.0332; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; FLEISCHER B, 1981, J CELL BIOL, V89, P246, DOI 10.1083/jcb.89.2.246; FLEISCHER B, 1993, BIOCHEMISTRY-US, V32, P2076, DOI 10.1021/bi00059a027; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; Hsieh HL, 1996, PLANT MOL BIOL, V30, P135, DOI 10.1007/BF00017808; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kegel B, 1997, NEUROPHARMACOLOGY, V36, P1189, DOI 10.1016/S0028-3908(97)00115-9; KHATRA BS, 1974, EUR J BIOCHEM, V44, P537, DOI 10.1111/j.1432-1033.1974.tb03513.x; Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; KUHN NJ, 1977, BIOCHEM J, V168, P423, DOI 10.1042/bj1680423; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PLESNER L, 1995, INT REV CYTOL, V158, P141; SABBADINI RA, 1989, J BIOENERG BIOMEMBR, V21, P163, DOI 10.1007/BF00812068; Swift LL, 1996, J BIOL CHEM, V271, P31491; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang TF, 1997, MOL BRAIN RES, V47, P295, DOI 10.1016/S0169-328X(97)00066-1; Wang TF, 1996, J BIOL CHEM, V271, P9898, DOI 10.1074/jbc.271.17.9898; YANAGISAWA K, 1990, J BIOL CHEM, V265, P19351; YOON KL, 1994, J BIOL CHEM, V269, P28249	37	95	101	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11392	11399		10.1074/jbc.273.18.11392	http://dx.doi.org/10.1074/jbc.273.18.11392			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556635	hybrid, Green Published			2022-12-27	WOS:000073395200087
J	Ballesteros, J; Kitanovic, S; Guarnieri, F; Davies, P; Fromme, BJ; Konvicka, K; Chi, L; Millar, RP; Davidson, JS; Weinstein, H; Sealfon, SC				Ballesteros, J; Kitanovic, S; Guarnieri, F; Davies, P; Fromme, BJ; Konvicka, K; Chi, L; Millar, RP; Davidson, JS; Weinstein, H; Sealfon, SC			Functional microdomains in g-protein-coupled receptors - The conserved Arginine-cage motif in the gonadotropin-releasing hormone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROJECTION STRUCTURE; LIGHT ACTIVATION; BINDING-SITES; RHODOPSIN; CLONING; 5-HYDROXYTRYPTAMINE(2A); EXPRESSION; SEROTONIN; RESIDUES; HELICES	An Arg present in the third transmembrane domain of all rhodopsin-like Gr-protein-coupled receptors is required for efficient signal transduction, Mutation of this Arg in the gonadotropin-releasing hormone receptor to Gin, His, or Lys abolished or severely impaired agonist-stimulated inositol phosphate generation, consistent with Arg having a role in receptor activation. To investigate the contribution of the surrounding structural domain in the actions of the conserved Arg, an integrated microdomain modeling and mutagenesis approach has been utilized. Two conserved residues that constrain the Arg side chain to a limited number of conformations have been identified. In the inactive wild-type receptor, the Arg side chain is proposed to form an ionic interaction with Asp(3.49(138)). Experimental results for the Asp(3.49(138)) --> Asn mutant receptor show a modestly enhanced receptor efficiency, consistent with the hypothesis that weakening the Asp(3.49(138))-Arg(3.50(139)) interaction by protonation of the Asp or by the mutation to Asn favors activation. With activation, the Asp(3.49(138)) Arg(3.50(139)) ionic bond would break, and the unrestrained Arg would be prevented from orienting itself toward the water phase by a steric clash with Ile(3.54(143)). The mutation IIe(3.54(143))--> Ala, which eliminates this clash in simulations, causes a marked reduction in measured receptor signaling efficiency, implying that solvation of Arg(3.50(139)) prevents it from functioning in the activation of the receptor. These data are consistent with residues Asp(3.49(138))and Ile(3.54(143)) forming a structural motif, which helps position Arg in its appropriate inactive and active receptor conformations.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Univ Cape Town, Dept Chem Pathol, ZA-7925 Cape Town, South Africa	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Cape Town	Ballesteros, J (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Box 1218, New York, NY 10029 USA.		WEINSTEIN, HAREL/O-8245-2019	WEINSTEIN, HAREL/0000-0003-3473-9818; SEALFON, Stuart/0000-0001-5791-1217; Millar, Robert P/0000-0003-3606-2708	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135, K05DA000060] Funding Source: NIH RePORTER; NIDA NIH HHS [5T32DA07135, KO5 DA00060] Funding Source: Medline; NIDDK NIH HHS [R01 DK46943] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Almaula N, 1996, J BIOL CHEM, V271, P14672, DOI 10.1074/jbc.271.25.14672; Almaula N, 1996, MOL PHARMACOL, V50, P34; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Arora KK, 1997, MOL ENDOCRINOL, V11, P1203, DOI 10.1210/me.11.9.1203; BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; CHI L, 1993, MOL CELL ENDOCRINOL, V91, P1; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Elling CE, 1996, EMBO J, V15, P6213, DOI 10.1002/j.1460-2075.1996.tb01011.x; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P8812, DOI 10.1021/bi00027a033; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Laakkonen LJ, 1996, BIOCHEMISTRY-US, V35, P7651, DOI 10.1021/bi952203j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; MIN KC, 1993, J BIOL CHEM, V268, P9400; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; OLIVEIRA L, 1994, TRENDS PHARMACOL SCI, V15, P170, DOI 10.1016/0165-6147(94)90137-6; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; RATH P, 1993, BIOCHEMISTRY-US, V32, P10277, DOI 10.1021/bi00090a001; REES DC, 1989, ANNU REV BIOCHEM, V58, P607; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Scheer A, 1997, J RECEPT SIGNAL TR R, V17, P57, DOI 10.3109/10799899709036594; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SCHERTLER GFX, 1995, P NATL ACAD SCI USA, V92, P11578, DOI 10.1073/pnas.92.25.11578; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; SEALFON SC, 1996, METH NEUROSCI, V29, P143; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; TSUTSUMI M, 1992, MOL ENDOCRINOL, V6, P1163, DOI 10.1210/me.6.7.1163; vanRhee AM, 1996, DRUG DEVELOP RES, V37, P1, DOI 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S; ZHANG DQ, 1993, J MED CHEM, V36, P934, DOI 10.1021/jm00059a021; ZHOU W, 1994, MOL PHARMACOL, V45, P165; ZHOU W, 1995, J BIOL CHEM, V270, P18853, DOI 10.1074/jbc.270.32.18853	38	222	224	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10445	10453		10.1074/jbc.273.17.10445	http://dx.doi.org/10.1074/jbc.273.17.10445			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553103	hybrid			2022-12-27	WOS:000073224200052
J	Gredinger, E; Gerber, AN; Tamir, Y; Tapscott, SJ; Bengal, E				Gredinger, E; Gerber, AN; Tamir, Y; Tapscott, SJ; Bengal, E			Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; NEURONAL DIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; MYOBLAST DIFFERENTIATION; MYOD TRANSCRIPTION; MAMMALIAN-CELLS; MYOGENIC CELLS; DNA-BINDING; PC12 CELLS; IN-VIVO	The differentiation of muscle cells is controlled by the MyoD family of transcription factors. This family is regulated by extracellular growth factors that transmit largely unknown signals into the cells. Here we show that the activity of extracellular signal-regulated protein kinase (ERK), a kinase that is part of the mitogenactivated protein kinase (MAPK) cascade, is low in myoblasts and is induced with the onset of terminal differentiation of C2 cells. ERK activity is also induced in fibroblasts that were modified to express MyoD, but not in the parental fibroblast cells. Thus, ERK induction is an intrinsic property of muscle cells. A specific MAPK kinase inhibitor (PD098059) that was added to C2 cells partially inhibited the fusion of myoblasts to multinucleated myotubes without affecting the expression of muscle-specific markers. This inhibitor blocked the induction of MyoD expression that normally takes place during terminal differentiation. Two lines of evidence suggest that the MAPK cascade induces the activity of MyoD: 1) the expression of constitutively activated forms of MEK1 or Raf1 enhanced the transcriptional activity of MyoD in 10T1/2 fibroblasts; and 2) the addition of PD098059 to fibroblast cells expressing a conditional MyoD-estrogen fusion protein significantly inhibited the expression of MyoD-responsive genes. Our results indicate that the MAPK pathway is activated in differentiating muscle cells and that it positively regulates the expression and activity of MyoD protein.	Technion Israel Inst Technol, Fac Med, Dept Biochem, Rappaport Inst Res Med Sci, IL-31096 Haifa, Israel; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Fred Hutchinson Cancer Center	Bengal, E (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Biochem, Rappaport Inst Res Med Sci, POB 9649, IL-31096 Haifa, Israel.			Tapscott, Stephen/0000-0002-0319-0968				AIREY JA, 1991, DEV BIOL, V148, P365, DOI 10.1016/0012-1606(91)90344-3; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; AN GH, 1982, MOL CELL BIOL, V2, P1628, DOI 10.1128/MCB.2.12.1628; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; BRENNAN TJ, 1990, J CELL BIOL, V110, P929, DOI 10.1083/jcb.110.4.929; CAMPBELL JS, 1995, P NATL ACAD SCI USA, V92, P870, DOI 10.1073/pnas.92.3.870; COFFER P, 1994, ONCOGENE, V9, P911; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; FELSENFELD AL, 1991, DEV BIOL, V148, P23, DOI 10.1016/0012-1606(91)90314-S; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Lassar AB, 1996, CURR OPIN NEUROBIOL, V6, P57, DOI 10.1016/S0959-4388(96)80009-2; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Moxham CM, 1996, J BIOL CHEM, V271, P30765, DOI 10.1074/jbc.271.48.30765; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pinset C, 1997, CR ACAD SCI III-VIE, V320, P367, DOI 10.1016/S0764-4469(97)85024-X; Ramocki MB, 1997, MOL CELL BIOL, V17, P3547, DOI 10.1128/MCB.17.7.3547; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; Soulez M, 1996, MOL CELL BIOL, V16, P6065; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Weyman CM, 1997, ONCOGENE, V14, P697, DOI 10.1038/sj.onc.1200874; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; ZENTELLA A, 1992, P NATL ACAD SCI USA, V89, P5176, DOI 10.1073/pnas.89.11.5176	51	170	173	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10436	10444		10.1074/jbc.273.17.10436	http://dx.doi.org/10.1074/jbc.273.17.10436			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553102	hybrid			2022-12-27	WOS:000073224200051
J	Spek, CA; Lannoy, VJ; Lemaigre, FP; Rousseau, GG; Bertina, RM; Reitsma, PH				Spek, CA; Lannoy, VJ; Lemaigre, FP; Rousseau, GG; Bertina, RM; Reitsma, PH			Type I protein C deficiency caused by disruption of a hepatocyte nuclear factor (HNF)-6/HNF-1 binding site in the human protein C gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENOUS THROMBOSIS; TRANSCRIPTION; REGION; EXPRESSION; MUTATIONS; ASSAY	Protein C is a vitamin K-dependent zymogen of a serine protease that inhibits blood coagulation by proteolytic inactivation of factors Va and VIIIa. Individuals affected by protein C deficiency are at risk for venous thrombosis. One such affected individual was shown earlier to carry a -14 T --> C mutation in the promoter region of the protein C gene. It is shown here that the region around this mutation corresponds to a binding site for the transcription factor hepatocyte nuclear factor (HNF)-6 and that this site completely overlaps an HNF-1 binding site. HNF-6 and HNF-1 bound in a mutually exclusive manner. The -14 T --> C mutation reduced HNF-6 binding. In transient transfection experiments, HNF-6 transactivated the wild-type protein C promoter and introduction of the mutation abolished transactivation by HNF-6. Similar experiments showed that wild-type protein C promoter activity was reduced by cotransfection of an HNF-1 expression vector. This inhibiting effect of HNF-1 was reversed to a stimulatory effect when promoter sequences either upstream or downstream of the HNF-6/HNF-1 site were deleted. It is concluded that HNF-6 is a major determinant of protein C gene activity. Moreover, this is the first report describing the putative involvement of HNF-6 and of an HNF-6 binding site in human pathology.	Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ Hosp, Dept Hematol, Ctr Hemostasis & Thrombosis Res, NL-2300 RC Leiden, Netherlands; Catholic Univ Louvain, Sch Med, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Spek, CA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Lab Expt Internal Med, Meibergdreef 9,rm G1-113, NL-1105 AZ Amsterdam, Netherlands.	C.A.SPEK@AMC.UVA.NL	Spek, Arnold/AAC-5866-2019; Bertina, Rogier/AGQ-5246-2022	Spek, Arnold/0000-0002-2149-4068; Lemaigre, Frederic/0000-0002-3609-434X				ALLAART CF, 1993, LANCET, V341, P134, DOI 10.1016/0140-6736(93)90003-Y; BERG LP, 1994, HUM MOL GENET, V3, P2147, DOI 10.1093/hmg/3.12.2147; BRANSON HE, 1983, LANCET, V2, P1165; BROEKMANS AW, 1983, NEW ENGL J MED, V309, P340, DOI 10.1056/NEJM198308113090604; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; ESMON CT, 1992, ARTERIOSCLER THROMB, V12, P135, DOI 10.1161/01.ATV.12.2.135; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; MARLAR RA, 1989, J PEDIATR-US, V114, P528, DOI 10.1016/S0022-3476(89)80688-2; Miao CH, 1996, J BIOL CHEM, V271, P9587, DOI 10.1074/jbc.271.16.9587; PLUTZKY J, 1986, P NATL ACAD SCI USA, V83, P546, DOI 10.1073/pnas.83.3.546; REITSMA PH, 1993, THROMB HAEMOSTASIS, V69, P77; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; Samadani U, 1996, MOL CELL BIOL, V16, P6273; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; SPEK CA, 1994, BLOOD COAGUL FIBRIN, V5, P309, DOI 10.1097/00001721-199404000-00022; SPEK CA, 1995, ARTERIOSCL THROM VAS, V15, P214, DOI 10.1161/01.ATV.15.2.214; SPEK CA, 1995, J BIOL CHEM, V270, P24216, DOI 10.1074/jbc.270.41.24216; Tsay W, 1996, DNA CELL BIOL, V15, P907, DOI 10.1089/dna.1996.15.907; Tsay W, 1997, DNA CELL BIOL, V16, P569, DOI 10.1089/dna.1997.16.569; VANHINSBERGH VWM, 1985, BLOOD, V65, P444; VAULONT S, 1989, J MOL BIOL, V209, P205, DOI 10.1016/0022-2836(89)90273-8; WALKER FJ, 1992, FASEB J, V6, P2561, DOI 10.1096/fasebj.6.8.1317308	30	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10168	10173		10.1074/jbc.273.17.10168	http://dx.doi.org/10.1074/jbc.273.17.10168			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553065	hybrid			2022-12-27	WOS:000073224200014
J	Yang, XH; Taylor, L; Polgar, P				Yang, XH; Taylor, L; Polgar, P			Mechanisms in the transcriptional regulation of bradykinin B-1 receptor gene expression - Identification of a minimum cell-type specific enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BINDING; AP-1; COLLAGENASE; INDUCTION; SEQUENCE; BDKRB1; PEA3; PMA	To investigate the mechanisms of bradykinin B-1 (BRB1) receptor gene expression, transient DNA transfection analyses of human BKB1 receptor gene promoter were performed in SV-40 transformed IMR90 cells. A positive regulatory element (PRE) located at position -604 to -448 base pair (bp) upstream of the transcription start site consistently exhibited, by far, the highest level of relative luciferase activity. A negative regulatory element, at position -682 to -604 bp, was able to completely ablate the function of the PRE. Transfection combined with deletion and mutation analyses illustrated that the PRE contains a classic, powerful enhancer. This enhancer was minimized to a 100-bp element at position -548 to -448 bp, A 78-bp fragment of negative regulatory element functioned as a silencer. Transient transfection of the enhancer construct, driven by heterologous herpes simplex thymidine kinase promoter, into a variety of cell types, showed that this enhancer presents a cell-type specific feature. In the characterization of the enhancer, motifs A (-548 to -532) and B (-483 to -477) were found to be essential for full enhancer activity. Motif D (-472 to -467) played a smaller role in enhancer activation. Gel shift and antibody supershift assays determined that an AP-1 factor binds with motif B. The nuclear protein which binds to motif A has yet to be identified. Both factors are the critical regulators for this enhancer activation.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Polgar, P (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	peterp@bu.edu		Polgar, Peter/0000-0002-9112-1101	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025776] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL25776] Funding Source: Medline; PHS HHS [A600115] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahluwalia A, 1996, J IMMUNOL, V156, P269; AUBLE DT, 1991, BIOCHEMISTRY-US, V30, P4629, DOI 10.1021/bi00232a039; Austin CE, 1997, J BIOL CHEM, V272, P11420; Bachvarov DR, 1996, GENOMICS, V33, P374, DOI 10.1006/geno.1996.0213; Barton MC, 1997, P NATL ACAD SCI USA, V94, P7257, DOI 10.1073/pnas.94.14.7257; BENNOW U, 1997, MATRIX BIOL, V15, P519; CAHILL M, 1988, AGENTS ACTIONS, V24, P224, DOI 10.1007/BF02028275; Chai KX, 1996, GENOMICS, V31, P51, DOI 10.1006/geno.1996.0008; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Davis CL, 1996, BRIT J PHARMACOL, V118, P1469, DOI 10.1111/j.1476-5381.1996.tb15562.x; DeCesare D, 1997, J BIOL CHEM, V272, P23921, DOI 10.1074/jbc.272.38.23921; DeCesare D, 1996, ONCOGENE, V13, P2551; Donaldson LF, 1997, TRENDS PHARMACOL SCI, V18, P171, DOI 10.1016/S0165-6147(97)90614-3; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; FRASER CM, 1994, PROG NUCLEIC ACID RE, V49, P113; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Guerrini L, 1996, FEBS LETT, V393, P69, DOI 10.1016/0014-5793(96)00854-X; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; Hall JM, 1997, GEN PHARMACOL, V28, P1, DOI 10.1016/S0306-3623(96)00174-7; HAMMANI K, 1996, J BIOL CHEM, V271, P25549; MACNEIL T, 1995, BBA-GENE STRUCT EXPR, V1264, P223, DOI 10.1016/0167-4781(95)00152-7; Maniatis T., 1982, MOL CLONING; Marceau F, 1997, CAN J PHYSIOL PHARM, V75, P725, DOI 10.1139/cjpp-75-6-725; MULLER S, 1995, J INVEST DERMATOL, V104, P970, DOI 10.1111/1523-1747.ep12606225; NERLOV C, 1991, ONCOGENE, V6, P1583; Rupniak NMJ, 1997, PAIN, V71, P89, DOI 10.1016/S0304-3959(97)03343-5; Sardi SP, 1997, EUR J PHARMACOL, V321, P33, DOI 10.1016/S0014-2999(96)00927-2; THMOS RS, 1997, ONCOGENE, V14, P2845; Willis SD, 1996, NUCLEIC ACIDS RES, V24, P1065, DOI 10.1093/nar/24.6.1065; Yang XH, 1996, BIOCHEM BIOPH RES CO, V222, P718, DOI 10.1006/bbrc.1996.0810; Yang XH, 1997, BBA-GENE STRUCT EXPR, V1350, P287, DOI 10.1016/S0167-4781(96)00225-4; Zhou XF, 1998, BIOCHEM J, V330, P361, DOI 10.1042/bj3300361; Zuzack JS, 1996, J PHARMACOL EXP THER, V277, P1337	33	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10763	10770		10.1074/jbc.273.17.10763	http://dx.doi.org/10.1074/jbc.273.17.10763			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553142	hybrid			2022-12-27	WOS:000073224200091
J	Hajjar, KA; Mauri, L; Jacovina, AT; Zhong, FM; Mirza, UA; Padovan, JC; Chait, BT				Hajjar, KA; Mauri, L; Jacovina, AT; Zhong, FM; Mirza, UA; Padovan, JC; Chait, BT			Tissue plasminogen activator binding to the annexin II tail domain - Direct modulation by homocysteine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL RECEPTOR; PROTEIN-C ACTIVATION; VASCULAR-DISEASE; RISK FACTOR; ATHEROGENIC STIMULUS; PLASMA HOMOCYSTEINE; THROMBOGENIC AGENT; CALPACTIN-I; T-PA; EXPRESSION	Tissue plasminogen activator binds to endothelial cells via the calcium-regulated phospholipid-binding protein annexin II, an interaction that is inhibited by the prothrombotic amino acid homocysteine. We sought to identify the tissue plasminogen activator binding domain of annexin II and to determine the mechanism of its modulation by homocysteine. Tissue plasminogen activator binding to immobilized annexin II was inhibited by intact fluid phase annexin II but not by its "core" fragment (residues 25-339). Two overlapping "tail" peptides specifically blocked 65-75% of binding. Localization of the tissue plasminogen activator binding domain was confirmed upon specific inhibition by the hexapeptide LCKLSL (residues 7-12). Expressed C9G annexin II protein failed to support tissue plasminogen activator binding, while binding to C133G, C262G, and C335G was equivalent to that of wild type annexin II. Upon exposure to homocysteine, annexin II underwent a 135 +/- 4-Da increase in mass localizing specifically to Cys(9) and a 60-66% loss in tissue plasminogen activator-binding capacity (I-50 = 11 mu M). Upon treatment of cultured endothelial cells with [S-35]homocysteine, the dithiothreitol-sensitive label was recovered by immunoprecipitation with anti-annexin II IgG. These data provide a potential mechanism for the prothrombotic effect of homocysteine by demonstrating direct blockade of the tissue plasminogen activator binding domain of annexin II.	Cornell Univ, Coll Med, Dept Pediat, Div Hematol Oncol, New York, NY 10021 USA; Cornell Univ, Coll Med, Dept Med, Div Hematol Oncol, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Cornell University; Cornell University; Rockefeller University	Hajjar, KA (corresponding author), Cornell Univ, Coll Med, Dept Pediat, Div Hematol Oncol, 1300 York Ave,Box 45, New York, NY 10021 USA.	khajjar@cornell.mail.med.edu			NHLBI NIH HHS [HL 58981, HL 42493, HL 56403] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058981, R01HL042493] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEEBE DP, 1989, BLOOD, V74, P2034; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; DAngelo A, 1997, BLOOD, V90, P1; DUERRE JA, 1966, ANAL BIOCHEM, V17, P310, DOI 10.1016/0003-2697(66)90209-0; EWADH MJA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P263, DOI 10.1016/0167-4889(90)90097-W; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; FRYER RH, 1993, ARTERIOSCLER THROMB, V13, P1327, DOI 10.1161/01.ATV.13.9.1327; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; GLENNEY JR, 1986, J BIOL CHEM, V261, P485; GLENNEY JR, 1991, METHOD ENZYMOL, V196, P65; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Hajjar K A, 1995, Curr Opin Hematol, V2, P345; HAJJAR KA, 1989, NATURE, V339, P303, DOI 10.1038/339303a0; HAJJAR KA, 1987, J CLIN INVEST, V80, P1712, DOI 10.1172/JCI113262; HAJJAR KA, 1986, J BIOL CHEM, V261, P1656; HAJJAR KA, 1993, J CLIN INVEST, V91, P2873, DOI 10.1172/JCI116532; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hajjar KA, 1997, ANN NY ACAD SCI, V811, P337, DOI 10.1111/j.1749-6632.1997.tb52013.x; HARDER T, 1992, GENE, V113, P269, DOI 10.1016/0378-1119(92)90406-F; HAYASHI T, 1992, BLOOD, V79, P2930; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354; LENTZ SR, 1991, J CLIN INVEST, V88, P1906, DOI 10.1172/JCI115514; Lentz SR, 1996, J CLIN INVEST, V98, P24, DOI 10.1172/JCI118771; Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; MIRZA UA, 1995, J BIOL CHEM, V270, P17185, DOI 10.1074/jbc.270.29.17185; Moss SE, 1997, TRENDS CELL BIOL, V7, P87, DOI 10.1016/S0962-8924(96)10049-0; Mudd S.H., 1995, METABOLIC MOL BASES, V1, P1279; MUDD SH, 1965, J BIOL CHEM, V240, P4382; MUDD SH, 1985, AM J HUM GENET, V37, P1; NISHINAGA M, 1993, J CLIN INVEST, V92, P1381, DOI 10.1172/JCI116712; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; REES MM, 1993, THROMB RES, V71, P337, DOI 10.1016/0049-3848(93)90160-P; RODGERS GM, 1986, J CLIN INVEST, V77, P1909, DOI 10.1172/JCI112519; RODGERS GM, 1990, BLOOD, V75, P895; Sehl LC, 1996, PROTEIN ENG, V9, P283, DOI 10.1093/protein/9.3.283; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; SMITH PD, 1994, TRENDS GENET, V10, P241, DOI 10.1016/0168-9525(94)90171-6; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; WANG J, 1993, THROMB HAEMOSTASIS, V70, P1047	45	196	202	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9987	9993		10.1074/jbc.273.16.9987	http://dx.doi.org/10.1074/jbc.273.16.9987			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545344	hybrid			2022-12-27	WOS:000073128800090
J	Li, YH; Zhou, LL; Twining, SS; Sugar, J; Yue, BYJT				Li, YH; Zhou, LL; Twining, SS; Sugar, J; Yue, BYJT			Involvement of Sp1 elements in the promoter activity of the alpha(1)-proteinase inhibitor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-ANTITRYPSIN GENE; LIVER-SPECIFIC TRANSCRIPTION; CELL-SPECIFIC EXPRESSION; BINDING; REGIONS; MACROPHAGES; KERATOCONUS; SEQUENCE; SITES; MOUSE	The transcripts of the alpha(1)-proteinase inhibitor in the cornea are different from those in hepatocytes and monocytes, suggesting that alpha(1)-proteinase inhibitor gene transcription may respond to different cell-specific regulatory mechanisms. Although information on alpha(1)-proteinase inhibitor gene structure has been obtained, little is known regarding the cis- and trans-acting factors that regulate its expression. In this study, we cloned and sequenced a 2,7-kilobase 5'-flanking region upstream from the corneal transcription initiation site of the gene, demonstrated functional promoter activity, and identified the regulatory elements. Sequencing revealed that the 5'-flanking element was highly G/C-rich in regions proximal to the corneal transcription start site. DNase I footprinting located 10 potential Spl-binding sites between nucleotides -1519 and +44. The putative promoter was functional in human corneal stromal cells, but not in human skin, scleral, and conjunctival fibroblasts, suggesting that the promoter may be corned cell-specific. The promoter activity in the corneal cells was repressed when Spl was coexpressed. In the cornea-thinning disease keratoconus, down-regulation of the alpha(1)-proteinase inhibitor gene and increased Spl expression have both been demonstrated. The current results suggest that down-regulation of the inhibitor in keratoconus corneas may be related directly to overexpression of the Spl gene. This information may help elucidate the molecular pathways leading to the altered alpha(1)-proteinase inhibitor expression in keratoconus.	Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical College of Wisconsin; Medical College of Wisconsin	Yue, BYJT (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA.	u24184@uic.edu			NATIONAL EYE INSTITUTE [R01EY005628, R01EY003890] Funding Source: NIH RePORTER; NEI NIH HHS [EY06663, EY05628, EY03890] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANTLY M, 1988, AM J MED, V84, P13; CILIBERTO G, 1985, CELL, V41, P531, DOI 10.1016/S0092-8674(85)80026-X; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; DESIMONE V, 1987, EMBO J, V6, P2759, DOI 10.1002/j.1460-2075.1987.tb02570.x; DYNAN WS, 1985, P NATL ACAD SCI USA, V82, P4915, DOI 10.1073/pnas.82.15.4915; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; ERIKSSON S, 1964, ACTA MED SCAND, V175, P197; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; GADEK JE, 1980, CLIN RES PROC, V16, P27; GRAYSON DR, 1988, MOL CELL BIOL, V8, P1055, DOI 10.1128/MCB.8.3.1055; HAFEEZ W, 1992, J CLIN INVEST, V89, P1214, DOI 10.1172/JCI115705; HARDON EM, 1988, EMBO J, V7, P1711, DOI 10.1002/j.1460-2075.1988.tb03000.x; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; KELSEY GD, 1987, GENE DEV, V1, P161, DOI 10.1101/gad.1.2.161; KITADAI Y, 1992, BIOCHEM BIOPH RES CO, V189, P1342, DOI 10.1016/0006-291X(92)90221-6; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Laurell C., 1975, PLASMA PROTEINS, P229; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; Maxam A M, 1980, Methods Enzymol, V65, P499; OLSEN GN, 1975, J CLIN INVEST, V55, P427, DOI 10.1172/JCI107947; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; PERLMUTTER DH, 1985, P NATL ACAD SCI USA, V82, P795, DOI 10.1073/pnas.82.3.795; PERLMUTTER DH, 1989, J BIOL CHEM, V264, P9485; RAMJI DP, 1991, NUCLEIC ACIDS RES, V19, P1139, DOI 10.1093/nar/19.5.1139; RANGAN VS, 1990, J BIOL CHEM, V265, P8874; SAFFER JD, 1990, GENE DEV, V4, P659, DOI 10.1101/gad.4.4.659; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SAWAGUCHI S, 1990, EXP EYE RES, V50, P549, DOI 10.1016/0014-4835(90)90044-U; SHARP HL, 1969, J LAB CLIN MED, V73, P934; TOKES ZA, 1981, J SUPRAMOL STR CELL, V17, P69, DOI 10.1002/jsscb.380170108; TWINING SS, 1994, INVEST OPHTH VIS SCI, V35, P458; WANG LH, 1993, BIOCHEM BIOPH RES CO, V190, P406, DOI 10.1006/bbrc.1993.1062; WHITE R, 1981, AM REV RESPIR DIS, V123, P447; Whitelock RB, 1997, INVEST OPHTH VIS SCI, V38, P529; Whitelock RB, 1997, BIOCHEM BIOPH RES CO, V235, P253, DOI 10.1006/bbrc.1997.6711; YUE BYJT, 1981, VISION RES, V21, P41, DOI 10.1016/0042-6989(81)90134-6; YUE BYJT, 1984, P SOC EXP BIOL MED, V175, P336	40	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9959	9965		10.1074/jbc.273.16.9959	http://dx.doi.org/10.1074/jbc.273.16.9959			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545340	hybrid			2022-12-27	WOS:000073128800086
J	Wu, SM; Zhang, P; Zeng, XR; Zhang, SJ; Mo, JY; Li, BQ; Lee, MYWT				Wu, SM; Zhang, P; Zeng, XR; Zhang, SJ; Mo, JY; Li, BQ; Lee, MYWT			Characterization of the p125 subunit of human DNA polymerase delta and its deletion mutants - Interaction with cyclin-dependent kinase-cyclins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; CATALYTIC SUBUNIT; CELL-CYCLE; CONSERVED REGION; FACTOR PCNA; IN-VITRO; ALPHA; PHOSPHORYLATION; BINDING; PURIFICATION	The catalytic subunit of human DNA polymerase (pol) delta was overexpressed in an active, soluble form by the use of a baculovirus system in insect cells. The recombinant enzyme was separated from endogenous DNA polymerases by phosphocellulose, Mono Q-Sepharose, and single-stranded DNA-cellulose chromatography, Recombinant DNA pol delta was also purified by immunoaffinity chromatography, The enzymatic properties of the purified catalytic subunit mere characterized, The enzyme was active and possessed both DNA polymerase and associated 3' to 5' exonuclease activities. NH2-terminal deletion mutants retained polymerase activity, whereas the core and COOH-terminal deletion mutants were devoid of any measurable activities. Coinfection of Sf9 cells with recombinant baculovirus vectors for pol delta and cyclin-dependent kinase (cdk)-cyclins followed by metabolic labeling with P-32(i) showed that the recombinant catalytic subunit of pol delta could be hyperphosphorylated by G(1) phase-specific cdk-cyclins, When cdk2 was coexpressed with pol delta in Sf9 cells, pol delta was found to coimmunoprecipitate with antibodies against cdk2. Experiments with deletion mutants of pol delta showed that the NH2-terminal region was essential for this interaction. Coimmunoprecipitation and Western blot experiments in Molt 4 cells confirmed the interaction in vivo. Preliminary experiments showed that phosphorylation of the catalytic subunit of pol delta by cdk2-cyclins had little or no effect on the specific activity of the enzyme.	Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA; New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	University of Miami; New York Medical College	Lee, MYWT (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA.				NIGMS NIH HHS [GM31973] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2; BRUSH GS, 1994, P NATL ACAD SCI USA, V91, P12520, DOI 10.1073/pnas.91.26.12520; CHANG LS, 1995, GENOMICS, V28, P411, DOI 10.1006/geno.1995.1169; CHIANG CS, 1993, P NATL ACAD SCI USA, V90, P9105, DOI 10.1073/pnas.90.19.9105; DONG Q, 1995, J BIOL CHEM, V270, P21563, DOI 10.1074/jbc.270.37.21563; DONG Q, 1993, J BIOL CHEM, V268, P24163; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; DUTTA A, 1992, EMBO J, V11, P2189, DOI 10.1002/j.1460-2075.1992.tb05278.x; Gibbs E, 1996, J BIOL CHEM, V271, P22847, DOI 10.1074/jbc.271.37.22847; GOULIAN M, 1990, J BIOL CHEM, V265, P16402; HAO H, 1992, CHROMOSOMA, V102, P121; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Herendeen DR, 1996, CELL, V84, P5, DOI 10.1016/S0092-8674(00)80069-0; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; JIANG YQ, 1995, ARCH BIOCHEM BIOPHYS, V320, P297, DOI 10.1016/0003-9861(95)90013-6; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LEE MYW, 1984, BIOCHEMISTRY-US, V23, P1900; LEE MYWT, 1991, J BIOL CHEM, V266, P2423; MARCY AI, 1990, NUCLEIC ACIDS RES, V18, P1307; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; PAN ZQ, 1995, P NATL ACAD SCI USA, V92, P4636, DOI 10.1073/pnas.92.10.4636; PODUST V, 1990, EUR J BIOCHEM, V193, P189, DOI 10.1111/j.1432-1033.1990.tb19322.x; PRUSSAK CE, 1989, BIOCHEM BIOPH RES CO, V159, P1397, DOI 10.1016/0006-291X(89)92265-1; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; Sun YB, 1997, J BIOL CHEM, V272, P13013, DOI 10.1074/jbc.272.20.13013; Voitenleitner C, 1997, ONCOGENE, V14, P1611, DOI 10.1038/sj.onc.1200975; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WANG TSF, 1989, FASEB J, V3, P14, DOI 10.1096/fasebj.3.1.2642867; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; XIONG Y, 1993, GENE DEV, V7, P1572, DOI 10.1101/gad.7.8.1572; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; YANG CL, 1992, NUCLEIC ACIDS RES, V20, P735, DOI 10.1093/nar/20.4.735; ZENG XR, 1994, J BIOL CHEM, V269, P24027; ZENG XR, 1994, J BIOL CHEM, V269, P13748; ZHANG P, 1995, J BIOL CHEM, V270, P7993, DOI 10.1074/jbc.270.14.7993; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; ZHANG SJ, 1995, J BIOL CHEM, V270, P7988, DOI 10.1074/jbc.270.14.7988; Zhou JQ, 1996, J BIOL CHEM, V271, P29740, DOI 10.1074/jbc.271.47.29740; Zhou JQ, 1997, NUCLEIC ACIDS RES, V25, P1094, DOI 10.1093/nar/25.6.1094	43	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9561	9569		10.1074/jbc.273.16.9561	http://dx.doi.org/10.1074/jbc.273.16.9561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545286	hybrid			2022-12-27	WOS:000073128800032
J	Muda, M; Theodosiou, A; Gillieron, C; Smith, A; Chabert, C; Camps, M; Boschert, U; Rodrigues, N; Davies, K; Ashworth, A; Arkinstall, S				Muda, M; Theodosiou, A; Gillieron, C; Smith, A; Chabert, C; Camps, M; Boschert, U; Rodrigues, N; Davies, K; Ashworth, A; Arkinstall, S			The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; TYROSINE-PHOSPHATASE; MAP KINASE; CRYSTAL-STRUCTURE; TRANSCRIPTION; PATHWAY; DEPHOSPHORYLATES; DIFFERENTIATION; TRANSFORMATION; PROLIFERATION	We have reported recently that the dual specificity mitogen-activated protein kinase phosphatase-3 (MKP-3) elicits highly selective inactivation of the extracellular signal-regulated kinase (ERK) class of mitogen-activated protein (MAP) kinases (Muda, M., Theodosiou, A., Rodrigues, N., Boschert, Il., Camps, M., Gillieron, C., Davies, It, Ashworth, A., and Arkinstall, S. (1996) J. Biol. Chem, 271, 27205-27208). We now show that MKP-3 enzymatic specificity is paralleled by tight binding to both ERK1 and ERK2 while, in contrast, little or no interaction with either c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK) or p38 MAP kinases was detected. Further study revealed that the N-terminal noncatalytic domain of MKP-3 (MKP-3 Delta C) binds both ERK1 and ERK2, while the C-terminal MKP-3 catalytic core (MKP-3 Delta N) fails to precipitate either of these MAP kinases. A chimera consisting of the N-terminal half of MKP-3 with the C-terminal catalytic core of M3-6 also bound tightly to ERK1 but not to JNK3/SAPK beta. Consistent with a role for N-terminal binding in determining MKP-3 specificity, at least 10-fold higher concentrations of purified MKP-3 Delta N than full-length MKP-3 is required to inhibit ERK2 activity. In contrast, both MKP-3 Delta N and full-length MKP-3 inactivate JNK/SAPK and p38 MAP kinases at similarly high concentrations. Also, a chimera of the M3-6 N terminus with the MKP-3 catalytic core which fails to bind ERK elicits non selective inactivation of ERK1 and JNK3/SAPK beta. Together, these observations suggest that the physiological specificity of MKP-3 for inactivation of ERK family MAP kinases reflects tight substrate binding by its N-terminal domain.	Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland; Inst Canc Res, Chester Beatty Labs, Canc Res Campaign, Ctr Cell & Mol Biol, London SW3 6JB, England; Univ Oxford, Dept Biochem, Genet Lab, Oxford OX1 3QU, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford	Arkinstall, S (corresponding author), Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland.	steve.arkinstall.ch_gva03@serono.com		Camps, Montserrat/0000-0002-9849-8657				ALESSI DR, 1993, ONCOGENE, V8, P2015; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; CHARLES CH, 1992, ONCOGENE, V7, P187; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; GERONDAKIS S, 1994, GENOMICS, V24, P182, DOI 10.1006/geno.1994.1598; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KEYSE SM, 1993, TRENDS BIOCHEM SCI, V18, P377, DOI 10.1016/0968-0004(93)90092-2; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; King AG, 1995, ONCOGENE, V11, P2553; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KWAK SP, 1994, J BIOL CHEM, V269, P3596; KWAK SP, 1995, J BIOL CHEM, V270, P1156, DOI 10.1074/jbc.270.3.1156; Leberer E, 1997, CURR OPIN GENET DEV, V7, P59, DOI 10.1016/S0959-437X(97)80110-4; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTELL KJ, 1995, J NEUROCHEM, V65, P1823; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1997, J BIOL CHEM, V272, P5141, DOI 10.1074/jbc.272.8.5141; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; STOKOE D, 1992, EMBO J, V11, P985; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Theodosiou AM, 1996, HUM MOL GENET, V5, P675, DOI 10.1093/hmg/5.5.675; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Wiland AM, 1996, J BIOL CHEM, V271, P33486, DOI 10.1074/jbc.271.52.33486; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; ZHONG WX, 1996, SCIENCE, V272, P1347	55	126	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9323	9329		10.1074/jbc.273.15.9323	http://dx.doi.org/10.1074/jbc.273.15.9323			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535927	hybrid			2022-12-27	WOS:000072990800104
J	Payen, E; Verkerk, T; Michalovich, D; Dreyer, SD; Winterpacht, A; Lee, B; De Zeeuw, CI; Grosveld, F; Galjart, N				Payen, E; Verkerk, T; Michalovich, D; Dreyer, SD; Winterpacht, A; Lee, B; De Zeeuw, CI; Grosveld, F; Galjart, N			The centromeric/nucleolar chromatin protein ZFP-37 May function to specify neuronal nuclear domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER GENE; KRUPPEL-ASSOCIATED BOX; DNA-BINDING; TRANSCRIPTIONAL REPRESSION; AFFINITY COELECTROPHORESIS; SUPRAOPTIC NEURONS; XENOPUS-LAEVIS; SATELLITE DNA; EXPRESSION; CELLS	Murine ZFP-37 is a member of the large family of C2H2 type zinc finger proteins, It is characterized by a truncated NH2-terminal Kruppel-associated box and is thought to play a role in transcriptional regulation. During development Zfp-37 mRNA is most abundant in the developing central nervous system, and in the adult mouse expression is restricted largely to testis and brain, Here we show that at the protein level ZFP-37 is detected readily in neurons of the adult central nervous system but hardly in testis, In brain ZFP-37 is associated with nucleoli and appears to contact heterochromatin. Mouse and human ZFP-37 have a basic histone H1-like linker domain, located between KRAB and zinc finger regions, which binds double-stranded DNA. Thus we suggest that ZFP-37 is a structural protein of the neuronal nucleus which plays a role in the maintenance of specialized chromatin domains.	Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Anat, NL-3000 DR Rotterdam, Netherlands; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Johannes Gutenberg Univ Mainz, Childrens Hosp, D-55101 Mainz, Germany	Erasmus University Rotterdam; Erasmus University Rotterdam; Baylor College of Medicine; Johannes Gutenberg University of Mainz	Galjart, N (corresponding author), Erasmus Univ, Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	galjart@ch1.fgg.eur.nl	Payen, Emmanuel/S-5357-2018; Galjart, Niels/D-1146-2010	Payen, Emmanuel/0000-0002-1329-2327; Galjart, Niels/0000-0003-1964-3607; Michalovich, David/0000-0003-4452-5776				Arranz V, 1997, MOL CELL BIOL, V17, P2116, DOI 10.1128/MCB.17.4.2116; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; BELLEFROID EJ, 1995, P NATL ACAD SCI USA, V92, P10757, DOI 10.1073/pnas.92.23.10757; BILLIA F, 1992, MOL BRAIN RES, V14, P101, DOI 10.1016/0169-328X(92)90016-5; BIRD AP, 1981, J MOL BIOL, V152, P1, DOI 10.1016/0022-2836(81)90092-9; Brock GJR, 1997, HUM MOL GENET, V6, P451, DOI 10.1093/hmg/6.3.451; BRODSKY VY, 1988, CELL DIFFER DEV, V24, P201, DOI 10.1016/0045-6039(88)90051-6; BURKE PS, 1992, NUCLEIC ACIDS RES, V20, P2827, DOI 10.1093/nar/20.11.2827; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHURCHILL MEA, 1991, TRENDS BIOCHEM SCI, V16, P92, DOI 10.1016/0968-0004(91)90040-3; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Denisenko ON, 1996, J BIOL CHEM, V271, P27701, DOI 10.1074/jbc.271.44.27701; Erickson B. W., 1976, PROTEINS, VII, P255; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Grondin B, 1996, J BIOL CHEM, V271, P15458, DOI 10.1074/jbc.271.26.15458; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HOSSEINI R, 1994, J MOL ENDOCRINOL, V13, P157, DOI 10.1677/jme.0.0130157; KHOCHBIN S, 1994, EUR J BIOCHEM, V225, P501, DOI 10.1111/j.1432-1033.1994.00501.x; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; KLOCKE B, 1994, BBA-GENE STRUCT EXPR, V1217, P81; KNOCHEL W, 1989, P NATL ACAD SCI USA, V86, P6097, DOI 10.1073/pnas.86.16.6097; LAFARGA M, 1989, J NEUROCYTOL, V18, P19, DOI 10.1007/BF01188420; LAFARGA M, 1995, MOL BRAIN RES, V29, P317, DOI 10.1016/0169-328X(94)00261-C; LAFARGA M, 1994, J NEUROCYTOL, V23, P500, DOI 10.1007/BF01184073; LANGE R, 1995, DNA CELL BIOL, V14, P971, DOI 10.1089/dna.1995.14.971; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; LIM WA, 1991, METHOD ENZYMOL, V208, P196; MANUELIDIS L, 1991, P NATL ACAD SCI USA, V88, P1049, DOI 10.1073/pnas.88.3.1049; MANUELIDIS L, 1984, P NATL ACAD SCI-BIOL, V81, P3123, DOI 10.1073/pnas.81.10.3123; MANUELIDIS L, 1984, J NEUROPATH EXP NEUR, V43, P225, DOI 10.1097/00005072-198405000-00002; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mazarakis N, 1996, GENOMICS, V33, P247, DOI 10.1006/geno.1996.0189; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; NEDVED ML, 1994, NUCLEIC ACIDS RES, V22, P5024, DOI 10.1093/nar/22.23.5024; NEDVED ML, 1995, ANAL BIOCHEM, V227, P80, DOI 10.1006/abio.1995.1255; NELKI D, 1990, NUCLEIC ACIDS RES, V18, P3655, DOI 10.1093/nar/18.12.3655; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Parseghian MH, 1993, CHROMOSOME RES, V1, P127, DOI 10.1007/BF00710036; PEBUSQUE MJ, 1985, J CELL SCI, V74, P65; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; Pengue G, 1996, P NATL ACAD SCI USA, V93, P1015, DOI 10.1073/pnas.93.3.1015; Perez M, 1996, FEBS LETT, V387, P117, DOI 10.1016/0014-5793(96)00474-7; PETERS A, 1991, FINE STRUCTURE NERVO, P48; PIELER T, 1994, MOL BIOL REP, V20, P1, DOI 10.1007/BF00999848; POLLOCK R, 1990, NUCLEIC ACIDS RES, V18, P6197, DOI 10.1093/nar/18.21.6197; POTT U, 1995, J NEUROCHEM, V65, P1955; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHMIDT C, 1995, MOL BIOL CELL, V6, P1875, DOI 10.1091/mbc.6.12.1875; SCHNEITER R, 1995, MOL BIOL CELL, V6, P357, DOI 10.1091/mbc.6.4.357; SCHWARZACHER HG, 1993, ANAT EMBRYOL, V188, P515; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; WITZGALL R, 1993, MOL CELL BIOL, V13, P1933, DOI 10.1128/MCB.13.3.1933; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; WOLFFE AP, 1995, CURR BIOL, V5, P452, DOI 10.1016/S0960-9822(95)00088-1; Wolffe AP, 1996, TRENDS GENET, V12, P58, DOI 10.1016/0168-9525(96)81401-6; ZLATANOVA J, 1991, DNA CELL BIOL, V10, P239, DOI 10.1089/dna.1991.10.239	68	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9099	9109		10.1074/jbc.273.15.9099	http://dx.doi.org/10.1074/jbc.273.15.9099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535899	hybrid, Green Published			2022-12-27	WOS:000072990800076
J	Walikonis, RS; Poduslo, JF				Walikonis, RS; Poduslo, JF			Activity of cyclic AMP phosphodiesterases and adenylyl cyclase in peripheral nerve after crush and permanent transection injuries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL PROLIFERATION; CEREBRAL-CORTEX SYNAPTOSOMES; MAJOR MYELIN GLYCOPROTEIN; DORSAL-ROOT-GANGLIA; BOUND S-100 PROTEIN; NUCLEOTIDE PHOSPHODIESTERASE; SCIATIC-NERVE; WALLERIAN DEGENERATION; CAMP PHOSPHODIESTERASE; SELECTIVE INHIBITORS	Recent studies demonstrate that cAMP levels are tightly controlled during demyelination and remyelination in Schwann cells as cAMP decreases to 8-10% of normal following both sciatic nerve crush or permanent transection injury and only begins to increase in the crushed nerve after remyelination (Poduslo, JF, Walikonis, RS, Domec, M, Berg, CT, and Holtz-Heppelmann, CJ (1995) J. Neurochem. 65, 149-159). To investigate the mechanisms responsible for this change in cAMP levels, cAMP phosphodiesterase (PDE) and adenylyl cyclase activities were determined before and after sciatic nerve injury. Basal cAMP PDE activity in soluble endoneurial homogenates of normal nerve was 34.9-/+1.9 pmol/mg of protein/min (chi-overbar-/+SE; n=10). This activity increased about 3-fold within 6 days following both injuries. Basal PDE activity remained elevated in the transected nerve, but declined to 70 pmol/mg of protein/min in the crushed nerve at 21 and 35 days following injury. Isozyme-specific inhibitors and stimulators were used to identify the PDE families in the sciatic nerve. The low K-m cAMP-specific (PDE4) and the Ca2+/calmodulin-stimulated (PDE1) families were found to predominate in assays using endoneurial homogenates. The PDE4 inhibitor rolipram also increased cAMP levels significantly after incubation of endoneurial tissue with various isozyme-specific inhibitors, indicating that PDE4 plays a major role in determining cAMP levels. PDE4 mRNA was localized by in situ hybridization to cells identified as Schwann cells by colabeling of S100, a Schwann cell specific protein. Adenylyl cyclase activity declined following injury, form 3.7 pmol/mg of protein/min in normal nerve to 0.70 pmol/mg/min by 7 days following injury. Both decreased synthesis and increased degradation contribute, therefore, to the reduced levels of cAMP following peripheral nerve injury and are likely critical to the process of Wallerian degeneration.	Mayo Clin & Mayo Fdn, Dept Neurol, Mol Neurobiol Lab, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Poduslo, JF (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, Mol Neurobiol Lab, 200 1St St Sw, Rochester, MN 55905 USA.							ARMATIGULSON P, 1980, DEV BIOL, V77, P213, DOI 10.1016/0012-1606(80)90467-4; BARONVANEVERCOOREN A, 1986, DEV NEUROSCI-BASEL, V8, P182, DOI 10.1159/000112252; BAUER AC, 1980, N-S ARCH PHARMACOL, V311, P193, DOI 10.1007/BF00510259; BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; BILLINGS.S, 1974, AM J ANAT, V141, P375, DOI 10.1002/aja.1001410308; BOLGER GB, 1994, MOL CELL ENDOCRINOL, V100, P75; BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1; BRAY JJ, 1971, BRAIN RES, V26, P385, DOI 10.1016/S0006-8993(71)80012-4; BROCKES JP, 1981, J EXP BIOL, V95, P215; BROWN MJ, 1981, EXP NEUROL, V74, P170, DOI 10.1016/0014-4886(81)90157-6; BUNGE MB, 1982, DEV BIOL, V92, P449, DOI 10.1016/0012-1606(82)90190-7; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; CARLSEN RC, 1982, BRAIN RES, V232, P413, DOI 10.1016/0006-8993(82)90284-0; CARLSEN RC, 1982, J NEUROCHEM, V39, P1467, DOI 10.1111/j.1471-4159.1982.tb12593.x; CARSON JH, 1983, DEV BIOL, V96, P485, DOI 10.1016/0012-1606(83)90185-9; CONTI M, 1991, ENDOCR REV, V12, P218, DOI 10.1210/edrv-12-3-218; COSTANTINOCECCARINI E, 1989, J NEUROCHEM, V53, P205, DOI 10.1111/j.1471-4159.1989.tb07315.x; CRANG AJ, 1986, J NEUROCYTOL, V15, P471, DOI 10.1007/BF01611730; DEGERMAN E, 1990, P NATL ACAD SCI USA, V87, P533, DOI 10.1073/pnas.87.2.533; DEGERMAN E, 1987, J BIOL CHEM, V262, P5797; DONATO R, 1975, BRAIN RES, V98, P561, DOI 10.1016/0006-8993(75)90373-X; DONATO R, 1976, BRAIN RES, V109, P649, DOI 10.1016/0006-8993(76)90047-0; DYCK PJ, 1970, MAYO CLIN PROC, V45, P286; ECCLESTON PA, 1992, EXP CELL RES, V199, P1, DOI 10.1016/0014-4827(92)90455-H; FRIEDE RL, 1993, ADV NEUROL, V59, P327; GENAIN CP, 1995, P NATL ACAD SCI USA, V92, P3601, DOI 10.1073/pnas.92.8.3601; GOW A, 1992, J CELL BIOL, V119, P605, DOI 10.1083/jcb.119.3.605; GUPTA SK, 1988, MOL BRAIN RES, V4, P133, DOI 10.1016/0169-328X(88)90005-8; HEAPE A, 1986, DEV BRAIN RES, V25, P181, DOI 10.1016/0165-3806(86)90207-5; HIDAKA H, 1984, ADV CYCLIC NUCL PROT, V16, P245; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; JOHNSON RA, 1991, METHOD ENZYMOL, V195, P3; KINCAID RL, 1988, METHOD ENZYMOL, V159, P457; LEBLANC AC, 1990, J NEUROSCI RES, V26, P317, DOI 10.1002/jnr.490260308; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1988, DEVELOPMENT, V102, P499; LIPMAN JM, 1989, ANAL BIOCHEM, V176, P128, DOI 10.1016/0003-2697(89)90282-0; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; MATA M, 1990, J NEUROCYTOL, V19, P432, DOI 10.1007/BF01188409; MCGARVEY ML, 1984, DEV BIOL, V105, P18, DOI 10.1016/0012-1606(84)90257-4; MIRSKY R, 1990, DEVELOPMENT, V109, P105; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; MURASHIMA S, 1990, BIOCHEMISTRY-US, V29, P5285, DOI 10.1021/bi00474a010; OAKLANDER AL, 1987, BRAIN RES, V419, P39, DOI 10.1016/0006-8993(87)90566-X; OGAWA Y, 1968, J BIOCHEM-TOKYO, V64, P255, DOI 10.1093/oxfordjournals.jbchem.a128887; OULTON MR, 1976, J LIPID RES, V17, P167; PERRY VH, 1992, BIOESSAYS, V14, P401, DOI 10.1002/bies.950140610; PODUSLO JF, 1995, J NEUROCHEM, V65, P149; PODUSLO JF, 1984, J NEUROCHEM, V42, P493, DOI 10.1111/j.1471-4159.1984.tb02705.x; PODUSLO JF, 1984, P NATL ACAD SCI-BIOL, V81, P1864, DOI 10.1073/pnas.81.6.1864; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; SCHULTZ G, 1984, METHOD ENZYMAT AN, P369; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SETTE C, 1994, MOL CELL ENDOCRINOL, V100, P75, DOI 10.1016/0303-7207(94)90282-8; SHINDO H, 1993, J ENDOCRINOL, V136, P431, DOI 10.1677/joe.0.1360431; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOBUE G, 1986, NEUROSCI LETT, V72, P253, DOI 10.1016/0304-3940(86)90522-7; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; SOBUE G, 1984, SCIENCE, V224, P72, DOI 10.1126/science.6322307; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; SPENCER PS, 1979, BRAIN RES, V165, P119, DOI 10.1016/0006-8993(79)90049-0; SPRECA A, 1989, J HISTOCHEM CYTOCHEM, V37, P441, DOI 10.1177/37.4.2926122; Strehler B. L., 1974, METHOD ENZYMAT AN, P2112, DOI [10.1016/b978-0-12-091304-6.50065-3, DOI 10.1016/B978-0-12-091304-6.50065-3]; STROOP SD, 1992, ADV SEC MESS PHOSPH, V25, P55; SUTER U, 1994, J BIOL CHEM, V269, P25795; SWINNEN JV, 1989, P NATL ACAD SCI USA, V86, P8197, DOI 10.1073/pnas.86.21.8197; TAKEDA S, 1991, ENDOCRINOLOGY, V129, P287, DOI 10.1210/endo-129-1-287; TAKEMOTO DJ, 1993, CELL SIGNAL, V5, P549, DOI 10.1016/0898-6568(93)90050-V; Thompson W J, 1974, Methods Enzymol, V38, P205; TRAPP BD, 1988, J NEUROSCI, V8, P3515; UYEMURA K, 1979, J NEUROCHEM, V32, P779, DOI 10.1111/j.1471-4159.1979.tb04561.x; VEGA JA, 1991, CELL MOL BIOL, V37, P173; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; WHALIN ME, 1988, BIOCHIM BIOPHYS ACTA, V972, P79; WOOD JG, 1976, J NEUROCYTOL, V5, P605, DOI 10.1007/BF01175573; WOOD PM, 1975, NATURE, V256, P662, DOI 10.1038/256662a0; YAMAKI M, 1992, AM J PHYSIOL, V262, pF957, DOI 10.1152/ajprenal.1992.262.6.F957; YAO JK, 1988, J NEUROCHEM, V50, P630, DOI 10.1111/j.1471-4159.1988.tb02957.x; YAO JK, 1990, NEUROCHEM RES, V15, P279, DOI 10.1007/BF00968672	84	26	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9070	9077		10.1074/jbc.273.15.9070	http://dx.doi.org/10.1074/jbc.273.15.9070			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535895	hybrid, Green Accepted			2022-12-27	WOS:000072990800072
J	Zhang, BL; Chernoff, J; Zheng, Y				Zhang, BL; Chernoff, J; Zheng, Y			Interaction of Rac1 with GTPase-activating proteins and putative effecters - A comparison with Cdc42 and RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; BINDING-PROTEIN; SACCHAROMYCES-CEREVISIAE; INORGANIC-PHOSPHATE; SIGNALING PATHWAY; FAMILY GTPASES; DOMAIN; KINASE; FILOPODIA; LAMELLIPODIA	The intrinsic GTPase activity of the Rho family GTP-binding protein Rad is drastically stimulated upon interaction with its GTPase-activating proteins (GAPs) and is significantly inhibited when coupled to certain effector targets such as the pal-activated kinases (PAKs) and IQGAPs, Here we have characterized the interaction of Rad with a panel of mammalian GAPs and putative effecters by measuring the kinetic and binding parameters involved and made comparisons with similar interactions for Cdc42 and RhoA. In contrast with Cdc42 (for which the GAP domain of p50RhoGAP is 50-fold more efficient than those of p190, Bcr, and 3BP-1) and with RhoA (toward which only p50RhoGAP and p190 displayed high efficiencies), the catalytic efficiencies (K-cat/K-m) of the GAP domains of p50RhoGAP, p190, Bcr, and 3BP-1 on Rad are found to be comparable in a range between 0.9 and 2.6 min(-1) mu M-1. However, similar to the cases of Cdc42 and RhoA, the K-m values of the GAP domains on Rad compare web to the binding affinity to the guanylyl imidodiphosphate-bound Rad, which ranges from 10.5 to 40.5 mu M suggesting a rapid equilibrium reaction mechanism. The dissociation constants of the pal-binding domains of PAK1, PAK2, and the RasGAP-related domain of IQGAP1, which all cause significant reduction of the intrinsic rate of GTP hydrolysis upon binding to Rac1-GTP, are found to be 0.71, 0.26, and 2.13 mu M for Rac1-GTP, compared with that determined for Cdc42-GTP at 2.9, 20.5, and 0.39 mu M, respectively, under similar conditions, These results suggest that p50RhoGAP, p190, Bcr, and 3BP-1 are all capable of acting as a negative regulator for Rad-mediated signaling, and that, although PAK1 and IQGAP1 can couple tightly with both Rad and Cdc42, PAK2 is likely to be a specific effector for Rad instead of Cdc42.	Univ Tennessee, Ctr Hlth Sci, Dept Biochem, Memphis, TN 38163 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University of Tennessee System; University of Tennessee Health Science Center; Fox Chase Cancer Center	Zheng, Y (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Biochem, Memphis, TN 38163 USA.		Chernoff, Jonathan/I-7631-2014; Zheng, Yi/J-7235-2015	Chernoff, Jonathan/0000-0002-4803-7836; Zheng, Yi/0000-0001-7089-6074	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053943] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53943] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Kozma R, 1996, MOL CELL BIOL, V16, P5069; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; VOUCKEN JW, 1995, CELL, V80, P719; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WEBB MR, 1992, BIOCHEM J, V287, P555, DOI 10.1042/bj2870555; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; ZHANG B, 1995, IN PRESS BIOCHEMISTR; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; ZHENG Y, 1995, J BIOL CHEM, V270, P626, DOI 10.1074/jbc.270.2.626; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; ZHENG Y, 1993, J BIOL CHEM, V268, P24629	42	59	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8776	8782		10.1074/jbc.273.15.8776	http://dx.doi.org/10.1074/jbc.273.15.8776			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535855	hybrid			2022-12-27	WOS:000072990800032
J	Zheng, B; Duan, C; Clemmons, DR				Zheng, B; Duan, C; Clemmons, DR			The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BALLOON DENUDATION; GENE-EXPRESSION; MESSENGER-RNA; RAT AORTA; ATHEROSCLEROSIS; MIGRATION; INTEGRINS; RECEPTOR; ALPHA(V)BETA(3); OSTEOPONTIN	The aim of this study was to determine if cultured porcine vascular smooth muscle cells (pSMCs) that had been maintained on different extracellular matrix proteins had an alteration in their expression of insulin-like growth factor binding protein-5 (IGFBP-5) and their responsiveness to insulin like growth factor-I (IGF-I). When pSMCs were plated on fibronectin, they synthesized 6.0 +/- 1.2-fold more IGFBP-5 than did cells maintained on laminin and type TV collagen. IGF-I increased IGFBP-5 gene expression 3-fold in the cells plated on fibronectin. The addition of an RGD peptide and echistatin to pSMC cultures that had been plated on fibronectin inhibited IGFBP-5 mRNA expression. The addition of an antibody against alpha(2) beta(1) integrin partially reversed the inhibitory effects of laminin and type IV collagen on IGFBP-5 expression. Cells maintained on fibronectin had a 5.0 +/- 1.1-fold greater DNA synthesis response to IGF-I compared with those maintained on laminin/type TV collagen, and echistatin significantly inhibited the DNA synthesis response of the fibronectin-maintained cells to IGF-I. The anti-alpha(2) beta(1) antibody partially reversed the inhibitory effect of laminin and type TV collagen on IGF-I stimulated DNA synthesis. The addition of IGFBP-5 to cultures plated on laminin and type TV collagen significantly increased their response to IGF-I. Atherosclerotic plaques from pig aorta contained abundant fibronectin and had increased IGFBP-5 mRNA (4.5 +/- 1.5-fold) compared with tissue from the normal vessel wall that had a low fibronectin content. These results indicate that fibronectin, laminin, and type TV collagen have major effects on IGFBP-5 expression and on IG;F-I-stimulated pSMC responses and that these effects are mediated by their respective integrins.	Univ N Carolina, Div Endocrinol, Dept Med, Chapel Hill, NC 27599 USA; Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, Dept Med, CB 7170,6111 Thurston Bowles Bldg, Chapel Hill, NC 27599 USA.				NHLBI NIH HHS [HL-56580] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Assoian RK, 1996, J CLIN INVEST, V98, P2436, DOI 10.1172/JCI119059; Bilato C, 1997, J CLIN INVEST, V100, P693, DOI 10.1172/JCI119582; BILATO C, 1995, J CLIN INVEST, V96, P1905, DOI 10.1172/JCI118236; BORNFELDT KE, 1990, J ENDOCRINOL, V125, P381, DOI 10.1677/joe.0.1250381; BOURNER MJ, 1992, J CELL BIOCHEM, V48, P215; CAMACHOHUBNER C, 1992, J BIOL CHEM, V267, P11949; CERCEK B, 1990, CIRC RES, V66, P1755, DOI 10.1161/01.RES.66.6.1755; CHAMBLEYCAMPBEL.JH, 1990, J CELL BIOL, V89, P379; CLEMMONS DR, 1985, CIRC RES, V56, P418, DOI 10.1161/01.RES.56.3.418; CLEMMONS DR, 1985, ENDOCRINOLOGY, V117, P77, DOI 10.1210/endo-117-1-77; CLYMAN RI, 1992, EXP CELL RES, V200, P272, DOI 10.1016/0014-4827(92)90173-6; COHICK WS, 1993, J CELL PHYSIOL, V157, P52, DOI 10.1002/jcp.1041570107; DARTSCH PC, 1990, ARTERIOSCLEROSIS, V10, P62, DOI 10.1161/01.ATV.10.1.62; DELAFONTAINE P, 1993, J BIOL CHEM, V268, P16866; DELAFONTAINE P, 1991, HYPERTENSION, V18, P742, DOI 10.1161/01.HYP.18.6.742; Delafontaine P, 1996, J CLIN INVEST, V97, P139, DOI 10.1172/JCI118381; Duan CM, 1996, J BIOL CHEM, V271, P4280; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; GOCKERMAN A, 1995, ENDOCRINOLOGY, V136, P4168, DOI 10.1210/en.136.10.4168; GRANT MB, 1994, CIRCULATION, V89, P1511, DOI 10.1161/01.CIR.89.4.1511; HEDIN U, 1988, J CELL BIOL, V107, P307, DOI 10.1083/jcb.107.1.307; HOSHIGA M, 1995, CIRC RES, V77, P1129, DOI 10.1161/01.RES.77.6.1129; Imai Y, 1997, J CLIN INVEST, V100, P2596, DOI 10.1172/JCI119803; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; KHORSANDI MJ, 1992, J CLIN INVEST, V90, P1926, DOI 10.1172/JCI116070; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; MOSS PRL, 1995, LAB INVEST, V53, P556; MOSSE PRL, 1986, ARTERIOSCLEROSIS, V6, P664, DOI 10.1161/01.ATV.6.6.664; NICHOLS TC, 1990, ARTERIOSCLEROSIS, V10, P449, DOI 10.1161/01.ATV.10.3.449; PAULY RR, 1995, CIRCULATION, V91, P1107, DOI 10.1161/01.CIR.91.4.1107; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; ROSS R, 1984, AM J PATHOL, V114, P79; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SKINNER MP, 1994, AM J PATHOL, V145, P1070; THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156	39	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8994	9000		10.1074/jbc.273.15.8994	http://dx.doi.org/10.1074/jbc.273.15.8994			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535886	hybrid, Green Published			2022-12-27	WOS:000072990800063
J	Horowitz, A; Simons, M				Horowitz, A; Simons, M			Regulation of syndecan-4 phosphorylation in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FIBROBLAST GROWTH-FACTOR; HEPARAN-SULFATE; TYROSINE PHOSPHORYLATION; MOLECULAR-CLONING; CYTOPLASMIC DOMAIN; RECEPTOR; BINDING; ACTIVATION; DIFFERENTIATION	Recent studies suggest that some of the heparan sulfate -carrying proteoglycans may directly participate in signaling via their cytoplasmic tail, The present investigation addresses the potential involvement of syndecan-4, a widely expressed transmembrane proteoglycan, in this process. We found that the cytoplasmic tail of syndecan-4 is phosphorylated on a single serine residue (Ser(183)) in growth-arrested NIH 3T3 fibroblasts, with a stoichiometry of 0.3 mol P-i/mol syndecan-4. Treatment of the cells with a protein kinase C (PKC)-activating phorbol ester lead to a 2.5-fold increase in Ser(183) phosphorylation. This increase was inhibited by a generic PKC inhibitor but not by an inhibitor specific to the calcium-dependent conventional PKCs, suggesting that the cytoplasmic tail of syndecan-4 is phosphorylated by a calcium-independent novel PKC isozyme. Application of 10-30 ng/ml basic fibroblast growth factor (bFGF) produced a 2-3-fold reduction in the phosphorylation of syndecan-4, Because treatment with the phosphatase inhibitor calyculin prevented the bFGF-induced decrease in syndecan-4 phosphorylation, the effect of bFGF appears to be mediated by a protein serine/threonine phosphatase type 1 or 2A. We conclude that the cytoplasmic tail of syndecan-4 is subject to in vivo phosphorylation on Ser(183), which is regulated by the activities of a novel PKC isozyme and a bFGF-dependent serine/threonine phosphatase.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Cardiovasc Div,Angiogenesis Res Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Simons, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Cardiovasc Div,Angiogenesis Res Ctr, RW453,330 Brookline Ave, Boston, MA 02215 USA.		Horowitz, Arie/AAT-9482-2021; Horowitz, Arie/F-4628-2015; Simons, Michael/G-8553-2014	Horowitz, Arie/0000-0001-6239-1287; Simons, Michael/0000-0003-0348-7734	NHLBI NIH HHS [HL-53793, HL-07374] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793, T32HL007374] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BRICKMAN YG, 1995, J BIOL CHEM, V270, P24941, DOI 10.1074/jbc.270.42.24941; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; CAREY DJ, 1994, EXP CELL RES, V214, P12, DOI 10.1006/excr.1994.1228; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; GOULD SE, 1992, P NATL ACAD SCI USA, V89, P3271, DOI 10.1073/pnas.89.8.3271; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Itano N, 1996, BIOCHEM J, V315, P925, DOI 10.1042/bj3150925; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KOJIMA T, 1992, J BIOL CHEM, V267, P4870; KOJIMA T, 1993, BIOCHEM BIOPH RES CO, V190, P814, DOI 10.1006/bbrc.1993.1122; Krufka A, 1996, BIOCHEMISTRY-US, V35, P11131, DOI 10.1021/bi960125+; LI WQ, 1994, J BIOL CHEM, V269, P2349; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Oh ES, 1997, ARCH BIOCHEM BIOPHYS, V344, P67, DOI 10.1006/abbi.1997.0180; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Prasthofer T, 1995, BIOCHEM MOL BIOL INT, V36, P793; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rapraeger AC, 1993, CURR OPIN CELL BIOL, V5, P844, DOI 10.1016/0955-0674(93)90034-N; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SHWORAK NW, 1994, J BIOL CHEM, V269, P21204; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	35	87	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10914	10918		10.1074/jbc.273.18.10914	http://dx.doi.org/10.1074/jbc.273.18.10914			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556568	hybrid			2022-12-27	WOS:000073395200020
J	Quiram, PA; Sine, SM				Quiram, PA; Sine, SM			Identification of residues in the neuronal alpha(7) acetylcholine receptor that confer selectivity for conotoxin ImI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHARMACOLOGICAL PROPERTIES; MOLECULAR DISSECTION; SUBUNIT INTERFACES; EPSILON-SUBUNIT; BINDING-SITE; CELLS; EXPRESSION	To identify residues in the neuronal alpha(7) acetylcholine subunit that confer high affinity for the neuronal-specific toxin conotoxin ImI (CTx ImI), we constructed alpha(7)-alpha(1) chimeras containing segments of the muscle alpha(1) subunit inserted into equivalent positions of the neuronal alpha(7) subunit. To achieve high expression in 293 human embryonic kidney cells and formation of homo-oligomers, we joined the extracellular domains of each chimera to the M1 junction of the 5-hydroxytryptamine-3 (5HT-3) subunit, Measurements of CTx ImI binding to the chimeric receptors reveal three pairs of residues in equivalent positions of the primary sequence that confer high affinity of CTx ImI for alpha(7)/5HT-3 over alpha(1)/5HT-3 homooligomers. Two of these pairs, alpha(7)Trp(55)/alpha(1)Arg(55) and alpha Ser(59)/alpha(1)Gln(59), are within one of the four loops that contribute to the traditional non-alpha subunit face of the muscle receptor binding site. The third pair, alpha(7)Thr(77)/alpha(1)Lys(77), is not within previously described loops of either the alpha or non-alpha faces and may represent a new loop or an allosterically coupled loop. Exchanging these residues between alpha(1) and alpha(7) subunits exchanges the affinities of the binding sites for CTx ImI, suggesting that the alpha(7) and alpha(1) subunits, despite sequence identity of only 38%, share similar protein scaffolds.	Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Receptor Biol Lab, Rochester, MN 55905 USA	Mayo Clinic	Sine, SM (corresponding author), Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Receptor Biol Lab, 200 1st St SW, Rochester, MN 55905 USA.	sine.steven@mayo.edu						ANAND R, 1993, FEBS LETT, V327, P241, DOI 10.1016/0014-5793(93)80177-V; ANDRUE D, 1994, METHODS MOL BIOL PEP, V35, P139; Bren N, 1997, J BIOL CHEM, V272, P30793, DOI 10.1074/jbc.272.49.30793; CHIARA DC, 1992, BIOPHYS J, V61; Cooper ST, 1997, J NEUROCHEM, V68, P2140; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GOPALAKRISHNAN M, 1995, EUR J PHARM-MOLEC PH, V290, P237, DOI 10.1016/0922-4106(95)00083-6; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; GU Y, 1991, NEURON, V6, P879, DOI 10.1016/0896-6273(91)90228-R; KREIENKAMP HJ, 1995, NEURON, V14, P635, DOI 10.1016/0896-6273(95)90320-8; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; PRINCE RJ, NICOTINIC ACETYLCHOL, P31; PUCHACZ E, 1994, FEBS LETT, V354, P155, DOI 10.1016/0014-5793(94)01108-7; SINE S, 1979, J BIOL CHEM, V254, P3315; Sine SM, 1997, J BIOL CHEM, V272, P23521, DOI 10.1074/jbc.272.38.23521; SINE SM, 1994, J BIOL CHEM, V269, P8808; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; Tsigelny I, 1997, BIOPHYS J, V73, P52, DOI 10.1016/S0006-3495(97)78047-0; TZARTOS SJ, 1988, P NATL ACAD SCI USA, V85, P2899, DOI 10.1073/pnas.85.9.2899; VicenteAgullo F, 1996, FEBS LETT, V399, P83, DOI 10.1016/S0014-5793(96)01291-4	30	64	70	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11001	11006		10.1074/jbc.273.18.11001	http://dx.doi.org/10.1074/jbc.273.18.11001			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556580	hybrid			2022-12-27	WOS:000073395200032
J	Ling, Y; West, AG; Roberts, EC; Lakey, JH; Sharrocks, AD				Ling, Y; West, AG; Roberts, EC; Lakey, JH; Sharrocks, AD			Interaction of transcription factors with serum response factor - Identification of the Elk-1 binding surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX-FORMATION; C-FOS PROMOTER; DNA-BINDING; DOMAIN; ELEMENTS; ACTIVATION; PATHWAYS; PROTEINS; SRF; SPECIFICITIES	Serum response elements (SREs) play important roles in transforming extracellular signals into specific nuclear responses. The SRE-binding protein, serum response factor (SRF), plays a pivotal role in this process. Several transcription factors have been shown to interact with SRF and thereby create distinct complexes with different regulatory potentials, The ETS domain transcription factor Elk-1 is one such protein and serves to integrate distinct mitogen activated protein kinase cascades at SREs, Elk-l uses a short hydrophobic surface presented on the surface of an ct-helix to interact with SRF, In this study we have used site-directed mutagenesis to identify residues in SRF that comprise the Elk-l binding surface. The Elk-1 binding surface is composed of residues that lie on a hydrophobic surface-exposed groove located at the junction of the MADS box and C-terminal SAM motif. Different residues are implicated in interactions between SRF and the transcription factor Fli-1, indicating that although some overlap with the Elk-1 binding surface occurs, their interaction surfaces on SRF are distinct. Our data are consistent with the hypothesis that the SRF DNA-binding domain acts as docking site for multiple transcription factors that can bind to small surface-exposed patches within this domain.	Univ Newcastle Upon Tyne, Sch Med, Dept Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Sharrocks, AD (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Dept Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.			West, Adam/0000-0003-3502-7804; Lakey, Jeremy/0000-0003-4646-9085				Bryant GO, 1996, GENE DEV, V10, P2491, DOI 10.1101/gad.10.19.2491; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Franzoso G, 1996, EMBO J, V15, P3403, DOI 10.1002/j.1460-2075.1996.tb00706.x; Groisman R, 1996, J BIOL CHEM, V271, P5258; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; MagnaghiJaulin L, 1996, NUCLEIC ACIDS RES, V24, P1052, DOI 10.1093/nar/24.6.1052; MUELLER CGF, 1991, EMBO J, V10, P4219, DOI 10.1002/j.1460-2075.1991.tb05000.x; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; SHARROCKS AD, 1995, NUCLEIC ACIDS RES, V23, P2442, DOI 10.1093/nar/23.13.2442; SHARROCKS AD, 1993, NUCLEIC ACIDS RES, V21, P215, DOI 10.1093/nar/21.2.215; SHARROCKS AD, 1993, MOL CELL BIOL, V13, P123, DOI 10.1128/MCB.13.1.123; SHAW PE, 1992, EMBO J, V11, P3011, DOI 10.1002/j.1460-2075.1992.tb05371.x; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Shore P, 1996, MOL CELL BIOL, V16, P3338; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; SHORE P, 1995, NUCLEIC ACIDS RES, V23, P4698, DOI 10.1093/nar/23.22.4698; Strahl T, 1996, P NATL ACAD SCI USA, V93, P11563, DOI 10.1073/pnas.93.21.11563; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tang H, 1996, P NATL ACAD SCI USA, V93, P1119, DOI 10.1073/pnas.93.3.1119; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; West AG, 1997, MOL CELL BIOL, V17, P2876, DOI 10.1128/MCB.17.5.2876; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360	35	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10506	10514		10.1074/jbc.273.17.10506	http://dx.doi.org/10.1074/jbc.273.17.10506			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553110	hybrid			2022-12-27	WOS:000073224200059
J	Matlib, MA; Zhou, Z; Knight, S; Ahmed, S; Choi, KM; Krause-Bauer, J; Phillips, R; Altschuld, R; Katsube, Y; Sperelakis, N; Bers, DM				Matlib, MA; Zhou, Z; Knight, S; Ahmed, S; Choi, KM; Krause-Bauer, J; Phillips, R; Altschuld, R; Katsube, Y; Sperelakis, N; Bers, DM			Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-ION TRANSPORT; SARCOPLASMIC-RETICULUM; HEART-MITOCHONDRIA; CHROMAFFIN CELLS; RAT-HEART; RELEASE; RED; <CA2+>(I); NEURONS; CYCLE	Ruthenium red is a well known inhibitor of Ca2+ uptake into mitochondria in vitro. However, its utility as an inhibitor of Ca2+ uptake into mitochondria in vivo or in situ in intact cells is limited because of its inhibitory effects on sarcoplasmic reticulum Ca2+ release channel and other cellular processes. We have synthesized a ruthenium derivative and found it to be an oxygen-bridged dinuclear ruthenium amine complex. It has the same chemical structure as Ru360 reported previously (Emerson, J.,, Clarke, M., J.,, Ying, W-L,, and Sanadi, D., R. (1993) J. Am, Chem. Sec. 115, 11799-11805). Ru360 has been shown to be a potent inhibitor of Ca2+-stimulated respiration of liver mitochondria in vitro. However, the specificity of Ru360 on Ca2+ uptake into mitochondria in vitro or in intact cells has not been determined. The present study reports in detail the potency, the effectiveness, and the mechanism of inhibition of mitochondrial Ca2+ uptake by Ru360 and its specificity in vitro in isolated mitochondria and in situ in isolated cardiac myocytes, Ru360 was more potent (IC50 = 0.184 nM) than ruthenium red (IC50 = 6.85 nM) in inhibiting Ca2+ uptake into mitochondria, (103)Ru360 was found to bind to isolated mitochondria with high affinity (K-d = 0.34 nM, B-max,, = 80 fmol/mg of mitochondrial protein). The IC50 of (103)Ru360 for the inhibition of Ca2+ uptake into mitochondria was also 0.2 nM, indicating that saturation of a specific binding site is responsible for the inhibition of Ca2+ uptake. Ru360, as high as 10 mu M,produced no effect on sarcoplasmic reticulum Ca2+ uptake or release, sarcolemmal Na+/Ca2+ exchange, actomyosin ATPase activity, L-type Ca2+ channel current, cytosolic Ca2+ transients, or cell shortening. (103)Ru360 was taken up by isolated myocytes in a time-dependent biphasic manner. Ru360 (10 mu M) applied outside intact voltage-clamped ventricular myocytes prevented Ca2+ uptake into mitochondria in situ where the cells were progressively loaded with Ca2+ via sarcolemmal Na+/Ca2+ exchange by depolarization to +110 mV. We conclude that Ru360 specifically blocks Ca2+ uptake into mitochondria and can be used in intact cells.	Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; Univ Cincinnati, Dept Chem, Cincinnati, OH 45267 USA; Univ Cincinnati, Dept Cellular & Mol Physiol, Cincinnati, OH 45267 USA; Loyola Univ, Dept Physiol, Maywood, IL 60153 USA; Ohio State Univ, Dept Med Biochem, Columbus, OH 43210 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Loyola University Chicago; University System of Ohio; Ohio State University	Matlib, MA (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, 231 Bethesda Ave,POB 670575, Cincinnati, OH 45267 USA.	matlibma@uc.edu	Bers, Donald M/C-4507-2012; zhou, zhuan/A-8285-2011	Bers, Donald/0000-0002-2237-9483	NHLBI NIH HHS [HL 36240, HL 30077, HL 56782] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056782, R01HL030077, R01HL036240, R37HL030077] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; CHAMBERLAIN BK, 1984, J BIOL CHEM, V259, P7547; COX DA, 1993, J BIOL CHEM, V268, P938; COX DA, 1993, TRENDS PHARMACOL SCI, V14, P408, DOI 10.1016/0165-6147(93)90063-P; DENTON RM, 1980, FEBS LETT, V119, P1, DOI 10.1016/0014-5793(80)80986-0; DILISA F, 1993, CARDIOVASC RES, V27, P1840; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; EMERSON J, 1993, J AM CHEM SOC, V115, P11799, DOI 10.1021/ja00078a019; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GLENNON MC, 1992, J BIOL CHEM, V267, P25568; Griffiths EJ, 1997, AM J PHYSIOL-CELL PH, V273, pC37, DOI 10.1152/ajpcell.1997.273.1.C37; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; GUPTA MP, 1988, AM J PHYSIOL, V255, pH1413, DOI 10.1152/ajpheart.1988.255.6.H1413; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HANSFORD RG, 1985, REV PHYSIOL BIOCH P, V102, P1, DOI 10.1007/BFb0034084; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; ISENBERG G, 1993, CARDIOVASC RES, V27, P1800, DOI 10.1093/cvr/27.10.1800; Jou MJ, 1996, J PHYSIOL-LONDON, V497, P299, DOI 10.1113/jphysiol.1996.sp021769; Katsube Y, 1996, EUR J PHARMACOL, V317, P391, DOI 10.1016/S0014-2999(96)00745-5; KIM HW, 1990, J BIOL CHEM, V265, P1702; KRANIAS EG, 1982, BIOCHIM BIOPHYS ACTA, V709, P28, DOI 10.1016/0167-4838(82)90417-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATLIB MA, 1988, AM J PHYSIOL, V255, pC323, DOI 10.1152/ajpcell.1988.255.3.C323; MATLIB MA, 1984, METHOD PHARMACOL, V5, P25; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Moravec CS, 1997, AM J PHYSIOL-HEART C, V273, pH1432; PAGANI ED, 1984, METHOD PHARMACOL, V5, P49; Prakriya M, 1996, J NEUROSCI, V16, P4344; REED KC, 1974, FEBS LETT, V46, P109, DOI 10.1016/0014-5793(74)80346-7; REED KC, 1974, BIOCHEM J, V140, P143, DOI 10.1042/bj1400143; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; SAVABI F, 1991, J MOL CELL CARDIOL, V23, P1323, DOI 10.1016/0022-2828(91)90089-5; Schreur JHM, 1996, BIOPHYS J, V70, P2571, DOI 10.1016/S0006-3495(96)79828-4; SHEU SS, 1994, J BIOENERG BIOMEMBR, V26, P487, DOI 10.1007/BF00762733; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; VAGHY PL, 1982, J BIOL CHEM, V257, P6000; VASSILEV PM, 1987, CANCER RES, V47, P519; WAN B, 1989, J BIOL CHEM, V264, P13430; WIMSATT DK, 1990, J BIOL CHEM, V265, P14849; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P379, DOI 10.1111/j.1469-7793.1998.379bt.x	49	246	253	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10223	10231		10.1074/jbc.273.17.10223	http://dx.doi.org/10.1074/jbc.273.17.10223			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553073	hybrid			2022-12-27	WOS:000073224200022
J	Shelly, M; Pinkas-Kramarski, R; Guarino, BC; Waterman, H; Wang, LM; Lyass, L; Alimandi, M; Kuo, A; Bacus, SS; Pierce, JH; Andrews, GC; Yarden, Y				Shelly, M; Pinkas-Kramarski, R; Guarino, BC; Waterman, H; Wang, LM; Lyass, L; Alimandi, M; Kuo, A; Bacus, SS; Pierce, JH; Andrews, GC; Yarden, Y			Epiregulin is a potent Pan-ErbB ligand that preferentially activates heterodimeric receptor complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; NEU DIFFERENTIATION FACTOR; FACTOR-RELATED PEPTIDES; EGF RECEPTOR; MICE LACKING; FACTOR-ALPHA; NEUREGULIN RECEPTOR; SIGNAL-TRANSDUCTION; CARDIAC DEVELOPMENT; HEREGULIN ISOFORMS	The ErbB signaling network consists of four transmembrane receptor tyrosine kinases and more than a dozen ligands sharing an epidermal growth factor (EGF) motif. The multiplicity of ErbB-specific ligands is incompletely understood in terms of signal specificity because all ErbB molecules signal through partially overlapping pathways. Here we addressed the action of epiregulin, a recently isolated ligand of ErbB-1. By employing a set of factor-dependent cell lines engineered to express individual ErbBs or their combinations, we found that epiregulin is the broadest specificity EGF-like ligand so far characterized: not only does it stimulate homodimers of both ErbB-1 and ErbB-4, it also activates all possible heterodimeric ErbB complexes. Consistent with its relaxed selectivity, epiregulin binds the various receptor combinations with an affinity that is approximately 100-fold lower than the affinity of ligands with more stringent selectivity, including EGF. Nevertheless, epiregulin's action upon most receptor combinations transmits a more potent mitogenic signal than does EGF. This remarkable discrepancy between binding affinity and bioactivity is permitted by a mechanism that prevents receptor down-regulation, and results in a weak, but prolonged, state of receptor activation.	Hebrew Univ Jerusalem, Dept Bioregulat, IL-76100 Rehovot, Israel; Pfizer Inc, Cent Res, Groton, CT 06340 USA; Adv Cellular Diagnost Inc, Elmhurst, IL 60126 USA	Hebrew University of Jerusalem; Pfizer	Yarden, Y (corresponding author), Hebrew Univ Jerusalem, Dept Bioregulat, IL-76100 Rehovot, Israel.	liyarden@weizmann.weizmann.ac.il	YARDEN, YOSEF/K-1467-2012; Alimandi, Maurizio/AAG-9246-2019	Alimandi, Maurizio/0000-0002-1409-6803; shelly, maya/0000-0002-2211-1751; Pinkas-Kramarski, Ronit/0000-0002-1000-369X				Alimandi M, 1997, EMBO J, V16, P5608, DOI 10.1093/emboj/16.18.5608; Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; BACUS SS, 1993, CANCER RES, V53, P5251; BACUS SS, 1992, CANCER RES, V52, P2580; BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Beerli RR, 1996, J BIOL CHEM, V271, P6071, DOI 10.1074/jbc.271.11.6071; BRANDTRAUF PW, 1989, J PROTEIN CHEM, V8, P749, DOI 10.1007/BF01024899; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Busfield SJ, 1997, MOL CELL BIOL, V17, P4007, DOI 10.1128/MCB.17.7.4007; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; EBNER R, 1991, CELL REGUL, V2, P599, DOI 10.1091/mbc.2.8.599; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; FAURE R, 1992, J BIOL CHEM, V267, P11215; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hamel FG, 1997, MOL CELL ENDOCRINOL, V126, P185, DOI 10.1016/S0303-7207(96)03981-0; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; KARUNAGARAN D, 1995, J BIOL CHEM, V270, P9982, DOI 10.1074/jbc.270.17.9982; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Klapper LN, 1997, ONCOGENE, V14, P2099, DOI 10.1038/sj.onc.1201029; Kornfeld K, 1997, TRENDS GENET, V13, P55, DOI 10.1016/S0168-9525(97)01005-6; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Levkowitz G, 1996, ONCOGENE, V12, P1117; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MARIKOVSKY M, 1995, ONCOGENE, V10, P1403; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Perrimon N, 1997, CELL, V89, P13, DOI 10.1016/S0092-8674(00)80177-4; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; Pinkas-Kramarski R, 1997, J MAMMARY GLAND BIOL, V2, P97, DOI 10.1023/A:1026343528967; PINKASKRAMARSI R, 1998, ONCOGENE, V14, P2099; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Reddy CC, 1996, NAT BIOTECHNOL, V14, P1696, DOI 10.1038/nbt1296-1696; Riese DJ, 1996, ONCOGENE, V12, P345; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SORKIN A, 1992, J BIOL CHEM, V267, P8672; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; STOCKSCHLAEDER MAR, 1991, HUM GENE THER, V2, P33, DOI 10.1089/hum.1991.2.1-33; Summerfield AE, 1996, J BIOL CHEM, V271, P19656, DOI 10.1074/jbc.271.33.19656; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Toyoda H, 1995, FEBS LETT, V377, P403, DOI 10.1016/0014-5793(95)01403-9; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Toyoda H, 1997, BIOCHEM J, V326, P69, DOI 10.1042/bj3260069; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; TZAHAR E, 1998, IN PRESS REV CANC, V1377; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YARDEN Y, 1981, BIOCHIM BIOPHYS ACTA, V674, P188, DOI 10.1016/0304-4165(81)90377-9; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562	63	121	131	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10496	10505		10.1074/jbc.273.17.10496	http://dx.doi.org/10.1074/jbc.273.17.10496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553109	hybrid			2022-12-27	WOS:000073224200058
J	Claus, V; Jahraus, A; Tjelle, T; Berg, T; Kirschke, H; Faulstich, H; Griffiths, G				Claus, V; Jahraus, A; Tjelle, T; Berg, T; Kirschke, H; Faulstich, H; Griffiths, G			Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages - Enrichment of cathepsin H in early endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOCYTOCHEMICAL LOCALIZATION; CULTURED MACROPHAGES; CYSTEINE PROTEINASES; REGULATED SECRETION; MEMBRANE-PROTEINS; CELLS; FUSION; COMPARTMENT; CHLOROQUINE; RECEPTOR	In this study we take advantage of recently developed methods using J774 macrophages to prepare enriched fractions of early endosomes, late endosomes, dense lysosomes, as well as phagosomes of different ages enclosing 1-mu m latex beads to investigate the steady state distribution and trafficking of lysosomal enzyme activity between these organelles. At steady state these cells appear to possess four different cellular structures, in addition to phagolysosomes, where acid hydrolases were concentrated. The first site of hydrolase concentration was the early endosomes, which contained the bulk of the cellular cathepsin H. This enzyme was acquired by phagosomes significantly faster than the other hydrolases tested. The second distinct site of lysosomal enzyme concentration was the late endosomes which contain the bulk of cathepsin S. The third and fourth large pools of hydrolases were found in two functionally distinct types of dense lysosomes, only one of which was found to be secreted in the presence of chloroquine or bafilomycin, Among this secreted pool was soluble furin, generally considered only as a membrane-bound trans-Golgi network resident protein. Thus, the organelles usually referred to as "lysosomes" in fact encompass a growing family of highly dynamic but functionally distinct endocytic organelles.	Max Planck Inst Med Res, Heidelberg, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Oslo, Dept Biol, N-0316 Oslo, Norway; Univ Halle Wittenberg, Dept Biochem, D-06097 Halle, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL); University of Oslo; Martin Luther University Halle Wittenberg	Claus, V (corresponding author), Max Planck Inst Med Res, Jahnstr 29, Heidelberg, Germany.							ABRAHAM R, 1970, EXP MOL PATHOL, V12, P148, DOI 10.1016/0014-4800(70)90046-8; ALBERTS B, 1994, MOL BIOL CELL, P610; ARAKI N, 1995, EXP CELL RES, V217, P469, DOI 10.1006/excr.1995.1111; AUTHIER F, 1995, J BIOL CHEM, V270, P15798, DOI 10.1074/jbc.270.26.15798; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Barrett AJ, 1977, LYSOSOMES LABORATORY, P19; BERG T, 1995, BIOCHEM J, V307, P313, DOI 10.1042/bj3070313; BERON W, 1995, TRENDS CELL BIOL, V5, P100, DOI 10.1016/S0962-8924(00)88958-8; BOSSHART H, 1994, J CELL BIOL, V126, P1157, DOI 10.1083/jcb.126.5.1157; BUTOR C, 1995, J CELL SCI, V108, P2213; CARDELLI JA, 1988, TRANSPORT TARGETING, P363; COHEN ML, 1983, J PHARMACOL EXP THER, V224, P379; DEAN RT, 1984, BIOCHEM J, V217, P27, DOI 10.1042/bj2170027; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; DENG YP, 1988, P NATL ACAD SCI USA, V85, P3860, DOI 10.1073/pnas.85.11.3860; DENG YP, 1991, J CELL SCI, V99, P571; Desjardins M, 1997, J CELL SCI, V110, P2303; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; DIMENT S, 1988, J BIOL CHEM, V263, P6901; Drose S, 1997, J EXP BIOL, V200, P1; FURUHASHI M, 1991, HISTOCHEMISTRY, V95, P231; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; GRIFFITHS G, 1990, J CELL SCI, V96, P691; GRIFFITHS G, 1990, J CELL SCI, V95, P441; Griffiths G, 1996, PROTOPLASMA, V195, P37, DOI 10.1007/BF01279185; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN, P137; Griffiths GM, 1996, TRENDS CELL BIOL, V6, P329, DOI 10.1016/0962-8924(96)20031-5; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HART PD, 1983, J EXP MED, V158, P477, DOI 10.1084/jem.158.2.477; HART PD, 1978, EXP CELL RES, V114, P486, DOI 10.1016/0014-4827(78)90516-5; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; JAHRAUS A, 1994, J CELL SCI, V107, P145; JESSUP W, 1982, BIOCHEM BIOPH RES CO, V105, P922, DOI 10.1016/0006-291X(82)91058-0; JESSUP W, 1984, BIOCHEM SOC T, V12, P529, DOI 10.1042/bst0120529; JOHNSON GD, 1990, ARCH BIOCHEM BIOPHYS, V276, P305, DOI 10.1016/0003-9861(90)90724-D; KIELIAN MC, 1980, J CELL BIOL, V85, P754, DOI 10.1083/jcb.85.3.754; KIRSCHKE H, 1994, METHOD ENZYMOL, V244, P500; KIRSCHKE H, 1977, ACTA BIOL MED GER, V36, P185; KIRSCHKE H, 1987, CHEM LYSOSOMAL PROTE, P196; KOMINAMI E, 1985, J BIOCHEM-TOKYO, V98, P87, DOI 10.1093/oxfordjournals.jbchem.a135277; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LEBORGNE R, 1993, J BIOL CHEM, V268, P22552; LODISH H, 1995, MOL CELL BIOL, P649; LUDWIG T, 1991, J CELL BIOL, V115, P1561, DOI 10.1083/jcb.115.6.1561; MAYORGA LS, 1991, J BIOL CHEM, V266, P6511; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; MULLER WA, 1980, J CELL BIOL, V86, P304, DOI 10.1083/jcb.86.1.304; MUNNELL JF, 1980, AM J PATHOL, V98, P385; NAGATSU T, 1985, ANAL BIOCHEM, V147, P80, DOI 10.1016/0003-2697(85)90011-9; OHKUMA A, 1987, LYSOSOMAL PROTON PUM, P115; PITT A, 1992, J BIOL CHEM, V267, P126; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; RAPSOSO G, 1996, J EXP MED, V183, P1161; REDDY VY, 1995, P NATL ACAD SCI USA, V92, P3849, DOI 10.1073/pnas.92.9.3849; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; ROEDERER M, 1987, J CELL PHYSIOL, V131, P200, DOI 10.1002/jcp.1041310209; ROME LH, 1981, J BIOL CHEM, V256, P763; ROZHIN J, 1994, CANCER RES, V54, P6517; STAUBER WT, 1981, EXP MOL PATHOL, V34, P87, DOI 10.1016/0014-4800(81)90038-1; STORRIE B, 1988, INT REV CYTOL, V111, P53, DOI 10.1016/S0074-7696(08)61731-3; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Tjelle TE, 1996, J CELL SCI, V109, P2905; TOOZE J, 1991, EUR J CELL BIOL, V56, P187; UCHIYAMA Y, 1990, J HISTOCHEM CYTOCHEM, V38, P633, DOI 10.1177/38.5.2159033; Ulbricht B, 1996, EXP CELL RES, V226, P255, DOI 10.1006/excr.1996.0226; VLADUTIU GD, 1982, BIOCHEM J, V208, P559, DOI 10.1042/bj2080559; WAGURI S, 1995, EUR J CELL BIOL, V67, P308; WIEDERANDERS B, 1986, BIOMED BIOCHIM ACTA, V45, P1421; WILSON RB, 1989, METHOD CELL BIOL, V31, P293	72	157	161	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9842	9851		10.1074/jbc.273.16.9842	http://dx.doi.org/10.1074/jbc.273.16.9842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545324	hybrid			2022-12-27	WOS:000073128800070
J	Li, C; Ioffe, E; Fidahusein, N; Connolly, E; Friedman, JM				Li, C; Ioffe, E; Fidahusein, N; Connolly, E; Friedman, JM			Absence of soluble leptin receptor in plasma from db(Pas)/db(Pas) and other db/db mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBESE GENE-PRODUCT; OB PROTEIN; CLONING; IDENTIFICATION; CIRCULATION; EXPRESSION; ADIPOSITY; BINDING; SERUM	The leptin receptor (Ob-R) is alternatively spliced into at least five different RNAs designated Ob-R(a-e). Ob-R(a-d) predict receptors with a single transmembrane domain, and Ob-Re predicts a secreted form of the receptor. The presence of an similar to 120-kDa soluble leptin receptor in mouse plasma was confirmed by precipitation with leptin-Sepharose beads followed by immunobloting with anti-leptin receptor antibodies. The soluble leptin receptor is larger than that predicted by the primary sequence. Deglycosylation of the receptor with peptide N:glycosidase F results in a decrease in molecular mass to a size consistent with that of the primary sequence. The secreted receptor was present in plasma from wild type mice but was truncated in plasma from db(3J)/db(3J) and absent in db(Pas)/db(Pas) plasma. Although db(3J)/db(3J) mice are known to have a frameshift mutation at amino acid 625, the basis for the mutation in db(Pas)/db(Pas) mice was not known. Further studies indicated that db(Pas)/db(Pas) mice carry a duplication of exons 4 and 5 of Ob-R. This mutation introduces a premature stop codon into the protein at amino acid 281. The absence of Ob-R in db(3J)/db(3J) and db(Pas)/db(Pas) mice confirm the identify of the 120-kDa plasma protein as Ob-Re.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave,Box 305, New York, NY 10021 USA.		Connolly, Eileen/AAX-9112-2021	Connolly, Eileen/0000-0001-6558-1932				Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chung WK, 1996, GENOME RES, V6, P1192, DOI 10.1101/gr.6.12.1192; Cumin F, 1997, INT J OBESITY, V21, P495, DOI 10.1038/sj.ijo.0800428; Cumin F, 1996, INT J OBESITY, V20, P1120; Devos R, 1997, J BIOL CHEM, V272, P18304, DOI 10.1074/jbc.272.29.18304; Golden PL, 1997, J CLIN INVEST, V99, P14, DOI 10.1172/JCI119125; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Houseknecht KL, 1996, DIABETES, V45, P1638, DOI 10.2337/diabetes.45.11.1638; Lee GH, 1997, MAMM GENOME, V8, P445, DOI 10.1007/s003359900466; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Liu CL, 1997, ENDOCRINOLOGY, V138, P3548, DOI 10.1210/en.138.8.3548; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	21	64	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10078	10082		10.1074/jbc.273.16.10078	http://dx.doi.org/10.1074/jbc.273.16.10078			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545355	hybrid			2022-12-27	WOS:000073128800101
J	Rawat, U; Rao, M				Rawat, U; Rao, M			Interactions of chaperone alpha-crystallin with the molten globule state of xylose reductase - Implications for reconstitution of the active enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; B-CRYSTALLIN; MOLECULAR CHAPERONE; NEUROSPORA-CRASSA; FOLDING REACTIONS; BINDING; INTERMEDIATE; INVOLVEMENT; ISOMERASE; DNAK	alpha-Crystallin is a multimeric protein that has been shown to function as a molecular chaperone. Present investigations were undertaken to understand its mechanism of chaperoning. For this functional in vitro analysis of alpha-crystallin we used xylose reductase (XR) from Neurospora crassa as the model system. Denaturation studies using the structure-perturbing agent guanidinium chloride indicated that IIR folds through a partially folded state that resembles the molten globule. Fluorescence and delay experiments revealed that alpha-crystallin interacts with the molten globule state of XR (XR-m) and prevents its aggregation. Cold lability of alpha-crystallin XR-m interaction was revealed by temperature shift experiments implicating the involvement of hydrophobic interactions in the formation of the complex. Reconstitution of active XR was observed on cooling the alpha-crystallin XR-m complex to 4 degrees C or on addition of ATP at 37 degrees C. ATP hydrolysis is not a prerequisite for XR release since the nonhydrolyzable analogue 5'-adenylyl imidodiphosphate (AMP-PNP) was capable of reconstitution of active XR. Experimental evidence has been provided for temperature- and ATP-mediated structural changes in the alpha-crystallin XR-m complex that shed some light on the mechanism of reconstitution of active XR by this chaperone. The relevance of our finding to the role of alpha-crystallin in vivo is discussed.	Natl Chem Lab, Div Biochem Sci, Poona 411008, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Rao, M (corresponding author), Natl Chem Lab, Div Biochem Sci, Poona 411008, Maharashtra, India.							ALDER AJ, 1973, METHOD ENZYMOL, V27, P675; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BERND N, 1996, BIOTECHNOL BIOENG, V52, P387; BLUMBERG H, 1991, NATURE, V349, P627, DOI 10.1038/349627a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; CAINES GH, 1990, BIOCHEMISTRY-US, V29, P7547, DOI 10.1021/bi00485a002; DAS KP, 1995, BIOCHEM J, V311, P367, DOI 10.1042/bj3110367; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; DUGID JR, 1988, P NATL ACAD SCI USA, V57, P5738; ELLIS RJ, 1990, SCIENCE, V250, P954, DOI 10.1126/science.250.4983.954; FINK AL, 1995, ANNU REV BIOPH BIOM, V24, P495, DOI 10.1146/annurev.bb.24.060195.002431; FREEDMAN RB, 1984, TRENDS BIOCHEM SCI, V9, P438, DOI 10.1016/0968-0004(84)90152-X; GOBOUBINOFF P, 1989, NATURE, V342, P884; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; IWAKI T, 1992, AM J PATHOL, V140, P345; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; Jaenicke R, 1986, Methods Enzymol, V131, P218; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; KELLEY MJ, 1993, J BIOL CHEM, V268, P18844; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Lakowicz J. R., 1983, PRINCIPLES FLUORESCE, P19; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LOWE J, 1990, LANCET, V336, P515, DOI 10.1016/0140-6736(90)92075-S; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Pace C N, 1986, Methods Enzymol, V131, P266; PALMISANO DV, 1995, BBA-PROTEIN STRUCT M, V1246, P91, DOI 10.1016/0167-4838(94)00176-H; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; RAMAN B, 1994, J BIOL CHEM, V269, P27264; Rawat U, 1997, BIOCHEM BIOPH RES CO, V239, P789, DOI 10.1006/bbrc.1997.7558; RAWAT U, 1993, BIOTECHNOL LETT, V15, P1173, DOI 10.1007/BF00131211; Rawat UB, 1996, BBA-PROTEIN STRUCT M, V1293, P222, DOI 10.1016/0167-4838(95)00249-9; Rawat UB, 1997, EUR J BIOCHEM, V246, P344, DOI 10.1111/j.1432-1033.1997.00344.x; SCHMIDT M, 1992, J BIOL CHEM, V267, P16829; SIMONS SS, 1979, BIOCHEMISTRY-US, V18, P4915, DOI 10.1021/bi00589a020; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; WANG KY, 1994, J BIOL CHEM, V269, P13601; ZETTLMEISSL G, 1979, BIOCHEMISTRY-US, V18, P5567, DOI 10.1021/bi00592a007	52	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9415	9423		10.1074/jbc.273.16.9415	http://dx.doi.org/10.1074/jbc.273.16.9415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545266	hybrid			2022-12-27	WOS:000073128800012
J	Jimi, E; Nakamura, I; Ikebe, T; Akiyama, S; Takahashi, N; Suda, T				Jimi, E; Nakamura, I; Ikebe, T; Akiyama, S; Takahashi, N; Suda, T			Activation of NF-kappa B is involved in the survival of osteoclasts promoted by interleukin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; BONE-RESORPTION; CELL-DEATH; RABBIT OSTEOCLASTS; IN-VITRO; APOPTOSIS; PROTEIN; ALPHA; MICE; PHOSPHORYLATION	We previously reported that interleukin-l (IL-1) promoted the survival of murine osteoclast-like cells (OCLs) formed in vitro and activated a transcription factor, NF-kappa B, of OCLs. The present study examined whether the activation of NF-kappa B is directly involved in the survival of OCLs promoted by IL-1. The expression of IL-l type I receptor mRNA in OCLs was detected by the polymerase chain reaction amplification of reverse-transcribed mRNA. An electrophoretic mobility shift assay showed that IL-l transiently activated NP-kappa B in the nuclei of the OCLs, and the maximal activation occurred at 30 min. The degradation of I kappa B alpha coincided with the activation of NF-kappa B in the OCLs. The immunocytochemical study revealed that p65, a subunit of NF-kappa B, was translocated from the cytoplasm into almost all of the nuclei of the OCLs within 30 min after IL-I stimulation. The purified OCLs spontaneously died via apoptosis, and IL-l promoted the survival of OCLs by preventing their apoptosis. The pretreatment of purified OCLs with proteasome inhibitors suppressed the IL-1-induced activation of NF-kappa B and prevented the survival of OCLs supported by IL-1. When OCLs were pretreated with antisense oligodeoxynucleotides to p65 and p50 of NF-kappa B, the expression of respective mRNAs by OCLs was suppressed, and the IL-l-induced survival of OCLs was concomitantly inhibited. These results indicate that IL-1 promotes the survival of osteoclasts through the activation of NF-kappa B.	Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan; Kyushu Univ, Fac Dent, Dept Oral & Maxillofacial Surg, Higashi Ku, Fukuoka 8128582, Japan	Showa University; Kyushu University	Suda, T (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.							ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W; AKATSU T, 1991, J BONE MINER RES, V6, P183; ANTWERP DJV, 1996, SCIENCE, V274, P787; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BESSHO R, 1994, BIOCHEM PHARMACOL, V48, P1883, DOI 10.1016/0006-2952(94)90586-X; BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142; CHAMBERS TJ, 1984, J CELL SCI, V66, P383; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jimi E, 1996, J BIOL CHEM, V271, P4605; JIMI E, 1995, ENDOCRINOLOGY, V136, P808, DOI 10.1210/en.136.2.808; KAMEDA T, 1997, J EXP MED, V186, P497; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Nakamura I, 1996, J BONE MINER RES, V11, P1873; Okahashi N, 1997, J BONE MINER RES, V12, P1116, DOI 10.1359/jbmr.1997.12.7.1116; ORIAN A, 1995, J BIOL CHEM, V270, P21707, DOI 10.1074/jbc.270.37.21707; Ozaki K, 1997, FEBS LETT, V410, P297, DOI 10.1016/S0014-5793(97)00653-4; READ MA, 1995, IMMUNITY, V2, P493, DOI 10.1016/1074-7613(95)90030-6; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Selander KS, 1996, MOL CELL ENDOCRINOL, V122, P119, DOI 10.1016/0303-7207(96)03870-1; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SUDA T, 1995, ENDOCRINE REV MONOGR, V4, P266; THOMSON BM, 1986, J EXP MED, V164, P104, DOI 10.1084/jem.164.1.104; TRANTHI TA, 1995, HEPATOLOGY, V22, P613, DOI 10.1016/0270-9139(95)90587-1; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Xu LX, 1996, LAB INVEST, V75, P677; YU HS, 1993, BIOCHEM BIOPH RES CO, V191, P343, DOI 10.1006/bbrc.1993.1223	37	161	167	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8799	8805		10.1074/jbc.273.15.8799	http://dx.doi.org/10.1074/jbc.273.15.8799			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535858	hybrid			2022-12-27	WOS:000072990800035
J	Kim, K; Biade, S; Matsumoto, Y				Kim, K; Biade, S; Matsumoto, Y			Involvement of flap endonuclease 1 in base excision DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DEOXYRIBOSE PHOSPHATE RESIDUES; SYNTHETIC ABASIC SITE; POLYMERASE-BETA; ESCHERICHIA-COLI; MAMMALIAN-CELLS; REPLICATION; HOMOLOG; FEN-1; MUTATIONS	Base excision repair can proceed in either one of two alternative pathways: a DNA polymerase beta-dependent pathway and a proliferating cell nuclear antigen (PCNA)dependent pathway, Excision of an apurinic/apyrimidinic (AP) site by cutting the phosphate backbone on its 3' side following incision at its 5' side by AP endonuclease is a prerequisite to completion of these repair pathways. Using a reconstituted system with the proteins derived from Xenopus laevis, we found that flap endonuclease 1 (FEN1) was a factor responsible for the excision of a 5'-incised AP site in the PCNA-dependent pathway. In this pathway, DNA synthesis was not required for the action of FEN1 in the presence of PCNA and a replication factor C-containing fraction. The polymerase beta-dependent pathway could also use FEN1 for excision of the synthetic AP sites, which were not susceptible to beta-elimination. In this pathway, FEN1 was functional without PCNA and replication factor C but required the DNA synthesis, which led to a flap structure formation.	Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Matsumoto, Y (corresponding author), Fox Chase Canc Ctr, Dept Radiat Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.			Matsumoto, Yoshihiro/0000-0001-6580-7188	NATIONAL CANCER INSTITUTE [R01CA063154, R29CA063154, P30CA006927] Funding Source: NIH RePORTER; NCI NIH HHS [CA06927, CA63154] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; DeMott MS, 1996, J BIOL CHEM, V271, P30068, DOI 10.1074/jbc.271.47.30068; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; GUGGENHEIMER RA, 1984, J BIOL CHEM, V259, P7815; HARLOW E, 1998, ANTIBODIES LAB MANUA, P53; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; HICKSON ID, 1997, BASE EXCISION REPAIR; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGENDRE N, 1993, PRACTICAL GUIDE PROT, P71; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1971, EUR J BIOCHEM, V18, P407, DOI 10.1111/j.1432-1033.1971.tb01257.x; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MATSUMOTO Y, 1991, MOL CELL BIOL, V11, P4441, DOI 10.1128/MCB.11.9.4441; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; MATSUMOTO Y, 1989, MOL CELL BIOL, V9, P3750, DOI 10.1128/MCB.9.9.3750; MOSBAUGH DW, 1980, J BIOL CHEM, V255, P239; MOSBAUGH DW, 1983, J BIOL CHEM, V258, P108; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; Nicholl ID, 1997, BIOCHEMISTRY-US, V36, P7557, DOI 10.1021/bi962950w; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; PODUST LM, 1994, NUCLEIC ACIDS RES, V22, P2970, DOI 10.1093/nar/22.15.2970; PRICE A, 1991, BIOCHEMISTRY-US, V30, P8631, DOI 10.1021/bi00099a020; PRICE A, 1992, FEBS LETT, V300, P101, DOI 10.1016/0014-5793(92)80173-E; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; SCHOEPFER R, 1993, GENE, V124, P83, DOI 10.1016/0378-1119(93)90764-T; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; SIEGAL G, 1992, P NATL ACAD SCI USA, V89, P9377, DOI 10.1073/pnas.89.20.9377; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; TAFURI SR, 1990, P NATL ACAD SCI USA, V87, P9028, DOI 10.1073/pnas.87.22.9028; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; VALLEN EA, 1995, MOL CELL BIOL, V15, P4291; WAGA S, 1994, J BIOL CHEM, V269, P10923; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036	41	189	196	3	96	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8842	8848		10.1074/jbc.273.15.8842	http://dx.doi.org/10.1074/jbc.273.15.8842			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535864	hybrid			2022-12-27	WOS:000072990800041
J	Cheng, CH; Shuman, S				Cheng, CH; Shuman, S			A catalytic domain of eukaryotic DNA topoisomerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC INTERACTION; STRAND CLEAVAGE; DUPLEX DNA; IDENTIFICATION; COVALENT; FRAGMENT; BINDING	Eukaryotic type IB topoisomerases catalyze the cleavage and rejoining of DNA strands through a DNA-(3'phosphotyrosyl)-enzyme intermediate, The 314-amino acid vaccinia topoisomerase is the smallest member of this family and is distinguished from its cellular counterparts by its specificity for cleavage at the target sequence 5'-CCCTT down arrow. Here we show that Topo-(81-314), a truncated derivative that lacks the N-terminal domain, performs the same repertoire of reactions as the full-sized topoisomerase: relaxation of supercoiled DNA, site specific DNA transesterification, and DNA strand transfer. Elimination of the N-terminal domain slows the rate of single-turnover DNA cleavage by 10(-3.6), but has little effect on the rate of single-turnover DNA religation. DNA relaxation and strand cleavage by Topo(81-314) are inhibited by salt and magnesium; these effects are indicative of reduced affinity in noncovalent DNA binding. We report that identical properties are displayed by a full-length mutant protein, Topo(Y70A/ Y72A), which lacks two tyrosine side chains within the N-terminal domain that contact the DNA target site in the major groove. We speculate that Topo-(81-314) is fully competent for transesterification chemistry, but is compromised with respect to a rate limiting precleavage conformational step that is contingent on DNA contacts made by Tyr-70 and Tyr-72.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Cheng, CH (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.				NIGMS NIH HHS [GM46330] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046330, R01GM046330] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cheng CH, 1997, J BIOL CHEM, V272, P8263, DOI 10.1074/jbc.272.13.8263; GUPTA M, 1995, BBA-GENE STRUCT EXPR, V1262, P1, DOI 10.1016/0167-4781(95)00029-G; KLEMPERER N, 1993, J BIOL CHEM, V268, P15887; Lue N, 1995, STRUCTURE, V3, P1315, DOI 10.1016/S0969-2126(01)00269-6; MORHAM SG, 1992, J BIOL CHEM, V267, P15984; Petersen BO, 1996, J MOL BIOL, V263, P181, DOI 10.1006/jmbi.1996.0568; Petersen BO, 1997, J BIOL CHEM, V272, P3891, DOI 10.1074/jbc.272.7.3891; SEKIGUCHI J, 1994, NUCLEIC ACIDS RES, V22, P5360, DOI 10.1093/nar/22.24.5360; Sekiguchi J, 1996, EMBO J, V15, P3448, DOI 10.1002/j.1460-2075.1996.tb00711.x; SEKIGUCHI J, 1995, J BIOL CHEM, V270, P11636, DOI 10.1074/jbc.270.19.11636; Sekiguchi J, 1997, J BIOL CHEM, V272, P15721, DOI 10.1074/jbc.272.25.15721; SEKIGUCHI J, 1994, J BIOL CHEM, V269, P31731; SEKIGUCHI J, 1994, J BIOL CHEM, V269, P29760; Sekiguchi J, 1997, NUCLEIC ACIDS RES, V25, P3649, DOI 10.1093/nar/25.18.3649; SHARMA A, 1994, STRUCTURE, V2, P767, DOI 10.1016/S0969-2126(94)00077-8; SHUMAN S, 1991, J BIOL CHEM, V266, P1796; SHUMAN S, 1991, J BIOL CHEM, V266, P11372; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; SHUMAN S, 1990, J BIOL CHEM, V265, P17826; SHUMAN S, 1993, J BIOL CHEM, V268, P18943; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P9793, DOI 10.1073/pnas.86.24.9793; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P327, DOI 10.1021/bi00167a043; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang LK, 1997, BIOCHEMISTRY-US, V36, P7944, DOI 10.1021/bi970498q; WITTSCHIEBEN J, 1994, J BIOL CHEM, V269, P29978; Wittschieben J, 1997, NUCLEIC ACIDS RES, V25, P3001, DOI 10.1093/nar/25.15.3001	28	26	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11589	11595		10.1074/jbc.273.19.11589	http://dx.doi.org/10.1074/jbc.273.19.11589			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565576	hybrid			2022-12-27	WOS:000073536700030
J	Home, LA; Iskandar, M; Ausio, J				Home, LA; Iskandar, M; Ausio, J			Folding of chromatin in the presence of heterogeneous histone H1 binding to nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER-ORDER STRUCTURE; LINKER HISTONES; CORE PARTICLES; DNA; TRANSCRIPTION; STABILITY; OLIGONUCLEOSOMES; ORGANIZATION; CONFORMATION; INVOLVEMENT	We have reconstituted oligonucleosome complexes containing histone Hi starting from a synthetic DNA template, consisting of 12 tandemly arranged 208-base pair fragments of the 5 S rRNA gene, purified HeLa histone octamers, and histone H1. A ratio of histone H1 per histone octamer used in the reconstitution (0.8-0.9 mol of histone H1/mol of histone octamer) similar to that observed in vivo was used. The reconstituted chromatin complexes exhibit a salt-dependent folding, which is almost indistinguishable from that exhibited by chromatin fragments obtained from nuclease digestion of native chromatin, The folding of this reconstituted chromatin complex seems to be rather independent of the symmetrical or asymmetrical position occupied by Hi in the individual nucleosomes. Binding of histone H1 to the oligonucleosome complexes, under the stoichiometric binding conditions used, had no inhibitory effect on the transcriptional potential of these complexes.	Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Ausio, J (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada.							ALLAN J, 1981, J CELL BIOL, V90, P279, DOI 10.1083/jcb.90.2.279; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Armstrong JA, 1996, MOL CELL BIOL, V16, P5634; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; AUSIO J, 1982, BIOCHEMISTRY-US, V21, P5910, DOI 10.1021/bi00266a028; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; AUSIO J, 1984, J MOL BIOL, V176, P77, DOI 10.1016/0022-2836(84)90383-8; AUSIO J, 1984, J MOL BIOL, V177, P373, DOI 10.1016/0022-2836(84)90291-2; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1981, DOI 10.1021/bi00356a022; AUSIO J, 1996, CHEMTRACTS, V6, P117; BOROCHOV N, 1984, NUCLEIC ACIDS RES, V12, P3089, DOI 10.1093/nar/12.7.3089; BURTON DR, 1978, NUCLEIC ACIDS RES, V5, P3643, DOI 10.1093/nar/5.10.3643; BUTLER PJG, 1983, CRC CR REV BIOCH MOL, V15, P57, DOI 10.3109/10409238309102801; BUTLER PJG, 1980, J MOL BIOL, V140, P505, DOI 10.1016/0022-2836(80)90268-5; BUTLER PJG, 1984, EMBO J, V3, P2599, DOI 10.1002/j.1460-2075.1984.tb02180.x; CARON F, 1981, J MOL BIOL, V146, P513, DOI 10.1016/0022-2836(81)90045-0; CASAS MT, 1993, EXP CELL RES, V204, P192, DOI 10.1006/excr.1993.1024; CraneRobinson C, 1997, TRENDS BIOCHEM SCI, V22, P75, DOI 10.1016/S0968-0004(97)01013-X; DELANGE RJ, 1976, HDB BIOCH MOL BIOL, V2, P294; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Eisenberg H, 1976, BIOL MACROMOLECULES; GARCIA-RAMIREZ M, 1990, Protein Expression and Purification, V1, P40, DOI 10.1016/1046-5928(90)90043-X; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; GARRARD WT, 1991, BIOESSAYS, V13, P87, DOI 10.1002/bies.950130208; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; HAYES JJ, 1993, P NATL ACAD SCI USA, V90, P6415, DOI 10.1073/pnas.90.14.6415; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; MEERSSEMAN G, 1991, J MOL BIOL, V220, P89, DOI 10.1016/0022-2836(91)90383-H; Moore SC, 1997, BIOCHEM BIOPH RES CO, V230, P136, DOI 10.1006/bbrc.1996.5903; NELSON PP, 1979, J BIOL CHEM, V254, P1751; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; Pruss D, 1996, SCIENCE, V274, P614, DOI 10.1126/science.274.5287.614; RENZ M, 1977, P NATL ACAD SCI USA, V74, P1879, DOI 10.1073/pnas.74.5.1879; ROCCHINI C, 1995, BIOCHEMISTRY-US, V34, P15704, DOI 10.1021/bi00048a015; Sambrook J., 2002, MOL CLONING LAB MANU; SANDALTZOPOULOS R, 1994, EMBO J, V13, P373, DOI 10.1002/j.1460-2075.1994.tb06271.x; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; STEIN A, 1979, J MOL BIOL, V130, P103, DOI 10.1016/0022-2836(79)90421-2; TATCHELL K, 1977, BIOCHEMISTRY-US, V16, P5295, DOI 10.1021/bi00643a021; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Travers AA, 1996, J MOL BIOL, V257, P486, DOI 10.1006/jmbi.1996.0178; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; van Holde K.E., 1988, CHROMATIN; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; VARGAWEISZ PD, 1995, EMBO J, V14, P2209, DOI 10.1002/j.1460-2075.1995.tb07215.x; YAGER TD, 1984, J BIOL CHEM, V259, P4212; ZLANATOVA J, 1992, J CELL SCI, V103, P889	56	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11625	11629						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565581				2022-12-27	WOS:000073536700035
J	Jerala, R; Zerovnik, E; Kidric, J; Turk, V				Jerala, R; Zerovnik, E; Kidric, J; Turk, V			pH-induced conformational transitions of the propeptide of human cathepsin L - A role for a molten globule state in zymogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCATHEPSIN-L; PAPAIN PRECURSOR; ESCHERICHIA-COLI; IN-VITRO; CYSTEINE PROTEASES; SUBTILISIN BPN'; PRO-REGION; PROTEIN; INHIBITION; MEMBRANES	Synthesis of proteases as inactive zymogens is a very important mechanism for the regulation of their activity. For lysosomal proteases proteolytic cleavage of the propeptide is triggered by the acidic pH, By using fluorescence, circular dichroism, and NMR spectroscopy, we show that upon decreasing the pH from 6.5 to 3 the propeptide of cathepsin L loses most of the tertiary structure, but almost none of the secondary structure is lost, Another partially structured intermediate, prone to aggregation, was identified between pH 6.5 and 4., The conformation, populated below pH 4, where the activation of cathepsin L occurs, is not completely unfolded and has the properties of molten globule, including characteristic binding of the 1-anilinonaphthalene-8-sulfonic acid. This pH unfolding of the propeptide parallels a decrease of its affinity for cathepsin L and suggests the mechanism for the acidic zymogen activation. Addition of anionic polysaccharides that activate cathepsin L already at pH 5.5 unfolds the tertiary structure of the propeptide at this pH, Propeptide of human cathepsin L which is able to fold independently represents an evolutionary intermediate in the emergence of novel inhibitors originating from the enzyme proregions.	Natl Inst Chem, Lab Mol Modeling & NMR Spect, Ljubljana 1000, Slovenia; Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Jerala, R (corresponding author), Natl Inst Chem, Lab Mol Modeling & NMR Spect, POB 3034,Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si	Zerovnik, Eva/AAB-6498-2022; Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251				Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BAKER D, 1992, PROTEINS, V12, P339, DOI 10.1002/prot.340120406; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910; BRYAN P, 1992, BIOCHEMISTRY-US, V31, P4937, DOI 10.1021/bi00136a003; BRYCE SD, 1994, GENOMICS, V24, P568, DOI 10.1006/geno.1994.1667; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; Chapman RL, 1997, J BIOL CHEM, V272, P8808, DOI 10.1074/jbc.272.13.8808; CHAUHAN SS, 1993, J BIOL CHEM, V268, P1039; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Dabora JM, 1996, BIOCHEMISTRY-US, V35, P11951, DOI 10.1021/bi9611671; DAVIS GE, 1990, CANCER RES, V50, P1113; DeFilippis V, 1996, BIOCHEMISTRY-US, V35, P11503, DOI 10.1021/bi9604587; DELARIA K, 1994, J BIOL CHEM, V269, P25172; DENIZOT F, 1989, EUR J IMMUNOL, V19, P631, DOI 10.1002/eji.1830190409; DOLINAR M, 1995, BIOL CHEM H-S, V376, P385; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; FLYNN GC, 1993, P NATL ACAD SCI USA, V90, P10826, DOI 10.1073/pnas.90.22.10826; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; FUSEK M, 1991, FEBS LETT, V287, P160, DOI 10.1016/0014-5793(91)80040-A; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; GOTO Y, 1991, J MOL BIOL, V222, P679, DOI 10.1016/0022-2836(91)90504-Y; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; HLODAN R, 1994, FEBS LETT, V343, P256, DOI 10.1016/0014-5793(94)80567-9; Hu ZX, 1996, J BIOL CHEM, V271, P3375; HU ZX, 1994, BIOCHEMISTRY-US, V33, P562, DOI 10.1021/bi00168a022; Ikeguchi M, 1997, PROTEINS, V27, P567, DOI 10.1002/(SICI)1097-0134(199704)27:4&lt;567::AID-PROT9&gt;3.0.CO;2-7; ISHIDOH K, 1994, FEBS LETT, V352, P281, DOI 10.1016/0014-5793(94)00924-4; ISHIDOH K, 1989, FEBS LETT, V259, P71, DOI 10.1016/0014-5793(89)81497-8; KAKEGAWA H, 1995, FEBS LETT, V370, P78, DOI 10.1016/0014-5793(95)00790-G; Kane S E, 1990, Semin Cancer Biol, V1, P127; KOMINAMI E, 1991, FEBS LETT, V287, P189, DOI 10.1016/0014-5793(91)80048-8; LAZZARINO D, 1990, J BIOL CHEM, V265, P11864; MACH L, 1994, J BIOL CHEM, V269, P13036; MACH L, 1994, J BIOL CHEM, V269, P13030; MASON RW, 1992, BIOCHEM BIOPH RES CO, V189, P1659, DOI 10.1016/0006-291X(92)90268-P; MASON RW, 1987, BIOCHEM J, V248, P449, DOI 10.1042/bj2480449; Maubach G, 1997, EUR J BIOCHEM, V250, P745, DOI 10.1111/j.1432-1033.1997.00745.x; MCINTYRE GF, 1991, J BIOL CHEM, V266, P15438; MCINTYRE GF, 1994, J BIOL CHEM, V269, P567; MCINTYRE GF, 1993, P NATL ACAD SCI USA, V90, P10588, DOI 10.1073/pnas.90.22.10588; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; NEURATH H, 1989, TRENDS BIOCHEM SCI, V14, P268, DOI 10.1016/0968-0004(89)90061-3; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; RICHO GR, 1994, J BIOL CHEM, V269, P14809; Sanz JM, 1997, EUR J BIOCHEM, V246, P328, DOI 10.1111/j.1432-1033.1997.00328.x; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; SMITH SM, 1989, J BIOL CHEM, V264, P20487; Stack MS, 1996, ARCH BIOCHEM BIOPHYS, V333, P163, DOI 10.1006/abbi.1996.0377; TAKEDAEZAKI M, 1993, ARCH BIOCHEM BIOPHYS, V304, P352, DOI 10.1006/abbi.1993.1361; TAKESHIMA H, 1995, J BIOCHEM-TOKYO, V118, P981, DOI 10.1093/jb/118.5.981; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; Tatsumi E, 1997, J BIOCHEM, V122, P300; TAYLOR MAJ, 1995, PROTEIN ENG, V8, P59, DOI 10.1093/protein/8.1.59; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; VENDRELL J, 1991, EMBO J, V10, P11, DOI 10.1002/j.1460-2075.1991.tb07915.x; VERNET T, 1991, J BIOL CHEM, V266, P21451; VERNET T, 1990, J BIOL CHEM, V265, P16661; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; WINTHER JR, 1991, P NATL ACAD SCI USA, V88, P9330, DOI 10.1073/pnas.88.20.9330; Zerovnik E, 1997, EUR J BIOCHEM, V245, P364, DOI 10.1111/j.1432-1033.1997.t01-1-00364.x	70	85	86	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11498	11504		10.1074/jbc.273.19.11498	http://dx.doi.org/10.1074/jbc.273.19.11498			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565563	hybrid			2022-12-27	WOS:000073536700017
J	Jhee, KH; Yang, LH; Ahmed, SA; McPhie, P; Rowlett, R; Miles, EW				Jhee, KH; Yang, LH; Ahmed, SA; McPhie, P; Rowlett, R; Miles, EW			Mutation of an active site residue of tryptophan synthase (beta-serine 377) alters cofactor chemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ASPARTATE-AMINOTRANSFERASE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; ABSORPTION-SPECTRA; SEMIEMPIRICAL CALCULATIONS; 3-DIMENSIONAL STRUCTURE; PYRIDOXAL-PHOSPHATE; SPATIAL STRUCTURE; ALPHA-SUBUNIT; MUTAGENESIS	To better understand how an enzyme controls cofactor chemistry, we have changed a tryptophan synthase residue that interacts with the pyridine nitrogen of the pyridoxal phosphate cofactor from a neutral Ser (beta-Ser(377)) to a negatively charged Asp or Glu, The spectroscopic properties of the mutant enzymes are altered and become similar to those of tryptophanase and aspartate aminotransferase, enzymes in which an Asp residue interacts with the pyridine nitrogen of pyridoxal phosphate. The absorption spectrum of each mutant enzyme undergoes a pH-dependent change (pK(a) similar to 7.7) from a form with a protonated internal aldimine nitrogen (lambda(max), = 416 nm) to a deprotonated form (lambda(max), = 336 nm), whereas the absorption spectra of the wild type tryptophan synthase beta(2), subunit and alpha(2) beta(2), complex are pH-independent. The reaction of the S377D alpha(2) beta(2) complex with L-serine, L-tryptophan, and other substrates results in the accumulation of pronounced absorption bands (lambda(max), = 498-510 nm) ascribed to quinonoid intermediates. We propose that the engineered Asp or Glu residue changes the cofactor chemistry by stabilizing the protonated pyridine nitrogen of pyridoxal phosphate, reducing the pK(a) of the internal aldimine nitrogen and promoting formation of quinonoid intermediates.	NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Miles, EW (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rm 225,8 Ctr Dr MSC 0830, Bethesda, MD 20892 USA.	EdithM@intra.niddk.nih.gov		Rowlett, Roger/0000-0002-9859-8164				Ahmed SA, 1996, J BIOL CHEM, V271, P8612, DOI 10.1074/jbc.271.15.8612; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; ANTSON AA, 1993, BIOCHEMISTRY-US, V32, P4195, DOI 10.1021/bi00067a006; CHEN VJ, 1987, J BIOL CHEM, V262, P14422; CLARK PA, 1993, J AM CHEM SOC, V115, P9789, DOI 10.1021/ja00074a053; CLARK PA, 1993, J AM CHEM SOC, V115, P1894, DOI 10.1021/ja00058a039; CREIGHTON TE, 1966, J BIOL CHEM, V241, P980; Darawshe S, 1997, BIOPHYS CHEM, V69, P53, DOI 10.1016/S0301-4622(97)00078-1; DEMENTIEVA IS, 1994, J MOL BIOL, V235, P783; DREWE WF, 1985, BIOCHEMISTRY-US, V24, P3977, DOI 10.1021/bi00336a027; GOLDBERG JM, 1991, BIOCHEMISTRY-US, V30, P305, DOI 10.1021/bi00215a041; GOLDBERG ME, 1968, BIOCHEMISTRY-US, V7, P3662, DOI 10.1021/bi00850a045; GOLDBERG ME, 1967, BIOCHEMISTRY-US, V6, P2113, DOI 10.1021/bi00859a032; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; HYDE CC, 1988, J BIOL CHEM, V263, P17857; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P133; JHEE KH, 1997, PROTEIN SCI S2, V6, P67; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; JUNE DS, 1981, BIOCHEMISTRY-US, V20, P2707, DOI 10.1021/bi00513a001; JUNE DS, 1981, BIOCHEMISTRY-US, V20, P2714, DOI 10.1021/bi00513a002; KALLEN RG, 1985, TRANSAMINASES, P60; KAWASAKI H, 1987, J BIOL CHEM, V262, P10678; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; METZLER CM, 1988, BIOCHEMISTRY-US, V27, P4923, DOI 10.1021/bi00413a050; METZLER CM, 1980, J AM CHEM SOC, V102, P6075, DOI 10.1021/ja00539a017; METZLER CM, 1991, J BIOL CHEM, V266, P9374; Metzler DE, 1997, METHOD ENZYMOL, V280, P30; METZLER DE, 1954, J AM CHEM SOC, V76, P648, DOI 10.1021/ja01632a004; Miles E.W., 1986, PYRIDOXAL PHOSPHAT B, V1, P253; MILES EW, 1987, METHOD ENZYMOL, V142, P398; MILES EW, 1989, J BIOL CHEM, V264, P6280; MILES EW, 1980, BIOCH MED ASPECTS TR, P137; MORINO Y, 1967, J BIOL CHEM, V242, P2800; NOZAKI Y, 1967, J BIOL CHEM, V242, P4731; ONUFFER JJ, 1994, PROTEIN ENG, V7, P413, DOI 10.1093/protein/7.3.413; Peracchi A, 1996, BIOCHEMISTRY-US, V35, P1872, DOI 10.1021/bi951889c; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; Rowlett R, 1998, BIOCHEMISTRY-US, V37, P2961, DOI 10.1021/bi972286z; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; SNELL EE, 1985, TRANSAMINASES, P19; Sundararaju B, 1997, BIOCHEMISTRY-US, V36, P6502, DOI 10.1021/bi962917+; TSCHOPP J, 1980, BIOCHEMISTRY-US, V19, P4514, DOI 10.1021/bi00560a020; Yang LH, 1996, PROTEIN EXPRES PURIF, V8, P126, DOI 10.1006/prep.1996.0082; YANG XJ, 1992, PROTEIN EXPRES PURIF, V3, P347, DOI 10.1016/1046-5928(92)90011-K; YANO T, 1993, BIOCHEMISTRY-US, V32, P1810, DOI 10.1021/bi00058a015; YANO T, 1993, J MOL BIOL, V234, P1218, DOI 10.1006/jmbi.1993.1672	46	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11417	11422		10.1074/jbc.273.19.11417	http://dx.doi.org/10.1074/jbc.273.19.11417			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565551	hybrid			2022-12-27	WOS:000073536700005
J	Kusche-Gullberg, M; Eriksson, I; Pikas, DS; Kjellen, L				Kusche-Gullberg, M; Eriksson, I; Pikas, DS; Kjellen, L			Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREACHER-COLLINS SYNDROME; RAT-LIVER; MOLECULAR-CLONING; BIOSYNTHESIS; PROTEOGLYCANS; PURIFICATION; ORGANIZATION	The biosynthesis of heparan sulfate/heparin is a complex process that requires the coordinate action of a number of different enzymes. In close connection with polymerization of the polysaccharide chain, the modification reactions are initiated by N-deacetylation followed by N-sulfation of N-acetylglucosamine units. These two reactions are carried out by a single protein. Proteins with such dual activities were first purified and cloned from rat liver and mouse mastocytoma. The mouse mastocytoma enzyme is encoded by an similar to 4-kilobase (kb) mRNA, whereas the rat liver transcript contains similar to 8 kb. In the present study, the primary structure of the enzyme encoded by the mouse 8-kb transcript is described. It is demonstrated that both the 4-and 8-kb transcripts have a wide tissue distribution and that they are encoded by separate genes. Characterization of the gene encoding the 4-kb transcript demonstrates that it spans a region of about 8 kb and that it contains at least 14 exons. The similarity of this gene and the previously characterized human gene for the 8-kb transcript is discussed.	Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Vet Med Chem, S-75007 Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Kusche-Gullberg, M (corresponding author), Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, Box 575, S-75123 Uppsala, Sweden.		Kjellen, Lena/F-1362-2011; Kusche-Gullberg, Marion/P-4466-2016	Kusche-Gullberg, Marion/0000-0002-5636-1695				BRANDAN E, 1988, J BIOL CHEM, V263, P2417; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Couchman JR, 1996, J CELL BIOCHEM, V61, P578, DOI 10.1002/(SICI)1097-4644(19960616)61:4<578::AID-JCB11>3.0.CO;2-C; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DIXON J, 1995, GENOMICS, V26, P239, DOI 10.1016/0888-7543(95)80206-2; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; FURTH J, 1957, P SOC EXP BIOL MED, V95, P824; Gladwin AJ, 1996, GENOMICS, V32, P471, DOI 10.1006/geno.1996.0145; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; HUANG RY, 1991, EUR J IMMUNOL, V21, P1611, DOI 10.1002/eji.1830210706; ISHIHARA M, 1993, J BIOL CHEM, V268, P20091; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sambrook J., 2002, MOL CLONING LAB MANU; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; SPILLMANN D, 1994, CURR OPIN STRUC BIOL, V4, P677, DOI 10.1016/S0959-440X(94)90165-1; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885	23	75	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11902	11907		10.1074/jbc.273.19.11902	http://dx.doi.org/10.1074/jbc.273.19.11902			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565617	hybrid			2022-12-27	WOS:000073536700071
J	Stolz, LE; Kuo, WJ; Longchamps, J; Sekhon, MK; York, JD				Stolz, LE; Kuo, WJ; Longchamps, J; Sekhon, MK; York, JD			INP51, a yeast inositol polyphosphate B-phosphatase required for phosphatidylinositol 4,5-bisphosphate homeostasis and whose absence confers a cold-resistant phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C GENE; SACCHAROMYCES-CEREVISIAE; HUMAN-PLATELETS; LOW-TEMPERATURE; 5-PHOSPHATASE; PROTEIN; 1,4,5-TRISPHOSPHATE; SYNTHASE; CALCIUM; TRISPHOSPHATE	Sequence analysis of Saccharomyces cerevisiae chromosome IX identified a 946 amino acid open reading frame (YIL002C), designated here as INP51, that has carboxyl-and amino-terminal regions similar to mammalian inositol polyphosphate 5-phosphatases and to yeast SAC1. This two-domain primary structure resembles the mammalian 5-phosphatase, synaptojanin. We report that Inp51p is associated with a particulate fraction and that recombinant Inp51p exhibits intrinsic phosphatidylinositol 4,5-bisphosphate B-phosphatase activity. Deletion of INP51 (inp51) results in a "cold-tolerant" phenotype, enabling significantly faster growth at temperatures below 15 degrees C as compared with a parental strain. Complementation analysis of an inp51 mutant strain demonstrates that the cold tolerance is strictly due to loss of 5-phosphatase catalytic activity. Furthermore, deletion of PLC1 in an inp51 mutant does not abrogate cold tolerance, indicating that Plc1p-mediated production of soluble inositol phosphates is not required. Cells lacking INP51 have a 2-4-fold increase in levels of phosphatidylinositol 4,5-bisphosphate and inositol 1,4,5-trisphosphate, whereas cells overexpressing Inp51p exhibit a 35% decrease in levels of phosphatidylinositol 4,5-bisphosphate. We conclude that INP51 function is critical for proper phosphatidylinositol 4,5-bisphosphate homeostasis. In addition, we define a novel role for a 5-phosphatase loss of function mutant that improves the growth of cells at colder temperatures without alteration of growth at normal temperatures, which may have useful commercial applications.	Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Duke University	York, JD (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol, DUMC 3813, Durham, NC 27710 USA.	yorkj@acpub.duke.edu			NHLBI NIH HHS [R01-HL 55672] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON MS, 1995, YEAST, V11, P187, DOI 10.1002/yea.320110210; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERTL A, 1992, PHILOS T R SOC B, V338, P63, DOI 10.1098/rstb.1992.0129; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881, DOI 10.1074/jbc.270.7.2881; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; Communi D, 1996, J BIOL CHEM, V271, P11676, DOI 10.1074/jbc.271.20.11676; Communi D, 1996, BIOCHEM J, V320, P181, DOI 10.1042/bj3200181; CONNOLLY TM, 1987, J BIOL CHEM, V262, P2146; CONNOLLY TM, 1985, J BIOL CHEM, V260, P7868; CUNNINGHAM KW, 1994, J EXP BIOL, V196, P157; CUNNINGHAM TW, 1990, J BIOL CHEM, V265, P21676; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; DAVIS TN, 1995, ADV SEC MESS PHOSPH, V30, P339; DEANJOHNSON M, 1989, J BIOL CHEM, V264, P1274; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; ESTEVEZ F, 1994, BIOCHEM J, V302, P709, DOI 10.1042/bj3020709; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Guthrie C, 1991, GUIDE YEAST GENETICS; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; JACKSON SP, 1995, EMBO J, V14, P4490, DOI 10.1002/j.1460-2075.1995.tb00128.x; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; Jefferson AB, 1997, J BIOL CHEM, V272, P5983, DOI 10.1074/jbc.272.9.5983; KAIBUCHI K, 1986, P NATL ACAD SCI USA, V83, P8172, DOI 10.1073/pnas.83.21.8172; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; LESTER RL, 1993, ADV LIPID RES, V26, P253; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Milligan SC, 1997, J CELL BIOL, V139, P351, DOI 10.1083/jcb.139.2.351; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; Mitchell CA, 1996, BIOCHEM SOC T, V24, P994, DOI 10.1042/bst0240994; Moore DD, 1995, GLOB MOB SURV; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; NIKAWA J, 1987, J BIOL CHEM, V262, P4876; NOVICK P, 1989, GENETICS, V121, P659; OHSUMI Y, 1985, J BIOL CHEM, V260, P482; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; PALTAUF F, 1992, MOL CELLULAR BIOL YE, V2, P415; PAYNE WE, 1993, MOL CELL BIOL, V13, P4351, DOI 10.1128/MCB.13.7.4351; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; SCHOMERUS C, 1992, FEBS LETT, V307, P249, DOI 10.1016/0014-5793(92)80688-D; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGH A, 1974, GENETICS, V77, P651; SMITH SW, 1974, J BIOL CHEM, V249, P3395; Srinivasan S, 1997, EUR J CELL BIOL, V74, P350; STOLZ LE, 1998, IN PRESS GENETICS, V148; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; TALWALKER RT, 1973, BIOCHIM BIOPHYS ACTA, V360, P306; THOMASHOW MF, 1994, ARABIDOPSIS, P807, DOI DOI 10.1101/0.807-834; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; UNO I, 1988, NATURE, V333, P188, DOI 10.1038/333188a0; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	76	83	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11852	11861		10.1074/jbc.273.19.11852	http://dx.doi.org/10.1074/jbc.273.19.11852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565610	hybrid			2022-12-27	WOS:000073536700064
J	Jeschke, M; Standke, GJR; Susa, M				Jeschke, M; Standke, GJR; Susa, M			Fluoroaluminate induces activation and association of Src and Pyk2 tyrosine kinases in osteoblastic MC3T3-E1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; GROWTH-FACTOR; DNA-SYNTHESIS; SODIUM-FLUORIDE; PERTUSSIS-TOXIN; BONE-CELLS; PHOSPHORYLATION; MECHANISM; OSTEOPOROSIS; STIMULATION	Fluoride is known to increase bone mass in vivo, probably through stimulation of osteoblast proliferation; however, the mechanisms of fluoroaluminate action in osteoblasts have not yet been elucidated. We have previously shown that in osteoblastic MC3T3-E1 cells, fluoroaluminate stimulates G protein-mediated protein tyrosine phosphorylation (SuSa, M., Standke, G, J, R,, Jeschke, R 1., and Rohner, D, (1997) Biochem. Biophys. Res. Commun. 235, 680-684). Although the Ser/Thr kinases Erk1, Erk2, and p70(S6K) were activated in response to fluoroaluminate, the identity of fluoroaluminate-activated tyrosine kinase(s) remained elusive. In this study, we show that in MC3T3-E1 cells, fluoroaluminate induces a 110-kDa tyrosine-phosphorylated protein that we identify as Pyk2, a cytoplasmic tyrosine kinase related to Fak (focal adhesion kinase), The tyrosine phosphorylation of Pyk2 increased in a dose-and time-dependent manner. The autophosphorylation activity of Pyk2 increased 3-fold and reached its maximum within 10 min of fluoroaluminate treatment. Fluoroaluminate also induced activation of Src and the association of Pyk2 with Src, The phosphorylation of Src-associated Pyk2 increased >20-fold in in vitro kinase assays, suggesting that Pyk2 is phosphorylated by Src, Although MC3T3-E1 cells express much more Fak than Pyk2, Src preferentially associated with Pyk2. In vitro, Pyk2 bound to the Src SH2 domain, suggesting that this interaction mediates the Src-Pyk2 association in cells, These data indicate that osteoblastic cells express Pyk2, which is tyrosine-phosphorylated and activated in response to G protein activation by fluoroaluminate, and that the mechanism of Pyk2 activation most likely involves Src, Thus, Src and Pyk2 are tyrosine kinases involved in G protein-mediated tyrosine phosphorylation in osteoblastic cells and may be important for the osteogenic action of fluoroaluminate.	Novartis Pharma AG, Res Bone Metab, CH-4002 Basel, Switzerland	Novartis	Susa, M (corresponding author), Novartis Pharma AG, Res Bone Metab, K-125-9-12, CH-4002 Basel, Switzerland.							Astier A, 1997, J BIOL CHEM, V272, P228; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BURGENER D, 1995, J BONE MINER RES, V10, P164; Caverzasio J, 1996, J BONE MINER RES, V11, P46; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; CHEN HC, 1994, J BIOL CHEM, V269, P31229; CHEN YH, 1994, J BIOL CHEM, V269, P27372; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DIKIC I, 1996, NATURE, V383, P47; FARLEY JR, 1983, SCIENCE, V222, P330; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; KAWASE T, 1991, PHARMACOL TOXICOL, V69, P330, DOI 10.1111/j.1600-0773.1991.tb01306.x; KOPP JB, 1990, CALCIFIED TISSUE INT, V47, P221, DOI 10.1007/BF02555923; KOZAWA O, 1994, J CELL BIOCHEM, V55, P373, DOI 10.1002/jcb.240550315; LAU KHW, 1989, METABOLISM, V38, P858; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Li X, 1997, J BIOL CHEM, V272, P14341, DOI 10.1074/jbc.272.22.14341; LITTLEWOOD AJ, 1991, J BONE MINER RES, V6, P141; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Ma EA, 1997, EUR J IMMUNOL, V27, P329, DOI 10.1002/eji.1830270147; MARIE PJ, 1992, J BONE MINER RES, V7, P103; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mitaka T, 1997, AM J PATHOL, V150, P267; PAK CYC, 1989, P SOC EXP BIOL MED, V191, P278; Pak CYC, 1996, J BONE MINER RES, V11, P561; PARIS S, 1987, J BIOL CHEM, V262, P1977; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; RAPUANO BE, 1994, PROSTAG LEUKOTR ESS, V50, P177, DOI 10.1016/0952-3278(94)90142-2; Saito Y, 1996, BIOCHEM BIOPH RES CO, V224, P23, DOI 10.1006/bbrc.1996.0978; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SECKL M, 1993, J BIOL CHEM, V268, P9548; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Susa M, 1997, BIOCHEM BIOPH RES CO, V235, P680, DOI 10.1006/bbrc.1997.6864; SUZAWA M, 1997, J BONE MINER RES, V12, pS161; Thomas AB, 1996, J CLIN ENDOCR METAB, V81, P2570, DOI 10.1210/jc.81.7.2570; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; TOKUDA H, 1994, ENDOCR J, V41, P189, DOI 10.1507/endocrj.41.189; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; WEZEMAN FH, 1990, CALCIFIED TISSUE INT, V46, P263, DOI 10.1007/BF02555006; YU H, 1996, J BIOL CHEM, V271, P2993	47	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11354	11361		10.1074/jbc.273.18.11354	http://dx.doi.org/10.1074/jbc.273.18.11354			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556630	hybrid			2022-12-27	WOS:000073395200082
J	Melle-Milovanovic, D; Milovanovic, M; Nagpal, S; Sachs, G; Shin, JM				Melle-Milovanovic, D; Milovanovic, M; Nagpal, S; Sachs, G; Shin, JM			Regions of association between the alpha and the beta subunit of the gastric H,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR-TRANSPORT; EXTRACELLULAR DOMAIN; FUNCTIONAL EXPRESSION; MEMBRANE TOPOLOGY; H+/K+-ATPASE; AMINO-ACIDS; K+-ATPASE; NA,K-ATPASE; IDENTIFICATION; TRANSMEMBRANE	A binding and a yeast two-hybrid analysis were carried out on the gastric H,K-ATPase to determine interactive regions of the extracytoplasmic domains of the alpha and beta subunits of this P type ATPase. Wheat germ agglutinin fractionation of fluorescein 5-maleimide-labeled tryptic fragments of detergent-solubilized H,K-ATPase showed that a fragment Leu(855) to Arg(922) of the alpha subunit was bound to the beta subunit, The yeast two-hybrid system showed that the region containing only a part of the seventh transmembrane segment, the loop, and part of the eighth transmembrane segment was capable of giving positive interaction signals with the ectodomain of the beta subunit, The sequence in the extracytoplasmic loop close to the eighth transmembrane segment, namely Arg(98) to Thr(928), was identified as being the site of interaction using this method. We deduced that the sequence Arg(898) to Arg(922) in the alpha subunit has strong interaction with the extracytoplasmic domain of the beta subunit, Again, using yeast two-hybrid analysis, two different sequences in the beta subunit Gln(64) to Asn(130) and Ala(156) to Arg(188) were identified as association domains in the extracytoplasmic sequence of the beta subunit. These data enable identification of major associative regions of the alpha-beta subunits of the H,K-ATPase.	Wadsworth VA Hosp, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Dept Physiol & Med, Los Angeles, CA 90073 USA; Allergan Pharmaceut Inc, Irvine, CA 92715 USA	University of California System; University of California Los Angeles; AbbVie; Allergan	Sachs, G (corresponding author), Wadsworth VA Hosp, Bldg 113,Rm 326, Los Angeles, CA 90073 USA.		Nagpal, Sunil/A-8007-2009		NIDDK NIH HHS [DK17294, DK40615, DK41301] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R37DK017294, R01DK017294, R01DK040615] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAMBERG K, 1992, BIOCHIM BIOPHYS ACTA, V1131, P69, DOI 10.1016/0167-4781(92)90100-E; BEGGAH AT, 1993, BIOCHEMISTRY-US, V32, P14117, DOI 10.1021/bi00214a007; BESANCON M, 1993, BIOCHEMISTRY-US, V32, P2345, DOI 10.1021/bi00060a028; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; FAMBROUGH DM, 1994, AM J PHYSIOL, V266, pC579, DOI 10.1152/ajpcell.1994.266.3.C579; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; GEERING K, 1987, J CELL BIOL, V105, P2613, DOI 10.1083/jcb.105.6.2613; GEERING K, 1993, AM J PHYSIOL, V265, pC1169, DOI 10.1152/ajpcell.1993.265.4.C1169; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; HAMRICK M, 1993, J BIOL CHEM, V268, P24367; HORISBERGER JD, 1991, J BIOL CHEM, V266, P19131; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; JAUNIN P, 1992, J BIOL CHEM, V267, P577; KLASSEN CHW, 1997, BOCH J, V321, P419; LEMAS MV, 1994, J BIOL CHEM, V269, P8255; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; MERCIER F, 1993, BIOCHIM BIOPHYS ACTA, V1149, P151, DOI 10.1016/0005-2736(93)90036-Y; NOGUCHI S, 1994, FEBS LETT, V341, P233, DOI 10.1016/0014-5793(94)80463-X; NOGUCHI S, 1990, J BIOL CHEM, V265, P15991; Palasis M, 1996, J BIOL CHEM, V271, P14176, DOI 10.1074/jbc.271.24.14176; RABON EC, 1988, METHOD ENZYMOL, V157, P649; RENAUD KJ, 1991, J BIOL CHEM, V266, P20491; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIN JM, 1994, J BIOL CHEM, V269, P8642; Tyagarajan K, 1997, BIOCHEMISTRY-US, V36, P10200, DOI 10.1021/bi9706125; Wang SG, 1997, AM J PHYSIOL-CELL PH, V272, pC923, DOI 10.1152/ajpcell.1997.272.3.C923	29	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11075	11081		10.1074/jbc.273.18.11075	http://dx.doi.org/10.1074/jbc.273.18.11075			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556592	hybrid			2022-12-27	WOS:000073395200044
J	Nakamura, I; Jimi, E; Duong, LT; Sasaki, T; Takahashi, N; Rodan, GA; Suda, T				Nakamura, I; Jimi, E; Duong, LT; Sasaki, T; Takahashi, N; Rodan, GA; Suda, T			Tyrosine phosphorylation of p130(Cas) is involved in actin organization in osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CELL-ADHESION; PHOSPHOTYROSINE-CONTAINING PROTEINS; EXTRACELLULAR-MATRIX; BONE-RESORPTION; V-CRK; VITRONECTIN RECEPTOR; CLEAR ZONE; SIGNAL-TRANSDUCTION; SUBSTRATE P130(CAS); STABLE ASSOCIATION	Integrin-mediated interaction with the extracellular matrix plays a critical role in the function of osteoclasts, the bone-resorbing cells. This study examines the role of p130(Cas) (Crk-associated substrate (Cas)) in actin organization in osteoclasts. Multinucleated osteoclast-like cells (OCLs) were obtained in a co-culture of murine bone marrow cells and primary osteoblasts. After plating on culture dishes, OCLs formed a ringlike structure consisting of F-actin dots at cell periphery (actin ring). The percentage of OCLs with actin rings and its diameter increased with time and cell spreading. Tyrosine phosphorylation of a protein (p130) increased with actin ring formation. Treatment with cytochalasin D disrupted actin rings and reduced tyrosine phosphorylation of p130. Using specific antibodies, p130 was identified as Gas. Ey immunocytochemistry, Cas was localized to the peripheral regions of OCLs and its distribution overlapped that of F-actin. In OCLs derived from Src(-/-) mice, in which osteoclast activity is severely compromised, tyrosine phosphorylation of Cas was markedly reduced. Moreover, Cas was diffusely distributed in the cytoplasm and actin ring formation is not observed. These findings suggest that Src-dependent tyrosine phosphorylation of Cas is involved in the adhesion-induced actin organization associated with osteoclast activation.	Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 142, Japan; Showa Univ, Sch Dent, Dept Oral Anat, Shinagawa Ku, Tokyo 142, Japan; Merck Res Labs, Dept Bone Biol, West Point, PA 19486 USA	Showa University; Showa University; Merck & Company	Suda, T (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 142, Japan.							AKATSU T, 1992, J BONE MINER RES, V7, P1297; Athanasou NA, 1996, J BONE JOINT SURG AM, V78A, P1096, DOI 10.2106/00004623-199607000-00016; BIRGE RB, 1992, J BIOL CHEM, V267, P10588; BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565; BOCKHOLT SM, 1995, CELL ADHES COMMUN, V3, P91, DOI 10.3109/15419069509081279; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Burnham MR, 1996, ONCOGENE, V12, P2467; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; HORNE WC, 1992, J CELL BIOL, V119, P1003, DOI 10.1083/jcb.119.4.1003; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jimi E, 1996, J BIOL CHEM, V271, P4605; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KANEHISA J, 1990, BONE, V11, P287, DOI 10.1016/8756-3282(90)90082-A; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; LAKKAKORPI PT, 1991, J CELL BIOL, V115, P1179, DOI 10.1083/jcb.115.4.1179; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; LAKKAKORPI PT, 1993, J CELL SCI, V104, P663; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MAYER BJ, 1990, P NATL ACAD SCI USA, V87, P2638, DOI 10.1073/pnas.87.7.2638; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Nakamura I, 1996, CELL TISSUE RES, V286, P507, DOI 10.1007/s004410050720; Nakamura I, 1996, J BONE MINER RES, V11, P1873; NESBITT S, 1993, J BIOL CHEM, V268, P16737; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; PATCH LA, 1995, J CELL SCI, V108, P1371; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; SAKAI R, 1994, J BIOL CHEM, V269, P32740; Sakai R, 1997, ONCOGENE, V14, P1419, DOI 10.1038/sj.onc.1200954; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SASAKI T, 1993, CALCIFIED TISSUE INT, V53, P217, DOI 10.1007/BF01321841; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Suda Tatsuo, 1996, P87; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; VAANANEN HK, 1995, J CELL SCI, V108, P2729; Vuori K, 1996, MOL CELL BIOL, V16, P2606; VUORI K, 1995, J BIOL CHEM, V270, P22259, DOI 10.1074/jbc.270.38.22259; ZAMBONINZALLONE A, 1988, J BONE MINER RES, V3, P517	53	107	110	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11144	11149		10.1074/jbc.273.18.11144	http://dx.doi.org/10.1074/jbc.273.18.11144			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556601	hybrid			2022-12-27	WOS:000073395200053
J	Rho, SB; Lee, JS; Jeong, EJ; Kim, KS; Kim, YG; Kim, S				Rho, SB; Lee, JS; Jeong, EJ; Kim, KS; Kim, YG; Kim, S			A multifunctional repeated motif is present in human bifunctional tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; AMINOACYL-TRANSFER-RNA; ELONGATION-FACTOR 1-ALPHA; METHIONYL-TRANSFER-RNA; CHAIN RELEASE FACTOR; LEUCYL-TRANSFER RNA; MULTISYNTHETASE COMPLEX; TERMINAL EXTENSION; AMPHIPHILIC HELIX; SEQUENCE	Tandem repeats located in the human bifunctional glutamyl-prolyl-tRNA synthetase (EPRS) have been found in many different eukaryotic tRNA synthetases and were previously shown to interact with another distinct repeated motifs in human isoleucyl-tRNA synthetase. Nuclear magnetic resonance and differential scanning calorimetry analyses of an isolated ERRS repeat showed that it consists of a helix-turn-helix with a melting temperature of 59 degrees C. Specific interaction of the EPRS repeats with those of isoleucyl-tRNA synthetase was confirmed by in vitro binding assays and shown to have a dissociation constant of approximately 2.9 mu M. The EPRS repeats also showed the binding activity to the N-terminal motif of arginyl-tRNA synthetase as well as to various nucleic acids, including tRNA. Results of the present work suggest that the region comprising the repeated motifs of ERRS provides potential sites for interactions with various biological molecules and thus plays diverse roles in the cell.	Sungkyunkwan Univ, Dept Biol, Jangan Gu, Suwon 440746, Kyunggido, South Korea; Korea Inst Sci & Technol, Struct Biol Ctr, Seoul 136791, South Korea; MIT, Dept Biol, Cambridge, MA 02139 USA	Sungkyunkwan University (SKKU); Korea Institute of Science & Technology (KIST); Massachusetts Institute of Technology (MIT)	Kim, S (corresponding author), Sungkyunkwan Univ, Dept Biol, Jangan Gu, 300 Chunchundong, Suwon 440746, Kyunggido, South Korea.	shkim@yurim.skku.ac.kr	Kim, Sunghoon/AAE-8314-2020					Agou F, 1997, EUR J BIOCHEM, V243, P259, DOI 10.1111/j.1432-1033.1997.0259a.x; ALZHANOVA AT, 1980, FEBS LETT, V120, P225, DOI 10.1016/0014-5793(80)80303-6; ALZHANOVA AT, 1982, FEBS LETT, V144, P149, DOI 10.1016/0014-5793(82)80589-9; Cerini C, 1997, EUR J BIOCHEM, V244, P176, DOI 10.1111/j.1432-1033.1997.00176.x; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; Cilley CD, 1997, RNA, V3, P57; CIRAKOGLU B, 1985, EUR J BIOCHEM, V151, P101, DOI 10.1111/j.1432-1033.1985.tb09074.x; DANG CV, 1986, BIOCHEM J, V239, P249, DOI 10.1042/bj2390249; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; ESCALANTE C, 1993, J BIOL CHEM, V268, P6014; FETT R, 1991, J BIOL CHEM, V266, P1448; FROLOVA LY, 1991, GENE, V109, P291, DOI 10.1016/0378-1119(91)90624-K; GARRET M, 1991, BIOCHEMISTRY-US, V30, P7809, DOI 10.1021/bi00245a021; GIRJES AA, 1995, GENE, V164, P347, DOI 10.1016/0378-1119(95)00502-W; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; HOU YM, 1989, TRENDS BIOCHEM SCI, V14, P233, DOI 10.1016/0968-0004(89)90033-9; JACOBOMOLINA A, 1989, J BIOL CHEM, V264, P16608; KAO J, 1994, J BIOL CHEM, V269, P25106; KISSELEV LL, 1994, PROG NUCLEIC ACID RE, V48, P83, DOI 10.1016/S0079-6603(08)60854-5; Lage H, 1996, GENE, V178, P187, DOI 10.1016/0378-1119(96)00313-7; LAZARD M, 1993, GENE, V132, P237, DOI 10.1016/0378-1119(93)90201-D; LEE CC, 1990, P NATL ACAD SCI USA, V87, P3508, DOI 10.1073/pnas.87.9.3508; LIM WA, 1991, METHOD ENZYMOL, V208, P196; MIRANDE M, 1992, EUR J BIOCHEM, V203, P459, DOI 10.1111/j.1432-1033.1992.tb16570.x; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; NADA S, 1993, J BIOL CHEM, V268, P7660; NICHOLS RC, 1995, GENE, V155, P299, DOI 10.1016/0378-1119(94)00634-5; Privalov P L, 1986, Methods Enzymol, V131, P4; REED VS, 1994, J BIOL CHEM, V269, P32932; REED VS, 1994, J BIOL CHEM, V269, P32937; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; SHIBA K, 1994, J BIOL CHEM, V269, P30049; SHIBA K, 1994, P NATL ACAD SCI USA, V91, P7435, DOI 10.1073/pnas.91.16.7435; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; TSUI FWL, 1987, GENE, V61, P349, DOI 10.1016/0378-1119(87)90198-3; TSUI FWL, 1987, NUCLEIC ACIDS RES, V15, P3349, DOI 10.1093/nar/15.8.3349; VELLEKAMP G, 1985, J BIOL CHEM, V260, P9843; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	41	57	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11267	11273		10.1074/jbc.273.18.11267	http://dx.doi.org/10.1074/jbc.273.18.11267			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556618	hybrid			2022-12-27	WOS:000073395200070
J	Li, J; Noguchi, CT; Miller, W; Hardison, R; Schechter, AN				Li, J; Noguchi, CT; Miller, W; Hardison, R; Schechter, AN			Multiple regulatory elements in the 5 '-flanking sequence of the human epsilon-globin gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; BETA-GLOBIN; DEVELOPMENTAL REGULATION; FACTOR-BINDING; GAMMA-GLOBIN; SILENCER; REGION; EXPRESSION; ACTIVATION; PROMOTER	We have previously reported, on the basis of transfection experiments, the existence of a silencer element in the 5'-flanking region of the human embryonic (epsilon) globin gene, located at -270 base pairs 5' to the cap site, which provides negative regulation for this gene. Experiments in transgenic mice suggest the physiological importance of this epsilon-globin silencer, but also suggest that downregulation of epsilon-globin gene expression may involve other negative elements flanking the epsilon-globin gene. We have now extended the analysis of epsilon-globin gene regulation to include the flanking region spanning up to 6 kilobase pairs 5' to the locus control region using reporter gene constructs with deletion mutations and transient transfection assays. We have identified and characterized other strong negative regulatory regions, as well as several positive regions that affect transcription activation. The negative regulatory regions at -3 kilobase pairs (epsilon NRA-I and epsilon NRA-II), flanked by a positive control element, has a strong effect on the epsilon-globin promoter both in erythroid K562 and nonerythroid HeLa cells and contains several binding sites for transcription factor GATA-1, as evidenced from DNA-protein binding assays. The GATA-1 sites within epsilon NRA-II are directly needed for negative control. Both epsilon NRA-I and epsilon NRA-II are active on a heterologous promoter and hence appear to act as transcription silencers. Another negative control region located at -1.7 kilobase pairs (epsilon NRB) does not exhibit general silencer activity as epsilon NRB does not affect transcription activity when used in conjunction with an epsilon-globin minimal promoter, The negative effect of epsilon NRB is erythroid specific, but not stage-specific as it can repress transcription activity in both K562 erythroid cells as well as in primary cultures of adult erythroid cells. Phylogenetic DNA sequence comparisons with other primate and other mammalian species show unusual degree of flanking sequence homology for the epsilon-globin gene, including in several of the regions identified in these functional and DNA-protein binding analyses, providing alternate evidence for their potential importance. We suggest that the down-regulation of epsilon-globin gene expression as development progresses involves complex, cooperative interactions of these negative regulatory elements, epsilon NRA-I/epsilon NRA-II, epsilon NRB, the epsilon-globin silencer and probably other negative and positive elements in the 5'-flanking region of the epsilon-globin gene.	NIDDK, Biol Chem Lab, NIH, Bethesda, MD 20892 USA; Penn State Univ, Ctr Gene Regulat, Dept Comp Sci & Engn, University Pk, PA 16802 USA; Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schechter, AN (corresponding author), NIDDK, Biol Chem Lab, NIH, Bldg 10,Rm 9N-307,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.		Hardison, Ross C/G-1142-2010	Hardison, Ross C/0000-0003-4084-7516; Schechter, Alan N/0000-0002-5235-9408	NIDDK NIH HHS [R01 DK27635] Funding Source: Medline; NLM NIH HHS [R01 LM05110, R01 LM05773] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027635] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005110, R01LM005773] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; CAO SX, 1989, P NATL ACAD SCI USA, V86, P5306, DOI 10.1073/pnas.86.14.5306; CHADA K, 1986, NATURE, V319, P685, DOI 10.1038/319685a0; Chao K M, 1994, J Comput Biol, V1, P271, DOI 10.1089/cmb.1994.1.271; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; ENVER T, 1989, P NATL ACAD SCI USA, V86, P7033, DOI 10.1073/pnas.86.18.7033; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; FIBACH E, 1989, BLOOD, V73, P100; GONG QH, 1993, MOL CELL BIOL, V13, P911, DOI 10.1128/MCB.13.2.911; GUMUCIO DL, 1993, P NATL ACAD SCI USA, V90, P6018, DOI 10.1073/pnas.90.13.6018; HARDISON R, 1994, GENOMICS, V21, P344, DOI 10.1006/geno.1994.1275; HARDISON R, 1993, DNA SEQUENCE, V4, P163, DOI 10.3109/10425179309015629; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; HARDISON RC, 1983, J BIOL CHEM, V258, P8739; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; KOLLIAS G, 1986, CELL, V46, P89, DOI 10.1016/0092-8674(86)90862-7; Li QL, 1997, P NATL ACAD SCI USA, V94, P2444, DOI 10.1073/pnas.94.6.2444; Liu QH, 1997, P NATL ACAD SCI USA, V94, P169, DOI 10.1073/pnas.94.1.169; MAGRAM J, 1985, NATURE, V315, P338, DOI 10.1038/315338a0; MOTAMED K, 1993, GENE, V123, P235, DOI 10.1016/0378-1119(93)90129-Q; PETERS B, 1993, J BIOL CHEM, V268, P3430; RAICH N, 1992, BLOOD, V79, P861; RAICH N, 1995, EMBO J, V14, P801, DOI 10.1002/j.1460-2075.1995.tb07058.x; SHAPIRO SG, 1983, J MOL BIOL, V269, P31; SHIH DM, 1993, J BIOL CHEM, V268, P3066; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Slightom JL, 1997, GENOMICS, V39, P90, DOI 10.1006/geno.1996.4458; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; TREPICCHIO WL, 1994, MOL CELL BIOL, V14, P3763, DOI 10.1128/MCB.14.6.3763; TREPICCHIO WL, 1994, DNA SEQUENCE, V4, P409, DOI 10.3109/10425179409010191; TREPICCHIO WL, 1993, MOL CELL BIOL, V13, P7457, DOI 10.1128/MCB.13.12.7457; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; WADAKIYAMA Y, 1992, J BIOL CHEM, V267, P11532; Watt Paul, 1993, Gene Expression, V3, P61; Ye JP, 1996, MOL CELL BIOL, V16, P4744	36	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10202	10209		10.1074/jbc.273.17.10202	http://dx.doi.org/10.1074/jbc.273.17.10202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553070	hybrid			2022-12-27	WOS:000073224200019
J	Charng, MJ; Zhang, D; Kinnunen, P; Schneider, MD				Charng, MJ; Zhang, D; Kinnunen, P; Schneider, MD			A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; SIGNAL-TRANSDUCTION; TRANSFERASE-ALPHA; KINASE RECEPTOR; FAMILY; YEAST; MUTATIONS; FKBP-12; CLONING; COMPLEX	Transforming growth factor beta (TGF beta) signal transduction is mediated by two receptor Ser/Thr kinases acting in series, type II TGF beta receptor (T beta R-II) phosphorylating type I TGF beta receptor (T beta R-I). Because the failure of interaction cloning, thus far, to identify bona fide T beta R-I substrates might reasonably have been due to the use of inactive T beta R-I as bait, we sought to identify molecules that interact specifically with active T beta R-I, employing the triple mutation L193A,P194A,T204D in a yeast two-hybrid system. The Leu-Pro substitutions prevent interaction with FK506-binding protein 12 (FKBP12), whose putative function in TGF beta signaling we have previously disproved; the charge substitution at Thr(204) constitutively activates T beta R-I. Unlike previous screens using mild-type T beta R-I, where FKBP12 predominated, none of the resulting colonies encoded FKBP12. A novel protein was identified, T beta R-I-associated protein-1 (TRAP-1), that interacts in yeast specifically with mutationally activated T beta R-I, but not wild-type T beta R-I, T beta R-II, or irrelevant proteins. In mammalian cells, TRAP-1 was co-precipitated only by mutationally activated T beta R-I and ligand-activated T beta R-I, but not wild-type T beta R-I in the absence of TGF beta. The partial TRAP-I protein that specifically binds these mutationally and ligand-activated farms of T beta R-I can inhibit signaling by the native receptor after stimulation with TGF beta or by the constitutively activated receptor mutation, as measured by a TGF beta-dependent reporter gene. Thus, TRAP-1 can distinguish activated forms of the receptor from wild-type receptor in the absence of TGF beta and may potentially have a functional role in TGF beta signaling.	Baylor Coll Med, Dept Med, Mol Cardiol Unit, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Cardiovasc Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Schneider, MD (corresponding author), Baylor Coll Med, Dept Med, Mol Cardiol Unit, 1 Baylor Plaza,Rm 506C, Houston, TX 77030 USA.				NHLBI NIH HHS [P01 HL49953, R01 HL47567, R01 HL52555] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047567, P01HL049953, R01HL052555] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ausubel FM, 1994, CURRENT PROTOCOLS MO; BENDIXEN C, 1994, NUCLEIC ACIDS RES, V22, P1778, DOI 10.1093/nar/22.9.1778; Charng MJ, 1996, J BIOL CHEM, V271, P22941, DOI 10.1074/jbc.271.38.22941; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KAWABATA M, 1995, J BIOL CHEM, V270, P29628; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; Okadome T, 1996, J BIOL CHEM, V271, P21687, DOI 10.1074/jbc.271.36.21687; PAWSON T, 1995, NATURE, V373, P477, DOI 10.1038/373477a0; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sambrook J., 2002, MOL CLONING LAB MANU; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Ventura F, 1996, J BIOL CHEM, V271, P13931, DOI 10.1074/jbc.271.24.13931; Wang TW, 1996, SCIENCE, V271, P1120, DOI 10.1126/science.271.5252.1120; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	30	56	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9365	9368		10.1074/jbc.273.16.9365	http://dx.doi.org/10.1074/jbc.273.16.9365			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545258	hybrid			2022-12-27	WOS:000073128800004
J	Ogata, H; Ford, D; Kouttab, N; King, TC; Vita, N; Minty, A; Stoeckler, J; Morgan, D; Girasole, C; Morgan, JW; Maizel, AL				Ogata, H; Ford, D; Kouttab, N; King, TC; Vita, N; Minty, A; Stoeckler, J; Morgan, D; Girasole, C; Morgan, JW; Maizel, AL			Regulation of interleukin-13 receptor constituents on mature human B lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CHAIN; IL-2 RECEPTOR; FUNCTIONAL COMPONENT; ALPHA CHAIN; CELLS; CLONING; CYTOKINE; STAT6; EXPRESSION; RESPONSES	Human B cells stimulated through both their immunoglobulin and CD40 receptors up-regulate 745 +/- 51 interleukin (IL)-13 ligand binding sites with an affinity of 0.91 +/- 0.08 nar within 24 h. IL-13 binds primarily to the IL-13R alpha 1 with subsequent sequestration of the IL-4R alpha into the complex. IL-13R alpha 1 may also be found in those receptors capable of binding IL-4. gamma chain (gamma(c)) participates in receptors capable of binding IL-4 but is not found in association with bound IL-13, Dimeric receptors composed of the IL-4R alpha complexed with either the IL-13R alpha 1 or gamma(c) occur simultaneously within defined B cell populations. mRNAs for all receptor constituents are increased subsequent to immunoglobulin stimulation alone, while maximal expression of IL-13R alpha 1 is more dependent upon co-stimulation of immunoglobulin and CD40 receptors, mRNA levels for IL-13R alpha 1 vary over a wider range subsequent to surface stimulation than other receptor components. Although gamma(c) is not bound to IL-13 in B cells under the conditions evaluated, it may influence IL-13 binding by competing with IL-13R alpha 1 for association/sequestration with the IL-4R alpha chain, IL-13R alpha 2 does not participate in the IL-13 receptor that is up-regulated upon activation of quiescent tonsillar B lymphocytes, although mRNA for the protein may be found in the centroblastic fraction of tonsillar cells.	Brown Univ, Roger Williams Med Ctr, Dept Pathol, Providence, RI 02908 USA; Sanofi Rech, LaBege Innopole, F-31676 Labege, France	Brown University; Roger Williams Medical Center; Sanofi-Aventis	Maizel, AL (corresponding author), Brown Univ, Roger Williams Med Ctr, Dept Pathol, 825 Chalkstone Ave, Providence, RI 02908 USA.	Abby_Maizel_MD@Brown.edu			NCI NIH HHS [CA45148] Funding Source: Medline; NIDDK NIH HHS [R29-DK49649] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA045148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049649] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aman MJ, 1996, J BIOL CHEM, V271, P29265, DOI 10.1074/jbc.271.46.29265; Billard C, 1997, EUR CYTOKINE NETW, V8, P19; Callard RE, 1996, IMMUNOL TODAY, V17, P108, DOI 10.1016/0167-5699(96)80600-1; Caput D, 1996, J BIOL CHEM, V271, P16921, DOI 10.1074/jbc.271.28.16921; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; COLIGAN J, CURRENT PROTOCOLS IM, V3; Debinski W, 1996, J BIOL CHEM, V271, P22428, DOI 10.1074/jbc.271.37.22428; DEFRANCE T, 1994, J EXP MED, V179, P135, DOI 10.1084/jem.179.1.135; FORSTER E, 1994, BIOTECHNIQUES, V16, P18; GALIZZI JP, 1989, J BIOL CHEM, V264, P6985; Gauchat JF, 1997, EUR J IMMUNOL, V27, P971, DOI 10.1002/eji.1830270425; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; HE YW, 1995, J IMMUNOL, V155, P9; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Kotowicz K, 1996, INT IMMUNOL, V8, P1915, DOI 10.1093/intimm/8.12.1915; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LOOK AT, 1982, BLOOD, V60, P959; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; Matthews DJ, 1997, EUR J IMMUNOL, V27, P116, DOI 10.1002/eji.1830270118; MATTHEWS DJ, 1995, BLOOD, V85, P38, DOI 10.1182/blood.V85.1.38.bloodjournal85138; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Morgan JW, 1996, J IMMUNOL, V157, P2900; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Murata T, 1997, CELL IMMUNOL, V175, P33, DOI 10.1006/cimm.1996.1051; Murata T, 1997, BIOCHEM BIOPH RES CO, V238, P90, DOI 10.1006/bbrc.1997.7248; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OBIRI NI, 1995, J BIOL CHEM, V270, P8797, DOI 10.1074/jbc.270.15.8797; Obiri NI, 1997, J BIOL CHEM, V272, P20251, DOI 10.1074/jbc.272.32.20251; Obiri NI, 1997, J IMMUNOL, V158, P756; Orchansky PL, 1997, J BIOL CHEM, V272, P22940, DOI 10.1074/jbc.272.36.22940; PalmerCrocker RL, 1996, J CLIN INVEST, V98, P604, DOI 10.1172/JCI118829; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Stoeckler JD, 1996, J IMMUNOL, V157, P4908; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; VITA N, 1995, J BIOL CHEM, V270, P3512, DOI 10.1074/jbc.270.8.3512; ZUBER CE, 1990, EUR J IMMUNOL, V20, P551, DOI 10.1002/eji.1830200314; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	47	29	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9864	9871		10.1074/jbc.273.16.9864	http://dx.doi.org/10.1074/jbc.273.16.9864			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545327	hybrid			2022-12-27	WOS:000073128800073
J	Sermon, BA; Lowe, PN; Strom, M; Eccleston, JF				Sermon, BA; Lowe, PN; Strom, M; Eccleston, JF			The importance of two conserved arginine residues for catalysis by the Ras GTPase-activating protein, neurofibromin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; MECHANISM; HYDROLYSIS; DOMAIN; GAP; ANALOG; P21	Ras proteins are guanine-nucleotide binding proteins that have a low intrinsic GTPase activity that is enhanced 10(5)-fold by the GTPase-activating proteins (GAPs) p120-GAP and neurofibromin. Comparison of the primary sequences of RasGAPs shows two invariant arginine residues (Arg(1276) and Arg(1391) of neurofibromin). In this study, site-directed mutagenesis was used to change each of these residues in the catalytic domain of neurofibromin (NF1-334) to alanine. The ability of the mutant proteins to bind to Ras GTP and to stimulate their intrinsic GTPase rate was then determined by kinetic methods under single turnover conditions using a fluorescent analogue of GTP, The separate contributions of each of these residues to catalysis and binding affinity to Ras were measured. Both the R1276A and the R1391A mutant NF1-334 proteins were 1000-fold less active than wild-type NF1-334 in activating the GTPase when measured at saturating concentrations. In contrast, there was only a minor effect of either mutation on NF1-334 affinity for wild-type Ha-Ras, These data are consistent with both arginines being required for efficient catalysis, Neither arginine is absolutely essential, because the mutant NF1-334 proteins increase the intrinsic Ras GTPase by at least 100-fold. The roles of Arg(1276) and Arg(1391) in neurofibromin are consistent with proposals based on the recently published x-ray structure of p120-GAP complexed with Ras.	Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Stevenage SG1 2NY, Herts, England	MRC National Institute for Medical Research; GlaxoSmithKline	Eccleston, JF (corresponding author), Natl Inst Med Res, Div Phys Biochem, Mill Hill, London NW7 1AA, England.							Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Graham Debbie L., 1997, Biochemical Society Transactions, V25, p512S; GRAND RJA, 1991, BIOCHEM J, V279, P609, DOI 10.1042/bj2790609; GUTMANN DH, 1993, ONCOGENE, V8, P761; HETTICH L, 1994, CANCER RES, V54, P5438; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Miao WY, 1996, J BIOL CHEM, V271, P15322, DOI 10.1074/jbc.271.26.15322; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; MOORE KJM, 1993, BIOCHEMISTRY-US, V32, P7451, DOI 10.1021/bi00080a016; Morcos P, 1996, MOL CELL BIOL, V16, P2496; NEAL SE, 1990, P NATL ACAD SCI USA, V87, P3562, DOI 10.1073/pnas.87.9.3562; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; RENSLAND H, 1991, BIOCHEMISTRY-US, V30, P11181, DOI 10.1021/bi00110a023; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Sermon BA, 1996, J BIOL CHEM, V271, P1566, DOI 10.1074/jbc.271.3.1566; SKINNER RH, 1994, ANAL BIOCHEM, V223, P259, DOI 10.1006/abio.1994.1582; SKINNER RH, 1991, J BIOL CHEM, V266, P14163; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0	26	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9480	9485		10.1074/jbc.273.16.9480	http://dx.doi.org/10.1074/jbc.273.16.9480			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545275	hybrid			2022-12-27	WOS:000073128800021
J	Mitsch, MJ; Voegele, RT; Cowie, A; Osteras, M; Finan, TM				Mitsch, MJ; Voegele, RT; Cowie, A; Osteras, M; Finan, TM			Chimeric structure of the NAD(P)(+)- and NADP(+)-dependent malic enzymes of Rhizobium (Sinorhizobium) meliloti	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; REGULATORY PROPERTIES; TRANSPORT MUTANTS; NITROGEN-FIXATION; EXPRESSION; SEQUENCE; BINDING; PURIFICATION; GENES; IDENTIFICATION	Malic enzymes catalyze the oxidative decarboxylation of malate to pyruvate in conjunction with the reduction of a nicotinamide cofactor. We determined the DNA sequence and transcriptional start sites of the genes encoding the diphosphopyridine nucleotide-dependent malic enzyme (DME, EC 1.1.1.39) and the triphosphopyridine nucleotide-dependent malic enzyme (TME, EC 1.1.1.40) of Rhizobium (Sinorhizobium) meliloti. The predicted DME and TME proteins contain 770 and 764 amino acids, respectively, and are approximately 320 amino acids larger than previously characterized prokaryotic malic enzymes. The increased size of DME and TME resides in the C-terminal extensions which are similar in sequence to phosphotransacetylase enzymes (EC 2.3.1.8). Modified DME and TME proteins which lack this C-terminal region retain malic enzyme activity but are unable to oligomerize into the native state. Data base searches have revealed that similar chimeric malic enzymes were uniquely present in Gram-negative bacteria. Thus DME and TME appear to be members of a new class of melic enzyme characterized by the presence of a phosphotransacetylase-like domain at the C terminus of the protein.	McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	McMaster University	Finan, TM (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	FINAN@MCMASTER.CA						AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BARTOLUCCI S, 1987, J BIOL CHEM, V262, P7725; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; BLATTNER FR, 1997, NCBI DATABASE; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUKATO G, 1995, INT J BIOCHEM CELL B, V27, P1003, DOI 10.1016/1357-2725(95)00080-9; CHANG GG, 1977, BIOCHIM BIOPHYS ACTA, V483, P228, DOI 10.1016/0005-2744(77)90051-1; Chen F, 1997, BIOSCI BIOTECH BIOCH, V61, P384, DOI 10.1271/bbb.61.384; COPELAND L, 1989, J GEN MICROBIOL, V135, P2005; CORBIN D, 1983, P NATL ACAD SCI-BIOL, V80, P3005, DOI 10.1073/pnas.80.10.3005; CUSHMAN JC, 1992, EUR J BIOCHEM, V208, P259, DOI 10.1111/j.1432-1033.1992.tb17181.x; DRINCOVICH MF, 1992, PLANT PHYSIOL, V100, P2035, DOI 10.1104/pp.100.4.2035; DRISCOLL BT, 1993, MOL MICROBIOL, V7, P865, DOI 10.1111/j.1365-2958.1993.tb01177.x; Driscoll BT, 1997, MICROBIOL-SGM, V143, P489, DOI 10.1099/00221287-143-2-489; Driscoll BT, 1996, J BACTERIOL, V178, P2224, DOI 10.1128/jb.178.8.2224-2231.1996; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FINAN TM, 1983, J BACTERIOL, V154, P1403, DOI 10.1128/JB.154.3.1403-1413.1983; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GARRIDOPERTIERRA A, 1983, BIOCHIMIE, V65, P629; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HANSEN EJ, 1975, BIOCHEM BIOPH RES CO, V65, P559, DOI 10.1016/S0006-291X(75)80183-5; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; HEDRICK JL, 1968, ARCH BIOCHEM BIOPHYS, V126, P155, DOI 10.1016/0003-9861(68)90569-9; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HSU RY, 1992, BIOCHEM J, V284, P869, DOI 10.1042/bj2840869; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; JAWALI N, 1987, PHYTOCHEMISTRY, V26, P1859, DOI 10.1016/S0031-9422(00)81716-1; Kaneko T, 1996, DNA Res, V3, P109; Kawai S, 1996, APPL ENVIRON MICROB, V62, P2692, DOI 10.1128/AEM.62.8.2692-2700.1996; KIMURA I, 1989, SOIL SCI PLANT NUTR, V35, P271, DOI 10.1080/00380768.1989.10434759; KOBAYASHI K, 1989, J BIOL CHEM, V264, P3200; KOBAYASHI M, 1990, NUCLEIC ACIDS RES, V18, P7367, DOI 10.1093/nar/18.24.7367; LAMED R, 1981, BIOCHIM BIOPHYS ACTA, V660, P251, DOI 10.1016/0005-2744(81)90167-4; LATIMER MT, 1993, J BACTERIOL, V175, P6822, DOI 10.1128/jb.175.21.6822-6829.1993; MAHAJAN SK, 1990, GENETICS, V125, P261; OSTERAS M, 1995, J BACTERIOL, V177, P1452, DOI 10.1128/jb.177.6.1452-1460.1995; RAO SR, 1991, PHYTOCHEMISTRY, V30, P431, DOI 10.1016/0031-9422(91)83699-L; RONSON CW, 1981, P NATL ACAD SCI-BIOL, V78, P4284, DOI 10.1073/pnas.78.7.4284; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANWAL BD, 1969, J BIOL CHEM, V244, P1817; SANWAL BD, 1968, BIOCHEM BIOPH RES CO, V31, P623, DOI 10.1016/0006-291X(68)90524-X; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SPINA J, 1970, BIOCHEMISTRY-US, V9, P3794, DOI 10.1021/bi00821a019; Stols L, 1997, APPL ENVIRON MICROB, V63, P2695, DOI 10.1128/AEM.63.7.2695-2701.1997; SUYE SI, 1992, J FERMENT BIOENG, V73, P343, DOI 10.1016/0922-338X(92)90275-Y; SWIERCZYNSKI J, 1980, BIOCHIM BIOPHYS ACTA, V612, P1, DOI 10.1016/0005-2744(80)90273-9; TANG CL, 1974, J BIOL CHEM, V249, P3916; VERNON CM, 1983, ARCH BIOCHEM BIOPHYS, V225, P296, DOI 10.1016/0003-9861(83)90033-4; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VILJOEN M, 1994, YEAST, V10, P613, DOI 10.1002/yea.320100506; WALTER MH, 1994, FEBS LETT, V227, P999; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; YAMAGUCHI M, 1973, J BIOCHEM, V73, P169; YAROSH OK, 1989, MOL MICROBIOL, V3, P813, DOI 10.1111/j.1365-2958.1989.tb00230.x	54	29	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9330	9336		10.1074/jbc.273.15.9330	http://dx.doi.org/10.1074/jbc.273.15.9330			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535928	hybrid			2022-12-27	WOS:000072990800105
J	Smirnov, MD; Safa, O; Regan, L; Mather, T; Stearns-Kurosawa, DJ; Kurosawa, S; Rezaie, AR; Esmon, NL; Esmon, CT				Smirnov, MD; Safa, O; Regan, L; Mather, T; Stearns-Kurosawa, DJ; Kurosawa, S; Rezaie, AR; Esmon, NL; Esmon, CT			A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; FACTOR-VA INACTIVATION; FACTOR-XA; ANTIPHOSPHOLIPID ANTIBODIES; C4B-BINDING PROTEIN; BLOOD-COAGULATION; TISSUE FACTOR; FACTOR-VIII; BINDING; ACTIVATION	To determine the structural basis of phosphatidylethanolamine (PE)-dependent activated protein C (APC) activity, we prepared a chimeric molecule in which the Gla domain and hydrophobic stack of protein C were replaced with the corresponding region of prothrombin. APC inactivation of factor Va was enhanced 10-20-fold by PE, Protein S enhanced inactivation 2-fold and independently of PE, PE and protein S had little effect on the activity of the chimera. Factor Va inactivation by APC was approximately 5-fold less efficient than with the chimera on vesicles lacking PE and slightly more efficient on vesicles containing PE, The cleavage patterns of factor Va by APC and the chimera were similar, and PE enhanced the rate of Arg(506) and Arg(306) cleavage by APC but not the chimera, APC and the chimera bound to phosphatidylserine:phosphatidylcholine vesicles with similar affinity (K-d approximate to 500 nM), and PE increased affinity 2-3-fold, Factor Va and protein S synergistically increased the affinity of APC on vesicles without PE to 140 nM and with PE: to 14 nn, but they were less effective in enhancing chimera binding to either vesicle, In a factor Xa one-stage plasma clotting assay, the chimera had similar to 5 times more anticoagulant activity than APC on PE-containing vesicles. Unlike APC, which showed a 10 fold dependence on protein S, the chimera was insensitive to protein S, To map the site of the PE and protein S dependence further, we prepared a chimera in which residues 1-22 were derived hom prothrombin and the remainder were derived from protein C, This protein exhibited PE and protein S dependence, Thus, these special properties of the protein C Gla domain are resident outside of the region normally hypothesized to be critical for membrane interaction, We conclude that the protein C Gla domain possesses unique properties allowing synergistic interaction with factor Va and protein S on PE-containing membranes.	Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Howard Hughes Med Inst, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; Howard Hughes Medical Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Esmon, CT (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13Th St, Oklahoma City, OK 73104 USA.			Stearns-Kurosawa, Deborah/0000-0003-2486-923X	PHS HHS [P50 54502] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALVING BM, 1992, AM J OBSTET GYNECOL, V167, P1184, DOI 10.1016/S0002-9378(12)90409-3; ARMSTRONG SA, 1990, J BIOL CHEM, V265, P6210; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; BILLY D, 1995, J BIOL CHEM, V270, P26883, DOI 10.1074/jbc.270.45.26883; BOCK PE, 1988, BIOCHEMISTRY-US, V27, P6633, DOI 10.1021/bi00417a063; CASTELLINO FJ, 1995, TRENDS CARDIOVAS MED, V5, P55, DOI 10.1016/1050-1738(94)00031-X; CHRISTIANSEN WT, 1994, BIOCHEMISTRY-US, V33, P5901, DOI 10.1021/bi00185a030; CHRISTIANSEN WT, 1995, BIOCHEMISTRY-US, V34, P10376, DOI 10.1021/bi00033a008; COLPITTS TL, 1994, BIOCHEMISTRY-US, V33, P3501, DOI 10.1021/bi00178a006; DAHLBACK B, 1992, BIOCHEMISTRY-US, V31, P12769, DOI 10.1021/bi00166a009; DAHLBACK B, 1994, J CLIN INVEST, V94, P923, DOI 10.1172/JCI117458; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Egan JO, 1997, PROTEIN SCI, V6, P2016, DOI 10.1002/pro.5560060922; ESMON CT, 1995, TRENDS CARDIOVAS MED, V5, P141, DOI 10.1016/1050-1738(95)00054-D; ESMON CT, 1993, METHOD ENZYMOL, V222, P359; ESMON CT, 1979, J BIOL CHEM, V254, P964; ESMON CT, 1973, THESIS WASHINGTON U; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Geng JP, 1997, THROMB HAEMOSTASIS, V77, P926; GILBERT GE, 1995, J BIOL CHEM, V270, P18500, DOI 10.1074/jbc.270.31.18500; GINSBERG JS, 1993, BLOOD, V81, P2958; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; Han XL, 1996, BIOCHEMISTRY-US, V35, P5822, DOI 10.1021/bi952927v; HEEB MJ, 1994, P NATL ACAD SCI USA, V91, P2728, DOI 10.1073/pnas.91.7.2728; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; KALAFATIS M, 1993, J BIOL CHEM, V268, P27246; KANE WH, 1981, J BIOL CHEM, V256, P1002; KOPPELMAN SJ, 1995, BLOOD, V86, P2653, DOI 10.1182/blood.V86.7.2653.bloodjournal8672653; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P9684; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P6970; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 1997, J BIOL CHEM, V272, P20678, DOI 10.1074/jbc.272.33.20678; MANN KG, 1992, SEMIN HEMATOL, V29, P213; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; NELSESTUEN GL, 1978, BIOCHEMISTRY-US, V17, P2134, DOI 10.1021/bi00604a017; NESHEIM ME, 1982, J BIOL CHEM, V257, P1443; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; OWEN WG, 1974, J BIOL CHEM, V249, P594; PEI G, 1993, J BIOL CHEM, V268, P3226; PIERANGELI SS, 1994, THROMB HAEMOSTASIS, V71, P670; RATCLIFFE JV, 1993, J BIOL CHEM, V268, P24339; RAUCH J, 1986, J BIOL CHEM, V261, P9672; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; REZAIE AR, 1995, BIOCHEMISTRY-US, V34, P12221, DOI 10.1021/bi00038a016; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; SESHADRI TP, 1994, BIOCHEMISTRY-US, V33, P1087, DOI 10.1021/bi00171a006; SHEN L, 1994, J BIOL CHEM, V269, P18735; SMALLEY DM, 1988, ANAL BIOCHEM, V172, P241, DOI 10.1016/0003-2697(88)90438-1; Smeets EF, 1996, THROMB RES, V81, P419, DOI 10.1016/0049-3848(96)00014-X; SMIRNOV M, 1996, CIRCULATION, V94, P694; SMIRNOV MD, 1995, J CLIN INVEST, V95, P309, DOI 10.1172/JCI117657; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; SORIANOGARCIA M, 1989, BIOCHEMISTRY-US, V28, P6805, DOI 10.1021/bi00443a004; TAYLOR F, 1991, BLOOD, V78, P357, DOI 10.1182/blood.V78.2.357.357; Thariath A, 1997, BIOCHEM J, V322, P309, DOI 10.1042/bj3220309; TRIPLETT DA, 1993, ARCH PATHOL LAB MED, V117, P78; vanWijnen M, 1996, THROMB HAEMOSTASIS, V76, P397; Varadi K, 1996, THROMB HAEMOSTASIS, V76, P208; WALKER FJ, 1981, J BIOL CHEM, V256, P1128; WANG CT, 1986, BIOCHIM BIOPHYS ACTA, V856, P244, DOI 10.1016/0005-2736(86)90034-9; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013; Yegneswaran S., 1997, Blood, V90, p145A; ZHANG L, 1993, J BIOL CHEM, V268, P12040; ZHANG L, 1994, J BIOL CHEM, V269, P3590; ZHANG L, 1992, BLOOD, V80, P942	69	46	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9031	9040		10.1074/jbc.273.15.9031	http://dx.doi.org/10.1074/jbc.273.15.9031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535891	hybrid			2022-12-27	WOS:000072990800068
J	Hanai, S; Uchida, M; Kobayashi, S; Miwa, M; Uchida, K				Hanai, S; Uchida, M; Kobayashi, S; Miwa, M; Uchida, K			Genomic organization of Drosophila poly(ADP-ribose) polymerase and distribution of its mRNA during development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; TRANSCRIPTION FACTORS; REGULATORY REGION; NUCLEAR-PROTEIN; PROMOTER REGION; XENOPUS-LAEVIS; DNA-BINDING; RAT-LIVER; GENE; CDNA	Poly(ADP-ribosyl)ation of proteins catalyzed by poly(ADP-ribose) polymerase (PARP; EC 2.4.2.30) modulates several biological activities. However, little is known about the role of PARP in developmental process. Here Fee report the organization of the Drosophila PARP gene and the expression patterns during Drosophila development. The Drosophila PARP gene was a single copy gene mapped at 81F and composed of six exons. Organization of exons corresponds to the functional domains of PARP. The DNA-binding domain was encoded by exons 1, 2, 3, and 4. The auto-modification domain was encoded by exon 5, and the catalytic domain was in exon 6. The promoter region of the PARP gene contained putative TATA box and CCAAT box unlike human PARP. Expression of the PARP gene was at high levels in embryos at 0-6 h after egg laying and gradually decreased until 8 h. PARP mRNA increased again at 8-12 h and was observed in pupae and adult flies but not in larvae. In situ mRNA hybridization of embryos revealed large amount of PARP mRNA observed homogeneously except the pole cells at the early stage of embryos, possibly due to presence of the maternal mRNA for PARP, and decreased gradually until the stage 12 in which stage PARP mRNA localized in anal plates. At late stage of embryogenesis PARP mRNA was localized in cells along the central nervous system.	Univ Tsukuba, Inst Basic Med Sci, Dept Biochem & Mol Oncol, Tsukuba, Ibaraki 305, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan	University of Tsukuba; University of Tsukuba	Uchida, K (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Biochem & Mol Oncol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305, Japan.							ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ALKHATIB HM, 1987, P NATL ACAD SCI USA, V84, P1224, DOI 10.1073/pnas.84.5.1224; Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; Ashburner M., 1989, DROSOPHILA LAB MANUA, P106; AUER B, 1989, DNA-J MOLEC CELL BIO, V8, P575, DOI 10.1089/dna.1989.8.575; Bhatia M, 1996, CELL GROWTH DIFFER, V7, P91; BIGGIN MD, 1989, TRENDS GENET, V5, P377, DOI 10.1016/0168-9525(89)90173-X; BOREK C, 1984, P NATL ACAD SCI-BIOL, V81, P243, DOI 10.1073/pnas.81.1.243; BURKLE A, 1987, CANCER RES, V47, P3632; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAILEY L, 1986, P NATL ACAD SCI USA, V83, P7241, DOI 10.1073/pnas.83.19.7241; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; ENGELS WR, 1986, FOCUS, V8, P6; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUN E, 1983, P NATL ACAD SCI-BIOL, V80, P7219, DOI 10.1073/pnas.80.23.7219; KUPPER JH, 1995, MOL CELL BIOL, V15, P3154; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lehner CF, 1997, J CELL SCI, V110, P523; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; LINDLSYE DL, 1992, GENOME DROSOPHILA ME; LUBET RA, 1986, CARCINOGENESIS, V7, P71, DOI 10.1093/carcin/7.1.71; MASUTANI M, 1994, EUR J BIOCHEM, V220, P607, DOI 10.1111/j.1432-1033.1994.tb18662.x; MENEGAZZI M, 1988, BIOCHEM BIOPH RES CO, V156, P995, DOI 10.1016/S0006-291X(88)80942-2; MIWA M, 1992, POSTTRANSLATIONAL MO, P171; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; NAKAGAWA K, 1988, CARCINOGENESIS, V9, P1167, DOI 10.1093/carcin/9.7.1167; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; OGURA T, 1990, BIOCHEM BIOPH RES CO, V167, P701, DOI 10.1016/0006-291X(90)92082-B; OZAWA Y, 1993, BIOCHEM BIOPH RES CO, V193, P119, DOI 10.1006/bbrc.1993.1598; POTVIN F, 1992, FEBS LETT, V302, P269, DOI 10.1016/0014-5793(92)80457-R; Sambrok J., 1989, MOL CLONING LAB MANU; SCHREIBER V, 1992, EMBO J, V11, P3263, DOI 10.1002/j.1460-2075.1992.tb05404.x; SCHREIBER V, 1995, P NATL ACAD SCI USA, V92, P4753, DOI 10.1073/pnas.92.11.4753; SHALL S, 1984, ADV RADIAT BIOL, V11, P1; SMITH JA, 1975, BIOCHEM J, V147, P523, DOI 10.1042/bj1470523; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; TAKAHASHI S, 1982, CHEM-BIOL INTERACT, V39, P363, DOI 10.1016/0009-2797(82)90052-7; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; UCHIDA K, 1994, MOL CELL BIOCHEM, V138, P25, DOI 10.1007/BF00928439; UCHIDA K, 1993, GENE, V137, P293, DOI 10.1016/0378-1119(93)90023-V; UCHIDA K, 1987, BIOCHEM BIOPH RES CO, V148, P617, DOI 10.1016/0006-291X(87)90921-1; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P3481, DOI 10.1073/pnas.90.8.3481; VANWIJNEN AJ, 1987, NUCLEIC ACIDS RES, V15, P1679, DOI 10.1093/nar/15.4.1679; WELLS DE, 1986, NUCLEIC ACIDS RES, V14, pR119, DOI 10.1093/nar/14.suppl.r119; YOKOYAMA Y, 1990, EUR J BIOCHEM, V194, P521, DOI 10.1111/j.1432-1033.1990.tb15647.x	54	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11881	11886		10.1074/jbc.273.19.11881	http://dx.doi.org/10.1074/jbc.273.19.11881			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565614	hybrid, Green Submitted			2022-12-27	WOS:000073536700068
J	Igarashi, K; Hoshino, H; Muto, A; Suwabe, N; Nishikawa, S; Nakauchi, H; Yamamoto, M				Igarashi, K; Hoshino, H; Muto, A; Suwabe, N; Nishikawa, S; Nakauchi, H; Yamamoto, M			Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for beta-globin locus control region complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NF-E2; POSITION-EFFECT VARIEGATION; PROTEIN INTERACTION MOTIF; DOMINANT CONTROL REGION; LEUCINE ZIPPER PROTEIN; HYPERSENSITIVE SITE; CHROMATIN STRUCTURE; ERYTHROID-CELLS; FAMILY PROTEINS; FACTOR GATA-1	The human beta-globin locus control region (LCR) is required to properly regulate chromatin domain opening, replication timing, and globin gene activation. The LCR contains multiple NF-E2 sites (Maf recognition elements, MAREs) that allow the binding of various basic leucine zipper (bZip) proteins like p45 NF-EB, Nrf1, Nrf2, Bach1, and Bach2, in some cases as obligate heterodimers with a small Maf protein. In addition to the bZip domain, the Each proteins bear a BTB/POZ domain, which has been implicated in the regulation of chromatin structure. We show here that Bach1 is highly expressed in hematopoietic cells and constitutes one of the two MARE-binding activities in murine erythroleukemic (MEL) cells. We further demonstrate that Bach1/MafK heterodimers interact with each other through the BTB domain, generating a multimeric and multivalent DNA binding complex. These results strongly implicate Bach1/MafK heterodimer as an architectural transcription factor that mediates interactions among multiple MAREs. Such a factor could then provide a model for assembly of the theoretical beta-globin LCR "holocomplex." Other BTB domain proteins have already been demonstrated to be involved in remodeling chromatin, and thus this class of proteins likely promote the formation of nucleoprotein complexes required to establish the architecture of regulatory domains.	Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 305, Japan; Kyoto Univ, Fac Med, Sakyo Ku, Kyoto 606, Japan	University of Tsukuba; University of Tsukuba; Kyoto University	Igarashi, K (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Tenno Dai 1-1-1, Tsukuba, Ibaraki 305, Japan.		Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Igarashi, Kazuhiko/0000-0002-2470-2475				ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Armstrong JA, 1996, MOL CELL BIOL, V16, P5634; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Blank V, 1997, BLOOD, V89, P3925, DOI 10.1182/blood.V89.11.3925; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P1006, DOI 10.1093/nar/22.6.1006; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; CHEN W, 1995, MOL CELL BIOL, V15, P3424; CHUI DHK, 1995, BIOCHEM BIOPH RES CO, V209, P40, DOI 10.1006/bbrc.1995.1467; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; DORN R, 1993, P NATL ACAD SCI USA, V90, P11376, DOI 10.1073/pnas.90.23.11376; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; Ellis J, 1996, EMBO J, V15, P562, DOI 10.1002/j.1460-2075.1996.tb00388.x; Elnitski L, 1997, J BIOL CHEM, V272, P369; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; FUJIWARA KT, 1993, ONCOGENE, V8, P2371; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; IGARASHI K, 1995, J BIOL CHEM, V270, P7615, DOI 10.1074/jbc.270.13.7615; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jackson JD, 1996, J BIOL CHEM, V271, P11871, DOI 10.1074/jbc.271.20.11871; JIMENEZ G, 1992, P NATL ACAD SCI USA, V89, P10618, DOI 10.1073/pnas.89.22.10618; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KATAOKA K, 1993, J VIROL, V67, P2133, DOI 10.1128/JVI.67.4.2133-2141.1993; KATAOKA K, 1995, MOL CELL BIOL, V15, P2180; LUNA L, 1994, GENOMICS, V22, P553, DOI 10.1006/geno.1994.1428; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MOI P, 1990, P NATL ACAD SCI USA, V87, P9000, DOI 10.1073/pnas.87.22.9000; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; NEY PA, 1990, NUCLEIC ACIDS RES, V18, P6011, DOI 10.1093/nar/18.20.6011; NEY PA, 1990, GENE DEV, V4, P993, DOI 10.1101/gad.4.6.993; Oyake T, 1996, MOL CELL BIOL, V16, P6083; PRUZINA S, 1994, BBA-GENE STRUCT EXPR, V1219, P351, DOI 10.1016/0167-4781(94)90059-0; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; YANG HY, 1995, MOL CELL BIOL, V15, P1353	60	171	174	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11783	11790		10.1074/jbc.273.19.11783	http://dx.doi.org/10.1074/jbc.273.19.11783			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565602	hybrid			2022-12-27	WOS:000073536700056
J	Yamamoto, K; Dang, QN; Kelly, RA; Lee, RT				Yamamoto, K; Dang, QN; Kelly, RA; Lee, RT			Mechanical strain suppresses inducible nitric-oxide synthase in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; GROWTH-FACTOR-BETA; GENE-EXPRESSION; PROTEIN-KINASE; IN-VITRO; TRANSFORMING GROWTH-FACTOR-BETA-1; VENTRICULAR MYOCYTES; PARACRINE MECHANISM; MESSENGER-RNA; INDUCTION	We investigated the effects of precisely controlled mechanical strain on nitric-oxide synthase activity in cultured neonatal rat cardiac myocytes. Incubation of cardiac myocytes for 24 h with 4 ng/ml interleukin-1 beta and 100 units/ml interferon-gamma stimulated an increase in nitric oxide production, inducible nitric-oxide synthase (MOS) mRNA, and iNOS protein. Mechanical strain suppressed nitric oxide production, iNOS mRNA, and iNOS protein stimulated by cytokines in an amplitude-dependent manner. Losartan (1 mu M), an angiotensin II type 1 receptor antagonist, weakly inhibited the effect of strain, suggesting that paracrine angiotensin II is not the mediator of the strain effect, In addition, cycloheximide (10 mu M), a protein synthesis inhibitor, inhibited the effect of strain by 46%. Transforming growth factor-beta (1 ng/ml) suppressed iNOS mRNA expression, but anti-transforming growth factor-beta antibody (30 mu g/ml) did not block the effect of strain. In contrast, staurosporine (100 nM; a nonselective protein kinase inhibitor), calphostin C (1 mu M; a selective protein kinase C inhibitor), and pretreatment with phorbol la-myristate 13-acetate abolished the effect of strain. Genistein (100 mu M), a tyrosine kinase inhibitor, partially inhibited the effect of strain. Thus, cyclic mechanical deformation suppresses cytokine-induced MOS expression in cardiac myocytes, and this effect is mediated at least partially via activation of protein kinase C.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lee, RT (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.	RTLEE@BICS.BWH.HARVARD.EDU			NHLBI NIH HHS [HL-54759, HL-52320] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL054759, P50HL052320, R01HL054759] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AWOLESI MA, 1995, J CLIN INVEST, V96, P1449, DOI 10.1172/JCI118181; BAKER KM, 1992, ANNU REV PHYSIOL, V54, P227, DOI 10.1146/annurev.physiol.54.1.227; BALLIGAND JL, 1995, AM J PHYSIOL-HEART C, V268, pH1293, DOI 10.1152/ajpheart.1995.268.3.H1293; BALLIGAND JL, 1993, J CLIN INVEST, V91, P2314, DOI 10.1172/JCI116461; BALLIGAND JL, 1994, J BIOL CHEM, V269, P27580; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DellItalia LJ, 1997, AM J PHYSIOL-HEART C, V273, pH961, DOI 10.1152/ajpheart.1997.273.2.H961; GILBERT RS, 1993, BIOCHEM BIOPH RES CO, V195, P380, DOI 10.1006/bbrc.1993.2054; Habib FM, 1996, LANCET, V347, P1151, DOI 10.1016/S0140-6736(96)90610-8; Haywood GA, 1996, CIRCULATION, V93, P1087, DOI 10.1161/01.CIR.93.6.1087; Hishikawa K, 1997, CIRCULATION, V96, P3610; HOSENPUD JD, 1989, J HEART TRANSPLANT, V8, P460; IKEDA U, 1995, CIRCULATION, V92, P2683, DOI 10.1161/01.CIR.92.9.2683; Ikeda U, 1996, J MOL CELL CARDIOL, V28, P1539, DOI 10.1006/jmcc.1996.0144; KOJIMA M, 1994, CIRCULATION, V89, P2204, DOI 10.1161/01.CIR.89.5.2204; KOMURO I, 1990, J BIOL CHEM, V265, P3595; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; KOMURO I, 1991, J BIOL CHEM, V266, P1265; Komuro I, 1996, FASEB J, V10, P631, DOI 10.1096/fasebj.10.5.8621062; LINDPAINTNER K, 1991, CIRC RES, V68, P905, DOI 10.1161/01.RES.68.4.905; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; McKenna TM, 1995, AM J PHYSIOL-HEART C, V269, pH1891, DOI 10.1152/ajpheart.1995.269.6.H1891; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONCADA S, 1991, PHARMACOL REV, V43, P109; NAKAYAMA I, 1994, J BIOL CHEM, V269, P11628; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NATHAN C, 1995, CELL, V82, P873, DOI 10.1016/0092-8674(95)90019-5; NISHIDA K, 1992, J CLIN INVEST, V90, P2092, DOI 10.1172/JCI116092; Obadia JF, 1997, J CARDIOVASC PHARM, V30, P191, DOI 10.1097/00005344-199708000-00007; Oddis CV, 1995, AM J PHYSIOL-HEART C, V269, pH2044, DOI 10.1152/ajpheart.1995.269.6.H2044; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; PERRELLA MA, 1994, J BIOL CHEM, V269, P14595; Perrella MA, 1996, J BIOL CHEM, V271, P13776, DOI 10.1074/jbc.271.23.13776; RANJAN V, 1995, AM J PHYSIOL-HEART C, V269, pH550, DOI 10.1152/ajpheart.1995.269.2.H550; ROBERTS AB, 1992, MOL ENDOCRINOL, V6, P1921, DOI 10.1210/me.6.11.1921; ROBERTS AB, 1992, J CLIN INVEST, V90, P2056, DOI 10.1172/JCI116087; RUBANYI GM, 1986, AM J PHYSIOL, V250, P1145, DOI 10.1152/ajpheart.1986.250.6.H1145; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SCHULZ R, 1992, BRIT J PHARMACOL, V105, P575, DOI 10.1111/j.1476-5381.1992.tb09021.x; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; Simmons WW, 1996, J BIOL CHEM, V271, P11694, DOI 10.1074/jbc.271.20.11694; SPRINGHORN JP, 1989, BIOCHEM J, V258, P73, DOI 10.1042/bj2580073; Suzuki H, 1996, TISSUE CELL, V28, P89, DOI 10.1016/S0040-8166(96)80047-4; TAKAHASHI N, 1994, J CLIN INVEST, V94, P1470, DOI 10.1172/JCI117485; Thienelt CD, 1997, CIRCULATION, V95, P2677, DOI 10.1161/01.CIR.95.12.2677; Wagner CT, 1997, J CLIN INVEST, V100, P589, DOI 10.1172/JCI119569; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; YAMAZAKI T, 1995, J CLIN INVEST, V96, P438, DOI 10.1172/JCI118054; YAMAZAKI T, 1993, J BIOL CHEM, V268, P12069; YANG XC, 1994, J CLIN INVEST, V94, P714, DOI 10.1172/JCI117390	53	20	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11862	11866		10.1074/jbc.273.19.11862	http://dx.doi.org/10.1074/jbc.273.19.11862			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565611	hybrid			2022-12-27	WOS:000073536700065
J	Ambrosini, G; Adida, C; Sirugo, G; Altieri, DC				Ambrosini, G; Adida, C; Sirugo, G; Altieri, DC			Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC GENE; ANTISENSE; RECEPTOR; PROTEIN; STRANDS; BCL-2; XA	Survivin is a new IAP apoptosis inhibitor expressed during development and in human cancer in vivo. The coding strand of the survivin gene was extensively complementary to that of effector cell protease receptor-1 (EPR-1), prompting the present investigation on the origin and functional relationship of these two transcripts. Southern blots of genomic DNA were consistent with the presence of multiple, evolutionarily conserved, EPR-1/Survivin-related genes. By pulsed field gel electrophoresis and single-and two-color fluorescence in situ hybridization, these were contained within a contiguous physical interval of 75-130 kilobases (kb) on chromosome 17q25. In Northern blots, a single strand-specific probe identified a 1.3-kb EPR-1 mRNA broadly distributed in normal adult and fetal tissues, structurally distinct from the 1.9-kb Survivin transcript expressed in transformed cell lines. Transient co-transfection of an EPR-1 cDNA potentially acting as a Survivin antisense with a lacZ reporter plasmid resulted in loss of viability of HeLa cells. In contrast, co-transfection of an antisense cDNA of intercellular adhesion molecule-1 or a sense-oriented Survivin cDNA was without effect. In stably transfected HeLa cells, ZnSO4 induction of an EPR-1 mRNA under the control of a metallothionein promoter suppressed the expression of endogenous survivin. This resulted in (i) increased apoptosis as detected by analysis of DNA content and in situ internucleosomal DNA fragmentation and (ii) inhibition of cell proliferation as compared with induced vector control transfectants, These findings suggest the existence of a potential EPR-1/survivin gene cluster and identify survivin as a new target for disrupting cell viability pathways in cancer.	Yale Univ, Sch Med, BCMM 436B, Dept Genet, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06536 USA	Yale University; Yale University	Altieri, DC (corresponding author), Yale Univ, Sch Med, BCMM 436B, Dept Genet, 295 Congress Ave, New Haven, CT 06536 USA.	Altieri@yale.edu	Sirugo, Giorgio/L-1628-2016; Sirugo, Giorgio/N-9056-2019		NHLBI NIH HHS [HL54131, HL43773] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131, R01HL043773] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADELMAN JP, 1987, SCIENCE, V235, P1514, DOI 10.1126/science.3547652; Adida C, 1998, AM J PATHOL, V152, P43; ALTIERI DC, 1995, FASEB J, V9, P860, DOI 10.1096/fasebj.9.10.7615156; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; CAMPOS L, 1994, BLOOD, V84, P595; CELANO P, 1992, J BIOL CHEM, V267, P15092; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Clem RJ, 1997, TRENDS CELL BIOL, V7, P337, DOI 10.1016/S0962-8924(97)01088-X; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; FARRELL CM, 1995, J BIOL CHEM, V270, P3400, DOI 10.1074/jbc.270.7.3400; GRAHAM GJ, 1995, J THEOR BIOL, V175, P71, DOI 10.1006/jtbi.1995.0122; Henry SP, 1997, ANTI-CANCER DRUG DES, V12, P395; KHOCHBIN S, 1989, EMBO J, V8, P4107, DOI 10.1002/j.1460-2075.1989.tb08595.x; KIMMELMAN D, 1989, CELL, V59, P687; KINDY MS, 1987, MOL CELL BIOL, V7, P2857, DOI 10.1128/MCB.7.8.2857; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; LUKASHEV ME, 1994, J BIOL CHEM, V269, P18311; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Nicholson AC, 1996, J BIOL CHEM, V271, P28407, DOI 10.1074/jbc.271.45.28407; REED JC, 1990, P NATL ACAD SCI USA, V87, P3660, DOI 10.1073/pnas.87.10.3660; ROTHE M, 1995, CELL, V83, P1242; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Webb A, 1997, LANCET, V349, P1137, DOI 10.1016/S0140-6736(96)11103-X; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997	30	389	523	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11177	11182		10.1074/jbc.273.18.11177	http://dx.doi.org/10.1074/jbc.273.18.11177			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556606	hybrid			2022-12-27	WOS:000073395200058
J	Asoh, S; Nishimaki, K; Nanbu-Wakao, R; Ohta, S				Asoh, S; Nishimaki, K; Nanbu-Wakao, R; Ohta, S			A trace amount of the human pro-apoptotic factor bax induces bacterial death accompanied by damage of DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; BCL-2; INDUCTION; FAMILY; HETERODIMERIZATION; SURVIVAL; DISTINCT; BCL-X(L)	An amount of human pro-apoptotic Bax as low as 0.01% of total protein was sufficient to cause cell death in Escherichia coli. The bacterial cell death was examined using a viable bacteria-specific fluorescence indicator system and loss of colony formation ability. Coexpression of anti-apoptotic Bcl-x(L) showed a modest inhibitory effect on the cell death caused by Bax. The trace amount of Bay elongated E. coli and accumulated monounsaturated fatty acids, suggesting an unusual metabolism of redox in the host. In fact, an increase of KCN-dependent O-2 consumption accompanied the expression of Bax. At the same time, a fluorescent pH indicator showed the apparent accumulation of protons outside the cell, suggesting that the membrane is intact. Bax increased the level of superoxide anion as measured by the expression of superoxide-dependent promoter. Nicked DNA was significantly generated, and the frequency of mutations resistant to rifampicin was increased by 30-fold, depending upon the expression of Bax. It is proposed that trace amounts of Bax increase oxygen consumption, triggering generation of superoxide, which affects DNA, leading to bacterial death.	Nippon Med Coll, Inst Gerontol, Dept Biochem & Cell Biol, Nakahara Ku, Kawasaki, Kanagawa 2110063, Japan	Nippon Medical School	Ohta, S (corresponding author), Nippon Med Coll, Inst Gerontol, Dept Biochem & Cell Biol, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2110063, Japan.	ohta@nms.ac.jp						Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; BOYD JM, 1995, ONCOGENE, V11, P1921; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; GARDNER PR, 1993, J BIOL CHEM, V268, P12958; Greenhalf W, 1996, FEBS LETT, V380, P169, DOI 10.1016/0014-5793(96)00044-0; HANADA M, 1995, J BIOL CHEM, V270, P11962, DOI 10.1074/jbc.270.20.11962; HASSAN HM, 1977, J BACTERIOL, V129, P1574, DOI 10.1128/JB.129.3.1574-1583.1977; HASSAN HM, 1977, J BACTERIOL, V132, P505, DOI 10.1128/JB.132.2.505-510.1977; HIGUCHI R, 1990, PCR PROTOCOL GUIDE M; Ishibashi Y, 1998, BIOCHEM BIOPH RES CO, V243, P609, DOI 10.1006/bbrc.1998.8145; Jurgensmeier JM, 1997, MOL BIOL CELL, V8, P325; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; KORSMEYER SJ, 1992, BLOOD, V80, P879; LEONHARDT H, 1971, J PHYS CHEM-US, V75, P245, DOI 10.1021/j100672a011; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; PRIVALLE CT, 1991, FREE RADICAL RES COM, V12-3, P419, DOI 10.3109/10715769109145812; PRIVALLE CT, 1988, J BIOL CHEM, V263, P4274; PRIVALLE CT, 1989, J BIOL CHEM, V264, P2758; PRIVALLE CT, 1993, P NATL ACAD SCI USA, V90, P2310, DOI 10.1073/pnas.90.6.2310; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Reed JC., 1996, MECH LYMPHOCYTE ACTI, V406, P99, DOI [10.1007/978-1-4899-0274-0_10, DOI 10.1007/978-1-4899-0274-0_10]; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shimizu S, 1996, ONCOGENE, V13, P21; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Simonian PL, 1996, J BIOL CHEM, V271, P22764, DOI 10.1074/jbc.271.37.22764; STANIER RY, 1976, MICROBIAL WORLD, P219; VISSER JWM, 1979, J HISTOCHEM CYTOCHEM, V27, P32, DOI 10.1177/27.1.35567; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zha HB, 1996, MOL CELL BIOL, V16, P6494	46	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11384	11391		10.1074/jbc.273.18.11384	http://dx.doi.org/10.1074/jbc.273.18.11384			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556634	hybrid			2022-12-27	WOS:000073395200086
J	Ludwig, J; Kerscher, S; Brandt, U; Pfeiffer, K; Getlawi, F; Apps, DK; Schagger, H				Ludwig, J; Kerscher, S; Brandt, U; Pfeiffer, K; Getlawi, F; Apps, DK; Schagger, H			Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; BOVINE HEART-MITOCHONDRIA; H+-ATPASE; V-ATPASE; ADENOSINE-TRIPHOSPHATASE; COMPLEX-I; NUCLEOTIDE-BINDING; 13-KDA SUBUNIT; B-SUBUNIT; PUMP	Vacuolar proton-translocating ATPase (holoATPase and free membrane sector) was isolated from bovine chromaffin granules by blue native polyacrylamide gel electrophoresis. A 5-fold excess of membrane sector over holoenzyme was determined in isolated chromaffin granule membranes. M9.2, a novel extremely hydrophobic 9.2-kDa protein comprising 80 amino acids, was detected in the membrane sector. It shows sequence and structural similarity to Vma21p, a yeast protein required for assembly of vacuolar ATPase. A second membrane sector-associated protein (M8-9) was identified and characterized by aminoterminal protein sequencing.	Univ Frankfurt Klinikum, Zentrum Biol Chem, D-60590 Frankfurt, Germany; Univ Edinburgh, Dept Biochem, Edinburgh EH8 9XD, Midlothian, Scotland	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Edinburgh	Schagger, H (corresponding author), Univ Frankfurt Klinikum, Zentrum Biol Chem, Theodor Stern Kai 7,Haus 25B, D-60590 Frankfurt, Germany.		Brandt, Ulrich/C-4406-2008; Brandt, Ulrich/GLV-1242-2022	Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811				APPS DK, 1980, BIOCHEM J, V190, P273, DOI 10.1042/bj1900273; APPS DK, 1989, BIOCHEM J, V263, P81, DOI 10.1042/bj2630081; ARAI H, 1988, J BIOL CHEM, V263, P8796; ARAI H, 1987, BIOCHEMISTRY-US, V26, P632; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; Bergman T, 1996, FEBS LETT, V390, P199, DOI 10.1016/0014-5793(96)00657-6; Bornstein P, 1977, Methods Enzymol, V47, P132; BRANDT U, 1994, J BIOL CHEM, V269, P12947; BROWN D, 1992, J EXP BIOL, V172, P231; Buchanan SK, 1996, BIOCHEM J, V318, P343, DOI 10.1042/bj3180343; CAPALDI RA, 1972, P NATL ACAD SCI USA, V69, P930, DOI 10.1073/pnas.69.4.930; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crider BP, 1997, J BIOL CHEM, V272, P10721; DELEAGE G, 1989, COMPUT APPL BIOSCI, V5, P159; DELEAGE G, 1988, COMPUT APPL BIOSCI, V4, P351; FEARNLEY IM, 1994, BIOCHEM SOC T, V22, P551, DOI 10.1042/bst0220551; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; FINBOW ME, 1995, BIOESSAYS, V17, P247, DOI 10.1002/bies.950170311; FONTANA A, 1983, METHOD ENZYMOL, V91, P311; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Getlawi F, 1996, NEUROSCI LETT, V219, P13, DOI 10.1016/S0304-3940(96)13151-7; GLUCK S, 1987, J BIOL CHEM, V262, P15780; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HEMKEN P, 1992, J BIOL CHEM, V267, P9948; HILL KJ, 1994, MOL BIOL CELL, V5, P1039, DOI 10.1091/mbc.5.9.1039; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; KANE PM, 1995, J BIOL CHEM, V270, P17025; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lepier A, 1996, J BIOL CHEM, V271, P8502, DOI 10.1074/jbc.271.14.8502; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MORIYAMA Y, 1987, J BIOL CHEM, V262, P14723; MYERS M, 1993, J CELL PHYSIOL, V156, P35, DOI 10.1002/jcp.1041560106; NELSON H, 1995, P NATL ACAD SCI USA, V92, P497, DOI 10.1073/pnas.92.2.497; NELSON H, 1990, J BIOL CHEM, V265, P20390; Nelson N, 1996, EXPERIENTIA, V52, P1101, DOI 10.1007/BF01952108; NELSON N, 1993, J PHYSIOLOGY-PARIS, V87, P171, DOI 10.1016/0928-4257(93)90028-R; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; NISHIGUCHI S, 1994, J BIOCHEM-TOKYO, V116, P128, DOI 10.1093/oxfordjournals.jbchem.a124485; PAN YX, 1991, FEBS LETT, V293, P89, DOI 10.1016/0014-5793(91)81158-5; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Peng SB, 1996, J BIOL CHEM, V271, P3324, DOI 10.1074/jbc.271.6.3324; PENG SB, 1994, J BIOL CHEM, V269, P17262; PERCY JM, 1985, BIOCHEM J, V231, P557, DOI 10.1042/bj2310557; PEREZCASTINEIRA JR, 1990, BIOCHEM J, V271, P127, DOI 10.1042/bj2710127; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; Sambrook J., 2002, MOL CLONING LAB MANU; Schagger H, 1995, METHOD ENZYMOL, V260, P82, DOI 10.1016/0076-6879(95)60132-5; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; SCHAGGER H, 1995, ELECTROPHORESIS, V16, P763, DOI 10.1002/elps.11501601125; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SUPEK F, 1994, J BIOL CHEM, V269, P24102; Supekova L, 1996, J EXP BIOL, V199, P1147; SUPEKOVA L, 1995, J BIOL CHEM, V270, P13726; Tomashek JJ, 1997, J BIOL CHEM, V272, P26787, DOI 10.1074/jbc.272.42.26787; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Von Jagow G, 1994, PRACTICAL GUIDE MEMB; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WANG SY, 1988, J BIOL CHEM, V263, P17638; Webster LC, 1996, EUR J BIOCHEM, V240, P156, DOI 10.1111/j.1432-1033.1996.0156h.x; XIE XS, 1986, J BIOL CHEM, V261, P2492; Xie XS, 1996, J BIOL CHEM, V271, P30980; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	71	241	258	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10939	10947		10.1074/jbc.273.18.10939	http://dx.doi.org/10.1074/jbc.273.18.10939			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556572	hybrid			2022-12-27	WOS:000073395200024
J	Hsu, YT; Youle, RJ				Hsu, YT; Youle, RJ			Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ROD PHOTORECEPTOR CELLS; MITOCHONDRIAL-MEMBRANES; ENDOPLASMIC-RETICULUM; BCL-2; BCL-X(L); HETERODIMERIZATION; INHIBITION; APOPTOSIS; CHANNEL	Bcl-2, Bcl-X-L, and Bax are members of the Bcl-2 family that play important roles in apoptosis regulation. These proteins are believed to be membrane-bound and to regulate apoptosis through formation of homo-and heterodimers. However, we recently found by subcellular fractionation that whereas Bcl-2 is predominantly a membrane protein as previously reported, Bax and a significant fraction of Bcl-X-L are soluble in thymocyte and splenocyte extracts. In addition, we have demonstrated that the ability of Bax to form dimers appears to be a detergent-induced phenomenon that coincides with a detergent-induced conformational change. We have further investigated the tertiary and quaternary states of Bax in the presence of various detergents. Detergents such as Triton X-100 and Triton X-114 readily enable Bax hetero-and homodimerization. However, other detergents such as polydocanol, W-l, octyl glucoside, dodecyl maltoside, Tween 20, and sodium cholate allow varying degrees of Bax hetero-and homodimerization. Detergents such as 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (Chaps) and Brij 35 allow neither hetero-nor homodimer formation. Immunoprecipitation analysis with the conformation-sensitive antibody uBax 6A7 revealed that whereas Triton X-100 readily exposes the N-terminal Bax epitope (amino acid 13-19), only limited exposure of the epitope occurs in Triton X-114, polydocanol, dodecyl maltoside, and sodium cholate, and no exposure of this epitope was observed in W-1, Chaps, octyl glucoside, between 20, and Brij 35. Moreover, we could not detect any proteins associated with the cytosolic form of Bax based on immunopurification of this protein. Sephacryl S-100 gel filtration chromatography analysis of the cytosolic Bax indicated that this protein is monomeric and displays an apparent molecular mass of 25 kDa. Induction of apoptosis which causes the insertion of the soluble form of Bax into membranes did not result in appreciable Bax/Bcl-X-L, Bax/Bcl-2 or Bax/Bax dimer formation as determined by cross-linking studies, Further analysis of Bax after apoptosis induction by immunoprecipitation in the presence of Chaps also revealed no significant heterodimer formation. In conclusion, Bax displays several distinct states in different detergents that expose defined regions of the protein. In addition, these results suggest that mechanisms other than the simple dimerization among members of the Bcl-2 family may be required for the regulation of apoptosis.	NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, 10 Ctr Dr,Rm 5D-37, Bethesda, MD 20892 USA.	youle@helix.nih.gov						AKAO Y, 1994, CANCER RES, V54, P2468; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Brauweiler A, 1997, VIROLOGY, V231, P135, DOI 10.1006/viro.1997.8509; Chen G, 1996, J BIOL CHEM, V271, P24221, DOI 10.1074/jbc.271.39.24221; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Elangovan B, 1997, J BIOL CHEM, V272, P24494, DOI 10.1074/jbc.272.39.24494; Greenhalf W, 1996, FEBS LETT, V380, P169, DOI 10.1016/0014-5793(96)00044-0; HAN J, 1996, GENE DEV, P461; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; JURGENSMEIER M, 1997, MOL BIOL CELL, V8, P325; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Middleton G, 1996, DEVELOPMENT, V122, P695; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; MOLDAY LL, 1990, J BIOL CHEM, V265, P18690; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nava VE, 1997, J VIROL, V71, P4118, DOI 10.1128/JVI.71.5.4118-4122.1997; Oh JH, 1997, NEUROREPORT, V8, P1851, DOI 10.1097/00001756-199705260-00012; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shindler KS, 1997, J NEUROSCI, V17, P3112; SILVERMAN JA, 1994, J BIOL CHEM, V269, P22524; Simonian PL, 1996, J BIOL CHEM, V271, P22764, DOI 10.1074/jbc.271.37.22764; Simonian PL, 1996, J BIOL CHEM, V271, P32073, DOI 10.1074/jbc.271.50.32073; Tao WK, 1997, J BIOL CHEM, V272, P15547, DOI 10.1074/jbc.272.24.15547; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yamamoto H, 1997, CANCER RES, V57, P4420; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101	49	441	451	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10777	10783		10.1074/jbc.273.17.10777	http://dx.doi.org/10.1074/jbc.273.17.10777			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553144	hybrid			2022-12-27	WOS:000073224200093
J	Lledias, F; Rangel, P; Hansberg, W				Lledias, F; Rangel, P; Hansberg, W			Oxidation of catalase by singlet oxygen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MIRABILIS PR CATALASE; NEUROSPORA-CRASSA; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; BACILLUS-SUBTILIS; DIFFERENTIAL EXPRESSION; GLUTAMINE-SYNTHETASE; REGULATED CATALASE	Different bands of catalase activity in zymograms (Cat-la Cat le) appear during Neurospora crassa development and under stress conditions. Here we demonstrate that singlet oxygen modifies Cat-la, giving rise to a sequential shift in electrophoretic mobility, similar to the one observed in vivo. Purified Cat-la was modified with singlet oxygen generated from a photosensitization reaction; even when the reaction was separated from the enzyme by an air barrier, a condition in which only singlet oxygen can reach the enzyme by diffusion. Modification of Cat-la was hindered when reducing agents or singlet oxygen scavengers were present in the photosensitization reaction. The sequential modification of the four monomers gave rise to five active catalase conformers with more acidic isoelectric points. The pi of purified Cat-la-Cat-le decreased progressively, and a similar shift in pi was observed as Cat-la was modified by singlet oxygen. No further change was detected once Cat-le was reached. Catalase modification was traced to a three-step reaction of the heme. The heme of Cat-la gave rise to three additional heme peaks in a high performance liquid chromatography when modified to Cat-1c. Full oxidation to Cat-le shifted all peaks into a single one. Absorbance spectra were consistent with an increase in asymmetry as heme was modified. Bacterial, fungal, plant, and animal catalases were all susceptible to modification by singlet oxygen, indicating that this is a general feature of the enzyme that could explain in part the variety of catalases seen in several organisms and the modifications observed in some catalases, Modification of catalases during development and under stress could indicate in vivo generation of singlet oxygen.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Hansberg, W (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Apartado Postal 70-242, Mexico City 04510, DF, Mexico.	whansber@ifcsun1.ifisiol.unam.mx		Lledias, Fernando/0000-0002-2141-8727				AGUIRRE J, 1989, J BACTERIOL, V171, P6243, DOI 10.1128/jb.171.11.6243-6250.1989; AGUIRRE J, 1986, J BACTERIOL, V166, P1040, DOI 10.1128/jb.166.3.1040-1045.1986; ALLEN JF, 1993, FEBS LETT, V332, P203, DOI 10.1016/0014-5793(93)80631-4; ALLEN RG, 1985, DEV GROWTH DIFFER, V27, P615; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BALDWIN JL, 1995, 18 FUNG GEN C MAR 21, P31; BOL DK, 1991, GENE, V109, P31, DOI 10.1016/0378-1119(91)90585-Y; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; BUZY A, 1995, J PROTEIN CHEM, V14, P59, DOI 10.1007/BF01888363; CHARY P, 1989, J BACTERIOL, V171, P2646, DOI 10.1128/jb.171.5.2646-2652.1989; CHENG L, 1981, PHOTOCHEM PHOTOBIOL, V34, P125, DOI 10.1111/j.1751-1097.1981.tb08973.x; COHEN G, 1988, EUR J BIOCHEM, V176, P159; DAHL TA, 1988, MUTAT RES, V201, P127, DOI 10.1016/0027-5107(88)90119-4; DAUB ME, 1992, P NATL ACAD SCI USA, V89, P9588, DOI 10.1073/pnas.89.20.9588; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; Eisenstark A, 1996, FREE RADICAL BIO MED, V21, P975, DOI 10.1016/S0891-5849(96)00154-2; EISING R, 1990, ARCH BIOCHEM BIOPHYS, V278, P258, DOI 10.1016/0003-9861(90)90256-X; ENGELMANN S, 1995, J BACTERIOL, V177, P5598, DOI 10.1128/jb.177.19.5598-5605.1995; Escobar JA, 1996, FREE RADICAL BIO MED, V20, P285, DOI 10.1016/0891-5849(95)02037-3; FARBER JM, 1986, J BIOL CHEM, V261, P4574; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; FEIERABEND J, 1986, ARCH BIOCHEM BIOPHYS, V251, P567, DOI 10.1016/0003-9861(86)90365-6; FITA I, 1985, J MOL BIOL, V185, P21, DOI 10.1016/0022-2836(85)90180-9; FOWLER T, 1993, MOL MICROBIOL, V9, P989, DOI 10.1111/j.1365-2958.1993.tb01228.x; FRIDOVICH I, 1977, BIOSCIENCE, V27, P462, DOI 10.2307/1297527; GANTCHEV TG, 1995, PHOTOCHEM PHOTOBIOL, V62, P123, DOI 10.1111/j.1751-1097.1995.tb05248.x; GARZARAMOS G, 1994, BIOCHEMISTRY-US, V33, P6960, DOI 10.1021/bi00188a027; GOUET P, 1995, J MOL BIOL, V249, P933, DOI 10.1006/jmbi.1995.0350; GRANDONI JA, 1989, J BIOL CHEM, V264, P6058; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; HANSBERG W, 1990, J THEOR BIOL, V142, P201, DOI 10.1016/S0022-5193(05)80222-X; HANSBERG W, 1993, FREE RADICAL BIO MED, V14, P287, DOI 10.1016/0891-5849(93)90025-P; HANSBERG W, 1996, CIENCIA CULTURA, V48, P67; Harris H., 1987, HDB ENZYME ELECTROPH; HARTIG A, 1986, EUR J BIOCHEM, V160, P487, DOI 10.1111/j.1432-1033.1986.tb10065.x; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; JACOB GS, BIOCHEMISTRY, V18, P2975; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Kawasaki L, 1997, J BACTERIOL, V179, P3284, DOI 10.1128/jb.179.10.3284-3292.1997; KIM HP, 1994, MICROBIOL-SGM, V140, P3391, DOI 10.1099/13500872-140-12-3391; KONO Y, 1982, J BIOL CHEM, V257, P5751; KULLIK I, 1994, REDOX REP, V1, P23, DOI 10.1080/13510002.1994.11746951; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; LOEWEN PC, 1988, BIOCHEM CELL BIOL, V66, P707, DOI 10.1139/o88-081; LOEWEN PC, 1987, J BACTERIOL, V169, P3601, DOI 10.1128/jb.169.8.3601-3607.1987; LOEWEN PC, 1984, J BACTERIOL, V160, P668, DOI 10.1128/JB.160.2.668-675.1984; LOEWEN PC, 1993, BIOCHEMISTRY-US, V32, P10159, DOI 10.1021/bi00089a035; LUCHI S, 1993, MOL MICROBIOL, V9, P9; MASTERS C, 1986, MOL CELL BIOCHEM, V70, P113; MELIKADAMYAN WR, 1986, J MOL BIOL, V188, P63, DOI 10.1016/0022-2836(86)90480-8; MULVEY MR, 1990, J BACTERIOL, V172, P6713, DOI 10.1128/jb.172.12.6713-6720.1990; Murshudov GN, 1996, J BIOL CHEM, V271, P8863, DOI 10.1074/jbc.271.15.8863; Navarro RE, 1996, CURR GENET, V29, P352, DOI 10.1007/s002940050056; QUAIL PH, 1971, P NATL ACAD SCI USA, V68, P1402, DOI 10.1073/pnas.68.7.1402; REDINBAUGH MG, 1988, BIOCHIM BIOPHYS ACTA, V951, P104, DOI 10.1016/0167-4781(88)90030-9; RIVETT AJ, 1985, J BIOL CHEM, V260, P300; RORTH M, 1967, BIOCHIM BIOPHYS ACTA, V139, P171, DOI 10.1016/0005-2744(67)90124-6; ROSEMAN JE, 1987, J BIOL CHEM, V262, P2101; Sarath G., 1989, PROTEOLYTIC ENZYMES, P25; Schopf JW, 1983, EARTHS EARLIEST BIOS; TOLEDO I, 1991, J BACTERIOL, V173, P3243, DOI 10.1128/JB.173.10.3243-3249.1991; TOLEDO I, 1994, MICROBIOL-UK, V140, P2391, DOI 10.1099/13500872-140-9-2391; TOLEDO I, 1995, ARCH BIOCHEM BIOPHYS, V319, P519, DOI 10.1006/abbi.1995.1326; TOLEDO I, 1990, EXP MYCOL, V14, P184, DOI 10.1016/0147-5975(90)90077-7; VAINSHTEIN BK, 1986, J MOL BIOL, V188, P49, DOI 10.1016/0022-2836(86)90479-1; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; VONOSSOWSKI I, 1991, J BACTERIOL, V173, P514, DOI 10.1128/jb.173.2.514-520.1991; WILLEKENS H, 1994, P NATL ACAD SCI USA, V91, P10450, DOI 10.1073/pnas.91.22.10450; Yano S, 1996, MOL CELL BIOCHEM, V165, P77, DOI 10.1007/BF00229747; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	72	133	139	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10630	10637		10.1074/jbc.273.17.10630	http://dx.doi.org/10.1074/jbc.273.17.10630			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553125	hybrid			2022-12-27	WOS:000073224200074
J	Quelo, I; Machuca, I; Jurdic, P				Quelo, I; Machuca, I; Jurdic, P			Identification of a vitamin D response element in the proximal promoter of the chicken carbonic anhydrase II gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; THYROID-HORMONE RECEPTOR; MYELOMONOCYTIC CELL-LINE; TRANSCRIPTION FACTOR; 5'-FLANKING REGION; OSTEOCALCIN GENE; ACID RECEPTORS; DNA-SEQUENCES; 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR; 24-HYDROXYLASE GENE	The carbonic anhydrase II gene, whose transcription is enhanced by 1,25-dihydroxyvitamin D-3 (1,25-(OH)(2)D-3), encodes an important enzyme in bone-resorbing cells derived from the fusion of monocytic progenitors. We analyzed the 1,25-(OH)(2)D-3-mediated activation of the avian gene by transient transfection assays with promoter/reporter constructs into HD11 chicken macrophages and by DNA mobility shift assays. Deletion and mobility shift analyses indicated that the -62/-29 region confers 1,25-(OH)(2)D-3 responsiveness and forms DNA-protein complexes. The addition of an anti-vitamin D receptor (VDR) antibody inhibited binding to this sequence, whereas anti-retinoid X receptor (RXR) antibody generated a lower mobility complex. Therefore, we concluded that this element binds a VDR RXR heterodimer, but the addition of extra 1,25-(OH)(2)D-3 had no effect on the formation of this complex. Moreover, the use of nuclear extracts from 1,25-(OH)(2)D-3-treated macrophages led to the formation of an additional high mobility complex also composed of VDR RXR heterodimer. Mutations provided evidence that the 1,25(OH)(2)D-3-mediated activation of the carbonic anhydrase II gene is mediated by VDR RXR heterodimers bound to a DR3-type vitamin D response element with sequence AGGGCAtggAGTTCG. This vitamin D response element is also functional in the ROS 17/2.8 osteoblasts.	Ecole Normale Super Lyon, Inst Natl Rech Agron 913, UMR 49 CNRS, Biol Cellulaire & Mol Lab, F-69394 Lyon 07, France	Ecole Normale Superieure de Lyon (ENS de LYON); INRAE	Jurdic, P (corresponding author), Ecole Normale Super Lyon, Inst Natl Rech Agron 913, UMR 49 CNRS, Biol Cellulaire & Mol Lab, 46 Allee Italie, F-69394 Lyon 07, France.	Pierre.Jurdic@ens-lyon.fr						Arbelle JE, 1996, ENDOCRINOLOGY, V137, P786, DOI 10.1210/en.137.2.786; BARAN DT, 1992, J CELL BIOCHEM, V50, P124, DOI 10.1002/jcb.240500203; BARSHAVIT Z, 1983, P NATL ACAD SCI-BIOL, V80, P5907, DOI 10.1073/pnas.80.19.5907; BAUDINO TA, 1997, VITAMIN D CHEM BIOL, P320; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BISKOBING DM, 1994, ENDOCRINOLOGY, V134, P1493, DOI 10.1210/en.134.3.1493; CAO X, 1993, J BIOL CHEM, V268, P27371; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; CARLBERG C, 1995, EUR J BIOCHEM, V231, P517, DOI 10.1111/j.1432-1033.1995.0517d.x; CAVAILLES V, 1994, P NATL ACAD SCI USA, V91, P10009, DOI 10.1073/pnas.91.21.10009; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; CHEN TC, 1993, J NUTR BIOCHEM, V4, P49, DOI 10.1016/0955-2863(93)90020-W; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; CHRISTAKOS S, 1996, BIOCHEM J, V316, P861; COLNOT S, 1995, MOL CELL ENDOCRINOL, V113, P89, DOI 10.1016/0303-7207(95)03618-H; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; DARWISH HM, 1992, P NATL ACAD SCI USA, V89, P603, DOI 10.1073/pnas.89.2.603; DEMAY MB, 1990, P NATL ACAD SCI USA, V87, P369, DOI 10.1073/pnas.87.1.369; DISELA C, 1991, GENE DEV, V5, P2033, DOI 10.1101/gad.5.11.2033; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; FELDMAN J, 1993, LEUKEMIA RES, V17, P97, DOI 10.1016/0145-2126(93)90146-C; FLINK IL, 1990, J BIOL CHEM, V265, P11233; FREEDMAN LP, 1994, MOL ENDOCRINOL, V8, P265, DOI 10.1210/me.8.3.265; HAHN CN, 1994, NUCLEIC ACIDS RES, V22, P2410, DOI 10.1093/nar/22.12.2410; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; HAUSSLER MR, 1997, VITAMIN D CHEM BIOL, P210; HAUSSLER MR, 1995, BONE S, V17, P33; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; Kim RH, 1996, BIOCHEM J, V318, P219, DOI 10.1042/bj3180219; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Koszewski NJ, 1996, J STEROID BIOCHEM, V59, P377, DOI 10.1016/S0960-0760(96)00127-6; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; LOMRI A, 1992, P NATL ACAD SCI USA, V89, P4688, DOI 10.1073/pnas.89.10.4688; MACDONALD PN, 1995, J BIOL CHEM, V270, P4748, DOI 10.1074/jbc.270.9.4748; MADER S, 1993, J BIOL CHEM, V268, P591; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MAURER RA, 1987, MOL CELL BIOL, V7, P4247, DOI 10.1128/MCB.7.12.4247; NISHIKAWA J, 1993, J BIOL CHEM, V268, P19739; NISHIKAWA J, 1995, NUCLEIC ACIDS RES, V23, P606, DOI 10.1093/nar/23.4.606; NISHIKAWA J, 1994, NUCLEIC ACIDS RES, V22, P2902, DOI 10.1093/nar/22.15.2902; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; NORMAN AW, 1993, J NUTR, V123, P310, DOI 10.1093/jn/123.suppl_2.310; OHYAMA Y, 1994, J BIOL CHEM, V269, P10545; ONATE SA, 1995, SCIENCE, V270, P1354; PAIN B, 1990, New Biologist, V2, P284; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PILLAI S, 1988, Skin Pharmacology, V1, P149; PRALLET B, 1992, J BONE MINER RES, V7, P405; QUELO I, 1994, DNA CELL BIOL, V13, P1181, DOI 10.1089/dna.1994.13.1181; RASCLE A, 1994, ONCOGENE, V9, P2853; REGMIER M, 1991, DIFFERENTIATION, V47, P173; ROODMAN GD, 1985, P NATL ACAD SCI USA, V82, P8213, DOI 10.1073/pnas.82.23.8213; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; ROTH DE, 1992, P NATL ACAD SCI USA, V89, P1804, DOI 10.1073/pnas.89.5.1804; SCHRADER M, 1994, J BIOL CHEM, V269, P6444; SHAPIRO LH, 1989, FEBS LETT, V249, P307, DOI 10.1016/0014-5793(89)80647-7; Shaw P E, 1994, Methods Mol Biol, V30, P79; SUDA T, 1989, P SOC EXP BIOL MED, V191, P214; SUEN CS, 1995, ENDOCRINOLOGY, V136, P2776, DOI 10.1210/en.136.6.2776; TOWERS TL, 1993, P NATL ACAD SCI USA, V90, P6310, DOI 10.1073/pnas.90.13.6310; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WOODS C, 1995, ENDOCRINOLOGY, V136, P85, DOI 10.1210/en.136.1.85; ZHENG MH, 1993, J BONE MINER RES, V8, P113; ZIEROLD C, 1994, P NATL ACAD SCI USA, V91, P900, DOI 10.1073/pnas.91.3.900	68	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10638	10646		10.1074/jbc.273.17.10638	http://dx.doi.org/10.1074/jbc.273.17.10638			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553126	hybrid			2022-12-27	WOS:000073224200075
J	Feng, JQ; Luan, XH; Wallace, J; Jing, D; Ohshima, T; Kulkarni, AB; D'Souza, RN; Kozak, CA; MacDougall, M				Feng, JQ; Luan, XH; Wallace, J; Jing, D; Ohshima, T; Kulkarni, AB; D'Souza, RN; Kozak, CA; MacDougall, M			Genomic organization, chromosomal mapping, and promoter analysis of the mouse dentin sialophosphoprotein (Dspp) gene, which codes for both dentin sialoprotein and dentin phosphoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT INCISOR; SEQUENCE DETERMINATION; PHOSPHOPHORYN; BIOSYNTHESIS; PROTEINS; RECEPTOR	Our laboratory has reported that two major noncollagenous dentin proteins, dentin sialoprotein and dentin phosphoprotein, are specific cleavage products of a larger precursor protein termed dentin sialophosphoprotein (MacDougall, M., Simmons, D., Luan, X., Nydegger, J., Feng, J. Q., and Gu, T. T. (1997) J. Biol. Chem. 272:835-842). To confirm our single gene hypothesis and initiate in vitro promoter studies, we have characterized the structural organization of the mouse dentin sialophosphoprotein gene. This gene has a transcription unit of similar to 9.4 kilobase pairs and is organized into 5 exons and 4 introns. Exon 1 contains a noncoding 5' sequence, and exon 2 contains the transcriptional start site, signal peptide, and first two amino acids of the NH2 terminus. Exons 3 and 4 contain coding information for 29 and 314 amino acids, respectively. The remainder of the coding information and the untranslated 3' region are contained in exon 5. Chromosomal mapping localized the gene to mouse chromosome 5q21 in close proximity to other dentin/bone matrix genes. Computer analysis of the promoter proximal 1.6-kilobase pair sequence revealed a number of potentially important cis-regulatory sequences; these include the recognition elements of AP-1, AP-2, Msx-1, serum response elements, SP-1, and TCF-1. In vitro studies showed that the DSPP promoter is active in an odontoblast cell line, MO6-G3, with basal activity mapped to -95 bp. Two potential enhancer and suppresser elements were identified in the regions between -1447 and -791 bp and -791 and -95 bp, respectively. The structural organization of the dentin sialophosphoprotein gene confirms our finding that both dentin sialoprotein and dentin phosphoprotein are encoded by a single gene with a continuous open reading frame.	Univ Texas, Hlth Sci Ctr, Sch Dent, Dept Pediat Dent, San Antonio, TX 78284 USA; NIDR, Gene Targeting Res & Core Facil, NIH, Bethesda, MD 20892 USA; Univ Texas, Hlth Sci Ctr, Dent Branch, San Antonio, TX 78284 USA; NIAID, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	MacDougall, M (corresponding author), Univ Texas, Hlth Sci Ctr, Sch Dent, Dept Pediat Dent, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.		MacDougall, Mary/ABG-8212-2021	D'Souza, Rena/0000-0002-1505-5173	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009875, R29DE009875] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE 11685, DE 09875] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ADAMSON MC, 1991, VIROLOGY, V183, P778, DOI 10.1016/0042-6822(91)91010-E; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; BUTLER WT, 1983, ARCH BIOCHEM BIOPHYS, V225, P178, DOI 10.1016/0003-9861(83)90021-8; BUTLER WT, 1981, COLLAGEN REL RES, V1, P187; BUTLER WT, 1992, MATRIX, V12, P343, DOI 10.1016/S0934-8832(11)80030-2; BUTLER WT, 1995, INT J DEV BIOL, V39, P169; CROBSY AH, 1996, MAMM GENOME, V7, P149; DEVRIES IG, 1986, ARCH ORAL BIOL, V31, P57, DOI 10.1016/0003-9969(86)90114-7; DEVRIES IG, 1989, ARCH ORAL BIOL, V31, P57; DIETRICH W, 1992, GENETICS, V131, P423; DIMUZIO MT, 1978, J BIOL CHEM, V253, P6845; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; FENG JQ, 1995, J BIOL CHEM, V270, P28364, DOI 10.1074/jbc.270.47.28364; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Green E., 1981, GENETICS PROBABILITY, DOI 10.1007/978-1-349-04904-2; HU CC, 1998, IN PRESS CONNECT TIS; Janknecht R, 1997, J BIOL CHEM, V272, P4219, DOI 10.1074/jbc.272.7.4219; Kozak C, 1997, MAMM GENOME, V7, pS80, DOI 10.1007/s003359900317; KOZAK CA, 1990, GENOMICS, V8, P519, DOI 10.1016/0888-7543(90)90039-W; KUZUOKA M, 1994, GENOMICS, V21, P85, DOI 10.1006/geno.1994.1228; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; MACDOUGALL, 1998, IN PRESS CONN TISSUE; MACDOUGALL M, 1985, BIOCHEM J, V232, P493, DOI 10.1042/bj2320493; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; MACDOUGALL M, 1996, P INT C DENT PULP CO, P116; MACDOUGALL M, 1998, IN PRESS CYTOGENET C; MACDOUGALL M, 1997, IN PRESS EUR J ORAL, V105; MUNKSGAARD EC, 1978, ARCH ORAL BIOL, V23, P583, DOI 10.1016/0003-9969(78)90275-3; Ritchie H H, 1995, Connect Tissue Res, V33, P73, DOI 10.3109/03008209509016985; RITCHIE HH, 1994, J BIOL CHEM, V269, P3698; Ritchie HH, 1996, J BIOL CHEM, V271, P21695, DOI 10.1074/jbc.271.36.21695; SABSAY B, 1991, BIOCHEM J, V276, P699, DOI 10.1042/bj2760699; Sambrook J., 2002, MOL CLONING LAB MANU; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; STETLERSTEVENSON WG, 1983, BIOCHEMISTRY-US, V22, P4326, DOI 10.1021/bi00287a025; UCHIDA T, 1991, HISTOCHEMISTRY, V96, P129, DOI 10.1007/BF00315983; UCHIDA T, 1997, IN PRESS EUR J ORAL, V105; WEINSTOCK M, 1973, J CELL BIOL, V56, P838, DOI 10.1083/jcb.56.3.838	39	175	192	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9457	9464		10.1074/jbc.273.16.9457	http://dx.doi.org/10.1074/jbc.273.16.9457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545272	hybrid			2022-12-27	WOS:000073128800018
J	Guan, C; Liu, Y; Shao, Y; Cui, T; Liao, W; Ewel, A; Whitaker, R; Paulus, H				Guan, C; Liu, Y; Shao, Y; Cui, T; Liao, W; Ewel, A; Whitaker, R; Paulus, H			Characterization and functional analysis of the cis-autoproteolysis active center of glycosylasparaginase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LYSOSOMAL ASPARTYLGLUCOSAMINIDASE; SINGLE-GENE ENCODES; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; CLEAVAGE; ACTIVATION; SUBUNITS; ACID; LEXA	Glycosylasparaginase is an N-terminal nucleophile hydrolase and is activated by intramolecular autoproteolytic processing. This cis-autoproteolysis possesses unique kinetics characterized by a reversible N-O acyl rearrangement step in the processing. Arg-180 and Asp-183, involved in binding of the substrate in the mature enzyme, are also involved in binding of free amino acids in the partially formed substrate pocket on certain mutant precursors. This binding site is sequestered in the wild-type precursor. Binding of free amino acids on mutant precursors can either inhibit or accelerate their processing, depending on the individual mutants and amino acids. The polypeptide sequence at the processing site, which is highly conserved, adopts a special conformation. Asp-151 is essential for maintaining this conformation, possibly by anchoring its side chain into the partially formed substrate pocket through interaction with Arg-180, The reactive nucleophile Thr-152 is activated not only by deprotonation by His-150 but also by interaction with Thr-170, suggesting a His-Thr-Thr active triad for the autoproteolysis.	New England Biolabs Inc, Beverly, MA 01915 USA; Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; Boston Biomed Res Inst, Boston, MA 02114 USA	University of South Alabama; Boston Biomedical Research Institute	Guan, C (corresponding author), New England Biolabs Inc, 32 Tozer Rd, Beverly, MA 01915 USA.		Wood, David W/B-2992-2012					BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; FISHER KJ, 1990, FEBS LETT, V269, P440, DOI 10.1016/0014-5793(90)81211-6; FISHER KJ, 1993, FEBS LETT, V323, P271, DOI 10.1016/0014-5793(93)81355-4; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; IKONEN E, 1993, EMBO J, V12, P295, DOI 10.1002/j.1460-2075.1993.tb05656.x; KIM B, 1993, CELL, V73, P1165, DOI 10.1016/0092-8674(93)90645-7; KYTE J, 1995, MECH PROTEIN CHEM, P20; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; LITTLE JW, 1993, J BACTERIOL, V175, P4943, DOI 10.1128/JB.175.16.4943-4950.1993; Liu Y, 1996, GLYCOBIOLOGY, V6, P527, DOI 10.1093/glycob/6.5.527; Liu Y, 1998, J BIOL CHEM, V273, P9688, DOI 10.1074/jbc.273.16.9688; MAKINO M, 1966, BIOCHEM BIOPH RES CO, V24, P961, DOI 10.1016/0006-291X(66)90344-5; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; RIGGS P, 1990, CURRENT PROTOCOLS MO, V2; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Shao Y, 1997, J PEPT RES, V50, P193; TARENTINO AL, 1995, ARCH BIOCHEM BIOPHYS, V316, P399, DOI 10.1006/abbi.1995.1053; TARENTINO AL, 1993, BIOCHEM BIOPH RES CO, V197, P179, DOI 10.1006/bbrc.1993.2457; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; VAJDA T, 1978, EUR J BIOCHEM, V85, P121, DOI 10.1111/j.1432-1033.1978.tb12219.x; VANPOELJE PD, 1990, BIOCHEMISTRY-US, V29, P132, DOI 10.1021/bi00453a016; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X	27	57	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9695	9702		10.1074/jbc.273.16.9695	http://dx.doi.org/10.1074/jbc.273.16.9695			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545304	hybrid			2022-12-27	WOS:000073128800050
J	Hersberger, M; Innerarity, TL				Hersberger, M; Innerarity, TL			Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CATALYTIC SUBUNIT; CELL-LINES; PROTEIN; APOBEC-1; ENZYME; INVITRO; MOTIF; LIPOPROTEINS; EXPRESSION	Normally, apolipoprotein B (apoB) mRNA editing deaminates a single cytidine (C-6666) in apoB mRNA, However, when the catalytic subunit of the editing enzyme complex, APOBEC-1, was overexpressed in transgenic mice and rabbits, numerous cytidines in the apoB mRNA and in a novel mRNA, NAT1, were aberrantly hyperedited, and the animals developed liver dysplasia and hepatocellular carcinomas. To identify the RNA motifs in the apoB mRNA that support physiological editing and those that support aberrant hyperediting, we constructed rabbit apoB RNA substrates and tested them in vitro for physiological editing and hyperediting. Three previously unrecognized RNA elements that are critical for efficient physiological editing at C-6666 were identified. In concert with the mooring sequence (6671-6681), the 5' efficiency element (6609-6628), an A-rich region (6629-6640), and the 3' efficiency element (6717-6747) increased editing at C-6666. Th, 5' efficiency element was the most potent, elevating physiological editing to wild-type levels in combination with the mooring sequence. The 3' efficiency element was somewhat less important but increased physiological editing to levels approaching wild type. These elements encompass 139 nucleotides on the apoB RNA transcript and are sufficient for editing with the efficiency of full-length apoB mRNA. Furthermore, a distal downstream apoB region (6747-6824) may function as a recognition element in the apoB mRNA, Hyperediting at C-6802 in the rabbit apoB mRNA is mediated by RNA elements similar to those required for normal physiological editing at C-6666. Similarly sized upstream and downstream flanking regions of C-6802 are necessary for hyperediting in combination with a degenerate mooring sequence.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Cardiovasc Res Inst, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Hersberger, M (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Cardiovasc Res Inst, POB 419100, San Francisco, CA 94141 USA.	martin_hersberger@quickmail.ucsf.edu		Hersberger, Martin/0000-0002-4472-329X	NHLBI NIH HHS [HL47660] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047660] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANANT S, 1995, J BIOL CHEM, V270, P14762, DOI 10.1074/jbc.270.24.14762; BACKUS JW, 1994, BBA-GENE STRUCT EXPR, V1217, P65; BACKUS JW, 1992, NUCLEIC ACIDS RES, V20, P6007, DOI 10.1093/nar/20.22.6007; BOSTROM K, 1989, J BIOL CHEM, V264, P15701; BOSTROM K, 1990, J BIOL CHEM, V265, P22446; Chan L, 1997, BBA-LIPID LIPID MET, V1345, P11, DOI 10.1016/S0005-2760(96)00156-7; CHEN SH, 1990, J BIOL CHEM, V265, P6811; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; DAVIDSON NO, 1995, RNA, V1, P3; DRISCOLL DM, 1994, J BIOL CHEM, V269, P19843; DRISCOLL DM, 1993, MOL CELL BIOL, V13, P7288, DOI 10.1128/MCB.13.12.7288; DRISCOLL DM, 1989, CELL, V58, P519, DOI 10.1016/0092-8674(89)90432-7; GARCIA ZC, 1992, ARTERIOSCLER THROMB, V12, P172, DOI 10.1161/01.ATV.12.2.172; GREEVE J, 1993, J LIPID RES, V34, P1367; HEINEMANN T, 1994, J LIPID RES, V35, P2200; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HODGES PE, 1991, NUCLEIC ACIDS RES, V19, P1197, DOI 10.1093/nar/19.6.1197; Innerarity TL, 1996, J BIOL CHEM, V271, P2353, DOI 10.1074/jbc.271.5.2353; JOHNSON DF, 1993, BIOCHEM BIOPH RES CO, V195, P1204, DOI 10.1006/bbrc.1993.2172; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3; NAVARATNAM N, 1991, NUCLEIC ACIDS RES, V19, P1741, DOI 10.1093/nar/19.8.1741; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; SHAH RR, 1991, J BIOL CHEM, V266, P16301; Smith H C, 1993, Semin Cell Biol, V4, P267, DOI 10.1006/scel.1993.1032; Sowden M, 1996, J BIOL CHEM, V271, P3011, DOI 10.1074/jbc.271.6.3011; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Yamanaka S, 1996, J BIOL CHEM, V271, P11506, DOI 10.1074/jbc.271.19.11506; YAMANAKA S, 1994, J BIOL CHEM, V269, P21725; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; ZUKER M, 1995, NUCLEIC ACIDS RES, V23, P2791, DOI 10.1093/nar/23.14.2791	33	38	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9435	9442		10.1074/jbc.273.16.9435	http://dx.doi.org/10.1074/jbc.273.16.9435			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545269	hybrid			2022-12-27	WOS:000073128800015
J	Marti, T				Marti, T			Refolding of bacteriorhodopsin from expressed polypeptide fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN BACTERIORHODOPSIN; PROTON TRANSLOCATION; ESCHERICHIA-COLI; BACTERIO-OPSIN; RECONSTITUTION; SUBSTITUTIONS; RENATURATION; CHROMOPHORE; MECHANISM; RESIDUES	Bacteriorhodopsin is a heptahelical membrane protein that can be refolded to the native state following denaturation. To analyze the in vitro folding process with independent structural domains, eight fragments comprising two (AB, FG), three (AC, EG), four (AD, DG) or five (AE, CG) of the transmembrane segments were produced by expression in Escherichia coli. The polypeptides were purified to homogeneity by solvent extraction off. coli membranes, repeated phase separation, and anion exchange chromatography employing the C-terminal tail of bacteriorhodopsin for adsorption. Upon reconstitution into phospholipid/detergent micelles pairs of complementary fragments (AB.CG, AC.DG, AD.EG, and AE.FG) assembled in the presence of retinal to regenerate the characteristic bacteriorhodopsin chromophore with high efficiency. Together with previous studies, these results demonstrate that the covalent connections in each of the six interhelical loops are dispensable for a correct association of the helices. The different loops, however, contribute to the stability of the folded structure, as shown by increased susceptibilities toward denaturation in SDS and at acidic pH, and decreased Schiff base pk(alpha) values for the AB.CG, AC.DG, AD.DG, and AE.FG complexes, compared with the intact protein. Notably, the heptahelical bundle structure was also generated by all possible combinations of pairs of overlapping fragments, containing one (AC.CG, AD.DG, AE.EG), two (AD.CG, AE.DG), or three (AE.CG) redundant helices. The spectral properties of the chromophores indicate that the retinal-binding pocket of the AC.CG, AD.CG, and AE.CG complexes is formed by helices A and B of the respective N-terminal fragment and the C-terminal CG fragment, whereas the AD.DG, AE.DG, and AE.EG complexes are likely to adopt a heptahelical bundle structure analogous to AD.EG. The combined data show that the specificity of the helix assembly of bacteriorhodopsin is influenced by connectivities provided by the C-D and E-F surface loops.	Bernhard Nocht Inst Trop Med, Dept Biol Mol, D-20359 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin	Marti, T (corresponding author), Bernhard Nocht Inst Trop Med, Dept Biol Mol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	marti@bni.uni-hamburg.de						BARSUKOV IL, 1992, EUR J BIOCHEM, V206, P665, DOI 10.1111/j.1432-1033.1992.tb16972.x; BERKOWER C, 1991, EMBO J, V10, P3777, DOI 10.1002/j.1460-2075.1991.tb04947.x; BHATTACHARYA S, 1992, J BIOL CHEM, V267, P6757; BOOTH PJ, 1995, NAT STRUCT BIOL, V2, P139, DOI 10.1038/nsb0295-139; Booth PJ, 1996, BIOCHEMISTRY-US, V35, P5902, DOI 10.1021/bi960129e; BRAIMAN MS, 1987, J BIOL CHEM, V262, P9271; GILLESGONZALEZ MA, 1991, J BIOL CHEM, V266, P8545; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; HACKETT NR, 1987, J BIOL CHEM, V262, P9277; HANSEN OK, 1994, BIOL CHEM H-S, V375, P715; HUANG KS, 1981, J BIOL CHEM, V256, P3802; HUANG KS, 1980, P NATL ACAD SCI-BIOL, V77, P323, DOI 10.1073/pnas.77.1.323; JAHNIG F, 1990, TRENDS BIOCHEM SCI, V15, P93, DOI 10.1016/0968-0004(90)90188-H; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P8829, DOI 10.1021/bi00152a020; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; KARNIK SS, 1987, J BIOL CHEM, V262, P9255; KHORANA HG, 1993, P NATL ACAD SCI USA, V90, P1166, DOI 10.1073/pnas.90.4.1166; KIMURA K, 1982, J BIOL CHEM, V257, P2859; Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KREBS MP, 1993, J BACTERIOL, V175, P1555, DOI 10.1128/JB.175.6.1555-1560.1993; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANYI JK, 1995, NATURE, V375, P461, DOI 10.1038/375461a0; LANYI JK, 1993, BIOCHIM BIOPHYS ACTA, V1183, P241, DOI 10.1016/0005-2728(93)90226-6; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; LIAO MJ, 1984, J BIOL CHEM, V259, P4200; LIAO MJ, 1984, J BIOL CHEM, V259, P4194; LIAO MJ, 1983, J BIOL CHEM, V258, P9949; LONDON E, 1982, J BIOL CHEM, V257, P7003; MARTI T, 1991, J BIOL CHEM, V266, P6919; MARTI T, 1991, J BIOL CHEM, V266, P18674; MARTI T, 1992, P NATL ACAD SCI USA, V89, P1219, DOI 10.1073/pnas.89.4.1219; MATHIES RA, 1991, ANNU REV BIOPHYS BIO, V20, P491, DOI 10.1146/annurev.bb.20.060191.002423; MATSUDAIRA P, 1993, PRACTICAL GUIDE PROT, P8; NASSAL M, 1987, J BIOL CHEM, V262, P9264; OESTERHELT D, 1992, J BIOENERG BIOMEMBR, V24, P181, DOI 10.1007/BF00762676; Ozawa S, 1997, BBA-BIOMEMBRANES, V1323, P145, DOI 10.1016/S0005-2736(96)00182-4; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; POPOT JL, 1993, CURR OPIN STRUC BIOL, V3, P532, DOI 10.1016/0959-440X(93)90079-Z; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; Ridge KD, 1996, J BIOL CHEM, V271, P7860, DOI 10.1074/jbc.271.13.7860; Riley ML, 1997, BIOCHEMISTRY-US, V36, P192, DOI 10.1021/bi962199r; ROTHE U, 1990, FEBS LETT, V263, P308, DOI 10.1016/0014-5793(90)81401-9; ROTHSCHILD KJ, 1992, J BIOENERG BIOMEMBR, V24, P147, DOI 10.1007/BF00762674; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; SIGRIST H, 1988, EUR J BIOCHEM, V177, P125, DOI 10.1111/j.1432-1033.1988.tb14352.x; SONAR S, 1994, J BIOL CHEM, V269, P28851; STERN LJ, 1989, J BIOL CHEM, V264, P14202; STOECKENIUS W, 1982, ANNU REV BIOCHEM, V51, P587, DOI 10.1146/annurev.bi.51.070182.003103; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; SUBRAMANIAM S, 1990, P NATL ACAD SCI USA, V87, P1013, DOI 10.1073/pnas.87.3.1013; TEUFEL M, 1993, EMBO J, V12, P3399, DOI 10.1002/j.1460-2075.1993.tb06014.x; YU HB, 1995, BIOCHEMISTRY-US, V34, P14963, DOI 10.1021/bi00046a002; ZEN KH, 1994, BIOCHEMISTRY-US, V33, P8198, DOI 10.1021/bi00193a005	59	109	109	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9312	9322		10.1074/jbc.273.15.9312	http://dx.doi.org/10.1074/jbc.273.15.9312			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535926	hybrid			2022-12-27	WOS:000072990800103
J	Qazi, U; Gettins, PGW; Stoops, JK				Qazi, U; Gettins, PGW; Stoops, JK			On the structural changes of native human alpha(2)-macroglobulin upon proteinase entrapment - Three-dimensional structure of the half-transformed molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-2-MACROGLOBULIN; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; SINGLE PARTICLES; THIOL ESTERS; BAIT REGION; METHYLAMINE; LOCALIZATION; RESOLUTION	The reconstructions of an intermediate form of human alpha(2)-macroglobulin (half-transformed alpha(2)M) in which two of its four bait regions and thiol ester sites were cleaved by chymotrypsin bound to Sepharose were obtained by three-dimensional electron microscopy from stain and frozen-hydrated specimens. The structures show excellent agreement and reveal a structure with approximate dimensions of 195 (length) x 135 (width) and 130 Angstrom (depth) with an internal funnel-shaped cavity. The structure shows that a chisel-shaped body is connected to a broad base at the opposing end by four stands. Four approximately 45 Angstrom diameter large openings in the body of the structure result in a central cavity that is more accessible to the proteinase than those associated with the native or fully transformed structures. The dissimilarity in the shapes between the two ends of alpha(2)M half-transformed and the similarity between its chisel-shaped body and that of native alpha(2)M indicate that the chymotrypsin has cleaved both bait regions in the bottom-half of the structure. Consequently, its functional division lies on the minor axis. The structural organization is in accord with biochemical studies, which show that the half-transformed alpha(2)M migrates on native polyacrylamide gels at a rate intermediate to the native and fully transformed alpha(2)M and is capable of trapping 1 mol of proteinase. Even though its upper portion is similar to the native molecule, significant differences in their shapes are apparent and these differences may be related to its slower reaction with a proteinase than the native structure. These structural comparisons further support the view that the transformation of alpha(2)M involves an untwisting of its strands with an opening of the cavity for entrance of the proteinase and a retwisting of the strands around the proteinase resulting in its encapsulation.	Univ Texas, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	University of Texas System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Stoops, JK (corresponding author), Univ Texas, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA.				NHLBI NIH HHS [HL 42886] Funding Source: Medline; NIGMS NIH HHS [GM 54414] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSEN GR, 1995, J BIOL CHEM, V270, P25133, DOI 10.1074/jbc.270.42.25133; Boisset N, 1996, J BIOL CHEM, V271, P25762, DOI 10.1074/jbc.271.42.25762; BOISSET N, 1994, ANN NY ACAD SCI, V737, P229, DOI 10.1111/j.1749-6632.1994.tb44315.x; Bowen ME, 1998, J BIOL CHEM, V273, P1825, DOI 10.1074/jbc.273.3.1825; BRETAUDIERE JP, 1988, P NATL ACAD SCI USA, V85, P1437, DOI 10.1073/pnas.85.5.1437; DELAIN E, 1988, J BIOL CHEM, V263, P2981; DELAIN E, 1992, ELECTRON MICROSC REV, V5, P231, DOI 10.1016/0892-0354(92)90012-F; ERICKSON HP, 1971, PHILOS T ROY SOC B, V261, P105, DOI 10.1098/rstb.1971.0040; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; FIGLER NL, 1991, J STRUCT BIOL, V106, P237, DOI 10.1016/1047-8477(91)90073-6; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1985, NEW METHODOLOGIES ST, P36; GETTINS P, 1989, BIOCHEMISTRY-US, V28, P5613, DOI 10.1021/bi00439a041; GETTINS P, 1988, BIOCHEMISTRY-US, V27, P2905, DOI 10.1021/bi00408a036; GETTINS P, 1990, BIOCHEMISTRY-US, V29, P7747, DOI 10.1021/bi00485a025; GETTINS PGW, 1994, FEBS LETT, V339, P276, DOI 10.1016/0014-5793(94)80430-3; GETTINS PGW, 1995, J BIOL CHEM, V270, P14160, DOI 10.1074/jbc.270.23.14160; GONIAS SL, 1989, J BIOL CHEM, V264, P9565; JENSEN PEH, 1986, J BIOL CHEM, V261, P5863; Kolodziej SJ, 1996, J STRUCT BIOL, V116, P366, DOI 10.1006/jsbi.1996.0054; Kolodziej SJ, 1997, J STRUCT BIOL, V120, P158, DOI 10.1006/jsbi.1997.3911; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; SCHROETER JP, 1992, J STRUCT BIOL, V109, P235, DOI 10.1016/1047-8477(92)90036-A; Schroeter JP, 1996, J STRUCT BIOL, V116, P131, DOI 10.1006/jsbi.1996.0021; SOTTRUPJENSEN L, 1990, J BIOL CHEM, V265, P17727; SOTTRUPJENSEN L, 1981, FEBS LETT, V128, P123, DOI 10.1016/0014-5793(81)81096-4; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Starkey P. M., 1977, PROTEINASES MAMMALIA, P663; STOOPS JK, 1992, J BIOL CHEM, V267, P24769; STOOPS JK, 1991, J ELECTRON MICR TECH, V18, P157, DOI 10.1002/jemt.1060180210; STRICKLAND DK, 1988, BIOCHEMISTRY-US, V27, P1458, DOI 10.1021/bi00405a010; TOYOSHIMA C, 1988, ULTRAMICROSCOPY, V25, P279, DOI 10.1016/0304-3991(88)90003-4; UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7; VLAICU R, 1985, ATHEROSCLEROSIS, V55, P35, DOI 10.1016/0021-9150(85)90164-9	37	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8987	8993		10.1074/jbc.273.15.8987	http://dx.doi.org/10.1074/jbc.273.15.8987			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535885	hybrid			2022-12-27	WOS:000072990800062
J	Ramaswamy, S; Kaur, P				Ramaswamy, S; Kaur, P			Nucleotide binding to the C-terminal nucleotide binding domain of ArsA - Studies with an ATP analogue, 5 '-p-fluorosulfonylbenzoyladenosine (FSBA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-TRANSLOCATING ATPASE; CATALYTIC SUBUNIT; PROTEINS; SITE; MUTAGENESIS; F1-ATPASE; PUMP	ArsA protein, the catalytic component of the plasmid-encoded anion-translocating ATPase in Escherichia coli, contains two consensus nucleotide binding domains, A1 and A2, that are connected by a flexible linker. ATP has previously been shown to cross-link to the A1 domain upon activation with UV light but not to the A2 domain, The ATP analogue, 5'-p-fluorosulfonylbenzoyladenosine (FSBA) was used to probe the nucleotide binding domains of ArsA. The covalently labeled protein was subjected to partial trypsin proteolysis, followed by Western blot analysis of the fragments with the anti-FSBA serum, The N-terminal amino acid sequence of the labeled fragment showed that FSBA binds preferentially to the C-terminal domain A2 both in the absence and the presence of antimonite, Occupancy of the two nucleotide binding sites was determined by protection from trypsin proteolysis. Trypsin cleaved the ArsA protein at Arg(290) in the linker to generate a 32-kDa N-terminal and a 27-kDa C-terminal fragment, The 32-kDa fragment is compact and largely inaccessible to trypsin; however, the 27-kDa was cleaved further, Incubation with FSBA, which binds to the C-terminal domain, resulted in significant protection of the 27-kDa fragment, This fragment was not protected upon incubation with ATP alone, indicating that A2 might be unoccupied. However, upon incubation with ATP and antimonite, almost complete protection from trypsin was seen, ATP and FSBA together mimicked the effect of ATP and antimonite, implying that this fully protected conformation might be the result of both sites occupied with the nucleotide, It is proposed that the A1 site in ArsA is a high affinity ATP site, whereas the allosteric ligand antimonite is required to allow ATP binding to A2, resulting in catalytic cooperativity. Thus antimonite binding may act as a switch in regulating ATP binding to A2 and hence the ATPase activity of ArsA.	Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Kaur, P (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.				NIGMS NIH HHS [R29 GM51981-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051981] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ANNAMALAI AE, 1981, J BIOL CHEM, V256, P276; ANOSTARIO M, 1990, ANAL BIOCHEM, V190, P60, DOI 10.1016/0003-2697(90)90133-T; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; BULLOUGH DA, 1986, J BIOL CHEM, V261, P14171; COLMAN RF, 1983, ANNU REV BIOCHEM, V52, P67, DOI 10.1146/annurev.bi.52.070183.000435; HSU CM, 1989, J BIOL CHEM, V264, P17349; HSU CM, 1991, J BIOL CHEM, V266, P2327; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; KAUR P, 1993, J BACTERIOL, V175, P351, DOI 10.1128/JB.175.2.351-357.1993; KAUR P, 1994, J BIOL CHEM, V269, P9698; KAUR P, 1992, J BIOL CHEM, V267, P19272; KAUR P, 1994, BIOCHEMISTRY-US, V33, P6456, DOI 10.1021/bi00187a010; KAUR P, 1998, ADV MOL CEL A&B, V23, P455; Li JX, 1996, J BIOL CHEM, V271, P25247, DOI 10.1074/jbc.271.41.25247; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WU JH, 1992, J BIOL CHEM, V267, P12570; WYATT JL, 1977, BIOCHEMISTRY-US, V16, P1333, DOI 10.1021/bi00626a015	19	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9243	9248		10.1074/jbc.273.15.9243	http://dx.doi.org/10.1074/jbc.273.15.9243			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535916	hybrid			2022-12-27	WOS:000072990800093
J	Asano, K; Mizobuchi, K				Asano, K; Mizobuchi, K			An RNA pseudoknot as the molecular switch for translation of the repZ gene encoding the replication initiator of IncI alpha plasmid ColIb-P9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; DNA; EXPRESSION; PROTEIN; CLONING; FRAGMENTS; TARGETS; SIGNALS; REGION	Translation initiation of the repZ gene encoding the replication initiator of plasmid ColIb-P9 is not only negatively regulated by the action of the antisense Inc RNA encoded in the leader region, but is also coupled to the translation and termination of a transcribed leader sequence, repY, a positive regulatory element for repZ gene expression. This translational coupling depends on base pairing between two complementary sequences, 5'-rGGCG-3' and 5'-rCGCC-3', which are located upstream of and in the middle of repY, respectively, and have the potential to form a pseudoknot with the stem-loop structure I, Another stem-loop called structure III near the 3'-end of repY sequesters both the 5'-rCGCC-3' sequence and the repZ ribosome-binding site. Here we show that the RepZ mRNA leader sequence synthesized in vitro indeed contains several stem-loop structures including structures I and III, but not the pseudoknot, However, disruption of structure III, without changing the repZ ribosome-binding site, by means of base substitution and deletion induces base pairing between the two short complementary sequences distantly separated, resulting in the formation of a pseudoknot, When the pseudoknot is allowed to form in vivo due to the same mutations, a maximum level of repZ expression is obtained comparable to one observed in the absence of Inc RNA. These results strengthen our previously proposed model that the pseudoknot induced by the translation and termination of the repY reading frame functions as the molecular switch for translational initiation of the repZ gene.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 113, Japan; Univ Electrocommun, Dept Appl Phys & Chem, Chofu, Tokyo 182, Japan	University of Tokyo; University of Electro-Communications - Japan	Asano, K (corresponding author), NICHD, Lab Eukaryot Gene Regulat, NIH, Bethesda, MD 20892 USA.							Asano K, 1998, J BIOL CHEM, V273, P11826, DOI 10.1074/jbc.273.19.11826; ASANO K, 1991, J BIOL CHEM, V266, P3774; ASANO K, 1991, J BIOL CHEM, V266, P24549; BLOMBERG P, 1992, EMBO J, V11, P2675, DOI 10.1002/j.1460-2075.1992.tb05333.x; BRIERLEY I, 1991, J MOL BIOL, V220, P889, DOI 10.1016/0022-2836(91)90361-9; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3; HAMA C, 1990, J BACTERIOL, V172, P1983, DOI 10.1128/jb.172.4.1983-1991.1990; HAMA C, 1990, J BIOL CHEM, V265, P10666; Kato A, 1994, DNA Res, V1, P201, DOI 10.1093/dnares/1.5.201; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P448; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Miller J.H., 1972, EXPT MOL GENETICS; MURRAY NE, 1974, NATURE, V251, P476, DOI 10.1038/251476a0; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; PHILIPPE C, 1990, J MOL BIOL, V211, P415, DOI 10.1016/0022-2836(90)90362-P; PRASZKIER J, 1991, J BACTERIOL, V173, P2393, DOI 10.1128/JB.173.7.2393-2397.1991; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIMMEL P, 1989, CELL, V58, P9, DOI 10.1016/0092-8674(89)90395-4; SHIBA K, 1990, J BACTERIOL, V172, P1992, DOI 10.1128/jb.172.4.1992-1997.1990; TANG CK, 1989, CELL, V57, P531, DOI 10.1016/0092-8674(89)90123-2; TENDAM E, 1992, BIOCHEMISTRY-US, V31, P11665, DOI 10.1021/bi00162a001; TOMIZAWA J, 1984, CELL, V38, P861, DOI 10.1016/0092-8674(84)90281-2; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; WILSON IW, 1993, J BACTERIOL, V175, P6476, DOI 10.1128/jb.175.20.6476-6483.1993	30	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11815	11825		10.1074/jbc.273.19.11815	http://dx.doi.org/10.1074/jbc.273.19.11815			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565606	hybrid			2022-12-27	WOS:000073536700060
J	Cao, DL; Fan, ST; Chung, SSM				Cao, DL; Fan, ST; Chung, SSM			Identification and characterization of a novel human aldose reductase-like gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MOUSE VAS-DEFERENS; DIABETIC COMPLICATIONS; KETO REDUCTASES; ADRENAL-GLAND; PROTEIN; EXPRESSION; RAT; PURIFICATION; ALDEHYDE	We have identified a novel human protein that is highly homologous to aldose reductase (AR), This protein, which we called ARL-1, consists of 316 amino acids, the same size as AR, and its amino acid sequence is 71% identical to that of AR. It is more closely related to the AR-like proteins such as mouse vas deferens protein, fibroblast growth factor-regulated protein, and Chinese hamster ovary reductase, with 81, 82, and 83%, respectively, of its amino acid sequence identical to the amino acid sequence of these proteins. The cDNA of ARL-1 was expressed in Escherichia coli to obtain recombinant protein for characterization of its enzymatic activities. For comparison, the cDNA of human AR was also expressed in E., coli and analyzed in parallel. These two enzymes differ in their pH optima and salt requirement, but they act on a similar spectrum of substrates, Similar to AR, ARL-1 can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses, While AR mRNA is found in most tissues studied, ARL-I is primarily expressed in the small intestines and in the colon, with a low level of its mRNA in the liver. The ability of ARL-1 to reduce various aldehydes and the locations of expression of this gene suggest that it may be responsible for detoxification of reactive aldehydes in the digested food before the nutrients are passed on to other organs. Interestingly, ARL-I and AR are overexpressed in some liver cancers, but it is not clear if they contribute to the pathogenesis of this disease.	Univ Hong Kong, Inst Mol Biol, Pokfulam, Peoples R China; Univ Hong Kong, Dept Surg, Pokfulam, Peoples R China	University of Hong Kong; University of Hong Kong	Chung, SSM (corresponding author), Univ Hong Kong, Inst Mol Biol, 8 Sassoon Rd, Hong Kong, Peoples R China.	smchung@hkucc.hku.hk	Fan, Sheung Tat/C-4138-2009					AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BOHREN KM, 1991, J BIOL CHEM, V266, P24031; BOHREN KM, 1994, BIOCHEMISTRY-US, V33, P2021, DOI 10.1021/bi00174a007; CARPER D, 1987, FEBS LETT, V220, P209, DOI 10.1016/0014-5793(87)80905-5; CHUNG S, 1989, J BIOL CHEM, V264, P14775; DONOHUE PJ, 1994, J BIOL CHEM, V269, P8604; GARCIAPEREZ A, 1989, J BIOL CHEM, V264, P16815; GRAHAM C, 1991, GENE, V107, P259, DOI 10.1016/0378-1119(91)90326-7; GUI T, 1995, EUR J BIOCHEM, V227, P448, DOI 10.1111/j.1432-1033.1995.tb20408.x; HAYMAN S, 1965, J BIOL CHEM, V240, P877; HERS HG, 1956, BIOCHIM BIOPHYS ACTA, V22, P202, DOI 10.1016/0006-3002(56)90247-5; Hsu DKW, 1997, BIOCHEM J, V328, P593, DOI 10.1042/bj3280593; Hyndman DJ, 1997, J BIOL CHEM, V272, P13286, DOI 10.1074/jbc.272.20.13286; INAZU N, 1994, J BIOCHEM-TOKYO, V115, P991, DOI 10.1093/oxfordjournals.jbchem.a124450; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0; KINOSHITA JH, 1988, DIABETES METAB REV, V4, P323, DOI 10.1002/dmr.5610040403; LAU ET, 1995, BIOCHEM J, V312, P609, DOI 10.1042/bj3120609; MARTINEZ A, 1990, MOL CELL ENDOCRINOL, V72, P201, DOI 10.1016/0303-7207(90)90144-W; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; SHEAFF CM, 1976, J BIOL CHEM, V251, P2696; TAKAHASHI M, 1995, INT J CANCER, V62, P749, DOI 10.1002/ijc.2910620617; VanderJagt DL, 1997, ADV EXP MED BIOL, V414, P491; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; WATANABE K, 1989, ADV PROSTAG THROMB L, V19, P462; WERMUTH B, 1982, EUR J BIOCHEM, V127, P279, DOI 10.1111/j.1432-1033.1982.tb06867.x; WILSON DK, 1995, BIOCHEMISTRY-US, V34, P14323, DOI 10.1021/bi00044a009; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; YAMAOKA T, 1992, BIOCHEM BIOPH RES CO, V183, P327, DOI 10.1016/0006-291X(92)91647-9; ZEINDLEBERHART E, 1994, J BIOL CHEM, V269, P14589	32	237	260	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11429	11435		10.1074/jbc.273.19.11429	http://dx.doi.org/10.1074/jbc.273.19.11429			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565553	hybrid			2022-12-27	WOS:000073536700007
J	Inoue, G; Cheatham, B; Emkey, R; Kahn, CR				Inoue, G; Cheatham, B; Emkey, R; Kahn, CR			Dynamics of insulin signaling in 3T3-L1 adipocytes - Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; HEXOSE-TRANSPORT; DOCKING PROTEIN; MEMBRANE; KINASE; PHOSPHORYLATION; STIMULATION; CELLS	The ability of the insulin receptor to phosphorylate multiple substrates and their subcellular localization are two of the determinants that contribute to diversity of signaling, We find that insulin receptor substrate (IRS)-1 is 2-fold more concentrated in the intracellular membrane (IM) compartment than in cytosol, whereas IRS-2 is 2-fold more concentrated in cytosol than in IM. Insulin stimulation induces rapid tyrosine phosphorylation of both IRS-1 and IRS-2. This occurs mainly in the IM compartment, even though IRS-S is located predominantly in cytosol, Furthermore, after insulin stimulation, both IRS-1 and IRS-2 translocate from IRI to cytosol with a t(1/2) of 3.5 min. Using an in vitro reconstitution assay, we have demonstrated an association between IRS-1 and internal membranes and have shown that the dissociation of IRS-1 from IM is dependent on serine/ threonine phosphorylation of IM. By comparison, within 1 min after insulin stimulation, 40% of the total pool of the 85-kDa subunit of phosphatidylinositol 3-kinase (p85) is recruited from cytosol to IM, the greater part of which can be accounted for by binding to IRS-1 present in the IM. The p85 binding and phosphatidylinositol 3-kinase activity associated with IRS-2 rapidly decrease in both IM and cytosol, whereas those associated with IRS-1 stay at a relatively high level in IM and increase with time in cytosol despite a return of p85 to the cytosol and decreasing tyrosine phosphorylation of cytosolic IRS-1. These data indicate that IRS-1 and IRS-2 are differentially distributed in the cell and move from IRI to cytosol following insulin stimulation. Insulin-stimulated IRS-1 and IRS-S signaling occurs mainly in the IM and shows different kinetics; IRS-l-mediated signaling is more stable, whereas IRS-a-mediated signaling is more transient. These differences in substrate utilization and compartmentalization may contribute to the complexity and diversity of the insulin signaling network.	Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Kahn, CR (corresponding author), Joslin Diabet Ctr, Div Res, Rm 620,1 Joslin Pl, Boston, MA 02215 USA.		Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R37DK031036, P30DK036836] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 31036, DK 36836] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; BeitnerJohnson D, 1996, J BIOL CHEM, V271, P9287, DOI 10.1074/jbc.271.16.9287; BERGERING BM, 1995, NATURE, V376, P599; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CLANCY BM, 1990, J BIOL CHEM, V265, P12434; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FROST SC, 1985, J BIOL CHEM, V260, P2646; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HOSOMI Y, 1994, J BIOL CHEM, V269, P11498; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KELLY KL, 1993, J BIOL CHEM, V268, P4391; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; LEE CH, 1993, P NATL ACAD SCI USA, V90, P11713, DOI 10.1073/pnas.90.24.11713; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; MYERS MG, 1995, J BIOL CHEM, V270, P11715, DOI 10.1074/jbc.270.20.11715; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; VOLIOVITCH H, 1995, J BIOL CHEM, V270, P18083, DOI 10.1074/jbc.270.30.18083; Wang B, 1996, BIOCHEM BIOPH RES CO, V227, P27, DOI 10.1006/bbrc.1996.1462; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300	36	145	148	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11548	11555		10.1074/jbc.273.19.11548	http://dx.doi.org/10.1074/jbc.273.19.11548			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565570	hybrid			2022-12-27	WOS:000073536700024
J	Guazzi, S; Pintonello, ML; Vigano, A; Boncinelli, E				Guazzi, S; Pintonello, ML; Vigano, A; Boncinelli, E			Regulatory interactions between the human HOXB1, HOXB2, and HOXB3 proteins and the upstream sequence of the Otx2 gene in embryonal carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; RETINOIC ACID; HOMEOBOX GENES; MOUSE OTX2; ANTERIOR NEUROECTODERM; ROSTRAL BRAIN; EXPRESSION; GASTRULATION; HOMEODOMAIN; SPECIFICITY	Vertebrate Hox and Otx genes encode homeodomain-containing transcription factors thought to transduce positional information along the body axis in the segmental portion of the trunk and in the rostral brain, respectively. Moreover, Hox and Otx2 genes show a complementary spatial regulation during embryogenesis. In this report, we show that a 1821-base pair (bp) upstream DNA fragment of the Otx2 gene is positively regulated by co-transfection with expression vectors for the human HOXB1, HOXB2, and HOXB3 proteins in an embryonal carcinoma cell line (NT2/D1) and that a shorter fragment of only 534 bp is able to drive this regulation. We also identified the HOXB1, HOXB2, and HOXB3 DNA-binding region on the 534-bp Otx2 genomic fragment using nuclear extracts from Hox-transfected COS cells and 12.5 days postcoitum mouse embryos or HOXB3 homeodomain containing bacterial extracts. HOXB1, HOXB3, and nuclear extracts from 12.5 days postcoitum mouse embryos bind to a sequence containing two palindromic TAATTA sites, which bear four copies of the ATTA core sequence, a common feature of most HOM-C/HOX binding sites, HOXB2 protected an adjacent site containing a direct repeat of an ACTT sequence, quite divergent from the ATTA consensus. The region bound by the three homeoproteins is strikingly conserved through evolution and necessary (at least for HOXB1 and HOXB3) to mediate the up-regulation of the Otx2 transcription. Taken together, our data support the hypothesis that anteriorly expressed Rot genes might play a role in the refinement of the Otx2 early expression boundaries in vivo.	San Raffaele Sci Inst, Unita Interazioni DNA Proteine 4PA1, DIBIT, Dept Biol & Biotechnol, I-20132 Milan, Italy; Consiglio Nazl Ric, Ctr Infrastrutture Cellulari, I-20129 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR)	Guazzi, S (corresponding author), San Raffaele Sci Inst, Unita Interazioni DNA Proteine 4PA1, DIBIT, Dept Biol & Biotechnol, Via Olgettina 58, I-20132 Milan, Italy.			vigano, maria alessandra/0000-0003-2009-0384	Telethon [TGT06S01, E.0450] Funding Source: Medline	Telethon(Fondazione Telethon)		ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ANG SL, 1994, DEVELOPMENT, V120, P2979; Ang SL, 1996, DEVELOPMENT, V122, P243; ARCIONI L, 1992, EMBO J, V11, P265, DOI 10.1002/j.1460-2075.1992.tb05049.x; BALLYCUIF L, 1995, MECH DEVELOP, V49, P49, DOI 10.1016/0925-4773(94)00301-3; BLITZ IL, 1995, DEVELOPMENT, V121, P993; CONLON RA, 1995, TRENDS GENET, V11, P314, DOI 10.1016/S0168-9525(00)89089-7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; EKKER SC, 1992, EMBO J, V11, P4059, DOI 10.1002/j.1460-2075.1992.tb05499.x; FINKELSTEIN R, 1994, TRENDS GENET, V10, P310, DOI 10.1016/0168-9525(94)90033-7; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; GUAZZI S, 1994, EMBO J, V13, P3339, DOI 10.1002/j.1460-2075.1994.tb06636.x; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; KIMURA C, 1997, DEVELOPMENT, V124, P3919; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MERCIER P, 1995, INT J DEV BIOL, V39, P559; Morrison A, 1996, DEVELOPMENT, V122, P1895; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PANNESE M, 1995, DEVELOPMENT, V121, P707; PELLERIN I, 1994, MOL CELL BIOL, V14, P4532, DOI 10.1128/MCB.14.7.4532; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; SENGUPTA PK, 1994, BLOOD, V83, P1420; Shimamura K, 1995, DEVELOPMENT, V121, P3923; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1995, MECH DEVELOP, V51, P83, DOI 10.1016/0925-4773(95)96241-M; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; ZHANG MB, 1994, DEVELOPMENT, V120, P2431	41	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11092	11099		10.1074/jbc.273.18.11092	http://dx.doi.org/10.1074/jbc.273.18.11092			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556594	hybrid			2022-12-27	WOS:000073395200046
J	Kopitz, J; von Reitzenstein, C; Burchert, M; Cantz, M; Gabius, HJ				Kopitz, J; von Reitzenstein, C; Burchert, M; Cantz, M; Gabius, HJ			Galectin-1 is a major receptor for ganglioside GM(1), a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURO-BLASTOMA CELLS; S-TYPE LECTIN; ENDOGENOUS LECTIN; PLASMA-MEMBRANE; BINDING-SPECIFICITY; NERVOUS-SYSTEM; ANIMAL LECTINS; GRANULE CELLS; DIFFERENTIATION; PROTEIN	Cell density-dependent inhibition of growth and neural differentiation in the human neuroblastoma cell line SK-N-MC are associated with a ganglioside sialidase-mediated increase of GM(1) and lactosylceramide at the cell surface. Because these glycolipids expose galactose residues, we have initiated the study of the potential role of galectins in such cellular events. Using specific antibodies, galectin-1 but not galectin-3 was found to be present at the cell surface. Assessment of carbohydrate-dependent binding revealed a saturable amount of ligand sites approaching 2.6 x 10(6) galectin-1 molecules bound/cell. Presence during cell culture of the sialidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid or of the GM(1)-binding cholera toxin B subunit effected a decrease of the presentation of galectin-1 ligands by 30-50%. The assumption that GM(1) is a major ligand for galectin-1 was reinforced by the correlation between the number of carbohydrate dependent I-125-iodinated GM(1)-neoganglioprotein binding sites and the amount of immunoreactive surface galectin-1, the marked sensitivity of probe binding to the presence of anti-galectin-1 antibody, and the inhibition of cell adhesion to surface-immobilized GM(1) by the antibody. The results open the possibility that the carbohydrate-dependent interaction between ganglioside GM(1) and galectin-(1) may relay sialidase-dependent alterations in this cell system.	Ruprecht Karls Univ, Inst Pathochem & Neurochem, Klinikum, D-69120 Heidelberg, Germany; Ludwigs Maximillian Univ, Inst Physiol Chem, Tierarztliche Fak, D-80539 Munich, Germany	Ruprecht Karls University Heidelberg; University of Munich	Cantz, M (corresponding author), Inst Pathochem & Neurochem, Neuenheimer Feld 220, D-69120 Heidelberg, Germany.			Gabius, Hans-Joachim/0000-0003-3467-3900				AGRWAL N, 1993, J BIOL CHEM, V268, P14932; AHMED H, 1990, BIOCHEMISTRY-US, V29, P5315, DOI 10.1021/bi00474a015; AVELLANAADALID V, 1994, GLYCOCONJUGATE J, V11, P286, DOI 10.1007/BF00731200; BARDOSI A, 1989, J HISTOCHEM CYTOCHEM, V37, P989, DOI 10.1177/37.7.2732460; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Bresalier RS, 1996, CANCER RES, V56, P4354; CARON M, 1993, J CHROMATOGR, V646, P327, DOI 10.1016/0021-9673(93)83345-S; CARON M, 1990, INT J BIOCHEM, V22, P1379, DOI 10.1016/0020-711X(90)90226-S; Chadli A, 1997, J NEUROCHEM, V68, P1640; CORNILLOT JD, 1992, INT J BIOCHEM, V24, P1585, DOI 10.1016/0020-711X(92)90174-Y; FISHMAN PH, 1982, J MEMBRANE BIOL, V69, P85, DOI 10.1007/BF01872268; FUESHKO SM, 1990, J NEUROCHEM, V54, P1791, DOI 10.1111/j.1471-4159.1990.tb01235.x; FUESHKO SM, 1992, J NEUROCHEM, V59, P527, DOI 10.1111/j.1471-4159.1992.tb09402.x; GABIUS HJ, 1991, HISTOCHEMISTRY, V95, P269; GABIUS HJ, 1990, ANAL BIOCHEM, V189, P91, DOI 10.1016/0003-2697(90)90050-J; GABIUS HJ, 1991, PROG HISTOCHEM CYTOC, V22, P1; Gabius HJ, 1997, EUR J BIOCHEM, V243, P543, DOI 10.1111/j.1432-1033.1997.t01-1-00543.x; Gabius HJ, 1997, CANCER INVEST, V15, P454, DOI 10.3109/07357909709047585; GABIUS HJ, 1993, HISTOL HISTOPATHOL, V8, P369; Gabius HJ, 1993, LECTINS GLYCOBIOLOGY; GABIUS S, 1990, BIOCHEM BIOPH RES CO, V169, P239, DOI 10.1016/0006-291X(90)91459-6; Galanina OE, 1997, J MOL RECOGNIT, V10, P139, DOI 10.1002/(SICI)1099-1352(199705/06)10:3<139::AID-JMR358>3.0.CO;2-R; GU MJ, 1994, J CELL SCI, V107, P175; Gupta D, 1996, GLYCOBIOLOGY, V6, P843, DOI 10.1093/glycob/6.8.843; GUPTA D, 1994, BIOCHEMISTRY-US, V33, P5526, DOI 10.1021/bi00184a022; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; JESSELL TM, 1990, ANNU REV NEUROSCI, V13, P227, DOI 10.1146/annurev.ne.13.030190.001303; JOUBERTCARON R, 1997, GLYCOSCIENCES STATUS, P611; Kaltner H, 1997, HISTOL HISTOPATHOL, V12, P945; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; Kopitz J, 1997, EUR J CELL BIOL, V73, P1; Kopitz J, 1996, GLYCOBIOLOGY, V6, P367, DOI 10.1093/glycob/6.3.367; KOPITZ J, 1994, BIOCHEM BIOPH RES CO, V199, P1188, DOI 10.1006/bbrc.1994.1356; KOPITZ J, 1997, GLYCOSCIENCES STATUS, P163; Lee R. T., 1997, GLYCOSCIENCES STATUS, P55; Lee Reiko T., 1994, P23; LEE RT, 1994, CARBOHYD RES, V254, P269, DOI 10.1016/0008-6215(94)84259-0; LEE RT, 1992, J BIOL CHEM, V267, P23722; LEE YC, 1991, LECTINS CANCER, P53; MAHANTHAPPA NK, 1994, DEVELOPMENT, V120, P1373; MANN KK, 1994, EUR J CELL BIOL, V65, P145; NAGAI Y, 1988, LECTINS GLYCOCONJUGA, P59; OHANNESIAN DW, 1997, GLYCOSCIENCES STATUS, P459; OZEKI Y, 1995, GLYCOBIOLOGY, V5, P255, DOI 10.1093/glycob/5.2.255; PITTO M, 1992, NEUROCHEM INT, V21, P367, DOI 10.1016/0197-0186(92)90187-V; RIBONI L, 1990, NEUROCHEM RES, V15, P1175, DOI 10.1007/BF01208577; SANDHOFF K, 1995, NATURWISSENSCHAFTEN, V82, P403, DOI 10.1007/BF01133673; SAQR HE, 1993, J NEUROCHEM, V61, P395; SCHENGRUND CL, 1982, J NEUROCHEM, V39, P940, DOI 10.1111/j.1471-4159.1982.tb11480.x; SCHENGRUND CL, 1973, J BIOL CHEM, V248, P4424; SCHENGRUND CL, 1988, J NEUROCHEM, V51, P277, DOI 10.1111/j.1471-4159.1988.tb04867.x; SCHNEIDERJAKOB HR, 1991, BIOL CHEM H-S, V372, P443, DOI 10.1515/bchm3.1991.372.1.443; Siebert HC, 1997, EUR J BIOCHEM, V249, P27, DOI 10.1111/j.1432-1033.1997.00027.x; SOLOMON JC, 1991, CARBOHYD RES, V213, P293, DOI 10.1016/S0008-6215(00)90616-5; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; TETTAMANTI G, 1993, ADV LIPID RES, V25, P235; TIEMEYER M, 1989, J BIOL CHEM, V264, P1671; Wasano K, 1997, J HISTOCHEM CYTOCHEM, V45, P275, DOI 10.1177/002215549704500212; WIEGANDT H, 1995, BEHAV BRAIN RES, V66, P85, DOI 10.1016/0166-4328(94)00129-4; Yang LJS, 1996, ANAL BIOCHEM, V236, P161, DOI 10.1006/abio.1996.0145; YOGEESWARAN G, 1975, BIOCHEMISTRY-US, V14, P2151, DOI 10.1021/bi00681a017; ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q	63	247	251	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11205	11211		10.1074/jbc.273.18.11205	http://dx.doi.org/10.1074/jbc.273.18.11205			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556610	hybrid			2022-12-27	WOS:000073395200062
J	Shilatifard, A				Shilatifard, A			Identification and purification of the Holo-ELL complex - Evidence for the presence of ELL-associated proteins that suppress the transcriptional inhibitory activity of ELL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CHROMOSOMAL TRANSLOCATIONS; MYELOID-LEUKEMIA; ELONGATION; GENE; T(11-19)(Q23-P13.1); CLONING	The human ELL gene on chromosome 19 undergoes frequent translocation with the trithorax-like MLL gene on chromosome 11 in acute myeloid leukemia. Recently, it was demonstrated that the product of the human ELL gene encodes an RNA polymerase II elongation factor (Shilatifard, A., Lane, TY. S., Jackson, It. W., Conaway, R. C., and Conaway, J. W. (1996) Science 271, 1873-1876), in addition to its elongation regulatory activity, ELL contains a novel type of RNA polymerase II interaction domain that is capable of negatively regulating polymerase activity in promoter-specific transcription in vitro (Shilatifard, A., Haque, D., Conaway, R. C., and Conaway, J. W. (1997) J. Biol. Chem. 272, 22355-22363). Here, we report the identification and purification of a large ELL-containing complex that contains three proteins in addition to ELL and that we have named the Holo-ELL complex. The Holo-ELL complex can increase the catalytic rate of transcription elongation by RNA polymerase II. However, unlike the ELL polypeptide alone, the Holo-ELL complex is not capable of negatively regulating polymerase activity in promoter-specific transcription in vitro. The inability of the Holo-ELL complex to negatively regulate polymerase activity in promoter-specific transcription suggests that one or more of the ELL-associated proteins regulate this activity, possibly through an interaction with the N-terminal domain of the ELL protein, which was shown to be required for the transcriptional inhibitory activity of ELL, Characterization of these ELL interacting proteins should help define the regulation of the biochemical activities of ELL and how loss of this regulation leads to the development of acute myeloid leukemia.	St Louis Univ, Sch Med, EA Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Shilatifard, A (corresponding author), St Louis Univ, Sch Med, EA Doisy Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.							Aso T, 1996, J CLIN INVEST, V97, P1561, DOI 10.1172/JCI118580; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MITANI K, 1995, BLOOD, V85, P2017, DOI 10.1182/blood.V85.8.2017.bloodjournal8582017; Prasad R, 1995, P NATL ACAD SCI USA, V92, P12160, DOI 10.1073/pnas.92.26.12160; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RICE GA, 1991, P NATL ACAD SCI USA, V88, P4245, DOI 10.1073/pnas.88.10.4245; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 1998, BIOL CHEM, V379, P27; Shilatifard A, 1997, J BIOL CHEM, V272, P22355, DOI 10.1074/jbc.272.35.22355; Stone Kathryn L., 1996, P427, DOI 10.1007/978-1-60327-259-9_72; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Williams Kenneth R., 1996, P541, DOI 10.1007/978-1-60327-259-9_91; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	17	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11212	11217		10.1074/jbc.273.18.11212	http://dx.doi.org/10.1074/jbc.273.18.11212			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556611	hybrid			2022-12-27	WOS:000073395200063
J	Tzagarakis-Foster, C; Privalsky, ML				Tzagarakis-Foster, C; Privalsky, ML			Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; ERB-A PROTEIN; V-ERBA; RESPONSE ELEMENT; ACID RECEPTORS; C-ERBA; MOLECULAR MECHANISMS; NUCLEAR RECEPTORS; TRANSCRIPTION; ALPHA	Thyroid hormone receptor (T3R) alpha-1 and its oncogenic derivative, the v-ERB A protein, are phosphorylated by cAMP-dependent protein kinase A. Although this phosphorylation appears to be necessary for the oncogenic properties of v-ERB A, the mechanism by which phosphorylation influences the functions of v-ERB A and of the normal T3R has not been established. The protein kinase A phosphorylation site in T3R alpha-1 is within a domain that is known to contribute to the DNA recognition properties of these receptors. We therefore analyzed the effects of protein kinase A phosphorylation on DNA recognition by the normal T3R alpha and by the v-ERB A oncoprotein. We report here that phosphorylation of these receptor derivatives does not significantly alter the overall affinity of receptor dimers for DNA. However, phosphorylation does notably alter DNA recognition by preventing, or greatly inhibiting, the ability of these receptors to bind to DNA as protein monomers. These studies suggest that the phosphorylation of T3R alpha-1 and v-ERB A by protein kinase A may provide a means of altering promoter recognition through a post-translational modification.	Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Div Biol Sci, Sect Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Privalsky, ML (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.	mlprivalsky@ucdavis.edu			NCI NIH HHS [R37-CA53394] Funding Source: Medline; NIGMS NIH HHS [T32 GM07377] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA053394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BHAT MK, 1994, P NATL ACAD SCI USA, V91, P7927, DOI 10.1073/pnas.91.17.7927; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; CHEN HW, 1993, MOL CELL BIOL, V13, P2366, DOI 10.1128/MCB.13.4.2366; CHEN HW, 1993, MOL CELL BIOL, V13, P5970, DOI 10.1128/MCB.13.10.5970; CHEN HW, 1995, P NATL ACAD SCI USA, V92, P442; CHIN WW, 1994, THYROID, V4, P389, DOI 10.1089/thy.1994.4.389; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; FORMAN B M, 1990, New Biologist, V2, P587; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; GLASS CK, 1990, BIOCHIM BIOPHYS ACTA, V1032, P157, DOI 10.1016/0304-419X(90)90002-I; GLINEUR C, 1990, GENE DEV, V4, P1663, DOI 10.1101/gad.4.10.1663; GLINEUR C, 1989, ONCOGENE, V4, P1247; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IKEDA M, 1994, ENDOCRINOLOGY, V135, P1628, DOI 10.1210/en.135.4.1628; JONES KE, 1994, ENDOCRINOLOGY, V134, P543, DOI 10.1210/en.134.2.543; Judelson C, 1996, J BIOL CHEM, V271, P10800, DOI 10.1074/jbc.271.18.10800; KATZ D, 1995, MOL CELL BIOL, V15, P2341; KATZ RW, 1994, J BIOL CHEM, V269, P18915; Katzenellenbogen JA, 1996, CHEM BIOL, V3, P529, DOI 10.1016/S1074-5521(96)90143-X; KUIPER GGJM, 1994, MOL CELL ENDOCRINOL, V100, P103, DOI 10.1016/0303-7207(94)90287-9; LAUDET V, 1995, CURR BIOL, V5, P124, DOI 10.1016/S0960-9822(95)00031-5; LAUDET V, 1992, Current Biology, V2, P293; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; LEE MS, 1993, SCIENCE, V260, P1117, DOI 10.1126/science.8388124; Leitman DC, 1996, J BIOL CHEM, V271, P21950, DOI 10.1074/jbc.271.36.21950; Lin BC, 1997, J BIOL CHEM, V272, P9860; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; ORTI E, 1992, ENDOCR REV, V13, P105, DOI 10.1210/er.13.1.105; PRIVALSKY ML, 1992, BIOCHIM BIOPHYS ACTA, V1114, P51, DOI 10.1016/0304-419X(92)90006-K; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; RIBEIRO RC, 1993, ANN NY ACAD SCI, V758, P366; SANDE S, 1993, J VIROL, V67, P1067, DOI 10.1128/JVI.67.2.1067-1074.1993; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHAWBE JW, 1993, CELL, V75, P567; SCHRADER M, 1994, J BIOL CHEM, V269, P6444; SCHROEDER C, 1992, ONCOGENE, V7, P217; SHARIF M, 1991, CELL, V63, P1277; SUGAWARA A, 1994, J BIOL CHEM, V269, P433; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; WAHLSTROM GM, 1992, MOL ENDOCRINOL, V6, P1013, DOI 10.1210/me.6.7.1013; Weigel NL, 1996, BIOCHEM J, V319, P657, DOI 10.1042/bj3190657; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; WONG CW, 1995, MOL ENDOCRINOL, V9, P551, DOI 10.1210/me.9.5.551; YANG YZ, 1995, ENDOCRINOLOGY, V136, P2896, DOI 10.1210/en.136.7.2896; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P	58	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10926	10932		10.1074/jbc.273.18.10926	http://dx.doi.org/10.1074/jbc.273.18.10926			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556570	hybrid			2022-12-27	WOS:000073395200022
J	Chen, ZG; Zhang, XL; Gonnella, NC; Pellas, TC; Boyar, WC; Ni, F				Chen, ZG; Zhang, XL; Gonnella, NC; Pellas, TC; Boyar, WC; Ni, F			Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MAGNETIC-RESONANCE DATA; NMR-SPECTROSCOPY; LIGAND-BINDING; IDENTIFICATION; NEUTROPHIL; EXPRESSION; ANALOGS; SUPPRESSION; ANTIBODIES	The functions of the C5a anaphylatoxin are expressed through its interaction with a cell-surface receptor with seven transmembrane helices. The interaction of C5a with the receptor has been explained by a two-site model whereby recognition and effector sites on C5a bind, respectively, to recognition and effector domains on the receptor, leading to receptor activation (Chenoweth, D. E., and Hugli, T. E. (1980) Mel. Immunol. 17, 151-161. In addition, the extracellular N-terminal region of the C5a receptor has been implicated as the recognition domain for C5a, responsible for similar to 50% of the binding energy of the C5a-receptor complex (Mery, L., and Boulay, F. (1994) J. Biol. Chem. 269, 3457-3463; DeMartino, J. A., Van Riper, G., Siciliano, S. J., Molineaux, C. J., Konteatis, Z. D., Rosen, H., and Springer, M. S. (1994) J. Biol. Chem. 269, 14446-14450). In this work, the interactions of C5a with the N-terminal domain of the C5a receptor were examined by use of recombinant human C5a molecules and peptide fragments M(1)NSFN(5)YTTPD(10)YGHYD(15)DKDTL(20)DLNTP(25)VDKTS(30)NTLR(hC5aRF-1-34), acetyl-HYD15DKDTL20DLNTP25VDKTS30NTLR (hC5aRF-13-34), and acetyl-TL20DLNTP25VDKTS30N-amide (hC5aRF-19-31) derived from human C5a receptor. Binding induced resonance perturbations in the NMR spectra of the receptor fragments and the C5a molecules indicated that the isolated N-terminal domain or residues 1-34 of the C5a receptor retain specific binding to C5a and to a C5a analog devoid of the agonistic C-terminal tail in the intact C5a. Residues of C5a perturbed by the binding of the receptor peptides are localized within the helical core of the C5a structure, in agreement with the results from functional studies employing mutated C5a and intact receptor molecules. All three receptor peptides, hC5aRF-1-34, hC5aRF-13-34, and hC5aRF-19-31, responded to the binding of C5a through the 21-30 region containing either hydrophobic, polar, or positively charged residues such as Thr(24),Pro(25), Val(26), Lys(28), Thr(29), and Ser(30). The 21-30 segment of all three receptor fragments was found to have a partially folded conformation in solution, independent of residues 1-18. These results indicate that a short peptide sequence, or residues 21-30, of the C5a receptor N terminus may constitute the binding domain for the recognition site on C5a.	Natl Res Council Canada, Biotechnol Res Inst, Biomol NMR Lab, Montreal, PQ H4P 2R2, Canada; Natl Res Council Canada, Biotechnol Res Inst, Montreal Joint Ctr Struct Biol, Montreal, PQ H4P 2R2, Canada; Nova Pharmaceut Corp, Summit, NJ 07901 USA	National Research Council Canada; National Research Council Canada; Novartis	Ni, F (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, Biomol NMR Lab, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.		Ni, Feng/AAN-6388-2020					BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; BOULAY F, 1991, BIOCHEMISTRY-US, V30, P2993, DOI 10.1021/bi00226a002; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BRAUNWALDER AF, 1992, MOL IMMUNOL, V29, P1319, DOI 10.1016/0161-5890(92)90168-W; BUBECK P, 1994, EUR J BIOCHEM, V219, P897, DOI 10.1111/j.1432-1033.1994.tb18571.x; CARNEY DF, 1993, PROTEIN SCI, V2, P1391, DOI 10.1002/pro.5560020904; CHENOWETH DE, 1978, P NATL ACAD SCI USA, V75, P3943, DOI 10.1073/pnas.75.8.3943; CHENOWETH DE, 1980, MOL IMMUNOL, V17, P151, DOI 10.1016/0161-5890(80)90067-X; DEMARTINO JA, 1995, J BIOL CHEM, V270, P15966, DOI 10.1074/jbc.270.27.15966; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; FULTON DB, 1995, 36 EXP NMR C MARC 26; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GOLDSTEIN IM, 1988, INFLAMMATION BASIC P, P55; GROTZINGER J, 1991, PROTEIN ENG, V4, P767, DOI 10.1093/protein/4.7.767; HUGLI T E, 1981, Critical Reviews in Immunology, V1, P321; HUGLI T E, 1986, Complement, V3, P111; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON RJ, 1985, J BIOL CHEM, V260, P339; KADKHODAEI M, 1993, J MAGN RESON SER A, V105, P104, DOI 10.1006/jmra.1993.1257; KAWAI M, 1991, J MED CHEM, V34, P2068, DOI 10.1021/jm00111a022; KAWAI M, 1990, Patent No. 09162; KOLAKOWSKI LF, 1995, J BIOL CHEM, V270, P18077, DOI 10.1074/jbc.270.30.18077; LIPPENS G, 1995, J BIOMOL NMR, V5, P327, DOI 10.1007/BF00211762; MERY L, 1994, J BIOL CHEM, V269, P3457; MERY L, 1993, EUR J HAEMATOL, V51, P282; MOLLISON KW, 1989, P NATL ACAD SCI USA, V86, P292, DOI 10.1073/pnas.86.1.292; MOLLISON KW, 1991, AGENT ACTION SUPPL, V35, P17; MORGAN EL, 1993, J IMMUNOL, V151, P377; MORGAN EL, 1992, J IMMUNOL, V148, P3937; NI F, 1992, J MAGN RESON, V99, P391, DOI 10.1016/0022-2364(92)90192-A; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; OPPERMANN M, 1993, J IMMUNOL, V151, P3785; PEASE JE, 1994, EUR J IMMUNOL, V24, P211, DOI 10.1002/eji.1830240133; PERRET JJ, 1992, BIOCHEM J, V288, P911, DOI 10.1042/bj2880911; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Raffetseder U, 1996, EUR J BIOCHEM, V235, P82, DOI 10.1111/j.1432-1033.1996.00082.x; SIEILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; TOTH MJ, 1994, PROTEIN SCI, V3, P1159, DOI 10.1002/pro.5560030802; VLATTAS I, 1994, J MED CHEM, V37, P2783, DOI 10.1021/jm00043a017; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; WILLIAMSON MP, 1990, BIOCHEMISTRY-US, V29, P2895, DOI 10.1021/bi00464a002; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P1; ZARBOCK J, 1988, FEBS LETT, V238, P289, DOI 10.1016/0014-5793(88)80499-X; Zhang XL, 1997, PROTEINS, V28, P261, DOI 10.1002/(SICI)1097-0134(199706)28:2<261::AID-PROT13>3.0.CO;2-G; Zhang XL, 1997, PROTEIN SCI, V6, P65; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P172, DOI 10.1021/bi00427a025	51	43	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10411	10419		10.1074/jbc.273.17.10411	http://dx.doi.org/10.1074/jbc.273.17.10411			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553099	hybrid			2022-12-27	WOS:000073224200048
J	Guo, YL; Kang, BB; Williamson, JR				Guo, YL; Kang, BB; Williamson, JR			Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; KINASE PHOSPHATASE-1; TERMINAL KINASE; JNK ACTIVATION; DEATH; PATHWAY; PROLIFERATION; SUPPRESSION; SPECIFICITY; INVITRO	Previously we showed that rat mesangial cells are normally resistant to tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis, They are made susceptible to the apoptotic effect of TNF-alpha when pretreated with actinomycin D, cycloheximide or vanadate, A sustained c-Jun N-terminal protein kinase (JNK) activation was closely correlated with the initiation of apoptosis under these conditions. We proposed that a TNF-alpha-inducible phosphatase was responsible for preventing a sustained activation of JNK and consequent apoptosis in these cells (Guo, Y,-L,, Baysal, K., Kang, B., Yang, L,-J., and Williamson, J. R. (1998) J. Biol. Chem. 273, 4027-4034), In the present study we provide further evidence to support this hypothesis. Ro318220, although originally identified as a specific inhibitor of protein kinase C, was subsequently found to be a strong inhibitor of MKP-1 expression, In rat mesangial cells, pretreatment of the cells with Ro318220 blocked expression of MKP-1 induced by TNF-alpha. This treatment also prolonged JNK activation and caused apoptosis, Taken together, our results support the currently controversial hypothesis that the JNK pathway is involved in TNF-alpha-induced apoptosis, In addition, we provide a mechanistic explanation for how mesangial cells in primary culture achieve resistance to TNF-alpha cytotoxicity. Specifically, induction of MKP-1 by TNF-alpha appears to be responsible for protection of the cells from apoptosis by preventing a prolonged activation of JNK.	Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Williamson, JR (corresponding author), Univ Penn, Dept Biochem & Biophys, Sch Med, 601 Goddard Labs,37th & Hamilton Walk, Philadelphia, PA 19104 USA.				NIDDK NIH HHS [DK-07314, DK-15120, DK-48493] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048493, R01DK015120] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baichwal V. R., 1997, CURR BIOL, V7, P94; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; BEYAERT R, 1994, FEBS LETT, V340, P9, DOI 10.1016/0014-5793(94)80163-0; Bokemeyer D, 1996, J BIOL CHEM, V271, P639, DOI 10.1074/jbc.271.2.639; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; KREISBERG JI, 1978, KIDNEY INT, V14, P21, DOI 10.1038/ki.1978.86; LEIST M, 1994, J IMMUNOL, V153, P1778; LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; SKEHAN P, 1995, CELL GROWTH APOPTOSI, P179; StClair EG, 1997, J BIOL CHEM, V272, P29347; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	31	76	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10362	10366		10.1074/jbc.273.17.10362	http://dx.doi.org/10.1074/jbc.273.17.10362			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553092	hybrid			2022-12-27	WOS:000073224200041
J	Roulston, A; Reinhard, C; Amiri, P; Williams, LT				Roulston, A; Reinhard, C; Amiri, P; Williams, LT			Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P55 TNF-RECEPTOR; PROTEIN-KINASE; KAPPA-B; SIGNAL-TRANSDUCTION; FAS ANTIGEN; CERAMIDE GENERATION; INDUCED APOPTOSIS; JNK ACTIVATION; DEATH; INHIBITION	Fas ligand and tumor necrosis factor alpha (TNF) bind to members of the TNF receptor superfamily. Stimulation by Fas ligand results in apoptosis, whereas TNF induces multiple effects including proliferation, differentiation, and apoptosis. Activation of the c-Jun N-terminal kinase (JNK) and p38 kinase pathways is common to Fas and TNF signaling; however, their role in apoptosis is controversial. Fas receptor cross-linking induces apoptosis in the absence of actinomycin D and activates JNK in a caspase-dependent manner. In contrast, TNF requires actinomycin D for apoptosis and activates JNK and p38 kinase with biphasic kinetics. The first phase is transient, precedes ap opto sis, and is caspase-independent, whereas the second phase is coincident with apoptosis and is caspase-dependent. Inhibition of early TNF-induced JNK and p38 kinases using MKK4/MKK6 mutants or the p38 inhibitor SB203580 increases TNF-induced apoptosis, whereas expression of wild type MKK4/MKK6 enhances survival. In contrast, the Mek inhibitor PD098059 has no effect on survival. These results demonstrate that early activation of p38 kinase (but not Mek) are necessary to protect cells from TNF-mediated cytotoxicity. Thus, early stress kinase activation initiated by TNF plays a key role in regulating apoptosis.	Chiron Corp, Chiron Technol, Emeryville, CA 94608 USA	Novartis	Roulston, A (corresponding author), Chiron Corp, Chiron Technol, 4560 Horton St,M-338, Emeryville, CA 94608 USA.							ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; BEYAERT R, 1994, FEBS LETT, V340, P9, DOI 10.1016/0014-5793(94)80163-0; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Cahill MA, 1996, ONCOGENE, V13, P2087; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; Danley DE, 1996, J IMMUNOL, V157, P500; Darnay BG, 1997, J LEUKOCYTE BIOL, V61, P559, DOI 10.1002/jlb.61.5.559; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; FUKANAGA R, 1997, EMBO J, V16, P1921; Gamen S, 1996, FEBS LETT, V390, P233, DOI 10.1016/0014-5793(96)00666-7; Goillot E, 1997, P NATL ACAD SCI USA, V94, P3302, DOI 10.1073/pnas.94.7.3302; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; ITOH N, 1993, J BIOL CHEM, V268, P10932; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; JUO P, 1997, MOL CELL BIOL, V17, P200; KIRSTEIN M, 1986, J BIOL CHEM, V261, P9565; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170, DOI 10.1128/MCB.17.1.170; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; NOPHAR Y, 1988, J IMMUNOL, V140, P3456; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; RUGGIERO V, 1987, J IMMUNOL, V138, P2711; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SCHULZEOSTHOFF K, 1994, EMBO J, V13, P4587, DOI 10.1002/j.1460-2075.1994.tb06780.x; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SONENBERG N, 1994, BIOCHIMIE, V76, P839, DOI 10.1016/0300-9084(94)90185-6; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; WALLACH D, 1984, J IMMUNOL, V132, P2464; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1994, J IMMUNOL, V152, P1751; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	74	353	359	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10232	10239		10.1074/jbc.273.17.10232	http://dx.doi.org/10.1074/jbc.273.17.10232			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553074	hybrid			2022-12-27	WOS:000073224200023
J	Stros, M				Stros, M			DNA bending by the chromosomal protein HMG1 and its high mobility group box domains - Effect of flanking sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; TRANSCRIPTIONAL ACTIVATION; NUCLEOPROTEIN STRUCTURES; CISPLATIN; COMPLEX; ELECTROPHORESIS; SPECIFICITY; CYCLIZATION; INTERACTS; SRY	HMG1 is an evolutionarily highly conserved chromosomal protein consisting of two folded DNA-binding domains, A and B ("high mobility group (HMG) boxes"), and an acidic C-terminal domain. Several lines of evidence suggest that previously reported sequence-independent DNA bending and looping by HMG1 and its HMG box domains might be important for the proposed role of the protein in transcription and recombination. We have used ligase-mediated circularization assays to investigate the contribution of the individual A and B EMG1 box domains and of the linker region between A/B- and B/C-domains, which flank the "minimal" B-domain (residues 92-162), to the ability of the HMG1 protein (residues 1-215) to bend DNA. Neither the minimal B-domain nor the minimal B-domain with a 7-residue N-terminal extension ((TKKKFKD91)-T-85) bent the DNA, The attachment of an extra 18-residue C-terminal additional extension (residues 163-180) to the minimal B-domain had only a small effect on the ability of the HMG box to bend DNA. On the other hand, circularization assay with a B-domain having both 7-residue N-terminal and 18-residue C-terminal flanking sequences (residues 85-180) revealed a strong bending of the DNA, suggesting that both extensions are a prerequisite for efficient DNA bending by the B-domain, We have also shown that a single lysine residue (Lys(90)) in a short N-terminal sequence (KD91)-K-90 attached to the B-domain is sufficient for strong distortion of DNA by bending, provided that the B-domain is flanked by the 18-residue C-terminaI flanking sequence. Although the DNA bending potential of HMG1 seems to be predominantly due to the B-domain flanked by basic sequences, covalent attachment of the A- and B-domains is necessary for efficient DNA flexure and the ability of the (A+B)-bidomain to bend DNA is further modulated in the native HMG1 protein by its acidic C-domain.	Acad Sci Czech Republ, Inst Biophys, CS-61265 Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Stros, M (corresponding author), Acad Sci Czech Republ, Inst Biophys, Kralovopolska 135, CS-61265 Brno, Czech Republic.							BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P1604, DOI 10.1093/nar/23.9.1604; BAZETTJONES DP, 1994, SCIENCE, V264, P1134, DOI 10.1126/science.8178172; BIANCHI ME, 1992, EMBO J, V11, P1055, DOI 10.1002/j.1460-2075.1992.tb05144.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; CARY PD, 1983, EUR J BIOCHEM, V131, P367, DOI 10.1111/j.1432-1033.1983.tb07272.x; CHOW CS, 1995, BIOCHEMISTRY-US, V34, P2956, DOI 10.1021/bi00009a027; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; FALCIOLA L, 1994, NUCLEIC ACIDS RES, V22, P285, DOI 10.1093/nar/22.3.285; FRIED MG, 1989, ELECTROPHORESIS, V10, P366, DOI 10.1002/elps.1150100515; GE H, 1994, J BIOL CHEM, V269, P17136; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; JONES DNM, 1994, STRUCTURE, V2, P609, DOI 10.1016/S0969-2126(00)00063-0; KAHN JD, 1992, P NATL ACAD SCI USA, V89, P6343, DOI 10.1073/pnas.89.14.6343; Kane SA, 1996, BIOCHEMISTRY-US, V35, P2180, DOI 10.1021/bi952240a; KOO HS, 1990, BIOCHEMISTRY-US, V29, P4227, DOI 10.1021/bi00469a027; LnenicekAllen M, 1996, NUCLEIC ACIDS RES, V24, P1047, DOI 10.1093/nar/24.6.1047; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; NER SS, 1994, TRENDS BIOCHEM SCI, V19, P185, DOI 10.1016/0968-0004(94)90017-5; ONATE SA, 1994, MOL CELL BIOL, V14, P3376, DOI 10.1128/MCB.14.5.3376; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Payet D, 1997, J MOL BIOL, V266, P66, DOI 10.1006/jmbi.1996.0782; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; Read C., 1995, NUCL ACIDS MOL BIOL, P222; READ CM, 1994, EMBO J, V13, P5639, DOI 10.1002/j.1460-2075.1994.tb06902.x; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; STROS M, 1987, EUR J BIOCHEM, V162, P111, DOI 10.1111/j.1432-1033.1987.tb10549.x; Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x; STROS M, 1994, FEBS LETT, V344, P201, DOI 10.1016/0014-5793(94)00364-5; STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044; STROS M, 1990, INT J BIOL MACROMOL, V12, P891; Suda T, 1996, NUCLEIC ACIDS RES, V24, P4733, DOI 10.1093/nar/24.23.4733; TEO SH, 1995, EUR J BIOCHEM, V230, P943, DOI 10.1111/j.1432-1033.1995.tb20640.x; Turchi JJ, 1996, BIOCHEMISTRY-US, V35, P2992, DOI 10.1021/bi951843j; WAGNER JP, 1995, J BIOL CHEM, V270, P7394, DOI 10.1074/jbc.270.13.7394; WATT F, 1988, NUCLEIC ACIDS RES, V16, P1471, DOI 10.1093/nar/16.4.1471; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P10713; WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P29261; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	47	102	104	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10355	10361						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553091				2022-12-27	WOS:000073224200040
J	Zhu, MH; Berry, JA; Russell, SM; Leonard, WJ				Zhu, MH; Berry, JA; Russell, SM; Leonard, WJ			Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3 - Jak1-independent functional recruitment of Jak3 to IL-2R beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CHAIN; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAINS; MOLECULAR-CLONING; TYROSINE KINASE; JANUS KINASE; ACTIVATION; CELLS; PHOSPHORYLATION; PROLIFERATION	Interleukin-2 (IL-2) induces heterodimerization of the IL-2 receptor beta (IL-2R beta) and gamma(c) chains of its receptor and activates the Janus family tyrosine kinases, Jak1 and Jak3, Whereas Jak1 associates with IL-2R beta, Jak3 associates primarily with gamma(c) but also with IL-2R beta. We analyzed four IL-2R beta mutations that diminish IL-2-induced proliferation and found that each also decreased IL-2-induced signal transducer and activator of transcription (STAT) activation. For this reason, and because the mutations were in the IL-2R beta membrane-proximal region, we investigated and found that each mutation diminished IL-2R beta association with both Jak1 and Jak3. This suggested that these Jaks might interact with the same region of IL-2R beta; however, certain IL-2R beta internal deletions and C-terminal truncations differentially affected the association of Jak1 and Jak3, Interestingly, just as Jak1-IL-2R beta association is Jak3-independent and functionally important, we show that Jak3-IL-2R beta association is Jak1-independent and implicate this association as being important for IL-2-induced Stat5 activation. Moreover, Jak1 and Jak3 could associate only in the presence of IL-2R beta, suggesting that these kinases can simultaneously bind to IL-2R beta, Thus, our data not only demonstrate that somewhat more distal as well as membrane-proximal cytoplasmic regions of a type I cytokine receptor are important for Jak kinase association but also suggest that two IL-2R beta-Jak kinase interactions are important for IL-2 signaling.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.		Russell, Sarah M/B-9341-2009; Leonard, Warren/AAA-1397-2022	Russell, Sarah M/0000-0001-5826-9641; 				Ascherman DP, 1997, J BIOL CHEM, V272, P8704, DOI 10.1074/jbc.272.13.8704; BOUSSIOTIS VA, 1994, SCIENCE, V266, P1039, DOI 10.1126/science.7973657; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DASILVA L, 1994, J BIOL CHEM, V269, P18267; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; GOLDSMITH MA, 1994, J BIOL CHEM, V269, P14698; GURNEY AL, 1995, P NATL ACAD SCI USA, V92, P5292, DOI 10.1073/pnas.92.12.5292; HAKIMI J, 1993, J IMMUNOL, V151, P1075; Higuchi M, 1996, EUR J IMMUNOL, V26, P1322, DOI 10.1002/eji.1830260622; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KAWAHARA A, 1994, MOL CELL BIOL, V14, P5433, DOI 10.1128/MCB.14.8.5433; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MORI H, 1991, INT IMMUNOL, V3, P149, DOI 10.1093/intimm/3.2.149; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OTANI H, 1992, P NATL ACAD SCI USA, V89, P2789, DOI 10.1073/pnas.89.7.2789; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SMITH KA, 1989, ANNU REV CELL BIOL, V5, P397; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L	36	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10719	10725		10.1074/jbc.273.17.10719	http://dx.doi.org/10.1074/jbc.273.17.10719			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553136	hybrid			2022-12-27	WOS:000073224200085
J	Habraken, Y; Sung, P; Prakash, L; Prakash, S				Habraken, Y; Sung, P; Prakash, L; Prakash, S			ATP-dependent assembly of a ternary complex consisting of a DNA mismatch and the yeast MSH2-MSH6 and MLH1-PMS1 protein complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR; HETERODIMER; MSH3; REQUIREMENT; CELLS; BINDS	MSH2 and MSH6 proteins exist as a stable complex, as do the MLH1 and PMS1 proteins. To study the mismatch binding properties of the MSH2-MSH6 complex and to examine its functional interaction with the MLH1-PMS1 complex, these protein complexes were purified to near homogeneity from overproducing yeast strains. As has been reported previously, the purified MSH2-MSH6 complex binds DNA substrates containing a GPT mismatch and insertion/deletion mismatches, but the binding affinity for the latter decreases as the size of the extrahelical loop increases. Addition of ATP or the nonhydrolyzable ATP gamma S reduces binding of the MSH2-MSH6 complex to the DNA substrates markedly. Here, we show that MSH2-MSH6 forms a ternary complex with MLH1-PMS1 on a mismatch containing DNA substrate, The formation of this ternary complex requires ATP, which can be substituted by ATP gamma S, suggesting that ATP binding alone is sufficient for ternary complex formation. Thus, it appears that ATP binding by the MSH2-MSH6 complex induces a conformation that is conducive for the interaction with MLH1-PMS1 complex, leading to the formation of the ternary complex.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA; Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health San Antonio	Prakash, S (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Med Res Bldg, Galveston, TX 77555 USA.		Prakash, Louise/C-7891-2012; Prakash, Satya/C-6420-2013	Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NATIONAL CANCER INSTITUTE [R01CA035035, R01CA041261, R37CA035035, R37CA041261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019261] Funding Source: NIH RePORTER; NCI NIH HHS [CA35035, CA41261] Funding Source: Medline; NIGMS NIH HHS [GM19261] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alani E, 1996, MOL CELL BIOL, V16, P5604; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; Iaccarino I, 1996, CURR BIOL, V6, P484, DOI 10.1016/S0960-9822(02)00516-X; Johnson RE, 1996, J BIOL CHEM, V271, P7285, DOI 10.1074/jbc.271.13.7285; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9	16	110	116	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9837	9841		10.1074/jbc.273.16.9837	http://dx.doi.org/10.1074/jbc.273.16.9837			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545323	hybrid			2022-12-27	WOS:000073128800069
J	Hirako, Y; Usukura, J; Uematsu, J; Hashimoto, T; Kitajima, Y; Owaribe, K				Hirako, Y; Usukura, J; Uematsu, J; Hashimoto, T; Kitajima, Y; Owaribe, K			Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENIGN EPIDERMOLYSIS-BULLOSA; ALPHA-6-BETA-4 INTEGRIN; BASEMENT-MEMBRANE; CELL-ADHESION; HEMIDESMOSOME FORMATION; PYLORIC ATRESIA; IDENTIFICATION; AUTOANTIBODIES; AUTOANTIGEN; DERMATOSIS	The hemidesmosome (HD) is a cell-to-substrate adhesion apparatus found in stratified and complex epithelia. One of the putative cell-matrix adhesion molecules present in the HD is the 18O-kDa bullous pemphigoid antigen (BP180), also termed type XVII collagen. In our previous study, using a monoclonal antibody (mAb) 1337, we have detected a 120-kDa collagenase-sensitive polypeptide in the HD fraction (Uematsu, J. and Owaribe, H. (1993) Cell Struct. Funct. 18, 588 (abstr.)). The present study was undertaken to assess the relation of the 120-kDa polypeptide to this BP180. Immunofluorescence microscopy of bovine skin revealed the basement membrane zone of skin to be stained clearly with mAb 1337, whereas the lateral surfaces of basal cells, which were decorated by typical antibodies against BP180, were not. The antibody did not detect HDs in cultured cells but rather in the culture medium. These results indicate a localization of mAb 1337 antigen distinct from BP180. However, the same polypeptide was also recognized by monoclonal antibodies to the extracellular but not the cytoplasmic part of BP180, and found to react with a polyclonal antibody against the non-collagenous 16A domain of BP180. Therefore, the polypeptide was identified as an extracellular fragment of BP180. mAb 1337 immunoprecipitated the 120-kDa fragment from the medium, but not the 180-kDa molecule of BP180 extracted from cultured cells, indicating that the antibody specifically recognizes the fragment. The mAb 1337 apparently recognizes a unique epitope that is exposed or formed by the cleavage. Hence, the staining pattern observed for bovine skin demonstrated the presence of the 120-kDa extracellular fragment. Rotary shadow electron microscopy of affinity-purified 120-kDa fragments demonstrated that they have the unique molecular shape consisting of a central rod and a flexible tail, without the globular head that is present in the BP180 molecule. From these results, we conclude that mAb 1337 shows unique epitope specificity, recognizing only the 120-kDa extracellular fragment of BP180, which is constitutively cleaved on the cell surface as a 120-kDa fragment both in in vivo and in vitro.	Nagoya Univ, Grad Sch Human Informat, Unit Biosyst, Chikusa Ku, Nagoya, Aichi 46401, Japan; Nagoya Univ, Sch Sci, Dept Biol Mol, Nagoya, Aichi 46401, Japan; Suzuka Univ Med Sci & Technol, Suzuka 51002, Japan; Kurume Univ, Sch Med, Dept Dermatol, Fukuoka 830, Japan; Gifu Univ, Sch Med, Dept Dermatol, Gifu 500, Japan; Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; Nagoya Univ, Sch Med, Dept Anat, Nagoya, Aichi 46401, Japan	Nagoya University; Nagoya University; Kurume University; Gifu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University	Hirako, Y (corresponding author), Nagoya Univ, Grad Sch Human Informat, Unit Biosyst, Chikusa Ku, Nagoya, Aichi 46401, Japan.			Usukura, Jiro/0000-0003-2286-5403				Balding SD, 1996, J INVEST DERMATOL, V106, P141, DOI 10.1111/1523-1747.ep12329728; Borradori L, 1997, J CELL BIOL, V136, P1333, DOI 10.1083/jcb.136.6.1333; Borradori L, 1996, CURR OPIN CELL BIOL, V8, P647, DOI 10.1016/S0955-0674(96)80106-2; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Dmochowski Marian, 1993, Journal of Dermatological Science, V6, P194; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; Hirako Y, 1996, J BIOL CHEM, V271, P13739, DOI 10.1074/jbc.271.23.13739; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; HOPKINSON SB, 1995, J CELL BIOL, V130, P117, DOI 10.1083/jcb.130.1.117; Ishiko A, 1996, J INVEST DERMATOL, V106, P739, DOI 10.1111/1523-1747.ep12345793; JONES JCR, 1994, EXP CELL RES, V213, P1, DOI 10.1006/excr.1994.1166; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; JONKMAN MF, 1995, J CLIN INVEST, V95, P1345, DOI 10.1172/JCI117785; KITAJIMA Y, 1988, CANCER RES, V48, P964; KITAJIMA Y, 1992, EXP CELL RES, V203, P17, DOI 10.1016/0014-4827(92)90034-6; Kitajima Y, 1995, EPITHELIAL CELL BIOL, V4, P70; KURPAKUS MA, 1991, J CELL BIOL, V115, P1737, DOI 10.1083/jcb.115.6.1737; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; LI KH, 1993, J BIOL CHEM, V268, P8825; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; Marinkovich MP, 1996, J INVEST DERMATOL, V106, P734, DOI 10.1111/1523-1747.ep12345782; Masunaga T, 1997, J INVEST DERMATOL, V109, P200, DOI 10.1111/1523-1747.ep12319337; Matsumura K, 1996, ARCH DERMATOL RES, V288, P507, DOI 10.1007/s004030050093; McGrath JA, 1996, J INVEST DERMATOL, V106, P771, DOI 10.1111/1523-1747.ep12345821; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; Niessen CM, 1996, J CELL SCI, V109, P1695; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; OWARIBE K, 1991, EXP CELL RES, V192, P622, DOI 10.1016/0014-4827(91)90084-8; Pas HH, 1997, J INVEST DERMATOL, V108, P423, DOI 10.1111/1523-1747.ep12289703; SCHMID E, 1983, J CELL BIOL, V96, P37, DOI 10.1083/jcb.96.1.37; Schumann H, 1997, AM J HUM GENET, V60, P1344, DOI 10.1086/515463; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; SPINARDI L, 1995, J CELL BIOL, V129, P473, DOI 10.1083/jcb.129.2.473; STANLEY JR, 1993, ADV IMMUNOL, V53, P291, DOI 10.1016/S0065-2776(08)60503-9; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; Uematsu Jun, 1993, Cell Structure and Function, V18, P588; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; ZONE JJ, 1990, J CLIN INVEST, V85, P812, DOI 10.1172/JCI114508	48	109	111	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9711	9717		10.1074/jbc.273.16.9711	http://dx.doi.org/10.1074/jbc.273.16.9711			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545306	hybrid			2022-12-27	WOS:000073128800052
J	Pan, JL; Xia, LJ; Yao, LB; McEver, RP				Pan, JL; Xia, LJ; Yao, LB; McEver, RP			Tumor necrosis factor-alpha- or lipopolysaccharide-induced expression of the murine P-selectin gene in endothelial cells involves novel kappa B sites and a variant activating transcription factor cAMP response element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; SIGNAL-TRANSDUCTION PATHWAY; CYTOKINE-INDUCED EXPRESSION; INFLAMMATORY CYTOKINES; MESSENGER-RNA; C-JUN; PROMOTER; PROTEIN; BINDING; MICE	Tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) increases expression of the P-selectin gene in murine, but not in human, endothelial cells. These mediators augment expression of a reporter gene driven by the murine, but not the human, P-selectin promoter in transfected endothelial cells. The regions from -593 to -474 and from -229 to -13 in the murine P-selectin promoter are required for TNF-alpha or LPS to stimulate reporter gene expression. Within these regions, we identified two tandem kappa B elements, a reverse-oriented kappa B site and a variant activating transcription factor/cAMP response element (ATF/CRE), that participate in TNF-alpha LPS-induced expression. The tandem kappa B elements bound to NF-kappa B heterodimers and p65 homodimers, the reverse-oriented kappa B site bound to p65 homodimers, and the variant ATF/CRE bound to nuclear proteins that included activating transcription factor-2. Mutations in each individual element eliminated binding to nuclear proteins and decreased by 20-60% the TNF-alpha-or LPS-induced expression of a reporter gene driven by the murine P-selectin promoter in transfected endothelial cells. Simultaneous mutations of all elements further decreased, but did not abolish, induced expression. Co-overexpression of p50 and p65 enhanced murine P-selectin promoter activity in a kappa KB site-dependent manner. These data indicate that the kappa B sites and the variant ATF/CRE are required for TNF-alpha or LPS to optimally induce expression of the murine P-selectin gene. The presence of these elements in the murine, but not the human, P-selectin gene may explain in part why TNF-alpha or LPS stimulates transcription of P-selectin in a species-specific manner.	Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Dept Med, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	McEver, RP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Dept Med, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@ouhsc.edu						ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BECKERANDRE M, 1992, EUR J BIOCHEM, V206, P401, DOI 10.1111/j.1432-1033.1992.tb16940.x; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; Bennett BL, 1997, J BIOL CHEM, V272, P10212; BRASIER AR, 1992, METHOD ENZYMOL, V216, P386; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2523; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; BURNS SA, 1995, J THORAC CARDIOV SUR, V110, P924, DOI 10.1016/S0022-5223(05)80159-X; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; COLLINS T, 1993, LAB INVEST, V68, P499; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; DISDIER M, 1992, MOL BIOL CELL, V3, P309, DOI 10.1091/mbc.3.3.309; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GOROSPE M, 1993, J BIOL CHEM, V268, P6214; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HAHNE M, 1993, J CELL BIOL, V121, P655, DOI 10.1083/jcb.121.3.655; HARPOLD MM, 1979, CELL, V17, P1025, DOI 10.1016/0092-8674(79)90341-6; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; MACKMAN N, 1990, P NATL ACAD SCI USA, V87, P2254, DOI 10.1073/pnas.87.6.2254; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McEver RP, 1997, GLYCOCONJUGATE J, V14, P585, DOI 10.1023/A:1018584425879; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PAN JL, 1993, J BIOL CHEM, V268, P22600; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; PARRY GCN, 1994, J BIOL CHEM, V269, P20823; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; SANDERS WE, 1992, BLOOD, V80, P795; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SHARAR SR, 1995, SPRINGER SEMIN IMMUN, V16, P359; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SILBER A, 1994, LAB INVEST, V70, P163; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; TAKEUCHI M, 1995, P NATL ACAD SCI USA, V92, P3561, DOI 10.1073/pnas.92.8.3561; THORNHILL MH, 1990, J IMMUNOL, V145, P865; WATSON ML, 1990, J EXP MED, V172, P263, DOI 10.1084/jem.172.1.263; WELLER A, 1992, J BIOL CHEM, V267, P15176; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81	69	58	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10068	10077		10.1074/jbc.273.16.10068	http://dx.doi.org/10.1074/jbc.273.16.10068			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545354	hybrid			2022-12-27	WOS:000073128800100
J	Sastry, S; Ross, BM				Sastry, S; Ross, BM			Mechanisms for the processing of a frozen topoisomerase-DNA conjugate by human cell-free extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC INTERACTION; CROSS-LINKS; PROTEIN CROSSLINKS; DUPLEX DNA; PSORALEN; REPAIR; TRANSCRIPTION; MONOADDUCTS; CLEAVAGE; BINDING	The metabolic fate of covalently linked DNA-protein complexes (cross-links) is not clearly understood. Our aim was to investigate the processing of protein-DNA cross-links by cellular enzymes. As an example of a DNA-protein cross-link, we have constructed frozen topoisomerase-DNA conjugates and investigated their processing by human cell-free extracts. A suicide DNA substrate was constructed that upon reaction with vaccinia type I topoisomerase yielded a highly stable covalent DNA-protein cross-link. When this conjugate was treated with human nuclear or whole cell extracts, two sites of DNA breakpoints were detected: one set of double-stranded breaks occurred close to the 3' side of the topoisomerase (topo) conjugation site, and there was another set of nicks about 30 nucleotides 3' to the topo site. The double-stranded breaks were not made by extracts from xeroderma pigmentosum group A mutant cells, suggesting that the xeroderma pigmentosum group A damage recognition protein may be required for the occurrence of DNA breakage. In addition to these DNA breakage reactions, there was an activity that resulted in the delinking of the frozen topoisomerase (or proteolytic fragments thereof) from the DNA substrate, which was followed by a ligation step that restored the continuity of the broken DNA strand at the erstwhile topo attachment site. We suggest that frozen topoisomerase-DNA conjugates (and perhaps other types of covalent DNA-protein complexes) are processed by multiple pathways that may involve the cleavage of the DNA in the covalent protein-DNA complex and/or enzymatic delinking followed by ligation of the broken DNA ends. These processes may represent the "repair" of DNA-protein cross-links.	Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA	Rockefeller University	Sastry, S (corresponding author), Rockefeller Univ, Mol Genet Lab, Box 174,1230 York Ave, New York, NY 10021 USA.	sastrys@rockvax.rockefeller.edu						BERNSTEIN C, 1991, AGING SEX DNA REPAIR, P19; CARERI G, 1975, Critical Reviews in Biochemistry, V3, P141, DOI 10.3109/10409237509102555; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; CHIU SM, 1989, RADIAT RES, V120, P545, DOI 10.2307/3577804; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GANTT R, 1987, MUTAT RES, V183, P75, DOI 10.1016/0167-8817(87)90048-4; Kane SA, 1996, BIOCHEMISTRY-US, V35, P2180, DOI 10.1021/bi952240a; KORNBERG A, 1992, DNA REPLICATION, P353; MANIATIS T, 1982, MOL CLONING LABORATO, P107; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; Maxam A M, 1980, Methods Enzymol, V65, P499; Petersen BO, 1997, NUCLEIC ACIDS RES, V25, P2091, DOI 10.1093/nar/25.11.2091; REARDON JT, 1991, NUCLEIC ACIDS RES, V19, P4623, DOI 10.1093/nar/19.17.4623; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; Ruzsicska BP, 1995, CRC HDB ORGANIC PHOT, P1289; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sastry SS, 1997, PHOTOCHEM PHOTOBIOL, V65, P937, DOI 10.1111/j.1751-1097.1997.tb07951.x; Sastry SS, 1997, J BIOL CHEM, V272, P3715, DOI 10.1074/jbc.272.6.3715; SASTRY SS, 1993, BIOCHEMISTRY-US, V32, P5526, DOI 10.1021/bi00072a006; Sastry SS, 1996, BIOCHEMISTRY-US, V35, P13519, DOI 10.1021/bi960982d; SHAW AA, 1992, BIOCHEMISTRY-US, V31, P10976, DOI 10.1021/bi00160a006; Shetlar M.D., 1980, PHOTOCHEMICAL AND PHOTOBIOLOGICAL REVIEWS, V5, P105; SHETLAR MD, 1984, PHOTOCHEM PHOTOBIOL, V39, P125, DOI 10.1111/j.1751-1097.1984.tb03417.x; SHUMAN S, 1991, J BIOL CHEM, V266, P11372; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; SHUMAN S, 1990, J BIOL CHEM, V265, P17826; SHUMAN S, 1993, J BIOL CHEM, V268, P18943; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P9793, DOI 10.1073/pnas.86.24.9793; VIDOCZY T, 1992, J PHOTOCH PHOTOBIO B, V14, P139, DOI 10.1016/1011-1344(92)85088-C; Wong SS., 1991, CHEM PROTEIN CONJUGA, P7; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	33	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9942	9950		10.1074/jbc.273.16.9942	http://dx.doi.org/10.1074/jbc.273.16.9942			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545338	hybrid			2022-12-27	WOS:000073128800084
J	Wang, HY; Zamorano, J; Keegan, AD				Wang, HY; Zamorano, J; Keegan, AD			A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 8 pathways - Analysis by mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC-CELLS; PTB DOMAIN; PROTEIN; IRS-1; JAK1; DISTINCT; STAT6; SUPERFAMILY; MITOGENESIS; KINASE	The interleukin (IL)-4 receptor alpha-chain (IL-4R alpha) contains a sequence motif ((488)PLVIAGNPAYRSFSD) termed the insulin IL-4 receptor motif (I4R motif). Mutation of the central Tyr(497) to Phe blocks the tyrosine phosphorylation of the insulin receptor substrate 1 (IRS1) and diminishes proliferation in response to IL-4. Recent data suggest that the I4R motif encodes binding sites for several protein tyrosine binding (PTB) domain-containing proteins such as IRS1 and Shc and potentially for the Src homology 2 domain of signal transducer and activator of transcription 6 (STAT6). To analyze the function of the I4R motif in regulating IL-4 signaling, we changed conserved residues upstream and downstream of the central Tyr to Ala in the human IL-4R alpha. We analyzed the ability of these constructs to signal the tyrosine phosphorylation of IRS2 and STAT6, the induction of DNA binding activity, and CD23 induction in response to human IL-4 (huIL-4) in transfected M12.4.1 cells. Mutagenesis of residues downstream of Tyr(497), such as Arg(498) or Phe(500), to Ala had no effect on any of these responses, suggesting that the I4R motif may not be important for functional Src homology 2 domain interactions. However, mutagenesis of Pro(488) to Ala (P488A) greatly diminished the tyrosine phosphorylation of IRS2 and abolished tyrosine phosphorylation of STAT6, induction of DNA binding activity, and CD23 induction in response to huIL-4. By contrast, a P488G mutant signaled these responses to huIL-4. Mutagenesis of hydrophobic amino acids previously shown to contact the PTB domain of IRS1, Leu(489) or Ile(491), to Ala had only minimal effects on responses to huIL-4. However, changing both Leu(498) and Ile(491) to Ala greatly diminished the tyrosine phosphorylation of IRS2 and abolished STAT6 activation. Taken together, these results indicate the important role of the I4R motif in regulating IRS docking and suggest that I4R docking to a PTB domain-containing protein regulates activation of the STAT6 pathway.	Amer Red Cross, Jerome Holland Labs, Dept Immunol, Rockville, MD 20855 USA	American Red Cross	Keegan, AD (corresponding author), Amer Red Cross, Jerome Holland Labs, Dept Immunol, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.	keegana@hlsun.redcross.org	Zamorano, Jose/Q-2514-2017	Zamorano, Jose/0000-0002-4271-3741	NIAID NIH HHS [AI38985] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038985, R01AI038985] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Borg JP, 1996, MOL CELL BIOL, V16, P6229; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; Chen XH, 1997, J BIOL CHEM, V272, P6556, DOI 10.1074/jbc.272.10.6556; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KEEGAN AD, 1991, J IMMUNOL, V146, P2272; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Keegan AD, 1996, IMMUNOLOGIST, V4, P194; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Leonard WJ, 1996, ANNU REV MED, V47, P229; MALABARBA MG, 1995, J BIOL CHEM, V270, P9630, DOI 10.1074/jbc.270.16.9630; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; NELMS K, 1995, 9 INT C IMM SAN FRAN; PAUL WE, 1991, BLOOD, V77, P1859; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PERNIS A, 1995, P NATL ACAD SCI USA, V92, P7971, DOI 10.1073/pnas.92.17.7971; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; RYAN J, 1995, 9 INT C IMM SAN FRAN; Ryan JJ, 1996, IMMUNITY, V4, P123, DOI 10.1016/S1074-7613(00)80677-9; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Wang HY, 1997, J IMMUNOL, V158, P1037; Wang HY, 1996, IMMUNITY, V4, P113, DOI 10.1016/S1074-7613(00)80676-7; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; WHITE MF, 1994, J BIOL CHEM, V269, P1; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; YIN TG, 1994, J BIOL CHEM, V269, P26614; Zamorano J, 1996, J IMMUNOL, V157, P4926; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	42	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9898	9905		10.1074/jbc.273.16.9898	http://dx.doi.org/10.1074/jbc.273.16.9898			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545332	hybrid			2022-12-27	WOS:000073128800078
J	Becker, A; Schlichting, I; Kabsch, W; Schultz, S; Wagner, AFV				Becker, A; Schlichting, I; Kabsch, W; Schultz, S; Wagner, AFV			Communication - Structure of peptide deformylase and identification of the substrate binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DIFFRACTION DATA; FORMYLTRANSFERASE; RESOLUTION; PROTEINS	Peptide deformylase is an essential metalloenzyme required for the removal of the formyl group at the N terminus of nascent polypeptide chains in eubacteria, The Escherichia coli enzyme uses Fe2+ and nearly retains its activity on substitution of the metal ion by Ni2+. We have solved the structure of the Ni2+ enzyme at 1.9-Angstrom resolution by x-ray crystallography. Each of the three monomers in the asymmetric unit contains one Ni2+ ion and, in close proximity, one molecule of polyethylene glycol. Polyethylene glycol is shown to be a competitive inhibitor with a K-I, value of 6 mM with respect to formyl-methionine under conditions similar to those used for crystallization. We have also solved the structure of the inhibitor-free enzyme at 2.5-Angstrom resolution. The two structures are identical within the estimated errors of the models. The hydrogen bond network stabilizing the active site involves nearly all conserved amino acid residues and well defined water molecules, one of which ligates to the tetrahedrally coordinated Ni2+ ion.	Max Planck Inst Med Forsch, Biophys Abt, D-69120 Heidelberg, Germany; Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44139 Dortmund, Germany; Ruprecht Karls Univ, Biochem Zentrum Heidelburg, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society; Ruprecht Karls University Heidelberg	Kabsch, W (corresponding author), Max Planck Inst Med Forsch, Biophys Abt, Jahnstr 29, D-69120 Heidelberg, Germany.		Schlichting, Ilme/I-1339-2013					ADAMS JM, 1968, J MOL BIOL, V33, P571, DOI 10.1016/0022-2836(68)90307-0; BALL LA, 1973, J MOL BIOL, V79, P531, DOI 10.1016/0022-2836(73)90404-X; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; Chan MK, 1997, BIOCHEMISTRY-US, V36, P13904, DOI 10.1021/bi9711543; Fields R, 1972, Methods Enzymol, V25, P464, DOI 10.1016/S0076-6879(72)25042-X; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; GOOLEY PR, 1994, NAT STRUCT BIOL, V1, P111, DOI 10.1038/nsb0294-111; GROCHE D, 1995, THESIS U HEIDELBERG; GUILLON JM, 1992, J BACTERIOL, V174, P4294, DOI 10.1128/JB.174.13.4294-4301.1992; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOZAK M, 1983, MICROBIOL REV, V47, P1; LIVINGSTON DM, 1969, BIOCHEMISTRY-US, V8, P435, DOI 10.1021/bi00829a059; MAZEL D, 1994, EMBO J, V13, P914, DOI 10.1002/j.1460-2075.1994.tb06335.x; Meinnel T, 1996, J MOL BIOL, V262, P375, DOI 10.1006/jmbi.1996.0521; Meinnel T, 1997, J MOL BIOL, V267, P749, DOI 10.1006/jmbi.1997.0904; MEINNEL T, 1993, J BACTERIOL, V175, P7737, DOI 10.1128/JB.175.23.7737-7740.1993; Rajagopalan PTR, 1997, BIOCHEMISTRY-US, V36, P13910, DOI 10.1021/bi971155v; Rajagopalan PTR, 1997, J AM CHEM SOC, V119, P12418, DOI 10.1021/ja9734096; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001	24	93	102	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11413	11416		10.1074/jbc.273.19.11413	http://dx.doi.org/10.1074/jbc.273.19.11413			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565550	hybrid, Green Published			2022-12-27	WOS:000073536700004
J	Sorci-Thomas, MG; Curtiss, L; Parks, JS; Thomas, MJ; Kearns, M; Landrum, M				Sorci-Thomas, MG; Curtiss, L; Parks, JS; Thomas, MJ; Kearns, M; Landrum, M			The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin : cholesterol acyltransferase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN PARTICLES; MONOCLONAL-ANTIBODIES; LIPID-BINDING; LOCALIZATION; TRANSPORT; EPITOPES; MOTIF; SIZE	Apolipoprotein A-I (apoA-I) activates the plasma enzyme lecithin:cholesterol acyltransferase (LCAT), catalyzing the rapid conversion of lipoprotein cholesterol to cholesterol ester, Structural mutants of apoA-I have been used to study the details of apoA-I-LCAT-catalyzed cholesterol ester formation. Several studies have shown that the alpha-helical segments corresponding to amino acids 143-164 and 165-186 (repeats 6 and 7) are essential for LCAT activation. In the present studies, we examined how the orientation of the hydrophobic face, independent of an increase in overall hydrophobicity, affects LCAT activation. we designed, expressed, and characterized a mutant, reverse of 6 apoA-I (RO6 apoA-I), in which the primary amino acid sequence of repeat 6 (amino acids 143-164) was reversed from its normal orientation. This mutation rotates the hydrophobic face of repeat 6 approximately 80 degrees, Lipid-free RO6 apoA-I showed a marked stabilization when denatured by guanidine hydrochloride, but showed significant destabilization to guanidine hydrochloride denaturation in the Lipid-bound state compared with wild-type apoA-I, Recombinant high density lipoprotein discs (rHDL) formed from RO6 apoA-I, sn-1-palmitoyl-sn-2-oleoyl phosphatidylcholine, and cholesterol were approximately 12 Angstrom smaller than wild-type apoA-I rHDL, The reduced size suggests that one of the repeats did not effectively participate in phospholipid binding and organization. The sn-1-palmitoyl-sn-2-oleoyl phosphatidylcholine RO6 rHDL were a less effective substrate for LCAT, Mapping the entire lipid-free and Lipid-bound RO6 apoA-I with a series of monoclonal antibodies revealed that both the lipid-free and lipid-bound RO6 apoA-I displayed altered or absent epitopes in domains within and adjacent to repeat 6, Together, these results suggest that the proper alignment and orientation of the hydrophobic face of repeat 6 is an important determinant for maintaining and stabilizing helix-bilayer and helix-helix interactions.	Wake Forest Univ, Sch Med, Dept Pathol & Comparat Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA	Wake Forest University; Wake Forest University; Scripps Research Institute; Scripps Research Institute	Sorci-Thomas, MG (corresponding author), Wake Forest Univ, Sch Med, Dept Pathol & Comparat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	msthomas@wfubmc.edu		Sorci-Thomas, Mary/0000-0002-6464-5006	NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, R01HL043815] Funding Source: NIH RePORTER; NCI NIH HHS [CA12197] Funding Source: Medline; NHLBI NIH HHS [HL-43815, HL-49373] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANANTHARAMAIAH GM, 1990, ARTERIOSCLEROSIS, V10, P95, DOI 10.1161/01.ATV.10.1.95; BANKA CL, 1991, J BIOL CHEM, V266, P23886; BONELLI FS, 1989, J BIOL CHEM, V264, P14723; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8; Buchko GW, 1996, J BIOL CHEM, V271, P3039, DOI 10.1074/jbc.271.6.3039; CHEN GC, 1984, BIOCHEMISTRY-US, V23, P6530, DOI 10.1021/bi00321a039; CURTISS LK, 1988, J BIOL CHEM, V263, P13779; Curtiss LK, 1996, J LIPID RES, V37, P884; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Dhoest A, 1997, J BIOL CHEM, V272, P15967, DOI 10.1074/jbc.272.25.15967; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIELDING CJ, 1985, METHOD ENZYMOL, V111, P267; GLOMSET JA, 1973, ADV LIPID RES, V1, P1; HOLVOET P, 1995, BIOCHEMISTRY-US, V34, P13334, DOI 10.1021/bi00041a009; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; JONAS A, 1993, J BIOL CHEM, V268, P1596; JONAS A, 1989, J BIOL CHEM, V264, P4818; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; LEROY A, 1993, J BIOL CHEM, V268, P4798; LI WH, 1988, J LIPID RES, V29, P245; LINS L, 1995, BBA-LIPID LIPID MET, V1258, P10, DOI 10.1016/0005-2760(95)00080-V; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANIATIS T, 1982, MOL CLONING LABORATO, P187; MENG QH, 1993, J BIOL CHEM, V268, P16966; MINNICH A, 1992, J BIOL CHEM, V267, P16553; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; PARKS JS, 1992, J LIPID RES, V33, P879; PONSIN G, 1986, J BIOL CHEM, V261, P9202; RIANWATER DL, 1996, J LIPID RES, V33, P1876; Rogers DP, 1997, BIOCHEMISTRY-US, V36, P288, DOI 10.1021/bi961876e; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; SorciThomas MG, 1996, J LIPID RES, V37, P673; SorciThomas MG, 1997, J BIOL CHEM, V272, P7278, DOI 10.1074/jbc.272.11.7278; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SWANEY JB, 1986, METHOD ENZYMOL, V128, P613; Uboldi P, 1996, J LIPID RES, V37, P2557; VERDERY RB, 1989, J LIPID RES, V30, P1085; WALD JH, 1990, J BIOL CHEM, V265, P20037; WANG C, 1996, BIOCHIM BIOPHYS ACTA, V1301, P174; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194	45	68	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11776	11782		10.1074/jbc.273.19.11776	http://dx.doi.org/10.1074/jbc.273.19.11776			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565601	hybrid			2022-12-27	WOS:000073536700055
J	Di Noia, JM; D'Orso, I; Aslund, L; Sanchez, DO; Frasch, ACC				Di Noia, JM; D'Orso, I; Aslund, L; Sanchez, DO; Frasch, ACC			The Trypanosoma cruzi mucin family is transcribed from hundreds of genes having hypervariable regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; TRANS-SIALIDASE; MAMMALIAN-CELLS; ANTIGENIC VARIATION; PROTEINS; GLYCOPROTEINS; 35-KILODALTON; ERYTHROCYTES; EXPRESSION; MECHANISMS	In previous works we have identified genes in the protozoan parasite Trypanosoma cruzi whose structure resemble those of mammalian mucin genes. Indirect evidence suggested that these genes might encode the core protein of parasite mucins, glycoproteins that were proposed to be involved in the interaction with, and invasion of, mammalian host cells. We now show that the mucin gene family from T. cruzi is much larger and diverse than expected. A minimal number of 484 mucin genes per haploid genome is calculated for a parasite clone. Most, if not all, genes are transcribed, as deduced from cDNA analysis. Comparison of the cDNA sequences showed evidences of a high mutation rate in localized regions of the genes. Sequence conservation among members of the family is much higher in the untranslated (UTR) regions than in the sequences encoding the mature mucin core protein. Transcription units can be classified into two main subfamilies according to the sequence homologies in the 5'-UTR, whereas the 3'-UTR is highly conserved in all clones analyzed. The common origin of members of this gene family as well as their relationships can be defined by sequence comparison of different domains in the transcription units. The regions encoding the N and C termini, supposed to correspond to the leader peptide and membrane-anchoring signal, respectively, (Di Noia, J. M., Sanchez, D. O., and Frasch, A. C. C. (1995) J. Biol. Chem. 270, 24146-24149) are highly conserved. Conversely, the central regions are highly variable. These regions encode the target sites for O-glycosylation and are made of a variable number of repetitive units rich in Thr and Pro residues or are nonrepetitive but still rich in Thr/Ser and Pro residues. The region putatively coding for the N-terminal domain of the mature core protein is hypervariable, being different in most of the transcripts sequenced. Nonrepetitive central domains are unique to each gene. Gene-specific probes show that the relative abundance of different mRNAs varies greatly within the same parasite clone.	Univ Nacl Gen San Martin, Inst Invest Biotecnol, RA-1650 San Martin, Buenos Aires, Argentina; Univ Uppsala, Ctr Biomed, Dept Med Genet, S-75123 Uppsala, Sweden	Uppsala University	Frasch, ACC (corresponding author), Univ Nacl Gen San Martin, Inst Invest Biotecnol, Av Gral Paz S-N,Edificio 24,Casilla de Correo 30, RA-1650 San Martin, Buenos Aires, Argentina.	cfrasch@inti.gov.ar	Di Noia, Javier Marcelo/D-2285-2012	Di Noia, Javier Marcelo/0000-0003-2896-0321; sanchez, daniel/0000-0002-5427-7764; Frasch, Alberto Carlos/0000-0001-7532-653X				ALMEIDA IC, 1994, BIOCHEM J, V304, P493; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BERBEROF M, 1995, EMBO J, V14, P2925, DOI 10.1002/j.1460-2075.1995.tb07292.x; BORST P, 1994, SCIENCE, V264, P1872, DOI 10.1126/science.7516579; BORST P, 1995, CELL, V82, P1, DOI 10.1016/0092-8674(95)90044-6; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; BRENER Z, 1963, Rev Inst Med Trop Sao Paulo, V5, P220; BURLEIGH BA, 1995, ANNU REV MICROBIOL, V49, P175, DOI 10.1146/annurev.mi.49.100195.001135; Camargo MM, 1997, J IMMUNOL, V158, P5890; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; CLAUSEN H, 1997, GLYCOCONJ J S1, V14, P8; DiNoia JM, 1996, J BIOL CHEM, V271, P32078, DOI 10.1074/jbc.271.50.32078; DINOIA JM, 1995, J BIOL CHEM, V270, P24146, DOI 10.1074/jbc.270.41.24146; Franchin G, 1997, INFECT IMMUN, V65, P2548, DOI 10.1128/IAI.65.7.2548-2554.1997; FREITASJUNIOR L, 1997, MEM I OSW CRUZ S1, V92, P92; GRAHAM SV, 1995, PARASITOL TODAY, V11, P217, DOI 10.1016/0169-4758(95)80081-6; GUM JR, 1992, AM J RESP CELL MOL, V7, P557, DOI 10.1165/ajrcmb/7.6.557; Hanke J, 1996, BIOTECHNIQUES, V21, P686; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MERTZ LM, 1994, FOCUS, V16, P45; MORTARA RA, 1992, INFECT IMMUN, V60, P4673, DOI 10.1128/IAI.60.11.4673-4678.1992; Noren K, 1997, EXP CELL RES, V231, P112, DOI 10.1006/excr.1996.3455; PARODI AJ, 1992, EMBO J, V11, P1705, DOI 10.1002/j.1460-2075.1992.tb05221.x; PREVIATO JO, 1994, BIOCHEM J, V301, P151, DOI 10.1042/bj3010151; REYES MB, 1994, GENE, V140, P139, DOI 10.1016/0378-1119(94)90745-5; RUIZ RD, 1993, PARASITE IMMUNOL, V15, P121, DOI 10.1111/j.1365-3024.1993.tb00591.x; Salazar NA, 1996, MOL BIOCHEM PARASIT, V78, P127, DOI 10.1016/S0166-6851(96)02617-5; SAMBROOK J, 1989, MOL CLONING LAB MANU, pCH9; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1993, MOL BIOCHEM PARASIT, V59, P293, DOI 10.1016/0166-6851(93)90227-O; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; THOMPSON CT, 1989, ANAL BIOCHEM, V177, P353, DOI 10.1016/0003-2697(89)90065-1; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; YOSHIDA N, 1989, INFECT IMMUN, V57, P1663, DOI 10.1128/IAI.57.6.1663-1667.1989; Yoshida N, 1997, MOL BIOCHEM PARASIT, V84, P57, DOI 10.1016/S0166-6851(96)02783-1; Zachara NE, 1996, EUR J BIOCHEM, V238, P511, DOI 10.1111/j.1432-1033.1996.0511z.x; ZINGALES B, 1985, MOL BIOCHEM PARASIT, V16, P21, DOI 10.1016/0166-6851(85)90046-5	43	66	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10843	10850		10.1074/jbc.273.18.10843	http://dx.doi.org/10.1074/jbc.273.18.10843			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556557	hybrid			2022-12-27	WOS:000073395200009
J	Na, SY; Lee, SK; Han, SJ; Choi, HS; Im, SY; Lee, JW				Na, SY; Lee, SK; Han, SJ; Choi, HS; Im, SY; Lee, JW			Communication - Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappa B-mediated transactivations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; TRANSCRIPTIONAL ACTIVATION; CO-REPRESSOR; PROTEIN CBP; P300; FAMILY; CREB; IMMUNOSUPPRESSION; GLUCOCORTICOIDS; ASSOCIATION	Steroid receptor coactivator-1 (SRC-1) specifically bound to the transcription factor NF kappa B subunit p50 but not to p65 as demonstrated by the yeast two hybrid tests and glutathione S-transferase pull down assays. The p50-binding site was localized to a subregion of SRC-1 (amino acids 759-1141) that encompasses the previously described CBP-p300-binding domain. In mammalian cells, SRC-1 potentiated the NF kappa B-mediated transactivations in a dose-dependent manner. Coexpression of p300 further enhanced this SRC-1-potentiated level of transactivations, consistent with the recent findings in which CBP and p300 were shown to be transcription coactivators of the p65 subunit (Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H., and Nabel, G. J. (1997) Science 275, 523-527; Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T. (1997) Proc. Acad. Natl. Sci. U.S. A. 94, 2927-2932). These results suggest that at least two distinct coactivator molecules may cooperate to regulate the NF kappa B-dependent transactivations in vivo and SRC-1, originally identified as a coactivator for the nuclear receptors, may constitute a more widely used coactivation complex.	Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea; Chonnam Natl Univ, Dept Biol, Kwangju 500757, South Korea; Chonnam Natl Univ, Hormone Res Ctr, Kwangju 500757, South Korea; Chonnam Natl Univ, Dept Microbiol, Kwangju 500757, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Lee, JW (corresponding author), Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea.	jlee@chonnam.chonnam.ac.kr						Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GILMORE TD, 1993, TRENDS GENET, V9, P427, DOI 10.1016/0168-9525(93)90106-R; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim CH, 1995, J INFLAMM, V45, P312; KIM HJ, 1998, IN PRESS MOL ENDOCRI; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEE JW, 1994, MOL ENDOCRINOL, V8, P1245, DOI 10.1210/me.8.9.1245; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Moore DD, 1995, GLOB MOB SURV; Na SY, 1998, J BIOL CHEM, V273, P3212, DOI 10.1074/jbc.273.6.3212; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONATE SA, 1995, SCIENCE, V270, P1354; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Weil R, 1997, J BIOL CHEM, V272, P9942; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	52	200	213	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10831	10834		10.1074/jbc.273.18.10831	http://dx.doi.org/10.1074/jbc.273.18.10831			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556555	hybrid			2022-12-27	WOS:000073395200007
J	Nishishita, T; Okazaki, T; Ishikawa, T; Igarashi, T; Hata, K; Ogata, E; Fujita, T				Nishishita, T; Okazaki, T; Ishikawa, T; Igarashi, T; Hata, K; Ogata, E; Fujita, T			A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,25-DIHYDROXYVITAMIN-D3 RECEPTOR; TRANSCRIPTIONAL REPRESSION; GLUCOCORTICOID RECEPTOR; V(D)J RECOMBINATION; 5'-FLANKING REGION; THYROID-HORMONE; RETINOIC ACID; IDENTIFICATION; EXPRESSION; SEQUENCES	We found that the human parathyroid hormone-related peptide (hPTHrP) gene contained a DNA element (nVDRE(hPTHrP)) homologous to a negative vitamin D response element in the human parathyroid hormone gene. It bound to vitamin D receptor (VDR) but not retinoic acid X alpha receptor (RXR alpha) in the human T cell line MT2 cells. VDR binding to this element was confirmed by the Southwestern assay combined with immunodepletion using anti-VDR monoclonal antibody, and this binding activity was repressed by 1,25-dihydroxyvitamin D-3. Such a repression was reversed by acid phosphatase treatment, suggesting that 1,25-dihydroxyvitamin D-3 phosphorylates VDR to weaken its binding activity to nVDRE(hPTHrP). In electrophoretic mobility shift assay, we found anti-Ku antigen antibody specifically supershifted the MT2 nuclear protein-nVDRE(hPTHrP) complex. The nVDRE(hPTHrP)-bearing reporter plasmid produced vitamin D-dependent inhibition of the reporter activity in MT2 cells, which was markedly masked by the introduction of the Ku antigen expression vector in the antisense orientation. On the other hand, such a procedure did not perturb the vitamin D response element-mediated gene stimulation by vitamin D. These results indicate that nVDRE(hPTHrP) interacts with Ku antigen in addition to VDR to mediate gene suppression by vitamin D.	Univ Tokyo, Sch Med, Dept Internal Med 4, Endocrine Genet & Hypertens Unit,Bunkyo Ku, Tokyo 112, Japan; Canc Inst Hosp, Toshima Ku, Tokyo 173, Japan; Mitsubishi Kagaku Bioclin Lab Inc, Itabashi Ku, Tokyo 174, Japan	University of Tokyo; Japanese Foundation for Cancer Research; Mitsubishi Kagaku Bio-Clinical Laboratories	Okazaki, T (corresponding author), Univ Tokyo, Sch Med, Dept Internal Med 4, Endocrine Genet & Hypertens Unit,Bunkyo Ku, Tokyo 112, Japan.	okbgeni-tky@umin.u-tokyo.ac.jp						ADLER SL, 1998, CELL, V52, P685; AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BLANCO JCG, 1995, P NATL ACAD SCI USA, V92, P1535, DOI 10.1073/pnas.92.5.1535; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; CARR FE, 1994, J BIOL CHEM, V269, P4175; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHUNG U, 1996, J BIOL CHEM, V271, P8693; DELRIOTSONIS K, 1994, BIOCHEM BIOPH RES CO, V204, P975, DOI 10.1006/bbrc.1994.2556; DEMAY MB, 1992, P NATL ACAD SCI USA, V89, P8097, DOI 10.1073/pnas.89.17.8097; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Falzon M, 1996, MOL ENDOCRINOL, V10, P672, DOI 10.1210/me.10.6.672; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GRIFFIN W, 1997, J BIOL CHEM, V272, P5647; GRIFFIN W, 1996, NATURE, V380, P265; INOUE D, 1993, J BIOL CHEM, V268, P16730; Katzenellenbogen JA, 1996, MOL ENDOCRINOL, V10, P119, DOI 10.1210/me.10.2.119; Kremer R, 1996, J BIOL CHEM, V271, P16310, DOI 10.1074/jbc.271.27.16310; LIU M, 1994, MOL ENDOCRINOL, V8, P1593, DOI 10.1210/me.8.12.1593; Liu SM, 1996, MOL ENDOCRINOL, V10, P206, DOI 10.1210/me.10.2.206; Mackey SL, 1996, MOL ENDOCRINOL, V10, P298, DOI 10.1210/me.10.3.298; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; OHYAMA Y, 1994, J BIOL CHEM, V269, P10545; OKAZAKI T, 1991, J BIOL CHEM, V266, P21903; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; OZONO K, 1990, J BIOL CHEM, V265, P21881; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Zhao XY, 1997, MOL ENDOCRINOL, V11, P366, DOI 10.1210/me.11.3.366	37	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10901	10907		10.1074/jbc.273.18.10901	http://dx.doi.org/10.1074/jbc.273.18.10901			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556566	hybrid			2022-12-27	WOS:000073395200018
J	Prasad, R; Beard, WA; Chyan, JY; Maciejewski, MW; Mullen, GP; Wilson, SH				Prasad, R; Beard, WA; Chyan, JY; Maciejewski, MW; Mullen, GP; Wilson, SH			Functional analysis of the amino-terminal 8-kDa domain of DNA polymerase beta as revealed by site-directed mutagenesis - DNA binding and 5 '-deoxyribose phosphate lyase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; RESIDUES; IDENTIFICATION; MECHANISM; ENDONUCLEASE; 5'-PHOSPHATE; PATHWAY	The amino-terminal 8-kDa domain of DNA polymerase beta functions in binding single-stranded DNA (ssDNA), recognition of a 5'-phosphate in gapped DNA structures, and as a 8'-deoxyribose phosphate (dRP) lyase, NMR and x-ray crystal structures of this domain have suggested several residues that may interact with ssDNA or play a role in the dRP lyase reaction. Nine of these residues were altered by site-directed mutagenesis. Each mutant was expressed in Escherichia coli, and the recombinant protein was purified to near homogeneity. CD spectra of these mutant proteins indicated that the alteration did not adversely affect the global protein structure, Single-stranded DNA binding was probed by photochemical cross-linking to oligo(dT)(16). Several mutants (F25W, K35A, K60A, and K68A) were impaired in ssDNA binding activity, whereas other mutants (H34G, E71Q, K72A, E75A, and K84A) retained near wild-type binding activity. The 5'-phosphate recognition activity of these mutants was examined by UV cross-linking to a 5-nucleotide gap DNA where the 5' terminus in the gap was either phosphorylated or unphosphorylated, The results indicate that Lys(35) is involved in 5'-phosphate recognition of DNA polymerase beta. Finally, the dRP lyase activity of these mutants was evaluated using a preincised apurinic/apyrimidinic DNA, Alanine mutants of Lys(35) and Lys(60) are significantly reduced in dRP lyase activity, consistent with the lower ssDNA binding activity. More importantly, alanine substitution for Lys(72) resulted in a greater than 90% loss of dRP lyase activity, without affecting DNA binding. Alanine mutants of Lys(68) and Lys(84) had wild-type dRP lyase activity. The triple alanine mutant, K35A/K68A/K72A, was devoid of dRP lyase activity, suggesting that the effects of the alanine substitution at Lys(72) and Lys(35) were additive. The results suggest that Lys(72) is directly involved in formation of a covalent imino intermediate and are consistent with Lys(72) as the predominant Schiff base nucleophile in the dRP lyase beta-elimination catalytic reaction.	NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA; Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System; University of Texas Medical Branch Galveston; University of Connecticut	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, POB 12233,111 TW Alexander Dr,Bldg 101,Rm B246, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293				BASU A, 1989, BIOCHEMISTRY-US, V28, P6305, DOI 10.1021/bi00441a023; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DOETSCH PW, 1986, BIOCHEMISTRY-US, V25, P2212, DOI 10.1021/bi00356a054; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; FRANKLIN WA, 1988, EMBO J, V7, P3617, DOI 10.1002/j.1460-2075.1988.tb03240.x; FRANKLIN WA, 1988, EMBO J, V7, P8631; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; LIU DJ, 1994, BIOCHEMISTRY-US, V33, P9537, DOI 10.1021/bi00198a020; Liu DJ, 1996, BIOCHEMISTRY-US, V35, P6188, DOI 10.1021/bi952656o; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mullen GP, 1997, BIOCHEMISTRY-US, V36, P4713, DOI 10.1021/bi962363a; Mullen GP, 1997, TETRAHEDRON, V53, P12057, DOI 10.1016/S0040-4020(97)00768-0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; PRASAD R, 1993, J BIOL CHEM, V268, P22746; PRASAD R, 1994, J BIOL CHEM, V269, P18096; PRICE A, 1991, BIOCHEMISTRY-US, V30, P8631, DOI 10.1021/bi00099a020; Sambrook J., 2002, MOL CLONING LAB MANU; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x	30	133	135	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11121	11126		10.1074/jbc.273.18.11121	http://dx.doi.org/10.1074/jbc.273.18.11121			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556598	hybrid			2022-12-27	WOS:000073395200050
J	Davidson, WS; Jonas, A; Clayton, DF; George, JM				Davidson, WS; Jonas, A; Clayton, DF; George, JM			Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPHIPATHIC HELICAL PEPTIDES; CENTRAL-NERVOUS-SYSTEM; AMINO-ACID-SEQUENCE; APOLIPOPROTEIN A-I; CIRCULAR-DICHROISM; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SYNAPTIC VESICLES; BETA COMPONENT; BRAIN	alpha-Synuclein is a highly conserved presynaptic protein of unknown function. A mutation in the protein has been causally linked to Parkinson's disease in humans, and the normal protein is an abundant component of the intraneuronal inclusions (Lewy bodies) characteristic of the disease. alpha-Synuclein is also the precursor to an intrinsic component of extracellular plaques in Alzheimer's disease. The alpha-synuclein sequence is largely composed of degenerate 11-residue repeats reminiscent of the amphipathic alpha-helical domains of the exchangeable apolipoproteins. We hypothesized that alpha-synuclein should associate with phospholipid bilayers and that this lipid association should stabilize an alpha-helical secondary structure in the protein. We report that alpha-synuclein binds to small unilamellar phospholipid vesicles containing acidic phospholipids, but not to vesicles with a net neutral charge. We further show that the protein associates preferentially with vesicles of smaller diameter (20-25 nm) as opposed to larger (similar to 125 nm) vesicles. Lipid binding is accompanied by an increase in alpha-helicity from 3% to approximately 80%. These observations are consistent with a role in vesicle function at the presynaptic terminal.	Univ Illinois, Dept Cell & Struct Biol, Chem & Life Sci Lab B107, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	George, JM (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Chem & Life Sci Lab B107, 601 S Goodwin, Urbana, IL 61801 USA.	j-george@uiuc.edu	Clayton, David/B-2190-2008; George, Julia M/B-2169-2008	Clayton, David/0000-0002-6395-3488; George, Julia M/0000-0001-6194-6914; Davidson, William/0000-0003-2756-2989	NIA NIH HHS [1R01 AG13762] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013762] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; BRECKENRIDGE WC, 1973, BIOCHIM BIOPHYS ACTA, V320, P681, DOI 10.1016/0304-4165(73)90148-7; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DAVIDSON WS, 1995, J BIOL CHEM, V270, P17106, DOI 10.1074/jbc.270.29.17106; DEUTSCH JW, 1981, BIOCHEMISTRY-US, V20, P378, DOI 10.1021/bi00505a024; EPAND RM, 1995, BIOPOLYMERS, V37, P319, DOI 10.1002/bip.360370504; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; GEOURJON C, 1993, COMPUT APPL BIOSCI, V9, P87; Hope MJ., 1993, LIPOSOME TECHNOLOGY, V1, P123; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JONAS A, 1989, J BIOL CHEM, V264, P4818; LETIZIA JY, 1991, BIOCHEMISTRY-US, V30, P866, DOI 10.1021/bi00217a041; LEVIN JM, 1988, BIOCHIM BIOPHYS ACTA, V955, P283, DOI 10.1016/0167-4838(88)90206-3; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; MAROTEAUX L, 1991, MOL BRAIN RES, V11, P335, DOI 10.1016/0169-328X(91)90043-W; MICHAELSON DM, 1983, BIOCHEM J, V211, P155, DOI 10.1042/bj2110155; Mishra VK, 1996, BIOCHEMISTRY-US, V35, P11210, DOI 10.1021/bi960760f; NAKAJO S, 1994, MOL BRAIN RES, V27, P81, DOI 10.1016/0169-328X(94)90187-2; NAKAJO S, 1993, EUR J BIOCHEM, V217, P1057, DOI 10.1111/j.1432-1033.1993.tb18337.x; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; OKAZAKI H, 1961, J NEUROPATH EXP NEUR, V20, P237, DOI 10.1097/00005072-196104000-00007; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1992, J LIPID RES, V33, P141; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; THOMAS PD, 1988, BIOCHEM J, V254, P155, DOI 10.1042/bj2540155; TYTLER EM, 1993, J BIOL CHEM, V268, P22112; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; YANG L, 1995, BIOCHEMISTRY-US, V34, P1500, DOI 10.1021/bi00005a005	42	1196	1216	1	132	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9443	9449		10.1074/jbc.273.16.9443	http://dx.doi.org/10.1074/jbc.273.16.9443			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545270	hybrid			2022-12-27	WOS:000073128800016
J	De Vos, K; Goossens, V; Boone, E; Vercammen, D; Vancompernolle, K; Vandenabeele, P; Haegeman, G; Fiers, W; Grooten, J				De Vos, K; Goossens, V; Boone, E; Vercammen, D; Vancompernolle, K; Vandenabeele, P; Haegeman, G; Fiers, W; Grooten, J			The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDUCED CYTOTOXICITY; SIGNALS CELL-DEATH; P55 TNF-RECEPTOR; NEUTRAL SPHINGOMYELINASE; SEQUENTIAL ACTIVATION; MICROTUBULE MOTILITY; CYTOPLASMIC DYNEIN; FACTOR-ALPHA; ICE-LIKE; IN-VIVO	The cytokine tumor necrosis factor (TNF) activates diverse signaling molecules resulting in gene expression, differentiation, and/or cell death. Here we report a novel feature induced by TNF, namely translocation of mitochondria from a dispersed distribution to a perinuclear cluster. Mitochondrial translocation correlated with sensitivity to the cell death-inducing activity of TNF and was mediated by the 55-kDa TNF receptor (TNF-R55), but not by Fas, indicating that the signaling pathway requires a TNF-RBS-specific but death domain-independent signal. Indeed, using L929 cells that express mutant TNF-R55, we showed that the membrane-proximal region of TNF-R55 was essential for signaling to mitochondrial translocation. In the absence of translocation, the cell death response was markedly delayed, pointing to a cooperative effect on cell death, Translocation of mitochondria, although dependent on the microtubules, was not imposed by the latter and was equally induced by TNF-independent immunoinhibition of the motor protein kinesin, Additionally, immunoinhibition with antibody directed against the tail domain of kinesin synergized with TNF-induced cell death. Based on this functional mimicry, we propose that a TNF-R55 membrane-proximal region-dependent signal impedes mitochondria-associated kinesin, resulting in cooperation with the TNF-R55 death domain-induced cytotoxic response and causing the observed clustering of mitochondria.	State Univ Ghent, Mol Biol Lab, B-9000 Ghent, Belgium; Flanders Interuniv Inst Biotechnol, Dept Mol Biol, Mol Immunol UNit, B-9000 Ghent, Belgium	Ghent University	Grooten, J (corresponding author), State Univ Ghent, Mol Biol Lab, Ledeganckstr 35, B-9000 Ghent, Belgium.	johang@lmb.rug.ac.be	Vercammen, Dominique/A-4237-2008; Vandenabeele, Peter/C-8597-2009; Vandenabeele, Peter/AAD-5793-2022; De Vos, Kurt/D-8380-2011	Vandenabeele, Peter/0000-0002-6669-8822; De Vos, Kurt/0000-0003-2161-6309				AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; BELKA C, 1995, EMBO J, V14, P1156, DOI 10.1002/j.1460-2075.1995.tb07099.x; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; BEYAERT R, 1994, FEBS LETT, V340, P9, DOI 10.1016/0014-5793(94)80163-0; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Bulinski JC, 1997, J CELL SCI, V110, P3055; Castellino AM, 1997, J BIOL CHEM, V272, P5861, DOI 10.1074/jbc.272.9.5861; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; CLARKE MSF, 1992, J CELL SCI, V102, P533; DING AH, 1990, J EXP MED, V171, P715, DOI 10.1084/jem.171.3.715; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Greidinger EL, 1996, FEBS LETT, V390, P299, DOI 10.1016/0014-5793(96)00678-3; GROOTEN J, 1993, CYTOKINE, V5, P546, DOI 10.1016/S1043-4666(05)80003-1; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; Jia L, 1996, BLOOD, V87, P2401, DOI 10.1182/blood.V87.6.2401.bloodjournal8762401; Kharbanda S, 1997, P NATL ACAD SCI USA, V94, P6939, DOI 10.1073/pnas.94.13.6939; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; Lindesmith L, 1997, J BIOL CHEM, V272, P22929, DOI 10.1074/jbc.272.36.22929; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOPEZ LA, 1993, CELL MOTIL CYTOSKEL, V24, P1, DOI 10.1002/cm.970240102; LOPEZ LA, 1995, J BIOL CHEM, V270, P12511, DOI 10.1074/jbc.270.21.12511; Macho A, 1996, CYTOMETRY, V25, P333, DOI 10.1002/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; MATTHIES HJG, 1993, J BIOL CHEM, V268, P11176; MCILVAIN JM, 1994, J BIOL CHEM, V269, P19176; PATESTOS NP, 1993, BIOCHIMIE, V75, P1007, DOI 10.1016/0300-9084(93)90153-J; RODIONOV VI, 1993, J CELL BIOL, V123, P1811, DOI 10.1083/jcb.123.6.1811; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; SCHROER TA, 1989, CELL, V56, P937, DOI 10.1016/0092-8674(89)90627-2; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Uslu R, 1996, CANCER, V77, P725, DOI 10.1002/(SICI)1097-0142(19960215)77:4<725::AID-CNCR19>3.0.CO;2-2; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vandevoorde V, 1997, J CELL BIOL, V137, P1627, DOI 10.1083/jcb.137.7.1627; VANHAESEBROECK B, 1991, CANCER RES, V51, P2469; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; Wallach D, 1997, FEBS LETT, V410, P96, DOI 10.1016/S0014-5793(97)00553-X; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661	50	138	140	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9673	9680		10.1074/jbc.273.16.9673	http://dx.doi.org/10.1074/jbc.273.16.9673			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545301	hybrid			2022-12-27	WOS:000073128800047
J	Ho, CK; Sriskanda, V; McCracken, S; Bentley, D; Schwer, B; Shuman, S				Ho, CK; Sriskanda, V; McCracken, S; Bentley, D; Schwer, B; Shuman, S			The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; MUTATIONAL ANALYSIS; ACTIVE-SITE; 5'-TRIPHOSPHATASE; KINASE; DNA; ASSOCIATION; EXPRESSION; SUBUNIT	We have conducted a biochemical and genetic analysis of mouse mRNA capping enzyme (Mce1), a bifunctional 597-amino acid protein with RNA triphosphatase and RNA guanylyltransferase activities. The principal conclusions are as follows: (i) the mammalian capping enzyme consists of autonomous and nonoverlapping functional domains; (ii) the guanylyltransferase domain Mce1(211-597) is catalytically active in vitro and functional in vivo in yeast in lieu of the endogenous guanylyltransferase Ceg1; (iii) the guanylyltransferase domain per se binds to the phosphorylated RNA polymerase II carboxyl-terminal domain (CTD), whereas the triphosphatase domain, Mce1(1-210), does not bind to the CTD; and (iv) a mutation of the active site cysteine of the mouse triphosphatase elicits a strong growth-suppressive phenotype in yeast, conceivably by sequestering pre-mRNA ends in a nonproductive complex or by blocking access of the endogenous yeast triphosphatase to RNA polymerase II. These findings contribute to an emerging model of mRNA biogenesis wherein RNA processing enzymes are targeted to nascent polymerase II transcripts through contacts with the CTD, The phosphorylation-dependent interaction between guanylyltransferase and the CTD is conserved from yeast to mammals.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Amgen Inst, Toronto, ON M5G 2C1, Canada; Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Cornell Univ, Coll Med, Dept Microbiol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cornell University	Shuman, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.		Ho, KIong/GPP-6051-2022					Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CONG PJ, 1995, MOL CELL BIOL, V15, P6222; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; FRESCO LD, 1994, P NATL ACAD SCI USA, V91, P6624, DOI 10.1073/pnas.91.14.6624; GUNNERY S, 1995, MOL CELL BIOL, V15, P3597; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1996, J VIROL, V70, P6658, DOI 10.1128/JVI.70.10.6658-6664.1996; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; ITOH N, 1984, J BIOL CHEM, V259, P3930; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Myette JR, 1996, J BIOL CHEM, V271, P11936, DOI 10.1074/jbc.271.20.11936; Myette JR, 1996, J BIOL CHEM, V271, P11945, DOI 10.1074/jbc.271.20.11945; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SCHWER B, 1994, P NATL ACAD SCI USA, V91, P4328, DOI 10.1073/pnas.91.10.4328; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; SHUMAN, 1997, P NATL ACAD SCI US, V94, P12758; SHUMAN S, 1982, J BIOL CHEM, V257, P7237; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; SHUMAN S, 1994, P NATL ACAD SCI USA, V91, P12046, DOI 10.1073/pnas.91.25.12046; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; SHUMAN S, 1980, J BIOL CHEM, V255, P1588; Steinmetz EJ, 1997, CELL, V89, P491, DOI 10.1016/S0092-8674(00)80230-5; STERNER DE, 1995, MOL CELL BIOL, V15, P5716; Takagi T, 1997, CELL, V89, P867, DOI 10.1016/S0092-8674(00)80272-X; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V239, P116, DOI 10.1006/bbrc.1997.7439; Wang SP, 1997, P NATL ACAD SCI USA, V94, P9573, DOI 10.1073/pnas.94.18.9573; YAGI Y, 1984, J BIOL CHEM, V259, P4695; YAGI Y, 1983, EMBO J, V2, P611, DOI 10.1002/j.1460-2075.1983.tb01471.x; YamadaOkabe T, 1996, MICROBIOL-UK, V142, P2515, DOI 10.1099/00221287-142-9-2515; Yu L, 1996, J VIROL, V70, P6162, DOI 10.1128/JVI.70.9.6162-6168.1996; Yu L, 1997, J VIROL, V71, P9837, DOI 10.1128/JVI.71.12.9837-9843.1997; Yue ZY, 1997, P NATL ACAD SCI USA, V94, P12898, DOI 10.1073/pnas.94.24.12898; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	41	112	115	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9577	9585		10.1074/jbc.273.16.9577	http://dx.doi.org/10.1074/jbc.273.16.9577			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545288	hybrid			2022-12-27	WOS:000073128800034
J	Ishii, I; Saito, E; Izumi, T; Ui, M; Shimizu, T				Ishii, I; Saito, E; Izumi, T; Ui, M; Shimizu, T			Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor - Role of cytoplasmic tail phosphorylation in each process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; PROTEIN-COUPLED RECEPTOR; FOLATE-BINDING-PROTEIN; BETA(2)-ADRENERGIC RECEPTOR; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; COATED VESICLES; KB CELLS; INTERNALIZATION; DESENSITIZATION	Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor (PAF) receptor were characterized in transfected Chinese hamster ovary cells. Exposure of the cells to PAF led to rapid sequestration of the receptors into the intracellular compartment and desensitization of the response to PAF, The sequestration was inhibited by pretreatments that perturbed the clathrin-mediated pathway. Subsequent removal of PAF by washing with receptor antagonists led to rapid recycling of the sequestered receptors to the cell surface accompanied by resensitization to PAF, To evaluate the potential role of phosphorylation in the receptor cytoplasmic tail during these processes, mutant receptors in which the tails were truncated or substituted, so as to lack serine/threonine residues, were created. PAF phosphorylated the wildtype receptor rapidly and strongly, but the mutants did not. The maximal extent of sequestration of each mutant was lower than that of the wild-type, and one of the substituted mutants showed no sequestration. Furthermore, the sequestration-defective mutant showed evidence of desensitization after agonist stimulation but not resensitization after agonist removal, Thus, agonist-induced phosphorylation of the cytoplasmic tail facilitates but is not essential for receptor sequestration, and sequestration/recycling appears important in receptor resensitization.	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan; RIKEN, Inst Phys & Chem Res, Ui Lab, Wako, Saitama 35101, Japan	University of Tokyo; RIKEN	Shimizu, T (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Hongo 7-3-1, Tokyo 113, Japan.			Ishii, Isao/0000-0002-5367-205X				Ali H, 1997, J BIOL CHEM, V272, P11706, DOI 10.1074/jbc.272.18.11706; ALI H, 1994, J BIOL CHEM, V269, P24557; ALI H, 1993, J BIOL CHEM, V268, P24247; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CHUANG TT, 1992, J BIOL CHEM, V267, P6886; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; ELWOOD PC, 1989, J BIOL CHEM, V264, P14893; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; GERARD NP, 1994, J IMMUNOL, V152, P793; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.bi.55.070186.002411; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; HUANG ZM, 1995, J BIOL CHEM, V270, P151, DOI 10.1074/jbc.270.1.151; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; HURTLEY SM, 1991, TRENDS BIOCHEM SCI, V16, P165, DOI 10.1016/0968-0004(91)90063-2; Ishii I, 1997, J BIOL CHEM, V272, P7846, DOI 10.1074/jbc.272.12.7846; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; KAMEN BA, 1986, P NATL ACAD SCI USA, V83, P5983, DOI 10.1073/pnas.83.16.5983; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; KENNELLY PJ, 1991, J BIOL CHEM, V266, P1555; Krueger KM, 1997, J BIOL CHEM, V272, P5; LeGouill C, 1997, J BIOL CHEM, V272, P21289, DOI 10.1074/jbc.272.34.21289; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; LUHRS CA, 1989, J BIOL CHEM, V264, P21446; MORRISON WJ, 1989, LIFE SCI, V45, P333, DOI 10.1016/0024-3205(89)90143-4; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; RAPOSO G, 1987, BIOL CELL, V60, P117, DOI 10.1111/j.1768-322X.1987.tb00551.x; RAPOSO G, 1989, EUR J CELL BIOL, V50, P340; RATNAM M, 1989, BIOCHEMISTRY-US, V28, P8249, DOI 10.1021/bi00446a042; Richardson RM, 1996, J BIOL CHEM, V271, P28717, DOI 10.1074/jbc.271.45.28717; Robinson MS, 1996, CELL, V84, P13, DOI 10.1016/S0092-8674(00)80988-5; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; SADASIVAN E, 1989, J BIOL CHEM, V264, P5806; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; TAKANO T, 1994, J BIOL CHEM, V269, P22453; Tolbert LM, 1996, J BIOL CHEM, V271, P17335, DOI 10.1074/jbc.271.29.17335; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; YU SS, 1993, J BIOL CHEM, V268, P337; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	53	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9878	9885		10.1074/jbc.273.16.9878	http://dx.doi.org/10.1074/jbc.273.16.9878			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545329	hybrid			2022-12-27	WOS:000073128800075
J	Sakurai, H; Fukasawa, T				Sakurai, H; Fukasawa, T			Functional correlation among Gal11, transcription factor (TF) IIE, and TFIIH in Saccharomyces cerevisiae - Gal11 and TFIIE cooperatively enhance TFIIH-mediated phosphorylation of RNA polymerase II carboxyl-terminal domain sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT DOMAIN; BASAL TRANSCRIPTION; INITIATION-FACTORS; LARGE SUBUNIT; IN-VIVO; HOLOENZYME; YEAST; PROTEIN; GENE; ACTIVATORS	Saccharomyces cerevisiae Gal11, a component of the holoenzyme of RNA polymerase II, interacts through its functional domains A and B with the small (Tfa2) and large (Tfa1) subunits of the general transcription factor (TF) IIE, respectively. We have recently suggested that Gal11 functions through a common pathway with TFIIE in transcriptional regulation (Sakurai, H., and Fukasawa, T. (1997) J. Biol. Chem. 272, 32663-32669). Here, we report that the activity of the TFIIH-associated kinase, responsible for phosphorylation of the largest subunit of RNA polymerase II at the carboxyl-terminal domain (CTD), is enhanced cooperatively by Gal11 and TFIIE. The enhancement of CTD phosphorylation was observed in the holoenzyme of RNA polymerase II, but not in its core enzyme. The stimulatory effect was completely abolished in the absence of either domain B of Gal11 or the Tfa1 subunit of TFIIE, suggesting that the domain B-Tfa1 interaction is necessary, if not sufficient, for an extensive phosphorylation of the CTD by TFIIH. Stimulation of basal transcription by Gal11 was coupled with enhancement of TFIIH-catalyzed CTD phosphorylation in a cell-free transcription system, suggesting that Gal11 activates transcription by stimulating the CTD phosphorylation in the cell.	Kanazawa Univ, Fac Med, Sch Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan	Kanazawa University; Kazusa DNA Research Institute	Sakurai, H (corresponding author), Kanazawa Univ, Fac Med, Sch Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.							BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; Bushnell DA, 1996, J BIOL CHEM, V271, P20170, DOI 10.1074/jbc.271.33.20170; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; FEAVER WJ, 1994, J BIOL CHEM, V269, P27549; Gustafsson CM, 1997, J BIOL CHEM, V272, P48; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Lee YC, 1997, MOL CELL BIOL, V17, P4622, DOI 10.1128/MCB.17.8.4622; LI Y, 1994, P NATL ACAD SCI USA, V91, P2362, DOI 10.1073/pnas.91.6.2362; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; NONET ML, 1989, GENETICS, V123, P715; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sakurai H, 1996, P NATL ACAD SCI USA, V93, P9488, DOI 10.1073/pnas.93.18.9488; Sakurai H, 1997, J BIOL CHEM, V272, P32663, DOI 10.1074/jbc.272.51.32663; SAKURAI H, 1994, FEBS LETT, V351, P176, DOI 10.1016/0014-5793(94)80098-7; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; SERIZAWA H, 1994, J BIOL CHEM, V269, P20750; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; TAJIMA M, 1986, MOL CELL BIOL, V6, P246, DOI 10.1128/MCB.6.1.246; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689; ZAWEL L, 1995, ANNU REV BIOCHEM, V64, P533	36	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9534	9538		10.1074/jbc.273.16.9534	http://dx.doi.org/10.1074/jbc.273.16.9534			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545282	hybrid			2022-12-27	WOS:000073128800028
J	Grunwald, ME; Yu, WP; Yu, HH; Yau, KW				Grunwald, ME; Yu, WP; Yu, HH; Yau, KW			Identification of a domain on the beta-subunit of the rod cGMP-gated cation channel that mediates inhibition by calcium-calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS ADENYLATE-CYCLASE; AMINO-ACID-SEQUENCE; PHOTORECEPTOR CELLS; ACTIVATED CONDUCTANCE; FUNCTIONAL EXPRESSION; ION-CHANNEL; MODULATION; BINDING; PROTEIN; CA2+-CALMODULIN	The cGMP-gated cation channel mediating phototransduction in retinal rods has recently been shown to be inhibited by calcium-calmodulin, through direct binding of the latter to the beta-subunit of the heterotetrameric channel complex, Here, we report the characterization of this inhibition and the identification of a domain crucial for this modulation, Heterologous expression of the alpha- and beta-subunits of the human rod channel in HEK 293 cells produced a cGMP-gated current that was highly sensitive to calcium-calmodulin, with half-maximal inhibition at approximately 4 nM, In biochemical and electrophysiological experiments on deletion mutants of the beta-subunit, we have identified a region on its cytoplasmic N terminus that binds calmodulin and is necessary for the calmodulin-mediated inhibition of the channel, However, in gel shift assays and fluorescence emission experiments, peptides derived from this region indicated a low calmodulin affinity, with dissociation constants of approximately 3-10 mu M On the C terminus, a region was also found to bind calmodulin, but it was likewise of low affinity, and its deletion did not abolish the calmodulin-mediated inhibition, We suggest that although the identified region on the N terminus of the beta-subunit is crucial for the calmodulin effect, other regions are likely to be involved as well, In this respect, the rod channel appears to differ from the olfactory cyclic nucleotide-gated channel, which is also modulated by calcium-calmodulin.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, 725 N Wolfe St, Baltimore, MD 21205 USA.	kwyau@welchlink.welch.jhu.edu	Yu, Hung-Hsiang/AGP-0497-2022	Yu, Hung-Hsiang/0000-0002-2430-9251				Ardell MD, 1996, FEBS LETT, V389, P213, DOI 10.1016/0014-5793(96)00588-1; Bauer PJ, 1996, J PHYSIOL-LONDON, V494, P675, DOI 10.1113/jphysiol.1996.sp021523; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; CRAESCU CT, 1995, J BIOL CHEM, V270, P7088, DOI 10.1074/jbc.270.13.7088; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; DHALLAN RS, 1992, J NEUROSCI, V12, P3248, DOI 10.1523/JNEUROSCI.12-08-03248.1992; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Finn JT, 1998, BIOPHYS J, V74, P1333, DOI 10.1016/S0006-3495(98)77846-4; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; GOMES AV, 1994, BIOESSAYS, V16, P853, DOI 10.1002/bies.950161113; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Grunwald ME, 1998, BIOPHYS J, V74, pA125; Grunwald ME, 1997, BIOPHYS J, V72, pTHAM1; Haynes LW, 1997, VISUAL NEUROSCI, V14, P233, DOI 10.1017/S0952523800011378; HSU YT, 1994, J BIOL CHEM, V269, P29765; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; KAUPP UB, 1995, CURR OPIN NEUROBIOL, V5, P434, DOI 10.1016/0959-4388(95)80002-6; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LADANT D, 1988, J BIOL CHEM, V263, P2612; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; MOLDAY RS, 1995, BEHAV BRAIN SCI, V18, P441, DOI 10.1017/S0140525X00039200; Molday RS, 1996, CURR OPIN NEUROBIOL, V6, P445, DOI 10.1016/S0959-4388(96)80048-1; MUNIER H, 1993, J BIOL CHEM, V268, P1695; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P731, DOI 10.1113/jphysiol.1988.sp016943; NAKATANI K, 1995, J PHYSIOL-LONDON, V484, P69, DOI 10.1113/jphysiol.1995.sp020648; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sagoo MS, 1996, J PHYSIOL-LONDON, V497, P309, DOI 10.1113/jphysiol.1996.sp021770; SUGIMOTO Y, 1991, P NATL ACAD SCI USA, V88, P3116, DOI 10.1073/pnas.88.8.3116; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Yu WP, 1996, FEBS LETT, V393, P211, DOI 10.1016/0014-5793(96)00889-7; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	51	82	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9148	9157		10.1074/jbc.273.15.9148	http://dx.doi.org/10.1074/jbc.273.15.9148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535905	hybrid			2022-12-27	WOS:000072990800082
J	Heding, A; Vrecl, M; Bogerd, J; McGregor, A; Sellar, R; Taylor, PL; Eidne, KA				Heding, A; Vrecl, M; Bogerd, J; McGregor, A; Sellar, R; Taylor, PL; Eidne, KA			Gonadotropin-releasing hormone receptors with intracellular carboxyl-terminal tails undergo acute desensitization of total inositol phosphate production and exhibit accelerated internalization kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GNRH RECEPTOR; RAPID DESENSITIZATION; PHOSPHORYLATION; ALPHA-T3-1; BINDING; CELLS; KINASE	The mammalian gonadotropin-releasing hormone receptor (GnRH-R) is the only G-protein-coupled receptor (GPCR) in which the intracellular C-terminal tail is completely absent. In contrast to other GPCRs, the GnRH-R does not show rapid desensitization of total inositol (IP) production, and the rates of internalization are exceptionally slow. We investigated whether the incorporation of a cytoplasmic tail into the C terminus of the GnRH-R affects desensitization events and receptor internalization rates. A GnRH-R/TRH-R chimera was created where the intracellular tail of the rat thyrotropin-releasing hormone receptor (TRH-R) was engineered into the C terminus of the rat GnRH-R, Three different rat GnRH-R cDNA stop codon mutations tone for each reading frame) were also made. The GnRH-stimulated IP production of the wild-type rat GnRH-R expressed in either COS-7 or HEK 293 cells did not desensitize even after prolonged stimulation with GnRH., In contrast, the catfish GnRH-R (which does possess an intracellular tail) and the TRH-R rapidly (<10 min) desensitized following agonist stimulation. The GnRH-R/TRH-R chimera also desensitized following treatment with GnRH, resembling the pattern shown by the TRH-R and the catfish GnRH-R, Two of the stop codon mutants did not show desensitization of IP production, and the third mutant with the longest tail was not functional. Internalization experiments showed that the rat GnRH-R had the slowest endocytosis and recycling rates compared with the TRH-R, the catfish GnRH-R, and the chimeric GnRH/TRH-R. This study demonstrates that the addition of a functional intracellular C-terminal tail to the GnRH-R produces rapid desensitization of IP production and significantly increases internalization rates.	MRC, Ctr Reprod Biol, Reprod Biol Unit, Edinburgh EH3 9EW, Midlothian, Scotland; Univ Utrecht, Dept Expt Zool, NL-3584 CH Utrecht, Netherlands	Utrecht University	Eidne, KA (corresponding author), MRC, Ctr Reprod Biol, Reprod Biol Unit, 37 Chalmers St, Edinburgh EH3 9EW, Midlothian, Scotland.		Vrecl, Milka/A-6127-2008; Bogerd, Jan/B-8858-2011	Bogerd, Jan/0000-0003-1120-7974				ANDERSON L, 1993, J ENDOCRINOL, V136, P51, DOI 10.1677/joe.0.1360051; ANDERSON L, 1995, ENDOCRINOLOGY, V136, P5228, DOI 10.1210/en.136.11.5228; Anderson L, 1996, Rev Reprod, V1, P193, DOI 10.1530/revreprod/1.3.193; ANDERSON L, 1995, BIOCHEM J, V311, P3565; Arora KK, 1997, MOL ENDOCRINOL, V11, P1203, DOI 10.1210/me.11.9.1203; BRAMLEY TA, 1992, PLACENTA, V13, P555, DOI 10.1016/0143-4004(92)90020-T; COOK JV, 1993, J ENDOCRINOL, V139, pR1, DOI 10.1677/joe.0.139R001; DAVIDSON JS, 1994, BIOCHEM J, V300, P299, DOI 10.1042/bj3000299; EIDNE KA, 1992, MOL CELL ENDOCRINOL, V90, pR5, DOI 10.1016/0303-7207(92)90116-N; FALCKPEDERSEN E, 1994, MOL PHARMACOL, V45, P684; Goldman PS, 1996, J BIOL CHEM, V271, P4215; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; MATUSLEIBOVITCH N, 1995, J BIOL CHEM, V270, P1041, DOI 10.1074/jbc.270.3.1041; MCARDLE CA, 1995, ENDOCRINOLOGY, V136, P4864, DOI 10.1210/en.136.11.4864; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; MOENTER SM, 1992, ENDOCRINOLOGY, V130, P2978, DOI 10.1210/en.130.5.2978; MORGAN RO, 1987, J BIOL CHEM, V262, P1166; NUSSENZVEIG DR, 1993, J BIOL CHEM, V268, P2389; PERLMAN JH, 1991, ENDOCRINOLOGY, V129, P2679, DOI 10.1210/endo-129-5-2679; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; Tensen C, 1997, EUR J BIOCHEM, V243, P134, DOI 10.1111/j.1432-1033.1997.0134a.x; TOBIN AB, 1995, BRIT J PHARMACOL, V116, P1723, DOI 10.1111/j.1476-5381.1995.tb16654.x; TROSKIE BE, 1997, END SOC 79 ANN M MIN; Wang Z, 1996, MOL ENDOCRINOL, V10, P748, DOI 10.1210/me.10.6.748	26	120	124	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11472	11477		10.1074/jbc.273.19.11472	http://dx.doi.org/10.1074/jbc.273.19.11472			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565559	hybrid			2022-12-27	WOS:000073536700013
J	Monteiro, MA; Chan, KHN; Rasko, DA; Taylor, DE; Zheng, PY; Appelmelk, BJ; Wirth, HP; Yang, MQ; Blaser, MJ; Hynes, SO; Moran, AP; Perry, MB				Monteiro, MA; Chan, KHN; Rasko, DA; Taylor, DE; Zheng, PY; Appelmelk, BJ; Wirth, HP; Yang, MQ; Blaser, MJ; Hynes, SO; Moran, AP; Perry, MB			Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOMBARDMENT MASS-SPECTROMETRY; CORE OLIGOSACCHARIDE REGIONS; POLYACRYLAMIDE GELS; MONOCLONAL-ANTIBODIES; O-ANTIGEN	Previous structural investigations performed on the lipopolysaccharides (LPSs) from the human gastric pathogen Helicobacter pylori have revealed that these cell surface glycan molecules express type 2 partially fucosylated, glucosylated, or galactosylated N-acetyllactosamine O antigen chains (O-chains) of various lengths, which may or may not be terminated at the nonreducing end by Lewis X (Le(x)) and/or Le(y) blood group epitopes in mimicry of human cell surface glycoconjugates and glycolipids, Subsequently, serological experiments with commercially available Lewis-specific monoclonal antibodies also have recognized the presence of Le(x) and Le(y) blood group antigens in LI, pylori but, in addition, have indicated the presence of type 1 chain Le(a), Le(b), and Le(d) (H-type 1) blood group epitopes in some H. pylori strains. To confirm their presence, structural studies and additional serological experiments mere undertaken on H., pylori strains suspected of carrying type 1 chain epitopes, These investigations revealed that the O chain region of H. pylori strain UA948 carried both Le(a) (type 1) and Le(x) (type 2) blood group determinants. The O-chain from H. pylori UA955 LPS expressed the terminal Lewis disaccharide (type 1 chain) and Le(x) and Le(y) antigens (type 2), The O-chain of H. pylori J223 LPS carried the type 1 chain precursor Le(c), the H-l epitope (Le(d), type 1 chain) and an elongated nonfucosylated type 2 N-acetyllactosamine chain (i antigen). Thus, O-chains from H., pylori LPSs can also express fucosylated type 1 sequences, and the LPS from a single H., pylori strain may carry O-chains with type 1 and 2 Lewis blood groups simultaneously. That monoclonal antibodies putatively specific for the Le(b) determinant can detect glycan substructures (Le disaccharide, Le(c), and Le(d)) of Le(b) indicates their nonspecificity. The expression of both type 1 and 2 Lewis antigens by H. pylori LPSs mimics the cell surface glycomolecules present in both the gastric superficial (which expresses mainly type 1 determinants) and the superficial and glandular epithelium regions (both of which express predominantly type 2 determinants). Therefore, each H., pylori strain may have a different niche within the gastric mucosa, and each individual LPS blood group antigen may have a dissimilar role in H. pylori adaptation.	Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; Univ Alberta, Dept Immunol & Med Microbiol, Edmonton, AB T6G 2H7, Canada; Vrije Univ Amsterdam, Dept Med Microbiol, Amsterdam, Netherlands; Univ Zurich, Sch Med, Div Gastroenterol, Zurich, Switzerland; Vanderbilt Univ, Dept Med, Nashville, TN USA; Vet Affairs Med Ctr, Nashville, TN 37212 USA; Natl Univ Ireland Univ Coll Galway, Dept Microbiol, Galway, Ireland	National Research Council Canada; University of Alberta; Vrije Universiteit Amsterdam; University of Zurich; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Ollscoil na Gaillimhe-University of Galway	Monteiro, MA (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	Mario.Monteiro@nrc.ca		David, Rasko/0000-0002-7337-7154; Hynes, Sean/0000-0002-3092-7945				Amano K, 1997, CLIN DIAGN LAB IMMUN, V4, P540, DOI 10.1128/CDLI.4.5.540-544.1997; Appelmelk BJ, 1996, INFECT IMMUN, V64, P2031, DOI 10.1128/IAI.64.6.2031-2040.1996; Aspinall G. O., 1994, CARBOHYDR LETT, V1, P156; Aspinall GO, 1997, EUR J BIOCHEM, V248, P592, DOI 10.1111/j.1432-1033.1997.00592.x; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2489, DOI 10.1021/bi951852s; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2498, DOI 10.1021/bi951853k; ASPINALL GO, 1997, IR J MED SCI S3, V166, P26; Berg DE, 1997, TRENDS MICROBIOL, V5, P468, DOI 10.1016/S0966-842X(97)01164-5; BLANCHARD D, 1992, REV FR TRANSFUS HEM, V35, P239, DOI 10.1016/S1140-4639(05)80102-9; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DAVIDSON JS, 1992, GASTROENTEROLOGY, V103, P1552, DOI 10.1016/0016-5085(92)91177-6; DELL A, 1990, CARBOHYD RES, V200, P59, DOI 10.1016/0008-6215(90)84182-T; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; EGGE H, 1987, MASS SPECTROM REV, V6, P331, DOI 10.1002/mas.1280060302; Ge ZM, 1997, J BIOL CHEM, V272, P21357, DOI 10.1074/jbc.272.34.21357; HENRY S, 1995, VOX SANG, V69, P166, DOI 10.1111/j.1423-0410.1995.tb02591.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Imberty A, 1996, BIOORGAN MED CHEM, V4, P1979, DOI 10.1016/S0968-0896(96)00179-4; KOBAYASHI K, 1993, AM J GASTROENTEROL, V88, P919; LEOTEIN K, 1978, CARBOHYD RES, V62, P359; Martin SL, 1997, J BIOL CHEM, V272, P21349, DOI 10.1074/jbc.272.34.21349; MOLLICONE R, 1985, LAB INVEST, V53, P219; Monteiro MA, 1998, GLYCOBIOLOGY, V8, P107, DOI 10.1093/glycob/8.1.107; Monteiro MA, 1997, FEMS MICROBIOL LETT, V154, P103, DOI 10.1016/S0378-1097(97)00309-1; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; RIESCHEL ET, 1996, CURR TOP MICROBIOL I, V216, P39; SAWARDEKER JH, 1967, ANAL CHEM, V39, P1602; SHERBURNE R, 1995, INFECT IMMUN, V63, P4564, DOI 10.1128/IAI.63.12.4564-4568.1995; SimoonsSmit IM, 1996, J CLIN MICROBIOL, V34, P2196, DOI 10.1128/JCM.34.9.2196-2200.1996; Suda Y, 1997, J BIOCHEM-TOKYO, V121, P1129; TAYLOR DE, 1987, AM J CLIN PATHOL, V87, P49, DOI 10.1093/ajcp/87.1.49; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; WALSH EJ, 1997, IRISH J MED SCI S3, V166, P27; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Wirth HP, 1997, GASTROENTEROLOGY, V113, P1091, DOI 10.1053/gast.1997.v113.pm9322503; Wirth HP, 1996, INFECT IMMUN, V64, P4598, DOI 10.1128/IAI.64.11.4598-4605.1996; WIRTH HP, 1997, GASTROENTEROLOGY, V112, P331	41	148	157	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11533	11543		10.1074/jbc.273.19.11533	http://dx.doi.org/10.1074/jbc.273.19.11533			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565568	hybrid			2022-12-27	WOS:000073536700022
J	Sun, B; Li, J; Okahara, K; Kambayashi, J				Sun, B; Li, J; Okahara, K; Kambayashi, J			P2X(1) purinoceptor in human platelets - Molecular cloning and functional characterization after heterologous expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PLATELETS; PHOSPHOLIPASE-C; P-2X RECEPTOR; ADP; IDENTIFICATION; ACTIVATION; ADENOSINE; CHANNELS; PROTEIN	ADP is an important physiological platelet agonist. The molecular identity of the ADP receptor(s) in human platelets, however, is still unclear. Although P2T purinoceptor was believed to be the ligand-gated cation channel for ADP in human platelets, recent patch clamp studies now suggest it is P2X(1), type. In the present study, we have cloned a cDNA encoding a P2X(1), purinoceptor from human platelets using degenerate reverse transcription and polymerase chain reaction. Northern blotting with a P2X(1)-specific probe revealed a band of 1.8 kilobases in human platelets as well as in several megakaryoblastic cell lines. 1321N1 human astrocytoma cells expressing the cloned P2X(1), cDNA exhibited both ATP-and ADP-stimulated Ca2+ influx that could be blocked by the purinoceptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid and suramin, Additionally, a polyclonal antibody raised against glutathione-S-transferase-P2X(1), fusion peptide reacted with a 70-kDa band on Western blot of human platelets. It is therefore concluded that functional P2X(1), purinoceptors are present in human platelets.	Otsuka Amer Pharmaceut Inc, Maryland Res Labs, Dept Thrombosis & Vasc Biol, Rockville, MD 20850 USA		Sun, B (corresponding author), Otsuka Amer Pharmaceut Inc, Maryland Res Labs, Dept Thrombosis & Vasc Biol, 9900 Med Ctr Dr, Rockville, MD 20850 USA.	bings@mrl.capi.com						ADLER JR, 1979, J BIOL CHEM, V254, P3866; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; Burnstock G, 1996, DRUG DEVELOP RES, V38, P67, DOI 10.1002/(SICI)1098-2299(199605)38:1<67::AID-DDR9>3.0.CO;2-J; CATTANEO M, 1992, BLOOD, V80, P2787; CRISTALLI G, 1993, BIOCHEM J, V291, P875, DOI 10.1042/bj2910875; FIGURES WR, 1981, J BIOL CHEM, V256, P7789; FILTZ TM, 1994, MOL PHARMACOL, V46, P8; Gachet C, 1997, THROMB HAEMOSTASIS, V78, P271; GACHET C, 1995, BRIT J HAEMATOL, V91, P434, DOI 10.1111/j.1365-2141.1995.tb05319.x; GRECO NJ, 1992, J BIOL CHEM, V267, P2966; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HECHLER B, 1995, NOUV REV FR HEMATOL, V37, P231; HOURANI SMO, 1994, TRENDS PHARMACOL SCI, V15, P103, DOI 10.1016/0165-6147(94)90045-0; Leon C, 1997, FEBS LETT, V403, P26, DOI 10.1016/S0014-5793(97)00022-7; MacKenzie AB, 1996, J BIOL CHEM, V271, P2879, DOI 10.1074/jbc.271.6.2879; MAHAUTSMITH MP, 1992, J BIOL CHEM, V267, P3060; Mills DCB, 1996, THROMB HAEMOSTASIS, V76, P835; NOZAWA Y, 1993, ADV EXP MED BIOL, V344, P37; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; SAGE SO, 1987, J BIOL CHEM, V262, P16364; SAVI P, 1994, THROMB RES, V76, P157, DOI 10.1016/0049-3848(94)90186-4; SURPRENANT A, 1995, TRENDS NEUROSCI, V18, P224, DOI 10.1016/0166-2236(95)93907-F; Valera S, 1995, RECEPTOR CHANNEL, V3, P283; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; WATSON SP, 1995, MOL PHARMACOL, V47, P823	25	80	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11544	11547		10.1074/jbc.273.19.11544	http://dx.doi.org/10.1074/jbc.273.19.11544			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565569	hybrid			2022-12-27	WOS:000073536700023
J	Xie, B; Laouar, A; Huberman, E				Xie, B; Laouar, A; Huberman, E			Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation - The signaling role of protein kinase C-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; ESTER-INDUCED DIFFERENTIATION; PROMYELOCYTIC LEUKEMIA-CELLS; HUMAN MONONUCLEAR PHAGOCYTES; HUMAN ALVEOLAR MACROPHAGES; MATRIX METALLOPROTEINASE-9; MONOCYTIC DIFFERENTIATION; TERMINAL DIFFERENTIATION; NEUTRAL PROTEINASES; POTENT INHIBITORS	Induction of the 92-kDa gelatinase (MMP-9) gene expression is associated with macrophage differentiation. In this study, we explored the regulatory mechanisms underlying this differentiation-associated MMP-9 gene expression in human HL-60 myeloid leukemia cells and human peripheral blood monocytes. Phorbol 12-myristate 13-acetate (PMA) markedly induced MMP-9 gene expression in HL-60 cells; the induction closely paralleled the timing and extent of PMA-induced cell adhesion and spreading, a hallmark of macrophage differentiation. Similarly, treatment with PMA or macrophage-colony stimulating factor stimulated adherence and spreading of blood monocytes with a concurrent 7- or 5-fold increase in MMP-9 production, respectively. In protein kinase C (PRC)-beta-deficient HL-60 variant cells (HL-525), PMA failed to induce cell adhesion and MMP-9 gene expression. Transfecting HL-525 cells with a PKC-beta expression plasmid restored PKC-beta levels and PMA inducibility of cell adhesion and spreading as well as MMP-9 gene expression. Induction of cell adhesion and MMP-9 gene expression in HL-60 cells and blood monocytes was strongly inhibited by neutralizing monoclonal antibodies to fibronectin (FN) and its receptor alpha(5) beta(1) integrin. HL-525 cells, which constitutively display high levels of surface alpha(5) beta(1) integrin, adhered and spread on immobilized FN with concomitant induction of MMP-9 gene expression. Cytochalasins B and D were each a potent inhibitor of MMP-9 production. Our results suggest that alpha(5) beta(1) integrin-mediated interaction of immature hematopoietic cells with FN plays a critical role in modulating matrix-degrading activities during macrophage differentiation.	Argonne Natl Lab, Ctr Mechanist Biol & Biotechnol, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Huberman, E (corresponding author), Argonne Natl Lab, Ctr Mechanist Biol & Biotechnol, 9700 S Cass Ave, Argonne, IL 60439 USA.							AIHARA H, 1991, P NATL ACAD SCI USA, V88, P11062, DOI 10.1073/pnas.88.24.11062; BARSHAVIT Z, 1985, P NATL ACAD SCI USA, V82, P5380, DOI 10.1073/pnas.82.16.5380; BECKER S, 1987, J IMMUNOL, V139, P3703; BRUGGER W, 1991, J LEUKOCYTE BIOL, V49, P483, DOI 10.1002/jlb.49.5.483; BURN P, 1988, P NATL ACAD SCI USA, V85, P497, DOI 10.1073/pnas.85.2.497; CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLINS SJ, 1987, BLOOD, V70, P1233; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; EIERMAN DF, 1989, J IMMUNOL, V142, P1970; FERREIRA OC, 1991, EXP CELL RES, V193, P20, DOI 10.1016/0014-4827(91)90533-Z; GAILIT J, 1988, J BIOL CHEM, V263, P12927; GIVAZZI R, 1993, EXP CELL RES, V146, P391; GLESNE DA, 1991, MOL CELL BIOL, V11, P5417, DOI 10.1128/MCB.11.11.5417; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HIBBS MS, 1987, J CLIN INVEST, V80, P1644, DOI 10.1172/JCI113253; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HOMMA Y, 1986, P NATL ACAD SCI USA, V83, P7316, DOI 10.1073/pnas.83.19.7316; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HUBERMAN E, 1979, P NATL ACAD SCI USA, V76, P1293, DOI 10.1073/pnas.76.3.1293; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IMAMURA K, 1990, EMBO J, V9, P2423, DOI 10.1002/j.1460-2075.1990.tb07418.x; KHARBANDA S, 1994, J BIOL CHEM, V269, P872; LAOUAR A, 1993, INT IMMUNOL, V5, P965, DOI 10.1093/intimm/5.8.965; LOTEM J, 1979, P NATL ACAD SCI USA, V76, P5158, DOI 10.1073/pnas.76.10.5158; MACFARLANE DE, 1994, J BIOL CHEM, V269, P4327; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MERCURIO AM, 1988, J CELL BIOL, V107, P1873, DOI 10.1083/jcb.107.5.1873; MIZEL SB, 1981, P NATL ACAD SCI-BIOL, V78, P2474, DOI 10.1073/pnas.78.4.2474; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; MURPHY G, 1989, BIOCHEM J, V258, P463, DOI 10.1042/bj2580463; NISHIKAWA M, 1990, CANCER RES, V50, P621; ROSALES C, 1995, J LEUKOCYTE BIOL, V57, P189, DOI 10.1002/jlb.57.2.189; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Saren P, 1996, J IMMUNOL, V157, P4159; SARIBAN E, 1985, NATURE, V316, P64, DOI 10.1038/316064a0; SATO H, 1993, ONCOGENE, V8, P395; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; SHIMA M, 1995, P NATL ACAD SCI USA, V92, P5179, DOI 10.1073/pnas.92.11.5179; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5; TONETTI DA, 1994, J BIOL CHEM, V269, P23230; TONETTI DA, 1992, CELL GROWTH DIFFER, V3, P739; WALLIS WJ, 1985, J IMMUNOL, V135, P2323; WATANABE H, 1993, J CELL SCI, V104, P991; WELGUS HG, 1985, J CLIN INVEST, V76, P219, DOI 10.1172/JCI111949; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WELGUS HG, 1986, J CLIN INVEST, V77, P1675, DOI 10.1172/JCI112485; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WILKINS JA, 1991, EUR J IMMUNOL, V21, P517, DOI 10.1002/eji.1830210239; WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149; XIE B, 1994, AM J PATHOL, V144, P1058; Xie B, 1998, J BIOL CHEM, V273, P11583, DOI 10.1074/jbc.273.19.11583; YANG KD, 1994, BLOOD, V83, P490	58	102	110	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11576	11582		10.1074/jbc.273.19.11576	http://dx.doi.org/10.1074/jbc.273.19.11576			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565574	hybrid			2022-12-27	WOS:000073536700028
J	Abe, Y; Odaka, M; Inagaki, F; Lax, I; Schlessinger, J; Kohda, D				Abe, Y; Odaka, M; Inagaki, F; Lax, I; Schlessinger, J; Kohda, D			Disulfide bond structure of human epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; IONIZATION MASS-SPECTROMETRY; LAMININ GAMMA-1 CHAIN; HEREGULIN-ALPHA; BINDING DOMAIN; SEQUENCE; LIGAND; INSULIN; MODULES	The extracellular domain of the human epidermal growth factor receptor (sEGFR) consists of 621 amino acid residues, including 50 cysteines. The connections of the 25 disulfide bonds in the recombinant sEGFR protein, obtained from Chinese hamster ovary cells, have been determined using N-terminal sequencing and matrix-assisted laser desorption/ionization mass spectroscopy. We identified a basic repeat of eight cysteines with a 1-3, 2-4, 5-6, and 7-8 disulfide pairing pattern in the two cysteine-rich regions of sEGFR. By comparison to other cysteine-rich motifs, it was concluded that the cysteine-rich repeat of sEGFR belongs to the laminin-type EGR-like (LE) structural motif, Three-dimensional structure models of the two cysteine-rich regions have been built, based on the three-dimensional structures of the LE domains from the laminin gamma 1 chain and secondary structure predictions for the EGF receptor.	Biomol Engn Res Inst, NMR Grp, Dept Biol Struct, Suita, Osaka 5650874, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Physiol, Bunkyo Ku, Tokyo 113, Japan; NYU, Med Ctr, Dept Pharmacol, New York, NY 10016 USA	Tokyo Metropolitan Institute of Medical Science; New York University	Kohda, D (corresponding author), Biomol Engn Res Inst, NMR Grp, Dept Biol Struct, Furedai 6 Chome, Suita, Osaka 5650874, Japan.		Abe, Yoshito/AAH-6141-2021; Odaka, Masafumi/C-2378-2013; Kohda, Daisuke/I-4990-2019; Abe, Yoshito/D-8370-2012	Abe, Yoshito/0000-0002-0016-8490; Kohda, Daisuke/0000-0001-8234-3776; Abe, Yoshito/0000-0002-0016-8490				BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2247, DOI 10.1093/nar/19.suppl.2247; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BARON M, 1991, TRENDS BIOCHEM SCI, V16, P13, DOI 10.1016/0968-0004(91)90009-K; Baumgartner R, 1996, J MOL BIOL, V257, P658, DOI 10.1006/jmbi.1996.0192; BORK P, 1995, TRENDS BIOCHEM SCI, V20, pC2; Campbell I D, 1989, Prog Growth Factor Res, V1, P13, DOI 10.1016/0955-2235(89)90038-0; CRIMMINS DL, 1995, ANAL BIOCHEM, V226, P355, DOI 10.1006/abio.1995.1236; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GUNTHER N, 1990, J BIOL CHEM, V265, P22082; Jacobsen NE, 1996, BIOCHEMISTRY-US, V35, P3402, DOI 10.1021/bi952626l; KARADI R, 1996, J MOL GRAPHICS, V14, P51; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; KOHDA D, 1993, J BIOL CHEM, V268, P1976; LAX I, 1991, J BIOL CHEM, V266, P13828; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAGATA K, 1994, EMBO J, V13, P3517, DOI 10.1002/j.1460-2075.1994.tb06658.x; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; PATTERSON SD, 1994, ANAL CHEM, V66, P3727, DOI 10.1021/ac00093a030; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; STEINER DF, 1992, J BIOL CHEM, V267, P23435; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; STULTZ CM, 1993, PROTEIN SCI, V2, P305; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WARD CW, 1995, PROTEINS, V22, P141, DOI 10.1002/prot.340220207	31	73	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11150	11157		10.1074/jbc.273.18.11150	http://dx.doi.org/10.1074/jbc.273.18.11150			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556602	hybrid			2022-12-27	WOS:000073395200054
J	Imamura, T; Haruta, T; Takata, Y; Usui, I; Iwata, M; Ishihara, H; Ishiki, M; Ishibashi, O; Ueno, E; Sasaoka, T; Kobayashi, M				Imamura, T; Haruta, T; Takata, Y; Usui, I; Iwata, M; Ishihara, H; Ishiki, M; Ishibashi, O; Ueno, E; Sasaoka, T; Kobayashi, M			Involvement of heat shock protein 90 in the degradation of mutant insulin receptors by the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; ENDOPLASMIC-RETICULUM; EXTRACELLULAR DOMAIN; ALPHA-SUBUNIT; CELL-SURFACE; MOLECULAR CHAPERONES; STEROID-RECEPTOR; BETA-SUBUNIT; MUTATION; TRANSPORT	We previously reported three families with type A insulin-resistant syndrome who had mutations, either Asp(1179) or Leu(1193), in the kinase domain of the insulin receptor. The extreme insulin resistance of these patients was found to be caused by the decreased number of insulin receptors on the cell surface, due to the intracellular rapid degradation (Imamura, T., Takata, Y., Sasaoka, T., Takada, Y., Morioka, H., Haruta, T., Sawa, T., Iwanishi, M., Yang, G. H., Suzuki, Y., Hamada, J., and Kobayashi, M. (1994) J. Biol. Chem. 269, 31019-31027). In the present study, we first examined whether these mutations caused rapid degradation of unprocessed proreceptors, using the exon 13 deleted mutant insulin receptors (Delta Ex13-IR), which were accumulated in the endoplasmic reticulum as unprocessed proreceptors. The addition of Asp(1179) or Leu(1193) mutation to Delta Ex13-IR caused accelerated degradation of the unprocessed Delta Ex13-IR in the transfected COS-7 cells. Next, we tested whether these mutant receptors were degraded by the proteasome. Treatment with proteasome inhibitors Z-Leu-Leu-Nva-H (MG-115) or Z-Leu-Leu-Leu-H (MG-132) prevented the accelerated degradation of these mutant receptors, resulting in increased amounts of the mutant receptors in the COS-7 cells. Essentially the same results were obtained in the patient's transformed lymphocytes. Finally, we found that these mutant receptors bound to heat shock protein 90 (Hsp90). To determine whether Hsp90 played an important role in the accelerated receptor degradation, we examined the effect of anti-Hsp90 antibody on the mutant receptor degradation. The microinjection of anti-Hsp90 antibody into cells prevented the accelerated degradation of both Asp(1179) and Leu(1193) mutant insulin receptors. Taken together, these results suggest that Hsp90 is involved in dislocation of the mutant insulin receptors out of the endoplasmic reticulum into the cytosol, where the mutant receptors are degraded by the proteasome.	Toyama Med & Pharmaceut Univ, Dept Med 1, Sugitani, Toyama 93001, Japan	University of Toyama	Kobayashi, M (corresponding author), Toyama Med & Pharmaceut Univ, Dept Med 1, 2630 Sugitani, Sugitani, Toyama 93001, Japan.							ACCILI D, 1992, J BIOL CHEM, V267, P586; ACCILI D, 1991, J BIOL CHEM, V266, P434; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; CAMA A, 1992, J BIOL CHEM, V267, P8383; CAMA A, 1993, J BIOL CHEM, V268, P8060; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRONSKOV K, 1993, BIOCHEM BIOPH RES CO, V192, P905, DOI 10.1006/bbrc.1993.1501; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HARUTA T, 1993, DIABETES, V42, P1837, DOI 10.2337/diabetes.42.12.1837; HARUTA T, 1995, BIOCHEM J, V305, P599, DOI 10.1042/bj3050599; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; IMAMURA T, 1994, J BIOL CHEM, V269, P31019; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; KADOWAKI T, 1991, J BIOL CHEM, V266, P21224; KADOWAKI T, 1990, J BIOL CHEM, V265, P19143; KOBAYASHI M, 1990, BIOCHEM BIOPH RES CO, V167, P1073, DOI 10.1016/0006-291X(90)90632-W; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LONGO N, 1993, P NATL ACAD SCI USA, V90, P60, DOI 10.1073/pnas.90.1.60; MAASSEN JA, 1991, BIOCHEMISTRY-US, V30, P10778, DOI 10.1021/bi00108a024; McGee TP, 1996, J BIOL CHEM, V271, P25630, DOI 10.1074/jbc.271.41.25630; MIYATA Y, 1995, BIOCHEMISTRY-US, V34, P8123, DOI 10.1021/bi00025a019; MOLLER DE, 1990, MOL ENDOCRINOL, V4, P1183, DOI 10.1210/mend-4-8-1183; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; RIVETT AJ, 1993, BIOCHEM J, V291, P1; RUTHERFORD SL, 1994, CELL, V79, P1129, DOI 10.1016/0092-8674(94)90003-5; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; Sawa T, 1996, BIOCHEM BIOPH RES CO, V218, P449, DOI 10.1006/bbrc.1996.0080; SEINO S, 1990, DIABETES, V39, P123, DOI 10.2337/diabetes.39.1.123; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; TAKATA Y, 1994, BIOCHEM BIOPH RES CO, V203, P763, DOI 10.1006/bbrc.1994.2248; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; VANDERVORM ER, 1992, J BIOL CHEM, V267, P66; VANDERVORM ER, 1994, J BIOL CHEM, V269, P14297; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; WERTHEIMER E, 1994, J BIOL CHEM, V269, P7587; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; YAMAUCHI K, 1994, J BIOL CHEM, V269, P31107	44	75	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11183	11188		10.1074/jbc.273.18.11183	http://dx.doi.org/10.1074/jbc.273.18.11183			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556607	hybrid			2022-12-27	WOS:000073395200059
J	Svetlov, V; Nolan, K; Burgess, RR				Svetlov, V; Nolan, K; Burgess, RR			Communication - Rpb3, stoichiometry and sequence determinants of the assembly into yeast RNA polymerase II in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; ALPHA-SUBUNIT; FUNCTIONAL MAP; ENZYME; DOMAIN	Stoichiometry of the third largest subunit (Rpb3) of the yeast RNA polymerase II is a subject of continuing controversy. In this work we utilized immunoaffinity and nickel-chelate chromatographic techniques to isolate the RNA polymerase II species assembled in vivo in the presence of the His(6)-tagged and untagged Rpb3. The distribution pattern of tagged and untagged subunits among the RNA polymerase II molecules is consistent with a stoichiometry of 1 Rpb3 polypeptide per molecule of RNA polymerase. Deletion of either alpha-homology region (amino acids 29-55 or 226-267) from the Rpb3 sequence abolished its ability to assemble into RNA polymerase II in vivo.	Univ Wisconsin, Mcardle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Svetlov, V (corresponding author), Univ Wisconsin, Mcardle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.			Burgess, Richard/0000-0001-9545-3165				Asturias FJ, 1997, J MOL BIOL, V272, P536, DOI 10.1006/jmbi.1997.1273; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; Gross CA, 1996, PHILOS T R SOC B, V351, P475, DOI 10.1098/rstb.1996.0045; HIGGINS DG, 1996, METHOD ENZYMOL, V266, P388; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; KIMURA M, 1995, J MOL BIOL, V248, P756, DOI 10.1006/jmbi.1995.0258; KIMURA M, 1994, J MOL BIOL, V242, P107, DOI 10.1006/jmbi.1994.1562; KIMURA M, 1995, J MOL BIOL, V254, P342, DOI 10.1006/jmbi.1995.0621; Kimura M, 1996, GENES CELLS, V1, P517, DOI 10.1046/j.1365-2443.1996.d01-258.x; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; KOLODZIEJ PA, 1991, MOL CELL BIOL, V11, P4669, DOI 10.1128/MCB.11.9.4669; Korobko IV, 1997, GENE, V185, P1, DOI 10.1016/S0378-1119(96)00626-9; LALO D, 1993, P NATL ACAD SCI USA, V90, P5524, DOI 10.1073/pnas.90.12.5524; LANGER D, 1995, P NATL ACAD SCI USA, V92, P5768, DOI 10.1073/pnas.92.13.5768; Larkin RM, 1997, J BIOL CHEM, V272, P12824, DOI 10.1074/jbc.272.19.12824; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; Ulmasov T, 1996, J BIOL CHEM, V271, P5085, DOI 10.1074/jbc.271.9.5085; WOYCHIK NA, 1994, TRANSCRIPTION MECH R, P227	21	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10827	10830		10.1074/jbc.273.18.10827	http://dx.doi.org/10.1074/jbc.273.18.10827			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556554	hybrid			2022-12-27	WOS:000073395200006
J	Hadzic, E; Habeos, I; Raaka, BM; Samuels, HH				Hadzic, E; Habeos, I; Raaka, BM; Samuels, HH			A novel multifunctional motif in the amino-terminal A/B domain of T3R alpha modulates DNA binding and receptor dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; RETINOIC ACID RECEPTORS; RESPONSE ELEMENTS; X-RECEPTOR; TRANSCRIPTION FACTOR; NUCLEAR RECEPTORS; AUXILIARY PROTEIN; DIRECT REPEATS; RXR-BETA; ALPHA	We reported previously that deletion of the 50-amino acid NH2-terminal A/B domain of the chicken (c) or rat thyroid hormone (T-3) receptor-alpha (T3R alpha) decreased the T-3-dependent stimulation of genes regulated by native thyroid hormone response elements (TREs). This requirement of the NH2-terminal A/B domain for transcriptional activation was mapped to amino acids 21-30 of cT(3)R alpha. Expression of transcription factor IIB (TFIIB) in cells was shown to enhance T-3-dependent transcriptional activation by cT(3)R alpha, and this enhancement by TFIIB was dependent on the same 10-amino acid sequence. In vitro binding studies indicated that cT(3)R alpha interacts efficiently with TFIIB, and this interaction requires amino acids (KRKRK27)-K-23 in the A/B domain. In this study we document the functional importance of these five basic residues in transcriptional activation by cT(3)R alpha, further supporting the biological significance of these residues and their interaction with TFIIB. Interestingly, we also find that the same amino acids also affect DNA binding and dimerization of cT(3)R alpha. Gel mobility shift assays reveal that a cT(3)R alpha mutant that has all five basic amino acids changed from (KRKRK27)-K-23 to (TITIT27)-T-23 binds to a palindromic TRE predominantly as a homodimer, whereas cT(3)R alpha with the wild-type (KRKRK27)-K-23 sequence binds predominantly as a monomer. This results from both a marked decrease in the ability of the cT(3)R alpha mutant to bind as a monomer and from an enhanced ability to dimerize as reflected by an increase in DNA-bound T3R-retinoic X receptor heterodimers. These effects of (KRKRK27)-K-23 on DNA binding, dimerization, transcriptional activation, and the association of T3R alpha with TFIIB support the notion that this basic amino acid motif may influence the overall structure and function of T3R alpha and, thus, play a role in determining the distinct context-dependent transactivation potentials of the individual T3R isoforms.	NYU, Med Ctr, Dept Med, Div Mol Endocrinol, New York, NY 10016 USA; NYU, Med Ctr, Dept Pharmacol, Div Mol Endocrinol, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; New York University	Samuels, HH (corresponding author), NYU, Med Ctr, Dept Med & Pharmacol, TH-454,550 1st Ave, New York, NY 10016 USA.	samueh01@mcrcr.med.nyu.edu			NCI NIH HHS [CA16087] Funding Source: Medline; NCRR NIH HHS [M01 RR00096] Funding Source: Medline; NIDDK NIH HHS [DK16636] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK016636, R01DK016636, R56DK016636] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; AUFLIEGNER M, 1993, MOL CELL BIOL, V13, P5725, DOI 10.1128/MCB.13.9.5725; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BERRODIN TJ, 1992, MOL ENDOCRINOL, V6, P1468, DOI 10.1210/me.6.9.1468; BRENT GA, 1992, MOL ENDOCRINOL, V6, P502, DOI 10.1210/me.6.4.502; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; CHEN HW, 1993, MOL CELL BIOL, V13, P2366, DOI 10.1128/MCB.13.4.2366; CHEN HW, 1995, P NATL ACAD SCI USA, V92, P422, DOI 10.1073/pnas.92.2.422; DARLING DS, 1993, J BIOL CHEM, V268, P10221; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FLUG F, 1987, J BIOL CHEM, V262, P6373; FORMAN BM, 1990, MOL ENDOCRINOL, V4, P1293, DOI 10.1210/mend-4-9-1293; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; FORMAN BM, 1991, GENE, V105, P9, DOI 10.1016/0378-1119(91)90507-8; FREEDMAN LP, 1992, ENDOCR REV, V13, P129, DOI 10.1210/er.13.2.129; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; GIGUERE V, 1995, MOL CELL BIOL, V15, P5858; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HADZIC E, 1995, MOL CELL BIOL, V15, P4507; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; HOLLENBERG AN, 1995, J BIOL CHEM, V270, P14274, DOI 10.1074/jbc.270.24.14274; Judelson C, 1996, J BIOL CHEM, V271, P10800, DOI 10.1074/jbc.271.18.10800; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; LAZAR MA, 1988, MOL ENDOCRINOL, V2, P893, DOI 10.1210/mend-2-10-893; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; LAZAR MA, 1989, P NATL ACAD SCI USA, V86, P7771, DOI 10.1073/pnas.86.20.7771; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; NELSON CC, 1993, MOL ENDOCRINOL, V7, P1185, DOI 10.1210/me.7.9.1185; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SELMI S, 1991, J BIOL CHEM, V266, P11589; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; TOMURA H, 1995, P NATL ACAD SCI USA, V92, P5600, DOI 10.1073/pnas.92.12.5600; TONEY JH, 1993, BIOCHEMISTRY-US, V32, P2, DOI 10.1021/bi00052a001; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; WAHLSTROM GM, 1992, MOL ENDOCRINOL, V6, P1013, DOI 10.1210/me.6.7.1013; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WONG CW, 1995, MOL ENDOCRINOL, V9, P551, DOI 10.1210/me.9.5.551; YEN PM, 1992, J BIOL CHEM, V267, P3565; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; Zhu XG, 1997, J BIOL CHEM, V272, P9048	56	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10270	10278		10.1074/jbc.273.17.10270	http://dx.doi.org/10.1074/jbc.273.17.10270			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553079	hybrid			2022-12-27	WOS:000073224200028
J	Kammerer, RA; Schulthess, T; Landwehr, R; Lustig, A; Fischer, D; Engel, J				Kammerer, RA; Schulthess, T; Landwehr, R; Lustig, A; Fischer, D; Engel, J			Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil alpha-helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERHELICAL SALT BRIDGES; GCN4 LEUCINE-ZIPPER; EXTRACELLULAR-MATRIX; PROTEIN; STABILITY; DOMAIN; DIMERIZATION; LOCALIZATION; TROPOMYOSIN; SPECIFICITY	We have investigated the oligomerization process of tenascin-C using a variety of recombinant wild-type and mutant polypeptide chain fragments produced by heterologous gene expression in Escherichia coli, Biochemical and biophysical analyses of the structures and assemblies of these fragments indicated a sequential two-step oligomerization mechanism of tenascin-C involving the concerted interaction of two distinct domains and cysteines 64, 111, and 113. First, the sequence between alanine 114 and glutamine 139 initiates hexabrachion formation via a parallel three stranded coiled coil. Subsequently, the tenascin assembly domain, which is unique to the tenascins, is responsible for the connection of two triplets to a hexamer. The oligomerization of the tenascin assembly domains by the three-stranded coiled coil increases their homophilic binding affinity and is an important prerequisite for tenascin-C hexamerization. Although formation of the characteristic hexabrachion structure involves the covalent linkage of the six subunits by cysteine residues, mutational analysis indicates that hexamer formation is not dependent on intermolecular disulfide bonds. Most interestingly, substitution of glutamate 130 within the coiled-coil domain by leucine or alanine resulted in the formation of parallel four-stranded helix structures, which further associated to dodecamers. Aside from supporting a sequential process of tenascin-C assembly, this finding provides experimental evidence that non-core residues can have profound effects on the oligomerization states of coiled coils.	Univ Basel, Bioctr, Dept Biophys Chem, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4002 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Engel, J (corresponding author), Univ Basel, Bioctr, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.	engel@ubaclu.unibas.ch		Kammerer, Richard/0000-0003-4570-5197				Beck K, 1997, EMBO J, V16, P3767, DOI 10.1093/emboj/16.13.3767; Brandenberger R, 1996, J CELL BIOL, V135, P1583, DOI 10.1083/jcb.135.6.1583; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; Carnemolla B, 1996, J BIOL CHEM, V271, P8157, DOI 10.1074/jbc.271.14.8157; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CHIQUET M, 1991, EUR J BIOCHEM, V199, P379, DOI 10.1111/j.1432-1033.1991.tb16134.x; CHIQUETEHRISMANN R, 1995, EXPERIENTIA, V51, P853, DOI 10.1007/BF01921736; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONWAY JF, 1991, INT J BIOL MACROMOL, V13, P14, DOI 10.1016/0141-8130(91)90004-E; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; DIERKS SE, 1993, J IMMUNOL, V150, P2372; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; ERICKSON HP, 1984, NATURE, V311, P267, DOI 10.1038/311267a0; Fairman R, 1996, BIOCHEMISTRY-US, V35, P2824, DOI 10.1021/bi952784c; FISCHER D, 1995, J BIOL CHEM, V270, P3378, DOI 10.1074/jbc.270.7.3378; Fischer D, 1997, J CELL SCI, V110, P1513; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; Hagios C, 1996, J CELL BIOL, V134, P1499, DOI 10.1083/jcb.134.6.1499; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hecht JT, 1997, MATRIX BIOL, V16, P72, DOI 10.1016/S0945-053X(97)90086-X; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JONES FS, 1989, P NATL ACAD SCI USA, V86, P1905, DOI 10.1073/pnas.86.6.1905; Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7; Lavigne P, 1996, SCIENCE, V271, P1136, DOI 10.1126/science.271.5252.1136; Lumb KJ, 1996, SCIENCE, V271, P1137, DOI 10.1126/science.271.5252.1137; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MONERA OD, 1994, BIOCHEMISTRY-US, V33, P3862, DOI 10.1021/bi00179a010; NORENBERG U, 1992, NEURON, V8, P849, DOI 10.1016/0896-6273(92)90199-N; OROURKE KM, 1992, J BIOL CHEM, V267, P24921; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; REDICK SD, 1995, J CELL SCI, V108, P1761; RETTIG WJ, 1992, BRAIN RES, V590, P219, DOI 10.1016/0006-8993(92)91099-Z; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800; SPRING J, 1989, CELL, V59, P325, DOI 10.1016/0092-8674(89)90294-8; SU JY, 1994, BIOCHEMISTRY-US, V33, P15501, DOI 10.1021/bi00255a032; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; Van Holde K. E., 1985, PHYSICAL BIOCH, P93; WHITBY DJ, 1991, J CELL SCI, V99, P583; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; ZHOU NE, 1994, J MOL BIOL, V237, P500, DOI 10.1006/jmbi.1994.1250	48	95	97	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10602	10608		10.1074/jbc.273.17.10602	http://dx.doi.org/10.1074/jbc.273.17.10602			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553121	hybrid			2022-12-27	WOS:000073224200070
J	Sivaraman, T; Kumar, TKS; Chang, DK; Lin, WY; Yu, C				Sivaraman, T; Kumar, TKS; Chang, DK; Lin, WY; Yu, C			Events in the kinetic folding pathway of a small, all beta-sheet protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NAJA-NAJA-ATRA; CIRCULAR-DICHROISM; NMR-SPECTROSCOPY; CARDIOTOXIN-III; INTERMEDIATE; IDENTIFICATION; LACTOGLOBULIN; MECHANISM; EXCHANGE; MODELS	The folding of cardiotoxin analogue III (CTX III), a small (60 amino acids), all beta-sheet protein from the venom of the Taiwan Cobra (Naja naja atra) is here investigated. The folding kinetics is monitored by using a variety of techniques such as NMR, fluorescence, and circular dichroism spectroscopy. The folding of the protein is complete within a time scale of 200 ms. The earliest detectable event in the folding pathway of CTX III is the formation of a hydrophobic cluster, which possess strong affinity to bind to nonpolar dye such as 1-anilino-8-naphthalene-sulfonic acid. Quenched-dow deuterium-hydrogen exchange experiments indicate that the segment spanning residues 51-55 along with Lys(23), Ile(39), Val(49), Tyr(51), and Val(52) could constitute the "hydrophobic cluster." Folding kinetics of CTX III based on the amide-protection data reveals that the triple-stranded, antiparallel beta-sheet segment, which is located in the central core of the molecule, appears to fold faster than the double-stranded beta-sheet segment.	Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan; Acad Sinica, Inst Chem, Taipei 115, Taiwan; Natl Taiwan Univ, Dept Chem, Taipei 100, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; National Taiwan University	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan.	cyu@chem.nthu.edu.tw	Chang, Ding-Kwo/E-7079-2015; Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020; Thirunavukkarasu, Sivaraman/P-3182-2017; Kumar, Suresh Thallapuranam/R-5606-2016	Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604; Thirunavukkarasu, Sivaraman/0000-0003-0425-588X; Kumar, Suresh Thallapuranam/0000-0001-7262-1373				AGASHE VR, 1995, PROTEIN SCI, V3, P1945; BAI V, 1993, PROTEIN-STRUCT FUNCT, V17, P75; BALBACH J, 1995, NAT STRUCT BIOL, V2, P865, DOI 10.1038/nsb1095-865; BALDWIN RL, 1995, J BIOMOL NMR, V5, P105; BHASKARAN R, 1994, J MOL BIOL, V235, P1291, DOI 10.1006/jmbi.1994.1082; CAMACHO CJ, 1993, PHYS REV LETT, V71, P2505, DOI 10.1103/PhysRevLett.71.2505; CHAFFOTTE AF, 1992, BIOCHEMISTRY-US, V31, P9694, DOI 10.1021/bi00155a024; DILL KA, 1995, PROTEIN SCI, V4, P561; DYSON HJ, 1992, J MOL BIOL, V226, P795, DOI 10.1016/0022-2836(92)90633-U; GOLDBERG ME, 1991, BIOCHEMISTRY-US, V30, P2790, DOI 10.1021/bi00225a008; GUTIN AM, 1995, BIOCHEMISTRY-US, V34, P3066, DOI 10.1021/bi00009a038; Hamada D, 1996, NAT STRUCT BIOL, V3, P868, DOI 10.1038/nsb1096-868; HIDER RC, 1988, BIOPHYS CHEM, V31, P45, DOI 10.1016/0301-4622(88)80007-3; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; JACOBS MD, 1994, P NATL ACAD SCI USA, V91, P449, DOI 10.1073/pnas.91.2.449; Jayaraman G, 1996, INT J BIOL MACROMOL, V18, P303, DOI 10.1016/0141-8130(95)01088-2; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; KUMAR TKS, 1995, BIOCHEM BIOPH RES CO, V207, P536, DOI 10.1006/bbrc.1995.1221; Kumar TKS, 1996, ADV EXP MED BIOL, V391, P115; Kumar TKS, 1996, BIOCHEM BIOPH RES CO, V219, P450, DOI 10.1006/bbrc.1996.0254; KUSZEWSKI J, 1994, PROTEIN SCI, V3, P1945, DOI 10.1002/pro.5560031106; Kuwajima K, 1996, J MOL BIOL, V264, P806, DOI 10.1006/jmbi.1996.0678; Lu H, 1997, J MOL BIOL, V265, P112, DOI 10.1006/jmbi.1996.0715; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; SHAKHNOVICH EI, 1989, EUROPHYS LETT, V9, P569, DOI 10.1209/0295-5075/9/6/013; Sivaraman T, 1997, BIOCHEM J, V321, P457, DOI 10.1042/bj3210457; Sivaraman T, 1998, BIOCHEM MOL BIOL INT, V44, P29; UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0; VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553	32	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10181	10189		10.1074/jbc.273.17.10181	http://dx.doi.org/10.1074/jbc.273.17.10181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553067	hybrid			2022-12-27	WOS:000073224200016
J	Szabo, K; Welker, E; Bakos, E; Muller, M; Roninson, I; Varadi, A; Sarkadi, B				Szabo, K; Welker, E; Bakos, E; Muller, M; Roninson, I; Varadi, A; Sarkadi, B			Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1 - Cooperation of the nucleotide binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER P-GLYCOPROTEIN; ATPASE ACTIVITY; RESISTANCE PROTEIN; INSECT CELLS; OVARY CELLS; RECONSTITUTION; SITE; EXPRESSION; HYDROLYSIS	The human multidrug transporter (MDR1 or P-glycoprotein) is an ATP-dependent cellular drug extrusion pump, and its function involves a drug-stimulated, vanadate-inhibited ATPase activity. In the presence of vanadate and MgATP, a nucleotide (ADP) is trapped in MDR1, which alters the drug binding properties of the protein. Here, we demonstrate that the rate of vanadate-dependent nucleotide trapping by MDR1 is significantly stimulated by the transported drug substrates in a concentration-dependent manner closely resembling the drug stimulation of MDR1-ATPase., Non-MDR1 substrates do not modulate, whereas N-ethylmaleimide, a covalent inhibitor of the ATPase activity, eliminates vanadate-dependent nucleotide trapping. A deletion in MDR1 (Delta amino acids 78-97), which alters the substrate stimulation of its ATPase activity, similarly alters the drug dependence of nucleotide trapping. MDR1 variants with mutations of key lysine residues to methionines in the N-terminal or C-terminal nucleotide binding domains (K433M, K1076M, and K433M/K1076M), which bind but do not hydrolyze ATP, do not show nucleotide trapping either with or without the transported drug substrates. These data indicate that vanadate dependent nucleotide trapping reflects a drug-stimulated partial reaction of ATP hydrolysis by MDR1, which involves the cooperation of the two nucleotide binding domains. The analysis of this drug-dependent partial reaction may significantly help to characterize the substrate recognition and the ATP-dependent transport mechanism of the MDR1 pump protein.	Hungarian Acad Sci, Res Grp, Natl Inst Haematol & Immunol, H-1113 Budapest, Hungary; Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1113 Budapest, Hungary; Univ Illinois, Dept Genet, Chicago, IL 60612 USA	Hungarian Academy of Sciences; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sarkadi, B (corresponding author), Hungarian Acad Sci, Res Grp, Natl Inst Haematol & Immunol, Daroczi U 24, H-1113 Budapest, Hungary.	B.Sarkadi@ohvi.hu	Varadi, Andras/A-2055-2012; Sarkadi, Balazs/I-5024-2013; Roninson, Igor/K-1310-2017; Welker, Ervin/AAC-6493-2022	Roninson, Igor/0000-0002-9211-1327; 	FOGARTY INTERNATIONAL CENTER [R03TW000586] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA040333] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW00586] Funding Source: Medline; NCI NIH HHS [R37 CA40333] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; Childs S, 1994, Important Adv Oncol, P21; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; GERMANN UA, 1995, J BIOENERG BIOMEMBR, V27, P53, DOI 10.1007/BF02110331; GERMANN UA, 1990, BIOCHEMISTRY-US, V29, P2295, DOI 10.1021/bi00461a013; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LOO TW, 1994, J BIOL CHEM, V269, P7750; Muller M, 1996, J BIOL CHEM, V271, P1877; Sankaran B, 1997, ARCH BIOCHEM BIOPHYS, V341, P160, DOI 10.1006/abbi.1997.9944; SARKADI B, 1994, FASEB J, V8, P766, DOI 10.1096/fasebj.8.10.7914178; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SCARBOROUGH GA, 1995, J BIOENERG BIOMEMBR, V27, P37, DOI 10.1007/BF02110329; SCHINKEL AH, 1993, J BIOL CHEM, V268, P7474; SENIOR AE, 1995, J BIOENERG BIOMEMBR, V27, P31, DOI 10.1007/BF02110328; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; TANAKA S, 1990, BIOCHEM BIOPH RES CO, V166, P180, DOI 10.1016/0006-291X(90)91928-L; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Wang Y, 1997, ANTICANCER RES, V17, P357; WELKER E, 1995, BIOCHEM BIOPH RES CO, V216, P602, DOI 10.1006/bbrc.1995.2665; YOUNT RG, 1992, PHILOS T ROY SOC B, V336, P55, DOI 10.1098/rstb.1992.0044	34	80	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10132	10138		10.1074/jbc.273.17.10132	http://dx.doi.org/10.1074/jbc.273.17.10132			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553060	hybrid			2022-12-27	WOS:000073224200009
J	Lincoln, AJ; Monczak, Y; Williams, SC; Johnson, PF				Lincoln, AJ; Monczak, Y; Williams, SC; Johnson, PF			Inhibition of CCAAT/enhancer-binding protein alpha and beta translation by upstream open reading frames	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR PROTEIN; DECARBOXYLASE MESSENGER-RNA; ACUTE-PHASE RESPONSE; C/EBP-ALPHA; ADIPOCYTE DIFFERENTIATION; 3T3-L1 PREADIPOCYTES; MYELOMONOCYTIC CELLS; EUKARYOTIC RIBOSOMES; GENE-EXPRESSION; FAMILY	CCAAT/enhancer-binding protein (C/EBP) alpha is a bZIP transcription factor whose expression is restricted to specific cell types. Analysis of C/EBP alpha mRNA and protein levels in various mammalian cells indicates that expression of this gene is controlled both transcriptionally and post-transcriptionally. We report here that C/EBP alpha translation is repressed in several cell lines by an evolutionarily conserved upstream open reading frame (uORF), which acts in cis to inhibit C/EBP alpha translation. Mutations that disrupt the uORF completely abolished translational repression of C/EBP alpha. The related c/ebp beta gene also contains an uORF that suppresses translation. The length of the spacer sequence between the uORF terminator and the ORF initiator codon (7 bases in all c/ebp alpha genes and 4 bases in c/ebp beta homologs) is precisely conserved. The effects of insertions, deletions, and base substitutions in the C/EBP alpha spacer showed that both the length and nucleotide sequence of the spacer are important for efficient translational repression. Our data indicate that the uORFs regulate translation of full-length C/EBP alpha and C/EBP beta and do not play a role in generating truncated forms of these proteins, as has been suggested by start site multiplicity models.	NCI, Frederick Canc Res & Dev Ctr, Adv Biosci Labs, Basic Res Program,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Johnson, PF (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Adv Biosci Labs, Basic Res Program,NIH, POB B, Frederick, MD 21702 USA.	johnsopf@fcrfv1.ncifcrf.gov	Johnson, Peter/A-1940-2012	Johnson, Peter/0000-0002-4145-4725				AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; An MR, 1996, MOL CELL BIOL, V16, P2295; ANTONSON P, 1995, BIOCHEM BIOPH RES CO, V215, P106, DOI 10.1006/bbrc.1995.2439; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; CALKHOVEN CF, 1994, NUCLEIC ACIDS RES, V22, P5540, DOI 10.1093/nar/22.25.5540; CALKHOVEN CF, 1992, NUCLEIC ACIDS RES, V20, P4093, DOI 10.1093/nar/20.15.4093; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHANDRASEKARAN C, 1993, P NATL ACAD SCI USA, V90, P8871, DOI 10.1073/pnas.90.19.8871; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; Constance CM, 1996, MOL CELL BIOL, V16, P3878; DANIELSON PE, 1988, DNA CELL BIOL, V1, P261; DEGNIN CR, 1993, J VIROL, V67, P5514, DOI 10.1128/JVI.67.9.5514-5521.1993; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HILL JR, 1993, J BIOL CHEM, V268, P726; HILL JR, 1992, J BIOL CHEM, V267, P21886; HINNEBUSCH AG, 1994, TRENDS BIOCHEM SCI, V19, P409, DOI 10.1016/0968-0004(94)90089-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOPP TP, 1988, BIOTECHNOLOGY, V6, P1205; Jamaluddin M, 1996, J VIROL, V70, P1554, DOI 10.1128/JVI.70.3.1554-1563.1996; JOHNSON PF, 1994, LIVER GENE EXPRESSIO, P231; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; LI F, 1995, AM J PHYSIOL-LUNG C, V269, pL241, DOI 10.1152/ajplung.1995.269.2.L241; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; McKnight SL, 1992, TRANSCRIPTIONAL REGU, P771; MILLER PF, 1989, GENE DEV, V3, P1217, DOI 10.1101/gad.3.8.1217; Moore DD, 1995, GLOB MOB SURV; MORRIS DR, 1995, PROG NUCLEIC ACID RE, V51, P339, DOI 10.1016/S0079-6603(08)60883-1; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Nalbant D, 1998, ENDOCRINOLOGY, V139, P272, DOI 10.1210/en.139.1.272; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; PANTOPOULOS K, 1994, PROG NUCLEIC ACID RE, V48, P181, DOI 10.1016/S0079-6603(08)60856-9; PIONTKEWITZ Y, 1993, ENDOCRINOLOGY, V133, P2327, DOI 10.1210/en.133.5.2327; SAMUELSSON L, 1991, EMBO J, V10, P3787, DOI 10.1002/j.1460-2075.1991.tb04948.x; SCHLEISS MR, 1991, J VIROL, V65, P6782, DOI 10.1128/JVI.65.12.6782-6789.1991; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; SCOTT LM, 1992, BLOOD, V80, P1725; Taniguchi Y, 1996, J ANIM SCI, V74, P2554; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; Yamaoka I, 1997, J ANIM SCI, V75, P587; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	63	75	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9552	9560		10.1074/jbc.273.16.9552	http://dx.doi.org/10.1074/jbc.273.16.9552			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545285	hybrid			2022-12-27	WOS:000073128800031
J	Spencer, AG; Woods, JW; Arakawa, T; Singer, II; Smith, WL				Spencer, AG; Woods, JW; Arakawa, T; Singer, II; Smith, WL			Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); HUMAN ALVEOLAR MACROPHAGES; INNER NUCLEAR-MEMBRANE; LAMIN-B RECEPTOR; ENDOPLASMIC-RETICULUM; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONIC-ACID; G/H SYNTHASE; MAST-CELLS; FORMING CYCLOOXYGENASE	Prostaglandin endoperoxide H synthases-1 and -2 (PGHS-1 and -2) are the major targets of nonsteroidal anti-inflammatory drugs like aspirin and ibuprofen. These enzymes catalyze the committed step in the formation of prostanoids from arachidonic acid. Although PGHS-1 and -2 are similar biochemically, a number of studies suggest that PGHS-1 and PGHS-2 function independently to form prostanoids that subserve different cellular functions. We have hypothesized that these isozymes may reside, at least in part, in different subcellular compartments and that their compartmentation may affect their access to arachidonic acid and serve to separate the functions of the enzymes. To obtain high resolution data on the subcellular locations of PGHS-1 and -2, we employed immunoelectron microscopy with multiple antibodies specific to each isozyme. Both PGHS-1 and -2 were found on the lumenal surfaces of the endoplasmic reticulum (ER) and nuclear envelope of human monocytes, murine NIH 3T3 cells, and human umbilical vein endothelial cells. Within the nuclear envelope, PGHS-1 and -2 were present on both the inner and outer nuclear membranes and in similar proportions. Western blotting data showed a similar distribution of PGHS-1 and -2 in subcellular fractions, and product analysis using isozyme-specific inhibitors suggested that both enzymes generate the same products in NIH 3T3 cells. Thus, we are unable to attribute the independent functioning of PGHS-1 and PGHS-2 to differences in their subcellular locations. Instead, the independent operation of these isozymes may be attributable to subtle kinetic differences (e.g. negative allosteric regulation of PGHS-1 at low concentrations of arachidonate (500-1000 nM)). A further conclusion of importance from a cell biological perspective is that membrane proteins such as PGHS-1 and -2, which are located on the lumenal surface of the ER, are able to diffuse freely among the ER and the inner and outer membranes of the nuclear envelope.	Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Biochem & Mol Pathol, Rahway, NJ 07065 USA	Michigan State University; Merck & Company	Smith, WL (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK022042, R37DK022042] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK22042] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; Bingham CO, 1996, J BIOL CHEM, V271, P25936, DOI 10.1074/jbc.271.42.25936; Byrum RS, 1997, J EXP MED, V185, P1065, DOI 10.1084/jem.185.6.1065; Capdevila JH, 1996, J BIOL CHEM, V271, P22663, DOI 10.1074/jbc.271.37.22663; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DEWITT DL, 1993, ARCH BIOCHEM BIOPHYS, V306, P94, DOI 10.1006/abbi.1993.1485; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; EVETT GE, 1993, ARCH BIOCHEM BIOPHYS, V306, P169, DOI 10.1006/abbi.1993.1496; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; HEMPEL SL, 1994, J CLIN INVEST, V93, P391, DOI 10.1172/JCI116971; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; HONIGMANN MRS, 1996, LAB INVEST, V74, P684; INNIS JW, 1983, MOL CELL BIOL, V3, P2203, DOI 10.1128/MCB.3.12.2203; KARGMAN S, 1992, J CELL BIOL, V119, P1701, DOI 10.1083/jcb.119.6.1701; Kargman S, 1996, GASTROENTEROLOGY, V111, P445, DOI 10.1053/gast.1996.v111.pm8690211; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; MATSUURA S, 1983, CELL STRUCT FUNCT, V8, P1, DOI 10.1247/csf.8.1; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; MURAKAMI M, 1995, J EXP MED, V182, P197, DOI 10.1084/jem.182.1.197; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1995, ADV PROSTAG THROMB L, V23, P29; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Otto JC, 1996, J BIOL CHEM, V271, P9906, DOI 10.1074/jbc.271.17.9906; PICOT D, 1994, FEBS LETT, V346, P21, DOI 10.1016/0014-5793(94)00314-9; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; REGIER MK, 1993, ARCH BIOCHEM BIOPHYS, V301, P439, DOI 10.1006/abbi.1993.1168; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; RUAN KH, 1993, J BIOL CHEM, V268, P19483; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SCHILLING LJ, 1994, NUCLEIC ACIDS RES, V22, P3061, DOI 10.1093/nar/22.15.3061; SHIMOKAWA T, 1991, J BIOL CHEM, V266, P6168; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SMITH S, 1993, J CELL BIOL, V120, P631, DOI 10.1083/jcb.120.3.631; SMITH WL, 1986, ANNU REV PHYSIOL, V48, P251; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; SMITH WL, 1978, AM J PHYSIOL, V235, pF451, DOI 10.1152/ajprenal.1978.235.5.F451; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; Song I, 1996, ARCH BIOCHEM BIOPHYS, V334, P67, DOI 10.1006/abbi.1996.0430; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Swinney DC, 1997, J BIOL CHEM, V272, P12393, DOI 10.1074/jbc.272.19.12393; TAKAHASHI Y, 1993, J BIOL CHEM, V268, P16443; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; VICKERS PJ, 1995, J LIPID MEDIAT CELL, V12, P185, DOI 10.1016/0929-7855(95)00018-L; WANG X, 1994, CELL, V477, P53; WOODS JW, 1995, J CLIN INVEST, V95, P2035, DOI 10.1172/JCI117889; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935	69	280	286	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9886	9893		10.1074/jbc.273.16.9886	http://dx.doi.org/10.1074/jbc.273.16.9886			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545330	hybrid			2022-12-27	WOS:000073128800076
J	Uria, JA; Jimenez, MG; Balbin, M; Freije, JMP; Lopez-Otin, C				Uria, JA; Jimenez, MG; Balbin, M; Freije, JMP; Lopez-Otin, C			Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; STROMELYSIN GENE-EXPRESSION; HUMAN-LUNG FIBROBLASTS; MESSENGER-RNA; MATRIX METALLOPROTEINASES; SUBSTRATE-SPECIFICITY; EXTRACELLULAR-MATRIX; RHEUMATOID-ARTHRITIS; CELL-PROLIFERATION; OSTEOBLASTIC CELLS	Collagenase-3 (MMP-13) is a matrix metalloproteinase (MMP) originally identified in breast carcinomas which is also produced at significant levels during fetal ossification and in arthritic processes. In this work, we have found that transforming growth factor beta 1 (TGF-beta 1), a growth factor widely assumed to be inhibitory for MMPs, strongly induces collagenase-3 expression in human KMST fibroblasts. In contrast, this growth factor down-regulated the expression in these cells of collagenase-1 (MMP-1), an enzyme highly related to collagenase-3 in terms of structure and enzymatic properties. The positive effect of TGF-beta 1 on collagenase-3 expression was dose-and time-dependent, but independent of the effects of this growth factor on cell proliferation rate. Analysis of the signal transduction mechanisms underlying the up-regulating effect of TGF-beta 1 on collagenase-3 expression demonstrated that this growth factor acts through a signaling pathway involving protein kinase C and tyrosine kinase activities. Functional analysis of the collagenase-3 gene promoter region revealed that the inductive effect of TGF-beta 1 is partially mediated by an AP-1 site. Comparative analysis with the promoter region of the collagenase-1 gene which contains an AP-1 site at equivalent position, confirmed that TGF-beta 1 did not have any effect on CAT activity levels of this promoter. Finally, by using electrophoretic mobility shift assays and antibody supershift analysis, we propose that c-Fos, c-Jun, and JunD may play major roles in the collagenase-3 activation by TGF-beta 1 in human fibroblasts.	Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Oviedo	Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.		Balbín, Milagros/I-4206-2015; Freije, José M.P./A-6535-2008; López-Otín, Carlos/AAB-2106-2020	Balbín, Milagros/0000-0001-5325-0407; Freije, José M.P./0000-0002-4688-8266; López-Otín, Carlos/0000-0001-6964-1904				ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; Banerjee C, 1996, ENDOCRINOLOGY, V137, P1991, DOI 10.1210/en.137.5.1991; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Chen Y, 1996, J BIOL CHEM, V271, P31602, DOI 10.1074/jbc.271.49.31602; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; FINE A, 1987, J BIOL CHEM, V262, P3897; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; GAIRE M, 1994, J BIOL CHEM, V269, P2032; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HASTY KA, 1987, J BIOL CHEM, V262, P10048; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Johansson N, 1997, CELL GROWTH DIFFER, V8, P243; KEETON MR, 1991, J BIOL CHEM, V266, P23048; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; KESKIOJA J, 1988, J CELL BIOL, V106, P451, DOI 10.1083/jcb.106.2.451; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LAIHO M, 1986, J CELL BIOL, V103, P2403, DOI 10.1083/jcb.103.6.2403; LI CY, 1995, J BIOL CHEM, V270, P4971, DOI 10.1074/jbc.270.10.4971; Lindy O, 1997, ARTHRITIS RHEUM-US, V40, P1391, DOI 10.1002/art.1780400806; Llano E, 1997, BIOCHEMISTRY-US, V36, P15101, DOI 10.1021/bi972120y; LUND LR, 1987, EMBO J, V6, P1281, DOI 10.1002/j.1460-2075.1987.tb02365.x; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; MACHWATE M, 1995, MOL ENDOCRINOL, V9, P187, DOI 10.1210/me.9.2.187; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MAUVIEL A, 1993, CURR BIOL, V3, P822, DOI 10.1016/0960-9822(93)90216-B; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MURPHY G, 1992, J RHEUMATOL, V19, P61; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Pendas AM, 1997, J BIOL CHEM, V272, P4281, DOI 10.1074/jbc.272.7.4281; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; PENDAS AM, 1995, GENOMICS, V26, P615, DOI 10.1016/0888-7543(95)80186-P; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Rydziel S, 1997, J CELL PHYSIOL, V170, P145, DOI 10.1002/(SICI)1097-4652(199702)170:2<145::AID-JCP6>3.0.CO;2-O; Sambrook J., 2002, MOL CLONING LAB MANU; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHAPIRO SD, 1994, AM J RESP CRIT CARE, V150, P5160; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; StahleBackdahl M, 1997, LAB INVEST, V76, P717; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Uria JA, 1997, CANCER RES, V57, P4882; VINCENTI MP, 1994, NUCLEIC ACIDS RES, V22, P4818, DOI 10.1093/nar/22.22.4818; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; Wernicke D, 1996, J RHEUMATOL, V23, P590; WESTERMARCK J, 1994, CELL GROWTH DIFFER, V5, P1205; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705	70	178	181	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9769	9777		10.1074/jbc.273.16.9769	http://dx.doi.org/10.1074/jbc.273.16.9769			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545314	hybrid			2022-12-27	WOS:000073128800060
J	Hamiche, A; Richard-Foy, H				Hamiche, A; Richard-Foy, H			The switch in the helical handedness of the histone (H3-H4)(2) tetramer within a nucleoprotein particle requires a reorientation of the H3-H3 interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL DNA RINGS; CHROMATIN RECONSTITUTION; SUPERCOILED DNA; CORE PARTICLE; CIRCULAR DNA; NUCLEOSOME; TRANSCRIPTION; PROTEIN; H-3; DEPENDENCE	It has recently been proposed that the histone (H3-H4)(2) tetramer undergoes structural changes, which allow the particle to accommodate both negatively and positively constrained DNA. To investigate this process, we modified histone H3 at the H3-H3 interface, within the histone (H2A-H2B-H3-H4)(2) octamer or the histone (H3-H4), tetramer, by forming adducts on the single cysteine of duck histone H3. We used three sulfhydryl reagents, iodoacetamide, N-ethylmaleimide, and 5,5'-dithiobis(2-nitrobenzoic acid). Torsionally constrained DNA was assembled on the modified histones. The H3 adducts, which have no effect on the structure of the nucleosome, dramatically affected the structural transitions that the (H3-H4)(2) tetrameric nucleoprotein particle can undergo. Iodoacetamide and N-ethylmaleimide treatment prevented the assembly of positively constrained DNA on the tetrameric particle, whereas 5,5'-dithiobis(2-nitrobenzoic acid) treatment strongly favored it, Determination of DNA topoisomer equilibrium after relaxation of the tetrameric nucleoprotein particles with topoisomerase I demonstrated that the structural transition occurs without histone dissociation. Incorporation of H2A-H2B dimers into the tetrameric particle containing modified or unmodified cysteines allowed nucleosomes to reform and blocked the structural transition of the particle. We demonstrate the importance of the histone H3-H3 contact region in the conformational changes of the histone tetramer nucleoprotein particle and the role of H2A-H2B in preventing a structural transition of the nucleosome.	CNRS, Lab Biol Mol Eucaryote, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Richard-Foy, H (corresponding author), CNRS, Lab Biol Mol Eucaryote, 118 Route de Narbonne, F-31062 Toulouse, France.	hrfoy@ibcg.biotoul.fr						ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; BAER BW, 1983, NATURE, V301, P482, DOI 10.1038/301482a0; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BATES DL, 1981, EUR J BIOCHEM, V119, P469, DOI 10.1111/j.1432-1033.1981.tb05631.x; BAUER WR, 1978, ANNU REV BIOPHYS BIO, V7, P287, DOI 10.1146/annurev.bb.07.060178.001443; BINASTEIN M, 1977, CELL, V11, P609, DOI 10.1016/0092-8674(77)90078-2; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; DABAN JR, 1982, J MOL BIOL, V156, P771, DOI 10.1016/0022-2836(82)90141-3; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; FEINSTEIN DL, 1986, BIOCHEMISTRY-US, V25, P8409, DOI 10.1021/bi00374a013; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; GOULET I, 1987, NUCLEIC ACIDS RES, V15, P2803, DOI 10.1093/nar/15.7.2803; Grayling RA, 1996, ADV PROTEIN CHEM, V48, P437; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; HOROWITZ DS, 1984, J MOL BIOL, V173, P75, DOI 10.1016/0022-2836(84)90404-2; JACKSON S, 1994, BIOCHEMISTRY-US, V33, P5392, DOI 10.1021/bi00184a006; JACKSON V, 1995, BIOCHEMISTRY-US, V34, P10607, DOI 10.1021/bi00033a036; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; JACKSON V, 1993, BIOCHEMISTRY-US, V32, P5901, DOI 10.1021/bi00073a024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBRET M, 1980, BIOPOLYMERS, V19, P619, DOI 10.1002/bip.1980.360190312; LEE MS, 1991, EMBO J, V10, P607, DOI 10.1002/j.1460-2075.1991.tb07988.x; LEE MS, 1991, P NATL ACAD SCI USA, V88, P9675, DOI 10.1073/pnas.88.21.9675; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LOUTERS L, 1985, BIOCHEMISTRY-US, V24, P3080, DOI 10.1021/bi00334a002; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PULLEYBLANK DE, 1975, P NATL ACAD SCI USA, V72, P4280, DOI 10.1073/pnas.72.11.4280; Reeve JN, 1997, CELL, V89, P999, DOI 10.1016/S0092-8674(00)80286-X; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Riordan J F, 1972, Methods Enzymol, V25, P449, DOI 10.1016/S0076-6879(72)25040-6; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; SOLLNERWEBB B, 1976, CELL, V9, P179, DOI 10.1016/0092-8674(76)90063-5; Starich MR, 1996, J MOL BIOL, V255, P187, DOI 10.1006/jmbi.1996.0016; STEIN A, 1979, J MOL BIOL, V130, P103, DOI 10.1016/0022-2836(79)90421-2; van Holde KE., 1989, SPRINGER SERIES MOL; WANG JC, 1982, COLD SPRING HARB SYM, V47, P85, DOI 10.1101/SQB.1983.047.01.011; Wolffe AP, 1997, NATURE, V387, P16, DOI 10.1038/387016a0; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P267, DOI 10.1016/0022-2836(88)90239-2; ZIVANOVIC Y, 1986, J MOL BIOL, V192, P645, DOI 10.1016/0022-2836(86)90282-2; ZIVANOVIC Y, 1990, J MOL BIOL, V214, P479, DOI 10.1016/0022-2836(90)90195-R	49	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9261	9269		10.1074/jbc.273.15.9261	http://dx.doi.org/10.1074/jbc.273.15.9261			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535919	hybrid			2022-12-27	WOS:000072990800096
J	Bae, CD; Min, DS; Fleming, IN; Exton, JH				Bae, CD; Min, DS; Fleming, IN; Exton, JH			Determination of interaction sites on the small G protein RhoA for phospholipase D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEIN; BOTULINUM C3 EXOENZYME; CELL-CYCLE PROGRESSION; KINASE-C; HL-60 CELLS; COILED-COIL; ACTIVATION; RAC; CDC42	Phospholipase D (PLD) has been identified as a target of small G proteins of the Rho family. The present study was directed at defining the interaction sites of RhoA with rat brain PLD in vitro using chimeric proteins between RhoA and Ha-Ras or Cdc42Hs and point mutations. The switch I region of RhoA, which is the common effector domain of Ras-like G proteins, was a crucial interaction site for PLD. Mutations in conserved amino acids (Tyr(34), Thr(37), Phe(39)) totally abolished PLD activation, while mutations in Val(38) or Tyr(42) caused partial loss. Two additional sites were responsible for the differential PLD activation ability between RhoA and Cdc42Hs. Changing Asp(76) in the switch II region of RhoA to the corresponding amino acid in Cdc42Hs led to partial loss of PLD activation. A chimeric protein with the N-terminal third of Cdc42Hs changed to RhoA showed enhanced PLD activation. Analysis of other Rho/Ha-Ras chimeric proteins and mutations indicated that Gln(52) adjacent to the switch II region is responsible for this gain of function. In conclusion, the present study shows that conserved amino acids in the switch I region of RhoA are major PLD interaction sites and that residues in the switch II and internal regions are responsible for the differential activation of PLD by RhoA and Cdc42Hs.	Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University	Exton, JH (corresponding author), Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, 221 Kirkland Hall, Nashville, TN 37232 USA.	john.exton@mcmail.vanderbilt.edu		Fleming, Ian/0000-0001-9505-6418				Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hess JA, 1997, J BIOL CHEM, V272, P1615, DOI 10.1074/jbc.272.3.1615; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; KURIBARA H, 1995, J BIOL CHEM, V270, P25667, DOI 10.1074/jbc.270.43.25667; KWAK JY, 1995, J BIOL CHEM, V270, P27093, DOI 10.1074/jbc.270.45.27093; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Li R, 1997, J BIOL CHEM, V272, P4671, DOI 10.1074/jbc.272.8.4671; Machesky LM, 1996, TRENDS CELL BIOL, V6, P304, DOI 10.1016/0962-8924(96)10026-X; Malcolm KC, 1996, J BIOL CHEM, V271, P13135, DOI 10.1074/jbc.271.22.13135; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Min DS, 1998, J BIOL CHEM, V273, P7044, DOI 10.1074/jbc.273.12.7044; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Ohguchi K, 1996, J BIOL CHEM, V271, P4366; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Schmidt M, 1996, J BIOL CHEM, V271, P2422, DOI 10.1074/jbc.271.5.2422; SELF AJ, 1993, ONCOGENE, V8, P655; SIDDIQI AR, 1995, J BIOL CHEM, V270, P8466, DOI 10.1074/jbc.270.15.8466; Singer WD, 1996, J BIOL CHEM, V271, P4504; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153; XU XM, 1994, J BIOL CHEM, V269, P23569; ZHANG FL, 1994, J BIOL CHEM, V269, P3175; ZHENG Y, 1995, METHOD ENZYMOL, V256, P77; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	46	72	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11596	11604		10.1074/jbc.273.19.11596	http://dx.doi.org/10.1074/jbc.273.19.11596			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565577	hybrid			2022-12-27	WOS:000073536700031
J	Miller, A; Wang, LG; Kendall, DA				Miller, A; Wang, LG; Kendall, DA			Communication - Synthetic signal peptides specifically recognize SecA and stimulate ATPase activity in the absence of preprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI INNER MEMBRANE; ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; PRECURSOR PROTEINS; BINDING; REGION; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPIDS; INSERTION; INTERACTS	Although it is known that virtually all exported proteins require a signal peptide, it is not clearly understood how the signal peptide interfaces with the translocation machinery to achieve transport. In this study we document a direct interaction between the signal peptide and SecA, a primary component of the translocase in Escherichia coli, and show that the signal peptide itself can stimulate SecA-lipid ATPase activity. Using synthetic signal peptides corresponding to the wild type alkaline phosphatase signal sequence and two model sequences, we find that the extent of stimulation of SecA ATPase activity by the different peptides parallels the hierarchy of results found for in vivo function (Izard, J. W.,, Doughty, M. B., and Kendall, D., A. (1995) Biochemistry 34, 9904-9912). The peptide-induced activity requires a lipid to protein molar ratio of at least 300:1 and liposomes enriched in negatively charged phospholipids. Furthermore, specific binding of the signal peptide to SecA was demonstrated using chemical crosslinking and competition with unlabeled peptides.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Kendall, DA (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Box U-44, Storrs, CT 06269 USA.	kendall@uconnvm.uconn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037639] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37639] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKITA M, 1990, J BIOL CHEM, V265, P8164; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CUNNINGHAM K, 1989, P NATL ACAD SCI USA, V86, P8630, DOI 10.1073/pnas.86.22.8630; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; FIKES JD, 1989, J BACTERIOL, V171, P402, DOI 10.1128/jb.171.1.402-409.1989; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; IZARD JW, 1995, BIOCHEMISTRY-US, V34, P9904, DOI 10.1021/bi00031a012; KIM YJ, 1994, CELL, V78, P845; KIMURA E, 1991, J BIOL CHEM, V266, P6600; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Mori H, 1997, BBA-BIOMEMBRANES, V1326, P23, DOI 10.1016/S0005-2736(97)00004-7; OLIVER DB, 1993, MOL MICROBIOL, V7, P159, DOI 10.1111/j.1365-2958.1993.tb01107.x; PHOENIX DA, 1993, J BIOL CHEM, V268, P17069; RAJAPANDI T, 1994, BIOCHEM BIOPH RES CO, V200, P1477, DOI 10.1006/bbrc.1994.1617; Randall LL, 1997, P NATL ACAD SCI USA, V94, P802, DOI 10.1073/pnas.94.3.802; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SELIGMAN SJ, 1993, ANAL BIOCHEM, V211, P324, DOI 10.1006/abio.1993.1277; Snyders S, 1997, J BIOL CHEM, V272, P11302; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514	25	52	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11409	11412		10.1074/jbc.273.19.11409	http://dx.doi.org/10.1074/jbc.273.19.11409			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565549	hybrid			2022-12-27	WOS:000073536700003
J	Ackermann, EJ; Ang, ETH; Kanter, JR; Tsigelny, I; Taylor, P				Ackermann, EJ; Ang, ETH; Kanter, JR; Tsigelny, I; Taylor, P			Identification of pairwise interactions in the alpha-neurotoxin-nicotinic acetylcholine receptor complex through double mutant cycles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; GATED ION CHANNELS; BINDING-SITE; LIGAND-BINDING; K+ CHANNEL; MOLECULAR DISSECTION; BUNGAROTOXIN BINDING; CONSERVED TYROSINES; SUBUNIT INTERFACES; GAMMA-SUBUNIT	alpha-Neurotoxins are potent inhibitors of the nicotinic acetylcholine receptor (nAChR), binding with high affinity to the two agonist sites located on the extracellular domain. Previous site-directed mutagenesis had identified three residues on the Lu-neurotoxin from Naja mossambica mossambica (Lys(27), Arg(33), and Lys(47)), and four residues on the mouse muscle nAChR cy-subunit (Val(188), Tyr(190), Pro(197) and Asp(200)) as contributing to binding, In this study, thermodynamic mutant cycle analysis was applied to these sets of residues to identify specific pairwise interactions. Amino acid variants of alpha-neurotoxin from N., mossambica mossambica at position 33 and of the nAChR at position 188 showed strong energetic couplings of 2-3 kcal/mol at both binding sites. Consistently smaller yet significant linkages of 1.6-2.1 kcal/mol were also observed between variants at position 27 on the toxin and position 188 on the receptor. Additionally, toxin residue 27 coupled to the receptor residues 190, 197, and 200 at the alpha delta binding site with observed coupling energies of 1.5-1.9 kcal/mol, No Linkages were found between toxin residue Lys(47) and the receptor residues studied here, These results provide direct evidence that the two conserved cationic residues Arg(33) and Lys(27), located on loop II of the toxin structure, are binding in close proximity to the alpha-subunit region between residues 188-200. The toxin residue Arg(33) is closer to Val(188), where it is likely stabilized by adjacent negative or aromatic residues on the receptor structure. Lys(27) is positioned closer to Tyr(190), Pro(197) and Asp(200), where it is likely stabilized through electrostatic interaction with Asp(200) and/or cation/pi; interactions with Try(190).	Univ Calif San Diego, Dept Pharmacol 0636, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Taylor, P (corresponding author), Univ Calif San Diego, Dept Pharmacol 0636, 9500 Gilman Dr, La Jolla, CA 92093 USA.	priley@ucsd.edu			NIGMS NIH HHS [GM 18360] Funding Source: Medline; NINDS NIH HHS [NS 10082] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360, R37GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010082] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; Ackermann EJ, 1997, BIOCHEMISTRY-US, V36, P12836, DOI 10.1021/bi971513u; AGARD DA, 1982, ACTA CRYSTALLOGR A, V38, P186, DOI 10.1107/S0567739482000436; ARNOUX B, 1994, FEBS LETT, V342, P12, DOI 10.1016/0014-5793(94)80574-1; AYLWIN ML, 1994, MOL PHARMACOL, V46, P1149; AYLWIN ML, 1994, FEBS LETT, V349, P99, DOI 10.1016/0014-5793(94)00649-0; BARCHAN D, 1995, BIOCHEMISTRY-US, V34, P9172, DOI 10.1021/bi00028a029; BASUS VJ, 1993, BIOCHEMISTRY-US, V32, P12290, DOI 10.1021/bi00097a004; BASUS VJ, 1988, BIOCHEMISTRY-US, V27, P2763, DOI 10.1021/bi00408a016; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CHATURVEDI V, 1993, BIOCHEMISTRY-US, V32, P9570, DOI 10.1021/bi00088a008; CZAJKOWSKI C, 1995, J BIOL CHEM, V270, P3160, DOI 10.1074/jbc.270.7.3160; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; Ducancel F, 1996, J BIOL CHEM, V271, P31345, DOI 10.1074/jbc.271.49.31345; ENDO T, 1987, PHARMACOL THERAPEUT, V34, P403, DOI 10.1016/0163-7258(87)90002-7; Faiman GA, 1996, PROTEIN ENG, V9, P315, DOI 10.1093/protein/9.3.315; FU DX, 1994, J BIOL CHEM, V269, P26152; FULACHIER MH, 1994, FEBS LETT, V338, P331, DOI 10.1016/0014-5793(94)80294-7; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GALZI JL, 1994, CURR OPIN STRUC BIOL, V4, P554, DOI 10.1016/S0959-440X(94)90218-6; HATANAKA H, 1994, J MOL BIOL, V240, P155, DOI 10.1006/jmbi.1994.1429; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Hucho F, 1996, EUR J BIOCHEM, V239, P539, DOI 10.1111/j.1432-1033.1996.0539u.x; KAO PN, 1984, J BIOL CHEM, V259, P1662; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KREIENKAMP HJ, 1994, J BIOL CHEM, V269, P8108; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; LOW BW, 1976, P NATL ACAD SCI USA, V73, P2991, DOI 10.1073/pnas.73.9.2991; MCLANE KE, 1991, BIOCHEMISTRY-US, V30, P4925, DOI 10.1021/bi00234a013; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Peng SS, 1997, J BIOL CHEM, V272, P7817, DOI 10.1074/jbc.272.12.7817; PILLET L, 1993, J BIOL CHEM, V268, P909; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1994, J BIOL CHEM, V269, P8808; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; SUGIYAMA M, 1998, IN PRESS MOL PHARM; Sugiyama N, 1996, J BIOL CHEM, V271, P26575, DOI 10.1074/jbc.271.43.26575; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Tsigelny I, 1997, BIOPHYS J, V73, P52, DOI 10.1016/S0006-3495(97)78047-0; Unwin N, 1996, J MOL BIOL, V257, P586, DOI 10.1006/jmbi.1996.0187; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; [No title captured]	55	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10958	10964		10.1074/jbc.273.18.10958	http://dx.doi.org/10.1074/jbc.273.18.10958			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556574	hybrid			2022-12-27	WOS:000073395200026
J	Lyckman, AW; Confaloni, AM; Thinakaran, G; Sisodia, SS; Moya, KL				Lyckman, AW; Confaloni, AM; Thinakaran, G; Sisodia, SS; Moya, KL			Post-translational processing and turnover kinetics of presynaptically targeted amyloid precursor superfamily proteins in the central nervous system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE GLYCOSAMINOGLYCAN; HAMSTER RETINOFUGAL AXONS; CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; OPTIC-NERVE; IN-VIVO; TRANSPORT; NEURONS	The amyloid precursor superfamily is composed of three highly conserved transmembrane glycoproteins, the amyloid precursor protein (APP) and amyloid precursor-like proteins 1 and 2 (APLP1, APLP2), whose functions are unknown. Proteolytic cleavage of APP yields the beta A4 peptide, the major component of cerebral amyloid in Alzheimer's disease. Here we show that five post-translationally modified, full-length species of APP and APLP2 (but not APLP1) arrive at the mature presynaptic terminal in the fastest wave of axonal transport and are subsequently rapidly cleared (mean half-life of 3.5 h). Rapid turnover of presynaptic APP and APLP2 occurs independently of visual activity. Turnover of the most rapidly arriving APP species was accompanied by a delayed accumulation of a 120-kDa, APP fragment lacking the C terminus, consistent with presynaptic APP turnover via constitutive proteolysis. Turnover of APLP2 was not accompanied by detectable APLP2 fragment peptides, suggesting either that APLP2 either is more rapidly degraded than is APP or is retrogradely transported shortly after reaching the terminus. A single 150-kDa APLP2 species containing the Kunitz protease inhibitor domain is the major amyloid precursor superfamily protein transported to the presynapse. Presynaptic APP and APLP2 are sialylated and N- and O-glycosylated, and some also carry chondroitin sulfate glycosaminoglycan and/or dermatan sulfate glycosaminoglycan. The rapid kinetics for turnover of APP and APLP2 predict a sensitive balance of synthesis, transport, and elimination rates that may be critical to normal neuronal functions and metabolic fates of these proteins.	CEA, Serv Hosp Frederic Joliot, DSV, DRM,INSERM,U334, F-91406 Orsay, France; Johns Hopkins Univ, Sch Med, Neuropathol Lab, Baltimore, MD 21205 USA; CEA, Serv Hosp Frederic Joliot, CNRS, URA 2210, F-91406 Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; CEA; Centre National de la Recherche Scientifique (CNRS)	Moya, KL (corresponding author), CEA, Serv Hosp Frederic Joliot, DSV, DRM,INSERM,U334, 4 Pl Gen Leclerc, F-91406 Orsay, France.	moya@uriens.shfj.cea.fr		Confaloni, Annamaria/0000-0002-5390-8536				ALLINQUANT B, 1994, J NEUROSCI, V14, P6842; AMARATUNGA A, 1995, J BIOL CHEM, V270, P17268, DOI 10.1074/jbc.270.29.17268; ARAI H, 1994, BRAIN RES, V642, P132, DOI 10.1016/0006-8993(94)90914-8; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; BHIDE PG, 1991, J NEUROSCI, V11, P485; BUSH AI, 1994, J BIOL CHEM, V269, P26618; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DOHERTY P, 1995, J NEUROBIOL, V26, P437, DOI 10.1002/neu.480260315; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; Goedert M, 1991, Curr Opin Neurobiol, V1, P441, DOI 10.1016/0959-4388(91)90067-H; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LeBlanc AC, 1996, J NEUROCHEM, V66, P2300; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Mizutani A, 1996, BRAIN RES, V739, P276, DOI 10.1016/S0006-8993(96)00834-7; MORIN PJ, 1993, J NEUROCHEM, V61, P464; MOYA KL, 1988, J NEUROSCI, V8, P4445; MOYA KL, 1994, J NEUROCHEM, V63, P1971; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; NITSCH RM, 1993, P NATL ACAD SCI USA, V90, P5191, DOI 10.1073/pnas.90.11.5191; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; OHTA M, 1993, DEV BRAIN RES, V75, P151, DOI 10.1016/0165-3806(93)90019-7; REFOLO LM, 1991, J NEUROSCI, V11, P3888; ROBERTSON RT, 1989, DEV BRAIN RES, V46, P69, DOI 10.1016/0165-3806(89)90144-2; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHIOI J, 1995, J BIOL CHEM, V270, P11839, DOI 10.1074/jbc.270.20.11839; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMALL DH, 1992, J NEUROSCI, V12, P4143; Suzuki T, 1997, BIOCHEMISTRY-US, V36, P4643, DOI 10.1021/bi962618k; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; THINAKARAN G, 1995, J BIOL CHEM, V270, P16522, DOI 10.1074/jbc.270.28.16522; THOMPSON I, 1989, J COMP NEUROL, V282, P371; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431	51	67	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11100	11106		10.1074/jbc.273.18.11100	http://dx.doi.org/10.1074/jbc.273.18.11100			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556595	hybrid			2022-12-27	WOS:000073395200047
J	Srivastava, S; Chandra, A; Wang, LF; Seifert, WE; DaGue, BB; Ansari, NH; Srivastava, SK; Bhatnagar, A				Srivastava, S; Chandra, A; Wang, LF; Seifert, WE; DaGue, BB; Ansari, NH; Srivastava, SK; Bhatnagar, A			Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; ALDOSE REDUCTASE; ALDEHYDE DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; FREE-RADICALS; CONJUGATE; ACID; EXPRESSION; MECHANISM; DISEASE	The metabolism of 4-hydroxy-trans-2-nonenal (HNE), an alpha,beta-unsaturated aldehyde generated during lipid peroxidation, was studied in isolated perfused rat hearts. High performance liquid chromatography separation of radioactive metabolites recovered from [H-3]HNE-treated hearts revealed four major peaks. Based on the retention times of synthesized standards, peak I, which accounted for 20% radioactivity administered to the heart, was identified to be due to glutathione conjugates of HNE. Peaks II and III, containing 2 and 37% radioactivity, were assigned to 1,4-dihydroxy-2-nonene (DHN) and 4-hydroxy-2-nonenoic acid, respectively. Peak TV was due to unmetabolized HNE. The electrospray ionization mass spectrum of peak I revealed two prominent metabolites with m/z values corresponding to [M + H](+) of HNE and DHN conjugates with glutathione. The presence of 4-hydroxy-2-nonenoic acid in peak III was substantiated using gas chromatography-chemical ionization mass spectroscopy. When exposed to sorbinil, an inhibitor of aldose reductase, no GS-DHN was recovered in the coronary effluent, and treatment with cyanamide, an inhibitor of aldehyde dehydrogenase, attenuated 4-hydroxy-2-nonenoic acid formation. These results show that the major metabolic transformations of HNE in rat heart involve conjugation with glutathione and oxidation to 4-hydroxy-2-nonenoic acid. Further metabolism of the GS HNE conjugate involves aldose reductase-mediated reduction, a reaction catalyzed in vitro by homogenous cardiac aldose reductase.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA; Univ Texas, Sch Med, Ctr Analyt Chem, Houston, TX 77225 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System	Bhatnagar, A (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 7-138 H Med Res Bldg, Galveston, TX 77555 USA.	abhatnag@utmb.edu	Srivastava, Sanjay/D-3921-2012		NHLBI NIH HHS [R01 HL055477, HL 55477] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118, R01DK036118, R37DK036118] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALARY J, 1995, CHEM RES TOXICOL, V8, P34, DOI 10.1021/tx00043a004; ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Ansari NH, 1996, BIOCHEM MOL MED, V58, P25, DOI 10.1006/bmme.1996.0028; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; BHATNAGAR A, 1992, BIOCHEM MED METAB B, V48, P91, DOI 10.1016/0885-4505(92)90055-4; BHATNAGAR A, 1995, CIRC RES, V76, P293, DOI 10.1161/01.RES.76.2.293; BHATNAGAR A, 1995, J CARDIOVASC PHARM, V26, P343, DOI 10.1097/00005344-199509000-00001; BLASIG IE, 1995, AM J PHYSIOL-HEART C, V269, pH14, DOI 10.1152/ajpheart.1995.269.1.H14; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; BURGER RM, 1994, J BIOL CHEM, V269, P25978; Chandra A, 1997, LIPIDS, V32, P779, DOI 10.1007/s11745-997-0100-6; Chen P, 1996, CHEM RES TOXICOL, V9, P970, DOI 10.1021/tx960040+; CRONHOLM T, 1993, BIOCHEM PHARMACOL, V45, P553, DOI 10.1016/0006-2952(93)90126-H; DALE WE, 1991, CIRC RES, V69, P791, DOI 10.1161/01.RES.69.3.791; DAS B, 1985, BIOCHIM BIOPHYS ACTA, V840, P324, DOI 10.1016/0304-4165(85)90212-0; DIPPLE KM, 1993, BIOCHEM BIOPH RES CO, V193, P420, DOI 10.1006/bbrc.1993.1640; EMMETT MR, 1994, J AM SOC MASS SPECTR, V5, P605, DOI 10.1016/1044-0305(94)85001-1; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1975, Z NATURFORSCH C, V30, P466; FERON VJ, 1991, MUTAT RES, V259, P363, DOI 10.1016/0165-1218(91)90128-9; GRIMSHAW CE, 1992, BIOCHEMISTRY-US, V31, P10139, DOI 10.1021/bi00157a001; GRUNE T, 1994, CANCER RES, V54, P5231; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; HARTLEY DP, 1995, ARCH BIOCHEM BIOPHYS, V316, P197, DOI 10.1006/abbi.1995.1028; ISHIKAWA T, 1986, J BIOL CHEM, V261, P1576; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; LANDER HM, 1995, J BIOL CHEM, V270, P21195, DOI 10.1074/jbc.270.36.21195; LORENZI M, 1987, DIABETOLOGIA, V30, P222, DOI 10.1007/BF00270419; Luo XP, 1997, BBA-MOL BASIS DIS, V1360, P45; Maulik N, 1996, MOL CELL BIOCHEM, V161, P241, DOI 10.1007/BF00240055; Mlakar A, 1996, CHEM PHYS LIPIDS, V79, P47, DOI 10.1016/0009-3084(95)02506-5; MONKS TJ, 1990, TOXICOL APPL PHARM, V106, P1, DOI 10.1016/0041-008X(90)90100-9; NATH RG, 1994, P NATL ACAD SCI USA, V91, P7491, DOI 10.1073/pnas.91.16.7491; NEELY JR, 1972, BIOCHEM J, V128, P147, DOI 10.1042/bj1280147; RAMU K, 1995, CHEM RES TOXICOL, V8, P515, DOI 10.1021/tx00046a005; Sayre LM, 1997, J NEUROCHEM, V68, P2092; SLADEK NE, 1988, PHARMACOL THERAPEUT, V37, P301, DOI 10.1016/0163-7258(88)90004-6; Spycher S, 1996, BIOCHEM BIOPH RES CO, V226, P512, DOI 10.1006/bbrc.1996.1386; Spycher SE, 1997, FASEB J, V11, P181, DOI 10.1096/fasebj.11.2.9039961; Srivastava S, 1995, BIOCHEM BIOPH RES CO, V217, P741, DOI 10.1006/bbrc.1995.2835; Stewart MJ, 1996, J INVEST MED, V44, P42; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Thompson CD, 1996, CHEM RES TOXICOL, V9, P1225, DOI 10.1021/tx9601566; TSUCHIDA M, 1987, CHEM PHYS LIPIDS, V44, P297, DOI 10.1016/0009-3084(87)90055-7; VANDERKRAAIJ AMM, 1990, CARDIOVASC RES, V24, P144, DOI 10.1093/cvr/24.2.144; VANNIEUWENHOVEN FA, 1995, BIOCHEM BIOPH RES CO, V207, P747, DOI 10.1006/bbrc.1995.1250; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; ZHANG ZH, 1995, BIOCHEM PHARMACOL, V50, P1607; ZIMNIAK P, 1994, J BIOL CHEM, V269, P992	51	217	219	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10893	10900		10.1074/jbc.273.18.10893	http://dx.doi.org/10.1074/jbc.273.18.10893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556565	Green Accepted, hybrid			2022-12-27	WOS:000073395200017
J	Bader, M; Muse, W; Zander, T; Bardwell, J				Bader, M; Muse, W; Zander, T; Bardwell, J			Reconstitution of a protein disulfide catalytic system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOND FORMATION INVIVO; ACTIVE-SITE CYSTEINE; FORMATION IN-VIVO; ESCHERICHIA-COLI; EFFICIENT CATALYSIS; DSBA; ISOMERASE; IDENTIFICATION; RESIDUES; PRODUCT	Disulfide bonds are important for the structure and stability of many proteins. In prokaryotes their formation is catalyzed by the Dsb proteins. The DsbA protein acts as a direct donor of disulfides to newly synthesized periplasmic proteins. Genetic evidence suggests that a second protein called DsbB acts to specifically reoxidize DsbA. Here we demonstrate the direct reoxidation of DsbA by DsbB. We have developed a fluorescence assay that allows us to directly follow the reoxidation of DsbA. We show that membranes containing catalytic amounts of DsbB can rapidly reoxidize DsbA to completion, The reaction strongly depends on the presence of oxygen, implying that oxygen serves as the final electron acceptor for this disulfide bond formation reaction. Membranes from a dsbB null mutant display no DsbA reoxidation activity. The ability of DsbB to reoxidize DsbA fits Michaelis-Menten behavior with DsbA acting as a high affinity substrate for DsbB with a K-m = 10 mu M. The in vitro reconstitution described here is the first biochemical analysis of DsbB and allows us to study the major pathway of disulfide bond formation in Escherichia coli.	Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bardwell, J (corresponding author), Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA.	Jbardwel@umich.edu						AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; BULL C, 1981, J BIOL CHEM, V256, P2673; Copeland RA, 1996, ENZYMES PRACTICAL IN; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; Frech C, 1996, EMBO J, V15, P392, DOI 10.1002/j.1460-2075.1996.tb00369.x; FREEDMAN RB, 1995, CURR OPIN STRUC BIOL, V5, P85, DOI 10.1016/0959-440X(95)80013-Q; Freedman Robert B., 1992, P455; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1997, PROTEIN SCI, V6, P1148, DOI 10.1002/pro.5560060603; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; JANDER G, 1996, THESIS HARVARD U; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Kishigami S, 1996, GENES CELLS, V1, P201, DOI 10.1046/j.1365-2443.1996.d01-233.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; WUNDERLICH M, 1993, BIOCHEMISTRY-US, V32, P12251, DOI 10.1021/bi00096a039; WUNDERLICH M, 1995, J MOL BIOL, V247, P28, DOI 10.1006/jmbi.1995.0119; ZAPUN A, 1994, BIOCHEMISTRY-US, V33, P5202, DOI 10.1021/bi00183a025; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; ZAPUN A, 1994, BIOCHEMISTRY-US, V33, P1907, DOI 10.1021/bi00173a038	31	75	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10302	10307		10.1074/jbc.273.17.10302	http://dx.doi.org/10.1074/jbc.273.17.10302			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553083	hybrid			2022-12-27	WOS:000073224200032
J	Liu, K; Li, GP				Liu, K; Li, GP			Catalytic domain of the p120 Ras GAP binds to Rab5 and stimulates its GTPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; ACTIVATING PROTEIN; TYROSINE KINASES; FUSION INVITRO; GENE-PRODUCT; P21 GTPASE; INHIBITION; MUTANTS; PHOSPHORYLATION; PURIFICATION	Ras is a master GTPase switch controlling multiple signal transduction cascades in the regulation of cell proliferation and differentiation. Rab5 is a local GTPase switch that is localized on early endosomes and controls early endosome fusion. This study demonstrates that the catalytic domain of p120 GTPase-activating protein (GAP), a well known Pas GAP, is able to interact physically with Rab5 and stimulate its GTPase activity, This GAP activity toward Rab5, however, cannot be extended to other Rab GTPases such as Rab3, Rab4, and Rab6, indicating that it is not a generic GAP for the Rab family of GTPases that regulate intracellular membrane fusion during endocytosis and exocytosis. The findings indicate a level of structural similarity between Pas and Rab5 unexpected from their primary sequences. They also suggest a possible signal transduction regulation of the Rab5-dependent endosome fusion via the Pas GAP.	Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Li, GP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.		Li, Guangpu/GRS-5397-2022	Liu, Kebin/0000-0003-1965-7240				ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; BOLLAG G, 1995, METHOD ENZYMOL, V255, P21; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HOFFENBERG S, 1995, J BIOL CHEM, V270, P5048, DOI 10.1074/jbc.270.10.5048; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; LI GP, 1994, J BIOL CHEM, V269, P14631; LI GP, 1993, J BIOL CHEM, V268, P24475; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; NUREKAMAL MSA, 1992, J BIOL CHEM, V267, P1415; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; PIZON V, 1988, ONCOGENE, V3, P201; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHABER MD, 1995, METHOD ENZYMOL, V255, P171; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; Wang ZX, 1996, CELL GROWTH DIFFER, V7, P123; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; WOODMAN PG, 1993, MOL BIOL CELL, V4, P541, DOI 10.1091/mbc.4.5.541; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	40	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10087	10090		10.1074/jbc.273.17.10087	http://dx.doi.org/10.1074/jbc.273.17.10087			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553053	hybrid			2022-12-27	WOS:000073224200002
J	Braun, H; Suske, G				Braun, H; Suske, G			Combinatorial action of HNF3 and Sp family transcription factors in the activation of the rabbit uteroglobin/CC10 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PROTEIN GENE; HEPATOCYTE NUCLEAR FACTOR-3-BETA; EXPLANTS CULTURED INVITRO; TATA-BOX REGION; FACTOR-I; HORMONAL-REGULATION; ENDOMETRIAL CELLS; EPITHELIAL-CELLS; MAMMALIAN-CELLS; LUNG	It has been reported that respiratory epithelium-specific transcription is mediated by thyroid transcription factor 1 and members of the HNF3/forkhead family of transcription factors. Here, we show that the uteroglobin/Clara cell 10-kDa promoters from rabbit and man are regulated by HNF3 alpha and HNF3 beta but not by HFH-4 and TTF-1. We have identified two HNF3-responsive elements in the rabbit uteroglobin/CC10 promoter located around 95 and 130 base pairs upstream of the transcriptional start site. Both elements contribute to promoter activity in H441 cells expressing uteroglobin/CC10 and HNF3 alpha. Gene transfer experiments into Drosophila Schneider cells that lack many mammalian transcription factor homologs revealed that HNF3 alpha and HNF3 beta on their own cannot activate the uteroglobin/CC10 promoter. However, HNF3 alpha and HNF3 beta strongly enhanced Sp1-mediated promoter activation. Synergistic activation by HNF3 alpha and Sp1 was absolutely dependent on the integrity of two Sp1 sites located at around -65 and -230. We show further that multiple activation domains of Sp1 are required for cooperativity with HNF3 alpha. These studies demonstrate that transcription from the rabbit uteroglobin/CC10 promoter in lung epithelium is controlled by the combinatorial action of the cell-specific factor HNF3 alpha and the ubiquitous factor Sp1.	Philipps Univ Marburg, Inst Mol Biol & Tumorforsch, D-35037 Marburg, Germany	Philipps University Marburg	Suske, G (corresponding author), Philipps Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-35037 Marburg, Germany.	suske@imt.uni-marburg.de		Braun, Harald/0000-0002-3491-9504; Suske, Guntram/0000-0002-4807-0513				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARNONE MI, 1995, J BIOL CHEM, V270, P12048, DOI 10.1074/jbc.270.20.12048; AUMULLER G, 1985, HISTOCHEMISTRY, V83, P413, DOI 10.1007/BF00509202; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BINGLE CD, 1995, BIOCHEM J, V308, P197, DOI 10.1042/bj3080197; BINGLE CD, 1993, BIOCHEM J, V295, P227, DOI 10.1042/bj2950227; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; CARDOSO WV, 1995, AM J PHYSIOL-LUNG C, V269, pL429, DOI 10.1152/ajplung.1995.269.4.L429; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CLEVIDENCE DE, 1994, DEV BIOL, V166, P195, DOI 10.1006/dbio.1994.1307; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DEHARO MSL, 1985, BIOCHEM J, V225, P255; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; DENNIG J, 1995, J BIOL CHEM, V270, P12737, DOI 10.1074/jbc.270.21.12737; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; FERNANDEZRENAU D, 1984, EUR J BIOCHEM, V144, P523, DOI 10.1111/j.1432-1033.1984.tb08497.x; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAGEN G, 1990, NUCLEIC ACIDS RES, V18, P2939, DOI 10.1093/nar/18.10.2939; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; IKEDA K, 1995, J BIOL CHEM, V270, P8108, DOI 10.1074/jbc.270.14.8108; Klug J, 1996, MOL CELL BIOL, V16, P6398; KLUG J, 1994, MOL CELL BIOL, V14, P6208, DOI 10.1128/MCB.14.9.6208; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Margana RK, 1997, J BIOL CHEM, V272, P3083, DOI 10.1074/jbc.272.5.3083; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MISSEYANNI A, 1991, NUCLEIC ACIDS RES, V19, P2849, DOI 10.1093/nar/19.11.2849; MULLER H, 1980, EUR J BIOCHEM, V112, P235, DOI 10.1111/j.1432-1033.1980.tb07199.x; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; RAY MK, 1995, J BIOL CHEM, V270, P2689, DOI 10.1074/jbc.270.6.2689; Ray MK, 1996, MOL CELL BIOL, V16, P2056; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; SANDMOLLER A, 1991, MECH DEVELOP, V34, P57, DOI 10.1016/0925-4773(91)90091-J; SAWAYA PL, 1993, MOL CELL BIOL, V13, P3860, DOI 10.1128/MCB.13.7.3860; SAWAYA PL, 1994, J BIOL CHEM, V269, P22211; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; STRIPP BR, 1994, GENOMICS, V20, P27, DOI 10.1006/geno.1994.1123; Suske Guntram, 1992, Gene Expression, V2, P339; SZYF M, 1990, MOL ENDOCRINOL, V4, P1144, DOI 10.1210/mend-4-8-1144; Toonen RFG, 1996, BIOCHEM J, V316, P467, DOI 10.1042/bj3160467; WAREMBOURG M, 1986, ENDOCRINOLOGY, V119, P1632, DOI 10.1210/endo-119-4-1632; Wolf Markus, 1992, Human Molecular Genetics, V1, P371, DOI 10.1093/hmg/1.6.371; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	47	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9821	9828		10.1074/jbc.273.16.9821	http://dx.doi.org/10.1074/jbc.273.16.9821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545321	hybrid			2022-12-27	WOS:000073128800067
J	Chang, SC; Heacock, PN; Clancey, CJ; Dowhan, W				Chang, SC; Heacock, PN; Clancey, CJ; Dowhan, W			The PEL1 gene (renamed PGS1) encodes the phosphatidylglycerophosphate synthase of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI INNER MEMBRANES; ESCHERICHIA-COLI; PHOSPHOLIPID BIOSYNTHESIS; PHOSPHATIDYLSERINE DECARBOXYLASE; PROTEIN TRANSLOCATION; ACIDIC PHOSPHOLIPIDS; CARDIOLIPIN BIOSYNTHESIS; PRECURSOR PROTEINS; GROWTH-PHASE; NULL ALLELE	Phosphatidylglycerophosphate (PG-P) synthase catalyzes the synthesis of PG-P from CDP-diacylglycerol and sn-glycerol 3-phosphate and functions as the committed and rate-limiting step in the biosynthesis of cardiolipin (CL), In eukaryotic cells, CL is found predominantly in the inner mitochondrial membrane and is generally thought to be an essential component of many mitochondrial functions. We have determined that the PEL1 gene (now renamed PGS1), previously proposed to encode a second phosphatidylserine synthase of yeast (Janitor, M., Jarosch, E., Schweyen, R. J., and Subik, J. (1995) Yeast 13, 1223-1231), in fact encodes a PG-P synthase of Saccharomyces cerevisiae, Overexpression of the PGS1 gene product under the inducible GAL1 promoter resulted in a 14-fold increase in in vitro PG-P synthase activity. Disruption of the PGS1 gene in a haploid strain of yeast did not lead to a loss of viability but did result in a dependence on a fermentable carbon source for growth, a temperature sensitivity for growth, and a petite lethal phenotype, The pgs1 null mutant exhibited no detectable in vitro PG-P synthase activity and no detectable CL or phosphatidylglycerol (PG); significant CL synthase activity was still present. The growth arrest phenotype and lack of PG-P synthase activity of a pgsA null allele of Escherichia coli was corrected by an N-terminal truncated derivative of the yeast PG-P synthase, These results unequivocally demonstrate that the PGS1 gene encodes the major PG-P synthase of yeast and that neither PG nor CL are absolutely essential for cell viability but may be important for normal mitochondrial function.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA	University of Texas System	Dowhan, W (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA.	wdowhan@utmmg.med.uth.tmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM054273, R01GM020478] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20478, GM54273] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADOLPHUS, 1983, EMBO J, V2, P1765, DOI 10.1002/j.1460-2075.1983.tb01655.x; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; BHAT PJ, 1990, GENETICS, V125, P281; BHAT PJ, 1991, GENETICS, V128, P233; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CARMAN GM, 1992, METHOD ENZYMOL, V209, P305; CARMAN GM, 1983, CAN J MICROBIOL, V29, P1452, DOI 10.1139/m83-222; Chang SC, 1997, FASEB J, V11, pA1079; Chupin V, 1996, BIOCHEMISTRY-US, V35, P3141, DOI 10.1021/bi952482a; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; Dowhan W, 1997, BBA-LIPID LIPID MET, V1348, P157, DOI 10.1016/S0005-2760(97)00111-2; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Dryden SC, 1996, J BACTERIOL, V178, P1030, DOI 10.1128/jb.178.4.1030-1038.1996; EILERS M, 1989, J BIOL CHEM, V264, P2945; ENDO T, 1989, J BIOL CHEM, V264, P2951; ESKO JD, 1980, J BIOL CHEM, V255, P4474; FERBEYRE G, 1993, BIOTECHNIQUES, V14, P386; FINE JB, 1982, J LIPID RES, V23, P660; FUJIMURA HA, 1993, BIOTECHNIQUES, V14, P538; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; GOPALAKRISHNAN AS, 1986, J BIOL CHEM, V261, P1329; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1988, MOL CELL BIOL, V8, P4773, DOI 10.1128/MCB.8.11.4773; Hatch GM, 1996, MOL CELL BIOCHEM, V159, P139, DOI 10.1007/BF00420916; HEACOCK PN, 1987, J BIOL CHEM, V262, P13044; HIRAOKA S, 1993, FEBS LETT, V336, P221, DOI 10.1016/0014-5793(93)80807-7; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; HJELMSTAD RH, 1991, J BIOL CHEM, V266, P5094; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; Janitor M, 1996, FEMS MICROBIOL LETT, V140, P43; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; JANITOR M, 1995, YEAST, V11, P1223, DOI 10.1002/yea.320111302; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; KINNEY AJ, 1990, J BACTERIOL, V172, P4115, DOI 10.1128/jb.172.7.4115-4117.1990; KONTINEN VP, 1995, FEBS LETT, V364, P157, DOI 10.1016/0014-5793(95)00378-M; Kuge O, 1997, BBA-LIPID LIPID MET, V1348, P151, DOI 10.1016/S0005-2760(97)00137-9; KUSTERS R, 1994, J BIOL CHEM, V269, P1560; KUSTERS R, 1991, J BIOL CHEM, V266, P8659; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Matsumoto K, 1997, BBA-LIPID LIPID MET, V1348, P214, DOI 10.1016/S0005-2760(97)00110-0; MOSSE MO, 1993, CURR GENET, V23, P66, DOI 10.1007/BF00336752; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NIKOLOFF DM, 1991, ANNU REV GENET, V25, P559; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; NISHIJIMA S, 1988, J BACTERIOL, V170, P775, DOI 10.1128/jb.170.2.775-780.1988; OHTA A, 1981, J BACTERIOL, V147, P552, DOI 10.1128/JB.147.2.552-562.1981; OHTSUKA T, 1993, J BIOL CHEM, V268, P22914; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Ponting CP, 1996, PROTEIN SCI, V5, P914; Roise D, 1997, J BIOENERG BIOMEMBR, V29, P19, DOI 10.1023/A:1022403604273; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Spencer J.F.T., 1989, YEAST GENETICS MANUA; SUBIK J, 1974, FEBS LETT, V42, P309, DOI 10.1016/0014-5793(74)80753-2; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; USUI M, 1994, J BACTERIOL, V176, P3389, DOI 10.1128/jb.176.11.3389-3392.1994; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; XIA WM, 1995, P NATL ACAD SCI USA, V92, P783, DOI 10.1073/pnas.92.3.783; Yamashita S, 1997, BBA-LIPID LIPID MET, V1348, P228, DOI 10.1016/S0005-2760(97)00102-1	71	168	173	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9829	9836		10.1074/jbc.273.16.9829	http://dx.doi.org/10.1074/jbc.273.16.9829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545322	hybrid			2022-12-27	WOS:000073128800068
J	de Koning, HP; Watson, CJ; Jarvis, SM				de Koning, HP; Watson, CJ; Jarvis, SM			Characterization of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEISHMANIA-DONOVANI; ADENOSINE TRANSPORTER; PARASITES; PURINE; 3'-NUCLEOTIDASE; IDENTIFICATION; PROMASTIGOTES; TUBERCIDIN; MEMBRANES; TOXICITY	Adenosine transport at 22 degrees C in procyclic forms of Trypanosoma brucei brucei was investigated using an oil-inhibitor stop procedure for determining initial rates of adenosine uptake in suspended cells. Adenosine influx was mediated by a single high affinity transporter (K-m 0.26 +/- 0.02 mu M, V-max 0.63 +/- 0.18 pmol/10(7) cells s(-1)). Purine nucleosides, with the exception of tubercidin (7-deazaadenosine), and dipyridamole inhibited adenosine influx (K-i 0.18-5.2 mu M). Purine nucleobases and pyrimidine nucleosides and nucleobases had no effect on adenosine transport. This specificity of the transporter appears to be similar to the previously described P1 adenosine transporter in bloodstream forms of trypanosomes. Uptake of adenosine was Na+-independent, but ionophores reducing the membrane potential and/or the transmembrane proton gradient (monitored with the fluorescent probes bis-(1,3-diethylthiobarbituric acid)-trimethine oxonol and 2',7'-bis(carboxyethyl)-5,6-carboxyfluorescein acetoxymethyl ester, respectively) inhibited adenosine transport. Similarly, an increase in extracellular pH from 7.3 to 8.0 reduced adenosine influx by 30%. A linear correlation was demonstrated between the rate of adenosine transport and the protonmotive force. Adenosine uptake was accompanied by a proton influx in base-loaded cells and was also shown to be electrogenic. These combined results indicate that transport of adenosine in T. brucei brucei procyclics is protonmotive force-driven and strongly suggest that the adenosine transporter functions as an HC symporter.	Univ Kent, Res Sch Biosci, Canterbury CT2 7NJ, Kent, England	University of Kent	Jarvis, SM (corresponding author), Univ Kent, Res Sch Biosci, Canterbury CT2 7NJ, Kent, England.	S.M.Jarvis@ukc.ac.uk		De Koning, Harry/0000-0002-9963-1827	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		APTED FIC, 1980, PHARMACOL THERAPEUT, V11, P391, DOI 10.1016/0163-7258(80)90035-2; ARONOW B, 1987, MOL BIOCHEM PARASIT, V22, P29, DOI 10.1016/0166-6851(87)90066-1; BAUM KF, 1993, J EUKARYOT MICROBIOL, V40, P643, DOI 10.1111/j.1550-7408.1993.tb06122.x; BERGER BJ, 1995, MOL BIOCHEM PARASIT, V69, P289, DOI 10.1016/0166-6851(94)00215-9; BRUN R, 1979, ACTA TROP, V36, P289; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; DefriseQuertain F, 1996, BIOCHEM J, V314, P595, DOI 10.1042/bj3140595; DeKoning HP, 1997, EUR J BIOCHEM, V247, P1102, DOI 10.1111/j.1432-1033.1997.01102.x; deKoning HP, 1997, MOL BIOCHEM PARASIT, V89, P245, DOI 10.1016/S0166-6851(97)00129-1; DEKONING HP, 1995, J PHYSIOL-LONDON, V489P, pP126; ELKOUNI MH, 1989, ANTIMICROB AGENTS CH, V33, P824, DOI 10.1128/AAC.33.6.824; GBENLE GO, 1992, BIOCHEM J, V285, P41, DOI 10.1042/bj2850041; GOTTLIEB M, 1986, COMP BIOCHEM PHYS B, V83, P63, DOI 10.1016/0305-0491(86)90332-9; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; HALL ST, 1993, INT J PARASITOL, V23, P1039, DOI 10.1016/0020-7519(93)90124-H; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; HARLEY ER, 1982, CANCER RES, V42, P1289; Harold F.M., 1977, CURR TOP BIOENERG, V6, P83; HAROLD FM, 1972, BACTERIOL REV, V36, P172, DOI 10.1128/MMBR.36.2.172-230.1972; JAMES DM, 1980, PARASITOLOGY, V81, P383, DOI 10.1017/S0031182000056110; JARVIS SM, 1982, BIOCHEM J, V208, P83, DOI 10.1042/bj2080083; MORISHIGE K, 1995, EXP PARASITOL, V80, P665, DOI 10.1006/expr.1995.1082; OGBUNUDE POJ, 1993, INT J BIOCHEM, V25, P471, DOI 10.1016/0020-711X(93)90652-U; OKABE Y, 1991, BIOCHIM BIOPHYS ACTA, V1059, P332, DOI 10.1016/S0005-2728(05)80218-X; PETERSON ARP, 1985, METHOD PHARMACOL, V6, P165; RALY JN, 1982, J MED CHEM, V25, P197; SCHWAB JC, 1995, MOL BIOCHEM PARASIT, V70, P59, DOI 10.1016/0166-6851(95)00005-L; THISSEN JA, 1991, EXP PARASITOL, V72, P243, DOI 10.1016/0014-4894(91)90143-K; Thorn JA, 1996, GEN PHARMACOL, V27, P613, DOI 10.1016/0306-3623(95)02053-5; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264; VIEIRA L, 1995, J BIOL CHEM, V270, P5299, DOI 10.1074/jbc.270.10.5299; WERY M, 1991, CURR OPIN INFECT DIS, V4, P838, DOI 10.1097/00001432-199112000-00020; Wohlhueter R M, 1978, Methods Cell Biol, V20, P211, DOI 10.1016/S0091-679X(08)62020-8; YAMANAKA H, 1984, BIOCHIM BIOPHYS ACTA, V798, P291, DOI 10.1016/0304-4165(84)90318-0; ZILBERSTEIN D, 1988, BIOCHEM J, V256, P13, DOI 10.1042/bj2560013; ZILBERSTEIN D, 1993, ADV PARASIT, V32, P261, DOI 10.1016/S0065-308X(08)60209-2; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	38	77	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9486	9494		10.1074/jbc.273.16.9486	http://dx.doi.org/10.1074/jbc.273.16.9486			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545276	hybrid			2022-12-27	WOS:000073128800022
J	Liu, Y; Guan, C; Aronson, NN				Liu, Y; Guan, C; Aronson, NN			Site-directed mutagenesis of essential residues involved in the mechanism of bacterial glycosylasparaginase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ASPARTYLGLUCOSAMINIDASE; PURIFICATION; DEGRADATION; SPECIFICITY; NUCLEOPHILE; ACTIVATION; SUBUNITS; CATALYST; CLONING	Flavobacterium glycosylasparaginase was cloned in an Escherichia coli expression system. Site-directed mutagenesis was performed at residues suggested to be important in the catalytic mechanism based on the crystal structure of the human enzyme and other biochemical studies. In vitro autoproteolysis allowed the mutant enzymes to be activated, including those that were slow to self-cleave. Based on the activity of the mutant enzymes, six catalytically essential amino acids were identified: Trp-ll, Asp-66, Thr-152, Thr-170, Arg-180, and Asp-183, Kinetic analysis of each mutant further defined the function of these residues in substrate specificity and reaction rate. Mutagenesis of the N-terminal nucleophile residue Thr-152 confirmed the key function of its side-chain hydroxyl group. Partial activities of mutants T152S/C were in agreement with the general mechanism of N-terminal nucleophile (Ntn)-amidohydrolases. The side-chain hydroxyl of Thr-170 contributes to the reaction rate based on studies of mutants T170S/C/A. Residues Asp-183 and Arg-180 were found to H-bond, respectively, with the charged alpha-amino and alpha-carboxyl group of the substrate (Asn-GlcNAc). Mutants R180Q/L and D183E/N had greatly decreased substrate affinity and reduced reaction rates. Kinetic studies also showed that Trp-ll is involved in regulation of the enzyme reaction rate, contradictory to a previous suggestion that this residue is involved in substrate binding. Asp-66 is a new residue found to be important in enzyme activity. The overall active site structure involving these catalytic residues resembles the glutaminase domain of glucosamine B-phosphate synthase, another member of the Ntn-amidohydrolase family of enzymes.	Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; New England Biolabs Inc, Beverly, MA 01915 USA	University of South Alabama	Aronson, NN (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033314] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-33314] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aronson NN, 1996, GLYCOBIOLOGY, V6, P669, DOI 10.1093/glycob/6.7.669; ARONSON NN, 1989, FASEB J, V3, P2615, DOI 10.1096/fasebj.3.14.2531691; BEAUDET AL, 1989, METABOLIC BASIS INHE, P1603; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P2045; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P231; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; FISHER KJ, 1990, FEBS LETT, V269, P440, DOI 10.1016/0014-5793(90)81211-6; FISHER KJ, 1993, FEBS LETT, V323, P271, DOI 10.1016/0014-5793(93)81355-4; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; IKONEN E, 1993, EMBO J, V12, P295, DOI 10.1002/j.1460-2075.1993.tb05656.x; ISUPOV MN, 1996, STRUCTURE LOND, V15, P801; KAARTINEN V, 1992, J BIOL CHEM, V267, P6855; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; LEVVY GA, 1989, BIOCHEM J, V73, P127; Liu Y, 1996, GLYCOBIOLOGY, V6, P527, DOI 10.1093/glycob/6.5.527; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MAKINO M, 1966, BIOCHEM BIOPH RES CO, V24, P961, DOI 10.1016/0006-291X(66)90344-5; MATHEWS CK, 1990, BIOCHEMISTRY-US, P357; MONONEN I, 1993, FASEB J, V7, P1247, DOI 10.1096/fasebj.7.13.8405810; Noronkoski T, 1997, GLYCOBIOLOGY, V7, P217, DOI 10.1093/glycob/7.2.217; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Perakyla M, 1997, J AM CHEM SOC, V119, P1189, DOI 10.1021/ja9628967; RIIKONEN A, 1995, J BIOL CHEM, V270, P4903, DOI 10.1074/jbc.270.9.4903; RISLEY JM, 1996, FASEB J, V10, P1104; SMITH TP, 1994, AM J NEURORADIOL, V15, P801; TANAKA M, 1973, J BIOCHEM-TOKYO, V73, P1285, DOI 10.1093/oxfordjournals.jbchem.a130202; TARENTINO AL, 1969, ARCH BIOCHEM BIOPHYS, V130, P295, DOI 10.1016/0003-9861(69)90036-8; TARENTINO AL, 1993, BIOCHEM BIOPH RES CO, V197, P179, DOI 10.1006/bbrc.1993.2457; TARENTINO AL, 1994, ARCH BIOCHEM BIOPHYS, V316, P399; TARENTINO AL, 1997, LYOSOSOMAL STORAGE D, P101; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; TOLLERSRUD OK, 1992, BIOCHEM J, V282, P891, DOI 10.1042/bj2820891; TOLLERSRUD OK, 1989, BIOCHEM J, V260, P101, DOI 10.1042/bj2600101; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034	36	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9688	9694		10.1074/jbc.273.16.9688	http://dx.doi.org/10.1074/jbc.273.16.9688			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545303	hybrid			2022-12-27	WOS:000073128800049
J	Wang, XM; Flynn, A; Waskiewicz, AJ; Webb, BLJ; Vries, RG; Baines, IA; Cooper, JA; Proud, CG				Wang, XM; Flynn, A; Waskiewicz, AJ; Webb, BLJ; Vries, RG; Baines, IA; Cooper, JA; Proud, CG			The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; FACTOR 4E; PROTEIN-SYNTHESIS; INSULIN-RECEPTOR; FACTOR EIF-4E; TRANSLATION; STIMULATION; SERINE-209; ACTIVATION; REPRESSION	Initiation factor eIF4E binds to the 5'-cap of eukaryotic mRNAs and plays a key role in the mechanism and regulation of translation. It may be regulated through its own phosphorylation and through inhibitory binding proteins (4E-BPs), which modulate its availability for initiation complex assembly. eIF4E phosphorylation is enhanced by phorbol esters. We show, using specific inhibitors, that this involves both the p38 mitogen-activated protein (MAP) kinase and Erk signaling pathways. Cell stresses such as arsenite and anisomycin and the cytokines tumor necrosis factor-alpha and interleukin-1 beta also cause increased phosphorylation of eIF4E, which is abolished by the specific p38 MAP kinase inhibitor, SB203580. These changes in eIF4E phosphorylation parallel the activity of the eIF4E kinase, Mnk1. However other stresses such as heat shock, sorbitol, and H2O2, which also stimulate p38 MAP kinase and increase Mnk1 activity, do not increase phosphorylation of eIF4E. The latter stresses increase the binding of eIF4E to 4E-BP1, and me show that this blocks the phosphorylation of eIF4E by Mnk1 in vitro, which may explain the absence of an increase in eIF4E phosphorylation under these conditions.	Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Kent; Fred Hutchinson Cancer Center	Proud, CG (corresponding author), Univ Dundee, Inst Med Sci, Dept Anat & Physiol, Dundee DD1 4HN, Scotland.	CGPROUD@bad.dundee.ac.uk	Waskiewicz, Andrew/A-3769-2014	Proud, Christopher/0000-0003-0704-6442; Webb, Benjamin/0000-0001-7165-0308	NCI NIH HHS [CA73987] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; BOAL TR, 1993, BIOCHIM BIOPHYS ACTA, V1176, P257, DOI 10.1016/0167-4889(93)90053-R; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DICKENS M, 1992, BIOCHEM J, V287, P201, DOI 10.1042/bj2870201; Diggle TA, 1996, BIOCHEM J, V316, P447, DOI 10.1042/bj3160447; DUNCAN RF, 1987, ARCH BIOCHEM BIOPHYS, V256, P651, DOI 10.1016/0003-9861(87)90622-9; DUNCAN RF, 1996, TRANSLATIONAL CONTRO, P271; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Flynn A, 1996, CANCER SURV, V27, P293; Flynn A, 1996, FEBS LETT, V389, P162, DOI 10.1016/0014-5793(96)00564-9; Flynn A, 1996, EUR J BIOCHEM, V236, P40, DOI 10.1111/j.1432-1033.1996.00040.x; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hazzalin CA, 1996, CURR BIOL, V6, P1028, DOI 10.1016/S0960-9822(02)00649-8; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mendez R, 1996, MOL CELL BIOL, V16, P2857; MORLEY SJ, 1989, J BIOL CHEM, V264, P2401; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; Pietersma A, 1997, BIOCHEM BIOPH RES CO, V230, P44, DOI 10.1006/bbrc.1996.5886; PRICE N, 1994, BIOCHIMIE, V76, P748, DOI 10.1016/0300-9084(94)90079-5; PRICE NT, 1989, BIOCHIM BIOPHYS ACTA, V1008, P177, DOI 10.1016/0167-4781(80)90005-6; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; TAN Y, 1996, EMBO J, V15, P101; Vries RGJ, 1997, J BIOL CHEM, V272, P32779, DOI 10.1074/jbc.272.52.32779; Wang XM, 1997, BIOCHEM BIOPH RES CO, V238, P207, DOI 10.1006/bbrc.1997.7273; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Whalen SG, 1996, J BIOL CHEM, V271, P11831, DOI 10.1074/jbc.271.20.11831	34	243	249	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9373	9377		10.1074/jbc.273.16.9373	http://dx.doi.org/10.1074/jbc.273.16.9373			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545260	hybrid			2022-12-27	WOS:000073128800006
J	Bremnes, T; Lauvrak, V; Lindqvist, B; Bakke, O				Bremnes, T; Lauvrak, V; Lindqvist, B; Bakke, O			A region from the medium chain adaptor subunit (mu) recognizes leucine- and tyrosine-based sorting signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II RECEPTOR; MANNOSE 6-PHOSPHATE RECEPTOR; CLATHRIN-ASSOCIATED PROTEINS; PLASMA-MEMBRANE; CYTOPLASMIC DOMAIN; COMPLEX AP-2; RAPID INTERNALIZATION; TRANSFERRIN RECEPTOR; SECONDARY-STRUCTURE; ENDOCYTIC PATHWAY	Tyrosine-based sorting signals in the cytosolic tails of membrane proteins have been found to bind directly to the medium chain subunit (mu) of the adaptor complexes AP-1 and AP-2, For the leucine-based signals, an interaction with AP-1 and AP-2 has been reported, but no specific interacting subunit has been demonstrated. After searching for molecules interacting with the leucine-based sorting signals within the cytosolic tail of the major histocompatibility complex class II-associated invariant chain using a phage display approach, we identified phage clones with homology to a conserved region of the AP-1 and AP-2 mu chains, To investigate the relevance of these findings, we have expressed regions of mouse mu(1) and mu(2), chains on phage gene product III and investigated the binding to tail sequences from various transmembrane proteins with known endosomal targeting signals, Enzyme-linked immunosorbent binding assays showed that these phages specifically recognized peptides containing functional leucine-and tyrosine-based sorting signals, suggesting that these regions of the mu(1) and mu(2) chains interact with both types of sorting signals.	Univ Oslo, Dept Mol Cell Biol, Div Biol, N-0316 Oslo, Norway; Ctr Biotechnol, N-0371 Oslo, Norway	University of Oslo	Bakke, O (corresponding author), Univ Oslo, Dept Mol Cell Biol, Div Biol, POB 1066 Blindern, N-0316 Oslo, Norway.			Bakke, Oddmund/0000-0003-4843-7626				BECK KA, 1991, J BIOL CHEM, V266, P4437; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; BOLL W, 1995, CURR BIOL, V5, P1168, DOI 10.1016/S0960-9822(95)00233-8; BREMNES B, 1994, J CELL SCI, V107, P2021; BREMNES T, IN PRESS IMMUNOTECHN; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COLLAWN JF, 1991, EMBO J, V10, P3247, DOI 10.1002/j.1460-2075.1991.tb04888.x; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Cortese R, 1996, CURR OPIN BIOTECH, V7, P616, DOI 10.1016/S0958-1669(96)80072-3; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; DYSON HJ, 1992, J MOL BIOL, V226, P819, DOI 10.1016/0022-2836(92)90634-V; DYSON HJ, 1992, J MOL BIOL, V226, P795, DOI 10.1016/0022-2836(92)90633-U; Gebhardt K, 1996, PEPTIDE RES, V9, P269; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P327, DOI 10.1093/nar/14.1.327; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; JADOT M, 1992, J BIOL CHEM, V267, P11069; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; MATSUI W, 1990, BIOCHEMISTRY-US, V29, P10791, DOI 10.1021/bi00500a011; Mauxion F, 1996, J BIOL CHEM, V271, P2171, DOI 10.1074/jbc.271.4.2171; MOTTA A, 1995, J BIOL CHEM, V270, P27165, DOI 10.1074/jbc.270.45.27165; NAKAYAMA Y, 1991, EUR J BIOCHEM, V202, P569, DOI 10.1111/j.1432-1033.1991.tb16409.x; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Robinson MS, 1997, TRENDS CELL BIOL, V7, P99, DOI 10.1016/S0962-8924(96)10048-9; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; SORKIN A, 1995, J BIOL CHEM, V270, P619, DOI 10.1074/jbc.270.2.619; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; SOSA MA, 1993, J BIOL CHEM, V268, P12537; Tijssen P., 1985, LAB TECHNIQUES BIOCH; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021	44	56	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8638	8645		10.1074/jbc.273.15.8638	http://dx.doi.org/10.1074/jbc.273.15.8638			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535838	hybrid			2022-12-27	WOS:000072990800015
J	Chibalin, AV; Pedemonte, CH; Katz, AI; Feraille, E; Berggren, PO; Bertorello, AM				Chibalin, AV; Pedemonte, CH; Katz, AI; Feraille, E; Berggren, PO; Bertorello, AM			Phosphorylation of the catalytic alpha-subunit constitutes a triggering signal for Na+,K+-ATPase endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NA+-K+-ATPASE; PROXIMAL TUBULE CELLS; DOPAMINE RECEPTOR; DISTAL NEPHRON; NA/K-ATPASE; KIDNEY; ACTIVATION; INHIBITION; NA,K-ATPASE	Inhibition of Na+,K+-ATPase activity by dopamine is an important mechanism by which renal tubules modulate urine sodium excretion during a high salt diet. However, the molecular mechanisms of this regulation are not clearly understood. Inhibition of Na+,K+-ATPase activity in response to dopamine is associated with endocytosis of its alpha- and beta-subunits, an effect that is protein kinase C-dependent. In this study we used isolated proximal tubule cells and a cell line derived from opossum kidney and demonstrate that dopamine-induced endocytosis of Na+,K+-ATPase and inhibition of its activity were accompanied by phosphorylation of the alpha-subunit. Inhibition of both the enzyme activity and its phosphorylation were blocked by the protein kinase C inhibitor bisindolylmaleimide. The early time dependence of these processes suggests a causal link between phosphorylation and inhibition of enzyme activity. However, after 10 min of dopamine incubation, the alpha-subunit was no longer phosphorylated, whereas enzyme activity remained inhibited due to its removal from the plasma membrane. Dephosphorylation occurred in the late endosomal compartment. To further examine whether phosphorylation was a prerequisite for subunit endocytosis, we used the opossum kidney cell line transfected with the rodent alpha-subunit cDNA. Treatment of this cell line with dopamine resulted in phosphorylation and endocytosis of the alpha-subunit with a concomitant decrease in Na+,K+-ATPase activity. In contrast, none of these effects were observed in cells transfected with the rodent alpha-subunit that lacks the putative protein kinase C-phosphorylation sites (Ser(11) and Ser(18)). Our results support the hypothesis that protein kinase C-dependent phosphorylation of the alpha-subunit is essential for Na+,K+-ATPase endocytosis and that both events are responsible for the decreased enzyme activity in response to dopamine.	Karolinska Inst, Karolinska Hosp, Roft Luft Ctr L6B 01, Dept Mol Med, S-17176 Stockholm, Sweden; Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Hop Cantonal Univ Geneva, Div Nephrol, CH-1211 Geneva 14, Switzerland	Karolinska Institutet; Karolinska University Hospital; University of Houston System; University of Houston; University of Chicago; University of Geneva	Bertorello, AM (corresponding author), Karolinska Inst, Karolinska Hosp, Roft Luft Ctr L6B 01, Dept Mol Med, S-17176 Stockholm, Sweden.	alejan@enk.ks.se		Berggren, Per-Olof/0000-0001-8991-413X; Chibalin, Alexander/0000-0002-6339-6271; Feraille, Eric/0000-0003-1656-8365	NIDDK NIH HHS [DK 52273] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK052273] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXANDER RW, 1974, J CLIN INVEST, V54, P194, DOI 10.1172/JCI107743; BALL SG, 1977, BRIT J CLIN PHARMACO, V4, P115, DOI 10.1111/j.1365-2125.1977.tb00681.x; BAUM M, 1988, AM J PHYSIOL, V254, pF9, DOI 10.1152/ajprenal.1988.254.1.F9; Beguin P, 1996, AM J PHYSIOL-CELL PH, V270, pC131, DOI 10.1152/ajpcell.1996.270.1.C131; Beron J, 1997, MOL BIOL CELL, V8, P387, DOI 10.1091/mbc.8.3.387; BERTORELLO A, 1988, AM J PHYSIOL, V254, pF795, DOI 10.1152/ajprenal.1988.254.6.F795; BERTORELLO A, 1990, AM J PHYSIOL, V259, pF924, DOI 10.1152/ajprenal.1990.259.6.F924; BERTORELLO A, 1989, AM J PHYSIOL, V256, pF370, DOI 10.1152/ajprenal.1989.256.2.F370; Bertorello AM, 1995, NEWS PHYSIOL SCI, V10, P253; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; BERTORELLO AM, 1992, J CELL SCI, V101, P343; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; BERTORELLO AM, 1993, AM J PHYSIOL, V265, pF743, DOI 10.1152/ajprenal.1993.265.6.F743; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carranza ML, 1996, FEBS LETT, V396, P309, DOI 10.1016/0014-5793(96)01121-0; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; CHIBALIN AV, 1992, J BIOL CHEM, V267, P22378; DOUCET A, 1979, AM J PHYSIOL, V237, pF105, DOI 10.1152/ajprenal.1979.237.2.F105; FELDER RA, 1989, AM J PHYSIOL, V257, pF315, DOI 10.1152/ajprenal.1989.257.3.F315; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; GESEK FA, 1990, AM J PHYSIOL, V258, pF514, DOI 10.1152/ajprenal.1990.258.3.F514; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HAGEGE J, 1985, KIDNEY INT, V27, P3, DOI 10.1038/ki.1985.2; HAMMOND TG, 1994, AM J PHYSIOL-RENAL, V267, pF516, DOI 10.1152/ajprenal.1994.267.4.F516; HAYASHI M, 1990, AM J PHYSIOL, V258, pF28, DOI 10.1152/ajprenal.1990.258.1.F28; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MR, 1982, CLIN SCI, V62, P439, DOI 10.1042/cs0620439; Logvinenko NS, 1996, P NATL ACAD SCI USA, V93, P9132, DOI 10.1073/pnas.93.17.9132; MIDDLETON JP, 1993, J BIOL CHEM, V268, P15958; NISHI A, 1993, ACTA PHYSIOL SCAND, V149, P377, DOI 10.1111/j.1748-1716.1993.tb09633.x; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nowicki S, 1997, J CLIN INVEST, V99, P1224, DOI 10.1172/JCI119279; Ominato M, 1996, J MEMBRANE BIOL, V152, P235, DOI 10.1007/s002329900101; Pedemonte CH, 1997, MOL PHARMACOL, V52, P88, DOI 10.1124/mol.52.1.88; Pedemonte CH, 1997, J MEMBRANE BIOL, V155, P219, DOI 10.1007/s002329900174; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; SATOH T, 1993, AM J PHYSIOL, V265, pF399, DOI 10.1152/ajprenal.1993.265.3.F399; SERI I, 1990, AM J PHYSIOL, V258, pF52, DOI 10.1152/ajprenal.1990.258.1.F52; SHANBAKY NM, 1994, AM J PHYSIOL, V267, pC590, DOI 10.1152/ajpcell.1994.267.2.C590; TAKEMOTO F, 1992, PFLUG ARCH EUR J PHY, V421, P302, DOI 10.1007/BF00374216	42	137	140	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8814	8819		10.1074/jbc.273.15.8814	http://dx.doi.org/10.1074/jbc.273.15.8814			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535860	hybrid			2022-12-27	WOS:000072990800037
J	Neuhuber, B; Gerster, U; Mitterdorfer, J; Glossmann, H; Flucher, BE				Neuhuber, B; Gerster, U; Mitterdorfer, J; Glossmann, H; Flucher, BE			Differential effects of Ca2+ channel beta(1a) and beta(2a) subunits on complex formation with alpha(1S) and on current expression in tsA201 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; RABBIT SKELETAL-MUSCLE; DIHYDROPYRIDINE RECEPTOR; DYSGENIC MUSCLE; 1,4-DIHYDROPYRIDINE RECEPTOR; CHARGE MOVEMENT; CA-2+ CHANNEL; IDENTIFICATION; ALPHA-1; ALPHA(1)-SUBUNIT	To study the interactions of the alpha(1S) subunit of the skeletal muscle L-type Ca2+ channel with the skeletal beta(1a) and the cardiac beta(2a), these subunits were expressed alone or in combination in tsA201 cells, Immunofluo rescence- and green fluorescent protein-labeling showed that, when expressed alone, beta(1a) was diffusely distributed throughout the cytoplasm, beta(2a) was localized in the plasma membrane, and alpha(1S) was concentrated in a tubular/reticular membrane system, presumably the endoplasmic reticulum (ER), Upon coexpression with alpha(1S), beta(1a) became colocalized with alpha(1S) in the ER, Upon coexpression with beta(2a), alpha(1S) redistributed to the plasma membrane, where it aggregated in large clusters, Coexpression of alpha(1S) with beta(1a) but not with beta(2a) increased the frequency at which cells expressed L-type currents, A point mutation (alpha(1S)-Y366S) or deletion (alpha(1S)-Delta 351-380) in the beta interaction domain of alpha(1S) blocked both translocation of beta(1a) to the ER and beta(2a)-induced translocation of the alpha(1S) mutants to the plasma membrane, However, the point mutation did not interfere with beta(1a)-induced current stimulation, Thus, beta(1a) and beta(2a) are differentially distributed in tsA201 cells and upon coexpression with alpha(1S), form alpha(1S).beta complexes in different cellular compartments, Complex formation but not current stimulation requires the intact beta interaction domain in the I-II cytoplasmic loop of alpha(1S).	Univ Innsbruck, Dept Biochem Pharmacol, A-6020 Innsbruck, Austria	University of Innsbruck	Flucher, BE (corresponding author), Univ Innsbruck, Dept Biochem Pharmacol, Peter Mayr Str 1, A-6020 Innsbruck, Austria.	bernhard.e.flucher@uibk.ac.at	Glossmann, Hartmut/AAL-9790-2020	glossmann, hartmut h./0000-0002-7392-3266; Flucher, Bernhard/0000-0002-5255-4705				Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; CAMPBELL V, 1995, J PHYSIOL-LONDON, V485, P365, DOI 10.1113/jphysiol.1995.sp020735; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; FLUCHER BE, 1991, J CELL BIOL, V115, P1345, DOI 10.1083/jcb.115.5.1345; FLUCHER BE, 1990, NEURON, V5, P339, DOI 10.1016/0896-6273(90)90170-K; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; FLUCHER BE, 1994, MOL BIOL CELL, V5, P1105, DOI 10.1091/mbc.5.10.1105; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HOCKERMAN GH, 1995, J BIOL CHEM, V270, P22119, DOI 10.1074/jbc.270.38.22119; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Johnson BD, 1997, J NEUROSCI, V17, P1243; JORGENSEN AO, 1989, J CELL BIOL, V109, P135, DOI 10.1083/jcb.109.1.135; Josephson IR, 1996, BIOPHYS J, V70, P1285, DOI 10.1016/S0006-3495(96)79685-6; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; LORY P, 1992, BIOPHYS J, V63, P1421, DOI 10.1016/S0006-3495(92)81705-8; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; MIKAMI A, 1989, NATURE, V340, P141; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; MORTON ME, 1987, J BIOL CHEM, V262, P11904; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; NEUHUBER B, IN PRESS P NATL ACAD; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1996, AM J PHYSIOL-CELL PH, V271, pC1539, DOI 10.1152/ajpcell.1996.271.5.C1539; Ren DJ, 1997, J BIOL CHEM, V272, P22393, DOI 10.1074/jbc.272.36.22393; RIOS E, 1991, J MUSCLE RES CELL M, V12, P127, DOI 10.1007/BF01774031; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SHISTIK E, 1995, J PHYSIOL-LONDON, V489, P55, DOI 10.1113/jphysiol.1995.sp021029; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; VAGHY PL, 1987, J BIOL CHEM, V262, P14337; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WAKAMORI M, 1993, BIOCHEM BIOPH RES CO, V196, P1170, DOI 10.1006/bbrc.1993.2374; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0	53	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9110	9118		10.1074/jbc.273.15.9110	http://dx.doi.org/10.1074/jbc.273.15.9110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535900	hybrid			2022-12-27	WOS:000072990800077
J	Tomita, S; Inoue, N; Maeda, Y; Ohishi, K; Takeda, J; Kinoshita, T				Tomita, S; Inoue, N; Maeda, Y; Ohishi, K; Takeda, J; Kinoshita, T			A homologue of Saccharomyces cerevisiae Dpm1p is not sufficient for synthesis of dolichol-phosphate-mannose in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR BIOSYNTHESIS; SUBSTRATE-SPECIFICITY; TRYPANOSOMA-BRUCEI; LYMPHOMA-CELLS; YEAST GENE; SYNTHASE; PROTEIN; GLYCOSYLATION; EXPRESSION	Dolichol-phosphate-mannose (Dol-P-Man) serves as a donor of mannosyl residues in major eukaryotic glycoconjugates, It donates four mannosyl residues in the N-linked oligosaccharide precursor and all three mannosyl residues in the core of the glycosylphosphatidylinositol anchor, In yeasts it also donates one mannose to the O-linked oligosaccharide. The yeast DPM1 gene encodes a Dol-P-Man synthase that is a transmembrane protein expressed in the endoplasmic reticulum, We cloned human and mouse homologues of DPM1, termed hDPM1 and mDPM1, respectively, both of which encode proteins of 260 amino acids, having 30% amino acid identity with yeast Dpm1 protein but lacking a hydrophobic transmembrane domain, which exists in the yeast synthase, Human and mouse DPM1 cDNA restored Dol-P-Man synthesis in mouse Thy-1-deficient mutant class E cells, Mouse class E mutant cells had an inactivating mutation in the mDPM1 gene, indicating that mDPM1 is the gene for class E mutant, In contrast, hDPM1 and mDPM1 cDNA did not complement another Dol-P-Man synthesis mutant, hamster Lec15 cells, whereas yeast DPM1 restored both mutants, Therefore, in contrast to yeast, mammalian cells require hDPM1/mDPM1 protein and a product of another gene that is defective in Lec15 mutant cells for synthesis of Dol-P-Man.	Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 565, Japan; Natl Inst Sericultural & Entomol Sci, Lab Cell Engn, Tsukuba, Ibaraki 305, Japan	Osaka University; National Institute of Agrobiological Sciences - Japan	Kinoshita, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, 3-1 Yamada Oka, Suita, Osaka 565, Japan.		Kinoshita, Taroh/C-7353-2009	Tomita, Shuichiro/0000-0002-0669-7721				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; BANERJEE DK, 1987, P NATL ACAD SCI USA, V84, P6389, DOI 10.1073/pnas.84.18.6389; BECK PJ, 1990, MOL CELL BIOL, V10, P4612, DOI 10.1128/MCB.10.9.4612; CAMP LA, 1993, J BIOL CHEM, V268, P6721; CHAPMAN A, 1980, J BIOL CHEM, V255, P4441; DEGASPERI R, 1990, SCIENCE, V250, P988, DOI 10.1126/science.1978413; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HIROSE S, 1992, J BIOL CHEM, V267, P16968; JENSEN JW, 1985, EUR J BIOCHEM, V153, P41, DOI 10.1111/j.1432-1033.1985.tb09264.x; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MARGOLSKEE RF, 1988, MOL CELL BIOL, V8, P2837, DOI 10.1128/MCB.8.7.2837; MazhariTabrizi R, 1996, BIOCHEM J, V316, P853, DOI 10.1042/bj3160853; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; SCHUTZBACH JS, 1993, J BIOL CHEM, V268, P24190; SINGH N, 1991, MOL CELL BIOL, V11, P391, DOI 10.1128/MCB.11.1.391; STOLL J, 1982, P NATL ACAD SCI-BIOL, V79, P2296, DOI 10.1073/pnas.79.7.2296; SUGIYAMA E, 1991, J BIOL CHEM, V266, P12119; TROWBRIDGE IS, 1978, CELL, V14, P21, DOI 10.1016/0092-8674(78)90297-0; VIDUGIRIENE J, 1993, J CELL BIOL, V121, P987, DOI 10.1083/jcb.121.5.987; Ware FE, 1996, J BIOL CHEM, V271, P13935, DOI 10.1074/jbc.271.24.13935; Watanabe R, 1996, J BIOL CHEM, V271, P26868, DOI 10.1074/jbc.271.43.26868; ZENG YC, 1990, J BIOL CHEM, V265, P2296; Zimmerman JW, 1996, YEAST, V12, P765, DOI 10.1002/(SICI)1097-0061(19960630)12:8<765::AID-YEA974>3.0.CO;2-A	28	51	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9249	9254		10.1074/jbc.273.15.9249	http://dx.doi.org/10.1074/jbc.273.15.9249			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535917	hybrid			2022-12-27	WOS:000072990800094
J	Xu, H; Moraitis, M; Reedstrom, RJ; Matthews, KS				Xu, H; Moraitis, M; Reedstrom, RJ; Matthews, KS			Kinetic and thermodynamic studies of purine repressor binding to corepressor and operator DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PURB; PRELIMINARY-X-RAY; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; REGULON REPRESSOR; GENE; BIOSYNTHESIS; PROTEIN; IDENTIFICATION; MECHANISM	The kinetic and thermodynamic parameters for purine repressor (PurR)-operator and PurR-guanine binding were determined using fluorescence spectroscopy and nitrocellulose filter binding. Operator binding affinity was increased by the presence of guanine as demonstrated previously (Choi, K. Y., Lu, F., and Zalkin, H, (1994) J. Biol. Chem. 269, 24066-24072; Rolfes, R, J,, and Zalkin, H, (1990) J. Bacteriol. 172, 5637-5642), and conversely guanine binding affinity was increased by the presence of operator, Guanine enhanced operator affinity by increasing the association rate constant and decreasing the dissociation rate constant for binding. Operator had minimal effect on the association rate constant for guanine binding; however, this DNA decreased the dissociation rate constant for corepressor by similar to 10-fold, Despite significant sequence and structural similarity between PurR and LacI proteins, PurR binds to its corepressor ligand with a lower association rate constant than LacI binds to its inducer ligand, However, the rate constant for PurR-guanine binding to operator is similar to 3-fold higher than for LacI binding to its cognate operator under the same solution conditions. The distinct metabolic roles of the enzymes under regulation by these two repressor proteins provide a rationale for the observed functional differences.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University	Matthews, KS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA.	ksm@bioc.rice.edu			NIGMS NIH HHS [GM22441] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022441] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIBA A, 1989, J BIOL CHEM, V264, P21239; BIN H, 1993, J BACTERIOL, V175, P3598, DOI 10.1128/jb.175.11.3598-3606.1993; CHANG WI, 1993, J BIOL CHEM, V268, P17613; CHOI KY, 1992, J BACTERIOL, V174, P6207, DOI 10.1128/JB.174.19.6207-6214.1992; CHOI KY, 1994, J BIOL CHEM, V269, P24066; CHOI KY, 1990, J BACTERIOL, V172, P3201, DOI 10.1128/jb.172.6.3201-3207.1990; CHOI KY, 1994, J BACTERIOL, V176, P1767, DOI 10.1128/jb.176.6.1767-1772.1994; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; HE B, 1990, J BACTERIOL, V172, P4555, DOI 10.1128/jb.172.8.4555-4562.1990; HE B, 1994, J BACTERIOL, V176, P1009, DOI 10.1128/JB.176.4.1009-1013.1994; HE B, 1992, J BACTERIOL, V174, P130, DOI 10.1128/jb.174.1.130-136.1992; HE B, 1992, J BACTERIOL, V174, P7121, DOI 10.1128/jb.174.22.7121-7127.1992; KILSTRUP M, 1989, J BACTERIOL, V171, P2124, DOI 10.1128/jb.171.4.2124-2127.1989; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; MAKAROFF CA, 1985, J BIOL CHEM, V260, P378; MENG LM, 1990, MOL MICROBIOL, V4, P2187, DOI 10.1111/j.1365-2958.1990.tb00580.x; MENG LM, 1990, EUR J BIOCHEM, V187, P373, DOI 10.1111/j.1432-1033.1990.tb15314.x; NAGADOI A, 1995, STRUCTURE, V3, P1217, DOI 10.1016/S0969-2126(01)00257-X; NEUHARD J, 1987, ESCHERICHIA COLI SAL, V1, P445; Nguyen CC, 1995, FEBS LETT, V377, P98, DOI 10.1016/0014-5793(95)01344-X; ROLFES RJ, 1988, J BIOL CHEM, V263, P19649; ROLFES RJ, 1988, J BIOL CHEM, V263, P19653; ROLFES RJ, 1990, J BACTERIOL, V172, P5637, DOI 10.1128/jb.172.10.5637-5642.1990; ROYER CA, 1993, ANAL BIOCHEM, V210, P91, DOI 10.1006/abio.1993.1155; SCHUMACHER MA, 1992, J MOL BIOL, V225, P1131, DOI 10.1016/0022-2836(92)90111-V; SCHUMACHER MA, 1994, J MOL BIOL, V242, P302, DOI 10.1006/jmbi.1994.1580; SCHUMACHER MA, 1993, J BIOL CHEM, V268, P12282; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; STEIERT JG, 1990, J BACTERIOL, V172, P3799, DOI 10.1128/jb.172.7.3799-3803.1990; TIEDEMAN AA, 1990, J BACTERIOL, V172, P6035, DOI 10.1128/jb.172.10.6035-6041.1990; WATANABE W, 1989, J BACTERIOL, V171, P198, DOI 10.1128/jb.171.1.198-204.1989; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; WILSON HR, 1990, J BACTERIOL, V172, P3208, DOI 10.1128/jb.172.6.3208-3213.1990; WILSON RL, 1993, J BACTERIOL, V175, P5129, DOI 10.1128/JB.175.16.5129-5134.1993; ZALKIN H, 1992, PROG NUCLEIC ACID RE, V42, P259, DOI 10.1016/S0079-6603(08)60578-4	36	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8958	8964		10.1074/jbc.273.15.8958	http://dx.doi.org/10.1074/jbc.273.15.8958			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535880	hybrid			2022-12-27	WOS:000072990800057
J	Yamaguchi, M; Dao, V; Modrich, P				Yamaguchi, M; Dao, V; Modrich, P			MutS and MutL activate DNA helicase II in a mismatch-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI REP; BASE-PAIR MISMATCHES; GENE-PRODUCT; FIDELITY; UVRD; PURIFICATION; POLYMERASE; AMPLIFICATION; INITIATION; EXTRACTS	MutS, MutL, and DNA helicase II are required for the mismatch-provoked excision step that occurs during Escherichia coli methyl-directed mismatch repair. In this study MutL is shown to enhance the unwinding activity of DNA helicase II more than 10-fold on a conventional helicase substrate in which a 35-residue oligonucleotide is annealed to a M13 circular single-stranded phage DNA under conditions where the two proteins are present at approximately molar stoichiometry with respect to the substrate. MutS- and MutL-dependent activation of DNA helicase II has also been demonstrated with a model substrate in which a 138-residue oligonucleotide was hybridized to a 138-nucleotide gap in an otherwise duplex 7,100-base pair circular DNA. Displacement of the oligoinucleotide requires MutS, MutL, DNA helicase II, and ATP and is dependent on the presence of a mismatch within the hybrid region, Although DNA helicase II and Rep helicase share substantial sequence homology and features of mechanism, Rep helicase is inactive in this reaction.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Modrich, P (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.			Modrich, Paul/0000-0001-8708-9885	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023719, R37GM023719] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23719] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Arai K, 1981, Prog Nucleic Acid Res Mol Biol, V26, P9, DOI 10.1016/S0079-6603(08)60392-X; AU KG, 1992, J BIOL CHEM, V267, P12142; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosh RM, 1997, J BIOL CHEM, V272, P572; CHASE JW, 1974, J BIOL CHEM, V249, P4553; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; GILCHRIST CA, 1987, NUCLEIC ACIDS RES, V15, P465, DOI 10.1093/nar/15.2.465; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LAHUE RS, 1987, P NATL ACAD SCI USA, V84, P1482, DOI 10.1073/pnas.84.6.1482; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; LOHMAN TM, 1989, J BIOL CHEM, V264, P10139; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; LU AL, 1983, P NATL ACAD SCI-BIOL, V80, P4639, DOI 10.1073/pnas.80.15.4639; LU AL, 1984, COLD SPRING HARB SYM, V49, P589, DOI 10.1101/SQB.1984.049.01.066; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1986, J BIOL CHEM, V261, P169; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; NEVERS P, 1975, MOL GEN GENET, V139, P233, DOI 10.1007/BF00268974; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P4128, DOI 10.1021/bi00066a039; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; WASHBURN BK, 1993, J BACTERIOL, V175, P341, DOI 10.1128/JB.175.2.341-350.1993; WONG I, 1993, J BIOL CHEM, V268, P20386; YAMAGUCHI M, 1997, THESIS DUKE U	39	128	134	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9197	9201		10.1074/jbc.273.15.9197	http://dx.doi.org/10.1074/jbc.273.15.9197			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535910	hybrid			2022-12-27	WOS:000072990800087
J	Ballinger, MD; Jones, JT; Lofgren, JA; Fairbrother, WJ; Akita, RW; Sliwkowski, MX; Wells, JA				Ballinger, MD; Jones, JT; Lofgren, JA; Fairbrother, WJ; Akita, RW; Sliwkowski, MX; Wells, JA			Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; TUMOR-CELLS; LIGAND; BINDING; DIFFERENTIATION; ACTIVATION; PROTEINS; DOMAIN; ALPHA; HER4/P180(ERBB4)	Heregulins (HRGs) are epidermal growth factor (egf) domain containing polypeptide growth factors that bind and activate several members of the ErbB receptor family, Although HRG can bind to ErbB3 and ErbB4 homodimers, the highest affinity and most intracellularly active receptor complexes are hetero-oligomers containing ErbB2. The HRG beta egf domain was displayed on the surface of M13 phage to facilitate mutagenic analysis and optimize for binding to a homodimeric ErbB3-immunoglobulin (IgG) fusion, Nine libraries were constructed in which virtually the entire sequence was randomized in stretches of four to six amino acids. These were selected separately for binding to immobilized ErbB3-IgG. Analysis of the resulting sequences revealed some areas that diverged radically from the wild-type, whereas others showed strong conservation. The degree of wild-type conservation correlated strongly with the functional importance of the residues as determined by alanine scanning mutagenesis (Jones, J. T., Ballinger, M. D., Pisacane, P. I., Lofgren, J. A. Fitzpatrick, V. D., Fairbrother, W. J., Wells, J. A., and Sliwkowski, M. X. (1998) J. Biol. Chem. 273, 11667-11674), Some variants from several libraries showed significant improvements in binding affinity to the ErbB3-IgG, These optimized segments were combined in various ways in the same molecule to generate variants (containing up to 16 mutations) that had > 50-fold higher affinity than wild-type HRG beta, The optimized variants stimulated ErbB2 phophorylation on MCF7 cells at levels similar to wildtype. This indicates wild-type affinity is optimized for potency and that factors other than affinity for ErbB3 are limiting, These variants showed enhanced affinity toward the ErbB4 homodimer, suggesting these receptors use very similar binding determinants despite them having 65% sequence identity.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Wells, JA (corresponding author), Genentech Inc, Dept Prot Engn, MS 27, San Francisco, CA 94080 USA.	jaw@gene.com	Wells, Jim A/O-9854-2016		NIGMS NIH HHS [GM16549-01] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; Braisted AC, 1996, P NATL ACAD SCI USA, V93, P5688, DOI 10.1073/pnas.93.12.5688; CAMPION SR, 1993, PROTEIN ENG, V6, P651, DOI 10.1093/protein/6.6.651; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; CHAN SDH, 1995, J BIOL CHEM, V270, P22608, DOI 10.1074/jbc.270.38.22608; CLACKSON T, 1994, TRENDS BIOTECHNOL, V12, P173, DOI 10.1016/0167-7799(94)90079-5; CUNNINGHAM BC, 1994, EMBO J, V13, P2508, DOI 10.1002/j.1460-2075.1994.tb06540.x; DOUGALL WC, 1993, J CELL BIOCHEM, V53, P61, DOI 10.1002/jcb.240530108; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Jacobsen NE, 1996, BIOCHEMISTRY-US, V35, P3402, DOI 10.1021/bi952626l; Jones JT, 1998, J BIOL CHEM, V273, P11667, DOI 10.1074/jbc.273.19.11667; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Lewis GD, 1996, CANCER RES, V56, P1457; LI B, 1995, SCIENCE, V270, P1657, DOI 10.1126/science.270.5242.1657; LOWMAN HB, 1991, BIOCHEMISTRY-US, V30, P10832, DOI 10.1021/bi00109a004; Lowman HB., 1991, METHODS COMPANION ME, V3, P205; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; NAGATA K, 1994, EMBO J, V13, P3517, DOI 10.1002/j.1460-2075.1994.tb06658.x; Pearce KH, 1997, J BIOL CHEM, V272, P20595, DOI 10.1074/jbc.272.33.20595; PELES E, 1993, EMBO J, V12, P961, DOI 10.1002/j.1460-2075.1993.tb05737.x; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Puddicombe SM, 1996, J BIOL CHEM, V271, P15367, DOI 10.1074/jbc.271.26.15367; Sadick MD, 1996, ANAL BIOCHEM, V235, P207, DOI 10.1006/abio.1996.0114; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sherrill JM, 1996, BIOCHEMISTRY-US, V35, P5705, DOI 10.1021/bi9602268; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Souriau C, 1997, NUCLEIC ACIDS RES, V25, P1585, DOI 10.1093/nar/25.8.1585; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M	41	41	43	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11675	11684		10.1074/jbc.273.19.11675	http://dx.doi.org/10.1074/jbc.273.19.11675			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565588	hybrid			2022-12-27	WOS:000073536700042
J	Baumann, B; Kistler, B; Kirillov, A; Bergman, Y; Wirth, T				Baumann, B; Kistler, B; Kirillov, A; Bergman, Y; Wirth, T			The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-kB activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-KAPPA-B; SIGNAL-INDUCED PHOSPHORYLATION; TRANSCRIPTION FACTOR; ALPHA PROTEOLYSIS; ENHANCER; DEGRADATION; INHIBITOR; REL; DISSOCIATION; MESSENGERS	Studies on the mechanisms of inducible and constitutive activity of NF-kappa B transcription factors have been hampered by the lack of appropriate mutant cell lines. We have analyzed the defect in the murine S107 plasmacytoma cell line, which was previously found to lack both constitutive and inducible NF-kappa B activity. Our analysis shows that these cells bear a specific defect that interferes with NF-kappa B induction by many diverse stimuli, such as lipopolysaccharide, phorbol 12-myristate 13-acetate, UV light, x-rays, and H2O2. This does not however represent a general signal transduction defect, because AP-1 transcription factors are readily induced by the same stimuli. Phosphatase inhibitors such as okadaic acid as well as calyculin A can efficiently induce NF-kappa B in S107 cells via a pathway apparently insensitive to the radical scavenger pyrrolidine dithiocarbamate. Furthermore, MEKK1 a protein kinase supposedly induced by some of the above stimuli, is also capable of activating NF-kappa B. Interestingly, both the potent physiological inducer of NF-kappa B TNF alpha as well as endoplasmic reticulum overload can induce NF-kappa B via a PDTC sensitive pathway. In all cases, DNA-binding NF-kappa B complexes are comprised predominantly of p50-RelA heterodimers, and NF-kappa B activation results in the induction of transiently transfected or resident reporter genes. In summary, these results suggest that the pathways for many NF-kappa B-inducing stimuli converge at a specific junction, and this pivotal step is mutated in the S107 cell line. Yet there are alternative routes bypassing this critical step that also lead to NF-kappa B induction. These routes utilized by tumor necrosis factor alpha and endoplasmic reticulum overload are still intact in this cell line.	Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Hebrew Univ Jerusalem, Hadassah Med Sch, Hubert H Humphrey Ctr Expt Med & Canc Res, IL-91120 Jerusalem, Israel	University of Wurzburg; Hebrew University of Jerusalem	Wirth, T (corresponding author), Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, Versbacher Str 5, D-97078 Wurzburg, Germany.	t.wirth@rzbox.uni-wuerzburg.de	Wirth, Thomas/X-7172-2019					ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; ATCHISON ML, 1987, CELL, V48, P121, DOI 10.1016/0092-8674(87)90362-X; ATCHISON ML, 1988, EMBO J, V7, P4213, DOI 10.1002/j.1460-2075.1988.tb03318.x; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; DOBRZANSKI P, 1994, EMBO J, V13, P4608, DOI 10.1002/j.1460-2075.1994.tb06782.x; GRILLI M, 1993, INT REV CYTOL, V143, P1; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kistler B, 1997, IMMUNOBIOLOGY, V198, P24, DOI 10.1016/S0171-2985(97)80024-1; Kistler B, 1998, J IMMUNOL, V160, P2308; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; LERNBECHER T, 1993, NATURE, V365, P767, DOI 10.1038/365767a0; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Meyer CF, 1996, J BIOL CHEM, V271, P8971, DOI 10.1074/jbc.271.15.8971; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; MIYAMOTO S, 1994, MOL CELL BIOL, V14, P3276, DOI 10.1128/MCB.14.5.3276; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Phillips RJ, 1997, MOL CELL BIOL, V17, P4390, DOI 10.1128/MCB.17.8.4390; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; SCHMIDT KN, 1995, J BIOL CHEM, V270, P27136, DOI 10.1074/jbc.270.45.27136; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SCHRECK R, 1997, NF TRANSCRIPTION FAC, P153; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; Suyang H, 1996, MOL CELL BIOL, V16, P5444; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; WHITESIDE ST, 1995, MOL CELL BIOL, V15, P5339; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	52	22	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11448	11455		10.1074/jbc.273.19.11448	http://dx.doi.org/10.1074/jbc.273.19.11448			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565556	hybrid			2022-12-27	WOS:000073536700010
J	Chen, Y; Le Caherec, F; Chuck, SL				Chen, Y; Le Caherec, F; Chuck, SL			Calnexin and other factors that alter translocation affect the rapid binding of ubiquitin to ApoB in the Sec61 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEP G2 CELLS; ENDOPLASMIC-RETICULUM MEMBRANE; APOLIPOPROTEIN-B; INTRACELLULAR DEGRADATION; PROTEASOME PATHWAY; SECRETORY PROTEIN; LIPOPROTEINS; BIOSYNTHESIS; PROTEOLYSIS; HEPATOCYTES	Several secretory proteins, including apolipoprotein B, have been shown to undergo degradation by proteasomes. We found that the rapid degradation of nascent apolipoprotein B in HepG2 cells was diminished but not abolished by the addition of any of three different inhibitors of proteasomes, Ubiquitin is conjugated to apolipoprotein B that is not assembled with sufficient lipids either during or soon after synthesis, In addition, we found that apolipoprotein B that has entered the endoplasmic reticulum sufficiently to become glycosylated can be degraded by proteasomes. Furthermore, we detected ubiquitin-apolipoprotein B that is associated with the Sec61 complex, the major constituent of the translocational channel. Treatment of cells with monomethylethanolamine or dithiothreitol decreased the translocation of apolipoprotein B and increased the proportion of ubiquitin-conjugated molecules associated with Sec61. Conversely, treatment of cells with oleic acid, which increased the proportion of translocated apolipoprotein B, decreased the amount of ubiquitin-apolipoprotein B in the Sec61 complex. Finally, we found that inhibition of the interaction between calnexin and apolipoprotein B decreases the translocation of apolipoprotein B, increases the ubiquitin-apolipoprotein B in the Sec61 complex, and increases the proteasomal degradation of glycosylated apolipoprotein B, Thus, ubiquitin can be attached to unassembled apolipoprotein B in the Sec61 complex, and this process is affected by factors including calnexin that alter the translocation of apolipoprotein B.	Beth Israel Deaconess Med Ctr E, Dept Med, Mol Med Unit, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Chuck, SL (corresponding author), Beth Israel Deaconess Med Ctr E, Dept Med, Mol Med Unit, RW 663,330 Brookline Ave, Boston, MA 02215 USA.							ADELI K, 1994, J BIOL CHEM, V269, P9166; Benoist F, 1996, EUR J BIOCHEM, V240, P713, DOI 10.1111/j.1432-1033.1996.0713h.x; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; BONNARDEL JA, 1995, J BIOL CHEM, V270, P28892, DOI 10.1074/jbc.270.48.28892; BOREN J, 1992, J BIOL CHEM, V267, P9858; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; Chang W, 1997, J BIOL CHEM, V272, P28925, DOI 10.1074/jbc.272.46.28925; CHUCK SL, 1990, NATURE, V346, P382, DOI 10.1038/346382a0; CHUCK SL, 1992, CELL, V8, P9; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DIXON JL, 1992, J CELL BIOL, V117, P1161, DOI 10.1083/jcb.117.6.1161; DIXON JL, 1991, J BIOL CHEM, V266, P5080; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GINSBERG HN, 1995, CURR OPIN LIPIDOL, V6, P275, DOI 10.1097/00041433-199510000-00006; Ginsberg HN, 1997, CLIN EXP PHARMACOL P, V24, pA29, DOI 10.1111/j.1440-1681.1997.tb03051.x; Gordon DA, 1996, J BIOL CHEM, V271, P33047, DOI 10.1074/jbc.271.51.33047; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Innerarity TL, 1996, J BIOL CHEM, V271, P2353, DOI 10.1074/jbc.271.5.2353; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KEARSE KP, 1994, EMBO J, V13, P3678, DOI 10.1002/j.1460-2075.1994.tb06677.x; Macri J, 1997, J BIOL CHEM, V272, P7328, DOI 10.1074/jbc.272.11.7328; McGee TP, 1996, J BIOL CHEM, V271, P25630, DOI 10.1074/jbc.271.41.25630; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Patel SB, 1996, J BIOL CHEM, V271, P18686, DOI 10.1074/jbc.271.31.18686; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROMAGNOLI P, 1995, J EXP MED, V182, P2027, DOI 10.1084/jem.182.6.2027; RUSINOL AE, 1993, J BIOL CHEM, V268, P25168; SAKATA N, 1993, J BIOL CHEM, V268, P22967; SATO R, 1990, J BIOL CHEM, V265, P11880; Shelness GS, 1996, J LIPID RES, V37, P408; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wu XJ, 1997, J BIOL CHEM, V272, P11575; YAO ZM, 1994, BBA-LIPID LIPID MET, V1212, P152, DOI 10.1016/0005-2760(94)90249-6; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; ZHOU MY, 1995, J BIOL CHEM, V270, P25220, DOI 10.1074/jbc.270.42.25220	50	82	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11887	11894		10.1074/jbc.273.19.11887	http://dx.doi.org/10.1074/jbc.273.19.11887			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565615	hybrid			2022-12-27	WOS:000073536700069
J	Ellis, MV; James, SR; Perisic, O; Downes, CP; Williams, RL; Katan, M				Ellis, MV; James, SR; Perisic, O; Downes, CP; Williams, RL; Katan, M			Catalytic domain of phosphoinositide-specific phospholipase C (PLC) - Mutational analysis of residues within the active site and hydrophobic ridge of PLC delta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOLAYER SURFACE PRESSURE; PLECKSTRIN HOMOLOGY DOMAIN; INOSITOL MONOPHOSPHATASE; BOVINE BRAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; BACILLUS-CEREUS; BINDING; PURIFICATION	Structural studies of phospholipase C delta 1 (PLC delta 1) in complexes with the inositol-lipid headgroup and calcium identified residues within the catalytic domain that could be involved in substrate recognition, calcium binding, and catalysis. In addition, the structure of the PLC delta 1 catalytic domain revealed a cluster of hydrophobic residues at the rim of the active site opening (hydrophobic ridge). To assess a role of each of these residues, we have expressed, purified, and characterized enzymes with the point mutations of putative active site residues (His(311), Asn(312), Glu(341), Asp(343), His(356), Glu(390), Lys(438), Lys(440), Ser(522), Arg(549) and Tyr(551)) and residues from the hydrophobic ridge (Leu(320), Phe(360), and Trp(555)). The replacements of most active site residues by alanine resulted in a great reduction (1,000-200,000-fold) of PLC activity analyzed in an inositol lipid/sodium cholate mixed micelle assay. Measurements of the enzyme activity toward phosphatidylinositol, phosphatidylinositol 4-monophosphate, and phosphatidylinositol 4,5-bisphosphate (PIP2) identified Ser(522), Lys(438), and Arg(549) as important for preferential hydrolysis of polyphosphoinositides, whereas replacement of Lys(440) selectively affected only hydrolysis of PIP2. When PLC activity was analyzed at different calcium concentrations, substitutions of Asn(312), Glu(390), Glu(341), and Asp(343) resulted in a shift toward higher calcium concentrations required for PIP2 hydrolysis, suggesting that all these residues contribute toward Ca2+ binding. Mutational analysis also confirmed the importance of His(311) (similar to 20,000-fold reduction) and His(356) (similar to 6,000-fold reduction) for the catalysis. Mutations within the hydrophobic ridge, which had little effect on PIP2 hydrolysis in the mixed-micelles, resulted in an enzyme that was less dependent on the surface pressure when analyzed in a monolayer. This systematic mutational analysis provides further insights into the structural basis for the substrate specificity, requirement for Ca2+ ion, catalysis, and surface pressure/activity dependence, with general implications for eukaryotic phosphoinositide-specific PLCs.	Inst Canc Res, Chester Beatty Labs, Canc Res Campaign, Ctr Cell & Mol Biol, London SW3 6JB, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Dundee, Inst Med Sci, Dept Biochem, Dundee DD1 4HN, Scotland	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; MRC Laboratory Molecular Biology; University of Dundee	Katan, M (corresponding author), Inst Canc Res, Chester Beatty Labs, Canc Res Campaign, Ctr Cell & Mol Biol, Fulham Rd, London SW3 6JB, England.			Williams, Roger/0000-0001-7754-4207; Perisic, Olga/0000-0002-3842-2896	MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036; BONE R, 1994, BIOCHEMISTRY-US, V33, P9460, DOI 10.1021/bi00198a011; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzik K S, 1994, Bioorg Med Chem, V2, P49, DOI 10.1016/S0968-0896(00)82002-7; CHENG HF, 1995, J BIOL CHEM, V270, P5495, DOI 10.1074/jbc.270.10.5495; CIFUENTES ME, 1993, J BIOL CHEM, V268, P11586; COCKCROFT S, 1992, BIOCHEM J, V288, P1; ELLIS MV, 1993, EUR J BIOCHEM, V213, P339, DOI 10.1111/j.1432-1033.1993.tb17767.x; ELLIS MV, 1995, BIOCHEM J, V307, P69, DOI 10.1042/bj3070069; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FUKUI T, 1988, J BIOL CHEM, V263, P17730; GINGER RS, 1992, EUR J BIOCHEM, V210, P155, DOI 10.1111/j.1432-1033.1992.tb17403.x; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hondal RJ, 1997, BIOCHEMISTRY-US, V36, P6633, DOI 10.1021/bi962866g; HUGHES AR, 1989, J BIOL CHEM, V264, P9400; JAMES SR, 1994, BIOCHEM J, V298, P499, DOI 10.1042/bj2980499; James SR, 1997, BIOCHEMISTRY-US, V36, P848, DOI 10.1021/bi962108q; JAMES SR, 1995, J BIOL CHEM, V270, P11872, DOI 10.1074/jbc.270.20.11872; James SR, 1996, BIOCHEM J, V314, P917, DOI 10.1042/bj3140917; James SR, 1997, CELL SIGNAL, V9, P329, DOI 10.1016/S0898-6568(96)00175-1; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KATAN M, 1988, CELL, V54, P171, DOI 10.1016/0092-8674(88)90549-1; KATAN M, 1987, EUR J BIOCHEM, V168, P413, DOI 10.1111/j.1432-1033.1987.tb13435.x; KATAN M, 1997, CELL DEV BIOL, V8, P287; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; MELDRUM E, 1989, EUR J BIOCHEM, V182, P673, DOI 10.1111/j.1432-1033.1989.tb14878.x; Paterson HF, 1995, BIOCHEM J, V312, P661, DOI 10.1042/bj3120661; POLLACK SJ, 1993, EUR J BIOCHEM, V217, P281, DOI 10.1111/j.1432-1033.1993.tb18244.x; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12748, DOI 10.1021/bi00166a006; REBECCHI MJ, 1987, J BIOL CHEM, V262, P12526; REBECCHI MJ, 1993, J BIOL CHEM, V268, P1735; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SIMOES AP, 1995, FEBS LETT, V365, P155; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; VOLWERK JJ, 1994, BIOCHEMISTRY-US, V33, P3464, DOI 10.1021/bi00178a002; WAHL MI, 1992, J BIOL CHEM, V267, P10447; Wang LP, 1996, J BIOL CHEM, V271, P24505, DOI 10.1074/jbc.271.40.24505; Williams RL, 1996, STRUCTURE, V4, P1387, DOI 10.1016/S0969-2126(96)00146-3; WU Y, 1997, BIOCHEMISTRY-US, V37, P11223	47	129	136	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11650	11659		10.1074/jbc.273.19.11650	http://dx.doi.org/10.1074/jbc.273.19.11650			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565585	hybrid			2022-12-27	WOS:000073536700039
J	Luque, CM; Lallena, MJ; Alonso, MA; Correas, I				Luque, CM; Lallena, MJ; Alonso, MA; Correas, I			An alternative domain determines nuclear localization in multifunctional protein 4.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTRIN-ACTIN BINDING; PRE-MESSENGER-RNA; MEMBRANE SKELETAL PROTEIN-4.1; ERYTHROCYTE PROTEIN-4.1; MONOCLONAL-ANTIBODIES; BAND 4.1; CELLS; SITE; EXPRESSION; MATRIX	Multiple protein 4.1 isoforms are originated by alternative pre-mRNA splicing, differential use of two translation initiation sites, and posttranslational modifications. The complexity of alternative splicing events suffered by the 4.1 pre-mRNA makes necessary the direct cloning of 4.1 full-coding cDNA sequences to ensure that the encoded 4.1 proteins are naturally occurring isoforms. We have approached this point by reverse transcription-polymerase chain reaction techniques using RNA from the nucleated human Molt-4 T-cell line as a starting template. Molecular cloning of 4.1 cDNAs using the second translation initiation codon has allowed us to identify two 4.1 isoforms, designated 4.1H and 4.1I, which are differentially targeted to the nucleus (4.1H) and the cytoplasm (4.1I), These two isoforms differ only in the inclusion (4.1H) or exclusion (4.1I) of 21 amino acids encoded by exon 16, A cluster of basic amino acids, KKKR, generated by joining of the sequences encoded by the constitutive exon 13 and the alternative exon 16, is necessary for the nuclear targeting of 4.1H, as demonstrated by site-directed mutagenesis analysis. Immunofluorescence microscopy and biochemical studies indicate that 4.1H belongs to the group of nuclear 4.1 proteins that are distributed diffusely throughout the nucleoplasm and that are extractable in 0.5% Triton X-100. This is the first demonstration of differential nuclear targeting by the presence of an alternative domain, among naturally occurring protein 4.1 isoforms.	Univ Autonoma Madrid, Fac Ciencias, Dept Mol Biol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Correas, I (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Mol Biol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Alonso, Miguel A/J-3945-2016; Luque, Carlos M./Q-6043-2019; Correas, Isabel/O-4061-2018; Luque, Carlos/H-6810-2015	Alonso, Miguel A/0000-0002-7001-8826; Luque, Carlos M./0000-0002-2993-4152; Correas, Isabel/0000-0002-2286-186X; Luque, Carlos/0000-0002-2993-4152				ANDERSON RA, 1988, J CELL BIOCHEM, V37, P269, DOI 10.1002/jcb.240370303; BACHS O, 1990, J BIOL CHEM, V265, P18595; Baklouti F, 1997, GENOMICS, V39, P289, DOI 10.1006/geno.1996.4512; Baklouti F, 1996, BLOOD, V87, P3934, DOI 10.1182/blood.V87.9.3934.bloodjournal8793934; Chasis JA, 1996, BLOOD, V87, P5324, DOI 10.1182/blood.V87.12.5324.bloodjournal87125324; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; CLARK TG, 1977, CELL, V12, P883, DOI 10.1016/0092-8674(77)90152-0; COHEN CM, 1982, NATURE, V299, P648, DOI 10.1038/299648a0; CONBOY J, 1986, P NATL ACAD SCI USA, V83, P9512, DOI 10.1073/pnas.83.24.9512; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; CORREAS I, 1986, J BIOL CHEM, V261, P3362; CORREAS I, 1991, BIOCHEM J, V279, P581, DOI 10.1042/bj2790581; CORREAS I, 1988, BIOCHEM J, V255, P217; CORREAS I, 1986, J BIOL CHEM, V261, P3310; DeCarcer G, 1995, BIOCHEM J, V312, P871, DOI 10.1042/bj3120871; DELAUNAY J, 1995, CRIT REV ONCOL HEMAT, V19, P79, DOI 10.1016/1040-8428(94)00139-K; DISCHER D, 1993, J BIOL CHEM, V268, P7186; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Favaloro J, 1980, Methods Enzymol, V65, P718; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GRANGER BL, 1984, CELL, V37, P597; HAGEN SJ, 1986, J CELL BIOL, V103, P2121, DOI 10.1083/jcb.103.6.2121; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORNE WC, 1993, BLOOD, V82, P2558; HUANG JP, 1993, J BIOL CHEM, V268, P3758; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lallena MJ, 1997, J CELL SCI, V110, P239; Lamond Angus I., 1993, Trends in Cell Biology, V3, P198, DOI 10.1016/0962-8924(93)90214-L; LETO TL, 1986, J CELL PHYSIOL, V127, P423, DOI 10.1002/jcp.1041270311; LETO TL, 1984, J BIOL CHEM, V259, P4603; MILANKOV K, 1993, EXP CELL RES, V209, P189, DOI 10.1006/excr.1993.1301; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; NAKAYASU H, 1983, EXP CELL RES, V143, P55, DOI 10.1016/0014-4827(83)90108-8; PASTERNACK GR, 1989, P NATL ACAD SCI USA, V86, P9712, DOI 10.1073/pnas.86.24.9712; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; Schischmanoff PO, 1997, J BIOL CHEM, V272, P10254, DOI 10.1074/jbc.272.15.10254; SCHISCHMANOFF PO, 1995, J BIOL CHEM, V270, P21243, DOI 10.1074/jbc.270.36.21243; Spector DL, 1993, CURR OPIN CELL BIOL, V5, P442, DOI 10.1016/0955-0674(93)90009-F; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; SUBRAHMANYAM G, 1991, P NATL ACAD SCI USA, V88, P5222, DOI 10.1073/pnas.88.12.5222; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TANG TK, 1988, P NATL ACAD SCI USA, V85, P3713, DOI 10.1073/pnas.85.11.3713; TANG TK, 1990, J CELL BIOL, V110, P617, DOI 10.1083/jcb.110.3.617; WINARDI R, 1995, BLOOD, V86, P4315, DOI 10.1182/blood.V86.11.4315.bloodjournal86114315	47	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11643	11649		10.1074/jbc.273.19.11643	http://dx.doi.org/10.1074/jbc.273.19.11643			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565584	hybrid			2022-12-27	WOS:000073536700038
J	Wible, BA; Yang, Q; Kuryshev, YA; Accili, EA; Brown, AM				Wible, BA; Yang, Q; Kuryshev, YA; Accili, EA; Brown, AM			Cloning and expression of a novel K+ channel regulatory protein, KChAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; POTASSIUM-CHANNEL; ALPHA-SUBUNITS; FUNCTIONAL EXPRESSION; BOVINE BRAIN; HUMAN ATRIUM; RAT-BRAIN; INACTIVATION; BINDING	Voltage-gated K+ (Kv) channels are important in the physiology of both excitable and nonexcitable cells. The diversity in Ky currents is reflected in multiple Kv channel genes whose products may assemble as multisubunit heteromeric complexes. Given the fundamental importance and diversity of Ky channels, surprisingly little is known regarding the cellular mechanisms regulating their synthesis, assembly, and metabolism. To begin to dissect these processes, we have used the yeast two-hybrid system to identify cytoplasmic regulatory molecules that interact with Ky channel proteins. Here we report the cloning of a novel gene encoding a Ky channel binding protein (KChAP, for K+ channel-associated protein), which modulates the expression of Kv2 channels in heterologous expression system assays, KChAP interacts with the N termini of Kv alpha 2 subunits, as well as the N termini of Kv alpha 1 and the C termini of Kv beta subunits, Kv2.1 and KChAP were coimmunoprecipitated from in vitro translation reactions supporting a direct interaction between the two proteins. The amplitudes of Kv2.1 and Kv2.2 currents are enhanced dramatically in Xenopus oocytes coexpressing RChAP, but channel kinetics and gating are unaffected. Although KChAP binds to Kv1.5, it has no effect on Kv1.5 currents. We suggest that RChAP may act as a novel type of chaperone protein to facilitate the cell surface expression of Kv2 channels.	Rammelkamp Ctr, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44109 USA	MetroHealth System; Case Western Reserve University; Case Western Reserve University	Wible, BA (corresponding author), Rammelkamp Ctr, 2500 Metrohealth Dr, Cleveland, OH 44109 USA.				NHLBI NIH HHS [HL-57146, HL-36930] Funding Source: Medline; NINDS NIH HHS [NS-23877] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036930, R43HL057146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023877] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Accili EA, 1997, J BIOL CHEM, V272, P25824, DOI 10.1074/jbc.272.41.25824; Chan KW, 1997, J BIOL CHEM, V272, P6548, DOI 10.1074/jbc.272.10.6548; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; Feldherr C M, 1978, Methods Cell Biol, V17, P75, DOI 10.1016/S0091-679X(08)61135-8; HEINEMANN SJ, 1995, FEBS LETT, V377, P393; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MORALES MJ, 1995, J BIOL CHEM, V270, P6272, DOI 10.1074/jbc.270.11.6272; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RHODES KJ, 1995, J NEUROSCI, V15, P5360; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SHI GY, 1994, J BIOL CHEM, V269, P23204; Shieh CC, 1997, J GEN PHYSIOL, V109, P767, DOI 10.1085/jgp.109.6.767; Valdez BC, 1997, BIOCHEM BIOPH RES CO, V234, P335, DOI 10.1006/bbrc.1997.6642; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wang ZG, 1996, J BIOL CHEM, V271, P28311, DOI 10.1074/jbc.271.45.28311; WIBLE BA, 1995, CIRC RES, V76, P343, DOI 10.1161/01.RES.76.3.343; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8	30	95	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11745	11751		10.1074/jbc.273.19.11745	http://dx.doi.org/10.1074/jbc.273.19.11745			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565597	hybrid			2022-12-27	WOS:000073536700051
J	Honer, M; Benke, D; Laube, B; Kuhse, J; Heckendorn, R; Allgeier, H; Angst, C; Monyer, H; Seeburg, PH; Betz, H; Mohler, H				Honer, M; Benke, D; Laube, B; Kuhse, J; Heckendorn, R; Allgeier, H; Angst, C; Monyer, H; Seeburg, PH; Betz, H; Mohler, H			Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes - Preferential interaction of CGP 61594 with NR1/2B receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT MESSENGER-RNAS; HETEROMERIC NMDA RECEPTORS; RAT-BRAIN; BINDING-SITE; MAMMALIAN-CELLS; MOLECULAR CHARACTERIZATION; DISTINCT DISTRIBUTIONS; REGIONAL EXPRESSION; ACTIVATED CHANNELS; XENOPUS OOCYTES	The binding site for the co-agonist glycine on N-methyl-D-aspartate (NMDA) receptors has been mapped to the NR1 subunit whereas binding of the principal agonist glutamate is mediated by the NR2 subunits, Using the novel glycine site antagonist and photoaffinity label CGP 61594, distinct contributions of the NR2 subunit variants to the glycine antagonist binding domains of NMDA receptor subtypes are demonstrated. High affinity sites for CGP 61594 were exclusively displayed by NR1/2B receptors, as shown by their co-distribution with the NR2B subunit, by subunit-selective immunoprecipitation and by functional analysis of NR1/2B receptors expressed in Xenopus oocytes (inhibitory potency, IC50 = 45 +/- 11 nM). Other NMDA receptor subtypes are clearly distinguished by reduced inhibitory potencies for CGP 61594, being low for NR1/2A and NR1/2D receptors (IC50 = 430 +/- 105 nm and 340 +/- 61 nM, respectively) and intermediate for NR1/2C receptors (IC50 = 164 +/- 27 nM). Glycine antagonist sites with low and intermediate affinity for [H-3]CGP 61594 were detected also in situ by radioligand binding in brain areas predominantly expressing the NR2A and NR2C subunits, respectively. Thus, [H-3]CGP 61594 is the first antagonist radioligand that reliably distinguishes the gig-cine site of NMDA receptor subtypes. [H-3]CGP 61594 is a promising tool to identify the NR2 subunit domains that contribute to differential glycine antagonist sites of NMDA receptor subtypes.	Swiss Fed Inst Technol, Inst Pharmacol, CH-8057 Zurich, Switzerland; Univ Zurich, CH-8057 Zurich, Switzerland; Nova Pharma AG, Nervous Syst Res, CH-4002 Basel, Switzerland; Max Planck Inst Med Res, Dept Mol Neurosci, D-69120 Heidelberg, Germany; Max Planck Inst Hirnforsch, Neurochem Abt, D-60528 Frankfurt, Germany	ETH Zurich; University of Zurich; Novartis; Max Planck Society; Max Planck Society	Monyer, H (corresponding author), Swiss Fed Inst Technol, Inst Pharmacol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Kuhse, Jochen/T-3864-2019					BENKE D, 1995, J RECEPT SIGNAL TR R, V15, P393, DOI 10.3109/10799899509045229; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; BULLER AL, 1994, J NEUROSCI, V14, P5471; Chazot PL, 1997, J NEUROCHEM, V68, P507; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CONSTANTINEPATON M, 1994, PSYCHOPHARMACOL BULL, V30, P561; CUDENNEC A, 1994, BRAIN RES, V664, P41, DOI 10.1016/0006-8993(94)91951-8; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; DUVAL D, 1992, NEUROSCI LETT, V137, P193, DOI 10.1016/0304-3940(92)90402-S; GRIMWOOD S, 1995, J NEUROCHEM, V64, P525; Grimwood S, 1996, J NEUROCHEM, V66, P2239; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; ISHII T, 1993, J BIOL CHEM, V268, P2836; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; Kendrick SJ, 1996, J NEUROCHEM, V67, P608; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; LYNCH DR, 1994, MOL PHARMACOL, V45, P540; LYNCH DR, 1995, J NEUROCHEM, V64, P1462; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MCDONALD JW, 1990, NEUROSCIENCE, V35, P653, DOI 10.1016/0306-4522(90)90336-3; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NICOLAS C, 1994, J NEUROCHEM, V63, P2248; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; PATAT A, 1994, INT CLIN PSYCHOPHARM, V9, P155, DOI 10.1097/00004850-199409000-00003; Priestley T, 1996, NEUROPHARMACOLOGY, V35, P1573, DOI 10.1016/S0028-3908(96)00141-4; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SEEBURG PH, 1995, RECENT PROG HORM RES, V50, P19; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Siegel BW, 1996, EUR J PHARMACOL, V312, P357, DOI 10.1016/0014-2999(96)00477-3; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; STERN P, 1992, P ROY SOC B-BIOL SCI, V250, P271, DOI 10.1098/rspb.1992.0159; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; WAFFORD KA, 1993, NEUROREPORT, V4, P1347, DOI 10.1097/00001756-199309150-00015; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WATANABE M, 1994, J COMP NEUROL, V343, P520, DOI 10.1002/cne.903430403; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512290-00010; Wenzel A, 1996, J NEUROCHEM, V66, P1240; Williams K, 1996, MOL PHARMACOL, V50, P701; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; YONEDA Y, 1994, J NEUROCHEM, V62, P102	64	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11158	11163		10.1074/jbc.273.18.11158	http://dx.doi.org/10.1074/jbc.273.18.11158			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556603	hybrid			2022-12-27	WOS:000073395200055
J	Lardans, A; Forster, B; Prasil, O; Falkowski, PG; Sobolev, V; Edelman, M; Osmond, CB; Gillham, NW; Boynton, JE				Lardans, A; Forster, B; Prasil, O; Falkowski, PG; Sobolev, V; Edelman, M; Osmond, CB; Gillham, NW; Boynton, JE			Biophysical, biochemical, and physiological characterization of Chlamydomonas reinhardtii mutants with amino acid substitutions at the Ala(251) residue in the D1 protein that result in varying levels of photosynthetic competence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; RESISTANT MUTANTS; OXYGEN EVOLUTION; LIGHT; PHOTOINHIBITION; PHYTOPLANKTON; QUINONE; PLASTOQUINONE; FLUORESCENCE; SENSITIVITY	The Q(B) binding site of the D1 reaction center protein, located within a stromal loop between transmembrane helices IV and V formed by residues Ile(219) to Leu(272), is essential for photosynthetic electron transport through photosystem II (PSII). We have examined the function of the highly conserved Ala(251) D1 residue in this domain in chloroplast transformants of Chlamydomonas reinhardtii and found that Arg, Asp, Gin, Glu, and His substitutions are nonphotosynthetic, whereas Cys, Ser, Pro, Gly, ne, Val, and Leu substitutions show various alterations in D1 turnover, photosynthesis, and photoautotrophic growth. The latter mutations reduce the rate of Q(A) to Q(B) electron transfer, but this is not necessarily rate-limiting for photoautotrophic growth. The Cys mutant divides and evolves O-2 at wild type rates, although it has slightly higher rates of D1 synthesis and turnover and reduced electron transfer between Q(A) and Q(B). O-2 evolution, D1 synthesis, and accumulation in the Ser, Pro, and Gly mutants in high light is reduced, but photoautotrophic growth rate is not affected. In contrast, the ne, Val, and Leu mutants are impaired in photoautotrophic growth and photosynthesis in both low and high light and have elevated rates of D1 synthesis and degradation, but D1 accumulation is normal. While rates of synthesis/degradation of the D1 protein are not necessarily correlated with alterations in specific parameters of PSII function in these mutants, bulkiness of the substituted amino acids is highly correlated with the dissociation constant for Q(B) in the seven mutants examined. These observations imply that the Ala(251) residue plays a hey role in D1 protein.	Duke Univ, DCMB Grp, Dept Bot, Durham, NC 27708 USA; Duke Univ, Dept Zool, Durham, NC 27708 USA	Duke University; Duke University	Boynton, JE (corresponding author), Duke Univ, DCMB Grp, Dept Bot, Box 91000, Durham, NC 27708 USA.		Baillet, Anita/R-6217-2018; Förster, Britta/O-7908-2015; Prasil, Ondrej/H-2454-2014	Prasil, Ondrej/0000-0002-0012-4359				ALLEN JF, 1995, CURR BIOL, V5, P869, DOI 10.1016/S0960-9822(95)00176-X; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Bowyer J. R., 1991, Herbicides., P27; CROFTS AR, 1993, Z NATURFORSCH C, V48, P259; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; ETIENNE AL, 1993, PHOTOSYNTH RES, V38, P387, DOI 10.1007/BF00046765; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 1981, PLANT PHYSIOL, V68, P969, DOI 10.1104/pp.68.4.969; FALKOWSKI PG, 1985, LIMNOL OCEANOGR, V30, P311, DOI 10.4319/lo.1985.30.2.0311; Forster B, 1997, Z NATURFORSCH C, V52, P654; Gray GR, 1996, PLANT PHYSIOL, V110, P61, DOI 10.1104/pp.110.1.61; GREENBERG BM, 1987, EMBO J, V6, P2865, DOI 10.1002/j.1460-2075.1987.tb02588.x; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Heifetz PB, 1997, PLANT CELL ENVIRON, V20, P1145, DOI 10.1046/j.1365-3040.1997.d01-143.x; JOHANNINGMEIER U, 1987, FEBS LETT, V211, P221, DOI 10.1016/0014-5793(87)81440-0; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; KIRILOVSKY DL, 1989, PLANT MOL BIOL, V13, P355, DOI 10.1007/BF00015547; KLESS H, 1994, BIOCHEMISTRY-US, V33, P10501, DOI 10.1021/bi00200a035; KLESS H, 1995, J MOL BIOL, V246, P120, DOI 10.1006/jmbi.1994.0071; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; KOLBER ZS, 1998, IN PRESS BIOCH BIOPH; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; Lardans A, 1997, J BIOL CHEM, V272, P210; LEDERMAN TC, 1981, BOT MAR, V24, P125, DOI 10.1515/botm.1981.24.3.125; LERS A, 1992, J BIOL CHEM, V267, P17494; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; OHAD N, 1992, PLANT CELL, V4, P273, DOI 10.1105/tpc.4.3.273; OQUIST G, 1992, PLANTA, V186, P450, DOI 10.1007/BF00195327; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; PEREWOSKA I, 1994, PLANT PHYSIOL, V104, P235, DOI 10.1104/pp.104.1.235; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; PutnamEvans C, 1996, PLANT MOL BIOL, V32, P1191, DOI 10.1007/BF00041405; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; SATOH K, 1993, PHOTOSYNTHETIC REACT, V1, P289; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Shapira M, 1997, PLANT MOL BIOL, V33, P1001, DOI 10.1023/A:1005814800641; SOBOLEV V, 1995, PROTEINS, V21, P214, DOI 10.1002/prot.340210304; SUKENIK A, 1987, BIOCHIM BIOPHYS ACTA, V891, P205, DOI 10.1016/0005-2728(87)90216-7; SVENSSON B, 1991, Z NATURFORSCH C, V46, P765; TREBST A, 1986, Z NATURFORSCH C, V41, P240; VANWIJK KJ, 1993, PLANTA, V189, P359, DOI 10.1007/BF00194432; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408	45	25	25	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11082	11091		10.1074/jbc.273.18.11082	http://dx.doi.org/10.1074/jbc.273.18.11082			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556593	hybrid			2022-12-27	WOS:000073395200045
J	Tatoyan, A; Giulivi, C				Tatoyan, A; Giulivi, C			Purification and characterization of a nitric oxide synthase from rat liver mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARGININE; TISSUE DISTRIBUTION; CYTOSOLIC ENZYME; SKELETAL-MUSCLE; CALMODULIN; BRAIN; IDENTIFICATION; CELLS; FLAVOPROTEIN; HEPATOCYTES	The biosynthesis of nitric oxide (NO.) in different cell types occurs concomitantly with the conversion of L-arginine to L-citrulline by the enzyme nitric-oxide synthase (NOS). NO. has been identified as a major participant in a number of basic physiological functions such as neurotransmission, vasodilation, and immune response. At the subcellular level, mitochondria have been identified as targets for NO.; however, to date, no unambiguous evidence has been presented to identify these organelles as sources of NO., In this study, a NOS was isolated to homogeneity from Percoll-purified rat Liver mitochondria. Kinetic parameters, molecular weight, requirement of cofactors, and cross-reactivity to monoclonal antibodies against macrophage NOS suggest similarities to the inducible form. However, the constitutive expression of the mitochondrial enzyme and its main membrane localization indicate the presence of either a distinctive isoform or a macrophage isoform containing posttranslational modifications that lead to different subcellular compartments. The detection of NADPH-oxidizing activities and a production of superoxide anion catalyzed by mtNOS and recombinant cytochrome P-450 reductase were consistent with the sequence homology reported for these two proteins. Given the role of NO. as cellular transmitter, messenger, or regulator, the presence of a functionally active mitochondrial NOS may have important implications for the intermediary metabolism.	Univ So Calif, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA	University of Southern California	Giulivi, C (corresponding author), Univ So Calif, Dept Mol Pharmacol & Toxicol, 1985 Zonal Ave, Los Angeles, CA 90033 USA.	cgiulivi@hsc.usc.edu	Giulivi, Cecilia/ABB-7809-2020; Giulivi, Cecilia/AAV-6774-2021	Giulivi, Cecilia/0000-0003-1033-7435; 	NIDDK NIH HHS [P30DK48522] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; BILLIAR TR, 1990, BIOCHEM BIOPH RES CO, V168, P1034, DOI 10.1016/0006-291X(90)91133-D; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CHANCE B, 1963, 5 P INT C BIOCH USSR, V5, P3; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; COHEN NS, 1992, BIOCHEM J, V282, P173, DOI 10.1042/bj2820173; CZAPSKI G, 1995, FREE RADICAL BIO MED, V19, P785, DOI 10.1016/0891-5849(95)00081-8; FELDMAN PL, 1993, CHEM ENG NEWS, V71, P26; FREEDLAND RA, 1984, BIOCHIM BIOPHYS ACTA, V802, P407, DOI 10.1016/0304-4165(84)90357-X; FREEDLAND RA, 1985, FED PROC, V44, P2453; Fridovich I, 1985, CRC HDB METHODS OXYG, P213; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; GAZZOTTI P, 1984, BIOCHEM BIOPH RES CO, V119, P343, DOI 10.1016/0006-291X(84)91657-7; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; GRAZI E, 1975, EUR J BIOCHEM, V60, P431, DOI 10.1111/j.1432-1033.1975.tb21020.x; GROSS SS, 1991, BIOCHEM BIOPH RES CO, V178, P823, DOI 10.1016/0006-291X(91)90965-A; HATASE O, 1983, BIOCHEM BIOPH RES CO, V113, P633, DOI 10.1016/0006-291X(83)91773-4; HATASE O, 1982, BIOCHEM BIOPH RES CO, V104, P673, DOI 10.1016/0006-291X(82)90689-1; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; HEVEL JM, 1994, METHOD ENZYMOL, V233, P250; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; IIDA S, 1992, J BIOL CHEM, V267, P25385; Keilin D., 1937, NATURE, V139, P548; KELLER DM, 1968, BIOCHIM BIOPHYS ACTA, V153, P113, DOI 10.1016/0005-2728(68)90151-5; KLATT P, 1992, J BIOL CHEM, V267, P11374; KOBZIK L, 1995, BIOCHEM BIOPH RES CO, V211, P375, DOI 10.1006/bbrc.1995.1824; KWONG E, 1982, J NUTR, V112, P2081; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYER B, 1989, BIOCHEM BIOPH RES CO, V164, P678, DOI 10.1016/0006-291X(89)91513-1; MAYER B, 1991, FEBS LETT, V288, P187, DOI 10.1016/0014-5793(91)81031-3; MCCORMACK JG, 1989, BIOCHIM BIOPHYS ACTA, V973, P420, DOI 10.1016/S0005-2728(89)80384-6; MONCADA S, 1991, PHARMACOL REV, V43, P109; OHSHIMA H, 1992, BIOCHEM BIOPH RES CO, V183, P238, DOI 10.1016/0006-291X(92)91634-3; PALACIOS M, 1989, BIOCHEM BIOPH RES CO, V165, P802, DOI 10.1016/S0006-291X(89)80037-3; PARDUE RL, 1981, CELL, V23, P533, DOI 10.1016/0092-8674(81)90149-5; POU S, 1992, J BIOL CHEM, V267, P24173; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; Ruben L, 1980, Ann N Y Acad Sci, V356, P427, DOI 10.1111/j.1749-6632.1980.tb29658.x; SALTER M, 1991, FEBS LETT, V291, P145, DOI 10.1016/0014-5793(91)81123-P; SCHMIDT HHHW, 1992, MOL PHARMACOL, V41, P615; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; YUI Y, 1991, J BIOL CHEM, V266, P12544	50	282	290	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11044	11048		10.1074/jbc.273.18.11044	http://dx.doi.org/10.1074/jbc.273.18.11044			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556587	hybrid			2022-12-27	WOS:000073395200039
J	Burt, AR; Sautel, M; Wilson, MA; Rees, S; Wise, A; Milligan, G				Burt, AR; Sautel, M; Wilson, MA; Rees, S; Wise, A; Milligan, G			Agonist occupation of an alpha(2A)-adrenoreceptor-G(i1)alpha fusion protein results in activation of both receptor-linked and endogenous G(i) proteins - Comparisons of their contributions to GTPase activity and signal transduction and analysis of receptor-G protein activation stoichiometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-1 FIBROBLASTS; KINASE PATHWAY; TRANSFECTED CELLS; EXPRESSION; IDENTIFICATION; G(S); P42; RAS; SHC	A fusion protein between a pertussis toxin-resistant (C351G) mutant of the alpha subunit of the G protein G(i1) and the porcine alpha(2A)-adrenoreceptor was stably expressed in Rat 1 fibroblasts, Agonists caused stimulation of high affinity GTPase activity, which was partially prevented by pertussis toxin treatment, demonstrating that the toxin-resistant component of the GTPase activity was derived from the receptor-fused G protein and the remainder hom endogenous G(i) alpha. Half-maximal stimulation of the GTPase activity of endogenous Gi was achieved with lower concentrations of agonist, Although the K-m for GTP of the fusion protein-linked G(i) was lower than for the endogenous G protein, V-max measurements demonstrated that adrenaline activated some 5 mol of endogenous G(i)/mol of fusion protein-linked G(i). The isolated alpha(2A)-adrenoreceptor could activate G(s); however, the fusion protein did not. Compared with adrenaline, the efficacy of a range of partial agonists to stimulate endogenous G(i) alpha was greater than for the fusion protein-constrained C351G G(i1)alpha. alpha(2A)-Adrenoreceptor agonists could stimulate both p44 mitogen-activated protein kinase and p70 S6 kinase and inhibit forskolin-amplified adenylyl cyclase activity in untreated alpha(2A)-adrenoreceptor-C351G G(i1)alpha fusion protein-expressing cells, but these signals were abolished following pertussis toxin treatment. These results demonstrate conclusively, and for the first time, that agonist occupancy of a receptor-G protein fusion protein can result in activation of G proteins other than that physically linked to the receptor. This was selective between G protein classes. Analysis of the contributions of fusion protein-linked and endogenous G proteins to agonist-stimulated GTPase activity provided a direct and original measure of receptor-G protein activation stoichiometry.	Univ Glasgow, Inst Biomed & Life Sci, Mol Pharmacol Grp, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Glaxo Wellcome Res & Dev Ltd, Receptor Syst Unit, Stevenage SG1 2NY, Herts, England	University of Glasgow; GlaxoSmithKline	Milligan, G (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Mol Pharmacol Grp, Div Biochem & Mol Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.		Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519				Airriess CN, 1997, BRIT J PHARMACOL, V122, P191, DOI 10.1038/sj.bjp.0701348; ALBLAS J, 1993, J BIOL CHEM, V268, P22235; ANDERSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1529, DOI 10.1006/bbrc.1994.1624; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Bertin B, 1997, RECEPTOR CHANNEL, V5, P41; BERTIN B, 1994, P NATL ACAD SCI USA, V91, P8827, DOI 10.1073/pnas.91.19.8827; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Burt AR, 1996, BIOCHEM J, V320, P227, DOI 10.1042/bj3200227; Chen YH, 1996, EMBO J, V15, P1037, DOI 10.1002/j.1460-2075.1996.tb00441.x; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; EASON MG, 1992, J BIOL CHEM, V267, P15795; EASON MG, 1995, J BIOL CHEM, V270, P24753, DOI 10.1074/jbc.270.42.24753; Gillard NP, 1996, BRIT J PHARMACOL, V117, pP298; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUYER CA, 1990, J BIOL CHEM, V265, P17307; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kranenburg O, 1997, EMBO J, V16, P3097, DOI 10.1093/emboj/16.11.3097; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; MERCOURIS M, 1997, J NEUROCHEM, V69, P2115; MILLIGAN G, 1991, J BIOL CHEM, V266, P6447; Milligan G, 1996, CELL SIGNAL, V8, P87, DOI 10.1016/0898-6568(95)02034-9; MILLIGAN G, 1988, BIOCHEM J, V255, P1; MILLIGAN G, 1996, ALPHA2 ADRENERGIC RE, P95; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; Torres M, 1996, J BIOL CHEM, V271, P13244, DOI 10.1074/jbc.271.22.13244; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wilson M, 1996, J BIOL CHEM, V271, P8537, DOI 10.1074/jbc.271.15.8537; WILSON M, 1996, BIOCHEM J, V325, P217; Wise A, 1997, BIOCHEM J, V321, P721, DOI 10.1042/bj3210721; Wise A, 1997, J BIOL CHEM, V272, P24673, DOI 10.1074/jbc.272.39.24673; Wise A, 1997, BIOCHEM J, V325, P17, DOI 10.1042/bj3250017; Wise A, 1997, FEBS LETT, V419, P141, DOI 10.1016/S0014-5793(97)01431-2; WONG YH, 1994, METHOD ENZYMOL, V238, P81; Yu R, 1997, MOL PHARMACOL, V51, P785, DOI 10.1124/mol.51.5.785	37	56	57	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10367	10375		10.1074/jbc.273.17.10367	http://dx.doi.org/10.1074/jbc.273.17.10367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553093				2022-12-27	WOS:000073224200042
J	Chung, SH; Song, WJ; Kim, K; Bednarski, JJ; Chen, J; Prestwich, GD; Holz, RW				Chung, SH; Song, WJ; Kim, K; Bednarski, JJ; Chen, J; Prestwich, GD; Holz, RW			The C2 domains of Rabphilin3a specifically bind phosphatidylinositol 4,5-bisphosphate containing vesicles in a Ca2+-dependent manner - In vitro characteristics and possible significance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-C; PC12 CELLS; CA2+-ACTIVATED SECRETION; SYNAPTIC VESICLES; SYNAPTOTAGMIN-I; PHOSPHOLIPASE-C; ALPHA-ACTININ; GTPASE RAB3A; EXOCYTOSIS	In the present study we investigated the lipid binding characteristics of the C2 domains of Rabphilin3a., We found that the tandem C2 domain of Rabphilin3a specifically bound lipid vesicles containing phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2,) in a Ca2+-dependent manner. There was little binding to vesicles containing PtdIns(3,4)P-2 in the presence or absence of Ca2+. Binding to phosphatidylinositol 3,4,5-triphosphate-containing vesicles was similar to binding to PtdIns(4,5)P-2-containing vesicles. The presence of physiological amounts of phosphatidylserine (PS) greatly potentiated the ability of PtdIns(4,5)P-2 to cause vesicle binding. As with the C2 domains together, the binding of individual C2 domain of Rabphilin3a was much greater to PtdIns(4,5)P-2-containing vesicles than PtdIns(3,4)P-2-containing vesicles. Both C2 domains also bound 29 mol % PS-containing vesicles in a Ca2+-dependent manner. Because of the importance of the C2B domain in the enhancement of secretion from chromaffin cells by Rabphilin3a, its biochemistry was further investigated. The mutation of aspartates 657 and 659 to asparagines in C2B decreased Ca2+-dependent and increased Ca2+-independent vesicle binding, indicating the Ca2+ dependence of the domain is provided by aspartic acid residues in the putative Ca2+-binding pocket. A peptide from the COOH-terminal region of the C2B domain specifically inhibited ATP-dependent secretion from permeabilized chromaffin cells and the binding of Rabphilin3a to phosphatidylcholine/PS/PtdIns(4,5)P-2-containing lipid vesicles, suggesting a role of this sequence in secretion through its ability to interact with acidic lipid vesicles.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah	Chung, SH (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1301 MSRB 3, Ann Arbor, MI 48109 USA.		Bednarski, Jeff/GLN-6651-2022		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050127, R01DK027959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029632] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK27959, R01 DK50127] Funding Source: Medline; NINDS NIH HHS [NS29632] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BITTNER MA, 1992, J BIOL CHEM, V267, P16226; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BUCKLEY JT, 1971, BIOCHIM BIOPHYS ACTA, V239, P517, DOI 10.1016/0005-2760(71)90047-6; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen J, 1996, J ORG CHEM, V61, P6305, DOI 10.1021/jo960895r; Chung SH, 1997, J NEUROCHEM, V69, P164; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; DARCHEN F, 1995, J CELL SCI, V108, P1639; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; Gu QM, 1996, J ORG CHEM, V61, P8642, DOI 10.1021/jo961226g; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; LEE MH, 1991, BIOCHEMISTRY-US, V30, P1041, DOI 10.1021/bi00218a023; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; McKiernan CJ, 1996, MOL CELL BIOL, V16, P4985; Mehrotra B, 1997, J BIOL CHEM, V272, P4237, DOI 10.1074/jbc.272.7.4237; MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063; MULLER TW, 1975, J NEUROCHEM, V24, P1155, DOI 10.1111/j.1471-4159.1975.tb03892.x; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PHILLIPS JH, 1973, BIOCHEM J, V136, P579, DOI 10.1042/bj1360579; Prestwich GD, 1996, ACCOUNTS CHEM RES, V29, P503, DOI 10.1021/ar960136v; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; STAHL B, 1994, J BIOL CHEM, V269, P24770; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Thum O, 1996, TETRAHEDRON LETT, V37, P9017, DOI 10.1016/S0040-4039(96)02117-X; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; WICK PF, 1993, J BIOL CHEM, V268, P10983; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164; YU FX, 1992, J BIOL CHEM, V267, P14616; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	48	94	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10240	10248		10.1074/jbc.273.17.10240	http://dx.doi.org/10.1074/jbc.273.17.10240			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553075	hybrid			2022-12-27	WOS:000073224200024
J	Ikezu, T; Trapp, BD; Song, KS; Schlegel, A; Lisanti, MP; Okamoto, T				Ikezu, T; Trapp, BD; Song, KS; Schlegel, A; Lisanti, MP; Okamoto, T			Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; BETA-PROTEIN; ANCHORED PROTEINS; COATED VESICLES; NEXIN-II; CELLS; RECEPTOR; IDENTIFICATION; CHOLESTEROL; CLEAVAGE	Caveolae are plasma membrane invaginations where key signaling elements are concentrated. In this report, both biochemical and histochemical analyses demonstrate that the amyloid precursor protein (APP), a source of A beta amyloid peptide, is enriched within caveolae. Caveolin-1, a principal component of caveolae, is physically associated with APP, and the cytoplasmic domain of APP directly participates in this binding. The characteristic C-terminal fragment that results from APP processing by alpha-secretase, an as yet unidentified enzyme that cleaves APP within the A beta amyloid sequence, was also localized within these caveolae-enriched fractions. Further analysis by cell surface biotinylation revealed that this cleavage event occurs at the cell surface. importantly, alpha-secretase processing was significantly promoted by recombinant overexpression of caveolin in intact cells, resulting in increased secretion of the soluble extracellular domain of APP, Conversely, caveolin depletion using antisense oligonucletotides prevented this cleavage event. Our current results indicate that caveolae and caveolins may play a pivotal role in the alpha-secretase-mediated proteolysis of APP in vivo.	Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Cleveland Clinic Foundation; Yeshiva University; Albert Einstein College of Medicine	Okamoto, T (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave,NC30, Cleveland, OH 44195 USA.	okamoto@cesmtp.ccf.org	Lisanti, Michael P/C-6866-2013; Lisanti, Michael/B-6131-2018	Lisanti, Michael/0000-0003-2034-1382; Ikezu, Tsuneya/0000-0002-3979-8596; Schlegel, Amnon/0000-0003-4060-2252	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH056036] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50443] Funding Source: Medline; NIMH NIH HHS [MH56036] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; CZECH C, 1994, EUR ARCH PSY CLIN N, V243, P291, DOI 10.1007/BF02191587; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Fielding CJ, 1997, P NATL ACAD SCI USA, V94, P3753, DOI 10.1073/pnas.94.8.3753; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HAYASHI Y, 1992, BIOCHEM BIOPH RES CO, V187, P1249, DOI 10.1016/0006-291X(92)90437-P; Ikezu T, 1996, EMBO J, V15, P2468, DOI 10.1002/j.1460-2075.1996.tb00604.x; IKEZU T, 1994, J BIOL CHEM, V269, P31955; JACOBSEN JS, 1994, J BIOL CHEM, V269, P8376; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; KOO EH, 1993, P NATL ACAD SCI USA, V90, P4748, DOI 10.1073/pnas.90.10.4748; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; OKAMOTO T, 1995, J BIOL CHEM, V270, P4205, DOI 10.1074/jbc.270.9.4205; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; RAPOSO G, 1987, BIOL CELL, V60, P117, DOI 10.1111/j.1768-322X.1987.tb00551.x; RAPOSO G, 1989, EUR J CELL BIOL, V50, P340; Reaume AG, 1996, J BIOL CHEM, V271, P23380, DOI 10.1074/jbc.271.38.23380; SAMBAMURTI K, 1992, ANN NY ACAD SCI, V674, P118, DOI 10.1111/j.1749-6632.1992.tb27481.x; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7; Sevinsky JR, 1996, J CELL BIOL, V133, P293, DOI 10.1083/jcb.133.2.293; SHARMA RK, 1983, METHOD ENZYMOL, V102, P210; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; VANNOSTRAND WE, 1989, NATURE, V341, P546; WANG R, 1991, J BIOL CHEM, V266, P16960; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; Yamatsuji T, 1996, EMBO J, V15, P498, DOI 10.1002/j.1460-2075.1996.tb00382.x	76	136	141	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10485	10495		10.1074/jbc.273.17.10485	http://dx.doi.org/10.1074/jbc.273.17.10485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553108	hybrid			2022-12-27	WOS:000073224200057
J	Jezewska, MJ; Rajendran, S; Bujalowska, D; Bujalowski, W				Jezewska, MJ; Rajendran, S; Bujalowska, D; Bujalowski, W			Does single-stranded DNA pass through the inner channel of the protein hexamer in the complex with the Escherichia coli DnaB helicase? Fluorescence energy transfer studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE ANALOGS; NUCLEIC-ACID; BINDING SITE; REPLICATION; ENZYME; STATES; FORMS; RINGS; ATP	The structure of the complex of the Escherichia coli primary replicative helicase DnaB protein with single-stranded (ss) DNA and replication fork substrates has been examined using the fluorescence energy transfer method, In these experiments, we used the DnaB protein variant, R14C, which has arginine 14 replaced by cysteine in the small 12-kDa domain of the protein using site-directed mutagenesis. The cysteine residues have been modified with a fluorescent marker which serves as a donor or an acceptor to another fluorescence label placed in different locations on the DNA substrates, Using the multiple fluorescence donor-acceptor approach, we provide evidence that, in the complex with the enzyme, ssDNA passes through the inner channel of the DnaB hexamer, This is the first evidence of the existence of such a structure of a hexameric helicase-ssDNA complex in solution. In the stationary complex with the 5' arm of the replication fork, without ATP hydrolysis, the distance between the 5' end of the arm and the 12-kDa domains of the hexamer (R = 47 Angstrom) is the same as in the complex with the isolated ssDNA oligomer (R = 47 Angstrom) having the same length as the arm of the fork. These data indicate that both ssDNA and the 5' arm of the fork bind in the same manner to the DNA binding site. Moreover, in the complex with the helicase, the length of the ssDNA is similar to the length of the ssDNA strand in the double-stranded DNA conformation. In the stationary complex, the helicase does not invade the duplex part of the fork beyond the first 2-3 base pairs. This result corroborates the quantitative thermodynamic data which showed that the duplex part of the fork does not contribute to the free energy of binding of the enzyme to the fork. Implications of these results for the mechanism of a hexameric: helicase binding to DNA are discussed.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bujalowski, W (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 301 Univ Blvd, Galveston, TX 77555 USA.	wbujalow@utmb.edu			NIEHS NIH HHS [5P30ES06676] Funding Source: Medline; NIGMS NIH HHS [GM-46679] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046679] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZUMI T, 1962, J CHEM PHYS, V37, P2413, DOI 10.1063/1.1733019; BAKER TA, 1987, J BIOL CHEM, V262, P6877; BERMAN HA, 1980, BIOCHEMISTRY-US, V19, P2226, DOI 10.1021/bi00551a036; BUJALOWSKI W, 1994, BIOCHEMISTRY-US, V33, P4682, DOI 10.1021/bi00181a028; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31359; BUJALOWSKI W, 1993, BIOCHEMISTRY-US, V32, P5888, DOI 10.1021/bi00073a023; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; CANTOR CR, 1971, P NATL ACAD SCI USA, V68, P2099, DOI 10.1073/pnas.68.9.2099; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Jezewska MJ, 1997, BIOPHYS CHEM, V64, P253, DOI 10.1016/S0301-4622(96)02221-1; Jezewska MJ, 1996, BIOPHYS J, V71, P2075, DOI 10.1016/S0006-3495(96)79406-7; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 1997, BIOCHEMISTRY-US, V36, P10320, DOI 10.1021/bi970712a; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Kornberg A., 1992, DNA REPLICATION; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LEKOWICZ JR, 1983, PRINCIPLE FLUORESCEN, pCH10; MCMACKEN R, 1978, J BIOL CHEM, V253, P3313; NAKAYAMA N, 1984, J BIOL CHEM, V259, P97; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; Saenger W., 1984, PRINCIPLES NUCL ACID; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; SCOTT TG, 1970, J AM CHEM SOC, V92, P687, DOI 10.1021/ja00706a043; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; STASIAK A, 1994, P NATL ACAD SCI USA, V91, P7618, DOI 10.1073/pnas.91.16.7618; WEBER G, 1954, T FARADAY SOC, V50, P552, DOI 10.1039/tf9545000552; WEBER G, 1960, BIOCHEM J, V75, P335, DOI 10.1042/bj0750335; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4; WICKNER S, 1973, P NATL ACAD SCI USA, V71, P783; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	36	115	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10515	10529		10.1074/jbc.273.17.10515	http://dx.doi.org/10.1074/jbc.273.17.10515			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553111	hybrid			2022-12-27	WOS:000073224200060
J	Saliba, KJ; Horner, HA; Kirk, K				Saliba, KJ; Horner, HA; Kirk, K			Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL MEMBRANE; PATHWAYS; PERMEATION; CULTURE; BLOOD	The growth of the human malaria parasite, Plasmodium falciparum, within its host erythrocyte is reliant on the uptake of a number of essential nutrients from the extracellular medium. One of these is pantothenic acid, a water-soluble vitamin that is a precursor of coenzyme A. In this study we show that normal uninfected erythrocytes are impermeable to pantothenate but that the vitamin is taken up rapidly into malaria-infected cells via a transport pathway that has the characteristics (furosemide sensitivity, nonsaturability) of previously characterized, broad specificity permeation pathways induced by the intracellular parasite in the host cell membrane. The transport of pantothenate therefore constitutes a critical physiological role for these pathways. Inside the parasitized cell pantothenate undergoes phosphorylation, the first step in its conversion to coenzyme A. Parasites within saponin-permeabilized erythrocytes were shown to take up and phosphorylate pantothenate, consistent with the intracellular parasite having both a pantothenate transporter and a pantothenate kinase, Comparisons of the rate of phosphorylation of pantothenate by lysates prepared from uninfected and infected erythrocytes revealed that the pantothenate kinase activity of the P., falciparum trophozoite is some 10-fold higher than that of its host cell and that most, if not all, of the phosphorylation of pantothenate within the malaria-infected cell occurs within the intracellular parasite. These results contrast with those of previous studies in which it was proposed that the avian malaria parasite Plasmodium lophurae lacks pantothenate kinase (as well as the other enzymes for the synthesis of coenzyme A) and is reliant upon the uptake of preformed coenzyme A from the host cell cytosol.	Australian Natl Univ, Fac Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	Australian National University; University of Oxford	Kirk, K (corresponding author), Australian Natl Univ, Fac Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia.	kiaran.kirk@anu.edu.au	Kirk, Kiaran/C-8299-2009; Saliba, Kevin J/C-9166-2009	Kirk, Kiaran/0000-0002-5613-2622; Saliba, Kevin J/0000-0003-3345-8440	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BENNETT TP, 1967, J PROTOZOOL, V14, P214, DOI 10.1111/j.1550-7408.1967.tb01985.x; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BIGGS BA, 1991, P NATL ACAD SCI USA, V88, P9171, DOI 10.1073/pnas.88.20.9171; BRACKETT S, 1946, J PARASITOL, V32, P453, DOI 10.2307/3272916; BROHN FH, 1975, P NATL ACAD SCI USA, V72, P2456, DOI 10.1073/pnas.72.6.2456; CABANTCHIK ZI, 1990, BLOOD CELLS, V16, P421; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; GERO AM, 1994, PARASITOL TODAY, V10, P395, DOI 10.1016/0169-4758(94)90231-3; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; GINSBURG H, 1994, BIOCHEM PHARMACOL, V48, P1847, DOI 10.1016/0006-2952(94)90582-7; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; KIRK K, 1995, BIOCHEM J, V311, P761, DOI 10.1042/bj3110761; KIRK K, 1994, J BIOL CHEM, V269, P3339; Kirk K, 1996, MOL BIOCHEM PARASIT, V82, P195, DOI 10.1016/0166-6851(96)02734-X; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; ROBISHAW JD, 1985, AM J PHYSIOL, V248, pE1, DOI 10.1152/ajpendo.1985.248.1.E1; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; TAHILIANI AG, 1991, VITAM HORM, V46, P165; TRAGER W, 1952, J EXP MED, V96, P465, DOI 10.1084/jem.96.5.465; TRAGER W, 1954, J PROTOZOOL, V1, P231, DOI 10.1111/j.1550-7408.1954.tb00822.x; UPSTON JM, 1995, BBA-BIOMEMBRANES, V1236, P249, DOI 10.1016/0005-2736(95)00055-8	24	175	177	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10190	10195		10.1074/jbc.273.17.10190	http://dx.doi.org/10.1074/jbc.273.17.10190			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553068	hybrid			2022-12-27	WOS:000073224200017
J	Zhang, JG; Zhang, Y; Owczarek, CM; Ward, LD; Moritz, RL; Simpson, RJ; Yasukawa, K; Nicola, NA				Zhang, JG; Zhang, Y; Owczarek, CM; Ward, LD; Moritz, RL; Simpson, RJ; Yasukawa, K; Nicola, NA			Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-6 SIGNAL TRANSDUCER; ONCOSTATIN-M BINDS; CYTOKINE RECEPTORS; HEXAMERIC COMPLEX; COMPONENT GP130; CNTF RECEPTOR; MOUSE SERUM; CELL-LINE; INTERLEUKIN-6; EXPRESSION	Leukemia inhibitory factor (LIF) is a polyfunctional cytokine known to require at least two distinct receptor components (LIF receptor alpha-chain and gp130) in order to form a high affinity, functional receptor complex. In this report, we present evidence that there are two distinct truncated forms of gp130 in normal human urine and plasma: a large form with a molecular weight of approximately 100,000, which is similar to a previously described form of soluble gp130 in human serum, and a previously undescribed small form with a molecular weight of approximately 50,000. Using a panel of monoclonal antibodies raised against the extracellular domain of human gp130, we were able to show that the small form of the urinary gp130 probably contained only the hemopoietin domain. Both forms of gp130 bound LIF specifically and were capable of forming heterotrimeric complexes with soluble human LIF receptor alpha-chain in the presence of human LIF. In addition to the soluble forms of gp130, a soluble form of LIF receptor alpha-chain was also detected in human urine and plasma.	PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; PO Royal Melbourne Hosp, Cooperat Res Ctr Cellular Growth Factors, Melbourne, Vic 3050, Australia; AMRAD Operat Pty Ltd, Richmond, Vic 3121, Australia; PO Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; Tosoh Corp, Ayase, Kanagawa 252, Japan	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Tosoh Corporation	Nicola, NA (corresponding author), PO Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.		Nicola, Nicos/D-2989-2011; Moritz, Robert L/B-9222-2011	Nicola, Nicos/0000-0003-1054-7889; Simpson, Richard/0000-0002-9834-0796	NATIONAL CANCER INSTITUTE [R01CA022556, R37CA022556] Funding Source: NIH RePORTER; NCI NIH HHS [CA-22556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; CONTRERAS MA, 1983, METHOD ENZYMOL, V92, P277; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DESERIO A, 1995, J MOL BIOL, V254, P795, DOI 10.1006/jmbi.1995.0655; Diamant M, 1997, FEBS LETT, V412, P379, DOI 10.1016/S0014-5793(97)00750-3; FOURCIN M, 1994, EUR J IMMUNOL, V24, P277, DOI 10.1002/eji.1830240143; GEARING DP, 1992, NEW BIOL, V4, P61; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; HONDA M, 1992, J IMMUNOL, V148, P2175; HORSTEN U, 1995, FEBS LETT, V360, P43, DOI 10.1016/0014-5793(95)00053-C; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; LAYTON MJ, 1992, P NATL ACAD SCI USA, V89, P8616, DOI 10.1073/pnas.89.18.8616; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; MODRELL B, 1994, GROWTH FACTORS, V11, P81, DOI 10.3109/08977199409001050; MurakamiMori K, 1996, INT IMMUNOL, V8, P595, DOI 10.1093/intimm/8.4.595; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; NICOLA NA, 1996, GROWTH FACTORS CYT B, V2, P605; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; Owczarek CM, 1996, J BIOL CHEM, V271, P5495, DOI 10.1074/jbc.271.10.5495; OWCZAREK CM, 1993, EMBO J, V12, P3487, DOI 10.1002/j.1460-2075.1993.tb06023.x; PAONESSA G, 1995, EMBO J, V14, P1942, DOI 10.1002/j.1460-2075.1995.tb07186.x; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; SAITO T, 1993, J IMMUNOL METHODS, V163, P217, DOI 10.1016/0022-1759(93)90125-Q; SPORENO E, 1994, J BIOL CHEM, V269, P10991; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Tomida M, 1997, BIOCHEM BIOPH RES CO, V232, P427, DOI 10.1006/bbrc.1997.6303; WARD LD, 1994, J BIOL CHEM, V269, P23286; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YAMAGUCHIYAMAMOTO Y, 1993, LEUKEMIA RES, V17, P515, DOI 10.1016/0145-2126(93)90127-7; YIN TG, 1993, J IMMUNOL, V151, P2555; Zhang JG, 1997, BIOCHEM J, V325, P693, DOI 10.1042/bj3250693	41	48	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10798	10805		10.1074/jbc.273.17.10798	http://dx.doi.org/10.1074/jbc.273.17.10798			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553147	hybrid			2022-12-27	WOS:000073224200096
J	Bennett, RJ; Sharp, JA; Wang, JC				Bennett, RJ; Sharp, JA; Wang, JC			Purification and characterization of the Sgs1 DNA helicase activity of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RECQ; TOPOISOMERASE-III; REVERSE GYRASE; GENE-PRODUCT; MOLECULAR-CLONING; I TOPOISOMERASE; HOMOLOG; IDENTIFICATION; PROTEIN; TOP3	The yeast Saccharomyces cerevisiae Sgs1 protein is a member of a family of DNA helicases that include the Escherichia coli RecQ protein and the products of human Bloom's syndrome and Werner's syndrome genes. To study the enzymatic characteristics of the protein, a recombinant Sgs1 fragment (amino acids 400-1268 of the 1447-amino acid full-length protein) was overexpressed in yeast and purified to near homogeneity. The purified protein exhibits an ATPase activity in the presence of single-or double-stranded DNA. In the presence of ATP or dATP, unwinding of duplex DNA or a DNA-RNA heteroduplex by the recombinant Sgs1 fragment was readily observed. Similar to the E. coli RecQ helicase, displacement of the DNA strand occurs in the 3' to 5' direction with respect to the single-stranded DNA flanking the duplex. The efficiency of unwinding was found to correlate inversely with the length of the duplex region and was enhanced by the presence off. coli single-stranded DNA binding protein. In addition, the recombinant Sgs1 fragment was found to bind more tightly to a forked DNA substrate than to either single-or double-stranded DNA.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Wang, JC (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.			Sharp, Judith/0000-0001-7441-6218; Bennett, Richard/0000-0001-7563-484X	NIGMS NIH HHS [GM24544] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024544, R01GM024544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753; DIGATE RJ, 1992, J BIOL CHEM, V267, P20532; DIGATE RJ, 1988, J BIOL CHEM, V263, P13366; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; HIASA H, 1994, J BIOL CHEM, V269, P2093; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; KAVASAKI K, 1997, GENOME RES, V7, P250; KIM RA, 1992, J BIOL CHEM, V267, P17178; KOZYAVKIN SA, 1994, J BIOL CHEM, V269, P11081; Lilley DMJ., 1995, NUCL ACIDS MOL BIOL, P84; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lombard DB, 1996, TRENDS GENET, V12, P283, DOI 10.1016/0168-9525(96)30065-6; LU J, 1996, SCIENCE, V383, P678; MATSON SW, 1989, P NATL ACAD SCI USA, V86, P4430, DOI 10.1073/pnas.86.12.4430; NADAL M, 1994, J BIOL CHEM, V269, P5255; NAKAYAMA K, 1985, MOL GEN GENET, V200, P266, DOI 10.1007/BF00425434; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; WANG JC, 1991, J BIOL CHEM, V266, P6659; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Watt PM, 1996, GENETICS, V144, P935; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	38	158	159	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9644	9650		10.1074/jbc.273.16.9644	http://dx.doi.org/10.1074/jbc.273.16.9644			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545297	hybrid			2022-12-27	WOS:000073128800043
J	Datta, AK; Sinha, A; Paulson, JC				Datta, AK; Sinha, A; Paulson, JC			Mutation of the sialyltransferase S-sialylmotif alters the kinetics of the donor and acceptor substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; DEVELOPMENTALLY-REGULATED MEMBER; GAL-BETA-1->3(4)GLCNAC ALPHA-2->3 SIALYLTRANSFERASE; NH2-TERMINAL SIGNAL ANCHOR; N-LINKED OLIGOSACCHARIDES; POLYMERASE CHAIN-REACTION; POLYSIALIC ACID SYNTHASE; MOLECULAR-CLONING; EXPRESSION CLONING; GAL-BETA-1,3GALNAC ALPHA-2,3-SIALYLTRANSFERASE	Protein sequence analysis of the cloned sialyltransferase gene family has revealed the presence of two conserved protein motifs in the middle of the lumenal catalytic domain, termed L-sialylmotif and S-sialylmotif, In our previous study (Datta, A. K., and Paulson, J. C. (1995) J. Biol. Chem. 270, 1497-1500) the larger L-sialylmotif of ST6Gal I was analyzed by site-directed mutagenesis, which provided evidence that it participates in the binding of the CMP-NeuAc, a common donor substrate for all the sialyltransferases, However, none of the mutants tested in this motif had any significant effect on their binding affinities toward the acceptor substrate asialo alpha(1)-acid glycoprotein, In this study, we have investigated the role of the S-sialylmotif of the same enzyme ST6Gal I. In total, nine mutants have been constructed by changing the conserved amino acids of this motif to mostly alanine by site-directed mutagenesis. Kinetic analysis for the mutants which retained sialyltransferase activity showed that the mutations in the S-sialylmotif caused a change of K-m values for both the donor and the acceptor substrates. Our results indicated that this motif participates in the binding of both the substrates, A sequence homology search also supported this finding, which showed that the downstream amino acid sequence of the S-sialylmotif is conserved for each subgroup of this enzyme family, indicating its association with the acceptor substrate.	Cytel Corp, San Diego, CA 92121 USA; Scripps Res Inst, Dept Chem & Mol Biol, San Diego, CA 92121 USA	Scripps Research Institute	Datta, AK (corresponding author), Dept Chem & Mol Biol, BCC 338,10550 N Torrey Pines Rd, San Diego, CA 92037 USA.	adatta@scripps.edu	Paulson, James/AAG-3565-2019		NIGMS NIH HHS [GM27904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027904] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOKI D, 1990, EMBO J, V9, P3171, DOI 10.1002/j.1460-2075.1990.tb07515.x; BAST BJEG, 1992, J CELL BIOL, V116, P423, DOI 10.1083/jcb.116.2.423; COLLEY KJ, 1989, J BIOL CHEM, V264, P17619; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; DATTA AK, 1995, NUCLEIC ACIDS RES, V23, P4530, DOI 10.1093/nar/23.21.4530; Datta AK, 1997, INDIAN J BIOCHEM BIO, V34, P157; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FIELD MC, 1995, GLYCOBIOLOGY, V5, P463, DOI 10.1093/glycob/5.5.463; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; GRUNDMANN U, 1990, NUCLEIC ACIDS RES, V18, P667, DOI 10.1093/nar/18.3.667; Hamamoto T, 1993, Bioorg Med Chem, V1, P141, DOI 10.1016/S0968-0896(00)82111-2; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; HarduinLepers A, 1995, GLYCOBIOLOGY, V5, P741, DOI 10.1093/glycob/5.8.741; HOLMES EH, 1995, J BIOL CHEM, V270, P8145, DOI 10.1074/jbc.270.14.8145; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; KOJIMA N, 1994, BIOCHEMISTRY-US, V33, P5772, DOI 10.1021/bi00185a014; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Kono M, 1996, J BIOL CHEM, V271, P29366, DOI 10.1074/jbc.271.46.29366; KUROSAWA N, 1994, J BIOL CHEM, V269, P19048; KUROSAWA N, 1994, J BIOL CHEM, V269, P1402; KUROSAWA N, 1995, BBA-GEN SUBJECTS, V1244, P216, DOI 10.1016/0304-4165(95)00012-Z; KUROSAWA N, 1994, EUR J BIOCHEM, V219, P375, DOI 10.1111/j.1432-1033.1994.tb19949.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EU, 1989, J BIOL CHEM, V264, P13848; LEE YC, 1993, EUR J BIOCHEM, V216, P377, DOI 10.1111/j.1432-1033.1993.tb18155.x; LEE YC, 1994, J BIOL CHEM, V269, P10028; LEGAULT DJ, 1995, J BIOL CHEM, V270, P20987, DOI 10.1074/jbc.270.36.20987; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; Nakayama J, 1996, J BIOL CHEM, V271, P3684; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NARA K, 1994, P NATL ACAD SCI USA, V91, P7952, DOI 10.1073/pnas.91.17.7952; PAULSON JC, 1977, J BIOL CHEM, V252, P2356; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI K, 1994, J BIOL CHEM, V269, P15950; SASAKI K, 1993, J BIOL CHEM, V268, P22782; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; Schmid K., 1975, PLASMA PROTEINS, P183; Sjoberg ER, 1996, J BIOL CHEM, V271, P7450, DOI 10.1074/jbc.271.13.7450; STAMENKOVIC I, 1990, J EXP MED, V172, P641, DOI 10.1084/jem.172.2.641; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; Tsuji S, 1996, GLYCOBIOLOGY, V6, pR5; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; WANG Y, 1994, BIOCHEM BIOPH RES CO, V204, P701, DOI 10.1006/bbrc.1994.2516; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; WEN DX, 1992, J BIOL CHEM, V267, P21011; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818; YADAV S, 1990, J BIOL CHEM, V265, P14163; YORK JL, 1986, TDB BIOCH, P117; YOSHIDA Y, 1995, J BIOCHEM-TOKYO, V118, P658, DOI 10.1093/oxfordjournals.jbchem.a124960; YOSHIDA Y, 1995, J BIOL CHEM, V270, P14628, DOI 10.1074/jbc.270.24.14628; Yoshida Y, 1996, GLYCOBIOLOGY, V6, P573, DOI 10.1093/glycob/6.6.573; Yoshida Y, 1996, J BIOL CHEM, V271, P30167, DOI 10.1074/jbc.271.47.30167; YOSHIMA H, 1981, J BIOL CHEM, V256, P8476	62	88	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9608	9614		10.1074/jbc.273.16.9608	http://dx.doi.org/10.1074/jbc.273.16.9608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545292	hybrid			2022-12-27	WOS:000073128800038
J	Fujita, Y; Kurata, S; Homma, K; Natori, S				Fujita, Y; Kurata, S; Homma, K; Natori, S			A novel lectin from Sarcophaga - Its purification, characterization, and cDNA cloning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEREGRINA FLESH FLY; EMBRYONIC-CELL LINE; MANNOSE-BINDING PROTEIN; MOLECULAR-CLONING; ANTIBACTERIAL PROTEIN; IMAGINAL DISKS; HUMORAL LECTIN; CULTURE-MEDIUM; DROSOPHILA; NIH-SAPE-4	A novel C-type lectin that agglutinates rabbit red cells was purified from NIH-Sape-4 cells derived from the flesh fly (Sarcophaga peregrina), and its cDNA was isolated. This lectin, named granulocytin, appeared to be a trimer of a 20-kDa subunit consisting of 151 amino acid residues. The gene for granulocytin was activated in third instar larvae, and its expression was enhanced when the larval body wall was injured. In third instar larvae, granulocytin was found to be synthesized by hemocytes and secreted into the hemolymph. The molecular mass and gene expression patterns of granulocytin were very similar to those of Drosophila lectin that we reported previously (Haq, S., Kubo, T., Kurata, S., Robayashi, A., and Natori, S. (1996) J. Biol. Chem. 271, 20213-20218), However, these two lectins showed amino acid identities of 20% at most, and no significant hapten sugar for granulocytin was identified.	Univ Tokyo, Fac Pharmaceut Sci, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Natori, S (corresponding author), Univ Tokyo, Fac Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.							ANDO K, 1988, BIOCHEMISTRY-US, V27, P1715, DOI 10.1021/bi00405a050; Boman Hans G., 1994, P3; BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; COCIANCICH S, 1994, PARASITOL TODAY, V10, P132, DOI 10.1016/0169-4758(94)90260-7; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Haq S, 1996, J BIOL CHEM, V271, P20213, DOI 10.1074/jbc.271.33.20213; Hetru Charles, 1994, P43; HOFFMANN JA, 1993, FEBS LETT, V325, P63, DOI 10.1016/0014-5793(93)81414-U; HOMMA K, 1994, J BIOL CHEM, V269, P15258; Homma K, 1996, J BIOL CHEM, V271, P13770, DOI 10.1074/jbc.271.23.13770; Homma K, 1996, EUR J BIOCHEM, V240, P443, DOI 10.1111/j.1432-1033.1996.0443h.x; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; KAWAGUCHI N, 1991, DEV BIOL, V144, P86, DOI 10.1016/0012-1606(91)90481-H; KOMANO H, 1981, J BIOL CHEM, V256, P7087; KOMANO H, 1983, J BIOL CHEM, V258, P2143; KOMANO H, 1987, BIOCHEM J, V248, P217, DOI 10.1042/bj2480217; KOMANO H, 1980, J BIOL CHEM, V255, P2919; KOMANO H, 1985, DEV COMP IMMUNOL, V9, P31, DOI 10.1016/0145-305X(85)90057-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SR, 1995, FEBS LETT, V368, P485, DOI 10.1016/0014-5793(95)00717-N; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSHALL RD, 1974, BIOCH SOC S, V40, P7; MATSUMOTO N, 1986, BIOCHEM J, V239, P717, DOI 10.1042/bj2390717; MATSUYAMA K, 1988, J BIOL CHEM, V263, P17117; MITSUHAS.J, 1964, CONTRIB BOYCE THOMPS, V22, P435; NAGASAWA Y, 1993, DEV GROWTH DIFFER, V35, P331, DOI 10.1111/j.1440-169X.1993.00331.x; NAKANISHIMATSUI M, 1995, EUR J BIOCHEM, V230, P396, DOI 10.1111/j.1432-1033.1995.0396h.x; NATORI S, 1990, RES IMMUNOL, V141, P938, DOI 10.1016/0923-2494(90)90198-8; NATORI S, 1994, CIBA F SYMP, V186, P123; Natori Shunji, 1996, P175; Natori Shunji, 1994, P67; OHTAKI T, 1966, JPN J MED SCI BIOL, V19, P97, DOI 10.7883/yoken1952.19.97; TAKAHASHI H, 1986, J INSECT PHYSIOL, V32, P771, DOI 10.1016/0022-1910(86)90080-6; TAKAHASHI H, 1985, J BIOL CHEM, V260, P2228; VASTA GR, 1996, NEW DIRECTIONS INVER, P187; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0	38	25	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9667	9672		10.1074/jbc.273.16.9667	http://dx.doi.org/10.1074/jbc.273.16.9667			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545300	hybrid			2022-12-27	WOS:000073128800046
J	Ni, RZ; Nishikawa, Y; Carr, BI				Ni, RZ; Nishikawa, Y; Carr, BI			Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-ACTIVITY; MENADIONE 2-METHYL-1,4-NAPHTHOQUINONE; ISOLATED HEPATOCYTES; PHOSPHATASE INHIBITOR; SIGNAL TRANSDUCTION; INDUCED APOPTOSIS; HEPATOMA-CELLS; CYTO-TOXICITY; HEPG2 CELLS; RECEPTOR	We have shown that a synthetic vitamin K analog, 2-(2-mercaptoethanol)-3-methyl-1,4-naphthoquinone or compound 5 (Cpd 5), potently inhibits cell growth and suggested that the analog exerts its effects mainly via sulfhydryl arylation rather than redox cycling. Since protein-tyrosine phosphatases (PTPases), which have pivotal roles in many cellular functions, have a critical cysteine in their active site, we have proposed PTPases as likely targets for Cpd 5. To test this hypothesis, we examined the effects of Cpd 5 on protein tyrosine phosphorylation of cellular proteins and on the activity of PTPases. We found that Cpd 5 rapidly induced protein tyrosine phosphorylation in a human hepatocellular carcinoma cell line (Hep3B) at growth inhibitory doses, and the effect was blocked by thiols but not by non-thiol antioxidants or tyrosine kinase inhibitors. Cpd 5 inhibited PTPase activity, which was also significantly antagonized by reduced glutathione. Furthermore, the well studied PTPase inhibitor orthovanadate also induced protein tyrosine phosphorylation and growth inhibition in Hep3B cells. These results suggest that inhibition of cellular PTPases by sulfhydryl arylation and subsequent perturbation of protein tyrosine phosphorylation may be involved in the mechanisms of Cpd 5-induced cell growth inhibition.	Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carr, BI (corresponding author), Univ Pittsburgh, Inst Transplantat, BST E1552,200 Lothrop St, Pittsburgh, PA 15213 USA.	bcarr@vms.cis.pitt.edu		Carr, Brian/0000-0002-6111-5077; ni, runzhou/0000-0001-8187-185X				AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; BARATTE B, 1992, ANTICANCER RES, V12, P873; BISHAYEE A, 1995, ANTICANCER RES, V15, P455; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; BRAUTIGAN DL, 1992, BIOCHIM BIOPHYS ACTA, V1114, P63, DOI 10.1016/0304-419X(92)90007-L; BROWN PC, 1991, ARCH BIOCHEM BIOPHYS, V285, P187, DOI 10.1016/0003-9861(91)90348-M; Carr B. I., 1997, Hepatology, V26, p268A; CHAO W, 1992, BIOCHEM J, V288, P777, DOI 10.1042/bj2880777; CHLEBOWSKI RT, 1985, CANCER TREAT REP, V69, P527; COLIN M, 1994, ANTICANCER RES, V14, P2383; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; GANT TW, 1988, CHEM-BIOL INTERACT, V65, P157, DOI 10.1016/0009-2797(88)90052-X; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; GLENNEY JR, 1992, BIOCHIM BIOPHYS ACTA, V1134, P113, DOI 10.1016/0167-4889(92)90034-9; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gulli LF, 1996, CELL GROWTH DIFFER, V7, P173; Ham SW, 1997, BIOORG CHEM, V25, P33, DOI 10.1006/bioo.1996.1052; HAMAGUCHI T, 1995, FEBS LETT, V372, P54, DOI 10.1016/0014-5793(95)00953-7; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hunter T, 1996, BIOCHEM SOC T, V24, P307, DOI 10.1042/bst0240307; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; IMOTO M, 1993, J ANTIBIOT, V46, P1342, DOI 10.7164/antibiotics.46.1342; JUAN CC, 1993, BIOCHEM BIOPH RES CO, V190, P907, DOI 10.1006/bbrc.1993.1135; KERNS J, 1995, BIOORG CHEM, V23, P101, DOI 10.1006/bioo.1995.1008; LEE RH, 1992, BIOCHEM BIOPH RES CO, V184, P765, DOI 10.1016/0006-291X(92)90656-6; LEIS JF, 1982, P NATL ACAD SCI-BIOL, V79, P6507, DOI 10.1073/pnas.79.21.6507; LYALL RM, 1989, J BIOL CHEM, V264, P14503; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matozaki T, 1996, CELL SIGNAL, V8, P13, DOI 10.1016/0898-6568(95)02015-2; MEYEROVITCH J, 1992, BIOCHEMISTRY-US, V31, P10338, DOI 10.1021/bi00157a023; NECHAY BR, 1996, FED PROC, V45, P123; NGO EO, 1991, BIOCHEM PHARMACOL, V42, P1961, DOI 10.1016/0006-2952(91)90596-W; NISHIKAWA Y, 1995, J BIOL CHEM, V270, P28304, DOI 10.1074/jbc.270.47.28304; NOTO V, 1989, CANCER, V63, P901, DOI 10.1002/1097-0142(19890301)63:5<901::AID-CNCR2820630518>3.0.CO;2-G; NUTTER LM, 1992, J BIOL CHEM, V267, P2474; POT DA, 1991, J BIOL CHEM, V266, P19688; PRASAD KN, 1981, LIFE SCI, V29, P1387, DOI 10.1016/0024-3205(81)90683-4; RAGO R, 1990, ANAL BIOCHEM, V191, P31; ROSS D, 1985, CHEM-BIOL INTERACT, V55, P177, DOI 10.1016/S0009-2797(85)80126-5; ROSS D, 1986, ARCH BIOCHEM BIOPHYS, V248, P460, DOI 10.1016/0003-9861(86)90499-6; SCHICK MR, 1993, J IMMUNOL, V151, P1918; STONE RL, 1994, J BIOL CHEM, V269, P31323; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; SUTTIE JW, 1993, FASEB J, V7, P445, DOI 10.1096/fasebj.7.5.8462786; SWARUP G, 1982, J BIOL CHEM, V257, P7298; Takenaga K, 1996, INVAS METAST, V16, P97; TALCOTT RE, 1984, BIOCHEM PHARMACOL, V33, P2663, DOI 10.1016/0006-2952(84)90642-7; THOR H, 1982, J BIOL CHEM, V257, P2419; UEHARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P803, DOI 10.1016/0006-291X(89)92293-6; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WANG ZQ, 1995, HEPATOLOGY, V22, P876, DOI 10.1016/0270-9139(95)90310-0; WILSON I, 1987, CHEM-BIOL INTERACT, V61, P229, DOI 10.1016/0009-2797(87)90003-2; WU FYH, 1993, ONCOGENE, V8, P2237; YAKURA H, 1994, CRIT REV IMMUNOL, V14, P311, DOI 10.1615/CritRevImmunol.v14.i3-4.50; YOUSEFI S, 1994, P NATL ACAD SCI USA, V91, P10868, DOI 10.1073/pnas.91.23.10868; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n	61	55	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9906	9911		10.1074/jbc.273.16.9906	http://dx.doi.org/10.1074/jbc.273.16.9906			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545333	hybrid			2022-12-27	WOS:000073128800079
J	Gladyshev, VN; Jeang, KT; Wootton, JC; Hatfield, DL				Gladyshev, VN; Jeang, KT; Wootton, JC; Hatfield, DL			A new human selenium-containing protein - Purification, characterization, and cDNA sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN REDUCTASE; IODOTHYRONINE DEIODINASE; SELENOCYSTEINE; SELENOPROTEIN; GENE; CLONING; MAP	Selenium which occurs in proteins as the amino acid, selenocysteine, is essential for numerous biological processes and for human health. A prominent Se-75-labeled protein detected in human T-cells migrated as a 15-kDa band by SDS-polyacrylamide gel electrophoresis. This protein subunit was purified and subjected to tryptic digestion and peptide sequence analyses. Sequences of tryptic peptides derived from the protein corresponded to a human placental gene sequence containing an open reading frame of 162 residues and a readthrough in-frame TGA codon. Three different peptide sequences of the 15-kDa protein corresponded to a nucleotide sequence located downstream of this codon, suggesting that the T-cell 15-kDa selenoprotein contains a selenocysteine residue encoded by TGA. Post-translational processing of the N-terminal portion of the predicted gene product to give the 15-kDa protein was suggested on the basis of molecular mass, amino acid analysis, and immunoblot assays of the purified protein. The 3'-untranslated region (UTR) of the gene encoding the 15-kDa protein contained a sequence that is very similar to the canonical selenocysteine-inserting sequence element. Computer analysis of transcript map data bases indicated that this gene was located on human chromosome 1. Its coding sequence showed no homology to known protein-encoding genes. The 15-kDa protein gene was expressed as mRNA in a wide range of tissues, with increased levels in the thyroid, parathyroid, and prostate-derived cells as evidenced by searches of partial cDNA sequences in public data bases. Genes corresponding to the 15-kDa selenocysteine containing protein were found in mice and rats, while the corresponding genes in Caenorhabditis elegans and Brugia malayi contained a cysteine codon in place of TGA The discovery of a new human selenoprotein provides an additional example of the role of selenium in mammalian systems.	NCI, Basic Res Lab, Sect Mol Biol Selenium, NIH, Bethesda, MD 20892 USA; NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Hatfield, DL (corresponding author), NCI, Basic Res Lab, Sect Mol Biol Selenium, NIH, Bldg 37,Rm 2D09,9000 Rockville Pike, Bethesda, MD 20892 USA.		Gladyshev, Vadim N/A-9894-2013; Jeang, Kuan-Teh/A-2424-2008	Gladyshev, Vadim/0000-0002-0372-7016				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; GASDASKA PY, 1995, FEBS LETT, V373, P5, DOI 10.1016/0014-5793(95)01003-W; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; GLADYSHEV VN, 1997, FASEB J, V11, P3; GLADYSHEV VN, 1996, BIOCHEMISTRY-US, V35, P213; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; HATFIELD DL, 1998, IN PRESS COMPR NAT P; Hill K. E., 1994, Selenium in biology and human health., P117; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; Krizman DB, 1996, CANCER RES, V56, P5380; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SONNHAMMER ELL, 1994, COMPUT APPL BIOSCI, V10, P301; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; Strausberg RL, 1997, NAT GENET, V15, P415, DOI 10.1038/ng0497supp-415; SUNDE RA, 1994, SELENIUM BIOL HUMAN, P146; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; URSINI F, 1995, METHOD ENZYMOL, V252, P38; VENDELAND SC, 1995, P NATL ACAD SCI USA, V92, P8749, DOI 10.1073/pnas.92.19.8749; Walczak R, 1996, RNA, V2, P367	30	153	164	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8910	8915		10.1074/jbc.273.15.8910	http://dx.doi.org/10.1074/jbc.273.15.8910			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535873	hybrid, Green Submitted			2022-12-27	WOS:000072990800050
J	Ishihara, H; Shibasaki, Y; Kizuki, N; Wada, T; Yazaki, Y; Asano, T; Oka, Y				Ishihara, H; Shibasaki, Y; Kizuki, N; Wada, T; Yazaki, Y; Asano, T; Oka, Y			Type I phosphatidylinositol-4-phosphate 5-kinases - Cloning of the third isoform and deletion/substitution analysis of members of this novel lipid kinase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; PLECKSTRIN HOMOLOGY DOMAINS; 4-PHOSPHATE 5-KINASE; PHOSPHATIDIC-ACID; TYROSINE KINASE; MAMMALIAN-CELLS; PROTEIN-KINASE; EXPRESSION; RHO; SEQUENCE	Type I phosphatidylinositol 4-phosphate (PtdIns(4)P) 5-kinases (PIP5K) catalyze the synthesis of phosphatidylinositol 4,5-bisphosphate, an essential lipid molecule in various cellular processes. Here, we report the cloning of the third member (PIP5K gamma) and the characterization of members of the type I PIP5K family. Type I PIP5K gamma has two alternative splicing forms, migrating at 87 and 90 kDa on SDS-polyacrylamide gel electrophoresis. The amino acid sequence of the central portion of this isoform shows approximately 80% identity with those of the alpha and beta isoforms, Northern blot analysis revealed that the gamma isoform is highly expressed in the brain, lung, and kidneys. Among three isoforms, the beta isoform has the greatest V-max value for the PtdIns(4)P kinase activity and the gamma isoform is most markedly stimulated by phosphatidic acid. By analyzing deletion mutants of the three isoforms, the minimal kinase core sequence of these isoforms were determined as an approximately 380-amino acid region, In addition, carboxyl-terminal regions of the beta and gamma isoforms were found to confer the greatest V-max value and the highest phosphatidic acid sensitivity, respectively, It was also discovered that lysine 138 in the putative ATP binding motif of the alpha isoform is essential for the PtdIns(4)P kinase activity, As was the case with the alpha isoform reported previously (Shibasaki, Y., Ishihara, H., Kizuki, N., Asano, T., Oka, Y., Yazaki; Y. (1997) J. Biol. Chem. 272, 7578-7581), overexpression of either the beta or the gamma isoform induced an increase in short actin fibers and a decrease in actin stress fibers in COS7 cells, Surprisingly, a kinase-deficient substitution mutant also induced an abnormal actin polymerization, suggesting a role of PIP5Ks via structural interactions with other molecules.	Univ Tokyo, Dept Internal Med 3, Bunkyo Ku, Tokyo 113, Japan; Yamaguchi Univ, Sch Med, Dept Internal Med 3, Ube, Yamaguchi 755, Japan	University of Tokyo; Yamaguchi University	Ishihara, H (corresponding author), Univ Tokyo, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.							BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881, DOI 10.1074/jbc.270.7.2881; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Davis JN, 1997, MOL CELL BIOL, V17, P7398, DOI 10.1128/MCB.17.12.7398; DIVECHA N, 1995, BIOCHEM J, V309, P715, DOI 10.1042/bj3090715; Fensome A, 1996, CURR BIOL, V6, P730, DOI 10.1016/S0960-9822(09)00454-0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Harlow E., 1988, ANTIBODIES LAB MANUA; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Ishihara H, 1996, DIABETES, V45, P1238, DOI 10.2337/diabetes.45.9.1238; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; MADHUSUDAN T, 1994, PROTEIN SCI, V3, P176; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Nakagawa T, 1996, J BIOL CHEM, V271, P12088, DOI 10.1074/jbc.271.20.12088; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756	38	236	245	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8741	8748		10.1074/jbc.273.15.8741	http://dx.doi.org/10.1074/jbc.273.15.8741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535851	hybrid			2022-12-27	WOS:000072990800028
J	King, P; Goodbourn, S				King, P; Goodbourn, S			STAT1 is inactivated by a caspase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INFLUENZA-VIRUS INFECTION; NF-KAPPA-B; INTERFERON-BETA PROMOTER; FACTOR-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH; WILD-TYPE P53; SIGNAL-TRANSDUCTION; RESPONSE ELEMENT; FAS ANTIGEN	Apoptosis involves the activation of a cascade of interleukin-lp converting enzyme-like proteases (caspases), a group of cysteine proteases related to the prototype interleukin-1 beta-converting enzyme (caspase-1). These proteases cleave specific intracellular targets such as poly(ADP-ribose) polymerase, DNA-dependent protein kinase, and nuclear lamins. We show here that apoptosis can be induced by double-stranded RNA. The induction of apoptosis by double-stranded RNA and other agents leads to the cleavage by a caspase of the signal transducer and activator of transcription factor, STAT1 which is pivotal in the signal transduction pathways of the interferons and many other cytokines and growth factors. The product of this cleavage is no longer able to mediate interferon-activated signal transduction and the cleavage event may play a role in regulating the apoptosis response itself.	Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Sci, Div Biochem, London SW17 0RE, England	St Georges University London	Goodbourn, S (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Sci, Div Biochem, London SW17 0RE, England.			Goodbourn, Stephen/0000-0002-4530-1179				Beyaert R, 1997, J BIOL CHEM, V272, P11694, DOI 10.1074/jbc.272.18.11694; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BRISCOE J, 1994, CURR BIOL, V4, P1033, DOI 10.1016/S0960-9822(00)00236-0; BUMP NJ, 1995, SCIENCE, V269, P1886; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Clemens MJ, 1996, TRANSLATIONAL CONTRO, P139; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Eldadah BA, 1996, NUCLEIC ACIDS RES, V24, P4092, DOI 10.1093/nar/24.20.4092; FEARNHEAD HO, 1995, FEBS LETT, V375, P283, DOI 10.1016/0014-5793(95)01228-7; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; GaleaLauri J, 1996, J IMMUNOL, V157, P4109; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GOODBOURN S, 1996, EUKARYOTIC GENE TRAN, P132; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Gossett R, 1996, J COMP PATHOL, V115, P353, DOI 10.1016/S0021-9975(96)80071-5; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hardwick J M, 1997, Adv Pharmacol, V41, P295, DOI 10.1016/S1054-3589(08)61063-7; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; ITOH N, 1993, J BIOL CHEM, V268, P10932; KING P, 1994, J BIOL CHEM, V269, P30609; Krajcsi P, 1996, J VIROL, V70, P4904, DOI 10.1128/JVI.70.8.4904-4913.1996; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lotem J, 1996, LEUKEMIA, V10, P925; Lotem J, 1996, P NATL ACAD SCI USA, V93, P12507, DOI 10.1073/pnas.93.22.12507; LOTEM J, 1995, LEUKEMIA, V9, P685; MARAN A, 1994, SCIENCE, V265, P789, DOI 10.1126/science.7914032; Margolin N, 1997, J BIOL CHEM, V272, P7223, DOI 10.1074/jbc.272.11.7223; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; MELLITS KH, 1993, NUCLEIC ACIDS RES, V21, P5059, DOI 10.1093/nar/21.22.5059; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Niwa M, 1997, LIFE SCI, V61, P205, DOI 10.1016/S0024-3205(97)00375-5; OFFERMANN MK, 1995, EUR J BIOCHEM, V232, P28, DOI 10.1111/j.1432-1033.1995.tb20777.x; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SLEATH PR, 1990, J BIOL CHEM, V265, P14526; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Takahashi A, 1996, CURR OPIN GENET DEV, V6, P50, DOI 10.1016/S0959-437X(96)90010-6; TAKIZAWA T, 1995, VIROLOGY, V209, P288, DOI 10.1006/viro.1995.1260; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Takizawa T, 1996, J VIROL, V70, P8128, DOI 10.1128/JVI.70.11.8128-8132.1996; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tan XQ, 1997, J BIOL CHEM, V272, P9613; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Ubeda M, 1997, J BIOL CHEM, V272, P19562, DOI 10.1074/jbc.272.31.19562; Uren AG, 1997, VITAM HORM, V53, P175, DOI 10.1016/S0083-6729(08)60707-4; WALKER PR, 1991, CANCER RES, V51, P1078; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WHITESIDE ST, 1992, NUCLEIC ACIDS RES, V20, P1531, DOI 10.1093/nar/20.7.1531; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yeung MC, 1996, P NATL ACAD SCI USA, V93, P12451, DOI 10.1073/pnas.93.22.12451	78	88	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8699	8704		10.1074/jbc.273.15.8699	http://dx.doi.org/10.1074/jbc.273.15.8699			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535846	hybrid			2022-12-27	WOS:000072990800023
J	Sharma, KK; Kaur, H; Kumar, GS; Kester, K				Sharma, KK; Kaur, H; Kumar, GS; Kester, K			Interaction of 1,1 '-bi(4-anilino)naphthalene-5,5 '-disulfonic acid with alpha-crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; MOLECULAR CHAPERONE; LENS CRYSTALLINS; B-CRYSTALLIN; A-CRYSTALLIN; CONFORMATIONAL-CHANGES; HYDROPHOBIC SURFACES; FLUORESCENT-PROBES; ENERGY-TRANSFER; TISSUES	The hydrophobic sites in cu-crystallin were evaluated using a fluorescent probe 1,1'-bi(4-anilino)naphthalenesulfonic acid (bis-ANS). Approximately one binding site/subunit of alpha-crystallin at 25 degrees C was estimated by equilibrium binding and Scatchard analysis (K-d = 1.1 mu M). Eased on fluorescence titration, the dissociation constant was 0.95 mu M The number of bis-ANS binding sites nearly doubled upon heat treatment of the protein at 60 degrees C. Likewise, the exposure of alpha-crystallin to 2-3 at urea resulted in increased binding of bis-ANS. Above 3 nn urea there was a rapid loss in the fluorescence indicating the loss of interaction between bis-ANS and protein. The alpha-crystallin refolded from 6 nr urea showed tryptophan fluorescence emission similar to the native alpha-crystallin However, the refolded alpha-crystallin showed a 60% increase in bis-ANS binding, suggesting distinct changes on the protein surface resulting from exposure to urea similar to the changes occurring due to heat treatment. The fluorescence of tryptophan in native alpha-crystallin was quenched by the addition of bis-ANS. The quenching was inversely related to the amount of bis-ANS bound to alpha-crystallin Additionally, the binding of bis-ANS reduced the chaperone-like activity of the protein. Photolysis of bis-ANS-alpha-crystallin complex resulted in incorporation of the probe to both A-and E-subunits, indicating that both subunits in native alpha-crystallin contribute to the surface hydrophobicity of the protein.	Univ Missouri, Mason Eye Inst, Dept Ophthalmol, Columbia, MO 65212 USA; Univ Missouri, Dept Biochem, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sharma, KK (corresponding author), Univ Missouri, Mason Eye Inst, Dept Ophthalmol, 1 Hosp Dr, Columbia, MO 65212 USA.	opthks@showme.missouri.edu	KUMAR, P. SURESH/AAT-8951-2020; Kumar, Gopinatha Suresh/W-1461-2019; Kumar, Dr Suresh/HHZ-2615-2022	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553				Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; ANDLEY UP, 1982, BIOCHEMISTRY-US, V21, P1853, DOI 10.1021/bi00537a023; AUGUSTEYN RC, 1993, BIOCHIM BIOPHYS ACTA, V1162, P61, DOI 10.1016/0167-4838(93)90128-E; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bloemendal H, 1981, MOL CELLULAR BIOL EY, P1; Borkman RF, 1996, EXP EYE RES, V62, P141, DOI 10.1006/exer.1996.0018; Carver JA, 1996, EXP EYE RES, V63, P639, DOI 10.1006/exer.1996.0158; Clark JI, 1996, P NATL ACAD SCI USA, V93, P15185, DOI 10.1073/pnas.93.26.15185; Das BK, 1997, CURR EYE RES, V16, P303, DOI 10.1076/ceyr.16.4.303.10691; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; EFTNIK MR, 1981, ANAL BIOCHEM, V114, P199; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; GANEA E, 1995, EUR J BIOCHEM, V231, P181, DOI 10.1111/j.1432-1033.1995.0181f.x; GOROVITS BM, 1995, BIOCHEMISTRY-US, V34, P13928, DOI 10.1021/bi00042a026; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HOROWITZ PM, 1995, J BIOL CHEM, V270, P1535, DOI 10.1074/jbc.270.4.1535; HORWITZ J, 1992, CURR EYE RES, V11, P817, DOI 10.3109/02713689209000754; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; IWAKI T, 1992, AM J PATHOL, V140, P345; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; JACOB U, 1993, J BIOL CHEM, V268, P1517; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1080, P173, DOI 10.1016/0167-4838(91)90146-Q; KOLLMANNKOCH A, 1989, EUR J BIOCHEM, V185, P441, DOI 10.1111/j.1432-1033.1989.tb15134.x; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Lee JS, 1997, J PROTEIN CHEM, V16, P283, DOI 10.1023/A:1026305025816; LIANG JN, 1991, EXP EYE RES, V53, P61, DOI 10.1016/0014-4835(91)90145-5; MERK KB, 1993, J BIOL CHEM, V268, P1046; MURANO S, 1991, MOL CELL BIOL, V11, P3905, DOI 10.1128/MCB.11.8.3905; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; PRASAD ARS, 1986, BIOCHEMISTRY-US, V25, P3536, DOI 10.1021/bi00360a010; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; RAMAN B, 1994, J BIOL CHEM, V269, P27264; RAMAN B, 1995, J BIOL CHEM, V270, P19888, DOI 10.1074/jbc.270.34.19888; RAO PV, 1993, BIOCHEM BIOPH RES CO, V190, P786, DOI 10.1006/bbrc.1993.1118; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SEALE JW, 1995, BIOCHEMISTRY-US, V34, P7443, DOI 10.1021/bi00022a018; SHARMA KK, 1995, EXP EYE RES, V61, P413; Sharma KK, 1997, BIOCHEM BIOPH RES CO, V239, P217, DOI 10.1006/bbrc.1997.7460; SHI L, 1994, BIOCHEMISTRY-US, V33, P7536, DOI 10.1021/bi00190a006; Smith JB, 1996, EXP EYE RES, V63, P125, DOI 10.1006/exer.1996.0100; Smulders RHPH, 1997, FEBS LETT, V409, P101, DOI 10.1016/S0014-5793(97)00498-5; Smulders RHPH, 1996, J BIOL CHEM, V271, P29060, DOI 10.1074/jbc.271.46.29060; SMULDERS RHPH, 1995, EUR J BIOCHEM, V232, P834, DOI 10.1111/j.1432-1033.1995.834zz.x; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Stevens A, 1997, EUR J BIOCHEM, V243, P792, DOI 10.1111/j.1432-1033.1997.00792.x; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sudhakar K, 1996, J BIOL CHEM, V271, P23015, DOI 10.1074/jbc.271.38.23015; Sun TX, 1997, J BIOL CHEM, V272, P6220, DOI 10.1074/jbc.272.10.6220; TAKEMOTO L, 1994, CURR EYE RES, V13, P35, DOI 10.3109/02713689409042396; WALLACH DFH, 1970, BIOCHIM BIOPHYS ACTA, V203, P67, DOI 10.1016/0005-2736(70)90036-2; WANG JL, 1971, J BIOL CHEM, V246, P1185; WANG KY, 1994, J BIOL CHEM, V269, P13601	57	140	140	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8965	8970		10.1074/jbc.273.15.8965	http://dx.doi.org/10.1074/jbc.273.15.8965			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535881	hybrid			2022-12-27	WOS:000072990800058
J	Uherek, C; Fominaya, J; Wels, W				Uherek, C; Fominaya, J; Wels, W			A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TRANSLOCATION; EFFICIENT DELIVERY; CATALYTIC DOMAIN; ERBB-2 RECEPTOR; TRANSFERRIN; EXPRESSION; COMPLEXES; CYTOSOL; LIGAND; ENDOCYTOSIS	Modular fusion proteins that combine distinct functions required for cell type-specific uptake and intracellular delivery of DNA present an attractive approach for the development of self-assembling vectors for targeted gene delivery. Here, we describe a novel DNA carrier protein termed GD5 that mimics the structure of the bacterial diphtheria toxin (DT) and facilitates target cell-specific gene transfer via receptor-mediated endocytosis. GD5 carries at the N terminus the DNA-binding domain of the yeast transcription factor Ga14, which is connected to a C-terminal antibody fragment specific for the tumor-associated ErbB2 antigen via an internal DT translocation domain as an endosome escape activity, Bacterially expressed GD5 protein specifically bound to ErbB2-expressing cells and formed protein-DNA complexes with a luciferase reporter gene construct, These complexes, after compensation of excess negative charge with poly-L-lysine, served as a specific transfection vector for ErbB2-expressing cells, Inhibitors of endosomal acidification drastically reduced GD5-mediated transfection, indicating that the DT translocation domain of GD5, similar to the parental toxin, is strictly dependent on the transit through an acidic environment, Our results suggest that fusion proteins that employ the natural endosome escape mechanism of bacterial toxins might aid in the development of efficient nonviral vectors for applications in gene therapy.	Inst Expt Canc Res, Tumor Biol Ctr, D-79106 Freiburg, Germany; Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Wels, W (corresponding author), Inst Expt Canc Res, Tumor Biol Ctr, Breisacher Str 117, D-79106 Freiburg, Germany.			Wels, Winfried/0000-0001-9858-3643				BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; CHEN SY, 1995, GENE THER, V2, P116; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Cooper MJ, 1996, SEMIN ONCOL, V23, P172; COTTEN M, 1990, P NATL ACAD SCI USA, V87, P4033, DOI 10.1073/pnas.87.11.4033; CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850; DONNELLY JJ, 1993, P NATL ACAD SCI USA, V90, P3530, DOI 10.1073/pnas.90.8.3530; Felgner PL, 1997, HUM GENE THER, V8, P511, DOI 10.1089/hum.1997.8.5-511; Fisher KJ, 1997, BIOCHEM J, V321, P49, DOI 10.1042/bj3210049; Fominaya J, 1998, GENE THER, V5, P521, DOI 10.1038/sj.gt.3300614; Fominaya J, 1996, J BIOL CHEM, V271, P10560, DOI 10.1074/jbc.271.18.10560; Fritz JD, 1996, HUM GENE THER, V7, P1395, DOI 10.1089/hum.1996.7.12-1395; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; HYNES NE, 1990, MOL CELL BIOL, V10, P4027, DOI 10.1128/MCB.10.8.4027; JIANG GS, 1989, J BIOL CHEM, V264, P13424; KAGAN BL, 1981, P NATL ACAD SCI-BIOL, V78, P4950, DOI 10.1073/pnas.78.8.4950; LONDON E, 1992, BIOCHIM BIOPHYS ACTA, V1113, P25, DOI 10.1016/0304-4157(92)90033-7; MADSHUS IH, 1994, J BIOL CHEM, V269, P4648; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; NELSON M, 1989, MOL CELL BIOL, V9, P384, DOI 10.1128/MCB.9.2.384; Novoa I, 1996, J VIROL, V70, P3319, DOI 10.1128/JVI.70.5.3319-3324.1996; OKEEFE DO, 1992, P NATL ACAD SCI USA, V89, P6202, DOI 10.1073/pnas.89.13.6202; OLSNES S, 1993, MED MICROBIOL IMMUN, V182, P51, DOI 10.1007/BF00189373; Paul RW, 1997, HUM GENE THER, V8, P1253, DOI 10.1089/hum.1997.8.10-1253; PERALES JC, 1994, EUR J BIOCHEM, V226, P255, DOI 10.1111/j.1432-1033.1994.tb20049.x; PROBA K, 1995, GENE, V159, P203, DOI 10.1016/0378-1119(95)00018-2; SANDVIG K, 1981, J BIOL CHEM, V256, P9068; Schnierle BS, 1996, GENE THER, V3, P1069; UMATA T, 1990, J BIOL CHEM, V265, P21940; VANDERSPEK J, 1994, J BIOL CHEM, V269, P21455; VANDERSPEK JC, 1993, J BIOL CHEM, V268, P12077; WAGNER E, 1994, ADV DRUG DELIVER REV, V14, P113, DOI 10.1016/0169-409X(94)90008-6; WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255; WAGNER E, 1992, P NATL ACAD SCI USA, V89, P7934, DOI 10.1073/pnas.89.17.7934; WELS W, 1995, INT J CANCER, V60, P137, DOI 10.1002/ijc.2910600120; Wels W, 1996, CURR TOP MICROBIOL, V213, P113; WELS W, 1992, BIO-TECHNOL, V10, P1128, DOI 10.1038/nbt1092-1128; WELS W, 1998, SELF ASSEMBLING COMP, P351; WU GY, 1987, J BIOL CHEM, V262, P4429; ZENKE M, 1990, P NATL ACAD SCI USA, V87, P3655, DOI 10.1073/pnas.87.10.3655	46	82	86	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8835	8841		10.1074/jbc.273.15.8835	http://dx.doi.org/10.1074/jbc.273.15.8835			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535863	hybrid			2022-12-27	WOS:000072990800040
J	Minowa, MT; Oguri, S; Yoshida, A; Hara, T; Iwamatsu, A; Ikenaga, H; Takeuchi, M				Minowa, MT; Oguri, S; Yoshida, A; Hara, T; Iwamatsu, A; Ikenaga, H; Takeuchi, M			cDNA cloning and expression of bovine UDP-N-acetylglucosamine: alpha 1,3-D-mannoside beta 1,4-N-acetylglucosaminyltransferase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-3-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE-I GENE; GLYCOPROTEIN-SYNTHESIS; MOLECULAR-CLONING; GOLGI RETENTION; UDP-N-ACETYLGLUCOSAMINE-ALPHA-3-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFE; ALPHA-1-ACID GLYCOPROTEIN; HUMAN ERYTHROPOIETIN; SUGAR CHAINS; RAT-KIDNEY; CELLS	UDP-N-acetulglucosamine:alpha 1,3-D-mannoside beta 1,4-N-acetylglucosaminyltransferase (GnT-IV) is one of the essential enzymes in the production of tri-and tetra-antennary Asn-linked sugar chains. Recently, we have successfully purified GnT-IV from bovine small intestine. Based on the partial amino acid sequence of the purified bovine GnT-IV enzyme, its cDNA has been cloned from bovine small intestine. The open reading frame is 1,605 base pairs long, and this sequence produced GnT-IV activity on transient expression in COS-7 cells. Although the deduced amino acid sequence does not have any significant homology with other known N-acetylglucosaminyltransferases (GnTs), the hydrophobicity profile showed a typical type II transmembrane protein structure, which is common to many glycosyltransferases, N-terminal amino acid sequencing of the purified GnT-IV revealed that 92 amino acids, including a transmembrane region, were truncated during purification. Of the three potential N-glycosylation sites Asn-458 was actually glycosylated in the purified enzyme, although this N-glycosylation site could be abolished without any reduction in GnT-IV activity. Serial deletions at both the N and C termini proved that the catalytic domain of GnT-IV is located in the central region of the enzyme. The GnT-IV mRNA level correlated with enzymatic activity in the various bovine tissues tested.	Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Kirin Brewery Company Limited	Takeuchi, M (corresponding author), Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.							Asada M, 1997, CANCER RES, V57, P1073; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; BENDIAK B, 1987, J BIOL CHEM, V262, P5775; BORIES PN, 1990, INFLAMMATION, V14, P315, DOI 10.1007/BF00915815; CAMPION B, 1989, EUR J BIOCHEM, V184, P405, DOI 10.1111/j.1432-1033.1989.tb15032.x; DAGOSTARO GAF, 1995, J BIOL CHEM, V270, P15211, DOI 10.1074/jbc.270.25.15211; DENNIS JW, 1991, CELL SURFACE CARBOHY, P161; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOULUTCHASSAING C, 1995, BBA-GEN SUBJECTS, V1244, P30, DOI 10.1016/0304-4165(94)00191-Y; HIRAIZUMI S, 1990, ARCH BIOCHEM BIOPHYS, V280, P9, DOI 10.1016/0003-9861(90)90511-V; HOBMAN TC, 1995, MOL BIOL CELL, V6, P7, DOI 10.1091/mbc.6.1.7; HUBBARD SC, 1987, J BIOL CHEM, V262, P16403; HULL E, 1991, BIOCHEM BIOPH RES CO, V176, P608, DOI 10.1016/S0006-291X(05)80227-X; IHARA Y, 1993, J BIOCHEM-TOKYO, V113, P692, DOI 10.1093/oxfordjournals.jbchem.a124105; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; KAZUTA Y, 1991, J BIOCHEM-TOKYO, V110, P708, DOI 10.1093/oxfordjournals.jbchem.a123645; KOBATA A, 1988, BIOCHIMIE, V70, P1575, DOI 10.1016/0300-9084(88)90293-3; Koyama N, 1996, EUR J BIOCHEM, V238, P853, DOI 10.1111/j.1432-1033.1996.0853w.x; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; KUMAR R, 1992, GLYCOBIOLOGY, V2, P383, DOI 10.1093/glycob/2.4.383; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MACKIEWICZ A, 1995, GLYCOCONJUGATE J, V12, P241, DOI 10.1007/BF00731326; MATSUOKA Y, 1994, J BIOL CHEM, V269, P22565; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; NISHIKAWA A, 1988, ANAL BIOCHEM, V170, P349, DOI 10.1016/0003-2697(88)90641-0; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; Oguri S, 1997, J BIOL CHEM, V272, P22721, DOI 10.1074/jbc.272.36.22721; PIERCE M, 1986, J BIOL CHEM, V261, P772; POWNALL S, 1992, GENOMICS, V12, P699, DOI 10.1016/0888-7543(92)90297-6; SAITO H, 1994, BIOCHEM BIOPH RES CO, V198, P318, DOI 10.1006/bbrc.1994.1045; SAITO H, 1995, EUR J BIOCHEM, V233, P18, DOI 10.1111/j.1432-1033.1995.018_1.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SARKAR M, 1991, P NATL ACAD SCI USA, V88, P234, DOI 10.1073/pnas.88.1.234; SCHACHTER H, 1989, METHOD ENZYMOL, V179, P351; SHAPER NL, 1986, P NATL ACAD SCI USA, V83, P1573, DOI 10.1073/pnas.83.6.1573; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; TAKEUCHI M, 1989, P NATL ACAD SCI USA, V86, P7819, DOI 10.1073/pnas.86.20.7819; TAN J, 1995, EUR J BIOCHEM, V231, P317, DOI 10.1111/j.1432-1033.1995.tb20703.x; TANG BL, 1995, EUR J CELL BIOL, V66, P365; Tokugawa K, 1996, GLYCOCONJUGATE J, V13, P53, DOI 10.1007/BF01049679; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; YADAV S, 1990, J BIOL CHEM, V265, P14163; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884	48	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11556	11562		10.1074/jbc.273.19.11556	http://dx.doi.org/10.1074/jbc.273.19.11556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565571	hybrid			2022-12-27	WOS:000073536700025
J	Will, A; Grassl, R; Erdmenger, J; Caspari, T; Tanner, W				Will, A; Grassl, R; Erdmenger, J; Caspari, T; Tanner, W			Alteration of substrate affinities and specificities of the Chlorella hexose/H+ symporters by mutations and construction of chimeras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GLUT1 GLUCOSE-TRANSPORTER; EXOFACIAL LIGAND-BINDING; ESCHERICHIA-COLI; SCHIZOSACCHAROMYCES-POMBE; HETEROLOGOUS EXPRESSION; H+-COTRANSPORTER; SUGAR-TRANSPORT; FISSION YEAST; RECOGNITION	The cDNAs HUP1 and HUP2 of Chlorella kessleri code for monosaccharide/H+ symporters that can be functionally expressed in Schizosaccharomyces pombe, By random mutagenesis three HUP1 mutants with an increased K-m value for D-glucose were isolated. The 40-fold increase in K-m of the first mutant is due to the amino acid exchange N436I in putative transmembrane helix XI, Two substitutions were found in a second (G97C/I303N) and third mutant (G120D/F292L), which show a 270-fold and 50-fold increase in K-m for D-glucose, respectively, An investigation of the individual mutations revealed that the substitutions I303N and F292L (both in helix VII) cause the K-m shifts seen in the corresponding double mutants. These mutations together with those previously found support the hypothesis that helices V, VII, and XI participate in the transmembrane sugar pathway. Whereas for most mutants obtained so far the K-m change for D-glucose is paralleled by a corresponding change for other hexoses tested, the exchange D44E exclusively alters the K-m for D-glucose, Moreover the pH profile of this mutant is shifted by more than 2 pH units to alkaline values, indicating that the activity of the transporter may require deprotonation of the corresponding carboxyl group. Chimeric transporters were constructed to study the 100-fold lower affinity for D-galactose of the HUP1 symporter as compared with that of the HUP2 protein. A crucial determinant for the differential D-galactose recognition was shown to be associated with the first external loop. The effect could be pinpointed to a single amino acid change: replacement of Asn-45 of HUP1 with isoleucine, the corresponding amino acid of HUP2, yields a transporter with a 20 times higher affinity for D-galactose, The reverse substitution (I47N) decreases the affinity of HUP2 for D-galactose 20-fold.	Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, D-93040 Regensburg, Germany	University of Regensburg	Tanner, W (corresponding author), Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, D-93040 Regensburg, Germany.			Caspari, Thomas/0000-0002-1450-4774				Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; CASPARI T, 1994, J BIOL CHEM, V269, P3498; Caspari T, 1996, PLANT J, V10, P1045, DOI 10.1046/j.1365-313X.1996.10061045.x; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Harrison MJ, 1996, PLANT J, V9, P491, DOI 10.1046/j.1365-313X.1996.09040491.x; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Kaback HR, 1997, P NATL ACAD SCI USA, V94, P5539, DOI 10.1073/pnas.94.11.5539; Kasahara M, 1996, FEBS LETT, V389, P174, DOI 10.1016/0014-5793(96)00567-4; KOMOR E, 1974, J GEN PHYSIOL, V64, P568, DOI 10.1085/jgp.64.5.568; KOMOR E, 1973, FEBS LETT, V38, P16, DOI 10.1016/0014-5793(73)80501-0; KOMOR E, 1976, EUR J BIOCHEM, V70, P197, DOI 10.1111/j.1432-1033.1976.tb10970.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; METZGER TG, 1995, FEBS LETT, V375, P1, DOI 10.1016/0014-5793(95)01185-H; MILBRADT B, 1994, MICROBIOL-SGM, V140, P2617, DOI 10.1099/00221287-140-10-2617; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; NISHIZAWA K, 1995, J BIOL CHEM, V270, P2423, DOI 10.1074/jbc.270.6.2423; OPEKAROVA M, 1994, BBA-BIOMEMBRANES, V1194, P149, DOI 10.1016/0005-2736(94)90214-3; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; SAUER N, 1993, PLANT J, V4, P601, DOI 10.1046/j.1365-313X.1993.04040601.x; SAUER N, 1990, EMBO J, V9, P3045, DOI 10.1002/j.1460-2075.1990.tb07500.x; SAUER N, 1989, FEBS LETT, V259, P43, DOI 10.1016/0014-5793(89)81489-9; SAUER N, 1990, P NATL ACAD SCI USA, V87, P7949, DOI 10.1073/pnas.87.20.7949; STADLER R, 1995, PLANT PHYSIOL, V107, P33, DOI 10.1104/pp.107.1.33; Tanner W, 1996, ANNU REV PLANT PHYS, V47, P595, DOI 10.1146/annurev.arplant.47.1.595; TANNER W, 1969, BIOCHEM BIOPH RES CO, V36, P278, DOI 10.1016/0006-291X(69)90326-X; Varela MF, 1997, J BACTERIOL, V179, P5570, DOI 10.1128/jb.179.17.5570-5573.1997; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; WEIG A, 1994, J PLANT PHYSIOL, V143, P178, DOI 10.1016/S0176-1617(11)81683-4; Will A, 1996, FEBS LETT, V381, P127, DOI 10.1016/0014-5793(96)00097-X; WILL A, 1994, P NATL ACAD SCI USA, V91, P10163, DOI 10.1073/pnas.91.21.10163	38	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11456	11462		10.1074/jbc.273.19.11456	http://dx.doi.org/10.1074/jbc.273.19.11456			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565557	hybrid			2022-12-27	WOS:000073536700011
J	Braam, LAM; Reznikoff, WS				Braam, LAM; Reznikoff, WS			Functional characterization of the Tn5 transposase by limited proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND TRANSFER; CATALYTIC DOMAIN; SITE; MULTIMERIZATION; INTEGRATION; MECHANISM; PROTEINS; BINDING; MUTANT	The 476 amino acid Tn5 transposase catalyzes DNA cutting and joining reactions that cleave the Tn5 transposon from donor DNA and integrate it into a target site. Protein-DNA and protein-protein interactions are important for this tranposition process. A truncated transposase variant, the inhibitor, decreases transposition rates via the formation of nonproductive complexes with transposase. Here, the inhibitor and the transposase are shown to have similar secondary and tertiary folding. Using limited proteolysis, the transposase has been examined structurally and functionally. A DNA binding region was localized to the N-terminal 113 amino acids. Generally, the N terminus of transposase is sensitive to proteolysis but can be protected by DNA. Two regions are predicted to contain determinants for protein-protein interactions, encompassing residues 114-314 and 441-476. The dimerization regions appear to be distinct and may have separate functions, one involved in synaptic complex formation and one involved in nonproductive multimerization. Furthermore, predicted catalytic regions are shown to lie between major areas of proteolysis.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, MD PHD Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Reznikoff, WS (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.				NIGMS NIH HHS [GM50692, GM07215] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bolland S, 1996, CELL, V84, P223, DOI 10.1016/S0092-8674(00)80977-0; BUJACZ G, 1995, J MOL BIOL, V253, P333, DOI 10.1006/jmbi.1995.0556; DELACRUZ NB, 1993, J BACTERIOL, V175, P6932, DOI 10.1128/jb.175.21.6932-6938.1993; DELONG A, 1991, P NATL ACAD SCI USA, V88, P6072, DOI 10.1073/pnas.88.14.6072; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; GORYSHIN IY, 1994, P NATL ACAD SCI USA, V91, P10834, DOI 10.1073/pnas.91.23.10834; JAIN C, 1993, MOL MICROBIOL, V9, P249, DOI 10.1111/j.1365-2958.1993.tb01687.x; KREBS MP, 1988, GENE, V63, P277, DOI 10.1016/0378-1119(88)90531-8; KWON D, 1995, P NATL ACAD SCI USA, V92, P8234, DOI 10.1073/pnas.92.18.8234; LEWIS M, 1996, SCIENCE, V271, P2147; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; POLARD P, 1995, MOL MICROBIOL, V15, P13, DOI 10.1111/j.1365-2958.1995.tb02217.x; POUDEROYEN G, 1997, EMBO J, V16, P6044; REZNIKOFF WS, 1993, ANNU REV MICROBIOL, V47, P945, DOI 10.1146/annurev.mi.47.100193.004501; REZSOHAZY R, 1993, MOL MICROBIOL, V9, P1283, DOI 10.1111/j.1365-2958.1993.tb01258.x; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; WEINREICH MD, 1994, J MOL BIOL, V241, P166, DOI 10.1006/jmbi.1994.1486; WEINREICH MD, 1994, GENE DEV, V8, P2363, DOI 10.1101/gad.8.19.2363; WIEGAND TW, 1994, J MOL BIOL, V235, P486, DOI 10.1006/jmbi.1994.1008; WIEGAND TW, 1992, J BACTERIOL, V174, P1229, DOI 10.1128/jb.174.4.1229-1239.1992; York D, 1996, NUCLEIC ACIDS RES, V24, P3790, DOI 10.1093/nar/24.19.3790; Zhou M, 1997, J MOL BIOL, V271, P362, DOI 10.1006/jmbi.1997.1188; ZHOU M, IN PRESS J MOL BIOL; [No title captured]	27	15	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10908	10913		10.1074/jbc.273.18.10908	http://dx.doi.org/10.1074/jbc.273.18.10908			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556567	hybrid			2022-12-27	WOS:000073395200019
J	Inoue, M; Kamiya, H; Fujikawa, K; Ootsuyama, Y; Murata-Kamiya, N; Osaki, T; Yasumoto, K; Kasai, H				Inoue, M; Kamiya, H; Fujikawa, K; Ootsuyama, Y; Murata-Kamiya, N; Osaki, T; Yasumoto, K; Kasai, H			Induction of chromosomal gene mutations in Escherichia coli by direct incorporation of oxidatively damaged nucleotides - New evaluation method for mutagenesis by damaged DNA precursors in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-HA-RAS; OPPOSITE 2-HYDROXYADENINE; IONIZING-RADIATION; SEQUENCE CONTEXTS; HUMAN-CELLS; LACI GENE; 8-HYDROXYGUANINE; REPAIR; FORM; MISINCORPORATION	We have developed a new strategy for the evaluation of the mutagenicity of a damaged DNA precursor (deoxyribonucleoside 5'-triphosphate) in Escherichia coli, 8-Hydroxydeoxyguanosine triphosphate (8-OH-dGTP) and 2-hydroxydeoxyadenosine triphosphate (2-OH-dATP) were chosen for this study because they appear to be formed abundantly by reactive oxygen species in cells, We introduced the oxidatively damaged nucleotides into competent E. coli and selected mutants of the chromosomal loci gene, Both damaged nucleotides induced loci gene mutations in a dose-dependent manner, whereas unmodified dATP and dGTP did not appear to elicit the mutations, The addition of 50 nmol of 8-OH-dGTP and 2-OH-dATP into an E. coli suspension induced 12- and 9-fold more substitution mutations than the spontaneous event, respectively. The 8-OH-dGTP induced A.T --> C.G transversions, and the 2-OH-dATP elicited G.C --> T.A transversions. These results indicate that the two oxidatively damaged nucleotides are mutagenic in vivo and suggest that 8-OH-dGTP and 2-OH-dATP were incorporated opposite A and G residues, respectively, in the E. coli DNA, This new method enables the evaluation and comparison of the mutagenic potentials of damaged DNA precursors in vivo.	Univ Occupat & Environm Hlth, Dept Environm Oncol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; Univ Occupat & Environm Hlth, Dept Hlth Policy & Management, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; Univ Occupat & Environm Hlth, Dept Surg 2, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Kasai, H (corresponding author), Univ Occupat & Environm Hlth, Dept Environm Oncol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	hirokam@med.uoeh-u.ac.jp; h-kasai@med.uoeh-u.ac.jp	Kamiya, Hiroyuki/G-2383-2019	Kamiya, Hiroyuki/0000-0001-6866-5322				AKASAKA S, 1994, MUTAT RES-DNA REPAIR, V315, P105, DOI 10.1016/0921-8777(94)90011-6; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Asami S, 1996, CANCER RES, V56, P2546; CHENG KC, 1992, J BIOL CHEM, V267, P166; HALLIDAY JA, 1991, MUTAT RES, V250, P55, DOI 10.1016/0027-5107(91)90162-H; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Jaruga P, 1996, NUCLEIC ACIDS RES, V24, P1389, DOI 10.1093/nar/24.8.1389; KAMIYA H, 1995, CARCINOGENESIS, V16, P883, DOI 10.1093/carcin/16.4.883; Kamiya H, 1996, FEBS LETT, V391, P113, DOI 10.1016/0014-5793(96)00714-4; Kamiya H, 1997, NUCLEIC ACIDS RES, V25, P304, DOI 10.1093/nar/25.2.304; KAMIYA H, 1995, J BIOL CHEM, V270, P19446, DOI 10.1074/jbc.270.33.19446; Kamiya H, 1997, BIOCHEMISTRY-US, V36, P11125, DOI 10.1021/bi970871u; KAMIYA H, 1992, CANCER RES, V52, P3483; KAMIYA H, 1995, NUCLEIC ACIDS RES, V23, P761, DOI 10.1093/nar/23.5.761; KASAI H, 1990, MUTAT RES, V243, P249, DOI 10.1016/0165-7992(90)90139-B; KASAI H, 1991, OXIDATIVE STRESS, V2, P99; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MATSUDA T, 1995, CARCINOGENESIS, V16, P2389, DOI 10.1093/carcin/16.10.2389; Miller J.H., 1972, EXPT MOL GENETICS; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MINNICK DT, 1994, NUCLEIC ACIDS RES, V22, P5658, DOI 10.1093/nar/22.25.5658; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; MurataKamiya N, 1997, J RADIAT RES, V38, P121, DOI 10.1269/jrr.38.121; MurataKamiya N, 1997, MUTAT RES-FUND MOL M, V377, P255, DOI 10.1016/S0027-5107(97)00083-3; ONO T, 1995, MUTAT RES-FUND MOL M, V326, P175, DOI 10.1016/0027-5107(94)00167-4; PURMAL AA, 1994, NUCLEIC ACIDS RES, V22, P3930, DOI 10.1093/nar/22.19.3930; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAAPER RM, 1991, GENETICS, V129, P317; SEELA F, 1995, HELV CHIM ACTA, V78, P1843, DOI 10.1002/hlca.19950780718; SEPIOL J, 1976, Z NATURFORSCH C, V31, P361; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Wagner J, 1997, J MOL BIOL, V265, P302, DOI 10.1006/jmbi.1996.0740; WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011; Yoshida M, 1997, NUCLEIC ACIDS RES, V25, P1570, DOI 10.1093/nar/25.8.1570	35	101	105	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11069	11074		10.1074/jbc.273.18.11069	http://dx.doi.org/10.1074/jbc.273.18.11069			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556591	hybrid			2022-12-27	WOS:000073395200043
J	Jiang, T; Sweeney, G; Rudolf, MT; Klip, A; Traynor-Kaplan, A; Tsien, RY				Jiang, T; Sweeney, G; Rudolf, MT; Klip, A; Traynor-Kaplan, A; Tsien, RY			Membrane-permeant esters of phosphatidylinositol 3,4,5-trisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL LINE; CHLORIDE SECRETION; GLUCOSE-TRANSPORT; CYCLIC-AMP; 3-KINASE; KINASE; CALCIUM; ACTIVATION; WORTMANNIN; CAMP	Phosphoinositide 3-OH kinases and their products, D-3 phosphorylated phosphoinositides, are increasingly recognized as crucial elements in many signaling cascades. A reliable means to introduce these lipids into intact cells would be of great value for showing the physiological roles of this pathway and for testing the specificity of pharmacological inhibitors of the kinases. We have stereospecifically synthesized di-C-8-PIP3/AM and di-C-12-PLP3/AM, the heptakis(acetoxymethyl) esters of dioctanoyl- and dilauroylphosphatidylinositol 3,4,5-trisphosphate, in 14 steps from myo-inositol. The ability of these uncharged lipophilic derivatives to deliver phosphatidylinositol 3,4,5-trisphosphate across cell membranes was demonstrated on 3T3-L1 adipocytes and T-84 colon carcinoma monolayers, Insulin stimulation of hexose uptake into adipocytes was inhibited by the kinase inhibitor wortmannin and was largely restored by di-C-8-PIP3/AM, which had no effect in the absence of insulin. Thus phosphatidylinositol 3,4,5-trisphosphate or a metabolite was necessary but not sufficient for stimulation of hexose transport, In T-84 epithelial monolayers, di-C-12-PIP3/AM mimicked epidermal growth factor in inhibiting chloride secretion and potassium efflux, suggesting that phosphatidylinositol 3,4,5-trisphosphate was sufficient to modulate these fluxes and mediate epidermal growth factor's action.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada; Univ Bremen, UFT, Inst Organ Chem, D-28359 Bremen, Germany; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Bremen; University of California System; University of California San Diego	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.				NIDDK NIH HHS [DK47240] Funding Source: Medline; NINDS NIH HHS [NS27177] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Barrett KE, 1998, AM J PHYSIOL-CELL PH, V274, pC958, DOI 10.1152/ajpcell.1998.274.4.C958; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUZIK KS, 1992, J AM CHEM SOC, V114, P6361, DOI 10.1021/ja00042a011; CARTWRIGHT CA, 1985, J CLIN INVEST, V76, P1837, DOI 10.1172/JCI112176; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; DHARMSATHAPHORN K, 1989, AM J PHYSIOL, V256, pC1224, DOI 10.1152/ajpcell.1989.256.6.C1224; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; DOWNWARD J, 1995, NATURE, V376, P553, DOI 10.1038/376553a0; Eckmann L, 1997, P NATL ACAD SCI USA, V94, P14456, DOI 10.1073/pnas.94.26.14456; Farese RV, 1996, P SOC EXP BIOL MED, V213, P1, DOI 10.3181/00379727-213-44030; Ferby IM, 1996, J BIOL CHEM, V271, P11684, DOI 10.1074/jbc.271.20.11684; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FREED JJ, 1989, BIOCHEM PHARMACOL, V38, P3193, DOI 10.1016/0006-2952(89)90613-8; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; KOHN AD, 1995, EMBO J, V14, P428; LI W, 1998, IN PRESS NATURE; Li WH, 1997, TETRAHEDRON, V53, P12017, DOI 10.1016/S0040-4020(97)00714-X; MACVINISH LJ, 1993, BRIT J PHARMACOL, V108, P462, DOI 10.1111/j.1476-5381.1993.tb12826.x; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; OKADA T, 1994, J BIOL CHEM, V269, P3568; REDDY KK, 1995, J ORG CHEM, V60, P3385, DOI 10.1021/jo00116a023; SASTRY JK, 1992, MOL PHARMACOL, V41, P441; SCHULTZ C, 1994, MOL PHARMACOL, V46, P702; SCHULTZ C, 1993, J BIOL CHEM, V268, P6316; Shepherd PR, 1996, J MOL ENDOCRINOL, V17, P175, DOI 10.1677/jme.0.0170175; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOKER A, 1994, J BIOL CHEM, V269, P32358; Uribe JM, 1996, J BIOL CHEM, V271, P26588, DOI 10.1074/jbc.271.43.26588; VAJANAPHANICH M, 1995, J CLIN INVEST, V96, P386, DOI 10.1172/JCI118046; VAJANAPHANICH M, 1994, NATURE, V371, P711, DOI 10.1038/371711a0; VENGLARIK CJ, 1990, AM J PHYSIOL, V259, pC358; WEYMER A, 1985, J CLIN INVEST, V76, P1828, DOI 10.1172/JCI112175; Yenush L, 1997, BIOESSAYS, V19, P491, DOI 10.1002/bies.950190608	43	137	144	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11017	11024		10.1074/jbc.273.18.11017	http://dx.doi.org/10.1074/jbc.273.18.11017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556583	hybrid			2022-12-27	WOS:000073395200035
J	Rhee, KY; Senear, DF; Hatfield, GW				Rhee, KY; Senear, DF; Hatfield, GW			Activation of gene expression by a ligand-induced conformational change of a protein-DNA complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; TRANSCRIPTIONAL REGULATORS; RNA-POLYMERASE; LYSR FAMILY; BINDING; PROMOTERS; REPRESSOR; ILVY; SEQUENCE; REGIONS	IlvY protein binds cooperatively to tandem operator sites in the divergent, overlapping, promoter-regulatory region of the ilvYC operon of Escherichia coli, IlvY positively regulates the expression of the ilvC gene in an inducer-dependent manner and negatively regulates the transcription of its own divergently transcribed structural gene in an inducer-independent manner. Although binding of IlvY protein to the tandem operators is sufficient to repress ilvY promoter-specific transcription, it is not sufficient to activate transcription from the ilvC promoter. Activation of ilvC promoter-specific transcription requires the additional binding of a small molecule inducer to the IlvY protein-DNA complex. The binding of inducer to IlvY protein does not affect the affinity of IlvY protein for the tandem operator sites. It does, however, cause a conformational change of the IlvY protein-DNA complex, which is correlated with the partial relief of an IlvY protein-induced bend of the DNA helix in the ilvC promoter region, This structural change in the IlvY protein-DNA complex results in a 100-fold increase in the affinity of RNA polymerase binding at the ilvC promoter site. The ability of a protein to regulate gene expression by ligand-responsive modulation of a protein-DNA structure is an emerging theme in gene regulation.	Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biochem & Mol Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Hatfield, GW (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.							ANSARI AZ, 1995, NATURE, V374, P371; ARFIN SM, 1969, BIOCHEM BIOPH RES CO, V37, P902, DOI 10.1016/0006-291X(69)90216-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GILBERT W, 1976, RNA POLYMERASE; GOODRICH J, 1992, THESIS CARNEGIE MELL; HAUSER CA, 1985, J BIOL CHEM, V260, P1765; HAWLEY DK, 1982, PROMOTERS; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; Hildebrand F. B., 1974, INTRO NUMERICAL ANAL; HRYNIEWICZ MM, 1994, J BACTERIOL, V176, P3673, DOI 10.1128/JB.176.12.3673-3682.1994; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; KIM J, 1989, GENE, V85, P5; Maniatis T., 1982, MOL CLONING LAB MANU; Parekh BS, 1996, P NATL ACAD SCI USA, V93, P1173, DOI 10.1073/pnas.93.3.1173; PARSEK MR, 1995, MOL MICROBIOL, V15, P819, DOI 10.1111/j.1365-2958.1995.tb02352.x; RATZKIN B, 1972, J BACTERIOL, V112, P131, DOI 10.1128/JB.112.1.131-141.1972; Sambrook J., 2002, MOL CLONING LAB MANU; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; Umbarger HE, 1987, ESCHERICHIA COLI SAL, P352; VIALE AM, 1991, J BACTERIOL, V173, P5224, DOI 10.1128/jb.173.16.5224-5229.1991; WANG L, 1992, CELL, V69, P659, DOI 10.1016/0092-8674(92)90229-6; WATSON MD, 1979, J BACTERIOL, V139, P1014, DOI 10.1128/JB.139.3.1014-1020.1979; WEK RC, 1986, J BIOL CHEM, V261, P2441; WEK RC, 1986, NUCLEIC ACIDS RES, V14, P2763, DOI 10.1093/nar/14.6.2763; WEK RC, 1988, J MOL BIOL, V203, P643, DOI 10.1016/0022-2836(88)90199-4; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	32	33	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11257	11266		10.1074/jbc.273.18.11257	http://dx.doi.org/10.1074/jbc.273.18.11257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556617	hybrid			2022-12-27	WOS:000073395200069
J	de Vet, ECJM; Ijlst, L; Oostheim, W; Wanders, RJA; van den Bosch, H				de Vet, ECJM; Ijlst, L; Oostheim, W; Wanders, RJA; van den Bosch, H			Alkyl-dihydroxyacetonephosphate synthase - Fate in peroxisome biogenesis disorders and identification of the point mutation underlying a single enzyme deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZELLWEGER SYNDROME; ACYLTRANSFERASE DEFICIENCY; INSITU HYBRIDIZATION; PHOSPHATE SYNTHASE; BETA-OXIDATION; FIBROBLASTS; PROTEIN; ACCUMULATION; PHENOTYPE; THIOLASE	Peroxisomes play an indispensible role in ether lipid biosynthesis as evidenced by the deficiency of ether phospholipids in fibroblasts and tissues from patients suffering from a number of peroxisomal disorders. Alkyl-dihydroxyacetonephosphate synthase, a peroxisomal enzyme playing a key role in the biosynthesis of ether phospholipids, contains the peroxisomal targeting signal type 2 in a N-terminal cleavable presequence. Using a polyclonal antiserum raised against alkyl-dihydroxyacetonephosphate synthase, levels of this enzyme were examined in fibroblast cell lines from patients affected by peroxisomal disorders. Strongly reduced levels were found in fibroblasts of Zellweger syndrome and rhizomelic chondrodysplasia punctata patients, indicating that the enzyme is not stable in the cytoplasm as a result of defective import into peroxisomes, In a neonatal adrenoleukodystrophy patient with an isolated import deficiency of proteins carrying the peroxisomal targeting signal type 1, the precursor form of alkyl-dihydroxyacetonephosphate synthase was detected at a level comparable to that of the mature form in control fibroblasts, in line with an intraperoxisomal localization. A patient with an isolated deficiency in alkyl-dihydroxyacetonephosphate (DHAP) synthase activity had normal levels of this protein. Analysis at the cDNA level revealed a missense mutation leading to a R419H substitution in the enzyme of this patient. Expression of a recombinant protein carrying this mutation in Escherichia coli yielded an inactive enzyme, whereas a comparable control recombinant enzyme was active, providing further proof that this substitution is responsible for the inactivity of the enzyme and the phenotype. In line with this result is the observation that wild-type alkyl-DHAP synthase activity can be inactivated by the arginine-modifying agent phenylglyoxal, The enzyme is efficiently protected against this inactivation when the substrate palmitoyl-DHAP is present at a saturating concentration. The gene encoding human alkyl-dihydroxyacetonephosphate synthase was mapped on chromosome 2q31.	Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Dept Biochem Lipids, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; Univ Hosp Amsterdam, Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands	Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	van den Bosch, H (corresponding author), Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Dept Biochem Lipids, Inst Biomembranes, Padualaan 8, NL-3584 CH Utrecht, Netherlands.							AUTHIER F, 1995, P NATL ACAD SCI USA, V92, P3859, DOI 10.1073/pnas.92.9.3859; BARR DGD, 1993, ARCH DIS CHILD, V68, P415, DOI 10.1136/adc.68.3.415; BOWEN P, 1964, B JOHNS HOPKINS HOSP, V114, P402; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BROWN FR, 1982, JOHNS HOPKINS MED J, V151, P344; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAYTON PT, 1994, J INHERIT METAB DIS, V17, P533, DOI 10.1007/BF00711587; COTTON FA, 1973, J AM CHEM SOC, V95, P2367, DOI 10.1021/ja00788a047; DeVet ECJM, 1997, EUR J BIOCHEM, V247, P511; deVet ECJM, 1997, BBA-LIPID LIPID MET, V1346, P25, DOI 10.1016/S0005-2760(97)00014-3; deVet ECJM, 1997, J BIOL CHEM, V272, P798, DOI 10.1074/jbc.272.2.798; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62; HARDEMAN D, 1991, BIOCHIM BIOPHYS ACTA, V1081, P285, DOI 10.1016/0005-2760(91)90284-O; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; HEYMANS HSA, 1983, NATURE, V306, P69, DOI 10.1038/306069a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; RIORDAN JF, 1977, SCIENCE, V195, P884, DOI 10.1126/science.190679; SCHRAKAMP G, 1985, J LIPID RES, V26, P867; SCHRAKAMP G, 1990, LIFE SCI ADV, V9, P1; SCHRAM AW, 1986, P NATL ACAD SCI USA, V83, P6156, DOI 10.1073/pnas.83.16.6156; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; Wanders R. J. A., 1996, INT PEDIAT, V11, P203; WANDERS RJA, 1987, J CLIN INVEST, V80, P1778, DOI 10.1172/JCI113271; WANDERS RJA, 1995, J NEUROPATH EXP NEUR, V54, P726, DOI 10.1097/00005072-199509000-00016; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; WANDERS RJA, 1994, J INHERIT METAB DIS, V17, P315, DOI 10.1007/BF00711817; ZOMER AWM, 1993, BIOCHIM BIOPHYS ACTA, V1170, P189, DOI 10.1016/0005-2760(93)90070-P	36	85	87	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10296	10301		10.1074/jbc.273.17.10296	http://dx.doi.org/10.1074/jbc.273.17.10296			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553082	hybrid			2022-12-27	WOS:000073224200031
J	Emsley, J; Cruz, M; Handin, R; Liddington, R				Emsley, J; Cruz, M; Handin, R; Liddington, R			Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-SCANNING MUTAGENESIS; ADHESION MOLECULE-1 ICAM-1; VONWILLEBRAND-FACTOR; ACID-RESIDUES; INTEGRIN; PROTEIN; RISTOCETIN; SITE; IDENTIFICATION; ACTIVATION	von Willebrand Factor (vWF) is a multimeric protein that mediates platelet adhesion to exposed subendothelium at sites of vascular injury under conditions of high flow/shear. The Al domain of vWF (vWF-A1) forms the principal binding site for platelet glycoprotein Ib (GpIb), an interaction that is tightly regulated. We report here the crystal structure of the vWF-A1 domain at 2.3-Angstrom resolution. As expected, the overall fold is similar to that of the vWF-A3 and integrin I domains. However, the structure also contains N- and C-terminal arms that wrap across the lower surface of the domain. Unlike the integrin I domains, vWF-A1 does not contain a metal ion-dependent adhesion site motif. Analysis of the available mutagenesis data suggests that the activator botrocetin binds to the right-hand face of the domain containing helices alpha 5 and alpha 6. Possible binding sites for GpIb are the front and upper surfaces of the domain. Natural mutations that lead to constitutive GpIb binding (von Willebrand type IIb disease) cluster in a different site, at the interface between the lower surface and the terminal arms, suggesting that they disrupt a regulatory region rather than forming part of the primary GpIb binding site. A possible pathway for propagating structural changes from the regulatory region to the ligand-binding surface is discussed.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Brigham & Womens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	University of Leicester; Harvard University; Brigham & Women's Hospital	Liddington, R (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.		Emsley, Jonas/A-8509-2016	Emsley, Jonas/0000-0002-8949-8030	NHLBI NIH HHS [R01 HL54876] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054876] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bienkowska J, 1997, J BIOL CHEM, V272, P25162, DOI 10.1074/jbc.272.40.25162; BRUNGER AT, 1992, X PLOR MANUAL VERSIO; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; EDWARDS CP, 1995, J BIOL CHEM, V270, P12635, DOI 10.1074/jbc.270.21.12635; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Hoylaerts MF, 1997, BIOCHEM J, V324, P185, DOI 10.1042/bj3240185; Huizinga EG, 1997, STRUCTURE, V5, P1147, DOI 10.1016/S0969-2126(97)00266-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMATA T, 1995, J BIOL CHEM, V270, P12531, DOI 10.1074/jbc.270.21.12531; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kroner PA, 1996, BIOCHEMISTRY-US, V35, P13460, DOI 10.1021/bi9610313; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; MAY ACW, 1994, PROTEIN ENG, V7, P475, DOI 10.1093/protein/7.4.475; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P59; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; RABINOWITZ I, 1992, P NATL ACAD SCI USA, V89, P9846, DOI 10.1073/pnas.89.20.9846; Rieu P, 1996, J BIOL CHEM, V271, P15858, DOI 10.1074/jbc.271.27.15858; Ruggeri ZM, 1997, J CLIN INVEST, V99, P559, DOI 10.1172/JCI119195; SADLER JE, 1995, THROMB HAEMOSTASIS, V74, P161; SCOTT JP, 1991, J BIOL CHEM, V266, P8149; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Siguret V, 1996, THROMB HAEMOSTASIS, V76, P453; SIXMA JJ, 1991, EUR J BIOCHEM, V196, P369, DOI 10.1111/j.1432-1033.1991.tb15826.x; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Zhang L, 1996, J BIOL CHEM, V271, P29953, DOI 10.1074/jbc.271.47.29953	34	225	243	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10396	10401		10.1074/jbc.273.17.10396	http://dx.doi.org/10.1074/jbc.273.17.10396			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553097	hybrid			2022-12-27	WOS:000073224200046
J	Feng, X; Zhang, J; Barak, LS; Meyer, T; Caron, MG; Hannun, YA				Feng, X; Zhang, J; Barak, LS; Meyer, T; Caron, MG; Hannun, YA			Visualization of dynamic trafficking of a protein kinase C beta II green fluorescent protein conjugate reveals differences in G protein-coupled receptor activation and desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-II; SIGNAL-TRANSDUCTION; DICTYOSTELIUM CELLS; PHOSPHOLIPASE-C; PHOSPHORYLATION; LOCALIZATION; ISOENZYMES; ISOZYME; ALPHA	Protein kinase C (PKC) links various extracellular signals to intracellular responses and is activated by diverse intracellular factors including diacylglycerol, Ca2+, and arachidonic acid, In this study, using a fully functional green fluorescent protein conjugated PRC beta II (GFP-PKC beta II), we demonstrate a novel approach to study the dynamic redistribution of PRC in live cells in response to G protein-coupled receptor activation. Agonist-induced PKC translocation was rapid, transient, and selectively mediated by the activation of Gq alpha-but not G(s) beta-or G(i) beta-coupled receptors, Interestingly, although the stimuli were continuously present, only one brief peak of PHC membrane translocation was observed, consistent with rapid desensitization of the signaling pathway. Moreover, when GFP-PKC beta II was used to examine cross-talk between two alpha-coupled receptors, angiotensin II type 1A receptor (AT(1A)R) and endothelin A receptor (ETAR), activation of ET(A)Rs resulted in a subsequent loss of AT(1A)R responsiveness, whereas stimulation of AT(1A)Rs did not cause desensitization of the ETAR signaling. The development of GFP-PKC beta II has allowed not only the real time visualization of the dynamic PRC trafficking in live cells in response to physiological stimuli but has also provided a direct and sensitive means in the assessment of activation and desensitization of receptors implicated in the phospholipase C signaling pathway.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem, 171 Ashley Ave, Charleston, SC 29425 USA.			Meyer, Tobias/0000-0003-4339-3804	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043707] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-43707] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Blobe GC, 1996, CANCER SURV, V27, P213; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Diviani D, 1997, J BIOL CHEM, V272, P28712, DOI 10.1074/jbc.272.45.28712; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; GRAYD EF, 1997, AM J PHYSIOL, V273, pC586; Greene NM, 1997, J BIOL CHEM, V272, P10341; JAKEN S, 1997, PROTEIN KINASE C, P179; KAETHER C, 1995, FEBS LETT, V369, P267, DOI 10.1016/0014-5793(95)00765-2; KAI H, 1994, HYPERTENSION, V24, P523, DOI 10.1161/01.HYP.24.4.523; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KILEY SC, 1995, J CELL SCI, V108, P1003; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; Mikoshiba K, 1997, CURR OPIN NEUROBIOL, V7, P339, DOI 10.1016/S0959-4388(97)80061-X; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Moores SL, 1996, P NATL ACAD SCI USA, V93, P443, DOI 10.1073/pnas.93.1.443; NarayFejesToth A, 1996, J BIOL CHEM, V271, P15436, DOI 10.1074/jbc.271.26.15436; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WATSON S, 1994, G PROTEIN LINKED REC, P296; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; Widmann C, 1996, J BIOL CHEM, V271, P19957, DOI 10.1074/jbc.271.33.19957; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; YUAN NY, 1994, J BIOL CHEM, V269, P23032; Zhang M, 1996, HYPERTENSION, V27, P269, DOI 10.1161/01.HYP.27.2.269	38	95	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10755	10762		10.1074/jbc.273.17.10755	http://dx.doi.org/10.1074/jbc.273.17.10755			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553141	hybrid			2022-12-27	WOS:000073224200090
J	Furukawa, M; Uchiumi, T; Nomoto, M; Takano, H; Morimoto, RI; Naito, S; Kuwano, M; Kohno, K				Furukawa, M; Uchiumi, T; Nomoto, M; Takano, H; Morimoto, RI; Naito, S; Kuwano, M; Kohno, K			The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase II alpha gene by heat shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; ADENOVIRUS E1A-INDUCED APOPTOSIS; MULTIDRUG RESISTANCE-1 GENE; ACID BINDING-PROTEINS; ENHANCED EXPRESSION; ESCHERICHIA-COLI; HUMAN HSP70; MDR1 GENE; KB CELLS; S-PHASE	Expression of the DNA topoisomerase II alpha (topoII alpha) gene is highly sensitive to various environmental stimuli including heat shock. The amount of topoII alpha mRNA was increased 1.5-3-fold 6-24 h after exposure of T24 human urinary bladder cancer cells to heat shock stress at 43 degrees C for 1 h. The effect of heat shock on the transcriptional activity of the human topoII alpha gene promoter was investigated by transient transfection of T24 cells with luciferase reporter plasmids containing various lengths of the promoter sequence. The transcriptional activity of the full-length promoter (nucleotides (nt) -295 to +85) and of three deletion constructs (nt -197 to +85, -154 to +85, and -74 to +85) was increased similar to 3-fold 24 h after heat shock stress. In contrast, the transcriptional activity of the minimal promoter (nt -20 to +85), which lacks the first inverted CCAAT element (ICE1), the GC box, and the heat shock element located between nt -74 and -21, was not increased by heat shock. Furthermore, the transcriptional activity of promoter constructs containing mutations in the GC box or heat shock element, but not that of a construct containing mutations in ICE1, was significantly increased by heat shock. Electrophoretic mobility shift assays revealed reduced binding of a nuclear factor to an oligonucleotide containing ICE1 when nuclear extracts were derived from cells cultured for 3-24 h after heat shock. No such change in factor binding was apparent with an oligonucleotide containing the heat shock element of the topoII alpha gene promoter. Finally, in vivo footprint analysis of the topoII alpha gene promoter revealed that two G residues of ICE1 that were protected in control cells became sensitive to dimethyl sulfate modification after heat shock. These results suggest that transcriptional activation of the topoII alpha gene by heat shock requires the release of a negative regulatory factor from ICE1.	Kyushu Univ, Sch Med, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; Kyushu Univ, Sch Med, Dept Urol, Higashi Ku, Fukuoka 8128582, Japan; Univ Occupat & Environm Hlth, Sch Med, Dept Biol Mol, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Kyushu University; Kyushu University; University of Occupational & Environmental Health - Japan; Northwestern University	Furukawa, M (corresponding author), Kyushu Univ, Sch Med, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan.							ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; ASAKUNO K, 1994, BIOCHEM BIOPH RES CO, V199, P1428, DOI 10.1006/bbrc.1994.1390; BECK J, 1994, CANCER LETT, V86, P135, DOI 10.1016/0304-3835(94)90190-2; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Brandt TL, 1997, J BIOL CHEM, V272, P6278, DOI 10.1074/jbc.272.10.6278; BROWN PO, 1979, P NATL ACAD SCI USA, V76, P6110, DOI 10.1073/pnas.76.12.6110; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; FRASER DJ, 1995, MOL PHARMACOL, V47, P696; GELLERT M, 1981, ANNU REV BIOCHEM, V50, P879, DOI 10.1146/annurev.bi.50.070181.004311; GOLDSMITH ME, 1993, J BIOL CHEM, V268, P5856; Goswami PC, 1996, MOL CELL BIOL, V16, P1500; GRANT CE, 1993, MOL CELL BIOL, V13, P4186, DOI 10.1128/MCB.13.7.4186; HIROHASHI Y, 1995, JPN J CANCER RES, V86, P1097, DOI 10.1111/j.1349-7006.1995.tb03026.x; HOCHHAUSER D, 1992, J BIOL CHEM, V267, P18961; Isaacs RJ, 1996, J BIOL CHEM, V271, P16741, DOI 10.1074/jbc.271.28.16741; ITO K, 1994, NUCLEIC ACIDS RES, V22, P2036, DOI 10.1093/nar/22.11.2036; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; KOHNO K, 1994, J BIOL CHEM, V269, P20503; KONISHI T, 1995, J BIOCHEM-TOKYO, V118, P1021, DOI 10.1093/jb/118.5.1021; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; KUBO T, 1995, CANCER RES, V55, P3860; LADOMERY M, 1995, BIOESSAYS, V17, P9, DOI 10.1002/bies.950170104; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P6848, DOI 10.1073/pnas.86.18.6848; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Makino Y, 1996, NUCLEIC ACIDS RES, V24, P1873, DOI 10.1093/nar/24.10.1873; MATSUO K, 1990, CANCER RES, V50, P5819; MATSUO K, 1993, CANCER RES, V53, P1085; MILARSKI KL, 1986, P NATL ACAD SCI USA, V83, P9517, DOI 10.1073/pnas.83.24.9517; MIYAZAKI M, 1992, BIOCHEM BIOPH RES CO, V187, P677, DOI 10.1016/0006-291X(92)91248-O; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; NAKAI A, 1995, MOL CELL BIOL, V15, P5268; Nakajima T, 1996, J BIOL CHEM, V271, P24842, DOI 10.1074/jbc.271.40.24842; NAKAJIMA T, 1995, ONCOGENE, V10, P651; Ohga T, 1996, CANCER RES, V56, P4224; Okimoto T, 1996, ONCOGENE, V12, P1625; PEARSON BE, 1991, MOL CELL BIOL, V11, P2081, DOI 10.1128/MCB.11.4.2081; SAKURA H, 1988, GENE, V73, P499; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; TAKANO H, 1991, CANCER RES, V51, P3951; TAKANO H, 1992, ANTI-CANCER DRUG, V3, P323, DOI 10.1097/00001813-199208000-00002; TING JPY, 1994, J EXP MED, V179, P1605, DOI 10.1084/jem.179.5.1605; TRAVALI S, 1989, J BIOL CHEM, V264, P7466; UCHIUMI T, 1993, CELL GROWTH DIFFER, V4, P147; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang QJ, 1997, MOL CELL BIOL, V17, P389, DOI 10.1128/MCB.17.1.389; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; WOLFFE AP, 1992, NEW BIOL, V4, P290; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; Yun J, 1995, ONCOL RES, V7, P583	55	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10550	10555		10.1074/jbc.273.17.10550	http://dx.doi.org/10.1074/jbc.273.17.10550			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553115	hybrid			2022-12-27	WOS:000073224200064
J	Gotte, M; Maier, G; Gross, HJ; Heumann, H				Gotte, M; Maier, G; Gross, HJ; Heumann, H			Localization of the active site of HIV-1 reverse transcriptase-associated RNase H domain on a DNA template using site-specific generated hydroxyl radicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RIBONUCLEASE-H; AVIAN-MYELOBLASTOSIS; PEROXONITROUS ACID; FOOTPRINT ANALYSIS; CRYSTAL-STRUCTURE; TYPE-1; POLYMERASE; MECHANISM; COMPLEXES	Reverse transcriptase (RT)-associated ribonuclease H (RNase H) can cleave both the RNA template of DNA/RNA hybrids as well as double-stranded (ds) RNA. This report shows that human immunodeficiency virus (HIV)-RT can also cleave the template strand of dsDNA when Mg2+ is replaced by Fe2+ in the RNase H active site of HIV-RT. The cleavage mechanisms as well as the positions of the cut vary depending on whether RNA or DNA is used. While DNA is cleaved 17 base positions upstream of the primer 3'-end, RNA is cleaved 18 base positions upstream, Competition experiments show that Fe2+ replaces the catalytically active Mg2+ of RT-associated RNase H, The bound Fe2+ is the source of locally generated OH-radicals that cleave the most proximate base in the DNA. Electrophoretic mobility studies of the cleaved fragments suggest that DNA is cleaved by an oxidative mechanism, while RNA is cleaved by an enzymatic mechanism which is indistinguishable from the Mg2+-dependent cleavage. The Fe2+-dependent cuts can be used to trace the active site of RT-associated RNase H on dsDNA as well as on dsRNA and DNA/RNA hybrids. The observed 1 base difference in the cleavage positions on DNA and RNA templates can be attributed to conformational differences of the bound nucleic acids. We suggest that the lower pitch of dsRNA and DNA/RNA hybrids compared with dsDNA permits accommodation of an additional base pair in the region between the primer 3'-end and the Fe2+-dependent cleavage position at the RNase H active site.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Bayer Julius Maximillian Univ, Inst Biochem, Biozentrum, D-97074 Wurzburg, Germany	Max Planck Society; University of Wurzburg	Heumann, H (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.							BENARTZI H, 1992, P NATL ACAD SCI USA, V89, P927, DOI 10.1073/pnas.89.3.927; BRUCE AG, 1978, NUCLEIC ACIDS RES, V5, P3665, DOI 10.1093/nar/5.10.3665; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P7423; DESTEFANO JJ, 1994, NUCLEIC ACIDS RES, V22, P3793, DOI 10.1093/nar/22.18.3793; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P24295; ETTNER N, 1995, BIOCHEMISTRY-US, V34, P22, DOI 10.1021/bi00001a004; Fedoroff OY, 1997, J MOL BIOL, V269, P225, DOI 10.1006/jmbi.1997.1024; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; FURFINE ES, 1991, J BIOL CHEM, V266, P406; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Gotte M, 1996, FEBS LETT, V390, P226, DOI 10.1016/0014-5793(96)00662-X; HOSTOMSKY Z, 1994, J VIROL, V68, P1970, DOI 10.1128/JVI.68.3.1970-1971.1994; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; KATI WM, 1992, J BIOL CHEM, V267, P25988; KING PA, 1993, NUCLEIC ACIDS RES, V21, P2473, DOI 10.1093/nar/21.10.2473; KING PA, 1992, J AM CHEM SOC, V114, P5430, DOI 10.1021/ja00039a068; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; LITVAK S, 1994, TRENDS BIOCHEM SCI, V19, P114, DOI 10.1016/0968-0004(94)90203-8; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; POGOZELSKI WK, 1995, J AM CHEM SOC, V117, P6428, DOI 10.1021/ja00129a002; RABA M, 1979, EUR J BIOCHEM, V97, P305, DOI 10.1111/j.1432-1033.1979.tb13115.x; SAENGER W, 1983, PRINCIPLES NUCLEIC A, P220; SCHATZ O, 1990, EMBO J, V9, P1171, DOI 10.1002/j.1460-2075.1990.tb08224.x; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; SHALKA AM, 1993, REVERSE TRANSCRIPTAS; SIGMAN DS, 1990, BIOCHEMISTRY-US, V29, P9097, DOI 10.1021/bi00491a001; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; WOHRL BM, 1990, BIOCHEMISTRY-US, V29, P10141, DOI 10.1021/bi00496a001; WOHRL BM, 1995, SCIENCE, V267, P96, DOI 10.1126/science.7528942; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107	38	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10139	10146		10.1074/jbc.273.17.10139	http://dx.doi.org/10.1074/jbc.273.17.10139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553061	hybrid			2022-12-27	WOS:000073224200010
J	Oh, ES; Woods, A; Lim, ST; Theibert, AW; Couchman, JR				Oh, ES; Woods, A; Lim, ST; Theibert, AW; Couchman, JR			Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION FORMATION; 4-PHOSPHATE 5-KINASE; ACTIVATION; BINDING; FIBRONECTIN; RHO; MEMBRANE; PHOSPHORYLATION; FIBROBLASTS; PROFILIN	Phosphatidylinositol 4,5-bisphosphate (PIP2) is involved in the organization of the actin cytoskeleton by regulating actin-associated proteins. The transmembrane heparan sulfate proteoglycan syndecan-4 also plays a critical role in protein kinase C (PKC) signaling in the formation of focal adhesions and actin stress fibers, The cytoplasmic domain of syndecan-4 core protein directly interacts with and potentiates PKC alpha activity, and it can directly interact with the phosphoinositide PIP2. We, therefore, investigated whether the interaction of inositol phosphates and inositol phospholipids with syndecan-4 could regulate PKC activity. Data from in vitro kinase assays using purified PKC alpha beta gamma show that in the absence of phosphatidylserine and diolein, PIP2 increased the extent of autophosphorylation of PKC alpha beta gamma and partially activated it to phosphorylate both histone III-S and an epidermal growth factor receptor peptide. This activity was dose-dependent, and its calcium dependence varied with PKC isotype/source. Addition of the cytoplasmic syndecan-4 peptide, but not equivalent syndecan-1 or syndecan-2 peptides, potentiated the partial activation of PKC alpha beta gamma by PIP2, resulting in activity greater than that observed with phosphatidylserine, diolein, and calcium. This study indicates that syndecan-4 cytoplasmic domain may bind both PIP2 and PKC alpha, localize them to forming focal adhesions, and potentiate PKC alpha activity there.	Univ Alabama, Dept Cell Biol, Cell Adhes & Matrix Res Ctr, Birmingham, AL 35294 USA; Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Couchman, JR (corresponding author), Univ Alabama, Dept Cell Biol, Cell Adhes & Matrix Res Ctr, VH 201C,Univ Blvd, Birmingham, AL 35294 USA.			Lim, Steve/0000-0003-0323-8607	NICHD NIH HHS [HD32901] Funding Source: Medline; NIGMS NIH HHS [GM50194] Funding Source: Medline; NIMH NIH HHS [MH50102] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD032901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050102, R01MH050102] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; BANYARD MRC, 1985, BRIT J CANCER, V51, P761, DOI 10.1038/bjc.1985.119; BELL RM, 1991, J BIOL CHEM, V266, P4661; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; CHAUHAN A, 1991, ARCH BIOCHEM BIOPHYS, V287, P283, DOI 10.1016/0003-9861(91)90480-7; CHAUHAN A, 1991, BIOCHEMISTRY-US, V28, P4952; CHAUHAN VPS, 1990, FEBS LETT, V272, P99, DOI 10.1016/0014-5793(90)80457-T; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; CHUN JS, 1993, MOL BIOL CELL, V4, P271; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; HARLAN JE, 1995, BIOCHEMISTRY-US, V34, P9859, DOI 10.1021/bi00031a006; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HERBERT JM, 1993, BIOCHEM PHARMACOL, V45, P527, DOI 10.1016/0006-2952(93)90123-E; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; HYATT SL, 1990, MOL CARCINOGEN, V3, P45, DOI 10.1002/mc.2940030202; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; JANMEY PA, 1995, CHEM BIOL, V2, P61, DOI 10.1016/1074-5521(95)90276-7; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; LEE MH, 1991, BIOCHEMISTRY-US, V30, P1041, DOI 10.1021/bi00218a023; Lewis JM, 1996, J CELL BIOL, V134, P1323, DOI 10.1083/jcb.134.5.1323; Machesky Laura M., 1993, Trends in Cell Biology, V3, P381, DOI 10.1016/0962-8924(93)90087-H; MACHESKY LM, 1990, CELL REGUL, V1, P937, DOI 10.1091/mbc.1.12.937; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; PALMER RH, 1995, J BIOL CHEM, V270, P22412, DOI 10.1074/jbc.270.38.22412; PAP EHW, 1993, BIOCHEMISTRY-US, V32, P13310, DOI 10.1021/bi00211a044; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; SCHWARTZ M A, 1992, Trends in Cell Biology, V2, P304, DOI 10.1016/0962-8924(92)90120-C; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SCHWARTZ MA, 1993, J CELL BIOL, V120, P1003, DOI 10.1083/jcb.120.4.1003; Shepherd PR, 1996, TRENDS CELL BIOL, V6, P92, DOI 10.1016/0962-8924(96)80998-6; SOHN RH, 1995, J BIOL CHEM, V270, P21114, DOI 10.1074/jbc.270.36.21114; SOMERS CE, 1993, J BIOL CHEM, V268, P22277; TAKAHASHI Y, 1992, J GERONTOL, V47, P65; TOKER A, 1994, J BIOL CHEM, V269, P32358; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; VUORI K, 1993, J BIOL CHEM, V268, P21459; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; WOODS A, 1992, ADV EXP MED BIOL, V313, P87; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; WOODS A, 1992, J CELL SCI, V101, P277; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; ZHANG J, 1993, J BIOL CHEM, V268, P22251	54	162	165	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10624	10629		10.1074/jbc.273.17.10624	http://dx.doi.org/10.1074/jbc.273.17.10624			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553124	hybrid			2022-12-27	WOS:000073224200073
J	Shriver, Z; Hu, Y; Sasisekharan, R				Shriver, Z; Hu, Y; Sasisekharan, R			Heparinase II from Flavobacterium heparinum - Role of histidine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; ESCHERICHIA-COLI; GLYCOSAMINOGLYCANS; PURIFICATION; EXPRESSION; CATALYSIS; YERSINIA; CYSTEINE	The three heparinases derived from Flavobacterium heparinum are powerful tools for studying heparin-like glycosaminoglycans in major biological processes, including angiogenesis and development. Heparinase II is unique among the three enzymes because it is able to catalytically cleave both heparin and heparan sulfate-like regions of heparin-like glycosaminoglycans. Toward understanding the catalytic mechanism of heparin-like glycosaminoglycan degradation by heparinase II, we set out to investigate the role of the histidines of heparinase II in catalysis. We observe concentration-dependent inactivation of heparinase II in the presence of the reversible histidine-modifying reagent diethylpyrocarbonate (DEPC). With heparin as the substrate, the rate constant of inactivation was found to be 0.16 min(-1) mM(-1); with heparan sulfate as the substrate, the rate constant was determined to be 0.24 min(-1) mM(-1). Heparinase II activity is restored following hydroxylamine treatment. This, along with other experiments, strongly suggests that the inactivation of heparinase II by DEPC is specific for histidine residues and that three histidines are modified by DEPC. Substrate protection experiments show that heparinase II preincubation with heparin followed by the addition of DEPC resulted in a loss of enzymatic activity toward heparan sulfate but not heparin, However, heparinase II preincubation with heparan sulfate was unable to protect heparinase II from DEPC inactivation for either of the substrates. Proteolytic mapping studies with Lys-C were consistent with the chemical modification experiments and identified histidines 238, 451, and 579 as being important for heparinase II activity. Further mapping studies identified histidine 451 as being essential for heparin degradation. Site-directed mutagenesis experiments on the 13 histidines of heparinase II corroborated the chemical modification and the peptide mapping studies, establishing the importance of histidines 238, 451 and 579 in heparinase II activity.	MIT, Whitaker Coll Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), MIT, Whitaker Coll Hlth Sci & Technol, 77 Massachusetts Ave,Bldg E18-568, Cambridge, MA 02139 USA.	ramnat@mit.edu						BERNSTEIN H, 1988, METHOD ENZYMOL, V137, P515; Binari RC, 1997, DEVELOPMENT, V124, P2623; CONRAD HE, 1989, ANN NY ACAD SCI, V556, P18; Cumberledge S, 1997, TRENDS GENET, V13, P421, DOI 10.1016/S0168-9525(97)01275-4; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Ernst S, 1996, BIOCHEM J, V315, P589, DOI 10.1042/bj3150589; Godavarti R, 1996, BIOCHEM BIOPH RES CO, V225, P751, DOI 10.1006/bbrc.1996.1246; Godavarti R, 1996, BIOCHEM BIOPH RES CO, V229, P770, DOI 10.1006/bbrc.1996.1879; Godavarti R, 1996, BIOCHEMISTRY-US, V35, P6846, DOI 10.1021/bi960356g; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; HASCALL VC, 1989, KERATAN SULPHATE CHE; Higuchi R., 1990, PCR PROTOCOLS GUIDE; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; LINHARDT RJ, 1992, ADV EXP MED BIOL, V313, P37; LINHARDT RJ, 1988, BIOCHEM J, V254, P781, DOI 10.1042/bj2540781; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; LUNDBLAD RL, 1995, TECHNIQUES PROTEIN M, P105; SASISEKHARAN R, 1994, P NATL ACAD SCI USA, V91, P1524, DOI 10.1073/pnas.91.4.1524; Sasisekharan R, 1996, J BIOL CHEM, V271, P3124, DOI 10.1074/jbc.271.6.3124; SASISEKHARAN R, 1995, BIOCHEMISTRY-US, V34, P14441, DOI 10.1021/bi00044a022; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	22	27	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10160	10167		10.1074/jbc.273.17.10160	http://dx.doi.org/10.1074/jbc.273.17.10160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553064	hybrid			2022-12-27	WOS:000073224200013
J	Chan, RYY; Adatia, FA; Krupa, AM; Jasmin, BJ				Chan, RYY; Adatia, FA; Krupa, AM; Jasmin, BJ			Increased expression of acetylcholinesterase T and R transcripts during hematopoietic differentiation is accompanied by parallel elevations in the levels of their respective molecular forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; IN-SITU HYBRIDIZATION; MESSENGER-RNA; GENE-EXPRESSION; MAMMALIAN ACETYLCHOLINESTERASE; DIMETHYL-SULFOXIDE; RAT-BRAIN; CELLS; CHOLINESTERASES; ENZYME	Differentiation of hematopoietic cells is known to be accompanied by profound changes in acetylcholinesterase (AChE) enzyme activity, yet the basic mechanisms underlying this developmental regulation remain unknown, We initiated a series of experiments to examine the molecular mechanisms involved in regulating AChE expression during hematopoiesis, Differentiation of murine erythroleukemia (MEL) cells using dimethyl sulfoxide resulted in a 5- and 10-fold increase in intracellular and secreted AChE enzyme activity, respectively, Interestingly, these increases resulted from a preferential induction of the globular molecular form G(1) and a slight increase in G(4) instead of an increase in the levels of the G(2) membrane-bound form, a molecular form expressed in mature erythrocytes, Concomitantly, expression of the two predominant AChE transcripts (R and T, for read-through and tail, respectively) in MEL cells was induced to a similar extent with differentiation. Nuclear run-on assays performed with nuclei isolated from induced versus uninduced MEL cells revealed that in contrast to the large increases seen in the transcription of the beta-globin gene, the transcriptional activity of the AChE gene remained largely unaffected after differentiation. Determination of the half-lives of the R and T transcripts demonstrated that they both exhibited an increase in stability in induced MEL cells. Taken together, results from these studies indicate that posttranscriptional regulatory mechanisms account for the increased expression of AChE in differentiated hematopoietic cells.	Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Merck & Co Inc, Merck Sharp & Dohme Res Labs, Dept Biochem & Mol Pathol, Rahway, NJ 07065 USA	Michigan State University; Merck & Company	Jasmin, BJ (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.							BENAZIZALOYA R, 1993, P NATL ACAD SCI USA, V90, P2471, DOI 10.1073/pnas.90.6.2471; BERNARD V, 1995, NEUROSCIENCE, V64, P995, DOI 10.1016/0306-4522(94)00497-S; BON S, 1979, P NATL ACAD SCI USA, V76, P2546, DOI 10.1073/pnas.76.6.2546; Chan R. Y. Y., 1995, Society for Neuroscience Abstracts, V21, P800; CHAN RYY, 1994, EUR J BIOCHEM, V220, P683, DOI 10.1111/j.1432-1033.1994.tb18669.x; Coleman BA, 1996, J BIOL CHEM, V271, P4410; CONSCIENCE JF, 1977, EXP CELL RES, V105, P401, DOI 10.1016/0014-4827(77)90137-9; EHRLICH G, 1992, GENOMICS, V13, P1192, DOI 10.1016/0888-7543(92)90037-S; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; FUENTES ME, 1993, NEURON, V10, P679, DOI 10.1016/0896-6273(93)90169-R; Greenberg ME, 1993, CONTROL MESSENGER RN, P199, DOI 10.1016/B978-0-08-091652-1.50013-X; HAMMOND P, 1994, P NATL ACAD SCI USA, V91, P10933, DOI 10.1073/pnas.91.23.10933; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; JASMIN BJ, 1990, J NEUROSCI, V10, P1444; KOEKEBAKKER M, 1988, AM J HEMATOL, V28, P252, DOI 10.1002/ajh.2830280408; LANDWEHRMEYER B, 1993, NEUROSCIENCE, V57, P615, DOI 10.1016/0306-4522(93)90010-D; LAYER PG, 1995, PROG HISTOCHEM CYTOC, V29, P1; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LevLehman E, 1997, BLOOD, V89, P3644, DOI 10.1182/blood.V89.10.3644.3644_3644_3653; LEVLEHMAN E, 1994, GENE THER, V1, P127; LI Y, 1993, J BIOL CHEM, V268, P5790; LI Y, 1991, J BIOL CHEM, V266, P23083; LUO ZG, 1994, J BIOL CHEM, V269, P27216; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; MORLEY P, 1993, J CELL PHYSIOL, V156, P219, DOI 10.1002/jcp.1041560202; OTT P, 1982, FEBS LETT, V138, P187, DOI 10.1016/0014-5793(82)80437-7; PAOLETTI F, 1992, BLOOD, V79, P2873; PAULUS JM, 1981, BLOOD, V58, P1100; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; SOREQ H, 1994, P NATL ACAD SCI USA, V91, P7907, DOI 10.1073/pnas.91.17.7907; SOREQ H, 1995, ENZYMES OF THE CHOLINESTERASE FAMILY, P1; Stephenson J, 1996, LEUKEMIA RES, V20, P235, DOI 10.1016/0145-2126(95)00146-8; SZELENYI JG, 1982, BRIT J HAEMATOL, V50, P241, DOI 10.1111/j.1365-2141.1982.tb01914.x; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433	38	54	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9727	9733		10.1074/jbc.273.16.9727	http://dx.doi.org/10.1074/jbc.273.16.9727			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545308	hybrid			2022-12-27	WOS:000073128800054
J	Deyrup, AT; Krishnan, S; Cockburn, BN; Schwartz, NB				Deyrup, AT; Krishnan, S; Cockburn, BN; Schwartz, NB			Deletion and site-directed mutagenesis of the ATP-binding motif (P-loop) in the bifunctional murine Atp-sulfurylase/adenosine 5 '-phosphosulfate kinase enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CHONDROSARCOMA; KINETIC MECHANISM; ESCHERICHIA-COLI; PROTEIN; MYOSIN; DOMAIN; IDENTIFICATION; MOTOR; GAMMA; FOLD	The P-loop is a common motif found in ATP- and GTP-binding proteins, The recently cloned murine ATP-sulfurylase/adenosine 5'-phosphosulfate (APS) kinase contains a P-loop (residues 59-66) in the APS kinase portion of the bifunctional protein. A series of enzymatic assays covering the multiplicity of functions of this unique protein (reverse ATP-sulfurylase, APS kinase, and an overall assay) were used to determine the effect of deleting or altering specific residues constituting this motif. In addition to the full-length cDNA construct (1MSK), two deletion mutants that progressively shortened the N terminus by 34 amino acids (2MSK) and 70 amino acids (3MSK) were designed to examine the effects of translation initiation before (2MSK) and after (3MSK) the P-loop, The 2MSK protein possessed sulfurylase and kinase activity equivalent to the full-length construct, but 3MSK exhibited no kinase activity and reduced sulfurylase activity. In light of the evident importance of this motif, a number of site-directed mutants were designed to investigate the contribution of key residues. Mutation of a highly conserved lysine in the P-loop to alanine (K65A) or arginine (K65R) or the following threonine (T66A) to alanine ablated APS kinase activity while leaving ATP-sulfurylase activity intact. Three mutations (G59A, G62A, and G64A) addressed the role of the conserved glycines as follows: G64A showed diminished APS kinase activity only, whereas G62A had no effect on either activity. G59A caused a significant decrease in ATP-sulfurylase activity without effect on APS kinase activity. A series of highly conserved flanking cysteines (Cys-53, Cys-77, and Cys-83) were mutated to alanine, but none of these mutations showed any effect on either enzyme activity.	Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Schwartz, NB (corresponding author), Univ Chicago, Dept Pediat, MC5058,5841 S Maryland Ave, Chicago, IL 60637 USA.	n-schwartz@uchicago.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD009402, R01HD017332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-09402, HD-17332] Funding Source: Medline; NIGMS NIH HHS [GM 07281] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DELEPELAIRE P, 1994, J BIOL CHEM, V269, P27952; Driscoll WJ, 1995, P NATL ACAD SCI USA, V92, P12328, DOI 10.1073/pnas.92.26.12328; Fisher A. J., 1995, Biophysical Journal, V68, P19; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; FOSTER BA, 1994, J BIOL CHEM, V269, P19777; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; GELLER DH, 1987, J BIOL CHEM, V262, P7374; GELLER DH, 1987, THESIS U CHICAGO; Higuchi R., 1989, PCR TECHNOLOGY, P61; KOMATSU K, 1994, BIOCHEM BIOPH RES CO, V204, P1178, DOI 10.1006/bbrc.1994.2587; LEYH TS, 1992, J BIOL CHEM, V267, P10405; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; LOGAN KM, 1993, J MOL BIOL, V232, P1048, DOI 10.1006/jmbi.1993.1459; LOWE PN, 1982, BIOORG CHEM, V11, P55, DOI 10.1016/0045-2068(82)90048-7; LYLE S, 1994, BIOCHEMISTRY-US, V33, P5920, DOI 10.1021/bi00185a032; LYLE S, 1994, BIOCHEM J, V301, P349, DOI 10.1042/bj3010349; LYLE S, 1994, BIOCHEMISTRY-US, V33, P6822, DOI 10.1021/bi00188a010; LYLE S, 1994, BIOCHEM J, V301, P355, DOI 10.1042/bj3010355; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; ROSENTHAL E, 1995, GENE, V165, P243, DOI 10.1016/0378-1119(95)00450-K; SAGE CR, 1995, BIOCHEMISTRY-US, V34, P7409, DOI 10.1021/bi00022a014; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SATISHCHANDRAN C, 1992, BIOCHEMISTRY-US, V31, P11684, DOI 10.1021/bi00162a003; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; STEPHENS KM, 1995, J BACTERIOL, V177, P27, DOI 10.1002/path.1711770106; SUNG YJ, 1995, BIOCHEMISTRY-US, V34, P3470, DOI 10.1021/bi00010a040; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Thomas PM, 1996, AM J HUM GENET, V59, P510; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	29	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9450	9456		10.1074/jbc.273.16.9450	http://dx.doi.org/10.1074/jbc.273.16.9450			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545271	hybrid			2022-12-27	WOS:000073128800017
J	Wellington, CL; Ellerby, LM; Hackam, AS; Margolis, RL; Trifiro, MA; Singaraja, R; McCutcheon, K; Salvesen, GS; Propp, SS; Bromm, M; Rowland, KJ; Zhang, TQ; Rasper, D; Roy, S; Thornberry, N; Pinsky, L; Kakizuka, A; Ross, CA; Nicholson, DW; Bredesen, DE; Hayden, MR				Wellington, CL; Ellerby, LM; Hackam, AS; Margolis, RL; Trifiro, MA; Singaraja, R; McCutcheon, K; Salvesen, GS; Propp, SS; Bromm, M; Rowland, KJ; Zhang, TQ; Rasper, D; Roy, S; Thornberry, N; Pinsky, L; Kakizuka, A; Ross, CA; Nicholson, DW; Bredesen, DE; Hayden, MR			Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; CAG REPEAT; CELL-DEATH; APOPTOSIS; PROTEASE; HUNTINGTIN; ACTIVATION; PHENOTYPE	The neurodegenerative diseases Huntington disease, dentatorubropallidoluysian atrophy, spinocerebellar atrophy type 3, and spinal bulbar muscular atrophy are caused by expansion of a polyglutamine tract within their respective gene products. There is increasing evidence that generation of truncated proteins containing an expanded polyglutamine tract may be a key step in the pathogenesis of these disorders. We now report that, similar to huntingtin, atrophin-1, ataxin-3, and the androgen receptor are cleaved in apoptotic extracts. Furthermore, each of these proteins is cleaved by one or more purified caspases, cysteine proteases involved in apoptotic death. The CAG length does not modulate susceptibility to cleavage of any of the full-length proteins. Our results suggest that by generation of truncated polyglutamine-containing proteins, caspase cleavage may represent a common step in the pathogenesis of each of these neurodegenerative diseases.	Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z4, Canada; Burnham Inst, Program Apoptosis & Cell Death, La Jolla, CA 92037 USA; Burnham Inst, Program Aging, La Jolla, CA 92037 USA; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Montreal, PQ, Canada; Merck Res Labs, Dept Enzymol, Rahway, NJ USA; Osaka Biosci Inst, Dept 4, Osaka, Japan; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	University of British Columbia; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; McGill University; Merck & Company; Merck & Company; Johns Hopkins University; Johns Hopkins University	Hayden, MR (corresponding author), Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V6T 1Z4, Canada.		Ross, Christopher A/H-8395-2013; Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867	NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH001275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012282] Funding Source: NIH RePORTER; NIA NIH HHS [AG12282] Funding Source: Medline; NIMH NIH HHS [MH01275-01A1] Funding Source: Medline; NINDS NIH HHS [NS34172] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREW SE, 1997, HUM MOL GENET, V6, P205; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Kakizuka A, 1997, CURR OPIN NEUROL, V10, P285, DOI 10.1097/00019052-199708000-00002; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Koshy BT, 1997, BRAIN PATHOL, V7, P927, DOI 10.1111/j.1750-3639.1997.tb00894.x; Loetscher H, 1997, J BIOL CHEM, V272, P20655, DOI 10.1074/jbc.272.33.20655; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margolis RL, 1996, MOL BRAIN RES, V36, P219, DOI 10.1016/0169-328X(95)00241-J; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MARTINDALE D, 1998, IN PRESS NAT GENET; Nance MA, 1997, BRAIN PATHOL, V7, P881, DOI 10.1111/j.1750-3639.1997.tb00892.x; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Porter AG, 1997, BIOESSAYS, V19, P501, DOI 10.1002/bies.950190609; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; Robitaille Y, 1997, BRAIN PATHOL, V7, P901, DOI 10.1111/j.1750-3639.1997.tb00893.x; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Ross CA, 1997, BRAIN PATHOL, V7, P1003, DOI 10.1111/j.1750-3639.1997.tb00898.x; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wellington CL, 1997, BRAIN PATHOL, V7, P979, DOI 10.1111/j.1750-3639.1997.tb00897.x; Wellington CL, 1997, CURR OPIN NEUROL, V10, P291, DOI 10.1097/00019052-199708000-00003; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	36	447	466	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9158	9167		10.1074/jbc.273.15.9158	http://dx.doi.org/10.1074/jbc.273.15.9158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535906	hybrid			2022-12-27	WOS:000072990800083
J	Kishida, S; Yamamoto, H; Ikeda, S; Kishida, M; Sakamoto, I; Koyama, S; Kikuchi, A				Kishida, S; Yamamoto, H; Ikeda, S; Kishida, M; Sakamoto, I; Koyama, S; Kikuchi, A			Communication - Axin, a negative regulator of the Wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; XENOPUS EMBRYOS; ASSOCIATION; RAS	The regulators of G protein signaling (RGS) domain of Axin, a negative regulator of the Wnt signaling pathway, made a complex with full-length adenomatous polyposis coli (APC) in COS, 293, and L cells but not with truncated APC in SW480 or DLD-1 cells. The RGS domain directly interacted with the region containing the 20-amino acid repeats but not with that containing the 15-amino acid repeats of APC, although both regions are known to bind to beta-catenin. In the region containing seven 20-amino acid repeats, the region containing the latter five repeats bound to the RGS domain of Axin. Axin and beta-catenin simultaneously interacted with APC. Furthermore, Axin stimulated the degradation of beta-catenin in COS cells. Taken together with our recent observations that Axin directly interacts with glycogen synthase kinase-3 beta (GSK-3 beta) and beta-catenin and that it promotes GSK-3 beta-dependent phosphorylation of beta-catenin, these results suggest that Axin, APC, GSK-3 beta, and beta-catenin make a tetrameric complex, resulting in the regulation of the stabilization of beta-catenin.	Hiroshima Univ, Sch Med, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University	Kikuchi, A (corresponding author), Hiroshima Univ, Sch Med, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.			kishida, shosei/0000-0003-0405-851X				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; GLUECKSOHNSCHOENHEIMER S, 1949, J EXP ZOOL, V110, P47, DOI 10.1002/jez.1401100105; Hinoi T, 1996, J BIOL CHEM, V271, P19710, DOI 10.1074/jbc.271.33.19710; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JACOBSCOHEN RJ, 1984, GENET RES, V43, P43, DOI 10.1017/S0016672300025702; Kikuchi A, 1996, J BIOL CHEM, V271, P588, DOI 10.1074/jbc.271.1.588; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Murai H, 1997, J BIOL CHEM, V272, P10483; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Reed SC, 1937, GENETICS, V22, P1; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	24	434	446	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10823	10826		10.1074/jbc.273.18.10823	http://dx.doi.org/10.1074/jbc.273.18.10823			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556553	hybrid			2022-12-27	WOS:000073395200005
J	Nordberg, J; Zhong, L; Holmgren, A; Arner, ESJ				Nordberg, J; Zhong, L; Holmgren, A; Arner, ESJ			Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART LIPOAMIDE DEHYDROGENASE; T-CELL LEUKEMIA; RIBONUCLEOTIDE REDUCTASE; GLUTATHIONE-REDUCTASE; DISULFIDE; NADPH; PURIFICATION; MECHANISM; GROWTH; OXYGEN	The immunostimulatory dinitrohalobenzene compound 1-chloro-2,4-dinitrobenzene (DNCB) irreversibly inhibits mammalian thioredoxin reductase (TrxR) in the presence of NADPH, inducing an NADPH oxidase activity in the modified enzyme (Arner, E. S. J., Bjornstedt, M., and Hohmgren, A. (1995) J. Biol. Chem. 270, 3479-3482). Here we have further analyzed the reactivity with the enzyme of DNCB and analogues with varying immunomodulatory properties. We have also identified the reactive residues in bovine thioredoxin reductase, recently discovered to be a selenoprotein. We found that 4-vinylpyridine competed with DNCB for inactivation of TrxR, with DNCB being about 10 times more efficient, and only alkylation with DNCB but not with 4-vinylpyridine induced an NADPH oxidase activity. A number of nonsensitizing DNCB analogues neither inactivated the enzyme nor induced any NADPH oxidase activity. The NADPH oxidase activity of TrxR induced by dinitrohalobenzenes generated superoxide, as detected by reaction with epinephrine (the adrenochrome method). Addition of superoxide dismutase quenched this reaction and also stimulated the NADPH oxidase activity. By peptide analysis using mass spectrometry and Edman degradation, both the cysteine and the selenocysteine in the conserved carboxyl-terminal sequence Gly-Cys-Sec-Gly (where Sec indicates selenocysteine) were determined to be dinitrophenyl-alkylated upon incubation of native TrxR with NADPH and DNCB. A model for the interaction between TrxR and dinitrohalobenzenes is proposed, involving a functional FAD in the alkylated TrxR generating an anion nitroradical in a dinitrophenyl group, which in turn reacts with oxygen to generate superoxide. Production of reactive oxygen species and inhibited reduction of thioredoxin by the modified thioredoxin reductase after reaction with dinitrohalobenzenes may play a major role in the inflammatory reactions provoked by these compounds.	Karolinska Inst, Med Nobel Inst Biochem 1, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet	Arner, ESJ (corresponding author), Karolinska Inst, Med Nobel Inst Biochem 1, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	elias.arner@mbb.ki.se	Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019	Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114				AHMED AR, 1983, ARCH DERMATOL, V119, P934, DOI 10.1001/archderm.119.11.934; [Anonymous], [No title captured]; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; BJORNSTEDT M, 1992, J BIOL CHEM, V267, P8030; CARLBERG I, 1986, J BIOL CHEM, V261, P1629; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; GASDASKA PY, 1995, FEBS LETT, V373, P5, DOI 10.1016/0014-5793(95)01003-W; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; HOLMGREN A, 1980, P NATL ACAD SCI-BIOL, V77, P5149, DOI 10.1073/pnas.77.9.5149; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HOLMGREN A, 1998, OXIDATIVE STRESS CAN, P229; HOPKINS N, 1995, BIOCHEMISTRY-US, V34, P11757, DOI 10.1021/bi00037a013; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; KURIYAN J, 1991, NATURE, V352, P172, DOI 10.1038/352172a0; LIU LF, 1993, BIOCHEM J, V296, P189, DOI 10.1042/bj2960189; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; MASON RP, 1975, BIOCHEM BIOPH RES CO, V67, P1267, DOI 10.1016/0006-291X(75)90163-1; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MAU BL, 1992, BIOCHEM PHARMACOL, V43, P1613, DOI 10.1016/0006-2952(92)90220-D; MAU BL, 1992, BIOCHEM PHARMACOL, V43, P1621; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MISRA HP, 1972, J BIOL CHEM, V247, P188; OBLONG JE, 1993, BIOCHEMISTRY-US, V32, P7271, DOI 10.1021/bi00079a025; PACKER L, 1995, METHOD ENZYMOL, V252, P199; POWIS G, 1995, PHARMACOL THERAPEUT, V68, P149, DOI 10.1016/0163-7258(95)02004-7; SCHALLREUTER KU, 1990, BIOCHIM BIOPHYS ACTA, V1054, P14, DOI 10.1016/0167-4889(90)90199-N; SCHALLREUTER KU, 1989, BIOCHEM BIOPH RES CO, V160, P573, DOI 10.1016/0006-291X(89)92471-6; SCHMIDT RJ, 1992, ARCH DERMATOL RES, V284, P400, DOI 10.1007/BF00372070; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; SREIDER CM, 1990, BIOCHEM PHARMACOL, V40, P1849, DOI 10.1016/0006-2952(90)90366-S; SREIDER CM, 1992, BIOCHEM INT, V28, P323; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; WAKSMAN G, 1994, J MOL BIOL, V236, P800, DOI 10.1006/jmbi.1994.1190; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; YODOI J, 1991, ADV CANCER RES, V57, P381; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581	45	167	171	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10835	10842		10.1074/jbc.273.18.10835	http://dx.doi.org/10.1074/jbc.273.18.10835			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556556	hybrid			2022-12-27	WOS:000073395200008
J	Quiram, PA; Sine, SM				Quiram, PA; Sine, SM			Structural elements in alpha-conotoxin ImI essential for binding to neuronal alpha(7) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; MOLECULAR DISSECTION; SUBUNIT INTERFACES; IDENTIFICATION; SPECTROSCOPY; SELECTIVITY; LIGAND; GI	The neuronal-specific toxin a-conotoxin ImI (CTx ImI) has the sequence Gly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Ala-Trp-Arg-Cys-NH2, in which each cysteine forms a disulfide bridge to produce a constrained two-loop structure. To investigate the structural basis for bioactivity we mutated individual residues in CTx ImI and determined bioactivity, Bioactivity of the toxins was determined by their competition against I-125-labeled alpha-bungarotoxin binding to homomeric receptors containing alpha(7) sequence in the major extracellular domain and 5HT-3 sequence elsewhere. The results reveal two regions in CTx ImI essential for binding to the alpha(7)/-5HT-3 receptor. The first is the triad Asp-Pro-Arg in the first loop, where conservative mutations of each residue diminish affinity by 2-3 orders of magnitude. The second region is the lone Trp in the second loop, where an aromatic side chain is required. The overall results suggest that within the triad of the first loop, Pro positions the flanking Asp and Arg for optimal interaction with one portion of the binding site, while within the second loop, Trp stabilizes the complex through its aromatic ring.	Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Receptor Biol Lab, Rochester, MN 55905 USA	Mayo Clinic	Sine, SM (corresponding author), Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Receptor Biol Lab, Rochester, MN 55905 USA.							ANDRUE D, 1994, METHODS MOL BIOL PEP, V35, P139; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Cooper ST, 1997, J NEUROCHEM, V68, P2140; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; FU DX, 1994, J BIOL CHEM, V269, P26152; Groebe DR, 1997, BIOCHEMISTRY-US, V36, P6469, DOI 10.1021/bi970195w; Guddat LW, 1996, BIOCHEMISTRY-US, V35, P11329, DOI 10.1021/bi960820h; Hann RM, 1997, BIOCHEMISTRY-US, V36, P9051, DOI 10.1021/bi970807c; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; HASHIMOTO K, 1985, EUR J PHARMACOL, V118, P351, DOI 10.1016/0014-2999(85)90147-5; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; KOBAYASHI Y, 1989, BIOCHEMISTRY-US, V28, P4853, DOI 10.1021/bi00437a050; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; PARDI A, 1989, BIOCHEMISTRY-US, V28, P5494, DOI 10.1021/bi00439a026; PRINCE RJ, 1998, NICOTINIC ACETYLCHOL, P31; Quiram PA, 1998, J BIOL CHEM, V273, P11001, DOI 10.1074/jbc.273.18.11001; Rangwala F, 1997, J NEUROSCI, V17, P8201; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Tsigelny I, 1997, BIOPHYS J, V73, P52, DOI 10.1016/S0006-3495(97)78047-0	23	83	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11007	11011		10.1074/jbc.273.18.11007	http://dx.doi.org/10.1074/jbc.273.18.11007			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556581	hybrid			2022-12-27	WOS:000073395200033
J	Shimizu, C; Yoshida, S; Shibata, M; Kato, K; Momota, Y; Matsumoto, K; Shiosaka, T; Midorikawa, R; Kamachi, T; Kawabe, A; Shiosaka, S				Shimizu, C; Yoshida, S; Shibata, M; Kato, K; Momota, Y; Matsumoto, K; Shiosaka, T; Midorikawa, R; Kamachi, T; Kawabe, A; Shiosaka, S			Characterization of recombinant and brain neuropsin, a plasticity-related serine protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; RECEPTOR ACTIVATION; NEURAL DEVELOPMENT; MESSENGER-RNA; MOUSE-BRAIN; THROMBIN; CELLS; FIBRONECTIN	Activity-dependent changes in neuropsin gene expression in the hippocampus implies an involvement of neuropsin in neural plasticity. Since the deduced amino acid sequence of the gene contained the complete triplet (His-Asp-Ser) of the serine protease domain, the protein was postulated to have proteolytic activity. Recombinant full-length neuropsin produced in the baculovirus/insect cell system was enzymatically inactive but was readily converted to active enzyme by endoprotease processing. The activational processing of prototype neuropsin involved the specific cleavage of the Lys(32)-Ile(33) bond near its N terminus. Native neuropsin that was purified with a purity of 1,100-fold from mouse brain had enzymatic characteristics identical to those of active-type recombinant neuropsin. Both brain and recombinant neuropsin had amidolytic activities cleaving Arg-X and Lys-X bonds in the synthetic chromogenic substrates, and the highest specific activity was found against Boc-Val-Pro-Arg-4-methylcoumaryl-7-amide. The active-type recombinant neuropsin effectively cleaved fibronectin, an extracellular matrix protein. Taken together, these results indicate that this protease, which is enzymatically novel, has significant limbic effects by changing the extracellular matrix environment.	Nara Inst Sci & Technol, Div Struct Cell Biol, Nara 6300101, Japan; Med & Biol Labs Co Ltd, Nagano 396, Japan; Ehime Coll Hlth Sci, Dept Med Lab Technol, Iyo, Ehime 79121, Japan	Nara Institute of Science & Technology	Shiosaka, S (corresponding author), Nara Inst Sci & Technol, Div Struct Cell Biol, 8916-5 Takayama, Nara 6300101, Japan.	sshiosak@bs.aist-nara.ac.jp	Shiosaka, Sadao/B-1142-2008					Chen ZL, 1998, J HISTOCHEM CYTOCHEM, V46, P313, DOI 10.1177/002215549804600304; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; DAMMERVAL C, 1987, ELECTROPHORESIS, V8, P158; DENT MAR, 1993, EUR J NEUROSCI, V5, P633, DOI 10.1111/j.1460-9568.1993.tb00529.x; Frey U, 1996, J NEUROSCI, V16, P2057; FURIE MB, 1980, J BIOL CHEM, V255, P3134; GRAND RJA, 1989, EMBO J, V8, P2209, DOI 10.1002/j.1460-2075.1989.tb08344.x; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; HAWKINS RL, 1986, BRAIN RES, V398, P63, DOI 10.1016/0006-8993(86)91250-3; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU Y, 1994, J NEUROBIOL, V25, P325, DOI 10.1002/neu.480250312; LYNCH G, 1984, SCIENCE, V224, P1067; Momota Y, 1998, EUR J NEUROSCI, V10, P760, DOI 10.1046/j.1460-9568.1998.00068.x; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; NELSON PG, 1995, PERSPECT DEV NEUROBI, V2, P399; NISHIZAWA K, 1991, J BIOL CHEM, V266, P3074; Okabe A, 1996, BRAIN RES, V728, P116, DOI 10.1016/S0006-8993(96)00473-8; PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; QUIGLEY JP, 1987, P NATL ACAD SCI USA, V84, P2776, DOI 10.1073/pnas.84.9.2776; Rao JS, 1996, J NEUROCHEM, V66, P1657; RASMUSSEN UB, 1993, J BIOL CHEM, V268, P14322; SANES JR, 1983, ANNU REV PHYSIOL, V45, P581, DOI 10.1146/annurev.ph.45.030183.003053; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Seeds NW, 1996, SEMIN NEUROSCI, V8, P405, DOI 10.1006/smns.1996.0049; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; SUZUKI J, 1995, NEUROSCI RES, V23, P345, DOI 10.1016/0168-0102(95)00960-2; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; TWINING SS, 1994, CRIT REV BIOCHEM MOL, V29, P315, DOI 10.3109/10409239409083484; UCHINO T, 1993, J BIOL CHEM, V268, P527; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; YEN SH, 1995, J NEUROCHEM, V65, P2577	38	105	107	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11189	11196		10.1074/jbc.273.18.11189	http://dx.doi.org/10.1074/jbc.273.18.11189			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556608	hybrid			2022-12-27	WOS:000073395200060
J	Tanaka, H; Moroi, K; Iwai, J; Takahashi, H; Ohnuma, N; Hori, S; Takimoto, M; Nishiyama, M; Masaki, T; Yanagisawa, M; Sekiya, S; Kimura, S				Tanaka, H; Moroi, K; Iwai, J; Takahashi, H; Ohnuma, N; Hori, S; Takimoto, M; Nishiyama, M; Masaki, T; Yanagisawa, M; Sekiya, S; Kimura, S			Novel mutations of the endothelin B receptor gene in patients with Hirschsprung's disease and their characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAH-WAARDENBURG SYNDROME; STOP-TRANSFER SEQUENCE; TYROSINE KINASE; RET PROTOONCOGENE; MICROSOMAL MEMBRANE; GERMLINE MUTATIONS; LIGAND-BINDING; COAT COLOR; MEGACOLON; GDNF	Hirschsprung's disease (HSCR) is a congenital intestinal disease, characterized by the absence of ganglion cells in the distal portion of the intestinal tract. Recently, three susceptibility genes have been identified in HSCR, namely the RET protooncogene, the endothelin B (ETB) receptor gene (EDNRB), and the endothelin-3 (ET-3) gene (EDN3). To investigate whether mutations in EDNRB could be related with HSCR in non-inbred populations in Japan, we examined alterations of the gene in 31 isolated patients. Three novel mutations were detected as follows: two transversions, A to T and C to A at nucleotides 311 (N104I) and 1170 (S390R), respectively, and a transition, T to C at nucleotide 325 (C109R). To analyze functions of these mutant receptors, they were expressed in Chinese hamster ovary cells. S390R mutation did not change the binding affinities but caused the decreases in the ligand-induced increment of intracellular calcium and in the inhibition of adenylyl cyclase activity, showing the impairment of the intracellular signaling. C109R receptors were proved to be localized near the nuclei as an unusual 44-kDa protein with the extremely low affinity to endothelin-l (ET-1) and not to be translocated into the plasma membrane. On the other hand, N104I receptors showed almost the same binding affinities and functional properties as those of the wild type. Therefore, we conclude that S390R and C109R mutations could cause HSCR but that N104I mutation might be polymorphous.	Chiba Univ, Sch Med, Ctr Biomed Sci, Div Cardiovasc Biol,Chuo Ku, Chiba 2600856, Japan; Chiba Univ, Sch Med, Ctr Biomed Sci, Dept Obstet & Gynecol, Chiba 2600856, Japan; Chiba Univ, Sch Med, Dept Pediat Surg, Chiba 2600856, Japan; Novartis Pharma KK, Res, Takarazuka, Hyogo 6650042, Japan; Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068315, Japan; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA	Chiba University; Chiba University; Chiba University; Novartis; Kyoto University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kimura, S (corresponding author), Chiba Univ, Sch Med, Ctr Biomed Sci, Div Cardiovasc Biol,Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan.	kimura@med.m.chiba-u.ac.jp		Kimura, Sadao/0000-0001-6768-7474				Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; ARAI H, 1993, J BIOL CHEM, V268, P3463; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; Auricchio A, 1996, HUM MOL GENET, V5, P351, DOI 10.1093/hmg/5.3.351; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; CECCHERINI I, 1995, HUM MOL GENET, V4, P2089, DOI 10.1093/hmg/4.11.2089; Chakravarti A, 1996, HUM MOL GENET, V5, P303; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Horstmeyer A, 1996, J BIOL CHEM, V271, P20811, DOI 10.1074/jbc.271.34.20811; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; KOSHIMIZU T, 1995, BIOCHEM BIOPH RES CO, V217, P354, DOI 10.1006/bbrc.1995.2784; KOZUKA M, 1991, J BIOL CHEM, V266, P16892; KUROIWA T, 1991, J BIOL CHEM, V266, P9251; Kusafuka T, 1996, HUM MOL GENET, V5, P347, DOI 10.1093/hmg/5.3.347; Pringault V, 1997, GENOMICS, V39, P86, DOI 10.1006/geno.1996.4476; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; SAKAMOTO A, 1993, J BIOL CHEM, V268, P8547; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SATO T, 1990, EMBO J, V9, P2391, DOI 10.1002/j.1460-2075.1990.tb07414.x; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Sokolovsky M, 1995, PHARMACOL THERAPEUT, V68, P435, DOI 10.1016/0163-7258(95)02015-2; TAKASUKA T, 1992, J BIOCHEM-TOKYO, V111, P748, DOI 10.1093/oxfordjournals.jbchem.a123830; WELLS JA, 1985, GENE, V34, P315, DOI 10.1016/0378-1119(85)90140-4; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YANAGISAWA M, 1994, CIRCULATION, V89, P1320, DOI 10.1161/01.CIR.89.3.1320; YORIMITSU K, 1992, FEBS LETT, V314, P395, DOI 10.1016/0014-5793(92)81513-L	45	72	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11378	11383		10.1074/jbc.273.18.11378	http://dx.doi.org/10.1074/jbc.273.18.11378			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556633	hybrid			2022-12-27	WOS:000073395200085
J	Selvamurugan, N; Chou, WY; Pearman, AT; Pulumati, MR; Partridge, NC				Selvamurugan, N; Chou, WY; Pearman, AT; Pulumati, MR; Partridge, NC			Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENIC-SARCOMA CELLS; MYELOID-LEUKEMIA GENE; TRANSCRIPTIONAL ACTIVATION; MESSENGER-RNA; DNA-BINDING; INTERSTITIAL COLLAGENASE; CHROMOSOMAL LOCALIZATION; HUMAN STROMELYSIN; OSTEOCALCIN GENE; HOMOLOGY DOMAIN	Parathyroid hormone induces collagenase-3 gene transcription in rat osteoblastic cells. Here, we characterized the basal, parathyroid hormone regulatory regions of the rat collagenase-3 gene and the proteins involved in this regulation. The minimal parathyroid hormone-responsive region was observed to be between base pairs -38 and -148, Deleted and mutated constructs showed that the activator protein-1 and the runt domain binding sites are both required for basal expression and parathyroid hormone activation of this gene, The runt domain site is identical to an osteoblast-specific element-2 or acute myelogenous leukemia binding sequence in the mouse and rat osteocalcin genes, respectively, Overexpression of an acute myelogenous leukemia-1 repressor protein inhibited parathyroid hormone activation of the promoter, indicating a requirement of acute myelogenous leukemia-related factor(s) for this activity. Overexpression of c-Fos, c-Jun, osteoblast-specific factor-2, and core binding factor-beta increased the response to parathyroid hormone of the wild type (-148) promoter but not with mutation of either or both the activator protein-1 and runt domain binding sites. In summary, we conclude that there is a cooperative interaction of acute myelogenous leukemia/polyomavirus enhancer-binding protein-2-related factor(s) binding to the runt domain binding site with members of the activator protein-1 transcription factor family binding to the activator protein-1 site in the rat collagenase-3 gene in response to parathyroid hormone in osteoblastic cells.	St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	Saint Louis University	Partridge, NC (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	Partrinc@SLU.EDU	Selvamurugan, Nagarajan/P-7894-2016	Selvamurugan, Nagarajan/0000-0003-3713-1920; Partridge, Nicola/0000-0002-5406-4814	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047420, R01DK048109, R56DK047420] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47420, R01 DK047420, DK48109] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; AUBLE DT, 1991, BIOCHEMISTRY-US, V30, P4629, DOI 10.1021/bi00232a039; BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Berthelsen J, 1996, J BIOL CHEM, V271, P3822; BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINCKERHOFF C E, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P145; BUTTICE G, 1991, NUCLEIC ACIDS RES, V19, P3723, DOI 10.1093/nar/19.13.3723; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CLOHISY JC, 1992, MOL ENDOCRINOL, V6, P1834, DOI 10.1210/me.6.11.1834; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GUTMAN A, 1991, TRENDS GENET, V7, P49, DOI 10.1016/0168-9525(91)90231-E; HEATH JK, 1984, BIOCHIM BIOPHYS ACTA, V802, P151, DOI 10.1016/0304-4165(84)90046-1; HENRIET P, 1995, FEBS LETT, V308, P211; Koe RC, 1997, CALCIFIED TISSUE INT, V61, P52, DOI 10.1007/s002239900294; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Korzus E, 1997, J BIOL CHEM, V272, P1188, DOI 10.1074/jbc.272.2.1188; KREAM BE, 1980, P NATL ACAD SCI-BIOL, V77, P5654, DOI 10.1073/pnas.77.10.5654; Kurokawa M, 1996, J BIOL CHEM, V271, P16870, DOI 10.1074/jbc.271.28.16870; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025; Meyers S, 1996, ONCOGENE, V13, P303; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Noti JD, 1996, MOL CELL BIOL, V16, P2940; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; OMURA TH, 1994, J BIOL CHEM, V269, P24994; PARTRIDGE NC, 1987, ENDOCRINOLOGY, V120, P1956, DOI 10.1210/endo-120-5-1956; PARTRIDGE NC, 1989, MOL ENDOCRINOL, V3, P232, DOI 10.1210/mend-3-2-232; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; PEARMAN AT, 1996, THESIS SAINT LOUIS U; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; QUINN CO, 1990, J BIOL CHEM, V265, P22342; Rajakumar RA, 1996, MOL ENDOCRINOL, V10, P867, DOI 10.1210/me.10.7.867; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHORPP M, 1995, BIOCHEM J, V308, P211, DOI 10.1042/bj3080211; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SIRUM KL, 1989, BIOCHEMISTRY-US, V28, P8691, DOI 10.1021/bi00448a004; Strewler GJ, 1995, ENDOCRINOLOGY METABO, P1407; TANAKA K, 1995, BIOCHEM BIOPH RES CO, V211, P1023, DOI 10.1006/bbrc.1995.1913; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Taylor DS, 1996, J BIOL CHEM, V271, P14020, DOI 10.1074/jbc.271.24.14020; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	54	148	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10647	10657		10.1074/jbc.273.17.10647	http://dx.doi.org/10.1074/jbc.273.17.10647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553127	hybrid			2022-12-27	WOS:000073224200076
J	Suzuki, T; Yan, Q; Lennarz, WJ				Suzuki, T; Yan, Q; Lennarz, WJ			Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FREE POLYMANNOSE OLIGOSACCHARIDES; UBIQUITIN-PROTEASOME PATHWAY; PROTEIN-DEGRADATION; N-GLYCOSYLATION; GLYCOPROTEIN-BIOSYNTHESIS; ER MEMBRANE; TRANSLOCATION; PEPTIDE; CYTOSOL; CELLS		SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Suzuki, T (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.		Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014	Suzuki, Tadashi/0000-0003-1030-7631; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033184] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33184] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P31; ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; Aridor M, 1996, TRENDS CELL BIOL, V6, P315, DOI 10.1016/0962-8924(96)10027-1; BELARD M, 1988, BIOCHEM J, V255, P235; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 1996, TRENDS BIOCHEM SCI, V21, P122, DOI 10.1016/0968-0004(96)20010-6; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Cacan R, 1996, BIOCHEM J, V313, P597, DOI 10.1042/bj3130597; Cacan R, 1997, TRENDS GLYCOSCI GLYC, V9, P365, DOI 10.4052/tigg.9.365; Cresswell P, 1997, CURR BIOL, V7, pR552, DOI 10.1016/S0960-9822(06)00279-X; Elliott T, 1997, ADV IMMUNOL, V65, P47, DOI 10.1016/S0065-2776(08)60741-5; GARCIA PD, 1988, J CELL BIOL, V106, P1093, DOI 10.1083/jcb.106.4.1093; GEETHAHABIB M, 1990, J BIOL CHEM, V265, P13655; GRAND T, 1996, BIOCHEM J, V316, P787; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HART GW, 1979, J BIOL CHEM, V254, P9747; HENLE KJ, 1995, TRENDS GLYOSCI GLYCO, V7, P251; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; JETHMALANI SM, 1994, J BIOL CHEM, V269, P23603; Johnson AE, 1997, TRENDS CELL BIOL, V7, P90, DOI 10.1016/S0962-8924(97)01029-5; KITAJIMA K, 1995, ARCH BIOCHEM BIOPHYS, V319, P393, DOI 10.1006/abbi.1995.1309; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KMIECIK D, 1995, GLYCOBIOLOGY, V5, P483, DOI 10.1093/glycob/5.5.483; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LENNARZ WJ, 1987, BIOCHEMISTRY-US, V26, P7205, DOI 10.1021/bi00397a001; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; OOI CE, 1992, CELL, V71, P87, DOI 10.1016/0092-8674(92)90268-H; PELHAM H R B, 1992, Trends in Cell Biology, V2, P183, DOI 10.1016/0962-8924(92)90230-K; PIERCE RJ, 1980, BIOCHEM J, V185, P261, DOI 10.1042/bj1850261; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Rapoport TA, 1996, CURR OPIN CELL BIOL, V8, P499, DOI 10.1016/S0955-0674(96)80027-5; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; ROMISCH K, 1992, P NATL ACAD SCI USA, V89, P7227, DOI 10.1073/pnas.89.15.7227; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; SUZUKI T, 1993, BIOCHEM BIOPH RES CO, V194, P1124, DOI 10.1006/bbrc.1993.1938; Suzuki T, 1997, P NATL ACAD SCI USA, V94, P6244, DOI 10.1073/pnas.94.12.6244; SUZUKI T, 1995, GLYCOCONJUGATE J, V12, P183, DOI 10.1007/BF00731318; VANLEYEN K, 1994, FEBS LETT, V355, P147, DOI 10.1016/0014-5793(94)01167-2; VILLERS C, 1994, BIOCHEM J, V298, P135, DOI 10.1042/bj2980135; Weng S, 1997, BIOCHEM J, V322, P655, DOI 10.1042/bj3220655; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; WIELAND FT, 1987, CELL, V50, P259; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	67	73	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10083	10086		10.1074/jbc.273.17.10083	http://dx.doi.org/10.1074/jbc.273.17.10083			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553052	hybrid			2022-12-27	WOS:000073224200001
J	Unson, CG; Wu, CR; Cheung, CP; Merrifield, RB				Unson, CG; Wu, CR; Cheung, CP; Merrifield, RB			Positively charged residues at positions 12, 17, and 18 of glucagon ensure maximum biological potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; ADENYLATE-CYCLASE; RECEPTOR-BINDING; REPLACEMENT ANALOGS; EXPRESSION CLONING; ANTAGONIST; SECRETIN; IDENTIFICATION; CONFORMATION; POLYPEPTIDE	Glucagon is a peptide hormone that plays a central role in the maintenance of normal circulating glucose levels. Structure-activity studies have previously demonstrated the importance of histidine at position 1 and the absolute requirement for aspartic acid at position 9 for transduction of the hormonal signal. Site-directed mutagenesis of the receptor protein identified Asp(64) on the extracellular N-terminal tail to be crucial for the recognition function of the receptor. In addition, antibodies generated against aspartic acid-rich epitopes from the extracellular region competed effectively with glucagon for receptor sites, which suggested that negative charges may line the putative glucagon binding pocket in the receptor, These observations led to the idea that positively charged residues on the hormone may act as counterions to these sites. Based on these initial findings, we synthesized glucagon analogs in which basic residues at positions 12, 17, and 18 were replaced with neutral or acidic residues to examine the effect of altering the positive charge on those sites on binding and adenylyl cyclase activity. The results indicate that unlike N-terminal histidine, Lys(12), Arg(17), and Arg(18) of glucagon have very large effects on receptor binding and transduction of the hormonal signal, although they are not absolutely critical. They contribute strongly to the stabilization of the binding interaction with the glucagon receptor that leads to maximum biological potency.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Unson, CG (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Fai, Cheung Chi/ABC-1100-2020	Fai, Cheung Chi/0000-0002-6066-7419	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK024039] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 24039] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Barany G, 1979, PEPTIDES           A, V2, P1; BREGMAN MD, 1980, J BIOL CHEM, V255, P1725; BUGGY JJ, 1995, J BIOL CHEM, V270, P7474, DOI 10.1074/jbc.270.13.7474; CARREY EA, 1982, J BIOL CHEM, V257, P624; CARRUTHERS CJL, 1994, J BIOL CHEM, V269, P29321; CARRUTHERS CJL, 1995, METH NEUROSCI, V25, P322; COTE TE, 1979, BIOCHIM BIOPHYS ACTA, V582, P295, DOI 10.1016/0304-4165(79)90392-1; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; HRUBY VJ, 1982, MOL CELL BIOCHEM, V44, P49, DOI 10.1007/BF00573846; HRUBY VJ, 1986, HORMONAL CONTROL GLU, V2, P3; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JOHNSON DG, 1982, SCIENCE, V215, P1115, DOI 10.1126/science.6278587; KRSTENANSKY JL, 1988, INT J PEPT PROT RES, V32, P468; KRSTENANSKY JL, 1986, J AM CHEM SOC, V108, P1696, DOI 10.1021/ja00267a053; LIN MC, 1975, BIOCHEMISTRY-US, V14, P1559, DOI 10.1021/bi00679a002; Merrifield Bruce, 1995, P93, DOI 10.1016/B978-012310920-0/50004-8; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; POHL SL, 1976, METHODS RECEPTOR R 1, P160; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; TRIVEDI D, 1998, IN PRESS PEPTIDES CH; UNGER RH, 1976, DIABETES, V25, P136, DOI 10.2337/diab.25.2.136; UNGER RH, 1994, JOSLINS DIABETES MEL, P163; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; UNSON CG, 1994, BIOCHEMISTRY-US, V33, P6884, DOI 10.1021/bi00188a018; UNSON CG, 1995, J BIOL CHEM, V270, P27720, DOI 10.1074/jbc.270.46.27720; UNSON CG, 1994, J BIOL CHEM, V269, P12548; Unson CG, 1996, P NATL ACAD SCI USA, V93, P310, DOI 10.1073/pnas.93.1.310; UNSON CG, 1993, ARCH BIOCHEM BIOPHYS, V300, P747, DOI 10.1006/abbi.1993.1103; UNSON CG, 1991, J BIOL CHEM, V266, P2763; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; UNSON CG, 1994, P NATL ACAD SCI USA, V91, P454, DOI 10.1073/pnas.91.2.454; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; VanTine BA, 1996, ENDOCRINOLOGY, V137, P3316, DOI 10.1210/en.137.8.3316; WRIGHT DE, 1979, J BIOL CHEM, V254, P268	39	21	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10308	10312		10.1074/jbc.273.17.10308	http://dx.doi.org/10.1074/jbc.273.17.10308			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553084	hybrid			2022-12-27	WOS:000073224200033
J	Li, M; Ye, XW; Woodward, RN; Zhu, C; Nichols, LA; Holland, LJ				Li, M; Ye, XW; Woodward, RN; Zhu, C; Nichols, LA; Holland, LJ			Analysis of the DNA-binding site for Xenopus glucocorticoid receptor accessory factor - Critical nucleotides for binding specificity in vitro and for amplification of steroid-induced fibrinogen gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; PRIMARY LIVER-CELLS; NUCLEAR FACTOR-I; SUBUNIT; PROMOTER; HORMONES; STIMULATION; ELEMENTS; LAEVIS	In addition to the glucocorticoid receptor, DNA-binding proteins called accessory factors play a role in hormone activation of many glucocorticoid-responsive genes. Hormonal regulation of the gamma-fibrinogen subunit gene from the frog Xenopus laevis requires a novel DNA sequence that binds a liver nuclear protein called Xenopus glucocorticoid receptor accessory factor (XGRAF), Here we demonstrate that the recognition site for XGRAF encompasses GAGTTAA at positions -175 to -169 relative to the start site of transcription. This sequence is not closely related to the binding sites for known transcription factors. The two guanosines make close contact with XGRAF, as shown by the methylation interference assay. Single-point mutagenesis of every nucleotide in the 9-base pair region from positions -177 to -169 showed an excellent correlation between ability to bind XGRAF in vitro and ability to amplify hormone-induced transcription from DNA transfected into Xenopus primary hepatocytes. Conversely, XGRAF had little or no effect on basal transcription of the gamma-fibrinogen gene. Maximal hormonal induction also requires three half-glucocorticoid response elements (half-GREs) homologous to the downstream half of the consensus GRE. Interestingly, the XGRAF-binding site is immediately adjacent to the most important half-GRE. This close proximity suggests a new mechanism for activation of a gene lacking a conventional full GRE.	Univ Missouri, Sch Med, Dept Physiol, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Holland, LJ (corresponding author), Univ Missouri, Sch Med, Dept Physiol, MA415 Med Sci Bldg, Columbia, MO 65212 USA.	physljh@muccmail.missouri.edu		Woodward, Robert/0000-0001-7514-498X	NHLBI NIH HHS [HL02934, R01-HL39095, HL07094] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K04HL002934, R01HL039095] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BHATTACHARYA A, 1991, MOL ENDOCRINOL, V5, P587, DOI 10.1210/mend-5-4-587; DEMDEN MC, 1992, MOL ENDOCRINOL, V6, P581, DOI 10.1210/me.6.4.581; DERBYSHIRE KM, 1986, GENE, V46, P145, DOI 10.1016/0378-1119(86)90398-7; DeRijk RH, 1996, J CLIN ENDOCR METAB, V81, P228, DOI 10.1210/jc.81.1.228; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; GARABEDIAN MJ, 1993, GENE TRANSCRIPTION P, P243; GOODSELL DS, 1993, P NATL ACAD SCI USA, V90, P2930, DOI 10.1073/pnas.90.7.2930; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; HOLLAND LJ, 1991, BIOCHEMISTRY-US, V30, P1965, DOI 10.1021/bi00221a033; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; HSU SC, 1992, EMBO J, V11, P3457, DOI 10.1002/j.1460-2075.1992.tb05425.x; IMAI E, 1993, J BIOL CHEM, V268, P5353; Katzenellenbogen JA, 1996, MOL ENDOCRINOL, V10, P119, DOI 10.1210/me.10.2.119; KUSHNER I, 1988, METHOD ENZYMOL, V163, P373; LUCAS PC, 1992, ANNU REV BIOCHEM, V61, P1131; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; Maxam A M, 1980, Methods Enzymol, V65, P499; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; POCKWINSE SM, 1995, EXP CELL RES, V216, P244, DOI 10.1006/excr.1995.1031; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; ROBERTS LR, 1993, BIOCHEMISTRY-US, V32, P11627, DOI 10.1021/bi00094a020; ROBERTS LR, 1993, ENDOCRINOLOGY, V132, P2563, DOI 10.1210/en.132.6.2563; ROUX J, 1995, DNA CELL BIOL, V14, P385, DOI 10.1089/dna.1995.14.385; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHMIDHAUSER C, 1990, P NATL ACAD SCI USA, V87, P9118, DOI 10.1073/pnas.87.23.9118; Schug J., 1997, CBILTR19971001 U PEN; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Suh DS, 1996, MOL ENDOCRINOL, V10, P1227, DOI 10.1210/me.10.10.1227; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wang JC, 1996, MOL ENDOCRINOL, V10, P794, DOI 10.1210/me.10.7.794; Wingender E, 1997, NUCLEIC ACIDS RES, V25, P265, DOI 10.1093/nar/25.1.265; Woodward RN, 1997, MOL ENDOCRINOL, V11, P563, DOI 10.1210/me.11.5.563	36	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9790	9796		10.1074/jbc.273.16.9790	http://dx.doi.org/10.1074/jbc.273.16.9790			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545317	hybrid			2022-12-27	WOS:000073128800063
J	Walensky, LD; Ruat, M; Bakin, RE; Blackshaw, S; Ronnett, GV; Snyder, SH				Walensky, LD; Ruat, M; Bakin, RE; Blackshaw, S; Ronnett, GV; Snyder, SH			Two novel odorant receptor families expressed in spermatids undergo 5 '-splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE OLFACTORY RECEPTOR; MAMMALIAN SPERM; MULTIGENE FAMILY; GERM-CELLS; EPITHELIUM; GENE; TRANSCRIPTION; CLONING; RAT; PURIFICATION	We report the identification of two novel families of odorant receptor (OdR)-like proteins, termed spermatid chemoreceptors (SCRs), in rat spermatids of the testis. The full-length genomic clones encode seven transmembrane domain receptors that share 35-40% identity with certain OdRs and are among the most divergent members of the OdR superfamily based on phylogenetic analysis. RNase protection assays and in situ hybridization studies confirmed the expression of SCRs in spermatids, the post meiotic, differentiating cell population in the testis. SCR transcripts were undetectable in the prepubertal testis but were readily identified in spermatids of sexually maturing and mature testis. Rapid amplification of cDNA end-polymerase chain reaction and genomic clone sequencing led to the discovery that SCRs are spliced upstream of their presumptive starting methionines. 5'-Splicing of OdRs may regulate the expression of functional chemoreceptors.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 813 WBSB,725 N Wolfe St, Baltimore, MD 21205 USA.				NIDA NIH HHS [DA-00074] Funding Source: Medline; NIGMS NIH HHS [GM-07309] Funding Source: Medline; NIMH NIH HHS [MH-18501] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Blackshaw S, 1997, J NEUROSCI, V17, P8074; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck L B, 1992, Curr Opin Neurobiol, V2, P282, DOI 10.1016/0959-4388(92)90116-3; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; DRUTEL G, 1995, RECEPTOR CHANNEL, V3, P33; DYM M, 1970, AM J ANAT, V128, P265, DOI 10.1002/aja.1001280302; EISENBACH M, 1992, AM J PHYSIOL, V262, pC1095, DOI 10.1152/ajpcell.1992.262.5.C1095; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; GU W, 1995, J BIOL CHEM, V270, P236, DOI 10.1074/jbc.270.1.236; HANSBROUGH J, 1982, J BIOL CHEM, V256, P1447; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; KILPATRICK DL, 1990, MOL CELL BIOL, V10, P3717, DOI 10.1128/MCB.10.7.3717; KISHIMOTO J, 1994, MOL BRAIN RES, V23, P33, DOI 10.1016/0169-328X(94)90208-9; KRIEGER J, 1994, EUR J BIOCHEM, V219, P829, DOI 10.1111/j.1432-1033.1994.tb18564.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; McCombie W R, 1992, DNA Seq, V2, P289, DOI 10.3109/10425179209030961; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; Nei M., 1987, MOL EVOLUTIONARY GEN, P287; Nekrasova E, 1996, EUR J BIOCHEM, V238, P28, DOI 10.1111/j.1432-1033.1996.0028q.x; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Sambrook J., 2002, MOL CLONING LAB MANU; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SHAPER NL, 1990, P NATL ACAD SCI USA, V87, P791, DOI 10.1073/pnas.87.2.791; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; SUZUKI N, 1984, BIOL REPROD, V30, P1167, DOI 10.1095/biolreprod30.5.1167; SUZUKI N, 1981, BIOCHEM BIOPH RES CO, V99, P1238, DOI 10.1016/0006-291X(81)90752-X; TASH JS, 1983, BIOL REPROD, V28, P75, DOI 10.1095/biolreprod28.1.75; Thomas MB, 1996, GENE, V178, P1, DOI 10.1016/0378-1119(96)00311-3; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; WALENSKY LD, 1995, MOL MED, V1, P130, DOI 10.1007/BF03401561; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0	41	50	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9378	9387		10.1074/jbc.273.16.9378	http://dx.doi.org/10.1074/jbc.273.16.9378			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545261	hybrid			2022-12-27	WOS:000073128800007
J	Coux, O; Goldberg, AL				Coux, O; Goldberg, AL			Enzymes catalyzing ubiquitination and proteolytic processing of the p105 precursor of nuclear factor kappa B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC PHOSPHORYLATION; B-ALPHA; CARRIER PROTEIN; CONJUGATING ENZYMES; DNA-BINDING; CYTOPLASMIC RETENTION; TRANSCRIPTION FACTOR; PROTEASOME PATHWAY; 20S PROTEASOME; P50 SUBUNIT	Nuclear factor kappa B1 (NF-kappa B) is a heterodimeric complex that regulates transcription of many genes involved in immune and inflammatory responses. Its 50-kDa subunit (p50) is generated by the ubiquitin-proteasome pathway from a 105-kDa precursor (p105). We have reconstituted this proteolytic process in HeLa cell extracts and purified the responsible enzymes. Ubiquitination of p105 requires El, and either of two types of E2s, E2-25K (for which p105 is the first proven substrate) or a member of the UBCH5 (UBC4) family. It also requires a new E3 of 50 kDa, which we call E3 kappa B. This set of enzymes differs from the E2s and E3 reported by others to catalyze p105 ubiquitination in reticulocytes. The ubiquitinating enzymes purified here, together with 26S proteasomes, allowed formation of p50. Thus, the 26S proteasome provides all the proteolytic activities necessary for p105 processing. Interestingly, in the reconstituted system, as observed in cells, the C-terminally truncated form of p105, p97, was processed into p50 more efficiently than normal p105, even when both species were ubiquitinated to a similar extent. Therefore, some additional mechanism involving the C-terminal region of p105 influences the proteolytic processing of the ubiquitinated precursor.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	agoldber@bcmp.med.harvard.edu	Coux, Olivier/B-3406-2010; Coux, Olivier/P-6847-2019	Coux, Olivier/0000-0001-8455-3849; Coux, Olivier/0000-0001-8455-3849				Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEERS EP, 1993, J BIOL CHEM, V268, P21645; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BLANK V, 1991, EMBO J, V10, P4159, DOI 10.1002/j.1460-2075.1991.tb04994.x; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; EYTAN E, 1993, J BIOL CHEM, V268, P4668; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GIROD PA, 1993, PLANT J, V3, P545, DOI 10.1046/j.1365-313X.1993.03040545.x; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Israel A, 1997, NATURE, V388, P519, DOI 10.1038/41433; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lin L, 1996, MOL CELL BIOL, V16, P2248; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; MacKichan ML, 1996, J BIOL CHEM, V271, P6084, DOI 10.1074/jbc.271.11.6084; Nefsky B, 1996, EMBO J, V15, P1301, DOI 10.1002/j.1460-2075.1996.tb00472.x; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; ORIAN A, 1995, J BIOL CHEM, V270, P21707, DOI 10.1074/jbc.270.37.21707; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROLFE M, 1995, P NATL ACAD SCI USA, V92, P3264, DOI 10.1073/pnas.92.8.3264; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; SCHEFFNER M, 1992, EMBO J, V11, P2425, DOI 10.1002/j.1460-2075.1992.tb05307.x; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; TAMURA T, 1991, FEBS LETT, V292, P154, DOI 10.1016/0014-5793(91)80856-X; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	58	56	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8820	8828		10.1074/jbc.273.15.8820	http://dx.doi.org/10.1074/jbc.273.15.8820			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535861	hybrid			2022-12-27	WOS:000072990800038
J	Iwabuchi, K; Yamamura, S; Prinetti, A; Handa, K; Hakomori, S				Iwabuchi, K; Yamamura, S; Prinetti, A; Handa, K; Hakomori, S			GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GANGLIOSIDE-MEDIATED MODULATION; TYROSINE KINASE-ACTIVITY; GPI-ANCHORED PROTEINS; CAVEOLAE MEMBRANE; PHOSPHATIDYLCHOLINE BILAYERS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; GM3 GANGLIOSIDE; INHIBITION	Mouse melanoma B16 cells are characterized by the predominant presence of ganglioside GM3 and adhere to lactosylceramide- or Gg3-coated plates through interaction of GM3 with lactosylceramide or Gg3, whereby not only adhesion but also spreading and enhancement of cell motility occur (Kojima, N., Hakomori, S. (1991) J. Biol. Chem. 266, 17552-17558). We now report that the adhesion process is based essentially on a glycosphingolipid-enriched microdomain (GEM) at the B16 cell surface, since >90% of GMS present in the original cells is found in GEM, and GEM is also enriched in several signal transducer molecules, e.g. c-Src, Ras, Rho, and focal adhesion kinase (FAK). GEM was isolated as a low density membranous fraction by homogenization of B16 cells in lysis buffer under two different conditions (i.e. buffer containing 1% Triton X-100, or hypertonic sodium carbonate without detergent), followed by sucrose density gradient centrifugation. A close association of GM3 with c-Src, Rho, and FAK was indicated by co-immunoprecipitation of GM3 present in GEM by anti-GMS monoclonal antibody DH2, followed by Western blotting with antibodies directed to these transducer molecules. The following data indicate that GEM is a structural and functional unit for initiation of GM3-dependent cell adhesion coupled with signal transduction. 1) Tyrosine phosphorylation in FAK was greatly enhanced in B16 cells adhered to Gg3 coated plates but was minimal in cells adhered to GM3-coated, GlcCer-coated, or noncoated plates. 2) GTP loading on Ras and Rho increased significantly when cells were adhered to Gg3-coated plates, compared with GM3-coated, GlcCer-coated, or noncoated plates. Since Ras and Rho are closely associated with GM3 in GEM, cell adhesion/stimulation through GM3 in GEM may induce activation of Ras and Rho through enhanced GTP binding.	Pacific NW Res Fdn, Seattle, WA 98122 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hakomori, S (corresponding author), Pacific NW Res Fdn, 720 Broadway, Seattle, WA 98122 USA.	hakomori@u.washington.edu	Prinetti, Alessandro/R-4206-2017; Sonnino, Sandro/R-4154-2017	Prinetti, Alessandro/0000-0003-0252-2593; Sonnino, Sandro/0000-0001-8180-5908	NCI NIH HHS [CA42505] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042505] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE K, 1983, J BIOL CHEM, V258, P1793; [Anonymous], 1977, Lipids, V12, P455; ARREAZA G, 1994, J BIOL CHEM, V269, P19123; Bovin N. V., 1997, GLYCOSCIENCES STATUS, P277; BREMER EG, 1986, J BIOL CHEM, V261, P2434; BREMER EG, 1982, BIOCHEM BIOPH RES CO, V106, P711, DOI 10.1016/0006-291X(82)91769-7; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHERESH DA, 1987, J CELL BIOL, V105, P1163, DOI 10.1083/jcb.105.3.1163; DOHI T, 1988, CANCER RES, V48, P5680; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; EGGENS I, 1989, J BIOL CHEM, V264, P9476; FRA AM, 1994, J BIOL CHEM, V269, P30745; HAKOMORI S, 1991, PURE APPL CHEM, V63, P473, DOI 10.1351/pac199163040473; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HANAI N, 1988, J BIOL CHEM, V263, P10915; HANDA K, 1991, BIOCHEM BIOPH RES CO, V181, P1223, DOI 10.1016/0006-291X(91)92069-V; Handa K, 1997, BIOCHEMISTRY-US, V36, P12412, DOI 10.1021/bi971181t; HATTORI M, 1995, J BIOL CHEM, V270, P7858, DOI 10.1074/jbc.270.14.7858; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kasahara K, 1997, J BIOL CHEM, V272, P29947, DOI 10.1074/jbc.272.47.29947; Kasahara K, 1996, GLYCOBIOLOGY, V6, P708; KOJIMA N, 1991, Glycobiology, V1, P623, DOI 10.1093/glycob/1.6.623; KOJIMA N, 1992, J BIOL CHEM, V267, P17264; KOJIMA N, 1989, J BIOL CHEM, V264, P20159; KOJIMA N, 1991, J BIOL CHEM, V266, P17552; KOPITZ J, 1997, GLYCOCONJ J, V14, pS10; LECKBAND D, 1997, GLYCOCONJ J S1, V14, pS31; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; MARTENSSON S, 1986, GLYCOCONJUGATE J, V3, P163, DOI 10.1007/BF01049374; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MINOGUCHI K, 1994, J BIOL CHEM, V269, P5249; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; OKADA M, 1991, J BIOL CHEM, V266, P24249; OKADA Y, 1984, EXP CELL RES, V155, P448, DOI 10.1016/0014-4827(84)90205-2; OTSUJI E, 1995, INT J ONCOL, V6, P319; PALADE GE, 1953, J APPL PHYS, V24, P1424; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; ROCK P, 1990, BIOCHEMISTRY-US, V29, P8484, DOI 10.1021/bi00488a040; ROCK P, 1991, BIOCHEMISTRY-US, V30, P19, DOI 10.1021/bi00215a003; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sakakura C, 1996, J BIOL CHEM, V271, P946, DOI 10.1074/jbc.271.2.946; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; STEWART RJ, 1993, BIOCHEMISTRY-US, V32, P10666, DOI 10.1021/bi00091a017; SVENNERHOLM L, 1964, J LIPID RES, V5, P145; Taki T, 1997, CANCER RES, V57, P1882; TILLACK TW, 1983, BIOCHIM BIOPHYS ACTA, V733, P15, DOI 10.1016/0005-2736(83)90086-X; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yamamura S, 1997, BIOCHEM BIOPH RES CO, V236, P218, DOI 10.1006/bbrc.1997.6933; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814; YATES AJ, 1993, EXP CELL RES, V204, P38, DOI 10.1006/excr.1993.1006; YOUNG WW, 1979, J EXP MED, V150, P1008, DOI 10.1084/jem.150.4.1008; ZHENG MZ, 1993, J BIOL CHEM, V268, P2217	61	277	280	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9130	9138		10.1074/jbc.273.15.9130	http://dx.doi.org/10.1074/jbc.273.15.9130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535903	hybrid			2022-12-27	WOS:000072990800080
J	Ribas, JC; Wickner, RB				Ribas, JC; Wickner, RB			The Gag domain of the Gag-Pol fusion protein directs incorporation into the L-A double-stranded RNA viral particles in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-ACETYLTRANSFERASE; REPLICATION; MAK3; ENCAPSIDATION; PR160GAG-POL; MUTAGENESIS; PROPAGATION; POLYMERASE; EXPRESSION	The L-A double-stranded RNA virus of yeast encodes its major coat protein, Gag, and a Gag-Pol fusion protein made by a -1 ribosomal frameshift, a coding strategy used by many retroviruses. We find that cells expressing only Gag from one plasmid and only Gag-Pol (in frame) from a separate plasmid can support the propagation of M-1 double-stranded RNA, encoding the killer toxin. We use this system to separately investigate the functions of Gag and the Gag part of Gag-Pol. L-A contains two fusion protein molecules per particle, and although N-terminal acetylation of Gag is essential for viral assembly, it is completely dispensable for function of Gag-Pol. In general, the requirements on Gag for viral assembly and propagation are more stringent than on the Gag part of Gag-Pol. Finally, we directly show that it is Gag that instructs the incorporation of Gag-Pol into the viral particles.	NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wickner, RB (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rm 225,8 Ctr Dr MSC 0830, Bethesda, MD 20892 USA.		Ribas, Juan C/C-9864-2015	Ribas, Juan C/0000-0001-6430-0895				Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dinman JD, 1997, P NATL ACAD SCI USA, V94, P6606, DOI 10.1073/pnas.94.13.6606; DINMAN JD, 1994, GENETICS, V136, P75; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; ESTEBAN R, 1986, MOL CELL BIOL, V6, P1552, DOI 10.1128/MCB.6.5.1552; ESTEBAN R, 1988, J VIROL, V62, P1278, DOI 10.1128/JVI.62.4.1278-1285.1988; FUJIMURA T, 1992, NATURE, V359, P746, DOI 10.1038/359746a0; FUJIMURA T, 1988, CELL, V55, P663, DOI 10.1016/0092-8674(88)90225-5; FUJIMURA T, 1990, CELL, V62, P819, DOI 10.1016/0092-8674(90)90125-X; ICHO T, 1989, J BIOL CHEM, V264, P6716; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lawton JA, 1997, J VIROL, V71, P7353, DOI 10.1128/JVI.71.10.7353-7360.1997; PARK J, 1992, J VIROL, V66, P6304, DOI 10.1128/JVI.66.11.6304-6313.1992; PERSING DH, 1987, J VIROL, V61, P1672, DOI 10.1128/JVI.61.5.1672-1677.1987; RIBAS JC, 1992, P NATL ACAD SCI USA, V89, P2185, DOI 10.1073/pnas.89.6.2185; RIBAS JC, 1994, J BIOL CHEM, V269, P28420; Shaw AL, 1996, STRUCTURE, V4, P957, DOI 10.1016/S0969-2126(96)00102-5; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; SRINIVASAKUMAR N, 1995, J VIROL, V69, P6106, DOI 10.1128/JVI.69.10.6106-6114.1995; TERCERO JC, 1992, J BIOL CHEM, V267, P20270; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; TERCERO JC, 1993, J BACTERIOL, V175, P3192, DOI 10.1128/JB.175.10.3192-3194.1993; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; VALLE RPC, 1993, J VIROL, V67, P2765; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; VERONESE FD, 1988, J VIROL, V62, P795, DOI 10.1128/JVI.62.3.795-801.1988; WICKNER RB, 1991, J VIROL, V65, P155, DOI 10.1128/JVI.65.1.155-161.1991; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; WICKNER RB, 1996, FIELDS VIROLOGY, V1, P557; YAO WS, 1995, VIROLOGY, V214, P215, DOI 10.1006/viro.1995.9938	37	25	26	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9306	9311		10.1074/jbc.273.15.9306	http://dx.doi.org/10.1074/jbc.273.15.9306			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535925	hybrid			2022-12-27	WOS:000072990800102
J	Stigger, E; Drissi, R; Lee, SH				Stigger, E; Drissi, R; Lee, SH			Functional analysis of human replication protein a in nucleotide excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING-PROTEIN; POLYMERASE-ALPHA-PRIMASE; SIMIAN VIRUS-40 DNA; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; DAMAGED DNA; HUMAN RAD52; T-ANTIGEN; SUBUNIT	Human replication protein A (RPA) is a three-subunit protein complex (70-, 34-, and 11-kDa subunits) involved in DNA replication, repair, and recombination. Both the 70- (p70) and 34-kDa (p34) subunits interact with Xeroderma pigmentosum group A complementing protein (XPA), a key protein involved in nucleotide excision repair. Our deletion analysis indicated that no particular domain(s) of RPA p70 was essential for its interaction with XPA, whereas 33 amino acids from the C terminus of p34 (p34 Delta 33C) were necessary for the XPA interaction. Furthermore, mutant RPA lacking the p34 C terminus failed to interact with XPA, suggesting that p34, not p70, is primarily responsible for the interaction of RPA with XPA. RPA stimulated the interaction of XPA with W-damaged DNA through an RPA-XPA complex on damaged DNA sites because (i) the RPA mutant lacking the C terminus of p34 failed to stimulate an XPA-DNA interaction, and (ii) the ssDNA binding domain of RPA (amino acids 296-458) was necessary for the stimulation of the XPA-DNA interaction. Two separate domains of p70, a single-stranded DNA binding domain and a zinc-finger domain, were necessary for RPA function in nucleotide excision repair. The mutant RPA (RPA: p34 Delta 33C), which lacks its stimulatory effect on the XPA-DNA interaction, also poorly supported nucleotide excision repair, suggesting that the XPA-RPA interaction on damaged DNA is necessary for DNA repair activity.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; St Jude Childrens Res Hosp, Dept Virol & Mol Biol, Memphis, TN 38105 USA; Indiana Univ, Sch Med, Ctr Canc, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; St Jude Children's Research Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Lee, SH (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	slee@iupui.edu			NIGMS NIH HHS [GM52358] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052358] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Braun KA, 1997, BIOCHEMISTRY-US, V36, P8443, DOI 10.1021/bi970473r; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Burns JL, 1996, J BIOL CHEM, V271, P11607, DOI 10.1074/jbc.271.20.11607; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; COLLINS KL, 1991, MOL CELL BIOL, V11, P2108, DOI 10.1128/MCB.11.4.2108; COVERLEY D, 1991, NATURE, V349, P538, DOI 10.1038/349538a0; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; ERDILE LF, 1990, J BIOL CHEM, V265, P3177; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Fried LM, 1996, P NATL ACAD SCI USA, V93, P13825, DOI 10.1073/pnas.93.24.13825; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; Ishiai M, 1996, J BIOL CHEM, V271, P20868, DOI 10.1074/jbc.271.34.20868; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P8757; Kim DK, 1996, J BIOL CHEM, V271, P15124, DOI 10.1074/jbc.271.25.15124; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SH, 1995, J BIOL CHEM, V270, P12801, DOI 10.1074/jbc.270.21.12801; LEE SH, 1995, J BIOL CHEM, V270, P21800, DOI 10.1074/jbc.270.37.21800; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; LI L, 1995, MOL CELL BIOL, V15, P5396; Lin YL, 1996, J BIOL CHEM, V271, P17190, DOI 10.1074/jbc.271.29.17190; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; MATSUMOTO T, 1990, P NATL ACAD SCI USA, V87, P9712, DOI 10.1073/pnas.87.24.9712; Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047; MELENDY T, 1993, J BIOL CHEM, V268, P3389; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; OHANDLEY S, 1995, BIOCHEMISTRY-US, V34, P2528, DOI 10.1021/bi00008a017; PAN ZQ, 1995, P NATL ACAD SCI USA, V92, P4636, DOI 10.1073/pnas.92.10.4636; PARK MS, 1995, J BIOL CHEM, V270, P15467, DOI 10.1074/jbc.270.26.15467; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Sambrook J., 2002, MOL CLONING LAB MANU; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; STIGGER E, 1994, P NATL ACAD SCI USA, V91, P579, DOI 10.1073/pnas.91.2.579; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; WOLD MS, 1989, J BIOL CHEM, V264, P2801; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896	50	68	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9337	9343		10.1074/jbc.273.15.9337	http://dx.doi.org/10.1074/jbc.273.15.9337			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535929	hybrid			2022-12-27	WOS:000072990800106
J	Takada, T; Matozaki, T; Takeda, H; Fukunaga, K; Noguchi, T; Fujioka, Y; Okazaki, I; Tsuda, M; Yamao, T; Ochi, F; Kasuga, M				Takada, T; Matozaki, T; Takeda, H; Fukunaga, K; Noguchi, T; Fujioka, Y; Okazaki, I; Tsuda, M; Yamao, T; Ochi, F; Kasuga, M			Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; SRC HOMOLOGY-2 DOMAINS; TYROSINE-PHOSPHORYLATED PEPTIDES; CELL ANTIGEN RECEPTOR; CARCINOEMBRYONIC ANTIGEN; SIGNAL-TRANSDUCTION; SH2 DOMAINS; MOLECULAR-CLONING; SYP PHOSPHATASE; SH-PTP2	SHPS-1 is a receptor-like protein that undergoes tyrosine phosphorylation and binds SHP-2, an SH2 domain-containing protein tyrosine phosphatase, in response to insulin and other mitogens. The overexpression of wildtype SHPS-1, but not of a mutant SHPS-1 in which all four tyrosine residues in its cytoplasmic region were mutated to phenylalanine, markedly enhanced insulin-induced activation of mitogen-activated protein kinase in Chinese hamster ovary cells that overexpress the human insulin receptor. Mutation of each tyrosine residue individually revealed that the major sites of tyrosine phosphorylation of SHPS-1 in response to insulin are Tyr(449) and Tyr(473). In addition, mutation of either Tyr(449) or Tyr(473) abolished the insulin-induced tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Surface plasmon resonance analysis showed that glutathione S-transferase fusion proteins containing the NH2-terminal or COOH-terminal SH2 domains of SHP-2 bound preferentially to phosphotyrosyl peptides corresponding to the sequences surrounding Tyr(449) or Tyr(473) respectively, of SHPS-1. Furthermore, phosphotyrosyl peptides containing Tyr(449) or Tyr(473) were effective substrates for the phosphatase activity of recombinant SHP-2 in vitro. Together, these results suggest that insulin may induce phosphorylation of SHPS-1 at Tyr(449) and Tyr(473), to which SHP-2 then binds through its NH,terminal and COOH-terminal SH2 domains, respectively. SHPS-1 may play a crucial role both in the recruitment of SHP-2 from the cytosol to a site near the plasma membrane and in increasing its catalytic activity, thereby positively regulating the RAS-mitogen-activated protein kinase signaling cascade in response to insulin.	Kobe Univ, Sch Med, Dept Internal Med 2, Chuo Ku, Kobe, Hyogo 650, Japan; Pharmacia Biotech, Yodogawa Ku, Osaka, Japan	Kobe University	Matozaki, T (corresponding author), Kobe Univ, Sch Med, Dept Internal Med 2, Chuo Ku, Kusunoki Cho, Kobe, Hyogo 650, Japan.	matozaki@med.kobe-u.ac.jp						Adachi M, 1996, CELL, V85, P15; Allard JD, 1996, DEVELOPMENT, V122, P1137; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BRUMMER J, 1995, ONCOGENE, V11, P1649; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; FELDER S, 1993, MOL CELL BIOL, V13, P1449, DOI 10.1128/MCB.13.3.1449; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; HINODA Y, 1988, P NATL ACAD SCI USA, V85, P6959, DOI 10.1073/pnas.85.18.6959; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Jackson DE, 1997, J BIOL CHEM, V272, P6986, DOI 10.1074/jbc.272.11.6986; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P13434; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; MATOZAKI T, 1994, J BIOL CHEM, V269, P2075; Matozaki T, 1996, CELL SIGNAL, V8, P13, DOI 10.1016/0898-6568(95)02015-2; MATOZAKI T, 1994, BIOCHEM BIOPH RES CO, V204, P874, DOI 10.1006/bbrc.1994.2541; MATOZAKI T, 1995, ADV PROTEIN PHOSPHAT, P319; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; NAJJAR SM, 1995, BIOCHEMISTRY-US, V34, P9341, DOI 10.1021/bi00029a009; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; Noguchi T, 1996, J BIOL CHEM, V271, P27652, DOI 10.1074/jbc.271.44.27652; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Ohnishi H, 1996, J BIOL CHEM, V271, P25569, DOI 10.1074/jbc.271.41.25569; PAYNE G, 1993, P NATL ACAD SCI USA, V90, P4902, DOI 10.1073/pnas.90.11.4902; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; PRONK GJ, 1994, MOL CELL BIOL, V14, P1575, DOI 10.1128/MCB.14.3.1575; ROCCHI S, 1995, ENDOCRINOLOGY, V136, P5291, DOI 10.1210/en.136.12.5291; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SASAOKA T, 1994, J BIOL CHEM, V269, P10734; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; TAUCHI T, 1994, J BIOL CHEM, V269, P25206; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; WHITE MF, 1994, J BIOL CHEM, V269, P1; XIAO S, 1994, J BIOL CHEM, V269, P21244; Yamao T, 1997, BIOCHEM BIOPH RES CO, V231, P61, DOI 10.1006/bbrc.1996.6047; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	56	105	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9234	9242		10.1074/jbc.273.15.9234	http://dx.doi.org/10.1074/jbc.273.15.9234			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535915	hybrid			2022-12-27	WOS:000072990800092
J	Webb, E; Claas, K; Downs, D				Webb, E; Claas, K; Downs, D			thiBPQ encodes an ABC transporter required for transport of thiamine and thiamine pyrophosphate in Salmonella typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE-ESTERS; GENE; BIOSYNTHESIS; TRANSDUCTION; RESISTANCE; OPERON	In Salmonella typhimurium, thiamine pyrophosphate (TPP) is a required cofactor for several enzymes in central metabolism. Herein we identify a new thi operon, thiBPQ (designated sfuABC in Escherichia coli), required for the transport of thiamine and TPP into the cell, Insertions in the operon result in strains that are phenotypically and biochemically defective in thiamine and TPP transport, Data presented herein show that this operon is transcriptionally repressed in the presence of exogenous thiamine, with TPP the likely regulatory molecule. This work represents the first identification of thiamine transport genes in bacteria and demonstrates the function of a proposed ABC transporter in E, coli.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Downs, D (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	Downs@vms2.macc.wisc.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BACKSTROM AD, 1995, J AM CHEM SOC, V117, P2351, DOI 10.1021/ja00113a025; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BEGLEY TP, 1996, NAT PROD REP, V13, P178; BELLION E, 1983, BIOCHIM BIOPHYS ACTA, V735, P331, DOI 10.1016/0005-2736(83)90146-3; BENSON NR, 1992, J BACTERIOL, V174, P1673, DOI 10.1128/jb.174.5.1673-1681.1992; BOOS W, 1996, ESCHERICHIA COLI SAL, P1175; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; CHEN P, 1995, J BACTERIOL, V177, P1461, DOI 10.1128/jb.177.6.1461-1469.1995; DAVIS RW, 1980, ADV BACTERIAL GENET, P207; DOWNS DM, 1994, J BACTERIOL, V176, P4858, DOI 10.1128/jb.176.16.4858-4864.1994; ESCALANTESEMERENA JC, 1987, J BACTERIOL, V169, P2251, DOI 10.1128/jb.169.5.2251-2258.1987; HONG JS, 1971, P NATL ACAD SCI USA, V68, P3158, DOI 10.1073/pnas.68.12.3158; HUGHES KT, 1985, GENETICS, V109, P263; IWASHIMA A, 1971, J BACTERIOL, V108, P1419, DOI 10.1128/JB.108.3.1419-1421.1971; KAWASAKI T, 1986, METHOD ENZYMOL, V122, P15, DOI 10.1016/0076-6879(86)22141-2; KAWASAKI T, 1971, ARCH BIOCHEM BIOPHYS, V142, P163, DOI 10.1016/0003-9861(71)90271-2; KAWASAKI T, 1969, ARCH BIOCHEM BIOPHYS, V131, P231, DOI 10.1016/0003-9861(69)90126-X; KAWASAKI T, 1969, ARCH BIOCHEM BIOPHYS, V131, P223, DOI 10.1016/0003-9861(69)90125-8; KLECKNER N, 1977, J MOL BIOL, V116, P125, DOI 10.1016/0022-2836(77)90123-1; MATSUDA T, 1981, ANAL BIOCHEM, V117, P203, DOI 10.1016/0003-2697(81)90711-9; Miller JH, 1972, EXPT MOL GENETICS, P47; MirandaRios J, 1997, J BACTERIOL, V179, P6887, DOI 10.1128/jb.179.22.6887-6893.1997; NAKAYAMA H, 1972, J BACTERIOL, V112, P1118, DOI 10.1128/JB.112.3.1118-1126.1972; NOSAKA K, 1993, J BIOL CHEM, V268, P17440; Petersen LA, 1997, J BACTERIOL, V179, P4894, DOI 10.1128/jb.179.15.4894-4900.1997; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Singleton CK, 1997, GENE, V199, P111, DOI 10.1016/S0378-1119(97)00354-5; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; Webb E, 1996, J BACTERIOL, V178, P2533, DOI 10.1128/jb.178.9.2533-2538.1996; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; Webb E, 1997, J BACTERIOL, V179, P4399, DOI 10.1128/jb.179.13.4399-4402.1997; YOUDERIAN P, 1988, GENETICS, V118, P581	36	71	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8946	8950		10.1074/jbc.273.15.8946	http://dx.doi.org/10.1074/jbc.273.15.8946			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535878	hybrid			2022-12-27	WOS:000072990800055
J	Caldas, TD; El Yaagoubi, A; Richarme, G				Caldas, TD; El Yaagoubi, A; Richarme, G			Chaperone properties of bacterial elongation factor EF-Tu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; PROTEIN-BIOSYNTHESIS; REPLICATION PROTEIN; BINDING; PURIFICATION; TRANSLATION; DNAJ; END; TS	Elongation factor Tu (EF-Tu) is involved in the binding and transport of the appropriate codon-specified aminoacyl-tRNA to the aminoacyl site of the ribosome. We report herewith that the Escherichia coli EF-Tu interacts with unfolded and denatured proteins as do molecular chaperones that are involved in protein folding and protein renaturation after stress. EF-Tu promotes the functional folding of citrate synthase and alpha-glucosidase after urea denaturation. It prevents the aggregation of citrate synthase under heat shock conditions, and it forms stable complexes with several unfolded proteins such as reduced carboxymethyl alpha-lactalbumin and unfolded bovine pancreatic trypsin inhibitor. The EF-Tu GDP complex is much more active than EF-Tu.GTP in stimulating protein renaturation. These chaperone-like functions of EF-Tu occur at concentrations that are at least 20-fold lower than the cellular concentration of this factor. These results suggest that EF-Tu, in addition to its function in translation elongation, might be implicated in protein folding and protection from stress.	Univ Paris 07, Inst Jacques Monod, F-75005 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Richarme, G (corresponding author), Univ Paris 07, Inst Jacques Monod, 2 Pl Jussieu, F-75005 Paris, France.	richarme@ccr.jussieu.fr						ARAI KI, 1974, J BIOCHEM-TOKYO, V76, P293, DOI 10.1093/oxfordjournals.jbchem.a130571; BLUMENTHAL T, 1972, P NATL ACAD SCI USA, V69, P1313, DOI 10.1073/pnas.69.5.1313; BROT N, 1977, MOL MECHANISMS PROTE, P375; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; CULL M, 1990, METHOD ENZYMOL, V182, P147; EHRENBERG M, 1990, J MOL BIOL, V211, P739, DOI 10.1016/0022-2836(90)90074-V; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P399; FAULKHAMMER HG, 1987, FEBS LETT, V217, P208; HATHAWAY JA, 1965, BIOCHEM BIOPH RES CO, V20, P661, DOI 10.1016/0006-291X(65)90452-3; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HENDRICK JP, 1993, P NATL ACAD SCI USA, V90, P10216, DOI 10.1073/pnas.90.21.10216; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; JACOBSON GR, 1976, NATURE, V261, P23, DOI 10.1038/261023a0; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kudlicki W, 1997, J BIOL CHEM, V272, P32206, DOI 10.1074/jbc.272.51.32206; Kurland C., 1996, ESCHERICHIA COLI SAL, V240, P979; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LANGER T, 1992, NATURE, V356, P383; LIBEREK K, 1991, P NATL ACAD SCI USA, V22, P14491; Miller DL, 1977, MOL MECH PROTEIN BIO, P323; MISSIAKAS D, 1993, J BACTERIOL, V175, P2616; MottaguiTabar S, 1996, BIOCHIMIE, V78, P953, DOI 10.1016/S0300-9084(97)86717-X; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; PARLATO G, 1981, FEBS LETT, V125, P257, DOI 10.1016/0014-5793(81)80733-8; PINGOUD A, 1977, EUR J BIOCHEM, V78, P403, DOI 10.1111/j.1432-1033.1977.tb11752.x; PINGOUD A, 1980, BIOCHEMISTRY-US, V19, P2108, DOI 10.1021/bi00551a017; RICHARME G, 1993, J BIOL CHEM, V268, P24074; Richarme G, 1997, J BIOL CHEM, V272, P15607, DOI 10.1074/jbc.272.25.15607; ROTHMAN JE, 1986, CELL, V46, P5, DOI 10.1016/0092-8674(86)90852-4; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; SPRINZL M, 1994, TRENDS BIOCHEM SCI, V19, P245, DOI 10.1016/0968-0004(94)90149-X; TRAVERS AA, 1970, NATURE, V228, P748, DOI 10.1038/228748a0; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; VALENT QA, 1995, EMBO J, V14, P5404; VITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665; WEIJLAND A, 1992, MOL MICROBIOL, V6, P683, DOI 10.1111/j.1365-2958.1992.tb01516.x; WEIJLAND A, 1993, SCIENCE, V259, P1311, DOI 10.1126/science.8446899; WEISSBACH H, 1970, ARCH BIOCHEM BIOPHYS, V137, P262, DOI 10.1016/0003-9861(70)90433-9; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; WOLF H, 1974, P NATL ACAD SCI USA, V71, P4910, DOI 10.1073/pnas.71.12.4910; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YOUNG CC, 1991, J BACTERIOL, V173, P3096, DOI 10.1128/JB.173.10.3096-3100.1991; ZYLICZ M, 1984, J BIOL CHEM, V259, P8820; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591; [No title captured]	46	220	227	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11478	11482		10.1074/jbc.273.19.11478	http://dx.doi.org/10.1074/jbc.273.19.11478			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565560	hybrid			2022-12-27	WOS:000073536700014
J	Shen, HF; Dowhan, W				Shen, HF; Dowhan, W			Regulation of phosphatidylglycerophosphate synthase levels in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHESIS; CDP-DIACYLGLYCEROL; YEAST; EXPRESSION; GENE; CARDIOLIPIN; ACTIVATION; MEMBRANES; INOSITOL; HAP2	The PGS1 gene of Saccharomyces cerevisiae encodes phosphatidylglycerophosphate (PG-P) synthase. PG-P synthase activity is regulated by factors affecting mitochondrial development and through cross-pathway control by inositol. The molecular mechanism of this regulation was examined by using a reporter gene under control of the PGS1 gene promoter (P-PGS1-lacZ). Gene expression subject to carbon source regulation was monitored both at steady-state level and during the switch between different carbon sources. Cells grown in a non-fermentable carbon source had beta-galactosidase levels 3-fold higher than those grown in glucose. A shift from glucose to lactate rapidly raised the level of gene expression, whereas a shift back to glucose had the opposite effect. In either a pgs1 null mutant or a rho mutant grown in glucose, P-PGS1-lacZ expression was 30-50% of the level in wild type cells. Addition of inositol to the growth medium resulted in a 2-3-fold reduction in gene expression in wild type cells. In ino2 and ino8 mutants, gene expression was greatly reduced and was not subject to inositol regulation consistent with inositol repression being dependent on the INO2 and INO4 regulatory genes. P(PGS1)-lacZ expression was elevated in a cds1 null mutant in the presence or absence of inositol, indicating that the capacity to synthesize CDP-diacylglycerol affects gene expression. Lack of cardiolipin synthesis (cls1 null mutant) had no effect on reporter gene expression.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA	University of Texas System	Dowhan, W (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA.	wdowhan@bmb.med.uth.tmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054273] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54273] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMOVITCH DA, 1990, BIOCHIM BIOPHYS ACTA, V1020, P34, DOI 10.1016/0005-2728(90)90090-Q; ADOLPHUS, 1983, EMBO J, V2, P1765, DOI 10.1002/j.1460-2075.1983.tb01655.x; Anderson MS, 1996, J BIOL CHEM, V271, P26596, DOI 10.1074/jbc.271.43.26596; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; CHANG SC, 1998, IN PRESS J BIOL CHEM, V273; DEWINDE JH, 1993, PROG NUCLEIC ACID RE, V46, P51, DOI 10.1016/S0079-6603(08)61018-1; EILERS M, 1989, J BIOL CHEM, V264, P2945; ENDO T, 1989, J BIOL CHEM, V264, P2951; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Gallet PF, 1997, BIOCHEM J, V324, P627, DOI 10.1042/bj3240627; GAYNOR PM, 1991, J BACTERIOL, V173, P6124, DOI 10.1128/jb.173.19.6124-6131.1991; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1988, MOL CELL BIOL, V8, P4773, DOI 10.1128/MCB.8.11.4773; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; JAKOVCIC S, 1971, J CELL BIOL, V48, P490, DOI 10.1083/jcb.48.3.490; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; KLIG LS, 1988, J BACTERIOL, V170, P1878, DOI 10.1128/jb.170.4.1878-1886.1988; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KURODA S, 1994, J BIOL CHEM, V269, P6153; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Schlame M, 1997, BBA-LIPID LIPID MET, V1348, P201, DOI 10.1016/S0005-2760(97)00117-3; Shen H, 1996, J BIOL CHEM, V271, P29043, DOI 10.1074/jbc.271.46.29043; Shen HF, 1997, J BIOL CHEM, V272, P11215; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Sherman F, 1986, LAB COURSE MANUAL ME; SIKORSKI RS, 1989, GENETICS, V122, P19; SNEL MME, 1995, BIOCHEMISTRY-US, V34, P3605, DOI 10.1021/bi00011a015; Stevens B., 1981, MOL BIOL YEAST SACCH, V11, P471; SUBIK J, 1974, FEBS LETT, V42, P309, DOI 10.1016/0014-5793(74)80753-2; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Weeks R, 1997, DNA CELL BIOL, V16, P281, DOI 10.1089/dna.1997.16.281; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	36	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11638	11642		10.1074/jbc.273.19.11638	http://dx.doi.org/10.1074/jbc.273.19.11638			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565583	hybrid			2022-12-27	WOS:000073536700037
J	Alterio, J; Ravassard, P; Haavik, J; Le Caer, JP; Biguet, NF; Waksman, G; Mallet, J				Alterio, J; Ravassard, P; Haavik, J; Le Caer, JP; Biguet, NF; Waksman, G; Mallet, J			Human tyrosine hydroxylase isoforms - Inhibition by excess tetrahydropterin and unusual behavior of isoform 3 after camp-dependent protein kinase phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; ACTIVATES TRYPTOPHAN 5-MONOOXYGENASE; MESSENGER-RNA; CYCLIC-AMP; 14-3-3 PROTEIN; PHORBOL ESTER; CLONED GENES; CDNA CLONE; 3-MONOOXYGENASE; EXPRESSION	Human tyrosine hydroxylase exists as four isoforms (hTH1-4), generated by alternative splicing of pre-mRNA, with tissue-specific distribution. Unphosphorylated hTH3 and hTH1 were produced in large amounts in Escherichia coli and purified to homogeneity. The phosphorylation sites were determined after labeling with [P-32]phosphate in the presence of cAMP-dependent protein kinase (PKA) and calmodulin-dependent protein kinase II (CaM-PKII). Ser(40) was phosphorylated by PKA, and both Ser(19) and Ser(40) were phosphorylated by CaM-PKII., The enzyme kinetics of hTH3 were determined in the presence of various concentrations of the natural co substrate (GR)-tetrahydrobiopterin and compared with those of recombinant hTH1 (similar to rat TH). We show that, under initial velocity conditions, excess (GR)-tetrahydrobiopterin inhibits hTH3 and hTH1, The TH catalytic constants (k(cat),,,) were determined for each of the two isoenzymes: hTH3 is about five times more active than hTH1. Phosphorylation by CaM-PKII did not affect the kinetic parameters of hTH3., The classical activation of TH by PKA phosphorylation, demonstrated for hTH1, was not observed with hTH3, Furthermore, hTH3 escapes activity regulation by phosphorylation and is always more active than phosphorylated hTH1, The properties of the hTH3 enzyme may be relevant to diseases affecting dopaminergic cells.	Hop La Pitie Salpetriere, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, F-75013 Paris, France; Univ Bergen, Dept Biochem & Mol Biol, N-5009 Bergen, Norway; Ecole Super Phys & Chim Ind, Biol Lab, F-75231 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Bergen; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Mallet, J (corresponding author), Hop La Pitie Salpetriere, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, LGN Batiment CERVI,83 Bd Hop, F-75013 Paris, France.		Haavik, Jan/AAI-3974-2020; Haavik, Jan/ABE-1535-2020	Haavik, Jan/0000-0001-7865-2808; ravassard, philippe/0000-0002-0393-9262				ABOUDONIA MM, 1981, P NATL ACAD SCI-BIOL, V78, P2703, DOI 10.1073/pnas.78.5.2703; ATKINSON J, 1987, J NEUROCHEM, V49, P1241, DOI 10.1111/j.1471-4159.1987.tb10016.x; AXELROD J, 1956, BIOCHEM J, V63, P634, DOI 10.1042/bj0630634; BIRMAN S, 1994, J BIOL CHEM, V269, P26559; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; D'MELLO SR, 1988, J NEUROSCI RES, V19, P440, DOI 10.1002/jnr.490190408; DAUBNER SC, 1992, J BIOL CHEM, V267, P12639; Dixon M, 1958, ENZYMES, P81; Dumas S, 1996, J NEUROCHEM, V67, P19; FITZPATRICK PF, 1990, J BIOL CHEM, V265, P2042; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P617, DOI 10.1073/pnas.82.2.617; HAAVIK J, 1990, FEBS LETT, V262, P363, DOI 10.1016/0014-5793(90)80230-G; HAAVIK J, 1991, EUR J BIOCHEM, V199, P371, DOI 10.1111/j.1432-1033.1991.tb16133.x; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; HIRATA Y, 1985, BIOCHEM PHARMACOL, V34, P2637, DOI 10.1016/0006-2952(85)90560-X; HORELLOU P, 1994, NEUROREPORT, V6, P49, DOI 10.1097/00001756-199412300-00014; HORELLOU P, 1988, J NEUROCHEM, V51, P652, DOI 10.1111/j.1471-4159.1988.tb01088.x; ICHIKAWA S, 1990, BIOCHEM BIOPH RES CO, V173, P1331, DOI 10.1016/S0006-291X(05)80933-7; ICHIKAWA S, 1991, BIOCHEM BIOPH RES CO, V176, P1610, DOI 10.1016/0006-291X(91)90472-J; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; ICHIMURA T, 1987, FEBS LETT, V219, P79, DOI 10.1016/0014-5793(87)81194-8; ISHII A, 1991, BIOCHEM BIOPH RES CO, V176, P1051, DOI 10.1016/0006-291X(91)90389-O; KANEDA N, 1987, BIOCHEM BIOPH RES CO, V146, P971, DOI 10.1016/0006-291X(87)90742-X; LEBOURDELLES B, 1988, J NEUROCHEM, V50, P988; LEBOURDELLES B, 1991, J BIOL CHEM, V266, P17124; LEWIS DA, 1993, NEUROSCIENCE, V54, P477, DOI 10.1016/0306-4522(93)90267-J; Martinez A, 1996, J BIOL CHEM, V271, P19737, DOI 10.1074/jbc.271.33.19737; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; NAGATSU T, 1983, NEUROCHEM INT, V5, P27, DOI 10.1016/0197-0186(83)90005-0; NASRIN S, 1994, J BIOCHEM-TOKYO, V116, P393, DOI 10.1093/oxfordjournals.jbchem.a124537; NICHOL CA, 1985, ANNU REV BIOCHEM, V54, P729, DOI 10.1146/annurev.biochem.54.1.729; OKUNO S, 1991, J NEUROCHEM, V57, P53, DOI 10.1111/j.1471-4159.1991.tb02098.x; POCOTTE SL, 1986, J BIOL CHEM, V261, P1873; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; RIBEIRO P, 1992, P NATL ACAD SCI USA, V89, P9593, DOI 10.1073/pnas.89.20.9593; SAADAT S, 1987, J BIOL CHEM, V262, P13007; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; TACHIKAWA E, 1987, J NEUROCHEM, V48, P1366, DOI 10.1111/j.1471-4159.1987.tb05673.x; VRANA KE, 1994, J NEUROCHEM, V63, P2014; VULLIET PR, 1985, FEBS LETT, V182, P335, DOI 10.1016/0014-5793(85)80328-8; WAYMIRE JC, 1991, J NEUROCHEM, V57, P1313, DOI 10.1111/j.1471-4159.1991.tb08296.x; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404	46	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10196	10201		10.1074/jbc.273.17.10196	http://dx.doi.org/10.1074/jbc.273.17.10196			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553069	hybrid			2022-12-27	WOS:000073224200018
J	Griffith, CE; Zhang, WG; Wange, RL				Griffith, CE; Zhang, WG; Wange, RL			ZAP-70-dependent and -independent activation of Erk in Jurkat T cells - Differences in signaling induced by H2O2 and CD3 cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; ANTIGEN RECEPTOR-ZETA; HYDROGEN-PEROXIDE; LYMPHOCYTES-T; ZAP-70; PHOSPHORYLATION; TRANSDUCTION; EXPRESSION; SLP-76; PATHWAYS	Oxidative stress in T cells induces signaling events similar to those initiated by T cell antigen receptor engagement, including tyrosine phosphorylation and activation of the critical protein-tyrosine kinase ZAP-70. Distal signaling events such as the activation of mitogen-activated protein kinases and downstream transcription factors are also initiated by oxidative stimuli. In this study Pile, a ZAP-70-negative Jurkat T cell line, was used to investigate the role of ZAP-70 in mediating activation of Erk in response to H2O2. Consistent with the hypothesis that ZAP-70 is required for activation of Erk in response to an oxidative stimulus, Erk1 and Erk2 could be rapidly activated in Jurkat cells but not in P116 cells upon addition of H2O2. P116 cells became competent for H2O2-induced Erk activation upon stable transfection with wild-type ZAP-70. An in vivo ZAP-70 substrate, SLP-76, implicated in Erk activation, also became rapidly tyrosine-phosphorylated in Jurkat cells, but not in P116 cells, upon treatment with H2O2. Surprisingly, although ZAP-70 was required for H2O2-mediated Erk activation, Erk activation in response to T cell antigen receptor engagement did not require ZAP-70. In addition to demonstrating a requirement for ZAP-70 in H2O2-stimulated Erk activation, these results provide the first evidence for the existence of a ZAP-70-independent pathway for Erk activation in T cells.	NIA, Biol Chem Lab, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA; NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Wange, RL (corresponding author), NIA, Biol Chem Lab, Gerontol Res Ctr, NIH, MSC 12,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	wanger@grc.nia.nih.gov	Wange, Ronald/AAI-2505-2021	Wange, Ronald/0000-0001-9593-3572				Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAUDHRI G, 1988, CELL IMMUNOL, V115, P204, DOI 10.1016/0008-8749(88)90174-8; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DROGE W, 1994, METHOD ENZYMOL, V234, P135; Eischen CM, 1997, J IMMUNOL, V159, P1135; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; HOMANMULLER JWT, 1975, J LAB CLIN MED, V85, P198; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Koretzky GA, 1997, IMMUNOL TODAY, V18, P401, DOI 10.1016/S0167-5699(97)01088-8; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Liu BQ, 1996, J IMMUNOL, V157, P160; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; LOS M, 1995, EUR J IMMUNOL, V25, P159, DOI 10.1002/eji.1830250127; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; Musci MA, 1997, J IMMUNOL, V159, P1639; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; NOVOGRODSKY A, 1982, P NATL ACAD SCI-BIOL, V79, P1171, DOI 10.1073/pnas.79.4.1171; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Osman N, 1996, EUR J IMMUNOL, V26, P1063, DOI 10.1002/eji.1830260516; OSMAN N, 1995, J BIOL CHEM, V270, P13981, DOI 10.1074/jbc.270.23.13981; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; QINA D, 1997, CURR OPIN CELL BIOL, V9, P205; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; SCHIEVEN GL, 1994, J BIOL CHEM, V269, P20718; SCHIEVEN GL, 1994, TRENDS ENDOCRIN MET, V5, P383, DOI 10.1016/1043-2760(94)90106-6; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SOZERI O, 1992, ONCOGENE, V7, P2259; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TIKU ML, 1990, J IMMUNOL, V145, P690; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WANGE RL, 1995, J BIOL CHEM, V270, P944, DOI 10.1074/jbc.270.2.944; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9	52	79	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10771	10776		10.1074/jbc.273.17.10771	http://dx.doi.org/10.1074/jbc.273.17.10771			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553143	hybrid			2022-12-27	WOS:000073224200092
J	Lee, SJ; Ha, MJ; Lee, J; Nguyen, P; Choi, YH; Pirnia, F; Kang, WK; Wang, XF; Kim, SJ; Trepel, JB				Lee, SJ; Ha, MJ; Lee, J; Nguyen, P; Choi, YH; Pirnia, F; Kang, WK; Wang, XF; Kim, SJ; Trepel, JB			Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA-SUSCEPTIBILITY GENE; CYCLIN-DEPENDENT KINASES; GROWTH-FACTOR-BETA; COMPETITIVE INHIBITOR; MEVALONATE PATHWAY; INDUCED APOPTOSIS; CDK INHIBITOR; CANCER-CELLS; G(1) ARREST; RB PROTEIN	Progression through the cell cycle is controlled by the induction of cyclins and the activation of cognate cyclin-dependent kinases. The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor lovastatin induces growth arrest and cell death in certain cancer cell types. We have pursued the mechanism of growth arrest in PC-3-M cells, a p53-null human prostate carcinoma cell line. Lovastatin treatment increased protein and mRNA levels of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1), increased binding of p21 with Cdk2, markedly inhibited cyclin E-and Cdk2-associated phosphorylation of histone H1 or GST-retinoblastoma protein, enhanced binding of the retinoblastoma protein to the transcription factor E2F-1 in vivo, and induced the activation of a p21 promoter reporter construct. By using p21 promoter deletion constructs, the lovastatin-responsive element was mapped to a region between -93 and -64 relative to the transcription start site. Promoter mutation analysis indicated that the lovastatin-responsive site coincided with the previously identified transforming growth factor-beta-responsive element. These data indicate that in human prostate carcinoma cells an inhibitor of the HMG-CoA reductase pathway can circumvent the loss of wild-type p53 function and induce critical downstream regulatory events leading to transcriptional activation of p21.	NCI, Med Branch, NIH, Div Clin Sci, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; NCI, Chemoprevent Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Trepel, JB (corresponding author), NCI, Med Branch, NIH, Div Clin Sci, Bldg 10,Rm 12N226, Bethesda, MD 20892 USA.							ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; BANG YJ, 1992, P NATL ACAD SCI USA, V89, P3556, DOI 10.1073/pnas.89.8.3556; BANSAL N, 1991, FASEB J, V5, P211, DOI 10.1096/fasebj.5.2.2004665; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; BORNER MM, 1995, CANCER RES, V55, P2122; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; CLURMAN BE, 1995, J NATL CANCER I, V87, P1499, DOI 10.1093/jnci/87.20.1499; COFFEY DS, 1993, CANCER S, V3, P880; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DECLUE JE, 1991, CANCER RES, V51, P712; DRAETTA GF, 1994, CURR OPIN CELL BIOL, V6, P842, DOI 10.1016/0955-0674(94)90054-X; FANG WG, 1992, J CLIN INVEST, V89, P191, DOI 10.1172/JCI115562; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GOLDSTEIN JL, 1979, J BIOL CHEM, V254, P5403; GrayBablin J, 1997, CANCER RES, V57, P604; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HE J, 1994, CANCER RES, V54, P5804; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; ISSACS WB, 1991, CANCER RES, V51, P4716; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; KEYUMARSI K, 1991, CANCER RES, V51, P3602; KIM SJ, 1991, P NATL ACAD SCI USA, V88, P3052, DOI 10.1073/pnas.88.8.3052; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KINZLER KW, 1994, NEW ENGL J MED, V331, P49, DOI 10.1056/NEJM199407073310113; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; LATHANGUE NB, 1994, TRENDS BIOCHEM SCI, V19, P108, DOI 10.1016/0968-0004(94)90202-X; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; MALTESE WA, 1985, J CLIN INVEST, V76, P1748, DOI 10.1172/JCI112165; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PEREZSALA D, 1995, J BIOL CHEM, V270, P6235, DOI 10.1074/jbc.270.11.6235; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; SCHERR CJ, 1995, GENE DEV, V9, P1149; Schnier JB, 1996, P NATL ACAD SCI USA, V93, P5941, DOI 10.1073/pnas.93.12.5941; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Thibault A, 1996, CLIN CANCER RES, V2, P483; UDVADIA AJ, 1993, P NATL ACAD SCI USA, V90, P3265, DOI 10.1073/pnas.90.8.3265; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WALDMAN T, 1995, CANCER RES, V55, P5187; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zeng YX, 1996, ONCOGENE, V12, P1557; ZHANG RD, 1991, INVAS METAST, V11, P204	57	152	155	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10618	10623		10.1074/jbc.273.17.10618	http://dx.doi.org/10.1074/jbc.273.17.10618			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553123	hybrid			2022-12-27	WOS:000073224200072
J	Bauer, PH; Bluml, K; Schroder, S; Hegler, J; Dees, C; Lohse, MJ				Bauer, PH; Bluml, K; Schroder, S; Hegler, J; Dees, C; Lohse, MJ			Interactions of phosducin with the subunits of G-proteins - Binding to the alpha as well as the beta gamma subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENERGIC-RECEPTOR KINASE; GTPASE-ACTIVATING PROTEINS; HETEROTRIMERIC G-PROTEINS; DEPENDENT PHOSPHORYLATION; GUANINE-NUCLEOTIDES; ADENOSINE RECEPTORS; TRANSDUCIN; COMPLEX; REGULATOR; DESENSITIZATION	The high affinity interactions of phosducin with G-proteins involve binding of phosducin to the G-protein beta gamma subunits. Here we have investigated whether phosducin interacts also with G-protein alpha subunits, Interactions of phosducin with the individual subunits of G(o) were measured by retaining phosducin-G-protein subunit complexes on columns containing immobilized anti-phosducin antibodies, Both the alpha and the beta subunits of trimeric G(o) were specifically retained by the antibodies in the presence of phosducin, This binding was almost completely abolished for both subunits following protein kinase A-mediated phosphorylation of phosducin and was reduced, more for alpha than for beta subunits, by the stable GTP analog guanosine 5'-(3-O-thio)triphosphate. Isolated alpha(o) was also retained on the columns in the presence of phosducin but not in the presence of protein kinase A-phosphorylated phosducin, Likewise, purified G-protein beta gamma subunit complexes as well as purified alpha subunits of G(o) and G(t) were precipitated together with His(6)-tagged phosducin with nickel-agarose; this co-precipitation occurred concentration-dependently, with apparent affinities for phosducin of 55 nM (G(beta gamma)), 110 nM (alpha(o)), and 200 nM (alpha(t)). In functional experiments, the steady state GTPase activity of isolated alpha(o) was inhibited by phosducin by approximate to 60% with an IC50 value of approximate to 300 nM, whereas the GTPase activity of trineric G(o) was inhibited by approximate to 90% with an IC50 value of approximate to 10 nM. Phosducin did not inhibit the GTP-hydrolytic activity of isolated alpha, as measured by single-turnover assays, but it inhibited the release of GDP from alpha(o); the rate constant of GDP release was decreased approximate to 40% by 500 nM phosducin, and the inhibition occurred with an IC50 value for phosducin of approximate to 100 nM. These data suggest that phosducin binds with high affinity to G-protein beta gamma subunits and with lower affinity to G-protein alpha subunits, We propose that the alpha subunit-mediated effects of phosducin might increase both the extent and the rapidity of its inhibitory effects compared with an action via the beta gamma subunit complex alone.	Univ Wurzburg, Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany	University of Wurzburg	Lohse, MJ (corresponding author), Univ Wurzburg, Inst Pharmakol & Toxikol, Versbacher Str 9, D-97078 Wurzburg, Germany.		Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510				BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; BAUER PH, 1998, IN PRESS NAUNYNSCHMI, V357; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; Bluml K, 1997, EMBO J, V16, P4908, DOI 10.1093/emboj/16.16.4908; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Danner S, 1996, P NATL ACAD SCI USA, V93, P10145, DOI 10.1073/pnas.93.19.10145; FREISSMUTH M, 1989, J BIOL CHEM, V264, P21907; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; GIERSCHIK P, 1984, FEBS LETT, V72, P321; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAGA K, 1990, FEBS LETT, V268, P43, DOI 10.1016/0014-5793(90)80968-O; HAWES BE, 1994, J BIOL CHEM, V269, P29825; HEKMAN M, 1994, FEBS LETT, V343, P120, DOI 10.1016/0014-5793(94)80302-1; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KUO CH, 1989, BIOCHEM BIOPH RES CO, V162, P1063, DOI 10.1016/0006-291X(89)90781-X; LEE RH, 1987, BIOCHEMISTRY-US, V26, P3983, DOI 10.1021/bi00387a036; LEE RH, 1992, J BIOL CHEM, V267, P25104; LOHSE MJ, 1986, MOL PHARMACOL, V30, P403; LOHSE MJ, 1984, MOL PHARMACOL, V26, P1; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; MULLER S, 1993, P NATL ACAD SCI USA, V90, P10439, DOI 10.1073/pnas.90.22.10439; MULLER S, 1995, BIOCHEM SOC T, V23, P141; Muller S, 1996, J BIOL CHEM, V271, P11781, DOI 10.1074/jbc.271.20.11781; Muller S, 1997, FEBS LETT, V401, P25, DOI 10.1016/S0014-5793(96)01424-X; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; OFFERMANNS S, 1994, N-S ARCH PHARMACOL, V350, P329; REIG JA, 1990, J BIOL CHEM, V265, P5816; Schulz K, 1996, J BIOL CHEM, V271, P22546, DOI 10.1074/jbc.271.37.22546; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRITTMATTER SM, 1991, J BIOL CHEM, V266, P22465; SUGDEN PH, 1976, BIOCHEM J, V159, P409, DOI 10.1042/bj1590409; Thibault C, 1997, J BIOL CHEM, V272, P12253, DOI 10.1074/jbc.272.19.12253; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; XU J, 1995, P NATL ACAD SCI USA, V92, P2086, DOI 10.1073/pnas.92.6.2086; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050	40	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9465	9471		10.1074/jbc.273.16.9465	http://dx.doi.org/10.1074/jbc.273.16.9465			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545273	hybrid			2022-12-27	WOS:000073128800019
J	Hirao, A; Huang, XL; Suda, T; Yamaguchi, N				Hirao, A; Huang, XL; Suda, T; Yamaguchi, N			Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; FAMILY KINASES; SIGNAL-TRANSDUCTION; T-LYMPHOCYTES; CSK; PROTEIN; GENE; INTEGRINS; ADHESION; FIBRONECTIN	The Csk homologous kinase (Chk), which is co-expressed with C-terminal Src kinase (Csk) in hematopoietic cells, negatively regulates Src family kinases in vitro with selectivity toward Lyn but not c-Src in platelets. To explore the role of Src family kinases in hematopoietic cell adhesion, we overexpressed Chk in the megakaryocytic cell line Dami and established clones exhibiting a 10-fold increase in the amount of Chk. Overexpression of Chk was found to suppress VLA5 integrin-mediated cell spreading, but not cell attachment, throughout fibronectin (FN) stimulation. Deletion and point mutagenesis analyses of Chk showed that this suppression was dependent upon both the SH3 domain, which is responsible for membrane anchoring, and kinase activity. FN-induced cell spreading accompanied a sustained increase in Lyn activity with coincidental kinetics and the activation of Lyn was also suppressed by overexpression of Chk but not a Chk mutant lacking the SH3 domain. Expression of a truncated Lyn mutant lacking the kinase domain inhibited both cell spreading and Lyn activation upon stimulation with FN. These results suggest that sustained activation of Lyn, which is regulated by membrane-anchored Chk, plays a crucial role in VLA5-mediated cell spreading but not cell attachment to a FN substrate.	Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Cell Differentiat, Kumamoto 8600811, Japan	Kumamoto University	Yamaguchi, N (corresponding author), Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Cell Differentiat, Honjo 2-2-1, Kumamoto 8600811, Japan.		Suda, Toshio/H-6761-2013	Suda, Toshio/0000-0001-7540-1771				AVRAHAM S, 1995, J BIOL CHEM, V270, P1833, DOI 10.1074/jbc.270.4.1833; BENNETT BD, 1994, J BIOL CHEM, V269, P1068; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; BERGMAN M, 1995, MOL CELL BIOL, V15, P711; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; CHOW LML, 1994, ONCOGENE, V9, P3437; CHOW LML, 1994, P NATL ACAD SCI USA, V91, P4975, DOI 10.1073/pnas.91.11.4975; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; Davidson D, 1997, J BIOL CHEM, V272, P1355, DOI 10.1074/jbc.272.2.1355; FUKUDA MN, 1995, GENE DEV, V9, P1199, DOI 10.1101/gad.9.10.1199; GREENBERG SM, 1988, BLOOD, V72, P1968; HAMAGUCHI I, 1994, ONCOGENE, V9, P3371; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402, DOI 10.1128/MCB.14.8.5402; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; JHUN BH, 1995, J BIOL CHEM, V270, P9661, DOI 10.1074/jbc.270.16.9661; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; KLAGES S, 1994, P NATL ACAD SCI USA, V91, P2597, DOI 10.1073/pnas.91.7.2597; KUCHINKE W, 1994, BIOCHEM BIOPH RES CO, V204, P606, DOI 10.1006/bbrc.1994.2502; KUO SS, 1994, J NEUROSCI RES, V38, P705, DOI 10.1002/jnr.490380613; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; MCVICAR DW, 1994, ONCOGENE, V9, P2037; MIYAKE K, 1992, J CELL BIOL, V119, P653, DOI 10.1083/jcb.119.3.653; MUSSO T, 1994, J EXP MED, V180, P2383, DOI 10.1084/jem.180.6.2383; MUSTELIN T, 1993, TRENDS BIOCHEM SCI, V18, P215, DOI 10.1016/0968-0004(93)90192-P; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; OKADA M, 1989, J BIOL CHEM, V264, P20886; OKADA M, 1991, J BIOL CHEM, V266, P24249; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; RYAN DH, 1991, J CLIN INVEST, V88, P995, DOI 10.1172/JCI115403; SABE H, 1992, P NATL ACAD SCI USA, V89, P2190, DOI 10.1073/pnas.89.6.2190; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; SAKANO S, 1994, ONCOGENE, V9, P1155; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SUGAHARA H, 1994, J EXP MED, V179, P1757, DOI 10.1084/jem.179.6.1757; TAMURA S, 1990, BLOOD, V76, P501; VANNHIEU GT, 1993, EMBO J, V12, P1887, DOI 10.1002/j.1460-2075.1993.tb05837.x; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; ZrihanLicht S, 1997, J BIOL CHEM, V272, P1856, DOI 10.1074/jbc.272.3.1856	45	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10004	10010		10.1074/jbc.273.16.10004	http://dx.doi.org/10.1074/jbc.273.16.10004			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545346	hybrid			2022-12-27	WOS:000073128800092
J	Misra, HS; Pandey, PK; Pandey, VN				Misra, HS; Pandey, PK; Pandey, VN			An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; DNA-POLYMERASE; PURIFICATION; INHIBITOR; P51	The existence of retroviral reverse transcriptases as monomers or dimers is rather intriguing. A classical example of the former is murine leukemia virus reverse transcriptase (MuLV RT), while human immunodeficiency virus type 1 (HIV-1) RT represents the latter. A careful scrutiny of the amino acid sequence alignment of the two enzymes pinpoints the region tentatively responsible for this phenomenon. We report here the construction of a chimeric enzyme containing the first 425 amino acid residues from the N-terminal domain of HIV-1 RT and 200 amino acid residues from the C-terminal domain of MuLV RT. The chimeric enzyme exists as a monomer with intact DNA polymerase and RNase-H functions.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Pandey, VN (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.			Pandey, Virendra N/0000-0001-6041-6786; Misra, Hari/0000-0002-9349-1229	NATIONAL CANCER INSTITUTE [R01CA072821, R29CA072821] Funding Source: NIH RePORTER; NCI NIH HHS [CA72821] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chowdhury K, 1996, BIOCHEMISTRY-US, V35, P16610, DOI 10.1021/bi961462l; HIZI A, 1990, VIROLOGY, V175, P575, DOI 10.1016/0042-6822(90)90444-V; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JONCKHEERE H, 1994, J BIOL CHEM, V269, P25255; Kaushik N, 1997, BIOCHEMISTRY-US, V36, P14430, DOI 10.1021/bi970645k; Kaushik N, 1996, BIOCHEMISTRY-US, V35, P11536, DOI 10.1021/bi960364x; Kaushik N, 1996, BIOCHEMISTRY-US, V35, P7256, DOI 10.1021/bi960537i; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lee R, 1998, BIOCHEMISTRY-US, V37, P900, DOI 10.1021/bi972197m; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; Maxam A M, 1980, Methods Enzymol, V65, P499; MODAK MJ, 1977, J BIOL CHEM, V252, P11; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; POST K, 1993, BIOCHEMISTRY-US, V32, P5508, DOI 10.1021/bi00072a004; RICHTERCOOK NJ, 1992, J BIOL CHEM, V267, P15952; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; TELESNITSKY A, 1993, P NATL ACAD SCI USA, V90, P1276, DOI 10.1073/pnas.90.4.1276; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wohrl BM, 1997, J BIOL CHEM, V272, P17581, DOI 10.1074/jbc.272.28.17581; WONDRAK EM, 1986, J GEN VIROL, V67, P2791, DOI 10.1099/0022-1317-67-12-2791	24	28	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9785	9789		10.1074/jbc.273.16.9785	http://dx.doi.org/10.1074/jbc.273.16.9785			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545316	hybrid			2022-12-27	WOS:000073128800062
J	Oeda, E; Oka, Y; Miyazono, K; Kawabata, M				Oeda, E; Oka, Y; Miyazono, K; Kawabata, M			Interaction of Drosophila inhibitors of apoptosis with thick veins, a type I serine/threonine kinase receptor for decapentaplegic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; PROTEIN TRANSFERASE-ALPHA; MAMMALIAN-CELLS; SIGNALING COMPLEX; CONSERVED FAMILY; BACULOVIRUS IAP; DPP RECEPTORS; GENE; IDENTIFICATION; SUPERFAMILY	Decapentaplegic (Dpp) is a Drosophila member of bone morphogenetic proteins, which belong to the transforming growth factor-beta superfamily. Members of this family regulate a variety of biological processes such as cell proliferation, morphogenesis, immune response, and apoptosis. Dpp plays a critical role in many aspects of Drosophila development. Members of the transforming growth factor-beta superfamily bind to two different types of serine/threonine kinase receptors, termed type I and type II. Type I receptors act as downstream components of type II receptors in the receptor complexes. Therefore, intracellular proteins that interact with the type I receptors are likely to play important roles in signaling. Several proteins have been identified through protein-protein interaction screenings. We identified Drosophila inhibitor of apoptosis (DIAP) 1 as an interacting protein of a Dpp type I receptor, Thick veins (Tkv). DIAP1 associates with Tkv in vivo. The binding region in DIAP1 is mapped to its C-terminal RING finger region. DIAP2, another Drosophila member of the inhibitor of apoptosis protein family, also interacts with Tkv in vivo. These data suggest that DIAP1 and DIAP2 may be involved, possibly as negative regulators, in the Dpp signaling pathway, which leads to cell apoptosis.	Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, Tokyo 1708455, Japan; Japan Soc Promot Sci, Res Future Program, Toshima Ku, Tokyo 1708455, Japan; Yamaguchi Univ, Sch Med, Dept Internal Med 3, Ube, Yamaguchi 7558505, Japan	Japanese Foundation for Cancer Research; Japan Society for the Promotion of Science; Yamaguchi University	Kawabata, M (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, 1-37-1 Kami Ikebukuro, Tokyo 1708455, Japan.							BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Charng MJ, 1996, J BIOL CHEM, V271, P22941, DOI 10.1074/jbc.271.38.22941; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; Chen RH, 1997, CELL GROWTH DIFFER, V8, P821; Chen Y, 1997, P NATL ACAD SCI USA, V94, P12938, DOI 10.1073/pnas.94.24.12938; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; CHILDS SR, 1993, P NATL ACAD SCI USA, V90, P9475, DOI 10.1073/pnas.90.20.9475; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; KAWABATA M, 1995, J BIOL CHEM, V270, P29628; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; Okadome T, 1996, J BIOL CHEM, V271, P21687, DOI 10.1074/jbc.271.36.21687; Padgett Richard W., 1997, Cytokine and Growth Factor Reviews, V8, P1, DOI 10.1016/S1359-6101(96)00050-0; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P309, DOI 10.1021/bi951880a; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Ventura F, 1996, J BIOL CHEM, V271, P13931, DOI 10.1074/jbc.271.24.13931; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Wang TW, 1996, SCIENCE, V271, P1120, DOI 10.1126/science.271.5252.1120; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; WANT T, 1996, CELL, V86, P435; Wiersdorff V, 1996, DEVELOPMENT, V122, P2153; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	40	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9353	9356		10.1074/jbc.273.16.9353	http://dx.doi.org/10.1074/jbc.273.16.9353			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545255	hybrid			2022-12-27	WOS:000073128800001
J	Liu, XX; Malbon, CC; Wang, HY				Liu, XX; Malbon, CC; Wang, HY			Identification of amino acid residues of Gs alpha critical to repression of adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; ADIPOSE CELL LINE; DIFFERENTIATION; SUBUNIT; ADIPOCYTES; ACTIVATION; CULTURE; INVIVO	Gs alpha regulates the differentiation of 3T3-L1 mouse embryonic fibroblasts to adipocytes, a process termed adipogenesis, Through the expression of chimera created by substituting regions of Gs alpha with corresponding regions of the G protein Gi alpha 2, the domain of Gs alpha involved in repression of adipogenesis was localized to sequence 146-235 of the molecule (Wang, H-y., Johnson, G. L., Liu, X., Malbon, C. C. (1996) J. Biol. Chem. 271, 22022-22029). As a prelude to alanine-scanning mutagenesis, chimeras in Gs alpha constructed from trisection of the sequence 125-213 of Gi alpha 2 mere expressed stably, and clones were evaluated for the ability of the chimera to repress adipogenesis in response to the inducers, dexamethasone and methylisobutylxanthine, in combination. The chimera containing sequence 150-177 of Gi alpha 2 repressed adipogenesis, whereas the chimeras with either sequence 125-149 or 178-213 of Gi alpha 2 failed to repress induction of adipogenesis, Alanine-scanning mutagenesis of these two critical domains was performed first in clusters and then confirmed by analysis of single mutations. Six residues unique to Gs alpha were identified as critical to repression of adipogenesis, Asn(167), Cys(200), Leu(203), Ser(205), Val(214), and Lys(216). Leu(208) and Ser(205) are required in tandem, as mutagenesis to alanine of either one alone was without effect on repressor activity. The remaining four residues are required for repressor activity; mutation of any one of these abolishes the ability of Gsa to repress adipogenesis, although not affecting the ability of the mutant form of Gs alpha to regulate adenylylcyclase, Using conserved landmarks found in the crystal structures of Gi alpha and Gs alpha, the Leu(203) and Ser(205) cluster appears to be exposed, closely aligned and located in switch I region. Asn(167), Val(214), and Lys(216) project to regions on Gs alpha that are exposed in the GTP gamma S-liganded state of the cu subunit. We speculate that these residues constitute an important contact domain between Gs alpha and the effector controlling adipogenesis, which is yet to be identified.	SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, DMDRP,Med Ctr, Stony Brook, NY 11794 USA; SUNY Stony Brook, Hlth Sci Ctr, Dept Mol Pharmacol, DMDRP,Med Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, HY (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, DMDRP,Med Ctr, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020		NIDDK NIH HHS [DK30111] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030111] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWN BL, 1971, BIOCHEM J, V121, P561, DOI 10.1042/bj1210561; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; GUPTA SK, 1991, J CELL BIOCHEM, V47, P359, DOI 10.1002/jcb.240470410; JONES DT, 1987, J BIOL CHEM, V262, P14241; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; OSAWA S, 1990, CELL, V63, P697, DOI 10.1016/0092-8674(90)90136-3; RUSSELL TR, 1976, P NATL ACAD SCI USA, V73, P4516, DOI 10.1073/pnas.73.12.4516; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; SU HL, 1993, AM J PHYSIOL, V265, pC1729, DOI 10.1152/ajpcell.1993.265.6.C1729; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; Wang HY, 1996, J BIOL CHEM, V271, P22022, DOI 10.1074/jbc.271.36.22022; WATKINS DC, 1989, BIOCHEM BIOPH RES CO, V165, P929, DOI 10.1016/0006-291X(89)92692-2; WATKINS DC, 1987, J BIOL CHEM, V262, P10651; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; WATKINS DC, 1989, J BIOL CHEM, V264, P4186	26	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11685	11694		10.1074/jbc.273.19.11685	http://dx.doi.org/10.1074/jbc.273.19.11685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565589	hybrid			2022-12-27	WOS:000073536700043
J	Ali, H; Sozzani, S; Fisher, I; Barr, AJ; Richardson, RM; Haribabu, B; Snyderman, R				Ali, H; Sozzani, S; Fisher, I; Barr, AJ; Richardson, RM; Haribabu, B; Snyderman, R			Differential regulation of formyl peptide and platelet-activating factor receptors - Role of phospholipase C beta(3) phosphorylation by protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; GUINEA-PIG NEUTROPHILS; GTP-BINDING PROTEIN; CHEMOATTRACTANT RECEPTORS; CROSS-DESENSITIZATION; ADENYLATE-CYCLASE; CAMP; FORMYLPEPTIDE; IDENTIFICATION; INTERLEUKIN-8	Formylated peptides (e.g. n-formyl-Met-Leu-Phe (fMLP)) and platelet-activating factor (PAF) mediate chemotactic and cytotoxic responses in leukocytes through receptors coupled to G proteins that activate phospholipase C (PLC), In RBL-2H3 cells, fMLP utilizes a pertussis toxin (pts)-sensitive G protein to activate PLC, whereas PAF utilizes a pts-insensitive G protein. Here we demonstrate that fMLP, but not PAF, enhanced intracellular cAMP levels via a ptx-sensitive mechanism. Protein kinase A (PRA) inhibition by H-89 enhanced inositol phosphate formation stimulated by fMLP but not PAF, Furthermore, a membrane-permeable cAMP analog 8-(4-chlorophenylthio)-cAMP (cpt-cAMP) inhibited phosphoinositide hydrolysis and secretion stimulated by fMLP but not PAF. Both cpt-cAMP and fMLP stimulated PLC beta(3) phosphorylation in intact RBL cells. The purified catalytic subunit of PKA phosphorylated PLC beta(3) immunoprecipitated from RBL cell lysate, Pretreatment of intact cells with cpt-cAMP and fMLP, but not PAF, resulted in an inhibition of subsequent PLC beta(3) phosphorylation by PRA in vitro. These data demonstrate that fMLP receptor, which couples to a ptx-sensitive G protein, activates both PLC and cAMP production. The resulting PKA activation phosphorylates PLC beta(3) and appears to block the ability of G(beta gamma) to activate PLC, Thus, both fMLP and PAF generate stimulatory signals for PLC beta(3), but only fMLP produces a PKA-dependent inhibitory signal. This suggests a novel mechanism for the bidirectional regulation of receptors which activate PLC by ptx-sensitive G proteins.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University	Ali, H (corresponding author), Duke Univ, Med Ctr, Dept Med, 201C MSRB,Box 3680, Durham, NC 27710 USA.	ali00001@mc.duke.edu	Bodduluri, Haribabu/A-2584-2010; Sozzani, Silvano/C-1447-2009	Bodduluri, Haribabu/0000-0002-8261-3294; Sozzani, Silvano/0000-0002-3144-8743; Barr, Alastair/0000-0001-7738-8419	NHLBI NIH HHS [HL-54166] Funding Source: Medline; NIAID NIH HHS [AI-38910] Funding Source: Medline; NIDCR NIH HHS [DE-03738] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL054166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038910, R29AI038910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003738] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ali H, 1997, J BIOL CHEM, V272, P11706, DOI 10.1074/jbc.272.18.11706; ALI H, 1994, J BIOL CHEM, V269, P24557; ALI H, 1993, J BIOL CHEM, V268, P24247; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; Banno Y, 1996, J BIOL CHEM, V271, P14989, DOI 10.1074/jbc.271.25.14989; Choi EJ, 1993, CURR OPIN CELL BIOL, V5, P269, DOI 10.1016/0955-0674(93)90115-7; DAI YL, 1994, J LEUKOCYTE BIOL, V56, P776, DOI 10.1002/jlb.56.6.776; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; KATO H, 1986, BIOCHEM BIOPH RES CO, V139, P1272, DOI 10.1016/S0006-291X(86)80315-1; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; MITSUYAMA T, 1995, MOL CELL BIOCHEM, V145, P19, DOI 10.1007/BF00925708; PARK D, 1992, J BIOL CHEM, V267, P16048; POLAKIS PG, 1988, J BIOL CHEM, V263, P4969; Premont RT, 1996, J BIOL CHEM, V271, P13900, DOI 10.1074/jbc.271.23.13900; RENSDOMIANO S, 1995, FASEB J, V9, P1059, DOI 10.1096/fasebj.9.11.7649405; RICHARDON RM, 1995, J BIOL CHEM, V270, P27829, DOI 10.1074/jbc.270.46.27829; Richardson RM, 1996, J BIOL CHEM, V271, P28717, DOI 10.1074/jbc.271.45.28717; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; SCHUDT C, 1991, N-S ARCH PHARMACOL, V344, P682; SIMCHOWITZ L, 1980, J IMMUNOL, V124, P1482; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SNYDERMAN R, 1992, INFLAMMATION BASIC P, P412; Spisani S, 1996, CELL SIGNAL, V8, P269, DOI 10.1016/0898-6568(96)00049-6; Stoffel RH, 1997, J MEMBRANE BIOL, V157, P1, DOI 10.1007/s002329900210; Suzuki T, 1996, BBA-MOL CELL RES, V1313, P72, DOI 10.1016/0167-4889(96)00048-1; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; TSU RC, 1995, MOL PHARMACOL, V47, P835; TSU RC, 1995, BIOCHEM J, V309, P331, DOI 10.1042/bj3090331; UHING RJ, 1992, BIOCHEM BIOPH RES CO, V183, P1033, DOI 10.1016/S0006-291X(05)80294-3; VERGHESE MW, 1985, J BIOL CHEM, V260, P6769; VERGHESE MW, 1987, J IMMUNOL, V138, P4374; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840	35	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11012	11016		10.1074/jbc.273.18.11012	http://dx.doi.org/10.1074/jbc.273.18.11012			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556582	hybrid			2022-12-27	WOS:000073395200034
J	Duina, AA; Marsh, JA; Kurtz, RB; Chang, HCJ; Lindquist, S; Gaber, RF				Duina, AA; Marsh, JA; Kurtz, RB; Chang, HCJ; Lindquist, S; Gaber, RF			The peptidyl-prolyl isomerase domain of the CyP-40 cyclophilin homolog Cpr7 is not required to support growth or glucocorticoid receptor activity in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; CYCLOSPORINE-A-BINDING; HEAT-SHOCK PROTEIN; RETICULOCYTE LYSATE; SIGNAL-TRANSDUCTION; STEROID-RECEPTOR; HSP90; CHAPERONE; IMMUNOPHILINS; HETEROCOMPLEXES	CyP-40 cyclophilins are found in association with molecular chaperone Hsp90-steroid receptor complexes. The amino-terminal portion of these cyclophilins harbors the characteristic peptidyl-prolyl isomerase (PPIase) domain, whereas three copies of the tetratricopeptide (TPR) motif, a structure shown to be involved in protein-protein interactions, and a putative calmodulin-binding domain are located in the carboxyl-terminal half of the protein. The TPR domains mediate binding to Hsp90, but a requirement for the PPIase domain has not been established. To address this, we have investigated the effects of mutations that alter the PPIase domain of the Saccharomyces cerevisiae CyP-40 homolog, Cpr7. Because Cpr7 is required for rapid growth and full Hsp90 activity, a functional assessment of the PPIase domain could be performed in vivo. A mutation in the catalytic domain altering a conserved site predicted to be essential for isomerase activity did not compromise Cpr7 function. Furthermore, deletion of the entire PPIase domain did not significantly affect growth or Hsp90-mediated steroid receptor activity. These results indicate that the TPR-containing carboxyl terminus of Cpr7 is sufficient for fundamental Cpr7-dependent activity.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Northwestern University; Howard Hughes Medical Institute; University of Chicago; University of Chicago	Gaber, RF (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-gaber@nwu.edu	Foreman, Hui-Chen (Jane)/GMW-4448-2022	Foreman, Hui-Chen (Jane)/0000-0001-9640-9780	NIGMS NIH HHS [T32GM-08449, GM25874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449, R01GM025874, R37GM025874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOHEN SP, 1995, SCIENCE, V268, P1303, DOI 10.1126/science.7761850; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Duina AA, 1996, YEAST, V12, P943, DOI 10.1002/(SICI)1097-0061(199608)12:10<943::AID-YEA997>3.0.CO;2-3; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P182; HOFFMANN K, 1995, BIOCHEM J, V307, P5, DOI 10.1042/bj3070005; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Kaiser C., 1994, METHODS YEAST GENETI; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; ONDEK B, 1992, J BIOL CHEM, V267, P16460; OWENSGRILLO JK, 1995, J BIOL CHEM, V270, P20479, DOI 10.1074/jbc.270.35.20479; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; RADANYI C, 1994, P NATL ACAD SCI USA, V91, P11197, DOI 10.1073/pnas.91.23.11197; RATAJCZAK T, 1995, BIOCHEM BIOPH RES CO, V209, P117, DOI 10.1006/bbrc.1995.1478; RUTHERFORD SL, 1994, CELL, V79, P1129, DOI 10.1016/0092-8674(94)90003-5; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; SCHUMACHER RJ, 1994, J BIOL CHEM, V269, P9493; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIKORSKI RS, 1989, GENETICS, V122, P19; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; Thulasiraman V, 1996, BIOCHEMISTRY-US, V35, P13443, DOI 10.1021/bi9615396; Uma S, 1997, J BIOL CHEM, V272, P11648; Warth R, 1997, BIOL CHEM, V378, P381, DOI 10.1515/bchm.1997.378.5.381; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	43	44	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10819	10822		10.1074/jbc.273.18.10819	http://dx.doi.org/10.1074/jbc.273.18.10819			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556552	hybrid			2022-12-27	WOS:000073395200004
J	Nishioka, J; Ning, M; Hayashi, T; Suzuki, K				Nishioka, J; Ning, M; Hayashi, T; Suzuki, K			Protein C inhibitor secreted from activated platelets efficiently inhibits activated protein C on phosphatidylethanolamine of platelet membrane and microvesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-VA; HUMAN-PLASMA; FACTOR-VIII; INTRAVASCULAR COAGULATION; MONOCLONAL-ANTIBODIES; VONWILLEBRAND-FACTOR; CELL-LINE; BINDING; COMPLEX; INACTIVATION	Protein C inhibitor (PCI) was detected in human platelets (2.9 ng/10(9) cells) and megakaryocytic cells (1.5 ng/10(6) cells). PCI mRNA was also detected in both platelets and megakaryocytic cells using nested polymerase chain reaction. PCI was found to be located in the alpha-granules of resting platelets. Approximately 30% of the total amount of PCI in platelets was released after stimulation with ADP, collagen, adrenalin, thrombin, or thrombin receptor-activating peptide. Secreted PCI was detected on the surface of activated platelets and phospholipid microvesicles. PCI secreted from thrombin receptor-activating peptide-stimulated platelets inhibited activated protein C (APC) efficiently. PCI significantly inhibited APC in the presence of phospholipid vesicles prepared using rabbit brain cephalin (RBC) or a mixture of 40% phosphatidylethanolamine (PE), 20% phosphatidylserine (PS), and 40% phosphatidylcholine (PC) with a second order rate constant of 1.0 x 10(6) M-1.min(-1). Of these phospholipids, PE was critical for this inhibition. The dissociation constants of the binding of APC or PCI to solid phase phospholipids showed that APC binds more preferably to PE than to RBC or PS, and PCI to PE or RBC than to PS or PC. PCI binding to solid phase phospholipids depended on the presence of PE. RBC- or PE-bound PCI inhibited APC significantly but only weakly the gamma-carboxyglutamic acid domainless APC. The gamma-carboxyglutamic acid fragment of protein C suppressed the PCI-mediated inhibition of APC on solid phase RBC or PE. Most of the APC PCI complex formed on solid phase RBC or PE was released into the soluble phase. These findings suggest that PCI secreted from activated platelets binds preferably to PE of platelet membrane and microvesicles and that it inhibits phospholipid-bound APC efficiently.	Mie Univ, Sch Med, Dept Mol Pathobiol, Tsu, Mie 514, Japan; Mie Univ, Sch Med, Dept Anat 2, Tsu, Mie 514, Japan	Mie University; Mie University	Suzuki, K (corresponding author), Mie Univ, Sch Med, Dept Mol Pathobiol, Tsu, Mie 514, Japan.							ADACHI M, 1991, EXP HEMATOL, V19, P923; BILLY D, 1995, J BIOL CHEM, V270, P26883, DOI 10.1074/jbc.270.45.26883; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; CHESNEY CM, 1981, P NATL ACAD SCI-BIOL, V78, P5180, DOI 10.1073/pnas.78.8.5180; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLVIN RB, 1986, VASCULAR ENDOTHELIUM, P220; COOPER ST, 1995, BIOCHEMISTRY-US, V34, P12991, DOI 10.1021/bi00040a009; DOOLITTLE RF, 1974, SCIENCE, V185, P368, DOI 10.1126/science.185.4148.368; ESMON NL, 1983, J BIOL CHEM, V258, P5548; ESPANA F, 1991, BLOOD, V77, P1754; ESPANA F, 1989, THROMB RES, V55, P671, DOI 10.1016/0049-3848(89)90298-3; FRANCIS RB, 1984, THROMB HAEMOSTASIS, V52, P71; FRESSINAUD E, 1987, BLOOD, V70, P1214; GILBERT GE, 1995, J BIOL CHEM, V270, P18500, DOI 10.1074/jbc.270.31.18500; GILBERT GE, 1991, J BIOL CHEM, V266, P17261; Gomori G, 1942, J LAB CLIN MED, V27, P955; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; HAYWARD CPM, 1995, J BIOL CHEM, V270, P19217, DOI 10.1074/jbc.270.33.19217; HEEB MJ, 1987, J BIOL CHEM, V262, P15813; HERMANS JM, 1994, BIOCHEMISTRY-US, V33, P5440, DOI 10.1021/bi00184a012; HOFFMAN M, 1992, THROMB HAEMOSTASIS, V68, P74; HOLME PA, 1995, BLOOD COAGUL FIBRIN, V6, P302, DOI 10.1097/00001721-199506000-00002; HOOGENDOORN H, 1990, BLOOD, V75, P2164; HORIE S, 1994, BIOCHEM J, V301, P683, DOI 10.1042/bj3010683; KANE WH, 1982, J BIOL CHEM, V257, P3963; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; KOPPELMAN SJ, 1995, BLOOD, V86, P1062; KOSTETSKII E, 1977, BIOKHIMIYA, V42, P671; LAURELL M, 1992, J CLIN INVEST, V89, P1094, DOI 10.1172/JCI115689; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Mann K G, 1976, Methods Enzymol, V45, P123; MARLAR RA, 1985, BLOOD, V66, P59; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; MOORE A, 1993, MOL REPROD DEV, V34, P280, DOI 10.1002/mrd.1080340308; MORITO F, 1985, BIOCHIM BIOPHYS ACTA, V844, P209, DOI 10.1016/0167-4889(85)90092-8; NAKASE T, 1994, BLOOD COAGUL FIBRIN, V5, P173, DOI 10.1097/00001721-199404000-00003; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Nishioka J, 1996, THROMB HAEMOSTASIS, V75, P275; Oi V.T., 1980, SELECTED METHODS CEL, P351; REZAIE AR, 1995, J BIOL CHEM, V270, P25336, DOI 10.1074/jbc.270.43.25336; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMAIER AH, 1993, BLOOD, V82, P465; SCHWARZ HP, 1989, BLOOD, V74, P213; SHATTIL SJ, 1987, BLOOD, V70, P307; SMIRNOV MD, 1995, J CLIN INVEST, V95, P309, DOI 10.1172/JCI117657; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; SUZUKI K, 1989, THROMB HAEMOSTASIS, V61, P337; SUZUKI K, 1987, J BIOL CHEM, V262, P611; SUZUKI K, 1990, J BIOCHEM, V107, P381, DOI 10.1093/oxfordjournals.jbchem.a123054; SUZUKI K, 1983, J BIOL CHEM, V258, P163; SUZUKI K, 1988, J BIOCHEM-TOKYO, V104, P628, DOI 10.1093/oxfordjournals.jbchem.a122523; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; SUZUKI K, 1985, J BIOCHEM-TOKYO, V97, P127, DOI 10.1093/oxfordjournals.jbchem.a135037; SUZUKI K, 1985, PROTEIN C BIOCH MED, P43; SUZUKI K, 1984, J BIOCHEM-TOKYO, V95, P87; TANIGAWA M, 1995, AM J HEMATOL, V49, P1, DOI 10.1002/ajh.2830490102; WADA H, 1993, AM J HEMATOL, V44, P101, DOI 10.1002/ajh.2830440206; WATKINS SC, 1990, HISTOCHEM J, V22, P507, DOI 10.1007/BF01007236; ZHENG XL, 1994, AM J PHYSIOL, V267, pC466, DOI 10.1152/ajpcell.1994.267.2.C466	59	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11281	11287		10.1074/jbc.273.18.11281	http://dx.doi.org/10.1074/jbc.273.18.11281			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556620	hybrid			2022-12-27	WOS:000073395200072
J	Li, J; Saunders, JC; Fowden, AL; Dauncey, MJ; Gilmour, RS				Li, J; Saunders, JC; Fowden, AL; Dauncey, MJ; Gilmour, RS			Transcriptional regulation of insulin-like growth factor-II gene expression by cortisol in fetal sheep during late gestation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVINE INSULIN; MESSENGER-RNA; 2 PROMOTERS; PLASMID DNA; CELLS; GLUCOCORTICOIDS; IDENTIFICATION; ELEMENTS; SEQUENCE	The objective of this study was to determine the mechanisms by which cortisol down-regulates hepatic insulin-like growth factor-II (IGF-II) gene expression in late gestation. Leader exons 6 and 7 of the ovine IGF-II gene, with their 5'-flanking regions, were first isolated. Characterization of transcription start sites revealed a unique site for exon 6 and three dispersed sites for exon 7. Nuclear run-on assays showed a 5-fold higher transcription rate of the IGF-II gene in liver of adrenalectomized fetuses compared with control animals, suggesting that regulation of IGF-II gene expression by cortisol is at the transcriptional level. RNase protection assays demonstrated hepatic leader exon 7 expression in adrenalectomized fetuses to be more than a-fold higher than in controls, whereas it was reduced by 50% in cortisol-infused fetuses compared with controls. There was no effect on the expression of other leader exons. Functions of the upstream regulatory region of leader exon 7 (i.e. promoter P4) were investigated by luciferase transient expression. A region of -172 bases downstream relative to the first transcription site of leader exon 7 was shown to retain basal promoter activity and respond to cortisol. These results suggest that cortisol may induce the prenatal decline in ovine hepatic IGF-II expression by suppressing promoter P4 of the IGF-II gene.	Babraham Inst, Dept Cellular Physiol, Cambridge CB2 4AT, England; Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Li, J (corresponding author), Babraham Inst, Dept Cellular Physiol, Cambridge CB2 4AT, England.							BELL GI, 1984, NATURE, V310, P775, DOI 10.1038/310775a0; CARICASOLE A, 1993, NUCLEIC ACIDS RES, V21, P1873, DOI 10.1093/nar/21.8.1873; CHATTERJEE VKK, 1991, MOL ENDOCRINOL, V5, P100, DOI 10.1210/mend-5-1-100; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DERCOLE AJ, 1987, J DEV PHYSIOL, V9, P481; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EVANS T, 1988, J MOL BIOL, V199, P61, DOI 10.1016/0022-2836(88)90379-8; FRUNZIO R, 1986, J BIOL CHEM, V261, P7138; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; IKEJIRI K, 1991, BIOCHEM J, V280, P439, DOI 10.1042/bj2800439; LI J, 1993, ENDOCRINOLOGY, V132, P2083, DOI 10.1210/en.132.5.2083; LI J, 1994, THESIS U CAMBRIDGE C; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; OHLSEN SM, 1994, DNA CELL BIOL, V13, P377, DOI 10.1089/dna.1994.13.377; OMAHONEY JV, 1991, MOL CELL ENDOCRINOL, V78, P87, DOI 10.1016/0303-7207(91)90189-Y; PAEK I, 1987, MOL CELL BIOL, V7, P1496, DOI 10.1128/MCB.7.4.1496; RAIZIS AM, 1993, BIOCHEM J, V289, P133, DOI 10.1042/bj2890133; ROBERTS CT, 1986, J BIOL CHEM, V261, P25; ROBINSON PM, 1983, Q J EXP PHYSIOL CMS, V68, P15, DOI 10.1113/expphysiol.1983.sp002697; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; SAUNDERS JC, 1991, J MOL ENDOCRINOL, V7, P233, DOI 10.1677/jme.0.0070233; SILVER M, 1990, EXP PHYSIOL, V75, P285, DOI 10.1113/expphysiol.1990.sp003405; SOARES MB, 1986, J MOL BIOL, V192, P737, DOI 10.1016/0022-2836(86)90025-2; Sussenbach J S, 1989, Prog Growth Factor Res, V1, P33, DOI 10.1016/0955-2235(89)90040-9; VANDIJK MA, 1991, MOL CELL ENDOCRINOL, V81, P81, DOI 10.1016/0303-7207(91)90207-9; VANDIJK MA, 1992, MOL CELL ENDOCRINOL, V88, P175, DOI 10.1016/0303-7207(92)90022-X; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; YEN HFY, 1990, CELL, V62, P1205	35	24	24	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10586	10593		10.1074/jbc.273.17.10586	http://dx.doi.org/10.1074/jbc.273.17.10586			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553119	hybrid			2022-12-27	WOS:000073224200068
J	Tian, WN; Braunstein, LD; Pang, JD; Stuhlmeier, KM; Xi, QC; Tian, XN; Stanton, RC				Tian, WN; Braunstein, LD; Pang, JD; Stuhlmeier, KM; Xi, QC; Tian, XN; Stanton, RC			Importance of glucose-6-phosphate dehydrogenase activity for cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTOSE-PHOSPHATE PATHWAY; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; RAT HEPATOCYTES; TYROSINE PHOSPHORYLATION; MALIC ENZYME; DEHYDROEPIANDROSTERONE; METABOLISM; INHIBITION; MECHANISM	The intracellular redox potential, which is determined by the level of oxidants and reductants, has been shown to play an important role in the regulation of cell growth. The principal intracellular reductant is NADPH, which is mainly produced by the pentose phosphate pathway through the actions of glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the pentose phosphate pathway, and by g-phosphogluconate dehydrogenase. Previous research has suggested that an increase in G6PD activity is important for cell growth. In this article, we suggest that G6PD activity plays a critical role in cell growth by providing NADPH for redox regulation. The results show the following: 1) inhibition of G6PD activity abrogated growth factor stimulation of [H-3]thymidine incorporation in all cell lines tested; 2) overexpression of G6PD stimulated cell growth, as measured by an increase in [H-3]thymidine incorporations as compared with cells transfected with vector alone; 3) inhibition of G6PD caused cells to be more susceptible to the growth inhibitory effects of H2O2; 4) inhibition of G6PD led to a 30-40% decrease in the NADPH/NADP ratio; and 5) inhibition of G6PD inhibited cell anchorage and significantly decreased the growth-related stimulation of tyrosine phosphorylation.	Beth Israel Deaconess Med Ctr, Div Renal, Joslin Diabet Ctr, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Stanton, RC (corresponding author), Beth Israel Deaconess Med Ctr, Div Renal, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	rstanton@bidmc.harvard.edu	Stanton, Robert C/AAG-7584-2020	Stanton, Robert C/0000-0002-3056-1277	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009265] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK09265-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Assoian RK, 1997, CURR OPIN CELL BIOL, V9, P93, DOI 10.1016/S0955-0674(97)80157-3; AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2; BENES P, 1972, J STEROID BIOCHEMIST, V3, P799, DOI 10.1016/0022-4731(72)90031-3; BOCCUZZI G, 1993, ANTICANCER RES, V13, P2267; BURDON RH, 1995, FREE RADICAL RES, V23, P471, DOI 10.3109/10715769509065268; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHIANG CM, 1993, PEPTIDE RES, V6, P62; CONRICODE KM, 1990, J BIOL CHEM, V265, P20931; CRAMER T, 1995, J BIOCHEM TOXICOL, V10, P293; DWORKIN CR, 1986, LIFE SCI, V38, P1451, DOI 10.1016/0024-3205(86)90557-6; EPEL D, 1964, BIOCHEM BIOPH RES CO, V17, P62, DOI 10.1016/0006-291X(64)90301-8; FARQUHAR JK, 1968, P SOC EXP BIOL MED, V129, P809; FARQUHARSON C, 1993, BONE MINER, V22, P105, DOI 10.1016/S0169-6009(08)80222-X; GORDON G, 1995, ARCH BIOCHEM BIOPHYS, V318, P25, DOI 10.1006/abbi.1995.1199; GORDON GB, 1987, ADV ENZYME REGUL, V26, P355, DOI 10.1016/0065-2571(87)90023-9; HENDERSON E, 1981, CARCINOGENESIS, V2, P683, DOI 10.1093/carcin/2.7.683; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; LIN KT, 1995, J BIOL CHEM, V270, P16487, DOI 10.1074/jbc.270.28.16487; Lin TH, 1997, J BIOL CHEM, V272, P8849; Martini G, 1996, BIOESSAYS, V18, P631, DOI 10.1002/bies.950180806; Mazurek S, 1997, J BIOL CHEM, V272, P4941, DOI 10.1074/jbc.272.8.4941; NIORT G, 1985, J STEROID BIOCHEM, V23, P657, DOI 10.1016/0022-4731(85)90018-4; OERTEL GW, 1972, J STEROID BIOCHEMIST, V3, P493, DOI 10.1016/0022-4731(72)90095-7; OMAYE ST, 1991, J TOXICOL ENV HEALTH, V33, P19, DOI 10.1080/15287399109531502; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; REED BY, 1987, J BIOL CHEM, V262, P8712; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SCHAFFER WT, 1985, AM J PHYSIOL, V248, pE719, DOI 10.1152/ajpendo.1985.248.6.E719; SCHIEVEN GL, 1993, J BIOL CHEM, V268, P16688; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; SOCHOR M, 1986, BIOCHEM J, V234, P573, DOI 10.1042/bj2340573; STANTON RC, 1988, AM J PHYSIOL, V254, pC267, DOI 10.1152/ajpcell.1988.254.2.C267; STANTON RC, 1991, J BIOL CHEM, V266, P12442; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; SULIS E, 1972, LANCET, V1, P1185, DOI 10.1016/S0140-6736(72)91416-X; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TIAN WN, 1994, J BIOL CHEM, V269, P14798; TRUDEL S, 1991, BIOCHEM J, V276, P611, DOI 10.1042/bj2760611; Ursini MV, 1997, BIOCHEM J, V323, P801, DOI 10.1042/bj3230801; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; WEBER G, 1987, MOD LIVER CELL EXP, V43, P303; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; WINKLER BS, 1988, INVEST OPHTH VIS SCI, V29, P821; WOOD T, 1985, PENLOSE PHOSPHATE PA; YOSHIMOTO K, 1983, J BIOL CHEM, V258, P2355; ZHANG ZY, 1994, BRAIN RES, V662, P189, DOI 10.1016/0006-8993(94)90812-5	49	380	398	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10609	10617		10.1074/jbc.273.17.10609	http://dx.doi.org/10.1074/jbc.273.17.10609			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553122	hybrid			2022-12-27	WOS:000073224200071
J	Liao, GJ; Gundersen, GG				Liao, GJ; Gundersen, GG			Kinesin is a candidate for cross-bridging microtubules and intermediate filaments - Selective binding of kinesin to detyrosinated tobulin and vimentin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE BRAIN KINESIN; ALPHA-TUBULIN; BETA-TUBULIN; MONOCLONAL-ANTIBODIES; MOTOR DOMAINS; PROTEIN; IDENTIFICATION; DIFFERENTIATION; PURIFICATION; POPULATIONS	We showed previously that stable, detyrosinated (Glu) microtubules function to localize vimentin intermediate filaments in fibroblasts (Gurland, G., and Gundersen, G. G. (1995) J. Cell Biol. 131, 1275-1290), To identify candidate proteins that mediate the Glu microtubule-vimentin interaction, we incubated microtubules with microtubule-interacting proteins and saturating levels of antibodies to Glu or tyrosinated (Tyr) tubulin. Antibodies to Glu tubulin prevented the microtubule binding of kinesin obtained from fibroblast or brain extracts more effectively than antibodies to Tyr tubulin. Scatchard plot analysis showed that kinesin heads bound to Glu microtubules with an similar to 2.8-fold higher affinity than to Tyr microtubules, Purified brain kinesin cosedimented with vimentin, but not with neurofilaments, indicating that kinesin specifically associates with vimentin without accessory molecules. Kinesin binding to vimentin was not sensitive to ATP, and kinesin heads failed to bind to vimentin. By SDS-polyacrylamide gel electrophoresis, a kinesin heavy chain of similar to 120 kDa and a light chain of similar to 64 kDa were detected in vimentin/kinesin pellets. The light chain reacted with a general kinesin light chain antibody, but not with two other antibodies that recognize the two known isoforms of kinesin light chain in brain, suggesting that the kinesin involved in binding to vimentin may be a specific one. These results demonstrate a kinesin-based mechanism for the preferential interaction of vimentin with detyrosinated microtubules.	Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Dept Anat & Cell Biol, 630 W 168th St, New York, NY 10032 USA.				NIAAA NIH HHS [NIAAC 00189] Funding Source: Medline; NIGMS NIH HHS [GM 42026] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042026] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAPIN SJ, 1991, METHOD ENZYMOL, V196, P254; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; GOLDSTEIN LSB, 1993, ANNU REV GENET, V27, P319; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V90, P8827; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; GYOEVA FK, 1991, NATURE, V353, P445, DOI 10.1038/353445a0; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Hirokawa N, 1996, TRENDS CELL BIOL, V6, P135, DOI 10.1016/0962-8924(96)10003-9; HOENGER A, 1995, NATURE, V376, P271, DOI 10.1038/376271a0; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KUMAR N, 1982, EUR J BIOCHEM, V128, P215; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; LAZZARINO DA, 1994, MOL BIOL CELL, V5, P907; LIEM RKH, 1982, BIOCHEMISTRY-US, V21, P3221, DOI 10.1021/bi00256a029; MOYER SA, 1986, P NATL ACAD SCI USA, V83, P5405, DOI 10.1073/pnas.83.15.5405; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; RICKARD JE, 1990, J CELL BIOL, V110, P1623, DOI 10.1083/jcb.110.5.1623; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker C, 1997, J BIOL CHEM, V272, P9481; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; WAGNER MC, 1991, METHOD ENZYMOL, V196, P157; WALKER RA, 1995, P NATL ACAD SCI USA, V92, P5960, DOI 10.1073/pnas.92.13.5960; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEHLAND J, 1983, J CELL BIOL, V97, P1467, DOI 10.1083/jcb.97.5.1467	40	222	232	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9797	9803		10.1074/jbc.273.16.9797	http://dx.doi.org/10.1074/jbc.273.16.9797			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545318	hybrid			2022-12-27	WOS:000073128800064
J	Sick, C; Schultz, U; Munster, U; Meier, J; Kaspers, B; Staeheli, P				Sick, C; Schultz, U; Munster, U; Meier, J; Kaspers, B; Staeheli, P			Promoter structures and differential responses to viral and nonviral inducers of chicken type I interferon genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA PROMOTER; INDUCTION; VIRUS; EXPRESSION; CELLS; GAMMA; INDUCIBILITY; TROPHOBLAST; IMIQUIMOD; ELEMENTS	Two serologically distinct type I interferons (IFNs), designated ChIFN1 and ChIFN2, are known in the chicken. ChIFN1 is encoded by a family of 10 or more genes, whereas ChIFN2 is encoded by a single gene. We show here that ChIFN1 and ChIFN2 transcripts are both strongly induced by Newcastle disease virus in primary chicken macrophages, By contrast, oral administration of the imidazoquinoline S-28463, which selectively induces IFN-alpha in mammals, led to a rapid accumulation of ChIFN1 (but not ChIFN2) transcripts in adult chicken spleen and thymus. The 5'-upstream region of the ChIFN2 gene contains a NF-kappa B consensus motif flanked by a sequence element that could serve as a binding site for transcription factor IRF-1, reminiscent of mammalian IFN-beta promoters, and it mediated powerful virus inducibility in a duck fibroblast cell line when cloned in front of a promoterless luciferase reporter gene. The 5'-upstream region of the cloned ChIFN1 gene contains two putative binding sites for IRF-1, but lacks NF-kappa B-binding sites, and it did not respond well to virus in transfected cells, Thus, the promoters of ChIFN1 and ChIFN2 genes not only exhibited differential responses to nonviral inducers in vivo, but also differed in structure and response to virus in transfected cells. These findings indicate that ChIFN2 represents the avian homolog of mammalian IFN-beta, whereas ChIFN1 seems to correspond to mammalian IFN-alpha.	Univ Freiburg, Inst Med Mikrobiol & Hyg, Dept Virol, Abt Virol, D-79008 Freiburg, Germany; Univ Munich, Inst Tierphysiol, D-80539 Munich, Germany	University of Freiburg; University of Munich	Staeheli, P (corresponding author), Univ Freiburg, Inst Med Mikrobiol & Hyg, Dept Virol, Abt Virol, Hermann Herder Str 11, D-79008 Freiburg, Germany.	staeheli@ukl.uni-freiburg.de						ADOLF GR, 1987, J GEN VIROL, V68, P1669, DOI 10.1099/0022-1317-68-6-1669; AU WC, 1993, J BIOL CHEM, V268, P24032; AU WC, 1992, NUCLEIC ACIDS RES, V20, P2877, DOI 10.1093/nar/20.11.2877; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BAZZIGHER L, 1992, VIROLOGY, V186, P154, DOI 10.1016/0042-6822(92)90069-2; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEMAYER EM, 1988, INTERFERONS OTHER RE; DIGBY MR, 1995, J INTERF CYTOK RES, V15, P939, DOI 10.1089/jir.1995.15.939; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; GAROUFALIS E, 1994, J VIROL, V68, P4707, DOI 10.1128/JVI.68.8.4707-4715.1994; GIBSON SJ, 1995, J INTERF CYTOK RES, V15, P537, DOI 10.1089/jir.1995.15.537; HISCOTT J, 1984, NUCLEIC ACIDS RES, V12, P3727, DOI 10.1093/nar/12.9.3727; HOSS A, 1989, J GEN VIROL, V70, P575, DOI 10.1099/0022-1317-70-3-575; JOKLIK WK, 1990, VIROLOGY, P383; JUNGWIRTH C, 1995, P NATL ACAD SCI USA, V92, P3105, DOI 10.1073/pnas.92.8.3105; KAADEN OR, 1982, IN VITRO CELL DEV B, V18, P827, DOI 10.1007/BF02796323; Karaca K, 1996, J INTERF CYTOK RES, V16, P327, DOI 10.1089/jir.1996.16.327; KUHL D, 1987, CELL, V50, P1057, DOI 10.1016/0092-8674(87)90172-3; LEAMAN DW, 1992, J INTERFERON RES, V12, P1, DOI 10.1089/jir.1992.12.1; LEFEVRE F, 1993, J BIOL CHEM, V268, P19760; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; PECK R, 1982, J IMMUNOL, V129, P4; Roberts RM, 1997, PROG NUCLEIC ACID RE, V56, P287, DOI 10.1016/S0079-6603(08)61008-9; RYALS J, 1985, CELL, V41, P497, DOI 10.1016/S0092-8674(85)80023-4; Sambrook J., 2002, MOL CLONING LAB MANU; SCHULTZ U, 1995, EUR J IMMUNOL, V25, P847, DOI 10.1002/eji.1830250332; SCHULTZ U, 1995, EUR J BIOCHEM, V229, P73, DOI 10.1111/j.1432-1033.1995.tb20439.x; SCHUMACHER B, 1994, VIROLOGY, V203, P144, DOI 10.1006/viro.1994.1464; SEKELLICK MJ, 1986, METHOD ENZYMOL, V119, P115; SEKELLICK MJ, 1994, J INTERFERON RES, V14, P71, DOI 10.1089/jir.1994.14.71; Sick C, 1996, J BIOL CHEM, V271, P7635, DOI 10.1074/jbc.271.13.7635; TANIGUCHI T, 1988, ANNU REV IMMUNOL, V6, P439, DOI 10.1146/annurev.iy.06.040188.002255; TOMAI MA, 1995, ANTIVIR RES, V28, P253, DOI 10.1016/0166-3542(95)00054-P; WEEKS CE, 1994, J INTERFERON RES, V14, P81, DOI 10.1089/jir.1994.14.81; Weining KC, 1996, EUR J IMMUNOL, V26, P2440, DOI 10.1002/eji.1830261026; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4; WILSON V, 1983, J MOL BIOL, V166, P457, DOI 10.1016/S0022-2836(83)80281-2; YOSHIDA I, 1990, J INTERFERON RES, V10, P461, DOI 10.1089/jir.1990.10.461	42	72	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9749	9754		10.1074/jbc.273.16.9749	http://dx.doi.org/10.1074/jbc.273.16.9749			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545311	hybrid			2022-12-27	WOS:000073128800057
J	Nett, JH; Schagger, H; Trumpower, BL				Nett, JH; Schagger, H; Trumpower, BL			Processing of the presequence of the Schizosaccharomyces pombe rieske iron-sulfur protein occurs in a single step and can be converted to two-step processing by mutation of a single proline to serine in the presequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL INTERMEDIATE PEPTIDASE; SACCHAROMYCES-CEREVISIAE; CLEAVAGE; IMPORT; ELECTROPHORESIS; PRECURSOR; SUBSTRATE; RESIDUES; COMPLEX; GENE	The iron-sulfur proteins of the cytochrome be, complexes of Schizosaccharomyces pombe and Saccharomyces cerevisiae contain the three amino acid motif RX(down arrow)(F/L/I)XX(T/S/G)XXXX(down arrow) that is typical for proteins that are cleaved sequentially in two steps by matrix processing peptidase (MPP) and mitochondrial intermediate peptidase (MIP). Despite the presence of this recognition sequence the S. pombe iron-sulfur protein is processed only once during import into mitochondria, whereas the S. cerevisiae protein is processed in two steps, Import of S. pombe iron-sulfur protein in which the putative MIP or MPP recognition sites are eliminated by site-directed mutagenesis and import of iron-sulfur protein into mitochondria from yeast mutants that lack MIP activity indicate that one step processing of the S. pombe iron-sulfur protein is independent of those sites and of MIP activity. Sequencing of the mature protein obtained after import in vitro and of the endogenous iron-sulfur protein isolated from mitochondrial membranes by preparative 2D-electrophoresis shows that MPP recognizes a second site in the presequence and processing occurs between residues 43 and 44. If proline-20 of the S. pombe presequence is changed into a serine, a second cleavage step is induced, Conversely, if serine-24 of the S. cerevisiae presequence is changed to a proline, the first cleavage step that is normally catalyzed by MPP is blocked, causing precursor iron-sulfur protein to accumulate. Together these results indicate that a single amino acid change in the presequence is responsible for one-step processing in S. pombe versus two-step processing in S. cerevisiae.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Univ Frankfurt Klinikum, Inst Biochem 1, ZBC, D-60590 Frankfurt, Germany	Dartmouth College; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Trumpower, BL (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail, Hanover, NH 03755 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020379, R37GM020379] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 20379] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albury MS, 1996, J BIOL CHEM, V271, P17062, DOI 10.1074/jbc.271.29.17062; ARRETZ M, 1994, J BIOL CHEM, V269, P4959; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; BRANDT U, 1993, J BIOL CHEM, V268, P8387; diRago JP, 1996, J BIOL CHEM, V271, P15341, DOI 10.1074/jbc.271.26.15341; FU W, 1990, J BIOL CHEM, V265, P16541; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P631; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; HORWICH AL, 1986, CELL, V44, P451, DOI 10.1016/0092-8674(86)90466-6; ISAYA G, 1994, MOL CELL BIOL, V14, P5603, DOI 10.1128/MCB.14.8.5603; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MOORE AL, 1992, YEAST, V8, P923, DOI 10.1002/yea.320081103; Nett JH, 1997, J BIOL CHEM, V272, P2212; Nett JH, 1996, J BIOL CHEM, V271, P26713, DOI 10.1074/jbc.271.43.26713; NIIDOME T, 1994, J BIOL CHEM, V269, P24719; Ogishima T, 1995, J BIOL CHEM, V270, P30322, DOI 10.1074/jbc.270.51.30322; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.bi.59.070190.001555; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1994, PRACTICAL GUIDE MEMB, P76; SJOLING S, 1994, J BIOL CHEM, V269, P32059; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; YANG XH, 1986, J BIOL CHEM, V261, P2282	26	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8652	8658		10.1074/jbc.273.15.8652	http://dx.doi.org/10.1074/jbc.273.15.8652			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535840	hybrid			2022-12-27	WOS:000072990800017
J	Wakita, T; Taya, C; Katsume, A; Kato, J; Yonekawa, H; Kanegae, Y; Saito, I; Hayashi, Y; Koike, M; Kohara, M				Wakita, T; Taya, C; Katsume, A; Kato, J; Yonekawa, H; Kanegae, Y; Saito, I; Hayashi, Y; Koike, M; Kohara, M			Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-B-HEPATITIS; CORE PROTEIN; NON-A; CRE RECOMBINASE; IN-VIVO; DNA RECOMBINATION; ADENOVIRUS; GENOME; GENE; HEPATOCYTES	Conditional gene expression has greatly facilitated the examination of the functions of particular gene products, Using the Cre/loxP system, we developed efficient conditional transgene activation of hepatitis C virus (HCV) cDNA (nucleotides 294-3435) in transgenic mice, Efficient recombination was observed in transgenic mouse liver upon intravenous administration of adenovirus that expresses Cre DNA recombinase. After transgene activation, most hepatocytes were stained with anti-core polyclonal antibody, and 21-, 37-, and 64-kDa proteins were detected by Western blot analysis in liver lysates using anti-core, El, and E2 monoclonal antibodies, respectively, Serum core protein was detected in transgenic mice 7 days after transgene activation with concurrent increases in serum alanine aminotransferase levels, Subsequently, an anti-core antibody response was detected 14 days after infection, Furthermore, a CD4 and CD8 positive cell depletion assay normalized both the serum alanine aminotransferase increases and pathological changes in the liver, These results suggest that HCV proteins are not directly cytopathic and that the host immune response plays a pivotal role in HCV infection, Thus, this HCV cDNA transgenic mouse provides a powerful tool with which to investigate the immune responses and pathogenesis of HCV infection.	Tokyo Metropolitan Inst Med Sci, Dept Microbiol, Bunkyo Ku, Tokyo 113, Japan; Tokyo Metropolitan Inst Med Sci, Lab Anim Sci, Bunkyo Ku, Tokyo 113, Japan; Tokyo Metropolitan Komagome Hosp, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Gotemba, Shizuoka 412, Japan; Univ Tokyo, Inst Med Sci, Mol Genet Lab, Minato Ku, Tokyo 108, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Chugai Pharmaceutical Co., Ltd.; Roche Holding; University of Tokyo	Wakita, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 113, Japan.	wakita@rinshoken.or.ip						Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; CHEN PJ, 1992, VIROLOGY, V188, P102, DOI 10.1016/0042-6822(92)90739-C; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kashiwakuma T, 1996, J IMMUNOL METHODS, V190, P79, DOI 10.1016/0022-1759(95)00261-8; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kawamura T, 1997, HEPATOLOGY, V25, P1014, DOI 10.1002/hep.510250437; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Koike K, 1997, P NATL ACAD SCI USA, V94, P233, DOI 10.1073/pnas.94.1.233; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Major ME, 1997, HEPATOLOGY, V25, P1527, DOI 10.1002/hep.510250637; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Moradpour D, 1996, J MED VIROL, V48, P234, DOI 10.1002/(SICI)1096-9071(199603)48:3<234::AID-JMV4>3.0.CO;2-9; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pasquinelli C, 1997, HEPATOLOGY, V25, P719, DOI 10.1002/hep.510250338; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; SHIH CM, 1993, J VIROL, V67, P5823, DOI 10.1128/JVI.67.10.5823-5832.1993; SHIMIZU YK, 1993, P NATL ACAD SCI USA, V90, P6037, DOI 10.1073/pnas.90.13.6037; StOnge L, 1996, NUCLEIC ACIDS RES, V24, P3875, DOI 10.1093/nar/24.19.3875; Tanaka T, 1995, J HEPATOL, V23, P742, DOI 10.1016/0168-8278(95)80043-3; Wang Y, 1996, P NATL ACAD SCI USA, V93, P3932, DOI 10.1073/pnas.93.9.3932; YANG YP, 1995, J IMMUNOL, V155, P2564; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	27	94	107	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9001	9006		10.1074/jbc.273.15.9001	http://dx.doi.org/10.1074/jbc.273.15.9001			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535887	hybrid			2022-12-27	WOS:000072990800064
J	Arora, T; Jelinek, DF				Arora, T; Jelinek, DF			Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA GENE-PRODUCT; DEPENDENT KINASES; MULTIPLE-MYELOMA; DAUDI CELLS; INHIBITORS; CDK4; PROTEIN; PHOSPHORYLATION; INTERLEUKIN-6; SUPPRESSION	Interferon-alpha (IFN-alpha) has been used as therapy for the treatment of a variety of viral diseases and malignancies including multiple myeloma, The effectiveness of interferon-alpha in treating multiple myeloma, however, has been somewhat variable, and the mechanism(s) accounting for this is not well understood, As a means to examine the basis for the differential effectiveness of this cytokine, we have analyzed IFN-alpha-mediated modulation of the cell cycle in two human myeloma cell lines. These two cell lines, ANBL-6 and KAS-6/1, display dramatically different outcomes in response to this cytokine, Although IFN-alpha inhibited the growth of ANBL-6 cells by blocking cell cycle progression from G(0)/G(1) to S phase, IFN-alpha stimulated cell cycle progression in KAS-6/1 cells. Moreover, the effects of IFN-alpha on cell cycle progression correlated with the phosphorylation status of the retinoblastoma protein. Of interest, IFN-alpha increased cyclin D2 expression and cyclin-dependent kinase activity in the KAS-6/1 cells but not in the ANBL-6 cells. To determine whether the differential effects of IFN-alpha on myeloma cell cycle progression could also result from differences in the expression of cyclin-dependent kinase inhibitors, we examined the effects of IFN-alpha on the induction of cyclin-dependent kinase inhibitors with broad regulatory function (p21 and p27) and those with specificity for G(1)-associated cyclin-cyclin-dependent kinase complexes (p15, pie, p18, and p19), Although we failed to detect an effect of IFN-alpha on expression levels of p21, p15, pie, or p18, IFN-alpha treatment of the ANBL-6 cell line resulted in induction of pie expression, whereas it was without effect on the KAS-6/1 cell line. These results suggest that heterogeneity in IFN-alpha-mediated growth effects in myeloma cells correlates with differential induction of cyclin D2 and p19(INK4d) expression.	Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic	Jelinek, DF (corresponding author), Mayo Clin & Mayo Fdn, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.				NATIONAL CANCER INSTITUTE [R01CA062228, R55CA062228] Funding Source: NIH RePORTER; NCI NIH HHS [CA-62228] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; BLADE J, 1991, BRIT J HAEMATOL, V79, P523, DOI 10.1111/j.1365-2141.1991.tb08068.x; BRENNING G, 1985, SCAND J HAEMATOL, V35, P543; Brooks AR, 1996, J BIOL CHEM, V271, P9090, DOI 10.1074/jbc.271.15.9090; CHAN FKM, 1995, MOL CELL BIOL, V15, P2682; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Franklin DS, 1996, MOL BIOL CELL, V7, P1587, DOI 10.1091/mbc.7.10.1587; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; HIRAMA T, 1995, BLOOD, V86, P841; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jelinek DF, 1997, J CLIN INVEST, V99, P447, DOI 10.1172/JCI119179; JELINEK DF, 1993, CANCER RES, V53, P5320; Jelinek DF, 1997, J IMMUNOL, V159, P487; Jelinek DF, 1997, CURR TOP MICROBIOL, V224, P261; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KATO J, 1993, GENE DEV, V7, P331; KUMAR R, 1992, P NATL ACAD SCI USA, V89, P6599, DOI 10.1073/pnas.89.14.6599; Miller CW, 1996, CANCER GENET CYTOGEN, V86, P136, DOI 10.1016/0165-4608(95)00216-2; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; OGAWA S, 1994, BLOOD, V84, P2431, DOI 10.1182/blood.V84.8.2431.bloodjournal8482431; OKEN MM, 1994, MAYO CLIN PROC, V69, P781, DOI 10.1016/S0025-6196(12)61100-8; OKUDA T, 1995, GENOMICS, V132, P309; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Raveh T, 1996, J BIOL CHEM, V271, P25479, DOI 10.1074/jbc.271.41.25479; RESNITZKY D, 1992, P NATL ACAD SCI USA, V89, P402, DOI 10.1073/pnas.89.1.402; Sangfelt O, 1997, ONCOGENE, V14, P415, DOI 10.1038/sj.onc.1200832; SAWAMURA M, 1992, BRIT J HAEMATOL, V82, P631, DOI 10.1111/j.1365-2141.1992.tb06484.x; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Subramaniam PS, 1997, J INTERF CYTOK RES, V17, P11, DOI 10.1089/jir.1997.17.11; Westendorf JJ, 1996, LEUKEMIA, V10, P866; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamada H, 1995, MOL CELL BIOCHEM, V152, P149, DOI 10.1007/BF01076077	35	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11799	11805		10.1074/jbc.273.19.11799	http://dx.doi.org/10.1074/jbc.273.19.11799			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565604	hybrid			2022-12-27	WOS:000073536700058
J	Kennedy, AP; Sekulic, A; Irvin, BJ; Nilson, AE; Dilworth, SM; Abraham, RT				Kennedy, AP; Sekulic, A; Irvin, BJ; Nilson, AE; Dilworth, SM; Abraham, RT			Polyomavirus middle T antigen as a probe for T cell antigen receptor-coupled signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TYROSINE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-1; TRANSDUCTION PATHWAYS; TUMOR-ANTIGEN; LYMPHOCYTES-T; PDGF RECEPTOR; ACTIVATION; BINDING	Stimulation of the T cell antigen receptor (TCR) triggers a complex series of signaling events that culminate in T cell. activation and proliferation. The complex structure of the TCR has hindered efforts to link specific signaling events induced by TCR cross-linkage to downstream activation responses, such as interleukin-2 (IL-2) gene transcription. Previous studies have shown that the polyomavirus-derived oncoprotein, middle T antigen (mT), transforms rodent fibroblasts by interacting with and activating several cytoplasmic signaling proteins (Src kinases, phospholipase C (PLC)-gamma 1, Shc, and phosphoinositide 3-kinase (PIS-K) implicated in cell growth control. In this study, we demonstrate that expression of mT activates Jurkat T cells, as measured by increases in IL-2 promoter-and NFAT (nuclear factor of activated T cells)-dependent reporter gene transcription. The transcriptional response provoked by mT was blocked by the immunosuppressive drug FK506, a potent inhibitor of TCR-mediated IL-2 gene expression, Mutations that disrupted the binding of mT to Src kinases or PLC-yl abrogated the ability of mT to deliver the signals needed for IL-2 promoter activation. In contrast, a mT mutant that failed to bind PI3-K induced a markedly elevated transcriptional response in Jurkat cells, whereas mutation of the Shc binding site in mT had little effect on the transactivating potential of this viral oncoprotein, Additional studies demonstrated that the association of mT with PLC-gamma 1 was necessary and sufficient to activate both Ca2+- and Ras dependent signaling cascades in Jurkat cells. These results indicate that PLC-yl activation plays pivotal and pleiotropic roles in the stimulation of IL-2 gene expression, whereas activation of PI3-K negatively modulates this response in Jurkat T cells.	Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; Hammersmith Hosp, Imperial Coll Sci Technol & Med, Sch Med, Dept Metab Med, London W12 0NN, England	Mayo Clinic; Mayo Clinic; Imperial College London	Abraham, RT (corresponding author), Mayo Clin, Div Oncol Res, Rm 1342,Guggenheim Bldg, Rochester, MN 55905 USA.	abraham.robert@mayo.edu			NIGMS NIH HHS [GM-47286] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047286] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUGUSTINE JA, 1991, MOL CELL BIOL, V11, P4431, DOI 10.1128/MCB.11.9.4431; Blaikie PA, 1997, J BIOL CHEM, V272, P20671, DOI 10.1074/jbc.272.33.20671; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; BRIZUELA L, 1995, EUR J IMMUNOL, V25, P385, DOI 10.1002/eji.1830250212; BURNS LA, 1993, J BIOL CHEM, V268, P17659; CAMPBELL KS, 1994, P NATL ACAD SCI USA, V91, P6344, DOI 10.1073/pnas.91.14.6344; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CHENG SH, 1988, EMBO J, V7, P3845, DOI 10.1002/j.1460-2075.1988.tb03270.x; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; DILWORTH SM, 1993, J VIROL, V67, P2235, DOI 10.1128/JVI.67.4.2235-2244.1993; DILWORTH SM, 1994, NATURE, V367, P87, DOI 10.1038/367087a0; Dilworth Stephen M., 1995, Trends in Microbiology, V3, P31, DOI 10.1016/S0966-842X(00)88866-6; DOWNWARD J, 1992, IMMUNOL TODAY, V13, P89, DOI 10.1016/0167-5699(92)90148-Z; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; Downward J, 1996, CANCER SURV, V27, P87; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FRUMAN DA, 1995, MOL CELL BIOL, V15, P3857; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; GUPTA S, 1994, J BIOL CHEM, V269, P17349; HAHN WC, 1993, GENE, V127, P267, DOI 10.1016/0378-1119(93)90731-H; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; Hutchcroft JE, 1996, J IMMUNOL, V156, P4071; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; KAPLAN DR, 1989, BIOCHIM BIOPHYS ACTA, V948, P345, DOI 10.1016/0304-419X(89)90006-1; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Lamkin TD, 1997, J BIOL CHEM, V272, P10396; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu L, 1997, J BIOL CHEM, V272, P8983; LOUIE RR, 1988, J VIROL, V62, P4673, DOI 10.1128/JVI.62.12.4673-4679.1988; MARKLAND W, 1987, BIOCHIM BIOPHYS ACTA, V907, P299, DOI 10.1016/0304-419X(87)90011-4; McIlroy J, 1997, MOL CELL BIOL, V17, P248, DOI 10.1128/MCB.17.1.248; NEL AE, 1990, J IMMUNOL, V144, P2683; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; NOVAK TJ, 1990, NUCLEIC ACIDS RES, V18, P4523, DOI 10.1093/nar/18.15.4523; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; RAVICHANDRAN KS, 1995, MOL CELL BIOL, V15, P593; REIF K, 1993, J BIOL CHEM, V268, P10780; Reif K, 1997, CURR BIOL, V7, P285, DOI 10.1016/S0960-9822(06)00151-5; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; SCHNEIDER H, 1995, J EXP MED, V181, P351, DOI 10.1084/jem.181.1.351; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; Seed B, 1995, Semin Immunol, V7, P3, DOI 10.1016/1044-5323(95)90002-0; Shaw A S, 1995, Semin Immunol, V7, P13, DOI 10.1016/1044-5323(95)90003-9; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SU W, 1995, J BIOL CHEM, V270, P12331, DOI 10.1074/jbc.270.21.12331; TALMAGE DA, 1989, CELL, V59, P55, DOI 10.1016/0092-8674(89)90869-6; TREISMAN R, 1981, NATURE, V292, P595, DOI 10.1038/292595a0; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WARD SG, 1993, EUR J IMMUNOL, V23, P2572, DOI 10.1002/eji.1830231029; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; YAMAUCHI K, 1993, J BIOL CHEM, V268, P14597; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zwilling S, 1997, SCIENCE, V277, P221, DOI 10.1126/science.277.5323.221	72	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11505	11513		10.1074/jbc.273.19.11505	http://dx.doi.org/10.1074/jbc.273.19.11505			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565564	hybrid			2022-12-27	WOS:000073536700018
J	Mueller, MJ; Andberg, M; Haeggstrom, JZ				Mueller, MJ; Andberg, M; Haeggstrom, JZ			Analysis of the molecular mechanism of substrate-mediated inactivation of leukotriene A(4) hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BIFUNCTIONAL ENZYME; LTA4 HYDROLASE; HUMAN-ERYTHROCYTES; EPOXIDE HYDROLASE; AMINOPEPTIDASE; 12-LIPOXYGENASE; TYROSINE-378; INHIBITOR; MUTATION	The bifunctional leukotriene A(4) hydrolase catalyzes the final step in the biosynthesis of the proinflammatory leukotriene B-4, During exposure to the substrate leukotriene A(4), a labile allylic epoxide, the enzyme is gradually inactivated as a consequence of the covalent binding of leukotriene A(4) to the active site. This phenomenon, commonly referred to as suicide inactivation, has previously been rationalized as a mechanism-based process in which the enzyme converts the substrate to a highly reactive intermediate within an activated enzyme-substrate complex that partitions between covalent bond formation (inactivation) and catalysis. To further explore the molecular mechanism of the self-inactivation of leukotriene A(4) hydrolase by leukotriene A(4), we prepared and analyzed mutated forms of the enzyme that were either catalytically incompetent or fully active but resistant toward substrate-mediated inactivation. These mutants were treated with leukotriene A(4) and leukotriene A(4) methyl and ethyl esters and subjected to differential peptide mapping and enzyme activity determinations, which showed that inactivation and/or covalent modification can be completely dissociated from catalysis. Our results, together with recent findings described in the literature, argue against a mechanism-based model for suicide inactivation. We conclude that the collected data on the substrate-mediated inactivation of leukotriene A(4) hydrolase best conforms to an affinity-labeling mechanism.	Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, S-17177 Stockholm, Sweden	Karolinska Institutet	Haeggstrom, JZ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, S-17177 Stockholm, Sweden.		mueller, martin j/C-7616-2019	Blomster Andberg, Martina/0000-0002-8021-9947				Andberg MB, 1997, J BIOL CHEM, V272, P23057, DOI 10.1074/jbc.272.37.23057; EVANS JF, 1985, J BIOL CHEM, V260, P966; EVANS JF, 1992, FEBS LETT, V297, P139, DOI 10.1016/0014-5793(92)80345-H; FERSHT A, 1984, ENZYME STRUCTURE MEC, P248; FITZPATRICK FA, 1982, J BIOL CHEM, V257, P4680; FITZPATRICK FA, 1994, ANN NY ACAD SCI, V714, P64, DOI 10.1111/j.1749-6632.1994.tb12031.x; GRIFFIN KJ, 1992, PROSTAGLANDINS, V44, P251, DOI 10.1016/0090-6980(92)90018-O; HAEGGSTROM JZ, 1990, BIOCHEM BIOPH RES CO, V173, P431, DOI 10.1016/S0006-291X(05)81076-9; HAEGGSTROM JZ, 1993, J LIPID MEDIATOR, V6, P1; Kishimoto K, 1996, BBA-LIPID LIPID MET, V1300, P56, DOI 10.1016/0005-2760(95)00241-3; KYTE J, 1995, MECH PROTEIN CHEM, P314; LEPLEY RA, 1994, J BIOL CHEM, V269, P2627; MCGEE J, 1985, J BIOL CHEM, V260, P2832; MEDINA JF, 1991, P NATL ACAD SCI USA, V88, P7620, DOI 10.1073/pnas.88.17.7620; MINAMI M, 1992, FEBS LETT, V309, P353, DOI 10.1016/0014-5793(92)80806-R; MUELLER MJ, 1995, P NATL ACAD SCI USA, V92, P8383, DOI 10.1073/pnas.92.18.8383; Mueller MJ, 1996, P NATL ACAD SCI USA, V93, P5931, DOI 10.1073/pnas.93.12.5931; Mueller MJ, 1996, J BIOL CHEM, V271, P24345, DOI 10.1074/jbc.271.40.24345; NATHANIEL DJ, 1985, BIOCHEM BIOPH RES CO, V131, P827, DOI 10.1016/0006-291X(85)91314-2; OHISHI N, 1987, J BIOL CHEM, V262, P10200; ORNING L, 1990, J BIOL CHEM, V265, P14911; ORNING L, 1992, J BIOL CHEM, V267, P22733; ORNING L, 1994, J BIOL CHEM, V269, P11269; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WETTERHOLM A, 1991, BIOCHIM BIOPHYS ACTA, V1080, P96, DOI 10.1016/0167-4838(91)90134-L	26	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11570	11575		10.1074/jbc.273.19.11570	http://dx.doi.org/10.1074/jbc.273.19.11570			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565573	hybrid			2022-12-27	WOS:000073536700027
J	Cai, RR; Williams, BRG				Cai, RR; Williams, BRG			Mutations in the double-stranded RNA-activated protein kinase insert region that uncouple catalysis from eIF2 alpha binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION FACTOR-II; INTERFERON ACTION; TRANSLATION INITIATION; ALPHA-SUBUNIT; P68 KINASE; MR 68,000; YEAST; DOMAIN; PKR; MECHANISM	The interferon-induced, double-stranded RNA (dsRNA)-activated protein kinase, PKR, inhibits protein synthesis tia phosphorylation of the alpha subunit of the translation initiation factor eIF2, A kinase insert region N-terminal of PKR kinase subdomain V, which is conserved among eIF2 alpha kinases, has been proposed to determine substrate specificity of these kinases, To investigate the function of this kinase insert region, selective PKR mutants were generated, and kinase activities and eIF2 alpha affinities were analyzed in vitro. The in vivo function was investigated by growth inhibitory assays in yeast and translational assays in COS cells. Among the 13 mutations, 5 lost kinase activity and 3 exhibited less than 30% of wild-type eIF2 alpha binding activity. The deletion of the conserved sequence (amino acids 362-370) resulted in a protein that had no kinase activity and only about 25% of wild-type eIF2 alpha binding, suggesting that this sequence is not only required for PKR kinase activity but also is important for substrate interaction. It was determined that the hydrophobicity of the conserved sequence of PKR is required for kinase activity but is not crucial for eIF2 alpha binding. The amino acid residue Glu-367 in the conserved motif was shown to be directly involved in substrate binding but was not important for kinase activity. These results suggest that the activation of PKR is not a prerequisite for its binding to the substrate and that the conserved motif in subdomain V contributes to the interaction of PKR and eIF2 alpha.	Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Williams, BRG (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	williab@cesmtp.ccf.org	Williams, Bryan R. G./A-5021-2009	Williams, Bryan R. G./0000-0002-4969-1151	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034039, R21AI034039] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34039-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKKARAJU GR, 1989, J BIOL CHEM, V264, P10321; BARBER GN, 1991, BIOCHEMISTRY-US, V30, P10356, DOI 10.1021/bi00106a038; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; BERRY MJ, 1985, J BIOL CHEM, V260, P1240; BLACK TL, 1989, J VIROL, V63, P2244, DOI 10.1128/JVI.63.5.2244-2251.1989; Cesareni G, 1987, GENETIC ENG PRINCIPL, V9, P135, DOI DOI 10.1007/978-1-4684-5377-5_9; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; FENG GS, 1992, P NATL ACAD SCI USA, V89, P5447, DOI 10.1073/pnas.89.12.5447; GALABRU J, 1987, J BIOL CHEM, V262, P15538; GREEN SR, 1995, MOL CELL BIOL, V15, P358, DOI 10.1128/MCB.15.1.358; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; KATZE MG, 1991, MOL CELL BIOL, V11, P5497, DOI 10.1128/MCB.11.11.5497; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; LEE TG, 1990, P NATL ACAD SCI USA, V87, P6208, DOI 10.1073/pnas.87.16.6208; LONDON IM, 1987, ENZYMES, V18, P359; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; MCCORMACK SJ, 1994, VIROLOGY, V198, P92, DOI 10.1006/viro.1994.1011; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; MCMILLAN NAJ, 1996, PROTEIN PHOSPHORYLAT, P225; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Patel RC, 1996, J BIOL CHEM, V271, P25657, DOI 10.1074/jbc.271.41.25657; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; ROMANO PR, 1995, MOL CELL BIOL, V15, P365, DOI 10.1128/MCB.15.1.365; SCHMEDT C, 1995, J MOL BIOL, V249, P29, DOI 10.1006/jmbi.1995.0278; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; THOMIS DC, 1992, P NATL ACAD SCI USA, V89, P10837, DOI 10.1073/pnas.89.22.10837; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756	39	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11274	11280		10.1074/jbc.273.18.11274	http://dx.doi.org/10.1074/jbc.273.18.11274			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556619	hybrid			2022-12-27	WOS:000073395200071
J	Lin, ZC; Mallavia, LP				Lin, ZC; Mallavia, LP			Membrane association of active plasmid partitioning protein A in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE-BINDING PROTEIN; MINI-F PLASMID; BACTERIAL PLASMIDS; P1 PLASMID; ALKALINE-PHOSPHATASE; DETECT GENES; SECA PROTEIN; EXPORT; CLONING; REGION	QsopA and SopA, proteins essential for stable maintenance of low copy number plasmids and encoded on plasmid QpH1 of Coxiella burnetii and the F plasmid of Escherichia coli, respectively, are shown to be membrane associated using three independent approaches: isolation of hybrid protein A-PhoA proteins that display PhoA (bacterial alkaline phosphatase) activity indicating a periplasmic location, biochemical fractionation by flotation gradient centrifugation, and subcellular localization by immunoelectron microscopy, These data provide insight into the mechanism by which partitioning protein A spatially directs plasmids into daughter cells at bacterial division.	Washington State Univ, Dept Microbiol, Pullman, WA 99164 USA	Washington State University	Mallavia, LP (corresponding author), Washington State Univ, Dept Microbiol, Pullman, WA 99164 USA.				NIAID NIH HHS [AI20190] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020190] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; AUSTIN S, 1990, CELL, V60, P351, DOI 10.1016/0092-8674(90)90584-2; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BIEK DP, 1994, P NATL ACAD SCI USA, V91, P8027, DOI 10.1073/pnas.91.17.8027; BOQUET PL, 1987, J BACTERIOL, V169, P1663, DOI 10.1128/jb.169.4.1663-1669.1987; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHUN SY, 1994, J BACTERIOL, V176, P4197, DOI 10.1128/jb.176.14.4197-4203.1994; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; DERMAN AI, 1995, J BACTERIOL, V177, P3764, DOI 10.1128/jb.177.13.3764-3770.1995; EZAKI B, 1991, J BACTERIOL, V173, P6643, DOI 10.1128/jb.173.20.6643-6646.1991; FUNNELL BE, 1995, J BACTERIOL, V177, P2381, DOI 10.1128/jb.177.9.2381-2386.1995; FUNNELL BE, 1994, BIOCHIMIE, V76, P924, DOI 10.1016/0300-9084(94)90017-5; GALLIE DR, 1987, J MOL BIOL, V193, P465, DOI 10.1016/0022-2836(87)90260-9; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; GUSTAFSSON P, 1983, EMBO J, V2, P27, DOI 10.1002/j.1460-2075.1983.tb01375.x; GUTIERREZ C, 1987, J MOL BIOL, V195, P289, DOI 10.1016/0022-2836(87)90650-4; HAYES F, 1994, MOL MICROBIOL, V11, P249, DOI 10.1111/j.1365-2958.1994.tb00305.x; HIRAGA S, 1992, ANNU REV BIOCHEM, V61, P283; HOHN B, 1980, GENE, V11, P291, DOI 10.1016/0378-1119(80)90069-4; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; LIN Z, 1995, GENE AMST, V161, P69; LIN ZC, 1994, MOL MICROBIOL, V13, P513, DOI 10.1111/j.1365-2958.1994.tb00446.x; MADDOCK JR, 1993, SCIENCE, V259, P1717; Maniatis T., 1982, MOL CLONING LAB MANU; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; MICHAELIS S, 1983, J BACTERIOL, V154, P366, DOI 10.1128/JB.154.1.366-374.1983; Miller J.H., 1972, EXPT MOL GENETICS; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; MORI H, 1989, J BIOL CHEM, V264, P15535; MORI H, 1986, J MOL BIOL, V192, P1, DOI 10.1016/0022-2836(86)90459-6; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; NORDSTROM K, 1989, ANNU REV GENET, V23, P37, DOI 10.1146/annurev.genet.23.1.37; OAKS EV, 1987, INFECT IMMUN, V55, P1156, DOI 10.1128/IAI.55.5.1156-1162.1987; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; OGURA T, 1980, P NATL ACAD SCI-BIOL, V77, P3993, DOI 10.1073/pnas.77.7.3993; OLIVER DB, 1982, CELL, V30, P311, DOI 10.1016/0092-8674(82)90037-X; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; ROSENFELD R, 1993, PLASMID, V29, P117, DOI 10.1006/plas.1993.1013; ROTHFIELD LI, 1994, CELL, V77, P963, DOI 10.1016/0092-8674(94)90435-9; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMIDT MG, 1988, J BACTERIOL, V170, P3404, DOI 10.1128/jb.170.8.3404-3414.1988; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THOM JR, 1988, J BACTERIOL, V170, P5654, DOI 10.1128/jb.170.12.5654-5661.1988; TOMOYASU T, 1993, J BACTERIOL, V175, P1352, DOI 10.1128/JB.175.5.1352-1357.1993; TREPTOW R, 1994, J BACTERIOL, V176, P1782, DOI 10.1128/jb.176.6.1782-1786.1994; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WATANABE E, 1992, MOL GEN GENET, V234, P346, DOI 10.1007/BF00538693; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; WILLIAMS DR, 1992, J GEN MICROBIOL, V138, P1; WORCEL A, 1974, J MOL BIOL, V82, P91, DOI 10.1016/0022-2836(74)90576-2; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	56	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11302	11312		10.1074/jbc.273.18.11302	http://dx.doi.org/10.1074/jbc.273.18.11302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556623	hybrid			2022-12-27	WOS:000073395200075
J	Majumdar, M; Seasholtz, TM; Goldstein, D; de Lanerolle, P; Brown, JH				Majumdar, M; Seasholtz, TM; Goldstein, D; de Lanerolle, P; Brown, JH			Requirement for rho-mediated myosin light chain phosphorylation in thrombin-stimulated cell rounding and its dissociation from mitogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEURITE RETRACTION; 1321N1 ASTROCYTOMA-CELLS; ACTIVATED PROTEIN-KINASE; ACTIN STRESS FIBERS; SMOOTH-MUSCLE; RECEPTOR ACTIVATION; PHOSPHOINOSITIDE HYDROLYSIS; DNA-SYNTHESIS; ADP-RIBOSYLTRANSFERASE; CLOSTRIDIUM-BOTULINUM	Thrombin treatment causes a dose-dependent rounding of 1321N1 astrocytoma cells, This cytoskeletal response is rapid, peaking 2 h after thrombin stimulation, and reverses by 50% after 24 h, The thrombin receptor peptide SFLLRNP also induces cell rounding, whereas other G; protein-linked receptor agonists such as carbachol, lysophosphatidic acid, or bradykinin fail to do so. Results of studies using pharmacological inhibitors do not support a requirement for phosphatidylinositol 3-kinase, mitogen-activated protein kinase, or Ca2+ mobilization in this response. Inhibition of protein kinase C or tyrosine kinase produces minimal blockade, Pertussis toxin treatment is also without effect. However, thrombin-induced rounding is fully blocked by the C3 toxin from Clostridium botulinum, which specifically ADP-ribosylates and inactivates the small G protein Rho, Thrombin also leads to a rapid, 2.4-fold increase in P-32 incorporation into myosin Light chain while carbachol does not, Myosin phosphorylation, like cell rounding is inhibited by inactivation of Rho with C3 exoenzyme, suggesting that myosin phosphorylation is necessary for this cytoskeletal response. This is supported by the observation that thrombin-induced rounding is also blocked by the myosin light chain kinase inhibitor KT5926. However, treatment with KT5926 fails to inhibit mitogenesis, Thus, cell rounding is not prerequisite to thrombin-induced DNA synthesis, We conclude that stimulation of the heterotrimeric G protein-coupled thrombin receptor in 1321N1 cells activates Rho-dependent pathways for both DNA synthesis and cell rounding, the cytoskeletal response being mediated in part through increases in myosin phosphorylation.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of California System; University of California San Diego; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu			NIGMS NIH HHS [GM36927] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036927, R56GM036927] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; BALMFORTH AJ, 1992, N-S ARCH PHARMACOL, V346, P303; Batty IH, 1996, BIOCHEM J, V317, P347, DOI 10.1042/bj3170347; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CHEN J, 1994, J BIOL CHEM, V269, P16041; Chihara K, 1997, J BIOL CHEM, V272, P25121, DOI 10.1074/jbc.272.40.25121; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Collins LR, 1996, J BIOL CHEM, V271, P17349, DOI 10.1074/jbc.271.29.17349; DELANEROLLE P, 1993, J BIOL CHEM, V268, P16883; DELANEROLLE P, 1991, AM J PHYSIOL, V261, pL1, DOI 10.1152/ajplung.1991.261.2.L1; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; FILTZ TM, 1994, MOL PHARMACOL, V46, P8; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Gandhi S, 1997, AM J PHYSIOL-RENAL, V272, pF214, DOI 10.1152/ajprenal.1997.272.2.F214; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gong MC, 1997, J BIOL CHEM, V272, P10704; GRABHAM P, 1995, J NEUROCHEM, V64, P583; Grand RJA, 1996, BIOCHEM J, V313, P353, DOI 10.1042/bj3130353; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; Hecht G, 1996, AM J PHYSIOL-CELL PH, V271, pC1678, DOI 10.1152/ajpcell.1996.271.5.C1678; HIRATA K, 1992, J BIOL CHEM, V267, P8719; HUNG DT, 1992, J BIOL CHEM, V267, P20831; HUNG DT, 1992, J CLIN INVEST, V89, P1350, DOI 10.1172/JCI115721; ISHII K, 1993, J BIOL CHEM, V268, P9780; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; JONES LG, 1989, MOL PHARMACOL, V36, P142; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; LAMORTE VJ, 1993, J BIOL CHEM, V268, P19411; LAMORTE VJ, 1993, J CELL BIOL, V121, P91, DOI 10.1083/jcb.121.1.91; LAPETINA EG, 1990, FEBS LETT, V268, P400, DOI 10.1016/0014-5793(90)81293-W; MASTERS SB, 1985, MOL PHARMACOL, V27, P325; MOHR C, 1992, FEBS LETT, V297, P95, DOI 10.1016/0014-5793(92)80335-E; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; NARUMIYA S, 1988, J BIOL CHEM, V263, P17255; NIETO M, 1994, MOL PHARMACOL, V46, P406; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8429; NISHIMURA J, 1988, BIOCHEM BIOPH RES CO, V157, P677, DOI 10.1016/S0006-291X(88)80303-6; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NODA M, 1995, FEBS LETT, V367, P246, DOI 10.1016/0014-5793(95)00573-R; OBBERGHENSCHILL.EV, 1985, EMBO J, V4, P2927; Post GR, 1996, FASEB J, V10, P741, DOI 10.1096/fasebj.10.7.8635691; Post GR, 1996, MOL BIOL CELL, V7, P1679, DOI 10.1091/mbc.7.11.1679; PRASAD MVVSV, 1995, J BIOL CHEM, V270, P18655, DOI 10.1074/jbc.270.31.18655; QUILLIAM LA, 1988, FEBS LETT, V238, P22, DOI 10.1016/0014-5793(88)80217-5; REILLY CF, 1993, BIOCHEM BIOPH RES CO, V190, P1001, DOI 10.1006/bbrc.1993.1148; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SEUWEN K, 1990, J BIOL CHEM, V265, P22292; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; Tigyi G, 1996, J NEUROCHEM, V66, P549; Tigyi G, 1996, J NEUROCHEM, V66, P537; TREJO J, 1992, MOL CELL BIOL, V12, P4742, DOI 10.1128/MCB.12.10.4742; Trejo J, 1996, J BIOL CHEM, V271, P21536, DOI 10.1074/jbc.271.35.21536; TRILIVAS I, 1991, J BIOL CHEM, V266, P8431; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; TUAZON PT, 1984, J BIOL CHEM, V259, P541; Turbedsky K, 1997, BIOCHEMISTRY-US, V36, P2063, DOI 10.1021/bi9624651; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WILSON AK, 1991, J CELL BIOL, V114, P277, DOI 10.1083/jcb.114.2.277; WYSOLMERSKI RB, 1991, AM J PHYSIOL, V261, pC32, DOI 10.1152/ajpcell.1991.261.1.C32	72	74	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10099	10106		10.1074/jbc.273.17.10099	http://dx.doi.org/10.1074/jbc.273.17.10099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553056	hybrid			2022-12-27	WOS:000073224200005
J	Srinivasula, SM; Ahmad, M; MacFarlane, M; Luo, ZW; Huang, ZW; Fernandes-Alnemri, T; Alnemri, ES				Srinivasula, SM; Ahmad, M; MacFarlane, M; Luo, ZW; Huang, ZW; Fernandes-Alnemri, T; Alnemri, ES			Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTING ENZYME; PROTEASE; MEDIATOR	Caspases play a major role in the transduction of the apoptotic signal and execution of apoptosis in mammalian cells. Ectopic overexpression of the short prodomain caspases-3 and -6 precursors in mammalian cells does not induce apoptosis. This is due to their inability to undergo autocatalytic processing/activation and suggests that they depend on the long prodomain caspases for activation. To investigate directly the apoptotic activity of these two caspases in vivo, we engineered constitutively active recombinant caspases-3 and -6 precursors. This was achieved by making contiguous precursor caspases-3 and -6 molecules, which have their small subunits preceding their large subunits. Unlike their wild type counterparts, these recombinant molecules were capable of autocatalytic processing in an in vitro translation reaction, suggesting that they are catalytically active. They were also capable of autoprocessing and inducing apoptosis in vivo independent of the upstream caspases. Furthermore, their autocatalytic and apoptotic activities were inhibited by the pancaspase inhibitor z-VAD-fluoromethylketone, but not by CrmA or Bcl-2, thus directly demonstrating that the targets of inhibition of apoptosis by CrmA and Bcl-2 are upstream of caspases-3 and -6. Since caspases-3 and -6 are the most downstream executioners of apoptosis, the constitutively active versions of these caspases could be used at very low concentrations in gene therapy model systems to induce apoptosis in target tissues or tumors.	Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	Jefferson University; Jefferson University; University of Leicester	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Bluemle Life Sci Bldg,904,233 S 10th St, Philadelphia, PA 19107 USA.		Alnemri, Emad S/B-4526-2010		NIA NIH HHS [AG13487] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013487] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmad M, 1997, CANCER RES, V57, P615; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo ZW, 1997, PROTEIN ENG, V10, P1039, DOI 10.1093/protein/10.9.1039; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICHOLSON WD, 1997, TRENDS BIOCHEM SCI, V257, P299; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; SRINIVASULA SM, 1996, P NATL ACAD SCI USA, V93, P13706; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5	23	132	161	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10107	10111		10.1074/jbc.273.17.10107	http://dx.doi.org/10.1074/jbc.273.17.10107			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553057	hybrid			2022-12-27	WOS:000073224200006
J	Hugo, N; Armengaud, J; Gaillard, J; Timmis, KN; Jouanneau, Y				Hugo, N; Armengaud, J; Gaillard, J; Timmis, KN; Jouanneau, Y			A novel [2Fe-2S] ferredoxin from Pseudomonas putida mt2 promotes the reductive reactivation of catechol 2,3-dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							META-CLEAVAGE PATHWAY; TOL PLASMID PWWO; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; NUCLEOTIDE-SEQUENCE; FUNCTIONAL-ANALYSIS; FE2-S2 FERREDOXIN; IN-VIVO; NITROGENASE	Catechol a,3-dioxygenase (XS LE) is a component of the TOL plasmid-encoded pathway for the degradation of toluene and xylenes and catalyzes the dioxygenolytic cleavage of the aromatic ring. Purified XylE is oxygen-sensitive and unstable in vitro, particularly in the presence of substituted catechol substrates, but it is stabilized in vivo by another protein, XylT, encoded by the xylT gene located just upstream of xylE, In this study, we have purified to homogeneity the XylT product from a recombinant Escherichia coli strain containing a hyper-expressible xylT gene and characterized it as a novel [2Fe-2S] ferredoxin, It is the first example of a soluble ferredoxin with a net positive charge at neutral pH, The EPR signal of the iron sulfur cluster has rhombic symmetry as is the case for plant-type ferredoxins, but the XylT absorbance spectrum resembles more closely that of adrenodoxin, The midpoint redox potential was determined to be -373 +/- 6 mV, at pH 8.5, XylT was unusually unstable for a [2Fe-2S] ferredoxin, with half-lives of 69 min at 25 degrees C in air and 70 min at 37 degrees C in argon, With photochemically reduced 5-deazaflavin for the controlled generation of reductant, it was demonstrated that XylT mediates the rapid reactivation of purified inactive catechol 2,3-dioxygenase in vitro, Inactivation of XylE by 4-methylcatechol resulted in oxidation of the active site iron to a high spin ferric state that was detectable by EPR, Spectroscopic evidence presented here demonstrates that XylT reactivates XylE through reduction of the iron atom in the active site of the enzyme. It is the first instance of a ferredoxin-mediated reactivation of an enzyme. The level of expression of XylT in Pseudomonas putida mt2 cells is low and the calculated XylT/XylE molar ratio is consistent with the proposal that XylE reactivation involves catalytic nonstoichiometric amounts of XylT.	CEA Grenoble, DBMS, BBSI, F-38054 Grenoble 9, France; CEA Grenoble, CNRS, UMR 314, F-38054 Grenoble 9, France; Natl Res Ctr Biotechnol, Div Microbiol, D-38124 Braunschweig, Germany; CEA Grenoble, Dept Rech Fondamentale Matiere Condensee, SCIB, SCPM, F-38054 Grenoble 9, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA	Jouanneau, Y (corresponding author), CEA Grenoble, DBMS, BBSI, F-38054 Grenoble 9, France.	Yves@pelvoux.ceng.cea.fr		ARMENGAUD, Jean/0000-0003-1589-445X				AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; ARCIERO DM, 1985, J BIOL CHEM, V260, P4035; ARMENGAUD J, 1995, PROTEIN EXPRES PURIF, V6, P176, DOI 10.1006/prep.1995.1022; Armengaud J, 1997, J BACTERIOL, V179, P3304, DOI 10.1128/jb.179.10.3304-3309.1997; Armengaud J, 1997, EUR J BIOCHEM, V247, P833, DOI 10.1111/j.1432-1033.1997.00833.x; BARTELS I, 1984, APPL ENVIRON MICROB, V47, P500, DOI 10.1128/AEM.47.3.500-505.1984; BOHME H, 1989, PLANT MOL BIOL, V12, P667, DOI 10.1007/BF00044157; BRUSCHI M, 1988, FEMS MICROBIOL LETT, V54, P155, DOI 10.1111/j.1574-6968.1988.tb02741.x; CAMMACK R, 1980, NATURE, V286, P442, DOI 10.1038/286442a0; CERDAN P, 1994, J BACTERIOL, V176, P6074, DOI 10.1128/jb.176.19.6074-6081.1994; CERDAN P, 1995, EUR J BIOCHEM, V229, P113, DOI 10.1111/j.1432-1033.1995.0113l.x; COGHLAN VM, 1989, P NATL ACAD SCI USA, V86, P835, DOI 10.1073/pnas.86.3.835; CUSHMAN DW, 1967, BIOCHEM BIOPH RES CO, V26, P577, DOI 10.1016/0006-291X(67)90104-0; DERVARTI.DV, 1967, BIOCHEM BIOPH RES CO, V26, P569, DOI 10.1016/0006-291X(67)90103-9; Eltis LD, 1996, J BACTERIOL, V178, P5930, DOI 10.1128/jb.178.20.5930-5937.1996; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; GRABAU C, 1991, J BIOL CHEM, V266, P3294; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; HARAYAMA S, 1993, MOL GEN GENET, V239, P81, DOI 10.1007/BF00281605; HARAYAMA S, 1991, FEBS LETT, V285, P85, DOI 10.1016/0014-5793(91)80730-Q; HARAYAMA S, 1986, J BACTERIOL, V167, P455, DOI 10.1128/jb.167.2.455-461.1986; JOUANNEAU Y, 1993, J BIOL CHEM, V268, P10636; JOUANNEAU Y, 1995, BBA-BIOENERGETICS, V1232, P33, DOI 10.1016/0005-2728(95)00106-X; KIMURA T, 1967, J BIOL CHEM, V242, P485; Kukor JJ, 1996, APPL ENVIRON MICROB, V62, P1728, DOI 10.1128/AEM.62.5.1728-1740.1996; LEE CN, 1994, GENE, V151, P29; MATSUBARA H, 1980, UCLA FORUM MED SCI, V21, P245; MOSHIRI F, 1994, MOL MICROBIOL, V14, P101, DOI 10.1111/j.1365-2958.1994.tb01270.x; NAUD I, 1994, EUR J BIOCHEM, V222, P933, DOI 10.1111/j.1432-1033.1994.tb18942.x; NOZAKI M, 1968, J BIOL CHEM, V243, P2682; POLISSI A, 1993, EMBO J, V12, P3339, DOI 10.1002/j.1460-2075.1993.tb06004.x; ROBSON RL, 1979, BIOCHEM J, V181, P569, DOI 10.1042/bj1810569; RYPNIEWSKI WR, 1991, BIOCHEMISTRY-US, V30, P4126, DOI 10.1021/bi00231a003; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHINGLER V, 1992, J BACTERIOL, V174, P711, DOI 10.1128/jb.174.3.711-724.1992; SHU LJ, 1995, BIOCHEMISTRY-US, V34, P6649, DOI 10.1021/bi00020a010; TAGAWA K, 1968, BIOCHIM BIOPHYS ACTA, V153, P602, DOI 10.1016/0005-2728(68)90188-6; TANAKA M, 1973, J BIOL CHEM, V12, P3689; TSUKIHARA T, 1990, J MOL BIOL, V216, P399, DOI 10.1016/S0022-2836(05)80330-4; WESSERFALLEN A, 1989, THESIS U GENEVA; WORSEY MJ, 1975, J BACTERIOL, V124, P7, DOI 10.1128/JB.124.1.7-13.1975; YOU IS, 1991, BIOCHEMISTRY-US, V30, P1635, DOI 10.1021/bi00220a028	43	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9622	9629		10.1074/jbc.273.16.9622	http://dx.doi.org/10.1074/jbc.273.16.9622			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545294	hybrid			2022-12-27	WOS:000073128800040
J	Ihara, K; Muraguchi, S; Kato, M; Shimizu, T; Shirakawa, M; Kuroda, S; Kaibuchi, K; Hakoshima, T				Ihara, K; Muraguchi, S; Kato, M; Shimizu, T; Shirakawa, M; Kuroda, S; Kaibuchi, K; Hakoshima, T			Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-RHO; PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; BOTULINUM ADP-RIBOSYLTRANSFERASE; GDP/GTP EXCHANGE PROTEIN; SERINE-THREONINE KINASE; DBL ONCOGENE PRODUCT; DIFFICILE TOXIN-B; H-RAS P21; PUTATIVE TARGET; SIGNAL-TRANSDUCTION	The 2.4-Angstrom resolution crystal structure of a dominantly active form of the small guanosine triphosphatase (GTPase) RhoA, RhoA(V14), complexed with the nonhydrolyzable GTP analogue, guanosine 5'-3-O-(thio)triphosphate (GTP gamma S), reveals a fold similar to RhoA-GDP, which has been recently reported (Wei, Y., Zhang, Y., Derewenda, U., Liu, X., Minor, W., Nakamoto, R. K., Somlyo, A. V., Somlyo, A. P., and Derewenda, Z. S. (1997) Nat. Struct. Biol. 4, 699-703), but shows large conformational differences localized in switch I and switch II. These changes produce hydrophobic patches on the molecular surface of switch I, which has been suggested to be involved in its effector binding. Compared with H-Ras and other GTPases bound to GTP or GTP analogues, the significant conformational differences are located in regions involving switches I and II and part of the antiparallel beta-sheet between switches I and II. Key residues that produce these conformational differences were identified. In addition to these differences, RhoA contains four insertion or deletion sites with an extra helical subdomain that seems to be characteristic of members of the Rho family, including Rad, but with several variations in details. These sites also display large displacements from those of H-Ras. The ADP-ribosylation residue, Asn(41), by CS-like exoenzymes stacks on the indole ring of Trp(58) With a hydrogen bond to the main chain of Glu(40). The recognition of the guanosine moiety of GTP gamma S by the GTPase contains water-mediated hydrogen bonds, which seem to be common in the Rho family. These structural differences provide an insight into specific interaction sites with the effecters, as well as with modulators such as guanine nucleotide exchange factor (GEF) and guanine nucleotide dissociation inhibitor (GDI).	Nara Inst Sci & Technol, Div Struct Biol, Nara 63001, Japan; Nara Inst Sci & Technol, Div Signal Transduct, Nara 63001, Japan; PRESTO, Inheritance & Variat Grp, Kyoto 61902, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Hakoshima, T (corresponding author), Nara Inst Sci & Technol, Div Struct Biol, 8916-5 Takayama, Nara 63001, Japan.	hakosima@bs.aist-nara.ac.jp	KURODA, SHINYA/G-4961-2014					Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; ARAKI S, 1990, J BIOL CHEM, V265, P13007; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Cherfils J, 1997, EMBO J, V16, P5582, DOI 10.1093/emboj/16.18.5582; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JUST I, 1992, J BIOL CHEM, V267, P10274; JUST I, 1994, J CELL SCI, V107, P1653; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; Keep NH, 1997, STRUCTURE, V5, P623, DOI 10.1016/S0969-2126(97)00218-9; KIKUCHI A, 1992, J BIOL CHEM, V267, P14611; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li R, 1997, J BIOL CHEM, V272, P4671, DOI 10.1074/jbc.272.8.4671; Machesky LM, 1996, TRENDS CELL BIOL, V6, P304, DOI 10.1016/0962-8924(96)10026-X; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; MORII N, 1991, J BIOL CHEM, V266, P7646; MORII N, 1988, J BIOL CHEM, V263, P12420; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SELF AJ, 1993, ONCOGENE, V8, P655; SIMON M, 1996, TRENDS BIOCHEM SCI, V21, P178; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; YAMAMOTO K, 1988, J BIOL CHEM, V263, P9926; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	71	163	169	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9656	9666		10.1074/jbc.273.16.9656	http://dx.doi.org/10.1074/jbc.273.16.9656			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545299	hybrid			2022-12-27	WOS:000073128800045
J	Kessler, SP; Rowe, TM; Blendy, JA; Erickson, RP; Sen, GC				Kessler, SP; Rowe, TM; Blendy, JA; Erickson, RP; Sen, GC			A cyclic AMP response element in the angiotensin-converting enzyme gene and the transcription factor CREM are required for transcription of the mRNA for the testicular isozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; MESSENGER-RNAS; SPERMATOGENESIS; RABBIT; MICE; EXPRESSION; CAMP; LOCALIZATION; PROMOTER; SWITCH	The angiotensin-converting enzyme (ACE) gene produces two mRNA species from tissue-specific promoters. The transcription start site of the mRNA for the smaller testicular isozyme (ACE(T)) is located within an intron of the larger transcription unit that encodes the pulmonary isozyme (ACE(p)). We have previously demonstrated that a 298-base pair DNA fragment, 5' to the rabbit ACE(T) mRNA transcription initiation site, can activate the testicular expression of a transgenic reporter gene. In the current study, using the same transgenic reporter system, we identified a putative cyclic AMP response element present within this DNA fragment to be absolutely essential for transcriptional activation. Moreover, we observed that ACE(T) mRNA was not expressed in the testes of mice homozygous for a null mutation in the transcription factor CREM. However, in the same mice, ACE(p) mRNA was abundantly expressed in the lung. Our observations indicate that ACE(T) mRNA expression in the testes is regulated by the putative cyclic AMP response element present 5' to the transcription start site and the corresponding transcription factor CREM.	Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Univ Penn, Med Ctr, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ 85724 USA; Univ Arizona, Coll Med, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA	Cleveland Clinic Foundation; University of Pennsylvania; University of Arizona; University of Arizona	Sen, GC (corresponding author), Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, 9500 Euclid Ave,NC20, Cleveland, OH 44195 USA.				NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA23074] Funding Source: Medline; NHLBI NIH HHS [HL-48258] Funding Source: Medline; NIEHS NIH HHS [P30 ES06694] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BERG T, 1986, J HISTOCHEM CYTOCHEM, V34, P753, DOI 10.1177/34.6.3009604; BERNSTEIN KE, 1989, J BIOL CHEM, V264, P11945; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BRENTJENS JR, 1986, EXPERIENTIA, V42, P399, DOI 10.1007/BF02118626; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; DELMAS V, 1992, P NATL ACAD SCI USA, V89, P4226, DOI 10.1073/pnas.89.10.4226; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; ELDORRY HA, 1982, J BIOL CHEM, V257, P4128; Erickson RP, 1996, MOL REPROD DEV, V44, P324, DOI 10.1002/(SICI)1098-2795(199607)44:3&lt;324::AID-MRD6&gt;3.0.CO;2-O; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FOULKES NS, 1993, NATURE, V362, P264, DOI 10.1038/362264a0; FRIEDLAND J, 1978, BIOCHEM BIOPH RES CO, V83, P843, DOI 10.1016/0006-291X(78)91471-7; GORAYA TY, 1994, NUCLEIC ACIDS RES, V22, P1194, DOI 10.1093/nar/22.7.1194; GORAYA TY, 1995, J BIOL CHEM, V270, P19078, DOI 10.1074/jbc.270.32.19078; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HOWARD T, 1993, MOL CELL BIOL, V13, P18, DOI 10.1128/MCB.13.1.18; Jegou B., 1993, MOL BIOL MALE REPROD, P271; Kessler SP, 1996, GENE EXPRESSION, V6, P73; Kessler SP, 1995, CELL MOL BIOL RES, V41, P595; KUMAR RS, 1991, J BIOL CHEM, V266, P3854; KUMAR RS, 1989, J BIOL CHEM, V264, P16754; LALLI E, 1994, J BIOL CHEM, V269, P17359; LANGFORD KG, 1993, BIOL REPROD, V48, P1210, DOI 10.1095/biolreprod48.6.1210; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Patchett A A, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P1; RISBRIDGER GP, 1989, TESTIS, P255; Safer R. L., 1981, BIOCH REGULATION BLO, P123; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; THEKKUMKARA TJ, 1992, NUCLEIC ACIDS RES, V20, P683, DOI 10.1093/nar/20.4.683; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P12262, DOI 10.1073/pnas.93.22.12262; Zhou YD, 1996, BIOCHEM BIOPH RES CO, V223, P48, DOI 10.1006/bbrc.1996.0844	32	20	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9971	9975		10.1074/jbc.273.16.9971	http://dx.doi.org/10.1074/jbc.273.16.9971			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545342	hybrid			2022-12-27	WOS:000073128800088
J	Lopez-Ilasaca, M; Schiene, C; Kullertz, G; Tradler, T; Fischer, G; Wetzker, R				Lopez-Ilasaca, M; Schiene, C; Kullertz, G; Tradler, T; Fischer, G; Wetzker, R			Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; CYTOSOLIC-BINDING-PROTEIN; CIS-TRANS ISOMERASE; IMMUNOSUPPRESSANT FK506; CIS/TRANS ISOMERASES; SIGNAL TRANSDUCTION; CYCLOSPORINE-A; TRIGGER FACTOR; CYCLOPHILIN; INHIBITION	FK506-binding proteins and cyclophilins are intracellular proteins that express peptidylproline cis-trans-isomerase (PPIase) activity. The effects of FK506-binding protein 12 (FKBP12) and the cyclophilins 18 and 23 on autophosphorylation of the epidermal growth factor (EGF) receptor prepared from plasma membranes of the human epidermoid cell line A431 have been investigated. Whereas FKBP12 inhibited EGF receptor tyrosine kinase activity in a concentration-dependent manner, the cyclophilins did not affect autophosphorylation, In contrast to the wild-type enzyme, several variants of FKBP12 with greatly reduced PPIase activity were unable to suppress EGF receptor tyrosine kinase significantly, Pervanadate an inhibitor of protein tyrosine phosphatases, abolished the effect of FKBP12 on EGF receptor autophosphorylation. Finally, FK506 and rapamycin, which are known to block the PPIase activity of FKBP12, induced a significant stimulation of EGF receptor autophosphorylation in intact A431 cells suggesting suppression of EGF receptor autophosphorylation by intracellular FKBP12 in vivo, Taken together the data point to an inhibitory function of FKBP12 in EGF receptor signaling, possibly induced by stimulation of a protein tyrosine phosphatase coupled to the EGF receptor. Both PPIase activity and substrate specificity of FKBP12 seem to be indispensable for this effect.	Res Unit, D-07747 Jena, Germany; Max Planck Res Unit, D-06120 Halle, Germany	Max Planck Society	Wetzker, R (corresponding author), Res Unit, Drackendorfer Str 1, D-07747 Jena, Germany.		Wetzker, Reinhard/AAD-8713-2019					AKIYAMA T, 1985, BIOCHEM BIOPH RES CO, V131, P442, DOI 10.1016/0006-291X(85)91822-4; BOONSTRA J, 1995, CELL BIOL INT, V19, P413, DOI 10.1006/cbir.1995.1086; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CHEN JK, 1993, LIFE SCI, V53, P635, DOI 10.1016/0024-3205(93)90273-6; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9808, DOI 10.1073/pnas.90.21.9808; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; FOLMER RHA, 1995, J BIOMOL NMR, V5, P427, DOI 10.1007/BF00182287; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; GSCHWENDT M, 1989, IMMUNOBIOLOGY, V179, P1; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Helekar SA, 1997, P NATL ACAD SCI USA, V94, P5432, DOI 10.1073/pnas.94.10.5432; Hesterkamp T, 1996, FEBS LETT, V389, P32, DOI 10.1016/0014-5793(96)00582-0; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; LEIVA MC, 1992, BIOCHEM BIOPH RES CO, V186, P1178, DOI 10.1016/0006-291X(92)90871-H; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lu KP, 1996, NATURE, V380, P544; LYONS WE, 1995, J NEUROSCI, V15, P2985; Mackay JP, 1996, BIOCHEMISTRY-US, V35, P4867, DOI 10.1021/bi952761y; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; PUMIGLIA KM, 1992, BIOCHEM J, V286, P441, DOI 10.1042/bj2860441; RICHTER A, 1995, BIOCHEM PHARMACOL, V49, P367, DOI 10.1016/0006-2952(94)00423-J; ROSENWIRTH B, 1994, ANTIMICROB AGENTS CH, V38, P1763, DOI 10.1128/AAC.38.8.1763; SIEKIERKA JJ, 1991, TRANSPLANT P, V23, P2720; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIEKIERKA JJ, 1990, J BIOL CHEM, V265, P21011; SNYDER SH, 1995, NAT MED, V1, P32, DOI 10.1038/nm0195-32; STARZL TE, 1991, TRANSPLANTATION, V52, P751; Steiner JP, 1996, MOL MED, V2, P325, DOI 10.1007/BF03401630; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; TAI PKK, 1994, BIOCHEMISTRY-US, V33, P10666, DOI 10.1021/bi00201a014; TOMIC S, 1995, J BIOL CHEM, V270, P21277, DOI 10.1074/jbc.270.36.21277; Tradler T, 1997, FEBS LETT, V407, P184, DOI 10.1016/S0014-5793(97)00345-1; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Wesselborg S, 1996, J BIOL CHEM, V271, P1274, DOI 10.1074/jbc.271.3.1274	38	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9430	9434		10.1074/jbc.273.16.9430	http://dx.doi.org/10.1074/jbc.273.16.9430			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545268	hybrid			2022-12-27	WOS:000073128800014
J	Rowe, JD; Patskovsky, YV; Patskovska, LN; Novikova, E; Listowsky, I				Rowe, JD; Patskovsky, YV; Patskovska, LN; Novikova, E; Listowsky, I			Rationale for reclassification of a distinctive subdivision of mammalian class Mu glutathione S-transferases that are primarily expressed in testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MOLECULAR-CLONING; RAT-LIVER; IDENTIFICATION; ISOENZYMES; BRAIN; FORM; NOMENCLATURE; MECHANISM; ENZYMES	A rat testicular Mu-class glutathione S-transferase (GST) resolved by reversed-phase high performance liquid chromatography cross-reacted with peptide sequence-specific antisera raised against the human hGSTM3 subunit, Electrospray ionization mass spectrometry indicated that this rat GST subunit (designated rGSTM5 in this report) has a significantly greater molecular mass (26,541 Da) than the other rat GST subunits, The mouse homologue (mGSTM5 subunit) was also identified and characterized by high performance liquid chromatography and electrospray ionization mass spectrometry, Sequence analysis of rGSTM5 peptide fragments and the sequence deduced from a cDNA clone showed that the protein is highly homologous to the hGSTM3 and murine mGSTM5 subunits, All three GSTs of this subclass have N- and C-terminal extensions with C-terminal cysteine residues, but the two penultimate amino acids near the C terminus are divergent in the three species. The proteins of this class Mu subfamily have similar catalytic specificities and mechanisms, are all cysteine rich, are found mainly in testis, and share characteristics that distinguish them from other GSTs. Moreover, the rGSTM5 subunit isolated from rat testis was not found in heterodimeric combination with other common Mu-class GST subunits. As the rGSTM5, mGSTM5, and hGSTM3 subunits are structurally more closely related to each other than they are to other Mu GSTs, it is proposed that they be considered a functionally distinct and separate subfamily within class Mu. The identification of this unique mammalian GST subclass could advance strategies for interspecies comparisons of GSTs and provides a rodent model for studies on functions and regulatory mechanisms for human GSTs.	Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Listowsky, I (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NCI NIH HHS [5-P30-CA1330, CA-42448] Funding Source: Medline; NIGMS NIH HHS [T32 GM-07128] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042448, K04CA001330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007128] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMOVITZ M, 1988, J BIOL CHEM, V263, P17627; Armstrong R N, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P1; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; AWASTHI YC, 1994, INT J BIOCHEM, V26, P195; CAMPBELL E, 1990, J BIOL CHEM, V265, P9188; COMSTOCK KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P487, DOI 10.1006/abbi.1994.1266; CORNISHBOWDEN A, 1995, FUNDAMENTALS ENZYME, P143; FULCHER KD, 1995, MOL REPROD DEV, V42, P415, DOI 10.1002/mrd.1080420407; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HAYES JD, 1988, BIOCHEM J, V255, P913, DOI 10.1042/bj2550913; Hsieh CH, 1997, BIOCHEM J, V323, P503, DOI 10.1042/bj3230503; IVANETICH KM, 1989, BIOCHIM BIOPHYS ACTA, V998, P7, DOI 10.1016/0167-4838(89)90111-8; IVANETICH KM, 1990, BIOCHEM PHARMACOL, V39, P999; JAKOBSON I, 1979, BIOCHEM J, V177, P861, DOI 10.1042/bj1770861; JAKOBY WB, 1984, BIOCHEM PHARMACOL, V33, P2539, DOI 10.1016/0006-2952(84)90621-X; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; JENSSON H, 1985, METHOD ENZYMOL, V113, P504; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; JOHNSON JA, 1992, BIOCHEM J, V282, P279, DOI 10.1042/bj2820279; KAMISAKA K, 1975, BIOCHEMISTRY-US, V14, P2175, DOI 10.1021/bi00681a021; Ketterer B, 1994, Adv Pharmacol, V27, P37, DOI 10.1016/S1054-3589(08)61029-7; KISPERT A, 1989, BIOCHEM J, V260, P789, DOI 10.1042/bj2600789; Koehler RT, 1997, PROTEINS, V28, P202, DOI 10.1002/(SICI)1097-0134(199706)28:2<202::AID-PROT9>3.0.CO;2-G; LAI HCJ, 1989, ARCH BIOCHEM BIOPHYS, V273, P423, DOI 10.1016/0003-9861(89)90501-8; LEE CYG, 1982, MOL CELL BIOCHEM, V49, P161; LISTOWSKY I, 1988, DRUG METAB REV, V19, P305, DOI 10.3109/03602538808994138; Listowsky Irving, 1993, P397; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; Mitchell AE, 1997, BIOCHEM J, V325, P207, DOI 10.1042/bj3250207; Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; Sambrook J., 2002, MOL CLONING LAB MANU; TAKAHASHI Y, 1993, J BIOL CHEM, V268, P8893; TOWNSEND AJ, 1989, J BIOL CHEM, V264, P21582	35	51	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9593	9601		10.1074/jbc.273.16.9593	http://dx.doi.org/10.1074/jbc.273.16.9593			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545290	hybrid			2022-12-27	WOS:000073128800036
J	Wilson, R; Lees, JF; Bulleid, NJ				Wilson, R; Lees, JF; Bulleid, NJ			Protein disulfide isomerase acts as a molecular chaperone during the assembly of procollagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROLYL 4-HYDROXYLASE; I PROCOLLAGEN; TRIPLE-HELIX; TERMINAL PROPEPTIDE; III PROCOLLAGEN; ALPHA-SUBUNIT; COLLAGEN; CELLS; BONDS	Protein-disulfide isomerase (PDI) has been shown to be a multifunctional enzyme catalyzing the formation of disulfide bonds, as well as being a component of the enzymes prolyl 4-hydroxylase (P4-H) and microsomal triglyceride transfer protein, It has also been proposed to function as a molecular chaperone during the refolding of denatured proteins in vitro. To investigate the role of this multifunctional protein within a cellular context, we have established a semi-permeabilized cell system that reconstitutes the synthesis, folding, modification, and assembly of procollagen as they would occur in the cell. We demonstrate here that P4-H associates transiently with the triple helical domain during the assembly of procollagen, The release of P4-H from the triple helical domain coincides with assembly into a thermally stable triple helix. However, if triple helix formation is prevented, P4-H remains associated, suggesting a role for this enzyme in preventing aggregation of this domain. We also show that PDI associates independently with the C-propeptide of monomeric procollagen chains prior to trimer formation, indicating a role for this protein in coordinating the assembly of heterotrimeric molecules, This demonstrates that PDI has multiple functions in the folding of the same protein, that is, as a catalyst for disulfide bond formation, as a subunit of P4-H during proline hydroxylation, and independently as a molecular chaperone during chain assembly.	Univ Manchester, Sch Biol Sci, Manchester M13 3PT, Lancs, England	University of Manchester	Bulleid, NJ (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg, Manchester M13 3PT, Lancs, England.	neil.bulleid@man.ac.uk	Wilson, Richard/H-8429-2012	Wilson, Richard/0000-0003-0152-4394; Bulleid, Neil/0000-0002-9839-5279				BERG RA, 1973, BIOCHEMISTRY-US, V12, P3395, DOI 10.1021/bi00742a005; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195; CAI H, 1994, J BIOL CHEM, V269, P24550; CHESSLER SD, 1992, J BIOL CHEM, V267, P7751; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4; GUREVICH VV, 1991, ANAL BIOCHEM, V195, P207, DOI 10.1016/0003-2697(91)90318-N; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; HU G, 1995, J CELL BIOCHEM, V59, P350, DOI 10.1002/jcb.240590307; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; JOHN DCA, 1994, BIOCHEMISTRY-US, V33, P14018, DOI 10.1021/bi00251a009; JUVA K, 1969, J BIOL CHEM, V244, P6486; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KLAPPA P, 1995, EUR J BIOCHEM, V232, P755, DOI 10.1111/j.1432-1033.1995.tb20870.x; KOIVU J, 1987, J BIOL CHEM, V262, P6159; Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988; LEES JF, 1994, J BIOL CHEM, V269, P24354; Lees JF, 1997, EMBO J, V16, P908, DOI 10.1093/emboj/16.5.908; LILIE H, 1994, J BIOL CHEM, V269, P14290; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; OTSU M, 1994, J BIOL CHEM, V269, P6874; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PUIG A, 1994, J BIOL CHEM, V269, P7764; PUIG A, 1994, J BIOL CHEM, V269, P19128; QUAN H, 1995, J BIOL CHEM, V270, P17078, DOI 10.1074/jbc.270.29.17078; Reddy P, 1996, EMBO J, V15, P2077, DOI 10.1002/j.1460-2075.1996.tb00561.x; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; UITTO J, 1979, ARCH BIOCHEM BIOPHYS, V192, P371, DOI 10.1016/0003-9861(79)90105-X; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	44	120	122	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9637	9643		10.1074/jbc.273.16.9637	http://dx.doi.org/10.1074/jbc.273.16.9637			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545296	hybrid			2022-12-27	WOS:000073128800042
J	Deckert, M; Elly, C; Altman, A; Liu, YC				Deckert, M; Elly, C; Altman, A; Liu, YC			Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; PROTOONCOGENE C-CBL; PHOSPHATIDYLINOSITOL 3-KINASE; T-CELLS; IN-VIVO; SIGNAL-TRANSDUCTION; ADAPTER PROTEINS; JURKAT CELLS; P85 SUBUNIT; SH3 DOMAIN	Cross-linking of the T cell antigen receptor (TCR)-CD3 complex induces rapid tyrosine phosphorylation and activation of Src (Lck and Fyn) and Syk (Syk and Zap-70) family protein tyrosine kinases (PTKs) which, in turn, phosphorylate multiple intracellular substrates. Cbl is a prominent PTK substrate suggesting a pivotal role for it in early signal transduction events. However, the regulation of Cbl function and tyrosine phosphorylation in T cells by upstream PTKs remains poorly understood. In the present study, we used genetic and biochemical approaches to demonstrate that Cbl directly interacts with Syk and Fyn via its N-terminal and C-terminal regions, respectively. Tyr-316 of Syk was required for the interaction with Cbl as well as for the maximal tyrosine phosphorylation of Cbl. However, both wild-type Syk and Y316F-mutated Syk phosphorylated equally well the C-terminal fragment of Cbl in vivo, suggesting the existence of an alternative, N terminus-independent mechanism for the Syk-induced tyrosine phosphorylation of Cbl, This mechanism appears to involve Fyn, since, in addition to its association with the C-terminal region of Cbl, Fyn also associated with Syk and enhanced the Syk-induced tyrosine phosphorylation of Cbl, These findings implicate Fyn as an adaptor protein that facilitates the interaction between Syk and Cbl, and suggest that Src and Syk family PTKs coordinately regulate the tyrosine phosphorylation of Cbl.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Liu, YC (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Deckert, Marcel/M-4998-2016; Deckert, Marcel/T-3566-2019	Deckert, Marcel/0000-0003-2094-559X; LIU, YUN-CAI/0000-0002-0996-7109	NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050819] Funding Source: NIH RePORTER; NCI NIH HHS [CA35299] Funding Source: Medline; NIGMS NIH HHS [GM50819] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andoniou CE, 1996, ONCOGENE, V12, P1981; ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; BLAKE TJ, 1991, ONCOGENE, V6, P653; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Buday L, 1996, J BIOL CHEM, V271, P6159, DOI 10.1074/jbc.271.11.6159; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; DEJONG R, 1995, J BIOL CHEM, V270, P21468, DOI 10.1074/jbc.270.37.21468; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; HARTLEY D, 1995, J BIOL CHEM, V270, P18260, DOI 10.1074/jbc.270.31.18260; Ingham RJ, 1996, J BIOL CHEM, V271, P32306, DOI 10.1074/jbc.271.50.32306; KIM TJ, 1995, J BIOL CHEM, V270, P27504, DOI 10.1074/jbc.270.46.27504; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; LI YC, 1998, IN PRESS CELL SIGNAL, V10; LIU YC, 1993, P NATL ACAD SCI USA, V90, P8957, DOI 10.1073/pnas.90.19.8957; Liu YC, 1997, J BIOL CHEM, V272, P168; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Marengere LEM, 1997, J IMMUNOL, V159, P70; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; ODAI H, 1995, J BIOL CHEM, V270, P10800, DOI 10.1074/jbc.270.18.10800; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Ribon V, 1996, MOL CELL BIOL, V16, P45; SAWASDIKOSOL S, 1995, J BIOL CHEM, V270, P2893, DOI 10.1074/jbc.270.7.2893; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Soltoff SP, 1996, J BIOL CHEM, V271, P563, DOI 10.1074/jbc.271.1.563; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Tsygankov AY, 1996, J BIOL CHEM, V271, P27130, DOI 10.1074/jbc.271.43.27130; Ueno H, 1997, J BIOL CHEM, V272, P8739, DOI 10.1074/jbc.272.13.8739; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556	43	107	111	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8867	8874		10.1074/jbc.273.15.8867	http://dx.doi.org/10.1074/jbc.273.15.8867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535867	hybrid			2022-12-27	WOS:000072990800044
J	Fagan, KA; Mons, N; Cooper, DMF				Fagan, KA; Mons, N; Cooper, DMF			Dependence of the Ca2+-inhibitable adenylyl cyclase of C6-2B glioma cells on capacitative Ca2+ entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP ACCUMULATION; ACTIVATED CALCIUM CURRENT; NCB-20 CELLS; MAST-CELLS; INHIBITION; RECEPTOR; MOBILIZATION; DEPLETION; STORES; EXPRESSION	The ability of adenylyl cyclases to be regulated by physiological transitions in Ca2+ provides a key point for integration of cytosolic Ca2+ concentration ([Ca2+](i)) and cAMP signaling, Ca2+-sensitive adenylyl cyclases, whether endogenously or heterologously expressed, require Ca2+ entry for their regulation, rather than Ca2+ release from intracellular stores (Chiono, Ri, Mahey, R., Tate, G., and Cooper, D. M. F. (1995) J. Biol. Chem. 270, 1149-1155; Fagan, K., Mahey, R., and Cooper, D. M. F. (1996) J. Biol. Chem. 271, 12438-12444). The present study compared the regulation by capacitative Ca2+ entry versus ionophore-mediated Ca2+ entry of an endogenously expressed Ca2+-inhibitable adenylyl cyclase in C6-2B cells, Even in the face of a dramatic [Ca2+](i) rise generated by ionophore, Ca2+ entry via capacitative Ca2+ entry channels was solely responsible for the regulation of the adenylyl cyclase, Selective efficacy of BAPTA over equal concentrations of EGTA in blunting the regulation of the cyclase by capacitative Ca2+ entry defined the intimacy between the adenylyl cyclase and the capacitative Ca2+ entry sites. This association could not be impaired by disruption of the cytoskeleton by a variety of strategies. These results not only establish an intimate spatial relationship between an endogenously expressed Ca2+-inhibitable adenylyl cyclase with capacitative Ca2+ entry sites but also provide a physiological role for capacitative Ca2+ entry other than store refilling.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Neurosci, Denver, CO 80262 USA; Univ Bordeaux 1, CNRS, URA 339, F-33405 Talence, France	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Cooper, DMF (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave,Box C-236, Denver, CO 80262 USA.		Mons, Nicole/AAD-5541-2019		NIGMS NIH HHS [GM 32483] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032483] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLIJANIAN MK, 1987, J PHARMACOL EXP THER, V241, P407; ALTIOK N, 1993, CELL SIGNAL, V5, P279, DOI 10.1016/0898-6568(93)90018-H; BIRD GS, 1993, J BIOL CHEM, V268, P17917; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; BURGESS GM, 1991, J BIOL CHEM, V266, P4772; CADOGAN AK, 1994, J NEUROCHEM, V62, P1816; CALDWELL KK, 1988, ANAL BIOCHEM, V175, P177, DOI 10.1016/0003-2697(88)90376-4; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; COLVIN RA, 1991, CELL CALCIUM, V12, P19, DOI 10.1016/0143-4160(91)90081-O; COOPER DMF, 1994, BIOCHEM J, V297, P437, DOI 10.1042/bj2970437; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; DEBERNARDI MA, 1993, BIOCHEM J, V293, P325, DOI 10.1042/bj2930325; DEBERNARDI MA, 1991, P NATL ACAD SCI USA, V88, P9257, DOI 10.1073/pnas.88.20.9257; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; EVANS T, 1984, MOL PHARMACOL, V26, P395; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; FASOLATO C, 1989, J BIOL CHEM, V264, P19630; GARRITSEN A, 1992, J NEUROCHEM, V59, P1630, DOI 10.1111/j.1471-4159.1992.tb10992.x; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Krause E, 1996, J BIOL CHEM, V271, P32523, DOI 10.1074/jbc.271.51.32523; Louzao MC, 1996, J BIOL CHEM, V271, P14807, DOI 10.1074/jbc.271.25.14807; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MONS N, 1995, P NATL ACAD SCI USA, V92, P8473, DOI 10.1073/pnas.92.18.8473; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Ribeiro CMP, 1997, J BIOL CHEM, V272, P26555, DOI 10.1074/jbc.272.42.26555; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; STEER ML, 1975, J BIOL CHEM, V250, P2080; STEVENS T, 1995, P NATL ACAD SCI USA, V92, P2696, DOI 10.1073/pnas.92.7.2696; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	38	106	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9297	9305		10.1074/jbc.273.15.9297	http://dx.doi.org/10.1074/jbc.273.15.9297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535924	hybrid			2022-12-27	WOS:000072990800101
J	Foguel, D; Silva, JL; de Prat-Gay, G				Foguel, D; Silva, JL; de Prat-Gay, G			Characterization of a partially folded monomer of the DNA-binding domain of human papillomavirus E2 protein obtained at high pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH HYDROSTATIC-PRESSURE; MOLTEN GLOBULE STATE; ARC REPRESSOR; EQUILIBRIUM DISSOCIATION; REGULATORY PROTEINS; RECOGNITION; DIMER; DENATURATION; INTERMEDIATE; ASSOCIATION	The pressure-induced dissociation of the dimeric DNA binding domain of the E2 protein of human papilloma virus (E2-DBD) is a reversible process with a K-d of 5.6 x 10(-8) M at pH 5.5. The complete exposure of the intersubunit tryptophans to water, together with the concentration dependence of the pressure effect, is indicative of dissociation, Dissociation is accompanied by a decrease in volume of 76 ml/mol, which corresponds to an estimated increase in solvent-exposed area of 2775 Angstrom(2). There is a decrease in fluorescence polarization of tryptophan overlapping the red shift of fluorescence emission, supporting the idea that dissociation of E2-DBD occurs in parallel with major changes in the tertiary structure, The dimer binds bis(8-anilinonaphthalene-1-sulfonate), and pressure reduces the binding by about 30%, in contrast with the almost complete loss of dye binding in the urea unfolded state, These results strongly suggest the persistence of substantial residual structure in the high pressure state, Further unfolding of the high pressure state was produced by low concentrations of urea, as evidenced by the complete loss of bis(8-anilinonaphthalene-1-sulfonate) binding with less than 1 M urea, Following pressure dissociation, a partially folded state is also apparent from the distribution of excited state lifetimes of tryptophan, The combined data show that the tryptophans of the protein in the pressure-dissociated state are exposed long enough to undergo solvent relaxation, but the persistence of structure is evident from the observed internal quenching, which is absent in the completely unfolded state, The average rotational relaxation time (derived from polarization and lifetime data) of the pressure-induced monomer is shorter than the urea denatured state, suggesting that the species obtained under pressure are more compact than that unfolded by urea.	Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, ICB, Dept Bioquim Med,Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Foguel, D (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, ICB, Dept Bioquim Med,Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.		SILVA, JERSON Lima/GRF-1442-2022; Silva, Jerson/J-8984-2014	SILVA, JERSON Lima/0000-0001-9523-9441; Silva, Jerson/0000-0001-9523-9441; Foguel, Debora/0000-0001-7312-7115; Prat Gay, Gonzalo/0000-0001-5748-6863				ALCALA JR, 1987, BIOPHYS J, V51, P597, DOI 10.1016/S0006-3495(87)83384-2; Beechem JM., 2002, TOPICS FLUORESCENCE, P241, DOI DOI 10.1007/0-306-47058-6_5; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; BREG JN, 1990, NATURE, V346, P586, DOI 10.1038/346586a0; BURGERING MJM, 1995, BIOPOLYMERS, V35, P217, DOI 10.1002/bip.360350210; CLERY C, 1995, FEBS LETT, V370, P212, DOI 10.1016/0014-5793(95)00787-A; DEVILLIERS EM, 1987, LANCET, V2, P703; ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022; FOGUEL D, 1994, P NATL ACAD SCI USA, V91, P8244, DOI 10.1073/pnas.91.17.8244; FOGUEL D, 1996, P NATL ACAD SCI USA, V93, P1062; GOROVITS B, 1995, J BIOL CHEM, V270, P2061, DOI 10.1074/jbc.270.5.2061; GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x; HAM J, 1991, TRENDS BIOCHEM SCI, V16, P440, DOI 10.1016/0968-0004(91)90172-R; HAYNIE DT, 1993, PROTEINS, V16, P115, DOI 10.1002/prot.340160202; HEDGE RS, 1992, NATURE, V359, P505; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; LAKOWICZ JR, 1984, BIOPHYS J, V46, P463, DOI 10.1016/S0006-3495(84)84043-6; Liang H, 1996, BIOCHEMISTRY-US, V35, P2095, DOI 10.1021/bi951932w; LILLEY DMJ, 1995, DNA PROTEIN STRUCTUR, P1; Lundback T, 1996, P NATL ACAD SCI USA, V93, P4754, DOI 10.1073/pnas.93.10.4754; Mauricio L, 1997, J BIOL CHEM, V272, P19295, DOI 10.1074/jbc.272.31.19295; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011; Mok YK, 1996, NAT STRUCT BIOL, V3, P711, DOI 10.1038/nsb0896-711; Mok YK, 1996, PROTEIN SCI, V5, P310; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PENG XD, 1994, BIOCHEMISTRY-US, V33, P8323, DOI 10.1021/bi00193a020; RAUMANN BE, 1994, CURR OPIN STRUC BIOL, V4, P36, DOI 10.1016/S0959-440X(94)90057-4; Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b; Robinson CR, 1997, J MOL BIOL, V273, P692, DOI 10.1006/jmbi.1997.1342; Robinson CR, 1995, METHOD ENZYMOL, V259, P395; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; SANDERS CM, 1994, NUCLEIC ACIDS RES, V22, P4890, DOI 10.1093/nar/22.23.4890; SCHEVITZ RW, 1985, NATURE, V317, P782, DOI 10.1038/317782a0; SILVA JL, 1989, J BIOL CHEM, V264, P15863; Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6; SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.pc.44.100193.000513; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; SILVA JL, 1993, PROTEIN SCI, V2, P945, DOI 10.1002/pro.5560020608; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Travers A., 1993, DNA PROTEIN INTERACT; VIDUGIRIS CAJ, 1995, BIOCHEMISTRY-US, V34, P4909; VONHIPPEL PH, 1994, SCIENCE, V263, P769, DOI 10.1126/science.8303292	46	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9050	9057		10.1074/jbc.273.15.9050	http://dx.doi.org/10.1074/jbc.273.15.9050			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535893	hybrid			2022-12-27	WOS:000072990800070
J	Murthy, YVSN; Massey, V				Murthy, YVSN; Massey, V			Synthesis and properties of SCN-flavin nucleotide analogs and studies with flavoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLD YELLOW ENZYME; AMINO-ACID OXIDASE; LIPOAMIDE DEHYDROGENASE; BINDING-SITES; IDENTIFICATION; FLAVODOXINS; CHEMISTRY; PROTEINS; BENZOATE; PROBES	A high potential analog of riboflavin with a cyano function at the 8-position was synthesized by employing novel reaction conditions, starting from 8-amino-riboflavin, This was converted to the FAD level with FAD synthetase, The reduced 8-CN-riboflavin, unlike normal reduced flavin, has a distinctive absorption spectrum with two distinctive peaks in the near ultraviolet region. The oxidation-reduction potential of the new flavin was determined to be -50 mV, similar to 160 mV more positive than that of normal riboflavin, The 8-CN-riboflavin and 8-CN-FMN were found to be photoreactive and need to be protected from exposure to light, However such complications were not encountered with protein-bound flavins, The apoproteins of flavodoxin and Old Yellow Enzyme (OYE) were reconstituted with the 8-CN-FMN and apoDAAO was reconstituted with 8-CN-FAD. Spectral properties of the enzyme-bound neutral and anionic semiquinones were determined from these reconstituted proteins, In the case of 8-CN-FMN-OYE I, it was shown that the comproportionation reaction of a mixture of reduced and oxidized enzyme bound flavin is very rapid, compared with the same reaction with native protein, resulting in similar to 100% thermodynamically stable anionic semiquinone, In the case of 8-CN-OYE I, it was shown that the rate of reduction of the enzyme bound flavin by NADPH is similar to 40 times faster, and the rate of reoxidation of reduced enzyme bound flavin by oxygen is an order of magnitude slower than with the normal FMN enzyme. This is in accord with the high oxidation-reduction potential of the flavin, which thermodynamically stabilizes the reduced enzyme.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Massey, V (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	massey@umich.edu						ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5321; ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; BECVAR J, 1982, J BIOL CHEM, V257, P5607; BEREZOVSKII VM, 1965, ZH OBSHCH KHIM, V35, P673; BRUICE TC, 1977, J AM CHEM SOC, V99, P6713, DOI 10.1021/ja00462a040; BRUICE TC, 1976, PROG BIOORG CHEM, V4, P1; CURTI B, 1992, CHEM BIOCH FLAVOENZY, V2, P69; DUDLEY KH, 1967, J ORG CHEM, V32, P3049, DOI 10.1021/jo01285a025; EHRENBERG A, 1967, EUR J BIOCHEM, V2, P286, DOI 10.1111/j.1432-1033.1967.tb00137.x; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; GHISLA S, 1986, BIOCHEM J, V239, P1; GHISLA S, 1976, EUR J BIOCHEM, V63, P373, DOI 10.1111/j.1432-1033.1976.tb10239.x; Heelis P. F., 1991, CHEM BIOCH FLAVOENZY, VI, P171; HODGSON HH, 1949, J CHEM SOC, P1131, DOI 10.1039/jr9490001131; KASAI S, 1983, J BIOCHEM-TOKYO, V93, P397, DOI 10.1093/oxfordjournals.jbchem.a134193; KEMAL C, 1977, J AM CHEM SOC, V99, P7272, DOI 10.1021/ja00464a030; Lambooy J. P., 1971, METHODS ENZYMOL B, V18, P437; LIGHT DR, 1980, J BIOL CHEM, V255, P4264; MASSEY V, 1977, J BIOL CHEM, V252, P5612; MASSEY V, 1966, J BIOL CHEM, V241, P2347; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MASSEY V, 1969, J BIOL CHEM, V244, P3999; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MAYHEW SG, 1971, BIOCHIM BIOPHYS ACTA, V235, P289, DOI 10.1016/0005-2744(71)90207-5; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; MAYHEW SG, 1971, BIOCHIM BIOPHYS ACTA, V235, P276, DOI 10.1016/0005-2744(71)90206-3; MILES DW, 1968, BIOCHEMISTRY-US, V7, P2791, DOI 10.1021/bi00848a014; MOORE EG, 1979, J BIOL CHEM, V254, P8173; MOORE EG, 1978, J BIOL CHEM, V253, P6413; MULLER F, 1969, J BIOL CHEM, V244, P4007; NIINO YS, 1995, J BIOL CHEM, V270, P1983, DOI 10.1074/jbc.270.5.1983; QUAY S, 1977, BIOCHEMISTRY-US, V16, P3348, DOI 10.1021/bi00634a010; RAIBEKAS AA, 1994, BIOCHEMISTRY-US, V33, P12656, DOI 10.1021/bi00208a017; RAIBEKAS AA, 1994, BIOCHEMISTRY-US, V33, P12649, DOI 10.1021/bi00208a016; RAIBEKAS AA, 1993, BIOCHEMISTRY-US, V32, P4420, DOI 10.1021/bi00067a035; SAITO K, 1991, J BIOL CHEM, V266, P20720; SCHOPFER LM, 1981, J BIOL CHEM, V256, P7329; SCHOPFER LM, 1990, STUDY ENZYMES, P247; SPENCER R, 1976, BIOCHEMISTRY-US, V15, P1043, DOI 10.1021/bi00650a015; STEWART RC, 1985, J BIOL CHEM, V260, P3639; STOTT K, 1993, J BIOL CHEM, V268, P6097; SUZUKI N, 1987, J CHEM SOC PERK T 1, P645, DOI 10.1039/p19870000645; THEORELL H, 1954, ACTA CHEM SCAND, V8, P877, DOI 10.3891/acta.chem.scand.08-0877; VANDENBERGHESNOREK S, 1985, J BIOL CHEM, V260, P3373; WALSH C, 1980, ACCOUNTS CHEM RES, V13, P148, DOI 10.1021/ar50149a004; WALSH C, 1978, BIOCHEMISTRY-US, V17, P1942, DOI 10.1021/bi00603a022; WEBER G, 1950, BIOCHEM J, V47, P114, DOI 10.1042/bj0470114; YAGI K, 1962, BIOCHIM BIOPHYS ACTA, V56, P413, DOI 10.1016/0006-3002(62)90592-9; Yonezawa N, 1996, SYNTHETIC COMMUN, V26, P1575, DOI 10.1080/00397919608003525	49	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8975	8982		10.1074/jbc.273.15.8975	http://dx.doi.org/10.1074/jbc.273.15.8975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535883	hybrid			2022-12-27	WOS:000072990800060
J	Xia, WL; Guo, YL; Vilaboa, N; Zuo, JR; Voellmy, R				Xia, WL; Guo, YL; Vilaboa, N; Zuo, JR; Voellmy, R			Transcriptional activation of heat shock factor HSF1 probed by phosphopeptide analysis of factor P-32-labeled in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; PROTEIN-KINASE; HELA-CELLS; FACTOR-I; STRESS; GENE; PHOSPHORYLATION; PROMOTER; ELEMENT; OLIGOMERIZATION	Mapping of tryptic phosphopeptides of heat shock factor 1 (HSF1) from non-stressed or moderately heat-stressed HeLa cells, labeled in vivo by [P-32]orthophosphate, revealed four major phosphopeptides A to D. Heat stress drastically increased phosphopeptide signals. To identify target peptides and amino acids and to correlate phosphorylation and transactivation function, phosphopeptide maps were produced of LexA-human HSF1 chimeras and mutant derivatives thereof, and transactivation activities of original and mutant chimeras were compared, LexA-HSF1 chimeras were previously shown to be regulated identically to HSF1, except that they transactivate promoters with LexA-binding sites instead of hsp promoters. The patterns of phosphopeptides of LexA-HSF1 and endogenous HSF1 were similar. Analysis of single residue substitutions suggested that phosphopeptide C is peptide VKEEPPSPPQSPR (297-309) phosphorylated on Ser-307 but not Ser-303, Substitution of Ser-307 but not Ser-303 caused deregulation of factor activity, Mapping of several constitutively active chimeras associated unphosphorylated peptide C with the transcriptionally active HSF1 conformation, suggesting that dephosphorylation of this peptide (at Ser-307) may either be an integral step in the activation process or serve to maintain the active conformation of HSF1, Exploiting this correlation, indirect evidence was obtained that activation domains of HSF1 interact with the distantly located regulatory domain to maintain the factor in an inactive state.	Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami	Voellmy, R (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.		Vilaboa, Nuria/S-2794-2019; Vilaboa, Nuria/L-1727-2014	Vilaboa, Nuria/0000-0003-4473-4498; 	NIGMS NIH HHS [GM31125] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRUCE JL, 1993, CANCER RES, V53, P12; CHOI HS, 1991, J BIOL CHEM, V266, P11858; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREEN M, 1995, MOL CELL BIOL, V15, P3354; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; HOJ A, 1994, EMBO J, V13, P2617; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; MIVECHI NF, 1995, CANCER RES, V55, P5512; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Newton EM, 1996, MOL CELL BIOL, V16, P839; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; ZUO J, 1995, THESIS U MIAMI MIAMI; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	30	41	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8749	8755		10.1074/jbc.273.15.8749	http://dx.doi.org/10.1074/jbc.273.15.8749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535852	hybrid			2022-12-27	WOS:000072990800029
J	Schneider, B; Xu, YW; Sellam, O; Sarfati, R; Janin, J; Veron, M; Deville-Bonne, D				Schneider, B; Xu, YW; Sellam, O; Sarfati, R; Janin, J; Veron, M; Deville-Bonne, D			Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURE; CRYSTAL-STRUCTURE; ACTIVE-SITE; DICTYOSTELIUM-DISCOIDEUM; 2-ANGSTROM RESOLUTION; DROSOPHILA; STABILITY; PHOSPHORYLATION; MUTAGENESIS; ENZYME	The pre-steady-state reaction of Dictyostelium nucleoside diphosphate (NDP) kinase with dideoxynucleotide triphosphates (ddNTP) and AZT triphosphate was studied by quenching of protein fluorescence after manual mixing or by stopped flow. The fluorescence signal, which is correlated with the phosphorylation state of the catalytic histidine in the enzyme active site, decreases upon ddNTP addition according to a monoexponential time course. The pseudo-first order rate constant was determined for different concentrations of the various ddNTPs and was found to be saturable. The data are compatible with a two-step reaction scheme, where fast association of the enzyme with the dideoxynucleotide is followed by a rate-limiting phosphorylation step. The rate constants and dissociation equilibrium constants determined for each dideoxynucleotide were correlated with the steady-state kinetic parameters measured in the enzymatic assay in the presence of the two substrates, It is shown that ddNTPs and AZT triphosphate are poor substrates for NDP kinase with a rate of phosphate transfer of 0.02 to 3.5 s(-1) and a K-S, of 1-5 mM., The equilibrium dissociation constants for ADP, GDP, ddADP, and ddGDP were also determined by fluorescence titration of a mutant F64W NDP kinase, where the introduction of a tryptophan at the nucleotide binding site provides a direct spectroscopic probe. The lack of the 3'-OH in ddNTP causes a 10-fold increase in K-D. Contrary to "natural" NTPs, NDP kinase discriminates between various ddNTPs, with ddGTP the more efficient and ddCTP the least efficient substrate within a range of 100 in k(cat),,, values.	Inst Pasteur, Unite Regulat Enzymat Activites Cellulaires, CNRS URA 1149, F-75724 Paris 15, France; Inst Pasteur, Unite Chim Organ, F-75724 Paris, France; CNRS UPR 9063, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Deville-Bonne, D (corresponding author), Inst Pasteur, Unite Regulat Enzymat Activites Cellulaires, CNRS URA 1149, 25 Rue Dr Roux, F-75724 Paris 15, France.		Janin, Joel/I-2958-2012; Schneider, Benoit/AAF-3850-2019	Schneider, Benoit/0000-0002-1377-2670				BALZARINI J, 1989, J BIOL CHEM, V264, P6127; BERNASCONI CF, 1976, RELAXATION KINETICS, P20; Bourdais J, 1996, J BIOL CHEM, V271, P7887, DOI 10.1074/jbc.271.14.7887; CHERFILS J, 1994, BIOCHEMISTRY-US, V33, P9062, DOI 10.1021/bi00197a006; CHIADMI M, 1993, STRUCTURE, V1, P283, DOI 10.1016/0969-2126(93)90016-A; DevilleBonne D, 1996, BIOCHEMISTRY-US, V35, P14643, DOI 10.1021/bi960945m; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; JOHNSON KA, 1992, ENZYMES, V20, P2; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LACOMBE ML, 1990, J BIOL CHEM, V265, P10012; LASCU I, 1993, J BIOL CHEM, V268, P20268; LASCU I, 1992, J BIOL CHEM, V267, P12775; LASCU I, 1994, J BIOL CHEM, V269, P7046; MORERA S, 1994, BIOCHEMISTRY-US, V33, P459, DOI 10.1021/bi00168a010; MORERA S, 1995, BIOCHEMISTRY-US, V34, P11062, DOI 10.1021/bi00035a011; Morera S, 1995, STRUCTURE, V3, P1307, DOI 10.1016/S0969-2126(01)00268-4; MOURAD N, 1966, J BIOL CHEM, V241, P3838; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; TEPPER AD, 1994, J BIOL CHEM, V269, P32175; WALINDER O, 1969, J BIOL CHEM, V244, P1060; WEBB PA, 1995, J MOL BIOL, V251, P574, DOI 10.1006/jmbi.1995.0457; WILLIAMS RL, 1993, J MOL BIOL, V234, P1230, DOI 10.1006/jmbi.1993.1673; Xu YW, 1997, P NATL ACAD SCI USA, V94, P3579, DOI 10.1073/pnas.94.8.3579; Xu YW, 1997, P NATL ACAD SCI USA, V94, P7162, DOI 10.1073/pnas.94.14.7162	25	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11491	11497		10.1074/jbc.273.19.11491	http://dx.doi.org/10.1074/jbc.273.19.11491			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565562	hybrid			2022-12-27	WOS:000073536700016
J	Tong, YZ; Liu-Chen, XY; Ercikan-Abali, EA; Capiaux, GM; Zhao, SC; Banerjee, D; Bertino, JR				Tong, YZ; Liu-Chen, XY; Ercikan-Abali, EA; Capiaux, GM; Zhao, SC; Banerjee, D; Bertino, JR			Isolation and characterization of Thymitaq (AG337) and 5-fluoro-2-deoxyuridylate-resistant mutants of human thymidylate synthase from ethyl methanesulfonate-exposed human sarcoma HT1080 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTION; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; HEMATOPOIETIC-CELLS; CRYSTAL-STRUCTURE; EXPRESSION; RESISTANCE; CDNA; MECHANISM; SITE	Thymidylate synthase plays an essential role in the synthesis of DNA, Recently, several new and specific thymidylate synthase inhibitors that occupy the folate binding site, including Tomudex(R), BW1843U89, and Thymitaq, have demonstrated therapeutic activity in patients with advanced cancer. In order to find drug-resistant forms of human thymidylate synthase for gene therapy applications, human sarcoma HT1080 cells were exposed to ethyl methanesulfonate and Thymitaq selection. Thymitaq-resistant clonal derived sublines were established, and analysis indicated that both gene amplification and point mutations contributed to drug resistance. Eight mutant cDNAs that were identified from Thymitaq-resistant sublines were generated by site-directed mutagenesis and transfected into thymidylate synthase-negative cells. Only K47E, D49G, or G52S mutants retain enzyme activity. Moreover, cytotoxicity studies demonstrated that D49G and G52S transfected cells, besides displaying resistance to Thymitaq with IC50 values 40- and 12-fold greater than wild-type enzyme transfected cells, respectively, also lead to fluorodeoxyuridine resistance (26- and 97-fold in IC50 values, respectively) but not to Tomudex or BW1843U89. Characterization of the purified altered enzymes obtained from expression in Escherichia coli is consistent with the cell growth inhibition results, We postulate that the D49G or G52S mutation leads to the structural perturbation of the highly conserved Arg(50) loop, decreasing the binding of thymidylate synthase to the inhibitors, Thymitaq and fluorodeoxyuridylate.	Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Therapeut, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Bertino, JR (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Therapeut, 1275 York Ave,Box 78, New York, NY 10021 USA.				NCI NIH HHS [CA08010] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA008010, R01CA008010] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLAY JA, 1995, BLOOD, V85, P3342, DOI 10.1182/blood.V85.11.3342.bloodjournal85113342; AYUSAWA D, 1981, SOMAT CELL GENET, V7, P523, DOI 10.1007/BF01549656; BARBOUR KW, 1992, MOL PHARMACOL, V42, P242; BARBOUR KW, 1990, MOL PHARMACOL, V37, P515; BRUICE TW, 1982, BIOCHEMISTRY-US, V21, P6703, DOI 10.1021/bi00269a014; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CHUNDURU SK, 1994, J BIOL CHEM, V269, P9547; CIESLA J, 1995, BBA-GENE STRUCT EXPR, V1261, P233, DOI 10.1016/0167-4781(95)00008-5; CLIMIE S, 1990, J BIOL CHEM, V265, P18776; DAVISSON VJ, 1989, J BIOL CHEM, V264, P9145; DAVISSON VJ, 1994, J BIOL CHEM, V269, P30740; FANIN R, 1993, MOL PHARMACOL, V44, P13; FAUMAN EB, 1994, BIOCHEMISTRY-US, V33, P1502, DOI 10.1021/bi00172a029; FINERMOORE J, 1993, J MOL BIOL, V232, P1101, DOI 10.1006/jmbi.1993.1463; HONGYO T, 1993, NUCLEIC ACIDS RES, V21, P3637, DOI 10.1093/nar/21.16.3637; HUGHEY CT, 1993, MOL PHARMACOL, V44, P316; Jackman AL, 1995, ANN ONCOL, V6, P871, DOI 10.1093/oxfordjournals.annonc.a059353; KAMB A, 1992, BIOCHEMISTRY-US, V31, P12876, DOI 10.1021/bi00166a024; KIM CW, 1992, PROTEINS, V13, P352, DOI 10.1002/prot.340130407; Koc ON, 1996, SEMIN ONCOL, V23, P46; LI MX, 1994, BLOOD, V83, P3403; MATTHEWS DA, 1990, J MOL BIOL, V214, P923, DOI 10.1016/0022-2836(90)90346-N; MICHAELS ML, 1990, P NATL ACAD SCI USA, V87, P3957, DOI 10.1073/pnas.87.10.3957; MONTFORT WR, 1990, BIOCHEMISTRY-US, V29, P6964, DOI 10.1021/bi00482a004; MOORE JT, 1993, PROTEIN EXPRES PURIF, V4, P160, DOI 10.1006/prep.1993.1022; MORITZ T, 1995, CANCER RES, V55, P2608; Nord L. Dee, 1993, Current Opinion in Oncology, V5, P1017, DOI 10.1097/00001622-199311000-00012; PedersenLane J, 1997, PROTEIN EXPRES PURIF, V10, P256, DOI 10.1006/prep.1997.0750; POGOLOTTI AL, 1986, J MED CHEM, V29, P478, DOI 10.1021/jm00154a009; SCHIFFER CA, 1991, J MOL BIOL, V219, P161, DOI 10.1016/0022-2836(91)90558-N; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; SORRENTINO BP, 1992, SCIENCE, V257, P99, DOI 10.1126/science.1352414; TAKEISHI K, 1985, NUCLEIC ACIDS RES, V13, P2035, DOI 10.1093/nar/13.6.2035; Wahba A. J., 1961, J BIOL CHEM, V236, P11; WARD WHJ, 1992, BIOCHEM PHARMACOL, V43, P2029, DOI 10.1016/0006-2952(92)90646-Z; Welsford D., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P559; Williams A., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P559	38	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11611	11618		10.1074/jbc.273.19.11611	http://dx.doi.org/10.1074/jbc.273.19.11611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565579	hybrid			2022-12-27	WOS:000073536700033
J	Gopalkrishnan, RV; Lam, EWF; Kedinger, C				Gopalkrishnan, RV; Lam, EWF; Kedinger, C			The p53 tumor suppressor inhibits transcription of the TATA-less mouse DP1 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; DEPENDENT PROTEIN-KINASE; MAMMALIAN-CELL CYCLE; BOX-BINDING PROTEIN; RETINOBLASTOMA PROTEIN; GENE-EXPRESSION; E2F; REPRESSION; ACTIVATION; GROWTH	Cell cycle progression is subject to several regulatory controls, of which the p53 protein plays a major role in growth arrest, subsequent to the detection of cellular aberrations. It is well documented that p53 has the ability to inhibit transcription driven by several promoters, possibly via distinct mechanisms. In this report, we show that expression of the cell cycle regulatory transcription factor DP1 is strongly inhibited by p53, at the level of transcription and probably through the basal TATA-less promoter. This inhibitory activity has a relative specificity for the DP1 promoter compared with the functionally related E2F1 promoter or unrelated promoters such as those of the transcription factor ATFa or the thymidine kinase gene. Inhibition of DPI transcription has implications in one of the several possible mechanisms through which p53 induces cell cycle arrest.	Univ Louis Pasteur Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; St Marys Hosp, Imperial Coll, Sch Med, Dept Med Microbiol, London W2 1PG, England; St Marys Hosp, Imperial Coll, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Imperial College London; Imperial College London; Ludwig Institute for Cancer Research	Kedinger, C (corresponding author), Univ Louis Pasteur Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, France.	kedinger@igbmc.u-strasbg.fr	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576				ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; BANDARA LR, 1994, EMBO J, V13, P3104, DOI 10.1002/j.1460-2075.1994.tb06609.x; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; Bourdon JC, 1997, ONCOGENE, V14, P85, DOI 10.1038/sj.onc.1200804; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DubsPoterszman MC, 1995, ONCOGENE, V11, P2445; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Farmer G, 1996, NUCLEIC ACIDS RES, V24, P4281, DOI 10.1093/nar/24.21.4281; FARNHAM PJ, 1993, BIOCHIM BIOPHYS ACTA, V1155, P125, DOI 10.1016/0304-419X(93)90001-S; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; Goetz J, 1996, J BIOL CHEM, V271, P29589, DOI 10.1074/jbc.271.47.29589; Good LF, 1996, J CELL PHYSIOL, V168, P580, DOI 10.1002/(SICI)1097-4652(199609)168:3<580::AID-JCP10>3.0.CO;2-3; Gopalkrishnan RV, 1996, ONCOGENE, V13, P2671; HAFFNER R, 1995, CURR OPIN GENET DEV, V5, P84, DOI 10.1016/S0959-437X(95)90058-6; Harris LC, 1996, CANCER RES, V56, P2029; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HIEBERT SW, 1995, MOL CELL BIOL, V15, P6864; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; HSIAO KM, 1994, GENE DEV, V8, P1526, DOI 10.1101/gad.8.13.1526; Iotsova V, 1996, ONCOGENE, V13, P2331; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; LAM EWF, 1994, CURR OPIN CELL BIOL, V6, P859; LEES E, 1992, GENE DEV, V6, P1874, DOI 10.1101/gad.6.10.1874; Leveillard T, 1996, EMBO J, V15, P1615, DOI 10.1002/j.1460-2075.1996.tb00506.x; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN D, 1992, P NATL ACAD SCI USA, V89, P9210, DOI 10.1073/pnas.89.19.9210; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Lu H, 1994, Harvey Lect, V90, P81; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; Lu H, 1997, MOL CELL BIOL, V17, P5923, DOI 10.1128/MCB.17.10.5923; LUNA RMD, 1995, NATURE, V378, P203; MARTIN DW, 1993, BIOCHEM BIOPH RES CO, V195, P428, DOI 10.1006/bbrc.1993.2061; MARTIN DW, 1993, J BIOL CHEM, V268, P13062; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; May M, 1996, EMBO J, V15, P3093, DOI 10.1002/j.1460-2075.1996.tb00672.x; Momand J, 1997, J CELL BIOCHEM, V64, P343; OCONNOR DJ, 1902, EMBO J, V1461, P95; PERREM K, 1995, ONCOGENE, V11, P1299; RAGIMOV N, 1993, ONCOGENE, V8, P1183; Sandri MI, 1996, NUCLEIC ACIDS RES, V24, P4464, DOI 10.1093/nar/24.22.4464; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; SUBLER MA, 1994, ONCOGENE, V9, P1351; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; TRUANT R, 1993, J BIOL CHEM, V268, P2284; Wang QJ, 1997, MOL CELL BIOL, V17, P389, DOI 10.1128/MCB.17.1.389; Weinberg RA, 1997, CELL, V88, P573, DOI 10.1016/S0092-8674(00)81897-8; WHYTE P, 1995, SEMIN CANCER BIOL, V6, P83, DOI 10.1006/scbi.1995.0011; ZAUBERMAN A, 1993, EMBO J, V12, P2799, DOI 10.1002/j.1460-2075.1993.tb05941.x	66	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10972	10978		10.1074/jbc.273.18.10972	http://dx.doi.org/10.1074/jbc.273.18.10972			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556576	hybrid			2022-12-27	WOS:000073395200028
J	Riese, DJ; Komurasaki, T; Plowman, GD; Stern, DF				Riese, DJ; Komurasaki, T; Plowman, GD; Stern, DF			Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEU DIFFERENTIATION FACTOR; TYROSINE KINASE-ACTIVITY; FACTOR RECEPTOR; CELLULAR-RESPONSE; HEREGULIN; PROTEIN; PHOSPHORYLATION; BINDING; CELLS; AMPHIREGULIN	Epiregulin (EPR) is a recently described member of the epidermal growth factor (EGF) family of peptide growth factors. The ever expanding size of the EGF family has made distinguishing the activities of these hormones paramount. We show here that EPR activates two members of the ErbB family of receptor tyrosine kinases, epidermal growth factor receptor (EGFR) and ErbB l. Therefore by these criteria, EPR is qualitatively similar to another EGF family hormone, betacellulin (BTC), Yet, here we also demonstrate quantitative differences between EPR and ETC. EPR stimulates higher levels of EGFR phosphorylation than does ETC, whereas ETC stimulates higher levels of ErbB4 phosphorylation than does EPR. Moreover, the EPR and ETC dose response curves show that although EGFR is more sensitive to EPR than is ErbB4, ErbB4 is more sensitive to ETC than is EGFR, Finally, ErbB2, which is not activated by EPR when expressed on its own, increases the sensitivity of ErbB4 for activation by EPR. Therefore, these results establish that EPR exhibits novel activities and modes of regulation, which may have significant implications for EPR function in vivo.	Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Bristol Myers Squibb Pharmaceut Res Inst, Seattle, WA 98121 USA; Sugen Inc, Redwood City, CA 94063 USA; Taisho Pharmaceut Co Ltd, Res Ctr, Mol Biol Lab, Omiya, Saitama 330, Japan; Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Yale University; Bristol-Myers Squibb; Taisho Pharmaceutical Holdings Co Ltd; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stern, DF (corresponding author), Yale Univ, Sch Med, Dept Pathol, BML-342,POB 208023, New Haven, CT 06520 USA.	Stern@Biomed.med.yale.edu	Riese, David/AAF-3581-2020; PLOWMAN, Greg D/E-2012-2011	Plowman, Gregory D/0000-0002-6465-309X; Riese, David/0000-0002-8823-5802	NCI NIH HHS [CA-23168, CA-45708] Funding Source: Medline; NICHD NIH HHS [HD-07149] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023168, R01CA045708] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bacus SS, 1996, AM J PATHOL, V148, P549; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Chen XM, 1996, J BIOL CHEM, V271, P7620, DOI 10.1074/jbc.271.13.7620; CULOUSCOU JM, 1993, J BIOL CHEM, V268, P18407; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; ELES E, CELL, V69, P205; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOLDMAN R, 1990, BIOCHEMISTRY-US, V29, P11024, DOI 10.1021/bi00502a002; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; JOHNSON GR, 1993, J BIOL CHEM, V268, P2924; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; Komurasaki T, 1997, ONCOGENE, V15, P2841, DOI 10.1038/sj.onc.1201458; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Riese DJ, 1996, ONCOGENE, V12, P345; Riese DJ, 1996, J BIOL CHEM, V271, P20047, DOI 10.1074/jbc.271.33.20047; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; Toyoda H, 1995, FEBS LETT, V377, P403, DOI 10.1016/0014-5793(95)01403-9; TOYODA H, 1995, J BIOL CHEM, V270, P7495, DOI 10.1074/jbc.270.13.7495; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D	33	90	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11288	11294		10.1074/jbc.273.18.11288	http://dx.doi.org/10.1074/jbc.273.18.11288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556621	hybrid			2022-12-27	WOS:000073395200073
J	Jarmuszkiewicz, W; Sluse-Goffart, CM; Hryniewiecka, L; Michejda, J; Sluse, FE				Jarmuszkiewicz, W; Sluse-Goffart, CM; Hryniewiecka, L; Michejda, J; Sluse, FE			Electron partitioning between the two branching quinol-oxidizing pathways in Acanthamoeba castellanii mitochondria during steady-state state 3 respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C REDUCTASE; CYANIDE-INSENSITIVE RESPIRATION; PLANT-MITOCHONDRIA; ALTERNATIVE OXIDASE; OXIDATIVE-PHOSPHORYLATION; MOLECULAR-BIOLOGY; REDOX POISE; KINETICS; POOL; TRANSPORT	Amoeba mitochondria possess a respiratory chain with two quinol-oxidizing pathways: the cytochrome pathway and the cyanide-resistant alternative oxidase pathway. The ADP/O method, based on the non-phosphorylating property of alternative oxidase, was used to determine contributions of both pathways in overall state 3 respiration in the presence of GMP (an activator of the alternative oxidase in amoeba) and succinate as oxidizable substrate. This method involves pair measurements of ADP/O ratios plus and minus benzohydroxamate (an inhibitor of the alternative oxidase). The requirements of the method are listed and verified. when overall state 3 respiration was decreased by increasing concentrations of n-butyl malonate (a non-penetrating inhibitor of succinate uptake), the quinone reduction level declined. At the same time, the alternative pathway contribution decreased sharply and became negligible when quinone redox state was lower than 50%, whereas the cytochrome pathway contribution first increased and then passed through a maximum at a quinone redox state of 58% and sharply decreased at a lower level of quinone reduction. This study is the first attempt to examine the steady-state kinetics of the two quinol-oxidizing pathways when both are active and to describe electron partitioning between them when the steady-state rate of the quinone-reducing pathway is varied.	Adam Mickiewicz Univ, Dept Bioenerget, PL-61701 Poznan, Poland; Univ Liege, Ctr Oxygen Biochem, Lab Bioenerget, B-4000 Cointe Ougree, Belgium	Adam Mickiewicz University; University of Liege	Jarmuszkiewicz, W (corresponding author), Adam Mickiewicz Univ, Dept Bioenerget, Fredry 10, PL-61701 Poznan, Poland.	wiesiaj@hum.amu.edu.pl		Jarmuszkiewicz, Wieslawa/0000-0001-8550-8337				BAHR JT, 1973, J BIOL CHEM, V248, P3441; Brandt U, 1996, BBA-BIOENERGETICS, V1275, P41, DOI 10.1016/0005-2728(96)00048-5; Day DA, 1996, PLANT PHYSIOL, V110, P1, DOI 10.1104/pp.110.1.1; DAY DA, 1995, J BIOENERG BIOMEMBR, V27, P379, DOI 10.1007/BF02110000; DAY DA, 1995, AUST J PLANT PHYSIOL, V22, P497, DOI 10.1071/PP9950497; DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103; DOUSSIERE J, 1984, BIOCHEM J, V220, P787, DOI 10.1042/bj2200787; DRY IB, 1989, ARCH BIOCHEM BIOPHYS, V273, P148, DOI 10.1016/0003-9861(89)90173-2; EDWARDS SW, 1977, J GEN MICROBIOL, V102, P135, DOI 10.1099/00221287-102-1-135; ESPOSTI MD, 1991, ARCH BIOCHEM BIOPHYS, V289, P303, DOI 10.1016/0003-9861(91)90415-F; FATO R, 1993, BIOCHEM J, V290, P225, DOI 10.1042/bj2900225; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GUY RD, 1992, PLANT RESP MOL BIOCH, P443; HRYNIEWIECKA L, 1986, Bulletin de la Societe des Amis des Sciences et des Lettres de Poznan Serie D Sciences Biologiques, V25, P15; Hryniewiecka L., 1980, Bulletin de la Societe des Amis des Sciences et des Lettres de Poznan Serie D Sciences Biologiques, V20, P15; HRYNIEWIECKA L, 1988, 5 EUR BIOEN C REP JU, P286; Jarmuszkiewicz W, 1997, FEBS LETT, V411, P110, DOI 10.1016/S0014-5793(97)00676-5; JARMUSZKIEWICZ W, 1996, 9 EUR BIOEN C REP AU, P36; JARMUSZKIEWICZ W, 1994, ACTA BIOCHIM POL, V2, P218; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; KROGER A, 1973, EUR J BIOCHEM, V34, P358, DOI 10.1111/j.1432-1033.1973.tb02767.x; LAMBOWITZ AM, 1972, J BIOL CHEM, V247, P7859; Lance C., 1985, ENCY PLANT PHYSL, P202; MCINTOSH L, 1994, PLANT PHYSIOL, V105, P781, DOI 10.1104/pp.105.3.781; Millar AH, 1995, PHYSIOL PLANTARUM, V95, P523, DOI 10.1111/j.1399-3054.1995.tb05518.x; MOORE AL, 1994, BBA-BIOENERGETICS, V1187, P145, DOI 10.1016/0005-2728(94)90101-5; MOORE AL, 1991, BIOCHIM BIOPHYS ACTA, V1059, P121, DOI 10.1016/S0005-2728(05)80197-5; RAGAN CI, 1985, BIOCHIM BIOPHYS ACTA, V811, P13; REED JS, 1987, BIOCHEM J, V247, P657, DOI 10.1042/bj2470657; Ribas-Carbo M, 1997, PLANT PHYSIOL, V113, P903, DOI 10.1104/pp.113.3.903; RIBAS-CARBO M, 1994, BBA-BIOENERGETICS, V1188, P205, DOI 10.1016/0005-2728(94)90037-X; RIGOULET M, 1993, BIOCHEM SOC T, V21, P773, DOI 10.1042/bst0210773; ROBINSON SA, 1995, AUST J PLANT PHYSIOL, V22, P487, DOI 10.1071/PP9950487; SAKAJO S, 1997, BIOSCI BIOTECH BIOCH, V61, P397; SHARPLESS TK, 1970, J BIOL CHEM, V245, P58; SIEDOW JN, 1995, PLANT CELL, V7, P821, DOI 10.1105/tpc.7.7.821; SIEDOW JN, 1993, BIOCHIM BIOPHYS ACTA, V1142, P165, DOI 10.1016/0005-2728(93)90098-Z; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; VANDAM K, 1980, BIOCHIM BIOPHYS ACTA, V591, P240, DOI 10.1016/0005-2728(80)90156-5; VANDENBERGEN CWM, 1994, EUR J BIOCHEM, V226, P1071; VANDERLEYDEN J, 1980, BIOCHEM J, V186, P309, DOI 10.1042/bj1860309; VANDERLEYDEN J, 1980, BIOCHEM J, V188, P141, DOI 10.1042/bj1880141; WAGNER AM, 1995, PHYSIOL PLANTARUM, V95, P318, DOI 10.1111/j.1399-3054.1995.tb00844.x; Westerhoff H., 1987, THERMODYNAMICS CONTR	44	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10174	10180		10.1074/jbc.273.17.10174	http://dx.doi.org/10.1074/jbc.273.17.10174			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553066	hybrid, Green Published			2022-12-27	WOS:000073224200015
J	Malnic, B; Farah, CS; Reinach, FC				Malnic, B; Farah, CS; Reinach, FC			Regulatory properties of the NH2- and COOH-terminal domains of troponin T - ATPase activation and binding to troponin I and troponin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE TROPONIN; THIN FILAMENT; TROPOMYOSIN REGULATION; ACTIN-TROPOMYOSIN; ALPHA-TROPOMYOSIN; ESCHERICHIA-COLI; COOPERATIVE UNIT; CA2+ REGULATION; FRAGMENTS; CONTRACTION	The contraction of skeletal muscle is regulated by Ca2+ binding to troponin C, which results in an internal reorganization of the interactions within the troponin-tropomyosin complex. Troponin T is necessary for Ca2+ dependent inhibition and activation of actomyosin. Troponin T consists of an extended NH2-terminal domain that interacts with tropomyosin and a globular COOH-terminal domain that interacts with tropomyosin, troponin I, and troponin C. In this study we used recombinant troponin T and troponin I fragments to delimit further the structural and regulatory interactions with the thin filament. Our results show the following: (i) the NH2-terminal region of troponin T activates the actomyosin ATPase in the presence of tropomyosin; (ii) the interaction of the globular domain of troponin T with the thin filament blocks ATPase activation in the absence of Ca2+; and (iii) the COOH-terminal region of the globular domain anchors the troponin C-troponin I binary complex to troponin T through a direct Ca2+-independent interaction with the NH2-terminal region of troponin I. This interaction is required for Ca2+-dependent activation of the actomyosin ATPase activity. Based on these results we propose a refined model for the troponin complex and its interaction with the thin filament.	Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05599970 Sao Paulo, Brazil	Universidade de Sao Paulo	Reinach, FC (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, CP 26-077, BR-05599970 Sao Paulo, Brazil.	fdcreina@quim.iq.usp.br	Malnic, Bettina/A-4905-2008; Farah, Chuck Shaker/G-5565-2012	Malnic, Bettina/0000-0002-5877-4784; Farah, Chuck Shaker/0000-0003-3110-6302				BREITBART RE, 1985, CELL, V41, P67, DOI 10.1016/0092-8674(85)90062-5; CHEUNG HC, 1987, BIOCHEMISTRY-US, V26, P5904, DOI 10.1021/bi00392a049; CHONG PCS, 1982, J BIOL CHEM, V257, P1667; CHONG PCS, 1983, FEBS LETT, V153, P372, DOI 10.1016/0014-5793(83)80646-2; EBASHI S, 1973, COLD SPRING HARB SYM, V37, P215, DOI 10.1101/SQB.1973.037.01.031; FARAH CS, 1994, J BIOL CHEM, V269, P5230; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; FISHER D, 1995, J BIOL CHEM, V270, P25455, DOI 10.1074/jbc.270.43.25455; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; FUJIMORI K, 1990, NATURE, V345, P182, DOI 10.1038/345182a0; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; GRABAREK Z, 1992, J MUSCLE RES CELL M, V13, P383, DOI 10.1007/BF01738034; GREASER ML, 1971, J BIOL CHEM, V246, P4226; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HITCHCOCK SE, 1975, EUR J BIOCHEM, V52, P255, DOI 10.1111/j.1432-1033.1975.tb03993.x; HITCHCOCK SE, 1973, J MOL BIOL, V80, P825, DOI 10.1016/0022-2836(73)90212-X; HITCHCOCKDEGREGORI SE, 1982, J BIOL CHEM, V257, P7372; HOLMES KC, 1995, BIOPHYS J S, V68, P2; INGRAHAM RH, 1984, J BIOL CHEM, V259, P9544; Jha PK, 1996, BIOCHEMISTRY-US, V35, P16573, DOI 10.1021/bi9622433; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MAK AS, 1981, J MOL BIOL, V149, P541, DOI 10.1016/0022-2836(81)90486-1; MALNIC B, 1994, EUR J BIOCHEM, V222, P49, DOI 10.1111/j.1432-1033.1994.tb18840.x; NAKAMURA S, 1981, J BIOCHEM-TOKYO, V89, P1639, DOI 10.1093/oxfordjournals.jbchem.a133359; OHTSUKI I, 1981, J BIOCHEM-TOKYO, V90, P259; OHTSUKI I, 1986, ADV PROTEIN CHEM, V38, P1, DOI 10.1016/S0065-3233(08)60525-2; ONOYAMA Y, 1986, J BIOCHEM-TOKYO, V100, P517, DOI 10.1093/oxfordjournals.jbchem.a121742; PAN BS, 1991, J BIOL CHEM, V266, P12432; PAN BS, 1992, J BIOL CHEM, V267, P23052; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PEARLSTONE JR, 1976, P NATL ACAD SCI USA, V73, P1902, DOI 10.1073/pnas.73.6.1902; PEARLSTONE JR, 1978, CAN J BIOCHEM CELL B, V56, P521, DOI 10.1139/o78-080; PEARLSTONE JR, 1982, J BIOL CHEM, V257, P587; PEARLSTONE JR, 1983, J BIOL CHEM, V258, P2534; PEARLSTONE JR, 1985, CAN J BIOCHEM CELL B, V63, P212, DOI 10.1139/o85-030; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; POTTER JD, 1974, ARCH BIOCHEM BIOPHYS, V162, P436, DOI 10.1016/0003-9861(74)90202-1; POTTER JD, 1993, BIOPHYS J, V64, P137; QUAGGIO RB, 1993, PROTEIN SCI, V2, P1053, DOI 10.1002/pro.5560020618; REINACH FC, 1982, J CELL BIOL, V95, P78, DOI 10.1083/jcb.95.1.78; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; SMILLIE LB, 1988, J BIOL CHEM, V263, P18816; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOBACMAN LS, 1988, J BIOL CHEM, V263, P2668; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; VANEERD JP, 1973, BIOCHEMISTRY-US, V12, P4972, DOI 10.1021/bi00748a024; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; YATES LD, 1983, J BIOL CHEM, V258, P5770; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	56	94	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10594	10601		10.1074/jbc.273.17.10594	http://dx.doi.org/10.1074/jbc.273.17.10594			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553120	hybrid			2022-12-27	WOS:000073224200069
J	Roe, MW; Worley, JF; Qian, F; Tamarina, N; Mittal, AA; Dralyuk, F; Blair, NT; Mertz, RJ; Philipson, LH; Dukes, ID				Roe, MW; Worley, JF; Qian, F; Tamarina, N; Mittal, AA; Dralyuk, F; Blair, NT; Mertz, RJ; Philipson, LH; Dukes, ID			Characterization of a Ca2+ release-activated nonselective cation current regulating membrane potential and [Ca2+](i) oscillations in transgenically derived beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC B-CELLS; INTRACELLULAR CALCIUM; MOUSE ISLETS; INOSITOL TRISPHOSPHATE; INSULIN-SECRETION; CYTOPLASMIC CA2+; K+ CHANNELS; GLUCOSE; LANGERHANS; TRP	Although stimulation of insulin secretion by glucose is regulated by coupled oscillations of membrane potential and intracellular Ca2+ ([Ca2+](i)), the membrane events regulating these oscillations are incompletely understood. In the presence of glucose and tetraethylammonium, transgenically derived beta-cells (beta TC3-neo) exhibit coupled voltage and [Ca2+](i) oscillations strikingly similar to those observed in normal islets in response to glucose. Using these cells as a model system, we investigated the membrane conductance underlying these oscillations. Alterations in delayed rectifier or Ca2+-activated K+ channels were excluded as a source of the conductance oscillations, as they are completely blocked by tetraethylammonium. ATP-sensitive K+ channels were also excluded, since the ATP-sensitive K+ channel blocker tolbutamide substituted for glucose in inducing [Ca2+](i) oscillations. Thapsigargin, which depletes intracellular Ca2+ stores, and maitotoxin, an activator of nonselective cation channels, both converted the glucose-dependent [Ca2+](i) oscillations into a sustained elevation. On the other hand, both SKF 96365, a blocker of Ca2+ store operated channels, and external Na+ removal suppressed the glucose-stimulated [Ca2+](i) oscillations. Maitotoxin activated a nonselective cation current in beta TC3 cells that was attenuated by removal of extracellular Na+ and by SKF 96365, in the same manner to a current activated in mouse beta-cells following depletion of intracellular Ca2+ stores. Currents similar to these are produced by the mammalian trp-related channels, a gene family that includes Ca2+ store-operated channels and inositol 1,4,5-trisphosphate-activated channels. We found several of the trp family genes were expressed in beta TC3 cells by reverse transcriptase polymerase chain reaction using specific primers, but by Northern blot analysis, mtrp-4 was the predominant message expressed. We conclude that a conductance underlying glucose-stimulated oscillations in beta-cells is provided by a Ca2+ store depletion-activated nonselective cation current, which is plausibly encoded by homologs of trp genes.	Glaxo Wellcome Inc, Res Inst, Dept Cell Physiol, Res Triangle Pk, NC 27709 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pharmacol & Physiol, Chicago, IL 60637 USA	GlaxoSmithKline; University of Chicago; University of Chicago	Dukes, ID (corresponding author), Glaxo Wellcome Inc, Res Inst, Dept Cell Physiol, Res Triangle Pk, NC 27709 USA.	id22327@glaxowellcome.com						ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; ATWATER I, 1978, J PHYSIOL-LONDON, V278, P117, DOI 10.1113/jphysiol.1978.sp012296; BENNETT DL, 1995, CURR BIOL, V5, P1225, DOI 10.1016/S0960-9822(95)00243-0; Berridge MJ, 1995, ANN NY ACAD SCI, V766, P31, DOI 10.1111/j.1749-6632.1995.tb26646.x; BERTRAM R, 1995, BIOPHYS J, V68, P2322; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; Clapham DE, 1996, NEURON, V16, P1069, DOI 10.1016/S0896-6273(00)80132-4; COOK DL, 1984, NATURE, V312, P446; Dukes I. D., 1995, Biophysical Journal, V68, pA121; Dukes ID, 1996, DIABETES, V45, P845, DOI 10.2337/diabetes.45.7.845; DUKES ID, 1994, J BIOL CHEM, V269, P10979; DUKES ID, 1993, AM J PHYSIOL, V264, pE348, DOI 10.1152/ajpendo.1993.264.3.E348; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; GILON P, 1993, J BIOL CHEM, V268, P22265; GILON P, 1992, J BIOL CHEM, V267, P20713; Gromada J, 1996, BIOCHEM J, V314, P339, DOI 10.1042/bj3140339; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HENQUIN JC, 1984, EXPERIENTIA, V40, P1043, DOI 10.1007/BF01971450; HOLZ GG, 1995, J BIOL CHEM, V270, P17749, DOI 10.1074/jbc.270.30.17749; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; KEAHEY HH, 1989, DIABETES, V38, P188, DOI 10.2337/diabetes.38.2.188; KEIZER J, 1995, BIOPHYS J, V68, P2216, DOI 10.1016/S0006-3495(95)80405-4; LEECH CA, 1995, ENDOCRINOLOGY, V136, P1530, DOI 10.1210/en.136.4.1530; LONGO EA, 1991, J BIOL CHEM, V266, P9314; MUSGRAVE IF, 1994, BIOCHEM J, V301, P437, DOI 10.1042/bj3010437; NADAL A, 1994, AM J PHYSIOL-ENDOC M, V267, pE769, DOI 10.1152/ajpendo.1994.267.5.E769; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; PHILIPSON LH, 1994, J BIOL CHEM, V269, P27787; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RINK TJ, 1990, FEBS LETT, V268, P381, DOI 10.1016/0014-5793(90)81290-5; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; ROE MW, 1994, J BIOL CHEM, V269, P18279; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; ROE MW, 1993, J BIOL CHEM, V268, P9953; ROJAS E, 1994, ENDOCRINOLOGY, V134, P1771, DOI 10.1210/en.134.4.1771; RORSMAN P, 1992, EMBO J, V11, P2877, DOI 10.1002/j.1460-2075.1992.tb05356.x; Sakura H, 1997, DIABETOLOGIA, V40, P528, DOI 10.1007/s001250050711; SATIN LS, 1994, ENDOCRINE, V2, P677; SILVA AM, 1994, J BIOL CHEM, V269, P17095; SMOLEN P, 1992, J MEMBRANE BIOL, V127, P9; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; VERADI A, 1996, BIOCHEM J, V319, P521; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; WORLEY JF, 1994, J BIOL CHEM, V269, P32055; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	54	87	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10402	10410		10.1074/jbc.273.17.10402	http://dx.doi.org/10.1074/jbc.273.17.10402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553098	hybrid			2022-12-27	WOS:000073224200047
J	Towers, TL; Freedman, LP				Towers, TL; Freedman, LP			Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D-3 receptor - Implications for allosteric influences on nuclear receptor structure and function by a DNA element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; PERIPHERAL-BLOOD LYMPHOCYTES; PARATHYROID-HORMONE GENE; LIGAND-BINDING DOMAIN; GLUCOCORTICOID RECEPTOR; RESPONSE ELEMENT; THYROID-HORMONE; 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR; NEGATIVE REGULATION; CRYSTAL-STRUCTURE	The primary function of activated T lymphocytes is to produce various cytokines necessary to elicit an immune response; these cytokines include interleukin-a (IL-2), interleukin-4, and granulocyte-macrophage colony-stimulating factor (GMCSF). Steroid hormones and vitamin A and D-3 metabolites act to repress the expression of cytokines. 1,25-Dihydroxyvitamin D-3 (1,25-(OH)(2)D-3) down-modulates activated IL-2 expression at the level transcription, through direct antagonism of the transactivating complex NFAT-1/AP-1 by the vitamin D-3 receptor (VDR). We report here that GMCSF transcription in Jurkat T cells is also directly repressed by 1,25-(OH)(2)D-3 and VDR. Among four NFAT/AP-1 elements in the GMCSF enhancer, we have focused on one such element that when multimerized, is sufficient in mediating both activation by NFAT-1 and AP-1 and repression in response to 1,25-(OH)(2)D-3. Although this element does not contain any recognizable vitamin D response elements (VDREs), high affinity DNA binding by recombinant VDR is observed. In contrast to VDR interactions with positive VDREs, this binding is independent of VDR's heterodimeric partner, the retinoid X receptor. Moreover, VDR appears to bind the GMCSF element as an apparent monomer in vitro. Protease digestion patterns of bound VDR, and receptor mutations affecting DNA binding and dimerization, demonstrate that the receptor binds to the negative site in a distinct conformation relative to a positive VDRE, suggesting that the DNA element itself acts as an allosteric effector of VDR function. This altered conformation may account for VDR's action as a repressing rather than activating factor at this locus.	Cornell Univ, Grad Sch Med Sci, Cell Biol Program, Mem Sloan Kettering Canc Ctr,Sloan Kettering Div, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Freedman, LP (corresponding author), Cornell Univ, Grad Sch Med Sci, Cell Biol Program, Mem Sloan Kettering Canc Ctr,Sloan Kettering Div, 1275 York Ave, New York, NY 10021 USA.	l-freedman@ski.mskcc.org			NCI NIH HHS [CA08748] Funding Source: Medline; NIDDK NIH HHS [DK454460] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; ALROY I, 1995, MOL CELL BIOL, V15, P5789; ALROY I, 1995, THESIS CORNELL U NEW; BARSHAVIT Z, 1983, P NATL ACAD SCI-BIOL, V80, P5907, DOI 10.1073/pnas.80.19.5907; Baur EV, 1996, EMBO J, V15, P110, DOI 10.1002/j.1460-2075.1996.tb00339.x; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; BLANCO JCG, 1995, P NATL ACAD SCI USA, V92, P1535, DOI 10.1073/pnas.92.5.1535; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Cheskis B, 1996, BIOCHEMISTRY-US, V35, P3309, DOI 10.1021/bi952283r; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; Christakos S, 1996, BIOCHEM J, V316, P361, DOI 10.1042/bj3160361; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; DEMAY MB, 1992, P NATL ACAD SCI USA, V89, P8097, DOI 10.1073/pnas.89.17.8097; DiRenzo J, 1997, MOL CELL BIOL, V17, P2166, DOI 10.1128/MCB.17.4.2166; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Freedman L. P., 1997, Vitamin D., P127; FREEDMAN LP, 1991, MOL ENDOCRINOL, V5, P1815, DOI 10.1210/mend-5-12-1815; FREEDMAN MH, 1992, BRIT J HAEMATOL, V80, P40, DOI 10.1111/j.1365-2141.1992.tb06398.x; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; Guo B, 1997, P NATL ACAD SCI USA, V94, P121, DOI 10.1073/pnas.94.1.121; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; JAIN JN, 1993, J IMMUNOL, V151, P837; JENKINS F, 1995, J IMMUNOL, V155, P1240; KATO M, 1992, LYMPHOKINE CYTOK RES, V11, P287; Kim RH, 1996, BIOCHEM J, V318, P219, DOI 10.1042/bj3180219; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Koszewski NJ, 1996, J STEROID BIOCHEM, V59, P377, DOI 10.1016/S0960-0760(96)00127-6; LAWSONMATTHEW P, 1989, BRIT J HAEMATOL, V73, P57, DOI 10.1111/j.1365-2141.1989.tb00220.x; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LEFTSIN JA, 1994, GENE DEV, V8, P2842; Lemon BD, 1997, MOL CELL BIOL, V17, P1923, DOI 10.1128/MCB.17.4.1923; Lemon BD, 1996, MOL CELL BIOL, V16, P1006; LEMON BD, 1997, THESIS CORNELL U NEW; LI Q, 1994, J BIOL CHEM, V269, P4934; LICHTLER A, 1989, J BIOL CHEM, V264, P3072; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu SM, 1996, MOL ENDOCRINOL, V10, P206, DOI 10.1210/me.10.2.206; LOWE K E, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P65; LUISI BF, 1994, VITAM HORM, V49, P1; MACDONALD PN, 1995, J BIOL CHEM, V270, P4748, DOI 10.1074/jbc.270.9.4748; MACDONALD PN, 1993, MOL CELL BIOL, V13, P5907, DOI 10.1128/MCB.13.9.5907; MANGELSDORF DJ, 1984, J CELL BIOL, V98, P391, DOI 10.1083/jcb.98.2.391; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; MINER JN, 1992, GENE DEV, V6, P2491, DOI 10.1101/gad.6.12b.2491; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; OKAZAKI T, 1988, J BIOL CHEM, V263, P2203; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; REICHEL H, 1987, P NATL ACAD SCI USA, V84, P3385, DOI 10.1073/pnas.84.10.3385; REICHEL H, 1989, NEW ENGL J MED, V320, P980, DOI 10.1056/NEJM198904133201506; REICHEL H, 1987, J CLIN ENDOCR METAB, V65, P1201, DOI 10.1210/jcem-65-6-1201; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; RIGBY WFC, 1987, J CLIN INVEST, V79, P1659, DOI 10.1172/JCI113004; RUSSELL NH, 1992, BLOOD REV, V6, P149, DOI 10.1016/0268-960X(92)90026-M; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SALBERT G, 1993, MOL ENDOCRINOL, V7, P1347, DOI 10.1210/me.7.10.1347; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; TOBLER A, 1987, J CLIN INVEST, V79, P1700, DOI 10.1172/JCI113009; TOWERS TL, 1993, P NATL ACAD SCI USA, V90, P6310, DOI 10.1073/pnas.90.13.6310; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; WHITFIELD GK, 1995, MOL ENDOCRINOL, V9, P1166, DOI 10.1210/me.9.9.1166; WILLIAMSON DJ, 1988, CLIN EXP IMMUNOL, V72, P67; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YU XP, 1991, J BIOL CHEM, V266, P7588	71	93	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10338	10348		10.1074/jbc.273.17.10338	http://dx.doi.org/10.1074/jbc.273.17.10338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553089	hybrid			2022-12-27	WOS:000073224200038
J	Buisson, N; Labbe-Bois, R				Buisson, N; Labbe-Bois, R			Flavohemoglobin expression and function in Saccharomyces cerevisiae - No relationship with respiration and complex response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; VITREOSCILLA HEMOGLOBIN; GENE-EXPRESSION; IN-VIVO; PHYSIOLOGICAL-FUNCTION; ALCALIGENES-EUTROPHUS; FLAVOHAEMOGLOBIN HMP; YEAST HEMOGLOBIN; PRIMARY SEQUENCE; SHUTTLE VECTORS	The yeast Saccharomyces cerevisiae contains a flavohemoglobin, encoded by the gene YHB1, whose function is unclear. Previous reports presented evidence that its maximal expression requires disruption of mitochondrial respiration and that it plays a role in the response to oxidative stress. We have studied the expression of YHB1 in respiratory deficient cells and in cells exposed to various compounds causing oxidative stress. Several different strains and approaches (spectroscopic detection of the oxygenated form of Yhb1p, p-galactosidase activity of a YHB1-lacZ fusion, and Northern blot analysis) were used to demonstrate that YHB1 expression and Yhb1p production are not increased by respiration deficiency. YHB1 expression was unchanged in cells challenged with antimycin A or menadione, while it decreased in cells exposed to H2O2, diamide, dithiothreitol, and Cu2+, Transcription of YHB1 is not under the control of the transcriptional factor Yap1p, These results do not support a participation of YHB1 in the genetic response to oxidative stress. We also analyzed the growth phenotypes associated with altered Yhb1p production using YHB1-deleted strains and strains that greatly overproduced Yhb1p, Yhb1p appears to protect cells against the damage caused by Cu2+ and dithiothreitol, while sensitizing them to H2O2. Yhb1p overproduction in a glucose-6-phosphate dehydrogenase-deficient mutant decreased its growth rate. These data indicate that there is a complex relationship(s) between Yhb1p function(s) and cell defense reactions against various stresses.	Univ Paris 07, Inst Jacques Monod, Lab Biochim Porphyrines, F-75251 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Labbe-Bois, R (corresponding author), Univ Paris 07, Inst Jacques Monod, Lab Biochim Porphyrines, 2 Pl Jussieu, F-75251 Paris, France.	labbe@ijm.jussieu.fr						ABBAS A, 1993, J BIOL CHEM, V268, P8541; AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; AMILLET JM, 1995, CURR GENET, V28, P503, DOI 10.1007/BF00518161; Andersson CR, 1996, P NATL ACAD SCI USA, V93, P5682, DOI 10.1073/pnas.93.12.5682; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Balagopalakrishna C, 1996, BIOCHEMISTRY-US, V35, P6393, DOI 10.1021/bi952875+; BRUNELLI JP, 1993, YEAST, V9, P1299, DOI 10.1002/yea.320091203; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHEN W, 1994, BIOTECHNOL PROGR, V10, P308, DOI 10.1021/bp00027a011; CRAMM R, 1994, J BIOL CHEM, V269, P7349; CRAWFORD MJ, 1995, J BIOL CHEM, V270, P6991, DOI 10.1074/jbc.270.12.6991; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; DeGray JA, 1997, J BIOL CHEM, V272, P2359; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; FAVEY S, 1995, MICROBIOL-UK, V141, P863, DOI 10.1099/13500872-141-4-863; GALIAZZO F, 1993, FEBS LETT, V315, P197, DOI 10.1016/0014-5793(93)81162-S; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOLDBERG DE, 1995, BIOESSAYS, V17, P177, DOI 10.1002/bies.950170213; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Holmberg N, 1997, NAT BIOTECHNOL, V15, P244, DOI 10.1038/nbt0397-244; IWASSA H, 1992, J MOL BIOL, V227, P948; JAMIESON DJ, 1995, REDOX REP, V1, P89, DOI 10.1080/13510002.1995.11746964; KEILIN D, 1953, NATURE, V172, P390, DOI 10.1038/172390a0; KHOSLA C, 1989, J MOL BIOL, V210, P79, DOI 10.1016/0022-2836(89)90292-1; Labbe-Bois R, 1990, BIOSYNTHESIS HEME CH, P235; LABBEBOIS R, 1977, MOL GEN GENET, V156, P177, DOI 10.1007/BF00283490; LaCelle M, 1996, J BACTERIOL, V178, P3803, DOI 10.1128/jb.178.13.3803-3808.1996; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; MembrilloHernandez J, 1997, J BACTERIOL, V179, P3164, DOI 10.1128/jb.179.10.3164-3170.1997; MembrilloHernandez J, 1996, FEBS LETT, V382, P141, DOI 10.1016/0014-5793(96)00154-8; Miller YI, 1996, BIOCHEMISTRY-US, V35, P13112, DOI 10.1021/bi960737u; MoradasFerreira P, 1996, MOL MICROBIOL, V19, P651, DOI 10.1046/j.1365-2958.1996.403940.x; Moreau S, 1996, J BIOL CHEM, V271, P32557, DOI 10.1074/jbc.271.51.32557; Motwani N, 1996, PROTEIN EXPRES PURIF, V8, P447, DOI 10.1006/prep.1996.0123; MOULD RM, 1994, BIOCHEM J, V298, P619, DOI 10.1042/bj2980619; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nie XZ, 1997, PLANT PHYSIOL, V114, P835, DOI 10.1104/pp.114.3.835; NOGAE I, 1990, GENE, V96, P161, DOI 10.1016/0378-1119(90)90248-P; OSHINO R, 1973, EUR J BIOCHEM, V39, P581, DOI 10.1111/j.1432-1033.1973.tb03157.x; OSHINO R, 1973, EUR J BIOCHEM, V35, P23, DOI 10.1111/j.1432-1033.1973.tb02805.x; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; Poole RK, 1997, MICROBIOL-SGM, V143, P1557, DOI 10.1099/00221287-143-5-1557; Poole RK, 1996, MICROBIOL-SGM, V142, P1141, DOI 10.1099/13500872-142-5-1141; Rizzi M, 1996, J MOL BIOL, V258, P1, DOI 10.1006/jmbi.1996.0228; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P8091; SIKORSKI RS, 1989, GENETICS, V122, P19; Tettelin H, 1997, NATURE, V387, P81, DOI 10.1038/387s081; THOMAS D, 1991, EMBO J, V10, P547, DOI 10.1002/j.1460-2075.1991.tb07981.x; Tsai PS, 1996, BIOTECHNOL BIOENG, V49, P139; URBANGRIMAL D, 1981, MOL GEN GENET, V183, P85, DOI 10.1007/BF00270144; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; WAKABAYASHI S, 1986, NATURE, V322, P481, DOI 10.1038/322481a0; WATERLAND RA, 1991, J BIOL CHEM, V266, P4180; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; YAMASHOJI S, 1991, BIOCHIM BIOPHYS ACTA, V1059, P99, DOI 10.1016/S0005-2728(05)80191-4; Zal F, 1996, J BIOL CHEM, V271, P8869, DOI 10.1074/jbc.271.15.8869; Zhao XJ, 1996, J BIOL CHEM, V271, P25131, DOI 10.1074/jbc.271.41.25131; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015; ZITOMER RS, 1992, MICROBIOL REV, V56, P1; ZOLADEK T, 1995, MOL GEN GENET, V247, P471, DOI 10.1007/BF00293149	67	42	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9527	9533		10.1074/jbc.273.16.9527	http://dx.doi.org/10.1074/jbc.273.16.9527			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545281	hybrid			2022-12-27	WOS:000073128800027
J	Mori, K; Ogawa, N; Kawahara, T; Yanagi, H; Yura, T				Mori, K; Ogawa, N; Kawahara, T; Yanagi, H; Yura, T			Palindrome with spacer of one nucleotide is characteristic of the cis-acting unfolded protein response element in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ENDOPLASMIC-RETICULUM; KAR2 BIP GENE; DISULFIDE ISOMERASE; TRANSMEMBRANE PROTEIN; RESIDENT PROTEINS; BINDING-PROTEIN; S-CEREVISIAE; CELL; INDUCTION; ENCODES	When unfolded proteins are accumulated in the endoplasmic reticulum (ER), an intracellular signaling pathway termed the unfolded protein response (UPR) is activated to induce transcription of ER-localized molecular chaperones and folding enzymes in the nucleus. In Saccharomyces cerevisiae, at least six lumenal proteins including essential Kar2p and Pdi1p are known to be regulated by the UPR. We and others recently demonstrated that the basic-leucine zipper protein Hac1p/Ern4p functions as a trans-acting factor responsible for the UPR. Hac1p binds directly to the cis-acting unfolded protein response element (UPRE) responsible for Kar2p induction. Moreover, we showed that the KAR2 UPRE contains an E box-like palindrome separated by one nucleotide (CAGCGTG) that is essential for its function. We report here that the promoter regions of each of five target proteins (Kar2p, Pdi1p, Eug1p, Fkb2p, and Lhs1p) contain a single UPRE sequence that is necessary and sufficient for induction and that binds specifically to Hac1p in vitro. All of the five functional UPRE sequences identified contain a palindromic sequence that has, in four cases, a spacer of one C nucleotide. This unique characteristic of UPRE explains why only a specific set of proteins are induced in the UPR to cope with ER stress.	HSP Res Inst, Shimogyo Ku, Kyoto 6008813, Japan		Mori, K (corresponding author), HSP Res Inst, Shimogyo Ku, Kyoto Res Pk, Kyoto 6008813, Japan.		Mori, Kazutoshi/K-6106-2015					Ausubel F.M., 1989, CURRENT PROTOCOLS MO, V2; Baxter BK, 1996, MOL CELL BIOL, V16, P6444; BEH CT, 1995, P NATL ACAD SCI USA, V92, P9820, DOI 10.1073/pnas.92.21.9820; BLUMBERG H, 1991, NATURE, V349, P627, DOI 10.1038/349627a0; Bowman S, 1997, NATURE, V387, P90, DOI 10.1038/387s090; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; Craven RA, 1997, TRENDS CELL BIOL, V7, P277, DOI 10.1016/S0962-8924(97)01079-9; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; FELDMAN RI, 1987, J BIOL CHEM, V262, P9332; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; Hamilton TG, 1996, J BIOL CHEM, V271, P30610, DOI 10.1074/jbc.271.48.30610; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HURST H, 1995, PROTEIN PROFILE TRAN, V2; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAMANTIA M, 1991, P NATL ACAD SCI USA, V88, P4453, DOI 10.1073/pnas.88.10.4453; LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9; LITTLEWOOD T, 1995, PROTEIN PROFILE TRAN, V2; McMillan D. Randy, 1994, Current Opinion in Biotechnology, V5, P540, DOI 10.1016/0958-1669(94)90071-X; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; NASMYTH KA, 1980, P NATL ACAD SCI-BIOL, V77, P2119, DOI 10.1073/pnas.77.4.2119; Nikawa J, 1996, NUCLEIC ACIDS RES, V24, P4222, DOI 10.1093/nar/24.21.4222; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Nunnari J, 1996, CELL, V84, P389, DOI 10.1016/S0092-8674(00)81283-0; Pahl HL, 1997, TRENDS CELL BIOL, V7, P50, DOI 10.1016/S0962-8924(96)10050-7; PARTALEDIS JA, 1993, P NATL ACAD SCI USA, V90, P5450, DOI 10.1073/pnas.90.12.5450; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Sherman F., 1986, METHODS YEAST GENETI; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIKORSKI RS, 1989, GENETICS, V122, P19; TACHIBANA C, 1992, MOL CELL BIOL, V12, P4601, DOI 10.1128/MCB.12.10.4601; TACHIKAWA H, 1991, J BIOCHEM, V110, P306, DOI 10.1093/oxfordjournals.jbchem.a123576	48	120	128	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9912	9920		10.1074/jbc.273.16.9912	http://dx.doi.org/10.1074/jbc.273.16.9912			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545334	hybrid			2022-12-27	WOS:000073128800080
J	Watt, RK; Ludden, PW				Watt, RK; Ludden, PW			The identification, purification, and characterization of CooJ - A nickel-binding protein that is CO-regulated with the Ni-containing CO dehydrogenase from Rhodospirillum rubrum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-MONOXIDE DEHYDROGENASE; CHELATE AFFINITY-CHROMATOGRAPHY; ESCHERICHIA-COLI; KLEBSIELLA-AEROGENES; CRYSTAL-STRUCTURE; HYDROGENASE; UREASE; HISTIDINE; SYSTEM; GENE	CooJ, a nickel-binding protein from the CO dehydrogenase system of Rhodospirillum rubrum, was purified by immobilized metal affinity chromatography. CooJ is a CO-induced protein predicted to contain a nickel binding motif composed of 16 histidine residues in the final 34 amino acids of the 12.5-kDa protein. When cells grown in the presence of CO were fractionated on an immobilized metal affinity chromatography column and analyzed by SDS-polyacrylamide gel electrophoresis, the major protein observed in the effluent migrated at an apparent molecular mass of 19 kDa. The 19-kDa protein was absent in extracts of cells grown in the absence of CO and the mutant strain, UR294, which lacks a functional cooJ gene. N-terminal sequence analysis confirmed that the 19-kDa protein is the product of the cooJ gene. Purified CooJ was shown to bind four nickel atoms per CooJ monomer with a K-d of 4.3 mu M. Other divalent metals competed with the following order of affinity and corresponding K-i:Zn2+ (5 mu M) > Cd2+ (19 mu M) > Co2+ (23 mu M) > Cu2+ (122 mu M). CooJ chromatographed on a calibrated Superose 12 gel filtration column eluted at 39 kDa, a position consistent with a multimeric native molecular mass for CooJ.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Ludden, PW (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.							BONAM D, 1984, J BACTERIOL, V159, P693, DOI 10.1128/JB.159.2.693-699.1984; BONAM D, 1989, J BACTERIOL, V171, P3102, DOI 10.1128/jb.171.6.3102-3107.1989; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brayman TG, 1996, J BACTERIOL, V178, P5410, DOI 10.1128/jb.178.18.5410-5416.1996; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; ENSIGN SA, 1989, BIOCHEMISTRY-US, V28, P4968, DOI 10.1021/bi00438a010; ENSIGN SA, 1991, J BIOL CHEM, V266, P18395; Fox JD, 1996, J BACTERIOL, V178, P1515, DOI 10.1128/jb.178.6.1515-1524.1996; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; FU CL, 1994, BBA-BIOENERGETICS, V1184, P135, DOI 10.1016/0005-2728(94)90163-5; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; GLENNON JD, 1982, BIOCHEM J, V203, P15, DOI 10.1042/bj2030015; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; Hu ZG, 1996, J AM CHEM SOC, V118, P830, DOI 10.1021/ja9528386; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Kansau I, 1996, MOL MICROBIOL, V22, P1013, DOI 10.1046/j.1365-2958.1996.01536.x; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; LEE MH, 1993, PROTEIN SCI, V2, P1042, DOI 10.1002/pro.5560020617; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Maier T, 1996, BIOCHEMISTRY-US, V35, P10089, DOI 10.1021/bi960567l; MAIER T, 1996, ADV INORG CHEM, V11, P173; MONCRIEF MBC, 1996, ADV INORG BIOCHEM, V11, P151; Olson JW, 1997, MOL MICROBIOL, V24, P119, DOI 10.1046/j.1365-2958.1997.3251690.x; ORMEROD JG, 1961, ARCH BIOCHEM BIOPHYS, V94, P449, DOI 10.1016/0003-9861(61)90073-X; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; REINARD T, 1989, ANAL BIOCHEM, V176, P157, DOI 10.1016/0003-2697(89)90286-8; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Rodrigue A, 1996, J BACTERIOL, V178, P4453, DOI 10.1128/jb.178.15.4453-4460.1996; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SRIWANTHANA B, 1994, J BACTERIOL, V176, P6836, DOI 10.1128/JB.176.22.6836-6841.1994; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; WULFING C, 1994, J BIOL CHEM, V269, P2895	40	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10019	10025		10.1074/jbc.273.16.10019	http://dx.doi.org/10.1074/jbc.273.16.10019			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545348	hybrid			2022-12-27	WOS:000073128800094
J	Belcourt, MF; Hodnick, WF; Rockwell, S; Sartorelli, AC				Belcourt, MF; Hodnick, WF; Rockwell, S; Sartorelli, AC			The intracellular location of NADH : cytochrome b(5) reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDOREDUCTASE DT-DIAPHORASE; XANTHINE DEHYDROGENASE; NADH-CYTOCHROME-B5 REDUCTASE; ANTITUMOR QUINONES; B5 REDUCTASE; EMT6 CELLS; PORFIROMYCIN; TOXICITY; CANCER; ACTIVATION	NADH:cytochrome b(5) reductase activates the mitomycins to alkylating intermediates in vitro. To investigate the intracellular role of this enzyme in mitomycin bioactivation, Chinese hamster ovary cell transfectants overexpressing rat NADH:cytochrome b(5) reductase were generated. An NADH:cytochrome b(5) reductase-transfected clone expressed 9-fold more enzyme than did parental cells; the levels of other mitomycin-activating oxidoreductases were unchanged. Although this enzyme activates the mitomycins in vitro, its overexpression in living cells caused decreases in sensitivity to mitomycin C in air and decreases in sensitivity to porfiromycin under both air and hypoxia, Mitomycin C cytotoxicity under hypoxia was similar to parental cells. Because NADH:cytochrome b(5) reductase resides predominantly in the mitochondria of these cells, this enzyme may sequester these drugs in this compartment, thereby decreasing nuclear DNA alkylations and reducing cytotoxicity. A cytosolic form of NADH:cytochrome b(5) reductase was generated. Transfectants expressing the cytosolic enzyme were restored to parental line sensitivity to both mitomycin C and porfiromycin in air with marked increases in drug sensitivity under hypoxia. The results implicate NADH:cytochrome b(5) reductase in the differential bioactivation of the mitomycins and indicate that the subcellular site of drug activation can have complex effects on drug cytotoxicity.	Yale Univ, Sch Med, Yale Canc Ctr, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Yale Canc Ctr, Therapeut Radiol & Dev Therapeut Program, New Haven, CT 06520 USA	Yale University; Yale University	Sartorelli, AC (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, Dept Pharmacol, New Haven, CT 06520 USA.		Rockwell, Sara/B-8458-2009					BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; BEALL HD, 1995, MOL PHARMACOL, V48, P499; Belcourt MF, 1996, BIOCHEM PHARMACOL, V51, P1669, DOI 10.1016/0006-2952(96)00143-8; Belcourt MF, 1996, P NATL ACAD SCI USA, V93, P456, DOI 10.1073/pnas.93.1.456; BORGESE N, 1980, J CELL BIOL, V86, P38, DOI 10.1083/jcb.86.1.38; BORGESE N, 1986, BIOCHEM J, V239, P393, DOI 10.1042/bj2390393; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; Borgese N, 1993, Subcell Biochem, V21, P313; Chen S, 1997, J BIOL CHEM, V272, P1437, DOI 10.1074/jbc.272.3.1437; ERNSTER L, 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1; Fisher J., 1982, DEV BIOCHEM, V21, P240; FRACASSO PM, 1986, CANCER RES, V46, P3939; FRANCK RW, 1990, CHEM ANTITUMOR AGENT, P379; GUSTAFSON D L, 1991, Proceedings of the American Association for Cancer Research Annual Meeting, V32, P5; GUSTAFSON DL, 1992, JNCI-J NATL CANCER I, V84, P1180, DOI 10.1093/jnci/84.15.1180; GUSTAFSON DL, 1992, CANCER RES, V52, P6936; Gustafson DL, 1996, MOL PHARMACOL, V50, P728; Haffty B G, 1997, Radiat Oncol Investig, V5, P235, DOI 10.1002/(SICI)1520-6823(1997)5:5<235::AID-ROI4>3.0.CO;2-Z; HAFFTY BG, 1993, INT J RADIAT ONCOL, V27, P241, DOI 10.1016/0360-3016(93)90234-M; HODNICK WF, 1993, CANCER RES, V53, P4907; HUGHES CS, 1991, CANCER COMMUN-US, V3, P29; KEYES SR, 1991, CANCER COMMUN-US, V3, P351, DOI 10.3727/095535491820873812; KEYES SR, 1984, CANCER RES, V44, P5638; King T.E., 1967, METHODS ENZYMOL, P216, DOI DOI 10.1016/0076-6879(67)10043-8; LEHNINGER AL, 1975, BIOCHEMISTRY-US, P477; Mikami K, 1996, CANCER RES, V56, P2823; PAN SS, 1984, J BIOL CHEM, V259, P959; PIETRINI G, 1992, J CELL BIOL, V117, P975, DOI 10.1083/jcb.117.5.975; PIETRINI G, 1988, P NATL ACAD SCI USA, V85, P7246, DOI 10.1073/pnas.85.19.7246; POWIS G, 1995, ANTICANCER RES, V15, P1141; PRITSOS CA, 1994, ONCOL RES, V6, P477; Pritsos CA, 1996, BRIT J CANCER, V74, pS15; ROCKWELL S, 1977, LAB ANIM SCI, V27, P831; ROCKWELL S, 1990, ANTITUMOR DRUG RAD I, P125; Sambrook J., 2002, MOL CLONING LAB MANU; SARTORELLI AC, 1995, ADV ENZYME REGUL, V35, P117, DOI 10.1016/0065-2571(94)00015-U; SARTORELLI AC, 1994, ONCOL RES, V6, P501; SARTORELLI AC, 1993, ADV ENZYME REGUL, V33, P3; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; WEISSBERG JB, 1989, INT J RADIAT ONCOL, V17, P3, DOI 10.1016/0360-3016(89)90362-3; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337; YOSHIDA T, 1995, BIOCHEM BIOPH RES CO, V214, P701, DOI 10.1006/bbrc.1995.2342; YUBISUI T, 1982, J BIOCHEM, V91, P1467, DOI 10.1093/oxfordjournals.jbchem.a133838	45	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8875	8881		10.1074/jbc.273.15.8875	http://dx.doi.org/10.1074/jbc.273.15.8875			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535868	hybrid			2022-12-27	WOS:000072990800045
J	Ma, YS; Su, Q; Tempst, P				Ma, YS; Su, Q; Tempst, P			Differentiation-stimulated activity binds an ETS-like, essential regulatory element in the human promyelocytic defensin-1 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; FACTOR-RECEPTOR PROMOTER; EARLY MYELOID GENE; RNA POLYMERASE-II; NF-M; MYELOGENOUS LEUKEMIA; MYELOMONOCYTIC CELLS; ACTIVATION DOMAIN; FAMILY MEMBERS; CD11B PROMOTER	The human HNP-defensin-1 gene encodes a peptide antibiotic found exclusively in neutrophils and is key to elimination of microbes. Expression is a marker for the granulocytic lineage and for certain stages of differentiation and is not known to be inducible in mature cells under physiological conditions. Low level of transcription also occurs in HL-60 promyelocytic leukemia cells and is greatly activated upon drug-induced granulocytic maturation and by low doses of retinoic acid, in a strictly cell-specific manner (Herwig, S., Su, Q., Ma, Y., and Tempst, P. (1996) Blood 87, 350-364). We have analyzed a 10-kilobase pair region, upstream of the defensin-1 cap site, for the presence of control elements, and we describe a minimal promoter (position -83 to +82) required to drive transcription in HL-60 cells in a quasi cell-specific manner. Our data also suggest the presence of negative regulatory elements in the -416/-191 region that may further contribute to cell specificity in a chromosomal context. The basal promoter contains two functionally essential, ETS-like (GGAA core sequence) elements. The proximal site (-22/-19) constitutively binds the PU.1 transcription factor in vitro and could function, together perhaps with an adjacent TA-rich sequence (-32/-25), in assembly of a myeloid-restricted, basal transcription factor complex. The distal site (-62/-59) interacts in vitro with an unidentified activity, distinct from PU.1, ETS-1, PEA3, and ELK-1 (factors with definite binding site similarities), and is greatly stimulated by phosphorylation during granulocytic differentiation of HL-60 cells. Identification of this protein will be important to resolve the molecular mechanisms controlling temporal, granulocytic restricted gene expression.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Tempst, P (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [F32CA071163] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA71163] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BATEMAN A, 1991, J BIOL CHEM, V266, P7524; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Carey JO, 1996, BLOOD, V87, P4316, DOI 10.1182/blood.V87.10.4316.bloodjournal87104316; Chen HM, 1996, J BIOL CHEM, V271, P15743, DOI 10.1074/jbc.271.26.15743; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; CHEN HM, 1993, J BIOL CHEM, V268, P8230; CHEN HM, 1995, ONCOGENE, V11, P1549; COLLINS SJ, 1987, BLOOD, V70, P1233; DAHER KA, 1988, P NATL ACAD SCI USA, V85, P7327, DOI 10.1073/pnas.85.19.7327; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; FEINMAN R, 1994, EMBO J, V13, P3852, DOI 10.1002/j.1460-2075.1994.tb06696.x; FISHER RJ, 1991, ONCOGENE, V6, P2249; Friedman AD, 1996, CURR TOP MICROBIOL, V211, P149; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1993, BLOOD, V82, P641; GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F; Ganz T, 1997, Curr Opin Hematol, V4, P53; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; Herwig S, 1996, BLOOD, V87, P350, DOI 10.1182/blood.V87.1.350.bloodjournal871350; HIRATA RK, 1993, HEMATOL PATHOL, V7, P225; Hodge DR, 1996, ONCOGENE, V12, P11; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; JOINER KA, 1989, J CELL BIOL, V109, P2771, DOI 10.1083/jcb.109.6.2771; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; KIM KY, 1995, BIOCHEM BIOPH RES CO, V213, P616, DOI 10.1006/bbrc.1995.2176; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KOEFFLER HP, 1983, BLOOD, V62, P709; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lehrer RI, 1996, ANN NY ACAD SCI, V797, P228, DOI 10.1111/j.1749-6632.1996.tb52963.x; LEHRER RI, 1990, BLOOD, V76, P2169; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LINZMEIER R, 1993, FEBS LETT, V321, P267, DOI 10.1016/0014-5793(93)80122-B; LUBBERT M, 1991, BLOOD, V77, P909; Mallow EB, 1996, J BIOL CHEM, V271, P4038; MARS WM, 1988, BLOOD, V71, P1713; MARS WM, 1985, BLOOD, V65, P1218; MOLLINEDO F, 1993, BIOCHEM J, V294, P137, DOI 10.1042/bj2940137; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; PAHL HL, 1993, J BIOL CHEM, V268, P5014; PALFREE RGE, 1993, MOL ENDOCRINOL, V7, P199, DOI 10.1210/me.7.2.199; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; PETTERSSON M, 1987, GENE DEV, V1, P962, DOI 10.1101/gad.1.9.962; Pfahl Magnus, 1994, Seminars in Cell Biology, V5, P95, DOI 10.1006/scel.1994.1013; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; QUANDT K, 1995, NUCLEIC ACIDS RES, V23, P4678; RABAULT B, 1994, J BIOL CHEM, V269, P28143; ROBERTSON KA, 1992, BLOOD, V80, P1885; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; SCOTT LM, 1992, BLOOD, V80, P1725; SELSTED ME, 1995, TRENDS CELL BIOL, V5, P114, DOI 10.1016/S0962-8924(00)88961-8; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SGOURAS DN, 1995, EMBO J, V14, P4781, DOI 10.1002/j.1460-2075.1995.tb00160.x; SHAPIRO LH, 1995, J BIOL CHEM, V270, P8763, DOI 10.1074/jbc.270.15.8763; SINGH A, 1988, BIOCHEM BIOPH RES CO, V155, P524, DOI 10.1016/S0006-291X(88)81118-5; SKALNIK DG, 1991, J BIOL CHEM, V266, P16736; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; THOMAS EL, 1988, REV INFECT DIS S2, V10, P450; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VALORE EV, 1992, BLOOD, V79, P1538; WIEDEMANN LM, 1989, LEUKEMIA, V3, P227; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Yang BS, 1996, MOL CELL BIOL, V16, P538; ZARET KS, 1990, P NATL ACAD SCI USA, V87, P5469, DOI 10.1073/pnas.87.14.5469; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373	78	31	33	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8727	8740		10.1074/jbc.273.15.8727	http://dx.doi.org/10.1074/jbc.273.15.8727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535850	hybrid			2022-12-27	WOS:000072990800027
J	von Ropenack, E; Parr, A; Schulze-Lefert, P				von Ropenack, E; Parr, A; Schulze-Lefert, P			Structural analyses and dynamics of soluble and cell wall-bound phenolics in a broad spectrum resistance to the powdery mildew fungus in barley	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-SP HORDEI; PHENYLALANINE AMMONIA-LYASE; ERYSIPHE-GRAMINIS; ML-O; ATTEMPTED PENETRATION; ARABIDOPSIS-THALIANA; FUNGICIDAL ACTIVITY; DISEASE RESISTANCE; CALLOSE FORMATION; EPIDERMAL-CELLS	High pressure liquid chromatography profiles of barley leaf epidermal soluble and cell wall-bound phenolics were analyzed in response to challenge with the fungal pathogen Erysiphe graminis f. sp. hordei. Only one soluble phenolic was found to accumulate differentially in a broad spectrum resistance reaction controlled by mlo resistance alleles in comparison to susceptible near isogenic Mlo lines. Structural analysis identified this compound as a novel phenolic conjugate, p-coumaroyl-hydroxyagmatine (p-CHA). p-CHA but not the nonhydroxylated derivative p-coumaroylagmatine exhibited antifungal activity both in vitro and in vivo. The accumulation of p-CHA in epidermal tissue correlated tightly with fungal penetration attempts of attacked host cells. Furthermore, upon penetration, epidermal cell wall-bound phenolics became resistant to saponification at sites of attempted fungal ingress (papilla), indicating a change in, or the addition of, different chemical bonding types. The switch in saponification sensitivity occurred at least 2 h earlier in the mlo-incompatible than in the Mlo-compatible interaction. Our results suggest that p-CHA and the speed of papillae compaction play important roles in non-race-specific powdery mildew defense.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Norwich Lab, Inst Food Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Schulze-Lefert, P (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	schlef@bbsrc.ac.uk	Schulze-Lefert, Paul/B-6707-2011; Schulze-Lefert, Paul/A-7746-2008					Aist J.R., 1983, DYNAMICS HOST DEFENC, P33; ARNESON PA, 1968, PLANT PHYSIOL, V43, P683, DOI 10.1104/pp.43.5.683; BAYLES CJ, 1990, PHYSIOL MOL PLANT P, V36, P63, DOI 10.1016/0885-5765(90)90092-C; BELL EA, 1963, NATURE, V199, P70, DOI 10.1038/199070a0; BELL EA, 1963, NATURE, V197, P901, DOI 10.1038/197901a0; BOHLMANN H, 1988, EMBO J, V7, P1559, DOI 10.1002/j.1460-2075.1988.tb02980.x; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; BUSHNELL WR, 1975, PHYTOPATHOLOGY, V65, P310, DOI 10.1094/Phyto-65-310; CAETANOANOLLES G, 1988, J BACTERIOL, V170, P3164, DOI 10.1128/jb.170.7.3164-3169.1988; CLARK TA, 1994, PHYSIOL MOL PLANT P, V44, P171, DOI 10.1016/S0885-5765(05)80002-5; COLLINGE DB, 1987, PLANT MOL BIOL, V8, P405, DOI 10.1007/BF00015818; CROMBIE WML, 1986, PHYTOCHEMISTRY, V25, P2075, DOI 10.1016/0031-9422(86)80069-3; EVANS PT, 1989, ANNU REV PLANT PHYS, V40, P235, DOI 10.1146/annurev.pp.40.060189.001315; FISCH MH, 1973, PHYTOCHEMISTRY, V12, P437, DOI 10.1016/0031-9422(73)80036-6; FOSTER SA, 1993, PESTIC SCI, V37, P267, DOI 10.1002/ps.2780370306; Francis SA, 1996, PHYSIOL MOL PLANT P, V49, P201, DOI 10.1006/pmpp.1996.0049; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Glazebrook J, 1997, GENETICS, V146, P381; Glazebrook J, 1996, GENETICS, V143, P973; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; HAMANA K, 1993, CAN J BOT, V71, P1381, DOI 10.1139/b93-165; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; HAVIS ND, 1994, PESTIC SCI, V41, P61, DOI 10.1002/ps.2780410111; HINZE K, 1991, P NATL ACAD SCI USA, V88, P3691, DOI 10.1073/pnas.88.9.3691; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; KOGA H, 1977, NIPPON SHOKUBUTSU BY, V43, P93; KOLSTER P, 1986, CROP SCI, V26, P903, DOI 10.2135/cropsci1986.0011183X002600050014x; KUMAR A, 1997, PLANT SCI, V2, P124; Kunoh H., 1982, PLANT INFECTION PHYS, P45; LYNKJAER MF, 1997, PHYSIOL MOL PLANT P, V50, P17; MAKISUMI S, 1961, J BIOCHEM-TOKYO, V49, P292, DOI 10.1093/oxfordjournals.jbchem.a127297; MAKISUMI S, 1961, J BIOCHEM-TOKYO, V49, P284, DOI 10.1093/oxfordjournals.jbchem.a127296; MANSFIELD JW, 1975, T BRIT MYCOL SOC, V64, P507, DOI 10.1016/S0007-1536(75)80151-3; Moerschbacher B.M., 1992, PLANT PEROXIDASES 19, P91; MULLER K. O., 1941, Arb. biol. Anst. (Reichsanst.) Berl., V23, P189; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; OKU H, 1975, PHYTOPATHOLOGY, V65, P1263, DOI 10.1094/Phyto-65-1263; OSAWA T, 1992, J AGR FOOD CHEM, V40, P1135, DOI 10.1021/jf00019a009; Osbourn A, 1996, TRENDS PLANT SCI, V1, P4, DOI 10.1016/S1360-1385(96)80016-1; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; RIDE JP, 1979, PHYSIOL PLANT PATHOL, V15, P79, DOI 10.1016/0048-4059(79)90041-9; RUIZHERRERA J, 1994, CRIT REV MICROBIOL, V20, P143, DOI 10.3109/10408419409113553; RUSSO VM, 1989, CAN J BOT, V67, P2912, DOI 10.1139/b89-374; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SAMBORSKI DJ, 1970, PHYTOCHEMISTRY, V9, P1939, DOI 10.1016/S0031-9422(00)85343-1; Schmidt J, 1995, EUR MASS SPECTROM, V1, P573, DOI 10.1255/ejms.92; ScottCraig JS, 1995, PHYSIOL MOL PLANT P, V47, P407, DOI 10.1006/pmpp.1995.1068; SKOU JP, 1984, PHYTOPATHOL Z, V109, P147; SMART MG, 1987, CAN J BOT, V65, P745, DOI 10.1139/b87-099; SMITH TA, 1985, BIOCHEM SOC T, V13, P319, DOI 10.1042/bst0130319; SMITH TA, 1978, PHYTOCHEMISTRY, V17, P1093, DOI 10.1016/S0031-9422(00)94295-X; SMITH TA, 1983, ADV POLYAMINE RES, V4, P347; STOESSL A, 1967, CAN J CHEMISTRY, V45, P1745, DOI 10.1139/v67-283; STOESSL A, 1970, CAN J BOTANY, V48, P465, DOI 10.1139/b70-066; TAKAHASHI K, 1990, PHYSIOL MOL PLANT P, V16, P283; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tiburcio AF, 1990, BIOCH PLANTS, P283, DOI DOI 10.1016/B978-0-08-092616-2.50013-9; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; WEI YD, 1994, PHYSIOL MOL PLANT P, V45, P469, DOI 10.1016/S0885-5765(05)80043-8; WOLFE M S, 1975, Phytopathologische Zeitschrift, V82, P297; ZEYEN RJ, 1995, PHYSIOL MOL PLANT P, V47, P119, DOI 10.1006/pmpp.1995.1047; ZEYEN RJ, 1979, CAN J BOT, V57, P898, DOI 10.1139/b79-111; ZEYEN RJ, 1993, CAN J BOT, V71, P284, DOI 10.1139/b93-029	66	190	194	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9013	9022		10.1074/jbc.273.15.9013	http://dx.doi.org/10.1074/jbc.273.15.9013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535889	hybrid			2022-12-27	WOS:000072990800066
J	Pegg, AE; Kanugula, S; Edara, S; Pauly, GT; Moschel, RC; Goodtzova, K				Pegg, AE; Kanugula, S; Edara, S; Pauly, GT; Moschel, RC; Goodtzova, K			Reaction of O-6-benzylguanine-resistant mutants of human O-6-alkylguanine-DNA alkyltransferase with O-6-benzylguanine in oligodeoxyribonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN O6-METHYLGUANINE-DNA METHYLTRANSFERASE; HUMAN O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ESCHERICHIA-COLI; ALKYLATING-AGENTS; DNA-REPAIR; CRYSTAL-STRUCTURE; INACTIVATION; O6-BENZYLGUANINE; SENSITIVITY; PROTEIN	Inactivation of the human DNA repair protein, O-6-alkylguanine-DNA alkyltransferase (AGT), by O-6-benzylguanine renders tumor cells susceptible to killing by alkylating agents, AGT mutants resistant to O-6-benzylguanine can be made by converting Pro(140) to an alanine (P140A) or Gly(156) to an alanine (G156A), These mutations had a much smaller effect on the reaction with O-6-benzylguanine when it was incorporated into a short single-stranded oligodeoxyribonucleotide. Such oligodeoxyribonucleotides could form the basis for the design of improved AGT inhibitors. AGT and mutants P140A and G156A preferentially reacted with O-6-benzylguanine when incubated with a mixture of two 16-mer oligodeoxyribonucleotides, one containing O-6-benzylguanine and the other, O-6-methylguanine. When the 6 amino acids located in positions 159-164 in AGT were replaced by the equivalent sequence from the Escherichia coli Ada-C protein (mutant AGT/6ada) the preference for benzyl repair was eliminated. Further mutation incorporating the P140A change into AGT/6ada giving mutant P140A/6ada led to a protein that resembled Ada-C in preference for the repair of methyl groups, but P140A/6ada did not differ from P140A in reaction with the free base O-6-benzylguanine. Changes in the AGT active site pocket can therefore affect the preference for repair of O-6-benzyl or -methyl groups when present in an oligodeoxyribonucleotide without altering the reaction with free O-6-benzylguanine.	Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA; NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Frederick, MD 21702 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Pegg, AE (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Coll Med, POB 850,500 Univ Dr, Hershey, PA 17033 USA.			Pauly, Gary/0000-0002-3481-7129				CHAN CL, 1993, ARCH BIOCHEM BIOPHYS, V300, P193, DOI 10.1006/abbi.1993.1027; Christian MC, 1997, SEMIN ONCOL, V24, P219; Christians FC, 1997, CANCER RES, V57, P2007; CIOCCO GM, 1995, CANCER RES, V55, P4085; CRONE TM, 1995, CARCINOGENESIS, V16, P1687, DOI 10.1093/carcin/16.8.1687; CRONE TM, 1994, CANCER RES, V54, P6221; CRONE TM, 1993, CANCER RES, V53, P4750; DEMPLE B, 1995, CURR BIOL, V5, P719, DOI 10.1016/S0960-9822(95)00143-6; DOLAN ME, 1991, CARCINOGENESIS, V12, P2305, DOI 10.1093/carcin/12.12.2305; DOLAN ME, 1991, CANCER RES, V51, P3367; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Dolan ME, 1997, CLIN CANCER RES, V3, P837; Dolan ME, 1997, ADV DRUG DELIVER REV, V26, P105; Edara S, 1996, CANCER RES, V56, P5571; ELDER RH, 1994, BIOCHEM J, V298, P231, DOI 10.1042/bj2980231; Fried MG, 1996, BIOCHEMISTRY-US, V35, P15295, DOI 10.1021/bi960971k; Gerson Stanton L., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P699; GOODTZOVA K, 1994, BIOCHEMISTRY-US, V33, P8385, DOI 10.1021/bi00194a001; Goodtzova K, 1997, J BIOL CHEM, V272, P8332, DOI 10.1074/jbc.272.13.8332; KANUGULA S, 1995, BIOCHEMISTRY-US, V34, P7113, DOI 10.1021/bi00021a024; LIEM LK, 1993, J MOL BIOL, V231, P950, DOI 10.1006/jmbi.1993.1344; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; MARGISON GP, 1996, ANTI-CANCER DRUG, V7, P109; MITRA S, 1993, PROG NUCLEIC ACID RE, V44, P109, DOI 10.1016/S0079-6603(08)60218-4; MOODY PCE, 1995, CONTR ONCOL, V49, P16; MOORE MH, 1994, EMBO J, V13, P1495, DOI 10.1002/j.1460-2075.1994.tb06410.x; MOSCHEL RC, 1992, J MED CHEM, V35, P4486, DOI 10.1021/jm00101a028; MOSCHEL RC, 1986, J ORG CHEM, V51, P4180, DOI 10.1021/jo00372a015; PAULY GT, 1991, BIOCHEMISTRY-US, V30, P11700, DOI 10.1021/bi00114a014; PAULY GT, 1988, CHEM RES TOXICOL, V1, P391, DOI 10.1021/tx00006a011; PEARL LH, 1995, TRENDS BIOCHEM SCI, V20, P421, DOI 10.1016/S0968-0004(00)89092-1; PEGG AE, 1993, BIOCHEMISTRY-US, V32, P11998, DOI 10.1021/bi00096a009; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Pegg Anthony E., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P565; ROBERTS RJ, 1995, CELL, V82, P9, DOI 10.1016/0092-8674(95)90046-2; Samson LD, 1992, ESSAYS BIOCHEM, V27, P69; SCICCHITANO D, 1982, BIOCHEM BIOPH RES CO, V109, P995, DOI 10.1016/0006-291X(82)92038-1; TAKAHASHI M, 1990, BIOCHEMISTRY-US, V29, P3431, DOI 10.1021/bi00466a002; Terashima I, 1997, CHEM RES TOXICOL, V10, P1234, DOI 10.1021/tx9700580; VERDINE GL, 1994, CELL, V76, P197, DOI 10.1016/0092-8674(94)90326-3	40	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10863	10867		10.1074/jbc.273.18.10863	http://dx.doi.org/10.1074/jbc.273.18.10863			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556560	hybrid			2022-12-27	WOS:000073395200012
J	Sadir, R; Forest, E; Lortat-Jacob, H				Sadir, R; Forest, E; Lortat-Jacob, H			The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; GROWTH-FACTOR; IFN-GAMMA; MONOCLONAL-ANTIBODIES; DIFFERENTIAL BINDING; IMMUNE INTERFERON; TERMINAL SEQUENCE; HUMAN-CELLS; DOMAINS; GLYCOSAMINOGLYCANS	Interferon-gamma (IFN gamma), in common with a number of growth factors, binds both to heparan sulfate or heparin-related molecules and to a specific high affinity receptor (IFN gamma R). Using surface plasmon resonance technology, kinetic analysis of the IFN gamma.IFN gamma R complex formation was performed with the extracellular part of IFN gamma R immobilized on a sensor chip. At the sensor chip surface, IFN gamma was bound by two IFN gamma R molecules with an affinity in the nanomolar range (0.68 nM). This binding was characterized by an important on rate k(on) = 7.3 x 10(6) M-1.s(-1), and an off rate, k(off) = 5 x 10(-3).s(-1). This binding assay was used to investigate a possible role of heparin in the IFN gamma.IFN gamma R complex formation. In contrast to growth factors for which binding to heparin is usually required for high affinity receptor interaction, we found in this study that IFN gamma bound to heparin displayed a strongly reduced affinity for its receptor. This is consistent with the fact that a cluster of basic amino acids (KTGKRKR, called the CI domain) in the carboxyl-terminal sequence of the cytokine was involved both in heparin and receptor recognition. To understand how a single domain of IFN gamma could be implicated in two discrete functions (i.e., binding to heparin and to IFN gamma R), we also analyzed in a detailed manner the role of the IFN gamma carboxyl-terminal sequence in receptor binding. Using forms of IFN gamma, with carboxyl terminus truncations of defined regions of the heparin binding sequence, we found that the Cl domain functioned by increasing the on rate of the IFN gamma IFN gamma R binding reaction but was not otherwise required for the stability of the complex. Interactions between the IFN gamma carboxyl-terminal domain and IFN gamma R could increased the association rate of the reaction either by increasing the number of encounters between the two molecules or by favoring productive collisions, The mechanisms by which heparan sulfate regulates IFN gamma activity may thus include both control of selective protease cleavage events, which directly affect the cytokine activity, and also an ability to modulate the interaction of IFN gamma with the IFN gamma R via competitive binding to the Cl domain.	Inst Biol Struct, Lab Mol Biophys, CNRS, UPR 9015, F-38027 Grenoble 01, France; Inst Biol Struct, Lab Spectrometrie Masse, CNRS, UPR 9015, F-38027 Grenoble 01, France; Inst Pasteur Lyon, CNRS, URA 1459, F-38027 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Lortat-Jacob, H (corresponding author), Inst Biol Struct, Lab Mol Biophys, CNRS, UPR 9015, 41 Ave Martyrs, F-38027 Grenoble 01, France.	lortat@ibs.ibs.fr	Forest, Eric/E-9042-2012					AVIEZER D, 1994, P NATL ACAD SCI USA, V91, P12173, DOI 10.1073/pnas.91.25.12173; BERG K, 1990, APMIS, V98, P156, DOI 10.1111/j.1699-0463.1990.tb01016.x; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CLARKE D, 1995, CYTOKINE, V7, P325, DOI 10.1006/cyto.1995.0041; COUSIN MA, 1992, HYBRIDOMA, V11, P561, DOI 10.1089/hyb.1992.11.561; CURLING EMA, 1990, BIOCHEM J, V272, P333, DOI 10.1042/bj2720333; DOBELI H, 1988, J BIOTECHNOL, V7, P199, DOI 10.1016/0168-1656(88)90052-1; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FOUNTOULAKIS M, 1992, BIO-TECHNOL, V10, P1143, DOI 10.1038/nbt1092-1143; FOUNTOULAKIS M, 1992, EUR J BIOCHEM, V208, P781, DOI 10.1111/j.1432-1033.1992.tb17248.x; GENTZ R, 1992, EUR J BIOCHEM, V210, P545, DOI 10.1111/j.1432-1033.1992.tb17453.x; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GREENLUND AC, 1993, J BIOL CHEM, V268, P18103; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; JARPE MA, 1990, J IMMUNOL, V145, P3304; JOHANSON K, 1995, J BIOL CHEM, V270, P9459, DOI 10.1074/jbc.270.16.9459; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Karlsson Robert, 1994, Methods (Orlando), V6, P99, DOI 10.1006/meth.1994.1013; Lortat-Jacob H, 1997, CYTOKINE, V9, P101, DOI 10.1006/cyto.1996.0142; LORTAT-JACOB H, 1991, FEBS LETT, V280, P152, DOI 10.1016/0014-5793(91)80225-R; LORTAT-JACOB H, 1991, CELL MOL BIOL, V37, P253; LORTAT-JACOB H, 1991, J CLIN INVEST, V87, P878, DOI 10.1172/JCI115093; Lortat-Jacob H, 1996, J BIOL CHEM, V271, P16139, DOI 10.1074/jbc.271.27.16139; LORTAT-JACOB H, 1992, BIOCHIM BIOPHYS ACTA, V1117, P126, DOI 10.1016/0304-4165(92)90069-7; Lortat-Jacob H, 1996, CYTOKINE, V8, P557, DOI 10.1006/cyto.1996.0075; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; LUNDELL DJ, 1994, PHARMACOL THERAPEUT, V64, P1, DOI 10.1016/0163-7258(94)90031-0; LYON M, 1994, J BIOL CHEM, V269, P11216; PONTIUS BW, 1993, TRENDS BIOCHEM SCI, V18, P181, DOI 10.1016/0968-0004(93)90111-Y; RAMSDEN L, 1992, EUR J IMMUNOL, V22, P3027, DOI 10.1002/eji.1830221139; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Shen BJ, 1996, EUR J BIOCHEM, V240, P252, DOI 10.1111/j.1432-1033.1996.0252h.x; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Taremi SS, 1996, BIOCHEMISTRY-US, V35, P2322, DOI 10.1021/bi951741t; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; VANLOON APGM, 1991, J LEUKOCYTE BIOL, V49, P462, DOI 10.1002/jlb.49.5.462; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; WETZEL R, 1990, PROTEIN ENG, V3, P611, DOI 10.1093/protein/3.7.611; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9	46	89	91	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10919	10925		10.1074/jbc.273.18.10919	http://dx.doi.org/10.1074/jbc.273.18.10919			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556569	hybrid			2022-12-27	WOS:000073395200021
J	Wu, XQ; Haystead, TAJ; Nakamoto, RK; Somlyo, AV; Somlyo, AP				Wu, XQ; Haystead, TAJ; Nakamoto, RK; Somlyo, AV; Somlyo, AP			Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin - Synergism with cyclic nucleotide-activated kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; INOSITOL 1,4,5-TRISPHOSPHATE; CHICKEN GIZZARD; PHOSPHORYLATION; GMP; PHOSPHATASE; CAMP; CGMP; CALMODULIN; INHIBITION	Incorporation of P-32 into telokin, a smooth muscle-specific, 17-18-kDa, acidic (pI 4.2-4.4) protein, was increased by forskolin (20 mu M) in intact rabbit ileum smooth muscle (ileum) and by 8-bromo-cyclic GRIP (100 mu m) in alpha-toxin-permeabilized ileum. Native telokin (5-20 mu M), purified from turkey gizzard, and recombinant rabbit telokin, expressed in Escherichia coli and purified to >90% purity, induced dose-dependent relaxation, associated with a significant decrease in regulatory myosin light chain phosphorylation, without affecting the rate of thiophosphorylation of regulatory myosin Light chain of ileum permeabilized with 0.1% Triton X-100. Endogenous telokin was lost from ileum during prolonged permeabilization (>20 min) with 0.1% Triton X-100, and the time course of loss was correlated with the loss of 8-bromo-cyclic GRIP-induced calcium desensitization. Recombinant and native gizzard telokins were phosphorylated, in vitro, by the catalytic subunit of cAMP-dependent protein kinase, cGMP-dependent protein kinase, and p42/44 mitogen-activated protein kinase; the recombinant protein was also phosphorylated by calmodulin dependent protein kinase II. Exogenous cGMP-dependent protein kinase (0.5 mu M) activated by 8-bromo-cyclic GMP (50 mu M) phosphorylated recombinant telokin (10 mu M) when added concurrently to ileum depleted of its endogenous telokin, and their relaxant effects were mutually potentiated Forskolin (20 mu M) also increased phosphorylation of telokin in intact ileum. We conclude that telokin induces calcium desensitization in smooth muscle by enhancing myosin light chain phosphatase activity and cGMP- and/or cAMP-dependent phosphorylation of telokin up-regulates its relaxant effect.	Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA; Univ Virginia, Hlth Sci Ctr, Dept Pharmacol, Charlottesville, VA 22906 USA	University of Virginia; University of Virginia	Somlyo, AP (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019242, P01HL048807] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL048807, P01-HL19242, P01-HL48807] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIALOJAN C, 1985, P SOC EXP BIOL MED, V178, P648; CASSIDY P, 1979, J BIOL CHEM, V254, P1148; COLLINGE M, 1992, MOL CELL BIOL, V12, P2359, DOI 10.1128/MCB.12.5.2359; DELANEROLLE P, 1984, SCIENCE, V223, P1415, DOI 10.1126/science.6322302; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; GONG MC, 1992, J BIOL CHEM, V267, P14662; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; HATHAWAY DR, 1985, J MOL CELL CARDIOL, V17, P841, DOI 10.1016/S0022-2828(85)80098-5; Herring BP, 1997, AM J PHYSIOL-CELL PH, V272, pC1394, DOI 10.1152/ajpcell.1997.272.4.C1394; Herring BP, 1996, AM J PHYSIOL-CELL PH, V270, pC1656, DOI 10.1152/ajpcell.1996.270.6.C1656; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; ITO M, 1989, J BIOL CHEM, V264, P13971; Kawada T, 1997, EUR J PHARMACOL, V323, P75, DOI 10.1016/S0014-2999(97)00028-9; Khromov AS, 1996, J PHYSIOL-LONDON, V492, P669, DOI 10.1113/jphysiol.1996.sp021336; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; KITAZAWA T, 1991, J BIOL CHEM, V266, P1708; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; Komalavilas P, 1996, J BIOL CHEM, V271, P21933, DOI 10.1074/jbc.271.36.21933; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; Lefebvre RA, 1997, BRIT J PHARMACOL, V120, P975, DOI 10.1038/sj.bjp.0700996; LINCOLN TM, 1990, AM J PHYSIOL, V258, pC399, DOI 10.1152/ajpcell.1990.258.3.C399; LINCOLN TM, 1994, HYPERTENSION, V23, P1141, DOI 10.1161/01.HYP.23.6.1141; LUBYPHELPS K, 1995, J BIOL CHEM, V270, P21532, DOI 10.1074/jbc.270.37.21532; Masato T, 1997, J BIOCHEM, V121, P225; MCDANIEL NL, 1994, CAN J PHYSIOL PHARM, V72, P1380, DOI 10.1139/y94-199; Nieznanski K, 1997, BIOCHEM J, V322, P65, DOI 10.1042/bj3220065; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8429; NISHIMURA J, 1989, BIOCHEM BIOPH RES CO, V163, P929, DOI 10.1016/0006-291X(89)92311-5; PFITZER G, 1986, PFLUG ARCH EUR J PHY, V407, P87, DOI 10.1007/BF00580726; PFITZER G, 1984, PFLUG ARCH EUR J PHY, V401, P277, DOI 10.1007/BF00582596; Rusconi F, 1997, BIOCHEMISTRY-US, V36, P11021, DOI 10.1021/bi970752e; SCHMIDT US, 1995, PFLUG ARCH EUR J PHY, V429, P708, DOI 10.1007/BF00373992; SCOTT A, 1995, J BIOL CHEM, V270, P24540, DOI 10.1074/jbc.270.41.24540; SHIRINSKY VP, 1993, J BIOL CHEM, V268, P16578; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; Silver DL, 1997, J BIOL CHEM, V272, P25353, DOI 10.1074/jbc.272.40.25353; Sobieszek A, 1997, BIOCHEM J, V328, P425, DOI 10.1042/bj3280425; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SOMLYO AP, 1989, ADV PROTEIN PHOSPHAT, V5, P181; STULL JT, 1993, MOL CELL BIOCHEM, V128, P229, DOI 10.1007/BF01076774; VOROTNIKOV AV, 1996, J MUSCLE RES CELL M, V17, P153; Warner T D, 1994, Adv Pharmacol, V26, P171, DOI 10.1016/S1054-3589(08)60054-X; WU X, 1997, BIOPHYS J, V72, P178; Wu XQ, 1996, BIOCHEM BIOPH RES CO, V220, P658, DOI 10.1006/bbrc.1996.0460; ZIMMERMANN B, 1995, J BIOL CHEM, V270, P23966, DOI 10.1074/jbc.270.41.23966	49	119	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11362	11369		10.1074/jbc.273.18.11362	http://dx.doi.org/10.1074/jbc.273.18.11362			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556631	hybrid			2022-12-27	WOS:000073395200083
J	Berra, E; Diaz-Meco, MT; Moscat, J				Berra, E; Diaz-Meco, MT; Moscat, J			The activation of p38 and apoptosis by the inhibition of ERK is antagonized by the phosphoinositide S-kinase/Akt pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-DEATH; CD95 FAS/APO-1; STRESS; SUPPRESSION	Considerable attention has recently been focused on the role played by different kinase cascades in the control of apoptosis, The triggering of stress-activated kinases concomitant with the inhibition of the extracellular signal-regulated kinase (ERK) pathway has been observed in a number of cell systems undergoing programmed cell death. In addition, the activation of the phosphoinositide 3-kinase (PI 3-kinase)-Akt signaling cascade has been shown to protect from apoptosis. Here we have explored the potential role played by the inhibition of ERK in the activation of the stress kinases as well as the possible cross-talk with the PI 3-kinase pathway in HeLa cells. We show that the simple inhibition of ERK basal activity is sufficient to trigger apoptosis and p38 activation with no changes in Jun N-terminal kinase/stress-activated protein kinase. This is a process dependent on the caspases and is completely abrogated by serum. The incubation with wortmannin or the transfection of dominant negative mutants of p85 or Akt block the inhibitory function of serum, suggesting the involvement of the PI 3-kinase-Akt system. Consistent with this, expression of active mutants of PI 3-kinase and Akt inhibits p38 activation and apoptosis. We also show here that the inhibition of ERK triggers the caspase system, which is abolished by serum in a wortmannin-dependent manner. Collectively, these results demonstrate a link between ERK and the p38 apoptotic pathway that is modulated by the survival PI 3-kinase-Akt module, acting upstream the caspase system.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Lab Glaxo Wellcome, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); GlaxoSmithKline	Moscat, J (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Lab Glaxo Wellcome, Canto Blanco, E-28049 Madrid, Spain.	jmoscat@mvax.cbm.uam.es	Moscat, Jorge/A-7011-2009; Berra, Edurne/F-9692-2011	Berra, Edurne/0000-0002-3820-5744; Diaz-Meco, Maria/0000-0003-0147-0998				Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Berra E, 1997, MOL CELL BIOL, V17, P4346, DOI 10.1128/MCB.17.8.4346; Canman CE, 1996, NATURE, V384, P213, DOI 10.1038/384213a0; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DIAZMECO MT, 1996, CELL, V86, P77; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Golstein P, 1997, SCIENCE, V275, P1081, DOI 10.1126/science.275.5303.1081; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; HerreraVelit P, 1997, J BIOL CHEM, V272, P16445, DOI 10.1074/jbc.272.26.16445; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mendez R, 1997, MOL CELL BIOL, V17, P5184, DOI 10.1128/MCB.17.9.5184; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Parrizas M, 1997, J BIOL CHEM, V272, P154; PESO LD, 1997, SCIENCE, V278, P687; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; REHMTULLA A, 1997, J BIOL CHEM, V272, P25783; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; Vaux DL, 1997, CELL, V90, P389, DOI 10.1016/S0092-8674(00)80497-3; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; XIA Z, 1995, SCIENCE, V270, P126; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; YAO R, 1995, SCIENCE, V2675, P2003; Yuan ZM, 1997, J BIOL CHEM, V272, P23485, DOI 10.1074/jbc.272.38.23485; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	39	228	232	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10792	10797		10.1074/jbc.273.17.10792	http://dx.doi.org/10.1074/jbc.273.17.10792			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553146	hybrid			2022-12-27	WOS:000073224200095
J	Edmonds, BT; Bell, A; Wyckoff, J; Condeelis, J; Leyh, TS				Edmonds, BT; Bell, A; Wyckoff, J; Condeelis, J; Leyh, TS			The effect of F-actin on the binding and hydrolysis of guanine nucleotide by Dictyostelium elongation factor 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; FACTOR-I-ALPHA; FACTOR-TU; MESSENGER-RNA; PROTEIN-SYNTHESIS; HELA-CELLS; CYTOSKELETAL FRAMEWORK; RABBIT RETICULOCYTES; FLUORESCENT ANALOGS; CRYSTAL-STRUCTURE	Indirect evidence implicates actin as a cofactor in eukaryotic protein synthesis. The present study directly examines the effects of F-actin on the biochemical properties of eukaryotic elongation factor 1A (eEF1A, formerly EF1 alpha), a major actin-binding protein, The basal mechanism of eEF1A alone is determined under physiological conditions with the critical finding that glycerol and guanine nucleotide are required to prevent protein aggregation and loss of enzymatic activity. The dissociation constants (K-d) for GDP and GTP are 2.5 mu M and 0.6 mu M, respectively, and the k(cat) of GTP hydrolysis is 1.0 x 10(-3) s(-1). When eEF1A binds to F-actin, there is a 7-fold decrease in the affinity for guanine nucleotide and an increase of 35% in the rate of GTP hydrolysis, Based upon our results and the relevant cellular concentrations, the predominant form of cellular eEF1A is calculated to be GTP eEF1A F-actin. We conclude that F-actin does not significantly modulate the basal enzymatic properties of eEF1A; however, actin may still influence protein synthesis by sequestering GTP eEF1A away from interactions with its known translational ligands, e,g, aminoacyl-tRNA and ribosomes.	Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Edmonds, BT (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, BioRes Technol & Prot, Indianapolis, IN 46285 USA.	edmonds@lilly.com			NIGMS NIH HHS [GM25813, GM54469] Funding Source: Medline; NINDS NIH HHS [NS08864] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054469, R01GM025813] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassell G, 1997, CURR OPIN CELL BIOL, V9, P109, DOI 10.1016/S0955-0674(97)80159-7; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRESNICK AR, 1991, METHOD ENZYMOL, V196, P70; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; CERVERA M, 1981, CELL, V23, P113, DOI 10.1016/0092-8674(81)90276-2; Cleland W W, 1979, Methods Enzymol, V63, P103; CRECHET JB, 1986, EUR J BIOCHEM, V161, P647, DOI 10.1111/j.1432-1033.1986.tb10489.x; CRECHET JB, 1986, EUR J BIOCHEM, V161, P655, DOI 10.1111/j.1432-1033.1986.tb10490.x; DEMMA M, 1990, J BIOL CHEM, V265, P2286; DHARMAWARDHANE S, 1991, CELL MOTIL CYTOSKEL, V20, P279, DOI 10.1002/cm.970200404; Eddy RJ, 1997, J CELL BIOL, V139, P1243, DOI 10.1083/jcb.139.5.1243; EDMONDS BT, 1993, J CELL BIOCHEM, V52, P134, DOI 10.1002/jcb.240520204; EDMONDS BT, 1995, J BIOL CHEM, V270, P15222, DOI 10.1074/jbc.270.25.15222; Edmonds BT, 1996, J CELL SCI, V109, P2705; FASANO O, 1982, J BIOL CHEM, V257, P3145; GIOVANE A, 1995, EUR J BIOCHEM, V227, P428, DOI 10.1111/j.1432-1033.1995.tb20405.x; HESKETH JE, 1991, BIOCHEM J, V277, P1; HEUIJERJANS JH, 1989, EXP CELL RES, V181, P317, DOI 10.1016/0014-4827(89)90091-8; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; HOWE JG, 1984, CELL, V37, P85; JANSSEN GMC, 1988, J BIOL CHEM, V263, P1773; JANSSEN GMC, 1990, RIBOSOMES PROTEIN SY, P51; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; KINZY TG, 1991, J BIOL CHEM, V266, P4099; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LATHAM VM, 1994, J CELL BIOL, V126, P1211, DOI 10.1083/jcb.126.5.1211; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; Liu G, 1996, J CELL BIOL, V135, P953, DOI 10.1083/jcb.135.4.953; Liu G, 1996, TRENDS CELL BIOL, V6, P168, DOI 10.1016/0962-8924(96)20013-3; Merrick WC., 1996, TRANSLATION CONTROL, P31; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; NAGATA S, 1977, J BIOCHEM-TOKYO, V82, P1633, DOI 10.1093/oxfordjournals.jbchem.a131859; NEAL SE, 1988, J BIOL CHEM, V263, P19718; NIELSEN P, 1983, CELL BIOL INT REP, V7, P245, DOI 10.1016/0309-1651(83)90057-7; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NYE L, 1988, AM BIOTECHNOL LAB, V6, P18; O'Sullivan W J, 1979, Methods Enzymol, V63, P294; OKAZAKI K, 1995, EUR J CELL BIOL, V66, P75; OWEN CH, 1992, J STRUCT BIOL, V109, P248, DOI 10.1016/1047-8477(92)90037-B; PALMITER RD, 1975, CELL, V4, P189, DOI 10.1016/0092-8674(75)90167-1; RIDDLE VGH, 1979, P NATL ACAD SCI USA, V76, P1298, DOI 10.1073/pnas.76.3.1298; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; ROOBOL K, 1978, EUR J BIOCHEM, V90, P471, DOI 10.1111/j.1432-1033.1978.tb12626.x; SAHA SK, 1986, J BIOL CHEM, V261, P2599; SANDBAKEN MG, 1988, GENETICS, V120, P923; SHESTAKOVA EA, 1993, CELL BIOL INT, V17, P409, DOI 10.1006/cbir.1993.1079; SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1; SLOBIN LI, 1976, EUR J BIOCHEM, V69, P367, DOI 10.1111/j.1432-1033.1976.tb10920.x; SLOBIN LI, 1980, EUR J BIOCHEM, V110, P555, DOI 10.1111/j.1432-1033.1980.tb04898.x; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; VANDAMME HTF, 1992, EUR J BIOCHEM, V207, P1025; WAGNER A, 1995, BIOCHEMISTRY-US, V34, P12535, DOI 10.1021/bi00039a007; Wang J. -X., 1992, RECEPTOR LIGAND INTE, P213; WANG RX, 1995, BIOCHEMISTRY-US, V34, P490, DOI 10.1021/bi00002a013; WINZOR DJ, 1995, QUANTITATIVE CHARACT, P37; WOLOSEWICK JJ, 1976, AM J ANAT, V147, P303, DOI 10.1002/aja.1001470305; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; Yang M, 1997, BIOCHEMISTRY-US, V36, P3270, DOI 10.1021/bi962140k	64	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10288	10295		10.1074/jbc.273.17.10288	http://dx.doi.org/10.1074/jbc.273.17.10288			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553081	hybrid			2022-12-27	WOS:000073224200030
J	Jones, SL; Knaus, UG; Bokoch, GM; Brown, EJ				Jones, SL; Knaus, UG; Bokoch, GM; Brown, EJ			Two signaling mechanisms for activation of alpha(M)beta(2) avidity in polymorphonuclear neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA-RECEPTOR; INTERCELLULAR-ADHESION MOLECULE-1; FUNCTION-ASSOCIATED ANTIGEN-1; INCREASED SURFACE EXPRESSION; LEUKOCYTE INTEGRIN LFA-1; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; CELL-ADHESION; MONOCLONAL-ANTIBODIES; RESPIRATORY BURST	Circulating polymorphonuclear neutrophils (PMN) are quiescent, nonadherent cells that rapidly activate at sites of inflammation, where they develop the capacity to perform a repertoire of functions that are essential for host defense. Induction of integrin-mediated adhesion, which requires an increase in integrin avidity, is critical for the development of these effector functions. Although a variety of stimuli can activate integrins in PMN, the signaling cascades involved are unclear. Phosphatidylinositol (PI) 3-kinase has been implicated in integrin activation in a variety of cells, including PMN. In this work, we have examined activation of the PMN integrin alpha(M) beta(2), assessing both adhesion and generation of the epitope recognized by the activation-specific antibody CBRM1/5. We have found that PI 3-kinase has a role in activation of alpha(M) beta(2) by immune complexes, but we have found no role for it in alpha(M) beta(2) activation by ligands for trimeric G protein-coupled receptors, including formylmethionylleucylphenylalanine (fMLP), interleukin-8, and C5a. Cytochalasin D inhibition suggests a role for the actin cytoskeleton in immune complex activation of alpha(M) beta(2), but cytochalasin has no effect on fMLP-induced activation. Similarly, immune complex activation of the Rac/Cdc42-dependent serine/threonine kinase Pak1 is blocked by PI 3-kinase inhibitors, but fMLP-induced activation is not. These results demonstrate that two signaling pathways exist in PMN for activation of alpha(M) beta(2)-One, induced by Fc gamma R ligation, is PI 3-kinase-dependent and requires the actin cytoskeleton. The second, initiated by G protein-linked receptors, is PI 3-kinase-independent and cytochalasin-insensitive. Pak1 may be in a final common pathway leading to activation of alpha(M) beta(2).	Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Washington University (WUSTL); Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Brown, EJ (corresponding author), Washington Univ, Sch Med, Div Infect Dis, Box 8051,660 S Euclid Ave, St Louis, MO 63110 USA.			jones, samuel/0000-0003-3040-8157				ALTIERI DC, 1991, J IMMUNOL, V147, P1891; ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; ANDERSON DC, 1984, J CLIN INVEST, V74, P536, DOI 10.1172/JCI111451; ANDERSON DC, 1986, J IMMUNOL, V137, P15; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; ARNAOUT MA, 1986, J CLIN INVEST, V78, P597, DOI 10.1172/JCI112615; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BERGER M, 1985, J IMMUNOL, V135, P1342; Berton G, 1996, INT J CLIN LAB RES, V26, P160, DOI 10.1007/BF02592978; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; BUYON JP, 1988, J IMMUNOL, V140, P3156; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Carr MW, 1996, IMMUNITY, V4, P179, DOI 10.1016/S1074-7613(00)80682-2; Chacko GW, 1996, J BIOL CHEM, V271, P10775, DOI 10.1074/jbc.271.18.10775; Chan ASH, 1997, J IMMUNOL, V159, P934; DETMERS PA, 1987, J CELL BIOL, V105, P1137, DOI 10.1083/jcb.105.3.1137; DETMERS PA, 1990, J EXP MED, V171, P1155, DOI 10.1084/jem.171.4.1155; DIAMOND MS, 1993, J CELL BIOL, V120, P546; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; GRAHAM IL, 1993, J CELL BIOL, V120, P1509, DOI 10.1083/jcb.120.6.1509; GRAHAM IL, 1994, J CELL BIOL, V127, P1139, DOI 10.1083/jcb.127.4.1139; GRESHAM HD, 1987, J IMMUNOL, V139, P4159; GRESHAM HD, 1991, J CLIN INVEST, V88, P588, DOI 10.1172/JCI115343; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; HUGHES BJ, 1992, J CLIN INVEST, V90, P1687, DOI 10.1172/JCI116041; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; KINASHI T, 1995, BLOOD, V86, P2086, DOI 10.1182/blood.V86.6.2086.bloodjournal8662086; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LO SK, 1989, J EXP MED, V169, P1779, DOI 10.1084/jem.169.5.1779; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; LOONEY RJ, 1986, J EXP MED, V163, P826, DOI 10.1084/jem.163.4.826; Lub M, 1997, MOL BIOL CELL, V8, P341, DOI 10.1091/mbc.8.2.341; Meacci E, 1997, P NATL ACAD SCI USA, V94, P1745, DOI 10.1073/pnas.94.5.1745; MURPHY, 1994, ANN REV IMMUNOL, V11, P593; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NATHAN C, 1990, J CELL BIOL, V111, P2171, DOI 10.1083/jcb.111.5.2171; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Nielsen M, 1996, J IMMUNOL, V157, P5350; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; OKADA T, 1994, J BIOL CHEM, V269, P3563; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PETER K, 1995, J EXP MED, V181, P315, DOI 10.1084/jem.181.1.315; RABB H, 1993, J IMMUNOL, V151, P990; ROSALES C, 1994, P NATL ACAD SCI USA, V91, P3534, DOI 10.1073/pnas.91.9.3534; ROSALES C, 1992, J BIOL CHEM, V267, P5265; SCHEIFFENBAUM B, 1989, J IMMUNOL, V142, P3537; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; SHAPPELL SB, 1990, J IMMUNOL, V144, P2702; Shimizu Y, 1995, J CELL BIOL, V131, P1867, DOI 10.1083/jcb.131.6.1867; SHIMIZU Y, 1996, IMMUNOL TODAY, V17, P566; STEPHENS L, 1994, CURR BIOL, V4, P203, DOI 10.1016/S0960-9822(00)00049-X; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Stewart MP, 1996, J IMMUNOL, V156, P1810; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; Thelen M, 1995, BIOCHEM BIOPH RES CO, V217, P1255, DOI 10.1006/bbrc.1995.2903; TODD RF, 1984, J CLIN INVEST, V74, P1280, DOI 10.1172/JCI111538; VEDDER NB, 1988, J CLIN INVEST, V81, P676, DOI 10.1172/JCI113372; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weber C, 1996, P NATL ACAD SCI USA, V93, P10939, DOI 10.1073/pnas.93.20.10939; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; WRIGHT SD, 1986, J IMMUNOL, V136, P1758; YANO H, 1993, J BIOL CHEM, V268, P25846; Zell T, 1996, J IMMUNOL, V156, P883; Zhang J, 1996, J BIOL CHEM, V271, P6265, DOI 10.1074/jbc.271.11.6265; ZHOU MJ, 1995, J BIOL CHEM, V270, P13553, DOI 10.1074/jbc.270.22.13553; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	87	115	118	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10556	10566		10.1074/jbc.273.17.10556	http://dx.doi.org/10.1074/jbc.273.17.10556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553116	hybrid			2022-12-27	WOS:000073224200065
J	Okada, T; Shimizu, S; Wakamori, M; Maeda, A; Kurosaki, T; Takada, N; Imoto, K; Mori, Y				Okada, T; Shimizu, S; Wakamori, M; Maeda, A; Kurosaki, T; Takada, N; Imoto, K; Mori, Y			Molecular cloning and functional characterization of a novel receptor-activated TRP Ca2+ channel from mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; DROSOPHILA TRP; INOSITOL 1,4,5-TRISPHOSPHATE; HUMAN-LYMPHOCYTES; STORE DEPLETION; HUMAN HOMOLOG; MAST-CELLS; PROTEIN; GENE; CONDUCTANCE	Characterization of mammalian homologues of Drosophila TRP proteins, which induce light-activated Ca2+ conductance in photoreceptors, has been an important clue to understand molecular mechanisms underlying receptor-activated Ca2+ influx in vertebrate cells. We have here isolated cDNA that encodes a novel TRP homologue, TRP5, predominantly expressed in the brain. Recombinant expression of the TRP5 cDNA in human embryonic kidney cells dramatically potentiated extracellular Ca2+-dependent rises of intracellular Ca2+ concentration ([Ca2+](i)) evoked by ATP. These [Ca2+](i) transients were inhibited by SK&F96365, a blocker of receptor-activated Ca2+ entry, and by La3+, Expression of the TRP5 cDNA, however, did not significantly affect [Ca2+](i) transients induced by thapsigargin, an inhibitor of endoplasmic reticulum Ca2+-ATPases. ATP stimulation of TRP5-transfected cells pretreated with thapsigargin to deplete internal Ca2+ stores caused intact extracellular Ca2+-dependent [Ca2+](i) transients, whereas ATP suppressed [Ca2+](i) in thapsigargin-pretreated control cells. Furthermore, in ATP-stimulated, TRP5-expressing cells, there was no significant correlation between Ca2+ release from the internal Ca2+ store and influx of extracellular Ca2+. Whole-cell mode of patch-clamp recording hom TRP5-expressing cells demonstrated that ATP application induced a large inward current in the presence of extracellular Ca2+. Omission of Ca2+ from intrapipette solution abolished the current in TRP5-expressing cells, whereas 10 nM intrapipette Ca2+ was sufficient to support TRP5 activity triggered by ATP receptor stimulation. Permeability ratios estimated from the zero-current potentials of this current were P-Ca:P-Na:P-Cs = 14.3:1.5:1, Our findings suggest that TRP5 directs the formation of a Ca2+-selective ion channel activated by receptor stimulation through a pathway that involves Ca2+ but not depletion of Ca2+ store in mammalian cells.	Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan; Univ Cincinnati, Coll Med, Inst Mol Pharmacol & Biophys, Cincinnati, OH 45267 USA; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Moriguchi, Osaka 570, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University System of Ohio; University of Cincinnati; Kansai Medical University	Mori, Y (corresponding author), Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan.	moriy@nips.ac.jp	Wakamori, Minoru/AAE-2661-2019; Okada, Takaharu/N-7931-2015; Maeda, Akito/AAX-6252-2020; Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Wakamori, Minoru/0000-0001-8574-3310; Imoto, Keiji/0000-0002-2861-5985				Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Bischof G, 1997, CELL CALCIUM, V21, P135, DOI 10.1016/S0143-4160(97)90037-3; BOLAND LM, 1991, BRAIN RES, V563, P142, DOI 10.1016/0006-8993(91)91527-8; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; CHANG WH, 1995, AM J PHYSIOL-ENDOC M, V269, pE864, DOI 10.1152/ajpendo.1995.269.5.E864; Clapham DE, 1996, NEURON, V16, P1069, DOI 10.1016/S0896-6273(00)80132-4; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clementi E, 1996, CELL CALCIUM, V19, P269, DOI 10.1016/S0143-4160(96)90068-8; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; Funayama M, 1996, MOL BRAIN RES, V43, P259, DOI 10.1016/S0169-328X(96)00208-2; Garcia RL, 1997, BIOCHEM BIOPH RES CO, V239, P279, DOI 10.1006/bbrc.1997.7458; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hardie RC, 1997, CELL CALCIUM, V21, P431, DOI 10.1016/S0143-4160(97)90054-3; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HAZAMA A, 1990, PFLUG ARCH EUR J PHY, V416, P710, DOI 10.1007/BF00370619; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HU YF, 1995, BIOCHEM J, V305, P605, DOI 10.1042/bj3050605; INESI G, 1994, J MEMBRANE BIOL, V141, P1; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; JOBLING SA, 1987, NATURE, V325, P622, DOI 10.1038/325622a0; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LACAMPAGNE A, 1994, BBA-BIOMEMBRANES, V1191, P205, DOI 10.1016/0005-2736(94)90250-X; LUCKHOFF A, 1992, NATURE, V355, P356, DOI 10.1038/355356a0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Mori Y, 1998, NEUROREPORT, V9, P507; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MOZHAYEVA GN, 1991, J MEMBRANE BIOL, V124, P113, DOI 10.1007/BF01870456; NAKAGAWA T, 1990, NEUROSCI RES, V8, P114, DOI 10.1016/0168-0102(90)90063-K; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Obukhov AG, 1996, EMBO J, V15, P5833, DOI 10.1002/j.1460-2075.1996.tb00970.x; Parekh AB, 1997, CELL, V89, P973, DOI 10.1016/S0092-8674(00)80282-2; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; PETERSEN CCH, 1995, BIOCHEM J, V311, P41, DOI 10.1042/bj3110041; PETERSEN CCH, 1994, J BIOL CHEM, V269, P32246; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Preuss KD, 1997, BIOCHEM BIOPH RES CO, V240, P167, DOI 10.1006/bbrc.1997.7528; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; RESTREPO D, 1990, SCIENCE, V249, P1166, DOI 10.1126/science.2168580; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakura H, 1997, DIABETOLOGIA, V40, P528, DOI 10.1007/s001250050711; SERAFINI AT, 1995, IMMUNITY, V3, P239, DOI 10.1016/1074-7613(95)90093-4; Sinkins WG, 1996, J BIOL CHEM, V271, P2955, DOI 10.1074/jbc.271.6.2955; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; UEDA S, 1989, BIOCHIM BIOPHYS ACTA, V1012, P254, DOI 10.1016/0167-4889(89)90105-5; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Waldron RT, 1997, J BIOL CHEM, V272, P6440, DOI 10.1074/jbc.272.10.6440; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	68	235	242	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10279	10287		10.1074/jbc.273.17.10279	http://dx.doi.org/10.1074/jbc.273.17.10279			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553080	hybrid			2022-12-27	WOS:000073224200029
J	Olson, MW; Toth, M; Gervasi, DC; Sado, Y; Ninomiya, Y; Fridman, R				Olson, MW; Toth, M; Gervasi, DC; Sado, Y; Ninomiya, Y; Fridman, R			High affinity binding of latent matrix metalloproteinase-9 to the alpha 2(IV) chain of collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; GELATINASE-A; TISSUE INHIBITOR; INTERSTITIAL COLLAGENASE; MONOCLONAL-ANTIBODIES; EXTRACELLULAR-MATRIX; PLASMA-MEMBRANES; TUMOR-CELLS; ACTIVATION; LOCALIZATION	Association of matrix metalloproteinases (MMPs) with the cell surface and with areas of cell-matrix contacts is critical for extracellular matrix degradation. Previously, we showed the surface association of pro-MMP-9 in human breast epithelial MCF10A cells. Here, we have characterized the binding parameters of pro-MMP-9 and show that the enzyme binds with high affinity (K-d similar to 22 nM) to MCF10A cells and other cell lines. Binding of pro-MMP-9 to MCF10A cells does not result in zymogen activation and is not followed by ligand internalization, even after complex formation with tissue inhibitor of metalloproteinase-1 (TIMP-1). A 190-kDa cell surface protein was identified by ligand blot analysis and affinity purification with immobilized pro-MMP-9. Microsequencing and immunoblot analysis revealed that the 190-kDa protein is the alpha 2(IV) chain of collagen IV. Specific pro-MMP-9 surface binding was competed with purified alpha 2(IV) and was significantly reduced after treatment of the cells with active MMP-9 before the binding assay since alpha 2(IV) is hydrolyzed by MMP-9. A pro-MMP-9 TIMP-1 complex and MMP-9 bind to alpha 2(IV), suggesting that neither the C-terminal nor the N-terminal domain of the enzyme is directly involved in alpha 2(IV) binding. The closely related pro-MMP-2 exhibits a weaker affinity for alpha 2(IV) compared with that of pro-MMP-9, suggesting that sites other than the gelatin-binding domain may be involved in the binding of alpha 2(IV) to pro-MMP-9. Although pro-MMP-9 forms a complex with alpha 2(IV), the proenzyme does not bind to triple-helical collagen IV. These studies suggest a unique interaction between pro-MMP-9 and alpha 2(IV) that may play a role in targeting the zymogen to cell-matrix contacts and in the degradation of the collagen IV network.	Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA	Wayne State University	Fridman, R (corresponding author), Wayne State Univ, Dept Pathol, 540 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu			NATIONAL CANCER INSTITUTE [R01CA061986] Funding Source: NIH RePORTER; NCI NIH HHS [CA-61986] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; BANYAI L, 1991, FEBS LETT, V282, P23, DOI 10.1016/0014-5793(91)80436-7; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chen Wen-Tien, 1992, Current Opinion in Cell Biology, V4, P802; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; DIGLIO CA, 1993, TISSUE CELL, V25, P833, DOI 10.1016/0040-8166(93)90032-G; Eble JA, 1996, J BIOL CHEM, V271, P30964, DOI 10.1074/jbc.271.48.30964; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; FRIDMAN R, 1995, CANCER RES, V55, P2548; Ginestra A, 1997, J BIOL CHEM, V272, P17216, DOI 10.1074/jbc.272.27.17216; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HOYHTYA M, 1994, INT J CANCER, V56, P500, DOI 10.1002/ijc.2910560408; KARELINA TV, 1993, J INVEST DERMATOL, V100, P159, DOI 10.1111/1523-1747.ep12462791; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MOLL UM, 1990, CANCER RES, V50, P6162; MURPHY G, 1994, J BIOL CHEM, V269, P6632; MURPHY G, 1995, METHOD ENZYMOL, V248, P470; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; OMURA TH, 1994, J BIOL CHEM, V269, P24994; Partridge CA, 1997, AM J PHYSIOL-LUNG C, V272, pL813, DOI 10.1152/ajplung.1997.272.5.L813; Powell WC, 1996, CURR TOP MICROBIOL, V213, P1; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SLOANE BF, 1991, BIOMED BIOCHIM ACTA, V50, P549; SOULE HD, 1990, CANCER RES, V50, P6075; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; TESTA JE, 1990, CANCER METAST REV, V9, P353, DOI 10.1007/BF00049524; Toth M, 1997, CANCER RES, V57, P3159; VISSCHER DW, 1994, INT J CANCER, V59, P339, DOI 10.1002/ijc.2910590308; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Zhou J, 1996, CONTRIB NEPHROL, V117, P80; ZUCKER S, 1989, INVAS METAST, V9, P167; ZUCKER S, 1990, INT J CANCER, V45, P1137, DOI 10.1002/ijc.2910450625; ZUCKER S, 1987, CANCER RES, V47, P1608	44	122	126	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10672	10681		10.1074/jbc.273.17.10672	http://dx.doi.org/10.1074/jbc.273.17.10672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553130	hybrid			2022-12-27	WOS:000073224200079
J	Owen, GI; Richer, JK; Tung, L; Takimoto, G; Horwitz, KB				Owen, GI; Richer, JK; Tung, L; Takimoto, G; Horwitz, KB			Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; TFIID COMPLEX; TRANSACTIVATION FUNCTION; RECEPTOR; DIFFERENTIATION; PROMOTER; CELLS; PROGESTINS; ACTIVATION; U937	Progesterone has biphasic effects on proliferation of breast cancer cells; it stimulates growth in the first cell cycle, then arrests cells at G(1)/S of the second cycle accompanied by up-regulation of the cyclin-dependent kinase inhibitor, p21. We now show that progesterone regulates transcription of the p21 promoter by an unusual mechanism. This promoter lacks a canonical progesterone response element. Instead, progesterone receptors (PRs) interact with the promoter through the transcription factor Spl at the third and fourth of six Spl binding sites located downstream of nucleotide 154. Mutation of Spl site 3 eliminates basal transcription, and mutation of sites 3 and 4 eliminates transcriptional up-regulation by progesterone. Progesterone-mediated transcription is further prevented by overexpression of E1A, suggesting that CBP/p300 is required. Indeed, in HeLa cells, Spl and CBP/p300 associate with stably integrated flag-tagged PRs in a multiprotein complex. Since many signals converge on p21, cross-talk between PRs and other factors co-localized on the p21 promoter, may explain how progesterone can be either proliferative or differentiative in different target cells.	Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Horwitz, KB (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, 4200 E 9th Ave,Campus Box B151, Denver, CO 80262 USA.			Horwitz, Kathryn/0000-0001-7402-6455	NCI NIH HHS [CA26869] Funding Source: Medline; NIDDK NIH HHS [DK48238] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA026869, R37CA026869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048238] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; Bamberger AM, 1996, P NATL ACAD SCI USA, V93, P6169, DOI 10.1073/pnas.93.12.6169; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Datto MB, 1997, MOL CELL BIOL, V17, P2030, DOI 10.1128/MCB.17.4.2030; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ESTES PA, 1987, BIOCHEMISTRY-US, V26, P6250, DOI 10.1021/bi00393a045; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GRAHAM JD, 1997, ENDOCR REV, V18, P4502; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; HORWITZ KB, 1992, ENDOCR REV, V13, P146, DOI 10.1210/er.13.2.146; HORWITZ KB, 1986, J STEROID BIOCHEM, V25, P911, DOI 10.1016/0022-4731(86)90323-7; HURWITZ KB, 1985, RECENT PROG HORM RES, V41, P249; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MUSGROVE EA, 1991, MOL CELL BIOL, V11, P5032, DOI 10.1128/MCB.11.10.5032; Musgrove EA, 1997, MOL ENDOCRINOL, V11, P54, DOI 10.1210/me.11.1.54; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; SARTORIUS CA, 1994, MOL ENDOCRINOL, V8, P1347, DOI 10.1210/me.8.10.1347; SARTORIUS CA, 1994, CANCER RES, V54, P3868; SCHWERK C, 1995, J BIOL CHEM, V270, P21331, DOI 10.1074/jbc.270.36.21331; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; STEINMAN RA, 1994, ONCOGENE, V9, P3389; Willard ST, 1997, CANCER RES, V57, P4447; WOOD WM, 1989, J BIOL CHEM, V264, P14840; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	40	311	315	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10696	10701		10.1074/jbc.273.17.10696	http://dx.doi.org/10.1074/jbc.273.17.10696			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553133	hybrid			2022-12-27	WOS:000073224200082
J	Bouton, C; Oliveira, L; Drapier, JC				Bouton, C; Oliveira, L; Drapier, JC			Converse modulation of IRP1 and IRP2 by immunological stimuli in murine RAW 264.7 macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-RESPONSIVE ELEMENT; FERRITIN MESSENGER-RNA; ERYTHROID 5-AMINOLEVULINATE SYNTHASE; NITRIC-OXIDE; BINDING-PROTEIN; TRANSFERRIN RECEPTOR; REGULATORY PROTEIN-2; OXIDATIVE STRESS; TRANSLATIONAL REGULATION; UNTRANSLATED REGION	Iron regulatory proteins (IRP1 and IRP2) are two cytoplasmic RNA-binding proteins that control iron metabolism in mammalian cells. Both IRPs bind to specific sequences called iron-responsive elements (IREs) located in the 3' or 5' untranslated regions of several mRNAs, in particular mRNA encoding ferritin and transferrin receptor. In this study, we followed in parallel the in vivo regulation of the two IRPs in physiologically stimulated macrophages. We show that stimulation of mouse RAW 264.7 macrophage-like cells increased IRP1 IRE binding activity 4-fold, whereas IRP2 activity decreased 2-fold 8 h after interferon-gamma/lipopolysaccharide treatment. Decrease in IRP2 was not due to nitric oxide (NO) production and did not require de novo protein synthesis. Our data therefore indicate that the two IRPs can be conversely regulated in response to the same stimulus. In addition, the effect of endogenously produced NO on IRP1 was further characterized in an activated macrophage/target cell system. We show that NO acts as an intercellular signal to increase IRP1 activity in adjacent cells. As the effect was detectable within 1 h and did not require de novo protein synthesis, this result supports a direct action of NO on IRP1.	Inst Curie, INSERM, U365, Sect Rech, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Drapier, JC (corresponding author), CNRS, Inst Chim Subst Nat, Ave Terrassse, F-91190 Gif Sur Yvette, France.	Jean-Claude.Drapier@icsn.cnrs-gif.fr	Bouton, Cecile/J-8663-2013					AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; BHASKER CR, 1993, J BIOL CHEM, V268, P12699; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bouton C, 1996, J BIOL CHEM, V271, P2300, DOI 10.1074/jbc.271.4.2300; Bouton C, 1997, J BIOL CHEM, V272, P19969, DOI 10.1074/jbc.272.32.19969; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; CAIRO G, 1995, EUR J BIOCHEM, V232, P358, DOI 10.1111/j.1432-1033.1995.tb20819.x; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; CASEY JL, 1988, P NATL ACAD SCI USA, V85, P1787, DOI 10.1073/pnas.85.6.1787; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Domachowske JB, 1996, BLOOD, V88, P2980; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; GUO B, 1994, J BIOL CHEM, V269, P24252; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Henderson ER, 1996, J BIOL CHEM, V271, P4900; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HENTZE MW, 1991, NUCLEIC ACIDS RES, V19, P1739, DOI 10.1093/nar/19.8.1739; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; JAFFREY SR, 1994, P NATL ACAD SCI USA, V91, P12994, DOI 10.1073/pnas.91.26.12994; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; ORIA R, 1995, BLOOD, V85, P2962, DOI 10.1182/blood.V85.10.2962.bloodjournal85102962; PANTOPOULOS K, 1995, P NATL ACAD SCI USA, V92, P1267, DOI 10.1073/pnas.92.5.1267; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Phillips JD, 1996, BLOOD, V87, P2983, DOI 10.1182/blood.V87.7.2983.bloodjournal8772983; Phillips JD, 1996, BIOCHEMISTRY-US, V35, P15704, DOI 10.1021/bi960653l; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schalinske KL, 1997, BIOCHEMISTRY-US, V36, P3950, DOI 10.1021/bi9624447; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; THEIL EC, 1994, BIOCHEM J, V304, P1; WALDEN WE, 1989, J BIOL CHEM, V264, P13765; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; Weiss G, 1997, J IMMUNOL, V158, P420; ZHENG LM, 1992, ARCH BIOCHEM BIOPHYS, V299, P356, DOI 10.1016/0003-9861(92)90287-7	55	57	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9403	9408		10.1074/jbc.273.16.9403	http://dx.doi.org/10.1074/jbc.273.16.9403			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545264	hybrid			2022-12-27	WOS:000073128800010
J	Engel, ME; Datta, PK; Moses, HL				Engel, ME; Datta, PK; Moses, HL			RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS; PROTEIN; RECEPTOR; GENE; SIGNALS; DOMAIN	Transforming growth factor beta (TGF-beta) is the prototype for an evolutionarily conserved superfamily of secreted factors implicated in diverse biological phenomena. The pleiotropic responses to TGF-beta are initiated by a heteromeric receptor complex that binds and phosphorylates downstream effecters. Among these, the Smads have been extensively studied. However, less attention has been directed toward alternative downstream effecters and their participation in TGF-beta signal transduction. We show that TGF-beta promotes accumulation of the labile monomeric GTPase RhoB by antagonizing its normal proteolytic destruction, presumably via the 26 S proteasome. RhoB accumulates in its isoprenylated form. Transient overexpression of wild type RhoB but not its dominant negative mutant RhoB-N19 antagonizes TGF-beta-mediated transcriptional activation. These results suggest a novel mechanism of regulation by TGF-beta and implicate RhoB as a negative regulator of TGF-beta signal transduction.	Vanderbilt Univ, Vanderbilt Canc Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Cell Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Moses, HL (corresponding author), Vanderbilt Univ, Vanderbilt Canc Ctr, 649 MRBII, Nashville, TN 37232 USA.	hal.moses@MCmail.vanderbilt.edu			NATIONAL CANCER INSTITUTE [P01CA048799, R35CA042572] Funding Source: NIH RePORTER; NCI NIH HHS [CA48799, CA42572] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECREMOUX P, 1994, INT J CANCER, V59, P408, DOI 10.1002/ijc.2910590320; Fleming IN, 1996, J BIOL CHEM, V271, P33067, DOI 10.1074/jbc.271.51.33067; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; KAWABATA M, 1995, J BIOL CHEM, V270, P29628; LEBOWITZ PF, 1995, MOL CELL BIOL, V15, P6613; Lebowitz PF, 1997, J BIOL CHEM, V272, P15591, DOI 10.1074/jbc.272.25.15591; Lebowitz PF, 1997, J BIOL CHEM, V272, P16093, DOI 10.1074/jbc.272.26.16093; LYONS RM, 1990, EUR J BIOCHEM, V187, P467, DOI 10.1111/j.1432-1033.1990.tb15327.x; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; Nakamura T, 1996, BIOCHEM BIOPH RES CO, V226, P688, DOI 10.1006/bbrc.1996.1415; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; QUI RG, 1995, P NATL ACAD SCI USA, V92, P11781; RIDLEY AJ, 1995, CURR OPIN GENET DEV, V5, P24, DOI 10.1016/S0959-437X(95)90049-7; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S	29	88	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9921	9926		10.1074/jbc.273.16.9921	http://dx.doi.org/10.1074/jbc.273.16.9921			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545335	hybrid			2022-12-27	WOS:000073128800081
J	Gerloff, T; Stieger, B; Hagenbuch, B; Madon, J; Landmann, L; Roth, J; Hofmann, AF; Meier, PJ				Gerloff, T; Stieger, B; Hagenbuch, B; Madon, J; Landmann, L; Roth, J; Hofmann, AF; Meier, PJ			The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; DEPENDENT TAUROCHOLATE TRANSPORT; PLASMA-MEMBRANE VESICLES; XENOPUS-LAEVIS OOCYTES; RAT-LIVER; MULTIDRUG-RESISTANCE; ACID TRANSPORT; ATP; PROTEIN; EXPRESSION	Canalicular secretion of bile salts is a vital function of the vertebrate liver, yet the molecular identity of the involved ATP-dependent carrier protein has not been elucidated. We cloned the full-length cDNA of the sister of P-glycoprotein (spgp; M-r similar to 160,000) of rat liver and demonstrated that it functions as an ATP-dependent bile salt transporter in cRNA injected Xenopus laevis oocytes and in vesicles isolated from transfected Sf9 cells. The latter demonstrated a 5-fold stimulation of ATP dependent taurocholate transport as compared with controls. This spgp-mediated taurocholate transport was stimulated solely by ATP, was inhibited by vanadate, and exhibited saturability with increasing concentrations of taurocholate (K-m = 5 mu M). Furthermore, spgp-mediated transport rates of various bile salts followed the same order of magnitude as ATP-dependent transport in canalicular rat liver plasma membrane vesicles, i.e. taurochenodeoxycholate > tauroursodeoxycholate = taurocholate > glycocholate = cholate. Tissue distribution assessed by Northern blotting revealed predominant, if not exclusive, expression of spgp in the liver, where it was further localized to the canalicular microvilli and to subcanalicular vesicles of the hepatocytes by in situ immunofluorescence and immunogold labeling studies. These results indicate that the sister of P-glycoprotein is the major canalicular bile salt export pump of mammalian liver.	Univ Zurich Hosp, Dept Med, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; Univ Basel, Inst Anat, CH-4056 Basel, Switzerland; Univ Zurich Hosp, Dept Pathol, Div Cellular & Mol Pathol, CH-8091 Zurich, Switzerland; Univ Calif San Diego, Dept Med, Div Gastroenterol, San Diego, CA 92093 USA	University of Zurich; University Zurich Hospital; University of Basel; University of Zurich; University Zurich Hospital; University of California System; University of California San Diego	Stieger, B (corresponding author), Univ Zurich Hosp, Dept Med, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland.		Stieger, Bruno/U-6323-2017; Hagenbuch, Bruno/M-5294-2016	Stieger, Bruno/0000-0002-7190-5785; Hagenbuch, Bruno/0000-0002-2938-8630	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021506] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 21506] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI Y, 1991, HEPATOLOGY, V14, P655, DOI 10.1016/0270-9139(91)90053-X; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; Bolder U, 1997, GASTROENTEROLOGY, V112, P214, DOI 10.1016/S0016-5085(97)70238-5; BROWN RS, 1995, P NATL ACAD SCI USA, V92, P5421, DOI 10.1073/pnas.92.12.5421; Buchler M, 1996, J BIOL CHEM, V271, P15091; CHAN KM, 1992, BIOCHIM BIOPHYS ACTA, V1171, P65, DOI 10.1016/0167-4781(92)90140-U; CHILDS S, 1995, CANCER RES, V55, P2029; Duane WC, 1996, J LIPID RES, V37, P431; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; ELFERINK RPJO, 1995, BBA-REV BIOMEMBRANES, V1241, P215, DOI 10.1016/0304-4157(95)00006-D; Gatmaitan ZC, 1997, AM J PHYSIOL-GASTR L, V272, pG1041, DOI 10.1152/ajpgi.1997.272.5.G1041; Gerloff T., 1997, Hepatology, V26, p358A; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; Hagenbuch B, 1996, BIOCHEM J, V316, P901, DOI 10.1042/bj3160901; HORTENSTEINER S, 1993, J BIOL CHEM, V268, P18446; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JACQUEMIN E, 1994, EUR J PEDIATR, V153, P424; Keppler D, 1997, FASEB J, V11, P509, DOI 10.1096/fasebj.11.7.9212074; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LACKIE PM, 1990, DEVELOPMENT, V110, P933; Lammert Frank, 1997, Hepatology, V26, p358A; Luther TT, 1997, GASTROENTEROLOGY, V113, P249, DOI 10.1016/S0016-5085(97)70102-1; Madon J, 1997, FEBS LETT, V406, P75, DOI 10.1016/S0014-5793(97)00245-7; Meier PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG801, DOI 10.1152/ajpgi.1995.269.6.G801; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; MULLER M, 1991, J BIOL CHEM, V266, P18920; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; Muller M., 1997, Journal of Hepatology, V26, P71; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1002/hep.1840140324; NISHIDA T, 1991, P NATL ACAD SCI USA, V88, P6590, DOI 10.1073/pnas.88.15.6590; Ortiz DF, 1997, J BIOL CHEM, V272, P15358, DOI 10.1074/jbc.272.24.15358; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; ROSSI SS, 1987, J LIPID RES, V28, P589; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SHNEIDER BL, 1993, J BIOL CHEM, V268, P6985; SIPPEL CJ, 1994, J BIOL CHEM, V269, P8220; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STIEGER B, 1992, BIOCHEM J, V284, P67, DOI 10.1042/bj2840067; STIEGER B, 1994, GASTROENTEROLOGY, V107, P1781, DOI 10.1016/0016-5085(94)90821-4; Strautnieks SS, 1997, AM J HUM GENET, V61, P630, DOI 10.1086/515501; Suchy FJ, 1997, FASEB J, V11, P199, DOI 10.1096/fasebj.11.4.9068608; TAZAWA Y, 1985, J PEDIATR GASTR NUTR, V4, P32, DOI 10.1097/00005176-198502000-00007; Thompson R. J., 1997, Hepatology, V26, p383A; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; Trauner M, 1997, GASTROENTEROLOGY, V113, P255, DOI 10.1016/S0016-5085(97)70103-3; WHITINGTON PF, 1994, J PEDIATR GASTR NUTR, V18, P134, DOI 10.1097/00005176-199402000-00003; WOLTERS H, 1992, J CLIN INVEST, V90, P2321, DOI 10.1172/JCI116120	49	797	814	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10046	10050		10.1074/jbc.273.16.10046	http://dx.doi.org/10.1074/jbc.273.16.10046			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545351	hybrid			2022-12-27	WOS:000073128800097
J	Kelleher, CD; Champoux, JJ				Kelleher, CD; Champoux, JJ			Characterization of RNA strand displacement synthesis by moloney murine leukemia virus reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 NUCLEOCAPSID PROTEIN; AVIAN-MYELOBLASTOSIS VIRUS; AMINO-ACID-RESIDUES; IN-VITRO; ZINC-FINGER; H ACTIVITY; ANNEALING ACTIVITIES; DNA-SYNTHESIS; THERMODYNAMIC PARAMETERS	The RNase H activity of reverse transcriptase (RT) is presumably required to cleave the RNA genome following minus strand synthesis to free the DNA for use as a template during plus strand synthesis. However, since RNA degradation by RNase H appears to generate RNA fragments too large to spontaneously dissociate from the minus strand, we have investigated the possibility that RNA displacement by RT during plus strand synthesis contributes to the removal of RNA fragments. By using an RNase H- mutant of Moloney murine leukemia virus (M-MuLV) RT, we demonstrate that the polymerase can displace long regions of RNA in hybrid duplex with DNA but that this activity is approximately 20-fold slower than DNA displacement and 20-fold slower than non-displacement synthesis. Furthermore, we find that although certain hybrid sequences seem nearly refractory to the initiation of RNA displacement, the same sequences may not significantly impede synthesis when preceded by a single-stranded gap. We find that the rate of RNA displacement synthesis by wild-type M-MuLV RT is significantly greater than that of the RNase H- RT but remains less than the rate of non-displacement synthesis. M-MuLV nucleocapsid protein increases the rates of RNA and DNA displacement synthesis approximately 2-fold, and this activity appears to require the zinc finger domain.	Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Champoux, JJ (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Box 357242, Seattle, WA 98195 USA.				NCI NIH HHS [R37 CA51605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA051605] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLAIN B, 1994, EMBO J, V13, P973, DOI 10.1002/j.1460-2075.1994.tb06342.x; AMACKER M, 1995, J VIROL, V69, P6273, DOI 10.1128/JVI.69.10.6273-6279.1995; Amacker M, 1997, AIDS, V11, P534; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BENARTZI H, 1993, J BIOL CHEM, V268, P16465; BOONE LR, 1981, J VIROL, V37, P117, DOI 10.1128/JVI.37.1.117-126.1981; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; CHAMPOUX JJ, 1993, REVERSE TRANSCRIPTAS, P103; CHARNEAU P, 1991, J VIROL, V65, P2415, DOI 10.1128/JVI.65.5.2415-2421.1991; CHEN MJ, 1980, P NATL ACAD SCI-BIOL, V77, P1296, DOI 10.1073/pnas.77.3.1296; DANNULL J, 1994, EMBO J, V13, P1525, DOI 10.1002/j.1460-2075.1994.tb06414.x; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; DEROCQUIGNY H, 1993, NUCLEIC ACIDS RES, V21, P823; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; DESTEFANO JJ, 1994, NUCLEIC ACIDS RES, V22, P3793, DOI 10.1093/nar/22.18.3793; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; DeStefano JJ, 1996, J BIOL CHEM, V271, P16350; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P24295; Drummond JE, 1997, AIDS RES HUM RETROV, V13, P533, DOI 10.1089/aid.1997.13.533; Fuentes GM, 1996, NUCLEIC ACIDS RES, V24, P1719, DOI 10.1093/nar/24.9.1719; Fuentes GM, 1996, J BIOL CHEM, V271, P1966, DOI 10.1074/jbc.271.4.2063; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Gorelick RJ, 1996, J VIROL, V70, P2593, DOI 10.1128/JVI.70.4.2593-2597.1996; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; Guo JH, 1997, J VIROL, V71, P5178, DOI 10.1128/JVI.71.7.5178-5188.1997; HAJJ FD, 1993, PROTEIN SCI, V2, P231; HERSCHLAG D, 1994, EMBO J, V13, P2913, DOI 10.1002/j.1460-2075.1994.tb06586.x; HOTTIGER M, 1994, J BIOL CHEM, V269, P986; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Ji XD, 1996, BIOCHEMISTRY-US, V35, P132, DOI 10.1021/bi951707e; KARPEL RL, 1987, J BIOL CHEM, V262, P4961; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; Khan R, 1996, NUCLEIC ACIDS RES, V24, P3568, DOI 10.1093/nar/24.18.3568; KHAN R, 1992, J BIOL CHEM, V267, P6689; Kornberg A., 1992, DNA REPLICATION; Kupiec JJ, 1996, J GEN VIROL, V77, P1987, DOI 10.1099/0022-1317-77-9-1987; LAPADATTAPOLSKY M, 1995, NUCLEIC ACIDS RES, V23, P2434, DOI 10.1093/nar/23.13.2434; Li XG, 1996, J VIROL, V70, P4996, DOI 10.1128/JVI.70.8.4996-5004.1996; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; MERIC C, 1989, J VIROL, V63, P1558; MILLER MD, 1995, J VIROL, V69, P3938, DOI 10.1128/JVI.69.6.3938-3944.1995; MIZRAHI V, 1989, BIOCHEMISTRY-US, V28, P9088, DOI 10.1021/bi00449a020; OYAMA F, 1989, J BIOL CHEM, V264, P18808; Palaniappan C, 1996, J BIOL CHEM, V271, P2063, DOI 10.1074/jbc.271.47.29605; PELISKA JA, 1994, BIOCHEMISTRY-US, V33, P13817, DOI 10.1021/bi00250a036; PRATS AC, 1991, NUCLEIC ACIDS RES, V19, P3533, DOI 10.1093/nar/19.13.3533; RANDOLPH CA, 1994, J BIOL CHEM, V269, P19207; RATTRAY AJ, 1987, J VIROL, V61, P2843, DOI 10.1128/JVI.61.9.2843-2851.1987; RODRIGUEZRODRIGUEZ L, 1995, J BIOL CHEM, V270, P15005, DOI 10.1074/jbc.270.25.15005; Sambrook J., 2002, MOL CLONING LAB MANU; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; SIKORAV JL, 1991, J MOL BIOL, V222, P1085, DOI 10.1016/0022-2836(91)90595-W; Stoylov SP, 1997, BIOPOLYMERS, V41, P301, DOI 10.1002/(SICI)1097-0282(199703)41:3&lt;301::AID-BIP5&gt;3.0.CO;2-W; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; SUROVOY A, 1993, J MOL BIOL, V229, P94, DOI 10.1006/jmbi.1993.1011; TANCHOU V, 1995, J MOL BIOL, V252, P563, DOI 10.1006/jmbi.1995.0520; TOPOLSKY ML, 1993, NUCLEIC ACIDS RES, V21, P831; TSUCHIHASHI Z, 1994, J VIROL, V68, P5863, DOI 10.1128/JVI.68.9.5863-5870.1994; VARMUS H, 1989, MOBILE DNA, P53; VOLKMANN S, 1993, J BIOL CHEM, V268, P2674; WHITING SH, 1994, J VIROL, V68, P4747, DOI 10.1128/JVI.68.8.4747-4758.1994; WOHRL BM, 1995, SCIENCE, V267, P96, DOI 10.1126/science.7528942; Wu WX, 1996, J VIROL, V70, P7132, DOI 10.1128/JVI.70.10.7132-7142.1996; YOU JC, 1994, J BIOL CHEM, V269, P31491; Yu QA, 1996, J VIROL, V70, P5791, DOI 10.1128/JVI.70.9.5791-5798.1996	67	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9976	9986		10.1074/jbc.273.16.9976	http://dx.doi.org/10.1074/jbc.273.16.9976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545343	hybrid			2022-12-27	WOS:000073128800089
J	Blanton, MP; Dangott, LJ; Raja, SK; Lala, AK; Cohen, JB				Blanton, MP; Dangott, LJ; Raja, SK; Lala, AK; Cohen, JB			Probing the structure of the nicotinic acetylcholine receptor ion channel with the uncharged photoactivable compound [H-3]diazofluorene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; AFFINITY BINDING-SITE; LIPID-EXPOSED REGIONS; H-3 CHLORPROMAZINE; NONCOMPETITIVE ANTAGONIST; DELTA-SUBUNIT; ALPHA-SUBUNIT; GEL-ELECTROPHORESIS; AMINO-ACIDS; M2 DOMAIN	The uncharged photoactivable probe 2-[H-3]diazofluorene ([H-3]DAF) was used to examine structural changes in the Torpedo californica nicotinic acetylcholine receptor (AChR) ion channel induced by agonists. Photoincorporation of [H-3]DAF into the AChR consisted of the following two components: a nonspecific component consistent with incorporation into residues situated at the lipid-protein interface, and a specific component, inhibitable by noncompetitive antagonists and localized to the M2 hydrophobic segments of AChR subunits. The nonspecific [3H]DAF incorporation was characterized in the M4 segment of each AChR subunit. The observed distribution and periodicity of labeled residues reinforce the conclusion that the M4 segments are organized as transmembrane a-helices with a common "face" of each helix in contact with lipid, Within the M2 segments, in the absence of agonist [H-3]DAF specifically labeled homologous residues beta Val-261 and delta Val-269, with incorporation into beta Val-269 at a 5-fold greater efficiency than into beta Val-261. This observation, coupled with the lack of detectable incorporation into alpha-M2 including the homologous alpha Val-255, indicates that within the resting channel [H-3]DAF is bound with its photoreactive diazo group oriented toward delta Val-269. In the presence of agonist, there is an similar to 90% reduction in the labeling of beta Val-261 and delta Val-269 accompanied by specific incorporation into residues (beta Leu-257, beta Ala-258, delta Ser-262, and delta Leu-265) situated 1 or 2 turns of an alpha-helix closer to the cytoplasmic end of the M2 segments. The results provide a further characterization of agonist-induced rearrangements of the M2 (ion channel) domain of the AChR.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Indian Inst Technol, Dept Chem, Biomembrane Lab, Bombay 400076, Maharashtra, India	Harvard University; Harvard Medical School; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jbcohen@warren.med.harvard.edu			NIGMS NIH HHS [GM 15904] Funding Source: Medline; NINDS NIH HHS [NS 19522] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019522] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; ANJANEYULU PSR, 1984, INDIAN J CHEM B, V23, P802; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; BLANTON MP, 1994, MOL PHARMACOL, V46, P1048; BLANTON MP, 1993, BIOPHYS J, V64, pA322; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; BRUNNER J, 1989, METHOD ENZYMOL, V172, P628; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COHEN JB, 1985, EFFECTS ANESTHESIA, P53; DIPAOLA M, 1989, J BIOL CHEM, V264, P15457; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; GALLAGHER MJ, 1994, BIOPHYS J, V66, pA212; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; GIRAUDAT J, 1989, FEBS LETT, V253, P190, DOI 10.1016/0014-5793(89)80957-3; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P3112, DOI 10.1021/bi00282a014; HUCHO F, 1986, EUR J BIOCHEM, V158, P211, DOI 10.1111/j.1432-1033.1986.tb09740.x; Hucho F, 1996, EUR J BIOCHEM, V239, P539, DOI 10.1111/j.1432-1033.1996.0539u.x; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; Kearney PC, 1996, NEURON, V17, P1221, DOI 10.1016/S0896-6273(00)80252-4; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALA AK, 1995, J BIOL CHEM, V270, P11348, DOI 10.1074/jbc.270.19.11348; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LESTER HA, 1997, HARVEY LECT, V91, P79; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; PALMA AL, 1991, J MEMBRANE BIOL, V122, P143, DOI 10.1007/BF01872637; PEDERSEN SE, 1992, J BIOL CHEM, V267, P10489; PEDERSEN SE, 1986, J BIOL CHEM, V261, P3735; PEPER K, 1982, PHYSIOL REV, V62, P1271, DOI 10.1152/physrev.1982.62.4.1271; PRADHAN D, 1987, J BIOL CHEM, V262, P8242; REVAH F, 1990, P NATL ACAD SCI USA, V87, P4675, DOI 10.1073/pnas.87.12.4675; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; TOMIOKA H, 1995, J AM CHEM SOC, V117, P4483, DOI 10.1021/ja00121a007; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1991, J BIOL CHEM, V266, P21595; WHITE BH, 1992, J BIOL CHEM, V267, P15770	45	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8659	8668		10.1074/jbc.273.15.8659	http://dx.doi.org/10.1074/jbc.273.15.8659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535841	hybrid			2022-12-27	WOS:000072990800018
J	Britton, KL; Stillman, TJ; Yip, KSP; Forterre, P; Engel, PC; Rice, DW				Britton, KL; Stillman, TJ; Yip, KSP; Forterre, P; Engel, PC; Rice, DW			Insights into the molecular basis of salt tolerance from the study of glutamate dehydrogenase from Halobacterium salinarum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; PYROCOCCUS-FURIOSUS; PROTEIN STRUCTURES; GENE; ARCHAEBACTERIUM; TRANSCRIPTION; ADAPTATION; CLONING	A homology-based modeling study on the extremely halophilic glutamate dehydrogenase from Halobacterium salinarum has been used to provide insights into the molecular basis of salt tolerance. The modeling reveals two significant differences in the characteristics of the surface of the halophilic enzyme that may contribute to its stability in high salt. The first of these is that the surface is decorated with acidic residues, a feature previously seen in structures of halophilic enzymes. The second is that the surface displays a significant reduction in exposed hydrophobic character. The latter arises not from a loss of surface-exposed hydrophobic residues, as has previously been proposed, but from a reduction in surface-exposed lysine residues. This is the first report of such an observation.	Univ Sheffield, Krebs Inst Biomolec Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ Paris Sud, Inst Genet & Microbiol, F-91405 Orsay, France; Natl Univ Ireland Univ Coll Dublin, Dept Biochem, Dublin 4, Ireland	University of Sheffield; UDICE-French Research Universities; Universite Paris Saclay; University College Dublin	Rice, DW (corresponding author), Univ Sheffield, Krebs Inst Biomolec Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; BALDACCI G, 1990, NUCLEIC ACIDS RES, V18, P507, DOI 10.1093/nar/18.3.507; BENACHENHOU N, 1991, MOL GEN GENET, V230, P345, DOI 10.1007/BF00280290; BENACHENHOULAHFA N, 1994, GENE, V140, P17, DOI 10.1016/0378-1119(94)90725-0; BONETE MJ, 1987, INT J BIOCHEM, V19, P1149, DOI 10.1016/0020-711X(87)90096-6; BRITTON KL, 1992, EUR J BIOCHEM, V209, P851, DOI 10.1111/j.1432-1033.1992.tb17357.x; CADENAS Q, 1994, BIOCHEM MOL BIOL INT, V33, P785; DYM O, 1995, SCIENCE, V267, P1344, DOI 10.1126/science.267.5202.1344; EGGEN RIL, 1993, GENE, V132, P143, DOI 10.1016/0378-1119(93)90527-A; EISENBERG H, 1992, ADV PROTEIN CHEM, V43, P1, DOI 10.1016/S0065-3233(08)60553-7; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; FLAM F, 1994, SCIENCE, V265, P471, DOI 10.1126/science.8036489; Frolow F, 1996, NAT STRUCT BIOL, V3, P452, DOI 10.1038/nsb0596-452; Galinski E. A., 1992, Molecular biology and biotechnology of extremophiles., P76; HUANG CC, 1991, J MOL GRAPHICS, V9, P230, DOI 10.1016/0263-7855(91)80016-S; JONES TA, 1985, METHOD ENZYMOL, V115, P157; Knapp S, 1997, J MOL BIOL, V267, P916, DOI 10.1006/jmbi.1996.0900; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LILLO JG, 1990, APPL ENVIRON MICROB, V56, P2517, DOI 10.1128/AEM.56.8.2517-2521.1990; MARAS B, 1994, J PROTEIN CHEM, V13, P253, DOI 10.1007/BF01891983; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Singh J., 1992, ATLAS PROTEIN SIDE C; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; TELLER JK, 1992, EUR J BIOCHEM, V206, P151, DOI 10.1111/j.1432-1033.1992.tb16912.x; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	30	44	46	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9023	9030		10.1074/jbc.273.15.9023	http://dx.doi.org/10.1074/jbc.273.15.9023			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535890	hybrid			2022-12-27	WOS:000072990800067
J	Harnish, DC; Evans, MJ; Scicchitano, MS; Bhat, RA; Karathanasis, SK				Harnish, DC; Evans, MJ; Scicchitano, MS; Bhat, RA; Karathanasis, SK			Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; HEP G2 CELLS; I GENE; POSTMENOPAUSAL WOMEN; RESPONSIVE ELEMENT; MESSENGER-RNA; SYNERGISTIC INTERACTIONS; HORMONE REPLACEMENT; RETINOIC ACID; DIETARY-FAT	Estrogen replacement therapy increases plasma concentrations of high density lipoprotein and its major protein constituent, apolipoprotein Al (apoAI), Studies with animal model systems, however, suggest opposite effects. In HepGa cells stably expressing estrogen receptor alpha (ER alpha), 17 beta-estradiol (E2) potently inhibited apoAI mRNA steady state levels. ApoAI promoter deletion mapping experiments indicated that ER alpha plus E2 inhibited apoAI activity through the liver-specific enhancer. Although the ER alpha DNA binding domain was essential but not sufficient for apoAI enhancer inhibition, ER alpha binding to the apoAI enhancer could not be detected by electrophoretic mobility shift assays. Western blotting and cotransfection assays showed that ER alpha plus E2 did not influence the abundance or the activity of the hepatocyte-enriched factors HNF-3 beta and HNF-4, two transcription factors essential for apoAI enhancer function, Expression of the ER alpha coactivator RIP140 dramatically repressed apoAI enhancer function in cotransfection experiments, suggesting that RIP140 may also function as a coactivator on the apoAI enhancer. Moreover, estrogen regulation of apoAI enhancer activity was dependent upon the balance between ER alpha and RIP140 levels. At low ratios of RIP140 to ER alpha, E2 repressed apoAI enhancer activity, whereas at high ratios this repression was reversed. Regulation of the apoAI gene by estrogen may thus vary in direction and magnitude depending not only on the presence of ER alpha and E2 but also upon the intracellular balance of ER alpha and coactivators utilized by ER alpha and the apoAI enhancer.	Wyeth Ayerst Res, Dept Nucl Receptors, Radnor, PA 19087 USA	Pfizer	Karathanasis, SK (corresponding author), Wyeth Ayerst Res, Dept Nucl Receptors, 145 King Prussia Rd, Radnor, PA 19087 USA.	karaths@war.wyeth.com						Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; APPLEBAUMBOWDEN D, 1989, J LIPID RES, V30, P1895; Auricchio F, 1996, ANN NY ACAD SCI, V784, P149, DOI 10.1111/j.1749-6632.1996.tb16234.x; AZROLAN N, 1995, J BIOL CHEM, V270, P19833, DOI 10.1074/jbc.270.34.19833; BarrettConnor E, 1996, MATURITAS, V23, P227, DOI 10.1016/0378-5122(95)00975-2; Baur EV, 1996, EMBO J, V15, P110, DOI 10.1002/j.1460-2075.1996.tb00339.x; BLOBEL GA, 1995, MOL CELL BIOL, V15, P3147; Bodine PVN, 1997, J CELL BIOCHEM, V65, P368, DOI 10.1002/(SICI)1097-4644(19970601)65:3<368::AID-JCB7>3.0.CO;2-Q; BRESLOW JL, 1982, P NATL ACAD SCI-BIOL, V79, P6861, DOI 10.1073/pnas.79.22.6861; Brinton EA, 1996, ARTERIOSCL THROM VAS, V16, P431, DOI 10.1161/01.ATV.16.3.431; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; CHAN J, 1993, NUCLEIC ACIDS RES, V21, P1205, DOI 10.1093/nar/21.5.1205; CLARKSON TB, 1990, OBSTET GYNECOL, V75, P217; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DiDomenico M, 1996, CANCER RES, V56, P4516; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; DYSON N, 1992, CANCER SURV, V12, P161; ETTINGER WH, 1994, ARTERIOSCLER THROMB, V14, P8, DOI 10.1161/01.ATV.14.1.8; GE RW, 1994, J BIOL CHEM, V269, P13185; GINSBURG GS, 1995, J CLIN INVEST, V96, P528, DOI 10.1172/JCI118065; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; HANSTEIN B, 1996, NATL ACAD SCI US, V21, P11540; Harnish DC, 1996, J BIOL CHEM, V271, P13621, DOI 10.1074/jbc.271.23.13621; HARNISH DC, 1994, J BIOL CHEM, V269, P28220; Jin FY, 1996, ARTERIOSCL THROM VAS, V16, P1052, DOI 10.1161/01.ATV.16.8.1052; Joyeux A, 1997, MOL ENDOCRINOL, V11, P193, DOI 10.1210/me.11.2.193; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KAPTEIN A, 1993, ARTERIOSCLER THROMB, V13, P1505, DOI 10.1161/01.ATV.13.10.1505; KARATHANASIS SK, 1992, MONOGR HUM GENET, V14, P140; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MALIK S, 1995, NUCLEIC ACIDS RES, V23, P1536, DOI 10.1093/nar/23.9.1536; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; ONATE SA, 1995, SCIENCE, V270, P1354; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; RichEdwards JW, 1996, CURR OPIN CARDIOL, V11, P440, DOI 10.1097/00001573-199607000-00014; ROTTMAN JN, 1991, MOL CELL BIOL, V11, P3814, DOI 10.1128/MCB.11.7.3814; Saarto T, 1996, J CLIN ONCOL, V14, P429, DOI 10.1200/JCO.1996.14.2.429; Smith CL, 1996, P NATL ACAD SCI USA, V93, P8884, DOI 10.1073/pnas.93.17.8884; SORCITHOMAS M, 1989, J LIPID RES, V30, P1397; STAELS B, 1989, J LIPID RES, V30, P1137; STEIN B, 1995, MOL CELL BIOL, V15, P4971; SUKOVICH DA, 1994, MOL CELL BIOL, V14, P7134, DOI 10.1128/MCB.14.11.7134; TANG JJ, 1991, J LIPID RES, V32, P1571; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; VANDENBROUCK Y, 1995, FEBS LETT, V376, P99, DOI 10.1016/0014-5793(95)01252-X; WALSH BW, 1994, J LIPID RES, V35, P2083; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WIDOM RL, 1991, MOL CELL BIOL, V11, P677, DOI 10.1128/MCB.11.2.677; WIDOM RL, 1992, MOL CELL BIOL, V12, P3380, DOI 10.1128/MCB.12.8.3380; WILLIAMS JK, 1995, ARTERIOSCL THROM VAS, V15, P827, DOI 10.1161/01.ATV.15.7.827; Yang NN, 1996, SCIENCE, V273, P1222, DOI 10.1126/science.273.5279.1222	63	73	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9270	9278		10.1074/jbc.273.15.9270	http://dx.doi.org/10.1074/jbc.273.15.9270			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535920	hybrid			2022-12-27	WOS:000072990800097
J	Varoqui, H; Erickson, JD				Varoqui, H; Erickson, JD			The cytoplasmic tail of the vesicular acetylcholine transporter contains a synaptic vesicle targeting signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE-CORE VESICLES; TRANS-GOLGI NETWORK; PHEOCHROMOCYTOMA CELL-LINE; ENDOCRINE-CELLS; MONOAMINE TRANSPORTER; PC12 CELLS; RAT-BRAIN; SECRETORY GRANULES; LOCALIZATION; STORAGE	The human homologue of the vesicular acetylcholine transporter (hVAChT) and the neuronal isoform of the vesicular monoamine transporter (hVMAT2) are differentially targeted to two populations of regulated secretory organelles when expressed in PC12 cells, Western blot analysis of subcellular fractions from sucrose equilibrium density gradients and glycerol velocity gradients of homogenates from stably transfected cells revealed hVAChT immunoreactivity in fractions that contain synaptophysin, a marker of synaptic vesicles, while hVMAT2 immunoreactivity was confined to heavy fractions containing chromogranin B, a marker of large dense core vesicles. In cells treated with nerve growth factor, hVAChT immunoreactivity alone co-localized with synaptophysin and was abundantly expressed on synaptic vesicle clusters. Chimeras between hVMAT2 and hVAChT were utilized to identify the domain of hVAChT required for its expression on synaptic vesicles and which would shift the expression of hVMAT2 from large dense core vesicles to synaptic vesicles. Biochemical, immunocytochemical, and electron microscopic analyses revealed that a chimera in which the cytoplasmic tail of hVMAT2 was replaced with hVAChT sequences was now preferentially targeted to synaptic vesicles. In addition, hVAChT expression on synaptic vesicles was nearly abolished when the hVMAT2 cytoplasmic tail was present, Thus, structural information resides within the terminal cytoplasmic domain of VAChT, which specifically targets it to synaptic vesicles.	Louisiana State Univ, Med Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; Louisiana State Univ, Med Ctr, Dept Pharmacol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University System	Varoqui, H (corresponding author), Louisiana State Univ, Med Ctr, Neurosci Ctr Excellence, 2020 Gravier St,Suite D, New Orleans, LA 70112 USA.	hvaroq@lsumc.edu			NINDS NIH HHS [NS36936] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036936] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGOSTON DV, 1988, EXP BRAIN RES, V72, P535; BAUERFEIND R, 1995, P NATL ACAD SCI USA, V92, P7342, DOI 10.1073/pnas.92.16.7342; BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; BLUMBERG D, 1992, J NEUROCHEM, V58, P801, DOI 10.1111/j.1471-4159.1992.tb09328.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; CUTLER DF, 1990, J CELL BIOL, V110, P721, DOI 10.1083/jcb.110.3.721; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DISDIER M, 1992, MOL BIOL CELL, V3, P309, DOI 10.1091/mbc.3.3.309; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; ERICKSON JD, 1990, BRAIN RES, V516, P155, DOI 10.1016/0006-8993(90)90912-U; Erickson JD, 1996, PROG BRAIN RES, V109, P69; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; FLOOR E, 1995, J NEUROCHEM, V64, P689; Gilmor ML, 1996, J NEUROSCI, V16, P2179; GREENE LA, 1977, NATURE, V268, P349, DOI 10.1038/268349a0; GREENE LA, 1977, BRAIN RES, V129, P247, DOI 10.1016/0006-8993(77)90005-1; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Grote E, 1996, J CELL BIOL, V132, P537, DOI 10.1083/jcb.132.4.537; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINSTEDT AD, 1991, J PHYSIOL-PARIS, V85, P90; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; Liu JP, 1997, CLIN EXP PHARMACOL P, V24, P611, DOI 10.1111/j.1440-1681.1997.tb02101.x; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; LUNDBERG JM, 1994, MOL CELLULAR MECH NE, P223; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NIRENBERG MJ, 1995, P NATL ACAD SCI USA, V92, P8773, DOI 10.1073/pnas.92.19.8773; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; PATZAK A, 1986, J CELL BIOL, V102, P510, DOI 10.1083/jcb.102.2.510; PHILIPPU A, 1973, N-S ARCH PHARMACOL, V278, P387, DOI 10.1007/BF00501482; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; ROBOIS RV, 1980, BIOCHEMISTRY-US, V19, P1240; Schafer MKH, 1995, J MOL NEUROSCI, V6, P225, DOI 10.1007/BF02736782; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P5184, DOI 10.1073/pnas.74.11.5184; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; TAKAHASHI S, 1995, J BIOL CHEM, V270, P28397; Tanner VA, 1996, J HISTOCHEM CYTOCHEM, V44, P1481, DOI 10.1177/44.12.8985140; Tao-Cheng J H, 1998, Adv Pharmacol, V42, P250; THURESONKLEIN AK, 1988, CELLULAR MOL BASIS S, P137; TRIMBLE WS, 1991, ANNU REV NEUROSCI, V14, P93, DOI 10.1146/annurev.ne.14.030191.000521; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Varoqui H, 1997, MOL NEUROBIOL, V15, P165, DOI 10.1007/BF02740633; Varoqui H, 1996, J BIOL CHEM, V271, P27229, DOI 10.1074/jbc.271.44.27229; Varoqui H, 1996, PROG BRAIN RES, V109, P83; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; WIEDENMANN B, 1988, FEBS LETT, V240, P71, DOI 10.1016/0014-5793(88)80342-9	59	59	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9094	9098		10.1074/jbc.273.15.9094	http://dx.doi.org/10.1074/jbc.273.15.9094			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535898	hybrid			2022-12-27	WOS:000072990800075
J	Zhi, G; Abdullah, SM; Stull, JT				Zhi, G; Abdullah, SM; Stull, JT			Regulatory segments of Ca2+/calmodulin-dependent protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; RABBIT SKELETAL-MUSCLE; TRACHEAL SMOOTH-MUSCLE; CALMODULIN-BINDING DOMAIN; OXIDE SYNTHASE ACTIVITIES; PSEUDOSUBSTRATE SEQUENCE; INTRASTERIC REGULATION; AUTOINHIBITORY DOMAIN; STRUCTURAL BASIS; PEPTIDE COMPLEX	Catalytic cores of skeletal and smooth muscle myosin Light chain kinases and Ca2+/calmodulin-dependent protein kinase II are regulated intrasterically by different regulatory segments containing autoinhibitory and calmodulin-binding sequences. The functional properties of these regulatory segments were examined in chimeric kinases containing either the catalytic core of skeletal muscle myosin light chain kinase or Ca2+/calmodulin-dependent protein kinase IT with different regulatory segments. Recognition of protein substrates by the catalytic core of skeletal muscle myosin light chain kinase was altered with the regulatory segment of protein kinase II but not with smooth muscle myosin light chain kinase. Similarly, the catalytic properties of the protein kinase II were altered with regulatory segments from either myosin light chain kinase. All chimeric kinases were dependent on Ca2+/calmodulin for activity. The apparent Ca2+/calmodulin activation constant was similarly low with all chimeras containing the skeletal muscle catalytic core. The activation constant was greater with chimeric kinases containing the catalytic core of Ca2+/calmodulin-dependent protein kinase II with its endogenous or myosin light chain kinase regulatory segments. Thus, heterologous regulatory segments affect substrate recognition and kinase activity. Furthermore, the sensitivity to calmodulin activation is determined primarily by the respective catalytic cores, not the calmodulin-binding sequences.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Stull, JT (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	jstull@mednet.swmed.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL006296, R01HL026043, R37HL026043] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL06296, HL26043] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BILLINGSLEY ML, 1985, P NATL ACAD SCI USA, V82, P7585, DOI 10.1073/pnas.82.22.7585; BREDT DS, 1992, J BIOL CHEM, V267, P10976; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; Chin D, 1997, J BIOL CHEM, V272, P5510, DOI 10.1074/jbc.272.9.5510; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; CRUZALEGUI FH, 1992, P NATL ACAD SCI USA, V89, P12127, DOI 10.1073/pnas.89.24.12127; DEKKER LV, 1993, FEBS LETT, V329, P129, DOI 10.1016/0014-5793(93)80208-C; DEKKER LV, 1993, J BIOL CHEM, V268, P19498; EDELMAN AM, 1985, J BIOL CHEM, V260, P1275; FAUX MC, 1993, J BIOL CHEM, V268, P12484; FITZSIMONS DP, 1992, J BIOL CHEM, V267, P23903; FUJISE A, 1994, J BIOL CHEM, V269, P31642; GALLAGHER PJ, 1993, J BIOL CHEM, V268, P26578; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; GAO ZH, 1995, J BIOL CHEM, V270, P10125, DOI 10.1074/jbc.270.17.10125; GEORGE SE, 1990, J BIOL CHEM, V265, P9228; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; HAGIWARA T, 1991, J BIOL CHEM, V266, P16401; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HATHAWAY DR, 1988, BIOCHEM SOC T, V16, P499, DOI 10.1042/bst0160499; HERRING BP, 1991, J BIOL CHEM, V266, P11838; HERRING BP, 1990, J BIOL CHEM, V265, P1724; HOGABOOM GK, 1982, FEBS LETT, V139, P309, DOI 10.1016/0014-5793(82)80877-6; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; IKEBE M, 1989, J BIOL CHEM, V264, P6967; IKEBE M, 1982, J BIOCHEM, V92, P1973, DOI 10.1093/oxfordjournals.jbchem.a134128; IKEBE M, 1987, J BIOL CHEM, V262, P13828; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; ISHIDA A, 1995, J BIOL CHEM, V270, P2163, DOI 10.1074/jbc.270.5.2163; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KELLY PT, 1988, P NATL ACAD SCI USA, V85, P4991, DOI 10.1073/pnas.85.14.4991; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KENNEDY MB, 1987, CALCIUM CELL FUNCTIO, P39; KENNELLY PJ, 1990, J BIOL CHEM, V265, P1742; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; Kobe B, 1996, EMBO J, V15, P6810, DOI 10.1002/j.1460-2075.1996.tb01072.x; KRUEGER JK, 1995, J BIOL CHEM, V270, P16848, DOI 10.1074/jbc.270.28.16848; Krueger JK, 1997, BIOCHEMISTRY-US, V36, P6017, DOI 10.1021/bi9702703; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MILLER JR, 1983, MOL PHARMACOL, V24, P235; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; PEARSON RB, 1988, SCIENCE, V241, P970, DOI 10.1126/science.3406746; PERSECHINI A, 1994, J BIOL CHEM, V269, P16148; Persechini A, 1996, BIOCHEMISTRY-US, V35, P224, DOI 10.1021/bi952383x; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; STULL JT, 1990, J BIOL CHEM, V265, P16683; STULL JT, 1986, ENZYMES, P113; STULL JT, 1988, MOL ASPECTS CELLULAR, V5, P91; SU ZH, 1994, J BIOL CHEM, V269, P16761; TANAKA M, 1995, EMBO J, V14, P2839, DOI 10.1002/j.1460-2075.1995.tb07283.x; VANBERKUM MFA, 1991, J BIOL CHEM, V266, P21488; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; WALSH MP, 1982, BIOCHEMISTRY-US, V21, P1919, DOI 10.1021/bi00537a034; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; ZHI G, 1994, J BIOL CHEM, V269, P24723	62	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8951	8957		10.1074/jbc.273.15.8951	http://dx.doi.org/10.1074/jbc.273.15.8951			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535879	hybrid			2022-12-27	WOS:000072990800056
J	Long, GL; Lu, DS; Xie, RL; Kalafatis, M				Long, GL; Lu, DS; Xie, RL; Kalafatis, M			Human protein S cleavage and inactivation by coagulation factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-DEPENDENT PROTEINS; FACTOR-VA; BLOOD-COAGULATION; FACTOR-VIII; GROWTH ARREST; THROMBIN; BOVINE; DEFICIENCY; BINDING; PROTHROMBINASE	Human factor Xa specifically cleaves the anticoagulant protein S within the thrombin-sensitive domain. Amino-terminal amino acid sequencing of the heavy chain cleavage product indicates cleavage of protein S by factor Xa at Arg(60), a Site that is distinct from those utilized by alpha-thrombin. Cleavage by factor Xa is unaffected by the presence of hirudin and is completely blocked by tick-anticoagulant-peptide and D-Glu-Gly-Arg-chloromethyl ketone, the latter two being specific inhibitors of factor Xa. The cleavage requires the presence of phospholipid and Ca2+, and is markedly inhibited by the presence of factor Va, Factor Xa-cleaved protein S no longer possesses its activated protein C-dependent or -independent anticoagulant activity, as measured in a factor VIII-based activated partial thromboplastin time clot assay. The apparent binding constant for protein S binding to phospholipid (K-d similar or equal to 4 nM +/- 1.0) is unaffected by factor Xa or thrombin cleavage, suggesting that the loss of anticoagulant activity resulting from cleavage is not primarily due to the loss of membrane binding ability. Cleavage and inactivation of protein S by factor Xa may be an additional way in which factor Xa exerts its procoagulant effect, after the initial stages of clot formation.	Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Long, GL (corresponding author), Univ Vermont, Coll Med, Dept Biochem, Given Bldg,Hlth Sci Complex, Burlington, VT 05405 USA.	glong@zoo.uvm.edu			PHS HHS [R01-38899] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BERTINA RM, 1985, HAEMOSTASIS, V15, P241; COMP PC, 1984, NEW ENGL J MED, V311, P1525, DOI 10.1056/NEJM198412133112401; COMP PC, 1984, J CLIN INVEST, V74, P2082, DOI 10.1172/JCI111632; DAHLBACK B, 1992, BIOCHEMISTRY-US, V31, P12769, DOI 10.1021/bi00166a009; DAHLBACK B, 1986, J BIOL CHEM, V261, P5111; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DISCIPIO RG, 1979, BIOCHEMISTRY-US, V18, P899, DOI 10.1021/bi00572a026; Egan JO, 1997, PROTEIN SCI, V6, P2016, DOI 10.1002/pro.5560060922; ESMON CT, 1986, SCIENCE, V35, P1348; GERSHAGEN S, 1989, NUCLEIC ACIDS RES, V17, P945; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; HEEB MJ, 1994, P NATL ACAD SCI USA, V91, P2728, DOI 10.1073/pnas.91.7.2728; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; HOSKINS J, 1987, P NATL ACAD SCI USA, V84, P349, DOI 10.1073/pnas.84.2.349; JOSEPH DR, 1992, FASEB J, V6, P2477, DOI 10.1096/fasebj.6.7.1532944; KALAFATIS M, 1993, J BIOL CHEM, V268, P27246; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P5824, DOI 10.1021/bi00645a029; KOELEMAN BPC, 1995, THROMB HAEMOSTASIS, V74, P580; KOPPELMAN SJ, 1995, BLOOD, V86, P1062; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGDELL RD, 1953, J LAB CLIN MED, V41, P637; LITWILLER RD, 1986, BLOOD, V67, P1583; Lu DS, 1996, BLOOD, V87, P4708, DOI 10.1182/blood.V87.11.4708.bloodjournal87114708; Lu DS, 1997, THROMB HAEMOSTASIS, V77, P1156; Lundblad R L, 1976, Methods Enzymol, V45, P156; LUNDWALL A, 1986, P NATL ACAD SCI USA, V83, P6716, DOI 10.1073/pnas.83.18.6716; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; MANN KG, 1990, BLOOD, V76, P1; Mann KG., 1994, HEMOSTASIS THROMBOSI, P184; MITCHELL CA, 1988, THROMB HAEMOSTASIS, V60, P298; MITCHELL CA, 1986, THROMB HAEMOSTASIS, V56, P151; NELSESTUEN GL, 1978, BIOCHEMISTRY-US, V17, P2134, DOI 10.1021/bi00604a017; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; RAPAPORT SI, 1993, WESTERN J MED, V158, P153; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; SCHMIDEL DK, 1990, BIOCHEMISTRY-US, V29, P7845, DOI 10.1021/bi00486a010; SCHMIDEL DK, 1991, BLOOD, V77, P551; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SHEN L, 1994, J BIOL CHEM, V269, P18735; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; vanWijnen M, 1996, THROMB HAEMOSTASIS, V76, P397; Varadi K, 1996, THROMB HAEMOSTASIS, V76, P208; WALKER FJ, 1984, J BIOL CHEM, V259, P335; WALKER FJ, 1984, SEMIN THROMB HEMOST, V10, P131, DOI 10.1055/s-2007-1004415; WALKER FJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P322, DOI 10.1016/0003-9861(87)90037-3; WALKER FJ, 1980, J BIOL CHEM, V255, P5521	49	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11521	11526		10.1074/jbc.273.19.11521	http://dx.doi.org/10.1074/jbc.273.19.11521			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565566	hybrid			2022-12-27	WOS:000073536700020
J	Cartaud, A; Coutant, S; Petrucci, TC; Cartaud, J				Cartaud, A; Coutant, S; Petrucci, TC; Cartaud, J			Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein - Consequence for acetylcholine receptor clustering at the synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC POSTSYNAPTIC MEMBRANES; TORPEDO ELECTRIC ORGAN; NEUROMUSCULAR-JUNCTION; ALPHA-DYSTROGLYCAN; TYROSINE KINASE; GLYCOPROTEIN COMPLEX; EXTRACELLULAR-MATRIX; SKELETAL-MUSCLE; AGRIN RECEPTOR; RICH MEMBRANES	The accumulation of dystrophin and associated proteins at the postsynaptic membrane of the neuromuscular junction and their co-distribution with nicotinic acetylcholine receptor (AChR) clusters in vitro suggested a role for the dystrophin complex in synaptogenesis. Co-transfection experiments in which alpha- and beta-dystroglycan form a complex with AChR and rapsyn, a peripheral protein required for AChR clustering (Apel, D. A., Roberds, S, L,, Campbell, K, P,, and Merlie, J, P, (1995) Neuron 15, 115-126), suggested that rapsyn functions as a link between AChR and the dystrophin complex. We have investigated the interaction between rapsyn and beta-dystroglycan in Torpedo AChR-rich membranes using in situ and in vitro approaches. Cross linking experiments were carried out to study the topography of postsynaptic membrane polypeptides. A cross-linked product of 90 kDa was labeled by antibodies to rapsyn and beta-dystroglycan; this demonstrates that these polypeptides are in close proximity to one another. Affinity chromatography experiments and ligand blot assays using rapsyn solubilized from Torpedo AChR-rich membranes and constructs containing beta-dystroglycan C-terminal fragments show that a rapsyn-binding site is present in the juxtamembranous region of the cytoplasmic tail of beta-dystroglycan, These data point out that rapsyn and dystroglycan interact in the postsynaptic membrane and thus reinforce the notion that dystroglycan could be involved in synaptogenesis.	Univ Paris 07, Inst Jacques Monod, CNRS, UMR 9922,Dept Biol Supramol & Cellulaire, F-75251 Paris 05, France; Ist Super Sanita, I-00161 Rome, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Istituto Superiore di Sanita (ISS)	Cartaud, J (corresponding author), Univ Paris 07, Inst Jacques Monod, CNRS, UMR 9922,Dept Biol Supramol & Cellulaire, 2 Pl Jussieu, F-75251 Paris 05, France.	cartaud@ijm.jussieu.fr						ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; APEL DE, 1997, NEURON, V18, P623; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; BARRANTES FJ, 1980, FEBS LETT, V112, P73, DOI 10.1016/0014-5793(80)80131-1; Bollag D.M., 1991, PROTEIN METHODS; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BURDEN SJ, 1983, CELL, V35, P687, DOI 10.1016/0092-8674(83)90101-0; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; CARBONETTO S, 1995, CURR OPIN NEUROBIOL, V5, P596, DOI 10.1016/0959-4388(95)80064-6; CARR C, 1989, J CELL BIOL, V109, P1753, DOI 10.1083/jcb.109.4.1753; CARR C, 1987, BIOCHEMISTRY-US, V26, P7090, DOI 10.1021/bi00396a034; CARR DW, 1992, TRENDS BIOCHEM SCI, V17, P246, DOI 10.1016/0968-0004(92)90402-U; Cartaud A, 1996, J CELL SCI, V109, P1837; CARTAUD A, 1993, J BIOL CHEM, V268, P13019; CARTAUD J, 1981, J CELL BIOL, V90, P148; COHEN MW, 1995, J CELL BIOL, V129, P1093, DOI 10.1083/jcb.129.4.1093; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; DEYST KA, 1995, J BIOL CHEM, V270, P25956, DOI 10.1074/jbc.270.43.25956; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FROEHNER SC, 1984, J CELL BIOL, V99, P88, DOI 10.1083/jcb.99.1.88; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; GVSIN R, 1983, BIOCHEMISTRY-US, V22, P5781, DOI 10.1021/bi00294a016; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; HILL JA, 1991, BIOCHEMISTRY-US, V30, P5579, DOI 10.1021/bi00236a034; Hopf C, 1996, J BIOL CHEM, V271, P5231; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LO MMS, 1980, FEBS LETT, V111, P407, DOI 10.1016/0014-5793(80)80838-6; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PENG HB, 1985, J CELL BIOL, V100, P1698, DOI 10.1083/jcb.100.5.1698; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; PHILLIPS WD, 1992, BIOESSAYS, V14, P671, DOI 10.1002/bies.950141005; PORTER S, 1983, J BIOL CHEM, V258, P34; Rosa G, 1996, BIOCHEM BIOPH RES CO, V223, P272, DOI 10.1006/bbrc.1996.0883; ROUSSELET A, 1982, EMBO J, V1, P439, DOI 10.1002/j.1460-2075.1982.tb01188.x; SAITOH T, 1980, EUR J BIOCHEM, V105, P51, DOI 10.1111/j.1432-1033.1980.tb04473.x; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711	53	124	125	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11321	11326		10.1074/jbc.273.18.11321	http://dx.doi.org/10.1074/jbc.273.18.11321			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556625	hybrid			2022-12-27	WOS:000073395200077
J	Johnstone, RW; Wang, J; Tommerup, N; Vissing, H; Roberts, T; Shi, Y				Johnstone, RW; Wang, J; Tommerup, N; Vissing, H; Roberts, T; Shi, Y			Ciao 1 is a novel WD40 protein that interacts with the tumor suppressor protein WT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILMS-TUMOR; GENE-PRODUCT; TRANSCRIPTIONAL REPRESSION; FUNCTIONAL INTERACTION; NUCLEAR-LOCALIZATION; GROWTH SUPPRESSION; WD-40 REPEAT; DOMAINS; CLONING; COMPLEX	The Wilms tumor suppressor protein, WT1, is a transcription factor capable of activating or repressing transcription of various cellular genes. The mechanisms involved in regulating the transcriptional activities of WT1 are beginning to be unraveled. It appears that physical interactions of other cellular proteins (p53 and par-4) with WT1 can modulate the function of WT1. Here, we report the identification and cloning of a novel WT1-interacting protein termed Ciao 1, a member of the WD40 family of proteins. Ciao 1 specifically interacts with WT1 both in vitro and in vivo. This interaction alters the mobility of a WT1 DNA complex in gel shift assays, and results in a decrease in transcriptional activation mediated by WT1, Ciao 1 does not inhibit binding of WT1 to its consensus nucleotide sequence and does not affect the repression activity of WT1. Thus, Ciao 1 appears to specifically modulate the transactivation activity of WT1 and may function to regulate the physiological functions of WT1 in cell growth and differentiation.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Div Cellular & Mol Biol, Boston, MA 02115 USA; Univ Copenhagen, Panum Inst, Dept Med Genet, DK-2200 Copenhagen, Denmark; Novo Nordisk AS, Mol Genet, DK-2880 Bagsvaerd, Denmark	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Copenhagen; Novo Nordisk	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	yshi@warren.med.harvard.edu	Johnstone, Ricky w/H-3748-2014; Tommerup, Niels/T-8776-2017	Johnstone, Ricky w/0000-0001-7053-9237; Tommerup, Niels/0000-0003-2304-0112	NATIONAL CANCER INSTITUTE [R01CA068258] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 68258] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARMSTRONG JF, 1992, MECH DEVELOP, V40, P85; AUSUBEL FM, 1993, CURRENT PROTOCOLS MO, V2; COPPES MJ, 1993, FASEB J, V7, P886, DOI 10.1096/fasebj.7.10.8393819; DALRYMPLE MA, 1989, CELL, V58, P811, DOI 10.1016/0092-8674(89)90930-6; DELUCA NA, 1992, NATURE, V56, P215; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRUMMOND IA, 1994, MOL CELL BIOL, V14, P3800, DOI 10.1128/MCB.14.6.3800; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Dunn LC, 1940, J HERED, V31, P343, DOI 10.1093/oxfordjournals.jhered.a104924; DYNLACHT BD, 1993, NATURE, V363, P176, DOI 10.1038/363176a0; ENGLERT C, 1995, EMBO J, V14, P4162; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GESSLER M, 1992, GENOMICS, V12, P807, DOI 10.1016/0888-7543(92)90313-H; Gluecksohn-Schoenheimer S, 1943, GENETICS, V28, P341; GUTJAHR T, 1995, EMBO J, V14, P4296, DOI 10.1002/j.1460-2075.1995.tb00104.x; HABER DA, 1992, ADV CANCER RES, V59, P41, DOI 10.1016/S0065-230X(08)60302-4; HABER DA, 1993, SCIENCE, V262, P2057, DOI 10.1126/science.8266105; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HABER DA, 1992, NEW BIOL, V4, P97; HILDEBRANDT F, 1995, GENOMICS, V25, P360, DOI 10.1016/0888-7543(95)80034-J; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; KOSEKI H, 1993, MAMM GENOME, V4, P324, DOI 10.1007/BF00357091; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KUDOH T, 1995, P NATL ACAD SCI USA, V92, P4517, DOI 10.1073/pnas.92.10.4517; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; MADDEN SL, 1993, ONCOGENE, V8, P1713; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; MAHESWARAN S, 1995, GENE DEV, V9, P2143, DOI 10.1101/gad.9.17.2143; MAHESWARAN S, 1993, P NATL ACAD SCI USA, V90, P5100, DOI 10.1073/pnas.90.11.5100; Maniatis T, 1982, MOL CLONING LAB MANU, V1; Min W, 1996, MOL CELL BIOL, V16, P359; MOFFETT P, 1995, P NATL ACAD SCI USA, V92, P11105, DOI 10.1073/pnas.92.24.11105; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; PELLETIER J, 1991, NATURE, V353, P431, DOI 10.1038/353431a0; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; REDDY JC, 1995, J BIOL CHEM, V270, P10878, DOI 10.1074/jbc.270.18.10878; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; SANGER F, 1977, P NATL ACAD SCI USA, V74, P4913; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; STAPLETON P, 1993, NAT GENET, V3, P292, DOI 10.1038/ng0493-292; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WANG ZY, 1993, J BIOL CHEM, V268, P9172; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; Ye Y, 1996, EMBO J, V15, P5606, DOI 10.1002/j.1460-2075.1996.tb00945.x; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	60	56	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10880	10887		10.1074/jbc.273.18.10880	http://dx.doi.org/10.1074/jbc.273.18.10880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556563	hybrid			2022-12-27	WOS:000073395200015
J	Joseph-Horne, T; Wood, PM; Wood, CK; Moore, AL; Headrick, J; Hollomon, D				Joseph-Horne, T; Wood, PM; Wood, CK; Moore, AL; Headrick, J; Hollomon, D			Characterization of a split respiratory pathway in the wheat "take-all" fungus, Gaeumannomyces graminis var. tritici	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANIDE-INSENSITIVE RESPIRATION; ALTERNATIVE OXIDASE PROTEIN; PLANT-MITOCHONDRIA; HANSENULA-ANOMALA; ACID; ACTIVATION; CYCLE	This article describes the first detailed analysis of mitochondrial electron transfer and oxidative phosphorylation in the pathogenic filamentous fungus, Gaeumannomyces graminis var. tritici, While oxygen consumption was cyanide insensitive, inhibition occurred following treatment with complex III inhibitors and the alternative oxidase inhibitor, salicylhydroxamic acid (SHAM). Similarly, maintenance of a Delta psi across the mitochondrial inner membrane was unaffected by cyanide but sensitive to antimycin A and SHAM when succinate was added as the respiratory substrate. As a result, ATP synthesis through complex V was demonstrated to be sensitive to these two inhibitors but not to cyanide, Analysis of the cytochrome content of mitochondria indicated the presence of those cytochromes normally associated with electron transport in eukaryotic mitochondria together with a third, b-type heme, exhibiting a dithionite-reduced absorbance maxima at 560 nm and not associated with complex III. Antibodies raised to plant alternative oxidase detected the presence of both the monomeric and dimeric forms of this oxidase, Overall this study demonstrates that a novel respiratory chain utilizing the terminal oxidases, cytochrome c oxidase and alternative oxidase, are present and constitutively active in electron transfer in G. graminis tritici, These results are discussed in relation to current understanding of fungal electron transfer and to the possible contribution of alternative redox centers in ATP synthesis.	Univ Bristol, IACR, Long Ashton Res Stn, Dept Agr Sci, Bristol BS41 9AF, Avon, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Monsanto, St Louis, MO 63198 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Bristol; University of Bristol; University of Sussex; Monsanto	Joseph-Horne, T (corresponding author), Univ Bristol, IACR, Long Ashton Res Stn, Dept Agr Sci, Bristol BS41 9AF, Avon, England.	TIM.JOSEPH-HORNE@bbsrc.ac.uk						BAHR JT, 1973, J BIOL CHEM, V248, P3446; CLOUGH JM, 1993, NAT PROD REP, V10, P565, DOI 10.1039/np9931000565; ELTHON TE, 1987, P NATL ACAD SCI USA, V84, P8399, DOI 10.1073/pnas.84.23.8399; Hayashi K, 1996, J PESTIC SCI, V21, P399; HENRY MF, 1975, SUB-CELL BIOCHEM, V4, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MatsunoYagi A, 1997, J BIOL CHEM, V272, P16928, DOI 10.1074/jbc.272.27.16928; MCINTOSH L, 1994, PLANT PHYSIOL, V105, P781, DOI 10.1104/pp.105.3.781; Millar AH, 1996, PLANT PHYSIOL, V111, P613, DOI 10.1104/pp.111.2.613; MINAGAWA N, 1987, J BIOCHEM-TOKYO, V101, P1141, DOI 10.1093/oxfordjournals.jbchem.a121978; MOORE AL, 1991, BIOCHIM BIOPHYS ACTA, V1059, P121, DOI 10.1016/S0005-2728(05)80197-5; RHOADS DM, 1991, P NATL ACAD SCI USA, V88, P2122, DOI 10.1073/pnas.88.6.2122; Ribas-Carbo M, 1997, PLANT PHYSIOL, V113, P903, DOI 10.1104/pp.113.3.903; Sakajo S, 1997, BIOSCI BIOTECH BIOCH, V61, P396, DOI 10.1271/bbb.61.396; SAKAJO S, 1993, FEBS LETT, V318, P310, DOI 10.1016/0014-5793(93)80535-3; Shidoji Y, 1997, BIOCHEM BIOPH RES CO, V230, P58, DOI 10.1006/bbrc.1996.5883; TOWBIN H, 1993, PLANT PHYSIOL, V103, P845; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; VANLERBERGHE GC, 1995, PLANT PHYSIOL, V109, P353, DOI 10.1104/pp.109.2.353; WAGNER AM, 1995, PLANT PHYSIOL, V108, P1035, DOI 10.1104/pp.108.3.1035; Ziogas BN, 1997, PESTIC SCI, V50, P28, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;28::AID-PS555&gt;3.0.CO;2-1	21	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11127	11133		10.1074/jbc.273.18.11127	http://dx.doi.org/10.1074/jbc.273.18.11127			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556599	hybrid			2022-12-27	WOS:000073395200051
J	Khelef, N; Buton, X; Beatini, N; Wang, HX; Meiner, V; Chang, TY; Farese, RV; Maxfield, FR; Tabas, I				Khelef, N; Buton, X; Beatini, N; Wang, HX; Meiner, V; Chang, TY; Farese, RV; Maxfield, FR; Tabas, I			Immunolocalization of acyl-coenzyme A : Cholesterol O-acyltransferase in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE PERITONEAL-MACROPHAGES; LOW-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; ENDOPLASMIC-RETICULUM; ESTERIFICATION PATHWAY; TRANSFERASE-ACTIVITY; PLASMA-MEMBRANE; HEPATOMA-CELLS; RAT-LIVER; BETA-VLDL	Macrophages in atherosclerotic lesions accumulate large amounts of cholesteryl-fatty acyl esters ("foam cell" formation) through the intracellular esterification of cholesterol by acyl-coenzyme A:cholesterol O-acyltransferase (ACAT), In this study, we sought to determine the subcellular localization of ACAT in macrophages, Using mouse peritoneal macrophages and immunofluorescence microscopy, we found that a major portion of ACAT was in a dense reticular cytoplasmic network and in the nuclear membrane that colocalized with the luminal endoplasmic reticulum marker protein-disulfide isomerase (PDI) and that was in a similar distribution as the membrane-bound endoplasmic reticulum marker ribophorin. Remarkably, another portion of the macrophage ACAT pattern did not overlap with PDI or ribophorin, but was found in as Set unidentified cytoplasmic structures that were juxtaposed to the nucleus. Compartments containing labeled beta-very low density lipoprotein, an atherogenic lipoprotein, did not overlap with the ACAT label, but rather were embedded in the dense reticular network of ACAT, Furthermore, cell-surface biotinylation experiments revealed that freshly harvested, non-Attached macrophages, but not those attached to tissue culture dishes, contained similar to 10-15% of ACAT on the cell surface. In summary, ACAT was found in several sites in macrophages: a cytoplasmic reticular/nuclear membrane site that overlaps with PDI and ribophorin and has the characteristics of the endoplasmic reticulum, a perinuclear cytoplasmic site that does not overlap with PDI or ribophorin and may be another cytoplasmic structure or possibly a unique subcompartment of the endoplasmic reticulum, and a cell-surface site in non-attached macrophages, Understanding possible physiological differences of ACAT in these locations may reveal an important component of ACAT regulation and macrophage foam cell formation.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Cornell Univ, Sch Med, Dept Biochem, New York, NY 10021 USA; Inst Pasteur, F-75724 Paris 15, France; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Gladstone Fdn Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, San Francisco, CA 94141 USA; Hadassah Univ Hosp, Dept Genet, IL-91120 Jerusalem, Israel; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Columbia University; Columbia University; Cornell University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Hebrew University of Jerusalem; Dartmouth College	Tabas, I (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.	iat1@columbia.edu	Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866; Chang, Ta-Yuan/0000-0002-3249-0468; KHELEF, Nadia/0000-0003-0391-2403	NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR010506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057560] Funding Source: NIH RePORTER; NCI NIH HHS [5 P30 CA13696] Funding Source: Medline; NCRR NIH HHS [S10 RR10506] Funding Source: Medline; NHLBI NIH HHS [HL-57560] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALASUBRAMANIAM S, 1978, BIOCHEM J, V174, P863, DOI 10.1042/bj1740863; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Green S, 1996, BIOCHEM BIOPH RES CO, V218, P924, DOI 10.1006/bbrc.1996.0163; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KREIBICH G, 1978, J SUPRAMOL STR CELL, V8, P279, DOI 10.1002/jss.400080307; KRUTH HS, 1995, J CELL BIOL, V129, P133, DOI 10.1083/jcb.129.1.133; LANGE Y, 1995, J LIPID RES, V36, P1092; LANGE Y, 1993, J BIOL CHEM, V268, P13838; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; LICHTENSTEIN AH, 1980, J BIOL CHEM, V255, P9098; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Meiner V, 1997, J LIPID RES, V38, P1928; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; MYERS JN, 1993, J CELL BIOL, V123, P1389, DOI 10.1083/jcb.123.6.1389; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; NOIVA R, 1992, J BIOL CHEM, V267, P3553; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; SCHISSEL SL, 1995, BIOCHEMISTRY-US, V34, P10463, DOI 10.1021/bi00033a019; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SITIA R, 1992, MOL BIOL CELL, V3, P1067, DOI 10.1091/mbc.3.10.1067; Skiba PJ, 1996, J BIOL CHEM, V271, P13392, DOI 10.1074/jbc.271.23.13392; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; TABAS I, 1991, J CELL BIOL, V115, P1547, DOI 10.1083/jcb.115.6.1547; TABAS I, 1987, J BIOL CHEM, V262, P12175; TABAS I, 1988, J BIOL CHEM, V263, P1266; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; TABAS I, 1987, J CLIN INVEST, V79, P418, DOI 10.1172/JCI112828; TABAS I, 1995, CURR OPIN LIPIDOL, V6, P260, DOI 10.1097/00041433-199510000-00004; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; Wang HX, 1996, ARTERIOSCL THROM VAS, V16, P809, DOI 10.1161/01.ATV.16.6.809; XU XX, 1991, J BIOL CHEM, V266, P17040; ZHA X, 1996, ARTERIOSCLER THROMB, V90, P1421	37	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11218	11224		10.1074/jbc.273.18.11218	http://dx.doi.org/10.1074/jbc.273.18.11218			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556612	hybrid			2022-12-27	WOS:000073395200064
J	Nabekura, J; Noguchi, K; Witt, MR; Nielsen, M; Akaike, N				Nabekura, J; Noguchi, K; Witt, MR; Nielsen, M; Akaike, N			Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; A RECEPTOR; ARACHIDONIC-ACID; PROTEIN-KINASE; SUBUNIT COMPOSITION; NMDA RECEPTOR; RAT-BRAIN; GABA; BINDING; SUBTYPES	Human gamma-aminobutyric acid type A (GABA(A)) receptors were expressed in the baculovirus/Sf-9 insect cell expression system using recombinant cDNA of alpha(1) beta(2) gamma(2s) subunits. The effect of unsaturated fatty acids on GABA(A) receptor complexes was investigated electrophysiologically using conventional whole cell recording under voltage clamp. Three distinct effects of docosahexaenoic acid (DHA) on the GABA responses were observed, First, DHA, at a concentration of 10(-7) ar or greater, accelerated the desensitization after the peak of the GABA-induced current Second, DHA (10(-6) M) potentiated the peak amplitude of GABA response. This potentiation by DHA was inhibited in the presence of Zn2+ (10(-5) M); Cu2+ and Ni2+ mimicked the action of Zn2+. Zn2+ (10(-5) M) did not block the GABA response on alpha(1) beta(2) gamma(2s) receptor complexes. Third, DHA, at a concentration of 3 x 10(-6) M or higher, gradually suppressed the peak amplitude of GABA response. A protein kinase A inhibitor, a protein kinase C inhibitor, and a Ca2+ chelator did not modify the effects of DHA on GABA-induced chloride ion current, Six unsaturated fatty acids other than DHA were examined. Arachidonic acid mimicked the effect of DHA while e.g. oleic acid had no effect, The inhibition of the GABA response in the presence of DHA was also observed in cells expressing GABAA receptors of alpha(1) and beta(2) subunit combinations. The data show that the gamma subunit is essential for DHA and arachidonic acid to potentiate the GABA-induced Cl- channel activity and to affect the desensitization kinetics of the GABA(A) receptor.	Kyushu Univ, Fac Med, Dept Physiol, Higashi Ku, Fukuoka 81282, Japan; St Hans Hosp, Res Inst Biol Psychiat, DK-4000 Roskilde, Denmark	Kyushu University	Nabekura, J (corresponding author), Kyushu Univ, Fac Med, Dept Physiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 81282, Japan.							CALDERARO V, 1994, MOL PHARMACOL, V45, P737; DHOPESHWARKAR GA, 1975, LIPIDS, V10, P238, DOI 10.1007/BF02532486; DONALDSON J, 1973, CAN J BIOCHEM CELL B, V51, P87, DOI 10.1139/o73-010; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; GAO B, 1994, EUR J NEUROSCI, V6, P837, DOI 10.1111/j.1460-9568.1994.tb00994.x; HADINGHAM KL, 1993, MOL PHARMACOL, V44, P1211; Hamano H, 1996, J NEUROPHYSIOL, V75, P1264, DOI 10.1152/jn.1996.75.3.1264; HONMA Y, 1994, J BIOCHEM, V116, P1025, DOI 10.1093/oxfordjournals.jbchem.a124623; Horimoto N, 1997, NEUROSCIENCE, V77, P661, DOI 10.1016/S0306-4522(96)00490-3; HUAG FS, 1967, HISTOCHEMISTRY, V8, P355; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; KILIC G, 1993, EUR J NEUROSCI, V5, P65, DOI 10.1111/j.1460-9568.1993.tb00206.x; KOENIG JA, 1992, BIOCHEM PHARMACOL, V44, P11, DOI 10.1016/0006-2952(92)90031-D; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; MURASE K, 1990, BRAIN RES, V525, P84, DOI 10.1016/0006-8993(90)91323-9; NIELSEN M, 1988, EUR J PHARMACOL, V146, P349, DOI 10.1016/0014-2999(88)90315-9; NISHIKAWA M, 1994, J PHYSIOL-LONDON, V475, P83, DOI 10.1113/jphysiol.1994.sp020051; PACKHAM DE, 1995, CELL CALCIUM, V17, P399, DOI 10.1016/0143-4160(95)90086-1; PETROU S, 1993, TRENDS BIOCHEM SCI, V18, P41, DOI 10.1016/0968-0004(93)90050-W; PIOMELLI D, 1990, TRENDS PHARMACOL SCI, V11, P367, DOI 10.1016/0165-6147(90)90182-8; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; PORTER NM, 1990, NEURON, V5, P789, DOI 10.1016/0896-6273(90)90338-G; QUIRK K, 1994, J BIOL CHEM, V269, P16020; SAMOCHOCKI M, 1993, NEUROCHEM INT, V23, P261, DOI 10.1016/0197-0186(93)90117-N; SCHMID A, 1995, J PHYSIOL-LONDON, V484, P661, DOI 10.1113/jphysiol.1995.sp020694; SCHOFIELD PR, 1989, FEBS LETT, V244, P361, DOI 10.1016/0014-5793(89)80563-0; SCHWARTZ RD, 1992, BRAIN RES, V585, P405, DOI 10.1016/0006-8993(92)91246-B; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; UENO E, 1981, NEUROPHARMACOLOGY, V20, P1169, DOI 10.1016/0028-3908(81)90059-9; WesthHansen SE, 1997, EUR J PHARMACOL, V329, P253, DOI 10.1016/S0014-2999(97)89186-8; WISDEN W, 1992, J NEUROSCI, V12, P1040; Witt MR, 1996, J NEUROCHEM, V67, P2141; WITT MR, 1994, J NEUROCHEM, V62, P1432; XIE XM, 1991, NATURE, V349, P521, DOI 10.1038/349521a0	39	54	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11056	11061		10.1074/jbc.273.18.11056	http://dx.doi.org/10.1074/jbc.273.18.11056			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556589	hybrid			2022-12-27	WOS:000073395200041
J	Nathanson, L; Gromet-Elhanan, Z				Nathanson, L; Gromet-Elhanan, Z			Mutagenesis of beta-Glu-195 of the Rhodospirillum rubrum F-1-ATPase and its role in divalent cation-dependent catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; NUCLEOTIDE-BINDING-SITES; ACTIVE BETA-SUBUNIT; F0.F1 ATP SYNTHASE; H+-ATPASE; ADENOSINE-TRIPHOSPHATASE; CHLOROPLAST CF1-ATPASE; TRANSLOCATING ATPASE; CHANGE MECHANISM; COMPLEMENTATION	We introduced mutations at the fully conserved residue Glu-195 in subunit beta of Rhodospirillum rubrum F-1-ATPase. The activities of the expressed wild type (WT) and mutant beta subunits were assayed by following their capacity to assemble into the earlier prepared beta-depleted, membrane-bound R. rubrum enzyme (Philosoph, S., Binder, A., and Gromet-Elhanan, Z. (1977) J. Biol. Chem. 252, 8742-8747) and to restore ATP synthesis and/or hydrolysis activity. All three mutations, beta-E195K, beta-E195Q, and beta-E195G, were found to bind as the WT beta into the beta-depleted enzyme. They restored between 30 and 60% of the WT restored photophosphorylation activity and 16, 45, and 105%, respectively of the CaATPase activity. The mutants required, however, much higher concentrations of divalent cations and could not restore any significant MgATPase or MnATPase activities. Only beta-E195G could restore some of these activities when assayed in the presence of 100 mM sulfite and high MgCl2, or MnCl2, concentrations. These results suggest that the observed difference in restoration of ATP synthesis and CaATPase, as compared with MgATPase and MnATPase, can be due to the tight regulation of the last two activities, resulting in their inhibition at cation/ATP ratios above 0.5. The R. rubrum F-1 beta-E195 is equivalent to the mitochondrial F-1 beta-E199, which points into the tunnel leading to the F-1 catalytic nucleotide binding sites (Abrahams, J. P., Leslie, A. G. W., Lutter, R., and Walker, J. E. (1994) Nature 370, 621-628). Our findings indicate that this residue, although not an integral part of the F-1 catalytic sites, affects divalent cation binding and release of inhibitory MgADP, suggesting its participation in the interconversion of the F, catalytic sites between different conformational states.	Weizmann Inst Sci, Dept Biochem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Gromet-Elhanan, Z (corresponding author), Weizmann Inst Sci, Dept Biochem, IL-76100 Rehovot, Israel.		Nathanson, Lubov/ABC-2642-2021	Nathanson, Lubov/0000-0003-1038-9083				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; AVNI A, 1991, J BIOL CHEM, V266, P7317; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; AVRON M, 1960, BIOCHIM BIOPHYS ACTA, V40, P257, DOI 10.1016/0006-3002(60)91350-0; BALTSCHEFFSKY M, 1992, RES PHOTOSYNTHESIS, V3, P385; BENGISGARBER C, 1979, BIOCHEMISTRY-US, V18, P3577, DOI 10.1021/bi00583a022; BIANCHET M, 1991, J BIOL CHEM, V266, P21197; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BURKOVSKI A, 1994, BBA-BIOENERGETICS, V1186, P243, DOI 10.1016/0005-2728(94)90184-8; CHEN ZG, 1995, J BIOL CHEM, V270, P17124, DOI 10.1074/jbc.270.29.17124; Clayton R. K., 1963, BACTERIAL PHOTOSYNTH, P495; DU ZY, 1990, BIOCHEMISTRY-US, V29, P402, DOI 10.1021/bi00454a014; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; ESCH FS, 1981, J BIOL CHEM, V256, P9084; FALK G, 1985, BIOCHEM J, V228, P391, DOI 10.1042/bj2280391; FELDMAN RI, 1985, J BIOL CHEM, V260, P3088; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GERSHONI JM, 1988, METHOD BIOCHEM ANAL, V33, P1; Gromet-Elhanan Z., 1995, ANOXYGENIC PHOTOSYNT, P807; GROMETELHANAN Z, 1989, BIOCHEMISTRY-US, V28, P3645, DOI 10.1021/bi00435a004; GrometElhanan Z, 1995, PHOTOSYNTH RES, V46, P79, DOI 10.1007/BF00020418; GROMETELHANAN Z, 1986, METHOD ENZYMOL, V126, P528; GROMETELHANAN Z, 1984, BIOCHEMISTRY-US, V23, P1022, DOI 10.1021/bi00300a034; GROMETELHANAN Z, 1992, J BIOENERG BIOMEMBR, V24, P447, DOI 10.1007/BF00762361; Hu DL, 1997, J BIOL CHEM, V272, P5457, DOI 10.1074/jbc.272.9.5457; IWAMOTO A, 1993, J BIOL CHEM, V268, P3156; JENSEN PR, 1992, J BACTERIOL, V174, P7635, DOI 10.1128/JB.174.23.7635-7641.1992; JOHANSSON BC, 1971, P 2 INT C PHOT RES F, V2, P1203; KHANANSHVILI D, 1985, BIOCHEMISTRY-US, V24, P2482, DOI 10.1021/bi00331a014; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON EM, 1989, BIOCHIM BIOPHYS ACTA, V973, P75; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCARTY RE, 1996, OXYGENIC PHOTOSYNTHE, P439; NATHANSON L, 1997, THESIS WEIZMANN I SC; NATHANSON L, 1995, PHOTOSYNTHESIS LIGHT, V3, P51; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; OHTA S, 1988, BIOCHIM BIOPHYS ACTA, V933, P141, DOI 10.1016/0005-2728(88)90064-3; OMOTE H, 1995, J BIOL CHEM, V270, P25656, DOI 10.1074/jbc.270.43.25656; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PENEFSKY HS, 1991, ADV ENZYMOL RELAT AR, V64, P173; PHILOSOPH S, 1977, J BIOL CHEM, V252, P8747; PHILOSOPH S, 1981, EUR J BIOCHEM, V119, P107, DOI 10.1111/j.1432-1033.1981.tb05583.x; Richardson J., 1981, ADV PROTEIN CHEM, V34, P168; RICHTER ML, 1996, OXYGENIC PHOTOSYNTHE, P453; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAKEYAMA M, 1990, J BIOL CHEM, V265, P21279; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WEBSTER GD, 1977, FEBS LETT, V76, P29, DOI 10.1016/0014-5793(77)80114-2; WEISS S, 1994, J BIOENERG BIOMEMBR, V26, P573, DOI 10.1007/BF00762742; YOSHIDA M, 1982, J BIOL CHEM, V257, P33	55	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10933	10938		10.1074/jbc.273.18.10933	http://dx.doi.org/10.1074/jbc.273.18.10933			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556571	hybrid			2022-12-27	WOS:000073395200023
J	Zhang, SW; Chang, MCY; Zylka, D; Turley, S; Harrison, R; Turley, EA				Zhang, SW; Chang, MCY; Zylka, D; Turley, S; Harrison, R; Turley, EA			The hyaluronan receptor RHAMM regulates extracellular-regulated kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; MAP KINASE; MEDIATED MOTILITY; MESODERM INDUCTION; CELLS; EXPRESSION; MIGRATION; TRANSFORMATION; THYMOCYTES; PATHWAYS	We have identified two RHAMM (receptor for hyaluronan-mediated motility) isoforms that encode an alternatively spliced exon 4 (Hall, C. L., Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S., Lange, L. A., Wang, C., Curpen, G. D., Savani, R. C., Greenberg, A. H., and Turley, E. A. (1995) Cell 82, 19-26 and Wang, C., Entwistle, J., Hou, G., Li, Q., and Turley, E. A. (1996) Gene 174, 299-306). One of these, RHAMM variant 4 (RHAMMv4), is transforming when overexpressed and regulates Ras signaling (Hall et al.). Here we note using now cytometry and confocal analysis that RHAMM isoforms encoding exon 4 occur both on the cell surface and in the cytoplasm. Epitope-tagging experiments indicate that RHAMMv4 occurs only in the cytoplasm. Several observations suggest that both cell surface RHAMM isoforms and RHAMMv4 are involved in regulating extracellular-regulated kinase (ERK) activity. Affinity-purified anti-RHAMM exon 4 antibodies block the ability of platelet-derived growth factor to activate ERK, and these reagents modify the protein tyrosine phosphorylation profile of proteins resulting from treatment with platelet-derived growth factor. A dominant negative form of RHAMMv4 inhibits mutant active Ras activation of ERK and coimmunoprecipitates with both mitogen-activated protein kinase kinase and ERI(, suggesting that the intracellular RHAMMv4 acts downstream of Ras, possibly at the level of mitogen-activated protein kinase kinase-ERK interactions. Consistent with this, overexpression of RHAMMv4 constitutively activates ERK. These results identify a novel mechanism for the regulation of the Ras-ERK signaling pathway and suggest that RHAMM plays multiple roles in this regulation.	Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Turley, EA (corresponding author), Hosp Sick Children, Div Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	eturley@sickkids.on.ca						Abmann V., 1996, CLIN CANCER RES, V2, P1607; ANDO Y, 1993, J INVEST DERMATOL, V100, P633, DOI 10.1111/1523-1747.ep12472297; ANDREE C, 1994, P NATL ACAD SCI USA, V91, P12188, DOI 10.1073/pnas.91.25.12188; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; BOS JL, 1989, CANCER RES, V49, P4682; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; BROWN RL, 1994, J SURG RES, V56, P562, DOI 10.1006/jsre.1994.1090; ClaessonWelsh L, 1996, INT J BIOCHEM CELL B, V28, P373, DOI 10.1016/1357-2725(95)00156-5; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DUBOIS DH, 1995, ADV EXP MED BIOL, V376, P105; ENTWISTLE J, 1995, GENE, V163, P233, DOI 10.1016/0378-1119(95)00398-P; ERREDE B, 1995, MOL REPROD DEV, V42, P477, DOI 10.1002/mrd.1080420416; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hall CL, 1996, ONCOGENE, V13, P2213; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; INDOLFI C, 1995, NAT MED, V1, P541, DOI 10.1038/nm0695-541; JUTILA MA, 1994, J LEUKOCYTE BIOL, V55, P133, DOI 10.1002/jlb.55.1.133; Kannagi R, 1996, Nihon Geka Gakkai Zasshi, V97, P131; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Konkoy CS, 1996, TRENDS PHARMACOL SCI, V17, P288, DOI 10.1016/0165-6147(96)10036-5; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; MARTIN P, 1994, EYE, V8, P155, DOI 10.1038/eye.1994.39; MASSAGUE J, 1992, CANCER SURV, V12, P81; PILARSKI LM, 1994, LEUKEMIA LYMPHOMA, V14, P363, DOI 10.3109/10428199409049691; PILARSKI LM, 1993, J IMMUNOL, V150, P4292; Resta R, 1997, CELL SIGNAL, V9, P131, DOI 10.1016/S0898-6568(96)00132-5; Reszka AA, 1997, MOL BIOL CELL, V8, P1219, DOI 10.1091/mbc.8.7.1219; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; ROBBINS DJ, 1994, ADV CANCER RES, V63, P93, DOI 10.1016/S0065-230X(08)60399-1; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAMUEL SK, 1993, J CELL BIOL, V123, P749, DOI 10.1083/jcb.123.3.749; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; SAVANI RC, 1995, P W PHARMACOL SOC, V38, P131; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; SOSNOWSKI RG, 1993, J CELL BIOL, V121, P113, DOI 10.1083/jcb.121.1.113; SPICER AP, 1995, GENOMICS, V30, P115, DOI 10.1006/geno.1995.0022; STANLEY P, 1995, FASEB J, V9, P1436, DOI 10.1096/fasebj.9.14.7589985; TEDER P, 1995, CANCER RES, V55, P3908; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; VarelaNieto I, 1996, COMP BIOCHEM PHYS B, V115, P223, DOI 10.1016/0305-0491(96)00087-9; Wang C, 1996, GENE, V174, P299, DOI 10.1016/0378-1119(96)00080-7; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; WHITMAN M, 1992, NATURE, V357, P252, DOI 10.1038/357252a0; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zanke BW, 1996, J BIOL CHEM, V271, P29876, DOI 10.1074/jbc.271.47.29876	59	188	202	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11342	11348		10.1074/jbc.273.18.11342	http://dx.doi.org/10.1074/jbc.273.18.11342			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556628	hybrid			2022-12-27	WOS:000073395200080
J	Mills, JS; Miettinen, HM; Barnidge, D; Vlases, MJ; Wimer-Mackin, S; Dratz, EA; Sunner, J; Jesaitis, AJ				Mills, JS; Miettinen, HM; Barnidge, D; Vlases, MJ; Wimer-Mackin, S; Dratz, EA; Sunner, J; Jesaitis, AJ			Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SCHIFF-BASE COUNTERION; BOVINE RHODOPSIN; CHEMOATTRACTANT RECEPTOR; CHEMOTACTIC RECEPTOR; MOLECULAR-CLONING; AMINO-ACIDS; CDNA; EXPRESSION; DOMAINS	A novel fluorescent photoaffinity cross-linking probe, formyl-Met-p-benzoyl-L-phenylalanine-Phe-Tyr-Lys-epsilon-N-fluorescein (fMBpaFYK-fl), was synthesized and used to identify binding site residues in recombinant human phagocyte chemoattractant formyl peptide receptor (FPR), After photoactivation, fluorescein-labeled membranes from Chinese hamster ovary cells were solubilized in octylglucoside and separated by tandem anion exchange and gel filtration chromatography, A single peak of fluorescence was observed in extracts of FPR-expressing cells that was absent in extracts from wild type controls. Photolabeled Chinese hamster ovary membranes were cleaved with CNBr, and the fluorescent fragments were isolated on an antifluorescein immunoaffinity matrix. Matrix-assisted laser desorption ionization mass spectrometry identified a major species with mass = 1754, consistent with the CNBr fragment of fMBpaFYK-fl cross-linked to Val-Arg-Lys-Ala-Hse (an expected CNBr fragment of FPR, residues 83-87), This peptide was further cleaved with trypsin, repurified by antifluorescein immunoaffinity, and subjected to matrix-assisted laser desorption ionization mass spectrometry, A tryptic fragment with mass = 1582 was observed, which is the mass of fMBpaFYK-fl cross-linked to Val-Arg-Lys (FPR residues 83-85), an expected trypsin cleavage product of Val-Arg-Lys-Ala-Hse. Residues 83-85 lie within the putative second transmembrane-spanning region of FPR near the extracellular surface, A 3D model of FPR is presented, which accounts for intramembrane, site-directed mutagenesis results (Miettinen, H. M., Mills, J., Gripentrog, J., Dratz, E. A., Granger, B. L., and Jesaitis, A. J. (1997) J. Immunol. 159, 4045-4054) and the photochemical cross-linking data.	Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Mills, JS (corresponding author), Montana State Univ, Dept Microbiol, 109 Lewis Hall, Bozeman, MT 59717 USA.	umbmj@gemini.oscs.montana.edu		Jesaitis, Algirdas/0000-0001-9001-5617	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NCRR NIH HHS [2P41RR06009] Funding Source: Medline; PHS HHS [R0122735, 1RO1A40108-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLEN RA, 1986, BIOCHIM BIOPHYS ACTA, V882, P271, DOI 10.1016/0304-4165(86)90248-5; Alvarez V, 1996, IMMUNOGENETICS, V44, P446, DOI 10.1007/BF02602806; Ames RS, 1996, J BIOL CHEM, V271, P20231, DOI 10.1074/jbc.271.34.20231; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BOHM M, 1993, HYPERTENSION, V22, P715, DOI 10.1161/01.HYP.22.5.715; BOULAY F, 1991, BIOCHEMISTRY-US, V30, P2993, DOI 10.1021/bi00226a002; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; FREER RJ, 1982, BIOCHEMISTRY-US, V21, P257, DOI 10.1021/bi00531a009; FREER RJ, 1980, BIOCHEMISTRY-US, V19, P2404, DOI 10.1021/bi00552a019; GAO JL, 1993, J BIOL CHEM, V268, P25395; GOLLOGLY JR, 1974, J IMMUNOL, V113, P1457; HAN M, 1995, BIOCHEMISTRY-US, V34, P1425, DOI 10.1021/bi00004a037; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Herzyk P, 1995, BIOPHYS J, V69, P2419, DOI 10.1016/S0006-3495(95)80112-8; HUANG RRC, 1994, BIOCHEMISTRY-US, V33, P3007, DOI 10.1021/bi00176a033; HUANG RRC, 1995, BIOCHEMISTRY-US, V34, P10048, DOI 10.1021/bi00031a029; JI IH, 1993, J BIOL CHEM, V268, P22971; KURTENBACH E, 1990, J BIOL CHEM, V265, P13702; LEE J, 1992, J BIOL CHEM, V267, P16283; MARASCO WA, 1983, AM J PATHOL, V111, P273; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Miettinen HM, 1997, J IMMUNOL, V159, P4045; MURPHY PM, 1990, FEBS LETT, V261, P353, DOI 10.1016/0014-5793(90)80590-F; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; NAKANISHI S, 1996, BIOPHYS CHEM, V56, P13; NAKAYAMA TA, 1990, J BIOL CHEM, V265, P15762; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NIEDEL J, 1980, J BIOL CHEM, V255, P7063; Porter JE, 1996, J BIOL CHEM, V271, P28318, DOI 10.1074/jbc.271.45.28318; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sautel M, 1996, MOL PHARMACOL, V50, P285; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; SHAWAR SM, 1995, BIOCHEM BIOPH RES CO, V211, P812, DOI 10.1006/bbrc.1995.1884; SHOWELL HJ, 1976, J EXP MED, V143, P1154, DOI 10.1084/jem.143.5.1154; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; SKLAR LA, 1990, BIOCHEMISTRY-US, V29, P313, DOI 10.1021/bi00454a002; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; THOMAS KM, 1991, J BIOL CHEM, V266, P14839; WANG JK, 1980, BIOCHEMISTRY-US, V19, P5111, DOI 10.1021/bi00563a027; WEITZ CJ, 1993, BIOCHEMISTRY-US, V32, P14176, DOI 10.1021/bi00214a016; WONG SKF, 1988, J BIOL CHEM, V263, P7925; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; YE RD, 1993, J IMMUNOL, V150, P1383; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154; ZHUKOVSKY EA, 1992, BIOCHEMISTRY-US, V31, P10400, DOI 10.1021/bi00157a030	53	63	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10428	10435		10.1074/jbc.273.17.10428	http://dx.doi.org/10.1074/jbc.273.17.10428			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553101	hybrid			2022-12-27	WOS:000073224200050
J	Rhoads, DB; Rosenbaum, DH; Unsal, H; Isselbacher, KJ; Levitsky, LL				Rhoads, DB; Rosenbaum, DH; Unsal, H; Isselbacher, KJ; Levitsky, LL			Circadian periodicity of intestinal Na+/glucose cotransporter 1 mRNA levels is transcriptionally regulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE GENE; CRYPT-VILLUS AXIS; FRUCTOSE TRANSPORTER GLUT5; RAT SMALL-INTESTINE; GLUCOSE TRANSPORTERS; MESSENGER-RNA; FUNCTIONAL-CHARACTERIZATION; TISSUE DISTRIBUTION; EXPRESSION; LIVER	Intestinal expression of the high affinity Na+/glucose cotransporter 1 (SGLT1), which absorbs dietary glucose and galactose, exhibits both circadian periodicity in its activity and induction by dietary carbohydrate. Because the daily variation in SGLT1 activity is established by the feeding schedule (whether ad libitum or imposed) and persists in the absence of food, this variation has been described as anticipatory. To delineate the mechanisms regulating SGLT1, its expression was examined in rats maintained in a 12-h photoperiod with free access to chow. SGLT1 mRNA levels varied significantly, with the maximum abundance occurring near the onset of dark. and the minimum near the onset of light. The SGLT1 transcription rate was 7-fold higher in the morning (1000-1100 h) than in the afternoon (1600-1700 h). An element for hepatocyte nuclear factor 1 (HNF-1) was identified in the SGLT1 promoter that formed different complexes with small intestinal nuclear extracts, depending on the time when the source animal was killed. Serological tests indicated that HNF-1 alpha was present in complexes throughout the day, while HNF-1 beta binding exhibited circadian periodicity. We propose that exchange of HNF-1 dimerization partners contributes to circadian changes in SGLT1 transcription, Because SGLT1 mRNA levels also varied in rhesus monkeys (offset by approximately one-half day from rats), a similar mechanism appears to be present in primates.	Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc, Lab Tumor Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rhoads, DB (corresponding author), Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, R37DK001392, R01DK001392] Funding Source: NIH RePORTER; NICHD NIH HHS [HD31215] Funding Source: Medline; NIDDK NIH HHS [DK01392, 5P30 DK40561] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHN YH, 1995, ARCH BIOCHEM BIOPHYS, V323, P387, DOI 10.1006/abbi.1995.0059; BERNARDS R, 1991, EMBO J, V10, P1119, DOI 10.1002/j.1460-2075.1991.tb08052.x; BURANT CF, 1994, J CLIN INVEST, V93, P578, DOI 10.1172/JCI117010; CATHALA G, 1993, DNA CELL BIOL, V2, P329; Corpe CP, 1996, AM J PHYSIOL-GASTR L, V271, pG211, DOI 10.1152/ajpgi.1996.271.1.G211; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; CRANE RK, 1961, MEMBRANE TRANSPORT M, P439; DAVIDSON NO, 1992, AM J PHYSIOL, V262, pC795, DOI 10.1152/ajpcell.1992.262.3.C795; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1069, DOI 10.1152/ajpgi.1992.262.6.G1069; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1060, DOI 10.1152/ajpgi.1992.262.6.G1060; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1047, DOI 10.1152/ajpgi.1992.262.6.G1047; FERRARIS RP, 1993, P NATL ACAD SCI USA, V90, P5868, DOI 10.1073/pnas.90.12.5868; FISHER RB, 1976, J PHYSIOL-LONDON, V254, P821, DOI 10.1113/jphysiol.1976.sp011262; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GHOSH D, 1990, NUCLEIC ACIDS RES, V18, P1749, DOI 10.1093/nar/18.7.1749; GREENBERG ME, 1990, CURRENT PROTOCOLS MO; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; HIRAYAMA BA, 1991, AM J PHYSIOL, V261, pC296, DOI 10.1152/ajpcell.1991.261.2.C296; KARASOV WH, 1987, PHYSL GASTROINTESTIN, V2, P1489; KAYANO T, 1990, J BIOL CHEM, V265, P13276; LEE WS, 1994, J BIOL CHEM, V269, P12032; LEE YH, 1994, J BIOL CHEM, V269, P14681; MAHRAOUI L, 1994, BIOCHEM J, V301, P169, DOI 10.1042/bj3010169; MENDEL DB, 1991, J BIOL CHEM, V266, P677; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; MIYAMOTO K, 1993, BIOCHEM J, V295, P211, DOI 10.1042/bj2950211; OGIER H, 1987, EUR J BIOCHEM, V166, P365, DOI 10.1111/j.1432-1033.1987.tb13524.x; RAND EB, 1993, AM J PHYSIOL, V264, pG1169, DOI 10.1152/ajpgi.1993.264.6.G1169; SAITO M, 1976, J BIOCHEM-TOKYO, V80, P563, DOI 10.1093/oxfordjournals.jbchem.a131312; SAITO M, 1978, AM J PHYSIOL, V234, pE500, DOI 10.1152/ajpendo.1978.234.5.E500; SIEGEL PS, 1961, J COMP PHYSIOL PSYCH, V54, P294, DOI 10.1037/h0044787; STEVENSON NR, 1976, AM J PHYSIOL, V230, P731, DOI 10.1152/ajplegacy.1976.230.3.731; STEVENSON NR, 1975, BIOCHIM BIOPHYS ACTA, V406, P131, DOI 10.1016/0005-2736(75)90048-6; THOMPSON KS, 1991, J BIOL CHEM, V266, P8679; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; THORENS B, 1990, AM J PHYSIOL, V259, pC286; THORENS B, 1990, DIABETES, V39, P712, DOI 10.2337/diabetes.39.6.712; TRABER PG, 1990, BIOCHEM BIOPH RES CO, V173, P765, DOI 10.1016/S0006-291X(05)80853-8; TURK E, 1994, J BIOL CHEM, V269, P15204; VAULONT S, 1989, J MOL BIOL, V209, P205, DOI 10.1016/0022-2836(89)90273-8; WEISER MM, 1973, J BIOL CHEM, V248, P2536; WU GD, 1994, J BIOL CHEM, V269, P17080; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	48	98	100	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9510	9516		10.1074/jbc.273.16.9510	http://dx.doi.org/10.1074/jbc.273.16.9510			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545279	hybrid			2022-12-27	WOS:000073128800025
J	Watanabe, R; Wu, K; Paul, P; Marks, DL; Kobayashi, T; Pittelkow, MR; Pagano, RE				Watanabe, R; Wu, K; Paul, P; Marks, DL; Kobayashi, T; Pittelkow, MR; Pagano, RE			Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; SERUM-FREE MEDIUM; CERAMIDE GLUCOSYLTRANSFERASE; PERMEABILITY BARRIER; MEMBRANE; IDENTIFICATION; FIBROBLASTS; EPIDERMIS; INDUCTION; APPARATUS	During keratinocyte differentiation, the glycolipid, glucosylceramide (GlcCer), is thought to be synthesized, stored in intracellular lamellar granules and eventually extruded into the intercellular space where GlcCer is hydrolyzed to ceramide, a major component of the epidermal permeability barrier. Previous studies showed that GlcCer synthase (GCS) activity increases during keratinocyte differentiation; however, the mechanism by which GCS activity is regulated was not established. In the present study, we prepared anti-peptide antibodies and amplified cDNA probes based on the cDNA sequence for human GCS (Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K. I.-P. J., and Hirabayashi, Y. (1996) Proc. Natl. Acad. Sci, U. S. A. 93, 4638-4643) in order to study GCS expression during keratinocyte differentiation. Confluent human keratinocytes in culture were induced to terminally differentiate by elevation of Ca+2 in the medium without exogenous hormones or growth factors. GlcCer synthesis assayed in situ using a fluorescent ceramide analog increased similar to 5-fold during keratinocyte differentiation, peaking at day 6. Fluorescence microscopy studies of living keratinocytes showed that fluorescent ceramide and/or its metabolites accumulated in the Golgi in undifferentiated cells but targeted to unique vesicular structures that may be derived from the trans-Golgi region. Expression of both GCS mRNA, a similar to 3.8-kilobase transcript on Northern blots, and GCS protein, a similar to 38-kDa polypeptide detected by Western blotting, increased dramatically (similar to 5-fold) during differentiation, reaching a maximum at about day 8. These results suggest that GCS is up-regulated at the transcriptional level during keratinocyte differentiation and provide the first direct evidence for GCS up-regulation in any cell type.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Dermatol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Pagano, RE (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Guggenheim 621-C,200 1st St,SW, Rochester, MN 55905 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022942] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM22942] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYCE ST, 1985, IN VITRO MODELS CANC, P245; Chen CS, 1997, BIOPHYS J, V72, P37, DOI 10.1016/S0006-3495(97)78645-4; DOWNING DT, 1992, J LIPID RES, V33, P301; ELIAS PM, 1998, IN PRESS J INVEST DE; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Hanley K, 1997, J LIPID RES, V38, P576; Harlow E., 1988, ANTIBODIES LAB MANUA, P447; HOLLERAN WM, 1994, J CLIN INVEST, V93, P1756, DOI 10.1172/JCI117160; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; INOKUCHI JI, 1987, J LIPID RES, V28, P565; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; LADINSKY MS, 1994, J CELL BIOL, V127, P29, DOI 10.1083/jcb.127.1.29; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PAGANO RE, 1989, J CELL BIOL, V113, P1276; PAGANO RE, 1997, CELL BIOL LAB HDB, P505; PILLAI S, 1988, J CELL PHYSIOL, V134, P229, DOI 10.1002/jcp.1041340208; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; ROOP DR, 1988, CANCER RES, V48, P3245; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; Sando GN, 1996, J BIOL CHEM, V271, P22044, DOI 10.1074/jbc.271.36.22044; SCHWAB M, 1983, NATURE, V303, P497, DOI 10.1038/303497a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; vanRuissen F, 1996, J CELL PHYSIOL, V168, P442; WILLE JJ, 1984, J CELL PHYSIOL, V121, P31, DOI 10.1002/jcp.1041210106	29	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9651	9655		10.1074/jbc.273.16.9651	http://dx.doi.org/10.1074/jbc.273.16.9651			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545298	hybrid			2022-12-27	WOS:000073128800044
J	Foltz, IN; Gerl, RE; Wieler, JS; Luckach, M; Salmon, RA; Schrader, JW				Foltz, IN; Gerl, RE; Wieler, JS; Luckach, M; Salmon, RA; Schrader, JW			Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; CD40; JNK; DROSOPHILA; CELLS; PHOSPHORYLATION; COSTIMULATION; MORPHOGENESIS; CYTOKINES; TYROSINE	We report the cloning of a novel human activator of c-Jun N-terminal kinase (JNK), mitogen-activated protein kinase kinase 7 (MKK7). The mRNA for MKK7 is widely expressed in humans and mice and encodes a 47-kDa protein (419 amino acids), as determined by immunoblotting endogenous MKK7 with an antibody raised against its N terminus. The kinase domain of MKK7 is closely related to a Drosophila JNK kinase dHep (69% identity) and to a newly identified ortholog from Caenorhabditis elegans (54% identity), and was more distantly related to MKK4, MKK3, and MKK6. MKK7 phosphorylated and activated JNK1 but failed to activate p38 MAPK in co-expression studies. In hemato poietic cells, endogenous MKK7 was activated by treatment with the growth factor interleukin-3 (but not interleukin-4), or by ligation of CD40, the B-cell antigen receptor, or the receptor for the Fc fragment of immunoglobulin. MKK7 was also activated when cells were exposed to heat, UV irradiation, anisomycin, hyperosmolarity or the pro-inflammatory cytokine tumor necrosis factor-alpha. Go-expression of constitutively active mutants of RAS, RAG, or CDC42 in HeLa epithelial cells or of RAC or CDC42 in Ba/F3 factor-dependent hematopoietic cells also activated MKK7, suggesting that MKK7 will be involved in many physiological pathways.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Schrader, JW (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.							BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; Cobb MH, 1991, CURR OPIN CELL BIOL, V3, P1025, DOI 10.1016/0955-0674(91)90124-H; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DURONIO V, 1992, P NATL ACAD SCI USA, V89, P1587, DOI 10.1073/pnas.89.5.1587; Foltz IN, 1997, BLOOD, V89, P3092, DOI 10.1182/blood.V89.9.3092; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Ishizuka T, 1997, P NATL ACAD SCI USA, V94, P6358, DOI 10.1073/pnas.94.12.6358; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lawler S, 1997, FEBS LETT, V414, P153, DOI 10.1016/S0014-5793(97)00990-3; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Meier R, 1996, EUR J BIOCHEM, V236, P796, DOI 10.1111/j.1432-1033.1996.00796.x; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MORIGUCHI T, 1995, J BIOL CHEM, V270, P12969, DOI 10.1074/jbc.270.22.12969; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Nagata Y, 1997, BLOOD, V89, P2664, DOI 10.1182/blood.V89.8.2664; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rausch O, 1997, MOL CELL BIOL, V17, P1170, DOI 10.1128/MCB.17.3.1170; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Rose DM, 1997, J IMMUNOL, V158, P3433; Salmon RA, 1997, J IMMUNOL, V159, P5309; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Sutherland CL, 1996, J IMMUNOL, V157, P3381; Takai T, 1996, Int Rev Immunol, V13, P369, DOI 10.3109/08830189609061759; Terada K, 1997, J BIOL CHEM, V272, P4544, DOI 10.1074/jbc.272.7.4544; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Toyoshima F, 1997, J CELL BIOL, V139, P1005, DOI 10.1083/jcb.139.4.1005; VALMORI D, 1992, J IMMUNOL, V149, P717; WELHAM MJ, 1992, J IMMUNOL, V149, P1683; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Winston BW, 1997, J IMMUNOL, V159, P4491; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378	50	82	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9344	9351		10.1074/jbc.273.15.9344	http://dx.doi.org/10.1074/jbc.273.15.9344			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535930	hybrid			2022-12-27	WOS:000072990800107
J	Inohara, N; Ekhterae, D; Garcia, I; Carrio, R; Merino, J; Merry, A; Chen, S; Nunez, G				Inohara, N; Ekhterae, D; Garcia, I; Carrio, R; Merino, J; Merry, A; Chen, S; Nunez, G			Mtd, a novel Bcl-2 family member activates apoptosis in the absence of heterodimerization with Bcl-2 and Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; E1B 19K; MURINE DEVELOPMENT; PROTEIN; BCL-X(L); BAX; HOMOLOG; INHIBITION; INDUCTION; INTERACTS	We have identified and characterized Mtd, a novel regulator of apoptosis. Sequence analysis revealed that Mtd is a member of the Bcl-2 family of proteins containing conserved BH1, BH2, BH3, and BH4 regions and a carboxyl-terminal hydrophobic domain. In adult tissues, Mtd mRNA was predominantly detected in the brain, liver, and lymphoid tissues, while in the embryo Mtd mRNA was detected in the liver, thymus, lung, and intestinal epithelium. Expression of Mtd promoted the death of primary sensory neurons, 293T cells and HeLa cells, indicating that Mtd is a proapoptotic protein. Unlike all other known death agonists of the Bcl-2 family, Mtd did not bind significantly to the survival-promoting proteins Bcl-2 or Bcl-X-L. Furthermore, apoptosis induced by Mtd was not inhibited by Bcl-2 or Bcl-X-L. A Mtd mutant with glutamine substitutions of highly conserved amino acids in the BH3 domain retained its ability to promote apoptosis, further indicating that Mtd does not promote apoptosis by heterodimerizing with Bcl-2 or Bcl-X-L. Mtd-induced apoptosis was not blocked by broad range synthetic caspase inhibitors z-VAD-fmk or a viral protein CrmA. Mtd is the first example of a naturally occurring Bcl-2 family member that can activate apoptosis independently of heterodimerization with survival-promoting Bcl-2 and Bcl-X-L.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Ctr Med Univ Geneva, Dept Pathol, CH-1211 Geneva, Switzerland; Univ Cantabria, Dept Biol Mol, Unidad Immunol, Santander 39011, Spain	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Geneva; Universidad de Cantabria	Inohara, N (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.		Nuñez, Gabriel/A-7160-2014	Carrio, Roberto/0000-0001-5527-8403	NATIONAL CANCER INSTITUTE [R01CA064556] Funding Source: NIH RePORTER; NCI NIH HHS [CA-64556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; BOYD JM, 1995, ONCOGENE, V11, P1921; Carrio R, 1996, AM J PATHOL, V149, P2133; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; CHINNAIYAN AM, 1997, SCIENCE, V275, P1123; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Han J, 1996, MOL CELL BIOL, V16, P5857; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NOVACK DV, 1994, AM J PATHOL, V145, P61; NUNEZ G, 1990, J IMMUNOL, V144, P2602; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Simonian PL, 1996, J BIOL CHEM, V271, P22764, DOI 10.1074/jbc.271.37.22764; Simonian PL, 1997, ONCOGENE, V15, P1871, DOI 10.1038/sj.onc.1201350; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; Wu DY, 1997, SCIENCE, V275, P1126, DOI 10.1126/science.275.5303.1126; Wu DY, 1997, J BIOL CHEM, V272, P21449, DOI 10.1074/jbc.272.34.21449; XIANG J, 1997, P NATL ACAD SCI USA, V93, P14559; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440	40	107	118	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8705	8710		10.1074/jbc.273.15.8705	http://dx.doi.org/10.1074/jbc.273.15.8705			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535847	hybrid			2022-12-27	WOS:000072990800024
J	Missiaen, L; Parys, JB; Sienaert, I; Maes, K; Kunzelmann, K; Takahashi, M; Tanzawa, K; De Smedt, H				Missiaen, L; Parys, JB; Sienaert, I; Maes, K; Kunzelmann, K; Takahashi, M; Tanzawa, K; De Smedt, H			Functional properties of the type-3 InsP(3) receptor in 16HBE14o - Bronchial mucosal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; SMOOTH-MUSCLE CELLS; CALCIUM RELEASE; ADENINE-NUCLEOTIDES; CA2+ RELEASE; TRISPHOSPHATE; REAGENTS; THIMEROSAL; CHANNELS; INCREASE	The type-3 inositol 1,4,5-trisphosphate (InsP(3)) receptor is the major isoform expressed in 16HBE14o-cells from bronchial mucosa, representing 93% at the mRNA level as determined by ratio reverse transcription-polymerase chain reaction and about 81% at the protein level as determined with isoform-specific antibodies (Sienaert, I., Huyghe, S., Parys, J. B., Malfait, M., Kunzelmann, a, De Smedt, H., Verleden, G, M., and Missiaen, L., Pflugers Arch. fur. Y. Physiol, in press). The present Ca-45(2+) efflux experiments indicate that these InsP, receptors were 3 times less sensitive to InsP, and 11 times less sensitive to ATP than those in A7r5 cells, where the type-1 InsP(3) receptor is the main isoform. ATP did not increase the cooperativity of the InsP(3)-induced Ca2+ release in 16HBE14o-cells, in contrast to its effect in A7r5 cells. The sulfhydryl reagent thimerosal also did not stimulate InsP(3)-induced Ca2+ release in 16HBE14o-cells, again in contrast to its effect in A7r5 cells. Adenophostin A was more potent than InsP(3) in stimulating the release in both cell types, The biphasic activation of the InsP, receptor by cytosolic Ca2+ occurred in both cell types. We conclude that Ca2+ release mediated by the type-3 InsP, receptor mainly differs from that mediated by the type-1 InsP(3) receptor by its lack of stimulation by sulfhydryl oxidation and its lower ATP and InsP(3) sensitivity. The predominant expression of the type-3 InsP(3) receptor in the bronchial mucosa may be part of a mechanism coping with oxidative stress in that tissue.	Catholic Univ Louvain, Fysiol Lab, B-3000 Louvain, Belgium; Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Sankyo Co Ltd, Biol Res Labs, Shinagawa Ku, Tokyo 140, Japan	Universite Catholique Louvain; University of Freiburg; Daiichi Sankyo Company Limited	Missiaen, L (corresponding author), Catholic Univ Louvain, Fysiol Lab, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	Ludwig.Missiaen@med.kuleuven.ac.be		Parys, Jan/0000-0002-3591-4967; Kunzelmann, Karl/0000-0002-4583-7037				ANGER M, 1993, FEBS LETT, V334, P45, DOI 10.1016/0014-5793(93)81677-R; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BIRD GS, 1993, J BIOL CHEM, V268, P17917; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; Cardy TJA, 1997, J PHYSIOL-LONDON, V499P, pP2; DESMEDT H, 1994, J BIOL CHEM, V269, P21691; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Grover AK, 1997, AM J PHYSIOL-CELL PH, V273, pC420, DOI 10.1152/ajpcell.1997.273.2.C420; HILLY M, 1993, J BIOL CHEM, V268, P16488; HIROTA J, 1995, FEBS LETT, V368, P248, DOI 10.1016/0014-5793(95)00659-W; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; JOSEPH SK, 1995, J BIOL CHEM, V270, P3588, DOI 10.1074/jbc.270.8.3588; KAPLIN AI, 1994, J BIOL CHEM, V269, P28972; Missiaen L, 1997, BIOCHEM J, V325, P661, DOI 10.1042/bj3250661; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; Missiaen L, 1998, BIOCHEM J, V329, P489, DOI 10.1042/bj3290489; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; PARYS JB, 1992, J BIOL CHEM, V267, P18776; PARYS JB, 1993, PFLUG ARCH EUR J PHY, V424, P516, DOI 10.1007/BF00374916; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; TAKAHASHI M, 1994, J BIOL CHEM, V269, P369; WILLCOCKS AL, 1987, BIOCHEM BIOPH RES CO, V146, P1071, DOI 10.1016/0006-291X(87)90756-X; Yoneshima H, 1997, BIOCHEM J, V322, P591, DOI 10.1042/bj3220591	30	79	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8983	8986		10.1074/jbc.273.15.8983	http://dx.doi.org/10.1074/jbc.273.15.8983			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535884	hybrid			2022-12-27	WOS:000072990800061
J	Storbeck, CJ; Sabourin, LA; Waring, JD; Korneluk, RG				Storbeck, CJ; Sabourin, LA; Waring, JD; Korneluk, RG			Definition of regulatory sequence elements in the promoter region and the first intron of the myotonic dystrophy protein kinase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLET REPEAT EXPANSION; MESSENGER-RNA; EXPRESSION; TRANSCRIPTION; MUSCLE; MYOD; ENHANCER; BETA; SKELETAL; CELLS	Myotonic dystrophy is the most common inherited adult neuromuscular disorder with a global frequency of 1/8000. The genetic defect is an expanding CTG trinucleotide repeat in the 3'-untranslated region of the myotonic dystrophy protein kinase gene. We present the in vitro characterization of vis regulatory elements controlling transcription of the myotonic dystrophy protein kinase gene in myoblasts and fibroblasts. The region 5' to the initiating ATG contains no consensus TATA or CCAAT box. We have mapped two transcriptional start sites by primer extension. Deletion constructs from this region fused to the bacterial chloramphenicol acetyltransferase reporter gene revealed only subtle muscle specific cis elements. The strongest promoter activity mapped to a 189-base pair fragment. This sequence contains a conserved GC box to which the transcription factor Sp1 binds. Reporter gene constructs containing a 2-kilobase pair first intron fragment of the myotonic dystrophy protein kinase gene enhances reporter activity up to g-fold in the human rhabdomyosarcoma myoblast cell line TE32 but not in NIH 3T3 fibroblasts. Cotransfection of a MyoD expression vector with reporter constructs containing the first intron into 10 T1/2 fibroblasts resulted in a 10-20-fold enhancement of expression. Deletion analysis of four E-box elements within the first intron reveal that these elements contribute to enhancer activity similarly in TE32 myoblasts and 10 T1/2 fibroblasts. These data suggest that E-boxes within the myotonic dystrophy protein kinase first intron mediate interactions with upstream promoter elements to upregulate transcription of this gene in myoblasts.	Univ Ottawa, Dept Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; Childrens Hosp Eastern Ontario, Solange Gauthier Karsh Mol Genet Lab, Ottawa, ON K1H 8L1, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario	Korneluk, RG (corresponding author), Univ Ottawa, Dept Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.							Bhagwati S, 1996, BBA-MOL BASIS DIS, V1317, P155, DOI 10.1016/S0925-4439(96)00057-9; BIRNBOIM HC, 1988, NUCLEIC ACIDS RES, V16, P1487, DOI 10.1093/nar/16.4.1487; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; CHRISTENSEN TH, 1993, MOL CELL BIOL, V13, P6752, DOI 10.1128/MCB.13.11.6752; Clegg CH, 1996, J BIOL CHEM, V271, P1638, DOI 10.1074/jbc.271.3.1638; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dunne PW, 1996, CELL MOTIL CYTOSKEL, V33, P52; Dunne PW, 1996, BIOCHEM BIOPH RES CO, V225, P281, DOI 10.1006/bbrc.1996.1167; ERNST H, 1991, MOL CELL BIOL, V11, P3735, DOI 10.1128/MCB.11.7.3735; FARRELL RE, 1993, RNA METHODOLOGIES LA, P158; FENG ZM, 1995, ENDOCRINOLOGY, V136, P947, DOI 10.1210/en.136.3.947; FEO S, 1995, MOL CELL BIOL, V15, P5991; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GUDAS JM, 1992, GENE, V118, P205, DOI 10.1016/0378-1119(92)90190-Z; Harper P.S., 1989, MYOTONIC DYSTROPHY; HERRICK KR, 1993, GENE, V126, P203, DOI 10.1016/0378-1119(93)90368-D; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; HOPPESEYLER F, 1991, NUCLEIC ACIDS RES, V19, P5080, DOI 10.1093/nar/19.18.5080; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; ITOH F, 1992, ONCOGENE, V7, P1201; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; King Stephanie K., 1996, Biochemical Society Transactions, V24, p283S; KOGA R, 1994, BIOCHEM BIOPH RES CO, V202, P577, DOI 10.1006/bbrc.1994.1967; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; LANS MS, 1994, J BIOL CHEM, V269, P14170; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MUSCAT GEO, 1994, NUCLEIC ACIDS RES, V22, P583, DOI 10.1093/nar/22.4.583; NOVELLI G, 1993, BIOCHEM MOL BIOL INT, V29, P291; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; PENN RB, 1994, J BIOL CHEM, V269, P14924; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; UCHIDA T, 1994, J BIOCHEM-TOKYO, V116, P508, DOI 10.1093/oxfordjournals.jbchem.a124554; VOSS H, 1991, J BIOL CHEM, V266, P13706; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; Wang SP, 1996, GENOMICS, V33, P99, DOI 10.1006/geno.1996.0164; YUTZEY KE, 1989, MOL CELL BIOL, V9, P1397, DOI 10.1128/MCB.9.4.1397; ZIEGLER SF, 1991, ONCOGENE, V6, P283	58	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9139	9147		10.1074/jbc.273.15.9139	http://dx.doi.org/10.1074/jbc.273.15.9139			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535904	hybrid			2022-12-27	WOS:000072990800081
J	Askjaer, P; Kjems, J				Askjaer, P; Kjems, J			Mapping of multiple RNA binding sites of human T-cell lymphotropic virus type I Rex protein within 5 '- and 3 '-Rex response elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; LEUKEMIA-VIRUS; GENE-EXPRESSION; REGULATORY PROTEINS; HTLV-I; SECONDARY STRUCTURE; ACTIVATION DOMAIN; MESSENGER-RNA; VIRAL-RNA; IDENTIFICATION	Interaction between the human T-cell lymphotropic virus type I Rex protein and viral transcripts in the nucleus is essential to the cytoplasmic appearance of unspliced and singly spliced viral RNA. Rex has been shown to mediate its function through direct interaction with a highly ordered secondary structure in the 3'-untranslated region of all human T-cell lymphotropic virus type I mRNAs termed the Rex response element (3'-RxRE). Part of the 3'-RxRE sequence is also present in the 5'-end of viral transcripts (5'-RxRE), and we demonstrate that Rex binds to this RNA with essentially the same affinity and specificity as to the 3'-RxRE. We have analyzed the secondary structures and binding sites of Rex within the 5'- and 5'-RxREs by enzymatic probing and chemical modification interference and show that multiple Rex molecules bind within a stem-loop, which is similarly structured in the two RxREs. Our experiments confirm the presence of a previously characterized Rex binding site but also identify a common motif within an extended region that comprises an additional Rex binding site. This suggests that Rex oligomerizes on the RxREs similarly to what has been observed for binding of the human immunodeficiency virus type 1 Rev protein to the Rev response element.	Univ Aarhus, Dept Biol Mol & Struct, DK-8000 Aarhus C, Denmark	Aarhus University	Kjems, J (corresponding author), Univ Aarhus, Dept Biol Mol & Struct, CF Mollers Alle,Bldg 130, DK-8000 Aarhus C, Denmark.	Kjems@biobase.dk	Kjems, Jorgen/I-3490-2016; Askjaer, Peter/I-3316-2012	Kjems, Jorgen/0000-0003-4128-9317; Askjaer, Peter/0000-0003-3192-4428				AHMED YF, 1990, GENE DEV, V4, P1014, DOI 10.1101/gad.4.6.1014; Bakker A, 1996, J VIROL, V70, P5511, DOI 10.1128/JVI.70.8.5511-5518.1996; BALLAUN C, 1991, J VIROL, V65, P4408, DOI 10.1128/JVI.65.8.4408-4413.1991; BASKERVILLE S, 1995, J VIROL, V69, P7559, DOI 10.1128/JVI.69.12.7559-7569.1995; BLACK AC, 1991, J VIROL, V65, P6645, DOI 10.1128/JVI.65.12.6645-6653.1991; BOGERD H, 1993, J VIROL, V67, P2496, DOI 10.1128/JVI.67.5.2496-2502.1993; BOGERD HP, 1992, J VIROL, V66, P7572, DOI 10.1128/JVI.66.12.7572-7575.1992; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; BOGERD HP, 1991, P NATL ACAD SCI USA, V88, P5704, DOI 10.1073/pnas.88.13.5704; Cann A.J., 1996, FIELDS VIROLOGY, P1849; COCHRANE AW, 1989, VIROLOGY, V173, P335, DOI 10.1016/0042-6822(89)90252-3; CULLEN BR, 1992, MICROBIOL REV, V56, P375, DOI 10.1128/MMBR.56.3.375-394.1992; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fridell RA, 1996, P NATL ACAD SCI USA, V93, P4421, DOI 10.1073/pnas.93.9.4421; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; GRASSMANN R, 1991, J VIROL, V65, P3721, DOI 10.1128/JVI.65.7.3721-3727.1991; GRONE M, 1994, VIROLOGY, V204, P144, DOI 10.1006/viro.1994.1518; Grone M, 1996, VIROLOGY, V218, P316, DOI 10.1006/viro.1996.0200; HANLY SM, 1989, GENE DEV, V3, P1534, DOI 10.1101/gad.3.10.1534; HIDAKA M, 1988, EMBO J, V7, P519, DOI 10.1002/j.1460-2075.1988.tb02840.x; HOPE TJ, 1991, J VIROL, V65, P6001, DOI 10.1128/JVI.65.11.6001-6007.1991; INOUE J, 1987, P NATL ACAD SCI USA, V84, P3653, DOI 10.1073/pnas.84.11.3653; INOUE JI, 1986, FEBS LETT, V209, P187, DOI 10.1016/0014-5793(86)81108-5; JAMISON SF, 1992, MOL CELL BIOL, V12, P4279, DOI 10.1128/MCB.12.10.4279; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; KIM JH, 1991, J VIROL, V65, P405, DOI 10.1128/JVI.65.1.405-414.1991; KJEMS J, 1993, J VIROL, V67, P4769, DOI 10.1128/JVI.67.8.4769-4776.1993; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; MCDONALD D, 1992, J VIROL, V66, P7232, DOI 10.1128/JVI.66.12.7232-7238.1992; OHTA M, 1988, J VIROL, V62, P4445, DOI 10.1128/JVI.62.12.4445-4451.1988; Palmeri D, 1996, J VIROL, V70, P6442, DOI 10.1128/JVI.70.9.6442-6445.1996; RIMSKY L, 1989, NATURE, V341, P453, DOI 10.1038/341453a0; SEIKI M, 1988, P NATL ACAD SCI USA, V85, P7124, DOI 10.1073/pnas.85.19.7124; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; TOYOSHIMA H, 1990, J VIROL, V64, P2825, DOI 10.1128/JVI.64.6.2825-2832.1990; UNGE T, 1991, P NATL ACAD SCI USA, V88, P7145, DOI 10.1073/pnas.88.16.7145; WEICHSELBRAUN I, 1992, J VIROL, V66, P2583, DOI 10.1128/JVI.66.4.2583-2587.1992; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; YIP MT, 1991, J VIROL, V65, P2261, DOI 10.1128/JVI.65.5.2261-2272.1991	42	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11463	11471		10.1074/jbc.273.19.11463	http://dx.doi.org/10.1074/jbc.273.19.11463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565558	hybrid			2022-12-27	WOS:000073536700012
J	Sun, QH; Paddock, C; Visentin, GP; Zukowski, MM; Muller, WA; Newman, PJ				Sun, QH; Paddock, C; Visentin, GP; Zukowski, MM; Muller, WA; Newman, PJ			Cell surface glycosaminoglycans do not serve as ligands for PECAM-1 - PECAM-1 is not a heparin-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE-1; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; IN-VIVO; TRANSENDOTHELIAL MIGRATION; CD31; INTEGRIN; MONOCYTES; DOMAINS; ALPHA(V)BETA(3)	Previous studies have suggested that PECAM-1 mediates cellular interactions via both homophilic and heterophilic adhesive mechanisms. Cell surface glycoaminoglycans have been implicated as one of the heterophilic ligands for PECAM-1. To determine whether PECAM-1 is capable of interacting directly with glycosaminoglycans, we examined the adhesive properties of multiple monovalent and multivalent forms of this adhesion molecule. We found that the binding of a bivalent PECAM-1/IgG chimeric protein or multivalent PECAM-1-containing proteoliposomes to multiple different cell lines was 1) strictly dependent upon cell surface expression of PECAM-1 and 2) unaffected by the presence of excess heparin or heparan sulfate. The extracellular domain of PECAM-1 failed to interact specifically with heparin-Sepharose, H-3-labeled heparin, or a heparin-bovine serum albumin conjugate. In addition, an amino acid sequence motif inadvertently created by the juxtaposition of PECAM-1 and IgG sequences within the hinge region of certain PECAM-1/IgG chimeric constructs was found to confer glycosaminoglycan binding properties not normally present within the extracellular domain of the native molecule. Together, these data suggest that the mechanism by which heparin is able to affect PECAM-1-dependent cell-cell adhesion is indirect and occurs via inhibition of events that occur downstream from PECAM-1 engagement.	Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53233 USA; Amgen Boulder Inc, Boulder, CO 80301 USA; Med Coll Wisconsin, Dept Cellular Biol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA; Cornell Univ, Coll Med, Dept Pathol, New York, NY 10021 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Cornell University	Newman, PJ (corresponding author), Blood Ctr SE Wisconsin Inc, Blood Res Inst, 638 N 18th St, Milwaukee, WI 53233 USA.				NHLBI NIH HHS [HL-46848, HL-40926] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040926] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; BERMAN ME, 1995, J IMMUNOL, V154, P299; Berman ME, 1996, J IMMUNOL, V156, P1515; BOGEN S, 1994, J EXP MED, V179, P1059, DOI 10.1084/jem.179.3.1059; BOGEN SA, 1992, AM J PATHOL, V141, P843; Buckley CD, 1996, J CELL SCI, V109, P437; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; DeLisser HM, 1997, AM J PATHOL, V151, P671; DELISSER HM, 1993, J BIOL CHEM, V268, P16037; GOLDBERGER A, 1994, J BIOL CHEM, V269, P17183; Gumina RJ, 1996, CIRCULATION, V94, P3327, DOI 10.1161/01.CIR.94.12.3327; Jackson DE, 1997, J BIOL CHEM, V272, P24868, DOI 10.1074/jbc.272.40.24868; Jackson DE, 1997, J BIOL CHEM, V272, P6986, DOI 10.1074/jbc.272.11.6986; Jackson Denise E., 1996, Blood, V88, p438A; LEAVESLEY DI, 1994, J IMMUNOL, V153, P4673; Levine BL, 1996, TISSUE ANTIGENS, V48, P319, DOI 10.1111/j.1399-0039.1996.tb02651.x; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; Lu TT, 1997, J BIOL CHEM, V272, P14442, DOI 10.1074/jbc.272.22.14442; Lu TT, 1996, P NATL ACAD SCI USA, V93, P11808, DOI 10.1073/pnas.93.21.11808; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; MARCUM JA, 1984, BIOCHEMISTRY-US, V23, P1737; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Masuda M, 1997, FEBS LETT, V408, P331, DOI 10.1016/S0014-5793(97)00457-2; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Matsumura T, 1997, J IMMUNOL, V158, P3408; MULLER WA, 1992, J EXP MED, V175, P1401, DOI 10.1084/jem.175.5.1401; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Murohara T, 1996, J IMMUNOL, V156, P3550; NEWMAN P J, 1987, Journal of Cell Biology, V105, p53A; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; NEWMAN PJ, 1994, PLATELET DEPENDENT V, P165; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; OHTO H, 1985, BLOOD, V66, P873; Osawa M, 1997, EUR J CELL BIOL, V72, P229; PIALI L, 1993, EUR J IMMUNOL, V23, P2464, DOI 10.1002/eji.1830231013; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; Prager E, 1996, J EXP MED, V184, P41, DOI 10.1084/jem.184.1.41; Sagawa K, 1997, J BIOL CHEM, V272, P13412, DOI 10.1074/jbc.272.20.13412; Sheibani N, 1997, MOL BIOL CELL, V8, P1329, DOI 10.1091/mbc.8.7.1329; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; TANAKA Y, 1992, J EXP MED, V176, P245, DOI 10.1084/jem.176.1.245; THIAGARAJAN P, 1985, J CLIN INVEST, V75, P896, DOI 10.1172/JCI111789; VANMOURIK JA, 1985, J BIOL CHEM, V260, P1300; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Varon D, 1998, BLOOD, V91, P500, DOI 10.1182/blood.V91.2.500.500_500_507; Wakelin MW, 1996, J EXP MED, V184, P229, DOI 10.1084/jem.184.1.229; WATT SM, 1993, BLOOD, V82, P2649; YAN HC, 1995, CELL ADHES COMMUN, V3, P45, DOI 10.3109/15419069509081277; Zocchi MR, 1996, EUR J IMMUNOL, V26, P759, DOI 10.1002/eji.1830260406	51	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11483	11490		10.1074/jbc.273.19.11483	http://dx.doi.org/10.1074/jbc.273.19.11483			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565561	hybrid			2022-12-27	WOS:000073536700015
J	Pannifer, ADB; Flint, AJ; Tonks, NK; Barford, D				Pannifer, ADB; Flint, AJ; Tonks, NK; Barford, D			Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by X-ray crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; HYDROLYSIS; MECHANISM; 1B; PURIFICATION; CATALYSIS; DOMAIN; TUMORS; MOTIF; GTP	Protein-tyrosine phosphatases (PTPs) are signal transduction enzymes that catalyze the dephosphorylation of phosphotyrosine residues via the formation of a transient cysteinyl-phosphate intermediate, The mechanism of hydrolysis of this intermediate has been examined by generating a Gln-262 --> Ala mutant of PTP1B, which allows the accumulation and trapping of the intermediate within a PTP1B crystal. The structure of the intermediate at 2.5-Angstrom resolution reveals that a conformationally flexible loop (the WPD loop) is closed over the entrance to the catalytic site, sequestering the phosphocysteine intermediate and catalytic site water molecules and preventing nonspecific phosphoryltransfer reactions to extraneous phosphoryl accepters. One of the catalytic site water molecules, the likely nucleophile, forms a hydrogen bond to the putative catalytic base, Asp-181. In the wild-type enzyme, the nucleophilic water molecule would be coordinated by the side chain of Gln-262, In combination with our previous structural data, we can now visualize each of the reaction steps of the PTP catalytic pathway. The hydrolysis of the cysteinyl-phosphate intermediate of PTPs is reminiscent of GTP hydrolysis by the GTPases, in that both families of enzymes utilize an invariant Gin residue to coordinate the attacking nucleophilic water molecule.	Univ Oxford, Mol Biophys Lab, Oxford OX1 3QU, England; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Oxford; Cold Spring Harbor Laboratory	Barford, D (corresponding author), Univ Oxford, Mol Biophys Lab, Rex Richards Bldg,S Parks Rd, Oxford OX1 3QU, England.	davidb@biop.ox.ac.uk			NCI NIH HHS [CA53840] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053840, R37CA053840] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; CHO HJ, 1992, J AM CHEM SOC, V114, P7296, DOI 10.1021/ja00044a052; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Fauman EB, 1996, J BIOL CHEM, V271, P18780, DOI 10.1074/jbc.271.31.18780; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; OTWINOSKI Z, 1994, P CCP4 STUDY WEEKEND, P80; POT DA, 1991, J BIOL CHEM, V266, P19688; ROUSSEL A, 1992, TURBO FRODO; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhang ZY, 1995, BIOCHEMISTRY-US, V34, P16389, DOI 10.1021/bi00050a020; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; ZHANG ZY, 1995, J BIOL CHEM, V270, P11199, DOI 10.1074/jbc.270.19.11199; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007; Zhao Y, 1998, J BIOL CHEM, V273, P5484, DOI 10.1074/jbc.273.10.5484	35	188	199	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10454	10462		10.1074/jbc.273.17.10454	http://dx.doi.org/10.1074/jbc.273.17.10454			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553104	hybrid			2022-12-27	WOS:000073224200053
J	Zhao, YY; Sawyer, DR; Baliga, RR; Opel, DJ; Han, XQ; Marchionni, MA; Kelly, RA				Zhao, YY; Sawyer, DR; Baliga, RR; Opel, DJ; Han, XQ; Marchionni, MA; Kelly, RA			Neuregulins promote survival and growth of cardiac myocytes - Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; NEU DIFFERENTIATION FACTOR; FACTOR RECEPTOR FAMILY; GENE-EXPRESSION; HYPERTROPHIC STIMULI; PARACRINE MECHANISM; PRIMARY CULTURE; MESSENGER-RNA; RAT; MUSCLE	Neuregulins (i.e. neuregulin-1 (NRG1), also called neu differentiation factor, heregulin, glial growth factor, and acetylcholine receptor-inducing activity) are known to induce growth and differentiation of epithelial, glial, neuronal, and skeletal muscle cells. Unexpectedly, mice with loss of function mutations of NRG1 or of either of two of their cognate receptors, ErbB2 and ErbB4, die during midembryogenesis due to the aborted development of myocardial trabeculae in ventricular muscle. To examine the role of NRG and their receptors in developing and postnatal myocardium, we studied the ability of a soluble NRG1 (recombinant human glial growth factor 2) to promote proliferation, survival, and growth of isolated neonatal and adult rat cardiac myocytes. Both ErbB2 and ErbB4 receptors were found to be expressed by neonatal and adult ventricular myocytes and activated by rhGGF2. rhGGF2 (30 ng/ml) provoked an approximate 2-fold increase in embryonic cardiac myocyte proliferation, rhGGF2 also promoted survival and inhibited apoptosis of subconfluent, serum-deprived myocyte primary cultures and also induced hypertrophic growth in both neonatal and adult ventricular myocytes, which was accompanied by enhanced expression of prepro-atrial natriuretic factor and skeletal cu-actin. Moreover, NRG1 mRNA could be detected in coronary microvascular endothelial cell primary cultures prepared from adult rat ventricular muscle. NRG1 expression in these cells was increased by endothelin-l, another locally acting cardiotropic peptide within the heart. The persistent expression of both a neuregulin and its cognate receptors in the postnatal and adult heart suggests a continuing role for neuregulins in the myocardial adaption to physiologic stress or injury.	Brigham & Womens Hosp, Div Cardiol, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Cambridge Neurosci Inc, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kelly, RA (corresponding author), Brigham & Womens Hosp, Div Cardiol, Dept Med, 75 Francis St, Boston, MA 02115 USA.	rakelly@bics.bwh.harvard.edu		ZHAO, YOU-YANG/0000-0002-0041-0339	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036141, R37HL036141] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36141] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIOK N, 1995, EMBO J, V14, P4258, DOI 10.1002/j.1460-2075.1995.tb00100.x; Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BERGER HJ, 1994, AM J PHYSIOL, V266, pH341, DOI 10.1152/ajpheart.1994.266.1.H341; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; CARROLL PD, 1996, NEURON, V17, P229; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COFAS G, 1996, NEURON, V14, P103; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FISCHER TA, 1997, AM J PHYSIOL, V292, pH958; Florini JR, 1996, J BIOL CHEM, V271, P12699, DOI 10.1074/jbc.271.22.12699; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Kajstura J, 1997, J MOL CELL CARDIOL, V29, P859, DOI 10.1006/jmcc.1996.0333; Kaye D, 1996, J CLIN INVEST, V97, P281, DOI 10.1172/JCI118414; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; LEVI ADO, 1995, J NEUROSCI, V15, P1329; MARCHIONNI MA, 1995, NATURE, V378, P334, DOI 10.1038/378334a0; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NISHIDA M, 1993, J CLIN INVEST, V91, P1934, DOI 10.1172/JCI116412; NISHIDA M, 1993, AM J PHYSIOL, V264, pH639, DOI 10.1152/ajpheart.1993.264.2.H639; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; PERRELLA MA, 1994, J BIOL CHEM, V269, P27045; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; RAMIREZ MT, 1995, J BIOL CHEM, V270, P8446, DOI 10.1074/jbc.270.15.8446; Ramirez MT, 1997, J BIOL CHEM, V272, P14057, DOI 10.1074/jbc.272.22.14057; Rokosh DG, 1996, J BIOL CHEM, V271, P5839, DOI 10.1074/jbc.271.10.5839; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SADOSHIMA J, 1995, CIRC RES, V76, P1; SEIDMAN CE, 1984, SCIENCE, V225, P324, DOI 10.1126/science.6234658; SHANI M, 1981, NUCLEIC ACIDS RES, V9, P579, DOI 10.1093/nar/9.3.579; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Singh K, 1996, J BIOL CHEM, V271, P1111, DOI 10.1074/jbc.271.2.1111; SPRINGHORN JP, 1992, J BIOL CHEM, V267, P14360; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Wu CF, 1997, J BIOL CHEM, V272, P14860, DOI 10.1074/jbc.272.23.14860; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562	53	405	442	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10261	10269		10.1074/jbc.273.17.10261	http://dx.doi.org/10.1074/jbc.273.17.10261			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553078	hybrid			2022-12-27	WOS:000073224200027
J	Zhu, T; Goh, ELK; Lobie, PE				Zhu, T; Goh, ELK; Lobie, PE			Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2 - FAK is not required for stat-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; EXTRACELLULAR-MATRIX; INTERFERON-GAMMA; GENE-EXPRESSION; ACTIVATION; BINDING; CELLS	We have demonstrated that growth hormone (GH) activates focal adhesion kinase (FAK), and this activation results in the tyrosine phosphorylation of two FAK substrates, paxillin and tensin. The activation of FAK is time-dependent (maximal activation at 5-15 min) and dose-dependent (maximal activation at 0.05 nM). FAK and paxillin are constitutively associated in the unstimulated state, remain associated during the stimulation phase, and recruit tyrosine phosphorylated tensin to the complex after GH stimulation. Half of the carboxyl-terminal region of the GH receptor is dispensable for FAK activation, but FAK activation does require the proline-rich box 1 region of the GH receptor, indicative that FAK is downstream of JAK2. FAK associates with JAK2 but not JAK1 after GH stimulation of cells. Using FAK-replete and FAK-deficient cells, we also show that FAK is not required for STAT-mediated transcriptional activation by GH. The use of FAK in the signal transduction pathway utilized by GH may be central to many of the pleiotropic effects of GH, including cytoskeletal reorganization, cell migration, chemotaxis, mitogenesis, and/or prevention of apoptosis and gene transcription.	Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 119260, Singapore; Natl Univ Singapore, Def Med Res Inst, Singapore 119260, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Lobie, PE (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 119260, Singapore.		Goh, Eyleen/A-8006-2013	Goh, Eyleen/0000-0002-8244-6959				ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Argetsinger LS, 1996, J BIOL CHEM, V271, P29415, DOI 10.1074/jbc.271.46.29415; Auger KR, 1996, J BIOL CHEM, V271, P23452, DOI 10.1074/jbc.271.38.23452; BERGAD PL, 1995, J BIOL CHEM, V270, P24903, DOI 10.1074/jbc.270.42.24903; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CAMPBELL GS, 1995, J BIOL CHEM, V270, P3974, DOI 10.1074/jbc.270.8.3974; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; Cary LA, 1996, J CELL SCI, V109, P1787; CHEN HC, 1994, J BIOL CHEM, V269, P31229; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Goh ELK, 1997, ENDOCRINOLOGY, V138, P3207, DOI 10.1210/en.138.8.3207; GOMILLEUX F, 1994, EMBO J, V13, P4361; Guan JL, 1996, INT REV CYTOL, V168, P81, DOI 10.1016/S0074-7696(08)60883-9; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Ilic D, 1996, EXP CELL RES, V222, P298, DOI 10.1006/excr.1996.0038; Ilic D, 1997, J CELL SCI, V110, P401; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; KELLY PA, 1993, RECENT PROG HORM RES, V48, P123; Kilgour E, 1996, BIOCHEM J, V315, P517, DOI 10.1042/bj3150517; LO SH, 1994, BIOESSAYS, V16, P817, DOI 10.1002/bies.950161108; MATHEWS LS, 1989, J BIOL CHEM, V264, P9905; MEYER DJ, 1994, J BIOL CHEM, V269, P4701; MOLDRUP A, 1995, P 77 END SOC M WASH; MULLER C, 1992, J BIOL CHEM, V267, P23408; RANKIN S, 1994, J BIOL CHEM, V269, P704; RIDDERSTRALE M, 1995, J BIOL CHEM, V270, P3471, DOI 10.1074/jbc.270.8.3471; RIDDERSTRALE M, 1994, BIOCHEM BIOPH RES CO, V203, P306, DOI 10.1006/bbrc.1994.2182; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Saito Y, 1996, BIOCHEM BIOPH RES CO, V224, P23, DOI 10.1006/bbrc.1996.0978; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHLAEPFER DD, 1994, NATURE, V372, P786; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; SMIT LS, 1996, MOL ENDOCRINOL, V10, P510; SOTIROPOULOS A, 1995, FEBS LETT, V369, P169, DOI 10.1016/0014-5793(95)00734-Q; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; TakahashiTezuka M, 1997, ONCOGENE, V14, P2273, DOI 10.1038/sj.onc.1201071; VANDERKUUR J, 1995, J BIOL CHEM, V270, P7587, DOI 10.1074/jbc.270.13.7587; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; VANDERKUUR JA, 1995, J BIOL CHEM, V270, P21738, DOI 10.1074/jbc.270.37.21738; WANG XY, 1993, J BIOL CHEM, V268, P3573; WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262; WIEDERMANN CJ, 1993, BLOOD, V82, P954; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; WINSTON LA, 1992, J BIOL CHEM, V267, P4747; WOOD TJJ, 1995, J BIOL CHEM, V270, P9448, DOI 10.1074/jbc.270.16.9448	51	74	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10682	10689		10.1074/jbc.273.17.10682	http://dx.doi.org/10.1074/jbc.273.17.10682			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553131	hybrid			2022-12-27	WOS:000073224200080
J	Beohar, N; Kawamoto, S				Beohar, N; Kawamoto, S			Transcriptional regulation of the human nonmuscle myosin II heavy chain-A gene - Identification of three clustered cis-elements in intron-1 which modulate transcription in a cell type- and differentiation state-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING-PROTEINS; MESSENGER-RNA; ACTIVATION DOMAINS; MYOD FAMILY; SP1; DNA; CLONING; EXPRESSION; PROMOTER; SEQUENCE	In an attempt to identify cis-acting elements for transcriptional regulation of the human nonmuscle myosin II heavy chain (MHC)-A gene, the region extending 20 kilobases (kb) upstream and 40 kb downstream from the transcription start sites, which includes the entire 37-kb intron 1, was examined. Using transient transfection analysis of luciferase reporter constructs, a 100-base pair (bp) region (N2d) in intron 1, located 23 kb downstream from the transcriptional start sites, has been found to activate transcription in a cell type-and differentiation state-dependent manner, Maximum activity (similar to 20-fold) is seen in NIH 3T3 fibroblasts and intermediate activity (7-fold) in proliferating and undifferentiated C2C12 myoblasts, In contrast, this region is almost inactive in terminally differentiated C2C12 myotubes, in which endogenous nonmuscle MHC-A expression is down-regulated, Gel mobility shift assays and methylation interference analyses were performed using NIH 3T3 nuclear extracts to determine the protein-binding elements for transcription factors, Three binding elements have been identified within the N2d region, Antibody-supershift experiments, as well as competition experiments using consensus binding sequences for specific transcription factors, revealed that the most 5'-element, C (GGGAGGGGCC) is recognized specifically and exclusively by Sp1 and Sp3 transcriptional factors, Element C is immediately followed by a novel element, A (GTGACCC), A third element, F (GTGTCAGGTG), which contains an E-box, is located 50 bp 3' to element A. Element F can be recognized partially by upstream stimulatory factors, USF1 and/or USF2, Transfection studies with luciferase reporter constructs which include mutations in all three elements in various combinations demonstrate that the A and C binding factors cooperatively activate transcriptional activity in NIH 3T3 cells, The F binding factor shows an additive effect on transcription.	NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kawamoto, S (corresponding author), NHLBI, Mol Cardiol Lab, NIH, Bldg 10,Rm 8N202,10 Ctr Dr,MSC 1762, Bethesda, MD 20892 USA.							AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GUALBERTO A, 1995, J BIOL CHEM, V270, P19680, DOI 10.1074/jbc.270.34.19680; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HALAZONETIS TD, 1991, P NATL ACAD SCI USA, V88, P6162, DOI 10.1073/pnas.88.14.6162; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; KAWAMOTO S, 1994, J BIOL CHEM, V269, P15101; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Liang YX, 1996, J BIOL CHEM, V271, P11792, DOI 10.1074/jbc.271.20.11792; Lin JX, 1997, MOL CELL BIOL, V17, P3714, DOI 10.1128/MCB.17.7.3714; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Noti JD, 1997, J BIOL CHEM, V272, P24038, DOI 10.1074/jbc.272.38.24038; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; ROBBINS J, 1995, ANN NY ACAD SCI, V752, P492, DOI 10.1111/j.1749-6632.1995.tb17458.x; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; SELLERS JR, 1995, PROTEIN PROFILE, V2, P1323; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; SPUDICH JA, 1989, CELL REGUL, V1, P1; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Weir L, 1996, GENE EXPRESSION, V6, P45; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783	41	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9168	9178		10.1074/jbc.273.15.9168	http://dx.doi.org/10.1074/jbc.273.15.9168			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535907	hybrid			2022-12-27	WOS:000072990800084
J	Rosoff, ML; Nathanson, NM				Rosoff, ML; Nathanson, NM			GATA factor-dependent regulation of cardiac m2 muscarinic acetylcholine gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC-DEVELOPMENT; DEVELOPING HEART; PROMOTER REGION; RECEPTOR GENE; EXPRESSION; CELLS; FAMILY; GATA-4/5/6	The m2 subtype is the predominant muscarinic acetylcholine receptor subtype expressed in heart and regulates the rate and force of cardiac contraction. We have previously reported the isolation of the promoter region for the chick m2 receptor gene and defined a region of the chick m2 promoter sufficient for high level expression in cardiac primary cultures. In this manuscript we demonstrate transactivation of cm2 promoter by the GATA family of transcription factors. In addition, we define the GATA-responsive element in the chick m2 promoter and demonstrate that this element is required for expression in cardiac primary cultures. Finally, we demonstrate specific binding of both a chick heart nuclear protein and of cloned chick GATA-4, -5, and -6 to the GATA-responsive element.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nathanson, NM (corresponding author), Univ Washington, Dept Pharmacol, Box 357750, Seattle, WA 98195 USA.				NHLBI NIH HHS [HL30639] Funding Source: Medline; NINDS NIH HHS [NS7332] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030639] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Gove C, 1997, EMBO J, V16, P355, DOI 10.1093/emboj/16.2.355; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; HALVORSEN SW, 1984, BIOCHEMISTRY-US, V23, P5813, DOI 10.1021/bi00319a021; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; HUANG WY, 1995, GENE, V155, P219, DOI 10.1016/0378-1119(94)00893-W; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; Jiang YM, 1996, DEV BIOL, V174, P258, DOI 10.1006/dbio.1996.0071; KATZ AM, 1977, PHYSL HEART; KELLEY C, 1993, DEVELOPMENT, V118, P817; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Latchman D. S., 1993, TRANSCRIPTION FACTOR; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MacNeill C, 1997, J BIOL CHEM, V272, P8396, DOI 10.1074/jbc.272.13.8396; MCKINNON LA, 1995, J BIOL CHEM, V270, P20636, DOI 10.1074/jbc.270.35.20636; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Mieda M, 1996, J BIOL CHEM, V271, P5177; MIGEON JC, 1994, J BIOL CHEM, V269, P9767; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Murphy AM, 1997, BIOCHEM J, V322, P393, DOI 10.1042/bj3220393; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; ORKIN SH, 1992, BLOOD, V80, P575; PEI DQ, 1991, MOL CELL BIOL, V11, P1480, DOI 10.1128/MCB.11.3.1480; Pepitoni S, 1997, J BIOL CHEM, V272, P17112, DOI 10.1074/jbc.272.27.17112; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; Rosoff ML, 1996, P NATL ACAD SCI USA, V93, P14889, DOI 10.1073/pnas.93.25.14889; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; Sambrook J., 2002, MOL CLONING LAB MANU; SIMON MC, 1995, NAT GENET, V11, P40; SUBERS EM, 1989, J BIOL CHEM, V264, P19685; THUERAUF DJ, 1994, J BIOL CHEM, V269, P17772; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; WEISS MJ, 1995, EXP HEMATOL, V23, P99; WEISS MJ, 1988, J BIOL CHEM, V263, P12002; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Wood IC, 1995, J BIOL CHEM, V270, P30933, DOI 10.1074/jbc.270.52.30933; ZOU YM, 1995, MOL CELL BIOL, V15, P2972	48	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9124	9129		10.1074/jbc.273.15.9124	http://dx.doi.org/10.1074/jbc.273.15.9124			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535902	hybrid			2022-12-27	WOS:000072990800079
J	Kainulainen, V; Wang, HM; Schick, C; Bernfield, M				Kainulainen, V; Wang, HM; Schick, C; Bernfield, M			Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE PROTEOGLYCAN; FIBROBLAST GROWTH-FACTOR; PROTEINASE-INHIBITORS; ALPHA-1-PROTEINASE INHIBITOR; EXTRACELLULAR-MATRIX; NEUTROPHIL ELASTASE; ENDOTHELIAL-CELLS; DEGRADATION; BINDING; FIBRONECTIN	An imbalance between proteases and antiproteases is thought to play a role in the inflammatory injury that regulates wound healing. The activities of some proteases and antiproteases found in inflammatory fluids can be modified in vitro by heparin, a mast cell-derived glycosaminoglycan, Because syndecans, a family of cell surface heparan sulfate proteoglycans, are the major cellular source of heparin-like glycosaminoglycan, we asked whether syndecans modify protease activities in vivo., Syndecan-1 and syndecan-4 ectodomains are shed into acute human dermal wound fluids (Subramanian, S., V., Fitzgerald, M., L.,, and Bernfield, M., (1997) J. Biol. Chem, 272, 14713-14720). Moreover, purified syndecan-1 ectodomain binds cathepsin G (K-d = 56 nM) and elastase (K-d = 35 nM) tightly and reduces the affinity of these proteases for their physiological inhibitors. Purified syndecan-1 ectodomain protects cathepsin G from inhibition by alpha(1)-antichymotrypsin and squamous cell carcinoma antigen 2 and elastase from inhibition by alpha(1)-proteinase inhibitor by decreasing second order rate constants for protease-antiprotease associations (k(ass),,,) by 3700-, 32-, and 60-fold, respectively. Both enzymatic degradation of heparan sulfate and immunodepletion of the syndecan-1 and -4 in wound fluid reduce these proteolytic activities in the fluid, indicating that the proteases in the wound environment are regulated by interactions with syndecan ectodomains. Thus, syndecans are shed into acute wound fluids, where they can modify the proteolytic balance of the fluid. This suggests a novel physiological role for these soluble heparan sulfate proteoglycans.	Harvard Univ, Sch Med, Dept Pediat, Div Dev & Newborn Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Bernfield, M (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Enders 9,300 Longwood Ave, Boston, MA 02115 USA.				NCI NIH HHS [CA-28735] Funding Source: Medline; NHLBI NIH HHS [HL-56398] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA028735] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056398] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASHKIN P, 1992, J CELL PHYSIOL, V151, P126, DOI 10.1002/jcp.1041510117; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BIETH JG, 1986, BIOL EXTRACELLULAR M, P217; BREUING K, 1992, J SURG RES, V52, P50, DOI 10.1016/0022-4804(92)90278-8; BRIGGAMAN RA, 1984, J EXP MED, V160, P1027, DOI 10.1084/jem.160.4.1027; CAMPBELL EJ, 1986, AM REV RESPIR DIS, V134, P435; CAMPBELL EJ, 1987, CHEST, V92, P161, DOI 10.1378/chest.92.1.161; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Clark R. A. F, 1996, MOL CELLULAR BIOL WO; COLERIDGESMITH PD, 1988, BRIT MED J, V296, P1726; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; ERIKSSON S, 1986, ACTA MED SCAND, V220, P447; ERMOLIEFF J, 1994, J BIOL CHEM, V269, P29502; FALANGA V, 1993, J INVEST DERMATOL, V100, P721, DOI 10.1111/1523-1747.ep12472373; FROMMHERZ KJ, 1991, J BIOL CHEM, V266, P15356; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; Grinnell F, 1996, J INVEST DERMATOL, V106, P335, DOI 10.1111/1523-1747.ep12342990; GRINNELL F, 1992, J INVEST DERMATOL, V98, P410, DOI 10.1111/1523-1747.ep12499839; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; KATO M, 1994, J BIOL CHEM, V269, P1881; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; LINDAHL U, 1994, THROMB RES, V57, P1; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mignatti P., 1996, MOL CELLULAR BIOL WO, P427; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Pepper MS, 1996, ENZYME PROTEIN, V49, P138, DOI 10.1159/000468622; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; PRATT CW, 1992, J BIOL CHEM, V267, P8795; RAO CN, 1995, J INVEST DERMATOL, V105, P572, DOI 10.1111/1523-1747.ep12323503; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Stevens R L, 1989, Prog Clin Biol Res, V297, P131; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; TAIPALE J, 1995, J BIOL CHEM, V270, P4689, DOI 10.1074/jbc.270.9.4689; Taylor JC, 1987, PULMONARY EMPHYSEMA; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451	43	165	168	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11563	11569		10.1074/jbc.273.19.11563	http://dx.doi.org/10.1074/jbc.273.19.11563			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565572	hybrid			2022-12-27	WOS:000073536700026
J	Rodriguez-Cousino, N; Nargang, FE; Baardman, R; Neupert, W; Lill, R; Court, DA				Rodriguez-Cousino, N; Nargang, FE; Baardman, R; Neupert, W; Lill, R; Court, DA			An import signal in the cytosolic domain of the Neurospora mitochondrial outer membrane protein TOM22	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE-SPACE DOMAIN; RECEPTOR COMPLEX PROTEIN; ANCHOR SEQUENCE; PRECURSOR PROTEINS; SURFACE-RECEPTORS; AMINO-TERMINUS; 70-KD PROTEIN; YEAST MAS17; TRANSLOCATION; INSERTION	TOM22 is an integral component of the preprotein translocase of the mitochondrial outer membrane (TOM complex). The protein is anchored to the lipid bilayer by a central trans-membrane segment, thereby exposing the amino-terminal domain to the cytosol and the carboxyl-terminal portion to the intermembrane space. Here, we describe the sequence requirements for the targeting and correct insertion of Neurospora TOM22 into the outer membrane. The orientation of the protein is not influenced by the charges flanking its trans-membrane segment, in contrast to observations regarding proteins of other membranes. In vitro import studies utilizing TOM22 preproteins harboring deletions or mutations in the cytosolic domain revealed that the combination of the trans-membrane segment and intermembrane space domain of TOM22 is not sufficient to direct import into the outer membrane. In contrast, a short segment of the cytosolic domain was found to be essential for the import and assembly of TOM22. This sequence, a novel internal import signal for the outer membrane, carries a net positive charge. A mutant TOM22 in which the charge of the import signal was altered to -1 was imported less efficiently than the wild-type protein. Our data indicate that TOM22 contains physically separate import and membrane anchor sequences.	Univ Salamanca, CSIC, Dept Genet & Microbiol, Inst Microbiol Bioquim, Salamanca 37000, Spain; Philipps Univ Marburg, Inst Zytobiol, D-35033 Marburg, Germany; Ludwigs Maximillian Univ, Adolf Butenandt Inst Physiol Chem, D-80336 Munich, Germany; Univ Alberta, Dept Sci Biol, Edmonton, AB T6G 2E9, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Philipps University Marburg; University of Munich; University of Alberta	Court, DA (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	Deborah_Court@umanitoba.ca	Rodríguez-Cousiño, Nieves/K-6465-2014; Nargang, Frank/A-2669-2014	Rodríguez-Cousiño, Nieves/0000-0002-6458-3677; Nargang, Frank/0000-0002-1383-4720; Court, Deborah A./0000-0003-1919-8339; Lill, Roland/0000-0002-8345-6518				ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bolliger L, 1995, EMBO J, V14, P6318, DOI 10.1002/j.1460-2075.1995.tb00322.x; CAO W, 1995, J BIOL CHEM, V270, P5674, DOI 10.1074/jbc.270.10.5674; Cao W, 1996, BIOCHEM BIOPH RES CO, V224, P457, DOI 10.1006/bbrc.1996.1048; Court DA, 1996, MOL CELL BIOL, V16, P4035; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; deKroon AIPM, 1997, BBA-BIOMEMBRANES, V1325, P108, DOI 10.1016/S0005-2736(96)00240-4; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; ENOCH HG, 1979, J BIOL CHEM, V254, P6483; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; Harley CA, 1996, J BIOL CHEM, V271, P24625, DOI 10.1074/jbc.271.40.24625; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HASE T, 1983, EMBO J, V2, P2169, DOI 10.1002/j.1460-2075.1983.tb01718.x; HASE T, 1984, EMBO J, V3, P3157, DOI 10.1002/j.1460-2075.1984.tb02274.x; HONLINGER A, 1995, MOL CELL BIOL, V15, P3382; HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x; JANIAK F, 1994, J BIOL CHEM, V269, P9842; KASSENBROCK CK, 1993, EMBO J, V12, P3023, DOI 10.1002/j.1460-2075.1993.tb05971.x; KEIL P, 1993, FEBS LETT, V321, P197, DOI 10.1016/0014-5793(93)80107-6; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; Lill R, 1996, TRENDS CELL BIOL, V6, P56, DOI 10.1016/0962-8924(96)81015-4; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MAYER A, 1995, CELL, V80, P127, DOI 10.1016/0092-8674(95)90457-3; MAYER A, 1993, J CELL BIOL, V121, P1233, DOI 10.1083/jcb.121.6.1233; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Nakai M, 1995, J BIOL CHEM, V270, P30571, DOI 10.1074/jbc.270.51.30571; NAKAI M, 1995, FEBS LETT, V357, P202; NARGANG FE, 1995, EMBO J, V14, P1099, DOI 10.1002/j.1460-2075.1995.tb07093.x; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; PFALLER R, 1989, J BIOL CHEM, V264, P34; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; ROISE D, 1988, J BIOL CHEM, V263, P4509; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; Steenaart NAE, 1996, BIOCHEMISTRY-US, V35, P3764, DOI 10.1021/bi9528053; Stuart RA, 1996, TRENDS BIOCHEM SCI, V21, P261, DOI 10.1016/S0968-0004(96)10035-9; SWANK RT, 1971, ANAL BIOCHEM, V39, P462, DOI 10.1016/0003-2697(71)90436-2; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x	50	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11527	11532		10.1074/jbc.273.19.11527	http://dx.doi.org/10.1074/jbc.273.19.11527			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565567	hybrid			2022-12-27	WOS:000073536700021
J	Frolov, A; Schroeder, F				Frolov, A; Schroeder, F			Acyl coenzyme A binding protein - Conformational sensitivity to long chain fatty acyl-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL CARRIER PROTEIN-2; RETINOL-BINDING; ACID; INHIBITION; FLUORESCENCE; TRANSPORT; FLUOROMETRY; MODULATION; ANISOTROPY; VESICLES	Cellular unbound long chain fatty acyl-CoAs (>14 carbon) are potent regulators of gene transcription and intracellular signaling. Although the cytosolic acyl-CoA binding protein (ACBP) has high affinity for medium chain fatty acyl-CoAs, direct interaction of ACBP with >14-carbon fatty acyl-CoAs has not been established. Steady state, photon counting fluorescence spectroscopy directly established that rat liver ACBP bound 18-carbon cis-and trans-parinaroyl-CoA, K-d = 7.03 +/- 0.95 and 4.40 +/- 0.43 nM. Time-resolved fluorometry revealed that ACBP-bound parinaroyl-CoAs had high rotational freedom within the single, relatively hydrophobic (epsilon <32), binding site. Tyr and Trp fluorescence dynamics demonstrated that apo-ACBP was an ellipsoidal protein taxes of 15 and 9 Angstrom) whose conformation was altered by oleoyl-CoA in the holo-ACBP as shown by a 2-Angstrom decrease of ACBP hydrodynamic diameter and increased Trp segmental motions. Thus, native liver ACBP binds > 14-carbon fatty acyl-CoAs with nanomolar affinity at a single binding site. Acyl-CoA-induced conformational alterations in ACBP may be significant to its putative functions in lipid metabolism and regulation of processes sensitive to unbound long chain fatty acyl-CoAs.	Texas A&M Univ, Texas Vet Med Ctr, Dept Physiol & Pharmacol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Schroeder, F (corresponding author), Texas A&M Univ, Texas Vet Med Ctr, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.	fschroeder@cvm.tamu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041402] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK41402] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baum CL, 1997, J BIOL CHEM, V272, P6490, DOI 10.1074/jbc.272.10.6490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P554; CHOY PC, 1990, PHOSPHATIDYLCHOLINE, P87; COMERFORD JG, 1993, BIOCHEM J, V289, P561, DOI 10.1042/bj2890561; DEMCHENKO AP, 1986, ULTRAVIOLET SPECTROS, P1; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Frolov A, 1997, BIOCHEMISTRY-US, V36, P505, DOI 10.1021/bi961392i; Frolov A, 1997, BIOCHEMISTRY-US, V36, P6545, DOI 10.1021/bi970205t; Frolov A, 1996, J BIOL CHEM, V271, P31878, DOI 10.1074/jbc.271.50.31878; GAVEY KL, 1981, J BIOL CHEM, V256, P2993; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; Gossett RE, 1998, ARCH BIOCHEM BIOPHYS, V350, P201, DOI 10.1006/abbi.1997.0521; Gossett RE, 1997, LIPIDS, V32, P577, DOI 10.1007/s11745-997-0073-5; Gossett RE, 1996, LIPIDS, V31, P895, DOI 10.1007/BF02522684; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; HUBBELL T, 1994, BIOCHEMISTRY-US, V33, P3327, DOI 10.1021/bi00177a025; JAKOBY MG, 1993, BIOCHEMISTRY-US, V32, P872, DOI 10.1021/bi00054a019; JEPSON CA, 1992, FEBS LETT, V310, P197, DOI 10.1016/0014-5793(92)81328-J; Jolly CA, 1997, ARCH BIOCHEM BIOPHYS, V341, P112, DOI 10.1006/abbi.1997.9957; JOLLY CA, 1998, BIOCHIM BIOPHYS ACTA, V1390, P58; KRAGELUND BB, 1993, J MOL BIOL, V230, P1260, DOI 10.1006/jmbi.1993.1240; Krisans SK, 1996, ANN NY ACAD SCI, V804, P142, DOI 10.1111/j.1749-6632.1996.tb18614.x; LAKOWICZ JR, 1986, J BIOL CHEM, V261, P2240; LAKOWICZ JR, 1987, BIOCHEMISTRY-US, V26, P82, DOI 10.1021/bi00375a012; LANDS WEM, 1965, J BIOL CHEM, V240, P1905; LEHRER G, 1981, J BIOL CHEM, V256, P5612; LI QL, 1990, J BIOCHEM-TOKYO, V107, P699, DOI 10.1093/oxfordjournals.jbchem.a123111; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Numa S, 1974, Curr Top Cell Regul, V8, P197; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARASASSI T, 1984, BIOCHEMISTRY-US, V23, P5660, DOI 10.1021/bi00318a042; PFANNER N, 1990, J CELL BIOL, V110, P955, DOI 10.1083/jcb.110.4.955; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; SCHROEDER F, 1995, BIOCHEMISTRY-US, V34, P11919, DOI 10.1021/bi00037a033; SCHROEDER F, 1998, IN PRESS CHEM PHYS L; SHA RS, 1993, J BIOL CHEM, V268, P7885; SHUG A, 1971, BIOCHEM BIOPH RES CO, V43, P557, DOI 10.1016/0006-291X(71)90650-4; SHUG AL, 1975, AM J PHYSIOL, V228, P689, DOI 10.1152/ajplegacy.1975.228.3.689; SINGH I, 1993, J LIPID RES, V34, P1755; Stolowich NJ, 1997, BIOCHEMISTRY-US, V36, P1719, DOI 10.1021/bi962317a; TIPPETT PS, 1982, J BIOL CHEM, V257, P2839; WANDERS RJA, 1995, J NEUROPATH EXP NEUR, V54, P726, DOI 10.1097/00005072-199509000-00016; WOLBER PK, 1981, BIOCHEMISTRY-US, V20, P2800, DOI 10.1021/bi00513a015; WOLDEGIORGIS G, 1981, J BIOL CHEM, V256, P2297	47	51	51	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11049	11055		10.1074/jbc.273.18.11049	http://dx.doi.org/10.1074/jbc.273.18.11049			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556588	hybrid			2022-12-27	WOS:000073395200040
J	Liu, B; Andrieu-Abadie, N; Levade, T; Zhang, P; Obeid, LM; Hannun, YA				Liu, B; Andrieu-Abadie, N; Levade, T; Zhang, P; Obeid, LM; Hannun, YA			Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; PHOSPHOLIPASE-D; INTRACELLULAR GLUTATHIONE; INDUCED APOPTOSIS; DNA-DAMAGE; CERAMIDE; ACID; DEPLETION; MECHANISM; PATHWAY	Tumor necrosis factor-alpha (TNF alpha)-induced cell death involves a diverse array of mediators and regulators including proteases, reactive oxygen species, the sphingolipid ceramide, and Bcl-2. It is not known, however, if and how these components are connected. We have previously reported that GSH inhibits, in vitro, the neutral magnesium-dependent sphingomyelinase (N-SMase) from Molt-4 leukemia cells. In this study, GSH was found to reversibly inhibit the N-SMase from human mammary carcinoma MCF7 cells. Treatment of MCF7 cells with TNF alpha induced a marked decrease in the level of cellular GSH, which was accompanied by hydrolysis of sphingomyelin and generation of ceramide. Pretreatment of cells with GSH, GSH-methylester, or N-acetylcysteine, a precursor of GSH biosynthesis, inhibited the TNF alpha-induced sphingomyelin hydrolysis and ceramide generation as well as cell death. Furthermore, no significant changes in GSH levels were observed in MCF7 cells treated with either bacterial SMase or ceramide, and GSH did not protect cells from death induced by ceramide. Taken together, these results show that GSH depletion occurs upstream of activation of N-SMase in the TNF alpha signaling pathway. TNF alpha has been shown to activate at least two groups of caspases involved in the initiation and "execution" phases of apoptosis. Therefore, additional studies were conducted to determine the relationship of GSH and the death proteases. Evidence is provided to demonstrate that depletion of GSH is dependent on activity of interleukin-1 beta-converting enzyme-like proteases but is upstream of the site of action of Bcl-2 and of the execution phase caspases. Taken together, these studies demonstrate a critical role for GSH in TNF alpha action and in connecting major components in the pathways leading to cell death.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Vet Adm Geriatr Res & Clin Ctr, Durham, NC 27710 USA; Inst Louis Bugnard, Biochim Lab, F-31403 Toulouse, France	Duke University; Duke University	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem, 171 Ashley Ave, Charleston, SC 29425 USA.		Levade, Thierry/O-8948-2014; Andrieu-Abadie, Nathalie/N-6793-2013	Andrieu-Abadie, Nathalie/0000-0003-2698-1970; obeid, lina/0000-0002-0734-0847	NIA NIH HHS [AG-12467] Funding Source: Medline; NIGMS NIH HHS [F32 GM017426, GM-43825, GM-17426, F32 GM017426-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, F32GM017426, R01GM043825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG012467, R55AG012467] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abousalham A, 1997, J BIOL CHEM, V272, P1069, DOI 10.1074/jbc.272.2.1069; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ANDRIEU N, 1994, BIOCHEM J, V303, P341, DOI 10.1042/bj3030341; BEAVER JP, 1995, EUR J CELL BIOL, V68, P47; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREZDEN CB, 1994, BIOCHEM PHARMACOL, V48, P361, DOI 10.1016/0006-2952(94)90108-2; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CHIAO C, 1995, CANCER RES, V55, P3576; Chiba T, 1996, EUR J IMMUNOL, V26, P1164, DOI 10.1002/eji.1830260530; CHRISTIE NA, 1994, ARCH BIOCHEM BIOPHYS, V313, P131, DOI 10.1006/abbi.1994.1369; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Dbaibo GS, 1997, J EXP MED, V185, P481, DOI 10.1084/jem.185.3.481; Deas O, 1997, INT IMMUNOL, V9, P117, DOI 10.1093/intimm/9.1.117; DHANBHOORA CM, 1992, ARCH BIOCHEM BIOPHYS, V293, P130, DOI 10.1016/0003-9861(92)90375-7; Froissard P, 1997, EUR J PHARMACOL, V326, P93, DOI 10.1016/S0014-2999(97)00155-6; GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; HAKOMORI S, 1993, BIOCHEM SOC T, V21, P583, DOI 10.1042/bst0210583; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hu SM, 1997, J BIOL CHEM, V272, P9621; ISHII Y, 1992, J CLIN INVEST, V89, P794, DOI 10.1172/JCI115658; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Jayadev S, 1997, J BIOL CHEM, V272, P17196, DOI 10.1074/jbc.272.27.17196; KALEN A, 1992, BIOCHIM BIOPHYS ACTA, V1125, P90, DOI 10.1016/0005-2760(92)90160-W; KATO S, 1992, NEUROSCIENCE, V48, P903, DOI 10.1016/0306-4522(92)90278-A; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; LEVINE ES, 1993, CARDIOVASC RES, V27, P1248, DOI 10.1093/cvr/27.7.1248; Liu B, 1997, SEMIN CELL DEV BIOL, V8, P311, DOI 10.1006/scdb.1997.0153; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; MACFARLANE M, 1997, J CELL BIOL, V137, P169; Macho A, 1997, J IMMUNOL, V158, P4612; Margolin N, 1997, J BIOL CHEM, V272, P7223, DOI 10.1074/jbc.272.11.7223; Nakamura Y, 1996, J IMMUNOL, V156, P256; NICHOLSON DW, 1997, TRENDS BIOCHEM SCI, V22, P30; Nyberg L, 1996, BBA-LIPID LIPID MET, V1300, P42, DOI 10.1016/0005-2760(95)00245-6; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Perry DK, 1997, CELL DEATH DIFFER, V4, P29, DOI 10.1038/sj.cdd.4400200; PHELPS DT, 1995, AM J PHYSIOL-LUNG C, V269, pL551, DOI 10.1152/ajplung.1995.269.4.L551; RATAN RR, 1994, J NEUROCHEM, V62, P376; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; SCHUTZE S, 1992, CELL, V71, P465; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; SHOJI Y, 1995, IMMUNOLOGY, V84, P543; SLATER AFG, 1995, BIOCHEM J, V306, P771, DOI 10.1042/bj3060771; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; STRUM JC, 1994, J BIOL CHEM, V269, P15493; Suchard SJ, 1997, BLOOD, V89, P2139, DOI 10.1182/blood.V89.6.2139; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; TEWARI M, 1995, CELL, V81, P1; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Um HD, 1996, J IMMUNOL, V156, P3469; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Venable ME, 1996, J BIOL CHEM, V271, P24800, DOI 10.1074/jbc.271.40.24800; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325; Zhang P, 1997, J BIOL CHEM, V272, P9609; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533; Zucker B, 1997, CELL DEATH DIFFER, V4, P388, DOI 10.1038/sj.cdd.4400258	68	309	332	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11313	11320		10.1074/jbc.273.18.11313	http://dx.doi.org/10.1074/jbc.273.18.11313			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556624	hybrid			2022-12-27	WOS:000073395200076
J	Poirier, MA; Hao, JC; Malkus, PN; Chan, C; Moore, MF; King, DS; Bennett, MK				Poirier, MA; Hao, JC; Malkus, PN; Chan, C; Moore, MF; King, DS; Bennett, MK			Protease resistance of syntaxin center dot SNAP-25 center dot VAMP complexes - Implications for assembly and structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE DOCKING; CLOSTRIDIAL NEUROTOXINS; COILED COILS; FUSION COMPLEX; SYNTAXIN; SYNAPTOBREVIN; SPECIFICITY; EXOCYTOSIS; ACTIVATION; PROTEINS	A stable ternary complex formed with vesicle-associated membrane protein 2 (VAMP2) and plasma membrane proteins syntaxin 1A and synaptosome-associated protein of 25 kDa (SNAP-25) is proposed to function in synaptic vesicle exocytosis. To analyze the structural characteristics of this synaptic protein complex, recombinant binary (syntaxin LA SNAP-SB), recombinant ternary, and native ternary complexes were subjected to Limited trypsin proteolysis. The protected fragments, defined by amino-terminal sequencing and mass spectrometry, included a carboxyl-terminal region of syntaxin 1A, the cytoplasmic domain of VAMP2, and amino- and carboxyl-terminal regions of SNAP-SS. Furthermore, separate amino-and carboxyl-terminal fragments of SNAP-25, when combined with VAMP2 and syntaxin LA, were sufficient for stable complex assembly. Analysis of ternary complexes formed with full-length proteins revealed that the carboxyl-terminal transmembrane anchors of both syntaxin 1A and VAMP2 were protected from trypsin digestion. Moreover, the stability of ternary complexes was increased by inclusion of these transmembrane domains. These results suggest that the transmembrane domains of VAMP2 and syntaxin LA contribute to complex assembly and stability and that amino-and carboxyl-terminal regions of SNAP-25 may function as independent domains.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bennett, MK (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.				NIGMS NIH HHS [GM 51313] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051313] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HANSON PI, 1997, ELL, V90, P523; Hao JC, 1997, J NEUROSCI, V17, P1596; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Regazzi R, 1996, EMBO J, V15, P6951, DOI 10.1002/j.1460-2075.1996.tb01087.x; Schiavo Giampietro, 1994, Seminars in Cell Biology, V5, P221, DOI 10.1006/scel.1994.1028; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Zhong PY, 1997, BIOCHEMISTRY-US, V36, P4317, DOI 10.1021/bi9625408	29	102	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11370	11377		10.1074/jbc.273.18.11370	http://dx.doi.org/10.1074/jbc.273.18.11370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556632	hybrid			2022-12-27	WOS:000073395200084
J	Gao, M; Yamazaki, M; Loe, DW; Westlake, CJ; Grant, CE; Cole, SPC; Deeley, RG				Gao, M; Yamazaki, M; Loe, DW; Westlake, CJ; Grant, CE; Cole, SPC; Deeley, RG			Multidrug resistance protein - Identification of regions required for active transport of leukotriene C-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; CONJUGATE EXPORT PUMP; CFTR CHLORIDE CHANNEL; HUMAN P-GLYCOPROTEIN; HUMAN TUMOR-CELLS; CONDUCTANCE REGULATOR; MONOCLONAL-ANTIBODIES; NUCLEOTIDE-BINDING; ESCHERICHIA-COLI; MRP	Multidrug resistance protein (MRP) is a broad specificity, primary active transporter of organic anion conjugates that confers a multidrug resistance phenotype when transfected into drug-sensitive cells. The protein was the first example of a subgroup of the ATP-binding cassette superfamily whose members have three membrane-spanning domains (MSDs) and two nucleotide binding domains. The role(s) of the third MSD of MRP and its related transporters is not known. To begin to address this question, we examined the ability of various MRP fragments, expressed individually and in combination, to transport the MRP substrate, leukotriene C-4, (LTC4). We found that elimination of the entire NH2-terminal MSD or just the first putative transmembrane helix, or substitution of the MSD with the comparable region of the functionally and structurally related transporter, the canalicular multispecific organic anion transporter (cMOAT/MRP2), had little effect on protein accumulation in the membrane. However, all three modifications decreased LTC4 transport activity by at least 90%. Transport activity could be reconstituted by co-expression of the NH2-terminal MSD with a fragment corresponding to the remainder of the MRP molecule, but this required both the region encoding the transmembrane helices of the NH2-terminal MSD and the cytoplasmic region linking it to the next MSD. In contrast, a major part of the cytoplasmic region linking the NH2-proximal nucleotide binding domain of the protein to the COOH-proximal MSD was not required for active transport of LTC4.	Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Deeley, RG (corresponding author), Toho Univ, Sch Pharmaceut Sci, Dept Pharmacokinet & Biopharmaceut, Rm A315,Botterell Hall, Kingston, ON K7L 3N6, Canada.		Deeley, Roger/J-4828-2012; Cole, Susan P.C./I-6389-2017; Westlake, Christopher/AAG-1150-2019	Cole, Susan P.C./0000-0001-6571-6884; Westlake, Christopher/0000-0001-7476-2014				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ALMQUIST KC, 1995, CANCER RES, V55, P102; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; BERKOWER C, 1991, EMBO J, V10, P3777, DOI 10.1002/j.1460-2075.1991.tb04947.x; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; CHAMBERS TC, 1994, BIOCHEM J, V299, P309, DOI 10.1042/bj2990309; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CHIN JE, 1989, MOL CELL BIOL, V9, P3808, DOI 10.1128/MCB.9.9.3808; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; DALBEY RE, 1987, SCIENCE, V235, P783, DOI 10.1126/science.3544218; FLENS MJ, 1994, CANCER RES, V54, P4557; Gao M, 1996, J BIOL CHEM, V271, P27782, DOI 10.1074/jbc.271.44.27782; GERMANN UA, 1995, J BIOENERG BIOMEMBR, V27, P53, DOI 10.1007/BF02110331; Grant CE, 1997, GENOMICS, V45, P368, DOI 10.1006/geno.1997.4950; GRANT CE, 1994, CANCER RES, V54, P357; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1996, CANCER RES, V56, P3307; HIPFNER DR, 1994, CANCER RES, V54, P5788; Jedlitschky G, 1996, CANCER RES, V56, P988; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; KRUH GD, 1994, CANCER RES, V54, P1649; Lee DW, 1996, EUR J CANCER, V32A, P945, DOI 10.1016/0959-8049(96)00046-9; LEIER I, 1994, EUR J BIOCHEM, V220, P599, DOI 10.1111/j.1432-1033.1994.tb18661.x; LEIER I, 1994, J BIOL CHEM, V269, P27807; Loe DW, 1997, MOL PHARMACOL, V51, P1034, DOI 10.1124/mol.51.6.1034; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; LOO TW, 1994, J BIOL CHEM, V269, P7750; MA LD, 1995, BIOCHEMISTRY-US, V34, P3338, DOI 10.1021/bi00010a024; MAYER R, 1995, J CELL BIOL, V131, P137, DOI 10.1083/jcb.131.1.137; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Ostedgaard LS, 1997, BIOCHEMISTRY-US, V36, P1287, DOI 10.1021/bi962174s; PANAGIOTIDIS CH, 1993, J BIOL CHEM, V268, P23685; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Shen HX, 1996, BIOCHEMISTRY-US, V35, P5719, DOI 10.1021/bi960098n; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; Stride BD, 1996, MOL PHARMACOL, V49, P962; Szabo K, 1997, J BIOL CHEM, V272, P23165, DOI 10.1074/jbc.272.37.23165; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; vanKuijck MA, 1996, P NATL ACAD SCI USA, V93, P5401, DOI 10.1073/pnas.93.11.5401; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; ZAMAN GJR, 1994, P NATL ACAD SCI USA, V91, P8822, DOI 10.1073/pnas.91.19.8822	48	94	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10733	10740		10.1074/jbc.273.17.10733	http://dx.doi.org/10.1074/jbc.273.17.10733			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553138	hybrid			2022-12-27	WOS:000073224200087
J	Guerineau, NC; Bonnefont, X; Stoeckel, L; Mollard, P				Guerineau, NC; Bonnefont, X; Stoeckel, L; Mollard, P			Synchronized spontaneous Ca2+ transients in acute anterior pituitary slices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; FOLLICULO-STELLATE CELLS; INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; PATCH-CLAMP; CYTOSOLIC CA-2+; PROLACTIN CELLS; RAT PITUITARY; BETA-CELLS; OSCILLATIONS	We investigated the organization of spontaneous rises in cytosolic free Ca2+ concentration ([Ca2+](i)) due to electrical activity in acute pituitary slices. Real time confocal imaging revealed that 73% of the cells generated fast peaking spontaneous [Ca2+](i) transients. Strikingly, groups of apposing cells enhanced their [Ca2+](i) in synchrony with a speed of coactivation >1,000 mu m/s. Single-cell injection of Neurobiotin or Lucifer yellow labeled clusters of cells, which corresponded to coactive cells. Halothane, a gap junction blocker, markedly reduced the spread of tracers. Coupling between excitable cells was mainly homologous in nature, with a prevalence of growth hormone-containing cells. We conclude that spontaneously active endocrine cells are either single units or arranged in synchronized gap junction-coupled assemblies scattered throughout the anterior pituitary gland. Synchrony between spontaneously excitable cells may help shape the patterns of basal secretion.	CNRS, INSERM U469, Ctr Pharmacol & Endocrinol, F-34094 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Guerineau, NC (corresponding author), CNRS, INSERM U469, Ctr Pharmacol & Endocrinol, 141 Rue de la Cardonille, F-34094 Montpellier 5, France.	guerinea@u469.montp.inserm.fr	BONNEFONT, Xavier/AAH-3882-2019	BONNEFONT, Xavier/0000-0003-4778-4060; Guerineau, Nathalie/0000-0003-2517-4210				ALLAERTS W, 1990, MOL CELL ENDOCRINOL, V71, P73, DOI 10.1016/0303-7207(90)90244-3; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; Baker B.L., 1974, HDB PHYSIOLOGY END 1, V4, P45; BEROD A, 1981, J HISTOCHEM CYTOCHEM, V29, P844, DOI 10.1177/29.7.6167611; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; BURT JM, 1989, CIRC RES, V65, P829, DOI 10.1161/01.RES.65.3.829; CHEN ZP, 1995, P NATL ACAD SCI USA, V92, P5219, DOI 10.1073/pnas.92.11.5219; Corrette B., 1995, ELECTROPHYSIOLOGY NE, P101; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FLETCHER WH, 1975, J CELL BIOL, V67, P469, DOI 10.1083/jcb.67.2.469; FOMINA AF, 1995, J NEUROSCI, V15, P4982; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; GUERINEAU N, 1991, ENDOCRINOLOGY, V129, P409, DOI 10.1210/endo-129-1-409; Guerineau N. C., 1996, Society for Neuroscience Abstracts, V22, P1347; Guerineau NC, 1997, J NEUROSCI METH, V73, P169, DOI 10.1016/S0165-0270(97)02224-3; GYLFE E, 1991, CELL CALCIUM, V12, P229, DOI 10.1016/0143-4160(91)90023-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JOHNSTON MF, 1980, NATURE, V286, P498, DOI 10.1038/286498a0; Lee A. K., 1997, Society for Neuroscience Abstracts, V23, P95; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LIPSCOMBE D, 1988, NEURON, V1, P355, DOI 10.1016/0896-6273(88)90185-7; LLEDO PM, 1991, J PHYSIOL-LONDON, V437, P477, DOI 10.1113/jphysiol.1991.sp018607; MEDA P, 1979, J CELL BIOL, V82, P441, DOI 10.1083/jcb.82.2.441; MEDA P, 1993, ENDOCRINOLOGY, V133, P2371, DOI 10.1210/en.133.5.2371; MEISSNER HP, 1976, NATURE, V262, P502, DOI 10.1038/262502a0; MINTA A, 1989, J BIOL CHEM, V264, P8171; MOLLARD P, 1995, P NATL ACAD SCI USA, V92, P3065, DOI 10.1073/pnas.92.7.3065; Morand I, 1996, ENDOCRINOLOGY, V137, P3356, DOI 10.1210/en.137.8.3356; Moser T, 1997, J NEUROSCI, V17, P2314; Newman EA, 1997, SCIENCE, V275, P844, DOI 10.1126/science.275.5301.844; OZAWA S, 1977, EXPERIENTIA, V34, P542; PEREZ FM, 1990, ENDOCRINOLOGY, V127, P1877, DOI 10.1210/endo-127-4-1877; PLOTSKY PM, 1985, SCIENCE, V230, P461, DOI 10.1126/science.2864742; ROSENZWEIG LJ, 1982, ENDOCRINOLOGY, V111, P1817, DOI 10.1210/endo-111-6-1817; SAEZ JC, 1986, P NATL ACAD SCI USA, V83, P2473, DOI 10.1073/pnas.83.8.2473; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SCHLEGEL W, 1987, NATURE, V329, P719, DOI 10.1038/329719a0; SCHLEGEL W, 1995, ELECTROPHYSIOLOGY NE, P23; SCHNEGGENBURGER R, 1992, PFLUG ARCH EUR J PHY, V421, P364, DOI 10.1007/BF00374225; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SOJI T, 1989, ANAT RECORD, V224, P523, DOI 10.1002/ar.1092240410; Tordjmann T, 1997, EMBO J, V16, P5398, DOI 10.1093/emboj/16.17.5398; VILAPORCILE E, 1972, Z ZELLFORSCH MIK ANA, V129, P328, DOI 10.1007/BF00307293; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WILFINGER WW, 1984, TISSUE CELL, V16, P483, DOI 10.1016/0040-8166(84)90026-0; YAMAMOTO T, 1993, HISTOCHEMISTRY, V100, P53, DOI 10.1007/BF00268878; YORK DH, 1971, NEUROENDOCRINOLOGY, V8, P10, DOI 10.1159/000121989; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	51	66	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10389	10395		10.1074/jbc.273.17.10389	http://dx.doi.org/10.1074/jbc.273.17.10389			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553096	hybrid			2022-12-27	WOS:000073224200045
J	Miau, LH; Chang, CJ; Shen, BJ; Tsai, WH; Lee, SC				Miau, LH; Chang, CJ; Shen, BJ; Tsai, WH; Lee, SC			Identification of heterogeneous nuclear ribonucleoprotein K (hnRNP K) as a repressor of C/EBP beta-mediated gene activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BINDING PROTEIN; NF-KAPPA-B; RNA-BINDING; TRANSCRIPTION-FACTOR; EXPRESSION NF-IL6; MOLECULAR-CLONING; GLYCOPROTEIN GENE; IN-VITRO; FAMILY; DOMAIN	Transcription factor C/EBP beta has been known to regulate a wide array of genes including those involved in the acute-phase response. One of the molecular mechanisms underlying transcription activation by C/EBP beta is through protein-protein interaction with other transcription factors. Here we report the identification and characterization of physical and functional interactions between C/EBP beta and heterogeneous nuclear ribonucleoprotein (hnRNP) K. This interaction results in the repression of C/EBP beta-dependent trans-activation of the agp gene. Footprinting assays indicate that hnRNP K cannot bind to the promoter region of agp gene or interfere with the binding of C/EBP beta to its cognate DNA site. Furthermore, agp gene activation by the synergistic interaction of Nopp140 and C/EBP beta is abolished by hnRNP K. The kinetics of appearance of C/EBP beta-hnRNP It complex in the nuclear extract after initiation of acute-phase reaction indicates that hnRNP K functions as a negative regulator of C/EBP beta-mediated activation of agp gene.	Acad Sinica, Inst Biol Chem, Taipei, Taiwan; Natl Taiwan Univ, Inst Mol Med, Dr HL Tsai Mem Lab, Coll Med, Taipei 10764, Taiwan; Natl Taiwan Univ, Coll Sci, Inst Biochem Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Chang, CJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.		Chang, Ching-Jin/G-4511-2019					AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; Calkhoven CF, 1996, BIOCHEM J, V317, P329, DOI 10.1042/bj3170329; CAO Z, 1991, GENE DEV, V6, P1538; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; CULLEN BR, 1992, METHOD ENZYMOL, V216, P362; DEJGAARD K, 1994, J MOL BIOL, V236, P33, DOI 10.1006/jmbi.1994.1116; Denisenko ON, 1996, J BIOL CHEM, V271, P27701, DOI 10.1074/jbc.271.44.27701; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; ENGEBRECHT J, 1990, MOL CELL BIOL, V10, P2379, DOI 10.1128/MCB.10.5.2379; GAILLARD C, 1988, J VIROL, V62, P2380, DOI 10.1128/JVI.62.7.2380-2385.1988; GAILLARD C, 1994, NUCLEIC ACIDS RES, V22, P4183, DOI 10.1093/nar/22.20.4183; GAILLARD C, 1990, J MOL BIOL, V215, P245, DOI 10.1016/S0022-2836(05)80343-2; HOBERT O, 1994, J BIOL CHEM, V269, P20225; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; ISSHIKI H, 1991, NEW BIOL, V3, P63; ITO K, 1994, NUCLEIC ACIDS RES, V22, P53, DOI 10.1093/nar/22.1.53; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Lee YH, 1997, MOL CELL BIOL, V17, P2038, DOI 10.1128/MCB.17.4.2038; Lee YM, 1996, MOL CELL BIOL, V16, P4257; LEE YM, 1993, MOL CELL BIOL, V13, P432, DOI 10.1128/MCB.13.1.432; MARGULIES L, 1993, J BIOL CHEM, V268, P15096; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Miau LH, 1997, MOL CELL BIOL, V17, P230, DOI 10.1128/MCB.17.1.230; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; ROMAN C, 1990, GENE DEV, V4, P1404, DOI 10.1101/gad.4.8.1404; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SATO K, 1992, MOL CELL BIOL, V12, P2525, DOI 10.1128/MCB.12.6.2525; SEUNINGEN IV, 1995, BIOCHEMISTRY-US, V34, P5644; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; TOMONAGA T, 1995, J BIOL CHEM, V270, P4875, DOI 10.1074/jbc.270.9.4875; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068	44	64	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10784	10791		10.1074/jbc.273.17.10784	http://dx.doi.org/10.1074/jbc.273.17.10784			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553145	hybrid			2022-12-27	WOS:000073224200094
J	Bai, RL; Choe, K; Ewell, JB; Nguyen, NY; Hamel, E				Bai, RL; Choe, K; Ewell, JB; Nguyen, NY; Hamel, E			Direct photoaffinity labeling of cysteine-295 of alpha-tubulin by guanosine 5 '-triphosphate bound in the nonexchangeable site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGEABLE NUCLEOTIDE SITE; AMINO-ACID-SEQUENCE; DIMER DISSOCIATION; BETA-TUBULIN; FLUORESCENCE ANISOTROPY; PORCINE BRAIN; BINDING SITE; GTP; MICROTUBULES; POLYMERIZATION	The alpha beta-tubulin heterodimer has two high affinity guanosine 5'-triphosphate binding sites, so that purified tubulin usually contains two molecules of bound guanosine nucleotide. Half this nucleotide is freely exchangeable with exogenous guanine nucleotide, and its binding site has been readily localized to the beta-subunit, The remaining nonexchangeable guanosine 5'-triphosphate can only be released from tubulin by denaturing the protein. We replaced the exchangeable site nucleotide of tubulin with 2'-deoxyguanosine 5'-diphosphate, exposed the resulting tubulin to ultraviolet light, degraded the protein, and isolated ribose-containing peptide derived from the nonexchangeable site. A large cyanogen bromide peptide was recovered, and its further degradation with endoproteinase Glu-C established that cysteine-295 of alpha-tubulin was the major reactive amino acid cross-linked to guanosine by ultraviolet irradiation.	NIH, Frederick Canc Res & Dev Ctr, Div Canc Treatment & Diag,Dev Therapeut Program, Lab Drug Discovery Res & Dev, Frederick, MD 21702 USA; NIH, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Frederick, MD 21702 USA; US FDA, Ctr Biol Evaluat & Res, Facil Biotechnol Resources, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; US Food & Drug Administration (FDA)	Hamel, E (corresponding author), NIH, Bldg 37,Rm 5D02, Bethesda, MD 20892 USA.							ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; BURNS RG, 1995, J CELL SCI, V108, P2123; DETRICH HW, 1978, BIOCHEMISTRY-US, V17, P3900, DOI 10.1021/bi00612a002; GROVER S, 1994, EUR J BIOCHEM, V222, P163, DOI 10.1111/j.1432-1033.1994.tb18854.x; HAMEL E, 1984, BIOCHEMISTRY-US, V23, P4173, DOI 10.1021/bi00313a026; HAMEL E, 1986, BIOCHEMISTRY-US, V25, P7054, DOI 10.1021/bi00370a045; HAMEL E, 1990, BIOCHEMISTRY-US, V29, P2720, DOI 10.1021/bi00463a015; HAMEL E, 1984, BIOCHEMISTRY-US, V23, P5314, DOI 10.1021/bi00317a033; HESSE J, 1987, J BIOL CHEM, V262, P15472; JAYARAM B, 1994, J BIOL CHEM, V269, P3233; KOBAYASH.T, 1974, J BIOCHEM-TOKYO, V76, P201, DOI 10.1093/oxfordjournals.jbchem.a130546; KRAUHS E, 1981, P NATL ACAD SCI-BIOL, V78, P4156, DOI 10.1073/pnas.78.7.4156; LEVI A, 1974, BIOCHIM BIOPHYS ACTA, V365, P450, DOI 10.1016/0005-2795(74)90022-1; LINSE K, 1988, J BIOL CHEM, V263, P15205; MEJILLANO MR, 1989, BIOCHEMISTRY-US, V28, P6518, DOI 10.1021/bi00441a053; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1993, SCIENCE, V261, P1044, DOI 10.1126/science.8102497; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; PANDA D, 1992, BIOCHEMISTRY-US, V31, P9709, DOI 10.1021/bi00155a026; PONSTINGL H, 1981, P NATL ACAD SCI-BIOL, V78, P2757, DOI 10.1073/pnas.78.5.2757; SACKETT DL, 1989, BIOCHEMISTRY-US, V28, P2662, DOI 10.1021/bi00432a045; SACKETT DL, 1991, BIOCHEMISTRY-US, V30, P3511, DOI 10.1021/bi00228a023; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P885, DOI 10.1021/bi00170a006; SHIVANNA BD, 1993, J BIOL CHEM, V268, P1277; SPIEGELMAN BM, 1977, CELL, V12, P587, DOI 10.1016/0092-8674(77)90259-8; STERNLICHT H, 1987, FEBS LETT, V214, P226, DOI 10.1016/0014-5793(87)80061-3; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; WEISENBERG RC, 1976, BIOCHEMISTRY-US, V15, P4248, DOI 10.1021/bi00664a018	28	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9894	9897		10.1074/jbc.273.16.9894	http://dx.doi.org/10.1074/jbc.273.16.9894			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545331	hybrid			2022-12-27	WOS:000073128800077
J	Kriajevska, M; Tarabykina, S; Bronstein, I; Maitland, N; Lomonosov, M; Hansen, K; Georgiev, G; Lukanidin, E				Kriajevska, M; Tarabykina, S; Bronstein, I; Maitland, N; Lomonosov, M; Hansen, K; Georgiev, G; Lukanidin, E			Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; CELL-LINE; MAMMARY ADENOCARCINOMA; MESSENGER-RNAS; PEL98 PROTEIN; GENE; EXPRESSION; CALMODULIN; IDENTIFICATION; FAMILY	Mts1 protein (S100A4 according to a new classification) has been implicated in the formation of the metastatic phenotype via regulation of cell motility and invasiveness, Previously we have demonstrated that Mts1 protein interacted with the heavy chain of nonmuscle myosin in a calcium-dependent manner. To elucidate the role of the Mts1-myosin interaction, we mapped the Mts1-binding region on the myosin heavy chain molecule. We prepared proteolytically digested platelet myosin and a series of overlapped myosin heavy chain protein fragments and used them in a blot overlay with Mts1 protein. Here we report that the Mts1-binding site is located within a 29-amino acid region, at the C-terminal end of the myosin heavy chain (between 1909-1937 amino acids). Two-dimensional phosphopeptide analysis showed that Mts1 protein inhibits protein kinase C phosphorylation of the platelet myosin heavy chain at Ser-1917. We hypothesize that Mts1 protein regulates cytoskeletal dynamics of the metastatic cells through modulation of the myosin phosphorylation by protein kinase C in calcium-dependent fashion.	Danish Canc Soc, Div Canc Biol, DK-2100 Copenhagen, Denmark; Univ York, Dept Chem, York YO1 5DD, N Yorkshire, England; Yorkshire Canc Res Campaign, York YO1 5DD, N Yorkshire, England; Russian Acad Sci, Inst Gene Biol, Moscow B317, Russia	Danish Cancer Society; University of York - UK; University of York - UK; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Kriajevska, M (corresponding author), Danish Canc Soc, Div Canc Biol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.			Maitland, Norman/0000-0003-1607-9035; Kostenko, Anna/0000-0002-6372-778X; Hansen, Klaus/0000-0001-9657-8816				AFSHAR M, 1994, J MOL BIOL, V244, P554, DOI 10.1006/jmbi.1994.1752; Ambartsumian NS, 1996, ONCOGENE, V13, P1621; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BAUDIER J, 1995, BIOCHEMISTRY-US, V34, P7834, DOI 10.1021/bi00024a007; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; BLUMEJENSEN P, 1995, J BIOL CHEM, V270, P14192, DOI 10.1074/jbc.270.23.14192; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONTI MA, 1991, BIOCHEMISTRY-US, V30, P966, DOI 10.1021/bi00218a012; DANIEL JL, 1992, METHOD ENZYMOL, V215, P78; DAVIES BR, 1993, ONCOGENE, V8, P999; Davies MPA, 1996, ONCOGENE, V13, P1631; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; FODSTAD O, 1986, INT J CANCER, V38, P33, DOI 10.1002/ijc.2910380107; FORD HL, 1995, ONCOGENE, V11, P2067; FORD HL, 1995, ONCOGENE, V10, P1597; GIULIANO KA, 1990, CELL MOTIL CYTOSKEL, V16, P14, DOI 10.1002/cm.970160104; GRIGORIAN M, 1994, ELECTROPHORESIS, V15, P463, DOI 10.1002/elps.1150150163; Grigorian M, 1996, INT J CANCER, V67, P831, DOI 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4; GRIGORIAN MS, 1993, GENE, V135, P229, DOI 10.1016/0378-1119(93)90070-J; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KIEHART DP, 1990, CELL, V60, P347, DOI 10.1016/0092-8674(90)90583-Z; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; LUDOWYKE RI, 1994, CELL MOTIL CYTOSKEL, V29, P354, DOI 10.1002/cm.970290408; Maelandsmo GM, 1996, CANCER RES, V56, P5490; Mailliard WS, 1996, J BIOL CHEM, V271, P719, DOI 10.1074/jbc.271.2.719; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Murakami N, 1995, BIOCHEMISTRY-US, V34, P16046, DOI 10.1021/bi00049a019; PENCIL SD, 1993, BREAST CANCER RES TR, V25, P165, DOI 10.1007/BF00662141; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; SHEU FS, 1995, ARCH BIOCHEM BIOPHYS, V316, P335, DOI 10.1006/abbi.1995.1045; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; SPUDICH A, 1994, CELL MOTIL CYTOSKEL, V29, P345, DOI 10.1002/cm.970290407; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; TAKENAGA K, 1994, CELL STRUCT FUNCT, V19, P133, DOI 10.1247/csf.19.133; TAKENAGA K, 1994, J CELL BIOL, V124, P757, DOI 10.1083/jcb.124.5.757; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; TAKENAGA K, 1994, JPN J CANCER RES, V85, P831, DOI 10.1111/j.1349-7006.1994.tb02955.x; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; WATANABE Y, 1993, FEBS LETT, V324, P51, DOI 10.1016/0014-5793(93)81530-D; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	51	124	129	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9852	9856		10.1074/jbc.273.16.9852	http://dx.doi.org/10.1074/jbc.273.16.9852			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545325	hybrid			2022-12-27	WOS:000073128800071
J	Babu, BR; Griffith, OW				Babu, BR; Griffith, OW			N-5-(1-imino-5-butenyl)-L-ornithine - A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-L-ARGININE; AMINO-L-ARGININE; NG-METHYLARGININE; L-THIOCITRULLINE; BLOOD-PRESSURE; INHIBITOR; MACROPHAGE; POTENT; HYPOTENSION; HEME	Nitric oxide synthase (NOS) catalyzes the NADPH-and O-2-dependent conversion of L-arginine to nitric oxide (NO) and citrulline; three isoforms, the neuronal (nNOS), endothelial, and inducible, have been identified. Because overproduction of NO is known to contribute to several pathophysiological conditions, NOS inhibitors are of interest as potential therapeutic agents, Inhibitors that are potent, mechanism-based, and relatively selective for the NOS isoform causing pathology are of particular interest, In the present studies we report that vinyl-L-NIO (N-5-(1-imino-3-butenyl)-L-ornithine; L-VNIO) binds to and inhibits nNOS in competition with L-arginine (K-i = 100 nM); binding is accompanied by a type I optical difference spectrum consistent with binding near the heme cofactor without interaction as a sixth axial heme ligand. Such binding is fully reversible, However, in the presence of NADPH and O-2, L-VNIO irreversibly inactivates nNOS (K-inact = 0.078 min(-1); K-I = 90 nM); inactivation is Ca2+/calmodulin-dependent. The cytochrome c reduction activity of the enzyme is not affected by such treatment, but the L-arginine-independent NADPH oxidase activity of nNOS is lost in parallel with the overall activity. Spectral analyses establish that the nNOS heme cofactor is lost or modified by L-VNIO-mediated mechanism-based inactivation of the enzyme, The inducible isoform of NOS is not inactivated by L-VNIO, and the endothelial isoform requires 20-fold higher concentrations to attain similar to 75% of the rate of inactivation seen with nNOS, Among the NOS inactivating L-arginine derivatives, L-VNIO is the most potent and nNOS-selective reported to date.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Griffith, OW (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.				NIDDK NIH HHS [DK48423] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048423] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; AISAKA K, 1989, BIOCHEM BIOPH RES CO, V160, P881, DOI 10.1016/0006-291X(89)92517-5; Babu BR, 1997, FASEB J, V11, pA884; BAYDOUN AR, 1994, BIOCHEM BIOPH RES CO, V200, P726, DOI 10.1006/bbrc.1994.1511; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; CORBIN JL, 1974, ANAL BIOCHEM, V57, P310, DOI 10.1016/0003-2697(74)90080-3; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; FELDMAN PL, 1993, J MED CHEM, V36, P491, DOI 10.1021/jm00056a009; FREY C, 1994, J BIOL CHEM, V269, P26083; FUKUTO JM, 1990, BIOCHEM BIOPH RES CO, V168, P458, DOI 10.1016/0006-291X(90)92343-X; FURFINE ES, 1994, J BIOL CHEM, V269, P26677; FURFINE ES, 1993, BIOCHEMISTRY-US, V32, P8512, DOI 10.1021/bi00084a017; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Griffith O. W., 1997, Japanese Journal of Pharmacology, V75, p3P; Griffith O. W., 1996, METHODS NITRIC OXIDE, P187; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; GROSS SS, 1990, BIOCHEM BIOPH RES CO, V170, P96, DOI 10.1016/0006-291X(90)91245-N; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017; HIBBS JB, 1987, J IMMUNOL, V138, P550; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; KILBOURN RG, 1992, J NATL CANCER I, V84, P827, DOI 10.1093/jnci/84.11.827; KILBOURN RG, 1990, BIOCHEM BIOPH RES CO, V172, P1132, DOI 10.1016/0006-291X(90)91565-A; KILBOURN RG, 1995, CRIT CARE MED, V23, P1018, DOI 10.1097/00003246-199506000-00005; KILBOURN RG, 1992, J NATL CANCER I, V84, P1008, DOI 10.1093/jnci/84.13.1008; KILBOURN RG, 1990, P NATL ACAD SCI USA, V87, P3629, DOI 10.1073/pnas.87.9.3629; KILBOURN RG, 1994, J APPL PHYSIOL, V76, P1130, DOI 10.1152/jappl.1994.76.3.1130; KLATT P, 1994, J BIOL CHEM, V269, P1674; Lassen LH, 1997, LANCET, V349, P401, DOI 10.1016/S0140-6736(97)80021-9; Liu JW, 1996, BIOCHEMISTRY-US, V35, P13277, DOI 10.1021/bi961720e; MARLETTA MA, 1994, J MED CHEM, V37, P1899, DOI 10.1021/jm00039a001; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; McDonald KK, 1997, BBA-BIOMEMBRANES, V1324, P133, DOI 10.1016/S0005-2736(96)00226-X; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; MCMILLAN K, 1993, BIOCHEMISTRY-US, V32, P9875, DOI 10.1021/bi00089a001; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; NARAYANAN K, 1995, J BIOL CHEM, V270, P11103, DOI 10.1074/jbc.270.19.11103; NARAYANAN K, 1994, J MED CHEM, V37, P885, DOI 10.1021/jm00033a004; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; NISHIKAWA T, 1993, STROKE, V24, P1717, DOI 10.1161/01.STR.24.11.1717; OLKEN NM, 1993, BIOCHEMISTRY-US, V32, P9677, DOI 10.1021/bi00088a020; OLKEN NM, 1994, BIOCHEMISTRY-US, V33, P14784, DOI 10.1021/bi00253a017; OLKEN NM, 1992, J MED CHEM, V35, P1137, DOI 10.1021/jm00084a020; OMURA T, 1964, J BIOL CHEM, V239, P2370; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; RAND MJ, 1995, ANNU REV PHYSIOL, V57, P659; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; REIF DW, 1995, ARCH BIOCHEM BIOPHYS, V320, P170, DOI 10.1006/abbi.1995.1356; RICE ASC, 1995, NEUROSCI LETT, V187, P111, DOI 10.1016/0304-3940(95)11356-8; SCANNELL JP, 1972, J ANTIBIOT, V25, P179, DOI 10.7164/antibiotics.25.179; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Sennequier N, 1996, BIOCHEMISTRY-US, V35, P5883, DOI 10.1021/bi952844e; SESSA WC, 1994, J VASC RES, V31, P131, DOI 10.1159/000159039; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; UMANS JG, 1995, ANNU REV PHYSIOL, V57, P771, DOI 10.1146/annurev.ph.57.030195.004011; Vallance P, 1993, New Horiz, V1, P77; Wolff DJ, 1996, ARCH BIOCHEM BIOPHYS, V325, P227, DOI 10.1006/abbi.1996.0028	60	112	114	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8882	8889		10.1074/jbc.273.15.8882	http://dx.doi.org/10.1074/jbc.273.15.8882			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535869	hybrid			2022-12-27	WOS:000072990800046
J	Habuchi, H; Kobayashi, M; Kimata, K				Habuchi, H; Kobayashi, M; Kimata, K			Molecular characterization and expression of heparan-sulfate 6-sulfotransferase - Complete cDNA cloning in human and partial cloning in Chinese hamster ovary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; DEACETYLASE N-SULFOTRANSFERASE; BINDING SEQUENCE; PURIFICATION; PROTEOGLYCANS; BIOSYNTHESIS; RECEPTOR; PROTEIN; OLIGOSACCHARIDES; IDENTIFICATION	Heparan-sulfate 6-sulfotransferase (HS6ST) catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 6 of the N-sulfoglucosamine residue of heparan sulfate. The enzyme was purified to apparent homogeneity from the serum-free culture medium of Chinese hamster ovary (CHO) cells (Habuchi, H., Habuchi, O., and Kimata, K. (1995) J. Biol Chem. 270, 4172-4179). From the amino acid sequence data of the purified enzyme, degenerate oligonucleotides were designed and used as primers for the reverse transcriptase polymerase chain reaction using poly(A)(+) RNA from CHO cells as a template. The amplified cDNA fragment was then used as a probe to screen a cDNA library of CHO cells. The cDNA clone thus obtained encoded a partial peptide sequence composed of 236 amino acid residues that included the sequences of six peptides obtained after endoproteinase digestion of the purified enzyme. This cDNA clone was applied to the screening of a human fetal brain cDNA library by crosshybridization. The isolated cDNA clones contained a whole open reading frame that predicts a type II transmembrane protein composed of 401 amino acid residues. No significant amino acid sequence identity to any other proteins, including heparan-sulfate 2-sulfotransferases, was observed. When the cDNA for the entire coding sequence of the protein was inserted into a eukaryotic expression vector and transfected into COS-7 cells, the HS6ST activity increased 7-fold over the control. The FLAG fusion protein purified by anti-FLAG affinity chromatography showed the HS6ST activity alone. Northern blot analysis revealed the occurrence of a single transcript of 3.9 kilobases in both human fetal brain and CHO cells. The results, together with the ones from our recent cDNA analysis of heparan sulfate 2-sulfotransferase (Kobayashi, M., Habuchi, H., Yoneda, M., Habuchi, O., and Kimata, K. (1997) J. Biol. Chem. 272, 13980-13985), suggest that at least two different gene products are responsible for 6- and 2-O-sulfations of heparan sulfate.	Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan	Aichi Medical University	Kimata, K (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 48011, Japan.	kimata@amugw.acihi-med-u.ac.jp						ARUFFO A, 1991, CURRENT PROTOCOLS S, V14; ASHIKARI S, 1995, J BIOL CHEM, V270, P29586, DOI 10.1074/jbc.270.49.29586; BAI X, 1997, J BIOL CHEM, V272, P23712; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BERNFIELD M, 1992, ANN REV CELL BIOL, V8, P369; Binari RC, 1997, DEVELOPMENT, V124, P2623; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DIXON J, 1995, GENOMICS, V26, P239, DOI 10.1016/0888-7543(95)80206-2; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; Inki P, 1996, ANN MED, V28, P63, DOI 10.3109/07853899608999076; ISHIHARA M, 1993, J BIOL CHEM, V268, P4675; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P42; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAHL U, 1984, J BIOL CHEM, V259, P2368; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; LuuThe V, 1996, ANN NY ACAD SCI, V784, P137, DOI 10.1111/j.1749-6632.1996.tb16233.x; LYON M, 1994, J BIOL CHEM, V269, P11216; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; NAKA D, 1993, EXP CELL RES, V209, P317, DOI 10.1006/excr.1993.1316; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rapraeger AC, 1993, CURR OPIN CELL BIOL, V5, P844, DOI 10.1016/0955-0674(93)90034-N; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sakata H, 1997, J BIOL CHEM, V272, P9457; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Shworak NW, 1996, J BIOL CHEM, V271, P27063, DOI 10.1074/jbc.271.43.27063; SPILLMANN D, 1994, CURR OPIN STRUC BIOL, V4, P677, DOI 10.1016/S0959-440X(94)90165-1; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I; WLAD H, 1994, J BIOL CHEM, V269, P24538; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZHENG YQ, 1994, J BIOL CHEM, V269, P30313	56	77	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9208	9213		10.1074/jbc.273.15.9208	http://dx.doi.org/10.1074/jbc.273.15.9208			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535912	hybrid			2022-12-27	WOS:000072990800089
J	Hamill, DR; Howell, B; Cassimeris, L; Suprenant, KA				Hamill, DR; Howell, B; Cassimeris, L; Suprenant, KA			Purification of a WD repeat protein, EMAP, that promotes microtubule dynamics through an inhibition of rescue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL DOMAIN; VIDEO LIGHT-MICROSCOPY; SEA-URCHIN EGGS; BINDING DOMAINS; TAU-PROTEIN; MOLECULAR CHARACTERIZATION; INDIVIDUAL MICROTUBULES; TRANSITION FREQUENCIES; KINETIC STABILIZATION; MONOCLONAL-ANTIBODIES	The major microtubule-associated protein in echinoderms is a 77-kDa, WD repeat protein, called EMAP. EMAP-related proteins have been identified in sea urchins, starfish, sanddollars, and humans. We describe the purification of sea urchin EMAP and demonstrate that EMAP binding to microtubules is saturable at a molar ratio of 1 mol of EMAP to 3 mol of tubulin dimer. Unlike MAP-2, MAP-4, or tan proteins, EMAP binding to microtubules is not lost by cleavage of tubulin with subtilisin. In addition to binding to the microtubule polymer, EMAP binds to tubulin dimers in a 1:1 molar ratio. The abundance of EMAP in the egg suggests that it could function to regulate microtubule assembly. To test this hypothesis, we examined the effects of EMAP on the dynamic instability of microtubules nucleated from axoneme fragments as monitored by video-enhanced differential interference contrast microscopy. Addition of 2.2 mu M EMAP to 21 mu m tubulin results in a slight increase in the elongation and shortening velocities at the microtubule plus ends but not at the minus ends. Significantly, EMAP inhibits the frequency of rescue 8-fold without producing a change in the frequency of catastrophe. These results indicate that EMAP, unlike brain microtubule-associated proteins, promotes microtubule dynamics.	Univ Kansas, Dept Biochem Mol & Cell Biol, Lawrence, KS 66045 USA; Lehigh Univ, Dept Sci Biol, Bethlehem, PA 18015 USA	University of Kansas; Lehigh University	Suprenant, KA (corresponding author), Univ Kansas, Dept Biochem Mol & Cell Biol, 4010 Haworth Hall, Lawrence, KS 66045 USA.	ksupre@kuhub.cc.ukans.edu						AIZAWA H, 1991, J BIOL CHEM, V266, P9841; Andersen SSL, 1997, J CELL BIOL, V139, P975, DOI 10.1083/jcb.139.4.975; ANDERSEN SSL, 1994, J CELL BIOL, V127, P1289, DOI 10.1083/jcb.127.5.1289; Bandera CA, 1997, CANCER RES, V57, P513; BELL CW, 1982, METHOD CELL BIOL, V24, P373; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BLOOM GS, 1985, CELL MOTIL CYTOSKEL, V5, P431, DOI 10.1002/cm.970050602; Brisch E, 1996, J CELL SCI, V109, P2885; Brodeur GM, 1995, CANCER SURV, V25, P67; CARLIER MF, 1981, BIOCHEMISTRY-US, V20, P1918, DOI 10.1021/bi00510a030; CASSIMERIS L, 1993, CELL MOTIL CYTOSKEL, V26, P275, DOI 10.1002/cm.970260402; CHAPIN SJ, 1991, J CELL SCI, V98, P27; CHENEVIXTRENCH G, 1992, ONCOGENE, V7, P1059; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; DRESCHEL DN, 1992, MOL BIOL CELL, V3, P1141; Eudy JD, 1997, GENOMICS, V43, P104, DOI 10.1006/geno.1997.4779; GELFAND VI, 1991, ANNU REV CELL BIOL, V7, P93, DOI 10.1146/annurev.cb.07.110191.000521; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; HAMILL D, 1994, J CELL BIOL, V127, P973, DOI 10.1083/jcb.127.4.973; HILL TL, 1983, P NATL ACAD SCI-BIOL, V80, P7234, DOI 10.1073/pnas.80.23.7234; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIROKAWA N, 1987, J CELL BIOL, V104, P1553, DOI 10.1083/jcb.104.6.1553; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; ITOH TJ, 1994, CELL STRUCT FUNCT, V19, P279, DOI 10.1247/csf.19.279; JOHANSSON B, 1993, GENE CHROMOSOME CANC, V8, P205, DOI 10.1002/gcc.2870080402; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KELLER TCS, 1982, J CELL BIOL, V93, P788, DOI 10.1083/jcb.93.3.788; KOWALSKI RJ, 1993, CELL MOTIL CYTOSKEL, V26, P282, DOI 10.1002/cm.970260403; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LANGKOPF A, 1992, J BIOL CHEM, V267, P16561; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LI QW, 1994, J BIOL CHEM, V269, P31777; MACCIONI RB, 1986, EUR J BIOCHEM, V156, P375, DOI 10.1111/j.1432-1033.1986.tb09593.x; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; McNally FJ, 1996, CURR OPIN CELL BIOL, V8, P23, DOI 10.1016/S0955-0674(96)80044-5; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MURPHY DB, 1977, J MOL BIOL, V117, P33, DOI 10.1016/0022-2836(77)90021-3; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; PRYER NK, 1992, J CELL SCI, V103, P965; SALMON T, 1989, BIOTECHNIQUES, V7, P624; Saxena K, 1996, BIOCHEMISTRY-US, V35, P15215, DOI 10.1021/bi961616x; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; SCHNAPP BJ, 1986, METHOD ENZYMOL, V134, P561; SCHOLEY JM, 1984, J BIOL CHEM, V259, P6516; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; SIMON JR, 1992, CELL MOTIL CYTOSKEL, V21, P1, DOI 10.1002/cm.970210102; SIMON JR, 1990, J CELL SCI, V96, P571; SLOBODA RD, 1976, BIOCHEMISTRY-US, V15, P4497, DOI 10.1021/bi00665a026; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; SUPRENANT KA, 1987, J CELL SCI, V87, P71; Suprenant KA, 1995, CURR TOP DEV BIOL, V31, P65; SUPRENANT KA, 1993, J CELL SCI, V104, P445; SUPRENANT KA, 1989, CELL MOTIL CYTOSKEL, V14, P401, DOI 10.1002/cm.970140310; SUPRENANT KA, 1993, CELL MOTIL CYTOSKEL, V25, P1, DOI 10.1002/cm.970250102; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; VALLEE RB, 1983, P NATL ACAD SCI-BIOL, V80, P6259, DOI 10.1073/pnas.80.20.6259; Vandecandelaere A, 1996, CELL MOTIL CYTOSKEL, V35, P134, DOI 10.1002/(SICI)1097-0169(1996)35:2<134::AID-CM6>3.0.CO;2-A; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; VOTER WA, 1984, J BIOL CHEM, V259, P430; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201	80	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9285	9291		10.1074/jbc.273.15.9285	http://dx.doi.org/10.1074/jbc.273.15.9285			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535922	hybrid			2022-12-27	WOS:000072990800099
J	Parissenti, AM; Kirwan, AF; Kim, SA; Colantonio, CM; Schimmer, BP				Parissenti, AM; Kirwan, AF; Kim, SA; Colantonio, CM; Schimmer, BP			Inhibitory properties of the regulatory domains of human protein kinase C alpha and mouse protein kinase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; PSEUDOSUBSTRATE PROTOTOPE; LIPID-BINDING; ACTIVATION; CONTAINS; PHOSPHATIDYLSERINE; SEQUENCE; ISOZYMES; SITE	Two fusion proteins in which the regulatory domains of human protein kinase C alpha (R alpha; amino acids 1-270) or mouse protein kinase C epsilon (R epsilon; amino acids 1-385) were linked in frame with glutathione S-transferase (GST) were examined for their abilities to inhibit the catalytic activities of protein kinase C alpha (PKC alpha; and other protein kinases in vitro, Both GST-R alpha and GST-R epsilon but not GST itself potently inhibited the activities of lipid-activated rat brain PKC alpha, In contrast, the fusion proteins had little or no inhibitory effect on the activities of the Ser/Thr protein kinases cAMP-dependent protein kinase, cGMP-dependent protein kinase, casein kinase II, myosin light chain kinase, and mitogen activated protein kinase or on the src Tyr kinase, GST-R alpha and GST-R epsilon, on a molar basis, were 100-200-fold more potent inhibitors of PKC alpha activity than was the pseudosubstrate peptide PKC19-36, In addition, a GST-R alpha fusion protein in which the first 32 amino acids of R alpha were deleted (including the pseudosubstrate sequence from amino acids 19-31) was an effective competitive inhibitor of PKC alpha activity, The three GST-R fusion proteins also inhibited protamine-activated PKC alpha and proteolytically activated PKC alpha (PKM), two lipid-independent forms of PKC alpha; however, the IC50 values for inhibition were 1 order of magnitude greater than the IC50 values obtained in the presence of lipid, These results suggest that part of the inhibitory effect of the GST-R fusion proteins on lipid-activated PKC alpha may have resulted from sequestration of lipid activators, Nonetheless, as evidenced by their abilities to inhibit the lipid-independent forms of the enzyme, the GST-R fusion proteins also inhibited PKC alpha catalytic activity through direct interactions, These data indicate that the R domains of PKC alpha and PKC epsilon are specific inhibitors of protein kinase C alpha activity and suggest that regions of the R domain outside the pseudosubstrate sequence contribute to autoinhibition of the enzyme.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L6, Canada; NE Ontario Reg Canc Ctr, Dept Res, Sudbury, ON P3E 5J1, Canada; Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada	University of Toronto; University of Toronto; Laurentian University	Schimmer, BP (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.							AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; BAZZI MD, 1992, J BIOL CHEM, V267, P22891; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P115, DOI 10.1021/bi00375a017; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; HOUSE C, 1990, CELL SIGNAL, V2, P187, DOI 10.1016/0898-6568(90)90022-3; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG K-P, 1990, Biofactors, V2, P171; HUANG KP, 1986, J BIOL CHEM, V261, P4781; Hundle B, 1997, J BIOL CHEM, V272, P15028, DOI 10.1074/jbc.272.23.15028; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; KAHN SM, 1994, CARCINOGENESIS, V15, P2919, DOI 10.1093/carcin/15.12.2919; KEMP BE, 1983, P NATL ACAD SCI-BIOL, V80, P7471, DOI 10.1073/pnas.80.24.7471; KEMP BE, 1977, J BIOL CHEM, V252, P488; KUNZEL EA, 1987, J BIOL CHEM, V262, P9136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MH, 1986, J BIOL CHEM, V261, P4867; LEHEL C, 1995, P NATL ACAD SCI USA, V92, P1406, DOI 10.1073/pnas.92.5.1406; LEVENTHAL PS, 1993, J BIOL CHEM, V268, P13906; LIAO L, 1994, CELL GROWTH DIFFER, V5, P1185; MAKOWSKE M, 1989, J BIOL CHEM, V264, P16155; MAURER MC, 1992, BIOCHEMISTRY-US, V31, P7714, DOI 10.1021/bi00148a036; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; ORR JW, 1994, J BIOL CHEM, V269, P8383; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; Parissenti AM, 1996, J CELL PHYSIOL, V166, P609, DOI 10.1002/(SICI)1097-4652(199603)166:3<609::AID-JCP16>3.0.CO;2-1; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; RIEDEL H, 1993, MOL CELL BIOL, V13, P4728, DOI 10.1128/MCB.13.8.4728; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; SELBIE LA, 1993, J BIOL CHEM, V268, P24296; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	34	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8940	8945		10.1074/jbc.273.15.8940	http://dx.doi.org/10.1074/jbc.273.15.8940			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535877	hybrid			2022-12-27	WOS:000072990800054
J	Citterio, E; Rademakers, S; van der Horst, GTJ; van Gool, AJ; Hoeijmakers, JHJ; Vermeulen, W				Citterio, E; Rademakers, S; van der Horst, GTJ; van Gool, AJ; Hoeijmakers, JHJ; Vermeulen, W			Biochemical and biological characterization of wild-type and ATPase-deficient Cockayne syndrome B repair protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SWI/SNF COMPLEX; DNA-REPAIR; XERODERMA-PIGMENTOSUM; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; ACTIVE GENES; BTF2 TFIIH; DHFR GENE; HELICASE; BINDING	Cockayne syndrome (CS) is a nucleotide excision repair disorder characterized by sun (UV) sensitivity and severe developmental problems. Two genes have been shown to be involved: CSA and CSB. Both proteins play an essential role in preferential repair of transcription-blocking lesions from active genes. In this study we report the purification and characterization of baculovirus-produced HA-His(6)-tagged CSB protein (dtCSB), using a highly efficient three-step purification protocol. Microinjection of dtCSB protein in CS-B fibroblasts shows that it is biologically functional in vivo. dtCSB exhibits DNA-dependent ATPase activity, stimulated by naked as well as nucleosomal DNA. Using structurally defined DNA oligonucleotides, we show that double-stranded DNA and double-stranded DNA with partial single-stranded character but not true single-stranded DNA act as efficient cofactors for CSB ATPase activity. Using a variety of substrates, no overt DNA unwinding by dtCSB could be detected, as found with other SNF2/SWI2 family proteins. By site-directed mutagenesis the invariant lysine residue in the NTP-binding motif of CSB was substituted with a physicochemically related arginine, As expected, this mutation abolished ATPase activity. Surprisingly, the mutant protein was nevertheless able to partially rescue the defect in recovery of RNA synthesis after UV upon microinjection in CS-B fibroblasts, These results indicate that integrity of the conserved nucleotide-binding domain is important for the in vivo function of CSB but that also other properties independent from ATP hydrolysis may contribute to CSB biological functions.	Erasmus Univ, Dept Cell Biol & Genet, Ctr Med Genet, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Dept Cell Biol & Genet, Ctr Med Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	hoeijmakers@gen.fgg.eur.nl	Hoeijmakers, Jan/AAX-6972-2021; van Gool, Alain J./L-4328-2015; van der Horst, Gijsbertus TJ/E-3661-2015; van Gool, Alain J/G-3806-2010; Vermeulen, Wim/W-8708-2019	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Vermeulen, Wim/0000-0003-3616-734X; van Gool, Alain/0000-0003-0010-5286; Citterio, Elisabetta/0000-0003-2347-3495				AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; BARETTINO D, 1994, NUCLEIC ACIDS RES, V22, P541, DOI 10.1093/nar/22.3.541; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BOOTSMA D, 1997, GENETIC BASIS HUMAN, pCH9; BOOTSMA D, 1996, GENETIC BASIS HUMAN, V65, P135; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GEORGE JW, 1994, J MOL BIOL, V235, P424, DOI 10.1006/jmbi.1994.1003; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; GORBALENYA AE, 1993, NUCLEIC ACIDS RES, V17, P4713; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; HOEIJMAKERS JHJ, 1994, EUR J CANCER, V30A, P1912, DOI 10.1016/0959-8049(94)00381-E; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; LEHMANN A R, 1987, Cancer Reviews, V7, P82; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; MAYNE LV, 1982, CANCER RES, V42, P1473; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Peterson CL, 1996, CURR OPIN GENET DEV, V6, P171, DOI 10.1016/S0959-437X(96)80047-5; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VANVUUREN AJ, 1994, EMBO J, V13, P1645, DOI 10.1002/j.1460-2075.1994.tb06428.x; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4; Winkler GS, 1998, J BIOL CHEM, V273, P1092, DOI 10.1074/jbc.273.2.1092; Wood Richard D., 1995, Methods (Orlando), V7, P163, DOI 10.1006/meth.1995.1022	52	91	91	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11844	11851		10.1074/jbc.273.19.11844	http://dx.doi.org/10.1074/jbc.273.19.11844			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565609	Green Published, hybrid			2022-12-27	WOS:000073536700063
J	Froesch, BA; Takayama, S; Reed, JC				Froesch, BA; Takayama, S; Reed, JC			BAG-1L protein enhances androgen receptor function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT VENTRAL PROSTATE; DNA-BINDING DOMAIN; RESPONSE ELEMENT; MAMMARY-TUMOR; BASAL CELLS; IN-VIVO; GENE; RESISTANCE; CLONING; CANCER	BAG-1 is a regulator of heat shock protein (Hsp) 70/ Hsc70 family proteins that interacts with steroid hormone receptors, The recently identified BAG-1 long (BAG-1L) protein, an isoform of BAG-1 that arises from translation initiation at a noncanonical CUG codon, was co-immunoprecipitated with androgen receptors (AR) from LNCaP prostate cancer cells and other cell lysates, whereas the shorter originally identified BAG-1 and BAG-1M (RAP 46) proteins were not. BAG-IL, but not BAG-1 or BAG-1M (RAP46), also markedly enhanced the ability of AR to transactivate reporter gene plasmids containing an androgen response element (ARE) in PC3 prostate cancer and other cell lines. A C-terminal region deletion mutant of BAG-IL failed to co-immunoprecipitate with AR and functioned as a trans-dominant inhibitor of BAG-IL, impairing AR-induced transactivation of ARE-containing reporter plasmids, In addition, BAG-IL significantly reduced the concentrations of 5 alpha-dihydrotestosterone (DHT) required for AR activity but did not induce Ligand-independent transactivation, BAG-IL also markedly improved the ability of AR to transactivate reporter genes when cells were cultured with DHT in combination with the anti-androgen cyproterone acetate. The effects of BAG-IL on AR could not be explained by detectable alterations in the DHT-induced translocation of AR from cytosol to nucleus, nor by BAG-1L-induced increases in the amounts of AR protein. These findings implicate BAG-IL in the regulation of AR function and may have relevance to mechanisms of prostate cancer resistance to hormone-ablative and anti-androgen therapy.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham-inst.org			NCI NIH HHS [CA-67329] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA067329] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BONKHOFF H, 1994, HUM PATHOL, V25, P42, DOI 10.1016/0046-8177(94)90169-4; BONKHOFF H, 1994, PROSTATE, V24, P114, DOI 10.1002/pros.2990240303; COETZEE GA, 1994, J NATL CANCER I, V86, P872, DOI 10.1093/jnci/86.11.872; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Koivisto P, 1997, CANCER RES, V57, P314; Krajewski S, 1996, ANAL BIOCHEM, V236, P221, DOI 10.1006/abio.1996.0160; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; LANDEL CC, 1994, MOL ENDOCRINOL, V8, P1407, DOI 10.1210/me.8.10.1407; LEE HJ, 1993, BIOCHEM BIOPH RES CO, V194, P97, DOI 10.1006/bbrc.1993.1790; MARCELLI M, 1992, J ENDOCRINOL INVEST, V15, P149, DOI 10.1007/BF03348684; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; MCPHAUL MJ, 1991, FASEB J, V5, P2910, DOI 10.1096/fasebj.5.14.1752359; MCPHAUL MJ, 1993, J CLIN ENDOCR METAB, V76, P17, DOI 10.1210/jc.76.1.17; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; MOWSZOWICZ I, 1993, MOL ENDOCRINOL, V7, P861, DOI 10.1210/me.7.7.861; NIELSEN DA, 1989, ANAL BIOCHEM, V179, P19, DOI 10.1016/0003-2697(89)90193-0; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; PRATT WB, 1994, SEMIN CELL BIOL, V5, P83; REED JC, 1991, CANCER RES, V51, P6529; Sambrook J., 2002, MOL CLONING LAB MANU; Selkirk James K., 1994, Applied and Theoretical Electrophoresis, V4, P11; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; SOEFFING WJ, 1995, J ANDROL, V16, P197; SRINIVASAN G, 1994, MOL ENDOCRINOL, V8, P189, DOI 10.1210/me.8.2.189; Takayama S, 1996, GENOMICS, V35, P494, DOI 10.1006/geno.1996.0389; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; VELDSCHOLTE J, 1994, J STEROID BIOCHEM, V49, P341, DOI 10.1016/0960-0760(94)90277-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483; ZEINER M, 1995, P NATL ACAD SCI USA, V92, P11465, DOI 10.1073/pnas.92.25.11465	41	155	165	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11660	11666		10.1074/jbc.273.19.11660	http://dx.doi.org/10.1074/jbc.273.19.11660			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565586	hybrid			2022-12-27	WOS:000073536700040
J	Steinert, PM; Kartasova, T; Marekov, LN				Steinert, PM; Kartasova, T; Marekov, LN			Biochemical evidence that small proline-rich proteins and trichohyalin function in epithelia by modulation of the biomechanical properties of their cornified cell envelopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; CROSS-LINKED ENVELOPE; HUMAN LORICRIN; INTERMEDIATE FILAMENTS; PRECURSOR PROTEINS; RETINOIC ACID; EXPRESSION; CALCIUM; FAMILY; GENE	The cornified cell envelope (CE) is a specialized structure involved in barrier function in stratified squamous epithelia, and is assembled by transglutaminase cross-linking of several proteins. Murine forestomach epithelium undergoes particularly rigorous mechanical trauma, and these CEs contain the highest known content of small proline-rich proteins (SPRs). Sequencing analyses of these CEs revealed that SPRs function as cross-bridgers by joining other proteins by use of multiple adjacent glutamines and lysines on only the amino and carboxyl termini and in functionally non-polar ways. Forestomach CEs also use trichohyalin as a novel cross-bridging protein. We performed mathematical modeling of amino acid compositions of the CEs of mouse and human epidermis of different body sites. Although the sum of loricrin + SPRs was conserved, the amount of SPRs varied in relation to the presumed physical requirements of the tissues. Our data suggest that SPRs could serve as modifiers of a composite CE material composed of mostly loricrin; we propose that increasing amounts of cross-bridging SPRs modify the structure of the CE, just as cross-linking proteins strengthen other types of tissues. In this way, different epithelia may use varying amounts of the cross-bridging SPRs to alter the biomechanical properties of the tissue in accordance with specific physical requirements and functions.	NIAMS, Skin Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Steinert, PM (corresponding author), NIAMS, Skin Biol Lab, NIH, Bldg 6,Rm 425,9000 Rockville Pike, Bethesda, MD 20892 USA.	pemast@helix.nih.gov						ABERNETHY JL, 1977, J BIOL CHEM, V252, P1837; AN G, 1993, J BIOL CHEM, V268, P10977; Austin SJ, 1996, J BIOL CHEM, V271, P3737, DOI 10.1074/jbc.271.7.3737; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; DOWNING DT, 1993, DERMATOLOGY GEN MED, P210; Elias Peter M., 1996, Journal of Dermatology (Tokyo), V23, P756; FIETZ MJ, 1993, J CELL BIOL, V121, P855, DOI 10.1083/jcb.121.4.855; Fraser R.D.B., 1972, KERATINS THEIR COMPO; Fujimoto W, 1997, J INVEST DERMATOL, V108, P200, DOI 10.1111/1523-1747.ep12334240; GERSTLE FP, 1985, ENCY POLYM SCI ENG, V3, P254; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; GRECO MA, 1995, J INVEST DERMATOL, V104, P204, DOI 10.1111/1523-1747.ep12612759; HARDING HWJ, 1976, BIOCHIM BIOPHYS ACTA, V427, P315, DOI 10.1016/0005-2795(76)90307-X; HOHL D, 1990, DERMATOLOGICA, V180, P201, DOI 10.1159/000248031; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; HOHL D, 1991, J INVEST DERMATOL, V96, P414, DOI 10.1111/1523-1747.ep12469779; HOHL D, 1991, J BIOL CHEM, V266, P6626; HOHL D, 1993, DIFFERENTIATION, V54, P5; Hohl Daniel, 1993, P151; Holbrook K.A., 1993, DERMATOLOGY GEN MED, P97; Jarnik M, 1998, J CELL SCI, V111, P1051; Jarnik M, 1996, J CELL SCI, V109, P1381; Jones LN, 1996, DERMATOL CLIN, V14, P633, DOI 10.1016/S0733-8635(05)70390-9; Kartasova T, 1996, J INVEST DERMATOL, V106, P294, DOI 10.1111/1523-1747.ep12340741; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2195, DOI 10.1128/MCB.8.5.2195; KIMONIS V, 1994, J INVEST DERMATOL, V103, P764, DOI 10.1111/1523-1747.ep12412771; LEE SC, 1993, J BIOL CHEM, V268, P12164; MARTINET N, 1988, BIOCHEM J, V271, P305; MARVIN KW, 1992, P NATL ACAD SCI USA, V89, P11026, DOI 10.1073/pnas.89.22.11026; MATOLTSY AG, 1966, J INVEST DERMATOL, V46, P127, DOI 10.1038/jid.1966.19; MICHEL S, 1988, J INVEST DERMATOL, V91, P11, DOI 10.1111/1523-1747.ep12463281; MICHEL S, 1987, J INVEST DERMATOL, V88, P301, DOI 10.1111/1523-1747.ep12466177; OKEEFE EJ, 1993, J INVEST DERMATOL, V101, pS65, DOI 10.1111/1523-1747.ep12362866; Orwin D F, 1979, Int Rev Cytol, V60, P331, DOI 10.1016/S0074-7696(08)61266-8; Owens DM, 1996, J INVEST DERMATOL, V106, P647, DOI 10.1111/1523-1747.ep12345463; REDDY SPM, 1995, J BIOL CHEM, V270, P26451, DOI 10.1074/jbc.270.44.26451; Reichert Uwe, 1993, P107; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; RODBARD D, 1974, ELECTROPHORESIS ISOE, P28; Rogers G, 1997, J INVEST DERMATOL, V108, P700, DOI 10.1111/1523-1747.ep12292083; ROGERS GE, 1964, EPIDERMIS, P179; RSUGUWARA K, 1979, AGR BIOL CHEM TOKYO, V43, P2543; SCHWEIZER J, 1988, CELL TISSUE RES, V253, P221; SIMON M, 1984, CELL, V36, P827, DOI 10.1016/0092-8674(84)90032-1; SIMON M, 1994, KERATINOCYTE HDB, P275; Steinert P M, 1995, Cell Death Differ, V2, P33; STEINERT PM, 1978, BIOCHEMISTRY-US, V17, P5045, DOI 10.1021/bi00616a029; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; STEINERT PM, 1993, J INVEST DERMATOL, V100, P729, DOI 10.1111/1523-1747.ep12475665; STEINERT PM, 1969, BIOCHIM BIOPHYS ACTA, V175, P1, DOI 10.1016/0005-2795(69)90138-X; STEVEN AC, 1994, J CELL SCI, V107, P693; STIENERT PM, 1997, J BIOL CHEM, V272, P2021; SWARTZENDRUBER DC, 1987, J INVEST DERMATOL, V88, P709, DOI 10.1111/1523-1747.ep12470383; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; YONEDA K, 1993, P NATL ACAD SCI USA, V90, P10754, DOI 10.1073/pnas.90.22.10754	60	91	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11758	11769		10.1074/jbc.273.19.11758	http://dx.doi.org/10.1074/jbc.273.19.11758			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565599	hybrid			2022-12-27	WOS:000073536700053
J	Walther, T; Balschun, D; Voigt, JP; Fink, H; Zuschratter, W; Birchmeier, C; Ganten, D; Bader, M				Walther, T; Balschun, D; Voigt, JP; Fink, H; Zuschratter, W; Birchmeier, C; Ganten, D; Bader, M			Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEVATED PLUS-MAZE; RAT-BRAIN; NERVOUS-SYSTEM; WATER MAZE; HIPPOCAMPUS; RECEPTOR; ONCOGENE; MOUSE; PERFORMANCE; EXPRESSION	The Mas protooncogene is a maternally imprinted gene encoding an orphan G protein-coupled receptor expressed mainly in forebrain and testis, Here, we provide evidence for a function of Mas in the central nervous system. Targeted disruption of the Mas protooncogene leads to an increased durability of long term potentiation in the dentate gyrus, without affecting hippocampal morphology, basal synaptic transmission, and presynaptic function. In addition, Mas(-/-) mice show alterations in the onset of depotentiation, The permissive influence of Mas ablation on hippocampal synaptic plasticity is paralleled by behavioral changes. While spatial learning in the Morris water maze is not significantly influenced, Mas-deficient animals display an increased anxiety as assessed in the elevated-plus maze. Thus, Mas is an important modulating factor in the electrophysiology of the hippocampus and is involved in behavioral pathways in the adult brain.	Max Delbruck Ctr Mol Med, MDC, D-13122 Berlin, Germany; Transgen Berlin Buch GMBH, Berlin, Germany; Inst Neurobiol, D-39008 Magdeburg, Germany; Humboldt Univ, Fac Med Charite, Inst Pharmacol & Toxicol, D-10098 Berlin, Germany; Free Univ Berlin, Dept Clin Pharmacol, D-12200 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Institut fur Neurobiologie (LIN); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Bader, M (corresponding author), Max Delbruck Ctr Mol Med, MDC, Robert Rossle Str 10, D-13122 Berlin, Germany.	mbader@mdc-berlin.de	Bader, Michael/K-2124-2013	Bader, Michael/0000-0003-4780-4164				Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; AMBROZ C, 1991, BIOCHIM BIOPHYS ACTA, V1133, P107, DOI 10.1016/0167-4889(91)90248-V; ANDERSEN P, 1960, ACTA PHYSIOL SCAND, V48, P178, DOI 10.1111/j.1748-1716.1960.tb01856.x; ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; Armstrong DL, 1996, PEPTIDES, V17, P689, DOI 10.1016/0196-9781(96)00030-7; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BARRIONUEVO G, 1980, LIFE SCI, V27, P2385, DOI 10.1016/0024-3205(80)90509-3; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUNNEMANN B, 1990, NEUROSCI LETT, V114, P147, DOI 10.1016/0304-3940(90)90063-F; BUNNEMANN B, 1991, ADV NEUROSC, V1, P131; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; CURTIS DR, 1960, J PHYSL, V183, P341; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; DANSCHER G, 1976, BRAIN RES, V112, P442, DOI 10.1016/0006-8993(76)90302-4; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; Doyere V, 1997, J NEUROPHYSIOL, V77, P571, DOI 10.1152/jn.1997.77.2.571; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hall JG, 1997, ANNU REV MED, V48, P35; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; KAISER FC, 1992, NEUROREPORT, V3, P922, DOI 10.1097/00001756-199210000-00026; KOLLER M, 1979, NEUROSCI LETT, V14, P71, DOI 10.1016/0304-3940(79)95346-1; KOROL DL, 1993, HIPPOCAMPUS, V3, P127, DOI 10.1002/hipo.450030204; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEE EHY, 1995, PEPTIDES, V16, P1069, DOI 10.1016/0196-9781(95)00073-S; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; MARTIN KA, 1993, MOL BRAIN RES, V19, P303, DOI 10.1016/0169-328X(93)90129-D; MARTIN KA, 1992, DEV BRAIN RES, V68, P75, DOI 10.1016/0165-3806(92)90249-V; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; METZGER R, 1995, FEBS LETT, V357, P27, DOI 10.1016/0014-5793(94)01292-9; MONNOT C, 1991, MOL ENDOCRINOL, V5, P1477, DOI 10.1210/mend-5-10-1477; MORGAN JM, 1977, SCIENCE, V196, P87, DOI 10.1126/science.402696; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Riesewijk AM, 1996, GENOMICS, V35, P380, DOI 10.1006/geno.1996.0372; ROGERS JH, 1992, NEUROSCIENCE, V51, P843, DOI 10.1016/0306-4522(92)90525-7; ROSS PC, 1990, P NATL ACAD SCI USA, V87, P3052, DOI 10.1073/pnas.87.8.3052; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; SCHWEGLER H, 1981, SCIENCE, V214, P817, DOI 10.1126/science.7292015; Schweifer N, 1997, GENOMICS, V43, P285, DOI 10.1006/geno.1997.4816; Staubli U, 1996, J NEUROSCI, V16, P853; TIMM F, 1958, Z ZELLFORSCH MIK ANA, V48, P548, DOI 10.1007/BF00342730; TIMM F, 1962, ACTA HISTOCHEM JEN S, V3, P142; VILLAR AJ, 1994, NAT GENET, V8, P373, DOI 10.1038/ng1294-373; Wagner JJ, 1996, HIPPOCAMPUS, V6, P24, DOI 10.1002/(SICI)1098-1063(1996)6:1<24::AID-HIPO5>3.0.CO;2-7; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Wilson W, 1996, BRAIN RES, V729, P1; WOLF G, 1990, AM J PHYSIOL, V259, pF768, DOI 10.1152/ajprenal.1990.259.5.F768; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P5339, DOI 10.1073/pnas.85.14.5339	54	163	167	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11867	11873		10.1074/jbc.273.19.11867	http://dx.doi.org/10.1074/jbc.273.19.11867			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565612	hybrid			2022-12-27	WOS:000073536700066
J	Chandler, JM; Cohen, GM; MacFarlane, M				Chandler, JM; Cohen, GM; MacFarlane, M			Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRMA-INHIBITABLE PROTEASE; MEDIATED APOPTOSIS; POLY(ADP-RIBOSE) POLYMERASE; CPP32-LIKE PROTEASES; CELL-DEATH; ICE-LIKE; IN-VIVO; ENZYME; MICE; INVOLVEMENT	Caspases plays a key role in the execution phase of apoptosis. "Initiator" caspases, such as caspase-8, activate "effector" caspases, such as caspase-3 and -7, which subsequently cleave cellular substrates thereby precipitating the dramatic morphological changes of apoptosis. Following treatment of mice with an agonistic anti-Fas antibody to induce massive hepatocyte apoptosis, we now demonstrate a distinct subcellular localization of the effector caspases-3 and -7. Active caspase-3 is confined primarily to the cytosol, whereas active caspase-7 is associated almost exclusively with the mitochondrial and microsomal fractions. These data suggest that caspases-3 and -7 exert their primary functions in different cellular compartments and offer a possible explanation of the presence of caspase homologs with overlapping substrate specificities. Translocation and activation of caspase-7 to the exoplasmic reticulum correlates with the proteolytic cleavage of the endoplasmic reticular-specific substrate, sterol regulatory element-binding protein 1. Liver damage, induction of apoptosis, activation and translocation of caspase-7, and proteolysis of sterol regulatory element-binding protein 1 are all blocked by the caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone (Z-VAD.fmk). Our data demonstrate for the first time the differential subcellular compartmentalization of specific effector caspases following the induction of apoptosis in vivo.	Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	MacFarlane, M (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mm21@le.ac.uk	Cohen, Gerald M/A-1687-2008					ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; AYALA JM, 1994, J IMMUNOL, V153, P2592; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Boulakia CA, 1996, ONCOGENE, V12, P529; Chandler JM, 1997, BIOCHEM J, V322, P19, DOI 10.1042/bj3220019; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Kamada S, 1997, ONCOGENE, V15, P285, DOI 10.1038/sj.onc.1201192; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; MacFarlane M, 1997, J CELL BIOL, V137, P469, DOI 10.1083/jcb.137.2.469; Manson MM, 1997, CARCINOGENESIS, V18, P1729, DOI 10.1093/carcin/18.9.1729; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pai JT, 1996, P NATL ACAD SCI USA, V93, P5437, DOI 10.1073/pnas.93.11.5437; Polverino AJ, 1997, J BIOL CHEM, V272, P7013, DOI 10.1074/jbc.272.11.7013; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Rouquet N, 1996, CURR BIOL, V6, P1192, DOI 10.1016/S0960-9822(02)70688-X; Schlegel J, 1996, J BIOL CHEM, V271, P1841, DOI 10.1074/jbc.271.4.1841; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	39	218	224	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10815	10818		10.1074/jbc.273.18.10815	http://dx.doi.org/10.1074/jbc.273.18.10815			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556551	hybrid			2022-12-27	WOS:000073395200003
J	Giulivi, C; Poderoso, JJ; Boveris, A				Giulivi, C; Poderoso, JJ; Boveris, A			Production of nitric oxide by mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ENDOTHELIAL-CELLS; RELAXING FACTOR; HYDROGEN-PEROXIDE; NITROGEN-OXIDES; SYNTHASE; ENZYME; ARGININE; PALMITOYLATION; OXYHEMOGLOBIN	The production of NO. by mitochondria was investigated by electron paramagnetic resonance using the spin-trapping technique, and by the oxidation of oxymyoglobin. Percoll-purified rat liver mitochondria exhibited a negligible contamination with other subcellular fractions (1-4%) and high degree of functionality (respiratory control ratio = 5-6). Toluene-permeabilized mitochondria, mitochondrial homogenates, and a elude preparation of nitric oxide synthase (NOS) incubated with the spin trap N-methyl-D-glucamine-dithiocarbamate-Fe-II produced a signal ascribed to the NO. spin adduct (g = 2.04; a(N) = 12.5 G). The intensity of the signal increased with time, protein concentration, and L-Arg, and decreased with the addition of the NOS inhibitor N-G-monomethyl-L-arginine. Intact mitochondria, mitochondrial homogenates, and submitochondrial particles produced NO. (followed by the oxidation of oxymyoglobin) at rates of 1.4, 4.9, and 7.1 nmol NO. x (min.mg protein)(-1), respectively, with a K-m for L-Arg of 5-7 mu M. Comparison of the rates of NO. production obtained with homogenates and submitochondrial particles indicated that most of the enzymatic activity was localized in the mitochondrial inner membrane. This study demonstrates that mitochondria are a source of NO., the production of which may effect energy metabolism, O-2 consumption, and O-2 free radical formation.	Univ So Calif, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA; Univ Hosp, Lab Oxygen Metab, RA-1113 Buenos Aires, DF, Argentina; Univ Buenos Aires, Sch Pharm & Biochem, Dept Phys Chem, Lab Free Rad Biol, RA-1113 Buenos Aires, DF, Argentina	University of Southern California; University of Buenos Aires; University of Buenos Aires	Giulivi, C (corresponding author), Univ So Calif, Dept Mol Pharmacol & Toxicol, 1985 Zonal Ave, Los Angeles, CA 90033 USA.	cgiulivi@hsc.usc.edu	Giulivi, Cecilia/ABB-7809-2020; Giulivi, Cecilia/AAV-6774-2021	Giulivi, Cecilia/0000-0003-1033-7435; 	NIDDK NIH HHS [P30DK485222] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; BUSTAMANTE E, 1977, ANAL BIOCHEM, V80, P401, DOI 10.1016/0003-2697(77)90661-3; BUTTNER H, 1972, INORG CHEM, V11, P971; CADENAS E, 1980, BIOCHEM J, V188, P31, DOI 10.1042/bj1880031; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; CHANCE B, 1963, 5 P INT C BIOCH USSR, V5, P3; CHEUNG CW, 1981, ARCH BIOCHEM BIOPHYS, V209, P643, DOI 10.1016/0003-9861(81)90324-6; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; FORSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788, DOI 10.1073/pnas.88.5.1788; FREEDLAND RA, 1984, BIOCHIM BIOPHYS ACTA, V802, P407, DOI 10.1016/0304-4165(84)90357-X; FREEDLAND RA, 1985, FED PROC, V44, P2453; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; GIULIVI C, 1994, METHOD ENZYMOL, V233, P189; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; GIULIVI C, 1998, REACTIVE OXYGEN SPEC; GRAZI E, 1975, EUR J BIOCHEM, V60, P431, DOI 10.1111/j.1432-1033.1975.tb21020.x; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868; ILEPERUMA OA, 1977, INORG CHEM, V16, P1876, DOI 10.1021/ic50174a011; KELLER DM, 1968, BIOCHIM BIOPHYS ACTA, V153, P113, DOI 10.1016/0005-2728(68)90151-5; KOBZIK L, 1995, BIOCHEM BIOPH RES CO, V211, P375, DOI 10.1006/bbrc.1995.1824; KOSAKA H, 1987, ENVIRON HEALTH PERSP, V73, P147, DOI 10.2307/3430605; Kotake Y, 1996, METHOD ENZYMOL, V268, P222; Kotake Y, 1996, BBA-GEN SUBJECTS, V1289, P362, DOI 10.1016/0304-4165(95)00172-7; KWONG E, 1982, J NUTR, V112, P2081; LIU JW, 1995, BIOCHEMISTRY-US, V34, P12333, DOI 10.1021/bi00038a029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARLETTA MA, 1989, TRENDS BIOCHEM SCI, V14, P488, DOI 10.1016/0968-0004(89)90181-3; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; MITCHELL JA, 1991, BIOCHEM BIOPH RES CO, V176, P1417, DOI 10.1016/0006-291X(91)90444-C; MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5; PALMER RMJ, 1989, BIOCHEM BIOPH RES CO, V158, P348, DOI 10.1016/S0006-291X(89)80219-0; PERTOFT H, 1978, ANAL BIOCHEM, V88, P271, DOI 10.1016/0003-2697(78)90419-0; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; REINHART PH, 1982, BIOCHEM J, V204, P731, DOI 10.1042/bj2040731; RUTTER GA, 1999, BIOCHIM BIOPHYS ACTA, V1014, P263; SCHMIDT HHHW, 1989, BIOCHEM BIOPH RES CO, V165, P284, DOI 10.1016/0006-291X(89)91067-X; STOCCO DM, 1983, ANAL BIOCHEM, V131, P453, DOI 10.1016/0003-2697(83)90198-7; Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044; TRACEY WR, 1990, J PHARMACOL EXP THER, V252, P922; ZAFIRIOU OC, 1980, ANAL CHEM, V52, P1662, DOI 10.1021/ac50061a029	48	480	502	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11038	11043		10.1074/jbc.273.18.11038	http://dx.doi.org/10.1074/jbc.273.18.11038			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556586	hybrid			2022-12-27	WOS:000073395200038
J	Kamitani, T; Kito, K; Nguyen, HP; Fukuda-Kamitani, T; Yeh, ETH				Kamitani, T; Kito, K; Nguyen, HP; Fukuda-Kamitani, T; Yeh, ETH			Characterization of a second member of the sentrin family of ubiquitin-like proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME PATHWAY; SACCHAROMYCES-CEREVISIAE; DEGRADATION; COMPLEX; CONJUGATION; HOMOLOGY; MITOSIS; LIGASE; MIF2	Sentrin is a novel ubiquitin-like protein that can be conjugated to other proteins in a manner analogous to ubiquitination, Two additional cDNA sequences that encode proteins highly homologous to sentrin have been reported to GenBank(TM), It is not known whether these sentrin-like proteins could also function as protein modifiers. In this report, a second member of the sentrin family was characterized in detail. Sentrin-2 is a 95-amino acid polypeptide that is 46% identical and 66% homologous to sentrin-1. Northern blot analysis showed that the sentrin-2 message was expressed in all tissues, but was barely detectable in the liver and placenta. The ability of sentrin-2 to conjugate to other proteins was tested by expressing hemagglutinin epitope-tagged sentrin-2 in COS cells. Western blot analysis showed that sentrin-2 could be transferred to other proteins in a pattern similar to that of sentrin-1 conjugation and had similar C-terminal processing. We further showed that both sentrin-1 and sentrin-2 could covalently modify RanGAP1, a Ran GTPase-activating protein critically involved in nuclear transport. Immunocytochemical analysis showed that sentrin-2 derivatives were highly enriched in the nucleus. Taken together, our results demonstrate that sentrin-2 is another protein modifier for the sentrinization pathway.	Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Mol Med, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Res Ctr Cardiovasc Dis, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Yeh, ETH (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Mol Med, 6431 Fannin,Suite 4200, Houston, TX 77030 USA.	eyeh@heart.med.uth.tmc.edu	Kamitani, Tetsu/GSI-7613-2022	Kamitani, Tetsu/0000-0002-3257-9630	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045851] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-45851] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boddy MN, 1996, ONCOGENE, V13, P971; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; Cenciarelli C, 1996, J BIOL CHEM, V271, P8709, DOI 10.1074/jbc.271.15.8709; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; HAAS AL, 1987, J BIOL CHEM, V262, P11315; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; HOPKIN K, 1997, J NIH RES, V9, P36; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; KAMITANI T, 1991, CLIN IMMUNOL IMMUNOP, V58, P217, DOI 10.1016/0090-1229(91)90138-Z; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; LAHAVBARATZ S, 1995, P NATL ACAD SCI USA, V92, P9303, DOI 10.1073/pnas.92.20.9303; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lapenta V, 1997, GENOMICS, V40, P362, DOI 10.1006/geno.1996.4556; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MURRAY A, 1995, CELL, V81, P149, DOI 10.1016/0092-8674(95)90322-4; Okura T, 1996, J IMMUNOL, V157, P4277; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Strous GJ, 1997, J BIOL CHEM, V272, P40; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9	31	110	114	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11349	11353		10.1074/jbc.273.18.11349	http://dx.doi.org/10.1074/jbc.273.18.11349			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556629	hybrid			2022-12-27	WOS:000073395200081
J	Jankowska-Anyszka, M; Lamphear, BJ; Aamodt, EJ; Harrington, T; Darzynkiewicz, E; Stolarski, R; Rhoads, RE				Jankowska-Anyszka, M; Lamphear, BJ; Aamodt, EJ; Harrington, T; Darzynkiewicz, E; Stolarski, R; Rhoads, RE			Multiple isoforms of eukaryotic protein synthesis initiation factor 4E in Caenorhabditis elegans can distinguish between mono- and trimethylated mRNA cap structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION; MESSENGER-RNAS; FACTOR EIF-4E; BINDING-PROTEIN; C-ELEGANS; SEQUENCE; EXPRESSION; ANALOGS; FORM; EFFICIENCY	The rate-limiting step for cap dependent translation initiation in eukaryotes is recruitment of mRNA to the ribosome, An early event in this process is recognition of the m(7)GTP-containing cap structure at the 5'-end of the mRNA by initiation factor eIF4E, In the nematode Caenorhabditis elegans, mRNAs from 70% of the genes contain a different cap structure, m(3)(2,2,7)GTP. This cap structure is poorly recognized by mammalian elF4E, suggesting that C, elegans may possess a specialized form of elF4E that can recognize m(3)(2,2,7)GTP. Analysis of the C. elegans genomic sequence data base revealed the presence of three elF4E-like genes, here named ife-1, ife-2, and ife-3, cDNAs for these three eIF4E isoforms were cloned and sequenced, Isoform-specific antibodies were prepared from synthetic peptides based on nonhomologous regions of the three proteins. All three eIF4E isoforms were detected in extracts of C. elegans and were retained on m(7)GTP-Sepharose. One eIF4E isoform, IFE-1, was also retained on m,2 2 7GTP-Sepharose. Furthermore, binding of IFE-1 and IFE-2 to m(7)GTP-Sepharose was inhibited by m(3)(2,2,7)GTP. These results suggest that IFE-1 and IFE-2 bind both m(7)GTP- and m(3)(2,2,7)GTP-containing mRNA cap structures, although with different affinities. In conjunction with IFE-3, these eIF4E isoforms would permit cap-dependent recruitment of all C, elegans mRNAs to the ribosome.	Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; Warsaw Univ, Dept Chem, PL-02093 Warsaw, Poland; Warsaw Univ, Dept Biophys, PL-02093 Warsaw, Poland	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Warsaw; University of Warsaw	Rhoads, RE (corresponding author), Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.			Stolarski, Ryszard/0000-0002-3272-5140	NCRR NIH HHS [RR10296] Funding Source: Medline; NIGMS NIH HHS [GM20818] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN ML, 1992, J BIOL CHEM, V267, P23232; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Blaxter M, 1996, INT J PARASITOL, V26, P1025, DOI 10.1016/S0020-7519(96)00060-4; BRENNER S, 1974, GENETICS, V77, P71; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; CARBERRY SE, 1990, BIOCHEMISTRY-US, V29, P3337, DOI 10.1021/bi00465a027; CARBERRY SE, 1992, BIOCHEMISTRY-US, V31, P1427, DOI 10.1021/bi00120a020; DARZYNKIEWICZ E, 1988, NUCLEIC ACIDS RES, V16, P8953, DOI 10.1093/nar/16.18.8953; DARZYNKIEWICZ E, 1985, BIOCHEMISTRY-US, V24, P1701, DOI 10.1021/bi00328a020; Harlow E., 1988, ANTIBODIES LAB MANUA; HERNANDEZ G, 1995, BBA-GENE STRUCT EXPR, V1261, P427, DOI 10.1016/0167-4781(95)00039-J; JANKOWSKA M, 1993, COLLECT CZECH CHEM C, V58, P132; Kevil C, 1995, ONCOGENE, V11, P2339; Lamphear BJ, 1996, BIOCHEMISTRY-US, V35, P15726, DOI 10.1021/bi961864t; LAMPHEAR BJ, 1990, J BIOL CHEM, V265, P5333; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LIOU RF, 1990, MOL CELL BIOL, V10, P1764, DOI 10.1128/MCB.10.4.1764; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARONEY PA, 1995, RNA, V1, P714; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; McDermott JB, 1996, BIOCHEMISTRY-US, V35, P9415, DOI 10.1021/bi952646n; Merrick WC., 1996, TRANSLATION CONTROL, P31; METZ AM, 1992, NUCLEIC ACIDS RES, V20, P4096, DOI 10.1093/nar/20.15.4096; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; MIYAGI Y, 1995, CANCER LETT, V91, P247, DOI 10.1016/0304-3835(95)03737-H; MIYAGI Y, 1995, LAB INVEST, V72, P890; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Nathan CAO, 1997, ONCOGENE, V15, P579, DOI 10.1038/sj.onc.1201216; Ptushkina M, 1996, J BIOL CHEM, V271, P32818, DOI 10.1074/jbc.271.51.32818; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; RHOADS RE, 1993, PROG NUCLEIC ACID RE, V46, P183, DOI 10.1016/S0079-6603(08)61022-3; RINKERSCHAEFFER CW, 1993, INT J CANCER, V55, P841, DOI 10.1002/ijc.2910550525; RODRIGUEZ CM, 1998, IN PRESS PLANT J; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; ROSS LH, 1995, J BIOL CHEM, V270, P22066, DOI 10.1074/jbc.270.37.22066; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Sulston J., 1988, NEMATODE CAENORHABDI, P587; VANDOREN K, 1990, MOL CELL BIOL, V10, P1769, DOI 10.1128/MCB.10.4.1769; WAKIYAMA M, 1995, FEBS LETT, V360, P191, DOI 10.1016/0014-5793(95)00081-J; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	43	77	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10538	10542		10.1074/jbc.273.17.10538	http://dx.doi.org/10.1074/jbc.273.17.10538			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553113	hybrid			2022-12-27	WOS:000073224200062
J	Jones, SM; Alb, JG; Phillips, SE; Bankaitis, VA; Howell, KE				Jones, SM; Alb, JG; Phillips, SE; Bankaitis, VA; Howell, KE			A phosphatidylinositol 3-kinase and phosphatidylinositol transfer protein act synergistically in formation of constitutive transport vesicles from the trans-Golgi network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID TRANSFER PROTEIN; CA2+-ACTIVATED SECRETION; YEAST; COMPLEX; PHOSPHORYLATION; RECEPTOR; SITE	Current evidence suggests that phosphatidylinositol (PI) kinases and phosphatidylinositol transfer protein (PITP) are involved in driving vesicular traffic from yeast and mammalian trans-Golgi network (TGN). We have tested the interaction between these cytosolic proteins in an assay that measures the formation of constitutive transport vesicles from the TGN in a hepatocyte cell-free system. This reaction is dependent on a novel PI 3-kinase, and we now report that, under conditions of limiting cytosol, purified PI 3-kinase and PITP functionally cooperate to drive exocytic vesicle formation. This synergy was observed with both yeast and mammalian PITPs, and it also extended to the formation of PI 3-phosphate. These collective findings indicate that the PI 3-kinase and PITP synergize to form a pool of PI 3-phosphate that is essential for formation of exocytic vesicles from the hepatocyte TGN.	Univ Colorado, Sch Med, Dept Cellular & Struct Biol, Denver, CO 80262 USA; Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alabama System; University of Alabama Birmingham	Howell, KE (corresponding author), Univ Colorado, Sch Med, Dept Cellular & Struct Biol, Box B-111, Denver, CO 80262 USA.	kathryn.howell@uchsc.edu		PHILLIPS, SCOTT/0000-0002-5451-0984	NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042629] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA-46934] Funding Source: Medline; NIDDK NIH HHS [P30 DK34914] Funding Source: Medline; NIGMS NIH HHS [GM 42629] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITKEN JF, 1990, J BIOL CHEM, V265, P4711; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Cunningham E, 1996, P NATL ACAD SCI USA, V93, P6589, DOI 10.1073/pnas.93.13.6589; CUNNINGHAM E, 1995, CURR BIOL, V5, P775, DOI 10.1016/S0960-9822(95)00154-0; Currie RA, 1997, CURR BIOL, V7, P184, DOI 10.1016/S0960-9822(97)70089-7; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hickinson DM, 1997, CURR BIOL, V7, P987, DOI 10.1016/S0960-9822(06)00418-0; JONES SM, 1993, J CELL BIOL, V122, P775, DOI 10.1083/jcb.122.4.775; Jones SM, 1997, J CELL BIOL, V139, P339, DOI 10.1083/jcb.139.2.339; JONES SM, 1997, CELL BIOL LAB HDB, V2, P12; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; LADINSKY MS, 1994, J CELL BIOL, V127, P29, DOI 10.1083/jcb.127.1.29; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Maizel JV, 1971, METHOD VIROL, V5, P179; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; OHASHI M, 1995, NATURE, V377, P544, DOI 10.1038/377544a0; SALAMERO J, 1990, P NATL ACAD SCI USA, V87, P7717, DOI 10.1073/pnas.87.19.7717; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; SKINNER HB, 1993, EMBO J, V12, P4775, DOI 10.1002/j.1460-2075.1993.tb06166.x; SZTUL ES, 1985, J CELL BIOL, V100, P1248, DOI 10.1083/jcb.100.4.1248; Taylor RS, 1997, MOL BIOL CELL, V8, P1911, DOI 10.1091/mbc.8.10.1911; Taylor RS, 1997, ELECTROPHORESIS, V18, P2601, DOI 10.1002/elps.1150181416	27	79	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10349	10354		10.1074/jbc.273.17.10349	http://dx.doi.org/10.1074/jbc.273.17.10349			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553090	hybrid			2022-12-27	WOS:000073224200039
J	Lu, CA; Lim, EK; Yu, SM				Lu, CA; Lim, EK; Yu, SM			Sugar response sequence in the promoter of a rice alpha-amylase gene serves as a transcriptional enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; CARBOHYDRATE STARVATION; DIFFERENTIAL EXPRESSION; TRANSFORMATION SYSTEM; METABOLIC REPRESSION; GLUCOSE REPRESSION; FEEDBACK-CONTROL; CULTURED-CELLS; ABSCISIC-ACID; HIGHER-PLANTS	Expression of alpha-amylase genes in both rice suspension cells and germinating embryos is repressed by sugars and the mechanism involves transcriptional regulation. The promoter of a rice alpha-amylase gene alpha Amy3 was analyzed by both loss-and gain-of-function studies and the major sugar response sequence (SRS) was located between 186 and 82 base pairs upstream of the transcription start site. The SRS conferred sugar responsiveness to a minimal promoter in an orientation-independent manner. It also converted a sugar-insensitive rice actin gene promoter into a sugar-sensitive promoter in a dose-dependent manner. Linker-scan mutation studies identified three essential motifs: the GC box, the G box, and the TATCCA element, within the SRS. Sequences containing either the GC box plus G box or the TATCCA element each mediated sugar response, however, they acted synergistically to give a high level glucose starvation-induced expression. Nuclear proteins from rice suspension cells binding to the TATCCA element in a sequence-specific and sugar-dependent manner were identified. The TATCCA element is also an important component of the gibberellin response complex of the alpha-amylase genes in germinating cereal grains, suggesting that the regulation of alpha-amylase gene expression by sugar and hormone signals may share common regulatory machinery.	Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Academia Sinica - Taiwan	Yu, SM (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.		Yu, Su-May/ABB-6950-2021	Yu, Su-May/0000-0001-8744-9246				BENKEL BF, 1987, P NATL ACAD SCI USA, V84, P1337, DOI 10.1073/pnas.84.5.1337; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BRIGGS DE, 1973, PHYTOCHEMISTRY, V12, P1047, DOI 10.1016/0031-9422(73)85013-7; BRUCE WB, 1989, P NATL ACAD SCI USA, V86, P9692, DOI 10.1073/pnas.86.24.9692; CAO J, 1992, PLANT CELL REP, V11, P586, DOI 10.1007/BF00233098; CARLSON M, 1987, J BACTERIOL, V169, P4873, DOI 10.1128/jb.169.11.4873-4877.1987; CHAN MT, 1993, PLANT MOL BIOL, V22, P491, DOI 10.1007/BF00015978; CHAN MT, 1994, J BIOL CHEM, V269, P17635; CHEN MH, 1994, PLANT J, V6, P625, DOI 10.1046/j.1365-313X.1994.6050625.x; D.P.S, PLANT MOL BIOL MANUA, P1, DOI 10.1007/978-94-009-0951-9; DEVETTEN NC, 1994, INT J BIOCHEM, V26, P1055, DOI 10.1016/0020-711X(94)90128-7; ENTIAN KD, 1992, TRENDS BIOCHEM SCI, V17, P506, DOI 10.1016/0968-0004(92)90341-6; FREARSON EM, 1973, DEV BIOL, V33, P130, DOI 10.1016/0012-1606(73)90169-3; GANCEDO JM, 1992, EUR J BIOCHEM, V206, P297, DOI 10.1111/j.1432-1033.1992.tb16928.x; GRAHAM IA, 1994, PLANT CELL, V6, P761, DOI 10.1105/tpc.6.5.761; GUBLER F, 1992, PLANT CELL, V4, P1435; HAYASHIMOTO A, 1990, PLANT PHYSIOL, V93, P857, DOI 10.1104/pp.93.3.857; HUANG N, 1990, PLANT MOL BIOL, V14, P655, DOI 10.1007/BF00016499; HUANG N, 1990, NUCLEIC ACIDS RES, V18, P7007, DOI 10.1093/nar/18.23.7007; HUANG N, 1993, PLANT MOL BIOL, V23, P737, DOI 10.1007/BF00021529; ITOH K, 1995, PLANT PHYSIOL, V107, P25, DOI 10.1104/pp.107.1.25; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KARRER EE, 1992, PLANT J, V2, P517; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; LANAHAN MB, 1992, PLANT CELL, V4, P203, DOI 10.1105/tpc.4.2.203; LIU ZB, 1994, PLANT CELL, V6, P645, DOI 10.1105/tpc.6.5.645; LUEHRSEN KR, 1992, METHOD ENZYMOL, V216, P397; MAAS C, 1990, EMBO J, V9, P3447, DOI 10.1002/j.1460-2075.1990.tb07552.x; MAGOULAS C, 1993, GENETICS, V134, P507; MCELROY D, 1990, PLANT CELL, V2, P163, DOI 10.1105/tpc.2.2.163; MITSUNAGA S, 1994, NUCLEIC ACIDS RES, V22, P1948, DOI 10.1093/nar/22.11.1948; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OULEE TM, 1986, P NATL ACAD SCI USA, V83, P6815, DOI 10.1073/pnas.83.18.6815; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; ROGERS JC, 1992, PLANT CELL, V4, P1443, DOI 10.1105/tpc.4.11.1443; ROGERS JC, 1994, PLANT PHYSIOL, V105, P151, DOI 10.1104/pp.105.1.151; SAIER MH, 1991, NEW BIOL, V3, P1137; SAIER MH, 1995, TRENDS BIOCHEM SCI, V20, P267, DOI 10.1016/S0968-0004(00)89041-6; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; SHEEN J, 1994, PHOTOSYNTH RES, V39, P427, DOI 10.1007/BF00014596; SHEU JJ, 1994, PLANT J, V5, P655, DOI 10.1111/j.1365-313X.1994.00655.x; Sheu JJ, 1996, J BIOL CHEM, V271, P26998, DOI 10.1074/jbc.271.43.26998; SKRIVER K, 1991, P NATL ACAD SCI USA, V88, P7266, DOI 10.1073/pnas.88.16.7266; SMITH MT, 1980, PHYTOCHEMISTRY, V19, P1025, DOI 10.1016/0031-9422(80)83052-4; SUTLIFF TD, 1991, PLANT MOL BIOL, V16, P579, DOI 10.1007/BF00023423; TANIDA I, 1994, MOL GEN GENET, V244, P127, DOI 10.1007/BF00283513; THOMAS BR, 1994, PLANT PHYSIOL, V106, P1235, DOI 10.1104/pp.106.4.1235; TONOMURA K, 1961, AGR BIOL CHEM TOKYO, V25, P1; TSUCHIYA K, 1992, BIOSCI BIOTECH BIOCH, V56, P1849, DOI 10.1271/bbb.56.1849; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; WANG YX, 1992, MOL CELL BIOL, V12, P3399, DOI 10.1128/MCB.12.8.3399; YU SM, 1992, GENE, V122, P247, DOI 10.1016/0378-1119(92)90212-8; YU SM, 1991, J BIOL CHEM, V266, P21131; Yu SM, 1996, PLANT MOL BIOL, V30, P1277, DOI 10.1007/BF00019558	57	137	149	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10120	10131		10.1074/jbc.273.17.10120	http://dx.doi.org/10.1074/jbc.273.17.10120			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553059	hybrid			2022-12-27	WOS:000073224200008
J	Pellegrini, M; Royo, M; Rosenblatt, M; Chorev, M; Mierke, DF				Pellegrini, M; Royo, M; Rosenblatt, M; Chorev, M; Mierke, DF			Addressing the tertiary structure of human parathyroid hormone-(1-34)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SECONDARY STRUCTURE; MOLECULAR-DYNAMICS; DISTANCE GEOMETRY; CHEMICAL-SHIFT; DODECYLPHOSPHOCHOLINE MICELLES; H-1-NMR SPECTROSCOPY; CIRCULAR-DICHROISM; COUPLING-CONSTANTS; PROTEIN-STRUCTURE	Parathyroid hormone (PTH) regulates mineral metabolism and bone turnover by activating specific receptors located on osteoblastic and renal tubular cells and is fully functional as the N-terminal 1-34 fragment, PTH-(1-34). Previously, a "U-shaped" conformation with Nand C-terminal helices brought in close proximity by a turn has been postulated. The general acceptance of this hypothesis, despite limited experimental evidence, has altered the direction of the design of PTH-analogs. Examining the structure of human PTH-(1-34) under conditions that encompass the different environments the hormone may experience in the approach to and interaction with the G-protein-coupled receptor (including benign aqueous and saline solutions and in the presence of dodecylphosphocholine), we observe no evidence for a U-shape conformation or any tertiary structure. Instead, the N- and C-terminal helical domains, which vary in length and stability depending on the conditions, are separated by a highly flexible region of undefined conformation. These observations are in complete accord with recent conformational studies of PTH-related protein analogs containing lactams (Mierke, D. F., Maretto, S., Schievano, E., DeLuca, D., Bisello, A., Mammi, S., Rosenblatt, M., Peggion, E., and Chorev, M. (1997) Biochemistry 36, 10372-10383) or a model amphiphilic cu-helix (Pellegrini, M., Bisello, A., Rosenblatt, M., Chorev, M., and Mierke, D. F. (1997) J. Med. Chem. 40, 3025-3031). Reliable structural data from different environmental conditions are absolutely requisite for the next step in the design of non-peptide PTH analogs.	Clark Univ, Gustaf H Carlson Sch Chem, Worcester, MA 01610 USA; Harvard Univ, Sch Med,Harvard Thorndike & Charles A Dana Labs, Beth Israel Deaconess Med Ctr, Div Bone & Mineral Metab, Boston, MA 02215 USA; Univ Massachusetts, Med Ctr, Dept Pharmacol & Mol Toxicol, Worcester, MA 01655 USA	Clark University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Mierke, DF (corresponding author), Brown Univ, Dept Mol Pharmacol, Box G-B4, Providence, RI 02912 USA.	dale_mierke@brown.edu	Royo, Miriam/B-1665-2013; Pellegrini, Maria/W-6005-2019; Royo, Miriam/AAH-4918-2019	Royo, Miriam/0000-0001-5292-0819; Pellegrini, Maria/0000-0003-3817-4412; Royo, Miriam/0000-0001-5292-0819	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054082, R01GM054082] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK47940] Funding Source: Medline; NIGMS NIH HHS [GM54082] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIRAKTARI E, 1990, BIOCHEMISTRY-US, V29, P10097, DOI 10.1021/bi00495a012; BARDEN JA, 1989, EUR J BIOCHEM, V184, P379, DOI 10.1111/j.1432-1033.1989.tb15030.x; Barden JA, 1997, J BIOL CHEM, V272, P29572, DOI 10.1074/jbc.272.47.29572; BARDEN JA, 1994, BBA-PROTEIN STRUCT M, V1208, P256, DOI 10.1016/0167-4838(94)90111-2; BARDEN JA, 1993, BIOCHEMISTRY-US, V32, P7126, DOI 10.1021/bi00079a008; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bisello A, 1997, BIOCHEMISTRY-US, V36, P3293, DOI 10.1021/bi9619029; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P81; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BROWN LR, 1981, BIOCHIM BIOPHYS ACTA, V642, P296, DOI 10.1016/0005-2736(81)90447-8; COHEN FE, 1991, J BIOL CHEM, V266, P1997; CREAMER TP, 1995, PROTEIN SCI, V4, P1305, DOI 10.1002/pro.5560040706; GARDELLA TJ, 1995, J BIOL CHEM, V270, P6584, DOI 10.1074/jbc.270.12.6584; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GUBA W, 1994, J AM CHEM SOC, V116, P7532, DOI 10.1021/ja00096a009; HAVEL TF, 1991, PROG BIOPHYS MOL BIO, V56, P43, DOI 10.1016/0079-6107(91)90007-F; JAHNKE W, 1994, J MOL BIOL, V240, P445, DOI 10.1006/jmbi.1994.1460; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KALLICK DA, 1995, J MAGN RESON SER B, V109, P60, DOI 10.1006/jmrb.1995.1146; KAPTEIN R, 1988, BIOCHEMISTRY-US, V27, P5389, DOI 10.1021/bi00415a001; KLAUS W, 1991, BIOCHEMISTRY-US, V30, P6936, DOI 10.1021/bi00242a018; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE KH, 1987, BIOCHIM BIOPHYS ACTA, V911, P144, DOI 10.1016/0167-4838(87)90003-3; Lee MS, 1996, PROTEIN ENG, V9, P15, DOI 10.1093/protein/9.1.15; LEE SC, 1989, BIOPOLYMERS, V28, P1115, DOI 10.1002/bip.360280606; LEVITT M, 1988, P NATL ACAD SCI USA, V85, P7557, DOI 10.1073/pnas.85.20.7557; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; MARX UC, 1995, J BIOL CHEM, V270, P15194, DOI 10.1074/jbc.270.25.15194; MCDONNELL PA, 1993, J MOL BIOL, V233, P447, DOI 10.1006/jmbi.1993.1523; Mierke DF, 1997, BIOCHEMISTRY-US, V36, P10372, DOI 10.1021/bi970771o; MIERKE DF, 1994, J AM CHEM SOC, V116, P1042, DOI 10.1021/ja00082a027; MIERKE DF, 1994, INT J PEPT PROT RES, V44, P325, DOI 10.1111/j.1399-3011.1994.tb01016.x; MIERKE DF, 1994, BIOPOLYMERS, V34, P559, DOI 10.1002/bip.360340411; MIERKE DF, 1993, BIOPOLYMERS, V33, P1103; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MORODER L, 1993, BIOCHEMISTRY-US, V32, P13551, DOI 10.1021/bi00212a022; PAPAVOINE CHM, 1994, BIOCHEMISTRY-US, V33, P12990, DOI 10.1021/bi00248a007; PASTORE A, 1990, J MAGN RESON, V90, P165, DOI 10.1016/0022-2364(90)90375-J; Pellegrini M, 1997, J MED CHEM, V40, P92, DOI 10.1021/jm9605391; Pellegrini M, 1997, J MED CHEM, V40, P3025, DOI 10.1021/jm970181o; Pellegrini M, 1997, J PEPT RES, V49, P404; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; POTTS JT, 1971, P NATL ACAD SCI USA, V68, P63, DOI 10.1073/pnas.68.1.63; POTTS JT, 1982, ADV PROTEIN CHEM, V35, P323, DOI 10.1016/S0065-3233(08)60471-4; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; SCHWYZER R, 1991, BIOPOLYMERS, V31, P785, DOI 10.1002/bip.360310624; SCHWYZER R, 1992, BRAZ J MED BIOL RES, V25, P1077; SCHWYZER R, 1986, NATURAL PRODUCTS BIO; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; STRICKLAND LA, 1993, BIOCHEMISTRY-US, V32, P6050, DOI 10.1021/bi00074a016; TAYLOR JW, 1987, METHOD ENZYMOL, V154, P473; VANDERSPOEL D, 1996, GROMAES USER MANUAL; WILLIS KJ, 1994, INT J PEPT PROT RES, V43, P23; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WRAY V, 1994, BIOCHEMISTRY-US, V33, P1684, DOI 10.1021/bi00173a010; WUTHRICH K, 1980, BIOCHEM BIOPH RES CO, V95, P1504, DOI 10.1016/S0006-291X(80)80067-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644; [No title captured]	61	90	102	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10420	10427		10.1074/jbc.273.17.10420	http://dx.doi.org/10.1074/jbc.273.17.10420			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553100	hybrid			2022-12-27	WOS:000073224200049
J	Caplin, BE; Ohya, Y; Marshall, MS				Caplin, BE; Ohya, Y; Marshall, MS			Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiae protein farnesyltransferase - Creating the perfect farnesyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYLTRANSFERASE TYPE-I; ALPHA-SUBUNIT; BETA-SUBUNIT; MUTATIONAL ANALYSIS; KINETIC MECHANISM; PEPTIDE-BINDING; CDNA CLONING; FARNESYL; TRANSFERASE; PURIFICATION	Studies of the yeast protein farnesyltransferase (FTase) have shown that the enzyme preferentially farnesylates proteins ending in CAAX (C = cysteine, A = aliphatic residue, X = cysteine, serine, methionine, alanine) and to a lesser degree CAAL. Furthermore, like the type I protein geranylgeranyltransferase (GGTase-I), FTase can also geranylgeranylate methionine-and leucine-ending substrates both in vitro and in vivo. Substrate overlap of FTase and GGTase I has not been determined to be biologically significant. In this study, specific residues that influence the substrate preferences of FTase have been identified using site-directed mutagenesis. Three of the mutations altered the substrate preferences of the wild type enzyme significantly. The ram1p-D-74 FTase farnesylated only Ras-CIIS and not Ras-CII(M,L), and it geranylgeranylated all three substrates as well or better than wild type. The ram1p-(DDLF)-D-206 FTase farnesylated Ras CII(S,M,L) at wild type levels but could no longer geranylgeranylate the Ras-CII(M,L) substrates. The ram1p-(FSKN)-F-351 FTase farnesylated Ras-CIIS and Ras-CIIM but not Ras-CIIL. The ram1p-(FSKN)-F-351 FTase was not capable of geranylgeranylating the Ras-CII(M,L) substrates, giving this mutant the attributes of the dogmatic FTase that only farnesylates non-leucine-ending CAAX substrates and does not geranylgeranylate any substrate. These results suggest that the isoprenoid and protein substrate specificities of FTase are interrelated. The availability of a mutant FTase that lacked substrate overlap with the protein GGTase-I made possible an analysis of the role of substrate overlap in normal cellular processes of yeast, such as mating and growth at elevated temperatures. Our findings suggest that neither farnesylation of leucine-ending CAAX substrates nor geranylgeranylation by the FTase is necessary for these cellular processes.	Walther Oncol Inst, Indianapolis, IN USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Div Hematol & Oncol, Indianapolis, IN 46202 USA; Univ Tokyo, Fac Sci, Dept Biol, Tokyo 113, Japan	Walther Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Tokyo	Marshall, MS (corresponding author), 1044 W Walnut St,Rm 351, Indianapolis, IN 46202 USA.	mark_marshall@iucc.iupui.edu						ANDRES DA, 1993, J BIOL CHEM, V268, P1383; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864, DOI 10.1074/jbc.270.14.7864; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CAPLIN BE, 1995, METHOD ENZYMOL, V250, P51; CAPLIN BE, 1994, BBA-PROTEIN STRUCT M, V1205, P39, DOI 10.1016/0167-4838(94)90089-2; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; Fu HW, 1996, J BIOL CHEM, V271, P28541, DOI 10.1074/jbc.271.45.28541; FURFINE ES, 1995, BIOCHEMISTRY-US, V34, P6857, DOI 10.1021/bi00020a032; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GLOMSET JA, 1990, TRENDS BIOCHEM SCI, V15, P139, DOI 10.1016/0968-0004(90)90213-U; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HE B, 1991, P NATL ACAD SCI USA, V88, P4448; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Maniatis T., 1982, MOL CLONING LAB MANU; MANNE V, 1990, P NATL ACAD SCI USA, V87, P7541, DOI 10.1073/pnas.87.19.7541; MARSHALL M, 1987, MOL CELL BIOL, V7, P4441, DOI 10.1128/MCB.7.12.4441; MAYER ML, 1992, J BIOL CHEM, V267, P20589; MAYER MP, 1993, GENE, V132, P41, DOI 10.1016/0378-1119(93)90512-2; MITSUZAWA H, 1995, P NATL ACAD SCI USA, V92, P1704, DOI 10.1073/pnas.92.5.1704; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Ohya Y, 1996, MOL GEN GENET, V252, P1, DOI 10.1007/BF02173199; OHYA Y, 1991, J BIOL CHEM, V266, P12356; Parish CA, 1996, BIOCHEMISTRY-US, V35, P8473, DOI 10.1021/bi960603g; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Pellicena P, 1996, BIOCHEMISTRY-US, V35, P13494, DOI 10.1021/bi961336h; POMPLIANO DL, 1992, BIOCHEMISTRY-US, V31, P3800, DOI 10.1021/bi00130a010; REISS Y, 1991, J BIOL CHEM, V266, P10672; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; Segel I.H., 1993, ENZYME KINETICS BEHA, P560; SKINNER RH, 1991, J BIOL CHEM, V266, P14163; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; VILLAR KD, 1997, J BIOL CHEM, V272, P680; YING WL, 1994, J BIOL CHEM, V269, P470; YOKOYAMA K, 1995, BIOCHEMISTRY-US, V34, P1344, DOI 10.1021/bi00004a029; YOKOYAMA K, 1993, J BIOL CHEM, V268, P4055; ZHANG FL, 1994, J BIOL CHEM, V269, P3175	39	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9472	9479		10.1074/jbc.273.16.9472	http://dx.doi.org/10.1074/jbc.273.16.9472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545274	hybrid			2022-12-27	WOS:000073128800020
J	Chin, MT; Pellacani, A; Wang, H; Lin, SSJ; Jain, MK; Perrella, MA; Lee, ME				Chin, MT; Pellacani, A; Wang, H; Lin, SSJ; Jain, MK; Perrella, MA; Lee, ME			Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-BETA GENE; GROUP PROTEIN HMG-I(Y); HMGI-C; VIRUS INDUCTION; CELLS; ACTIVATION; EXPRESSION; PROMOTER; REQUIRES; ELEMENT	The mechanisms by which HMG-I proteins regulate cell growth are unknown, and their effects on gene expression have only been partially elucidated. We explored the potential interaction between HMG-I proteins and serum-response factor (SRF), a member of the MADS-box family of transcription factors. In cotransfection experiments, HMG-I(Y) potentiated SRF-dependent activation (by more than 5-fold) of two distinct SRF-responsive promoters, c-fos and the smooth muscle-specific gene SM22 alpha. This effect was also observed with a heterologous promoter containing multiple copies of the CC(A/T)(6)GG (CArG) box. HMG-I proteins bound specifically to the CArG boxes of c-fos and SM22 alpha in gel mobility shift analysis and enhanced binding of SRF to these CArG; boxes. By chelating peptide-immobilized metal affinity chromatography, we mapped the domain of HMG-I(Y) that interacts with SRF to amino acids 50-81, a region that does not bind specifically to DNA in electrophoretic mobility shift assays even though it includes the third AT-hook DNA-binding domain. Surprisingly, HMG-I(Y) mutants that failed to bind DNA still enhanced SRF binding to DNA and SRF-dependent transcription. In contrast, deletion of the HMG-I(I) 50-81 domain that bound SRF prevented enhancement of transcription. To our knowledge, this is the first report of an HMG-I protein interacting with a MADS-box transcription factor. Our observations suggest that members of the HMG-I family play an important role in SRF-dependent transcription and that their effect is mediated primarily by a protein-protein interaction.	Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Lee, ME (corresponding author), Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, 677 Huntington Ave, Boston, MA 02115 USA.				NHLBI NIH HHS [HL03745, HL03194] Funding Source: Medline; NIGMS NIH HHS [GM53249] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053249] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASHAR HR, 1995, CELL, V82, P57; Bagga R, 1997, GENE DEV, V11, P629, DOI 10.1101/gad.11.5.629; BERLINGIERI MT, 1995, MOL CELL BIOL, V15, P1545; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; DU W, 1994, P NATL ACAD SCI USA, V91, P11318, DOI 10.1073/pnas.91.24.11318; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; Galvagni F, 1997, MOL CELL BIOL, V17, P1731, DOI 10.1128/MCB.17.3.1731; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; GIANCOTTI V, 1987, EMBO J, V6, P1981, DOI 10.1002/j.1460-2075.1987.tb02461.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; KASHER MS, 1993, BIOTECHNIQUES, V14, P630; Kho CJ, 1997, J BIOL CHEM, V272, P3845, DOI 10.1074/jbc.272.6.3845; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LEGER H, 1995, MOL CELL BIOL, V15, P3738; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; REEVES R, 1990, J BIOL CHEM, V265, P8573; Sambrook J., 2002, MOL CLONING LAB MANU; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; WANG DZ, 1995, J BIOL CHEM, V270, P22924, DOI 10.1074/jbc.270.39.22924; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; Yie JM, 1997, MOL CELL BIOL, V17, P3649, DOI 10.1128/MCB.17.7.3649; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	46	67	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9755	9760		10.1074/jbc.273.16.9755	http://dx.doi.org/10.1074/jbc.273.16.9755			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545312	hybrid			2022-12-27	WOS:000073128800058
J	Oh, H; Fujio, Y; Kunisada, K; Hirota, H; Matsui, H; Kishimoto, T; Yamauchi-Takihara, K				Oh, H; Fujio, Y; Kunisada, K; Hirota, H; Matsui, H; Kishimoto, T; Yamauchi-Takihara, K			Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; TRANSDUCING RECEPTOR COMPONENT; SMOOTH-MUSCLE CELLS; SIGNAL TRANSDUCER; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; INTERLEUKIN-6 FAMILY; MIDDLE-T; GP130; CYTOKINES	Phosphatidylinositol (PI) 3-kinase is known to be activated by cytokine stimulation through different types of receptors to transduce intracellular responses. We have previously reported that leukemia inhibitory factor (LIF) induces the activation of Janus kinase signal transducer and activator of transcription (JAK-STAT) and mitogen-activated protein (MAP) kinase pathways through glycoprotein (gp) 130 in cardiac myocytes, However, whether PI 3-kinase is involved in regulation of gp130 signaling and the activation mechanisms by which it associates with other tyrosine-phosphorylated proteins remain unknown. We found that LIF induced the activation of PI 3-kinase in cardiac myocytes, Moreover, JAK1 binds to PI 3-kinase, and LIF stimulation increases the PI 3-kinase activity in JAK1 immunoprecipitates. Activation of MAP kinase and protein kinase B by LIF was attenuated by wortmannin. LIF-induced p70 S6 kinase activation, protein synthesis, and c-fos mRNA expression were inhibited by wortmannin and rapamycin. Both inhibitors failed to appreciably affect the phosphorylation of STAT3. In conclusion, PI 3-kinase is activated with LIF in cardiac myocytes, and JAK1 is found to associate with this enzyme. PI 3-kinase provides a crucial link between gp130, MAP kinase, protein kinase B, and p70 S6 kinase in cardiac myocytes.	Osaka Univ, Sch Med, Dept Med 3, Suita, Osaka 565, Japan	Osaka University	Yamauchi-Takihara, K (corresponding author), Osaka Univ, Sch Med, Dept Med 3, 2-2 Yamadaoka, Suita, Osaka 565, Japan.	takihara@imed3.med.osaka-u.ac.jp	Kishimoto, Tadamitsu/C-8470-2009; Fujio, Yasushi/H-3421-2017	Fujio, Yasushi/0000-0003-0828-2930				Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cowen DS, 1996, J BIOL CHEM, V271, P22297, DOI 10.1074/jbc.271.37.22297; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; FERBY IM, 1994, J BIOL CHEM, V269, P30485; Foncea R, 1997, J BIOL CHEM, V272, P19115, DOI 10.1074/jbc.272.31.19115; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GIASSON E, 1995, J BIOL CHEM, V270, P5225, DOI 10.1074/jbc.270.10.5225; GOLD MR, 1994, J BIOL CHEM, V269, P5403; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; HAYASHI H, 1992, J BIOL CHEM, V267, P22575; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Hu ZW, 1996, J BIOL CHEM, V271, P8977, DOI 10.1074/jbc.271.15.8977; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kunisada K, 1996, CIRCULATION, V94, P2626, DOI 10.1161/01.CIR.94.10.2626; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Ng J, 1997, J BIOL CHEM, V272, P24542, DOI 10.1074/jbc.272.39.24542; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Rahimi N, 1996, J BIOL CHEM, V271, P24850, DOI 10.1074/jbc.271.40.24850; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; Saward L, 1997, CIRC RES, V81, P249, DOI 10.1161/01.RES.81.2.249; Scheid MP, 1996, J BIOL CHEM, V271, P18134, DOI 10.1074/jbc.271.30.18134; SCHIEMANN WP, 1994, J BIOL CHEM, V269, P6376; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; TERADA N, 1993, J BIOL CHEM, V268, P12062; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; URICH M, 1995, J BIOL CHEM, V270, P29286, DOI 10.1074/jbc.270.49.29286; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Wijkander J, 1997, J BIOL CHEM, V272, P21520, DOI 10.1074/jbc.272.34.21520; Wilson M, 1996, J BIOL CHEM, V271, P8537, DOI 10.1074/jbc.271.15.8537; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; YAMAUCHI K, 1993, J BIOL CHEM, V268, P14597; YAMAUCHITAKIHARA K, 1995, CIRCULATION, V91, P1520, DOI 10.1161/01.CIR.91.5.1520; YANO H, 1993, J BIOL CHEM, V268, P25846; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; YIN TG, 1994, J BIOL CHEM, V269, P3731; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407	64	183	184	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9703	9710		10.1074/jbc.273.16.9703	http://dx.doi.org/10.1074/jbc.273.16.9703			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545305	hybrid			2022-12-27	WOS:000073128800051
J	Shimoyama, Y; Shibata, T; Kitajima, M; Hirohashi, S				Shimoyama, Y; Shibata, T; Kitajima, M; Hirohashi, S			Molecular cloning and characterization of a novel human classic cadherin homologous with mouse muscle cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MULTIGENE FAMILY; BETA-CATENIN; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODY; CYTOPLASMIC REGION; COMPLEMENTARY-DNA; SEQUENCE-ANALYSIS; CARCINOMA-CELLS; NERVOUS-SYSTEM	We used a novel cDNA cloning method based on the cadherin-beta-catenin protein interaction and identified a new human classic-type cadherin, which we named cadherin-15, from adult brain and skeletal muscle cDNA libraries. Sequence analysis revealed that this cadherin was closely related to mouse muscle cadherin and seemed to be its human counterpart. However, its deduced amino acid sequence differed from that of mouse muscle cadherin in that it had an extra 31-amino acid sequence at its C terminus that has been found neither in mouse muscle cadherin nor in any other known classic cadherin. Analysis of cadherin-15 protein expressed in L fibroblasts showed that it was cleaved proteolytically, expressed on the cell surfaces as a mature form of about 124-kDa, and functioned as a cell-cell adhesion molecule in a homophilic and specific manner, but Ca2+ did not protect it against degradation by trypsin. Our findings also suggest that cadherin-15 mediates cell-cell adhesion with a binding strength comparable to that of E-cadherin.	Natl Okura Hosp, Dept Surg, Setagaya Ku, Tokyo 157, Japan; Japan Sci & Technol Corp, Tsukuba Res Consortium, Exploratory Res Adv Technol, Hirohashi Cell Configurat Project, Tsukuba, Ibaraki 30026, Japan; Natl Okura Hosp, Dept Clin Res, Setagaya Ku, Tokyo 157, Japan; Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 105, Japan; Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 160, Japan	Japan Science & Technology Agency (JST); National Cancer Center - Japan; Keio University	Shimoyama, Y (corresponding author), Natl Okura Hosp, Dept Surg, Setagaya Ku, 2-10-1 Okura, Tokyo 157, Japan.							AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; BERTOLOTTI R, 1980, P NATL ACAD SCI-BIOL, V77, P4831, DOI 10.1073/pnas.77.8.4831; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BUSSEMAKERS MJG, 1993, MOL BIOL REP, V17, P123, DOI 10.1007/BF00996219; CHOI YS, 1990, J CELL BIOL, V110, P1575, DOI 10.1083/jcb.110.5.1575; COLLINS JE, 1991, J CELL BIOL, V113, P381, DOI 10.1083/jcb.113.2.381; DAMSKY CH, 1983, CELL, V34, P455, DOI 10.1016/0092-8674(83)90379-3; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; DOHERTY P, 1991, NEURON, V6, P2247; DONALIES M, 1991, P NATL ACAD SCI USA, V88, P8024, DOI 10.1073/pnas.88.18.8024; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GINSBERG D, 1991, DEVELOPMENT, V111, P315; HATTA K, 1985, P NATL ACAD SCI USA, V82, P2789, DOI 10.1073/pnas.82.9.2789; HEIMARK RL, 1990, J CELL BIOL, V110, P1745, DOI 10.1083/jcb.110.5.1745; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; HYAFIL F, 1980, CELL, V21, P927, DOI 10.1016/0092-8674(80)90456-0; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; KOCH PJ, 1990, EUR J CELL BIOL, V53, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SW, 1996, NAT MED, V2, P776, DOI 10.1038/nm0796-776; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; NAPOLITANO EW, 1991, J CELL BIOL, V113, P893, DOI 10.1083/jcb.113.4.893; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; OKAZAKI M, 1994, J BIOL CHEM, V269, P12092; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; POULIOT Y, 1994, DEV DYNAM, V200, P305, DOI 10.1002/aja.1002000405; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; ROSE O, 1994, DEV DYNAM, V201, P245, DOI 10.1002/aja.1002010308; ROSE O, 1995, P NATL ACAD SCI USA, V92, P6022, DOI 10.1073/pnas.92.13.6022; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Shibata T, 1997, J BIOL CHEM, V272, P5236, DOI 10.1074/jbc.272.8.5236; SHIMOYAMA Y, 1989, J CELL BIOL, V109, P1787, DOI 10.1083/jcb.109.4.1787; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SHIMOYAMA Y, 1995, CANCER RES, V55, P2206; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; SHIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245, DOI 10.1247/csf.11.245; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SUZUKI S, 1991, CELL REGUL, V2, P261, DOI 10.1091/mbc.2.4.261; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; TANIHARA H, 1994, CELL ADHES COMMUN, V2, P15, DOI 10.3109/15419069409014199; TANIHARA H, 1994, J CELL SCI, V107, P1697; THOMSON RB, 1995, J BIOL CHEM, V270, P17594, DOI 10.1074/jbc.270.29.17594; VOLK T, 1986, J CELL BIOL, V103, P1451, DOI 10.1083/jcb.103.4.1451; WOLLNER DA, 1992, J CELL BIOL, V116, P889, DOI 10.1083/jcb.116.4.889; XIANG YY, 1994, CANCER RES, V54, P3034; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOSHIDANORO C, 1984, DEV BIOL, V101, P19, DOI 10.1016/0012-1606(84)90112-X	63	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10011	10018		10.1074/jbc.273.16.10011	http://dx.doi.org/10.1074/jbc.273.16.10011			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545347	hybrid			2022-12-27	WOS:000073128800093
J	Dunn, SD; Chandler, J				Dunn, SD; Chandler, J			Characterization of a b(2)delta complex from Escherichia coli ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; CONFERRING PROTEIN OSCP; DELTA-SUBUNIT; ADENOSINE-TRIPHOSPHATASE; H+-ATPASE; CROSS-LINKING; F1-ATPASE; F1; BINDING; EXPRESSION	The delta subunit of Escherichia coli ATP synthase has been expressed and purified, both as the intact polypeptide and as delta', a proteolytic fragment composed of residues 1-134. The solution structure of delta' as a five-helix bundle has been previously reported (Wilkens, S., Dunn, S. D., Chandler, J., Dahlquist, F. W., and Capaldi, R. A. (1997) Nat. Struct. Biol. 4, 198-201). The delta subunit, in conjunction with delta-depleted F-1-ATPase, was fully capable of reconstituting energy-dependent fluorescence quenching in membrane vesicles that had been depleted of F-1. A complex of delta with the cytoplasmic domain of the b subunit of F-0 was demonstrated and characterized by analytical ultracentrifugation using b(ST34-156), a form of the b domain lacking aromatic residues. Molecular weight determination by sedimentation equilibrium supported a b(2) delta subunit stoichiometry. The sedimentation coefficient of the complex, 2.1 S, indicated a frictional ratio of approximately 2, suggesting that delta and the b dimer are arranged in an end-to-end rather than side-by-side manner. These results indicate the feasibility of the b(2) delta complex reaching from the membrane to the membrane-distal portion of the F-1 sector, as required if it is to serve as a second stalk.	Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Dunn, SD (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	sdunn@julian.uwo.ca	Dunn, Stanley/D-3418-2013					ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; ARIS JP, 1983, J BIOL CHEM, V258, P4599; BECKERS G, 1992, BIOCHIM BIOPHYS ACTA, V1101, P97, DOI 10.1016/0167-4838(92)90473-Q; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cohn E., 1943, PROTEINS AMINO ACIDS, P157; COLLINSON IR, 1994, J MOL BIOL, V242, P408; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNN SD, 1980, J BIOL CHEM, V255, P6891; DUNN SD, 1992, J BIOL CHEM, V267, P7630; ENGELBRECHT S, 1990, BIOCHIM BIOPHYS ACTA, V1015, P379, DOI 10.1016/0005-2728(90)90072-C; ENGELBRECHT S, 1988, EUR J BIOCHEM, V172, P213, DOI 10.1111/j.1432-1033.1988.tb13875.x; Fillingame RH, 1997, J EXP BIOL, V200, P217; FRAGA D, 1989, J BIOL CHEM, V264, P6797; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; HERMOLIN J, 1983, J BIOL CHEM, V258, P4550; HOPPE J, 1983, EMBO J, V2, P105, DOI 10.1002/j.1460-2075.1983.tb01389.x; JOSHI S, 1990, J BIOL CHEM, V265, P14518; JOSHI S, 1992, J BIOL CHEM, V267, P12860; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lill H, 1996, J BIOL CHEM, V271, P32737, DOI 10.1074/jbc.271.51.32737; MACFERRIN KD, 1990, P NATL ACAD SCI USA, V87, P1937, DOI 10.1073/pnas.87.5.1937; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; MENDELHARTVIG J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P115, DOI 10.1016/S0005-2728(05)80126-4; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; MUKHOPADHYAY A, 1992, J BIOL CHEM, V267, P25690; NAKAMOTO RK, 1996, BIOMEMBR, V5, P343; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ogilvie I, 1997, J BIOL CHEM, V272, P16652, DOI 10.1074/jbc.272.26.16652; PATEL AM, 1990, MOL MICROBIOL, V4, P1941, DOI 10.1111/j.1365-2958.1990.tb02043.x; PATEL AM, 1995, J BACTERIOL, V177, P3917, DOI 10.1128/jb.177.14.3917-3922.1995; PATI S, 1992, MOL MICROBIOL, V6, P3559, DOI 10.1111/j.1365-2958.1992.tb01791.x; PERLIN DS, 1983, J BIOL CHEM, V258, P9793; Rodgers AJW, 1997, J BIOL CHEM, V272, P31058, DOI 10.1074/jbc.272.49.31058; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sabbert D, 1997, P NATL ACAD SCI USA, V94, P4401, DOI 10.1073/pnas.94.9.4401; Sambrook J., 2002, MOL CLONING LAB MANU; Sawada K, 1997, J BIOL CHEM, V272, P30047, DOI 10.1074/jbc.272.48.30047; Schulenberg B, 1997, EUR J BIOCHEM, V249, P134, DOI 10.1111/j.1432-1033.1997.t01-1-00134.x; Smith SP, 1996, BIOCHEMISTRY-US, V35, P8805, DOI 10.1021/bi952698c; STAFFORD WF, 1992, ANAL BIOCHEM, V161, P70; STEINEMANN D, 1994, BBA-BIOENERGETICS, V1187, P354, DOI 10.1016/0005-2728(94)90009-4; STERNWEIS PC, 1977, BIOCHEMISTRY-US, V16, P4020, DOI 10.1021/bi00637a013; TOZER RG, 1986, EUR J BIOCHEM, V161, P513, DOI 10.1111/j.1432-1033.1986.tb10472.x; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Wilkens S, 1997, NAT STRUCT BIOL, V4, P198, DOI 10.1038/nsb0397-198; XIAO R, 1994, J BIOL CHEM, V269, P19232; Zhou YT, 1996, BBA-BIOENERGETICS, V1275, P96, DOI 10.1016/0005-2728(96)00056-4	51	69	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8646	8651		10.1074/jbc.273.15.8646	http://dx.doi.org/10.1074/jbc.273.15.8646			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535839	hybrid			2022-12-27	WOS:000072990800016
J	Jezewska, MJ; Rajendran, S; Bujalowski, W				Jezewska, MJ; Rajendran, S; Bujalowski, W			Functional and structural heterogeneity of the DNA binding site of the Escherichia coli primary replicative helicase DnaB protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; FLUORESCENT NUCLEOTIDE ANALOGS; NUCLEIC ACID INTERACTIONS; ENERGY-TRANSFER; HEXAMER; STATES; ATP	The structure-function relationship within the DNA binding site of the Escherichia coli replicative helicase DnaB protein was studied using nuclease digestion, quantitative fluorescence titration, centrifugation, and fluorescence energy transfer techniques, Nuclease digestion of the enzyme-single-stranded DNA (ssDNA) complexes reveals large structural heterogeneity within the binding site, The total site is built of two subsites differing in structure and affinity, although both occlude similar to 10 nucleotides. ssDNA affinity for the strong subsite is similar to 3 orders of magnitude higher than that for the weak subsite, Fluorescence energy transfer experiments provide direct proof that the DnaB hexamer binds ssDNA in a single orientation, with respect to the polarity of the sugar-phosphate backbone, This is the first evidence of directional binding to ssDNA of a hexameric helicase in solution, The strong binding subsite is close to the small 12-kDa domains of the DnaB hexamer and occludes the 5'-end of the ssDNA The strict orientation of the helicase on ssDNA indicates that, when the enzyme approaches the replication fork, it faces double-stranded DNA with its weak subsite. The data indicate that the different binding subsites are located sequentially, with the weak binding subsite constituting the entry site for double-stranded DNA of the replication fork.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bujalowski, W (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, 301 Univ Blvd, Galveston, TX 77555 USA.				NIEHS NIH HHS [5P30ES06676] Funding Source: Medline; NIGMS NIH HHS [GM-46679] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046679] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AZUMI T, 1962, J CHEM PHYS, V37, P2413, DOI 10.1063/1.1733019; BAKER TA, 1987, J BIOL CHEM, V262, P6877; BERMAN HA, 1980, BIOCHEMISTRY-US, V19, P2226, DOI 10.1021/bi00551a036; BUJALOWSKI W, 1994, BIOCHEMISTRY-US, V33, P4682, DOI 10.1021/bi00181a028; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31359; BUJALOWSKI W, 1993, BIOCHEMISTRY-US, V32, P5888, DOI 10.1021/bi00073a023; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; CANTOR CR, 1971, P NATL ACAD SCI USA, V68, P2099, DOI 10.1073/pnas.68.9.2099; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; HEYDUK T, 1992, BIOCHEMISTRY-US, V31, P5165, DOI 10.1021/bi00137a011; Jezewska MJ, 1997, BIOPHYS CHEM, V64, P253, DOI 10.1016/S0301-4622(96)02221-1; Jezewska MJ, 1996, BIOPHYS J, V71, P2075, DOI 10.1016/S0006-3495(96)79406-7; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 1997, BIOCHEMISTRY-US, V36, P10320, DOI 10.1021/bi970712a; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Kornberg A., 1992, DNA REPLICATION; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P111; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LEDNEVA RK, 1977, NUCLEIC ACIDS RES, V5, P4226; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MCMACKEN R, 1978, J BIOL CHEM, V253, P3313; NAKAYAMA N, 1984, J BIOL CHEM, V259, P97; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; REHAKRANTZ LJ, 1978, J BIOL CHEM, V253, P4051; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; UEDA K, 1978, J BIOL CHEM, V253, P261; WICKNER S, 1973, P NATL ACAD SCI USA, V71, P783; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297	33	70	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9058	9069		10.1074/jbc.273.15.9058	http://dx.doi.org/10.1074/jbc.273.15.9058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535894	hybrid			2022-12-27	WOS:000072990800071
J	Kuil, CW; Brouwer, A; van der Saag, PT; van der Burg, B				Kuil, CW; Brouwer, A; van der Saag, PT; van der Burg, B			Interference between progesterone and dioxin signal transduction pathways - Different mechanisms are involved in repression by the progesterone receptor A and B isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; STEROID-HORMONE RECEPTORS; ESTROGEN-RECEPTOR; AH RECEPTOR; CROSS-TALK; GENE-EXPRESSION; IN-VITRO; CELLS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; FORM	Interactions between transcription factors are an important means of regulating gene transcription, leading to modifications in the pattern of gene expression and cell fate. In this study, we report that the progesterone receptor (PR) can strongly interfere with transactivation mediated by the arylhydrocarbon receptor (AhR) in T47D breast cancer cells. This interference was not only demonstrated by induction of a transfected dioxin-responsive reporter plasmid but also on the AhR-mediated up-regulation of the endogenous cytochrome P450-1A1 activity. The interference was not mutual, as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most potent activator of the AhR, did not inhibit progestin-induced promoter activity. When the isoforms of the human PR, hPR-A and hPR-B, were expressed separately in HepG-2 hepatocarcinoma cells, both negatively interfered with the AhR signaling, indicating that the effect is not restricted to T47D cells. In addition, results obtained from studies with both antiprogestins and mutant receptors indicate differences in the underlying molecular mechanisms of repression for both PR isoforms, The suppression by hPR-A does not require additional gene expression or a full transcriptional competent conformation of the receptor. For the repressive effects of hPR-B, however, additional gene expression seems to be involved, as only the agonist-bound, wild-type hPR-B could clearly repress the TCDD-induced response. In conclusion, these studies highlight different mechanisms of repression for the progesterone receptor isoforms on the AhR-mediated trans-activation and underscore the importance of interactions between transcription factors of different families in the regulation of gene transcription.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Wageningen Univ Agr, Dept Toxicol, NL-6700 EA Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Wageningen University & Research	Kuil, CW (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	kuil@niob.knaw.nl						Bamberger AM, 1996, P NATL ACAD SCI USA, V93, P6169, DOI 10.1073/pnas.93.12.6169; BIRNBAUM LS, 1995, ENVIRON HEALTH PERSP, V103, P157, DOI 10.2307/3432463; CHRISTOU M, 1995, MOL CELL ENDOCRINOL, V115, P41, DOI 10.1016/0303-7207(95)03668-W; Cummings AM, 1996, TOXICOL APPL PHARM, V138, P131, DOI 10.1006/taap.1996.0106; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; GIBBONS A, 1993, SCIENCE, V262, P1373, DOI 10.1126/science.8248776; GIERTHY JF, 1993, CANCER RES, V53, P3149; Gillesby BE, 1997, BIOCHEMISTRY-US, V36, P6080, DOI 10.1021/bi962131b; GRADIN K, 1994, MOL CELL ENDOCRINOL, V104, P47; HARPER N, 1994, MOL CELL ENDOCRINOL, V104, P47, DOI 10.1016/0303-7207(94)90050-7; HORWITZ KB, 1983, ENDOCRINOLOGY, V113, P2195, DOI 10.1210/endo-113-6-2195; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; KLEINHITPASS L, 1991, NUCLEIC ACIDS RES, V19, P1227, DOI 10.1093/nar/19.6.1227; KRAUS WL, 1995, MOL CELL BIOL, V15, P1847; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mayani A, 1997, HUM REPROD, V12, P373, DOI 10.1093/humrep/12.2.373; MCDONNELL DP, 1994, J BIOL CHEM, V269, P11945; MCDONNELL DP, 1994, J STEROID BIOCHEM, V48, P425, DOI 10.1016/0960-0760(94)90190-2; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Murk AJ, 1996, FUND APPL TOXICOL, V33, P149, DOI 10.1006/faat.1996.0152; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; SAFE SH, 1995, PHARMACOL THERAPEUT, V67, P247, DOI 10.1016/0163-7258(95)00017-B; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; SPINK DC, 1990, P NATL ACAD SCI USA, V87, P6917, DOI 10.1073/pnas.87.17.6917; TAKIMOTO GS, 1992, P NATL ACAD SCI USA, V89, P3050, DOI 10.1073/pnas.89.7.3050; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; TUNG L, 1993, MOL ENDOCRINOL, V7, P1256, DOI 10.1210/me.7.10.1256; VANDERBURG B, 1988, J CELL PHYSIOL, V134, P101, DOI 10.1002/jcp.1041340112; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356; WHITLOCK JP, 1994, TRENDS ENDOCRIN MET, V5, P183, DOI 10.1016/1043-2760(94)90075-2; ZACHAREWSKI T, 1991, BIOCHEM PHARMACOL, V41, P1931, DOI 10.1016/0006-2952(91)90133-P; Zhang X, 1996, J BIOL CHEM, V271, P14825, DOI 10.1074/jbc.271.25.14825	38	42	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8829	8834		10.1074/jbc.273.15.8829	http://dx.doi.org/10.1074/jbc.273.15.8829			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535862	hybrid			2022-12-27	WOS:000072990800039
J	Liaw, PCY; Fredenburgh, JC; Stafford, AR; Tulinsky, A; Austin, RC; Weitz, JI				Liaw, PCY; Fredenburgh, JC; Stafford, AR; Tulinsky, A; Austin, RC; Weitz, JI			Localization of the thrombin-binding domain on prothrombin fragment 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C ACTIVATION; HUMAN ALPHA-THROMBIN; ACTIVE-SITE; THROMBOMODULIN; FLUORESCENCE; SPECIFICITY; COMPLEXES; HEPARIN; EXOSITE	Co-crystallographic studies have shown that the interaction of human prothrombin fragment 2 (F2) with thrombin involves the formation of salt bridges between the kringle inner loop of F2 and anion-binding exosite II of thrombin. When F2 binds to thrombin, it has been shown to evoke conformational changes at the active site and at exosite I of the enzyme. Using plasma, recombinant, and synthetic F2 peptides (F2, rF2, and sF2, respectively) we have further localized the thrombin-binding domain on F2. F2, rF2-(1-116), rF2-(55-116), and sF2-(63-116), all of which contain the kringle inner loop (residues 64-93) and the acidic COOH-terminal connecting peptide (residues 94-116), bind to thrombin-agarose. In contrast, analogues of the kringle inner loop, sF2-(63-90), or the COOH-terminal connecting peptide, sF2-(92-116), do not bind. Thus, contrary to predictions from the crystal structure, the COOH-terminal connecting peptide as well as the kringle inner loop are involved in the interaction of F2 with thrombin. F2 and sF2-(63-116) bind saturably to fluorescently labeled active site-blocked thrombin with K-d values of 4.1 and 51.3 mu M, respectively. The affinity of sF2-(63-116) for thrombin increases about 5-fold (K-d = 10 mu M) when Val at position 78 is substituted with Glu. F2 and sF2-(63-116) bind to exosite II on thrombin because both reduce the heparin-catalyzed rate of thrombin inhibition by antithrombin similar to 4-fold. In contrast, only F2 slows the uncatalyzed rate of thrombin inactivation by antithrombin. Like F2, sF2-(63-116) induces allosteric changes in the active site and exosite I of thrombin because it alters the rates of thrombin-mediated hydrolysis of chromogenic substrates and displaces fluorescently labeled hirudin(54-65) from active site-blocked thrombin, respectively. Both peptides also prolong the thrombin clotting time of fibrinogen in a concentration-dependent fashion, reflecting their effects on the active site and/or exosite I. These studies provide further insight into the regions of F2 that evoke functional changes in thrombin.	Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Hamilton, ON L8V 1C3, Canada; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	McMaster University; McMaster University; Michigan State University	Weitz, JI (corresponding author), Hamilton Civ Hosp, Res Ctr, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	weitzj@fhs.mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550				ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; ARNI RK, 1994, CHEM PHYS LIPIDS, V67-8, P59, DOI 10.1016/0009-3084(94)90124-4; AUSTIN RC, 1995, HUM MOL GENET, V4, P1475; Ausubel FM, 1988, MOL REPROD DEV; BAJAJ SP, 1975, J BIOL CHEM, V250, P2150; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BODE W, 1992, PROTEIN SCI, V1, P426; BULLEID NJ, 1988, BIOCHEM J, V254, P805, DOI 10.1042/bj2540805; CHURCH FC, 1989, J BIOL CHEM, V264, P18419; CHURCH WR, 1991, J BIOL CHEM, V266, P8384; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; HAYASHI T, 1990, J BIOL CHEM, V265, P20156; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; HEMKER HC, 1967, NATURE, V215, P248, DOI 10.1038/215248a0; JAKUBOWSKI HV, 1986, J BIOL CHEM, V261, P3876; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P3319, DOI 10.1021/bi9623993; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU LW, 1994, J BIOL CHEM, V269, P11807; LIU LW, 1991, J BIOL CHEM, V266, P23632; Mann K G, 1976, Methods Enzymol, V45, P123; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MYRMEL KH, 1976, BIOCHEMISTRY-US, V15, P1767, DOI 10.1021/bi00653a027; OLSEN ST, 1993, METHOD ENZYMOL, V222, P525; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; vandeLocht A, 1996, J BIOL CHEM, V271, P3413; WALKER FJ, 1979, J BIOL CHEM, V254, P5618; YE J, 1991, J BIOL CHEM, V266, P23016; ZUSHI M, 1989, J BIOL CHEM, V264, P10351	30	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8932	8939		10.1074/jbc.273.15.8932	http://dx.doi.org/10.1074/jbc.273.15.8932			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535876	hybrid			2022-12-27	WOS:000072990800053
J	Torres, J; Cooper, CE; Wilson, MT				Torres, J; Cooper, CE; Wilson, MT			A common mechanism for the interaction of nitric oxide with the oxidized binuclear centre and oxygen intermediates of cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; DIOXYGEN ACTIVATION; CELL RESPIRATION; REDUCTION; FERRYL; RAMAN; INHIBITION; REVERSAL; BINDING; ENERGY	The reactions of nitric oxide (NO) with fully oxidized cytochrome c oxidase (O) and the intermediates P and F have been investigated by optical spectroscopy, using both static and kinetic methods. The reaction of NO with O leads to a rapid (similar to 100 s(-1)) electron ejection from the binuclear center to cytochrome a and Cu-A. The reaction with the intermediates P and F leads to the depletion of these species in slower reactions, yielding the fully oxidized enzyme. The fastest optical change, however, takes place within the dead time of the stopped-flow apparatus (similar to 1 ms), and corresponds to the formation of the F intermediate (580 nm) upon reaction of NO with a species that we postulate is at the peroxide oxidation level. This species can be formulated as either Fe5+ = O Cu-B(2+) or Fe4+ = O Cu-B(3+), and it is spectrally distinct from the P intermediate (607 nm). All of these reactions have been rationalized through a mechanism in which NO reacts with Cu-B(2+), generating the nitrosonium species Cu-B(1+) NO+, which upon hydration yields nitrous acid and Cu-B(1+). This is followed by redox equilibration of Cu-B with Fe-a/Cu-A or Fe-a3 (in which Fe-a and Fe-a3 are the iron centers of cytochromes a and a(3), respectively). In agreement with this hypothesis, our results indicate that nitrite is rapidly formed within the binuclear center following the addition of NO to the three species tested (O, P, and F). This work suggests that nitrosylation at Cu-B(2+) instead of at Fe-a3(2+) is a key event in the fast inhibition of cytochrome c oxidase by NO.	Univ Essex, Dept Sci Biol, Colchester CO4 3SQ, Essex, England	University of Essex	Wilson, MT (corresponding author), Univ Essex, Dept Sci Biol, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	wilsmt@essex.ac.uk	Torres, Jaume/A-2179-2011; Cooper, Chris/AAK-9729-2020; Torres, Jaume/AAJ-4510-2020	Torres, Jaume/0000-0002-1282-9727; Cooper, Chris/0000-0003-0381-3990; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Averill BA, 1996, CHEM REV, V96, P2951, DOI 10.1021/cr950056p; Babcock GT, 1996, INORG CHIM ACTA, V243, P345, DOI 10.1016/0020-1693(96)04925-0; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BLACKMORE RS, 1991, J BIOL CHEM, V266, P19245; BLAIR DF, 1985, J AM CHEM SOC, V107, P7389, DOI 10.1021/ja00311a029; Borutaite V, 1996, BIOCHEM J, V315, P295, DOI 10.1042/bj3150295; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; BRUDVIG GW, 1980, BIOCHEMISTRY-US, V19, P5275, DOI 10.1021/bi00564a020; CHANCE B, 1975, J BIOL CHEM, V250, P9226; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Cole AP, 1996, SCIENCE, V273, P1848, DOI 10.1126/science.273.5283.1848; Collman JP, 1997, SCIENCE, V275, P949, DOI 10.1126/science.275.5302.949; Cooper CE, 1997, FEBS LETT, V414, P281, DOI 10.1016/S0014-5793(97)01009-0; FABIAN M, 1995, BIOCHEMISTRY-US, V34, P13802, DOI 10.1021/bi00042a011; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Giuffre A, 1996, J BIOL CHEM, V271, P33404, DOI 10.1074/jbc.271.52.33404; GORBUNOV NV, 1995, BIOCHEMISTRY-US, V34, P6689, DOI 10.1021/bi00020a014; MOODY AJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P189, DOI 10.1016/S0005-2728(05)80204-X; Morgan JE, 1996, BIOCHEMISTRY-US, V35, P12235, DOI 10.1021/bi961634e; NICHOLLS P, 1981, BIOCHIM BIOPHYS ACTA, V634, P256, DOI 10.1016/0005-2728(81)90144-4; Ogura T, 1996, J AM CHEM SOC, V118, P5443, DOI 10.1021/ja951922i; Proshlyakov DA, 1996, BIOCHEMISTRY-US, V35, P8580, DOI 10.1021/bi952096t; Proshlyakov DA, 1996, BIOCHEMISTRY-US, V35, P76, DOI 10.1021/bi9511705; PROSHLYAKOV DA, 1994, J BIOL CHEM, V269, P29385; SOULIMANE T, 1995, EUR J BIOCHEM, V227, P588, DOI 10.1111/j.1432-1033.1995.tb20429.x; STEVENS TH, 1979, P NATL ACAD SCI USA, V76, P3320, DOI 10.1073/pnas.76.7.3320; Sucheta A, 1997, BIOCHEMISTRY-US, V36, P554, DOI 10.1021/bi962422k; Torres J, 1996, METHOD ENZYMOL, V269, P3; TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169; Torres J, 1996, BIOCHEM SOC T, V24, pS450, DOI 10.1042/bst024450s; Torres Jaume, 1997, Biochemical Society Transactions, V25, p402S; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; VAROTSIS CA, 1995, J AM CHEM SOC, V117, P11260, DOI 10.1021/ja00150a025; VERKHOVSKY MI, 1994, BIOCHEMISTRY-US, V33, P3079, DOI 10.1021/bi00176a042; Verkhovsky MI, 1996, NATURE, V380, P268, DOI 10.1038/380268a0; Verkhovsky MI, 1996, P NATL ACAD SCI USA, V93, P12235, DOI 10.1073/pnas.93.22.12235; WENG LC, 1991, BIOCHEMISTRY-US, V30, P5727, DOI 10.1021/bi00237a014; WIKSTROM M, 1981, P NATL ACAD SCI-BIOL, V78, P4051, DOI 10.1073/pnas.78.7.4051; WIKSTROM M, 1992, J BIOL CHEM, V267, P10266; WILSON MT, 1982, BIOCHEM J, V203, P483, DOI 10.1042/bj2030483; Wilson MT, 1997, BIOCHEM SOC T, V25, P905, DOI 10.1042/bst0250905; YANG Y, 1996, J AM CHEM SOC, V118, P3972; ZHAO XJ, 1994, BIOCHEM BIOPH RES CO, V204, P537, DOI 10.1006/bbrc.1994.2492	43	98	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8756	8766		10.1074/jbc.273.15.8756	http://dx.doi.org/10.1074/jbc.273.15.8756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535853	hybrid			2022-12-27	WOS:000072990800030
J	Klingenberg, O; Wiedlocha, A; Rapak, A; Munoz, R; Falnes, PO; Olsnes, S				Klingenberg, O; Wiedlocha, A; Rapak, A; Munoz, R; Falnes, PO; Olsnes, S			Inability of the acidic fibroblast growth factor mutant K132E to stimulate DNA synthesis after translocation into cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-A-FRAGMENT; SITE-DIRECTED MUTAGENESIS; DIPHTHERIA-TOXIN; HEPARIN-BINDING; VERO CELLS; FACTOR-I; MEMBRANE TRANSLOCATION; NUCLEAR TRANSLOCATION; PROTEIN TRANSFERASE; MITOGENIC ACTIVITY	Acidic fibroblast growth factor (aFGF) is a potent mitogen, It acts through activation of specific cell surface receptors leading to intracellular tyrosine phosphorylation cascades, but several reports also indicate that aFGF enters cells and that it has an intracellular function as well. The aFGF(K132E) mutant binds to and activates fibroblast growth factor receptors equally strongly as the wild-type pe, but it is a poor mitogen, me demonstrate that aFGF(K132E) enters NIH 3T3 cells and is transported to the nuclear fraction Like wild-type aFGF, A fusion protein of aFGF(K132E) and diphtheria toxin A-fragment (aFGF(K132E)-DT-A) and a similar fusion protein containing mild-type aFGF (aFGF-DT-A) were reconstituted with diphtheria toxin B-fragment. Both fusion proteins were translocated to the cytosol by the diphtheria toxin pathway and subsequently recovered from the nuclear fraction. Whereas translocation of aFGF-DT-A stimulated DNA synthesis in U2OSDR1 cells lacking functional fibroblast growth factor receptors, aFGF(R132E)-DT-A did not. The mutation disrupts a protein kinase C phosphorylation site in the growth factor making it unable to be phosphorylated, The data indicate that a defect in the intracellular action of aFGF(K132E) is the reason for its strongly reduced mitogenicity, possibly due to inability to be phosphorylated.	Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway	University of Oslo	Olsnes, S (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway.		Rapak, Andrzej/ABE-6262-2021; Falnes, Pål Ø./AAA-4581-2020	Rapak, Andrzej/0000-0003-4897-0287; Munoz, Raquel/0000-0001-9861-0349; Falnes, Pal/0000-0001-8114-6025				BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BIRNBOIM HC, 1988, NUCLEIC ACIDS RES, V16, P1487, DOI 10.1093/nar/16.4.1487; BOUCHE G, 1987, P NATL ACAD SCI USA, V84, P6770, DOI 10.1073/pnas.84.19.6770; BURGESS WH, 1994, MOL REPROD DEV, V39, P56, DOI 10.1002/mrd.1080390110; BURGESS WH, 1991, J CELL BIOCHEM, V45, P131, DOI 10.1002/jcb.240450203; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CASEY PJ, 1991, P NATL ACAD SCI USA, V88, P8631, DOI 10.1073/pnas.88.19.8631; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; FALNES PO, 1995, J BIOL CHEM, V270, P20787, DOI 10.1074/jbc.270.35.20787; FALNES PO, 1994, J BIOL CHEM, V269, P8402; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARPER JW, 1988, BIOCHEMISTRY-US, V27, P671, DOI 10.1021/bi00402a027; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; Klingenberg O, 1996, BIOCHEM J, V313, P647, DOI 10.1042/bj3130647; KRUKEMYER JJ, 1987, PHARMACOTHERAPY, V7, P198; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; MASCARELLI F, 1989, EMBO J, V8, P2265, DOI 10.1002/j.1460-2075.1989.tb08351.x; MIDDLEBROOK JL, 1978, J BIOL CHEM, V253, P7325; MOSKAUG JO, 1988, J BIOL CHEM, V263, P2518; OLSNES S, 1986, J BIOL CHEM, V261, P1553; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; Sambrook J., 2002, MOL CLONING LAB MANU; SANDVIG K, 1982, J BIOL CHEM, V257, P7495; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; SCHABER MD, 1990, J BIOL CHEM, V265, P14701; SINENSKY M, 1994, J CELL SCI, V107, P61; STENMARK H, 1992, BIOCHEM J, V281, P619, DOI 10.1042/bj2810619; SUNDAN A, 1982, J BIOL CHEM, V257, P9733; WENNSTROM S, 1992, J BIOL CHEM, V267, P13749; Wiedlocha A, 1995, J BIOL CHEM, V270, P30680, DOI 10.1074/jbc.270.51.30680; WIEDLOCHA A, 1994, CELL, V76, P1039, DOI 10.1016/0092-8674(94)90381-6; Wiedlocha A, 1996, MOL CELL BIOL, V16, P270; WIEDLOCHA A, 1992, EMBO J, V11, P4835, DOI 10.1002/j.1460-2075.1992.tb05589.x; ZHAN X, 1992, BIOCHEM BIOPH RES CO, V188, P982, DOI 10.1016/0006-291X(92)91328-N; ZHAN X, 1993, J BIOL CHEM, V268, P9611	41	42	44	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11164	11172		10.1074/jbc.273.18.11164	http://dx.doi.org/10.1074/jbc.273.18.11164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556604	Green Published, hybrid			2022-12-27	WOS:000073395200056
J	Krapivinsky, G; Pu, W; Wickman, K; Krapivinsky, L; Clapham, DE				Krapivinsky, G; Pu, W; Wickman, K; Krapivinsky, L; Clapham, DE			pICln binds to a mammalian homolog of a yeast protein involved in regulation of cell morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CHLORIDE CURRENT; XENOPUS OOCYTES; VOLUME; CONDUCTANCE; EXPRESSION; ACTIVATION; CHANNELS; CLONING; PI(CLN); SHK1	Since its cloning and tentative identification as a chloride channel, the function of the pICln protein has been debated. Although there is no consensus regarding the specific function of pICln, it was suggested to play a role, directly or indirectly, in the function of a swelling-induced chloride conductance. Previously, the protein was shown to exist in several discrete protein complexes. To determine the function of the protein, we have begun the systematic identification of all proteins to which it binds. Here we show that four proteins firmly bind to pICln and identify the 72-kDa pICln-binding protein by affinity purification and peptide microsequencing. The interaction between this protein and pICln was verified several ways, including the extraction of several pICln clones from a cDNA library using the 72-kDa protein as a bait in a yeast two-hybrid screen. The protein is homologous to the yeast Skb1 protein. Skb1 interacts with Shk1, a homolog of the p21(Cdc42/Rac) activated protein kinases (PAKs). The known involvement of PAKs in cytoskeletal rearrangement suggests that pICln may be linked to a system regulating cell morphology.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Cardiovasc Div, 1309 Enders Bldg,320 Longwood Ave, Boston, MA 02115 USA.	clapham@rascal.med.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Pu, William/AAJ-8301-2020	Clapham, David/0000-0002-4459-9428; Pu, William/0000-0002-4551-8079; Wickman, Kevin/0000-0002-5179-9540				ACKERMAN MJ, 1994, JPN J PHYSIOL, V44, pS17; Buyse G, 1997, J BIOL CHEM, V272, P3615, DOI 10.1074/jbc.272.6.3615; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Gilbreth M, 1996, P NATL ACAD SCI USA, V93, P13802, DOI 10.1073/pnas.93.24.13802; GSCHWENTNER M, 1995, PFLUG ARCH EUR J PHY, V430, P464, DOI 10.1007/BF00373882; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Laich A, 1997, KIDNEY INT, V51, P477, DOI 10.1038/ki.1997.65; MARCUS S, 1995, P NATL ACAD SCI USA, V92, P6180, DOI 10.1073/pnas.92.13.6180; OKADA H, 1995, BBA-BIOMEMBRANES, V1234, P145, DOI 10.1016/0005-2736(95)00015-U; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; STRANGE K, 1995, KIDNEY INT, V48, P994, DOI 10.1038/ki.1995.381; Strange K, 1996, NEWS PHYSIOL SCI, V11, P146; Tilly BC, 1996, MOL BIOL CELL, V7, P1419, DOI 10.1091/mbc.7.9.1419; Voets T, 1996, J PHYSIOL-LONDON, V495, P441, DOI 10.1113/jphysiol.1996.sp021605	18	58	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10811	10814		10.1074/jbc.273.18.10811	http://dx.doi.org/10.1074/jbc.273.18.10811			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556550	hybrid			2022-12-27	WOS:000073395200002
J	Mitsuoka, C; Sawada-Kasugai, M; Ando-Furui, K; Izawa, M; Nakanishi, H; Nakamura, S; Ishida, H; Kiso, M; Kannagi, R				Mitsuoka, C; Sawada-Kasugai, M; Ando-Furui, K; Izawa, M; Nakanishi, H; Nakamura, S; Ishida, H; Kiso, M; Kannagi, R			Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(1,3)FUCOSYLTRANSFERASE FUC-TVII; N-ACETYLGLUCOSAMINE RESIDUES; GLYCOPROTEIN LIGAND-1; MONOCLONAL-ANTIBODY; LINKED OLIGOSACCHARIDES; CELL-ADHESION; TYPE-2 CHAIN; EXPRESSION; ANTIGEN; ELAM-1	We investigated the molecular species of sulfated sialyl Lewis X determinants, the putative L-selectin ligand, expressed on high endothelial venules (HEV) in human lymph nodes. Comparison of the reactivity pattern of HEV with the reactivity of the pure 6-sulfo, 6'-sulfo, or 6,6'-bissulfo sialyl Lewis X determinant with hitherto known anti-sialyl Lewis X antibodies strongly suggested 6-sulfo sialyl Leu is X to be the best candidate for the major sulfated sialyl Lewis X determinant on HEV, followed by 6,6'-bissulfo sialyl Lewis X, whereas 6'-sulfo sialyl Lewis X was unlikely. We newly generated mono clonal antibodies (mAbs) G152 and G72 directed against B-sulfo sialyl Lewis X, which intensely labeled HEV in immunohistochemical examination and inhibited binding of recombinant L-selectin-IgG to HEV, suggesting that the determinant serves as a ligand for L-selectin. To test the concomitant expression of 6,6'-bissulfo sialyl Lewis X, specific mAbs (G2706, G27011, G27037, and G27039) were generated, but all antibodies failed to react to HEV, Next, we established mAbs (AG97 and AG273) directed against B-sulfo Lewis X, the asialo form of B-sulfo sialyl Lewis X, The antibodies were not reactive to untreated HEV, but strongly reacted to sialidase-treated HEV, This indicated the predominance of the sialylated form of 6-sulfo sialyl Lewis X and minimal expression of its asialo form, corroborating that it was synthesized by fucosyltransferase VII, the isoenzyme that preferentially produces the sialylated form of the determinant.	Aichi Canc Ctr, Program Expt Psychol, Nagoya, Aichi 464, Japan; Aichi Canc Ctr, Pathol Lab, Nagoya, Aichi 464, Japan; Aichi Canc Ctr, Clin Pathol Lab, Nagoya, Aichi 464, Japan; Gifu Univ, Fac Agr, Dept Appl Bioorgan Chem, Gifu 50111, Japan	Aichi Cancer Center; Aichi Cancer Center; Aichi Cancer Center; Gifu University	Kannagi, R (corresponding author), Aichi Canc Ctr, Program Expt Pathol, Res Inst, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	rkannagi@aichi-cc.pref.aichi.jp	Kannagi, Reiji/Q-6459-2018; Nakamura, Shigeo/I-1571-2012	Kannagi, Reiji/0000-0003-4202-2921; 				BERG EL, 1992, BIOCHEM BIOPH RES CO, V184, P1048, DOI 10.1016/0006-291X(92)90697-J; BERG EL, 1991, J BIOL CHEM, V266, P14869; BRANDLEY BK, 1993, GLYCOBIOLOGY, V3, P633, DOI 10.1093/glycob/3.6.633; CAPON C, 1989, EUR J BIOCHEM, V182, P139, DOI 10.1111/j.1432-1033.1989.tb14810.x; DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; FUKUSHI Y, 1985, CANCER RES, V45, P3711; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GEOFFROY JS, 1989, J CELL BIOL, V109, P2463, DOI 10.1083/jcb.109.5.2463; Guyer DA, 1996, BLOOD, V88, P2415, DOI 10.1182/blood.V88.7.2415.bloodjournal8872415; Habuchi O, 1997, GLYCOBIOLOGY, V7, P405, DOI 10.1093/glycob/7.3.405; HAKOMORI S, 1986, HDB EXPT IMMUNOLOGY, V1, P91; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4830, DOI 10.1021/bi00182a011; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; KAMEYAMA A, 1991, CARBOHYD RES, V209, pC1, DOI 10.1016/0008-6215(91)80171-I; KANNAGI R, 1986, CANCER RES, V46, P2619; KANNAGI R, 1985, J BIOL CHEM, V260, P6410; KANNAGI R, 1998, LEUKOCYTE TYPING 6, P352; KANNAGI R, 1986, HDB EXPT IMMUNOLOGY, V4, P1171; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Komba S, 1996, CARBOHYD RES, V285, pC1, DOI 10.1016/S0008-6215(96)90188-3; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; LOWE JB, 1990, CELL, V63, P475, DOI 10.1016/0092-8674(90)90444-J; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mitsuoka C, 1997, BIOCHEM BIOPH RES CO, V230, P546, DOI 10.1006/bbrc.1996.6012; Mitsuoka C, 1997, BIOCHEM BIOPH RES CO, V233, P576, DOI 10.1006/bbrc.1997.6463; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; OHMORI K, 1993, BLOOD, V82, P2797; PAAVONEN T, 1992, AM J PATHOL, V141, P1259; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Sanders WJ, 1996, BIOCHEMISTRY-US, V35, P14862, DOI 10.1021/bi9613640; SASAKI K, 1994, J BIOL CHEM, V269, P14730; SAWADA M, 1993, BIOCHEM BIOPH RES CO, V193, P337, DOI 10.1006/bbrc.1993.1629; Smith PL, 1996, J BIOL CHEM, V271, P8250, DOI 10.1074/jbc.271.14.8250; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Spiro RG, 1996, BIOCHEM J, V319, P209, DOI 10.1042/bj3190209; TAKADA A, 1991, BIOCHEM BIOPH RES CO, V179, P713, DOI 10.1016/0006-291X(91)91875-D; Tu LL, 1996, J IMMUNOL, V157, P3995; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; Yoshino K, 1997, J MED CHEM, V40, P455, DOI 10.1021/jm9605290	43	222	224	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11225	11233		10.1074/jbc.273.18.11225	http://dx.doi.org/10.1074/jbc.273.18.11225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556613	hybrid			2022-12-27	WOS:000073395200065
J	Saunders, DN; Buttigieg, KML; Gould, A; McPhun, V; Baker, MS				Saunders, DN; Buttigieg, KML; Gould, A; McPhun, V; Baker, MS			Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE-BOND LOOP; GEL-ELECTROPHORESIS; ANTITHROMBIN; ALPHA-1-ANTITRYPSIN; PROTEINASES; APOPTOSIS; ANTIBODY; HEPARIN; REGION; CELLS	The physiological roles of plasminogen activator inhibitor-a (PAI-2) are not yet well understood. Kinetic studies suggest a role in the regulation of plasminogen activator-driven proteolysis in many cell types, This study describes a monoclonal antibody (2H5), which uniquely recognizes neoepitope determinants on PAI-2 appearing after thermodynamic relaxation of the molecule. Enzyme-linked immunosorbent assays and native polyacrylamide gel electrophoresis immunoblotting confirmed the specificity of 2H5 for urokinase type plasminogen activator PAI-2 complexes. Examination of the affinity of 2H5 for complexes formed between PAI-2 and a synthetic 14-mer reactive site loop peptide, PAI-P treated with tissue plasminogen activator, or thrombin suggests that the 2H5 epitope is determined exclusively by sequences found only on PAI-S following proteolytic cleavage of the Arg(380)-Thr(381) bond and insertion of the reactive site loop into beta-sheet A. Peptides lacking both the P13 (Glu(368)) and P14 (Thr(367)) residues did not induce a conformational change or affect the inhibitory activity of PAI-2, indicating that one or both of these residues are critical for PAI-2 function. To our knowledge, this is the first description of a monoclonal antibody that can distinguish conformational changes in PAI-2 related specifically to its potential biological function(s).	Univ Wollongong, Dept Biol Sci, Wollongong, NSW 2522, Australia; Biotech Australia Pty Ltd, Roseville, NSW 2069, Australia; Australian Natl Univ, John Curtin Sch Med Res, Div Cell Biol, Canberra, ACT 2601, Australia	University of Wollongong; Australian National University; John Curtin School of Medical Research	Baker, MS (corresponding author), Univ Wollongong, Dept Biol Sci, Wollongong, NSW 2522, Australia.		Saunders, Darren/B-7677-2008	Baker, Mark/0000-0001-5858-4035; Saunders, Darren/0000-0003-0924-0513				BJORK I, 1992, J BIOL CHEM, V267, P1976; BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; DAWES J, 1994, BIOCHEMISTRY-US, V33, P4375, DOI 10.1021/bi00180a035; DEAGOSTINI A, 1988, J CLIN INVEST, V82, P700, DOI 10.1172/JCI113650; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; ELDERING E, 1995, J BIOL CHEM, V270, P2579, DOI 10.1074/jbc.270.6.2579; ENGHILD JJ, 1994, J BIOL CHEM, V269, P20159; GETTINS P, 1992, HEMATOL ONCOL CLIN N, V6, P1393, DOI 10.1016/S0889-8588(18)30282-X; GETTINS P, 1993, BIOESSAYS, V15, P461, DOI 10.1002/bies.950150705; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; HAMILTON JA, 1993, CELL IMMUNOL, V152, P7, DOI 10.1006/cimm.1993.1263; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JENSEN PH, 1994, BRIT J CANCER, V70, P834, DOI 10.1038/bjc.1994.407; KENT SBH, 1988, ANNU REV BIOCHEM, V57, P957, DOI 10.1146/annurev.bi.57.070188.004521; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KRUITHOF EKO, 1986, J BIOL CHEM, V261, P1207; KUMAR S, 1991, J BIOL CHEM, V266, P20960; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; SUMIYOSHI K, 1992, INT J CANCER, V50, P345, DOI 10.1002/ijc.2910500303; Tsatas D, 1997, J HISTOCHEM CYTOCHEM, V45, P1593, DOI 10.1177/002215549704501202	27	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10965	10971		10.1074/jbc.273.18.10965	http://dx.doi.org/10.1074/jbc.273.18.10965			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556575	hybrid			2022-12-27	WOS:000073395200027
J	Nicolas, E; Reichhart, JM; Hoffmann, JA; Lemaitre, B				Nicolas, E; Reichhart, JM; Hoffmann, JA; Lemaitre, B			In vivo regulation of the I kappa B homologue cactus during the immune response of Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL-VENTRAL POLARITY; INSECT IMMUNITY; TRANSMEMBRANE PROTEIN; DORSOVENTRAL POLARITY; SIGNAL-TRANSDUCTION; EMBRYONIC POLARITY; GENE; EXPRESSION; ALPHA; SEQUENCE	The dorsoventral regulatory gene pathway (spatzlel Toll/cactus) controls the expression of several antimicrobial genes during the immune response of Drosophila. This regulatory cascade shows striking similarities with the cytokine-induced activation cascade of NF-kappa B during the inflammatory response in mammals. Here, we have studied the regulation of the I kappa B homologue Cactus in the fat body during the immune response. We observe that the cactus gene is up-regulated in response to immune challenge. Interestingly, the expression of the cactus gene is controlled by the spatzle/Toll/cactus gene pathway, indicating that the cactus gene is auto-regulated. We also show that two Cactus isoforms are expressed in the cytoplasm of fat body cells and that they are rapidly degraded and resynthesized after immune challenge. This degradation is also dependent on the Toll signaling pathway. Altogether, our results underline the striking similarities between the regulation of I kappa B and cactus during the immune response.	Inst Biol Mol & Cellulaire, UPR 9022 CNRS, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Lemaitre, B (corresponding author), Inst Biol Mol & Cellulaire, UPR 9022 CNRS, 15 Rue Rene Descartes, F-67084 Strasbourg, France.		Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667				ANDERSON K, 1986, DORSAL GROUP GENES D, P117; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HEGUY A, 1992, J BIOL CHEM, V267, P2605; Hoffmann JA, 1997, TRENDS CELL BIOL, V7, P309, DOI 10.1016/S0962-8924(97)01087-8; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; KUBOTA K, 1995, NUCLEIC ACIDS RES, V23, P3111, DOI 10.1093/nar/23.16.3111; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1991, P NATL ACAD SCI USA, V88, P4419, DOI 10.1073/pnas.88.10.4419; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; PETERSEN UM, 1995, EMBO J, V14, P3146, DOI 10.1002/j.1460-2075.1995.tb07317.x; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; REICHHART JM, 1993, CR ACAD SCI III-VIE, V316, P1218; ROTH S, 1991, DEVELOPMENT, V112, P371; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; WASSERMAN SA, 1993, MOL BIOL CELL, V4, P767, DOI 10.1091/mbc.4.8.767; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; WICKER C, 1990, J BIOL CHEM, V265, P22493; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	49	82	87	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10463	10469		10.1074/jbc.273.17.10463	http://dx.doi.org/10.1074/jbc.273.17.10463			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553105	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000073224200054
J	Richardson, RM; Ali, H; Pridgen, BC; Haribabu, B; Snyderman, R				Richardson, RM; Ali, H; Pridgen, BC; Haribabu, B; Snyderman, R			Multiple signaling pathways of human interleukin-8 receptor A - Independent regulation by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; CHEMOATTRACTANT RECEPTORS; HUMAN NEUTROPHILS; G-PROTEINS; DESENSITIZATION; TRANSDUCTION; CHEMOKINES; CELLS	Interleukin-8 (IL-8) receptor A (CXCR1) couples to a pertussis toxin-sensitive G protein to mediate phospholipase C beta (PLC beta) activation and cellular responses. Responses to CXCR1 are attenuated by prior exposure of neutrophils to either IL-8, a cleavage product of the fifth component of complement (C5a) or n-formylated peptides (formylmethionylleucylphenylalanine, fMLP). To characterize the role of receptor phosphorylation in the regulation of the CXCR1, a phosphorylation-deficient mutant, M2CXCR1, was constructed. This receptor, stably expressed in RBL-2H3 cells, coupled more efficiently to G protein and stimulated enhanced phosphoinositide hydrolysis, cAMP production, exocytosis, and phospholipase D activation, and was resistant to IL-8-induced receptor internalization. The rate and total amount of ligand stimulated actin polymerization remained unchanged, but interestingly, chemotaxis was decreased by similar to 30% compared with the wild type receptor. To study the role of receptor phosphorylation in cross desensitization of chemoattractant receptors, M2CXCR1 was coexpressed with cDNAs encoding receptors for either fMLP (FR), C5a (C5aR), or platelet-activating factor (PAFR). Both C5aR and PAFR were cross-phosphorylated upon M2CXCR1 activation, resulting in attenuated guanosine 5'-3'-O-(thio)triphosphate (GTP gamma S) binding in membranes. In contrast, FR and M2CXCR1 were resistant to cross-phosphorylation and cross-inhibition of GTP gamma S binding by other receptors. Despite the resistance of M2CXCR1 to cross-phosphorylation and receptor/G protein uncoupling, its susceptibility to cross-desensitization of its Ca2+ response by fMLP and C5a, was equivalent to CXCR1. Regardless of the enhancement in certain receptor functions in M2CXCR1 compared with the wild type CXCR1, the mutated receptors mediated equivalent PLC beta(3), phosphorylation and cross-desensitization of Ca2+ mobilization by FR, C5aR, and PAFR. The results herein indicate that phosphorylation of CXCR1 regulates some, but not all of the receptors functions. While receptor phosphorylation inhibits G protein turnover, PLC activation, Ca2+ mobilization and secretion, it is required for normal chemotaxis and receptor internalization. Since phosphorylation of CXCR1 had no effect on its ability to induce phosphorylation of PLC beta(3), or to mediate class-desensitization, these activities may be mediated by independently regulated pathways.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University	Richardson, RM (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3680, Durham, NC 27710 USA.	richa021@mc.duke.edu	Bodduluri, Haribabu/A-2584-2010	Bodduluri, Haribabu/0000-0002-8261-3294	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL054166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038910, R29AI038910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003738] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54166] Funding Source: Medline; NIAID NIH HHS [AI-38910] Funding Source: Medline; NIDCR NIH HHS [DE-03738] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ali H, 1997, J BIOL CHEM, V272, P11706, DOI 10.1074/jbc.272.18.11706; ALI H, 1994, J BIOL CHEM, V269, P24557; ALI H, 1993, J BIOL CHEM, V268, P24247; ALI H, 1998, IN PRESS J BIOL CHEM, V273; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; BAGGIOLINI M, 1994, IMMUNOL TODAY, V15, P127, DOI 10.1016/0167-5699(94)90156-2; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; BAGGIOLINI M, 1992, INFLAMMATION BASIC P, P247; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; GRIMM MC, 1998, IN PRESS J EXP MED; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Kim JY, 1997, J BIOL CHEM, V272, P27313, DOI 10.1074/jbc.272.43.27313; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; LIGGETT SB, 1994, REGULATION CELLULAR, P71; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; Mayer S E, 1974, Methods Enzymol, V38, P66; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Prado GN, 1996, J BIOL CHEM, V271, P19186, DOI 10.1074/jbc.271.32.19186; Prossnitz ER, 1997, J BIOL CHEM, V272, P15213, DOI 10.1074/jbc.272.24.15213; RICHARDON RM, 1995, J BIOL CHEM, V270, P27829, DOI 10.1074/jbc.270.46.27829; Richardson RM, 1996, J BIOL CHEM, V271, P28717, DOI 10.1074/jbc.271.45.28717; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; SNYDERMAN R, 1992, INFLAMMATION BASIC P, P421; TOMHAVE E, 1994, J IMMUNOL, V154, P3267; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840	32	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10690	10695		10.1074/jbc.273.17.10690	http://dx.doi.org/10.1074/jbc.273.17.10690			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553132	hybrid			2022-12-27	WOS:000073224200081
J	Cousin, X; Bon, S; Massoulie, J; Bon, C				Cousin, X; Bon, S; Massoulie, J; Bon, C			Identification of a novel type of alternatively spliced exon from the acetylcholinesterase gene of Bungarus fasciatus - Molecular forms of acetylcholinesterase in the snake liver and muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-TAILED FORMS; RAT ACETYLCHOLINESTERASE; TORPEDO CHOLINESTERASES; NONAMPHIPHILIC FORMS; CATALYTIC SUBUNIT; PHOSPHOLIPASE-C; CELL-SURFACE; SINGLE GENE; EXPRESSION; CLONING	The venom of the snake Bungarus fasciatus contains a hydrophilic, monomeric species of acetylcholinesterase (AChE), characterized by a C-terminal region that does not resemble the alternative T-or H-peptides. Here, we show that the snake contains a single gene for AChE, possessing a novel alternative exon (S) that encodes the C-terminal region of the venom enzyme, located down-stream of the T exon. Alternative splicing generates S mRNA in the venom gland and S and T mRNAs in muscle and liver. We found no evidence for the presence of an H exon between the last common "catalytic" exon and the T exon, where H exons are located in Torpedo and in mammals. Moreover, COS cells that were transfected with AChE expression vectors containing the T exon with or without the preceding genomic region produced exclusively AChE, subunits, In the snake tissues, we could not detect any glycophosphatidylinositol-anchored AChE form that would have derived from H subunits. In the liver, the cholinesterase activity comprises both AChE and butyrylcholinesterase components; butyrylcholinesterase corresponds essentially to nonamphiphilic tetramers and AChE to nonamphiphilic monomers (G(1)(na)). In muscle, AChE is largely predominant: it consists of globular forms (G(1)(a) and G(4)(a)) and trace amounts of asymmetric forms (A(8) and A(12)), which derive from AChE(T) subunits. Thus, the Bungarus AChE gene possesses alternatively spliced T and S exons but no II exon; the absence of an H exon may be a common feature of AChE genes in reptiles and birds.	Inst Pasteur, Unite Venins, F-75015 Paris, France; CNRS, URA 1857, Neurobiol Cellulaire & Mol Lab, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Bon, C (corresponding author), Inst Pasteur, Unite Venins, 28 Rue Dr Roux, F-75015 Paris, France.		Cousin, Xavier/E-2542-2013	Cousin, Xavier/0000-0002-8520-3610				ARPAGAUS M, 1994, J BIOL CHEM, V269, P9957; BON S, 1988, J NEUROCHEM, V51, P776, DOI 10.1111/j.1471-4159.1988.tb01812.x; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BON S, 1978, EUR J BIOCHEM, V85, P1, DOI 10.1111/j.1432-1033.1978.tb12207.x; BON S, 1988, J NEUROCHEM, V51, P786, DOI 10.1111/j.1471-4159.1988.tb01813.x; CAMP S, 1995, J CLIN INVEST, V95, P333, DOI 10.1172/JCI117661; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cousin X, 1996, J BIOL CHEM, V271, P15099, DOI 10.1074/jbc.271.25.15099; Cousin X, 1996, FEBS LETT, V387, P196, DOI 10.1016/0014-5793(96)00447-4; COUSIN X, 1991, CHOLINESTERASES STRU, P195; COUSSEN F, 1995, EUR J CELL BIOL, V67, P254; DELAHUNTY MD, 1993, J BIOL CHEM, V268, P12017; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; DUVAL N, 1992, J CELL BIOL, V118, P641, DOI 10.1083/jcb.118.3.641; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; Frobert Y, 1997, BBA-PROTEIN STRUCT M, V1339, P253, DOI 10.1016/S0167-4838(97)00009-5; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FUTERMAN AH, 1985, J NEUROCHEM, V45, P1487, DOI 10.1111/j.1471-4159.1985.tb07217.x; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; Iwanaga S., 1979, HDB EXPT PHARMACOLOG, V52, P61; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; LEGAY C, 1993, FEBS LETT, V315, P163, DOI 10.1016/0014-5793(93)81155-S; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LI Y, 1991, J BIOL CHEM, V266, P23083; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MILLER RL, 1970, ARCH BIOCHEM BIOPHYS, V139, P104, DOI 10.1016/0003-9861(70)90051-2; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PERELMAN A, 1989, EUR J BIOCHEM, V182, P203, DOI 10.1111/j.1432-1033.1989.tb14818.x; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RANDALL WR, 1994, BBA-GENE STRUCT EXPR, V1218, P453, DOI 10.1016/0167-4781(94)90204-6; ROSSI SG, 1993, J BIOL CHEM, V268, P19152; ROTUNDO RL, 1988, P NATL ACAD SCI USA, V85, P7805, DOI 10.1073/pnas.85.20.7805; SIKORAV JL, 1988, EMBO J, V7, P2983, DOI 10.1002/j.1460-2075.1988.tb03161.x; SIKORAV JL, 1987, EMBO J, V6, P1865, DOI 10.1002/j.1460-2075.1987.tb02445.x; Simon S, 1997, J BIOL CHEM, V272, P33045, DOI 10.1074/jbc.272.52.33045; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; TOUTANT JP, 1988, HDB EXP PHARM, V86, P225; WEISE C, 1990, EMBO J, V9, P3885, DOI 10.1002/j.1460-2075.1990.tb07607.x	42	35	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9812	9820		10.1074/jbc.273.16.9812	http://dx.doi.org/10.1074/jbc.273.16.9812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545320	hybrid			2022-12-27	WOS:000073128800066
J	Melendez, A; Floto, RA; Gillooly, DJ; Harnett, MM; Allen, JM				Melendez, A; Floto, RA; Gillooly, DJ; Harnett, MM; Allen, JM			Fc gamma RI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR CROSS-LINKING; AFFINITY IGE RECEPTOR; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; ANTIGEN RECEPTOR; 2ND MESSENGER; U937 CELLS; PROTEIN; SPHINGOSINE-1-PHOSPHATE; ACTIVATION	Aggregation of receptors specific for the constant region of immunoglobulin G activates a repertoire of monocyte responses that can lead ultimately to targeted cell killing via antibody-directed cellular cytotoxicity. The high affinity receptor, Fc gamma RI, contains no recognized signaling motif in its cytoplasmic tail but rather utilizes the gamma-chain of Fc epsilon RI as an accessory molecule to recruit tyrosine kinases for signal transduction. We show here that, in a human monocytic cell line primed with interferon-gamma, Fc gamma RI mobilizes intracellular calcium stores using a novel pathway that involves tyrosine kinase coupling to phospholipase D and resultant downstream activation of sphingosine kinase, Moreover, Fc gamma RI is not coupled to phospholipase C; hence, calcium release from intracellular stores occurred in the absence of any measurable rise in inositol triphosphate. Finally, as this novel activation pathway is also shown to be responsible for mediating the vesicular trafficking of internalized immune complexes for degradation, it is likely to play a key role in controlling intracellular events triggered by Fc gamma RI.	Univ Glasgow, Dept Med & Therapeut, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England; Univ Glasgow, Dept Immunol, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Cambridge; University of Glasgow	Allen, JM (corresponding author), Univ Glasgow, Dept Med & Therapeut, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	janet.allen@bio.gla.ac.uk						ALLEN JM, 1989, SCIENCE, V243, P378, DOI 10.1126/science.2911749; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; BRISCOE CP, 1994, BIOCHEM J, V298, P61, DOI 10.1042/bj2980061; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; Choi OH, 1996, NATURE, V380, P634; DAVIS W, 1994, CELL CALCIUM, V16, P29, DOI 10.1016/S0143-4160(05)80005-3; DUCHEMIN AM, 1994, J BIOL CHEM, V269, P12111; Duchemin AM, 1997, J IMMUNOL, V158, P865; Ely P, 1996, BLOOD, V87, P3813, DOI 10.1182/blood.V87.9.3813.bloodjournal8793813; FANGER MW, 1989, IMMUNOL TODAY, V10, P92, DOI 10.1016/0167-5699(89)90234-X; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARNETT W, 1993, J IMMUNOL, V151, P4829; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; HARRISON PT, 1994, J BIOL CHEM, V269, P24396; HEEMSKERK JWM, 1993, J BIOL CHEM, V268, P356; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO F, 1992, P NATL ACAD SCI USA, V89, P3659, DOI 10.1073/pnas.89.8.3659; LIN CT, 1994, J CLIN IMMUNOL, V14, P1, DOI 10.1007/BF01541170; Mao CG, 1996, P NATL ACAD SCI USA, V93, P1993, DOI 10.1073/pnas.93.5.1993; MATTIE M, 1994, J BIOL CHEM, V269, P3181; MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLIVERA A, 1994, J BIOL CHEM, V269, P17924; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; QUALLIOTINEMANN D, 1993, J BIOL CHEM, V268, P23843; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RANKIN BM, 1993, J IMMUNOL, V150, P605; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Sambrook J., 2002, MOL CLONING LAB MANU; SARGEANT P, 1992, CELL CALCIUM, V13, P53; SCHOLL PR, 1993, P NATL ACAD SCI USA, V90, P8847, DOI 10.1073/pnas.90.19.8847; STENGELIN S, 1988, EMBO J, V7, P1053, DOI 10.1002/j.1460-2075.1988.tb02913.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDEWINKEL JGJ, 1991, J LEUKOCYTE BIOL, V49, P511, DOI 10.1002/jlb.49.5.511; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484	41	158	165	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9393	9402		10.1074/jbc.273.16.9393	http://dx.doi.org/10.1074/jbc.273.16.9393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545263	hybrid			2022-12-27	WOS:000073128800009
J	Vega-Palas, MA; Venditti, S; Di Mauro, E				Vega-Palas, MA; Venditti, S; Di Mauro, E			Heterochromatin organization of a natural yeast telomere - Changes of nucleosome distribution driven by the absence of Sir3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTONOMOUSLY REPLICATING SEQUENCES; SILENT MATING LOCI; SACCHAROMYCES-CEREVISIAE; DNA-SEQUENCES; HISTONE H3; RAP1; PROTEINS; REPRESSION; ENDS; CHROMOSOMES	We have defined the in vivo heterochromatin structure of the left telomere of Saccharomyces cerevisiae chromosome III (LIII), Analysis of heterochromatin of a single telomere was so far lacking, due to the difficulties intrinsic to the highly repetitive nature of telomeric sequences. In LIII, the terminal (C(1-3)A)(n) repetitive sequences are followed by a complete X element and by the single copy Ty5-1 retrotransposon, Both the telosome and the X element exhibit overall resistance to micrococcal nuclease digestion reflecting their tight chromatin structure organization. The X element contains protein complexes and irregularly distributed but well localized nucleosomes. In contrast, a regular array of phased nucleosomes is associated with the promoter region of Ty5-1 and with the more centromere-proximal sequences. The lack of a structural component of yeast telomeres, the SIRS protein, does not alter the overall tight organization of the X element but causes a nucleosome rearrangement within the promoter region of Ty5-1 and releases Ty5-1 silencing. Thus, Sir3p links the modification of the heterochromatin structure with loss of transcriptional silencing.	Univ Rome La Sapienza, Dipartimento Genet & Biol Mol, Fdn Cenci Bolognetti, Fdn Ist Pasteur, I-00185 Rome, Italy; CNR, Ctr Acidi Nucl, Roma, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Di Mauro, E (corresponding author), Univ Rome La Sapienza, Dipartimento Genet & Biol Mol, Fdn Cenci Bolognetti, Fdn Ist Pasteur, P Aldo Moro 5, I-00185 Rome, Italy.		Palas, Miguel Angel Vega/K-6424-2014	Palas, Miguel Angel Vega/0000-0003-1841-540X				APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CHAN CSM, 1983, J MOL BIOL, V168, P505, DOI 10.1016/S0022-2836(83)80299-X; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; LOUIS EJ, 1994, GENETICS, V136, P789; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; PRYDE FE, 1995, YEAST, V11, P371, DOI 10.1002/yea.320110410; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; VegaPalas MA, 1997, NAT GENET, V15, P232, DOI 10.1038/ng0397-232; VENDITTI S, 1994, MOL GEN GENET, V242, P3811; WALMSLEY RM, 1984, NATURE, V310, P157, DOI 10.1038/310157a0; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	35	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9388	9392		10.1074/jbc.273.16.9388	http://dx.doi.org/10.1074/jbc.273.16.9388			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545262	hybrid			2022-12-27	WOS:000073128800008
J	Elbirt, KK; Whitmarsh, AJ; Davis, RJ; Bonkovsky, HL				Elbirt, KK; Whitmarsh, AJ; Davis, RJ; Bonkovsky, HL			Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells - Role of mitogen-activated protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK-EMBRYO LIVER; DELTA-AMINOLEVULINATE SYNTHASE; SIGNAL-TRANSDUCTION PATHWAY; UPSTREAM STIMULATORY FACTOR; HUMAN-SKIN FIBROBLASTS; HEAT-SHOCK; OXIDATIVE STRESS; MESSENGER-RNA; GENE-EXPRESSION; DIFFERENTIAL ACTIVATION	Heme oxygenase-1 is an inducible enzyme that catalyzes heme degradation and has been proposed to play a role in protecting cells against oxidative stress-related injury. We investigated the induction of heme oxygenase-1 by the tumor promoter arsenite in a chicken hepatoma cell line, LMH. We identified a heme oxygenase-1 promoter-driven luciferase reporter construct that was highly and reproducibly expressed in response to sodium arsenite treatment. This construct was used to investigate the role of mitogen-activated protein (MAP) kinases in arsenite-mediated heme oxygenase-1 gene expression. In LMH cells, sodium arsenite, cadmium, and heat shock, but not heme, induced activity of the MAP kinases extracellular-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. To examine whether these MAP kinases were involved in mediating heme oxygenase-1 gene expression, we utilized constitutively activated and dominant negative components of the ERK, JNK, and p38 MAP kinase signaling pathways. Involvement of an AP-1 site in arsenite induction of heme oxygenase-1 gene expression was studied. We conclude that the MAP kinases ERK and p38 are involved in the induction of heme oxygenase-1, and that at least one AP-1 element (located - 1576 base pairs upstream of the transcription start site) is involved in this response.	Univ Massachusetts, Sch Med, Div Digest Dis & Nutr, Howard Hughes Med Inst,Dept Biochem & Mol Biol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Program Mol Biol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Med, Worcester, MA 01655 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Elbirt, KK (corresponding author), Univ Massachusetts, Sch Med, Div Digest Dis & Nutr, Howard Hughes Med Inst,Dept Biochem & Mol Biol, Rm S6-326,55 Lake Ave N, Worcester, MA 01655 USA.	kimberly.gabis@ummed.edu		Whitmarsh, Alan/0000-0003-1184-6610	NCI NIH HHS [CA-65861] Funding Source: Medline; NIDDK NIH HHS [DK-38825] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADLER V, 1995, J BIOL CHEM, V270, P26071, DOI 10.1074/jbc.270.44.26071; ALAM J, 1994, J BIOL CHEM, V269, P1001; ALAM J, 1994, J BIOL CHEM, V269, P25049; ALAM J, 1995, J BIOL CHEM, V270, P11977, DOI 10.1074/jbc.270.20.11977; ALAM J, 1989, J BIOL CHEM, V264, P6371; APPLEGATE LA, 1991, CANCER RES, V51, P974; Bokemeyer D, 1996, KIDNEY INT, V49, P1187, DOI 10.1038/ki.1996.172; BONKOVSKY HL, 1992, BIOCHEM PHARMACOL, V43, P2359, DOI 10.1016/0006-2952(92)90314-9; Brown JL, 1996, CANCER LETT, V98, P227; CABLE EE, 1991, BIOCHIM BIOPHYS ACTA, V1080, P245, DOI 10.1016/0167-4838(91)90009-O; CABLE EE, 1994, EUR J BIOCHEM, V225, P651, DOI 10.1111/j.1432-1033.1994.00651.x; CABLE EE, 1994, HEPATOLOGY, V20, pA179; CABLE EE, 1993, HEPATOLOGY, V18, P119, DOI 10.1016/0270-9139(93)90515-O; CABLE EE, 1994, J CLIN INVEST, V94, P649, DOI 10.1172/JCI117381; CAMHI SL, 1995, AM J RESP CELL MOL, V13, P387, DOI 10.1165/ajrcmb.13.4.7546768; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Coroneos E, 1996, BIOCHEM J, V316, P13, DOI 10.1042/bj3160013; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; EWING JF, 1993, J NEUROCHEM, V61, P1015, DOI 10.1111/j.1471-4159.1993.tb03615.x; EyssenHernandez R, 1996, FEBS LETT, V382, P229, DOI 10.1016/0014-5793(96)00127-5; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gabis KK, 1996, BBA-GEN SUBJECTS, V1290, P113, DOI 10.1016/0304-4165(96)00009-8; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Graves JD, 1995, ANN NY ACAD SCI, V766, P320, DOI 10.1111/j.1749-6632.1995.tb26684.x; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Inamdar NM, 1996, BIOCHEM BIOPH RES CO, V221, P570, DOI 10.1006/bbrc.1996.0637; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; KIKUCHI G, 1983, MOL CELL BIOCHEM, V53-4, P163; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LAMBRECHT RW, 1994, BIOCHEM PHARMACOL, V47, P1669, DOI 10.1016/0006-2952(94)90546-0; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; LEE TC, 1994, CANCER RES, V54, P1660; LINCOLN BC, 1988, BIOCHEM J, V250, P189, DOI 10.1042/bj2500189; LINCOLN BC, 1989, BIOCHIM BIOPHYS ACTA, V992, P49, DOI 10.1016/0304-4165(89)90049-4; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; LLESUY SF, 1994, BBA-MOL CELL RES, V1223, P9, DOI 10.1016/0167-4889(94)90067-1; Lu TH, 1997, BBA-GENE STRUCT EXPR, V1352, P293, DOI 10.1016/S0167-4781(97)00028-6; Lu TH, 1998, GENE, V207, P177, DOI 10.1016/S0378-1119(97)00623-9; Maeshima H, 1996, NUCLEIC ACIDS RES, V24, P2959, DOI 10.1093/nar/24.15.2959; MAINES MD, 1977, SCIENCE, V198, P1215, DOI 10.1126/science.337492; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; Meier R, 1996, EUR J BIOCHEM, V236, P796, DOI 10.1111/j.1432-1033.1996.00796.x; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MITANI K, 1990, BIOCHEM BIOPH RES CO, V166, P1429, DOI 10.1016/0006-291X(90)91026-O; Oguro T, 1996, BIOCHEM BIOPH RES CO, V221, P259, DOI 10.1006/bbrc.1996.0583; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Raju VS, 1997, BBA-GENE STRUCT EXPR, V1351, P89, DOI 10.1016/S0167-4781(96)00183-2; RAPP UR, 1994, ONCOGENE, V9, P3493; RIFKIND AB, 1973, J PHARMACOL EXP THER, V185, P214; RIZZARDINI M, 1993, BIOCHEM J, V290, P343, DOI 10.1042/bj2900343; ROBBINS DJ, 1994, ADV CANCER RES, V63, P93, DOI 10.1016/S0065-230X(08)60399-1; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; RUSSO SM, 1994, EUR J CLIN INVEST, V24, P406, DOI 10.1111/j.1365-2362.1994.tb02184.x; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SARDANA MK, 1982, J BIOL CHEM, V257, P4806; SASSA S, 1977, J BIOL CHEM, V252, P2428; SATO M, 1990, EUR J BIOCHEM, V188, P231, DOI 10.1111/j.1432-1033.1990.tb15394.x; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHIBAHARA S, 1993, J BIOCHEM-TOKYO, V113, P214, DOI 10.1093/oxfordjournals.jbchem.a124028; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; SINCLAIR JF, 1979, BIOCHEM BIOPH RES CO, V86, P710, DOI 10.1016/0006-291X(79)91771-6; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; TAKEDA K, 1994, J BIOL CHEM, V269, P22858; TAKETANI S, 1989, FEBS LETT, V245, P173, DOI 10.1016/0014-5793(89)80215-7; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TRIGON S, 1995, J BIOL CHEM, V270, P13091, DOI 10.1074/jbc.270.22.13091; TYRRELL RM, 1994, METHOD ENZYMOL, V234, P224; TYRRELL RM, 1993, CARCINOGENESIS, V14, P761, DOI 10.1093/carcin/14.4.761; VANDELFT S, 1993, BIOCHEM BIOPH RES CO, V197, P542, DOI 10.1006/bbrc.1993.2513; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; YAN MH, 1994, NATURE, V372, P798; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	93	213	216	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8922	8931		10.1074/jbc.273.15.8922	http://dx.doi.org/10.1074/jbc.273.15.8922			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535875	hybrid			2022-12-27	WOS:000072990800052
J	Ford, CM; Boss, PK; Hoj, PB				Ford, CM; Boss, PK; Hoj, PB			Cloning and characterization of Vitis vinifera UDP-glucose : flavonoid 3-O-glucosyltransferase, a homologue of the enzyme encoded by the maize Bronze-1 locus that may primarily serve to glucosylate anthocyanidins in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZEA-MAYS; GRAPE BERRIES; BIOSYNTHESIS; GLUCOSYLTRANSFERASE; PURIFICATION; EXPRESSION; CITRUS; GENES; QUERCETIN; EXTRACTS	We report here the cloning and optimized expression at 16 degrees C and the characterization of a Vitis vinifera UDP-glucose:flavonoid 3-O-glucosyltransferase, an enzyme responsible for a late step in grapevine anthocyanin biosynthesis. The properties of this and other UDP-glucose:flavonoid 3-O-glucosyltransferases, homologues of the product encoded by the maize Bronze-1 locus, are a matter of conjecture. The availability of a purified recombinant enzyme allowed for the unambiguous determination of the characteristics of a flavonoid 3-O-glucosyltransferase. Kinetic analyses showed that k(cat) for glucosylation of cyanidin, an anthocyanidin substrate, is 48 times higher than for glucosylation of the flavonol quercetin, whereas K-m values are similar for both substrates. Activity toward other classes of substrates is absent. Cu2+ ions strongly inhibit the action of this and other glucosyltransferases; however, we suggest that this phenomenon in large part is due to Cu2+-mediated substrate degradation rather than inhibition of the enzyme. Additional lines of complementary biochemical data also indicated that in the case of V. vinifera, the principal, if not only, role of UDP-glucose:flavonoid 3-O-glucosyltransferases is to glucosylate anthocyanidins in red fruit during ripening. Other glucosyltransferases with a much higher relative activity toward quercetin are suggested to glucosylate flavonols in a distinct spatial and temporal pattern. It should be considered whether gene products homologous to Bronze-1 in some cases more accurately should be referred to as UDP-glucose:anthocyanidin 3-O-glucosyltransferases.	Univ Adelaide, Dept Hort Viticulture & Oenol, Glen Osmond, SA 5064, Australia; Cooperat Res Ctr Viticulture, Glen Osmond, SA 5064, Australia; CSIRO, Hort Res Unit, Glen Osmond, SA 5064, Australia; Australian Wine Res Inst, Glen Osmond, SA 5064, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Wine Research Institute	Hoj, PB (corresponding author), Univ Adelaide, Dept Hort Viticulture & Oenol, Waite Campus PMB1, Glen Osmond, SA 5064, Australia.		Hoj, Peter B/E-8526-2011; Boss, Paul K/A-1292-2010; Ford, Chris/B-4657-2015	Boss, Paul K/0000-0003-0356-9342; 				Bandurski Robert S., 1995, P39; BARPELED M, 1991, J BIOL CHEM, V266, P20953; Boss P. K., 1996, Australian Journal of Grape and Wine Research, V2, P163, DOI 10.1111/j.1755-0238.1996.tb00104.x; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Brouillard R., 1982, ANTHOCYANINS FOOD CO, P1, DOI [10.1016/b978-0-12-472550-8.50005-6, DOI 10.1016/B978-0-12-472550-8.50005-6, DOI 10.1016/B978-0-12-472550-8.X5001-X]; Brouillard R., 1993, FLAVONOIDS ADV RES 1, P565; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Davies C, 1996, PLANT PHYSIOL, V111, P275, DOI 10.1104/pp.111.1.275; Do CB, 1995, PLANT SCI, V112, P43, DOI 10.1016/0168-9452(95)04250-X; DOONER HK, 1979, PHYTOCHEMISTRY, V18, P749, DOI 10.1016/0031-9422(79)80007-2; DOONER HK, 1977, BIOCHEM GENET, V15, P509, DOI 10.1007/BF00520194; DOONER HK, 1977, P NATL ACAD SCI USA, V74, P5623, DOI 10.1073/pnas.74.12.5623; FEDOROFF NV, 1984, P NATL ACAD SCI-BIOL, V81, P3825, DOI 10.1073/pnas.81.12.3825; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; FURTEK D, 1988, PLANT MOL BIOL, V11, P473, DOI 10.1007/BF00039028; Gholami M., 1995, Australian Journal of Grape and Wine Research, V1, P67, DOI 10.1111/j.1755-0238.1995.tb00080.x; Harborne J. B., 1988, FLAVONOIDS ADV RES 1, P303; Harlow E, 1988, ANTIBODIES LABORATOR, P471; HAWKER JS, 1969, PHYTOCHEMISTRY, V8, P337, DOI 10.1016/S0031-9422(00)85429-1; HAWKER JS, 1969, PHYTOCHEMISTRY, V8, P9, DOI 10.1016/S0031-9422(00)85788-X; Heller W., 1993, FLAVONOIDS ADV RES 1, P499; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Horvath DM, 1996, PLANT MOL BIOL, V31, P1061, DOI 10.1007/BF00040724; HRAZDINA G, 1988, BIOCHIM BIOPHYS ACTA, V955, P301, DOI 10.1016/0167-4838(88)90208-7; HUGHES J, 1994, DNA SEQUENCE, V5, P41, DOI 10.3109/10425179409039703; JONSSON LMV, 1984, Z NATURFORSCH C, V39, P559; Kanellis AK, 1993, BIOCH FRUIT RIPENING, P189, DOI DOI 10.1007/978-94-011-1584-1_6; KOWALCZYK S, 1991, BIOCHEM J, V279, P509, DOI 10.1042/bj2790509; LARSON RL, 1971, PHYTOCHEMISTRY, V10, P3073, DOI 10.1016/S0031-9422(00)97355-2; LARSON RL, 1972, PLANTA, V103, P361, DOI 10.1007/BF00386709; LARSON RL, 1977, BIOCHEM GENET, V15, P153, DOI 10.1007/BF00484558; LARSON RL, 1973, CEREALS RES COMMUN H, V1, P13; LEWINSOHN E, 1989, PLANT PHYSIOL, V91, P1323, DOI 10.1104/pp.91.4.1323; MARTIN C, 1991, PLANT J, V1, P37, DOI 10.1111/j.1365-313X.1991.00037.x; MCINTOSH CA, 1990, PHYTOCHEMISTRY, V29, P1533, DOI 10.1016/0031-9422(90)80115-W; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; Moehs CP, 1997, PLANT J, V11, P227, DOI 10.1046/j.1365-313X.1997.11020227.x; PARRY AD, 1994, PHYTOCHEMISTRY, V37, P655, DOI 10.1016/S0031-9422(00)90333-9; PRICE SF, 1995, AM J ENOL VITICULT, V46, P187; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwinn KE, 1997, PLANT SCI, V125, P53, DOI 10.1016/S0168-9452(97)04624-4; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; STYLES ED, 1981, CAN J GENET CYTOL, V23, P691, DOI 10.1139/g81-075; SZERSZEN JB, 1994, SCIENCE, V265, P1699, DOI 10.1126/science.8085154; Tanaka Y, 1996, PLANT CELL PHYSIOL, V37, P711, DOI 10.1093/oxfordjournals.pcp.a029004; Tattersall DB, 1997, PLANT PHYSIOL, V114, P759, DOI 10.1104/pp.114.3.759; TEUSCH M, 1986, Z NATURFORSCH C, V41, P699; Warnecke DC, 1997, PLANT MOL BIOL, V35, P597, DOI 10.1023/A:1005806119807; WILLIAMS CA, 1993, FLAVONOIDS ADV RES 1, P337; WILLIAMS PJ, 1981, AM J ENOL VITICULT, V32, P230; WILLIAMS PJ, 1995, J AGR FOOD CHEM, V43, P121, DOI 10.1021/jf00049a023	54	207	248	3	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9224	9233		10.1074/jbc.273.15.9224	http://dx.doi.org/10.1074/jbc.273.15.9224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535914	hybrid			2022-12-27	WOS:000072990800091
J	Rapaport, D; Mayer, A; Neupert, W; Lill, R				Rapaport, D; Mayer, A; Neupert, W; Lill, R			cis and trans sites of the TOM complex of mitochondria in unfolding and initial translocation of preproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; PRECURSOR PROTEINS; OUTER-MEMBRANE; INNER MEMBRANE; DYNAMIC INTERACTION; YEAST MITOCHONDRIA; NEUROSPORA-CRASSA; RECEPTOR; HSP70; PRESEQUENCE	Translocation of preproteins across the mitochondrial outer membrane is mediated by the TOM: complex, Our previous studies led to the concept of two preprotein binding sites acting in series, the surface exposed cis site and the trans site exposed to the intermembrane space, We report here that preproteins are bound to the cis site in a labile fashion even at low ionic strength, whereas intermediates arrested at the trans site remained firmly bound at higher salt concentration, The stability of the trans site intermediate results from interactions of both the presequence and unfolded parts of the mature part of the preprotein with the TOM complex, Binding to the trans site proceeded at rates comparable with those of unfolding of the mature domain and appeared to be kinetically limited by the unfolding reaction, Efficient binding to the trans site and unfolding were observed with both outer membrane vesicles and intact mitochondria whose membrane potential, Delta Psi, was dissipated, Upon re establishing Delta Psi, trans site-bound preprotein resumed translocation into the matrix, The rates of unfolding and binding to the trans site were the same as those for translocation into intact energized mitochondria, We conclude that preprotein unfolding in intact mitochondria can take place without the involvement of the translocation machinery of the inner membrane and, in particular, the matrix Hsp70 chaperone. Further, preprotein unfolding at the outer membrane can be a rate-limiting step for formation of the trans site intermediate and for the entire translocation reaction.	Philipps Univ Marburg, Inst Zytobiol, D-35033 Marburg, Germany; Univ Munich, Inst Physiol Chem, D-80336 Munich, Germany	Philipps University Marburg; University of Munich	Lill, R (corresponding author), Philipps Univ Marburg, Inst Zytobiol, Robert Koch Str 5, D-35033 Marburg, Germany.	Lill@mailer.uni-marburg.de		Lill, Roland/0000-0002-8345-6518				ARRETZ M, 1994, J BIOL CHEM, V269, P4959; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; BERTHOLD J, 1995, CELL, V81, P1085, DOI 10.1016/S0092-8674(05)80013-3; Bolliger L, 1995, EMBO J, V14, P6318, DOI 10.1002/j.1460-2075.1995.tb00322.x; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; EILERS M, 1988, EMBO J, V7, P1139, DOI 10.1002/j.1460-2075.1988.tb02923.x; EILERS M, 1988, CELL, V52, P481, DOI 10.1016/0092-8674(88)90458-8; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; HAUCKE V, 1995, J BIOL CHEM, V270, P5565, DOI 10.1074/jbc.270.10.5565; Honlinger A, 1996, EMBO J, V15, P2125, DOI 10.1002/j.1460-2075.1996.tb00566.x; HORST M, 1995, EMBO J, V14, P2293, DOI 10.1002/j.1460-2075.1995.tb07223.x; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; KRONIDOU NG, 1994, P NATL ACAD SCI USA, V91, P12818, DOI 10.1073/pnas.91.26.12818; Lill R, 1996, TRENDS CELL BIOL, V6, P56, DOI 10.1016/0962-8924(96)81015-4; Lill R, 1996, CURR OPIN CELL BIOL, V8, P505, DOI 10.1016/S0955-0674(96)80028-7; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; MAYER A, 1995, CELL, V80, P127, DOI 10.1016/0092-8674(95)90457-3; MAYER A, 1993, J CELL BIOL, V121, P1233, DOI 10.1083/jcb.121.6.1233; MAYER A, 1995, EMBO J, V14, P4204, DOI 10.1002/j.1460-2075.1995.tb00094.x; Mihara K, 1996, TRENDS CELL BIOL, V6, P104, DOI 10.1016/0962-8924(96)81000-2; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; NARGANG FE, 1995, EMBO J, V14, P1099, DOI 10.1002/j.1460-2075.1995.tb07093.x; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; NEUPERT W, 1997, ANNU REV BIOCHEM, V66, P861; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; PFANNER N, 1995, CURR BIOL, V5, P132; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHLEYER M, 1985, CELL, V43, P330; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; SCHNELL DJ, 1995, CELL, V83, P521, DOI 10.1016/0092-8674(95)90090-X; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; STUART RA, 1994, EUR J BIOCHEM, V220, P9, DOI 10.1111/j.1432-1033.1994.tb18593.x; Subramani S, 1996, CURR OPIN CELL BIOL, V8, P513, DOI 10.1016/S0955-0674(96)80029-9; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; Ungermann C, 1996, EMBO J, V15, P735, DOI 10.1002/j.1460-2075.1996.tb00409.x; VESTWEBER D, 1988, EMBO J, V7, P1147, DOI 10.1002/j.1460-2075.1988.tb02924.x; Voos W, 1996, EMBO J, V15, P2668, DOI 10.1002/j.1460-2075.1996.tb00627.x; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514	46	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8806	8813		10.1074/jbc.273.15.8806	http://dx.doi.org/10.1074/jbc.273.15.8806			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535859	hybrid			2022-12-27	WOS:000072990800036
J	Fuh, G; Li, B; Crowley, C; Cunningham, B; Wells, JA				Fuh, G; Li, B; Crowley, C; Cunningham, B; Wells, JA			Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL FACTOR; TYROSINE KINASE; VEGF RECEPTORS; LIGAND-BINDING; FACTOR FAMILY; DIMERIZATION; TRANSDUCTION; FLT-1; IDENTIFICATION; SUPERFAMILY	Vascular endothelial growth factor (VEGF) is a dimeric hormone that controls much of vascular development through binding and activation of its kinase domain receptor (KDR). We produced analogs of VEGF that show it has two receptor-binding sites which are located near the poles of the dimer and straddle the interface between subunits. Deletion experiments in KDR indicate that of the seven IgG-like domains in the extracellular domain, only domains 2-3 are needed for tight binding of VEGF, Monomeric forms of the extracellular domain of KDR bind similar to 100 times weaker than dimeric forms showing a strong avidity component for binding of VEGF to predimerized forms of the receptor. Eased upon these structure-function studies and a mechanism in which receptor dimerization is critical for signaling, we constructed a receptor antagonist in the form of a heterodimer of VEGF that contained one functional and one non-functional site. These studies establish a functional foundation for the design of VEGF analogs, mimics, and antagonists.	Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA; Genentech Inc, Dept Biol Mol, S San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Wells, JA (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, S San Francisco, CA 94080 USA.		Wells, Jim A/O-9854-2016					AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Barleon B, 1997, J BIOL CHEM, V272, P10382; BECK JT, 1994, MOL IMMUNOL, V31, P1335, DOI 10.1016/0161-5890(94)90052-3; BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; BRADSHAW RA, 1994, PROTEIN SCI, V3, P901; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; Chamow SM, 1996, TRENDS BIOTECHNOL, V14, P52, DOI 10.1016/0167-7799(96)80921-8; Cunningham SA, 1997, BIOCHEM BIOPH RES CO, V231, P596, DOI 10.1006/bbrc.1997.6156; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; FINNERTY H, 1993, ONCOGENE, V8, P2293; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HERREN B, 1993, J BIOL CHEM, V268, P15088; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lemmon MA, 1997, J BIOL CHEM, V272, P6311, DOI 10.1074/jbc.272.10.6311; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LEV S, 1992, J BIOL CHEM, V267, P15970; Lucas BK, 1996, NUCLEIC ACIDS RES, V24, P1774, DOI 10.1093/nar/24.9.1774; MAHADEVAN D, 1995, J BIOL CHEM, V270, P27595, DOI 10.1074/jbc.270.46.27595; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; PAJUSOLA K, 1994, ONCOGENE, V9, P3545; PARK JE, 1994, J BIOL CHEM, V269, P25646; POTGENS AJG, 1994, J BIOL CHEM, V269, P32879; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WANG F, 1995, J BIOL CHEM, V270, P10222, DOI 10.1074/jbc.270.17.10222; WEISMANN C, 1997, CELL, V91, P695; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	37	221	266	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11197	11204		10.1074/jbc.273.18.11197	http://dx.doi.org/10.1074/jbc.273.18.11197			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556609	hybrid			2022-12-27	WOS:000073395200061
J	Grune, T; Blasig, IE; Sitte, N; Roloff, B; Haseloff, R; Davies, KJA				Grune, T; Blasig, IE; Sitte, N; Roloff, B; Haseloff, R; Davies, KJA			Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; GLUTAMINE-SYNTHETASE; OXIDATIVE MODIFICATION; LIPID-PEROXIDATION; ESCHERICHIA-COLI; SELECTIVE DEGRADATION; SUPEROXIDE-DISMUTASE; MODIFIED HEMOGLOBIN; HYDROGEN-PEROXIDE; OXYGEN RADICALS	We report that exposure of aconitase to moderate concentrations of peroxynitrite, 3-morpholinosydnonimine (SIN-1; a superoxide-and nitric oxide-liberating substance), or hydrogen peroxide, inhibits the enzyme and enhances susceptibility to proteolytic digestion by the isolated 20 S proteasome. Exposure to more severe levels of oxidative stress, from these same agents, causes further inhibition of the enzymatic activity of aconitase but actually decreases its proteolytic breakdown by proteasome. It should be noted that the superoxide and nitric oxide liberated by SIN-1 decomposition react to form a steady flux of peroxynitrite. S-Nitroso-N-acetylpenicillamine, a compound that liberates nitric oxide alone, causes only a small loss of aconitase activity (25% or less) and has no effect on the proteolytic susceptibility of the enzyme. Proteasome also seems to be the main protease in cell lysates that can degrade aconitase after it has been oxidatively modified by exposure to peroxynitrite, SIN-1, or hydrogen peroxide. Using cell lysates isolated from K562 cells treated for several days with an antisense oligodeoxynucleotide to the initiation codon region of the C2 subunit of proteasome (a treatment which diminishes proteasome activity by 50-60%), the enhanced degradation of moderately damaged aconitase was essentially abolished. Other model proteins as well as complex mixtures of proteins, such as cell lysates, also exhibit enhanced proteolytic susceptibility after moderate SIN-1 treatment. Therefore we conclude that peroxynitrite reacts readily with proteins and that mild modification by peroxynitrite results in selective recognition and degradation by proteasome.	Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Humboldt Univ, Fac Med Charite, Clin Phys Med, D-10098 Berlin, Germany; Humboldt Univ, Fac Med Charite, Clin Rehabil, D-10098 Berlin, Germany; Inst Mol Pharmacol, D-10315 Berlin, Germany	University of Southern California; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Davies, KJA (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, 3715 McClintock Ave,Rm 306, Los Angeles, CA 90089 USA.	kelvin@rcf.usc.edu		Davies, Kelvin/0000-0001-7790-3003; Grune, Tilman/0000-0003-4775-9973	NIEHS NIH HHS [ES-03598] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R23ES003598, R01ES003598, R56ES003598] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bouton C, 1997, J BIOL CHEM, V272, P19969, DOI 10.1074/jbc.272.32.19969; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; CROW JP, 1994, FREE RADICAL BIO MED, V16, P331, DOI 10.1016/0891-5849(94)90034-5; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; DAVIES KJA, 1988, FREE RADICAL BIO MED, V5, P215, DOI 10.1016/0891-5849(88)90015-9; DAVIES KJA, 1987, J BIOL CHEM, V262, P8220; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Dean RT, 1997, BIOCHEM J, V324, P1; DEAN RT, 1993, TRENDS BIOCHEM SCI, V18, P437, DOI 10.1016/0968-0004(93)90145-D; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GIULIVI C, 1994, ARCH BIOCHEM BIOPHYS, V311, P329, DOI 10.1006/abbi.1994.1245; GIULIVI C, 1993, J BIOL CHEM, V268, P8752; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HEISS LN, 1994, P NATL ACAD SCI USA, V91, P267, DOI 10.1073/pnas.91.1.267; HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KING PA, 1992, J AM CHEM SOC, V114, P5430, DOI 10.1021/ja00039a068; KUCKELKORN U, 1995, EUR J IMMUNOL, V25, P2605, DOI 10.1002/eji.1830250930; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; LEVINE RL, 1983, J BIOL CHEM, V258, P1828; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; LEVINE RL, 1983, J BIOL CHEM, V258, P1823; MARLETTA MA, 1989, TRENDS BIOCHEM SCI, V14, P488, DOI 10.1016/0968-0004(89)90181-3; MONCADA S, 1991, PHARMACOL REV, V43, P109; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; PACIFICI RE, 1990, METHOD ENZYMOL, V186, P485; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; RIVETT AJ, 1985, J BIOL CHEM, V260, P2600; RIVETT AJ, 1985, J BIOL CHEM, V260, P300; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; RUBBO H, 1994, J BIOL CHEM, V269, P26066; SALO DC, 1990, J BIOL CHEM, V265, P11919; STADLER J, 1991, AM J PHYSIOL, V260, pC910, DOI 10.1152/ajpcell.1991.260.5.C910; STADLER J, 1991, ARCH SURG-CHICAGO, V126, P186; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; VERNIQUET F, 1991, BIOCHEM J, V276, P643, DOI 10.1042/bj2760643; WOLFF SP, 1986, BIOCHEM J, V234, P399, DOI 10.1042/bj2340399; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	53	217	227	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10857	10862		10.1074/jbc.273.18.10857	http://dx.doi.org/10.1074/jbc.273.18.10857			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556559	hybrid			2022-12-27	WOS:000073395200011
J	Isenring, P; Jacoby, SC; Payne, JA; Forbush, B				Isenring, P; Jacoby, SC; Payne, JA; Forbush, B			Comparison of Na-K-Cl cotransporters - NKCC1, NKCC2, and the HEK cell Na-K-Cl cotransporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; SHARK RECTAL GLAND; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; CHLORIDE COTRANSPORTER; NA-K-2CL COTRANSPORTER; TRANSPORT; RABBIT; RAT; PHOSPHORYLATION	The Na-K-Cl cotransporter (NKCC) mediates the coupled movement of ions into most animal cells, playing important roles in maintenance of cell volume and in epithelial Cl transport. Two forms of NKCC have been described: NKCC1, the "housekeeping" isoform that is also responsible for C1 accumulation in secretory epithelial cells, and NKCC2, which mediates apical Na+K+Cl entry into renal epithelial cells. Here we examine the kinetic properties of NKCC1, NKCC2, and the endogenous HEK-293 cell cotransporter, Stable expression of rabbit NKCC2A was obtained in HEK-293 cells utilizing a chimera (h(1)r(2A)0.7) in which the 5'-untranslated region and cDNA encoding 104 amino acids of the N terminus are replaced by the corresponding sequence of NKCC1. h(1)r(2A)0.7 exhibits Na and C1 affinities near those of NKCC1, but it has a 4-fold lower Rb affinity, and a 3-fold higher affinity for the inhibitor bumetanide, The activity of h(1)r(2A)0.7 is increased on incubation in low [C1] media as is NKCC1, but the resting level of activity is higher in h(1)r(2A)0.7 and activation is more rapid. h(1)r(2A)0.7 exhibits an appropriate volume response, unlike NKCC1 for which concomitant changes in [Cl](i) appear to be the overriding factor. These results support a model in which apical NKCC2 activity is matched to basolateral C1 exit through changes in [C1],, Reverse transcriptase-polymerase chain reaction of HEK-293 cell mRNA is positive with NKCC1 primers and negative with NKCC2 primers, Surprisingly, we found that the behavior of the endogenous HEK cell Na-K-Cl cotransporter is unlike either of the two forms which have been described: compared with NKCC1, HEK cell cotransporter has a 2.5-fold lower Na affinity, an 8-fold lower Rb affinity, and a 4-fold higher bumetanide affinity. These results suggest the presence of a novel isoform of NKCC in HEK-293 cells.	Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University	Isenring, P (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06510 USA.	paul.isenring@yale.edu; biff.forbush@yale.edu			NIDDK NIH HHS [DK-17433] Funding Source: Medline; NIEHS NIH HHS [ES-3828] Funding Source: Medline; PHS HHS [KD-47661] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES003828, P30ES003828] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BECK PJ, 1990, MOL CELL BIOL, V10, P4612, DOI 10.1128/MCB.10.9.4612; BEHNKE R, 1997, B MT DESERT IS BIO L, V36, P59; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V271, pF619, DOI 10.1152/ajprenal.1996.271.3.F619; FORBUSH B, 1992, AM J PHYSIOL, V262, pC1000, DOI 10.1152/ajpcell.1992.262.4.C1000; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Ginns SM, 1996, J AM SOC NEPHROL, V7, P2533; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; HAAS M, 1994, AM J PHYSIOL, V266, pC1440, DOI 10.1152/ajpcell.1994.266.5.C1440; HAAS M, 1989, ANNU REV PHYSIOL, V51, P443, DOI 10.1146/annurev.physiol.51.1.443; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; KAJI DM, 1993, BIOCHIM BIOPHYS ACTA, V1152, P289, DOI 10.1016/0005-2736(93)90260-7; Kaplan MR, 1996, KIDNEY INT, V49, P40, DOI 10.1038/ki.1996.6; Kaplan MR, 1996, J CLIN INVEST, V98, P723, DOI 10.1172/JCI118844; LYTLE C, 1992, J BIOL CHEM, V267, P25428; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; MCMANUS TJ, 1985, ANN NY ACAD SCI, V456, P183, DOI 10.1111/j.1749-6632.1985.tb14863.x; MOLONY DA, 1987, AM J PHYSIOL, V252, pF177, DOI 10.1152/ajprenal.1987.252.1.F177; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; PAYNE JA, 1995, CURR OPIN CELL BIOL, V7, P493, DOI 10.1016/0955-0674(95)80005-0; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; PAYNE JA, 1995, J AM SOC NEPHROL, V6, P348; PAYNE JA, 1996, J BIOL CHEM, V271, P16924; RANDALL J, IN PRESS AM J PHYSL; ROBERTSON MA, 1994, AM J PHYSIOL, V267, pC146, DOI 10.1152/ajpcell.1994.267.1.C146; SCHLATTER E, 1985, PFLUG ARCH EUR J PHY, V405, P367, DOI 10.1007/BF00595690; SILVA P, 1992, COMP BIOCHEM PHYS C, V103, P569, DOI 10.1016/0742-8413(92)90183-8; SUSSMAN I, 1985, J CELL PHYSIOL, V124, P153, DOI 10.1002/jcp.1041240124; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Yang TX, 1996, AM J PHYSIOL-RENAL, V271, pF931, DOI 10.1152/ajprenal.1996.271.4.F931	34	106	108	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11295	11301		10.1074/jbc.273.18.11295	http://dx.doi.org/10.1074/jbc.273.18.11295			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556622	hybrid			2022-12-27	WOS:000073395200074
J	Klionsky, DJ				Klionsky, DJ			Nonclassical protein sorting to the yeast vacuole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SACCHAROMYCES-CEREVISIAE; AMINOPEPTIDASE-I; SECRETORY PATHWAY; DEFICIENT MUTANTS; TARGETING PATHWAY; STATIONARY-PHASE; AUTOPHAGY; DEGRADATION; CYTOPLASM; BIOSYNTHESIS		Univ Calif Davis, Microbiol Sect, Livermore, CA 95616 USA	University of California System; University of California Davis	Klionsky, DJ (corresponding author), Univ Calif Davis, Microbiol Sect, 156 Hutchison Hall,1 Shields Ave, Livermore, CA 95616 USA.							Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; CHANG YH, 1989, J BIOL CHEM, V264, P6979; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; CUEVA R, 1989, FEBS LETT, V259, P125, DOI 10.1016/0014-5793(89)81510-8; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Hoffman M, 1996, GENETICS, V143, P1555; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Klionsky DJ, 1997, J MEMBRANE BIOL, V157, P105, DOI 10.1007/s002329900220; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; LOFFLER HG, 1979, Z NATURFORSCH C, V34, P381; Martinez E, 1997, J MOL BIOL, V267, P1124, DOI 10.1006/jmbi.1997.0925; METZ G, 1977, Z NATURFORSCH C, V32, P929; METZ G, 1976, BIOCHIM BIOPHYS ACTA, V429, P933, DOI 10.1016/0005-2744(76)90338-7; Nakamura N, 1997, J BIOCHEM, V121, P338; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; NOTHWEHR SF, 1994, J BIOL CHEM, V269, P10185; Oda MN, 1996, J CELL BIOL, V132, P999, DOI 10.1083/jcb.132.6.999; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Riezman H, 1996, EXPERIENTIA, V52, P1033, DOI 10.1007/BF01952099; Scott SV, 1997, TRENDS CELL BIOL, V7, P225, DOI 10.1016/S0962-8924(97)01050-7; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Scott SV, 1995, J CELL BIOL, V131, P1727, DOI 10.1083/jcb.131.6.1727; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; SEGUIREAL B, 1995, EMBO J, V14, P5476, DOI 10.1002/j.1460-2075.1995.tb00234.x; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TITORENKO VI, 1995, J BACTERIOL, V177, P357, DOI 10.1128/jb.177.2.357-363.1995; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; TUTTLE DL, 1995, J CELL SCI, V108, P25; VanDenHazel HB, 1996, YEAST, V12, P1, DOI 10.1002/(SICI)1097-0061(199601)12:1<1::AID-YEA902>3.0.CO;2-N; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Xu ZY, 1997, J CELL BIOL, V136, P299, DOI 10.1083/jcb.136.2.299	52	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10807	10810		10.1074/jbc.273.18.10807	http://dx.doi.org/10.1074/jbc.273.18.10807			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556549	hybrid			2022-12-27	WOS:000073395200001
J	Magalon, A; Rothery, RA; Lemesle-Meunier, D; Frixon, C; Weiner, JH; Blasco, F				Magalon, A; Rothery, RA; Lemesle-Meunier, D; Frixon, C; Weiner, JH; Blasco, F			Inhibitor binding within the NarI subunit (Cytochrome b(nr)) Escherichia coli nitrate reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSLOCATION; ELECTRON-TRANSFER; BETA-SUBUNIT; PARACOCCUS-DENITRIFICANS; EPR CHARACTERIZATION; MEMBRANE; SITES; OXIDOREDUCTASE; REASSESSMENT; MECHANISM	We have used inhibitors and site-directed mutants to investigate quinol binding to the cytochrome b(nr) (NarI) of Escherichia coli nitrate reductase (NarGHI). Both stigmatellin and 2-n-heptyl-4-hydroxyquinoline-N-oxide (HOQNO) inhibit menadiol:nitrate oxidoreductase activity with I-50 values of 0.25 and 6 mu M, respectively, and prevent the generation of a NarGHI-dependent proton electrochemical potential across the cytoplasmic membrane. These inhibitors have little effect on the rate of reduction of the two hemes of NarI (b(L) and b(H)), but have an inhibitory effect on the extent of nitrate-dependent heme reoxidation. No quinol-dependent heme b(H) reduction is detected in a mutant lacking heme b(L) (NarI-H66Y), whereas a slow but complete heme b(L) reduction is detected in a mutant lacking heme b(H) (NarI-H56R). This is consistent with physiological quinol binding and oxidation occurring at a site (Q(P)) associated with heme b(L) which is located toward the periplasmic side of NarI. Optical and EPR spectroscopies performed in the presence of stigmatellin or HOQNO provide further evidence that these inhibitors bind at a heme b(L)-associated Q(P) site. These results suggest a model for electron transfer through NarGHI that involves quinol binding and oxidation in the vicinity of heme b(L) and electron transfer through heme b(H) to the cytoplasmically localized membrane-extrinsic catalytic NarGH dimer.	CNRS, Chim Bacterienne Lab, IBSM, F-13402 Marseille 20, France; CNRS, IBSM, Lab Bioenerget & Ingn Prot, F-13402 Marseille, France; Univ Alberta, Dept Biochem, MRC, Grp Mol Biol Membranes, Edmonton, AB T6G 2H7, Canada	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Alberta	Blasco, F (corresponding author), CNRS, Chim Bacterienne Lab, IBSM, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.			Rothery, Richard/0000-0003-3265-1783; Magalon, Axel/0000-0002-3375-738X				AUGIER V, 1993, BIOCHEMISTRY-US, V32, P2013, DOI 10.1021/bi00059a018; BERKS BC, 1995, MOL MICROBIOL, V15, P319, DOI 10.1111/j.1365-2958.1995.tb02246.x; BILOUS PT, 1985, J BACTERIOL, V163, P369, DOI 10.1128/JB.163.1.369-375.1985; BLASCO F, 1992, MOL MICROBIOL, V6, P209, DOI 10.1111/j.1365-2958.1992.tb02002.x; BLASCO F, 1989, MOL GEN GENET, V218, P249, DOI 10.1007/BF00331275; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; BRITO F, 1995, J BACTERIOL, V177, P3728, DOI 10.1128/jb.177.13.3728-3735.1995; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CRASKE A, 1986, EUR J BIOCHEM, V158, P429, DOI 10.1111/j.1432-1033.1986.tb09771.x; DERVARTANIAN DV, 1975, BIOCHIM BIOPHYS ACTA, V379, P74, DOI 10.1016/0005-2795(75)90009-4; ESPOSTI MD, 1989, BIOCHIM BIOPHYS ACTA, V977, P249, DOI 10.1016/S0005-2728(89)80079-9; GARLAND PB, 1975, BIOCHEM J, V152, P547, DOI 10.1042/bj1520547; GUIGLIARELLI B, 1992, EUR J BIOCHEM, V207, P61, DOI 10.1111/j.1432-1033.1992.tb17020.x; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; HOWELL N, 1993, BIOCHEMISTRY-US, V32, P11162, DOI 10.1021/bi00092a028; JONES RW, 1980, BIOCHEM J, V190, P79, DOI 10.1042/bj1900079; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; JONES RW, 1980, FEMS MICROBIOL LETT, V8, P167, DOI 10.1111/j.1574-6968.1980.tb05072.x; KAMENSKY Y, 1985, FEBS LETT, V181, P95, DOI 10.1016/0014-5793(85)81120-0; KUNZ WS, 1983, FEBS LETT, V155, P237, DOI 10.1016/0014-5793(82)80611-X; Magalon A, 1997, J BIOL CHEM, V272, P25652, DOI 10.1074/jbc.272.41.25652; Magalon A, 1997, J BACTERIOL, V179, P5037, DOI 10.1128/jb.179.16.5037-5045.1997; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MORPETH FF, 1985, BIOCHEMISTRY-US, V24, P40, DOI 10.1021/bi00322a007; OHNISHI T, 1988, EUR J BIOCHEM, V176, P385, DOI 10.1111/j.1432-1033.1988.tb14293.x; PARSONAGE D, 1983, FEBS LETT, V153, P108, DOI 10.1016/0014-5793(83)80128-8; PASCAL MC, 1982, MOL GEN GENET, V188, P103, DOI 10.1007/BF00333001; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; RICHARDSON DJ, 1986, ARCH MICROBIOL, V146, P159, DOI 10.1007/BF00402344; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SMIRNOVA IA, 1995, FEBS LETT, V359, P23, DOI 10.1016/0014-5793(94)01442-4; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60	36	32	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10851	10856		10.1074/jbc.273.18.10851	http://dx.doi.org/10.1074/jbc.273.18.10851			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556558	hybrid			2022-12-27	WOS:000073395200010
J	Grant, KM; Hassan, P; Anderson, JS; Mottram, JC				Grant, KM; Hassan, P; Anderson, JS; Mottram, JC			The crk3 gene of Leishmania mexicana encodes a stage-regulated cdc2-related histone H1 kinase that associates with p12(cks1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASES; DEPENDENT KINASES; CDC2-LIKE KINASE; CDC2 PROTEIN; HOMOLOG; EXPRESSION; DIVISION	A cdc2-related protein kinase gene, crk3, has been isolated from the parasitic protozoan Leishmania mexicana. Data presented here suggests that crk3 is a good candidate to be the leishmanial cdc2 homologue but that the parasite protein has some characteristics which distinguish it from mammalian cdc2. crk3 is predicted to encode a 35.6-kDa protein with 54% sequence identity with the human cyclin-dependent kinase cdc2 and 78% identity with the Trypanosoma brucei CRK3. The trypanosomatid CRK3 proteins have an unusual, poorly conserved 19-amino acid N-terminal extension not present in human cdc2. crk3 is single copy, and there is B-fold higher mRNA in the replicative promastigote life-cycle stage than in the non-dividing metacyclic form or mammalian amastigote form. A leishmanial sue-binding cdc2-related Kinase (SBCRK) histone H1 kinase, has previously been described which binds the yeast protein, p13(suc1),, and that has stage-regulated activity (Mottram d. C., Kinnaird, J., Shiels, B. R., Tait, A., and Barry, J. D. (1993) J. Biol. Chem. 268, 21044-21051). CRK3 from cell extracts of the three life-cycle stages was found to bind p13(suc1) and the leishmanial homologue p12(cks1). CRK3 fused with six histidines at the C terminus was expressed in L. mexicana and shown to have SBCRK histone H1 kinase activity. Depletion of histidine-tagged CRK3 from L. mexicana cell extracts, by Ni-nitrilotriacetic acid agarose selection, reduced histone H1 kinase activity binding to p13(suc1). These data imply that crk3 encodes the kinase subunit of SBCRK. SBCRK and histidine-tagged CRK3 activities were inhibited by the purine analogue olomoucine with an IC50,, of 28 and 42 mu M, respectively, 5-6-fold higher than human p34(cdc2)/cyclinB.	Univ Glasgow, Anderson Coll, Wellcome Unit Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland	University of Glasgow	Mottram, JC (corresponding author), Univ Glasgow, Anderson Coll, Wellcome Unit Mol Parasitol, 56 Dumbarton Rd, Glasgow G11 6NU, Lanark, Scotland.			Mottram, Jeremy/0000-0001-5574-3766				AFFRANCHINO JL, 1993, GENE, V132, P75, DOI 10.1016/0378-1119(93)90516-6; BRIZUELA L, 1987, EMBO J, V6, P3507, DOI 10.1002/j.1460-2075.1987.tb02676.x; BROWN L, 1992, NUCLEIC ACIDS RES, V20, P5451, DOI 10.1093/nar/20.20.5451; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUCOMMUN B, 1991, MOL CELL BIOL, V11, P6177, DOI 10.1128/MCB.11.12.6177; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; ENDICOTT JA, 1994, PROTEIN ENG, V7, P243, DOI 10.1093/protein/7.2.243; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HARLOW E, 1988, ANTIBODIES LAB MANUA, P53; HAYLES J, 1986, MOL GEN GENET, V202, P291, DOI 10.1007/BF00331653; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JOHN PCL, 1991, PROTOPLASMA, V161, P70, DOI 10.1007/BF01328899; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEE MG, 1988, NATURE, V333, P676, DOI 10.1038/333676a0; LEES E, 1995, CURR OPIN CELL BIOL, V7, P773, DOI 10.1016/0955-0674(95)80060-3; LORINCZ AT, 1986, MOL CELL BIOL, V6, P4099; Martin-Castellanos C, 1997, TRENDS CELL BIOL, V7, P95, DOI 10.1016/S0962-8924(96)10055-6; MCGOWAN CH, 1990, MOL CELL BIOL, V10, P3847, DOI 10.1128/MCB.10.7.3847; Meijer L, 1996, TRENDS CELL BIOL, V6, P393, DOI 10.1016/0962-8924(96)10034-9; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORI H, 1994, MOL GEN GENET, V245, P781, DOI 10.1007/BF00297285; Mottram JC, 1997, J BIOL CHEM, V272, P14285, DOI 10.1074/jbc.272.22.14285; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; MOTTRAM JC, 1994, PARASITOL TODAY, V10, P253, DOI 10.1016/0169-4758(94)90136-8; Mottram JC, 1996, BIOCHEM J, V316, P833, DOI 10.1042/bj3160833; Mottram JC, 1996, MOL MICROBIOL, V22, P573, DOI 10.1046/j.1365-2958.1996.00136.x; MOTTRAM JC, 1995, GENE, V162, P147, DOI 10.1016/0378-1119(95)00350-F; MOTTRAM JC, 1993, J BIOL CHEM, V268, P2104; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; REED SI, 1990, P NATL ACAD SCI USA, V87, P5697, DOI 10.1073/pnas.87.15.5697; RICHARDSON HE, 1990, GENE DEV, V4, P1332, DOI 10.1101/gad.4.8.1332; SOGIN ML, 1986, P NATL ACAD SCI USA, V83, P1383, DOI 10.1073/pnas.83.5.1383; TAKAHASHI M, 1995, J NEUROSCI, V15, P6222; TANG L, 1994, J EUKARYOT MICROBIOL, V41, P381, DOI 10.1111/j.1550-7408.1994.tb06093.x	40	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10153	10159		10.1074/jbc.273.17.10153	http://dx.doi.org/10.1074/jbc.273.17.10153			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553063	hybrid			2022-12-27	WOS:000073224200012
J	Edwards, GM; Wilford, FH; Liu, XW; Hennighausen, L; Djiane, J; Streuli, CH				Edwards, GM; Wilford, FH; Liu, XW; Hennighausen, L; Djiane, J; Streuli, CH			Regulation of mammary differentiation by extracellular matrix involves protein-tyrosine phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; EPITHELIAL-CELLS; GENE-EXPRESSION; DNA-BINDING; SIGNAL-TRANSDUCTION; BASEMENT-MEMBRANE; KINASE JAK2; ACTIVATION; PROLACTIN; PHOSPHORYLATION	Extracellular matrix and growth factors cooperate to regulate signaling pathways and gene transcription in adherent cells. However, the mechanism of extracellular matrix signaling is poorly defined. In mammary gland, the expression of milk protein genes is controlled by cross-talk between signals derived from the basement membrane protein, laminin, and the lactogenic hormone, prolactin. Signals from basement membrane are transduced by beta(1) integrins and are required for prolactin to activate DNA binding of the milk protein gene transcription factor, Stat5. Here we show that basement membrane is necessary for tyrosine phosphorylation of the prolactin receptor and thus directly affects cytokine signaling and differentiation at the level of the plasma membrane. Prolactin does not induce tyrosine phosphorylation of its receptor, Jak2, or Stat5 in nondifferentiated breast epithelia cultured on collagen I, and we show that this is due to a vanadate-sensitive activity that inhibits the prolactin pathway. We suggest that protein-tyrosine phosphatases are novel targets for regulation by extracellular matrix and in mammary cells represent an additional control to the requirement of integrins for milk protein production.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; INRA, Unite Endocrinol Mol, F-78352 Jouy En Josas, France; NIDDK, Biochem & Metab Lab, NIH, Bethesda, MD 20892 USA	University of Manchester; INRAE; UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Streuli, CH (corresponding author), Univ Manchester, Sch Biol Sci, 3-239 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.			Hennighausen, Lothar/0000-0001-8319-9841	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ali S, 1996, EMBO J, V15, P135, DOI 10.1002/j.1460-2075.1996.tb00341.x; Assoian RK, 1997, CURR OPIN CELL BIOL, V9, P93, DOI 10.1016/S0955-0674(97)80157-3; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; BURDON TG, 1994, FEBS LETT, V350, P177, DOI 10.1016/0014-5793(94)00757-8; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen QM, 1996, J BIOL CHEM, V271, P18122, DOI 10.1074/jbc.271.30.18122; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DAVID M, 1994, P NATL ACAD SCI USA, V91, P7174, DOI 10.1073/pnas.91.15.7174; DELCOMMENNE M, 1995, J BIOL CHEM, V270, P26794, DOI 10.1074/jbc.270.45.26794; FOURT ID, 1984, ENDOCRINOLOGY, V114, P1021; Fuchs M, 1996, J BIOL CHEM, V271, P16712, DOI 10.1074/jbc.271.28.16712; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; GIANCOTTI GG, 1997, CURR OPIN CELL BIOL, V9, P691; GILMOUR KC, 1994, P NATL ACAD SCI USA, V91, P6850, DOI 10.1073/pnas.91.15.6850; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; HOWLETT AR, 1995, J CELL SCI, V108, P1945; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Hynes NE, 1997, J MAMMARY GLAND BIOL, V2, P19, DOI 10.1023/A:1026317428542; KALNAY SMB, 1995, J CELL BIOL, V130, P977; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; MAHER PA, 1993, P NATL ACAD SCI USA, V90, P11177, DOI 10.1073/pnas.90.23.11177; Meredith JE, 1996, ENDOCR REV, V17, P207, DOI 10.1210/er.17.3.207; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Ouwens DM, 1996, BIOCHEM J, V318, P609, DOI 10.1042/bj3180609; PAGES CS, 1995, EMBO J, V14, P2827; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Pullan Shirley E., 1996, P97; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263; RUI H, 1994, J BIOL CHEM, V269, P5364; Sabe H, 1997, ONCOGENE, V14, P1779, DOI 10.1038/sj.onc.1201022; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; STREULI C, 1996, LAMININS, P217; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; Streuli CH, 1997, ENDOCR-RELAT CANCER, V4, P45, DOI 10.1677/erc.0.0040045; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Streuli M, 1996, CURR OPIN CELL BIOL, V8, P182, DOI 10.1016/S0955-0674(96)80064-0; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; Wartmann M, 1996, J BIOL CHEM, V271, P31863, DOI 10.1074/jbc.271.50.31863; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; WELTE T, 1994, MOL ENDOCRINOL, V8, P1091, DOI 10.1210/me.8.8.1091; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	54	81	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9495	9500		10.1074/jbc.273.16.9495	http://dx.doi.org/10.1074/jbc.273.16.9495			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545277	hybrid			2022-12-27	WOS:000073128800023
J	Sen, R; Nagai, H; Hernandez, VJ; Shimamoto, N				Sen, R; Nagai, H; Hernandez, VJ; Shimamoto, N			Reduction in abortive transcription from the lambda P-R promoter by mutations in region 3 of the sigma(70) subunit of Escherichia coli RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAC UV5 PROMOTER; CONSERVED REGION-3; TERNARY COMPLEXES; START SITE; IN-VIVO; INITIATION; MECHANISM; GREA; DNA; HOLOENZYME	Transcription initiation by Escherichia coli RNA polymerase at most promoters is associated with a reiterative synthesis and release of short abortive RNA products. We have investigated the mechanism of abortive RNA synthesis by using holoenzymes containing mutant sigma(70) subunits with changes in region 3 (S506F and P504L), which reduce the ratio of abortive to full-length products. Binary complexes formed by these mutant enzymes at a modified AP, promoter contained a smaller fraction of open complexes than for normal polymerase, suggesting an involvement of region 3 in melting duplex DNA or in maintenance of the open complex. The half-lives of the majority of binary complexes formed by the mutant enzymes were less than 1 min, in contrast to 30 min for the wild-type complexes. The time courses of transcription and pulse-labeling assays showed that moribund complexes, which generate only abortive products (Kubori, T., and Shimamoto, N. (1996) J. Mol. Biol. 256, 449-457), were formed by the mutant enzymes. However, they accumulated to a lesser extent than for the wild-type enzyme, due both to faster dissociation and conversion into inactive complexes. This is the main cause of the low degree of abortive transcription displayed by the mutant enzymes on this promoter.	Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 411, Japan; SUNY Buffalo, Sch Med, Buffalo, NY 14214 USA	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shimamoto, N (corresponding author), Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 411, Japan.		Shimamoto, Nobuo/AAJ-4999-2020; Nagai, Hiroki/G-4113-2015; Nagai, Hiroki/GXZ-7815-2022	Shimamoto, Nobuo/0000-0001-7579-0084; Nagai, Hiroki/0000-0003-1659-2197; 				CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; FENG GH, 1994, J BIOL CHEM, V269, P22282; FERRANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P263; GONZALEZ N, 1977, ARCH BIOCHEM BIOPHYS, V182, P404, DOI 10.1016/0003-9861(77)90521-5; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HERNANDEZ VJ, 1995, J MOL BIOL, V252, P536; Hernandez VJ, 1996, J BIOL CHEM, V271, P18775, DOI 10.1074/jbc.271.31.18775; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Johnston D. E., 1976, RNA POLYMERASE, P413; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; Kubori T, 1997, NUCLEIC ACIDS RES, V25, P2640, DOI 10.1093/nar/25.13.2640; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; MUNSON LM, 1981, BIOCHEMISTRY-US, V20, P2081, DOI 10.1021/bi00511a003; NAGAI H, 1998, IN PRESS GENES CELLS; PFEFFER SR, 1977, J BIOL CHEM, V252, P5403; ROE JH, 1985, J MOL BIOL, V184, P441, DOI 10.1016/0022-2836(85)90293-1; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; STRANEY DC, 1987, J MOL BIOL, V193, P279, DOI 10.1016/0022-2836(87)90219-1; SUH WC, 1993, SCIENCE, V259, P358, DOI 10.1126/science.8420002; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133	27	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9872	9877		10.1074/jbc.273.16.9872	http://dx.doi.org/10.1074/jbc.273.16.9872			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545328	hybrid			2022-12-27	WOS:000073128800074
J	Dho, SE; Jacob, S; Wolting, CD; French, MB; Rohrschneider, LR; McGlade, CJ				Dho, SE; Jacob, S; Wolting, CD; French, MB; Rohrschneider, LR; McGlade, CJ			The mammalian Numb phosphotyrosine-binding domain - Characterization of binding specificity and identification of a novel PDZ domain-containing Numb binding protein, LNX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR RECEPTOR; TYROSINE-PHOSPHATASE; SIGNAL-TRANSDUCTION; PTB DOMAIN; ASYMMETRIC LOCALIZATION; CELL FATES; SH2 DOMAIN; DROSOPHILA; DISTINCT	Numb is a phosphotyrosine-binding (PTB) domain-containing protein implicated in the control of cell fate decisions during development. A modified two-hybrid screen in yeast was used to identify Numb PTB domain-interacting proteins important for Numb function. Here we report the identification of a novel protein, LNX, which interacts specifically with the Numb PTB domain. Two differentially expressed LNX messages encode overlapping proteins with predicted molecular masses of 80 kDa (LNX) and 70 kDa (LNX-b). LNX and LNX-b contain unique amino-terminal sequences and share four PDZ domains. The unique amino-terminal region of LNX includes a RING finger domain. The Numb PTB domain binding region of LNX was mapped to the sequence motif LDNPAY, found in both protein isoforms. Mutational analysis of LNX and peptide competition experiments showed that phosphorylation of the tyrosine residue within this motif was not required for binding to the Numb PTB domain. Finally, we also provide evidence that tyrosine phosphorylation of the LDNPAY sequence motif in LNX could generate a binding site for the phosphorylation-dependent binding of other PTB domain-containing proteins such as SHC. We speculate that LNX may be important for clustering PTB-containing proteins with functionally related transmembrane proteins in specific membrane compartments.	Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Amgen Inc, Toronto, ON M5G 2C1, Canada; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Fred Hutchinson Cancer Center	McGlade, CJ (corresponding author), Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Amgen Inc, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.	JMcGlade@Amgen.com		French, Michelle/0000-0002-4157-0371				BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; BLAKE TJ, 1993, EMBO J, V12, P2017, DOI 10.1002/j.1460-2075.1993.tb05851.x; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Borg JP, 1996, MOL CELL BIOL, V16, P6229; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurzchalia T, 1996, TRENDS CELL BIOL, V6, P131, DOI 10.1016/0962-8924(96)20003-0; LEVITAN DJ, 1994, P NATL ACAD SCI USA, V91, P6108, DOI 10.1073/pnas.91.13.6108; Li SC, 1997, P NATL ACAD SCI USA, V94, P7204, DOI 10.1073/pnas.94.14.7204; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; MAEKAWA K, 1994, FEBS LETT, V337, P200, DOI 10.1016/0014-5793(94)80273-4; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; RAVICHANDRAN KS, 1996, P NATL ACAD SCI USA, V93, P5725; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; TRUB T, 1995, J BIOL CHEM, V270, P18205; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; vanderGeer P, 1996, P NATL ACAD SCI USA, V93, P963, DOI 10.1073/pnas.93.3.963; VANDERGEER P, 1995, CURR BIOL, V5, P404, DOI 10.1016/S0960-9822(95)00081-9; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Vervoort M, 1997, DEVELOPMENT, V124, P2819; Wang SW, 1997, DEVELOPMENT, V124, P4435; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yajnik V, 1996, J BIOL CHEM, V271, P1813, DOI 10.1074/jbc.271.4.1813; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	57	100	110	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9179	9187		10.1074/jbc.273.15.9179	http://dx.doi.org/10.1074/jbc.273.15.9179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535908	hybrid			2022-12-27	WOS:000072990800085
J	Gunwar, S; Ballester, F; Noelken, ME; Sado, Y; Ninomiya, Y; Hudson, BG				Gunwar, S; Ballester, F; Noelken, ME; Sado, Y; Ninomiya, Y; Hudson, BG			Glomerular basement membrane - Identification of a novel disulfide-cross-linked network of alpha 3, alpha 4, and alpha 5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCOLLAGENOUS DOMAIN HEXAMER; GOODPASTURE ANTIGEN; COL4A5 GENE; MOLECULAR ARCHITECTURE; LATERAL ASSOCIATIONS; CDNA ISOLATION; BASAL LAMINAE; MUTATIONS; LOCALIZATION; EXPRESSION	Glomerular basement membrane (GEM) plays a crucial function in the ultrafiltration of blood plasma by the kidney. This function is impaired in Alport syndrome, a hereditary disorder that is caused by mutations in the gene encoding type IV collagen, but it is not known how the mutations lead to a defective GBM. In the present study, the supramolecular organization of type IV collagen of GEM was investigated. This was accomplished by using pseudolysin (EC 3.4.24.26) digestion to excise truncated triple-helical protomers for structural studies. Two distinct sets of truncated protomers were solubilized, one at 4 degrees C and the other at 25 degrees C, and their chain composition was determined by use of monoclonal antibodies. The 4 degrees C protomers comprise the alpha 1(IV) and alpha 2(IV) chains, whereas the 25 degrees C protomers comprised mainly alpha 3(IV), alpha 4(IV), and alpha 5(IV) chains along with some alpha 1(IV) and alpha 2(TV) chains. The structure of the 25 degrees C protomers was examined by electron microscopy and was found to be characterized by a network containing loops and supercoiled triple helices, which are stabilized by disulfide cross-links between alpha 3(TV), alpha 4(IV), and alpha 5(IV) chains. These results establish a conceptual framework to explain several features of the GEM abnormalities of Alport syndrome. In particular, the alpha 3(IV).alpha 4(IV).alpha 5(IV) network, involving a covalent linkage between these chains, suggests a molecular basis for the conundrum in which mutations in the gene encoding the alpha 5(IV) chain cause defective assembly of not only alpha 5(IV) chain but also the alpha 3(IV) and alpha 4(TV) chains in the GEM of patients with Alport syndrome.	Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; Shigei Med Res Inst, Div Immunol, Okayama 70102, Japan; Okayama Univ, Sch Med, Dept Biochem & Mol Biol, Okayama 700, Japan	University of Kansas; University of Kansas Medical Center; Okayama University	Hudson, BG (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.			Hudson, Billy/0000-0002-5420-4100	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018381, R01DK018381] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 18381] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTIGNAC C, 1994, J CLIN INVEST, V93, P1195, DOI 10.1172/JCI117073; BARTOSCH B, 1991, ARCH DIS CHILD, V66, P248, DOI 10.1136/adc.66.2.248; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; BUTKOWSKI RJ, 1989, KIDNEY INT, V35, P1195, DOI 10.1038/ki.1989.110; BUTKOWSKI RJ, 1982, METHOD ENZYMOL, V82, P410; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; Dehan P, 1996, NEPHROL DIAL TRANSPL, V11, P1983, DOI 10.1093/oxfordjournals.ndt.a027085; DING J, 1994, KIDNEY INT, V45, P1504, DOI 10.1038/ki.1994.196; FREYTAG JW, 1976, BIOCHEM BIOPH RES CO, V72, P796; GUNWAR S, 1991, J BIOL CHEM, V266, P14088; GUNWAR S, 1991, J BIOL CHEM, V266, P15318; Heiskari N, 1996, J AM SOC NEPHROL, V7, P702; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HUDSON BG, 1989, LAB INVEST, V61, P256; HUDSON BG, 1992, KIDNEY INT, V42, P179, DOI 10.1038/ki.1992.276; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; HUNG CH, 1981, J BIOL CHEM, V256, P3822; HUSZAR G, 1980, ANAL BIOCHEM, V105, P424, DOI 10.1016/0003-2697(80)90481-9; JOHANSSON C, 1992, J BIOL CHEM, V267, P24533; Kahsai TZ, 1997, J BIOL CHEM, V272, P17023, DOI 10.1074/jbc.272.27.17023; KALLURI R, 1994, KIDNEY INT, V45, P721, DOI 10.1038/ki.1994.96; Kalluri R, 1997, J CLIN INVEST, V99, P2470, DOI 10.1172/JCI119431; KASHTAN CE, 1992, KIDNEY INT, V42, P115, DOI 10.1038/ki.1992.269; KLEPPEL MM, 1992, J BIOL CHEM, V267, P4137; KLEPPEL MM, 1989, AM J PATHOL, V134, P813; KLEPPEL MM, 1992, KIDNEY INT, V41, P1629, DOI 10.1038/ki.1992.235; LANGEVELD JPM, 1988, J BIOL CHEM, V263, P10481; LEINONEN A, 1994, J BIOL CHEM, V269, P26172; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; MARIYAMA M, 1994, J BIOL CHEM, V269, P23013; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; MORRISON KE, 1991, AM J HUM GENET, V49, P545; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NINOMIYA Y, 1995, J CELL BIOL, V130, P1; OOHASHI T, 1994, J BIOL CHEM, V269, P7520; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PEISSEL B, 1995, J CLIN INVEST, V96, P1948, DOI 10.1172/JCI118241; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; Rauf S, 1996, VIRCHOWS ARCH, V428, P281; Renieri A, 1996, AM J HUM GENET, V58, P1192; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SAUS J, 1988, J BIOL CHEM, V263, P13374; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOININEN R, 1987, FEBS LETT, V225, P188; SUGIMOTO M, 1993, FEBS LETT, V330, P122, DOI 10.1016/0014-5793(93)80256-T; Thorner PS, 1996, J BIOL CHEM, V271, P13821, DOI 10.1074/jbc.271.23.13821; TIMONEDA J, 1990, CONNECT TISSUE RES, V24, P169, DOI 10.3109/03008209009152147; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; Tryggvason K, 1997, KIDNEY INT, V51, P1493, DOI 10.1038/ki.1997.205; WEST TW, 1980, J BIOL CHEM, V255, P451; YURCHENCO PD, 1994, METHOD ENZYMOL, V245, P489; YURCHENCO PD, 1988, AM J PATHOL, V132, P278; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; ZHOU J, 1994, J BIOL CHEM, V269, P13193; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449; ZHOU J, 1992, J BIOL CHEM, V267, P12475	64	161	162	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8767	8775		10.1074/jbc.273.15.8767	http://dx.doi.org/10.1074/jbc.273.15.8767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535854	hybrid			2022-12-27	WOS:000072990800031
J	Strassburg, CP; Manns, MP; Tukey, RH				Strassburg, CP; Manns, MP; Tukey, RH			Expression of the UDP-glucuronosyltransferase 1A locus in human colon - Identification and characterization of the novel extrahepatic UGT1A8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NAJJAR TYPE-I; HUMAN BILIRUBIN; GENE-COMPLEX; CLONING; PHENOL; GLUCURONIDATION; HEPATITIS; PROTEIN; FAMILY; CELLS	UDP-glucuronosyltransferases (UGT) catalyze the conjugation of lipophilic exobiotic and endobiotic compounds, which leads to the excretion of hydrophilic glucuronides via bile or urine, By a mechanism of exon sharing, the transcripts of individual first exon cassettes located at the 5' end of the human UGT1A locus are spliced to exons 2-5, leading to the expression of at least nine individual UGT genes. Recently, the tissue-specific expression of the UGT1A locus has been demonstrated in extrahepatic tissue, leading to the identification of UGT1A7 and UGT1A10 mRNA (Strassburg, C. P., Oldhafer, K., Manns, M. P., and Tukey, R H. (1997) Mol. Pharmacol 52, 212), However, UGT1A expression has not been defined in human colon, which is a metabolically active, external surface organ and a common route of drug administration. UGT1A expression was analyzed in 5 colonic, 16 hepatic, 4 biliary, and 13 gastric human tissue specimens by quantitative duplex reverse transcription-polymerase chain reaction and Western blot analysis, demonstrating lower UGT1A mRNA in the extrahepatic tissues. The precise analysis of unique UGT1A transcripts by exon 1-specific duplex reverse transcription-polymerase chain reaction revealed the expression of UGT1A1, UGT1A3, UGT1A4, UGT1A6, and UGT1A9 in the colon, which are also present in human liver, In addition, the expression of extrahepatic UGT1A10 and UGT1A8 was demonstrated. UGT1A8 was found to be closely related to gastric UGT1A7 with a 93.8% identity of first exon sequences. Expressed UGT1A7 and UGT1A10 protein showed unique catalytic activity profiles, while UGT1A8 was not active with the substrates tested, The ability of UGT1A10 to glucuronidate estrone represents only the second example of a human estrone UGT. The highly related human UGT1A7-1A10 cluster is expressed in a tissue-specific fashion and underlines the role and diversity of physiological glucuronidation at the distal end of the digestive tract.	Univ Calif San Diego, Ctr Canc, Dept Pharmacol, La Jolla, CA 92093 USA; Med Hsch Hannover, Dept Gastroenterol & Hepatol, D-30625 Hannover, Germany	University of California System; University of California San Diego; Hannover Medical School	Tukey, RH (corresponding author), Univ Calif San Diego, Ctr Canc, Dept Pharmacol, 0636,9500 Gilman Dr, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049135] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49135] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURCHELL B, 1991, DNA CELL BIOL, V10, P487, DOI 10.1089/dna.1991.10.487; Chowdhury Jayanta Roy, 1994, P471; Dutton G.F., 1980, GLUCURONIDATION DRUG; EBNER T, 1993, MOL PHARMACOL, V43, P649; EBNER T, 1993, DRUG METAB DISPOS, V21, P50; Green MD, 1996, DRUG METAB DISPOS, V24, P356; HARDING D, 1988, P NATL ACAD SCI USA, V85, P8381, DOI 10.1073/pnas.85.22.8381; Kim PM, 1997, J PHARMACOL EXP THER, V280, P200; Li Q, 1997, J BIOL CHEM, V272, P3272, DOI 10.1074/jbc.272.6.3272; MOGHRABI N, 1993, GENOMICS, V18, P171, DOI 10.1006/geno.1993.1451; Mojarrabi B, 1996, BIOCHEM BIOPH RES CO, V225, P785, DOI 10.1006/bbrc.1996.1251; MONAGHAN G, 1994, GENOMICS, V23, P496, DOI 10.1006/geno.1994.1531; Nguyen N, 1997, DRUG METAB DISPOS, V25, P745; Owens I.S., 1995, PROG NUCL ACID RES, V51, P306; PHILIPP T, 1994, LANCET, V344, P578, DOI 10.1016/S0140-6736(94)91966-6; RITTER JK, 1992, J CLIN INVEST, V90, P150, DOI 10.1172/JCI115829; RITTER JK, 1992, J BIOL CHEM, V267, P3257; RITTER JK, 1991, J BIOL CHEM, V266, P1043; SEPPEN J, 1994, J CLIN INVEST, V94, P2385, DOI 10.1172/JCI117604; Strassburg CP, 1997, MOL PHARMACOL, V52, P212, DOI 10.1124/mol.52.2.212; Strassburg CP, 1997, CANCER RES, V57, P2979; Strassburg CP, 1996, GASTROENTEROLOGY, V111, P1576, DOI 10.1016/S0016-5085(96)70020-3; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WEI QY, 1995, CANCER RES, V55, P5025; WOOSTER R, 1991, BIOCHEM J, V278, P465, DOI 10.1042/bj2780465	26	246	251	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8719	8726		10.1074/jbc.273.15.8719	http://dx.doi.org/10.1074/jbc.273.15.8719			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535849	hybrid			2022-12-27	WOS:000072990800026
J	Goto, H; Kosako, H; Tanabe, K; Yanagida, M; Sakurai, M; Amano, M; Kaibuchi, K; Inagaki, M				Goto, H; Kosako, H; Tanabe, K; Yanagida, M; Sakurai, M; Amano, M; Kaibuchi, K; Inagaki, M			Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEIN; SERINE-THREONINE KINASE; INTERMEDIATE FILAMENTS; PUTATIVE TARGET; SERINE/THREONINE KINASE; SMOOTH-MUSCLE; MITOSIS; CELLS; RAS; REORGANIZATION	We found that vimentin, the most widely expressed intermediate filament protein, served as an excellent substrate for Rho-associated kinase (Rho-kinase) and that vimentin phosphorylated by Rho-kinase lost its ability to form filaments in vitro. Two amino-terminal sites on vimentin, Ser(38) and Ser(71), were identified as the major phosphorylation sites for Rho-kinase, and Ser(71) was the most favored and unique phosphorylation site for Rho-kinase in vitro. To analyze the vimentin phosphorylation by Rho-kinase in vivo, we prepared an antibody GK71 that specifically recognizes the phosphorylation of vimentin-Ser(71). Ectopic expression of constitutively active Rho-kinase in COS-7 cells induced phosphorylation of vimentin at Ser(71), followed by the reorganization of vimentin filament networks. During the cell cycle, the phosphorylation of vimentin-Ser(71) occurred only at the cleavage furrow in late mitotic cells but not in interphase or early mitotic cells. This cleavage furrow-specific phosphorylation of vimentin-Ser(71) was observed in the various types of cells we examined. All these accumulating observations increase the possibility that Rho-kinase may have a definite role in governing regulatory processes in assembly-disassembly and turnover of vimentin filaments at the cleavage furrow during cytokinesis.	Aichi Canc Ctr, Res Inst, Biochem Lab, Chikusa Ku, Nagoya, Aichi 464, Japan; Aichi Canc Ctr, Res Inst, Biophys Unit, Nagoya, Aichi 464, Japan; Mie Univ, Sch Med, Dept Pediat, Tsu, Mie 514, Japan; Nara Inst Sci & Technol, Div Signal Transduct, Ikoma 63001, Japan	Aichi Cancer Center; Aichi Cancer Center; Mie University; Nara Institute of Science & Technology	Inagaki, M (corresponding author), Aichi Canc Ctr, Res Inst, Biochem Lab, Chikusa Ku, Nagoya, Aichi 464, Japan.		Amano, Mutsuki/M-4820-2014; Inagaki, Masaki/B-9920-2016	Amano, Mutsuki/0000-0002-0662-1524; Goto, Hidemasa/0000-0002-6796-4467				Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BLOSE SH, 1979, P NATL ACAD SCI USA, V76, P3372, DOI 10.1073/pnas.76.7.3372; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; FRANKE WW, 1983, J CELL BIOL, V97, P1255, DOI 10.1083/jcb.97.4.1255; FRANKE WW, 1984, EXP CELL RES, V154, P567, DOI 10.1016/0014-4827(84)90181-2; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; HIRATA K, 1992, J BIOL CHEM, V267, P8719; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Inagaki M, 1997, J BIOCHEM, V121, P407; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Inagaki N, 1997, J BIOL CHEM, V272, P25195, DOI 10.1074/jbc.272.40.25195; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; JONES JCR, 1985, J CELL BIOL, V100, P93, DOI 10.1083/jcb.100.1.93; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kosako H, 1997, J BIOL CHEM, V272, P10333; LANE EB, 1982, EMBO J, V1, P1365, DOI 10.1002/j.1460-2075.1982.tb01324.x; Leung T, 1996, MOL CELL BIOL, V16, P5313; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; LIAO J, 1995, J CELL BIOL, V131, P1291, DOI 10.1083/jcb.131.5.1291; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; MABUCHI I, 1986, INT REV CYTOL, V101, P175, DOI 10.1016/S0074-7696(08)60249-1; Mabuchi I, 1993, ZYGOTE, V1, P325, DOI 10.1017/S0967199400001659; Machesky LM, 1996, TRENDS CELL BIOL, V6, P304, DOI 10.1016/0962-8924(96)10026-X; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MATSUOKA Y, 1992, EMBO J, V11, P2895, DOI 10.1002/j.1460-2075.1992.tb05358.x; MEYER HE, 1986, FEBS LETT, V204, P61, DOI 10.1016/0014-5793(86)81388-6; NISHIZAWA K, 1991, J BIOL CHEM, V266, P3074; OGAWARA M, 1995, J CELL BIOL, V131, P1055, DOI 10.1083/jcb.131.4.1055; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; PERRY MM, 1971, EXP CELL RES, V65, P249, DOI 10.1016/S0014-4827(71)80075-7; RAPPAPORT R, 1986, INT REV CYTOL, V105, P245, DOI 10.1016/S0074-7696(08)61065-7; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROSEVEAR ER, 1990, CELL MOTIL CYTOSKEL, V17, P150, DOI 10.1002/cm.970170303; Schroeder T. E., 1968, Experimental Cell Research, V53, P272, DOI 10.1016/0014-4827(68)90373-X; Sekimata M, 1996, J CELL BIOL, V132, P635, DOI 10.1083/jcb.132.4.635; SHIMIZU K, 1994, J BIOL CHEM, V269, P22917; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Takai Y, 1996, J CELL BIOL, V133, P141, DOI 10.1083/jcb.133.1.141; TAKAISHI K, 1994, ONCOGENE, V9, P273; TAKAISHI K, 1995, ONCOGENE, V11, P39; TOMINAGA T, 1993, J CELL BIOL, V120, P1529, DOI 10.1083/jcb.120.6.1529; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; WOOD L, 1989, GENE, V76, P171, DOI 10.1016/0378-1119(89)90020-6	58	181	185	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11728	11736		10.1074/jbc.273.19.11728	http://dx.doi.org/10.1074/jbc.273.19.11728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565595	hybrid			2022-12-27	WOS:000073536700049
J	Pan, CQ; Lazarus, RA				Pan, CQ; Lazarus, RA			Hyperactivity of human DNase I variants - Dependence on the number of positively charged residues and concentration, length, and environment of DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; ESCHERICHIA-COLI; OPERATOR BINDING; REPRESSOR; MUTAGENESIS; ASSOCIATION; RESOLUTION; PROTEINS; COMPLEX; ROLES	Human DNase I, an enzyme used to treat cystic fibrosis patients, has been engineered to more effectively degrade double-stranded DNA to lower molecular weight forms by introducing positively charged amino acids at positions that can interact favorably with the proximal negatively charged phosphate groups of the DNA. A series of combination mutants having from one to six additional basic residues compared with the wild type has been constructed, expressed in human 293 cells, and characterized. The degree of hyperactivity for the mutants was highly dependent upon the conditions in various assays, including the concentration and length of the DNA substrate and the salt and divalent metal ion concentrations. The level of hyperactivity was inversely proportional to both DNA concentration and DNA length, consistent with the processive nicking mechanism for the hyperactive variants. Salt was inhibitory for wild type DNase I but actually enhanced the activity of the hyperactive variants. Under optimal conditions for wild type, variants with one additional positive charge possessed the highest activity, which was only severalfold greater than that for wild type. However, in the presence of low DNA concentrations and molecular weights, no Ca2+, and 150 mM NaCl, the variant with six engineered basic residues was most active, having >10,000-fold higher activity than the mild type enzyme. Therefore, any potential increase in potency for the hyperactive variants in vivo will be determined by the concentration, length, and environment of the DNA.	Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Lazarus, RA (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, S San Francisco, CA 94080 USA.							CAMPBELL VW, 1980, J BIOL CHEM, V255, P3726; DOHERTY AJ, 1995, J MOL BIOL, V251, P366, DOI 10.1006/jmbi.1995.0440; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; GUENOT J, 1994, PROTEIN SCI, V3, P1276, DOI 10.1002/pro.5560030814; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HURLBURT BK, 1990, J BIOL CHEM, V265, P7853; KUNITZ M, 1950, J GEN PHYSIOL, V33, P349, DOI 10.1085/jgp.33.4.349; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAHM A, 1991, J MOL BIOL, V222, P645, DOI 10.1016/0022-2836(91)90502-W; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; MISRA VK, 1994, J MOL BIOL, V238, P264, DOI 10.1006/jmbi.1994.1286; NELSON HCM, 1985, CELL, V42, P549, DOI 10.1016/0092-8674(85)90112-6; Pan CQ, 1997, BIOCHEMISTRY-US, V36, P6624, DOI 10.1021/bi962960x; Pan CQ, 1998, PROTEIN SCI, V7, P628, DOI 10.1002/pro.5560070312; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; RAMSEY BW, 1993, AM REV RESPIR DIS, V148, P145, DOI 10.1164/ajrccm/148.1.145; Ramsey BW, 1996, NEW ENGL J MED, V335, P179, DOI 10.1056/NEJM199607183350307; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Sambrook J., 2002, MOL CLONING LAB MANU; SINICROPI D, 1994, ANAL BIOCHEM, V222, P351, DOI 10.1006/abio.1994.1502; TIAN GL, 1994, MOL MICROBIOL, V13, P599, DOI 10.1111/j.1365-2958.1994.tb00454.x; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; Ulmer JS, 1996, P NATL ACAD SCI USA, V93, P8225, DOI 10.1073/pnas.93.16.8225; WESTON SA, 1992, J MOL BIOL, V226, P1237, DOI 10.1016/0022-2836(92)91064-V; WOLF E, 1995, PROTEIN ENG, V8, P79	25	28	29	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11701	11708		10.1074/jbc.273.19.11701	http://dx.doi.org/10.1074/jbc.273.19.11701			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565591	hybrid			2022-12-27	WOS:000073536700045
J	Rodriguez-Romero, A; Almog, O; Tordova, M; Randhawa, Z; Gilliland, GL				Rodriguez-Romero, A; Almog, O; Tordova, M; Randhawa, Z; Gilliland, GL			Primary and tertiary structures of the Fab fragment of a monoclonal anti-E-selectin 7A9 antibody that inhibits neutrophil attachment to endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHINOVIRUS NEUTRALIZING ANTIBODY; CRYSTAL-STRUCTURE; ADHESION MOLECULE-1; BINDING-SITE; CRYSTALLIZATION; RECOGNITION; REFINEMENT; COMPLEX; GROWTH	The murine monoclonal IgG1 antibody 7A9 binds specifically to the endothelial leukocyte adhesion molecule-1 (E-selectin), inhibiting the attachment of neutrophils to endothelial cells. The primary and three-dimensional structures of the Fab fragment of 7A9 are reported. The amino acid sequence was determined by automated Edman degradation analysis of proteolytic fragments of both the heavy and light chains of the Fab, The sequences of the two chains are consistent with that of the IgG1 class with an associated kappa light chain with two intrachain disulfide bridges in each of the heavy and light chains. The tertiary structure of the antibody fragment was determined by x-ray crystallographic methods at 2.8 Angstrom resolution. The F(ab')(2) molecule, treated with dithiothreitol, crystallizes in the space group P2(1)2(1)2(1) with unit cell parameters a = 44.5 Angstrom, b = 83.8 Angstrom, and c 132.5 Angstrom with one Fab molecule in the asymmetric unit. The structure was solved by the molecular replacement method and subsequently refined using simulated annealing followed by conventional least squares optimization of the coordinates. The resulting model has reasonable stereochemistry with an R factor of 0.195, The 7A9 Fab structure has an elbow bend of 162 degrees and is remarkably similar to that of the monoclonal anti-intercellular adhesion molecule-1 (ICAM-1) antibody Fab fragment. The 7A9 antigen combining site presents a groove resembling the structure of the anti-ICAM-1 antibody, and other antibodies raised against surface receptors and peptides, Residues from the six complementary determining regions (CDRs) and framework residues form the floor and walls of the groove that is approximately 22 Angstrom wide and 8 Angstrom deep and that is lined with many aromatic residues. The groove is large enough to accommodate the loop between beta-strands beta(4) and beta(5), of the lectin domain of E-selectin that has been implicated in neutrophil adhesion (1).	Natl Inst Stand & Technol, Rockville, MD 20850 USA; Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Natl Autonomous Univ Mexico, Inst Quim, Mexico City 04510, DF, Mexico; Otsuka Amer Pharmaceut Inc, Rockville, MD 20850 USA	National Institute of Standards & Technology (NIST) - USA; Universidad Nacional Autonoma de Mexico	Rodriguez-Romero, A (corresponding author), Natl Inst Stand & Technol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.		RODRIGUEZ-ROMERO, ADELA/C-7723-2015	RODRIGUEZ-ROMERO, ADELA/0000-0001-7641-6545				BOXER LA, 1990, BLOOD CELLS, V16, P25; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BRUNGER AT, 1992, XPLOR VERSION 3 1 SY, P187; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CUDNEY B, 1994, ACTA CRYSTALLOGR D, V50, P414, DOI 10.1107/S0907444994002660; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; GHIARA JB, 1994, SCIENCE, V264, P82, DOI 10.1126/science.7511253; GILLILAND GL, 1984, METHOD ENZYMOL, V104, P370; GRABER N, 1990, J IMMUNOL, V145, P819; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; HERZBERG O, 1991, PROTEINS, V11, P223, DOI 10.1002/prot.340110307; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JEDRZEJAS MJ, 1995, ACTA CRYSTALLOGR D, V51, P380, DOI 10.1107/S0907444994011054; KABAT EA, 1987, SEQUENCES PROTEINS I, P210; KOLATKAR PR, 1992, J MOL BIOL, V225, P1127, DOI 10.1016/0022-2836(92)90110-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; Martin ACR, 1996, J MOL BIOL, V263, P800, DOI 10.1006/jmbi.1996.0617; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NEWMAN W, 1993, J IMMUNOL, V150, P644; NICOLLS A, 1991, PROTEINS, V11, P281; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; RINI JM, 1993, P NATL ACAD SCI USA, V90, P6325, DOI 10.1073/pnas.90.13.6325; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SHERIFF S, 1988, STRUCTURE EXPRESSION, V1, P449; SHOHAM M, 1993, J MOL BIOL, V232, P1169, DOI 10.1006/jmbi.1993.1469; SHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098; Tormo J, 1995, PROTEINS, V23, P491, DOI 10.1002/prot.340230404; TORMO J, 1994, EMBO J, V13, P2247, DOI 10.1002/j.1460-2075.1994.tb06506.x; TORMO J, 1992, PROTEIN SCI, V1, P1154, DOI 10.1002/pro.5560010909; VARGASMADRAZO E, 1995, J MOL BIOL, V254, P497, DOI 10.1006/jmbi.1995.0633; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; WLODAWER A, 1975, P NATL ACAD SCI USA, V72, P398, DOI 10.1073/pnas.72.1.398	38	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11770	11775		10.1074/jbc.273.19.11770	http://dx.doi.org/10.1074/jbc.273.19.11770			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565600	hybrid			2022-12-27	WOS:000073536700054
J	Yamaoka, K; Masuda, K; Ogawa, H; Takagi, K; Umemoto, N; Yasuoka, S				Yamaoka, K; Masuda, K; Ogawa, H; Takagi, K; Umemoto, N; Yasuoka, S			Cloning and characterization of the cDNA for human airway trypsin-like protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AMINOPEPTIDASE-N; BRUSH-BORDER MEMBRANE; CYSTIC-FIBROSIS; TRYPTASE CLARA; LUNG-DISEASE; SENDAI VIRUS; MAST-CELLS; PROTEINS; LOCALIZATION; CHYMASE	Previously we isolated a trypsin-like enzyme designated human airway trypsin-like protease from the sputum of patients with chronic airway diseases. This paper describes the cDNA cloning, characterization of the primary protein structure deduced from the cDNA, and gene expression of this enzyme in various human tissues. We obtained an entire 1517-base pair sequence of cDNA with an open reading frame encoding a polypeptide with 418-amino acid residues. The polypeptide consisted of a 232-residue catalytic region and a 186-residue noncatalytic region with a hydrophobic putative transmembrane domain near the NH2 terminus. The polypeptide was suggested to be a type II integral membrane protein in which the COOH-terminal catalytic region is extracellular. Therefore, this protein is thought to be synthesized as a membrane-bound precursor and to mature to a soluble and active protease by limited proteolysis, It showed 29-38% identity in the sequence of the catalytic region with human hepsin, enteropeptidase, acrosin, and mast cell tryptase. The noncatalytic region had little similarity to other known proteins. In Northern blot analysis a transcript of 1.9 kilobases was detectable most prominently in the trachea among 17 human tissues examined.	Teijin Inst Biomed Res, Hino, Tokyo 191, Japan; Univ Tokushima, Sch Med Sci, Dept Nursing, Tokushima 770, Japan	Tokushima University	Yamaoka, K (corresponding author), Teijin Inst Biomed Res, 4-3-2 Asahigaoka, Hino, Tokyo 191, Japan.							ADHAM IM, 1990, HUM GENET, V84, P125; AUSUBEL FM, 1997, CURRENT PROTOCOLS S, V38; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Blow D. M., 1971, ENZYMES, VIII, P185, DOI DOI 10.1016/S1874-6047(08)60397-2; BOWES D, 1977, THORAX, V32, P163, DOI 10.1136/thx.32.2.163; CAUGHEY GH, 1994, AM J RESP CRIT CARE, V150, P138; COHEN AB, 1983, AM REV RESPIR DIS S, V127, P2; DAVIE EW, 1955, J BIOL CHEM, V212, P515; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; DEWATER R, 1986, AM REV RESPIR DIS, V133, P882; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GERVASONI JE, 1986, J IMMUNOL, V136, P285; GOODMAN MR, 1981, AM REV RESPIR DIS, V123, P115; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HIGH S, 1992, BIOESSAYS, V14, P535, DOI 10.1002/bies.950140807; JANOFF A, 1983, J APPL PHYSIOL, V55, P285, DOI 10.1152/jappl.1983.55.2.285; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; KALINER M, 1986, AM REV RESPIR DIS, V134, P612; KEIL B, 1971, ENZYMES, V3, P250; KIDO H, 1992, J BIOL CHEM, V267, P13573; KIDO H, 1991, BIOMED BIOCHIM ACTA, V50, P781; KITAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P4562, DOI 10.1021/bi00014a008; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; KURACHI K, 1994, METHOD ENZYMOL, V244, P100; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE CT, 1981, NEW ENGL J MED, V304, P192, DOI 10.1056/NEJM198101223040402; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1067, DOI 10.1021/bi00403a032; MEYER KC, 1991, AM REV RESPIR DIS, V144, P580, DOI 10.1164/ajrccm/144.3_Pt_1.580; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; Nakano A, 1997, J IMMUNOL, V159, P1987; OCONNOR CM, 1993, AM REV RESPIR DIS, V148, P1665, DOI 10.1164/ajrccm/148.6_Pt_1.1665; PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U; Patthy L, 1990, Blood Coagul Fibrinolysis, V1, P153; PEJLER G, 1993, J BIOL CHEM, V268, P11817; POWER SD, 1986, P NATL ACAD SCI USA, V83, P3096, DOI 10.1073/pnas.83.10.3096; SAARINEN J, 1994, J BIOL CHEM, V269, P18134; SAKAI K, 1993, J HISTOCHEM CYTOCHEM, V41, P89, DOI 10.1177/41.1.8380186; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SODERBERG C, 1993, J VIROL, V67, P6576; SUTER S, 1991, EUR RESPIR J, V4, P40; TASHIRO M, 1992, J VIROL, V66, P7211, DOI 10.1128/JVI.66.12.7211-7216.1992; VONHEIJNE G, 1990, PROTEIN ENG, V4, P109, DOI 10.1093/protein/4.2.109; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WELLS JA, 1983, NUCLEIC ACIDS RES, V11, P7911, DOI 10.1093/nar/11.22.7911; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003; WICKNER W, 1980, SCIENCE, V210, P861, DOI 10.1126/science.7001628; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; YOUNG CL, 1978, ATLAS PROTEIN SEQ S3, V5, P73	59	93	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11895	11901		10.1074/jbc.273.19.11895	http://dx.doi.org/10.1074/jbc.273.19.11895			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565616	hybrid			2022-12-27	WOS:000073536700070
J	Bagni, C; Lapeyre, B				Bagni, C; Lapeyre, B			Gar1p binds to the small nucleolar RNAs snR10 and snR30 in vitro through a nontypical RNA binding element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; SACCHAROMYCES-CEREVISIAE; GLYCINE-RICH; PRERIBOSOMAL RNA; PROTEIN GAR1; YEAST; GENE; IDENTIFICATION; RECOGNITION	The nucleolar proteins Gar1p and fibrillarin possess a typical nucleolar glycine/arginine-rich domain and belong to ribonucleoprotein particles. Both proteins are essential for yeast cell growth and are required for pre-rRNA processing. In addition, Gar1p is involved in pre-rRNA pseudouridylation, whereas fibrillarin is required for pre-rRNA methylation. Gar1p and fibrillarin are each associated with a different subset of the small nucleolar RNAs (snoRNAs). Gar1p is co-immunoprecipitated with the H/ACA family of snoRNAs, whereas fibrillarin is co-immunoprecipitated with the C/D family. However, attempts to demonstrate direct interactions between fibrillarin and snoRNAs have failed, and such interactions between Gar1p and the H/ACA snoRNAs had not get been reported. Among the H/ACA snoRNAs associated with Gar1p, one can distinguish a large group of snoRNAs that are not essential in yeast and serve as guides for pseudouridine synthesis onto the pre-rRNA molecule. In contrast, the two snoRNAs snR10 and snR30 are required for normal cell growth and for pre-rRNA cleavage. We show here that Gar1p interacts in vitro directly and specifically with these two snoRNAs, Deletion analysis of Gar1p indicates that a major RNA binding element, which is extremely well conserved throughout evolution, lies in the middle of the protein. However, this domain alone binds poorly to the target RNAs and an accessory domain is required to restore efficient binding. The accessory domain can be either one of the glycine/arginine-rich domains or a second element of the core of the protein that is highly conserved between different species.	Ctr Rech Biochim Macromol, F-34293 Montpellier 01, France; Lab Biol Mol Eucaryote, F-31062 Toulouse, France	Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Lapeyre, B (corresponding author), Ctr Rech Biochim Macromol, 1919 Route de Mende,BP5051, F-34293 Montpellier 01, France.			Bagni, Claudia/0000-0002-4419-210X				BACHELLERIE JP, 1995, TRENDS BIOCHEM SCI, V20, P261, DOI 10.1016/S0968-0004(00)89039-8; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BousquetAntonelli C, 1997, EMBO J, V16, P4770, DOI 10.1093/emboj/16.15.4770; COBIANCHI F, 1988, J BIOL CHEM, V263, P1063; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Ganot P, 1997, GENE DEV, V11, P941, DOI 10.1101/gad.11.7.941; GHISOLFI L, 1992, EUR J BIOCHEM, V209, P541, DOI 10.1111/j.1432-1033.1992.tb17318.x; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GIRARD JP, 1994, J BIOL CHEM, V269, P18499; GIRARD JP, 1992, EMBO J, V11, P673, DOI 10.1002/j.1460-2075.1992.tb05099.x; GIRARD JP, 1993, NUCLEIC ACIDS RES, V21, P2149, DOI 10.1093/nar/21.9.2149; HAMM J, 1987, EMBO J, V6, P3479, DOI 10.1002/j.1460-2075.1987.tb02672.x; JONG AYS, 1987, MOL CELL BIOL, V7, P2947, DOI 10.1128/MCB.7.8.2947; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; LAPEYRE B, 1986, J BIOL CHEM, V261, P9167; LEE WC, 1991, J CELL BIOL, V113, P1, DOI 10.1083/jcb.113.1.1; LUBBEN B, 1995, J BIOL CHEM, V270, P11549, DOI 10.1074/jbc.270.19.11549; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; MORRISSEY JP, 1995, TRENDS BIOCHEM SCI, V20, P78, DOI 10.1016/S0968-0004(00)88962-8; MORRISSEY JP, 1993, MOL CELL BIOL, V13, P2469, DOI 10.1128/MCB.13.4.2469; NADLER SG, 1991, BIOCHEMISTRY-US, V30, P2968, DOI 10.1021/bi00225a034; NEWMAN T, 1994, PLANT PHYSIOL, V106, P1241, DOI 10.1104/pp.106.4.1241; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; RUSSELL ID, 1992, J CELL BIOL, V119, P737, DOI 10.1083/jcb.119.4.737; SCHERLY D, 1989, EMBO J, V8, P4163, DOI 10.1002/j.1460-2075.1989.tb08601.x; SCHMITT ME, 1994, GENE DEV, V8, P2617, DOI 10.1101/gad.8.21.2617; Smith CM, 1997, CELL, V89, P669, DOI 10.1016/S0092-8674(00)80247-0; TOLLERVEY D, 1985, EMBO J, V4, P3873, DOI 10.1002/j.1460-2075.1985.tb04160.x; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; Venema J, 1997, MOL CELL BIOL, V17, P3398, DOI 10.1128/MCB.17.6.3398	34	47	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10868	10873		10.1074/jbc.273.18.10868	http://dx.doi.org/10.1074/jbc.273.18.10868			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556561	Green Published, hybrid			2022-12-27	WOS:000073395200013
J	Garcia, AJ; Huber, F; Boettiger, D				Garcia, AJ; Huber, F; Boettiger, D			Force required to break alpha(5)beta(1) integrin-fibronectin bonds in intact adherent cells is sensitive to integrin activation state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; BIOLOGICAL-ACTIVITY; INITIAL BINDING; SHEAR-STRESS; BETA-SUBUNIT; ADHESION; RECEPTOR; SURFACE; MODULATION; FLOW	Binding of integrin receptors to extracellular ligands is a complex process involving receptor-ligand interactions at the cell-substrate interface, signals activating the receptors, and assembly of cytoskeletal and adhesion plaque proteins at the cytoplasmic face. To analyze the contribution of these elements to overall cell adhesion, Fee have developed a model system that characterizes the functional binding characteristic for adhesion receptors as the force required to separate the integrin-ligand bond. A spinning disk device was used to apply a range of controlled hydrodynamic forces to adherent cells. The adhesion of K562 erythroleukemia cells, a cell line expressing a single fibronectin receptor, integrin alpha(5) beta(1), which was uniformly activated with the monoclonal antibody TS2/16, to defined fibronectin surface densities was examined. Cell adhesion strength increased linearly with receptor and ligand densities. Eased on chemical equilibrium principles, it is shown that adhesion strength is directly proportional to the number of receptor-ligand bonds. This analysis provides for the definition of a new physical parameter, the adhesion constant psi, which is related to the bond strength and binding equilibrium constant and has units of force-length(2). This parameter can be measured by the experimental system presented and is governed by the activation state of integrin receptors, This simplified model isolates the integrin receptor-ligand binding parameters and provides a basis for analysis of the functions of signaling and cytoskeletal elements in the adhesion process.	Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Garcia, AJ (corresponding author), Univ Penn, Dept Microbiol, 211 Johnson Pavil,36th & Hamilton Walk, Philadelphia, PA 19104 USA.	garciaa@mail.med.upenn.edu	Huber, Francois/G-6245-2011		NCI NIH HHS [CA16502, CA49866] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA016502, R01CA049866] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; AKIYAMA SK, 1995, CELL ADHES COMMUN, V3, P13, DOI 10.3109/15419069509081275; ALBELDA SM, 1993, LAB INVEST, V68, P4; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Chen Wen-Tien, 1992, Current Opinion in Cell Biology, V4, P802; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; DANILOV YN, 1989, J CELL BIOL, V108, P1925, DOI 10.1083/jcb.108.5.1925; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; DIMILLA PA, 1992, J COLLOID INTERF SCI, V153, P212, DOI 10.1016/0021-9797(92)90313-B; DOROSZEWSKI J, 1977, EXP CELL RES, V104, P335, DOI 10.1016/0014-4827(77)90099-4; EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2; EVANS EA, 1985, BIOPHYS J, V48, P185, DOI 10.1016/S0006-3495(85)83771-1; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; Fowler H.W., 1980, MICROBIAL ADHESION S, P143; Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2; Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4; GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; HAMMER DA, 1987, BIOPHYS J, V52, P475, DOI 10.1016/S0006-3495(87)83236-8; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503; Hynes R.O., 1990, FIBRONECTINS, P113, DOI DOI 10.1007/978-1-4612-3264-3_6; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816; KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3; LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LAWRENCE MB, 1987, BLOOD, V70, P1284; LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; MCCLAY DR, 1981, P NATL ACAD SCI-BIOL, V78, P4975, DOI 10.1073/pnas.78.8.4975; MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; MOGHIMI SM, 1990, CRIT REV THER DRUG, V7, P187; MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99; SHARMA SK, 1980, J CHROMATOGR, V184, P471, DOI 10.1016/S0021-9673(00)93875-5; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; SUNG KLP, 1993, BLOOD, V81, P419; TOZEREN A, 1989, BIOPHYS J, V55, P479, DOI 10.1016/S0006-3495(89)82841-3; TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006; UNDERWOOD PA, 1993, J CELL SCI, V104, P793; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5; WARD MD, 1994, BIOPHYS J, V67, P2522, DOI 10.1016/S0006-3495(94)80742-8; WEISS LEONARD, 1961, EXPTL CELL RES SUPPL, V8, P141, DOI 10.1016/0014-4827(61)90345-7; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	59	123	127	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10988	10993		10.1074/jbc.273.18.10988	http://dx.doi.org/10.1074/jbc.273.18.10988			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556578	hybrid			2022-12-27	WOS:000073395200030
J	Hata, D; Kitaura, J; Hartman, SE; Kawakami, Y; Yokota, T; Kawakami, T				Hata, D; Kitaura, J; Hartman, SE; Kawakami, Y; Yokota, T; Kawakami, T			Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells - Dependence on the c-Jun N-terminal kinase activation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; X-LINKED AGAMMAGLOBULINEMIA; FACTOR-ALPHA GENE; AFFINITY IGE RECEPTOR; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; CROSS-LINKING; MAP KINASE; TRANSCRIPTIONAL ACTIVATION; ANTIGEN RECEPTOR	Cross-linking of the high affinity IgE receptor (Fc epsilon RI) on mast cells induces secretion of cytokines, including interleukin (IL)-2, through transcriptional activation of cytokine genes. Previously, defects in the gene coding for Bruton's tyrosine kinase (Btk) were shown to result in defective cytokine production in mast cells, and thereby mice carrying btk mutations exhibited diminished anaphylactic reactions in response to IgE and antigen. In this study, we provide evidence that the transcription factors involved in the IL-2 gene expression in T cells are also required for maximal activation of the IL-2 gene in Fc epsilon RI-stimulated mast cells. Among them, AP-1 (Jun/Fos) and NF-AT were identified as candidate transcription factors that are regulated by Btk. Consistent with our previous data indicating that Btk regulates stress-activated protein kinases, c-Jun N-terminal kinase (JNK), c-Jun and other JNK-regulatable transcription factors are activated by Fc epsilon RI cross-linking in a Btk-dependent manner. Further, Fc epsilon RI-induced IL-2 gene activation is dependent on c-Jun and a component, SEK1, of its upstream activation pathway. Collectively, these data demonstrate that Btk regulates the transcription of the IL-2 gene through the JNK-regulatable transcription factors in Fc epsilon RI-stimulated mast cells.	La Jolla Inst Allergy & Immunol, Div Allergy, San Diego, CA 92121 USA; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 108, Japan	La Jolla Institute for Immunology; University of Tokyo	Kawakami, T (corresponding author), La Jolla Inst Allergy & Immunol, Div Allergy, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	toshi_kawakami@liai.org	Kawakami, Toshiaki/O-1616-2015; Yokota, Takashi/J-8483-2015; Yokota, Takashi/F-6021-2011		NIAID NIH HHS [AI33617, AI38348] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038348, R01AI033617] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADLER V, 1992, P NATL ACAD SCI USA, V89, P5341, DOI 10.1073/pnas.89.12.5341; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEAVEN MA, 1993, IMMUNOL TODAY, V14, P222, DOI 10.1016/0167-5699(93)90167-J; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Chang EY, 1997, J IMMUNOL, V159, P2624; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EISEMAN E, 1992, NATURE, V355, P78; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; FRASER JD, 1993, IMMUNOL TODAY, V14, P357, DOI 10.1016/0167-5699(93)90236-E; FUJITA T, 1986, CELL, V46, P401, DOI 10.1016/0092-8674(86)90660-4; FUKAMACHI H, 1993, INT ARCH ALLERGY IMM, V102, P15, DOI 10.1159/000236546; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ishizuka T, 1996, J BIOL CHEM, V271, P12762, DOI 10.1074/jbc.271.22.12762; Janknecht R, 1997, J BIOL CHEM, V272, P4219, DOI 10.1074/jbc.272.7.4219; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; KAWAKAMI T, 1992, J IMMUNOL, V148, P3513; Kawakami Y, 1996, IMMUNOL LETT, V54, P113, DOI 10.1016/S0165-2478(96)02659-4; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; KIHARA H, 1994, J BIOL CHEM, V269, P22427; LEE HJ, 1993, J IMMUNOL, V151, P6135; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MORIGUCHI T, 1995, J BIOL CHEM, V270, P12969, DOI 10.1074/jbc.270.22.12969; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OFFERMANNS S, 1994, J IMMUNOL, V152, P250; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SETH A, 1992, J BIOL CHEM, V267, P24796; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tashiro M, 1997, J IMMUNOL, V158, P2382; Teramoto H, 1997, J BIOL CHEM, V272, P10751; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; TSAI M, 1993, EUR J IMMUNOL, V23, P3286, DOI 10.1002/eji.1830231234; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TSURUTA L, 1995, J IMMUNOL, V154, P5255; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VOJTEK AB, 1995, CELL, V82, P527, DOI 10.1016/0092-8674(95)90023-3; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; WILSON BS, 1995, J BIOL CHEM, V270, P4013, DOI 10.1074/jbc.270.8.4013; YAMADA N, 1993, BIOCHEM BIOPH RES CO, V192, P231, DOI 10.1006/bbrc.1993.1404; YAN MH, 1994, NATURE, V372, P798; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175	85	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10979	10987		10.1074/jbc.273.18.10979	http://dx.doi.org/10.1074/jbc.273.18.10979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556577	hybrid			2022-12-27	WOS:000073395200029
J	Qiu, HW; Belanger, A; Yoon, HWP; Bunn, HF				Qiu, HW; Belanger, A; Yoon, HWP; Bunn, HF			Homodimerization restores biological activity to an inactive erythropoietin mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIERYTHROPOIETIN MONOCLONAL-ANTIBODIES; HUMAN GROWTH-HORMONE; RECEPTOR DIMERIZATION; SCANNING MUTAGENESIS; PROTEIN HORMONE; EPO RECEPTOR; ACTIVATION; COMPLEX; OLIGOMERIZATION; MODEL	Erythropoietin (Epo) is believed to transduce a signal by bringing two Epo receptors into close proximity, enabling cross-phosphorylation. We compared monomeric Epos with homodimers in which two Epo monomers are linked by polyglycine. Monomeric Epo mutant R103A is unable to support Epo-dependent cell growth or trigger Janus kinase 2 and STATE activation, even at concentrations greater than 7,000 times that sufficient for wildtype Epo activity. In contrast, R103A homodimer induces proliferation and transduces signal at concentrations similar to that of wild-type Epo monomer and homodimer. These experiments show that two discrete domains on Epo are required for receptor binding and activation. Our results also suggest that the EpoR can be dimerized by different forms and sizes of molecules, as long as two recognition moths are provided in the same molecule. Design of other dimeric molecules may enhance our understanding of cytokine specificity and signal transduction.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bunn, HF (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol, LMRC-223,221 Longwood Ave, Boston, MA 02115 USA.				NHLBI NIH HHS [R01 HL 42949-09, HL09674-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009674] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BOISSEL JP, 1993, J BIOL CHEM, V268, P15983; CUNNINGHAM BC, 1989, SCIENCE, V243, P1330, DOI 10.1126/science.2466339; Damen JE, 1996, EXP HEMATOL, V24, P1455; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DONG YJ, 1993, EXP HEMATOL, V21, P483; Elliott S, 1997, BLOOD, V89, P493, DOI 10.1182/blood.V89.2.493; Elliott S, 1996, J BIOL CHEM, V271, P24691, DOI 10.1074/jbc.271.40.24691; Elliott S, 1996, BLOOD, V87, P2714, DOI 10.1182/blood.V87.7.2714.bloodjournal8772714; Elliott S, 1996, BLOOD, V87, P2702, DOI 10.1182/blood.V87.7.2702.bloodjournal8772702; GOLDBERG MA, 1987, P NATL ACAD SCI USA, V84, P7972, DOI 10.1073/pnas.84.22.7972; GRODBERG J, 1993, EUR J BIOCHEM, V218, P597, DOI 10.1111/j.1432-1033.1993.tb18413.x; Harding PA, 1996, J BIOL CHEM, V271, P6708, DOI 10.1074/jbc.271.12.6708; KOMATSU N, 1993, BLOOD, V82, P456; KRYSTAL G, 1983, EXP HEMATOL, V11, P649; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Lodish HF, 1995, COLD SPRING HARB SYM, V60, P93, DOI 10.1101/SQB.1995.060.01.012; LONGMORE GD, 1991, CELL, V67, P1089, DOI 10.1016/0092-8674(91)90286-8; Matthews DJ, 1996, P NATL ACAD SCI USA, V93, P9471, DOI 10.1073/pnas.93.18.9471; MAYEUX P, 1991, J BIOL CHEM, V266, P23380; MIURA O, 1993, ARCH BIOCHEM BIOPHYS, V306, P200, DOI 10.1006/abbi.1993.1501; MIURA O, 1993, BLOOD, V81, P1739; Schneider H, 1997, BLOOD, V89, P473, DOI 10.1182/blood.V89.2.473; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553; WELLS JA, 1994, CURR OPIN CELL BIOL, V6, P163, DOI 10.1016/0955-0674(94)90132-5; WEN DY, 1994, J BIOL CHEM, V269, P22839; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458	30	29	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11173	11176		10.1074/jbc.273.18.11173	http://dx.doi.org/10.1074/jbc.273.18.11173			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556605	hybrid			2022-12-27	WOS:000073395200057
J	Yet, SF; Folta, SC; Jain, MK; Hsieh, CM; Maemura, K; Layne, MD; Zhang, D; Marria, PB; Yoshizumi, M; Chin, MT; Perrella, MA; Lee, ME				Yet, SF; Folta, SC; Jain, MK; Hsieh, CM; Maemura, K; Layne, MD; Zhang, D; Marria, PB; Yoshizumi, M; Chin, MT; Perrella, MA; Lee, ME			Molecular cloning, characterization, and promoter analysis of the mouse Crp2/SmLim gene - Preferential expression of its promoter in the vascular smooth muscle cells of transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH PROTEIN; ENHANCER-BINDING-FACTOR; LIM-DOMAIN PROTEINS; ALPHA-ACTIN GENE; HEAVY-CHAIN GENE; DNA METHYLATION; ZINC-FINGER; TRANSCRIPTIONAL ACTIVATION; REGULATORY ELEMENTS; FUNCTIONAL PROMOTER	Several members of the LIM protein family have important roles in development and differentiation. We recently isolated a rat cDNA encoding a new member of this family, CRP2/SmLIM, that contains two LIM domains and is expressed preferentially in vascular smooth muscle cells (VSMC). To study the molecular mechanisms that regulate VSMC-specific transcription of the Crp2/SmLim gene, we cloned the cDNA and gene of mouse Crp2/SnLim. Mouse Crp2/SmLim is a single copy gene of six exons and five introns spanning approximately 20 kilobases of genomic DNA. By 5'-rapid amplification of cDNA ends and S1 nuclease protection assay, we determined that the transcription start site is an A residue 80 base pairs 5' of the translation initiation codon. A TATA-like sequence is located 27 base pairs 5' of the transcription start site, and there are potential cis-acting elements (GATA, Spl, AP-2, E box, CCAC box, and GArC motif) in the 5'-flanking sequence. In transient transfection assays in rat aortic smooth muscle cells in primary culture, 5 kilobases of the Crp2/SmLim 5'-flanking sequence generated a high level of luciferase reporter gene activity. By deletion analysis and gel mobility shift assay, we found that the region between bases -74 and -39 of this 5 kilobase DNA fragment binds Spl and confers basal promoter activity in the Crp2/SmLim gene. In vitro, the 5-kilobase fragment was active in multiple cell types. In vivo, however, the B-kilobase fragment directed high level expression of the lacZ reporter gene preferentially in the VSMC of transgenic mice, indicating the presence of VSMC-specific element(s) in this fragment.	Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, ME (corresponding author), Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, 677 Huntingdon Ave, Boston, MA 02115 USA.		Yet, Shaw-Fang/B-1067-2010; Yet, Shaw-Fang/O-8583-2019	Layne, Matthew/0000-0003-0007-4870; Yet, Shaw-Fang/0000-0001-9097-3962	NHLBI NIH HHS [HL03194] Funding Source: Medline; NIGMS NIH HHS [GM53249] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053249] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; BASSELDUBY R, 1993, CIRC RES, V73, P360, DOI 10.1161/01.RES.73.2.360; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Bhavsar PK, 1996, GENOMICS, V35, P11, DOI 10.1006/geno.1996.0317; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BUCHER P, 1986, NUCLEIC ACIDS RES, V14, P10009, DOI 10.1093/nar/14.24.10009; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CRAWFORD AW, 1994, J CELL BIOL, V124, P117, DOI 10.1083/jcb.124.1.117; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; Felsenfeld G, 1996, CELL, V86, P13, DOI 10.1016/S0092-8674(00)80073-2; FIRE A, 1992, GENET ANAL-BIOMOL E, V9, P151, DOI 10.1016/1050-3862(92)90042-4; FOSTER DN, 1992, J BIOL CHEM, V267, P11995; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; GOLDHAMER DJ, 1992, SCIENCE, V256, P538, DOI 10.1126/science.1315077; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Hogan B, 1994, MANIPULATING MOUSE E; Jain MK, 1996, J BIOL CHEM, V271, P10194, DOI 10.1074/jbc.271.17.10194; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KATOH Y, 1994, J BIOL CHEM, V269, P30538; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEE ME, 1990, J BIOL CHEM, V265, P10446; LEE ME, 1991, J BIOL CHEM, V266, P19034; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Liang YX, 1996, J BIOL CHEM, V271, P11792, DOI 10.1074/jbc.271.20.11792; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; MABLY JD, 1993, J BIOL CHEM, V268, P476; MIN BH, 1990, J BIOL CHEM, V265, P16667; MIZUNO K, 1994, ONCOGENE, V9, P1605; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NUNOUE K, 1995, ONCOGENE, V11, P701; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OWENS GK, 1995, PHYSIOL REV, V75, P487; Perrella MA, 1996, J BIOL CHEM, V271, P13776, DOI 10.1074/jbc.271.23.13776; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; Stronach BE, 1996, J CELL BIOL, V134, P1179, DOI 10.1083/jcb.134.5.1179; Struhl K, 1996, CELL, V84, P179, DOI 10.1016/S0092-8674(00)80970-8; VERDINE GL, 1994, CELL, V76, P197, DOI 10.1016/0092-8674(94)90326-3; WANG XK, 1992, GENOMICS, V14, P391, DOI 10.1016/S0888-7543(05)80231-9; WANG XK, 1992, J BIOL CHEM, V267, P9176; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WEISKIRCHEN R, 1995, J BIOL CHEM, V270, P28946, DOI 10.1074/jbc.270.48.28946; WEISKIRCHEN R, 1993, ONCOGENE, V8, P2317; White SL, 1996, J BIOL CHEM, V271, P15008, DOI 10.1074/jbc.271.25.15008; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266	59	37	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10530	10537		10.1074/jbc.273.17.10530	http://dx.doi.org/10.1074/jbc.273.17.10530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553112	hybrid			2022-12-27	WOS:000073224200061
J	Englaro, W; Bertolotto, C; Busca, R; Brunet, A; Pages, G; Ortonne, JP; Ballotti, R				Englaro, W; Bertolotto, C; Busca, R; Brunet, A; Pages, G; Ortonne, JP; Ballotti, R			Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HUMAN MELANOCYTES; MAP KINASE; STIMULATING HORMONE; NEURONAL DIFFERENTIATION; TYROSINASE ACTIVITY; GROWTH-FACTOR; PC12 CELLS; PHOSPHORYLATION; MELANOGENESIS; PROLIFERATION	In B16 melanoma cells, mitogen-activated protein (MAP) kinases are activated during cAMP-induced melanogenesis (Englaro, W., Rezzonico, R., Durand-Clement, M., Lallemand, D., Ortonne, J. P., and Ballotti, R. (1995) J. Biol. Chem. 270, 24315-24320). To establish the role of the MAP kinases in melanogenesis, we studied the effects of a specific MAP kinase kinase (MEK) inhibitor PD 98059 on different melanogenic parameters. We showed that PD 98059 inhibits the activation of MAP kinase extracellular signal-regulated kinase 1 by cAMP, but does not impair the effects of cAMP either on the morphological differentiation, characterized by an increase in dendrite outgrowth, or on the up-regulation of tyrosinase that is the key enzyme in melanogenesis. On the contrary, PD 98059 promotes by itself cell dendricity and increases the tyrosinase amount and activity. Moreover, down-regulation of the MAP kinase pathway by PD 98059, or with dominant negative mutants of p21(ras) and MEK, triggers a stimulation of the tyrosinase promoter activity and enhances the effect of cAMP on this parameter. Conversely, activation of the MAP kinase pathway, using constitutive active mutants of p21(ras) and MEK, leads to an inhibition of basal and cAMP-induced tyrosinase gene transcription. These results demonstrate that the MAP kinase pathway activation is not required for cAMP-induced melanogenesis. Furthermore, the inhibition of this pathway induces B16 melanoma cell differentiation, while a sustained activation impairs the melanogenic effect of cAMP-elevating agents.	Fac Med, INSERM, U385, F-06107 Nice 2, France; Fac Sci, CNRS, UMR 134, Ctr Biochim, F-06018 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Ballotti, R (corresponding author), Fac Med, INSERM, U385, Ave Valombrose, F-06107 Nice 2, France.	ballotti@unice.fr	BALLOTTI, Robert/F-8825-2013; Bertolotto-Ballotti, Corine/O-2155-2016; Pages, Gilles/N-7135-2017; Bertolotto, Corine/AAF-6634-2021	Bertolotto, Corine/0000-0001-6971-7753; BALLOTTI, Robert/0000-0002-7322-4908				ABDELMALEK Z, 1992, J CELL PHYSIOL, V150, P416, DOI 10.1002/jcp.1041500226; ABERDAM E, 1993, J CELL SCI, V106, P1015; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Busca R, 1996, J BIOL CHEM, V271, P31824, DOI 10.1074/jbc.271.50.31824; CALLUS B, 1995, EXP CELL RES, V219, P39, DOI 10.1006/excr.1995.1202; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ENGLARO W, 1995, J BIOL CHEM, V270, P24315, DOI 10.1074/jbc.270.41.24315; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Franklin DS, 1996, MOL BIOL CELL, V7, P1587, DOI 10.1091/mbc.7.10.1587; FRIEDMANN PS, 1987, J CELL PHYSIOL, V133, P88, DOI 10.1002/jcp.1041330111; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; HALABAN R, 1983, J CELL BIOL, V97, P480, DOI 10.1083/jcb.97.2.480; HILL SE, 1989, PIGM CELL RES, V2, P161, DOI 10.1111/j.1600-0749.1989.tb00181.x; HUNT G, 1994, J CELL SCI, V107, P205; Iwasaki S, 1996, J BIOL CHEM, V271, P17360, DOI 10.1074/jbc.271.29.17360; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; KRANENBURG O, 1995, J CELL BIOL, V131, P227, DOI 10.1083/jcb.131.1.227; LEVINE N, 1991, JAMA-J AM MED ASSOC, V266, P2730, DOI 10.1001/jama.266.19.2730; MEDRANO EE, 1995, CANCER RES, V55, P4047; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MOTHE I, 1993, MOL BIOL CELL, V4, P737, DOI 10.1091/mbc.4.7.737; OKEEFE E, 1974, P NATL ACAD SCI USA, V71, P2500, DOI 10.1073/pnas.71.6.2500; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; RomeroGraillet C, 1996, J BIOL CHEM, V271, P28052, DOI 10.1074/jbc.271.45.28052; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; SUZUKI H, 1994, BIOCHEM BIOPH RES CO, V205, P1984, DOI 10.1006/bbrc.1994.2903; TAKAHASHI H, 1992, J INVEST DERMATOL, V98, P481, DOI 10.1111/1523-1747.ep12499862; TSUKAMOTO K, 1992, PIGM CELL RES, P181; VAILLANCOURT RR, 1995, MOL CELL BIOL, V15, P3644; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; Xiong W, 1997, MOL CELL BIOL, V17, P6585, DOI 10.1128/MCB.17.11.6585	38	180	185	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9966	9970		10.1074/jbc.273.16.9966	http://dx.doi.org/10.1074/jbc.273.16.9966			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545341	hybrid			2022-12-27	WOS:000073128800087
J	Lucero, HA; Lebeche, D; Kaminer, B				Lucero, HA; Lebeche, D; Kaminer, B			ERcalcistorin/protein-disulfide isomerase acts as a calcium storage protein in the endoplasmic reticulum of a living cell - Comparison with calreticulin and calsequestrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN EGGS; SARCOPLASMIC-RETICULUM; INOSITOL TRISPHOSPHATE; RYANODINE RECEPTOR; TRANSPORT; RELEASE; IDENTIFICATION; EXPRESSION; INCREASES; OVEREXPRESSION	ERcalcistorin/protein-disulfide isomerase (ECaSt/ PDI), a high capacity low affinity Ca2+-binding protein in the endoplasmic reticulum of sea urchin eggs (Lebeche, D., and Kaminer, B. (1992) Biochem. J. 287, 741-747), shares 55% sequence identity with mammalian PDI and has PDI activity (Lucero, Iii, Lebeche, D., and Kaminer, B. (1994) J. Biol. Chem. 269, 23112-23119). We report on ECaSt/PDI functioning as a Ca2+ storage protein in the endoplasmic reticulum (ER) of a living cell and compare it with calsequestrin and calreticulin, high capacity low affinity Ca2+-binding proteins in the sarcoplasmic reticulum and ER, respectively. Stably transfected Chinese hamster ovary cell clones expressed these proteins, which were localized in the ER of the cell. Microsomes from cells expressing ECaSt/PDI, calreticulin, and calsequestrin accumulated 17.2 +/- 0.27, 20.0 +/- 0.82, and 38.0 +/- 0.28 nmol of Ca2+/mg of protein, respectively; control microsomes accumulated from 2.6 +/- 0.17 to 2.9 +/- 0.14 nmol of Ca2+/mg of protein. The initial rate of Ca2+ uptake was similar in microsomes from transfected and control cells. Microsomes containing an ECaSt/PDI mutant in which 45% of the acidic residue pairs in the C terminus were truncated had a reduced Ca2+ storage capacity. This supports our previous hypothesis that the degree of low affinity Ca2+ binding is dependent on the number of pairs of carboxyl groups in the molecule. The maximal Ca2+ accumulation by microsomes containing the expressed ECaSt/PDI, C-terminally truncated ECaSt/PDI, calreticulin, or calsequestrin correlates approximately with the Ca2+ binding capacity of the respective proteins.	Boston Univ, Sch Med, Dept Physiol L708, Boston, MA 02118 USA	Boston University	Kaminer, B (corresponding author), Boston Univ, Sch Med, Dept Physiol L708, 80 E Concord St, Boston, MA 02118 USA.							BAKSH S, 1991, J BIOL CHEM, V266, P21458; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; Fiske CH, 1925, J BIOL CHEM, V66, P375; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; GASKO OD, 1976, ANAL BIOCHEM, V72, P57, DOI 10.1016/0003-2697(76)90506-6; GOLDIN SM, 1989, METHODS ENZYMOL, V172, P34; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; HASELGROVE JC, 1985, ANAL BIOCHEM, V150, P449, DOI 10.1016/0003-2697(85)90534-2; HENSON JH, 1989, J CELL BIOL, V109, P149, DOI 10.1083/jcb.109.1.149; HEPLER PK, 1992, INT REV CYTOL, V138, P239, DOI 10.1016/S0074-7696(08)61590-9; IKEMOTO N, 1989, BIOCHEMISTRY-US, V28, P6764, DOI 10.1021/bi00442a033; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; JAFFE LF, 1983, DEV BIOL, V99, P256; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBECHE D, 1992, BIOCHEM J, V287, P741, DOI 10.1042/bj2870741; LEBECHE D, 1994, BIOCHEM BIOPH RES CO, V202, P556, DOI 10.1006/bbrc.1994.1964; LEVY S, 1992, J NEUROSCI, V12, P2120; LIU NG, 1994, J BIOL CHEM, V269, P28635; LUCERO HA, 1994, J BIOL CHEM, V269, P23112; LUCERO HA, 1995, J BIOL CHEM, V270, P11701; MACER DRJ, 1988, J CELL SCI, V91, P61; MacLennan D., 1983, CALCIUM CELL FUNCT, V4, P151; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MEISSNER G, 1975, BIOCHIM BIOPHYS ACTA, V389, P51, DOI 10.1016/0005-2736(75)90385-5; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NOIVA R, 1992, J BIOL CHEM, V267, P3553; OBERDORF JA, 1986, J CELL BIOL, V102, P2205, DOI 10.1083/jcb.102.6.2205; OBERDORF JA, 1988, J BIOL CHEM, V263, P6806; PARYS JB, 1994, DEV BIOL, V161, P466, DOI 10.1006/dbio.1994.1045; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Primm TP, 1996, J BIOL CHEM, V271, P33664, DOI 10.1074/jbc.271.52.33664; PUIG A, 1994, J BIOL CHEM, V269, P7764; RAICHMAN M, 1995, J CELL BIOL, V128, P341, DOI 10.1083/jcb.128.3.341; ROSSI B, 1979, J BIOL CHEM, V254, P2302; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILVER RB, 1983, J BIOL CHEM, V258, P3287; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; STEPHENS RE, 1992, J CELL SCI, V101, P837; Stephens RE, 1997, MOL BIOL CELL, V8, P2187, DOI 10.1091/mbc.8.11.2187; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Wharton DC., 1967, METHOD ENZYMOL, P245; WHITAKER M, 1993, DEVELOPMENT, V117, P1; XIE WQ, 1991, BIOTECHNIQUES, V11, P324	57	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9857	9863		10.1074/jbc.273.16.9857	http://dx.doi.org/10.1074/jbc.273.16.9857			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545326	hybrid			2022-12-27	WOS:000073128800072
J	Chen, YY; Garrison, S; Weis, JJ; Weis, JH				Chen, YY; Garrison, S; Weis, JJ; Weis, JH			Identification of pactolus, an integrin beta subunit-like cell-surface protein preferentially expressed by cells of the bone marrow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-KIT LIGAND; POLYMERASE CHAIN-REACTION; AMINO-ACID-SEQUENCE; MOUSE MAST-CELLS; CR3 CD11B/CD18; A-DOMAIN; TRANSCRIPTIONAL CONTROL; DIFFERENTIAL DISPLAY; CYTOPLASMIC DOMAIN; MESSENGER-RNAS	We have sought to develop methodologies to identify genes that are preferentially expressed during the differentiation of mast cells from their hematopoietic stem cell precursors, By using a modified differential display protocol, we compared a subset of transcripts expressed in bone marrow cells differentiated into immature mast cells with the exogenous addition of stem cell factor (SCF) or interleukin 3, One gene was identified that was preferentially expressed in the SCF-derived cells and encodes a novel murine integrin beta subunit-like molecule, dubbed Pactolus-1 (Pactolus). Two distinct forms of Pactolus mRNA were detected which, via alternative splicing, are predicted to encode a membrane-bound form and truncated version of the protein, The full-length Pactolus gene product is very similar to a number of beta subunit integrin chains, particularly beta 2, with the notable exceptions of the apparent deletion of the metal-binding site within the putative metal ion-dependent adhesion site-like domain of the Pactolus gene product and a cytoplasmic domain that shares no obvious homology to similar domains of the other beta subunit integrin proteins, Although the Pactolus sequence was first identified in immature mast cell samples, screening of murine tissues indicated the highest level of Pactolus expression was found in the bone marrow, suggesting that the expression of Pactolus is confined to immature and maturing bone marrow-derived cells, and that the SCF-derived mast cells are more representative of this state than are the interleukin 3-derived mast cells, Immunoprecipitation of Pactolus revealed a cell-surface protein with an apparent molecular mass of about 95 kDa, Surprisingly, no associating a integrin subunit could be identified suggesting that either Pactolus does not associate with another integrin subunit or the association is too weak to be identified. These data suggest that Pactolus represents a gene and gene product related to those of the integrin beta subunits but whose function(s) may be quite distinct from those of the integrin beta subunits.	Univ Utah, Sch Med, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Weis, JH (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Cell Biol & Immunol, 50 N Med Dr, Salt Lake City, UT 84132 USA.				NIAID NIH HHS [AI-24158] Funding Source: Medline; NIAMS NIH HHS [AR43521] Funding Source: Medline; NIDDK NIH HHS [DK49219] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049219] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; ATRUDA F, 1990, GENE AMST, V95, P261; BAJT ML, 1994, J BIOL CHEM, V269, P20913; BAUER D, 1993, NUCLEIC ACIDS RES, V21, P4272, DOI 10.1093/nar/21.18.4272; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Clevers HC, 1996, IMMUNOL TODAY, V17, P336, DOI 10.1016/0167-5699(96)10019-0; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; DUCHARME LA, 1992, EUR J IMMUNOL, V22, P2603, DOI 10.1002/eji.1830221020; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; GURISH MF, 1992, J IMMUNOL, V149, P1964; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; HOGERVORST F, 1990, EMBO J, V9, P765, DOI 10.1002/j.1460-2075.1990.tb08171.x; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; LANGUINO LR, 1992, J BIOL CHEM, V267, P7116; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269; Marietta EV, 1996, EUR J IMMUNOL, V26, P49, DOI 10.1002/eji.1830260108; MEKORI YA, 1993, J IMMUNOL, V151, P3775; MERIDITH J, 1995, SCIENCE, V269, P1570; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOYLE M, 1991, J BIOL CHEM, V266, P19650; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; RAMASWAMY H, 1990, EMBO J, V9, P1561, DOI 10.1002/j.1460-2075.1990.tb08275.x; RIEU P, 1994, J CELL BIOL, V127, P2081, DOI 10.1083/jcb.127.6.2081; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; SHEPPARD D, 1990, J BIOL CHEM, V265, P11502; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; SWAROOP A, 1991, NUCLEIC ACIDS RES, V19, P1954, DOI 10.1093/nar/19.8.1954; Tan S S, 1992, PCR Methods Appl, V2, P137; TSAI M, 1991, P NATL ACAD SCI USA, V88, P6382, DOI 10.1073/pnas.88.14.6382; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; WARDLAW AJ, 1990, J EXP MED, V172, P335, DOI 10.1084/jem.172.1.335; WEIS JH, 1992, TRENDS GENET, V8, P263, DOI 10.1016/0168-9525(92)90242-V; WILSON RW, 1989, NUCLEIC ACIDS RES, V17, P5397, DOI 10.1093/nar/17.13.5397; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; ZHIDKOVA NI, 1995, BIOCHEM BIOPH RES CO, V214, P279, DOI 10.1006/bbrc.1995.2285	40	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8711	8718		10.1074/jbc.273.15.8711	http://dx.doi.org/10.1074/jbc.273.15.8711			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535848	hybrid			2022-12-27	WOS:000072990800025
J	Clairmont, FR; Milne, RE; Pham, VT; Carriere, MB; Kaplan, H				Clairmont, FR; Milne, RE; Pham, VT; Carriere, MB; Kaplan, H			Role of DNA in the activation of the Cry1A insecticidal crystal protein from Bacillus thuringiensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; DELTA-ENDOTOXIN; MOLECULAR-STRUCTURE; MANDUCA-SEXTA; BOMBYX-MORI; SPECIFICITY; PROTOXIN; KURSTAKI; MIDGUT; TOXINS	The Cry1A insecticidal crystal protein (protoxin) from six subspecies of Bacillus thuringiensis as well as the Cry1Aa, Cry1Ab, and Cry1Ac proteins cloned in Escherichia coli was found to contain 20-kilobase pair DNA, Only the N-terminal toxic moiety of the protoxin was found to interact with the DNA. Analysis of the crystal gave approximately 3 base pairs of DNA per molecule of protoxin, indicating that only a small region of the N-terminal toxic moiety interacts with the DNA, It is proposed that the DNA-protoxin complex is virus-like in structure with a central DNA core surrounded by protein interacting with the DNA with the peripheral ends of the C-terminal region extending outward, It is shown that this structure accounts for the unusual proteolysis observed in the generation of toxin in which it appears that peptides are removed by obligatory sequential cleavages starting from the C terminus of the protoxin. Activation of the protoxin by spruce budworm (Choristoneura fumiferana) gut juice is shown to proceed through intermediates consisting of protein-DNA complexes, Larval trypsin initially converts the 20-kilobase pair DNA-protoxin complex to a 20-kilobase pair DNA-toxin complex, which is subsequently converted to a 100-base pair DNA-toxin complex by a gut nuclease and ultimately to the DNA-free toxin.	Univ Ottawa, Dept Chem, Ottawa, ON K1N 6N5, Canada; Canadian Forest Serv, Sault Ste Marie, ON P6A 5M7, Canada	University of Ottawa; Natural Resources Canada; Canadian Forest Service	Kaplan, H (corresponding author), Univ Ottawa, Dept Chem, Ottawa, ON K1N 6N5, Canada.			Carriere, Marjolaine/0000-0002-7963-5943				ADANG MJ, 1985, GENE, V36, P289, DOI 10.1016/0378-1119(85)90184-2; BIETLOT H, 1989, BIOCHEM J, V260, P87, DOI 10.1042/bj2600087; BIETLOT HP, 1993, J BIOL CHEM, V268, P8240; BIETLOT HP, 1993, THESIS U OTTAWA; BROUSSEAU R, 1988, BIOTECHNOL ADV, V6, P697, DOI 10.1016/0734-9750(88)91920-9; CAREY PR, 1986, BIOCHIM BIOPHYS ACTA, V872, P169, DOI 10.1016/0167-4838(86)90268-2; CHESTUKHINA GG, 1982, ARCH MICROBIOL, V132, P159, DOI 10.1007/BF00508723; CHOMA CT, 1990, EUR J BIOCHEM, V189, P523, DOI 10.1111/j.1432-1033.1990.tb15518.x; CHOMA CT, 1991, BIOCHEM BIOPH RES CO, V179, P933, DOI 10.1016/0006-291X(91)91908-U; Fast PG, 1981, MICROBIAL CONTROL PE, p[223, 949]; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; HOFTE H, 1989, MICROBIOL REV, V53, P242; HOLMES KC, 1965, J MOL BIOL, V14, P572, DOI 10.1016/S0022-2836(65)80205-4; JAQUET F, 1987, APPL ENVIRON MICROB, V53, P500, DOI 10.1128/AEM.53.3.500-504.1987; Kates M., 1986, TECHNIQUES LIPIDOLOG, P114; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; LIEBIG B, 1995, J INSECT PHYSIOL, V41, P17, DOI 10.1016/0022-1910(94)00093-V; MASSON L, 1990, BIOCHEM J, V269, P507, DOI 10.1042/bj2690507; MASSON L, 1995, J BIOL CHEM, V270, P20309, DOI 10.1074/jbc.270.35.20309; MILNE R, 1993, INSECT BIOCHEM MOLEC, V23, P663, DOI 10.1016/0965-1748(93)90040-Y; MONRO HN, 1966, METHOD BIOCHEM ANAL, P113; NAGAMATSU Y, 1984, AGR BIOL CHEM TOKYO, V48, P611, DOI 10.1080/00021369.1984.10866193; NICKERSON KW, 1980, BIOTECHNOL BIOENG, V22, P1305, DOI 10.1002/bit.260220704; STUBBS G, 1989, TOP MOL STRUCT BIOL, V10, P87; TOJO A, 1983, APPL ENVIRON MICROB, V45, P576, DOI 10.1128/AEM.45.2.576-580.1983; Volkin D.B., 1989, PROTEIN FUNCTION PRA, P1; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3	27	21	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9292	9296		10.1074/jbc.273.15.9292	http://dx.doi.org/10.1074/jbc.273.15.9292			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535923	hybrid			2022-12-27	WOS:000072990800100
J	Vannier, B; Zhu, X; Brown, D; Birnbaumer, L				Vannier, B; Zhu, X; Brown, D; Birnbaumer, L			The membrane topology of human transient receptor potential 3 as inferred from glycosylation-scanning mutagenesis and epitope immunocytochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA TRP; G-PROTEIN; CHANNEL; PHOTOTRANSDUCTION; SUBUNIT; CELLS; ENTRY; GENE	Transient receptor potential (Trp) proteins form ion channels implicated in the calcium entry observed after stimulation of the phospholipase C pathway, Kyte-Doolittle analysis of the amino acid sequence of Trp proteins identifies seven hydrophobic regions (H1-H7) with potential of forming transmembrane segments, A limited sequence similarity to voltage-gated calcium channel alpha 1 subunits lead to the prediction of six transmembrane (TM) segments flanked by intracellular N and C termini and a putative pore region between TM5 and TM6, However, experimental evidence supporting this model is missing, Using human Trp 3 to test Trp topology, we now confirm the intracellular nature of the termini by immunocytochemistry, We also demonstrate presence of a unique glycosylation site in position 418, which defines one extracellular loop between H2 and H3, After removal of this site and insertion of ten separate glycosylation sites, we defined two additional extracellular loops between H4 and H5, and H6 and H7, This demonstrated the existence of six transmembrane segments formed of H2-H7, Thus, the first hydrophobic region of Trp rather than being a transmembrane segment is intracellular and available for protein-protein interactions, A site placed in the center of the putative pore region was glycosylated, suggesting that this region may have been luminal and was reinserted into the membrane at a late stage of channel assembly.	Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Vannier, B (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90024 USA.			Vannier, Brigitte/0000-0002-6870-507X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054235] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-45198] Funding Source: Medline; NIGMS NIH HHS [GM-54235] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHANG XB, 1994, J BIOL CHEM, V269, P18572; HARTENECK C, 1995, FEBS LETT, V358, P297, DOI 10.1016/0014-5793(94)01455-A; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PUTNEY JW, 1988, J EXP BIOL, V139, P135; PUTNEY JW, 1994, TRENDS ENDOCRIN MET, V5, P256, DOI 10.1016/1043-2760(94)P3085-L; Sambrook J., 2002, MOL CLONING LAB MANU; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; Schwalbe RA, 1996, J BIOL CHEM, V271, P24201, DOI 10.1074/jbc.271.39.24201; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Vannier B, 1996, BIOCHEMISTRY-US, V35, P1358, DOI 10.1021/bi952290f; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Zhu X, 1996, P NATL ACAD SCI USA, V93, P2827, DOI 10.1073/pnas.93.7.2827; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	19	110	121	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8675	8679		10.1074/jbc.273.15.8675	http://dx.doi.org/10.1074/jbc.273.15.8675			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535843	hybrid			2022-12-27	WOS:000072990800020
J	Yu, J; Le Brun, NE				Yu, J; Le Brun, NE			Studies of the cytochrome subunits of menaquinone : cytochrome c reductase (bc complex) of Bacillus subtilis - Evidence for the covalent attachment of heme to the cytochrome b subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOPSEUDOMONAS-SPHAEROIDES R-26; SITE-DIRECTED MUTAGENESIS; RHODOBACTER-SPHAEROIDES; PROTEIN; MUTANTS; DNA; EXPRESSION; EVOLUTION; BACTERIA; SEQUENCE	The menaquinone:cytochrome c reductase, or be complex, of Bacillus subtilis belongs to a third class of bc-type complex, distinct from the bc(1) and b(6)f classes. Using a mutagenesis approach, we demonstrate that the cytochrome b (QcrB) and c (QcrC) subunits of the complex give rise to bands at 22 and 29 kDa, respectively, after denaturing electrophoresis; that both subunits are required for proper complex assembly and/or stability; and that both subunits retain one heme molecule under denaturing conditions. This unusual property of a b-type cytochrome was investigated further. We present evidence for the existence of a covalent linkage between the polypeptide and heme b(H) and of an important role for Cys(43) in binding of heme b(H). It is proposed that heme is also covalently attached to the cytochrome b subunit of b(6)f complexes of chloroplasts and cyanobacteria.	Lund Univ, Dept Microbiol, S-22362 Lund, Sweden; Temple Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19140 USA	Lund University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Le Brun, NE (corresponding author), Lund Univ, Dept Microbiol, Solvegatan 12, S-22362 Lund, Sweden.			Le Brun, Nick/0000-0001-9780-4061	NIGMS NIH HHS [GM43577] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043577] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Arciero DM, 1997, FEBS LETT, V410, P457, DOI 10.1016/S0014-5793(97)00635-2; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; CLAROS MG, 1995, EUR J BIOCHEM, V228, P762, DOI 10.1111/j.1432-1033.1995.0762m.x; COPPEE JY, 1994, FEBS LETT, V339, P1, DOI 10.1016/0014-5793(94)80373-0; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; FERRARI E, 1988, J BACTERIOL, V170, P289, DOI 10.1128/JB.170.1.289-295.1988; FORTNAGEL P, 1968, J BACTERIOL, V95, P1431, DOI 10.1128/JB.95.4.1431-1438.1968; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; HACKER B, 1994, BIOCHEMISTRY-US, V33, P13022, DOI 10.1021/bi00248a011; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HAUSKA G, 1986, METHOD ENZYMOL, V126, P271; HENNER DJ, 1990, METHOD ENZYMOL, V185, P223; HICKS DB, 1995, BBA-BIOENERGETICS, V1229, P303, DOI 10.1016/0005-2728(95)00024-D; HOCH JA, 1991, METHOD ENZYMOL, V204, P305; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; ITAYA M, 1989, NUCLEIC ACIDS RES, V17, P4410, DOI 10.1093/nar/17.11.4410; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; KRUIP J, 1994, BBA-BIOENERGETICS, V1188, P443, DOI 10.1016/0005-2728(94)90068-X; KUTOH E, 1988, J BIOL CHEM, V263, P9020; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; MUKAI K, 1989, EUR J BIOCHEM, V178, P649, DOI 10.1111/j.1432-1033.1989.tb14494.x; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; Perego Marta, 1993, P615; PRINCE RC, 1995, TRENDS BIOCHEM SCI, V20, P217, DOI 10.1016/S0968-0004(00)89018-0; Rieske JS, 1967, METHOD ENZYMOL, V10, P488, DOI DOI 10.1016/0076-6879(67)10081-5; SALERNO JC, 1986, BIOCHEM BIOPH RES CO, V136, P616, DOI 10.1016/0006-291X(86)90485-7; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schiott T, 1997, J BACTERIOL, V179, P1962, DOI 10.1128/jb.179.6.1962-1973.1997; Sone N, 1996, J BIOL CHEM, V271, P12457, DOI 10.1074/jbc.271.21.12457; STRAGIER P, 1988, CELL, V52, P679; TAKABE T, 1986, IRON SULFUR PROTEIN, P270; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; VONWACHENFELDT C, 1992, FEMS MICROBIOL LETT, V100, P91, DOI 10.1016/0378-1097(92)90194-S; VONWACHENFELDT C, 1990, J BIOL CHEM, V265, P13939; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; YU J, 1995, J BACTERIOL, V177, P6751, DOI 10.1128/jb.177.23.6751-6760.1995; YU L, 1984, BIOCHEM BIOPH RES CO, V123, P1234, DOI 10.1016/S0006-291X(84)80265-X; YU L, 1984, J BIOL CHEM, V259, P5752; YUN CH, 1991, BIOCHEMISTRY-US, V30, P6747, DOI 10.1021/bi00241a017; YUN CH, 1990, EUR J BIOCHEM, V194, P399, DOI 10.1111/j.1432-1033.1990.tb15633.x; Zito F, 1997, PLANT MOL BIOL, V33, P79, DOI 10.1023/A:1005734809834	45	60	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8860	8866		10.1074/jbc.273.15.8860	http://dx.doi.org/10.1074/jbc.273.15.8860			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535866	hybrid			2022-12-27	WOS:000072990800043
J	Cowan, PJ; Tsang, D; Pedic, CM; Abbott, LR; Shinkel, TA; d'Apice, AJF; Pearse, MJ				Cowan, PJ; Tsang, D; Pedic, CM; Abbott, LR; Shinkel, TA; d'Apice, AJF; Pearse, MJ			The human ICAM-2 promoter is endothelial cell-specific in vitro and in vivo and contains critical Sp1 and GATA binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILLEBRAND-FACTOR GENE; INTERCELLULAR-ADHESION MOLECULE-2; GROWTH-FACTOR; TRANSGENIC MICE; FUNCTIONAL-ANALYSIS; EXPRESSION; TRANSCRIPTION; RECEPTOR; IDENTIFICATION; CLONING	The expression of intercellular adhesion molecule 2 (ICAM-2) in adult tissues is restricted to vascular endothelial cells and megakaryocytes. We have previously shown that the endothelial-specific in vivo activity of the human ICAM-2 promoter is contained within a small (0.33-kilobase (kbp)) 5'-flanking region of the gene. Here we describe the in vitro characterization of this region. The ICAM-2 promoter is TATA-less, and transcription in endothelial cells initiates at four sites. Reporter gene expression directed by the promoter was 125-fold greater than vector alone in bovine aortic endothelial cells but less than a-fold vector alone in non-endothelial (COS) cells, confirming that specificity in vivo was paralleled in vitro. The addition of 2.7 kbp of 5'-flanking region to the 0.33-kbp fragment had no effect on promoter activity or specificity. The mutation of an Spl motif centered at base pair -194 or an eight-base pair palindrome at -268 each reduced promoter activity by 70%. Mutation of GATA motifs at -145 and -53 reduced promoter activity by 78 and 61%, respectively. Specific binding of bovine aortic endothelial cells nuclear proteins to the Spl and GATA sites was demonstrated by gel shift analysis. Promoter activity in COS cells was transactivated 3-4-fold by overexpression of GATA-8. The results presented here suggest that transcription from the ICAM-2 promoter in endothelial cells is regulated by the interplay of several positive-acting factors and provide the basis for further analysis of endothelial-specific gene expression.	St Vincents Hosp, Immunol Res Ctr, Fitzroy, Vic 3065, Australia	St Vincent's Hospital Melbourne	Pearse, MJ (corresponding author), St Vincents Hosp, Immunol Res Ctr, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	pearsemj@svkm.org.au	Cowan, Peter/AAH-7218-2020; Cowan, Peter J/B-8730-2013	Cowan, Peter J/0000-0001-9016-4954				AGURA ED, 1992, BLOOD, V79, P602; AIRD WC, 1995, P NATL ACAD SCI USA, V92, P4567, DOI 10.1073/pnas.92.10.4567; Bach FH, 1997, NAT MED, V3, P944, DOI 10.1038/nm0997-944; BAUERLE PA, 1994, ADV IMMUNOL, V65, P111; BOOYSE FM, 1975, THROMB DIATH HAEMOST, V34, P825, DOI 10.1055/s-0038-1654001; Carpenito C, 1997, SCAND J IMMUNOL, V45, P248, DOI 10.1046/j.1365-3083.1997.d01-391.x; Cowan PJ, 1996, TRANSPLANTATION, V62, P155, DOI 10.1097/00007890-199607270-00002; COWAN PJ, IN PRESS TRANSPLANTA; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DIACOVO TG, 1994, J CLIN INVEST, V94, P1243, DOI 10.1172/JCI117442; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gumina RJ, 1997, BLOOD, V89, P1260, DOI 10.1182/blood.V89.4.1260; HARATS D, 1995, J CLIN INVEST, V95, P1335, DOI 10.1172/JCI117784; HONG X, 1992, J IMMUNOL, V149, P2650; Jahroudi N, 1996, BLOOD, V88, P3801, DOI 10.1182/blood.V88.10.3801.bloodjournal88103801; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; KAWANA M, 1995, MOL CELL BIOL, V15, P4225; KHACHIGIAN LM, 1994, J BIOL CHEM, V269, P22647; KORHONEN J, 1995, BLOOD, V86, P1828, DOI 10.1182/blood.V86.5.1828.bloodjournal8651828; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEMARCHANDEL V, 1993, MOL CELL BIOL, V13, P668, DOI 10.1128/MCB.13.1.668; Ludlow LB, 1996, J BIOL CHEM, V271, P22076, DOI 10.1074/jbc.271.36.22076; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; ORKIN SH, 1992, BLOOD, V80, P575; PAN JL, 1993, J BIOL CHEM, V268, P22600; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Patterson C, 1997, J BIOL CHEM, V272, P8410, DOI 10.1074/jbc.272.13.8410; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RISAU W, 1995, FASEB J, V9, P926, DOI 10.1096/fasebj.9.10.7615161; Ronicke V, 1996, CIRC RES, V79, P277, DOI 10.1161/01.RES.79.2.277; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Swanson HI, 1996, J BIOL CHEM, V271, P31657, DOI 10.1074/jbc.271.49.31657; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823; WeilerGuettler H, 1996, CIRC RES, V78, P180, DOI 10.1161/01.RES.78.2.180; Wingender E, 1997, NUCLEIC ACIDS RES, V25, P265, DOI 10.1093/nar/25.1.265; YAMAMOTO M, 1990, GENE DEV, V2, P1089; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320	46	61	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11737	11744		10.1074/jbc.273.19.11737	http://dx.doi.org/10.1074/jbc.273.19.11737			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565596	hybrid			2022-12-27	WOS:000073536700050
J	Katoh, T; Konishi, K; Yazawa, M				Katoh, T; Konishi, K; Yazawa, M			Skeletal muscle myosin monomer in equilibrium with filaments forms a folded conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHORYLATION; CHICKEN GIZZARD MUSCLE; SMOOTH-MUSCLE; MOLECULES; ANTIBODIES	Rabbit skeletal myosin forms stable filaments under physiological conditions, and only a small amount stays as a monomer in equilibrium with filaments. The myosin monomers were observed in two conformational states, as extended and folded forms upon electron microscopy and gel filtration high performance liquid chromatography, The fraction of monomers in the folded conformation increased with a decrease in the concentration of NaCl below 0.2 M, and the conformational state was affected neither by the presence of ATP nor by the phosphorylation of regulatory light chain. In most of the folded monomers, the tail bent back toward the heads at one region, 45 nm apart from the head-tail junction, and the remaining tail portion containing the C-terminal tip appeared to interact with the head-hail junction., Only a small percentage of the folded monomers was in a more compact conformation close to the 10 S conformation of vertebrate smooth muscle and non-muscle myosins, The folded monomers, however, may not trap the products of ATP hydrolysis as assessed by single turnover experiments. The percentage of monomers in the 10 S-like conformation was increased by the exchange of a regulatory light chain with the smooth muscle light chain, indicating the participation of head-tail junction, including the regulatory light chain in the formation of folded conformation. The folded conformation may be common to various myosin IIs, suggestive of common roles for the folded monomers.	Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 060, Japan	Hokkaido University	Katoh, T (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 060, Japan.							ANKRETT RJ, 1991, J MOL BIOL, V217, P323, DOI 10.1016/0022-2836(91)90546-I; CASTELLANI L, 1987, P NATL ACAD SCI USA, V84, P4058, DOI 10.1073/pnas.84.12.4058; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; CROSS RA, 1988, J MOL BIOL, V203, P173, DOI 10.1016/0022-2836(88)90100-3; CROSS RA, 1986, EMBO J, V5, P2637, DOI 10.1002/j.1460-2075.1986.tb04545.x; HASEGAWA Y, 1990, J BIOCHEM-TOKYO, V108, P909, DOI 10.1093/oxfordjournals.jbchem.a123313; HASEGAWA Y, 1988, J BIOCHEM-TOKYO, V103, P15, DOI 10.1093/oxfordjournals.jbchem.a122222; HOROWITZ A, 1994, J CELL BIOL, V126, P1195, DOI 10.1083/jcb.126.5.1195; Katoh T, 1996, J BIOL CHEM, V271, P9992, DOI 10.1074/jbc.271.17.9992; KATOH T, 1989, J CELL BIOL, V109, P1549, DOI 10.1083/jcb.109.4.1549; KATOH T, 1993, J BIOL CHEM, V268, P2380; KATOH T, 1995, J BIOCHEM-TOKYO, V119, P428; NAGAMOTO H, 1984, J BIOCHEM, V95, P1119, DOI 10.1093/oxfordjournals.jbchem.a134700; Olney JJ, 1996, J BIOL CHEM, V271, P20375, DOI 10.1074/jbc.271.34.20375; ONISHI H, 1983, J BIOCHEM-TOKYO, V94, P1147, DOI 10.1093/oxfordjournals.jbchem.a134459; ONISHI H, 1982, J BIOCHEM-TOKYO, V92, P871, DOI 10.1093/oxfordjournals.jbchem.a134001; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; PERRY SV, 1955, METHOD ENZYMOL, V2, P582, DOI 10.1016/S0076-6879(55)02258-1; SUZUKI H, 1978, J BIOCHEM, V84, P1529, DOI 10.1093/oxfordjournals.jbchem.a132278; TAKAHASHI M, 1989, J BIOCHEM-TOKYO, V105, P149, DOI 10.1093/oxfordjournals.jbchem.a122628; TRYBUS KM, 1988, J BIOL CHEM, V263, P16485; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; TRYBUS KM, 1984, J BIOL CHEM, V259, P8564; WALKER M, 1985, J MOL BIOL, V184, P535, DOI 10.1016/0022-2836(85)90300-6	24	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11436	11439		10.1074/jbc.273.19.11436	http://dx.doi.org/10.1074/jbc.273.19.11436			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565554	hybrid			2022-12-27	WOS:000073536700008
J	Phelps, RG; Jones, VL; Coughlan, M; Turner, AN; Rees, AJ				Phelps, RG; Jones, VL; Coughlan, M; Turner, AN; Rees, AJ			Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ACETYLCHOLINE-RECEPTOR; MYASTHENIA-GRAVIS; INTACT PROTEINS; IV COLLAGEN; MHC; MOLECULES; ANTIGEN; SPECIFICITY; CHAIN; DETERMINANTS	Class II molecules are believed to influence immune responses by selectively binding antigen-derived peptides for recognition by T cells. In Goodpasture's (antiglomerular basement membrane) disease, autoimmunity to the NC1 domain of the alpha 3-chain of type IV collagen (alpha 3(IV)NC1) is strongly associated with HLA-DR15. We have examined the influence of the peptide binding preferences of DR15 molecules on the selection of alpha 3(TV)NC1-derived peptides displayed bound to DR15 molecules on the surface of alpha 3(TV)NC1-pulsed DR15-homozygous Epstein-Barr virus-transformed human B cells. The preferences of DR15 molecules were investigated using a panel of 24 overlapping peptides spanning the sequence of alpha 3(IV)NC1. The alpha 3(TV)NC1-derived peptides selected for display to T cells were determined by biochemical analysis as reported previously (Phelps, R., G.,, Turner, A. N.,, and Rees, A. J., (1996) J., Biol. Chem. 271, 18549-18553). Three nested sets of naturally presented alpha 3(TV)NC1 peptides were detectable bound to DR15 molecules. Peptides representative of each nested set bound to DR15 molecules, but almost two-thirds of the alpha 3(TV)NC1 peptides studied had as good or better DR15 affinity than those identified as naturally processed. Thus alpha 3(IV)NC1 presentation to T cells is determined more by "processing factors" than by the preferences of relatively indiscriminate DR15 molecules. The results have important implications for the use of class II peptide binding data to aid identification of potential T cell epitopes, especially for antigens which, like alpha 3(IV)NC1, contain many sequences able to bind class II molecules.	Univ Aberdeen, Inst Med Sci, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Phelps, RG (corresponding author), Univ Aberdeen, Inst Med Sci, Dept Med & Therapeut, Foresterhill, Aberdeen AB25 2ZD, Scotland.			Turner, Neil/0000-0003-4547-873X				BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CIBOTTI R, 1992, P NATL ACAD SCI USA, V89, P416, DOI 10.1073/pnas.89.1.416; DAVENPORT MP, 1995, P NATL ACAD SCI USA, V92, P6567, DOI 10.1073/pnas.92.14.6567; DONERMEYER DL, 1989, J IMMUNOL, V142, P1063; Fisher M, 1997, KIDNEY INT, V51, P222, DOI 10.1038/ki.1997.27; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GLIMCHER LH, 1983, J IMMUNOL, V131, P2868; Hammer J, 1997, ADV IMMUNOL, V66, P67, DOI 10.1016/S0065-2776(08)60596-9; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; Harding CV, 1996, CRIT REV IMMUNOL, V16, P13, DOI 10.1615/CritRevImmunol.v16.i1.20; Jensen P E, 1995, Semin Immunol, V7, P347, DOI 10.1006/smim.1995.0039; JENSEN PE, 1993, J IMMUNOL, V150, P3347; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; MANFREDI AA, 1994, J IMMUNOL, V152, P4165; Marshall K W, 1995, Biomed Pept Proteins Nucleic Acids, V1, P157; MARSHALL KW, 1995, J IMMUNOL, V154, P5927; Moudgil K D, 1993, Int Rev Immunol, V10, P365, DOI 10.3109/08830189309061711; MOURITSEN S, 1991, SCAND J IMMUNOL, V34, P421, DOI 10.1111/j.1365-3083.1991.tb01565.x; MOURITSEN S, 1992, J IMMUNOL, V149, P1987; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; OSULLIVAN D, 1990, J IMMUNOL, V145, P1799; Phelps R. G., 1996, Immunology, V89, P79; Phelps RG, 1996, J BIOL CHEM, V271, P18549, DOI 10.1074/jbc.271.31.18549; Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; RAONAIK C, 1995, PROTEINS, V22, P168, DOI 10.1002/prot.340220209; ROUAS N, 1993, J IMMUNOL, V150, P782; SAUS J, 1988, J BIOL CHEM, V263, P13374; SCHAEFFER EB, 1989, P NATL ACAD SCI USA, V86, P4649, DOI 10.1073/pnas.86.12.4649; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SETTE A, 1992, J IMMUNOL, V148, P844; SETTE A, 1989, J IMMUNOL, V143, P1265; SETTE A, 1993, INT IMMUNOL, V5, P631, DOI 10.1093/intimm/5.6.631; SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; TOMPKINS SM, 1993, J IMMUNOL METHODS, V163, P209; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; VALLI A, 1993, J CLIN INVEST, V91, P616, DOI 10.1172/JCI116242; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wicker LS, 1996, J CLIN INVEST, V98, P2597, DOI 10.1172/JCI119079; WILKINSON D, 1988, J EXP MED, V167, P1442, DOI 10.1084/jem.167.4.1442; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Yuen MH, 1996, J AUTOIMMUN, V9, P67, DOI 10.1006/jaut.1996.0009	50	49	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11440	11447		10.1074/jbc.273.19.11440	http://dx.doi.org/10.1074/jbc.273.19.11440			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565555	hybrid			2022-12-27	WOS:000073536700009
J	Yasoda, A; Ogawa, Y; Suda, M; Tamura, N; Mori, K; Sakuma, Y; Chusho, H; Shiota, K; Tanaka, K; Nakao, K				Yasoda, A; Ogawa, Y; Suda, M; Tamura, N; Mori, K; Sakuma, Y; Chusho, H; Shiota, K; Tanaka, K; Nakao, K			Natriuretic peptide regulation of endochondral ossification - Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; MICE LACKING; TRANSGENIC MICE; INDIAN HEDGEHOG; CYCLIC-GMP; RECEPTOR; BRAIN; MOUSE; GENES; CNP	The natriuretic peptide family consists of three structurally related endogenous ligands: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), The biological actions of natriuretic peptides are thought to be mediated through the activation of two guanylyl cyclase (GC)-coupled receptor subtypes (GC-A and GC-B), In this study, we examined the effects of ANP and CNP, which are endogenous ligands for GC-A and GC-B, respectively, on bone growth using an organ culture of fetal mouse tibias, an in vitro model of endochondral ossification. CNP increased the cGMP production much more potently than ANP, thereby resulting in an increase in the total longitudinal bone length. Histological examination revealed an increase in the height of the proliferative and hypertrophic chondrocyte zones in fetal mouse tibias treated with CNP, The natriuretic peptide stimulation of bone growth, which was mimicked by 8-bromo-cGMP, was inhibited by HS-142-1, a non-peptide GC-coupled natriuretic peptide receptor antagonist. The spontaneous increase in the total longitudinal bone growth and cGMP production was also inhibited significantly by HS-142-1. CNP mRNA was expressed abundantly in fetal mouse tibias, where no significant amounts of ANP and BNP mRNAs were detected. A considerable amount of GC-B mRNA was present in fetal mouse tibias, This study suggests the physiologic significance of the CNP/GC-B pathway in the process of endochondral ossification.	Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 606, Japan; Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Sakyo Ku, Kyoto 606, Japan	Kyoto University; Kyoto University	Ogawa, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 606, Japan.		Mori, Kiyoshi/N-1267-2014	Mori, Kiyoshi/0000-0002-7285-8351; Ogawa, Yoshihiro/0000-0002-0834-2836				AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; CHINKERS M, 1991, ANNU REV BIOCHEM, V60, P553, DOI 10.1146/annurev.bi.60.070191.003005; CHRISMAN TD, 1993, J BIOL CHEM, V268, P3698; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; DAGNINO L, 1991, MOL ENDOCRINOL, V5, P1292, DOI 10.1210/mend-5-9-1292; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; HAGIWARA H, 1994, J BIOL CHEM, V269, P10729; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311, DOI 10.1152/ajpcell.1996.270.5.C1311; HOLLIDAY LS, 1995, J BIOL CHEM, V270, P18983, DOI 10.1074/jbc.270.32.18983; HORTON WA, 1983, J HISTOCHEM CYTOCHEM, V31, P417, DOI 10.1177/31.3.6338106; Howell D.D., 1992, DISORDERS BONE MINER, P313; INOUE A, 1995, BIOCHEM BIOPH RES CO, V215, P1104, DOI 10.1006/bbrc.1995.2577; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; KOMATSU Y, 1991, ENDOCRINOLOGY, V129, P1104, DOI 10.1210/endo-129-2-1104; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; OGAWA Y, 1994, GENOMICS, V24, P383, DOI 10.1006/geno.1994.1633; OGAWA Y, 1994, J CLIN INVEST, V93, P1911, DOI 10.1172/JCI117182; Ogawa Y, 1995, HYPERTENSION PATHOPH, V1, P833; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Recker R.R., 1992, DISORDERS BONE MINER, P219; ROSENZWEIG A, 1991, ANNU REV BIOCHEM, V60, P229, DOI 10.1146/annurev.biochem.60.1.229; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SHIOTA K, 1990, ACTA ANAT, V137, P59; SOSKOLNE WA, 1986, BONE, V7, P41, DOI 10.1016/8756-3282(86)90150-X; STEINHELPER ME, 1990, HYPERTENSION, V16, P301, DOI 10.1161/01.HYP.16.3.301; Suda M, 1996, BIOCHEM BIOPH RES CO, V223, P1, DOI 10.1006/bbrc.1996.0836; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; TAKAHASHI T, 1992, CIRC RES, V71, P9, DOI 10.1161/01.RES.71.1.9; Tamura N, 1996, J MOL CELL CARDIOL, V28, P1811, DOI 10.1006/jmcc.1996.0170; TAMURA N, 1994, J CLIN INVEST, V94, P1059, DOI 10.1172/JCI117420; TOKI S, 1992, NEUROSCI LETT, V135, P117, DOI 10.1016/0304-3940(92)90149-2; VOLLMAR AM, 1993, ENDOCRINOLOGY, V132, P1872, DOI 10.1210/en.132.4.1872; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613	42	166	183	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11695	11700		10.1074/jbc.273.19.11695	http://dx.doi.org/10.1074/jbc.273.19.11695			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565590	hybrid			2022-12-27	WOS:000073536700044
J	Yokosaki, Y; Matsuura, N; Higashiyama, S; Murakami, I; Obara, M; Yamakido, M; Shigeto, N; Chen, J; Sheppard, D				Yokosaki, Y; Matsuura, N; Higashiyama, S; Murakami, I; Obara, M; Yamakido, M; Shigeto, N; Chen, J; Sheppard, D			Identification of the ligand binding site for the integrin alpha(theta)beta(1) in the third fibronectin type III repeat of tenascin-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL INTEGRINS; CELL-ADHESION MOLECULE-1; CRYSTAL-STRUCTURE; RECEPTOR; ATTACHMENT; SEQUENCE; DOMAIN; SUBUNIT; ALPHA-V-BETA-6; ALPHA-4-BETA-1	The integrin alpha(9) subunit forms a single heterodimer, alpha(9) beta(1) that mediates cell adhesion to a site within the third fibronectin type III repeat of tenascin-C (TNfn3), In contrast to at least 3 other integrins that bind to this region of tenascin-C, alpha(9) beta(1) does not recognize the common integrin recognition motif, Arg-Gly-Asp (RGD). In this report, we have used substitution mutagenesis to identify a unique ligand recognition sequence in TNfn3. We introduced mutations substituting alanine for each of the acidic residues in or adjacent to each of the exposed loops predicted from the solved crystal structure. Most of these mutations had little or no effect on adhesion of alpha(9)-transfected SW480 colon carcinoma cells, but mutations of either of two acidic residues in the B-C loop region markedly reduced attachment of these cells. In contrast, cells expressing the integrin alpha(v) beta(3),, previously reported to bind to the RGD sequence in the adjacent F-G loop, attached to all mutant fragments except one in which the RGD site was mutated to RAA. The peptide, AEIDGIEL, based on the sequence of human tenascin-C in this region blocked the binding of alpha(9)-transfected cells, but not beta(3)-transfected cells to wild type TNfn3, This sequence contains a tripeptide, IDG, homologous to the sequences LDV, IDA, and LDA in fibronectin and IDS in VCAM-1 recognized by the closely related integrin alpha(4) beta(1). These findings support the idea that this tripeptide motif serves as a ligand binding site for the alpha(4)/alpha(9), subfamily of integrins.	Natl Hiroshima Hosp, Dept Internal Med, Higashihiroshima 7390041, Japan; Natl Hiroshima Hosp, Dept Lab Med, Higashihiroshima 7390041, Japan; Osaka Univ, Sch Allied Hlth Sci, Dept Pathol, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Med, Dept Biochem, Suita, Osaka 5650871, Japan; Hiroshima Univ, Fac Sci, Dept Dev Sci, Higashihiroshima 7398526, Japan; Hiroshima Univ, Sch Med, Dept Internal Med 2, Minami Ku, Hiroshima 7348551, Japan; Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA	Osaka University; Osaka University; Hiroshima University; Hiroshima University; University of California System; University of California San Francisco	Yokosaki, Y (corresponding author), Natl Hiroshima Hosp, Dept Internal Med, 513 Jike, Higashihiroshima 7390041, Japan.				NHLBI NIH HHS [HL/AI33259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHIQUETEHRISMANN R, 1995, CURR OPIN CELL BIOL, V7, P715, DOI 10.1016/0955-0674(95)80114-6; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; CLEMENTS JM, 1994, J CELL SCI, V107, P2127; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; JOSHI P, 1993, J CELL SCI, V106, P389; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Moyano JV, 1997, J BIOL CHEM, V272, P24832, DOI 10.1074/jbc.272.40.24832; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Sheppard D, 1996, CHEST, V109, pS29, DOI 10.1378/chest.109.3_Supplement.29S; Sheppard D, 1996, BIOESSAYS, V18, P655, DOI 10.1002/bies.950180809; Stadel J.M., 1994, INTEGRINS MOL BIOLOG, P237, DOI [10.1016/B978-0-08-091729-0.50014-0, DOI 10.1016/B978-0-08-091729-0.50014-0]; TAKADA Y, 1989, EMBO J, V8, P1361, DOI 10.1002/j.1460-2075.1989.tb03516.x; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; WEINACKER A, 1994, J BIOL CHEM, V269, P6940; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; YOKOSAKI Y, 1995, TRENDS GLYCOSCI GLYC, V7, P417, DOI 10.4052/tigg.7.417	29	134	142	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11423	11428		10.1074/jbc.273.19.11423	http://dx.doi.org/10.1074/jbc.273.19.11423			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565552	hybrid			2022-12-27	WOS:000073536700006
J	Siemeister, G; Marme, D; Martiny-Baron, G				Siemeister, G; Marme, D; Martiny-Baron, G			The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCHAIN DISULFIDE BONDS; TUMOR ANGIOGENESIS FACTOR; PERMEABILITY FACTOR; FACTOR VEGF; CRYSTAL-STRUCTURE; TYROSINE KINASE; GENE-EXPRESSION; MESSENGER-RNA; FACTOR-B; IN-VIVO	Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and a key mediator of aberrant endothelial cell proliferation and vascular permeability in a variety of human pathological situations such as tumor angiogenesis, diabetic retinopathy, or psoriasis, By amino-terminal deletion analysis and by site-directed mutagenesis we have identified a new domain within the amino-terminal alpha-helix that is essential for dimerization of VEGF. VEGF(121) variants containing amino acids 8 to 121 or 14 to 121, respectively, either expressed in Escherichia coli and refolded in vitro, or expressed in Chinese hamster ovary cells, were in a dimeric conformation and showed full binding activity to VEGF receptors and stimulation of endothelial cell proliferation as compared with wild-type VEGF, In contrast, a VEGF(121) variant covering amino acids 18 to 121, as well as a variant in which the hydrophobic amino acids Val(14), Val(15), Phe(17), and Met(18) within the amphipathic alpha-helix near the amino terminus were replaced by serine, failed to form biological active VEGF dimers, From these data we conclude that a domain between amino acids His(12) and Asp(19) within the aminoterminal alpha-helix is essential for formation of VEGF dimers, and we propose hydrophobic interactions between VEGF monomers to stabilize or favor dimerization.	Inst Mol Med, Tumor Biol Ctr, D-79106 Freiburg, Germany		Siemeister, G (corresponding author), Inst Mol Med, Tumor Biol Ctr, Breisacher Str 117, D-79106 Freiburg, Germany.			, Gerhard/0000-0002-4712-0531				AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Barleon B, 1997, J BIOL CHEM, V272, P10382; Birkenhager R, 1996, BIOCHEM J, V316, P703, DOI 10.1042/bj3160703; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; Cao YH, 1996, J CLIN INVEST, V98, P2507, DOI 10.1172/JCI119069; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CLAFFEY KP, 1995, BBA-PROTEIN STRUCT M, V1246, P1, DOI 10.1016/0167-4838(94)00144-6; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DIRKS W, 1993, GENE, V128, P247, DOI 10.1016/0378-1119(93)90569-O; FAVA RA, 1994, J EXP MED, V180, P341, DOI 10.1084/jem.180.1.341; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Finkenzeller G, 1997, ONCOGENE, V15, P669, DOI 10.1038/sj.onc.1201219; GEOURJON C, 1995, J MOL GRAPHICS, V13, P209, DOI 10.1016/0263-7855(95)00035-5; GRUGEL S, 1995, J BIOL CHEM, V270, P25915, DOI 10.1074/jbc.270.43.25915; HANNINK M, 1984, SCIENCE, V226, P1197, DOI 10.1126/science.6095451; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; KENNEY WC, 1994, J BIOL CHEM, V269, P12351; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; KIESER A, 1994, ONCOGENE, V9, P963; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KING CR, 1985, P NATL ACAD SCI USA, V82, P5295, DOI 10.1073/pnas.82.16.5295; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; MARTINYBARON G, 1995, CURR OPIN BIOTECH, V6, P675, DOI 10.1016/0958-1669(95)80111-1; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; POTGENS AJG, 1994, J BIOL CHEM, V269, P32879; PRESTRELSKI SJ, 1994, INT J PEPT PROT RES, V44, P357; RAK J, 1995, CANCER RES, V55, P4575; Redmer DA, 1996, J REPROD FERTIL, V108, P157, DOI 10.1530/jrf.0.1080157; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SHARMA HS, 1995, BBA-GENE STRUCT EXPR, V1260, P235, DOI 10.1016/0167-4781(94)00221-N; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Siemeister G, 1996, BIOCHEM BIOPH RES CO, V222, P249, DOI 10.1006/bbrc.1996.0730; Siemeister G, 1996, CANCER RES, V56, P2299; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Thomas KA, 1996, J BIOL CHEM, V271, P603, DOI 10.1074/jbc.271.2.603; TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0; WEINDEL K, 1992, BIOCHEM BIOPH RES CO, V183, P1167, DOI 10.1016/S0006-291X(05)80313-4	53	20	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11115	11120		10.1074/jbc.273.18.11115	http://dx.doi.org/10.1074/jbc.273.18.11115			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556597	hybrid			2022-12-27	WOS:000073395200049
J	Welch, H; Eguinoa, A; Stephens, LR; Hawkins, PT				Welch, H; Eguinoa, A; Stephens, LR; Hawkins, PT			Protein kinase B and Rac are activated in parallel within a phosphatidylinositide 30H-kinase-controlled signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI LAC REPRESSOR; MAMMALIAN-CELLS; S6 KINASE; C-AKT; PHOSPHOINOSITIDE 3-KINASE; V-AKT; EXPRESSION; MEMBRANE; OPERATOR; RHO	The GTPase Rac and the protein kinase B (PKB) are downstream targets of phosphatidylinositide 30H-kinase in platelet-derived growth factor-stimulated signaling pathways. We have generated PAE cell lines inducibly expressing mutants of Rac, Use of these cell lines suggests that Rac is involved in both platelet-derived growth factor-stimulated membrane ruffling and the activation of p70(S6K) but not in the activation of PRE. Furthermore, expression of constitutively active alleles of PKB in PAE cells suggests that PKB is able to regulate the activity of p70(S6K) but not the cytoskeletal changes underlying membrane ruffling. Thus, our results indicate that Rac and PRE are on separate pathways downstream of phosphatidylinositide SOH-kinase in these cells but that both of these pathways are involved in the regulation of p70(S6K).	Babraham Inst, Dept Signaling, Inositide Lab, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Hawkins, PT (corresponding author), Babraham Inst, Dept Signaling, Inositide Lab, Cambridge CB2 4AT, England.			Welch, Heidi/0000-0001-7865-7000; stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464				AHMED NN, 1993, ONCOGENE, V8, P1957; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; BELLACOSA A, 1993, ONCOGENE, V8, P745; BROWN M, 1987, CELL, V49, P603, DOI 10.1016/0092-8674(87)90536-8; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHAPMAN BS, 1991, NUCLEIC ACIDS RES, V19, P3979, DOI 10.1093/nar/19.14.3979; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DELALUNA S, 1988, GENE, V62, P121; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; FIGGE J, 1988, CELL, V52, P713, DOI 10.1016/0092-8674(88)90409-6; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; KOEGL M, 1994, BIOCHEM J, V303, P749, DOI 10.1042/bj3030749; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; LEMON MA, 1997, TRENDS CELL BIOL, V7, P237; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PRICE LS, 1995, CURR BIOL, V5, P68, DOI 10.1016/S0960-9822(95)00018-2; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; Wilson M, 1996, J BIOL CHEM, V271, P8537, DOI 10.1074/jbc.271.15.8537	41	80	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11248	11256		10.1074/jbc.273.18.11248	http://dx.doi.org/10.1074/jbc.273.18.11248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556616	hybrid			2022-12-27	WOS:000073395200068
J	Gontarek, RR; Li, H; Nurse, K; Prescott, CD				Gontarek, RR; Li, H; Nurse, K; Prescott, CD			The N terminus of eukaryotic translation elongation factor 3 interacts with 18 S rRNA and 80 S ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-III; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; CANDIDA-ALBICANS; RNA; YEAST; SUBUNITS; GTPASE; ATPASE; SITES	Elongation factor-3 (EF-3) is an essential fungal-specific translation factor which exhibits a strong ribosome-dependent ATPase activity and has sequence homologies that may predict domains critical for its role in protein synthesis, including a domain at the N terminus, which exhibits sequence homology with Escherichia coli ribosomal protein S5. A portion of the N terminus of Saccharomyces cerevisiae EF-3 (spanning the S5 homology region) has been cloned, expressed, and purified from E. coli, UV cross-linking experiments revealed that the N-terminal EF-3 protein (N-term EF-3) can be specifically cross-linked to 18 S rRNA. Filter-binding assays confirmed these data, and also established that the interaction has a K-d, similar to 238 nM. Additional evidence shows that N-term EF-3 is able to associate with yeast ribosomes and inhibit the ribosome-dependent ATPase activity of native EF-3. These data taken together suggest that at least one of the ribosome-binding sites of EF-3 is located at the N terminus.	SmithKline Beecham Pharmaceut, Dept Mol Recognit, RNA Res Grp, King Of Prussia, PA 19406 USA	GlaxoSmithKline	Gontarek, RR (corresponding author), SmithKline Beecham Pharmaceut, Dept Mol Recognit, RNA Res Grp, 709 Swedeland Rd, King Of Prussia, PA 19406 USA.							BELFIELD GP, 1993, MOL MICROBIOL, V9, P411, DOI 10.1111/j.1365-2958.1993.tb01702.x; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CHAKRABURTTY K, 1988, INT J BIOCHEM, V20, P581, DOI 10.1016/0020-711X(88)90096-1; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; COLTHURST DR, 1992, MOL MICROBIOL, V6, P1025, DOI 10.1111/j.1365-2958.1992.tb02168.x; COLTHURST DR, 1991, FEMS MICROBIOL LETT, V80, P45, DOI 10.1111/j.1574-6968.1991.tb04634.x; DASMAHAPATRA B, 1981, J BIOL CHEM, V256, P9999; Heilek GM, 1996, SCIENCE, V272, P1659, DOI 10.1126/science.272.5268.1659; KAMATH A, 1989, J BIOL CHEM, V264, P15423; Kambampati R, 1997, J BIOL CHEM, V272, P6377, DOI 10.1074/jbc.272.10.6377; KOVALCHUKE O, 1995, INDIAN J BIOCHEM BIO, V32, P336; OSSWALD M, 1987, NUCLEIC ACIDS RES, V15, P3221, DOI 10.1093/nar/15.8.3221; RAMAKRISHNAN V, 1992, NATURE, V358, P768, DOI 10.1038/358768a0; SKOGERSON L, 1976, P NATL ACAD SCI USA, V73, P73, DOI 10.1073/pnas.73.1.73; STERN S, 1988, J MOL BIOL, V201, P683, DOI 10.1016/0022-2836(88)90467-6; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; URITANI M, 1988, J BIOCHEM-TOKYO, V103, P522, DOI 10.1093/oxfordjournals.jbchem.a122302; URITANI M, 1996, BIOCHEM MOL BIOL INT, V39, P227; Yang HM, 1996, BBA-MOL CELL RES, V1310, P303, DOI 10.1016/0167-4889(95)00179-4	19	13	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10249	10252		10.1074/jbc.273.17.10249	http://dx.doi.org/10.1074/jbc.273.17.10249			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553076	hybrid			2022-12-27	WOS:000073224200025
J	Rong, M; Durbin, RK; McAllister, WT				Rong, M; Durbin, RK; McAllister, WT			Template strand switching by T7 RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION COMPLEX; TRANSCRIPTION INITIATION; T7-RNA POLYMERASE; THUMB SUBDOMAIN; SYNTHETIC DNA; BACTERIOPHAGE-T7; TERMINATION; SITE; PROCESSIVITY; PROMOTER	T7 RNA polymerase (RNAP) is able to traverse a variety of discontinuities in the template (T) strand of duplex DNA, including nicks, gaps, and branched junctions in which the 3' end of the T strand is not complementary to the non-template (NT) strand. The products represent a faithful copy of the T strand, with no insertions or deletions. On double-stranded templates having protruding 3' ends the polymerase is able to insert the free 3' end of the NT strand and to utilize this as a new T strand ("turn around transcription"), resulting in the anomalous production of high molecular weight transcripts. The capacity of T7 RNAP to bypass interruptions in the T strand depends upon the stability of the elongation complex, Sequences that are expected to stabilize a local RNA:DNA hybrid (such as the presence of a C-6, tract in the T strand) dramatically reduce dissociation of the RNAP while still allowing the enzyme to insert a new 3' end. Similar effects on RNAP release are observed when the enzyme reaches the end of a template (i.e. when synthesizing runoff products), resulting in markedly different yields of RNA product during multiple rounds of transcription.	SUNY Hlth Sci Ctr, Morse Inst Mol Genet, Dept Immunol & Microbiol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	McAllister, WT (corresponding author), SUNY Hlth Sci Ctr, Morse Inst Mol Genet, Dept Immunol & Microbiol, 450 Clarkson Ave,Box 44, Brooklyn, NY 11203 USA.	pogo51@aol.com			NIGMS NIH HHS [GM38147] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONNER G, 1994, J BIOL CHEM, V269, P25129; CHEN YH, 1993, J BIOL CHEM, V268, P5849; Diaz GA, 1996, BIOCHEMISTRY-US, V35, P10837, DOI 10.1021/bi960488+; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; LEE BL, 1988, NUCLEIC ACIDS RES, V16, P10681, DOI 10.1093/nar/16.22.10681; LING ML, 1989, NUCLEIC ACIDS RES, V17, P1605, DOI 10.1093/nar/17.4.1605; Lyakhov DL, 1997, J MOL BIOL, V269, P28, DOI 10.1006/jmbi.1997.1015; LYAKHOV DL, 1992, MOL BIOL+, V26, P679; LYAKHOV DL, 1998, IN PRESS J MOL BIOL; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; MACDONALD LE, 1994, J MOL BIOL, V238, P145, DOI 10.1006/jmbi.1994.1277; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; MASLAK M, 1993, BIOCHEMISTRY-US, V32, P4281, DOI 10.1021/bi00067a017; MASLAK M, 1994, BIOCHEMISTRY-US, V33, P6918, DOI 10.1021/bi00188a022; MCALLISTER WT, 1997, NUCL ACIDS MOL BIOL, V11, P15; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; RONG M, 1997, THESIS STATE U NEW Y; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SASTRY SS, 1991, J MOL BIOL, V221, P1091, DOI 10.1016/0022-2836(91)90921-R; SCHENBORN ET, 1985, NUCLEIC ACIDS RES, V13, P6223, DOI 10.1093/nar/13.17.6223; SHI YB, 1988, J BIOL CHEM, V263, P527; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; SOUSA R, 1994, J MOL BIOL, V244, P6, DOI 10.1006/jmbi.1994.1699; SOUSA R, 1997, NUCL ACIDS MOL BIOL, V11, P1; ZHOU W, 1994, BIOCHEMISTRY-US, V33, P14926, DOI 10.1021/bi00253a032; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601; ZHOU W, 1995, CELL, V82, P577, DOI 10.1016/0092-8674(95)90030-6	35	31	33	5	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10253	10260		10.1074/jbc.273.17.10253	http://dx.doi.org/10.1074/jbc.273.17.10253			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553077	hybrid			2022-12-27	WOS:000073224200026
J	Bodor, J; Habener, JF				Bodor, J; Habener, JF			Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; RESPONSE ELEMENT-BINDING; ACCESSORY MOLECULE CD28; INTERLEUKIN-2 PROMOTER; CAMP INHIBITION; PROTEIN-KINASE; NUCLEAR FACTOR; IL-2; CREB; LYMPHOCYTES	Proliferating human medullary thymocytes can exhibit characteristic T helper cell type 1 cytokine responses exemplified by the immediate early expression of interleukin-2, interferon-gamma, tumor necrosis factor-alpha, and lymphotoxin-beta. Here we report that cAMP-mediated attenuation of the transcription of T helper-1-specific cytokine genes in human medullary thymocytes correlates with the induction of the cAMP-mediated transcriptional repressor ICER (inducible cAMP early repressor). We show that ICER binds specifically to several NFAT/AP-1 (nuclear factor of activated T cells/activating protein-1) composite DNA sites essential for the activation of the interleukin (IL)-2 promoter as well as to a homologous DNA motif present in the proximal segment of the interferon-gamma promoter, In the presence of the minimal NFAT DNA-binding domain, which is sufficient for both DNA binding and AP-1 complex formation, ICER and NFAT form NFAT/ICER ternary complexes on several NFAT/AP-1 DNA composite sites previously identified as essential for the expression of the immunoregulatory cytokines such as IL-2, IL-4, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. In extracts prepared from human medullary thymocytes treated with forskolin and ionomycin, these composite sites bind endogenously expressed ICER either singly or in complexes. Moreover, in Jurkat cells, ectopically expressed ICER represses transcription from NFAT-mediated, phorbol ester/ionophore-activated IL-2, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha promoters. We present evidence that ICER interactions with NFAT/AP-1 composite DNA sites correlate with its ability to repress transcription. These findings provide further insight into the mechanisms involved in cAMP-mediated transcriptional attenuation of cytokine expression.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Endocrinol Lab,Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Bodor, J (corresponding author), NCI, Expt Immunol Branch, Div Basic Sci, NIH, Bldg 10,R4B14,10 Ctr Dr, Bethesda, MD 20892 USA.	Bodorj@exchange.nih.gov			NIDDK NIH HHS [DK 25532] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025532] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; Aune TM, 1997, MOL CELL BIOL, V17, P199, DOI 10.1128/MCB.17.1.199; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bodor J, 1995, FEBS LETT, V377, P413, DOI 10.1016/0014-5793(95)01299-0; Bodor J, 1996, P NATL ACAD SCI USA, V93, P3536, DOI 10.1073/pnas.93.8.3536; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; CHEN D, 1994, J EXP MED, V179, P931, DOI 10.1084/jem.179.3.931; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; COCKERILL PN, 1995, MOL CELL BIOL, V15, P2071; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; FRASER JD, 1992, MOL CELL BIOL, V12, P4357, DOI 10.1128/MCB.12.10.4357; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; GHOSH P, 1993, P NATL ACAD SCI USA, V90, P1696, DOI 10.1073/pnas.90.5.1696; GOLDFELD AE, 1994, J EXP MED, V180, P763, DOI 10.1084/jem.180.2.763; Good LF, 1996, EMBO J, V15, P3744, DOI 10.1002/j.1460-2075.1996.tb00744.x; HODGE MR, 1995, J IMMUNOL, V154, P6397; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HSUEH YP, 1995, J BIOL CHEM, V270, P18094, DOI 10.1074/jbc.270.30.18094; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; LAI JH, 1995, MOL CELL BIOL, V15, P4260; LALLI E, 1994, J BIOL CHEM, V269, P17359; Masuda ES, 1997, MOL CELL BIOL, V17, P2066, DOI 10.1128/MCB.17.4.2066; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; MUNOZ E, 1990, J EXP MED, V172, P95, DOI 10.1084/jem.172.1.95; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NOVAK TJ, 1990, P NATL ACAD SCI USA, V87, P9353, DOI 10.1073/pnas.87.23.9353; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; PEREIRA P, 1985, P NATL ACAD SCI USA, V82, P7691, DOI 10.1073/pnas.82.22.7691; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; RON D, 1992, BIOTECHNIQUES, V13, P866; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; Tsai EY, 1996, MOL CELL BIOL, V16, P459; TSURUTA L, 1995, J IMMUNOL, V154, P5255; Tsuruta L, 1995, J ALLERGY CLIN IMMUN, V96, P1126, DOI 10.1016/S0091-6749(95)70197-4; Walker WH, 1996, TRENDS ENDOCRIN MET, V7, P133, DOI 10.1016/1043-2760(96)00035-5	46	100	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9544	9551		10.1074/jbc.273.16.9544	http://dx.doi.org/10.1074/jbc.273.16.9544			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545284	hybrid			2022-12-27	WOS:000073128800030
J	Delgado-Partin, VM; Dalbey, RE				Delgado-Partin, VM; Dalbey, RE			The proton motive force, acting on acidic residues, promotes translocation of amino-terminal domains of membrane proteins when the hydrophobicity of the translocation signal is low	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVELY CHARGED RESIDUES; M13 PROCOAT PROTEIN; ESCHERICHIA-COLI; LEADER PEPTIDASE; INDEPENDENT TRANSLOCATION; CYTOPLASMIC MEMBRANE; PLASMA-MEMBRANE; INSERTION; ORIENTATION; TOPOLOGY	We have shown previously that the first transmembrane segment of leader peptidase can function to translocate the polar amino-terminal Pf3 domain across the membrane into the periplasm independently of the proton motive force (pmf) (Lee, J. I., Kuhn, A., and Dalbey, R.E. (1992) J. Biol. Chem. 267, 938-943). We now show that when the first transmembrane segment lacks a strong hydrophobic character, the pmf is required for translocation. In addition, we find that the amino-terminal acidic residue proximal to the transmembrane domain plays a critical role in pmf-dependent amino-terminal translocation. Moreover, the pmf is required to hold the amino-terminal domain in the periplasm to prevent it from slipping such that the amino terminus is no longer exposed to the periplasm. In all cases, translocation occurs under conditions in which the function of the Sec machinery is impaired. These studies show that the low hydrophobicity of the first apolar domain (the translocation signal) can be compensated for by a negative charge in the amino-terminal region, upon which the pmf acts.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	Ohio State University	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem, Columbus, OH 43210 USA.							ANDERSSON H, 1994, EMBO J, V13, P2267, DOI 10.1002/j.1460-2075.1994.tb06508.x; ANDERSSON H, 1992, J BIOL CHEM, V267, P1491; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; CAO GQ, 1994, EMBO J, V13, P4662, DOI 10.1002/j.1460-2075.1994.tb06789.x; CAO GQ, 1995, EMBO J, V14, P866, DOI 10.1002/j.1460-2075.1995.tb07068.x; CHEN HF, 1995, J BIOL CHEM, V270, P14115, DOI 10.1074/jbc.270.23.14115; CHOU MM, 1990, J BIOL CHEM, V265, P2873; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; DALBEY RE, 1995, TRENDS CELL BIOL, V5, P380, DOI 10.1016/S0962-8924(00)89079-0; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; DANIELS CJ, 1981, P NATL ACAD SCI-BIOL, V78, P5396, DOI 10.1073/pnas.78.9.5396; DOUD SK, 1993, BIOCHEMISTRY-US, V32, P1251, DOI 10.1021/bi00056a008; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; GELLER B, 1993, J BIOL CHEM, V268, P9442; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; High S, 1997, TRENDS CELL BIOL, V7, P206; HIKITA C, 1992, J BIOL CHEM, V267, P4882; ITO K, 1980, J BIOL CHEM, V255, P2123; JOHNSTON S, 1985, GENE, V34, P137, DOI 10.1016/0378-1119(85)90121-0; Kiefer D, 1997, EMBO J, V16, P2197, DOI 10.1093/emboj/16.9.2197; KUHN A, 1986, EMBO J, V5, P3681, DOI 10.1002/j.1460-2075.1986.tb04699.x; KUHN A, 1990, EMBO J, V9, P2385, DOI 10.1002/j.1460-2075.1990.tb07413.x; LEE E, 1994, J BIOL CHEM, V269, P28822; LEE JI, 1992, J BIOL CHEM, V267, P938; MACINTYRE S, 1990, MOL GEN GENET, V221, P466; Miller J.H., 1972, EXPT MOL GENETICS; MOORE KE, 1987, J BIOL CHEM, V262, P8806; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; RUSCH SL, 1994, J BIOL CHEM, V269, P1243; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Soekarjo M, 1996, BIOCHEMISTRY-US, V35, P1232, DOI 10.1021/bi951087h; SPIESS M, 1995, FEBS LETT, V369, P76, DOI 10.1016/0014-5793(95)00551-J; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; WHITLEY P, 1995, J BIOL CHEM, V270, P29831; WHITLEY P, 1994, EMBO J, V13, P4653, DOI 10.1002/j.1460-2075.1994.tb06788.x; WOLFE PB, 1983, J BIOL CHEM, V258, P2073; WOLFE PB, 1984, CELL, V36, P1067, DOI 10.1016/0092-8674(84)90056-4; WOLFE PB, 1985, J BIOL CHEM, V260, P1836; ZHU HY, 1989, J BIOL CHEM, V264, P11833	46	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9927	9934		10.1074/jbc.273.16.9927	http://dx.doi.org/10.1074/jbc.273.16.9927			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545336	hybrid			2022-12-27	WOS:000073128800082
J	Fitzgerald, DJ; Fryling, CM; McKee, ML; Vennari, JC; Wrin, T; Cromwell, MEM; Daugherty, AL; Mrsny, RJ				Fitzgerald, DJ; Fryling, CM; McKee, ML; Vennari, JC; Wrin, T; Cromwell, MEM; Daugherty, AL; Mrsny, RJ			Characterization of V3 loop-Pseudomonas exotoxin chimeras - Candidate vaccines for human immunodeficiency virus-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRINCIPAL NEUTRALIZING DOMAIN; HIV-SERONEGATIVE VOLUNTEERS; RECEPTOR-RELATED PROTEIN; ANTIBODY-RESPONSES; MONOCLONAL-ANTIBODIES; RECOMBINANT GP160; PEPTIDE VACCINE; PRIMARY ISOLATE; T-CELLS; INFECTION	To develop a candidate vaccine for human immunodeficiency virus, type 1 (HIV-1), chimeric proteins were constructed by inserting sequences derived from the V3 loop of gp120 into a nontoxic form of Pseudomonas exotoxin (PE). Inserts of 14 or 26 amino acids, constrained by a disulfide bond, were introduced between domains II and III of PE. V3 loop-toxin proteins expressed in Escherichia coli and corresponding to either MN (subtype B) or Thai (subtype E) strains, were recognized by strain-specific monoclonal anti-gp120 antibodies. When loop sequences were introduced into an enzymatically active form of the toxin, there was no loss of toxin-mediated cell killing, suggesting that these sequences were co-transported to the cytosol. Sera from rabbits injected with nontoxic PE-V3 loop chimeras were reactive for strain-specific gp120s in Western blots, immunocapture assays, enzyme-linked immunosorbent assays, and neutralized HIV-1 infectivity. Since toxin vectors were designed to receive oligonucleotide duplexes encoding any V3 loop sequence, this approach should allow for the production of V3 loop-toxin chimeras corresponding to multiple HIV isolates.	NCI, NIH, Biotherapy Sect, Mol Biol Lab,Div Basic Sci, Bethesda, MD 20892 USA; Genentech Inc, Pharmaceut Res & Dev, Cell Banking, S San Francisco, CA 94080 USA; Genentech Inc, Pharmaceut Res & Dev, Drug Delivery Biol, S San Francisco, CA 94080 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roche Holding; Genentech; Roche Holding; Genentech	Fitzgerald, DJ (corresponding author), Bldg 37,Rm 4B03,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.							AHLERS JD, 1993, J IMMUNOL, V150, P5647; Ahlers JD, 1996, AIDS RES HUM RETROV, V12, P259, DOI 10.1089/aid.1996.12.259; ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; BACKSTROM M, 1994, GENE, V149, P211, DOI 10.1016/0378-1119(94)90152-X; Berman PW, 1996, J INFECT DIS, V173, P52, DOI 10.1093/infdis/173.1.52; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; BUKAWA H, 1995, NAT MED, V1, P681, DOI 10.1038/nm0795-681; CATASTI P, 1995, J BIOL CHEM, V270, P2224, DOI 10.1074/jbc.270.5.2224; CEASE KB, 1994, ANNU REV IMMUNOL, V12, P923, DOI 10.1146/annurev.iy.12.040194.004423; CHIRON MF, 1994, J BIOL CHEM, V269, P18167; Cohen D, 1997, LANCET, V349, P155, DOI 10.1016/S0140-6736(96)06255-1; Cohen D, 1996, INFECT IMMUN, V64, P4074, DOI 10.1128/IAI.64.10.4074-4077.1996; CRYZ SJ, 1995, VACCINE, V13, P67, DOI 10.1016/0264-410X(95)80013-4; CUKOR G, 1983, J CLIN MICROBIOL, V18, P457, DOI 10.1128/JCM.18.3.457-462.1983; DEBINSKI W, 1991, MOL CELL BIOL, V11, P1751, DOI 10.1128/MCB.11.3.1751; DONNELLY JJ, 1993, P NATL ACAD SCI USA, V90, P3530, DOI 10.1073/pnas.90.8.3530; EATON AM, 1994, AIDS RES HUM RETROV, V10, P13, DOI 10.1089/aid.1994.10.13; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; EVANS DJ, 1989, NATURE, V339, P385, DOI 10.1038/339385a0; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; FONTENOT JD, 1995, P NATL ACAD SCI USA, V92, P315, DOI 10.1073/pnas.92.1.315; Goletz TJ, 1997, HUM IMMUNOL, V54, P129, DOI 10.1016/S0198-8859(97)00081-5; GORRY PA, 1990, ANAL CHEM, V62, P570, DOI 10.1021/ac00205a007; GORSE GJ, 1995, VACCINE, V13, P209, DOI 10.1016/0264-410X(95)93138-Y; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KOVACS JA, 1993, J CLIN INVEST, V92, P919, DOI 10.1172/JCI116667; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LUKAC M, 1988, INFECT IMMUN, V56, P3095, DOI 10.1128/IAI.56.12.3095-3098.1988; MESTECKY J, 1994, AIDS RES HUM RETROV, V10, pS11; MITCHELL WM, 1995, AIDS, V9, P27, DOI 10.1097/00002030-199501000-00004; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; MOLDOVEANU Z, 1995, VACCINE, V13, P1013, DOI 10.1016/0264-410X(95)00018-V; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; OGATA M, 1990, J BIOL CHEM, V265, P20678; OGATA M, 1992, J BIOL CHEM, V267, P25396; OGATA M, 1991, INFECT IMMUN, V59, P407, DOI 10.1128/IAI.59.1.407-414.1991; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PASTAN I, 1992, ANNU REV BIOCHEM, V61, P331, DOI 10.1146/annurev.bi.61.070192.001555; PERALES MA, 1995, J ACQ IMMUN DEF SYND, V10, P27; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; PRIOR TI, 1992, BIOCHEMISTRY-US, V31, P3555, DOI 10.1021/bi00129a001; ROBERTSON GA, 1988, J VIROL METHODS, V20, P195, DOI 10.1016/0166-0934(88)90123-1; RUBINSTEIN A, 1995, AIDS, V9, P243, DOI 10.1097/00002030-199509030-00005; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; STEIMER KS, 1991, SCIENCE, V254, P105, DOI 10.1126/science.1718036; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389, DOI 10.1111/j.1365-2249.1994.tb06040.x; WANG CY, 1991, SCIENCE, V254, P285, DOI 10.1126/science.1925584; WHITESCHARF ME, 1993, VIROLOGY, V192, P197, DOI 10.1006/viro.1993.1022; WRIN T, 1995, J VIROL, V69, P39, DOI 10.1128/JVI.69.1.39-48.1995	52	14	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9951	9958		10.1074/jbc.273.16.9951	http://dx.doi.org/10.1074/jbc.273.16.9951			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545339	hybrid			2022-12-27	WOS:000073128800085
J	Li, X; Hunter, D; Morris, J; Haskill, JS; Earp, HS				Li, X; Hunter, D; Morris, J; Haskill, JS; Earp, HS			A calcium-dependent tyrosine kinase splice variant in human monocytes - Activation by a two-stage process involving adherence and a subsequent intracellular signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MOLECULAR-CLONING; PROTEIN; PHOSPHORYLATION; TRANSCRIPTION; CELLS; BETA	Freshly isolated human monocytes do not express p125(FAK) but upon adherence to substrata activate the highly related calcium-dependent tyrosine kinase (CADTK), also known as Pyk2, CAK beta, RAFTK, and FAK2, The monocyte CADTK was 5 kDa smaller than protein from epithelial cells; isolation and sequencing of the monocyte CADTK cDNA revealed a predicted 42-amino acid deletion between the two proline-rich domains of the enzyme. The nucleic acid sequence suggests that the deletion is caused by alternative RNA splicing. This species was also found in T and B lymphocytes and appears to be the predominant form of cytoskeletal associated tyrosine kinase in non-neoplastic, circulating, hematopoietic cells. CADTK was not activated when monocytes maintained in suspension were treated with agents that produce an intracellular calcium (thapsigargin) or protein kinase C (phorbol 12-myristate 13-acetate) signal including a chemokine, RANTES, that binds to the HIV co-receptor, CCK5, In contrast, monocyte adherence to tissue culture plastic-stimulated CADTK tyrosine phosphorylation, a process that was enhanced by thapsigargin, phorbol 12-myristate 13-acetate, and RANTES but that was completely blocked by preincubation with cytochalasin D. When compared with plastic, adherence to fibronectin-or collagen-coated surfaces produced only minimal CADTK activation but permitted significant stimulation by added thapsigargin, These data suggest that in a cell type that lacks p125(FAK), CADTK plays an early role in post-adherence signaling. Its activation involves two stages, cytoskeletal engagement, which is permissive, and co-stimulatory signals (calcium or protein kinase C) generated by extensive cell surface engagement, agonists, or inflammatory chemokines.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Earp, HS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.							ANJU RK, 1997, J EXP MED, V185, P1055; Astier A, 1997, J BIOL CHEM, V272, P228; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; BEEKHUIZEN H, 1993, J LEUKOCYTE BIOL, V54, P363, DOI 10.1002/jlb.54.4.363; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; EARP HS, 1995, J BIOL CHEM, V270, P28440; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; Herzog H, 1996, GENOMICS, V32, P484, DOI 10.1006/geno.1996.0149; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1997, J BIOL CHEM, V272, P14341, DOI 10.1074/jbc.272.22.14341; LOFQUIST AK, 1995, MOL CELL BIOL, V15, P1737; MONDAL K, 1995, BIOCHEM SOC T, V23, P460, DOI 10.1042/bst0230460; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; PARARROYO M, 1994, IMMUNOBIOLOGY, V191, P474; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; Qian DP, 1997, J EXP MED, V185, P1253, DOI 10.1084/jem.185.7.1253; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; SPORN SA, 1990, J IMMUNOL, V144, P4434; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993	25	70	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9361	9364		10.1074/jbc.273.16.9361	http://dx.doi.org/10.1074/jbc.273.16.9361			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545257	hybrid			2022-12-27	WOS:000073128800003
J	Nguyen, BD; Zhao, XF; Vyas, K; La Mar, GN; Lile, RA; Brucker, EA; Phillips, GN; Olson, JS; Wittenberg, JB				Nguyen, BD; Zhao, XF; Vyas, K; La Mar, GN; Lile, RA; Brucker, EA; Phillips, GN; Olson, JS; Wittenberg, JB			Solution and crystal structures of a sperm whale myoglobin triple mutant that mimics the sulfide-binding hemoglobin from Lucina pectinata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; AMINO-ACID-SEQUENCES; HEME CAVITY; LIGAND-BINDING; CRYSTALLOGRAPHIC ANALYSIS; RESONANCE ASSIGNMENT; CYANO-METMYOGLOBIN; 2-DIMENSIONAL NMR; 1.5-A RESOLUTION; DISTAL HISTIDINE	The bivalve mollusc Lucina pectinata harbors sulfide-oxidizing chemoautotrophic bacteria and expresses a monomeric hemoglobin I, HbI, with normal O-2, but extraordinarily high sulfide affinity. The crystal structure of aquomet Lucina HbI has revealed an active site with three residues not commonly found in vertebrate globins: Phe(B10), Gln(E7), and Phe(E11) (Rizzi, M., Wittenberg, J. B., Coda, A., Fasano, M., Ascenzi, P., and Bolognesi, M. (1994) J. Mol. Biol. 244, 86-89). Engineering these three residues into sperm whale myoglobin results in a triple mutant with similar to 700-fold higher sulfide affinity than for wild-type. The single crystal x-ray structure of the aquomet derivative of the myoglobin triple mutant and the solution H-1 NMR active site structures of the cyanomet derivatives of both the myoglobin mutant and Lucina HbI have been determined to examine further the structural origin of their unusually high sulfide affinities. The major differences in the distal pocket is that in the aquomet form the carbonyl of Gln(64)(E7) serves as a H-bond acceptor, whereas in the cyanomet form the amido group acts as H-bond donor to the bound ligand. Phe(68)(E11) is rotated similar to 90 degrees about chi(2) and located similar to 1-2 Angstrom closer to the iron atom in the myoglobin triple mutant relative to its conformation in Lucina HbI. The change in orientation potentially eliminates the stabilizing interaction with sulfide and, together with the decrease in size of the distal pocket, accounts for the 7-fold lower sulfide affinity of the myoglobin mutant compared with that of Lucina HbI.	Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, WM Keck Ctr Computat Biol, Houston, TX 77005 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	University of California System; University of California Davis; Rice University; Rice University; Yeshiva University; Albert Einstein College of Medicine	La Mar, GN (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.			Olson, John/0000-0002-0760-5403	NHLBI NIH HHS [HL16087, HL47020] Funding Source: Medline; NIGMS NIH HHS [GM35649] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016087, R37HL016087, R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLOCATELLI CT, 1993, BIOCHEMISTRY-US, V32, P6041; ARENTS G, 1989, J MOL BIOL, V210, P149, DOI 10.1016/0022-2836(89)90297-0; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Bax A., 1982, 2 DIMENSIONAL NUCL M; BISIG DA, 1995, J BIOL CHEM, V270, P20754, DOI 10.1074/jbc.270.35.20754; BOLOGNESI M, 1989, J MOL BIOL, V205, P529, DOI 10.1016/0022-2836(89)90224-6; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger A.T., 1992, X PLOR VERSION 3 1 M; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CARVER TE, 1992, J BIOL CHEM, V267, P14443; CARVER TE, 1990, J BIOL CHEM, V265, P20007; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; CHIU ML, 1992, THESIS U ILLINOIS UR; DALVIT C, 1987, J MOL BIOL, V194, P313, DOI 10.1016/0022-2836(87)90378-0; DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052; EGEBERG KD, 1990, J BIOL CHEM, V265, P11788; EMERSON SD, 1990, BIOCHEMISTRY-US, V29, P1545, DOI 10.1021/bi00458a028; EMERSON SD, 1990, BIOCHEMISTRY-US, V29, P1556, DOI 10.1021/bi00458a029; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FISHER CR, 1990, REV AQUAT SCI, V2, P399; GUPTA RK, 1976, J MAGN RESON, V24, P461, DOI 10.1016/0022-2364(76)90124-4; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KRAUS DW, 1990, J BIOL CHEM, V265, P16043; KURIYAN J, 1986, J MOL BIOL, V192, P133, DOI 10.1016/0022-2836(86)90470-5; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; LILJEQVIST G, 1982, J MOL EVOL, V18, P102, DOI 10.1007/BF01810828; PHILLIPS GN, 1990, PROTEINS, V7, P358, DOI 10.1002/prot.340070407; QIN J, 1993, BIOPHYS J, V65, P2178, DOI 10.1016/S0006-3495(93)81270-0; QIN J, 1992, J BIOMOL NMR, V2, P597, DOI 10.1007/BF02192849; QIN J, 1993, J MOL BIOL, V231, P1009, DOI 10.1006/jmbi.1993.1348; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; RAJARATHNAM K, 1992, J AM CHEM SOC, V114, P9048, DOI 10.1021/ja00049a042; RAJARATHNAM K, 1994, BIOCHEMISTRY-US, V33, P5493, DOI 10.1021/bi00184a018; RAJARATHNAM K, 1993, BIOCHEMISTRY-US, V32, P5670, DOI 10.1021/bi00072a024; Rashid AK, 1997, J BIOL CHEM, V272, P2992, DOI 10.1074/jbc.272.5.3000; Rizzi M, 1996, J MOL BIOL, V258, P1, DOI 10.1006/jmbi.1996.0228; RIZZI M, 1994, J MOL BIOL, V244, P86, DOI 10.1006/jmbi.1994.1706; ROMEROHERRERA AE, 1981, J MOL EVOL, V17, P140, DOI 10.1007/BF01733907; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; STENZEL P, 1979, J BIOL CHEM, V254, P2071; SUZUKI T, 1988, ZOOL SCI, V5, P69; SUZUKI T, 1993, J PROTEIN CHEM, V12, P45, DOI 10.1007/BF01024913; VINOGRADOV SN, 1993, COMP BIOCHEM PHYS B, V106, P1, DOI 10.1016/0305-0491(93)90002-M; VYAS K, 1993, J BIOL CHEM, V268, P14826; WITTENBERG JB, 1991, STRUCTURE AND FUNCTION OF INVERTEBRATE OXYGEN CARRIERS, P323; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; WITTENBERG JB, 1985, B BIOL SOC WASH, V6, P301; Zhang W, 1997, BIOPHYS J, V73, P1019, DOI 10.1016/S0006-3495(97)78135-9; Zhang W, 1996, EUR J BIOCHEM, V237, P841, DOI 10.1111/j.1432-1033.1996.0841p.x; Zhang W, 1997, J BIOL CHEM, V272, P3000, DOI 10.1074/jbc.272.5.3000; ZHAO XF, 1995, J BIOL CHEM, V270, P20763, DOI 10.1074/jbc.270.35.20763	57	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9517	9526		10.1074/jbc.273.16.9517	http://dx.doi.org/10.1074/jbc.273.16.9517			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545280	hybrid			2022-12-27	WOS:000073128800026
J	Tjaden, J; Schwoppe, C; Mohlmann, T; Quick, PW; Neuhaus, HE				Tjaden, J; Schwoppe, C; Mohlmann, T; Quick, PW; Neuhaus, HE			Expression of a plastidic ATP/ADP transporter gene in Escherichia coli leads to a functional adenine nucleotide transport system in the bacterial cytoplasmic membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARCH SYNTHESIS; ADENYLATE TRANSLOCATOR; ROOT PLASTIDS; PROTEIN; MITOCHONDRIA; AMYLOPLASTS; GLUCOSE-6-PHOSPHATE; CHLOROPLASTS; SEQUENCE; ACID	Recently, a second type of eucaryotic adenine nucleotide transporter located in the inner envelope membrane of higher plants has been identified at the molecular level (Neuhaus, H. E., Them, E., Mohlmann, T., Steup, M., and Kampfenkel, K. (1997) Plant J. 11, 73-82). Here we have analyzed the biochemical properties of this ATP/ADP transporter from Arabidopsis thaliana (AATP1, At). This analysis was carried out by expressing a cDNA encoding this carrier as a histidine-tagged chimeric protein heterologously in Escherichia coli. Isopropyl-1-thio-beta-D-galactopyranoside (IPTG)-induced E. coli cells were able to import radioactively labeled [alpha-P-32] ATP, Uninduced E. coli cells did not import [alpha-P-32]ATP. Further control experiments revealed that IPTG induction did not promote import of other phosphorylated or unphosphorylated metabolites into the bacterial cell indicating the specificity of [alpha-P-32]ATP transport. [alpha-P-32] ATP uptake into induced E. coli cells was linear with time for several minutes allowing for determination of kinetic constants. The apparent K-m for ATP was 17 mu M which is close to values reported on the authentic protein in isolated plastids. ADP was a strong competitive inhibitor of [alpha-P-32]ATP uptake (K-i ADP 3.6 mu M). Other metabolites like AMP, ADP glucose, UTP, UDP, NAD, and NADP did not influence [alpha-P-32]ATP uptake. IPTG-induced E. coli cells preloaded with [alpha-P-32]ATP exported radioactively labeled adenylates after exogenous addition of unlabeled ATP or ADP indicating a counter exchange mechanism of transport. The biochemical properties of the heterologously expressed AATP1 gene product demonstrated that the protein is functionally integrated in the cytoplasmic membrane off. coli. This is the first report of the functional expression of a plant membrane protein in E. coli leading to new transport properties across the cytoplasmic membrane. The functional integration of a plant membrane protein in the cytoplasmic membrane off. coli offers new possibilities for future studies of the structural and mechanistic properties of this transporter. Since IPTG induction allowed synthesis of a 67-kDa protein in E. coli, which was subsequently specifically enriched by metal-chelate chromatography, this procaryotic heterologous expression system might provide a suitable system for overproduction of membrane proteins of eucaryotic origin in the near future.	Univ Osnabruck, Dept Biol & Chem, D-49069 Osnabruck, Germany; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2UQ, S Yorkshire, England	University Osnabruck; University of Sheffield	Neuhaus, HE (corresponding author), Univ Osnabruck, Dept Biol & Chem, Barbarastr 11, D-49069 Osnabruck, Germany.	Neuhaus@sfbbio1.biologie.uni-Osnabrueck.de						BERGMEYER U, 1974, GRUNDLAGEN ENZYMATIS; BOWSHER CG, 1992, PLANT J, V2, P893, DOI 10.1111/j.1365-313X.1992.00893.x; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; EMES MJ, 1993, INT REV CYTOL, V145, P149, DOI 10.1016/S0074-7696(08)60427-1; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; FROMMER WB, 1995, ANNU REV PLANT PHYS, V46, P419, DOI 10.1146/annurev.pp.46.060195.002223; HELDT HW, 1969, FEBS LETT, V5, P11, DOI 10.1016/0014-5793(69)80280-2; HERMANN RG, 1992, CELL ORGANELLES, P275; HILL LM, 1991, PLANTA, V185, P91, DOI 10.1007/BF00194519; KAMPFENKEL K, 1995, FEBS LETT, V374, P351, DOI 10.1016/0014-5793(95)01143-3; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KNIGHT JS, 1995, PLANT CELL, V7, P1421, DOI 10.1105/tpc.7.9.1421; KRAUSE DC, 1985, P NATL ACAD SCI USA, V82, P3015, DOI 10.1073/pnas.82.9.3015; Lubeck J, 1997, J CELL BIOL, V137, P1279, DOI 10.1083/jcb.137.6.1279; MANGOLD HK, 1967, DUNNSCHICHT CHROMATO, P749; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MOHLMANN T, 1994, PLANTA, V194, P492, DOI 10.1007/BF00714461; Mohlmann T, 1997, BIOCHEM J, V324, P503, DOI 10.1042/bj3240503; Neuhaus HE, 1996, BIOCHEM J, V318, P945, DOI 10.1042/bj3180945; NEUHAUS HE, 1993, PLANT PHYSIOL, V101, P573, DOI 10.1104/pp.101.2.573; Neuhaus HE, 1997, PLANT J, V11, P73, DOI 10.1046/j.1365-313X.1997.11010073.x; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; PLANO GV, 1991, J BACTERIOL, V173, P3389, DOI 10.1128/jb.173.11.3389-3396.1991; POZUETAROMERO J, 1991, P NATL ACAD SCI USA, V88, P5769, DOI 10.1073/pnas.88.13.5769; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHUNEMANN D, 1993, PLANT PHYSIOL, V103, P131, DOI 10.1104/pp.103.1.131; Segel IH, 1975, ENZYME KINETICS BEHA; STANKOVIC ZS, 1977, PLANT PHYSIOL, V59, P428, DOI 10.1104/pp.59.3.428; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TETLOW IJ, 1994, PLANTA, V194, P454, DOI 10.1007/BF00714456; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1990, PROTEIN ENG, V4, P109, DOI 10.1093/protein/4.2.109; WILLIAMSON LR, 1989, GENE, V80, P269, DOI 10.1016/0378-1119(89)90291-6; WINKLER HH, 1986, METHOD ENZYMOL, V125, P253	36	66	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9630	9636		10.1074/jbc.273.16.9630	http://dx.doi.org/10.1074/jbc.273.16.9630			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545295	hybrid			2022-12-27	WOS:000073128800041
J	Bhandari, V; Lim, KL; Pallen, CJ				Bhandari, V; Lim, KL; Pallen, CJ			Physical and functional interactions between receptor-like protein-tyrosine phosphatase alpha and p59(fyn)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; CD45 PHOSPHOTYROSINE PHOSPHATASE; GROWTH-FACTOR RECEPTOR; HUMAN LYMPHOCYTES-T; SRC-FAMILY KINASES; C-SRC; NEURONAL DIFFERENTIATION; SIGNAL-TRANSDUCTION; NEURITE OUTGROWTH; BINDING-SITE	We have examined the in vivo activity of receptor-like protein-tyrosine phosphatase alpha (PTP alpha) toward p59(fyn), a widely expressed Src family kinase. In a coexpression system, PTP alpha effected a dose-dependent tyrosine dephosphorylation and activation of p59(fyn), where maximal dephosphorylation correlated with a 5-fold increase in kinase activity. PTP alpha expression resulted in increased accessibility of the p59(fyn) SH2 domain, consistent with a PTP alpha-mediated dephosphorylation of the regulatory C-terminal tyrosine residue of p59(fyn). No p59(fyn) dephosphorylation was observed with an enzymatically inactive mutant form of PTP alpha: or with another receptorlike PTP, CD45. Many enzyme-linked receptors are complexed with their substrates, and we examined whether PTP alpha and p59(fyn) underwent association, Reciprocal immunoprecipitations and assays detected p59(fyn) and an appropriate kinase activity in PTP alpha immunoprecipitates and PTP alpha and PTP activity in p59(fyn) immunoprecipitates, No association between CD45 and p59(fyn) was detected in similar experiments. The PTP alpha-mediated activation of p59(fyn) is not prerequisite for association since wild-type and inactive mutant PTP alpha bound equally well to p59(fyn). Endogenous PTP alpha and p59(fyn) were also found in association in mouse brain, Together, these results demonstrate a physical and functional interaction of PTP alpha and p59(fyn) that may be of importance in PTP alpha-initiated signaling events.	Natl Univ Singapore, Inst Mol & Cell Biol, Cell Regulat Lab, Singapore 117609, Singapore	Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Pallen, CJ (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, Cell Regulat Lab, 30 Med Dr, Singapore 117609, Singapore.	mcbcp@imcb.nus.edu.sg	Lim, Kah-Leong/AAY-3308-2020; Lim, Kah/L-5426-2019	Lim, Kah-Leong/0000-0002-5440-2588; Pallen, Catherine/0000-0002-3576-5295				AUTERO M, 1994, MOL CELL BIOL, V14, P1308, DOI 10.1128/MCB.14.2.1308; BAGRODIA S, 1993, MOL CELL BIOL, V13, P1464, DOI 10.1128/MCB.13.3.1464; BAGRODIA S, 1994, J BIOL CHEM, V269, P10247; BARE DJ, 1993, ONCOGENE, V8, P1429; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN VK, 1994, J BIOL CHEM, V269, P17238; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1986, MOL CELL BIOL, V6, P1562, DOI 10.1128/MCB.6.5.1562; CHEADLE C, 1994, J BIOL CHEM, V269, P24034; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; DASILVA AJ, 1993, J EXP MED, V178, P2107, DOI 10.1084/jem.178.6.2107; DAUM G, 1994, J BIOL CHEM, V269, P10524; DAVIDSON D, 1994, J BIOL CHEM, V269, P10956; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; denHertog J, 1996, MECH DEVELOP, V58, P89, DOI 10.1016/S0925-4773(96)00561-8; denHertog J, 1996, EMBO J, V15, P3016, DOI 10.1002/j.1460-2075.1996.tb00665.x; DIANZANI U, 1992, EUR J IMMUNOL, V22, P365, DOI 10.1002/eji.1830220212; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; Fang KS, 1996, MOL BRAIN RES, V37, P1, DOI 10.1016/0169-328X(95)00240-S; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HURLEY TR, 1993, MOL CELL BIOL, V13, P1651, DOI 10.1128/MCB.13.3.1651; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KATAGIRI T, 1995, J BIOL CHEM, V270, P27987; KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KORETZKY GA, 1993, J BIOL CHEM, V268, P8958; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; LYNCH SA, 1986, SCIENCE, V234, P873, DOI 10.1126/science.3095923; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P4444, DOI 10.1073/pnas.87.12.4444; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; PLEIMAN CM, 1994, P NATL ACAD SCI USA, V91, P4268, DOI 10.1073/pnas.91.10.4268; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; ROSE JK, 1980, P NATL ACAD SCI-BIOL, V77, P3884, DOI 10.1073/pnas.77.7.3884; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; SCHRAVEN B, 1991, EUR J IMMUNOL, V21, P2469, DOI 10.1002/eji.1830211025; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; SU J, 1994, J BIOL CHEM, V269, P18731; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; TAYLOR SJ, 1993, CURR OPIN GENET DEV, V3, P26, DOI 10.1016/S0959-437X(05)80337-5; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TWAMLEY GM, 1992, ONCOGENE, V7, P1893; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; vanInzen WG, 1996, DEV BRAIN RES, V91, P304, DOI 10.1016/0165-3806(95)00186-7; WANG Y, 1991, EMBO J, V10, P3231, DOI 10.1002/j.1460-2075.1991.tb04886.x; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Wu L, 1997, J BIOL CHEM, V272, P6994, DOI 10.1074/jbc.272.11.6994; YAGI T, 1993, ONCOGENE, V8, P3343; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; ZHENG XM, 1994, J BIOL CHEM, V269, P23302; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	76	77	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8691	8698		10.1074/jbc.273.15.8691	http://dx.doi.org/10.1074/jbc.273.15.8691			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535845	hybrid			2022-12-27	WOS:000072990800022
J	Eguchi, S; Numaguchi, K; Iwasaki, H; Matsumoto, T; Yamakawa, T; Utsunomiya, H; Motley, ED; Kawakatsu, H; Owada, KM; Hirata, Y; Marumo, F; Inagami, T				Eguchi, S; Numaguchi, K; Iwasaki, H; Matsumoto, T; Yamakawa, T; Utsunomiya, H; Motley, ED; Kawakatsu, H; Owada, KM; Hirata, Y; Marumo, F; Inagami, T			Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATES TYROSINE PHOSPHORYLATION; RAT CARDIAC FIBROBLASTS; SIGNAL-TRANSDUCTION; PHOSPHOLIPASE C-GAMMA-1; COUPLED RECEPTORS; AT(1) RECEPTOR; MAP KINASES; C-JUN; SRC; PP60(C-SRC)	We have recently reported that angiotensin II (Ang II) induced mitogen-activated protein kinase (MAPK) activation is mainly mediated by Ca2+-dependent activation of a protein tyrosine kinase through G(q)-coupled Ang II type 1 receptor in cultured rat vascular smooth muscle cells (VSMC). In the present study, we found Ang II rapidly induced the tyrosine phosphorylation of the epidermal growth factor (EGF) receptor and its association with Shc and Grb2. These reactions were inhibited by the EGF receptor kinase inhibitor, AG1478. The Ang II-induced phosphorylation of the EGF receptor was mimicked by a Ca2+ ionophore and completely inhibited by an intracellular Ca2+ chelator. Thus, AG1478 abolished the MAPK activation induced by Ang II, a Ca2+ ionophore as well as EGF but not by a phorbol ester or platelet-derived growth factor-BE in the VSMC. Moreover, Ang II induced association of EGF receptor with catalytically active c-Src. This reaction was not affected by AG1478. These data indicate that Ang II induces Ca2+-dependent transactivation of the EGF receptor which serves as a scaffold for pre-activated c-Src and for downstream adaptors, leading to MAPK activation in VSMC.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Tokyo Med & Dent Univ, Dept Internal Med 2, Tokyo 113, Japan; Meharry Med Coll, Dept Anat & Physiol, Nashville, TN 37208 USA; Kyoto Pharmaceut Univ, Inst Mol & Cellular Biol Pharmaceut Sci, Kyoto 607, Japan	Vanderbilt University; Tokyo Medical & Dental University (TMDU); Meharry Medical College; Kyoto Pharmaceutical University	Inagami, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.				NHLBI NIH HHS [HL-03320, HL-58205, HL-35323] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058205, R37HL058205, R01HL035323, K14HL003320] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Chen YH, 1996, EMBO J, V15, P1037, DOI 10.1002/j.1460-2075.1996.tb00441.x; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DUFF JL, 1992, BIOCHEM BIOPH RES CO, V188, P257, DOI 10.1016/0006-291X(92)92378-B; EGUCHI S, 1994, ENDOCRINOLOGY, V134, P222, DOI 10.1210/en.134.1.222; Eguchi S, 1996, J BIOL CHEM, V271, P14169, DOI 10.1074/jbc.271.24.14169; GalchevaGargova Z, 1995, ONCOGENE, V11, P2649; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GIASSON E, 1995, J BIOL CHEM, V270, P5225, DOI 10.1074/jbc.270.10.5225; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; Goodfriend TL, 1996, NEW ENGL J MED, V334, P1649, DOI 10.1056/NEJM199606203342507; GRIENDLING KK, 1986, J BIOL CHEM, V261, P5901; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; INUI H, 1993, J BIOL CHEM, V268, P17045; ISHIDA M, 1995, CIRC RES, V77, P1053, DOI 10.1161/01.RES.77.6.1053; Kawakatsu H, 1996, J BIOL CHEM, V271, P5680, DOI 10.1074/jbc.271.10.5680; LEDUC I, 1995, J BIOL CHEM, V270, P4401, DOI 10.1074/jbc.270.9.4401; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; MARRERO MB, 1995, J BIOL CHEM, V270, P15734, DOI 10.1074/jbc.270.26.15734; MARRERO MB, 1994, J BIOL CHEM, V269, P10935; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; NAFTILAN AJ, 1990, MOL CELL BIOL, V10, P5536, DOI 10.1128/MCB.10.10.5536; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; POLTE TR, 1994, J CELL BIOCHEM, V55, P106, DOI 10.1002/jcb.240550113; PTASZNIK A, 1995, J BIOL CHEM, V270, P19969, DOI 10.1074/jbc.270.34.19969; ROCHE S, 1995, MOL CELL BIOL, V15, P1102; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Sadoshima J, 1996, EMBO J, V15, P775, DOI 10.1002/j.1460-2075.1996.tb00413.x; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; SAKAI H, 1995, J BIOL CHEM, V270, P21206; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; Schieffer B, 1996, J BIOL CHEM, V271, P10329, DOI 10.1074/jbc.271.17.10329; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SCHORB W, 1993, CIRC RES, V72, P1245, DOI 10.1161/01.RES.72.6.1245; SCHORB W, 1994, J BIOL CHEM, V269, P19626; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; TSUDA T, 1992, CIRC RES, V71, P620, DOI 10.1161/01.RES.71.3.620; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; WEBER H, 1994, J CLIN INVEST, V93, P788, DOI 10.1172/JCI117033; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	60	492	507	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8890	8896		10.1074/jbc.273.15.8890	http://dx.doi.org/10.1074/jbc.273.15.8890			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535870	hybrid			2022-12-27	WOS:000072990800047
J	Garcia-Higuera, I; Gaitatzes, C; Smith, TF; Neer, EJ				Garcia-Higuera, I; Gaitatzes, C; Smith, TF; Neer, EJ			Folding a WD repeat propeller - Role of highly conserved aspartic acid residues in the G protein beta subunit and Sec13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GAMMA; INVITRO	The beta subunit of the heterotrimeric G proteins that transduce signals across the plasma membrane is made up of an amino-terminal alpha-helical segment followed by seven repeating units called mo (Trp-Asp) repeats that occur in about 140 different proteins. The seven WD repeats in G beta, the only WD repeat protein whose crystal structure is known, form seven antiparallel beta sheets making up the blades of a toroidal propeller structure (Wall, M. A., Coleman, D. E., Lee, E., Iniguez-Lluhi, J. A., Posner, B. A., Gilman, A. Gr., and Sprang, S. R. (1995) Cell 83, 1047-1058; Sondek, J., Bohm, A., Lambright, D. G., Hamm, H. E., and Sigler, P. B. (1996) Nature 379, 369-374). It is likely that all proteins with WD repeats form a propeller structure. Alignment of the sequence of 918 unique WD repeats reveals that 85% of the repeats have an aspartic acid (D) residue (not the D of WD) in the turn connecting beta strands b and c of each putative propeller blade. We mutated each of these conserved Asp residues to Gly individually and in pairs in G beta and in Sec13, a yeast WD repeat protein involved in vesicular traffic, and then analyzed the ability of the mutant proteins to fold in vitro and in COS-7 cells. lit vitro, most single mutant G beta subunits fold into G beta gamma dimers more slowly than wild type to a degree that varies with the blade. In contrast, all single mutants form normal amounts of G beta gamma in COS-7 cells, although some dimers show subtle local distortions of structure. Most double mutants assemble poorly in both systems. We conclude that the conserved Asp residues are not equivalent and not all are essential for the folding of the propeller structure. Some may affect the folding pathway or the affinity for chaperonins. Mutations of the conserved Asp in Sec13 affect folding equally in vitro and in COS-7 cells. The repeats that most affected folding were not at the same position in Sec13 and G beta. Our finding, both in G beta and in Sec13, that no mutation of the conserved Asp entirely prevents folding suggests that there is no obligatory folding order for each repeat and that the folding order is probably not the same for different WD repeat proteins, or even necessarily constant for the same protein.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Biomol Engn Res Ctr, Boston, MA 02111 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University	Neer, EJ (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.		Garcia-Higuera, Irene/L-5004-2014	Garcia-Higuera, Irene/0000-0001-6331-075X	NIGMS NIH HHS [GM36259] Funding Source: Medline; NLM NIH HHS [P41 LM05205-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [P41LM005205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; GarciaHiguera I, 1996, J BIOL CHEM, V271, P528, DOI 10.1074/jbc.271.1.528; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; HARRISON SC, 1985, P NATL ACAD SCI USA, V82, P4028, DOI 10.1073/pnas.82.12.4028; JOBLING SA, 1987, NATURE, V325, P622, DOI 10.1038/325622a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; MENDE U, 1995, J BIOL CHEM, V270, P15892, DOI 10.1074/jbc.270.26.15892; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Saxena K, 1996, BIOCHEMISTRY-US, V35, P15215, DOI 10.1021/bi961616x; SCHMIDT CJ, 1991, J BIOL CHEM, V266, P4538; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	15	62	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9041	9049		10.1074/jbc.273.15.9041	http://dx.doi.org/10.1074/jbc.273.15.9041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535892	hybrid			2022-12-27	WOS:000072990800069
J	Mellet, P; Boudier, C; Mely, Y; Bieth, JG				Mellet, P; Boudier, C; Mely, Y; Bieth, JG			Stopped flow fluorescence energy transfer measurement of the rate constants describing the reversible formation and the irreversible rearrangement of the elastase-alpha(1)-proteinase inhibitor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PROTEINASE-INHIBITORS; 2-STEP REACTION-MECHANISM; RAY CRYSTAL-STRUCTURE; ALPHA-1-PROTEINASE INHIBITOR; EGLIN-C; SERPINS; ELASTASE; BINDING; RESOLUTION; KINETICS	Serpins are thought to inhibit proteinases by first forming a Michaelis-type complex that later converts into a stable inhibitory species, However, there is only circumstantial evidence for such a two-step reaction pathway, Here we directly observe the sequential appearance of two complexes by measuring the time-dependent change in fluorescence resonance energy transfer between fluorescein-elastase and rhodamine-alpha(1)-protease inhibitor, A moderately tight initial Michaelis-type complex EI1 (K-i = 0.38-0.52 mu M) forms and dissociates rapidly (k(1) = 1.5 x 10(6) M-1 s(-1), k(-1) = 0.58 s(-1)). EI1 then slowly converts into EI2 (k(2) = 0.13 s(-1)), the fluorescence intensity of which is stable for at least 50 s, The two species differ by their donor-acceptor energy transfer efficiency (0.41 and 0.26, respectively), EI2 might be the final product of the elastase + inhibitor association because its transfer efficiency is the same as that of a complex incubated for 30 min, The time-dependent change in fluorescence resonance energy transfer between fluorescein-elastase and rhodamine-eglin c, a canonical inhibitor, again allows the fast formation of a complex to be observed, However, this complex does not undergo any fluorescently detectable transformation.	Univ Louis Pasteur Strasbourg 1, Enzymol Lab, INSERM, U392, F-67000 Strasbourg, France; Univ Louis Pasteur Strasbourg 1, CNRS, URA 491, Biophys Lab, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bieth, JG (corresponding author), Fac Pharm, INSERM, U392, 74 Route Rhin, F-67401 Illkirch Graffenstaden, France.		Boudier, Christian/N-3841-2018	Boudier, Christian/0000-0002-5534-6389; Mellet, Philippe/0000-0001-5499-9735				Aertgeerts K, 1997, J STRUCT BIOL, V118, P236, DOI 10.1006/jsbi.1997.3860; BANZON JA, 1992, PROTEIN ENG, V5, P113, DOI 10.1093/protein/5.2.113; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BEATTY K, 1982, BIOCHIM BIOPHYS ACTA, V704, P221, DOI 10.1016/0167-4838(82)90149-2; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BIETH JG, 1984, BIOCHEM MED METAB B, V32, P387, DOI 10.1016/0006-2944(84)90046-2; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BOUDIER C, 1992, J BIOL CHEM, V267, P4370; BRUCH M, 1989, BIOCHEM J, V259, P929, DOI 10.1042/bj2590929; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; FALLER B, 1993, BIOCHEMISTRY-US, V32, P9230, DOI 10.1021/bi00086a031; FALLER B, 1990, BIOCHEM J, V270, P639, DOI 10.1042/bj2700639; Finkenstadt W. R., 1965, J BIOL CHEM, V240, P962; HIPLER K, 1992, FEBS LETT, V309, P139, DOI 10.1016/0014-5793(92)81082-W; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; MERCOLA DA, 1972, BIOCHEMISTRY-US, V11, P3860, DOI 10.1021/bi00771a005; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; OLSON ST, 1982, J BIOL CHEM, V257, P4891; PIGAULT C, 1984, PHOTOCHEM PHOTOBIOL, V40, P291, DOI 10.1111/j.1751-1097.1984.tb04590.x; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; SHIEH BH, 1989, J BIOL CHEM, V264, P13420; Song HK, 1995, FEBS LETT, V377, P150; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; STONE SR, 1987, ARCH BIOCHEM BIOPHYS, V252, P237, DOI 10.1016/0003-9861(87)90028-2; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; SUN XJ, 1989, EUR J BIOCHEM, V185, P225, DOI 10.1111/j.1432-1033.1989.tb15106.x; WEI A, 1994, STRUCT BIOL, V1, P251; Whisstock J, 1996, PROTEINS, V26, P288, DOI 10.1002/(SICI)1097-0134(199611)26:3<288::AID-PROT5>3.0.CO;2-A; WILCZYNSKA M, 1995, J BIOL CHEM, V270, P29652; Wilczynska M, 1997, NAT STRUCT BIOL, V4, P354, DOI 10.1038/nsb0597-354; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303; WRIGHT HT, 1990, J MOL BIOL, V213, P513	38	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9119	9123		10.1074/jbc.273.15.9119	http://dx.doi.org/10.1074/jbc.273.15.9119			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535901	hybrid			2022-12-27	WOS:000072990800078
J	Banfic, H; Downes, CP; Rittenhouse, SE				Banfic, H; Downes, CP; Rittenhouse, SE			Biphasic activation of PKB alpha/Akt in platelets - Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; PROTEIN-KINASE-C; THROMBIN; INTEGRIN; LIGAND; 3-KINASE; INHIBITION; RECEPTOR; BINDING; COMPLEX	Stimulation of platelet thrombin receptors or protein kinase C causes fibrinogen-dependent aggregation that is a function of integrin alpha(IIb)beta(3) activation. Such platelets rapidly and transiently form phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) and a small amount of phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P-2). After aggregation, a larger amount of PtdIns(3,4)P-2 is generated. We report that this latter PtdIns(3,4)P-2 arises largely through wortmannin-inhibitable generation of PtdIns3P and then phosphorylation by PtdIns3P 4-kinase (PtdIns3P 4-K), a novel pathway apparently contingent upon the activation of the Ca2+-dependent protease calpain. Elevation of cytosolic Ca2+ by ionophore, without integrin/ligand binding, is insufficient to activate the pathway. PtdIns3P 4-K is not the recently described "PIP5KII alpha." Cytoskeletal activities of phosphatidylinositol 3-kinase and PtdIns3P 4-K increase after aggregation. Prior to aggregation, PtdIns3P 4-K can be regulated negatively by the beta gamma subunit of heterotrimeric GTP-binding protein. After aggregation, PtdIns3P 4-K calpain-dependently loses its susceptibility to G beta gamma and is, in addition, activated. Both PtdIns(3,4,5)P-3 and PtdIns(3, 4)P-2 have been shown to stimulate PKB alpha/Akt phosphorylation and activation by phosphoinositide-dependent kinase 1. We find that activation of PKB alpha Akt in platelets is phosphorylation-dependent and biphasic; the initial phase is PtdIns(3,4,5)P-3-dependent and more efficient, whereas the second phase depends upon PtdIns(3,4)P-2 generated after aggregation. There is thus potential for both pre-and post aggregation-dependent signaling by PKB alpha Akt.	Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; Univ Dundee, Dept Biochem, Dundee DD1 4HN, Scotland	Jefferson University; Jefferson University; University of Dundee	Rittenhouse, SE (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, 1020 Locust St, Philadelphia, PA 19107 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038622] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 38622] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Banfic H, 1998, J BIOL CHEM, V273, P13, DOI 10.1074/jbc.273.1.13; CARTER AN, 1994, BIOCHEM J, V301, P415, DOI 10.1042/bj3010415; DIVECHA N, 1995, BIOCHEM J, V309, P715, DOI 10.1042/bj3090715; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; Hemmings BA, 1997, SCIENCE, V277, P534, DOI 10.1126/science.277.5325.534; Hinchliffe KA, 1996, EMBO J, V15, P6516, DOI 10.1002/j.1460-2075.1996.tb01042.x; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; Montsarrat N, 1997, FEBS LETT, V404, P23, DOI 10.1016/S0014-5793(97)00079-3; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Norris FA, 1997, J BIOL CHEM, V272, P10987; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; RYBAK MEM, 1989, J BIOL CHEM, V264, P14617; SINGH SS, 1993, BIOCHEM BIOPH RES CO, V195, P104, DOI 10.1006/bbrc.1993.2016; SORISKY A, 1992, BIOCHEM J, V286, P581, DOI 10.1042/bj2860581; SULTAN C, 1991, J BIOL CHEM, V266, P23554; Tang XW, 1997, J BIOL CHEM, V272, P14193, DOI 10.1074/jbc.272.22.14193; TOKER A, 1994, J BIOL CHEM, V269, P32358; Whiteford CC, 1997, BIOCHEM J, V323, P597, DOI 10.1042/bj3230597; YAMAGUCHI A, 1987, FEBS LETT, V225, P228, DOI 10.1016/0014-5793(87)81163-8; ZHANG J, 1995, J BIOL CHEM, V270, P6589, DOI 10.1074/jbc.270.12.6589; ZHANG J, 1995, J BIOL CHEM, V270, P22807, DOI 10.1074/jbc.270.39.22807; Zhang J, 1996, J BIOL CHEM, V271, P6265, DOI 10.1074/jbc.271.11.6265; ZHANG J, 1992, J BIOL CHEM, V267, P4686; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756	34	80	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11630	11637		10.1074/jbc.273.19.11630	http://dx.doi.org/10.1074/jbc.273.19.11630			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565582	hybrid			2022-12-27	WOS:000073536700036
J	Cai, JY; Jones, DP				Cai, JY; Jones, DP			Communication - Superoxide in apoptosis - Mitochondrial generation triggered by cytochrome c loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-DEATH; BCL-2; ACTIVATION; TNF; THIOLS; DNA	Activation of apoptosis is associated with generation of reactive oxygen species. The present research shows that superoxide is produced by mitochondria isolated from apoptotic cells due to a switch from the normal 4-electron reduction of O-2, to a 1-electron reduction when cytochrome c is released from mitochondria. Bcl-2, a protein that protects against apoptosis and blocks cytochrome c release, prevents superoxide production when it is overexpressed. The switch in electron transfer provides a mechanism for redox signaling that is concomitant with cytochrome c-dependent activation of caspases. The block of cytochrome c release provides a mechanism for the apparent antioxidant function of Bcl-2.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Jones, DP (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	dpjones@emory.edu			NEI NIH HHS [EY 07892] Funding Source: Medline; NIEHS NIH HHS [ES 09047] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY007892, R01EY007892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adachi S, 1997, J BIOL CHEM, V272, P21878, DOI 10.1074/jbc.272.35.21878; ALBRECHT H, 1994, FEBS LETT, V351, P45, DOI 10.1016/0014-5793(94)00817-5; ANDERSSON BS, 1987, AM J PHYSIOL, V252, pC349, DOI 10.1152/ajpcell.1987.252.4.C349; Atabay C, 1996, J NEUROSCI RES, V43, P465; Backway KL, 1997, CANCER RES, V57, P2446; Bustamante J, 1997, ARCH BIOCHEM BIOPHYS, V337, P121, DOI 10.1006/abbi.1996.9754; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Dobmeyer TS, 1997, FREE RADICAL BIO MED, V22, P775, DOI 10.1016/S0891-5849(96)00403-0; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hampton MB, 1998, BIOCHEM J, V329, P95; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HRISH T, 1997, BIOSCIENCE REP, V17, P67; Iwata S, 1997, J IMMUNOL, V158, P3108; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; JONES DP, 1995, IMMUNOL LETT, V205, P45; KAKINUMA K, 1978, BIOCHIM BIOPHYS ACTA, V538, P50, DOI 10.1016/0304-4165(78)90251-9; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kharbanda S, 1997, P NATL ACAD SCI USA, V94, P6939, DOI 10.1073/pnas.94.13.6939; Kim CN, 1997, CANCER RES, V57, P3115; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629; LASH LH, 1993, MITOCHONDRIAL DYSFUN, V2, P8; LEMASTERS JJ, 1994, METH TOXICOL, V1, P438; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Marchetti P, 1997, EUR J IMMUNOL, V27, P289, DOI 10.1002/eji.1830270142; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; ROST J, 1964, NATURE, V201, P185, DOI 10.1038/201185a0; ROTHE G, 1991, J IMMUNOL METHODS, V138, P133, DOI 10.1016/0022-1759(91)90074-P; SATO N, 1995, J IMMUNOL, V154, P3194; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Sies H., 1982, METABOLIC COMPARTMEN, P205; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Stefan C, 1997, CHEM RES TOXICOL, V10, P636, DOI 10.1021/tx970006a; Sun XM, 1996, CHEM-BIOL INTERACT, V100, P267, DOI 10.1016/0009-2797(96)03704-0; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang JH, 1997, AM J PHYSIOL-CELL PH, V272, pC1543, DOI 10.1152/ajpcell.1997.272.5.C1543; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	48	676	691	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11401	11404		10.1074/jbc.273.19.11401	http://dx.doi.org/10.1074/jbc.273.19.11401			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565547	hybrid			2022-12-27	WOS:000073536700001
J	Chellaiah, M; Fitzgerald, C; Alvarez, U; Hruska, K				Chellaiah, M; Fitzgerald, C; Alvarez, U; Hruska, K			c-Src is required for stimulation of gelsolin-associated phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; OSTEOCLASTIC BONE-RESORPTION; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; VITRONECTIN RECEPTOR; ALPHA-ACTININ; BINDING-SITE; SH2 DOMAINS; CELLS	me have shown that osteopontin binding to integrin alpha(v) beta(3) in osteoclasts stimulates gelsolin-associated phosphatidylinositol (PtdIns) 3-hydroxyl kinase (PI 3-kinase), leading to increased levels of gelsolin-bound Pt-dIns 3,4-P-2, PtdIns 4,5-P-2, and PtdIns 3,4,5-P-3, uncapping of barbed end actin, and actin filament formation. Inhibition of PI 3-kinase activity by wortmannin blocks osteopontin stimulation of actin filament formation, suggesting that activation of gelsolin-associated PI 3-kinase is an important pathway in cytoskeletal regulation. To study the mechanism of gelsolin-associated PI 3-kinase activation, we analyzed anti-gelsolin immunoprecipitates for the association of protein kinases. We demonstrated that c-Src co-immunoprecipitates with gelsolin, and that osteopontin stimulates its activity. Elimination of osteopontin-stimulated Src activity associated with gelsolin through antisense oligodeoxynucleotides blocked the stimulation of PI 3-kinase activity associated with gelsolin and the gelsolin-dependent cytoskeletal reorganization induced by osteopontin, including increased F-actin levels. In addition, treatment of osteoclasts with antisense oligonucleotides to Src reduced bone resorption. Our results demonstrate that osteopontin stimulates gelsolin-associated Src, leading to increased gelsolin-associated PI 3-kinase activity and PtdIns 3,4,5-P-3 levels, which facilitate actin filament formation, osteoclast motility, and bone resorption.	Washington Univ, Sch Med, Barnes Jewish Hosp, Div Renal, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL)	Hruska, K (corresponding author), Washington Univ, Sch Med, Barnes Jewish Hosp, Div Renal, 216 S Kingshighway, St Louis, MO 63110 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049728, P01DK009976] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41677] Funding Source: Medline; NIDDK NIH HHS [DK09976, DK49728] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVAREZ JI, 1991, ENDOCRINOLOGY, V128, P2324, DOI 10.1210/endo-128-5-2324; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BARRY E, 1993, BIOFEEDBACK, V15, P1019; BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565; BOYCE BF, 1993, BONE, V14, P335, DOI 10.1016/8756-3282(93)90161-3; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; BROWN PD, 1988, J CELL BIOL, V106, P171, DOI 10.1083/jcb.106.1.171; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chellaiah M, 1996, ENDOCRINOLOGY, V137, P2432, DOI 10.1210/en.137.6.2432; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; CHELLAIAH M, 1997, J BONE MINER RES, V12, pS137; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; COBB B, 1994, MOL CELL BIOL, V4, P147; COOPER J A, 1992, P47; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; DeCorte V, 1997, FEBS LETT, V401, P191, DOI 10.1016/S0014-5793(96)01471-8; Duncan RL, 1996, P NATL ACAD SCI USA, V93, P1864, DOI 10.1073/pnas.93.5.1864; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Fincham VJ, 1996, J CELL BIOL, V135, P1551, DOI 10.1083/jcb.135.6.1551; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; FUKUI Y, 1991, MOL CELL BIOL, V11, P1972, DOI 10.1128/MCB.11.4.1972; FUKUI Y, 1989, ONCOGENE RES, V4, P283; GRAVES DD, 1990, BIOCHEM J, V190, P407; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; GUTKIND JS, 1990, MOL CELL BIOL, V10, P3806, DOI 10.1128/MCB.10.7.3806; HALL TJ, 1994, BIOCHEM BIOPH RES CO, V199, P1237, DOI 10.1006/bbrc.1994.1363; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; HORNE WC, 1992, J CELL BIOL, V119, P1003, DOI 10.1083/jcb.119.4.1003; HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9; HRUSKA KA, 1995, ENDOCRINOLOGY, V136, P2984, DOI 10.1210/en.136.7.2984; IKEDA T, 1992, J HISTOCHEM CYTOCHEM, V40, P1079, DOI 10.1177/40.8.1619274; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; JACKSON TR, 1992, J BIOL CHEM, V267, P16627; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LIU X, 1993, MOL CELL BIOL, V13, P5226; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; NAKAMURA I, 1995, FEBS LETT, V361, P79, DOI 10.1016/0014-5793(95)00153-Z; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; ZAMBONINZALLONE A, 1989, EXP CELL RES, V182, P645, DOI 10.1016/0014-4827(89)90266-8	63	95	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11908	11916		10.1074/jbc.273.19.11908	http://dx.doi.org/10.1074/jbc.273.19.11908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565618	hybrid			2022-12-27	WOS:000073536700072
J	Frugier, M; Helm, M; Felden, B; Giege, R; Florentz, C				Frugier, M; Helm, M; Felden, B; Giege, R; Florentz, C			Sequences outside recognition sets are not neutral for tRNA aminoacylation - Evidence for nonpermissive combinations of nucleotides in the acceptor stem of yeast tRNA(Phe)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; PHENYLALANINE TRANSFER-RNA; MINOR GROOVE; BASE-PAIR; IDENTITY; HELIX; SPECIFICITY; TRNA(ALA); REMOVAL	Phenylalanine identity of yeast tRNA(p)he is governed by five nucleotides including residues A73, G20, and the three anticodon nucleotides (Sampson et al., 1989, Science 243, 1363-1366), Analysis of in vitro transcripts derived from yeast tRNA(Phe) and Escherichia coli tRNA(Ala) bearing these recognition elements shows that phenylalanyl-tRNA synthetase is sensitive to additional nucleotides within the acceptor stem. Insertion of G2-C71 has dramatic negative effects in both tRNA frameworks. These effects become compensated by a second-site mutation, the insertion of the wobble G3-U70 pair, which by itself has no effect on phenylalanylation. From a mechanistic point of view, the G2-C71/G3-U70 combination is not a "classical" recognition element since its antideterminant effect is compensated for by a second-site mutation. This enlarges our understanding of tRNA identity that appears not only to be the outcome of a combination of positive and negative signals forming the so-called recognition/identity set but that is also based on the presence of nonrandom combinations of sequences elsewhere in tRNA. These sequences, we name "permissive elements," are retained by evolution so that they do not hinder aminoacylation. Likely, no nucleotide within a tRNA is of random nature but has been selected so that a tRNA can fulfill all its functions efficiently.	CNRS, Inst Biol Mol & Cellulaire, UPR Struct Macromol Biol & Mecanism Reconnaissanc, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Giege, R (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR Struct Macromol Biol & Mecanism Reconnaissanc, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	giege@ibmc.u-strasbg.fr	felden, brice/L-4825-2015; Helm, Mark/AAD-5433-2022	Helm, Mark/0000-0002-0154-0928				ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; ALLAIN FHT, 1995, J MOL BIOL, V250, P333, DOI 10.1006/jmbi.1995.0381; Becker HD, 1996, BIOCHEMISTRY-US, V35, P7447, DOI 10.1021/bi9601058; BEHLEN LS, 1990, BIOCHEMISTRY-US, V29, P2515, DOI 10.1021/bi00462a013; Beuning PJ, 1997, P NATL ACAD SCI USA, V94, P10150, DOI 10.1073/pnas.94.19.10150; BROWNLEE GG, 1972, DETERMINATION SEQUEN; CAVARELLI J, 1992, STRUCTURAL TOOLS ANA, P287; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; FLORENTZ C, 1991, EUR J BIOCHEM, V195, P229, DOI 10.1111/j.1432-1033.1991.tb15698.x; FRANCKLYN C, 1992, EUR J BIOCHEM, V206, P315, DOI 10.1111/j.1432-1033.1992.tb16929.x; FRUGIER M, 1993, BIOCHEMISTRY-US, V32, P14053, DOI 10.1021/bi00213a039; Gabriel K, 1996, SCIENCE, V271, P195, DOI 10.1126/science.271.5246.195; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; HOU YM, 1992, BIOCHEMISTRY-US, V31, P10310, DOI 10.1021/bi00157a019; HOU YM, 1993, P NATL ACAD SCI USA, V90, P6776, DOI 10.1073/pnas.90.14.6776; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; KRZYZOSIAK WJ, 1988, BIOCHEMISTRY-US, V27, P5771, DOI 10.1021/bi00415a056; LADNER JE, 1975, P NATL ACAD SCI USA, V72, P4414, DOI 10.1073/pnas.72.11.4414; Limmer S, 1996, FEBS LETT, V385, P15, DOI 10.1016/0014-5793(96)00339-0; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P6147, DOI 10.1073/pnas.88.14.6147; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P9272, DOI 10.1073/pnas.88.20.9272; McClain William H., 1995, P335; MUSIERFORSYTH K, 1995, J AM CHEM SOC, V117, P7253, DOI 10.1021/ja00132a029; MUSIERFORSYTH K, 1992, NATURE, V357, P513, DOI 10.1038/357513a0; MUSIERFORSYTH K, 1991, SCIENCE, V253, P784, DOI 10.1126/science.1876835; PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0; PERRET V, 1992, J MOL BIOL, V226, P323, DOI 10.1016/0022-2836(92)90950-O; PERRET V, 1990, FEBS LETT, V270, P4, DOI 10.1016/0014-5793(90)81221-9; Ramos A, 1997, NUCLEIC ACIDS RES, V25, P2083, DOI 10.1093/nar/25.11.2083; RHODES D, 1977, EUR J BIOCHEM, V81, P91, DOI 10.1111/j.1432-1033.1977.tb11930.x; ROMBY P, 1985, J MOL BIOL, V184, P455, DOI 10.1016/0022-2836(85)90294-3; Rudinger J, 1996, EMBO J, V15, P650, DOI 10.1002/j.1460-2075.1996.tb00397.x; Saks ME, 1996, EMBO J, V15, P2843, DOI 10.1002/j.1460-2075.1996.tb00645.x; SAKS ME, 1994, SCIENCE, V263, P191, DOI 10.1126/science.7506844; SAMPSON JR, 1992, BIOCHEMISTRY-US, V31, P4161, DOI 10.1021/bi00132a002; SAMPSON JR, 1990, BIOCHEMISTRY-US, V29, P2523, DOI 10.1021/bi00462a014; SAMPSON JR, 1989, SCIENCE, V243, P1363; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SHI JP, 1990, BIOCHEMISTRY-US, V29, P3621, DOI 10.1021/bi00467a005; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8; WYATT JR, 1991, BIOTECHNIQUES, V11, P764	45	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11605	11610		10.1074/jbc.273.19.11605	http://dx.doi.org/10.1074/jbc.273.19.11605			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565578	Green Published, hybrid			2022-12-27	WOS:000073536700032
J	Griffiths, G; Cook, NJ; Gottfridson, E; Lind, T; Lidholt, K; Roberts, IS				Griffiths, G; Cook, NJ; Gottfridson, E; Lind, T; Lidholt, K; Roberts, IS			Characterization of the glycosyltransferase enzyme from the Escherichia coli K5 capsule gene cluster and identification and characterization of the glucuronyl active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSAMINYLTRANSFERASE REACTIONS; ENCODING PROTEINS; POLYSACCHARIDE; BIOSYNTHESIS; EXPRESSION; HEPARIN; BACTERIA; REGION-1; SEQUENCE; DISEASE	Bacterial capsular polysaccharides play an important role in virulence and survival. The Escherichia coli K5 capsule consists of a repeat structure of -4)GlcA-beta(1,4)GlcNAc alpha(1-, identical to N-acetylheparosan. A 60-kDa protein, KfiC, has been identified as a bifunctional glycosyltransferase, responsible for the alternating alpha and beta addition of each UDP-sugar to the nonreducing end of the polysaccharide chain. Using hydrophobic cluster analysis, a conserved secondary structure motif characteristic of beta-glycosyltransferases was identified along with two highly conserved aspartic acid residues at positions 301 and 352 within the KfiC protein. Site-directed mutagenesis was used to identify catalytically active amino acids within domain A of the KfiC protein. The conserved aspartic acid residues at 301 and 352 were shown to be critical for the beta addition of UDP-GlcA (uridine diphosphoglucuronic acid) to defined nonreducing end oligosaccharide accepters, suggesting that these conserved aspartic acid residues are catalytically important for beta-glycosyltransferase activity. A deleted derivative of the kfiC gene was generated, which encoded for a truncated KfiC (kfiC') protein. This protein lacked 139 amino acids at the C terminus. This enzyme had no UDP-GlcA transferase activity but still retained UDP-GlcNAc transferase activity, indicating that two separate active sites are present within the KfiC protein.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Uppsala Univ, Dept Med & Physiol Chem, Ctr Biomed, S-75123 Uppsala, Sweden	University of Manchester; Uppsala University	Roberts, IS (corresponding author), Univ Manchester, Sch Biol Sci, 1-800 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	ISROBERT@fs1.scg.man.ac.uk		Lind, Thomas/0000-0003-2791-688X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BRONNER D, 1993, FEMS MICROBIOL LETT, V113, P279, DOI 10.1016/0378-1097(93)90218-Q; BRONNER D, 1993, J BACTERIOL, V175, P5984, DOI 10.1128/JB.175.18.5984-5992.1993; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; DOUGHERTY BA, 1994, J BIOL CHEM, V269, P169; FINKE A, 1991, J BACTERIOL, V173, P4088, DOI 10.1128/jb.173.13.4088-4094.1991; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; JANN K, 1992, CAN J MICROBIOL, V38, P705, DOI 10.1139/m92-116; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; LEMESLEVARLOOT L, 1990, BIOCHIMIE, V72, P555, DOI 10.1016/0300-9084(90)90120-6; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; LIDHOLT K, 1994, CARBOHYD RES, V255, P87, DOI 10.1016/S0008-6215(00)90972-8; LIND T, 1993, J BIOL CHEM, V268, P20705; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; NAGAHASHI S, 1995, J BIOL CHEM, V270, P13961, DOI 10.1074/jbc.270.23.13961; Nataro J. P., 1994, P285; ORSKOV F, 1992, CAN J MICROBIOL, V38, P699, DOI 10.1139/m92-115; PAZZANI C, 1993, J BACTERIOL, V175, P5978, DOI 10.1128/JB.175.18.5978-5983.1993; PEARCE R, 1995, J BACTERIOL, V177, P3992, DOI 10.1128/jb.177.14.3992-3997.1995; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; ROBERTS IS, 1995, MICROBIOL-SGM, V141, P2023, DOI 10.1099/13500872-141-9-2023; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; SIEBERTH V, 1995, J BACTERIOL, V177, P4562, DOI 10.1128/jb.177.15.4562-4565.1995; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x	28	57	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11752	11757		10.1074/jbc.273.19.11752	http://dx.doi.org/10.1074/jbc.273.19.11752			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565598	hybrid			2022-12-27	WOS:000073536700052
J	Hrmova, M; MacGregor, EA; Biely, P; Stewart, RJ; Fincher, GB				Hrmova, M; MacGregor, EA; Biely, P; Stewart, RJ; Fincher, GB			Substrate binding and catalytic mechanism of a barley beta-D-glucosidase/(1,4)-beta-D-glucan exohydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; BETA-GLUCOSIDASE; GLYCOSYL HYDROLASES; SUBSITE AFFINITIES; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; HORDEUM-VULGARE; PROTEIN MODELS; SPECIFICITY; CELLOTETRAOSE	A beta-glucosidase, designated isoenzyme beta II, from germinated barley (Hordeum vulgare L.) hydrolyzes aryl-beta-glucosides and shares a high level of amino acid sequence similarity with beta-glucosidases of diverse origin. It releases glucose from the non-reducing termini of cellodextrins with catalytic efficiency factors, k(cat)/K-m, that increase approximately 9-fold as the degree of polymerization of these substrates increases from 2 to 6. Thus, the enzyme has a specificity and action pattern characteristic of both beta-glucosidases (EC 3.2.1.21) and the polysaccharide exohydrolase, (1,4)-beta-glucan glucohydrolase (EC 3.2.1.74). At high concentrations (100 mM) of 4-nitrophenyl beta-glucoside, beta-glucosidase isoenzyme beta II catalyzes glycosyl transfer reactions, which generate 4-nitrophenyl-beta-laminaribioside, -cellobioside, and -gentiobioside. Subsite mapping with cellooligosaccharides indicates that the barley beta-glucosidase isoenzyme beta II has six substrate-binding subsites, each of which binds an individual beta-glucosyl residue. Amino acid residues Glu(181) and Glu(391) are identified as the probable catalytic acid and catalytic nucleophile, respectively. The enzyme is a family 1 glycoside hydrolase that is likely to adopt a (beta/alpha)(8) barrel fold and in which the catalytic amino acid residues appear to be located at the bottom of a funnel-shaped pocket in the enzyme.	Univ Adelaide, Dept Plant Sci, Glen Osmond, SA 5064, Australia; Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; Slovak Acad Sci, Inst Chem, Bratislava 84238, Slovakia	University of Adelaide; University of Manitoba; Slovak Academy of Sciences	Fincher, GB (corresponding author), Univ Adelaide, Dept Plant Sci, Waite Campus, Glen Osmond, SA 5064, Australia.	gfincher@waite.adelaide.edu.au	Hrmova, Maria/AAH-3951-2020; Biely, Peter/ABF-3465-2020	Biely, Peter/0000-0002-9915-7707; Hrmova, Maria/0000-0002-3545-0605				ALLEN JD, 1976, BIOCHEM J, V159, P121, DOI 10.1042/bj1590121; [Anonymous], 1983, CARBOHYD POLYM, DOI 10.1016/0144-8617(83)90019-x; BARRETT T, 1995, STRUCTURE, V3, P951, DOI 10.1016/S0969-2126(01)00229-5; BIELY P, 1991, EUR J BIOCHEM, V200, P157, DOI 10.1111/j.1432-1033.1991.tb21062.x; BULIGA GS, 1986, CARBOHYD RES, V157, P139, DOI 10.1016/0008-6215(86)85065-0; CHEN L, 1993, J BIOL CHEM, V268, P13318; Coutinho PM, 1997, PROTEINS, V28, P162, DOI 10.1002/(SICI)1097-0134(199706)28:2<162::AID-PROT5>3.3.CO;2-0; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; Fischer D, 1996, PROTEIN SCI, V5, P947; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HIROMI K, 1973, BIOCHIM BIOPHYS ACTA, V302, P362, DOI 10.1016/0005-2744(73)90164-2; HOARE DG, 1967, J BIOL CHEM, V242, P2447; HRMOVA M, 1995, J BIOL CHEM, V270, P14556, DOI 10.1074/jbc.270.24.14556; Hrmova M, 1996, J BIOL CHEM, V271, P5277, DOI 10.1074/jbc.271.9.5277; HRMOVA M, 1993, BIOCHEM J, V289, P453, DOI 10.1042/bj2890453; IM H, 1995, CARBOHYD RES, V277, P145, DOI 10.1016/0008-6215(95)00212-C; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEAH R, 1995, J BIOL CHEM, V270, P15789, DOI 10.1074/jbc.270.26.15789; Legler G, 1977, Methods Enzymol, V46, P368; LEVY HM, 1963, J BIOL CHEM, V238, P3654; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MORRALL P, 1978, PHYTOCHEMISTRY, V17, P1495, DOI 10.1016/S0031-9422(00)94628-4; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V4, P281; NUCCI R, 1993, BIOTECHNOL APPL BIOC, V17, P239; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PEITSCH MC, 1993, INT IMMUNOL, V5, P233, DOI 10.1093/intimm/5.2.233; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; RAABO E, 1960, SCAND J CLIN LAB INV, V12, P402; RAYMOND S, 1995, MACROMOLECULES, V28, P2096, DOI 10.1021/ma00110a051; REESE ET, 1968, CAN J BIOCHEM CELL B, V46, P25, DOI 10.1139/o68-005; RIXON JE, 1992, BIOCHEM J, V285, P947, DOI 10.1042/bj2850947; Rost B, 1997, J MOL BIOL, V270, P471, DOI 10.1006/jmbi.1997.1101; ROST B, 1995, 3 INT C INT SYST MOL, P314; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; SAMUELS ML, 1991, STAT LIFE SCI; SAYLE R, 1996, RASMOL VERSION 2 6 M; SIMOS G, 1994, BBA-GEN SUBJECTS, V1199, P52, DOI 10.1016/0304-4165(94)90095-7; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; SUGANUMA T, 1978, J BIOCHEM-TOKYO, V84, P293, DOI 10.1093/oxfordjournals.jbchem.a132130; VARGHESE JN, 1994, P NATL ACAD SCI USA, V91, P2785, DOI 10.1073/pnas.91.7.2785; WOODWARD JR, 1982, CARBOHYD RES, V106, P111, DOI 10.1016/S0008-6215(00)80737-5	49	83	84	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11134	11143		10.1074/jbc.273.18.11134	http://dx.doi.org/10.1074/jbc.273.18.11134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556600	hybrid			2022-12-27	WOS:000073395200052
J	Veinger, L; Diamant, S; Buchner, J; Goloubinoff, P				Veinger, L; Diamant, S; Buchner, J; Goloubinoff, P			The small heat-shock protein IbpB from Escherichia coli stabilizes stress-denatured proteins for subsequent refolding by a multichaperone network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOFLUORESCENT ASTROCYTIC INCLUSIONS; MOLECULAR CHAPERONE; ALPHA-CRYSTALLIN; EXPRESSION; GROWTH; CELLS; DNAK	The role of small heat-shock proteins in Escherichia coli is still enigmatic. We show here that the small heat-shock protein IbpB is a molecular chaperone that assists the refolding of denatured proteins in the presence of other chaperones. IbpB oligomers bind and stabilize heat-denatured malate dehydrogenase (MDH) and ureadenatured lactate dehydrogenase and thus prevent the irreversible aggregation of these proteins during stress. While IbpB-stabilized proteins alone do not refold spontaneously, they are specifically delivered to the DnaK/DnaJ/GrpE (KJE) chaperone system where they refold in a strict ATPase-dependent manner. Although GroEL/GroES (LS) chaperonins do not interact directly with IbpB-released proteins, LS accelerate the rate of KJE-mediated refolding of IbpB-released MDH, and to a lesser extent lactate dehydrogenase, by rapidly processing KJE-released early intermediates. Kinetic and gelfiltration analysis showed that denatured MDH preferentially transfers from IbpB to KJE, then from KJE to LS, and then forms a active enzyme. IbpB thus stabilizes aggregation-prone folding intermediates during stress and, as an integral part of a cooperative multichaperone network, is involved in the active refolding of stress-denatured proteins.	Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Plant Sci, IL-91904 Jerusalem, Israel; Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany	Hebrew University of Jerusalem; University of Regensburg	Goloubinoff, P (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Plant Sci, IL-91904 Jerusalem, Israel.	pierre@vms.huji.ac.il	Buchner, Johannes/A-2651-2010	Goloubinoff, Pierre/0000-0002-4802-0807; Buchner, Johannes/0000-0003-1282-7737				ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; Buchberger A, 1996, J MOL BIOL, V261, P328, DOI 10.1006/jmbi.1996.0465; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; Corrales FJ, 1996, FOLD DES, V1, P265, DOI 10.1016/S1359-0278(96)00040-5; DIAMANT S, 1995, J BIOL CHEM, V270, P28387; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; EHRNSPERGER M, 1998, MOL CHAPERONES LIFE, P533; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Goloubinoff P, 1997, FEBS LETT, V407, P215, DOI 10.1016/S0014-5793(97)00348-7; HEAD MW, 1993, AM J PATHOL, V143, P1743; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; JAENICKE R, 1979, BIOCHEMISTRY-US, V18, P1217, DOI 10.1021/bi00574a016; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KNAUF U, 1992, FEBS LETT, V309, P297, DOI 10.1016/0014-5793(92)80793-G; LANDRY J, 1991, J CELL PHYSIOL, V147, P93, DOI 10.1002/jcp.1041470113; Laskowska E, 1996, BIOCHIMIE, V78, P117, DOI 10.1016/0300-9084(96)82643-5; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lorimer GH, 1996, FASEB J, V10, P5, DOI 10.1096/fasebj.10.1.8566548; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MYDLARSKI MB, 1993, BRAIN RES, V627, P113, DOI 10.1016/0006-8993(93)90754-B; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, V2, P1334; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PLESOFSKYVIG N, 1992, J MOL EVOL, V35, P537, DOI 10.1007/BF00160214; SCHIPPER HM, 1995, GLIA, V14, P55, DOI 10.1002/glia.440140108; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; Schonfeld HJ, 1995, PROG COLL POL SCI S, V99, P7; SCHRIMER EC, 1994, PLANT CELL, V6, P1899; TAKANO T, 1972, NATURE-NEW BIOL, V239, P34, DOI 10.1038/newbio239034a0; TOROK S, 1997, P NATL ACAD SCI USA, V94, P2192; VANDENIJSSEL PRLA, 1994, FEBS LETT, V355, P54, DOI 10.1016/0014-5793(94)01175-3; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; YOKOYAMA N, 1993, ACTA NEUROPATHOL, V85, P248; ZAVYALOV VP, 1995, FEMS IMMUNOL MED MIC, V11, P265, DOI 10.1016/0928-8244(95)00032-3; ZEILSTRARYALLS J, 1993, J BACTERIOL, V175, P1134, DOI 10.1128/JB.175.4.1134-1143.1993	39	281	293	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11032	11037		10.1074/jbc.273.18.11032	http://dx.doi.org/10.1074/jbc.273.18.11032			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556585	hybrid			2022-12-27	WOS:000073395200037
J	Wieder, T; Orfanos, CE; Geilen, CC				Wieder, T; Orfanos, CE; Geilen, CC			Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CANINE KIDNEY-CELLS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; TOPICAL TREATMENT; SKIN METASTASES; ALKYLPHOSPHOCHOLINES; CYTIDYLYLTRANSFERASE; PROLIFERATION; INHIBIT; DEATH	The prototype of a new class of antiproliferative phospholipid analogs, hexadecylphosphocholine (HePC), has been shown to inhibit tumor growth and is currently used for the treatment of cutaneous metastases of mammary carcinomas. Although several cellular targets of HePC, e.g. protein kinase C and CTP:phosphocholine cytidylyltransferase, have been proposed, the mechanisms of HePC-induced anticancer activity are still unclear, Considering that the antiproliferative effect of HePC correlates with inhibition of phosphatidylcholine biosynthesis, which is tightly coupled to sphingomyelin biosynthesis, we tested the hypothesis that treatment of cells with the anticancer drug leads to increased cellular ceramide and subsequently to apoptotic cell death. In the present study, we showed that 25 mu mol/liter HePC induced apoptosis, In further experiments, we demonstrated that HePC inhibited the incorporation of radio-labeled choline into phosphatidylcholine and at a later time point into sphingomyelin. This was confirmed by metabolic labeling of the lipid backbone using radio-labeled serine, and it was shown that HePC decreased the incorporation of serine into sphingomyelin by 35% and simultaneously increased the incorporation of serine into ceramide by 70%. Determination of the amount of ceramide revealed an increase of 53% in HePC-treated cells compared with controls. In accordance with the hypothesis that elevated ceramide levels may be the missing link between the metabolic effects of HePC and its proapoptotic properties, HePC-induced apoptosis was blocked by fumonisin B-1, an inhibitor of ceramide synthesis, Furthermore, we found that membrane-permeable ceramides additively increased the apoptotic effect of HePC.	Free Univ Berlin, Med Ctr Benjamin Franklin, Dept Dermatol, D-12200 Berlin, Germany; Free Univ Berlin, Med Ctr Benjamin Franklin, Inst Mol Biol & Biochem, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Geilen, CC (corresponding author), Free Univ Berlin, Med Ctr Benjamin Franklin, Dept Dermatol, Hindenburgdamm 30, D-12200 Berlin, Germany.							BERDEL WE, 1985, PHOSPHOLIPIDS CELLUL, V2, P41; BERKOVIC D, 1994, EUR J CANCER, V30A, P509, DOI 10.1016/0959-8049(94)90428-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; BOGGS KP, 1995, J BIOL CHEM, V270, P11612, DOI 10.1074/jbc.270.19.11612; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; Clive S, 1997, LANCET, V349, P621, DOI 10.1016/S0140-6736(05)61570-X; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DECHAVES EP, 1995, BIOCHEM J, V312, P411, DOI 10.1042/bj3120411; DETMAR M, 1994, J INVEST DERMATOL, V102, P490, DOI 10.1111/1523-1747.ep12373109; DIOMEDE L, 1993, INT J CANCER, V53, P124, DOI 10.1002/ijc.2910530123; Engelmann J, 1996, ANTICANCER RES, V16, P1429; FLEER EAM, 1993, LIPIDS, V28, P731, DOI 10.1007/BF02535995; GEILEN CC, 1994, BBA-LIPID LIPID MET, V1211, P14, DOI 10.1016/0005-2760(94)90133-3; Geilen CC, 1996, FEBS LETT, V378, P88, DOI 10.1016/0014-5793(95)01421-7; GEILEN CC, 1991, EUR J CANCER, V27, P1650, DOI 10.1016/0277-5379(91)90438-J; GEILEN CC, 1992, J BIOL CHEM, V267, P6719; GEILEN CC, 1992, J LABELLED COMPD RAD, V31, P1071, DOI 10.1002/jlcr.2580311216; GEILEN CC, 1994, J LIPID RES, V35, P625; HAASE R, 1991, FEBS LETT, V288, P129, DOI 10.1016/0014-5793(91)81018-4; HAMPTON RY, 1989, SCIENCE, V246, P1050, DOI 10.1126/science.2555921; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P72; HESBEEN EC, 1991, FEBS LETT, V290, P231; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; JI L, 1995, FEBS LETT, V358, P211, DOI 10.1016/0014-5793(94)01428-4; KALEN A, 1992, BIOCHIM BIOPHYS ACTA, V1125, P90, DOI 10.1016/0005-2760(92)90160-W; Merrill AH, 1996, TRENDS CELL BIOL, V6, P218, DOI 10.1016/0962-8924(96)10021-0; NAKAMURA S, 1993, ADV SEC MESS PHOSPH, V28, P171; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; SPENCE MW, 1989, PHOSPHATIDYLCHOLINE, P185; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TOUCHSTONE JC, 1980, LIPIDS, V15, P61, DOI 10.1007/BF02534120; UBERALL F, 1991, CANCER RES, V51, P807; UNGER C, 1992, PROG EXP TUMOR RES, V34, P153; UNGER C, 1992, PROG EXP TUMOR RES, V34, P25; UNGER C, 1989, ACTA ONCOL, V28, P213, DOI 10.3109/02841868909111249; UNGER C, 1988, ONKOLOGIE, V11, P295, DOI 10.1159/000216563; VOGLER WR, 1985, EXP HEMATOL, V13, P629; Vogler WR, 1996, LEUKEMIA RES, V20, P947, DOI 10.1016/S0145-2126(96)00070-7; WIEDER T, 1993, BIOCHEM J, V291, P561, DOI 10.1042/bj2910561; Wieder T, 1997, FEBS LETT, V411, P260, DOI 10.1016/S0014-5793(97)00717-5; WIEDER T, 1995, LIPIDS, V30, P389, DOI 10.1007/BF02536296; Wieder T, 1996, CANCER LETT, V100, P71, DOI 10.1016/0304-3835(95)04072-2; WIEDER T, 1995, BIOCHEM J, V311, P873, DOI 10.1042/bj3110873; ZEISIG R, 1991, ANTI-CANCER DRUG, V2, P411, DOI 10.1097/00001813-199108000-00012; ZHENG B, 1990, CANCER RES, V50, P3025	48	146	147	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11025	11031		10.1074/jbc.273.18.11025	http://dx.doi.org/10.1074/jbc.273.18.11025			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556584	hybrid			2022-12-27	WOS:000073395200036
J	Zhang, HP; Varmalova, O; Vargas, FM; Falany, CN; Leyh, TS				Zhang, HP; Varmalova, O; Vargas, FM; Falany, CN; Leyh, TS			Sulfuryl transfer: The catalytic mechanism of human estrogen sulfotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC SULFOTRANSFERASES; BINDING; SULFATION; RECEPTORS; PANCREAS; PROTEINS; LIGAND; CELLS	Estrogen sulfotransferase (EST) catalyzes the transfer of the sulfuryl group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to 17 beta-estradiol (E-2), The sulfation of E-2 prevents it from binding to, and thereby activating, the estrogen receptor. The regulation of EST appears to be causally linked to tumorigenesis in the breast and endometrium. In this study, recombinant human EST is characterized, and the catalytic mechanism of the transfer reaction is investigated in ligand binding and initial rate experiments. The native enzyme is a dimer of 35-kDa subunits, The apparent equilibrium constant for transfer to E-2 is (4.5 +/- 0.2) x 10(3) at pH 6.3 and T = 25 +/- 2 degrees C. Initial rate studies provide the kinetic constants for the reaction and suggest a sequential mechanism. E-2 is a partial substrate inhibitor (K-i = 80 +/- 5 nM). The binding of two E-2 per EST subunit suggests that the partial inhibition occurs through binding at an allosteric site. In addition to providing the dissociation constants for the ligand-enzyme complexes, binding studies demonstrate that each substrate binds independently to the enzyme and that both the E.PAP.E2S and E.PAP.E-2 dead-end complexes form. These results strongly suggest a Random Ri Ri mechanism with two dead-end complexes.	Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Univ Alabama, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA	Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham	Leyh, TS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038953, R29GM038953, R01GM054469] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54469, GM38953] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND SJ, 1984, NATURE, V309, P456, DOI 10.1038/309456a0; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W. W, 1970, ENZYMES, V2, P1; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R; FALANY CN, 1994, J STEROID BIOCHEM, V48, P369, DOI 10.1016/0960-0760(94)90077-9; Falany JL, 1996, CANCER RES, V56, P1551; FALANY JL, 1998, IN PRESS ONCOL RES; FROMM HJ, 1975, INITIAL RATE ENZYME, P145; GARAY RP, 1990, J PHARMACOL EXP THER, V255, P415; GORSKI J, 1968, J BIOL CHEM, V244, P1097; GUERRERO R, 1975, CONTRACEPTION, V11, P169, DOI 10.1016/0010-7824(75)90028-1; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4820, DOI 10.1021/bi00182a010; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P5172, DOI 10.1021/bi00473a025; JENSEN RT, 1982, J BIOL CHEM, V257, P5554; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; LEYH TS, 1993, CRIT REV BIOCHEM MOL, V28, P515, DOI 10.3109/10409239309085137; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MERRIAM GR, 1980, STEROIDS, V36, P1, DOI 10.1016/0039-128X(80)90062-8; Miller J. H., 1972, EXPT MOL GENETICS, P431; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; UNSWORTH CD, 1982, NATURE, V295, P519, DOI 10.1038/295519a0; WARD LD, 1985, METHOD ENZYMOL, V117, P400; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4	27	192	195	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					10888	10892		10.1074/jbc.273.18.10888	http://dx.doi.org/10.1074/jbc.273.18.10888			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556564	hybrid			2022-12-27	WOS:000073395200016
J	He, XY; Schulz, H; Yang, SY				He, XY; Schulz, H; Yang, SY			A human brain L-3-hydroxyacyl coenzyme A dehydrogenase is identical to an amyloid p-peptide-binding protein involved in Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; ENOYL-COA HYDRATASE; ESCHERICHIA-COLI; SHORT-CHAIN; 20-BETA-HYDROXYSTEROID DEHYDROGENASE; 3-HYDROXYACYL-COA DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; BETA-OXIDATION; FADB GENE	A novel L-3-hydroxyacyl-CoA dehydrogenase from human brain has been cloned, expressed, purified, and characterized. This enzyme is a homotetramer with a molecular mass of 108 kDa. Its subunit consists of 261 amino acid residues and has structural features characteristic of short chain dehydrogenases. It was found that the amino acid sequence of this human brain enzyme is identical to that of an endoplasmic reticulum amyloid beta-peptide-binding protein (ERAB), which mediates neurotoxicity in Alzheimer's disease (Yan, S. D., Fu, J., Soto, C., Chen, X, Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A, Stern, E., Saido, T., Tohyama, M., Ogawa, S., Roher, A, and Stern, D. (1997) Nature 389, 689-695). The purification of human brain short chain L-3-hydroxyacyl-CoA dehydrogenase made it possible to characterize the structural and catalytic properties of ERAB. This NAD(+)-dependent dehydrogenase catalyzes the reversible oxidation of L-3-hydroxyacyl-CoAs to form 3-ketoacyl-CoAs, but it does not act on the D-isomers. The catalytic rate constant of the purified enzyme was estimated to be 37 s(-1) with apparent K-m values of 89 and 20 mu M for aceto-acetyl-CoA and NADH, respectively. The activity ratio of this enzyme for substrates with chain lengths of C-4, C-8, and C-16 was similar to 1:2:2. The human short chain L-5-hydroxyacyl-CoA dehydrogenase gene is organized into six exons and five introns and maps to chromosome Xp11.2. The amino-terminal NAD-binding region of the dehydrogenase is encoded by the first three exons, whereas the other exons code for the carboxyl-terminal substrate-binding region harboring putative catalytic residues. The results of this study lead to the conclusion that ERAB involved in neuronal dysfunction is encoded by the human short chain L-3-hydroxyacyl-CoA dehydrogenase gene.	New York State Inst Basic Res Dev Disabil, Dept Pharmacol, Staten Isl, NY 10314 USA; CUNY City Coll, Dept Chem, New York, NY 10031 USA	Institute for Basic Research in Developmental Disabilities; City University of New York (CUNY) System; City College of New York (CUNY)	Yang, SY (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Pharmacol, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.				NHLBI NIH HHS [HL30847] Funding Source: Medline; NIDDK NIH HHS [DK47392] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047392] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAKAWA H, 1990, J BIOCHEM-TOKYO, V107, P160, DOI 10.1093/oxfordjournals.jbchem.a123001; Beyreuther K, 1997, NATURE, V389, P677, DOI 10.1038/39479; Binstock J F, 1981, Methods Enzymol, V71 Pt C, P403; BIRKTOFT JJ, 1987, P NATL ACAD SCI USA, V84, P8262, DOI 10.1073/pnas.84.23.8262; BLACKSHEAR PJ, 1984, METHOD ENZYMOL, V104, P237; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; CHEN Z, 1993, BIOCHEMISTRY-US, V32, P3342, DOI 10.1021/bi00064a017; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; EDWARDS CAF, 1978, BIOCHEMISTRY-US, V17, P4370, DOI 10.1021/bi00614a003; FREUND K, 1985, BIOCHEMISTRY-US, V24, P5996, DOI 10.1021/bi00342a046; Furuta S, 1997, BBA-GENE STRUCT EXPR, V1350, P317, DOI 10.1016/S0167-4781(96)00171-6; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; GOLDMAN P, 1961, J BIOL CHEM, V236, P2620; He XY, 1996, BIOCHEMISTRY-US, V35, P9625, DOI 10.1021/bi960374y; He XY, 1997, BIOCHEMISTRY-US, V36, P261, DOI 10.1021/bi961841e; HE XY, 1989, ANAL BIOCHEM, V180, P105, DOI 10.1016/0003-2697(89)90095-X; Jarabak J, 1969, METHOD ENZYMOL, V15, P746, DOI DOI 10.1016/S0076-6879(69)15041-7; Kobayashi A, 1996, J BIOCHEM-TOKYO, V119, P775, DOI 10.1093/oxfordjournals.jbchem.a021307; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MAREKOV L, 1990, FEBS LETT, V266, P51, DOI 10.1016/0014-5793(90)81504-H; PEOPLES OP, 1989, MOL MICROBIOL, V3, P349, DOI 10.1111/j.1365-2958.1989.tb00180.x; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; Scopes R. K, 1994, PROTEIN PURIFICATION, V3rd, DOI 10.1007/978-1-4757-2333-5; Segel IH, 1975, ENZYME KINETICS BEHA; SEUBERT W, 1960, BIOCHEM PREP, V7, P80; STRICKLER JE, 1984, ANAL BIOCHEM, V140, P533; THORPE C, 1986, ANAL BIOCHEM, V155, P391, DOI 10.1016/0003-2697(86)90452-5; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Yan SD, 1997, NATURE, V389, P689; YANG SY, 1994, COMP BIOCHEM PHYS B, V109, P557, DOI 10.1016/0305-0491(94)90117-1; YANG SY, 1988, J BACTERIOL, V170, P2543, DOI 10.1128/jb.170.6.2543-2548.1988; YANG SY, 1987, J BIOL CHEM, V262, P13027; YANG XYH, 1991, BIOCHEMISTRY-US, V30, P6788, DOI 10.1021/bi00241a023	37	108	111	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10741	10746		10.1074/jbc.273.17.10741	http://dx.doi.org/10.1074/jbc.273.17.10741			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553139	hybrid			2022-12-27	WOS:000073224200088
J	Jenkins, TD; Opitz, OG; Okano, J; Rustgi, AK				Jenkins, TD; Opitz, OG; Okano, J; Rustgi, AK			Transactivation of the human keratin 4 and Epstein-Barr virus ED-L2 promoters by gut-enriched Kruppel-like factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; BOX-BINDING PROTEIN; TRANSCRIPTION FACTOR; FACTOR EKLF; EXPRESSION; CELLS; FAMILY; IDENTIFICATION; CARCINOMAS; EPITHELIA	The Kruppel-like family of transcription factors comprises genes that appear to have tissue-restricted functions, Expression of gut-enriched Kruppel-like factor (GKLF) may be important in the switch from proliferation to differentiation in the squamous epithelium, We sought to determine transcriptionally mediated effects of GKLF on two promoters active in the esophageal squamous epithelium, namely the Epstein-Barr virus ED-LS and human keratin 4 promoters. Both promoters contain a CACCC-like motif previously shown to bind GKLF. To determine whether GI(LF regulates genes containing this element, we first demonstrated expression and then cloned the full-length human GI(LF hom an esophageal squamous carcinoma cell line. In a transient transfection system, GKLF increased the activity of both promoters >25-fold, localized to regions containing the CACCC-like element, Recombinant GKLF specifically binds the CACCC-like motif in both promoters. GKLF epitope-tagged protein leads to the formation of two proteins of 65 and 34 kDa. The chromatographically purified 65-kDa protein binds the CACCC-like element from both Epstein-Barr virus ED-L2 and keratin 4 promoters, which is not attenuated by the 34-kDa protein. In summary, GKLF is expressed in esophageal squamous epithelial cells and transcriptionally activates two esophageal epithelial promoters important at the transition toward differentiation.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Hematol Oncol Unit, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Rustgi, AK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Jackson 904,50 Blossom St, Boston, MA 02114 USA.				NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191, R01DK053377] Funding Source: NIH RePORTER; NIDCR NIH HHS [1P01-DE12467-01A1] Funding Source: Medline; NIDDK NIH HHS [R01-DK53377, DK07191] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHSEE KW, 1994, CANCER RES, V54, P1617; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; BYRNE C, 1993, DEVELOPMENT, V94, P2369; CASATORRES J, 1994, J BIOL CHEM, V269, P20489; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Falchuk K H, 1993, Prog Clin Biol Res, V380, P91; FARRELL PJ, 1983, EMBO J, V2, P1331, DOI 10.1002/j.1460-2075.1983.tb01588.x; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Harlow E., 1988, ANTIBODIES LABORATOR, P1; Jenkins TD, 1997, J BIOL CHEM, V272, P24433, DOI 10.1074/jbc.272.39.24433; Jerpseth B., 1992, STRATEGIES MOL BIOL, V5, P81; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Miura K, 1996, CANCER RES, V56, P1629; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Nakagawa H, 1997, ONCOGENE, V14, P1185, DOI 10.1038/sj.onc.1200937; Nakagawa H, 1997, J BIOL CHEM, V272, P16688, DOI 10.1074/jbc.272.26.16688; NAKAGAWA H, 1995, CANCER-AM CANCER SOC, V76, P541, DOI 10.1002/1097-0142(19950815)76:4<541::AID-CNCR2820760402>3.0.CO;2-I; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Rosenberg IM, 1996, PROTEIN ANAL PURIFIC, P265; Shields JM, 1997, J BIOL CHEM, V272, P18504, DOI 10.1074/jbc.272.29.18504; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SHORT JM, 1992, METHOD ENZYMOL, V216, P495; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; VANMUIJEN GNP, 1986, EXP CELL RES, V162, P97, DOI 10.1016/0014-4827(86)90429-5; WILSON JB, 1990, CELL, V61, P1315, DOI 10.1016/0092-8674(90)90695-B	36	76	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10747	10754		10.1074/jbc.273.17.10747	http://dx.doi.org/10.1074/jbc.273.17.10747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553140	hybrid			2022-12-27	WOS:000073224200089
J	Ohnishi, M; Yamawaki-Kataoka, Y; Kariya, K; Tamada, M; Hu, CD; Kataoka, T				Ohnishi, M; Yamawaki-Kataoka, Y; Kariya, K; Tamada, M; Hu, CD; Kataoka, T			Selective inhibition of ras interaction with its particular effector by synthetic peptides corresponding to the ras effector region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE DISSOCIATION STIMULATOR; AMINO-ACID-RESIDUES; SIGNAL-TRANSDUCTION; H-RAS; SCHIZOSACCHAROMYCES-POMBE; FLUORESCENCE POLARIZATION; GTPASE ACTIVITY; IN-VITRO; B-RAF; PROTEIN	Ras proteins possess multiple downstream effecters of distinct structures. We and others demonstrated that Ha-Ras carrying certain effector region mutations could interact differentially with its effecters, implying that significant differences exist in their Ras recognition mechanisms. Here, by employing the fluorescence polarization method, we measured the activity of effector region synthetic peptides bearing various amino acid substitutions to inhibit association of Ras with the effecters human Raf-l and Schizosaccharomyces pombe Byr2. The effect of these peptides on association with another effector Saccharomyces cerevisiae adenylyl cyclase was also examined by measuring inhibition of the Res-dependent adenylyl cyclase activity. The peptide corresponding to the residues 17-44 competitively inhibited Ras association with all the three effecters at the K-i values of 1 similar to 10 mu M, and the inhibition was considerably attenuated by the D38A mutation. The peptide with the D38N mutation inhibited association of Ha-Ras with Byr2 but not with the others, whereas that with the P34G: mutation inhibited association of Ha-Ras with Raf-l and Byr2 but not with adenylyl cyclase. Thus, the specificity observed with the whole Ras protein was retained in the effector region peptide. These results suggest that the effector region residues constitute a major determinant for differential recognition of the effector molecules, raising a possibility for selective inhibition of a particular Ras function.	Kobe Univ, Sch Med, Dept Physiol 2, Chuo Ku, Kobe, Hyogo 650, Japan	Kobe University	Kataoka, T (corresponding author), Kobe Univ, Sch Med, Dept Physiol 2, Chuo Ku, 7-5-1 Kusonoki Cho, Kobe, Hyogo 650, Japan.	kataoka@kobe-u.ac.jp						Akasaka K, 1996, J BIOL CHEM, V271, P5353, DOI 10.1074/jbc.271.10.5353; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Barnard D, 1995, ONCOGENE, V10, P1283; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; CHECOVICH WJ, 1995, NATURE, V375, P254, DOI 10.1038/375254a0; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DIAZMECO MT, 1994, J BIOL CHEM, V269, P31706; FUJITAYOSHIGAKI J, 1995, J BIOL CHEM, V270, P4661, DOI 10.1074/jbc.270.9.4661; FUJITAYOSHIGAKI J, 1991, FEBS LETT, V294, P187, DOI 10.1016/0014-5793(91)80665-P; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; GIBBS JB, 1989, MICROBIOL REV, V53, P171, DOI 10.1128/MMBR.53.2.171-185.1989; Gorman C, 1996, J BIOL CHEM, V271, P6713, DOI 10.1074/jbc.271.12.6713; HAN LM, 1995, MOL CELL BIOL, V15, P1318; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; Hu CD, 1995, J BIOL CHEM, V270, P30274, DOI 10.1074/jbc.270.51.30274; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; MAEDA H, 1979, ANAL BIOCHEM, V92, P222, DOI 10.1016/0003-2697(79)90649-3; MARSHALL MS, 1993, TRENDS BIOCHEM SCI, V18, P250, DOI 10.1016/0968-0004(93)90175-M; MARSHALL MS, 1991, MOL CELL BIOL, V11, P3997, DOI 10.1128/MCB.11.8.3997; MASUDA T, 1995, J BIOL CHEM, V270, P1979, DOI 10.1074/jbc.270.5.1979; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MINATO T, 1994, J BIOL CHEM, V269, P20845; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NUREKAMAL MSA, 1992, J BIOL CHEM, V267, P1415; Okada T, 1996, J BIOL CHEM, V271, P4671; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Perrin F, 1926, J PHYS-PARIS, V7, P390, DOI 10.1051/jphysrad:01926007012039000; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; PUMIGLIA K, 1995, MOL CELL BIOL, V15, P398, DOI 10.1128/MCB.15.1.398; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Shima F, 1997, MOL CELL BIOL, V17, P1057, DOI 10.1128/MCB.17.3.1057; Shinkai M, 1996, BIOCHEM BIOPH RES CO, V223, P729, DOI 10.1006/bbrc.1996.0964; SHIROUZU M, 1994, ONCOGENE, V9, P2153; SHIROUZU M, 1992, ONCOGENE, V7, P475; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WANG Y, 1991, MOL CELL BIOL, V11, P3554, DOI 10.1128/MCB.11.7.3554; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WEBER G, 1953, ADV PROTEIN CHEM, V8, P415, DOI 10.1016/S0065-3233(08)60096-0; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646; Winkler DG, 1997, J BIOL CHEM, V272, P24402, DOI 10.1074/jbc.272.39.24402	49	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10210	10215		10.1074/jbc.273.17.10210	http://dx.doi.org/10.1074/jbc.273.17.10210			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553071	hybrid			2022-12-27	WOS:000073224200020
J	de Virgilio, M; Weninger, H; Ivessa, NE				de Virgilio, M; Weninger, H; Ivessa, NE			Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION; RAT-LIVER; GOLGI-APPARATUS; RIBOPHORIN-I; INTRACELLULAR-TRANSPORT; MOLECULAR CHAPERONE; SECRETORY PATHWAY; MEMBRANE-PROTEIN; UDP-GLC; CALNEXIN	In the endoplasmic reticulum (ER), an efficient "quality control system" operates to ensure that mutated and incorrectly folded proteins are selectively degraded. We are studying ER-associated degradation using a truncated variant of the rough ER-specific type I transmembrane glycoprotein, ribophorin I. The truncated polypeptide (RI332) consists of only the 332 amino-terminal amino acids of the protein corresponding to most of its luminal domain and, in contrast to the long-lived endogenous ribophorin I, is rapidly degraded. Here we show that the ubiquitin-proteasome pathway is involved in the destruction of the truncated ribophorin I. Thus, when RI332 that itself appears to be a substrate for ubiquitination was expressed in a mutant hamster cell line harboring a temperature-sensitive mutation in the ubiquitin-activating enzyme El affecting ubiquitin dependent proteolysis, the protein is dramatically stabilized at the restrictive temperature. Moreover, inhibitors of proteasome function effectively block the degradation of RI332. Cell fractionation experiments indicate that RI332 accumulates in the cytosol when degradation is prevented by proteasome inhibitors but remains associated with the lumen of the ER under ubiquitination deficient conditions, suggesting that the release of the protein into the cytosol is ubiquitination-dependent. Accordingly, when ubiquitination is impaired, a considerable amount of RI332, binds to the ER chaperone calnexin and to the Sec61 complex that could effect retro-translocation of the polypeptide to the cytosol, Before proteolysis of RI332, its N-linked oligosaccharide is cleaved in two distinct steps, the first of which might occur when the protein is still associated with the ER, as the trimmed glycoprotein intermediate efficiently interacts with calnexin and Sec61, From our data we conclude that the steps that lead a newly synthesized luminal ER glycoprotein to degradation by the proteasome are tightly coupled and that especially ubiquitination plays a crucial role in the retro-translocation of the substrate protein for proteolysis to the cytosol.	Univ Vienna, Dept Mol Genet, A-1030 Vienna, Austria; Bioctr Vienna, A-1030 Vienna, Austria	University of Vienna; Vienna Biocenter (VBC)	Ivessa, NE (corresponding author), Univ Vienna, Dept Mol Genet, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	ivessa@mol.univie.ac.at						BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P123; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; BISCHOFF J, 1986, J BIOL CHEM, V261, P4766; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; CRIMAUDO C, 1987, EMBO J, V6, P75, DOI 10.1002/j.1460-2075.1987.tb04721.x; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; DICE JF, 1987, FASEB J, V1, P349, DOI 10.1096/fasebj.1.5.2824267; Ermonval M, 1997, J CELL SCI, V110, P323; ESSER V, 1988, J BIOL CHEM, V263, P13276; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; GALLAGHER SR, 1996, CURRENT PROTOCOLS MO, V2; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HARNIKORT V, 1987, J CELL BIOL, V104, P855, DOI 10.1083/jcb.104.4.855; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; HURTLEY SM, 1989, ANN REV CELL BIOL, V5, P227; IVESSA NE, 1992, J CELL BIOL, V117, P949, DOI 10.1083/jcb.117.5.949; IVESSA NE, 1995, J BIOL CHEM, V270, P25960, DOI 10.1074/jbc.270.43.25960; JASMIN BJ, 1989, P NATL ACAD SCI USA, V86, P7218, DOI 10.1073/pnas.86.18.7218; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KNITTLER MR, 1995, P NATL ACAD SCI USA, V92, P1764, DOI 10.1073/pnas.92.5.1764; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; KRUPPA J, 1977, J CELL BIOL, V74, P414, DOI 10.1083/jcb.74.2.414; KULKA RG, 1988, J BIOL CHEM, V263, P15726; LABRIOLA C, 1995, J CELL BIOL, V130, P771, DOI 10.1083/jcb.130.4.771; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; LAMBERT N, 1985, BIOCHEM J, V228, P635, DOI 10.1042/bj2280635; LAU MMH, 1989, J BIOL CHEM, V264, P21376; LE A, 1990, J BIOL CHEM, V265, P14001; LE AQ, 1994, J BIOL CHEM, V269, P7514; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; Lippincott-Schwartz Jennifer, 1993, Trends in Cell Biology, V3, P81, DOI 10.1016/0962-8924(93)90078-F; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; MARCANTONIO EE, 1984, J CELL BIOL, V99, P2254, DOI 10.1083/jcb.99.6.2254; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MCCRACKEN AA, 1993, MOL BIOL CELL, V4, P729, DOI 10.1091/mbc.4.7.729; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; PIND S, 1994, J BIOL CHEM, V269, P12784; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; Rodan AR, 1996, EMBO J, V15, P6921, DOI 10.1002/j.1460-2075.1996.tb01084.x; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROSENFELD MG, 1984, J CELL BIOL, V99, P1076, DOI 10.1083/jcb.99.3.1076; Smith SE, 1996, BIOL CHEM, V377, P437; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; WADA I, 1991, J BIOL CHEM, V266, P19599; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Weng SA, 1996, ARCH BIOCHEM BIOPHYS, V325, P113, DOI 10.1006/abbi.1996.0014; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3	74	145	146	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9734	9743		10.1074/jbc.273.16.9734	http://dx.doi.org/10.1074/jbc.273.16.9734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545309	hybrid			2022-12-27	WOS:000073128800055
J	Farr, CD; Slepenkov, SV; Witt, SN				Farr, CD; Slepenkov, SV; Witt, SN			Visualization of a slow, ATP-induced structural transition in the bacterial molecular chaperone DnaK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; X-RAY-SCATTERING; ESCHERICHIA-COLI; POTASSIUM AFFECTS; COMPLEX-FORMATION; UNCOATING ATPASE; BINDING DOMAINS; HSC70; DISSOCIATION; PURIFICATION	Recent reports have shown that the binding of ATP to a 79-kDa molecular chaperone induces a rapid global conformational transition from a "high affinity" state to a "low affinity" state, where these states are defined by tight and weak binding to (poly)peptides, respectively. To complete the activity cycle, a chaperone molecule must ultimately return to the high affinity state. In this report, this return to the high affinity state was studied using a chemical cross-linking assay in conjunction with SDS-polyacrylamide gel electrophoresis, The basis for this assay is that in the absence of nucleotide or in the presence of ADP, conditions that stabilize the high affinity state, cross-linking of the Escherichia coli molecular chaperone DnaK yielded two monomeric forms, with apparent molecular masses of 70 kDa (77%) and 90 kDa (23%), whereas cross-linking yielded only the 70-kDa monomeric form in the presence of ATP, This ATP-dependent difference in cross-linking was used to follow the kinetics of the low affinity to high affinity transition under single turnover conditions. The rate of this transition (k(obs) = 3.4 (+/-0.6) x 10(-4) s(-1) at 25 degrees C) is almost identical to the reported rate of ATP hydrolysis (k(hy) = 2.7 (+/-0.7) x 10(-4) s(-1) at 22 degrees C). These results are consistent with a two-step sequential reaction where rate-limiting ATP hydrolysis precedes the conformational change, Models for the formation of two cross-linked DnaK monomers in the absence of ATP are discussed.	Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Witt, SN (corresponding author), Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA.		Witt, Stephan N/M-7922-2013	Witt, Stephan N/0000-0002-6462-2840				ANDERSON CM, 1978, J MOL BIOL, V123, P207, DOI 10.1016/0022-2836(78)90321-2; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; BENAROUDJ N, 1994, EUR J BIOCHEM, V221, P121, DOI 10.1111/j.1432-1033.1994.tb18720.x; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Farr CD, 1997, BIOCHEMISTRY-US, V36, P10793, DOI 10.1021/bi971082f; FARR CD, 1995, BIOCHEMISTRY-US, V34, P15574, DOI 10.1021/bi00047a024; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Fung KL, 1996, J BIOL CHEM, V271, P21559, DOI 10.1074/jbc.271.35.21559; Gao BC, 1996, J BIOL CHEM, V271, P16792, DOI 10.1074/jbc.271.28.16792; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; HA JH, 1995, BIOCHEMISTRY-US, V34, P11635, DOI 10.1021/bi00036a040; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HOGGETT JG, 1995, BIOCHEM J, V305, P405, DOI 10.1042/bj3050405; HOHFELD J, 1995, CELL, V83, P589; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; MONTGOMERY D, 1993, J MOL BIOL, V232, P680, DOI 10.1006/jmbi.1993.1418; OBRIEN MC, 1995, J BIOL CHEM, V270, P2247, DOI 10.1074/jbc.270.5.2247; PALLEROS DR, 1993, FEBS LETT, V336, P124, DOI 10.1016/0014-5793(93)81624-9; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; PRASAD K, 1994, J BIOL CHEM, V269, P6931; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Shi L, 1996, BIOCHEMISTRY-US, V35, P3297, DOI 10.1021/bi951984l; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; WILBANKS SM, 1995, BIOCHEMISTRY-US, V34, P12095, DOI 10.1021/bi00038a002; WILBANKS SM, 1995, J BIOL CHEM, V270, P2251, DOI 10.1074/jbc.270.5.2251; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; ZYLICZ M, 1984, J BIOL CHEM, V259, P8820	29	21	21	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9744	9748		10.1074/jbc.273.16.9744	http://dx.doi.org/10.1074/jbc.273.16.9744			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545310	hybrid			2022-12-27	WOS:000073128800056
J	Harada-Shiba, M; Kinoshita, M; Kamido, H; Shimokado, K				Harada-Shiba, M; Kinoshita, M; Kamido, H; Shimokado, K			Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; SMOOTH-MUSCLE CELLS; HUMAN-MONOCYTES; CHOLESTERYL ESTERS; GENE-EXPRESSION; CERAMIDE; DEATH; OXIDATION; LYSOPHOSPHATIDYLCHOLINE; INDUCTION	Oxidized low density lipoprotein (oxLDL) induces apoptosis in vascular cells, To elucidate the mechanisms involved in this apoptosis, we studied the apoptosis-inducing activity in lipid fractions of oxLDL and the roles of two common mechanisms, ceramide generation and the activation of caspases, in apoptosis in human umbilical vein endothelial cells treated with oxLDL. We also studied the effects of antioxidants and cholesterol. oxLDL induced endothelial apoptosis in a time-and dose-dependent fashion. Apoptosis-inducing activity was recovered in the neutral lipid fraction of oxLDL. Various oxysterols in this fraction induced endothelial apoptosis. Neither the phospholipid fraction nor its component lysophosphatidylcholine induced apoptosis. oxLDL induced ceramide accumulation temporarily at 15 min in a dose-dependent fashion. Two inhibitors of acid sphinogomyelinase inhibited both the increase in ceramide and the apoptosis induced by oxLDL. Furthermore, a membrane-permeable ceramide (C-2-ceramide) induced endothelial apoptosis. These findings demonstrated that ceramide generation by acid sphingomyelinase is indispensable for the endothelial apoptosis induced by oxLDL, Inhibitors of both caspase-1 and caspase-3 inhibited the apoptosis, suggesting that oxLDL induced apoptosis by activating these cysteine proteases. The antioxidants butylated hydroxytoluene and superoxide dismutase but not catalase inhibited the apoptosis induced by oxLDL or 25-hydroxycholesterol. This suggests not only that superoxide plays an important role but also that a critical interaction between oxLDL and the cell takes place on the outer surface of the membrane, because superoxide dismutase is not membrane-permeable, Exogenous cholesterol also inhibited the apoptosis. Our study demonstrated that neutral lipids in oxLDL induce endothelial apoptosis by activating membrane sphingomyelinase in a superoxide-dependent manner, as well as by activating caspases.	Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 5658565, Japan; Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 8300011, Japan	National Cerebral & Cardiovascular Center - Japan; Kurume University	Shimokado, K (corresponding author), Natl Cardiovasc Ctr, Res Inst, 7-1 Fujishirodai 5 Chome, Suita, Osaka 5658565, Japan.							ALBOUZ S, 1986, LIFE SCI, V38, P357, DOI 10.1016/0024-3205(86)90083-4; ARAKI S, 1990, BIOCHEM BIOPH RES CO, V168, P1194, DOI 10.1016/0006-291X(90)91155-L; Auge N, 1996, J BIOL CHEM, V271, P19251, DOI 10.1074/jbc.271.32.19251; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bjorkerud B, 1996, ARTERIOSCL THROM VAS, V16, P416, DOI 10.1161/01.ATV.16.3.416; Bjorkerud S, 1996, AM J PATHOL, V149, P367; BOCHATONPIALLAT ML, 1995, AM J PATHOL, V146, P1059; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; CHISOLM GM, 1994, P NATL ACAD SCI USA, V91, P11452, DOI 10.1073/pnas.91.24.11452; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; CIFONE MG, 1993, J EXP MED, V177, P1547; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DEBONO DP, 1995, ATHEROSCLEROSIS, V114, P235, DOI 10.1016/0021-9150(94)05488-5; Dimmeler S, 1997, CIRCULATION, V95, P1760; EHRENWALD E, 1994, J CLIN INVEST, V93, P1493, DOI 10.1172/JCI117127; EscargueilBlanc I, 1997, ARTERIOSCL THROM VAS, V17, P331, DOI 10.1161/01.ATV.17.2.331; ESCARGUEILBLANC I, 1994, FASEB J, V8, P1075, DOI 10.1096/fasebj.8.13.7926374; Farschon DM, 1997, J CELL BIOL, V137, P1117, DOI 10.1083/jcb.137.5.1117; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; HAN DKM, 1995, AM J PATHOL, V147, P267; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HAVEL RI, 1955, J CLIN INVEST, V39, P1345; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; HIGUCHI M, 1996, J IMMUNOL, V156, P297; HIRAMATSU K, 1987, ARTERIOSCLEROSIS, V7, P55, DOI 10.1161/01.ATV.7.1.55; Ishii H, 1996, J BIOL CHEM, V271, P8458, DOI 10.1074/jbc.271.14.8458; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; KAMIDO H, 1993, LIPIDS, V28, P331, DOI 10.1007/BF02536319; Kinscherf R, 1997, FEBS LETT, V405, P55, DOI 10.1016/S0014-5793(97)00157-9; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; KUME N, 1994, J CLIN INVEST, V93, P907, DOI 10.1172/JCI117047; LAMB DJ, 1995, FEBS LETT, V374, P12, DOI 10.1016/0014-5793(95)01068-P; LISTER MD, 1993, BIOCHIM BIOPHYS ACTA, V1165, P314, DOI 10.1016/0005-2760(93)90142-V; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Lizard G, 1996, AM J PATHOL, V148, P1625; MANGIN EL, 1993, CIRC RES, V72, P161, DOI 10.1161/01.RES.72.1.161; Masamune A, 1996, J BIOL CHEM, V271, P9368, DOI 10.1074/jbc.271.16.9368; MASSON M, 1992, J NEUROSCI RES, V31, P84, DOI 10.1002/jnr.490310112; MOREL DW, 1984, ARTERIOSCLEROSIS, V4, P357, DOI 10.1161/01.ATV.4.4.357; MOREL DW, 1983, J LIPID RES, V24, P1070; Murugesan G, 1996, J CLIN INVEST, V97, P2736, DOI 10.1172/JCI118728; MUSCHEL RJ, 1995, CANCER RES, V55, P995; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAKANO T, 1994, P NATL ACAD SCI USA, V91, P1069, DOI 10.1073/pnas.91.3.1069; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; PARTHASARATHY S, 1985, P NATL ACAD SCI USA, V82, P3000, DOI 10.1073/pnas.82.9.3000; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; REID VC, 1993, J PATHOL, V171, P321, DOI 10.1002/path.1711710413; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SEVANIAN A, 1995, J LIPID RES, V36, P1971; SHIMOKADO K, 1995, EXP CELL RES, V220, P266, DOI 10.1006/excr.1995.1315; Slowik MR, 1996, CIRC RES, V79, P736, DOI 10.1161/01.RES.79.4.736; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; THORIN E, 1994, ARTERIOSCLER THROMB, V14, P453, DOI 10.1161/01.ATV.14.3.453; VANVELDHOVEN PP, 1995, BIOCHEM MOL BIOL INT, V36, P21; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; Woodle ES, 1997, J IMMUNOL, V158, P2156; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971; YUI S, 1993, ARTERIOSCLER THROMB, V13, P331, DOI 10.1161/01.ATV.13.3.331	68	217	227	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9681	9687		10.1074/jbc.273.16.9681	http://dx.doi.org/10.1074/jbc.273.16.9681			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545302	hybrid			2022-12-27	WOS:000073128800048
J	Vittone, L; Mundina-Weilenmann, C; Said, M; Mattiazzi, A				Vittone, L; Mundina-Weilenmann, C; Said, M; Mattiazzi, A			Mechanisms involved in the acidosis enhancement of the isoproterenol-induced phosphorylation of phospholamban in the intact heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; PROTEIN PHOSPHATASES; ADENYLYL-CYCLASE; MUSCLE; IDENTIFICATION; STIMULATION; CONTRACTION; MYOCYTES; SITES	Previous experiments have shown that acidosis enhances isoproterenol-induced phospholamban (PHL) phosphorylation (Mundina-Weilemann, C., Vittone, L., Cingolani, H. E., Orchard, C. H. (1996) Am. J. Physiol. 270, C107-C114). In the present experiments, performed in isolated Langendorff perfused rat hearts, phosphorylation site-specific antibodies to PHL combined with the quantitative measurement of P-32 incorporation into PHL were used as experimental tools to gain further insight into the mechanism involved in this effect. At all isoproterenol concentrations tested (3-300 nM), phosphorylation of Thr(17) of PHL was significantly higher at pH(o) 6.80 than at pH(o) 7.40, without significant changes in Ser(16) phosphorylation, This increase in Thr(17) phosphorylation was associated with an enhancement of the isoproterenol-induced relaxant effect. In the absence of isoproterenol, the increase in [Ca](o) at pH(o) 6.80 (but not at pH(o) 7.40) evoked an increase in PHL phosphorylation that was exclusively due to an increase in Thr(17) phosphorylation and that was also associated with a significant relaxant effect. This effect and the phosphorylation of Thr(17) evoked by acidosis were both offset by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62. In the presence of isoproterenol, either the increase in [Ca](o) or the addition of a 1 mu M concentration of the phosphatase inhibitor okadaic acid was able to mimic the increase in isoproterenol-induced Thr(17) phosphorylation produced by acidosis. In contrast, these two interventions have opposite effects on phosphorylation of Ser(16). Whereas the increase in [Ca](o) significantly decreased phosphorylation of Ser(16), the addition of okadaic acid significantly increased the phosphorylation of this residue. The results are consistent with the hypothesis that the increase in phospholamban phosphorylation produced by acidosis in the presence of isoproterenol is the consequence of two different mechanisms triggered by acidosis: an increase in [Ca2+](i) and an inhibition of phosphatases.	Natl Univ La Plata, Fac Ciencias Med, Ctr Invest Cardiovasc, RA-1900 La Plata, Argentina	National University of La Plata	Mattiazzi, A (corresponding author), Natl Univ La Plata, Fac Ciencias Med, Ctr Invest Cardiovasc, 60 & 120, RA-1900 La Plata, Argentina.	cicme@isis.unlp.edu.ar	Mattiazzi, Alicia/L-1512-2019					AHMAD Z, 1989, J BIOL CHEM, V264, P3859; BARRON JT, 1979, J BIOL CHEM, V254, P4954; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1989, J BIOL CHEM, V264, P21435; DRAGO GA, 1994, J BIOL CHEM, V269, P25073; ESPINASSE I, 1995, J MOL CELL CARDIOL, V27, P1789, DOI 10.1016/0022-2828(95)90002-0; Gupta RC, 1996, AM J PHYSIOL-HEART C, V270, pH1159, DOI 10.1152/ajpheart.1996.270.4.H1159; HARRISON SM, 1992, AM J PHYSIOL, V262, pC348; HUBBARD MJ, 1990, EUR J BIOCHEM, V189, P243, DOI 10.1111/j.1432-1033.1990.tb15483.x; LINDEMANN JP, 1985, J BIOL CHEM, V260, P4516; MACDOUGALL LK, 1991, EUR J BIOCHEM, V196, P725, DOI 10.1111/j.1432-1033.1991.tb15871.x; MundinaWeilenmann C, 1996, AM J PHYSIOL-CELL PH, V270, pC107, DOI 10.1152/ajpcell.1996.270.1.C107; MundinaWeilenmann C, 1996, J BIOL CHEM, V271, P33561, DOI 10.1074/jbc.271.52.33561; NAPOLITANO R, 1992, J MOL CELL CARDIOL, V24, P387, DOI 10.1016/0022-2828(92)93193-N; NEUMANN J, 1993, AM J PHYSIOL, V265, pH257, DOI 10.1152/ajpheart.1993.265.1.H257; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SPITZER KW, 1992, AM J PHYSIOL, V262, pC316, DOI 10.1152/ajpcell.1992.262.2.C316; SUZUKI T, 1986, J BIOL CHEM, V261, P7018; TADA M, 1982, MOL CELL BIOCHEM, V46, P73; THAN N, 1994, CARDIOVASC RES, V28, P1209, DOI 10.1093/cvr/28.8.1209; VITTONE L, 1993, MOL CELL BIOCHEM, V124, P33, DOI 10.1007/BF01096379; VITTONE L, 1990, AM J PHYSIOL, V258, pH318, DOI 10.1152/ajpheart.1990.258.2.H318; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716	26	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9804	9811		10.1074/jbc.273.16.9804	http://dx.doi.org/10.1074/jbc.273.16.9804			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545319	Green Published, hybrid			2022-12-27	WOS:000073128800065
J	Xu, JY; Wirtz, D; Pollard, TD				Xu, JY; Wirtz, D; Pollard, TD			Dynamic cross-linking by alpha-actinin determines the mechanical properties of actin filament networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; BINDING DOMAIN; PROTEOLYTIC FRAGMENTS; CHICKEN GIZZARD; RATE CONSTANTS; PROTEIN; GELS; TEMPERATURE; GELATION; SEQUENCE	We used smooth muscle ar-actinin to evaluate the contribution of cross-linker dynamics to the mechanical properties of actin filament networks. Recombinant actin-binding domain (residues 2-269) binds actin filaments with a K-d of 1 mu M at 25 degrees C, 20 times stronger than actin-binding domain produced by thermolysin digestion of native alpha-actinin (residues 25-257). Between 8 and 25 degrees C the rate constants for recombinant actin-binding domain to bind to (0.8-2.7 mu M-1 s(-1)) and dissociate from (0.2-2.4 s(-1)) actin filaments depend on temperature. At 8 degrees C actin filaments cross-linked with alpha-actinin are stiff and nearly solid, whereas at 25 degrees C the mechanical properties approach those of actin filaments alone. In these experiments, high actin concentrations kept most of the alpha-actinin bound to actin and temperature varied a single parameter, cross-linker dynamics, because the mechanical properties of pure actin filaments (a viscoelastic gel) or biotinylated actin filaments cross-linked irreversibly by avidin (a stiff viscoelastic solid) depend little on temperature. These results show that the rate of exchange of dynamic cross-links between actin filaments is an important determinant of the mechanical properties of the networks.	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Chem Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Pollard, TD (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pollard@salk.edu	Wirtz, Denis/A-3257-2010		NIGMS NIH HHS [GM 26338] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1980, VISCOELASTIC PROPERT; BARON MD, 1987, J BIOL CHEM, V262, P17623; BENNETT JP, 1984, BIOCHEMISTRY-US, V23, P5081, DOI 10.1021/bi00316a039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY D, 1986, J CELL SCI, P71; BRESNICK AR, 1991, J BIOL CHEM, V266, P12989; CORRADO K, 1994, FEBS LETT, V344, P255, DOI 10.1016/0014-5793(94)00397-1; CRAIG SW, 1982, METHOD ENZYMOL, V85, P316; CRITCHLEY DR, 1993, ALPHA ACTININS GUIDE, P22; DAVISON MD, 1989, INT J BIOL MACROMOL, V11, P81, DOI 10.1016/0141-8130(89)90047-0; ELSON EL, 1988, ANNU REV BIOPHYS BIO, V17, P397; Frey-Wyssling A., 1953, SUBMICROSCOPIC MORPH; GOLDMANN WH, 1993, FEBS LETT, V336, P408, DOI 10.1016/0014-5793(93)80847-N; Goldsmith SC, 1997, NAT STRUCT BIOL, V4, P708, DOI 10.1038/nsb0997-708; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; GRAZI E, 1994, BIOCHEM J, V298, P129, DOI 10.1042/bj2980129; GRAZI E, 1993, BIOCHEMISTRY-US, V32, P8896, DOI 10.1021/bi00085a022; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; HARTWIG JH, 1981, J MOL BIOL, V145, P563, DOI 10.1016/0022-2836(81)90545-3; HATANO S, 1966, BIOCHIM BIOPHYS ACTA, V127, P488, DOI 10.1016/0304-4165(66)90402-8; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HOLMES GR, 1971, BIOCHIM BIOPHYS ACTA, V253, P240, DOI 10.1016/0005-2728(71)90250-7; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; Janssen KP, 1996, ARCH BIOCHEM BIOPHYS, V325, P183, DOI 10.1006/abbi.1996.0023; KUHLMAN PA, 1994, FEBS LETT, V339, P297, DOI 10.1016/0014-5793(94)80434-6; MACLEANFLETCHER SD, 1980, J CELL BIOL, V85, P414, DOI 10.1083/jcb.85.2.414; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; POLLARD TD, 1976, J SUPRAMOL STR CELL, V5, P317, DOI 10.1002/jss.400050306; POLLARD TD, 1970, J CELL BIOL, V46, P267, DOI 10.1083/jcb.46.2.267; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; SATO M, 1987, NATURE, V325, P828, DOI 10.1038/325828a0; SATO M, 1985, J BIOL CHEM, V260, P8585; SINARD JH, 1990, J BIOL CHEM, V265, P3654; SINGH I, 1977, BIOCHIM BIOPHYS ACTA, V491, P29, DOI 10.1016/0005-2795(77)90038-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STRAUB FB, 1950, BIOCHIM BIOPHYS ACTA, V4, P455, DOI 10.1016/0006-3002(50)90052-7; TAIT JF, 1982, BIOCHEMISTRY-US, V21, P3666, DOI 10.1021/bi00258a022; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835	42	153	156	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9570	9576		10.1074/jbc.273.16.9570	http://dx.doi.org/10.1074/jbc.273.16.9570			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545287	hybrid			2022-12-27	WOS:000073128800033
J	Yang, BX; Verkman, AS				Yang, BX; Verkman, AS			Urea transporter UT3 functions as an efficient water channel - Direct evidence for a common water/urea pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-KIDNEY; RED-CELL; CLONING; EXPRESSION; PERMEABILITY; SYSTEM	A family of molecular urea transporters (UTs) has been identified whose members appear to have an exceptionally high transport turnover rate. To test the hypothesis that urea transport involves passage through an aqueous channel, osmotic water permeability was measured in Xenopus oocytes expressing UTs, The UT3 class of urea transporters functioned as efficient water channels. Quantitative measurement of single channel water permeability (p(f)) using epitope-tagged rat UTs gave p(f) (in cm(3)/s x 10(-14)) of 0.14 +/- 0.11 (UT2) and 1.4 +/- 0.2 (UT3), compared with 6.0 and 2.3 for water channels AQP1 and AQP3, respectively. Relative single channel urea permeabilities (p(urea)) were 1.0 (UT2), 0.44 (UT3), and 0.0 (AQP1), UT3-mediated water and urea transport were weakly temperature-dependent (activation energy <4 kcal/mol), inhibited > 75% by the urea transport inhibitor 1,3-dimethylthiourea, but not inhibited by the water transport inhibitor HgCl2. To test for a common water/urea pore, the urea reflection coefficient (sigma(urea)) was measured by independent induced osmosis and solvent drag methods. In UT3-expressing oocytes, the time course of oocyte volume in response to different urea gradients (induced osmosis) gave sigma(urea) similar to 0.3 for the UT3 pathway, in agreement with sigma(urea) determined by the increase in uptake of [C-14]urea during osmotic gradient-induced oocyte swelling (solvent drag). In oocytes of comparable water and urea permeability coexpressing AQP1 (permeable to water, not urea) and UT2 (permeable to urea, not water), sigma(urea) = 1. These results indicate that UT3 functions as a urea/water channel utilizing a common aqueous pathway. The water transporting function and low urea reflection coefficient of UT3 in vasa recta may be important for the formation of a concentrated urine by countercurrent exchange in the kidney.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	verkman@itsa.ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL042368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, R01DK035124, R01DK043840] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL42368] Funding Source: Medline; NIDDK NIH HHS [DK35124, DK43840] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREOLI TE, 1979, AM J PHYSIOL, V237, pF455, DOI 10.1152/ajprenal.1979.237.6.F455; CHANG R, 1991, AM J PHYSIOL, V260, pC26; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; CORMAN B, 1983, PFLUG ARCH EUR J PHY, V397, P35, DOI 10.1007/BF00585165; EDWARDSMOULDS J, 1988, VOX SANG, V55, P181, DOI 10.1111/j.1423-0410.1988.tb05089.x; Finkelstein A., 1987, WATER MOVEMENT LIPID; FROHLICH O, 1991, AM J PHYSIOL, V260, pF778; GOLDSTEIN DA, 1960, J GEN PHYSIOL, V44, P1, DOI 10.1085/jgp.44.1.1; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; KNEPPER MA, 1993, AM J PHYSIOL, V265, pF214, DOI 10.1152/ajprenal.1993.265.2.F214; KOKKO JP, 1972, KIDNEY INT, V2, P214, DOI 10.1038/ki.1972.97; MANNUZZU LM, 1993, J MEMBRANE BIOL, V133, P85; MLEKODAY HJ, 1983, J GEN PHYSIOL, V81, P213, DOI 10.1085/jgp.81.2.213; Nielsen S, 1996, P NATL ACAD SCI USA, V93, P5495, DOI 10.1073/pnas.93.11.5495; OLIVES B, 1994, J BIOL CHEM, V269, P31649; OLIVES B, 1995, J BIOL CHEM, V270, P15607, DOI 10.1074/jbc.270.26.15607; PALLONE TL, 1994, AM J PHYSIOL, V267, pR260, DOI 10.1152/ajpregu.1994.267.1.R260; SANDS JM, 1992, J AM SOC NEPHROL, V2, P1689; Sands JM, 1997, AM J PHYSIOL-RENAL, V273, pF321, DOI 10.1152/ajprenal.1997.273.3.F321; Shayakul C, 1997, AM J PHYSIOL-RENAL, V272, pF654, DOI 10.1152/ajprenal.1997.272.5.F654; Shayakul C, 1996, J CLIN INVEST, V98, P2580, DOI 10.1172/JCI119077; SMITH CP, 1995, J CLIN INVEST, V96, P1556, DOI 10.1172/JCI118194; STEPHENSON JL, 1972, KIDNEY INT, V2, P85, DOI 10.1038/ki.1972.75; Tsukaguchi H, 1997, J CLIN INVEST, V99, P1506, DOI 10.1172/JCI119313; VERKMAN AS, 1989, AM J PHYSIOL, V257, pC837, DOI 10.1152/ajpcell.1989.257.5.C837; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Xu YC, 1997, KIDNEY INT, V51, P138, DOI 10.1038/ki.1997.17; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; YOU GF, 1993, NATURE, V365, P844, DOI 10.1038/365844a0; YOUSEF LW, 1989, BIOCHIM BIOPHYS ACTA, V984, P281, DOI 10.1016/0005-2736(89)90294-0; ZHANG R, 1990, J BIOL CHEM, V265, P15375	31	71	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9369	9372		10.1074/jbc.273.16.9369	http://dx.doi.org/10.1074/jbc.273.16.9369			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545259	hybrid			2022-12-27	WOS:000073128800005
J	Goodwin, DC; Gunther, MR; Hsi, LC; Crews, BC; Eling, TE; Mason, RP; Marnett, LJ				Goodwin, DC; Gunther, MR; Hsi, LC; Crews, BC; Eling, TE; Mason, RP; Marnett, LJ			Nitric oxide trapping of tyrosyl radicals generated during prostaglandin endoperoxide synthase turnover - Detection of the radical derivative of tyrosine 385	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER OXIDATION-STATES; H SYNTHASE; RIBONUCLEOTIDE REDUCTASE; PEROXIDASE REACTION; VESICULAR GLAND; CATALYSIS; BIOSYNTHESIS; MACROPHAGES; ENZYME; HEME	Tyrosyl radicals have been detected during turnover of prostaglandin endoperoxide H synthase (PGHS), and they are speculated to participate in cyclooxygenase catalysis, Spectroscopic approaches to elucidate the identity of the radicals have not been definitive, so we have attempted to trap the radical(s) with nitric oxide (NO), NO quenched the EPR signal generated by reaction of purified ram seminal vesicle PGHS with arachidonic acid, suggesting that NO coupled with a tyrosyl radical to form inter alia nitrosocyclohexadienone, Subsequent formation of nitrotyrosine was detected by Western blotting of PGHS incubated with NO and arachidonic acid or organic hydroperoxides using an antibody against nitrotyrosine. Both arachidonic acid and NO were required to form nitrotyrosine, and tyrosine nitration was blocked by the PGHS inhibitor indomethacin. The presence of superoxide dismutase had no effect on nitration, indicating that peroxynitrite was not the nitrating agent, To identify which tyrosines were nitrated, PGHS was digested with trypsin, and the resulting peptides were separated by high pressure liquid chromatography and monitored with a diode array detector, A single peptide was detected that exhibited a spectrum consistent with the presence of nitrotyrosine. Consistent with Western blotting results, both NO and arachidonic acid were required to observe nitration of this peptide, and its formation was blocked by the PGHS inhibitor indomethacin, Peptide sequencing indicated that the modified residue was tyrosine 385, the source of the putative catalytically active tyrosyl radical.	Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Dept Biochem, Nashville, TN 37232 USA; NIEHS, Lab Pharmacol & Chem, NIH, Res Triangle Pk, NC 27709 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Dept Biochem, Nashville, TN 37232 USA.	marnett@toxicology.mc.vanderbilt.edu	Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109; Goodwin, Douglas/0000-0002-7869-7704	NATIONAL CANCER INSTITUTE [R35CA047479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47479] Funding Source: Medline; NIEHS NIH HHS [ES 00267] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bakovic M, 1996, J BIOL CHEM, V271, P2048, DOI 10.1074/jbc.271.4.2048; Curtis JF, 1996, ARCH BIOCHEM BIOPHYS, V335, P369, DOI 10.1006/abbi.1996.0518; DEGRAY JA, 1992, J BIOL CHEM, V267, P23583; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; EISERICH JP, 1995, BIOCHEM J, V310, P745, DOI 10.1042/bj3100745; Gunther MR, 1997, J BIOL CHEM, V272, P17086, DOI 10.1074/jbc.272.27.17086; HEMLER ME, 1979, ARCH BIOCHEM BIOPHYS, V193, P340, DOI 10.1016/0003-9861(79)90038-9; HEMLER ME, 1983, PROSTAGLANDINS, V25, P531; HSI LC, 1995, BIOCHEM BIOPH RES CO, V207, P652, DOI 10.1006/bbrc.1995.1237; JANZEN EG, 1993, J ORG CHEM, V58, P3597, DOI 10.1021/jo00066a001; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; LASSMANN G, 1991, J BIOL CHEM, V266, P20045; LEPOIVRE M, 1994, J BIOL CHEM, V269, P21891; Marnett L. J., 1991, PEROXIDASES CHEM BIO, V1, P293; MARNETT LJ, 1984, MOL PHARMACOL, V26, P328; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; OGINO N, 1978, J BIOL CHEM, V253, P5061; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; ROY B, 1995, BIOCHEMISTRY-US, V34, P5411, DOI 10.1021/bi00016a012; Sanakis Y, 1997, BIOCHEMISTRY-US, V36, P1411, DOI 10.1021/bi9622074; SHIMOKAWA T, 1991, J BIOL CHEM, V266, P6168; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; SMITH WL, 1972, BIOCHEMISTRY-US, V11, P3276, DOI 10.1021/bi00767a024; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; STRIEDER S, 1992, J BIOL CHEM, V267, P13870; Szalai VA, 1996, BIOCHEMISTRY-US, V35, P15080, DOI 10.1021/bi961117w; TSAI AL, 1994, J BIOL CHEM, V269, P5085; TSAI AL, 1994, ARCH BIOCHEM BIOPHYS, V313, P367, DOI 10.1006/abbi.1994.1400; TSAI AL, 1995, J BIOL CHEM, V270, P10503, DOI 10.1074/jbc.270.18.10503; WILCOX AL, 1993, J CHEM SOC CHEM COMM, P1377, DOI 10.1039/c39930001377	32	117	119	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8903	8909		10.1074/jbc.273.15.8903	http://dx.doi.org/10.1074/jbc.273.15.8903			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535872	hybrid			2022-12-27	WOS:000072990800049
J	Kickhoefer, VA; Rajavel, KS; Scheffer, GL; Dalton, WS; Scheper, RJ; Rome, LH				Kickhoefer, VA; Rajavel, KS; Scheffer, GL; Dalton, WS; Scheper, RJ; Rome, LH			Vaults are up-regulated in multidrug-resistant cancer cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOPROTEIN-PARTICLES; DRUG-RESISTANCE; P-GLYCOPROTEIN; PROTEIN MRP; TUMOR-CELLS; SMALL RNA; OVEREXPRESSION; CARCINOMA; CONTAIN; LRP	Vaults are 13-MDa ribonucleoprotein particles composed largely of a 104-kDa protein, termed major vault protein or MVP, and a small vault RNA, vRNA While MVP levels have been found to increase up to 15-fold in non-P-glycoprotein multidrug-resistant cell lines, the levels of vault particles have not been investigated, As both the function of vault particles and the mechanism of drug resistance in non-P-glycoprotein cells are unknown, we decided to determine whether vault synthesis was coupled to MDR. By cloning the human gene for vRNA and careful quantitation of the MVP and vRNA levels in MDR cells, we find that vRNA is in considerable excess to MVP. Sedimentation measurements of vault particles in multidrug resistance cells have indeed revealed up to a 15-fold increase in vault synthesis, coupled with a comparable shift of associated vRNA, demonstrating that vault formation is limited by expression of MVP or the minor vault proteins, The observation that vault synthesis is linked directly to multidrug resistance supports a direct role for vaults in drug resistance.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Free Univ Amsterdam Hosp, Dept Pathol, Amsterdam, Netherlands; Univ S Florida, Canc & Res Inst, Tampa, FL 33612 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; State University System of Florida; University of South Florida	Rome, LH (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, 33-257 CHS, Los Angeles, CA 90095 USA.		Rome, Leonard H/E-8786-2016	Rome, Leonard H/0000-0002-1236-2063; Kickhoefer, Valerie/0000-0002-0048-0580	NIGMS NIH HHS [GM38097] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038097] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHUGANI DC, 1993, J CELL SCI, V106, P23; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; FUTSCHER BW, 1994, BIOCHEM PHARMACOL, V47, P1601, DOI 10.1016/0006-2952(94)90538-X; GRANT CE, 1994, CANCER RES, V54, P357; Izquierdo MA, 1996, AM J PATHOL, V148, P877; IZQUIERDO MA, 1995, JNCI-J NATL CANCER I, V87, P1230; KEDERSHA NL, 1986, ANAL BIOCHEM, V156, P161, DOI 10.1016/0003-2697(86)90168-5; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; KEDERSHA NL, 1990, J CELL BIOL, V110, P895, DOI 10.1083/jcb.110.4.895; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; KICKHOEFER VA, 1993, J BIOL CHEM, V268, P7868; Kickhoefer VA, 1996, TRENDS CELL BIOL, V6, P174, DOI 10.1016/0962-8924(96)10014-3; Kuiper C. M., 1990, J CELL PHARM, V1, P35; List AF, 1996, BLOOD, V87, P2464, DOI 10.1182/blood.V87.6.2464.bloodjournal8762464; Rome L, 1991, Trends Cell Biol, V1, P47, DOI 10.1016/0962-8924(91)90088-Q; RONINSON IBE, 1991, MOL CELLULAR BIOL MU; SCHEFFER GL, 1995, NAT MED, V1, P578, DOI 10.1038/nm0695-578; SCHEPER RJ, 1991, INT J CANCER, V48, P562, DOI 10.1002/ijc.2910480414; SCHEPER RJ, 1993, CANCER RES, V53, P1475; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202; VERSANTVOORT CHM, 1995, INT J CANCER, V61, P375, DOI 10.1002/ijc.2910610317; ZAMAN GJR, 1994, P NATL ACAD SCI USA, V91, P8822, DOI 10.1073/pnas.91.19.8822; ZIJLSTRA JG, 1987, CANCER RES, V47, P1780	23	199	212	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8971	8974		10.1074/jbc.273.15.8971	http://dx.doi.org/10.1074/jbc.273.15.8971			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535882	hybrid			2022-12-27	WOS:000072990800059
J	Duranteau, J; Chandel, NS; Kulisz, A; Shao, ZH; Schumacker, PT				Duranteau, J; Chandel, NS; Kulisz, A; Shao, ZH; Schumacker, PT			Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR-ENERGY METABOLISM; DEPENDENCE; RAT; RESPIRATION; OXIDASE; CELLS	Cardiomyocytes suppress contraction and O-2 consumption during hypoxia. Cytochrome oxidase undergoes a decrease in V-max during hypoxia, which could alter mitochondrial redox and increase generation of reactive oxygen species (ROS), We therefore tested whether ROS generated by mitochondria act as second messengers in the signaling pathway linking the detection of O-2 with the functional response. Contracting cardiomyocytes were superfused under controlled O-2 conditions while fluorescence imaging of 2,7-dichlorofluorescein (DCF) was used to assess ROS generation. Compared with normoxia (PO2 similar to 107 torr, 15% O-2), graded increases in DCF fluorescence were seen during hypoxia, with responses at PO2 = 7 torr > 20 torr > 35 torr. The antioxidants 2-mercaptopropionyl glycine and 1,10-phenanthroline attenuated these increases and abolished the inhibition of contraction. Superfusion of normoxic cells with H2O2 (25 mu M) for >60 min mimicked the effects of hypoxia by eliciting decreases in contraction that mere reversible after washout of H2O2. To test the role of cytochrome oxidase, sodium azide (0.75-2 mu M) was added during normoxia to reduce the V-max of the enzyme. Azide produced graded increases in ROS signaling, accompanied by graded decreases in contraction that were reversible. These results demonstrate that mitochondria respond to graded hypoxia by increasing the generation of ROS and suggest that cytochrome oxidase may contribute to this O-2 sensing.	Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Schumacker, PT (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC6026, Chicago, IL 60637 USA.			Schumacker, Paul T/0000-0001-9591-2034	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032646, R55HL032646, R01HL035440] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32646, HL35440] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARRY WH, 1980, AM J PHYSIOL, V239, pH651, DOI 10.1152/ajpheart.1980.239.5.H651; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Budinger GRS, 1998, J BIOL CHEM, V273, P3320, DOI 10.1074/jbc.273.6.3320; BUDINGER GRS, 1996, AM J PHYSIOL, V14, pL37; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; CHANCE B, 1955, J BIOL CHEM, V217, P383; CHANDEL N, 1995, AM J PHYSIOL-LUNG C, V268, pL918, DOI 10.1152/ajplung.1995.268.6.L918; Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672; Chandel NS, 1997, J BIOL CHEM, V272, P18808, DOI 10.1074/jbc.272.30.18808; COOPER CE, 1990, BIOCHIM BIOPHYS ACTA, V1017, P187, DOI 10.1016/0005-2728(90)90184-6; EINARSDOTTIR O, 1995, BBA-BIOENERGETICS, V1229, P129, DOI 10.1016/0005-2728(94)00196-C; ERECINSKA M, 1982, J MEMBRANE BIOL, V70, P1, DOI 10.1007/BF01871584; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Laderoute KR, 1997, CIRC RES, V80, P336, DOI 10.1161/01.RES.80.3.336; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Lo LW, 1996, ANAL BIOCHEM, V236, P153, DOI 10.1006/abio.1996.0144; MOHAZZAB HKM, 1995, AM J PHYSIOL, V269, pL637; MohazzabH KM, 1997, CIRCULATION, V96, P614; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; PARTRIDGE RS, 1994, ARCH BIOCHEM BIOPHYS, V310, P210, DOI 10.1006/abbi.1994.1159; PETERSEN LC, 1977, BIOCHIM BIOPHYS ACTA, V460, P299, DOI 10.1016/0005-2728(77)90216-X; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; RUMSEY WL, 1990, J BIOL CHEM, V265, P15392; Sawada GA, 1996, CYTOMETRY, V25, P254, DOI 10.1002/(SICI)1097-0320(19961101)25:3<254::AID-CYTO6>3.3.CO;2-3; SCHUMACKER PT, 1993, AM J PHYSIOL, V265, pL395, DOI 10.1152/ajplung.1993.265.4.L395; Silverman HS, 1997, CIRC RES, V80, P699, DOI 10.1161/01.RES.80.5.699; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; WILSON DF, 1988, J BIOL CHEM, V263, P2712; WILSON DF, 1979, ARCH BIOCHEM BIOPHYS, V195, P485, DOI 10.1016/0003-9861(79)90375-8	35	554	571	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11619	11624		10.1074/jbc.273.19.11619	http://dx.doi.org/10.1074/jbc.273.19.11619			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565580	hybrid			2022-12-27	WOS:000073536700034
J	Betz, A; Krishnaswamy, S				Betz, A; Krishnaswamy, S			Regions remote from the site of cleavage determine macromolecular substrate recognition by the prothrombinase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-THROMBIN; DEPENDENT ENZYME COMPLEXES; TICK ANTICOAGULANT PEPTIDE; FACTOR-XA; ACTIVE-SITE; FACTOR-VA; PHOSPHOLIPID-VESICLES; BLOOD-COAGULATION; EXTINCTION COEFFICIENTS; ZETA-THROMBIN	The proteolytic formation of thrombin is catalyzed by the prothrombinase complex of blood coagulation. The kinetics of prethrombin 2 cleavage was studied to delineate macro-molecular substrate structures necessary for recognition at the exosite(s) of prothrombinase. The product, cu-thrombin, was a linear competitive inhibitor of prethrombin 2 activation without significantly inhibiting peptidyl substrate cleavage by prothrombinase. Prethrombin 2 and alpha-thrombin compete for binding to the exosite without restricting access to the active site of factor Xa within prothrombinase, Inhibition by alpha-thrombin was not altered by saturating concentrations of low molecular weight heparin, Furthermore, proteolytic removal of the fibrinogen recognition site in alpha-thrombin only had a modest effect on its inhibitory properties. Both alpha-thrombin and prethrombin 2 were cleaved with chymotrypsin at Trp(148) and separated into component domains. The C-terminal-derived xi 2 fragment retained the ability to selectively inhibit macromolecular substrate cleavage by prothrombinase, while the xi 1 fragment was without effect. As the xi 2 fragment lacks the fibrinogen recognition site, the P1-P3 residues or the intact cleavage site, specific recognition of the macromolecular substrate by the exosite in prothrombinase is achieved through substrate regions, distinct from the fibrinogen recognition or heparin-binding sites, and spatially removed from structures surrounding the scissile bond.	Emory Univ, Dept Med, Atlanta, GA 30322 USA	Emory University	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Res Inst, 324 S 34th St,310 Abramson, Philadelphia, PA 19104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052883] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-52883] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1997, BIOCHEMISTRY-US, V36, P181, DOI 10.1021/bi962060g; Bevington P. R, 1969, DATA REDUCTION ERROR; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1988, BIOCHEMISTRY-US, V27, P6633, DOI 10.1021/bi00417a063; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BOISSEL JP, 1984, J BIOL CHEM, V259, P5691; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; BREZNIAK DV, 1990, BIOCHEMISTRY-US, V29, P3536, DOI 10.1021/bi00466a017; CHASE T, 1970, METHOD ENZYMOL, V19, P20; CHURCH WR, 1988, BLOOD, V72, P1911; ELLIS V, 1984, BIOCHEMISTRY-US, V23, P5882, DOI 10.1021/bi00319a030; ESMON CT, 1974, J BIOL CHEM, V249, P7791; FASSMAN GD, 1975, HDB BIOCH MOL BIOL, V2; FENTON JW, 1977, CHEM BIOL THROMBIN, P43; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P5290, DOI 10.1021/bi00723a006; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GITEL SN, 1973, P NATL ACAD SCI USA, V70, P1344, DOI 10.1073/pnas.70.5.1344; Gomori G, 1942, J LAB CLIN MED, V27, P955; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; HOFSTEENGE J, 1988, BIOCHEMISTRY-US, V27, P2144, DOI 10.1021/bi00406a049; JACKSON CM, 1968, BIOCHEMISTRY-US, V7, P4492, DOI 10.1021/bi00852a046; Jesty J, 1976, Methods Enzymol, V45, P95; KALAFATIS M, 1994, BBA-MOL BASIS DIS, V1227, P113, DOI 10.1016/0925-4439(94)90086-8; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P5714; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P3319, DOI 10.1021/bi9623993; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai MT, 1997, J BIOL CHEM, V272, P30275, DOI 10.1074/jbc.272.48.30275; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LAROCHE Y, 1994, BIO-TECHNOL, V12, P1119, DOI 10.1038/nbt1194-1119; LAUE TM, 1984, BIOCHEMISTRY-US, V23, P1339, DOI 10.1021/bi00302a001; LEWIS SD, 1992, PROTEIN SCI, V1, P998, DOI 10.1002/pro.5560010805; LIU LW, 1991, J BIOL CHEM, V266, P23632; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; MATTHIAS FR, 1977, THROMB RES, V10, P365, DOI 10.1016/0049-3848(77)90148-7; NESHEIM ME, 1981, J BIOL CHEM, V256, P6537; NESHEIM ME, 1981, J BIOL CHEM, V256, P9874; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; REZAIE AR, 1995, J BIOL CHEM, V270, P16176, DOI 10.1074/jbc.270.27.16176; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Segel IH, 1975, ENZYME KINETICS BEHA; STONE SR, 1993, METHOD ENZYMOL, V223, P312; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; STUBBS MT, 1995, TRENDS BIOCHEM SCI, V20, P23, DOI 10.1016/S0968-0004(00)88945-8; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; WALKER RK, 1993, J BIOL CHEM, V268, P13920; WALKER RK, 1994, J BIOL CHEM, V269, P27441	62	73	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10709	10718		10.1074/jbc.273.17.10709	http://dx.doi.org/10.1074/jbc.273.17.10709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553135	hybrid			2022-12-27	WOS:000073224200084
J	Fantin, VR; Sparling, JD; Slot, JW; Keller, SR; Lienhard, GE; Lavan, BE				Fantin, VR; Sparling, JD; Slot, JW; Keller, SR; Lienhard, GE; Lavan, BE			Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; REGULATED MEMBRANE AMINOPEPTIDASE; JAK-3 JANUS KINASE; TYROSINE PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; SPECIFICITIES; INTERLEUKIN-2; REQUIREMENTS; PHOSPHATASE; ACTIVATION	We recently cloned IRS-4, a new member of the insulin receptor substrate (IRS) family. In this study we have characterized IRS-4 in human embryonic kidney 293 cells, where it was originally discovered. IRS-4 was the predominant insulin-elicited phosphotyrosine protein in these cells. Subcellular fractionation revealed that about 50% of IRS-4 was located in cellular membranes, and immunofluorescence indicated that IRS-4 was concentrated at the plasma membrane. Immunoelectron microscopy conclusively established that a large portion of the IRS-4 was located at the cytoplasmic surface of the plasma membrane in both the unstimulated and insulin-treated states. IRS-4 was found to be associated with two src homology 2 (SH2) domain-containing proteins, phosphatidylinositol 3-kinase and Grb2, the adaptor to the guanine nucleotide exchange factor for Ras. On the other hand, no significant association was detected with two other SH2 domain proteins, the SH2-containing protein tyrosine phosphatase 2 and phospholipase C gamma. Insulin-like growth factor I acting through its receptor was as effective as insulin in eliciting tyrosine phosphorylation of IRS-4, but interleukin 4 and epidermal growth factor were ineffective.	Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA; Univ Utrecht, Sch Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Dartmouth College; Utrecht University	Lienhard, GE (corresponding author), Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA.	gustav.e.lienhard@dartmouth.edu			NIDDK NIH HHS [DK42816] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042816, R56DK042816] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; BEITNERJOHNSON D, 1995, J BIOL CHEM, V270, P5187, DOI 10.1074/jbc.270.10.5187; BellPedersen D, 1996, MOL CELL BIOL, V16, P513; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Burfoot MS, 1997, J BIOL CHEM, V272, P24183, DOI 10.1074/jbc.272.39.24183; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HARDY RW, 1995, ENDOCRINOLOGY, V136, P431, DOI 10.1210/en.136.2.431; Heijnen HFG, 1997, J CELL BIOL, V138, P323, DOI 10.1083/jcb.138.2.323; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Keller Susanne R., 1994, Trends in Cell Biology, V4, P115, DOI 10.1016/0962-8924(94)90065-5; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KUHNE MR, 1995, BIOCHEM BIOPH RES CO, V211, P190, DOI 10.1006/bbrc.1995.1795; LAMPHERE L, 1992, ENDOCRINOLOGY, V131, P2196, DOI 10.1210/en.131.5.2196; LAMPHERE L, 1994, AM J PHYSIOL, V266, pE486, DOI 10.1152/ajpendo.1994.266.3.E486; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Myers MG, 1996, ANNU REV PHARMACOL, V36, P615, DOI 10.1146/annurev.pa.36.040196.003151; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Sciacchitano S, 1997, ENDOCRINOLOGY, V138, P4931, DOI 10.1210/en.138.11.4931; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Sun XJ, 1997, MOL ENDOCRINOL, V11, P251, DOI 10.1210/me.11.2.251; Suzuki J, 1997, ONCOGENE, V15, P1689, DOI 10.1038/sj.onc.1201333; WHITE MF, 1994, J BIOL CHEM, V269, P1; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; ZHAO ZZ, 1994, J BIOL CHEM, V269, P8780	36	82	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10726	10732		10.1074/jbc.273.17.10726	http://dx.doi.org/10.1074/jbc.273.17.10726			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553137	hybrid			2022-12-27	WOS:000073224200086
J	Kosaki, A; Nelson, J; Webster, NJG				Kosaki, A; Nelson, J; Webster, NJG			Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SECONDARY STRUCTURE; DEPENDENT DIABETES-MELLITUS; MESSENGER-RNA; PREMESSENGER RNA; SR-PROTEINS; SPONTANEOUSLY OBESE; SKELETAL-MUSCLE; DOWNSTREAM EXON; RHESUS-MONKEY; IN-VIVO	The insulin receptor exists as two isoforms, A and B, that result from alternative splicing of exon 11 in the primary transcript. We have shown previously that the alternative splicing is developmentally and hormonally regulated. Consequently, these studies were instigated to identify sequences within the primary RNA transcript that regulate the alternative splicing. Minigenes containing exons 10, 11, and 12 and the intervening introns were constructed and transfected into HepG2 cells, which contain both isoforms of the insulin receptor. The cells were able to splice the minigene transcript to give both A (- exon 11) and B-like (+ exon 11) RNAs. A series of internal deletions within intron 10 were tested for their ability to give A and B RNAs. Intron 10 contained two sequences that modulated exon 11 inclusion; a 48-nucleotide purine-rich sequence at the 5' end of intron 10 that functions as a splicing enhancer and causes an increase in exon 11 inclusion, and a 43-nucleotide sequence at the 3' end of intron 10 upstream of the branch point sequence that favors skipping of exon 11. Increasing the length of the polypyrimidine tract at the 3' end of intron 10 caused exon 11 to be spliced constitutively, indicating that a weak splice site is required for alternative splicing. Finally, point mutations, insertions, and deletions within exon 11 itself were able to regulate inclusion of the exon both positively and negatively.	Vet Adm Med Ctr, Med Res Serv, San Diego, CA 92161 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, Whittier Diabet Res Program, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego			Webster, Nick/AAI-8410-2021					ANDERSON CM, 1993, J CLIN ENDOCR METAB, V76, P1380, DOI 10.1210/jc.76.5.1380; BALVAY L, 1993, BIOESSAYS, V15, P165, DOI 10.1002/bies.950150304; BENECKE H, 1992, J CLIN INVEST, V89, P2066, DOI 10.1172/JCI115819; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; CHEW SL, 1995, ENDOCRINOLOGY, V136, P1939, DOI 10.1210/en.136.5.1939; DIRKSEN WP, 1995, J BIOL CHEM, V270, P5346, DOI 10.1074/jbc.270.10.5346; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; FU XD, 1995, RNA, V1, P663; FURDON PJ, 1988, MOL CELL BIOL, V8, P860, DOI 10.1128/MCB.8.2.860; HANSEN T, 1993, J CLIN ENDOCR METAB, V77, P1500, DOI 10.1210/jc.77.6.1500; HUANG Z, 1994, J CLIN INVEST, V94, P1289, DOI 10.1172/JCI117447; Huang Z, 1996, J CLIN ENDOCR METAB, V81, P1552, DOI 10.1210/jc.81.4.1552; KELLERER M, 1993, DIABETOLOGIA, V36, P628, DOI 10.1007/BF00404072; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; MCKEOWN M, 1992, ANNU REV CELL BIOL, V8, P133, DOI 10.1146/annurev.cb.08.110192.001025; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1993, P NATL ACAD SCI USA, V90, P2633, DOI 10.1073/pnas.90.7.2633; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728; NELSON KK, 1990, P NATL ACAD SCI USA, V87, P6253, DOI 10.1073/pnas.87.16.6253; NORGREN S, 1994, J CLIN ENDOCR METAB, V78, P757, DOI 10.1210/jc.78.3.757; NORGREN S, 1993, DIABETES, V42, P675, DOI 10.2337/diabetes.42.5.675; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SELL SM, 1994, J BIOL CHEM, V269, P30769; SHIFRIN VI, 1993, J BIOL CHEM, V268, P25376; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; SOLNICK D, 1987, MOL CELL BIOL, V7, P3194, DOI 10.1128/MCB.7.9.3194; STERNER DA, 1993, MOL CELL BIOL, V13, P2677, DOI 10.1128/MCB.13.5.2677; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WANG J, 1995, RNA, V1, P335; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660	43	67	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10331	10337		10.1074/jbc.273.17.10331	http://dx.doi.org/10.1074/jbc.273.17.10331			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553088	hybrid			2022-12-27	WOS:000073224200037
J	Dunlevy, JR; Neame, PJ; Vergnes, JP; Hassell, JR				Dunlevy, JR; Neame, PJ; Vergnes, JP; Hassell, JR			Identification of the N-linked oligosaccharide sites in chick corneal lumican and keratocan that receive keratan sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEATS; MOLECULAR-CLONING; LINKAGE REGION; MONKEY CORNEA; CORE PROTEIN; PROTEOGLYCAN; DECORIN; GENE; FIBROMODULIN; SEQUENCE	Corneal proteoglycans have chondroitin/dermatan and keratan sulfate (KS) chains and belong to the leucine-rich proteoglycan gene family. Corneal KS is N-linked to Asn of an NX(S/T) site through a complex oligosaccharide linkage region. Only some sites receive KS, whereas others remain in a high mannose form. To determine whether the attachment of KS was biased toward specific sites, we isolated trypsin-digested KS-containing fragments of chick corneal proteoglycans and sequenced the peptides, Results showed that all of the peptides sequenced aligned to the deduced amino acid sequence of either chick lumican or chick keratocan at the first, third, and fourth potential N-linked sites. Sites 1 and 4 in lumican and keratocan are in a homologous location. By analogy with the structure of ribonuclease inhibitor (a Leu-rich repeat containing protein), the KS chains would extend outward on the outer face of a horseshoe-like structure. The amino acid sequences surrounding the potential N-linked sites were also compared. Sites receiving KS tend to have a higher occurrence of aromatic residues, in particular Phe, located within 3 amino acids of NX(SPT), These conserved Phe residues may have a role in the conversion of high mannose N-linked oligosaccharides to polylactosamine and/or keratan sulfate.	Univ S Florida, Coll Med, Shriners Hosp Children Tampa, Tampa, FL 33612 USA; Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA	State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dunlevy, JR (corresponding author), Univ S Florida, Coll Med, Shriners Hosp Children Tampa, 12502 N Pine Dr, Tampa, FL 33612 USA.				NATIONAL EYE INSTITUTE [P30EY008098, R01EY008104, R37EY008104, F32EY006623] Funding Source: NIH RePORTER; NEI NIH HHS [EY08104, EY06623, EY08098] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P20613; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; CHAKRAVARTI S, 1995, GENOMICS, V27, P481, DOI 10.1006/geno.1995.1080; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P14226; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Grover J, 1996, GENOMICS, V38, P109, DOI 10.1006/geno.1996.0605; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; LI W, 1992, ARCH BIOCHEM BIOPHYS, V296, P190, DOI 10.1016/0003-9861(92)90562-B; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; MIDURA RJ, 1989, J BIOL CHEM, V264, P1423; NAKAZAWA K, 1984, J BIOL CHEM, V259, P3751; NAKAZAWA K, 1983, J BIOL CHEM, V258, P6051; NILSSON B, 1983, J BIOL CHEM, V258, P6056; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; PLAAS AHK, 1990, J BIOL CHEM, V265, P20634; UJITA M, 1995, GENE, V158, P237, DOI 10.1016/0378-1119(95)00070-M; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	22	43	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9615	9621		10.1074/jbc.273.16.9615	http://dx.doi.org/10.1074/jbc.273.16.9615			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545293	hybrid			2022-12-27	WOS:000073128800039
J	Purmal, AA; Lampman, GW; Bond, JP; Hatahet, Z; Wallace, SS				Purmal, AA; Lampman, GW; Bond, JP; Hatahet, Z; Wallace, SS			Enzymatic processing of uracil glycol, a major oxidative product of DNA cytosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE RING SATURATION; IONIZING-RADIATION; ESCHERICHIA-COLI; EXONUCLEASE ACTIVITY; SEQUENCE CONTEXT; NUCLEIC-ACIDS; UREA RESIDUES; POLYMERASE-I; HUMAN-CELLS; DAMAGE	A major stable oxidation product of DNA cytosine is uracil glycol (Ug). Because of the potential of Ug to be a strong premutagenic lesion, it is important to assess whether it is a blocking lesion to DNA polymerase as is its structural counterpart, thymine glycol (Tg), and to evaluate its pairing properties. Here, a series of oligonucleotides containing Ug or Tg were prepared and used as templates for a model enzyme, Escherichia coli DNA polymerase I Klenow fragment (exo-). During translesion DNA synthesis, Ug was bypassed more efficiently than Tg in all sequence contexts examined. Furthermore, only dAMP was incorporated opposite template Ug and Tg and the kinetic parameters of incorporation showed that dAMP was inserted opposite Ug more efficiently than opposite Tg. Ug opposite G and A was also recognized and removed in vitro by the E. coli DNA repair glycosylases, endonuclease III (endo III), endonuclease VIII (endo VIII), and formamidopyrimidine DNA glycosylase. The steady state kinetic parameters indicated that Ug was a better substrate for endo III and formamidopyrimidine DNA glycosylase than Tg; for endonuclease VIII, however, Tg was a better substrate.	Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Wallace, SS (corresponding author), Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Stafford Hall, Burlington, VT 05405 USA.	swallace@zoo.uvm.edu		Wallace, Susan S./0000-0002-3906-0321	NCI NIH HHS [CA22435, R37 CA33657, CA52040] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA033657, R01CA052040, P30CA022435] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHEY PM, 1983, RADIAT RES, V93, P609, DOI 10.2307/3576040; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933; AYAKI H, 1986, NUCLEIC ACIDS RES, V14, P5013, DOI 10.1093/nar/14.12.5013; BASU AK, 1989, P NATL ACAD SCI USA, V86, P7677, DOI 10.1073/pnas.86.20.7677; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; CHENG KC, 1992, J BIOL CHEM, V267, P166; CLARK JM, 1989, BIOCHEMISTRY-US, V28, P775, DOI 10.1021/bi00428a054; CLARK JM, 1987, BIOCHEMISTRY-US, V26, P5404, DOI 10.1021/bi00391a028; CLARK JM, 1987, BIOCHEMISTRY-US, V26, P5398, DOI 10.1021/bi00391a027; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DICKERSON RE, 1989, NUCLEIC ACIDS RES, V17, P1797, DOI 10.1093/nar/17.5.1797; DIZDAROGLU M, 1984, RADIAT RES, V100, P41, DOI 10.2307/3576519; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EVANS J, 1993, MUTAT RES, V299, P147, DOI 10.1016/0165-1218(93)90092-R; FEIG DI, 1994, P NATL ACAD SCI USA, V91, P6609, DOI 10.1073/pnas.91.14.6609; GOODMAN M, 1994, DNA DAMAGE EFFECTS D, P132; HATAHET Z, 1993, NUCLEIC ACIDS RES, V21, P1563, DOI 10.1093/nar/21.7.1563; Hatahet Z, 1998, CONT CANC RES, P229; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; HAYES RC, 1986, NUCLEIC ACIDS RES, V14, P1045, DOI 10.1093/nar/14.2.1045; IDE H, 1987, BIOCHEMISTRY-US, V26, P964, DOI 10.1021/bi00377a042; IDE H, 1985, NUCLEIC ACIDS RES, V13, P8035, DOI 10.1093/nar/13.22.8035; JABERABOANSARI A, 1991, RADIAT RES, V127, P202, DOI 10.2307/3577966; Kung HC, 1997, J BIOL CHEM, V272, P9227; KUWABARA M, 1991, RADIAT PHYS CHEM, V37, P691; LASPIA MF, 1988, J BACTERIOL, V170, P3359, DOI 10.1128/jb.170.8.3359-3366.1988; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MCBRIDE TJ, 1991, BIOCHEMISTRY-US, V30, P207, DOI 10.1021/bi00215a030; MIASKIEWICZ K, 1993, INT J RADIAT BIOL, V63, P677, DOI 10.1080/09553009314552071; MIASKIEWICZ K, 1995, BIOPOLYMERS, V35, P113, DOI 10.1002/bip.360350112; MILLER J, 1994, DNA DAMAGE EFFECTS D, P71; MORAN E, 1985, MUTAT RES, V146, P229, DOI 10.1016/0167-8817(85)90063-X; PazElizur T, 1997, BIOCHEMISTRY-US, V36, P1766, DOI 10.1021/bi9621324; PEARLMAN DA, 1995, AMBER 4 1; PURMAL AA, 1994, NUCLEIC ACIDS RES, V22, P3930, DOI 10.1093/nar/22.19.3930; Purmal AA, 1998, BIOCHEMISTRY-US, V37, P330, DOI 10.1021/bi972153d; PURMAL AA, 1994, NUCLEIC ACIDS RES, V22, P72, DOI 10.1093/nar/22.1.72; ROUET P, 1985, CANCER RES, V45, P6113; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Shibutani S, 1996, BIOCHEMISTRY-US, V35, P14992, DOI 10.1021/bi961446o; SHIBUTANI S, 1993, J BIOL CHEM, V268, P11703; STRAUSS BS, 1990, CARCINOGENESIS, V11, P2103, DOI 10.1093/carcin/11.12.2103; SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D; TEOULE R, 1987, INT J RADIAT BIOL, V51, P573, DOI 10.1080/09553008414552111; TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401; WAGNER JR, 1992, P NATL ACAD SCI USA, V89, P3380, DOI 10.1073/pnas.89.8.3380; WALLACE S, 1997, OXIDATIVE STRESS MOL; Wang D, 1997, BIOCHEMISTRY-US, V36, P8628, DOI 10.1021/bi970341y; WATERS LC, 1991, RADIAT RES, V127, P190, DOI 10.2307/3577965	53	90	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10026	10035		10.1074/jbc.273.16.10026	http://dx.doi.org/10.1074/jbc.273.16.10026			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545349	hybrid			2022-12-27	WOS:000073128800095
J	Zhang, ZG; Realini, C; Clawson, A; Endicott, S; Rechsteiner, M				Zhang, ZG; Realini, C; Clawson, A; Endicott, S; Rechsteiner, M			Proteasome activation by REG molecules lacking homolog-specific inserts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; THERMOPLASMA-ACIDOPHILUM; MULTICATALYTIC PROTEASE; PHENOTYPIC SELECTION; 20-S PROTEASOME; PURIFICATION; COMPLEX; IDENTIFICATION; UBIQUITIN; REGULATOR	The peptidase activities of eukaryotic proteasomes are markedly activated by the 11 S REG or PA28, The three identified REG subunits, designated alpha, beta, and gamma, differ significantly in sequence over a short span of 15-30 amino acids that we call homolog-specific inserts. These inserts were deleted from each REG to produce the mutant proteins REG alpha Delta i, REG beta Delta i, and REG gamma Delta i. The purified recombinant proteins were then tested for their ability to oligomerize and activate the proteasome, Both REG alpha Delta i and REG gamma Delta i formed apparent heptamers and activated human red cell proteasomes to the same extent as their full-length counterparts. By contrast, REG beta Delta i exhibited, at low protein concentrations, reduced proteasome activation when compared with the wild-type REG beta protein. REG beta Delta i was able to form hetero-oligomers with a single site, monomeric REG alpha mutant and with REG alpha Delta i. At low concentrations, the REG alpha Delta i/REG beta Delta i hetero-oligomers stimulated the proteasome less than REG alpha/REG beta oligomers formed from wild-type subunits, and the reduced activation by REG alpha Delta i/REG beta Delta i was due to removal of the REG beta insert, not the REG alpha insert. These studies demonstrate that the REG alpha and REG gamma inserts play virtually no role in oligomerization or in proteasome activation. By contrast, removal of REG beta insert reduces binding of this subunit and REG alpha/REG beta oligomers to proteasomes. On the whole, however, our findings show that BEG inserts are not required for binding and activating the proteasome, We speculate that they serve to localize REG-proteasome complexes within cells, possibly by binding components in endoplasmic reticulum membranes.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Zhang, ZG (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA.				NIGMS NIH HHS [GM37009] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037009] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P182; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; GRZIWA A, 1991, FEBS LETT, V290, P186, DOI 10.1016/0014-5793(91)81256-8; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hoffman L, 1996, CURR TOP CELL REGUL, V34, P1, DOI 10.1016/S0070-2137(96)80001-X; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; KOPP F, 1995, J MOL BIOL, V248, P264; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; LUPAS A, 1993, ENZYME PROTEIN, V47, P252, DOI 10.1159/000468684; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1992, J BIOL CHEM, V267, P10515; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; PETERS JM, 1994, J BIOL CHEM, V269, P7709; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; REALINI C, 1994, J BIOL CHEM, V269, P20727; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Song XL, 1997, J BIOL CHEM, V272, P27994, DOI 10.1074/jbc.272.44.27994; Tanahashi N, 1997, GENES CELLS, V2, P195, DOI 10.1046/j.1365-2443.1997.d01-308.x; Tanaka K, 1997, ADV IMMUNOL, V64, P1, DOI 10.1016/S0065-2776(08)60885-8; UDVARDY A, 1993, J BIOL CHEM, V268, P9055; USTRELL V, 1995, FEBS LETT, V376, P155, DOI 10.1016/0014-5793(95)01257-9; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807	31	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9501	9509		10.1074/jbc.273.16.9501	http://dx.doi.org/10.1074/jbc.273.16.9501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545278	hybrid			2022-12-27	WOS:000073128800024
J	Bauer, JH; Liu, KD; You, Y; Lai, SY; Goldsmith, MA				Bauer, JH; Liu, KD; You, Y; Lai, SY; Goldsmith, MA			Heteromerization of the gamma(c) chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; CELL GROWTH-FACTOR; SIGNAL-TRANSDUCTION; IL-2 RECEPTOR; BETA-CHAIN; INTERFERON-ALPHA/BETA; THYMIC LYMPHOMAS; EXPRESSION; CLONING; MURINE	Interleukin-9 (IL-9) is a cytokine with pleiotropic effects on mast cell and T cell lines. It exerts its effects through the IL-9R complex consisting of IL-9R alpha and the common gamma(c) subunit, Here we report functional evidence for receptor heteromerization for efficient signal transduction, and we define minimal requirements in the two receptor subunits for IL-9R function, Tyrosine 336 of the IL-9R alpha and the membrane-proximal segment of gamma(c) are both crucial for signaling. The activated IL-9R complex employs the Janus kinases JAK1 and JAK3 for subsequent activation of the signal transducer and activator transcription (STAT) factors STAT-I, STAT-3, and STAT-5. This process is independent of Tyk2. We demonstrate further that the activated STAT complexes consist of STAT-1 and STAT-B homodimers and STAT-1-STAT-3 heterodimers. Finally, we show that IL-9R signaling in a T cell line does not result in detectable mitogen-activated protein kinase activation and leads to unsustained proliferation. Nonetheless, these T cells are efficiently protected from dexamethasone-induced apoptosis. These results further define the molecular architecture of the IL-SR and its specific connections to various biologic responses.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; Free University of Berlin	Goldsmith, MA (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, POB 419100, San Francisco, CA 94141 USA.	Mark_Goldsmith@quickmail.ucsf.edu		Lai, Stephen/0000-0001-8301-7286	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054351] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM54351] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; GAFFEN SL, 1995, P NATL ACAD SCI USA, V92, P7192, DOI 10.1073/pnas.92.16.7192; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GOLDSMITH MA, 1995, J BIOL CHEM, V270, P21729, DOI 10.1074/jbc.270.37.21729; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; GRUSS HJ, 1992, CANCER RES, V52, P1026; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; Liu KD, 1997, CURR BIOL, V7, P817, DOI 10.1016/S0960-9822(06)00369-1; Louahed J, 1996, J IMMUNOL, V156, P3704; LOUAHED J, 1995, J IMMUNOL, V154, P5061; MERZ H, 1991, BLOOD, V78, P1311; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; RENAULD JC, 1994, ONCOGENE, V9, P1327; RENAULD JC, 1995, BLOOD, V85, P1300, DOI 10.1182/blood.V85.5.1300.bloodjournal8551300; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Smets LA, 1996, LEUKEMIA LYMPHOMA, V20, P199, DOI 10.3109/10428199609051608; Stoecklin Elisabeth, 1996, Nature (London), V383, P726; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VINK A, 1993, EUR J IMMUNOL, V23, P1134, DOI 10.1002/eji.1830230523; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YIN TG, 1995, BLOOD, V85, P3101, DOI 10.1182/blood.V85.11.3101.bloodjournal85113101; YIN TG, 1995, J BIOL CHEM, V270, P20497, DOI 10.1074/jbc.270.35.20497	33	76	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9255	9260		10.1074/jbc.273.15.9255	http://dx.doi.org/10.1074/jbc.273.15.9255			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535918	hybrid			2022-12-27	WOS:000072990800095
J	Heinrichs, DE; Monteiro, MA; Perry, MB; Whitfield, C				Heinrichs, DE; Monteiro, MA; Perry, MB; Whitfield, C			The assembly system for the lipopolysaccharide R2 core-type of Escherichia coli is a hybrid of those found in Escherichia coli K-12 and Salmonella enterica - Structure and function of the R2 WaaK and WaaL homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GALACTAN-I; POLYACRYLAMIDE GELS; TYPHIMURIUM LT2; O-ANTIGEN; GENES; BIOSYNTHESIS; CLONING; POLYSACCHARIDE; BACTERIA; SEQUENCE	In Escherichia coli F632, the 14-kilobase pair chromosomal region located between waaC (formerly rfaC) and waaA (kdtA) contains genes encoding enzymes required for the synthesis of the type R2 core oligosaccharide portion of lipopolysaccharide. Ten of the 13 open reading frames encode predicted products sharing greater than 90% total similarity with homologs in E. coli K-12, However, the products of waaK (rfaK) and waaL (rfaL) each resemble homologs in Salmonella enterica serovar Typhimurium but share little similarity with E. coli K-12. The F632 WaaK and WaaL proteins therefore define differences between the type R2 and K-12 outer core oligosaccharides of E. coli lipopolysaccharides. Based on the chemical structure of the core oligosaccharide of an E. coli F632 waaK::aacC1 mutant and in vitro glycosyltransferase analyses, waaK encodes UDP-N-acetyl-glucosamine:(glucose) lipopolysaccharide alpha 1,2-N-acetyl-glucosaminyltransferase. The WaaK enzyme adds a terminal GlcNAc side branch substituent that is crucial for the recognition of core oligosaccharide acceptor by the O-polysaccharide ligase, WaaL, Results of complementation analyses of E. coli K-12 and F632 waaL mutants suggest that structural differences between the WaaL proteins play a role in recognition of, and interaction with, terminal lipopolysaccharide core moieties.	Univ Guelph, Dept Microbiol, Guelph, ON N1G 2W1, Canada; Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; National Research Council Canada	Whitfield, C (corresponding author), Univ Guelph, Dept Microbiol, Guelph, ON N1G 2W1, Canada.		Heinrichs, David/ABD-5702-2021	Heinrichs, David/0000-0002-7217-2456				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amor PA, 1997, MOL MICROBIOL, V26, P145, DOI 10.1046/j.1365-2958.1997.5631930.x; BEHER MG, 1981, J BACTERIOL, V147, P972, DOI 10.1128/JB.147.3.972-985.1981; BINOTTO J, 1991, CAN J MICROBIOL, V37, P474, DOI 10.1139/m91-078; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; CARSTENIUS P, 1990, NUCLEIC ACIDS RES, V18, P6128, DOI 10.1093/nar/18.20.6128; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CLARKE BR, 1995, J BACTERIOL, V177, P5411, DOI 10.1128/jb.177.19.5411-5418.1995; CLARKE BR, 1992, J BACTERIOL, V174, P4614, DOI 10.1128/JB.174.14.4614-4621.1992; CREEGER ES, 1979, J BIOL CHEM, V254, P804; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DUBOIS M, 1956, ANAL BIOCHEM, V28, P167; GAMIAN A, 1992, CARBOHYD RES, V236, P195, DOI 10.1016/0008-6215(92)85016-S; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HAMMERLING G, 1971, EUR J BIOCHEM, V22, P331, DOI 10.1111/j.1432-1033.1971.tb01549.x; HELLERQV.CG, 1971, CARBOHYD RES, V16, P39, DOI 10.1016/S0008-6215(00)86096-6; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; HOLST O, 1992, BACTERIAL ENDOTOXIC, V1, P134; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; KADAM SK, 1985, J BACTERIOL, V161, P277, DOI 10.1128/JB.161.1.277-284.1985; KLENA JD, 1992, J BACTERIOL, V174, P7297, DOI 10.1128/jb.174.22.7297-7307.1992; KLENA JD, 1992, J BACTERIOL, V174, P4746, DOI 10.1128/JB.174.14.4746-4752.1992; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; LINDBERG AA, 1971, J BACTERIOL, V105, P57, DOI 10.1128/JB.105.1.57-64.1971; MACLACHLAN PR, 1991, J BACTERIOL, V173, P7151, DOI 10.1128/jb.173.22.7151-7163.1991; Makela P. H., 1984, HDB ENDOTOXIN, P59; MILLER JH, 1992, SHORT COURSE BACTERI, P439; MULLER E, 1972, J BIOL CHEM, V247, P2614; Neidhardt, 1996, ESCHERICHIA COLIAND, V2, P2460; OSBORN MJ, 1964, BIOCHEM BIOPH RES CO, V16, P568, DOI 10.1016/0006-291X(64)90194-9; OSBORN MJ, 1966, METHOD ENZYMOL, V8, P456; PARKER CT, 1992, J BACTERIOL, V174, P2525, DOI 10.1128/jb.174.8.2525-2538.1992; PRADEL E, 1992, J BACTERIOL, V174, P4736, DOI 10.1128/JB.174.14.4736-4745.1992; Raetz C. R. H., 1996, ESCHERICHIA COLI SAL, V1, P1035; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; ROHR TE, 1980, J BIOL CHEM, V255, P2332; Sambrook J., 2002, MOL CLONING LAB MANU; SAWARDEKER JH, 1967, ANAL CHEM, V39, P1602; SCHMIDT G, 1970, EUR J BIOCHEM, V14, P357, DOI 10.1111/j.1432-1033.1970.tb00297.x; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; WOLLIN R, 1983, J BIOL CHEM, V258, P3769	49	81	92	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8849	8859		10.1074/jbc.273.15.8849	http://dx.doi.org/10.1074/jbc.273.15.8849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535865	hybrid			2022-12-27	WOS:000072990800042
J	Keeney, DS; Skinner, C; Wei, SZ; Friedberg, T; Waterman, MR				Keeney, DS; Skinner, C; Wei, SZ; Friedberg, T; Waterman, MR			A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; ESCHERICHIA-COLI; RAT-KIDNEY; CYTOCHROME-P450; EXPRESSION; IDENTIFICATION; CALCIUM; GENE; DIFFERENTIATION; BIOACTIVATION	The CYP monooxygenase, CYP2B12, is the first identified skin-specific cytochrome P450 enzyme. It is characterized by high, constitutive expression in an extrahepatic tissue, the sebaceous glands of cutaneous tissues. It is expressed exclusively in a subset of differentiated keratinocytes called sebocytes, as demonstrated by Northern blot analysis, in situ hybridization, and polymerase chain reaction. The onset of its expression coincides with the morphological appearance of sebaceous glands in the neonatal rat. Recombinant CYP2B12 produced in Escherichia coli epoxidizes arachidonic acid to 11,12- and 8,9-epoxyeicosatrienoic acids (80 and 20% of total metabolites, respectively). The identification of arachidonic acid as a substrate for this skin-specific CYP monooxygenase suggests an endogenous function in keratinocytes in the generation of bioactive lipids and intracellular signaling.	Vanderbilt Univ, Sch Med, Dept Biochem & Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Dermatol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Nephrol, Nashville, TN 37232 USA; Univ Dundee, Ninewells Hosp & Med Sch, Ctr Biomed Res, Dundee DD1 9SY, Scotland	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Dundee	Keeney, DS (corresponding author), Vanderbilt Univ, Dept Biochem & Med Dermatol, 607 Light Hall, Nashville, TN 37232 USA.	keeney@ctrvax.vanderbilt.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NIAMS NIH HHS [P30 AR41943] Funding Source: Medline; NIDDK NIH HHS [P30 DK26657] Funding Source: Medline; NIEHS NIH HHS [P30 ES00267] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ATCHISON M, 1986, P NATL ACAD SCI USA, V83, P2300, DOI 10.1073/pnas.83.8.2300; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385; CAPDEVILA JH, 1990, J BIOL CHEM, V265, P10865; CAPDEVILA JH, 1996, ADV MOL CEL, V14, P317; Capdevila Jorge H., 1995, P443; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; FITZPATRICK FA, 1988, PHARMACOL REV, V40, P229; FRIEDBERG T, 1992, BIOCHEM J, V287, P775, DOI 10.1042/bj2870775; HAMMONDS TD, 1989, ANAL BIOCHEM, V182, P300, DOI 10.1016/0003-2697(89)90598-8; HENDERSON CJ, 1992, PROGR DRUG METABOLIS, V13, P73; HENNINGS H, 1989, CARCINOGENESIS, V10, P777, DOI 10.1093/carcin/10.4.777; IMAOKA S, 1993, J PHARMACOL EXP THER, V267, P1012; JOHN GH, 1994, ARCH BIOCHEM BIOPHYS, V314, P367, DOI 10.1006/abbi.1994.1455; KARARA A, 1993, J BIOL CHEM, V268, P13565; KARARA A, 1991, J BIOL CHEM, V266, P7561; KEENEY DS, 1995, MOL ENDOCRINOL, V9, P1091, DOI 10.1210/me.9.8.1091; KNICKLE LC, 1994, MOL PHARMACOL, V45, P1273; LAETHEM RM, 1992, MOL PHARMACOL, V42, P958; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; NAKAYAMA K, 1993, GENE, V136, P333, DOI 10.1016/0378-1119(93)90490-T; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; NICOLAIDES N, 1974, SCIENCE, V186, P19, DOI 10.1126/science.186.4158.19; OMURA T, 1964, J BIOL CHEM, V239, P2379; SANDHU P, 1993, ARCH BIOCHEM BIOPHYS, V306, P443, DOI 10.1006/abbi.1993.1536; WHEATLEY VR, 1986, PHYSL PATHOPHYSIOLOG, V9, P2705; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; ZELDIN DC, 1995, J CLIN INVEST, V95, P2150, DOI 10.1172/JCI117904; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438; Zhang QY, 1997, ARCH BIOCHEM BIOPHYS, V340, P270, DOI 10.1006/abbi.1997.9922; ZHU Y, 1995, HYPERTENSION, V25, P854, DOI 10.1161/01.HYP.25.4.854	36	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9279	9284		10.1074/jbc.273.15.9279	http://dx.doi.org/10.1074/jbc.273.15.9279			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535921	hybrid			2022-12-27	WOS:000072990800098
J	Zhu, CX; Roche, CJ; Papanicolaou, N; DiPietrantonio, A; Tse-Dinh, YC				Zhu, CX; Roche, CJ; Papanicolaou, N; DiPietrantonio, A; Tse-Dinh, YC			Site-directed mutagenesis of conserved aspartates, glutamates and arginines in the active site region of Escherichia coli DNA topoisomerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVALENT METAL-IONS; RESTRICTION-ENDONUCLEASE; SEQUENCE-ANALYSIS; POLYMERASE-BETA; MU-TRANSPOSASE; REVERSE GYRASE; MG2+ BINDING; ECORV; PROTEIN; GENOME	To catalyze relaxation of supercolied DNA, DNA topoisomerases form a covalent enzyme-DNA intermediate via nucleophilic attack of a tyrosine hydroxyl group on the DNA phosphodiester backbone bond during the step of DNA cleavage, Strand passage then takes place to change the linking number, This is followed by DNA religation during which the displaced DNA hydroxyl group attacks the phosphotyrosine linkage to reform the DNA phosphodiester bond, Mg(II) is required for the relaxation activity of type LA and type II DNA topoisomerases, A number of conserved amino acids with acidic and basic side chains are present near Tyr-319 in the active site of the crystal structure of the 67-kDa N-terminal fragment of Escherichia coli DNA topoisomerase I, Their roles in enzyme catalysis were investigated by site-directed mutation to alanine, Mutation of Arg-136 abolished all the enzyme relaxation activity even though DNA cleavage activity was retained, The Glu-9, Asp-lll, Asp-113, Glu-115, and Arg-321 mutants had partial loss of relaxation activity in vitro, All the mutants failed to complement chromosomal topA mutation in E. coli AS17 at 42 degrees C, possibly accounting for the conservation of these residues in evolution.	New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	New York Medical College	Tse-Dinh, YC (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	yuk-ching_tse-dinh@nymc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054226] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54226] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER TA, 1994, P NATL ACAD SCI USA, V91, P6654, DOI 10.1073/pnas.91.14.6654; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bjornsti MA, 1991, CURR OPIN STRUC BIOL, V1, P99, DOI 10.1016/0959-440X(91)90017-N; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Chandler MS, 1996, GENE, V169, P25, DOI 10.1016/0378-1119(95)00777-6; CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753; delaTour CB, 1995, BBA-GENE STRUCT EXPR, V1264, P279, DOI 10.1016/0167-4781(96)83596-2; Derbyshire V, 1995, METHOD ENZYMOL, V262, P363; DIGATE RJ, 1989, J BIOL CHEM, V264, P17924; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; GUPTA M, 1995, BBA-GENE STRUCT EXPR, V1262, P1, DOI 10.1016/0167-4781(95)00029-G; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; JELTSCH A, 1995, BIOCHEMISTRY-US, V34, P6239, DOI 10.1021/bi00018a028; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; KIM K, 1995, J BIOL CHEM, V270, P1472, DOI 10.1074/jbc.270.3.1472; KOSTREWA D, 1995, BIOCHEMISTRY-US, V34, P683, DOI 10.1021/bi00002a036; Krah R, 1996, P NATL ACAD SCI USA, V93, P106, DOI 10.1073/pnas.93.1.106; LEE J, 1992, J MOL BIOL, V228, P1091, DOI 10.1016/0022-2836(92)90317-D; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; LUTTINGER A, 1995, MOL MICROBIOL, V15, P601, DOI 10.1111/j.1365-2958.1995.tb02369.x; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; OSHEROFF N, 1989, PHARMACOL THERAPEUT, V41, P223, DOI 10.1016/0163-7258(89)90108-3; POLARD P, 1995, MOL MICROBIOL, V15, P13, DOI 10.1111/j.1365-2958.1995.tb02217.x; PRUSS GJ, 1986, J BACTERIOL, V168, P276, DOI 10.1128/jb.168.1.276-282.1986; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; REHAKRANTZ LJ, 1993, J BIOL CHEM, V268, P27100; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SELENT U, 1992, BIOCHEMISTRY-US, V31, P4808, DOI 10.1021/bi00135a010; TSE YC, 1980, J BIOL CHEM, V255, P5560; TSEDINH YC, 1988, J BIOL CHEM, V263, P15857; TSEDINH YC, 1986, J BIOL CHEM, V261, P931; TseDinh YC, 1997, TRENDS MICROBIOL, V5, P323, DOI 10.1016/S0966-842X(97)01080-9; TSEDINH YC, 1986, J MOL BIOL, V191, P312; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WIGLEY DB, 1995, ANNU REV BIOPH BIOM, V24, P185, DOI 10.1146/annurev.bb.24.060195.001153; Yang FD, 1996, GENE, V178, P63, DOI 10.1016/0378-1119(96)00335-6; Zhu CX, 1997, J BIOL CHEM, V272, P16206, DOI 10.1074/jbc.272.26.16206; ZHU CX, 1995, J MOL BIOL, V250, P609, DOI 10.1006/jmbi.1995.0402; ZUMSTEIN L, 1986, J MOL BIOL, V191, P333, DOI 10.1016/0022-2836(86)90130-0	45	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8783	8789		10.1074/jbc.273.15.8783	http://dx.doi.org/10.1074/jbc.273.15.8783			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535856	hybrid			2022-12-27	WOS:000072990800033
J	Frank, DW; Waechter, CJ				Frank, DW; Waechter, CJ			Purification and characterization of a polyisoprenyl phosphate phosphatase from pig brain - Possible dual specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; CIS-ISOPRENYLTRANSFERASE ACTIVITY; SEA-URCHIN EMBRYO; DOLICHYL-PHOSPHATE; RAT-LIVER; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; LINKED OLIGOSACCHARIDES; PROTEIN GLYCOSYLATION; PLASMA-MEMBRANES	Microsomal fractions from pig and calf brain catalyze the enzymatic dephosphorylation of endogenous and exogenous dolichyl monophosphate (Dol-P) (Sumbilla, C, A, and Waechter, C, J, (1985) Methods Enzymol. 111, 471-482), The Dol-P phosphatase (EC 3.1.3.51) has been solubilized by extracting pig brain microsomes with the nonionic detergent Nonidet P-40 and purified approximately 1,107-fold by a combination of anion exchange chromatography, polyethylene glycol fractionation, dye-ligand chromatography, and wheat germ agglutinin affinity chromatography. Treatment of the enzyme with neuraminidase prevented binding to wheat germ agglutinin-Sepharose, indicating the presence of one or more N-acetylneuraminyl residues per molecule of enzyme, When the highly purified polyisoprenyl phosphate phosphatase was analyzed by SDS-polyacrylamide gel electrophoresis, a major 33-kDa polypeptide was observed. Enzymatic dephosphorylation of Dol-P by the purified phosphatase was 1) optimal at pH 7; 2) potently inhibited by F-, orthovanadate, and Zn2+ > Co2+ > Mn2+ but unaffected by Mg2+; 3) exhibited an approximate K-m for C-95-Dol-P of 45 mu M; and 4) was sensitive to N-ethylmale-imide, phenylglyoxal, and diethylpyrocarbonate. The pig brain phosphatase did not dephosphorylate glucose 6-phosphate, mannose 6-phosphate, 5'-AMP, or p-nitrophenylphosphate, but it dephosphorylated dioleoylphosphatidic acid at initial rates similar to those determined for Dol-P, Based on the virtually identical sensitivity of Dol-P and phosphatidic acid dephosphorylation by the highly purified enzyme to N-ethylmale-imide, F-, phenylglyoxal, and diethylpyrocarbonate, both substrates appear to be hydrolyzed by a single enzyme with an apparent dual specificity. This is the first report of the purification of a neutral Dol-P phosphatase from mammalian tissues. Although the enzyme is Mg2+-independent and capable of dephosphorylating Dol-P and PA, several enzymological properties distinguish this lipid phosphomonoesterase from PAP2.	Univ Kentucky, Albert B Chandler Med Ctr, Coll Med, Dept Biochem, Lexington, KY 40536 USA	University of Kentucky	Waechter, CJ (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Coll Med, Dept Biochem, Lexington, KY 40536 USA.				NIGMS NIH HHS [GM36065] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036065] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; ADAIR WL, 1985, METHOD ENZYMOL, V111, P201; ADAIR WL, 1984, J BIOL CHEM, V259, P4441; ALLEN CM, 1978, BIOCHEMISTRY-US, V17, P5020, DOI 10.1021/bi00616a025; APPELKVIST EL, 1981, BIOSCIENCE REP, V1, P619, DOI 10.1007/BF01116277; BELOCOPITOW E, 1982, EUR J BIOCHEM, V125, P167, DOI 10.1111/j.1432-1033.1982.tb06664.x; BHAT NR, 1991, J NEUROCHEM, V56, P339, DOI 10.1111/j.1471-4159.1991.tb02600.x; BRINDLEY DN, 1988, PHOSPHATIDATE PHOSPH, V1, P21; BURTON WA, 1979, J BIOL CHEM, V254, P7129; BURTON WA, 1981, ARCH BIOCHEM BIOPHYS, V208, P409, DOI 10.1016/0003-9861(81)90526-9; CARSON DD, 1981, J BIOL CHEM, V256, P1552; CHEN Z, 1988, ARCH BIOCHEM BIOPHYS, V266, P98, DOI 10.1016/0003-9861(88)90240-8; CRICK DC, 1991, J NEUROCHEM, V57, P1354, DOI 10.1111/j.1471-4159.1991.tb08301.x; CRICK DC, 1994, J BIOL CHEM, V269, P10559; CRICK DC, 1994, J NEUROCHEM, V62, P247; DANILOV LL, 1989, CHEM PHYS LIPIDS, V51, P191, DOI 10.1016/0009-3084(89)90006-6; DEROSA PA, 1984, ARCH BIOCHEM BIOPHYS, V234, P537, DOI 10.1016/0003-9861(84)90301-1; Dillon DA, 1997, J BIOL CHEM, V272, P10361; DITTMER JC, 1964, J LIPID RES, V5, P126; FRANK D, 1990, FASEB J, V4, P1930; GRANGE DK, 1977, BIOCHEM BIOPH RES CO, V79, P734, DOI 10.1016/0006-291X(77)91173-1; HARFORD JB, 1977, BIOCHEM BIOPH RES CO, V76, P1036, DOI 10.1016/0006-291X(77)90960-3; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P102; HUBBARD SC, 1980, J BIOL CHEM, V255, P1782; IDOYAGAVARGAS V, 1980, FEBS LETT, V112, P63, DOI 10.1016/0014-5793(80)80128-1; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; KANOH H, 1992, J BIOL CHEM, V267, P25309; Kates M., 1986, TECHNIQUES LIPIDOLOG, V2nd; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENNARZ WJ, 1985, TRENDS BIOCHEM SCI, V10, P248, DOI 10.1016/0968-0004(85)90144-6; LIN YP, 1989, J BIOL CHEM, V264, P8641; LUCAS JJ, 1977, J BIOL CHEM, V252, P4330; MARTIN A, 1994, SIGNAL ACTIVATED PHO, P139; MATSUOKA S, 1991, J BIOL CHEM, V266, P3464; MCCLOSKEY MA, 1980, BIOCHEMISTRY-US, V19, P2061, DOI 10.1021/bi00551a009; MCSWEENEY GP, 1965, J CHROMATOGR, V17, P183, DOI 10.1016/S0021-9673(00)99850-9; Miles E W, 1977, Methods Enzymol, V47, P431; MILLER RL, 1982, J BIOL CHEM, V257, P7574; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; PAN YT, 1990, BIOCHEMISTRY-US, V29, P8077, DOI 10.1021/bi00487a013; PERRY DK, 1993, J BIOL CHEM, V268, P25302; RAVI K, 1983, BIOCHEM J, V213, P513, DOI 10.1042/bj2130513; RIP JW, 1981, J BIOL CHEM, V256, P1929; RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6; ROSSIGNOL DP, 1983, J BIOL CHEM, V258, P9122; RUSH JS, 1992, ANAL BIOCHEM, V206, P328, DOI 10.1016/0003-2697(92)90374-G; SAGAMI H, 1993, J BIOL CHEM, V268, P10109; SAKAKIHARA Y, 1985, J BIOL CHEM, V260, P5413; SCHER MG, 1984, ARCH BIOCHEM BIOPHYS, V231, P293, DOI 10.1016/0003-9861(84)90391-6; SCHER MG, 1985, J BIOL CHEM, V260, P3742; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPIRO MJ, 1986, J BIOL CHEM, V261, P4725; SUMBILLA C, 1985, ARCH BIOCHEM BIOPHYS, V238, P75, DOI 10.1016/0003-9861(85)90142-0; SUMBILLA C, 1985, METHOD ENZYMOL, V111, P471; WAECHTER CJ, 1989, NEUROBIOLOGY GLYCOCO, P127; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; WAGGONER DW, 1995, J BIOL CHEM, V270, P19422, DOI 10.1074/jbc.270.33.19422; WEDGWOOD JF, 1980, J BIOL CHEM, V255, P1120; WOLF M J, 1991, Glycobiology, V1, P405, DOI 10.1093/glycob/1.4.405; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	62	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11791	11798		10.1074/jbc.273.19.11791	http://dx.doi.org/10.1074/jbc.273.19.11791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565603	hybrid			2022-12-27	WOS:000073536700057
J	Jones, JT; Ballinger, MD; Pisacane, PI; Lofgren, JA; Fitzpatrick, VD; Fairbrother, WJ; Wells, JA; Sliwkowski, MX				Jones, JT; Ballinger, MD; Pisacane, PI; Lofgren, JA; Fitzpatrick, VD; Fairbrother, WJ; Wells, JA; Sliwkowski, MX			Binding interaction of the heregulin beta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; SITE-DIRECTED MUTAGENESIS; RESOLUTION SOLUTION STRUCTURE; FACTOR-ALPHA; HIGH-AFFINITY; NEUREGULINS; ACTIVATION; ANTIBODIES; LIGANDS; PEPTIDE	Individual residues of the heregulin beta (HRG) egf domain were mutated to alanine and displayed monovalently on phagemid particles as gene III fusion proteins. Wild type HRG beta egf domain displayed on phage was properly folded as evidenced by its ability to bind ErbB3 and ErbB4 receptor-IgG fusion proteins with affinities close to those measured for bacterially produced HRG beta egf domain. Binding to ErbB3 and ErbB4 receptors was affected by mutation of residues throughout the egf domain; including the NH, terminus (His(2) and Leu(3)), the two beta-turns (Val(15)-Gly(18) and Gly(42)-Gln(46)), and some discontinuous residues (including Leu(3), Val(4), Phe(13), Val(23), and Leu(33)) that form a patch on the major beta-sheet and the COOH-terminal region (Tyr(48) and Met(50)-Phe(53)). Binding affinity was least changed by mutations throughout the Omega-loop and the second strand of the major beta-sheet. More mutants had greater affinity loss for ErbB3 compared with ErbB4 implying that it has more stringent binding requirements. Many residues important for HRG binding to its receptors correspond to critical residues for epidermal growth factor (EGF) and transforming growth factor alpha binding to the EGF receptor. Specificity may be determined in part by bulky groups that prevent binding to the unwanted receptor. All of the mutants tested were able to induce phosphorylation and mitogen-activated protein kinase activation through ErbB4 receptors and were able to modulate a transphosphorylation signal from ErbB3 to ErbB2 in MCF7 cells. An understanding of binding similarities and differences among the EGF family of ligands may facilitate the development of egf-like analogs with broad or narrow specificity.	Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Sliwkowski, MX (corresponding author), Genentech Inc, Dept Prot Chem, MS 63, San Francisco, CA 94080 USA.	marks@gene.com	Wells, Jim A/O-9854-2016					Ballinger MD, 1998, J BIOL CHEM, V273, P11675, DOI 10.1074/jbc.273.19.11675; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; CAMPION SR, 1990, BIOCHEMISTRY-US, V29, P9988, DOI 10.1021/bi00494a032; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Chau BN, 1996, BIOCHEM BIOPH RES CO, V229, P882, DOI 10.1006/bbrc.1996.1896; Cohen BM, 1996, J BIOL CHEM, V271, P4813; CUNNINGHAM BC, 1994, EMBO J, V13, P2508, DOI 10.1002/j.1460-2075.1994.tb06540.x; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; ENGLER DA, 1990, FEBS LETT, V271, P47, DOI 10.1016/0014-5793(90)80368-S; FENDLY BM, 1990, CANCER RES, V50, P1550; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P2; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; HARVEY TS, 1991, EUR J BIOCHEM, V198, P555, DOI 10.1111/j.1432-1033.1991.tb16050.x; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HOMMEL U, 1992, J MOL BIOL, V227, P271, DOI 10.1016/0022-2836(92)90697-I; HOMMEL U, 1991, BIOCHEMISTRY-US, V30, P8891, DOI 10.1021/bi00100a024; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Jacobsen NE, 1996, BIOCHEMISTRY-US, V35, P3402, DOI 10.1021/bi952626l; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; KATSUURA M, 1989, J BIOCHEM-TOKYO, V106, P87, DOI 10.1093/oxfordjournals.jbchem.a122826; KOMORIYA A, 1984, P NATL ACAD SCI-BIOL, V81, P1351, DOI 10.1073/pnas.81.5.1351; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MATSUNAMI RK, 1991, J CELL BIOCHEM, V46, P242, DOI 10.1002/jcb.240460307; MODJTAHEDI H, 1994, INT J ONCOL, V4, P277; NAGATA K, 1994, EMBO J, V13, P3517, DOI 10.1002/j.1460-2075.1994.tb06658.x; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Puddicombe SM, 1996, J BIOL CHEM, V271, P15367, DOI 10.1074/jbc.271.26.15367; RICHTER A, 1995, J BIOL CHEM, V270, P1612, DOI 10.1074/jbc.270.4.1612; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Sadick MD, 1996, ANAL BIOCHEM, V235, P207, DOI 10.1006/abio.1996.0114; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; VANDEPOLL MLM, 1995, J BIOL CHEM, V270, P22337, DOI 10.1074/jbc.270.38.22337; WELLS J A, 1992, Current Opinion in Biotechnology, V3, P355, DOI 10.1016/0958-1669(92)90163-D; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; WILEY HS, 1989, J BIOL CHEM, V264, P18912; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562	43	53	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11667	11674		10.1074/jbc.273.19.11667	http://dx.doi.org/10.1074/jbc.273.19.11667			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565587	hybrid			2022-12-27	WOS:000073536700041
J	Kash, JC; Menon, KMJ				Kash, JC; Menon, KMJ			Identification of a hormonally regulated luteinizing hormone human chorionic gonadotropin receptor mRNA binding protein - Increased mRNA binding during receptor down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYC MESSENGER-RNA; LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; CODING REGION; RIBONUCLEIC-ACID; SPECIFICALLY INTERACTS; HALF-LIFE; SEQUENCE; STABILITY; DEGRADATION; EXPRESSION	To elucidate the molecular events associated with the regulation of luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor mRNA stability during hCG-induced receptor down-regulation, we have identified an LH/hCG receptor-specific mRNA binding protein. Proteins were isolated from control and down-regulated rat ovary and were incubated with in vitro transcribed RNAs corresponding to the full-length LW hCG receptor, as well as 5'- and 3'-truncated receptor forms. Resultant ribonucleoprotein complexes were analyzed by RNA gel mobility shift. A prominent M-r 50,000 ribonucleoprotein complex was identified with the following characteristics: 1) specificity for LH/hCG receptor open reading frame sequences located between nucleotides 102 and 282; 2) lack of competition by nonspecific RNAs; 3) a 3-fold increase in RNA binding activity during hCG-induced receptor down-regulation; and 4) limited tissue expression. This report describes the first evidence of an LH/hCG receptor mRNA binding protein, which we term LRBP-1, for luteinizing hormone receptor RNA binding protein-1. This protein is a candidate for a trans-acting factor involved in the hormonal regulation of LH/hCG; receptor mRNA stability in rat ovary.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Obstet Gynecol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Menon, KMJ (corresponding author), 6428 Med Sci Bldg 1,1300 Catherine, Ann Arbor, MI 48109 USA.		Kash, John/ABE-8280-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD006656] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007048, R37HD006656] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-06656, PR5-T32-HD-07048] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AASHEIM HC, 1994, NUCLEIC ACIDS RES, V22, P959, DOI 10.1093/nar/22.6.959; BERNARD MP, 1990, MOL CELL ENDOCRINOL, V71, pR19, DOI 10.1016/0303-7207(90)90034-6; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; CHEN CYA, 1992, MOL CELL BIOL, V12, P5748, DOI 10.1128/MCB.12.12.5748; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEKKER CJ, 1994, TRENDS BIOL SCI, V19, P336; GAY DA, 1989, P NATL ACAD SCI USA, V86, P5763, DOI 10.1073/pnas.86.15.5763; HERRICK DJ, 1994, MOL CELL BIOL, V14, P2119, DOI 10.1128/MCB.14.3.2119; HOFFMAN YM, 1991, ENDOCRINOLOGY, V128, P388, DOI 10.1210/endo-128-1-388; HU ZZ, 1994, BBA-MOL CELL RES, V1220, P333, DOI 10.1016/0167-4889(94)90158-9; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; KOO YB, 1991, ENDOCRINOLOGY, V128, P2297, DOI 10.1210/endo-128-5-2297; KOVACIC N, 1972, ENDOCRINOLOGY, V91, P910, DOI 10.1210/endo-91-4-910; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Lu DL, 1996, BIOCHEMISTRY-US, V35, P12347, DOI 10.1021/bi961019a; LU DL, 1993, ENDOCRINOLOGY, V132, P235, DOI 10.1210/en.132.1.235; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; PACHTER JS, 1987, CELL, V51, P283, DOI 10.1016/0092-8674(87)90155-3; PORT JD, 1992, J BIOL CHEM, V267, P24103; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; QIAN ZW, 1991, MOL CELL BIOL, V11, P5312, DOI 10.1128/MCB.11.10.5312; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIAVI SC, 1994, J BIOL CHEM, V269, P3441; SEGALOFF DL, 1993, ENDOCR REV, V14, P324, DOI 10.1210/er.14.3.324; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; THEIL EC, 1994, BIOCHEM J, V304, P1; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WANG HY, 1991, ENDOCRINOLOGY, V129, P133, DOI 10.1210/endo-129-1-133; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; YEN TJ, 1988, MOL CELL BIOL, V8, P1224, DOI 10.1128/MCB.8.3.1224	37	57	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10658	10664		10.1074/jbc.273.17.10658	http://dx.doi.org/10.1074/jbc.273.17.10658			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553128	hybrid			2022-12-27	WOS:000073224200077
J	Kinnunen, T; Kaksonen, M; Saarinen, J; Kalkkinen, N; Peng, HB; Rauvala, H				Kinnunen, T; Kaksonen, M; Saarinen, J; Kalkkinen, N; Peng, HB; Rauvala, H			Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-ASSOCIATED MOLECULE; HEPARAN-SULFATE PROTEOGLYCANS; EMBRYONAL CARCINOMA-CELLS; DEVELOPING RAT-BRAIN; HB-GAM; BINDING-PROTEIN; TYROSINE PHOSPHORYLATION; MOUSE EMBRYOGENESIS; SURFACE RECEPTOR; CONE MEMBRANES	N-syndecan (syndecan-3) was previously isolated as a cell surface receptor for heparin-binding growth-associated molecule (HB-GAM) and suggested to mediate the neurite growth-promoting signal from cell matrix-bound HB-GAM to the cytoskeleton of neurites, However, it is unclear whether N-syndecan would possess independent signaling capacity in neurite growth or in related cell differentiation phenomena. In the present study, we have transfected N18 neuroblastoma cells with a rat N-syndecan cDNA and show that N-syndecan transfection clearly enhances HB-GAM-dependent neurite growth and that the transfected N-syndecan distributes to the growth cones and the filopodia of the neurites. The N-syndecan-dependent neurite outgrowth is inhibited by the tyrosine kinase inhibitors herbimycin A and PP1, Biochemical studies show that a kinase activity, together with its substrate(s), binds specifically to the cytosolic moiety of N-syndecan immobilized to an affinity column. Western blotting reveals both c-Src and Fyn in the active fractions. In addition, cortactin, tubulin, and a 30-kDa protein are identified in the kinase-active fractions that bind to the cytosolic moiety of N-syndecan, Ligation of N-syndecan in the transfected cells by HB-GARI increases phosphorylation of c-Src and cortactin, We suggest that N-syndecan binds a protein complex containing Src family tyrosine kinases and their substrates and that N-syndecan acts as a neurite outgrowth receptor via the Src kinase-cortactin pathway.	Univ Helsinki, Inst Biotechnol, Mol Neurobiol Lab, Helsinki 00014, Finland; Univ Helsinki, Dept Biosci, Div Biochem, Helsinki 00014, Finland; Univ Helsinki, Prot Chem Lab, Inst Biotechnol, Helsinki 00014, Finland; Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA	University of Helsinki; University of Helsinki; University of Helsinki; University of North Carolina; University of North Carolina Chapel Hill	Kinnunen, T (corresponding author), Univ Helsinki, Inst Biotechnol, Mol Neurobiol Lab, POB 56, Helsinki 00014, Finland.		Kalkkinen, Nisse EJ/B-3923-2010	Rauvala, Heikki/0000-0001-7809-9811; Kaksonen, Marko/0000-0003-3645-7689; Kinnunen, Dr Tarja K/0000-0001-5630-2233				AbuAmer Y, 1997, J CELL BIOL, V137, P247, DOI 10.1083/jcb.137.1.247; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BIXBY JL, 1993, J NEUROSCI, V13, P3421; Bush MS, 1996, EUR J NEUROSCI, V8, P235, DOI 10.1111/j.1460-9568.1996.tb01208.x; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; Carey DJ, 1997, BIOCHEM J, V327, P1; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Daggett DF, 1996, MOL CELL NEUROSCI, V8, P272, DOI 10.1006/mcne.1996.0063; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; GINZBURG I, 1985, EMBO J, V4, P3667, DOI 10.1002/j.1460-2075.1985.tb04133.x; GORDONWEEKS PR, 1991, NEUROREPORT, V2, P573, DOI 10.1097/00001756-199110000-00005; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; JALKANEN M, 1993, TRENDS GLYCOSCI GLYC, V5, P107; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kinnunen A, 1998, EUR J NEUROSCI, V10, P635, DOI 10.1046/j.1460-9568.1998.00082.x; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; LEMISCHKA I, 1982, NATURE, V300, P330, DOI 10.1038/300330a0; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; MATSUBARA S, 1990, J BIOL CHEM, V265, P9441; MATTEN WT, 1990, J CELL BIOL, V111, P1959, DOI 10.1083/jcb.111.5.1959; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; NEEPER M, 1992, J BIOL CHEM, V267, P14998; NOLO R, 1995, NEUROSCI LETT, V191, P39, DOI 10.1016/0304-3940(94)11551-1; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Peng HB, 1997, J NEUROCYTOL, V26, P637, DOI 10.1023/A:1018545827369; PENG HB, 1995, J NEUROSCI, V15, P3027; Rapraeger AC, 1993, CURR OPIN CELL BIOL, V5, P844, DOI 10.1016/0955-0674(93)90034-N; RAULO E, 1994, J BIOL CHEM, V269, P12999; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; RAUVALA H, 1984, J CELL BIOL, V98, P1010, DOI 10.1083/jcb.98.3.1010; RAUVALA H, 1994, DEV BRAIN RES, V79, P157, DOI 10.1016/0165-3806(94)90121-X; SEEDS NW, 1970, P NATL ACAD SCI USA, V66, P160, DOI 10.1073/pnas.66.1.160; Szabat E, 1996, DEV BIOL, V178, P77, DOI 10.1006/dbio.1996.0199; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; URIOS P, 1991, BIOCHEM BIOPH RES CO, V175, P617, DOI 10.1016/0006-291X(91)91610-O; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; VUORI K, 1995, J BIOL CHEM, V270, P22259, DOI 10.1074/jbc.270.38.22259; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451	56	190	193	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10702	10708		10.1074/jbc.273.17.10702	http://dx.doi.org/10.1074/jbc.273.17.10702			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553134	hybrid, Green Published			2022-12-27	WOS:000073224200083
J	Steinmetz, A; Hermann, M; Nimpf, J; Aebersold, R; Ducret, A; Weinberg, RB; Schneider, WJ				Steinmetz, A; Hermann, M; Nimpf, J; Aebersold, R; Ducret, A; Weinberg, RB; Schneider, WJ			Expression and conservation of apolipoprotein AIT in an avian species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; LOW-DENSITY LIPOPROTEINS; CHICKEN OOCYTE RECEPTOR; B MESSENGER-RNA; A-IV; PLASMA APOLIPOPROTEINS; NUCLEOTIDE-SEQUENCE; MOLECULAR-BASIS; STOP CODON; C-III	In birds, intestinally derived lipoproteins are thought to be secreted directly into the portal vein rather than to enter the circulation via the lymphatic system as in mammals. Hepatic clearance of these so-called portomicrons must be rapid, but the protein(s) mediating their catabolism, presumably analogues of the 36-kDa mammalian apolipoprotein E, have not been identified. In searching for such a mediator(s), we have isolated a hitherto unknown 38-kDa protein from chicken serum, which we identified by microsequencing and molecular cloning as a counterpart to mammalian apolipoprotein AIV (apoAIV), Mature chicken apoAIV consists of 347 amino acids, lacks cysteine residues, and displays 57% sequence identity with human apoAIV and, to a significantly lesser extent, with apoAIVs of rodents. This first nonmammalian apoAIV characterized is the smallest homologue reported so far, because of the lack of repeated motifs at the carboxyl terminus with the consensus sequence Glu-Gln-Glu/Ala-Gln, a hallmark of mammalian apoAIVs, Chicken apoAIV (isoelectric point, 4.65) is also considerably more acidic than its human counterpart. Agarose gel electrophoresis revealed that unlike human apoAIV, which migrates to a pre-alpha-position, chicken apoAIV shows fast alpha migration. Functional characterization demonstrated that the avian protein is able to activate the enzyme lecithin:cholesterol acyltransferase. Roosters and hens express apoAIV predominantly in the gut, one-fifth as much in the liver, and no other sites of expression are identifiable by Northern blot analysis. Although pronounced intestinal synthesis is common to apoAIVs, the features of the avian protein support the notion that it represents a prototype of an apoprotein that evolved to acquire possibly distinct functions in mammals and birds.	Univ Vienna, Dept Mol Genet, A-1030 Vienna, Austria; Bioctr Vienna, A-1030 Vienna, Austria; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA	University of Vienna; Vienna Biocenter (VBC); University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest Baptist Medical Center	Schneider, WJ (corresponding author), Univ Vienna, Dept Mol Genet, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	wjs@mol.univie.ac.at		Hermann, Marcela/0000-0003-2298-4269	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030897, R23HL030897] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL030897, R01 HL030897-23, HL30897] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARAKAT HA, 1985, J LIPID RES, V26, P1252; BARBER DL, 1991, J BIOL CHEM, V266, P18761; BEISIEGEL U, 1995, CURR OPIN LIPIDOL, V6, P117, DOI 10.1097/00041433-199506000-00002; BEISIEGEL U, 1979, EUR J BIOCHEM, V93, P601, DOI 10.1111/j.1432-1033.1979.tb12860.x; BENSADOUN A, 1972, P SOC EXP BIOL MED, V41, P814; BOGUSKI MS, 1985, P NATL ACAD SCI USA, V82, P992, DOI 10.1073/pnas.82.4.992; BOGUSKI MS, 1984, P NATL ACAD SCI-BIOL, V81, P5021, DOI 10.1073/pnas.81.16.5021; BROWN EM, 1990, J CHROMATOGR, V512, P203, DOI 10.1016/S0021-9673(01)89486-3; BUJO H, 1994, EMBO J, V13, P5163; CHEN CH, 1982, J LIPID RES, V23, P680; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; DAVIDSON WS, 1994, J BIOL CHEM, V269, P8959; DAVIS RW, 1991, J LIPID RES, V32, P1013; DELOOF H, 1987, BIOCHIM BIOPHYS ACTA, V911, P45, DOI 10.1016/0167-4838(87)90268-8; DUVERGER N, 1991, EUR J BIOCHEM, V201, P373, DOI 10.1111/j.1432-1033.1991.tb16294.x; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; ELSHOURBAGY NA, 1986, J BIOL CHEM, V261, P1998; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P8242, DOI 10.1073/pnas.82.23.8242; GEORGE R, 1987, J BIOL CHEM, V262, P16838; GHISELLI G, 1985, J BIOL CHEM, V260, P5662; GORDON JI, 1982, BIOCHEMISTRY-US, V21, P5424, DOI 10.1021/bi00265a007; HACKLER R, 1994, J LIPID RES, V35, P153; HACKLER R, 1995, ANAL BIOCHEM, V230, P281, DOI 10.1006/abio.1995.1475; HAYASHI K, 1989, J BIOL CHEM, V264, P3131; HENGSTSCHLAGEROTTNAD E, 1995, J BIOL CHEM, V270, P26139, DOI 10.1074/jbc.270.44.26139; HERMIER D, 1985, BIOCHIM BIOPHYS ACTA, V836, P105, DOI 10.1016/0005-2760(85)90226-7; HIXSON JE, 1991, J LIPID RES, V32, P1529; HIXSON JE, 1993, J BIOL CHEM, V268, P15667; HOSPATTANKAR AV, 1987, BIOCHEM BIOPH RES CO, V148, P279, DOI 10.1016/0006-291X(87)91107-7; HUI DY, 1984, J BIOL CHEM, V259, P5060; KANE JP, 1980, P NATL ACAD SCI-BIOL, V77, P2465, DOI 10.1073/pnas.77.5.2465; KARATHANASIS SK, 1986, BIOCHEMISTRY-US, V25, P3962, DOI 10.1021/bi00361a034; KIRCHGESSNER TG, 1987, GENE, V59, P241, DOI 10.1016/0378-1119(87)90332-5; KRISHNAIAH KV, 1980, P NATL ACAD SCI USA, V82, P992; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASPADA AR, 1994, ANN NEUROL, V36, P814, DOI 10.1002/ana.410360604; LOHSE P, 1990, J BIOL CHEM, V265, P12734; Lohse P., 1991, CURR OPIN LIPIDOL, V2, P90; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NIMPF J, 1994, J BIOL CHEM, V269, P212; OSADA J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P335, DOI 10.1016/0167-4781(93)90226-4; PANABIERES F, 1984, BIOCHEM BIOPH RES CO, V118, P767, DOI 10.1016/0006-291X(84)91461-X; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; PIETZSCH J, 1995, BBA-LIPID LIPID MET, V1254, P77, DOI 10.1016/0005-2760(94)00171-T; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; RAJAVASHISTH TB, 1987, J BIOL CHEM, V262, P7058; REUE K, 1991, J BIOL CHEM, V266, P12715; SCHAEFER JR, 1995, CLIN CHEM, V41, P76; Scott James, 1994, Current Opinion in Lipidology, V5, P87, DOI 10.1097/00041433-199404000-00004; SEGREST JP, 1992, J LIPID RES, V33, P142; STEINMETZ A, 1985, EUR J BIOCHEM, V152, P747, DOI 10.1111/j.1432-1033.1985.tb09256.x; STEINMETZ A, 1988, ATHEROSCLEROSIS, V69, P21, DOI 10.1016/0021-9150(88)90285-7; STEINMETZ A, 1985, J BIOL CHEM, V260, P2258; STEYRER E, 1990, J BIOL CHEM, V265, P19575; TENG BB, 1992, J BIOL CHEM, V267, P21265; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P1350; VIEIRA AV, 1994, CELL BIOL LAB HDB, P314; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WEINBERG RB, 1983, J LIPID RES, V24, P52; WEINBERG RB, 1994, J LIPID RES, V35, P2212; WILLIAMS SC, 1986, MOL CELL BIOL, V6, P3807, DOI 10.1128/MCB.6.11.3807; WILLIAMS SC, 1989, J BIOL CHEM, V264, P19009; WU AL, 1979, J BIOL CHEM, V254, P7316	63	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10543	10549		10.1074/jbc.273.17.10543	http://dx.doi.org/10.1074/jbc.273.17.10543			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553114	hybrid			2022-12-27	WOS:000073224200063
J	Yu, XC; Margolin, W				Yu, XC; Margolin, W			Inhibition of assembly of bacterial cell division protein FtsZ by the hydrophobic dye 5,5 '-bis-(8-anilino-1-naphthalenesulfonate)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BINDING-PROTEIN; TUBULIN; PROBE; RING; GENE; SITE; HOMOLOG; GTPASE; ACID	To gain further insight into the structural relatedness of tubulin and FtsZ, the tubulin-like prokaryotic cell division protein, we tested the effect of tubulin assembly inhibitors on FtsZ assembly. Common tubulin inhibitors, such as colchicine, colcemid, benomyl, and vinblastine, had no effect on Ca2+-promoted GTP-dependent assembly of FtsZ into polymers. However, the hydrophobic probe 5,5'-bis-(8-anilino-1-naphthalenesulfonate) (bis-ANS) inhibited FtsZ assembly. The potential mechanisms for inhibition are discussed. Titrations of FtsZ with bis-ANS indicated that FtsZ has one high affinity binding site an multiple low affinity binding sites. ANS (8-anilino-1-naphthalenesulfonate), a hydrophobic probe similar to bis-ANS, had no inhibitory effect on FtsZ assembly. Because tubulin assembly has also been shown to be inhibited by bis-ANS but not by ANS, it supports the idea that FtsZ and tubulin share similar conformational properties. Ca2+, which promotes GTP-dependent FtsZ assembly, stimulated binding of bis-ANS or ANS to FtsZ, suggesting that Ca2+ binding induces changes in the hydrophobic conformation of the protein. Interestingly, depletion of bound Ca2+ with EGTA further enhanced bis-ANS fluorescence. These findings suggest that both binding and dissociation of Ca2+ are capable of inducing FtsZ conformational changes, and these changes could promote the GTP dependent assembly of FtsZ.	Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System	Margolin, W (corresponding author), Univ Texas, Sch Med, Dept Microbiol & Mol Genet, 6431 Fannin, Houston, TX 77030 USA.	margolin@utmmg.med.uth.tmc.edu						BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; DAI K, 1994, J BACTERIOL, V176, P130, DOI 10.1128/JB.176.1.130-136.1994; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; dePereda JM, 1996, BIOCHEMISTRY-US, V35, P14203, DOI 10.1021/bi961357b; Dustin P., 1984, MICROTUBULES, P171; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Erickson HP, 1996, J CELL BIOL, V135, P5, DOI 10.1083/jcb.135.1.5; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; HANSSENS I, 1990, BIOCHEMISTRY-US, V29, P5160, DOI 10.1021/bi00473a023; HOROWITZ P, 1984, J BIOL CHEM, V259, P4647; HOROWITZ PM, 1985, BIOCHEMISTRY-US, V24, P2587, DOI 10.1021/bi00332a001; Huang J, 1996, J BACTERIOL, V178, P5080, DOI 10.1128/jb.178.17.5080-5085.1996; LUTKENHAUS J, 1993, MOL MICROBIOL, V9, P403, DOI 10.1111/j.1365-2958.1993.tb01701.x; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Margolin W, 1996, J BACTERIOL, V178, P1320, DOI 10.1128/jb.178.5.1320-1327.1996; MAZUMDAR M, 1992, BIOCHEMISTRY-US, V31, P6470, DOI 10.1021/bi00143a016; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; ORBACH MJ, 1986, MOL CELL BIOL, V6, P2452, DOI 10.1128/MCB.6.7.2452; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; PLOUG M, 1994, BIOCHEMISTRY-US, V33, P8991, DOI 10.1021/bi00196a017; PRASAD ARS, 1986, BIOCHEMISTRY-US, V25, P739, DOI 10.1021/bi00351a035; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Rothfield LI, 1997, CELL, V88, P581, DOI 10.1016/S0092-8674(00)81899-1; SARKAR N, 1995, BIOCHEMISTRY-US, V34, P13367, DOI 10.1021/bi00041a013; SEALE JW, 1995, BIOCHEMISTRY-US, V34, P7443, DOI 10.1021/bi00022a018; SERRANO L, 1986, J BIOL CHEM, V261, P7076; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOLOMON F, 1977, BIOCHEMISTRY-US, V16, P358, DOI 10.1021/bi00622a003; VOSKUIL JLA, 1994, J BACTERIOL, V176, P1886, DOI 10.1128/jb.176.7.1886-1893.1994; Wang X, 1996, MOL MICROBIOL, V21, P313, DOI 10.1046/j.1365-2958.1996.6421360.x; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; WARD LD, 1994, BIOCHEMISTRY-US, V33, P11891, DOI 10.1021/bi00205a027; Wilson L., 1973, ADV CELL MOLECULAR B, V3, P21; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	36	50	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10216	10222		10.1074/jbc.273.17.10216	http://dx.doi.org/10.1074/jbc.273.17.10216			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553072	hybrid			2022-12-27	WOS:000073224200021
J	Zhao, XJ; Zhao, J; Zhou, QS; Sims, PJ				Zhao, XJ; Zhao, J; Zhou, QS; Sims, PJ			Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN CD59; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MEMBRANE ATTACK COMPLEX; HOMOLOGOUS COMPLEMENT; HUMAN-ERYTHROCYTES; ORGAN REJECTION; ACTIVE-SITE; CELL-LYSIS; C9; PROTECTION	The membrane-anchored glycoprotein CD59 inhibits assembly of the C5b-9 membrane attack complex (MAC) of human complement, This inhibitory function of CD59 is markedly selective for MAC assembled from human complement components C8 and C9, and CD59 shows little inhibitory function toward MAC assembled from rabbit and many other non-primate species. We have used this species selectivity of CD59 to identify the residues regulating its complement inhibitory function: cDNA of rabbit CD59 was cloned and used to express human/rabbit CD59 chimeras in murine SV-T2 cells. Plasma membrane expression of each CD59 chimera was quantified by use of a 5'-TAG peptide epitope, and each construct was tested for its ability to inhibit assembly of functional MAC from human versus rabbit C8 and C9, These experiments revealed that the species selectivity of CD59 is entirely determined by sequence contained between residues 42 and 58 of the human CD59 polypeptide, whereas chimeric substitution outside this peptide segment has little effect on the MAC inhibitory function of CD59. Substitution of human CD59 residues 42-58 into rabbit CD59 resulted in a molecule that was functionally indistinguishable from native human CD59, whereas the complementary construct (corresponding residues of rabbit CD59 substituted into human CD59) was functionally indistinguishable from rabbit CD59. Based on the solved solution structure of CD59, these data suggest that selectivity for human C8 and C9 resides in a cluster of closely spaced side chains on the surface of CD59 contributed by His(44), Asn(48), Asp(49), Thr(51), Thr(52), Arg(55), and Glu(68) of the polypeptide.	Blood Res Inst, Ctr Blood, Milwaukee, WI 53201 USA	Versiti Blood Center of Wisconsin	Sims, PJ (corresponding author), Blood Res Inst, Ctr Blood, POB 2178, Milwaukee, WI 53201 USA.	peter_S@BCSEW.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036061] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL36061] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBRECHT JC, 1992, VIROLOGY, V190, P527, DOI 10.1016/0042-6822(92)91247-R; Bodian DL, 1997, J EXP MED, V185, P507, DOI 10.1084/jem.185.3.507; BYRNE GW, 1995, TRANSPLANTATION, V60, P1149, DOI 10.1097/00007890-199511270-00016; CHANG CP, 1994, J BIOL CHEM, V269, P26424; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; FLETCHER CM, 1993, PROTEIN SCI, V2, P2015, DOI 10.1002/pro.5560021203; FODOR WL, 1995, IMMUNOGENETICS, V41, P51, DOI 10.1007/BF00188435; FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153; GERBER LD, 1992, J BIOL CHEM, V267, P12168; HOLGUIN MH, 1989, J CLIN INVEST, V84, P7, DOI 10.1172/JCI114172; HOULE JJ, 1988, BLOOD, V71, P287; HOULE JJ, 1984, J IMMUNOL, V133, P1444; Husler T, 1996, BIOCHEMISTRY-US, V35, P3263, DOI 10.1021/bi952862w; HUSLER T, 1995, J BIOL CHEM, V270, P3483; KENNEDY SP, 1994, TRANSPLANTATION, V57, P1494; KIEFFER B, 1994, BIOCHEMISTRY-US, V33, P4471, DOI 10.1021/bi00181a006; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; LOCKERT DH, 1995, J BIOL CHEM, V270, P19723, DOI 10.1074/jbc.270.34.19723; MATIS LA, 1995, NAT MED, V1, P839, DOI 10.1038/nm0895-839; MCCURRY KR, 1995, NAT MED, V1, P423, DOI 10.1038/nm0595-423; MERI S, 1990, IMMUNOLOGY, V71, P1; NAKANO Y, 1995, MOL IMMUNOL, V32, P241, DOI 10.1016/0161-5890(94)00154-S; NINOMIYA H, 1992, J BIOL CHEM, V267, P13675; NINOMIYA H, 1992, J BIOL CHEM, V267, P8404; Okada N, 1989, Int Immunol, V1, P205, DOI 10.1093/intimm/1.2.205; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; PETRANKA JG, 1992, P NATL ACAD SCI USA, V89, P7876, DOI 10.1073/pnas.89.17.7876; PHILBRICK WM, 1990, EUR J IMMUNOL, V20, P87, DOI 10.1002/eji.1830200113; Powell MB, 1997, J IMMUNOL, V158, P1692; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; Rother RP, 1996, J BIOL CHEM, V271, P23842, DOI 10.1074/jbc.271.39.23842; ROUSH W, 1995, SCIENCE, V270, P234, DOI 10.1126/science.270.5234.234; RUSHMERE NK, 1994, BIOCHEM J, V304, P595, DOI 10.1042/bj3040595; SUGITA Y, 1988, J BIOCHEM-TOKYO, V104, P633, DOI 10.1093/oxfordjournals.jbchem.a122524; TOMLINSON S, 1995, J IMMUNOL, V155, P436; VANDENBERG CW, 1993, IMMUNOLOGY, V78, P349; WIEDMER T, 1985, J MEMBRANE BIOL, V84, P249, DOI 10.1007/BF01871388; WIEDMER T, 1985, J BIOL CHEM, V260, P8014; YAMASHINA M, 1990, NEW ENGL J MED, V323, P1184, DOI 10.1056/NEJM199010253231707; Yu JH, 1997, BIOCHEMISTRY-US, V36, P9423, DOI 10.1021/bi970832i; Yu JH, 1997, J EXP MED, V185, P745, DOI 10.1084/jem.185.4.745; ZHAO J, 1991, J BIOL CHEM, V266, P13418; Zhou QS, 1996, MOL IMMUNOL, V33, P1127, DOI 10.1016/S0161-5890(96)00074-0	45	29	33	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10665	10671		10.1074/jbc.273.17.10665	http://dx.doi.org/10.1074/jbc.273.17.10665			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553129	hybrid			2022-12-27	WOS:000073224200078
J	Ishitsuka, R; Kojima, K; Utsumi, H; Ogawa, H; Matsumoto, I				Ishitsuka, R; Kojima, K; Utsumi, H; Ogawa, H; Matsumoto, I			Glycosaminoglycan binding properties of annexin IV, V, and VI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URINARY TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; PROTEIN P33/41; MAMMALIAN BRAIN; BOVINE KIDNEY; CELL-ADHESION; HEPARIN; EXPRESSION; CALCIUM	We have previously demonstrated that annexin IV, one of the calcium/phospholipid-binding annexin family proteins, binds to glycosaminoglycans (GAGs) in a calcium-dependent manner (Kojima, K., Yamamoto, K., Irimura, T., Osawa, T., Ogawa, H., and Matsumoto, I. (1996) J. Biol. Chem. 271, 7679-7685). In this study, we investigated the GAG binding specificities of annexins IV, V, and VI by affinity chromatography and solid phase assays. Annexin IV was found to bind in a calcium-dependent manner to all the GAG columns tested. Annexin V bound to heparin and heparan sulfate columns but not to chondroitin sulfate columns. Annexin VI was adsorbed to heparin and heparan sulfate columns in a calcium-independent manner, and to chondroitin sulfate columns in a calcium-dependent manner. An N-terminal half fragment (A6NH) and a C-terminal half fragment (A6CH) of annexin VI, each containing four units, were prepared by digestion with V8 protease and examined for GAG binding activities. A6NH bound to heparin in the presence of calcium but not to chondroitin sulfate C, whereas A6CH bound to heparin calcium-independently and to chondroitin sulfate C calcium-dependently. The results showed that annexin IV, V, and VI have different GAG binding properties. Some annexins have been reported to be detected not only in the cytoplasm but also on the cell surface or in extracellular components. The findings suggest that the some annexins function as recognition elements for GAGs in extracellular space.	Ochanomizu Univ, Fac Sci, Dept Chem, Bunkyo Ku, Tokyo 1128610, Japan	Ochanomizu University	Matsumoto, I (corresponding author), Ochanomizu Univ, Fac Sci, Dept Chem, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	isamu@hososipc.chem.ocha.ac.jp						AKIYAMA F, 1978, NATL SCI REP OCHANOM, V29, P147; BARTON GJ, 1991, EUR J BIOCHEM, V198, P749, DOI 10.1111/j.1432-1033.1991.tb16076.x; Barwise JL, 1996, J CELL SCI, V109, P247; Benz J, 1996, J MOL BIOL, V260, P638, DOI 10.1006/jmbi.1996.0426; BLIX G, 1948, ACTA CHEM SCAND, V2, P467, DOI 10.3891/acta.chem.scand.02-0467; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CARDIN AD, 1991, METHOD ENZYMOL, V203, P556; CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499; COMERA C, 1992, ANNEXINS, P86; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; CREUTZ CE, 1987, J BIOL CHEM, V262, P1860; CROMPTON MR, 1988, EMBO J, V7, P21, DOI 10.1002/j.1460-2075.1988.tb02779.x; DODGSON KS, 1962, BIOCHEM J, V84, P106, DOI 10.1042/bj0840106; DONATO R, 1990, FEBS LETT, V262, P72, DOI 10.1016/0014-5793(90)80157-E; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; EDWARDS HC, 1995, MOL CELL BIOCHEM, V149, P293, DOI 10.1007/BF01076591; Gabius HJ, 1997, EUR J BIOCHEM, V243, P543, DOI 10.1111/j.1432-1033.1997.t01-1-00543.x; GARDELL S, 1953, ACTA CHEM SCAND, V7, P207, DOI 10.3891/acta.chem.scand.07-0207; Goulding NJ, 1996, BIOCHEM J, V316, P593, DOI 10.1042/bj3160593; GOULDING NJ, 1993, BIOCHEM BIOPH RES CO, V192, P351, DOI 10.1006/bbrc.1993.1422; GUO NH, 1992, J BIOL CHEM, V267, P19349; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Harlow E., 1988, ANTIBODIES LAB MANUA; HAZARIKA P, 1991, J CELL BIOCHEM, V46, P86, DOI 10.1002/jcb.240460113; HUBER R, 1990, FEBS LETT, V275, P15, DOI 10.1016/0014-5793(90)81428-Q; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; JOHNSSON N, 1990, EUR J BIOCHEM, V188, P1, DOI 10.1111/j.1432-1033.1990.tb15363.x; Kassam G, 1997, J BIOL CHEM, V272, P15093, DOI 10.1074/jbc.272.24.15093; Kawasaki H, 1996, BBA-MOL CELL RES, V1313, P277, DOI 10.1016/0167-4889(96)00100-0; KIMATA K, 1995, GLYCOCONJ J, V12, P481; KITAGAKIOGAWA H, 1990, BIOCHIM BIOPHYS ACTA, V1033, P49, DOI 10.1016/0304-4165(90)90193-Z; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kojima K, 1996, J BIOL CHEM, V271, P7679, DOI 10.1074/jbc.271.13.7679; KOJIMA K, 1992, J CHROMATOGR, V597, P323, DOI 10.1016/0021-9673(92)80127-G; KOJIMA K, 1992, J BIOL CHEM, V267, P20536; KOJIMA K, 1994, FEBS LETT, V342, P313, DOI 10.1016/0014-5793(94)80523-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEARMONTH MP, 1992, BIOCHIM BIOPHYS ACTA, V1160, P76, DOI 10.1016/0167-4838(92)90040-K; Liemann S, 1997, CELL MOL LIFE SCI, V53, P516, DOI 10.1007/s000180050065; MATSUMOTO I, 1979, J BIOCHEM-TOKYO, V85, P1091, DOI 10.1093/oxfordjournals.jbchem.a132417; OGAMO A, 1989, CARBOHYD RES, V193, P165, DOI 10.1016/0008-6215(89)85116-X; PETITOU M, 1988, CARBOHYD RES, V179, P163, DOI 10.1016/0008-6215(88)84116-8; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; Satoh A, 1996, J BIOCHEM-TOKYO, V119, P346; SHADLE PJ, 1985, J BIOL CHEM, V260, P6354; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; SUDHOF TC, 1988, P NATL ACAD SCI USA, V85, P664, DOI 10.1073/pnas.85.3.664; SWAIRJO MA, 1994, ANNU REV BIOPH BIOM, V23, P193, DOI 10.1146/annurev.bb.23.060194.001205; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; TOYODA H, 1993, BIOL PHARM BULL, V16, P945; TOYODA H, 1992, CHEM PHARM BULL, V40, P2882, DOI 10.1248/cpb.40.2882; TRESSLER RJ, 1994, EXP CELL RES, V215, P395, DOI 10.1006/excr.1994.1358; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WOOLGAR JA, 1990, J NEUROCHEM, V54, P62, DOI 10.1111/j.1471-4159.1990.tb13283.x; YEATMAN TJ, 1993, CLIN EXP METASTAS, V11, P37, DOI 10.1007/BF00880064	58	90	93	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9935	9941		10.1074/jbc.273.16.9935	http://dx.doi.org/10.1074/jbc.273.16.9935			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545337	hybrid			2022-12-27	WOS:000073128800083
J	Janicke, RU; Sprengart, ML; Wati, MR; Porter, AG				Janicke, RU; Sprengart, ML; Wati, MR; Porter, AG			Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELLS; DEATH; PROTEASE; CED-3	Interleukin 1 beta-converting enzyme-like proteases (caspases) are crucial components of cell death pathways. Among the caspases identified, caspase-3 stands out because it is commonly activated by numerous death signals and cleaves a variety of important cellular proteins. Studies in caspase-3 knock-out mice have shown that this protease is essential for brain development. To investigate the requirement for caspase-3 in apoptosis, we took advantage of the MCF-7 breast carcinoma cell line, which we show here has lost caspase-3 owing to a 47-base pair deletion within exon 3 of the CASP-3 gene. This deletion results in the skipping of exon 3 during pre-mRNA splicing, thereby abrogating translation of the CASP-3 mRNA. Although MCF-7 cells were still. sensitive to tumor necrosis factor (TNF)- or staurosporine-induced apoptosis, no DNA fragmentation was observed. In addition, MCF-7 cells undergoing cell death did not display some of the distinct morphological features typical of apoptotic cells such as shrinkage and blebbing. Introduction of the CASP-3 gene into MCF-7 cells resulted in DNA fragmentation and cellular blebbing following TNF treatment. These results indicate that although caspase-3 is not essential for TNF- or staurosporine-induced apoptosis, it is required for DNA fragmentation and some of the typical morphological changes of cells undergoing apoptosis.	Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Janicke, RU (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.		Wati, Mas Rina R/F-3078-2010	Haji Abdul Hamid, Mas Rina Wati/0000-0002-2570-9740				BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Cosulich SC, 1997, EMBO J, V16, P6182, DOI 10.1093/emboj/16.20.6182; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P377; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Janicke RU, 1996, MOL CELL BIOL, V16, P5245; JANICKE RU, 1994, MOL CELL BIOL, V14, P5661; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; Juan TSC, 1996, ONCOGENE, V13, P749; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; NILSEN TW, 1994, CELL, V78, P1, DOI 10.1016/0092-8674(94)90563-0; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Porter AG, 1997, BIOESSAYS, V19, P501, DOI 10.1002/bies.950190609; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; UCKER DS, 1992, MOL CELL BIOL, V12, P3060, DOI 10.1128/MCB.12.7.3060; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660	30	1692	1739	1	92	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9357	9360		10.1074/jbc.273.16.9357	http://dx.doi.org/10.1074/jbc.273.16.9357			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545256	hybrid			2022-12-27	WOS:000073128800002
J	Lam, EWF; Choi, MSK; van der Sman, J; Burbidge, SA; Klaus, GGB				Lam, EWF; Choi, MSK; van der Sman, J; Burbidge, SA; Klaus, GGB			Modulation of E2F activity via signaling through surface IgM and CD40 receptors in WEHI-231 B lymphoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA GENE-PRODUCT; UBIQUITIN-PROTEASOME PATHWAY; S-PHASE ENTRY; TRANSCRIPTION FACTOR; GROWTH ARREST; CYCLIN-A; ANTI-MU; IN-VIVO; MYB TRANSCRIPTION; CLONAL DELETION	Stimulation of the phenotypically immature B cell lymphoma WEHI-231 with anti-IgM induces G(1) arrest followed by apoptotic cell death, which can be reversed by stimulation via the CD40 receptor. Here, we show that cells expressing bcl-x(L) (WEHI-bcl-x(L)) arrest at G(0)/G(1) following culture with anti-IgM but do not undergo apoptosis. These arrested cells can be induced to reenter the cell cycle by ligation of CD40. We have therefore used these cells as a model to study the regulation of the transcription factor E2F, which is critically involved in transit through the cell cycle. We found that anti-IgM treatment induces the appearance of an inhibitory DNA binding complex containing the pRB-related pocket protein p130 together with E2F and a concomitant decrease in "free" E2F, consisting of E2F1 and its partner DP1; these effects were reversed following stimulation via CD40. These changes in free E2F levels were regulated by changes in E2F1 gene transcription, which is at least partly a result of control of E2F1 promoter activity through its E2F binding sites. Transient transfection experiments showed that either E2F1 or the viral oncoprotein E1A, which sequesters pocket proteins, including p130, overcame anti-IgM-induced cell cycle arrest in WEHI-bcl-x(L). Taken together, these results indicate that WEHI-231 sIgM ligation induces the accumulation of hypophosphorylated p130 with consequent inhibition of E2F1 gene transcription and cell cycle arrest. Conversely, ligation of CD40 causes hyperphosphorylation of p130, thereby releasing the repression of E2F1 and other E2F-regulated genes, enabling the cells to reenter the cycle. These results, therefore, provide novel insights into the mechanisms whereby antigen receptors on immature B cells deliver inhibitory signals (leading to negative selection of self-reactive B cells) and how these signals can be modulated by positive signals generated via CD40.	Univ London Imperial Coll Sci Technol & Med, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Med Microbiol, London W2 1PG, England; Natl Inst Med Res, Div Cellular Immunol, London NW7 1AA, England	Imperial College London; Ludwig Institute for Cancer Research; Imperial College London; MRC National Institute for Medical Research	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Ludwig Inst Canc Res, Norfolk Pl, London W2 1PG, England.		Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576				BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BANDARA LR, 1994, EMBO J, V13, P3104, DOI 10.1002/j.1460-2075.1994.tb06609.x; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; Belbrahem A, 1996, EXP CELL RES, V225, P286, DOI 10.1006/excr.1996.0178; BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; Carman JA, 1996, J IMMUNOL, V156, P4562; CHOI MSK, 1995, EUR J IMMUNOL, V25, P1352, DOI 10.1002/eji.1830250533; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; ERIS JM, 1994, P NATL ACAD SCI USA, V91, P4392, DOI 10.1073/pnas.91.10.4392; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Ezhevsky SA, 1996, MOL BIOL CELL, V7, P553, DOI 10.1091/mbc.7.4.553; FATTAEY AR, 1993, MOL CELL BIOL, V13, P7267, DOI 10.1128/MCB.13.12.7267; FISCHER G, 1994, J EXP MED, V179, P221, DOI 10.1084/jem.179.1.221; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; HAN H, 1996, CURR BIOL, V4, P8; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810; Hateboer G, 1996, GENE DEV, V10, P2960, DOI 10.1101/gad.10.23.2960; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; HIJMANS EM, 1995, MOL CELL BIOL, V15, P3082; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; HSIAO KM, 1994, GENE DEV, V8, P1526, DOI 10.1101/gad.8.13.1526; IKEDA MA, 1993, MOL CELL BIOL, V13, P7029, DOI 10.1128/MCB.13.11.7029; ISHIDA T, 1995, J IMMUNOL, V155, P5527; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; JOHNSON DG, 1995, ONCOGENE, V11, P1685; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; JOSEPH LF, 1995, CELL GROWTH DIFFER, V6, P51; KATO J, 1993, GENE DEV, V7, P331; Klinman NR, 1996, IMMUNOL REV, V150, P91, DOI 10.1111/j.1600-065X.1996.tb00697.x; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; LAM EWF, 1994, EMBO J, V13, P871, DOI 10.1002/j.1460-2075.1994.tb06330.x; LAM EWF, 1995, GENE, V160, P277, DOI 10.1016/0378-1119(95)00184-8; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; LAM EWF, 1994, CURR OPIN CELL BIOL, V6, P859; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; LI Y, 1994, MOL CELL BIOL, V14, P1861, DOI 10.1128/MCB.14.3.1861; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LUND FE, 1995, EUR J IMMUNOL, V25, P1338, DOI 10.1002/eji.1830250531; MAHESWARAN S, 1991, ONCOGENE, V6, P1965; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; MAYOL X, 1995, ONCOGENE, V11, P801; MERINO R, 1995, J IMMUNOL, V155, P3830; MUDRYJ M, 1991, CELL, V65, P1243, DOI 10.1016/0092-8674(91)90019-U; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; NEVINS JR, 1992, SCIENCE, V258, P424; NOSSAL GJV, 1994, IMMUNOL REV, V137, P173, DOI 10.1111/j.1600-065X.1994.tb00664.x; OKAMOTO CT, 1992, J BIOL CHEM, V267, P9925; PARRY SL, 1994, J IMMUNOL, V152, P2821; PIKE BL, 1982, P NATL ACAD SCI-BIOL, V79, P2013, DOI 10.1073/pnas.79.6.2013; QIAN YY, 1992, MOL CELL BIOL, V12, P5363, DOI 10.1128/MCB.12.12.5363; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SCHNEIDER JF, 1987, EMBO J, V6, P2053, DOI 10.1002/j.1460-2075.1987.tb02470.x; SCOTT DW, 1986, J EXP MED, V164, P156, DOI 10.1084/jem.164.1.156; Shan B, 1996, CELL GROWTH DIFFER, V7, P689; SHAN B, 1994, MOL CELL BIOL, V14, P299, DOI 10.1128/MCB.14.1.299; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; VALENTINE MA, 1992, EUR J IMMUNOL, V22, P3141, DOI 10.1002/eji.1830221217; VanKooten C, 1996, ADV IMMUNOL, V61, P1; Wang H, 1996, ONCOGENE, V13, P373; WARNER GL, 1992, CELL GROWTH DIFFER, V3, P175; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WU CL, 1995, MOL CELL BIOL, V15, P2536; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; ZHANG YH, 1995, ONCOGENE, V10, P2085; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x; ZHU LG, 1995, MOL CELL BIOL, V15, P3552	79	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10051	10057		10.1074/jbc.273.16.10051	http://dx.doi.org/10.1074/jbc.273.16.10051			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545352	hybrid			2022-12-27	WOS:000073128800098
J	Leech, AP; Boetzel, R; McDonald, C; Shrive, AK; Moore, GR; Coggins, JR; Sawyer, L; Kleanthous, C				Leech, AP; Boetzel, R; McDonald, C; Shrive, AK; Moore, GR; Coggins, JR; Sawyer, L; Kleanthous, C			Re-evaluating the role of His-143 in the mechanism of type I dehydroquinase from Escherichia coli using two-dimensional H-1,C-13 NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; CATALYTIC MECHANISM; SALMONELLA-TYPHI; N-15 NMR; HISTIDINE; PURIFICATION; RESIDUES; 3-DEHYDROQUINASE; CRYSTALLIZATION; IDENTIFICATION	Type I dehydroquinase from the shikimate pathway of Escherichia coli dehydrates dehydroquinate to dehydroshikimate, pH/log V-max profiles of the enzyme indicate the presence of a single ionizing group with a pK(a) of 6.2, Chemical modification experiments with diethyl pyrocarbonate have identified the conserved residue His-143 as essential for catalysis in this enzyme and the pK(a) for this modification is also 6.2, implying that this is the single ionizing residue in dehydroquinase that may be acting as a general base in the catalytic mechanism, Subsequent mutagenesis of this residue (Leech, A. P., James, R., Coggins, J. R., and Kleanthous, C. (1995) J. Biol. Chem. 270, 25827-25836) further suggested that His-143 may be involved in Schiff base formation/breakdown as well as being the proton abstracting general base. The importance of this residue was confirmed by recent x-ray crystallographic data showing His-143 to be at the center of a hydrogen-bonded triad, flanked by the essential Schiff base forming residue Lys-170 and Glu-86, In the present study, we have used mutagenesis and H-1 and C-13 NMR to assign the resonance of His-143 and probe its ionization state to define more precisely its role in the mechanism of type I dehydroquinase, Following isotopic enrichment of wild-type and H143A dehydroquinase enzymes with [2-C-13]histidine, the resonance for His-143 was assigned by comparing their H-1,C-13 heteronuclear single quantum correlation NMR spectra, pH titrations revealed that whether in the liganded or unliganded state, His-143 does not ionize over the pH range 6-9.5 and so cannot possess a pK(a) of 6.2. The NMR data are consistent with this residue remaining unprotonated at pH values optimal for the activity of this enzyme (pH > 7), The role of His-143 is re-evaluated in light of these and the recent structural data, and an alternative candidate for the pK(a) of 6.2 is discussed.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Chem Sci, Norwich NR4 7TJ, Norfolk, England; Univ Edinburgh, Struct Biochem Grp, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Glasgow, Dept Biochem, Glasgow G12 8QQ, Lanark, Scotland	University of East Anglia; University of East Anglia; University of Edinburgh; University of Glasgow	Kleanthous, C (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	c.kleanthous@uea.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BACHOVCHIN WW, 1986, BIOCHEMISTRY-US, V25, P7751, DOI 10.1021/bi00371a070; BACHOVCHIN WW, 1981, P NATL ACAD SCI-BIOL, V78, P7323, DOI 10.1073/pnas.78.12.7323; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bottomley JR, 1996, BIOCHEM J, V319, P559, DOI 10.1042/bj3190559; BOYS CWG, 1992, J MOL BIOL, V227, P352, DOI 10.1016/0022-2836(92)90704-N; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAUDHURI S, 1991, BIOCHEM J, V275, P1; CHAUDHURI S, 1986, BIOCHEM J, V239, P699, DOI 10.1042/bj2390699; Creighton T. E., 1993, PROTEINS STRUCTURES; DEKA RK, 1992, J BIOL CHEM, V267, P22237; ELSEMORE DA, 1995, J BACTERIOL, V177, P5971, DOI 10.1128/jb.177.20.5971-5978.1995; EUVERINK GJW, 1992, J GEN MICROBIOL, V138, P2449, DOI 10.1099/00221287-138-11-2449; GILES NH, 1967, P NATL ACAD SCI USA, V58, P1930, DOI 10.1073/pnas.58.5.1930; GOURLEY DG, 1994, J MOL BIOL, V241, P488, DOI 10.1006/jmbi.1994.1524; GREWE R, 1968, BIOCH PREP, V12, P21; HANSON KR, 1963, P NATL ACAD SCI USA, V50, P981, DOI 10.1073/pnas.50.5.981; HARRIS J, 1993, J CHEM SOC CHEM COMM, P1080, DOI 10.1039/c39930001080; Harris JM, 1996, BIOCHEM J, V319, P333, DOI 10.1042/bj3190333; Highbarger LA, 1996, BIOCHEMISTRY-US, V35, P41, DOI 10.1021/bi9518306; Jardetzky O., 1981, NMR MOL BIOL; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; KLEANTHOUS C, 1988, J BIOL CHEM, V263, P13062; KLEANTHOUS C, 1992, BIOCHEM J, V282, P687, DOI 10.1042/bj2820687; KLEANTHOUS C, 1991, J BIOL CHEM, V266, P10893; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEECH AP, 1995, J BIOL CHEM, V270, P25827, DOI 10.1074/jbc.270.43.25827; LODI PJ, 1991, BIOCHEMISTRY-US, V30, P6948, DOI 10.1021/bi00242a020; MOORE JD, 1993, BIOCHEM J, V295, P277, DOI 10.1042/bj2950277; PERUTZ MF, 1985, J MOL BIOL, V183, P491, DOI 10.1016/0022-2836(85)90016-6; Roberts G.C.K., 1993, NMR MACROMOLECULES; SACHS DH, 1971, J BIOL CHEM, V246, P6576; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7	33	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9602	9607		10.1074/jbc.273.16.9602	http://dx.doi.org/10.1074/jbc.273.16.9602			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545291	hybrid			2022-12-27	WOS:000073128800037
J	Liu, SC; Julian, J; Carson, DD				Liu, SC; Julian, J; Carson, DD			Peptide sequence of heparin/heparan sulfate (HP/HS)-interacting protein supports selective, high affinity binding of HP/HS and cell attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTERINE EPITHELIAL-CELLS; HEPARIN HEPARAN-SULFATE; GROWTH-FACTOR; MOUSE EMBRYOS; LINE RL95; PROTEOGLYCAN; GLYCOSAMINOGLYCANS; EXPRESSION; DOMAINS; PROLIFERATION	We previously have identified a novel cell surface heparan sulfate/heparin (HS/HP)-interacting protein (HIP) found in human uterine epithelia and a variety of other human epithelial and endothelial cells and cell lines (Liu, S., Smith, S. E., Julian, J., Rohde, L. H., Karin, N. J., and Carson, D. D. (1996) J. Biol. Chem. 271, 11817-11823; Rohde, L. H., Julian, J., Babaknia, A., and Carson, D. D. (1996) J. Biol. Chem. 271, 11824-11830). The amino acid sequence predicted for HIP revealed a potential HS/HP-binding motif. In the present studies, a synthetic peptide corresponding to this putative HS/HP-binding motif, HIP peptide, was synthesized and examined with regard to its HS/HP binding and cell attachment promoting activity. Results using solid phase binding assays demonstrate that HIP peptide binds HS/HP with high selectivity and has high affinity for bulk HP (50% saturation congruent to 300 nm) and even higher affinity for a subset of polysaccharides found in commercial [H-3]HP (half-saturation congruent to 10 nM). Moreover, HIP peptide binds subsets of cell and extracellular matrix-associated HS and dermatan sulfate expressed by RL95 cells, a human uterine adenocarcinoma cell line. HIP peptide also binds a similar fraction of HS as well as dermatan sulfate expressed by JAR cells, a human choriocarcinoma cell line. In contrast to binding of cell-or extracellular matrix-associated HS, HIP peptide does not bind secreted or released forms of HS or DS from either RL95 or JAR cells to a significant extent. HS species that bind to HIP peptide are generally larger, have a higher negative charge density, and have a larger proportion of di-and trisulfated disaccharide units than HS species that do not bind to HIP peptide, demonstrating structural differences among these polysaccharides. This same peptide supports MS-dependent JAR cell attachment. Collectively, these data demonstrate that a linear peptide sequence-found within HIP can account, at least in part, for the HS/HP binding and cell adhesion promoting activities of this protein.	Univ Texas, Md Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Carson, DD (corresponding author), Univ Texas, Md Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dcarson@odin.mdacc.tmc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025235, R37HD025235] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25235] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOURIN MC, 1993, BIOCHEM J, V289, P313, DOI 10.1042/bj2890313; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CARSON DD, 1993, DEV BIOL, V155, P97, DOI 10.1006/dbio.1993.1010; CARSON DD, 1992, CELL SURFACE CARBOHY, P257; CASTELLOT JJ, 1986, J CELL BIOL, V102, P1979, DOI 10.1083/jcb.102.5.1979; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; CHANG CD, 1978, INT J PEPT PROT RES, V11, P246; DZIADEK M, 1985, EMBO J, V4, P905, DOI 10.1002/j.1460-2075.1985.tb03717.x; FARACH MC, 1988, BIOL REPROD, V39, P443, DOI 10.1095/biolreprod39.2.443; FARACH MC, 1987, DEV BIOL, V123, P401, DOI 10.1016/0012-1606(87)90398-8; GALLAGHER JT, 1990, BIOCHEM SOC T, V18, P200; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; HOOK M, 1976, FEBS LETT, V66, P90, DOI 10.1016/0014-5793(76)80592-3; Jacobs AL, 1997, CANCER RES, V57, P5148; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; LANDEGREN V, 1984, J IMMUNOL METHODS, V67, P377; LANKES W, 1988, BIOCHEM J, V251, P831, DOI 10.1042/bj2510831; Liu SC, 1996, J BIOL CHEM, V271, P11817, DOI 10.1074/jbc.271.20.11817; Liu SC, 1997, P NATL ACAD SCI USA, V94, P1739, DOI 10.1073/pnas.94.5.1739; Liu SC, 1997, J BIOL CHEM, V272, P25856, DOI 10.1074/jbc.272.41.25856; Marchetti D, 1996, CANCER RES, V56, P2856; Marchetti D, 1997, J BIOL CHEM, V272, P15891, DOI 10.1074/jbc.272.25.15891; PATTILLO RA, 1971, ANN NY ACAD SCI, V172, P288, DOI 10.1111/j.1749-6632.1971.tb34942.x; RABOUDI N, 1992, J BIOL CHEM, V267, P11930; ROHDE LH, 1993, J CELL PHYSIOL, V155, P185, DOI 10.1002/jcp.1041550124; Rohde LH, 1996, J BIOL CHEM, V271, P11824, DOI 10.1074/jbc.271.20.11824; Rohde LH, 1998, BIOL REPROD, V58, P1075, DOI 10.1095/biolreprod58.4.1075; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SKUBITZ APN, 1988, J BIOL CHEM, V263, P4861; Smith SE, 1997, DEV BIOL, V184, P38, DOI 10.1006/dbio.1997.8521; SPICER AP, 1991, J BIOL CHEM, V266, P15099; TANG JP, 1987, J BIOL CHEM, V262, P12832; TEKOTTE H, 1994, J NEUROCHEM, V62, P1126; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; VLODAVSKY I, 1980, CELL, V19, P607, DOI 10.1016/S0092-8674(80)80037-7; WILSON O, 1990, J CELL PHYSIOL, V143, P60, DOI 10.1002/jcp.1041430108; YABKOWITZ R, 1989, J BIOL CHEM, V264, P10888	37	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					9718	9726		10.1074/jbc.273.16.9718	http://dx.doi.org/10.1074/jbc.273.16.9718			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545307	hybrid			2022-12-27	WOS:000073128800053
J	Mikalsen, SO; Kaalhus, O				Mikalsen, SO; Kaalhus, O			Properties of pervanadate and permolybdate - Connexin43, phosphatase inhibition, and thiol reactivity as model systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASES; JUNCTIONAL INTERCELLULAR COMMUNICATION; INSULIN-RECEPTOR KINASE; HAMSTER EMBRYO CELLS; RAT ADIPOCYTES; AQUEOUS-SOLUTION; VANADATE; ACTIVATION; PHOSPHORYLATION; COMPLEXES	Pervanadate and permolybdate are irreversible protein-tyrosine phosphatase inhibitors, with IC50 values of 0.3 and 20 mu M respectively, in intact cells. Maximal inhibition was obtained within 1 min at higher concentrations of the compounds. They induced prominent changes in the phosphorylation status of the gap junction protein, connexin43. These effects were utilized as model systems to assess the stability and inactivation of the compounds. Although the concentrated stock solutions were relatively stable, the diluted compounds were unstable. The biological activity had decreased to 20-30% after 6 h of incubation in a phosphate buffer, 1 h in phosphate buffer with 10% fetal calf serum, and 13 minutes in culture medium. Thiols reacted rapidly with the compounds and inactivated them (initial reaction rates with cysteine: permolybdate > pervanadate > H2O2). Catalase inactivated the compounds, and permolybdate was the more sensitive. The cells inactivated permolybdate faster than pervanadate. Cellular inactivation of permolybdate, and to a lesser degree pervanadate, appeared to be partly dependent on catalase and thiols. However, a general decrease in cellular thiols was not the mediator of the biological effects of pervanadate or permolybdate. Mathematical modeling of the thiol reactivity suggested that monoperoxovanadate at maximum could possess 20% of the biological activity of diperoxovanadate.	Norwegian Radium Hosp, Inst Canc Res, Dept Environm & Occupat Canc, N-0310 Oslo, Norway; Norwegian Radium Hosp, Inst Canc Res, Dept Biophys, N-0310 Oslo, Norway	University of Oslo; University of Oslo	Mikalsen, SO (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Environm & Occupat Canc, N-0310 Oslo, Norway.	s.o.mikalsen@labmed.uio.no		Mikalsen, Svein-Ole/0000-0002-7128-4464				BOURGOIN S, 1992, J BIOL CHEM, V267, P11908; BUTLER A, 1994, CHEM REV, V94, P625, DOI 10.1021/cr00027a004; CAMPBELL NJ, 1989, POLYHEDRON, V8, P1379, DOI 10.1016/S0277-5387(00)86249-X; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; EVANS GA, 1994, J BIOL CHEM, V269, P23407; FANTUS IG, 1989, BIOCHEMISTRY-US, V28, P8864, DOI 10.1021/bi00448a027; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; HAQUE SJ, 1995, J BIOL CHEM, V270, P25709, DOI 10.1074/jbc.270.43.25709; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; HUSOY T, 1993, CARCINOGENESIS, V14, P2257, DOI 10.1093/carcin/14.11.2257; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; IMBERT V, 1994, BIOCHEM J, V297, P163, DOI 10.1042/bj2970163; JASWAL JS, 1991, INORG CHEM, V30, P3718, DOI 10.1021/ic00019a030; KADOTA S, 1987, J BIOL CHEM, V262, P8252; KADOTA S, 1987, BIOCHEM BIOPH RES CO, V147, P259, DOI 10.1016/S0006-291X(87)80115-8; KOLE HK, 1995, BIOCHEM J, V311, P1025, DOI 10.1042/bj3111025; LEREA KM, 1989, BIOCHEMISTRY-US, V28, P9286, DOI 10.1021/bi00450a008; LI JP, 1995, BIOCHEMISTRY-US, V34, P6218, DOI 10.1021/bi00018a026; Li JP, 1996, BIOCHEMISTRY-US, V35, P8314, DOI 10.1021/bi960209i; MACARA IG, 1980, BIOCHIM BIOPHYS ACTA, V629, P95, DOI 10.1016/0304-4165(80)90268-8; Mikalsen SO, 1997, BBA-MOL CELL RES, V1356, P207, DOI 10.1016/S0167-4889(96)00163-2; Mikalsen SO, 1996, BBA-GEN SUBJECTS, V1290, P308, DOI 10.1016/0304-4165(96)00034-7; MIKALSEN SO, 1994, CARCINOGENESIS, V15, P381, DOI 10.1093/carcin/15.2.381; MIKALSEN SO, 1990, INT J CANCER, V46, P950, DOI 10.1002/ijc.2910460533; MIKALSEN SO, 1990, BIOCHEM PHARMACOL, V39, P527, DOI 10.1016/0006-2952(90)90060-X; MILALSEN SO, 1997, FEBS LETT, V401, P271; POSNER BI, 1994, J BIOL CHEM, V269, P4596; PUMIGLIA KM, 1992, BIOCHEM J, V286, P441, DOI 10.1042/bj2860441; RAVISHANKAR HN, 1995, ARCH BIOCHEM BIOPHYS, V321, P477, DOI 10.1006/abbi.1995.1420; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; SHAVER A, 1993, INORG CHEM, V32, P3109, DOI 10.1021/ic00066a024; SHISHEVA A, 1994, ENDOCRINOLOGY, V134, P507, DOI 10.1210/en.134.1.507; STAHLS A, 1992, BIOCHEM BIOPH RES CO, V187, P73, DOI 10.1016/S0006-291X(05)81460-3; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; SVENSSON IB, 1971, ACTA CHEM SCAND, V25, P898, DOI 10.3891/acta.chem.scand.25-0898; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; TONKS NK, 1988, J BIOL CHEM, V263, P6731; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816; Zhao ZZ, 1996, J BIOL CHEM, V271, P22251, DOI 10.1074/jbc.271.36.22251	40	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10036	10045		10.1074/jbc.273.16.10036	http://dx.doi.org/10.1074/jbc.273.16.10036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545350	hybrid			2022-12-27	WOS:000073128800096
J	Pan, JL; Xia, LJ; McEver, RP				Pan, JL; Xia, LJ; McEver, RP			Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GRANULE MEMBRANE-PROTEIN; NECROSIS-FACTOR-ALPHA; LEUKOCYTE ADHESION MOLECULE-1; WEIBEL-PALADE BODIES; DNA-BINDING; SEQUENCE SIMILARITY; FUNCTIONAL-ANALYSIS; PLASMA-MEMBRANE; GROWTH-FACTOR	P-selectin, an adhesion receptor for leukocytes, is constitutively expressed in megakaryocytes and endothelial cells. Tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) increases synthesis of P-selectin in murine but not in human endothelial cells. To identify potential species-specific and conserved mechanisms for regulation of expression of P-selectin, we cloned the 5'-flanking region of the murine P-selectin gene and compared its features with those previously reported for the human gene. The murine and human genes shared conserved Stat-like, Hox, Ets, GATA, and GT-IIC elements. In the murine gene, a conserved GATA element bound to GATA-2 and functioned as a positive regulatory element, whereas a conserved Ets element bound to GA-binding protein and functioned as a negative regulatory element. Significantly, the murine P-selectin gene had several features not found in the human gene. These included an insertion from -987 to -649 that contained tandem GATA and tandem AP1-like sequences, which resembled enhancers in beta-globin locus control regions. Both tandem elements bound specifically to nuclear proteins. The murine gene lacked the unique kappa B site specific for p50 or p52 homodimers found in the human gene. Instead, it contained two tandem kappa B elements and a variant activating transcription factor/cAMP response element site, which closely resembled sites in the E-selectin gene that are required for TNF-alpha-or LPS-inducible expression. TNF-alpha or LPS augmented expression of a reporter gene driven by the murine, but not the human, P-selectin promoter in transfected endothelial cells. Deletional analysis of the murine 5'-flanking region revealed several sequences that were required for either constitutive or inducible expression. These data suggest that both species-specific and conserved mechanisms regulate transcription of the human and murine P-selectin genes.	Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Dept Med, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	McEver, RP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Dept Med, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@ouhsc.edu						AIRD WC, 1994, J BIOL CHEM, V269, P883; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BERMAN CL, 1986, J CLIN INVEST, V78, P130, DOI 10.1172/JCI112542; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BONFANTI R, 1989, BLOOD, V73, P1109; BURGLIN TR, 1991, CELL, V66, P1; BURNS SA, 1995, J THORAC CARDIOV SUR, V110, P924, DOI 10.1016/S0022-5223(05)80159-X; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DISDIER M, 1992, MOL BIOL CELL, V3, P309, DOI 10.1091/mbc.3.3.309; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; FONG TC, 1992, GENE DEV, V6, P521, DOI 10.1101/gad.6.4.521; Frenette PS, 1997, THROMB HAEMOSTASIS, V78, P60; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; HAHNE M, 1993, J CELL BIOL, V121, P655, DOI 10.1083/jcb.121.3.655; HAMBURGER SA, 1990, BLOOD, V75, P550; HASHIMOTO Y, 1995, J BIOL CHEM, V270, P24532, DOI 10.1074/jbc.270.41.24532; HATTORI R, 1989, J BIOL CHEM, V264, P7768; HICKEY MJ, 1993, J BIOL CHEM, V268, P3438; HOLMBERG M, 1995, EUR J BIOCHEM, V231, P466, DOI 10.1111/j.1432-1033.1995.tb20720.x; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; JOHNSTON GI, 1990, J BIOL CHEM, V265, P21381; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KOOP BF, 1994, NAT GENET, V7, P48, DOI 10.1038/ng0594-48; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; LEE ME, 1990, J BIOL CHEM, V265, P10446; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; Martin ME, 1996, J BIOL CHEM, V271, P25617, DOI 10.1074/jbc.271.41.25617; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; MCEVER RP, 1997, SELECTINS INITIATORS, P31; MEACOCK S, 1994, J BIOL CHEM, V269, P31756; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; PAJOVIC S, 1994, J BIOL CHEM, V269, P2215; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; PAN JL, 1993, J BIOL CHEM, V268, P22600; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; RAVID K, 1991, MOL CELL BIOL, V11, P6116, DOI 10.1128/MCB.11.12.6116; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; SANDERS WE, 1992, BLOOD, V80, P795; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; TAKEUCHI M, 1995, P NATL ACAD SCI USA, V92, P3561, DOI 10.1073/pnas.92.8.3561; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; UZAN G, 1991, J BIOL CHEM, V266, P8932; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; WANG DZ, 1995, J BIOL CHEM, V270, P22924, DOI 10.1074/jbc.270.39.22924; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WELLER A, 1992, J BIOL CHEM, V267, P15176; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; WORKMAN JL, 1993, TRENDS BIOCHEM SCI, V18, P90, DOI 10.1016/0968-0004(93)90160-O; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; ZWIEB C, 1989, GENE DEV, V3, P606, DOI 10.1101/gad.3.5.606	73	83	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 17	1998	273	16					10058	10067		10.1074/jbc.273.16.10058	http://dx.doi.org/10.1074/jbc.273.16.10058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZH610	9545353	hybrid			2022-12-27	WOS:000073128800099
J	Betton, JM; Sassoon, N; Hofnung, M; Laurent, M				Betton, JM; Sassoon, N; Hofnung, M; Laurent, M			Degradation versus aggregation of misfolded maltose-binding protein in the periplasm of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-TRANSPORT; INCLUSION-BODIES; SIGMA-FACTOR; GENE; INVIVO; PROTEOLYSIS; CHEMOTAXIS; MEMBRANE; GROWTH	The periplasmic fates of misfolded MalE31, a defective folding mutant of the maltose-binding protein, were determined by manipulating two cellular activities affecting the protein folding pathway in host cells: (i) the malEp promoter activity, which is controlled by the transcriptional activator MalT, and (ii) the DegP and Protease III periplasmic proteolytic activity. At a low level of expression, the degradation of misfolded MalE31 was partially impaired in cells lacking DegP or Protease III. At a high level of expression, misfolded MalE31 rapidly formed periplasmic inclusion bodies and thus escaped degradation, However, the manipulated host cell activities did not enhance the production of periplasmic, soluble MalE31. A kinetic competition between folding, aggregation, and degradation is proposed as a general model for the biogenesis of periplasmic proteins.	Inst Pasteur, CNRS URA1444, Dept Biotechnol, Unite Programmat Mol & Toxicol Genet, F-75015 Paris, France; Universite Paris Sud, CNRS URA D2227, Serv Imagerie Cellulaire, F-91405 Orsay, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay	Betton, JM (corresponding author), Inst Pasteur, CNRS URA1444, Dept Biotechnol, Unite Programmat Mol & Toxicol Genet, 25 Rue Dr Roux, F-75015 Paris, France.							BANEYX F, 1991, J BACTERIOL, V173, P2696, DOI 10.1128/jb.173.8.2696-2703.1991; BETTON JM, 1994, EMBO J, V13, P1226, DOI 10.1002/j.1460-2075.1994.tb06372.x; Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Betton JM, 1996, J MOL BIOL, V262, P140, DOI 10.1006/jmbi.1996.0504; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Chan W, 1996, FOLD DES, V1, P77, DOI 10.1016/S1359-0278(96)00017-X; DEBARBOUILLE M, 1978, J MOL BIOL, V124, P359, DOI 10.1016/0022-2836(78)90304-2; DUPLAY P, 1987, J MOL BIOL, V194, P663, DOI 10.1016/0022-2836(87)90243-9; ENFORS SO, 1992, TRENDS BIOTECHNOL, V10, P310, DOI 10.1016/0167-7799(92)90256-U; FERENCI T, 1978, FEBS LETT, V94, P213, DOI 10.1016/0014-5793(78)80940-5; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; INOUE I, 1994, J BIOL CHEM, V269, P29241; JAENICKE R, 1995, PHILOS T ROY SOC B, V348, P97, DOI 10.1098/rstb.1995.0050; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Missiakas D, 1997, TRENDS BIOCHEM SCI, V22, P59, DOI 10.1016/S0968-0004(96)10072-4; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; NIKAIDO H, 1994, FEBS LETT, V346, P55, DOI 10.1016/0014-5793(94)00315-7; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Richet E, 1996, J MOL BIOL, V264, P852, DOI 10.1006/jmbi.1996.0682; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Wang J, 1997, MOL MICROBIOL, V26, P1141	32	50	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8897	8902		10.1074/jbc.273.15.8897	http://dx.doi.org/10.1074/jbc.273.15.8897			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535871	hybrid			2022-12-27	WOS:000072990800048
J	Denke, E; Merbitz-Zahradnik, T; Hatzfeld, OM; Snyder, CH; Link, TA; Trumpower, BL				Denke, E; Merbitz-Zahradnik, T; Hatzfeld, OM; Snyder, CH; Link, TA; Trumpower, BL			Alteration of the midpoint potential and catalytic activity of the Rieske iron-sulfur protein by changes of amino acids forming hydrogen bonds to the iron-sulfur cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER-SOLUBLE FRAGMENT; SACCHAROMYCES-CEREVISIAE; MUTATIONAL ANALYSIS; CYTOCHROME-BC(1) COMPLEX; ELECTRON-TRANSFER; 2FE-2S CENTER; BC1 COMPLEX; Q-CYCLE; MITOCHONDRIA; OXIDOREDUCTASE	The crystal structure of the bovine Rieske iron-sulfur protein indicates a sulfur atom (S-1) of the iron-sulfur cluster and the sulfur atom (S gamma of a cysteine residue that coordinates one of the iron atoms form hydrogen bonds with the hydroxyl groups of Ser-163 and Tyr-165, respectively, We have altered the equivalent Ser-183 and Tyr-185 in the Saccharomyces cerevisiae Rieske iron-sulfur protein by site-directed mutagenesis of the iron-sulfur protein gene to examine how these hydrogen bonds affect the midpoint potential of the iron-sulfur cluster and how changes in the midpoint potential affect the activity of the enzyme, Eliminating the hydrogen bond from the hydroxyl group of Ser-183 to S-1 of the cluster lowers the midpoint potential of the cluster by 130 mV, and eliminating the hydrogen bond from the hydroxyl group of Tyr-185 to S-gamma of Cys-159 lowers the midpoint potential by 65 mV, Eliminating both hydrogen bonds has an approximately additive effect, lowering the midpoint potential by 180 mV, Thus, these hydrogen bonds contribute significantly to the positive midpoint potential of the cluster but are not essential for its assembly, The activity of the bc(1) complex decreases with the decrease in midpoint potential, confirming that oxidation of ubiquinol by the iron-sulfur protein is the rate-limiting partial reaction in the bc(1) complex, and that the rate of this reaction is extensively influenced by the midpoint potential of the iron-sulfur cluster.	Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA; Univ Frankfurt Klinikum, Inst Biochem 1, ZBC, D-60590 Frankfurt, Germany	Dartmouth College; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Trumpower, BL (corresponding author), Dartmouth Coll, Sch Med, Dept Biochem, 7200 Vail, Hanover, NH 03755 USA.				NIGMS NIH HHS [GM 20379] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKMANN JD, 1989, J BIOL CHEM, V264, P3713; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Crane FL, 1985, COENZYME Q, P1; CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; FU W, 1990, J BIOL CHEM, V265, P16541; GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5; GEIER BM, 1992, EUR J BIOCHEM, V208, P375, DOI 10.1111/j.1432-1033.1992.tb17197.x; GRAHAM LA, 1991, J BIOL CHEM, V266, P22485; GRAHMAN LA, 1994, J BIOENERG BIOMEMBR, V25, P245; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HAUSKA G, 1983, BIOCHIM BIOPHYS ACTA, V726, P97, DOI 10.1016/0304-4173(83)90002-2; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link TA, 1996, EUR J BIOCHEM, V237, P71, DOI 10.1111/j.1432-1033.1996.0071n.x; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; Link TA, 1996, BIOCHEMISTRY-US, V35, P7546, DOI 10.1021/bi960004+; LJUNGDAHL O, 1987, BIOCHIM BIOPHYS ACTA, V891, P227; LJUNGDAHL PO, 1989, J BIOL CHEM, V264, P3723; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Nett JH, 1997, J BIOL CHEM, V272, P2212; PHILLIPS JD, 1993, J BIOL CHEM, V268, P11727; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; RIEDEL A, 1993, BIOCHIM BIOPHYS ACTA, V1183, P263, DOI 10.1016/0005-2728(93)90227-7; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; SCHUTZ M, 1994, PHOTOSYNTH RES, V39, P163, DOI 10.1007/BF00029383; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; TRUMPOWER BL, 1981, BIOCHIM BIOPHYS ACTA, V639, P129, DOI 10.1016/0304-4173(81)90008-2; TRUMPOWER BL, 1979, FEBS LETT, V100, P13, DOI 10.1016/0014-5793(79)81121-7	33	150	153	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9085	9093		10.1074/jbc.273.15.9085	http://dx.doi.org/10.1074/jbc.273.15.9085			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535897	hybrid			2022-12-27	WOS:000072990800074
J	Dziarski, R; Tapping, RI; Tobias, PS				Dziarski, R; Tapping, RI; Tobias, PS			Binding of bacterial peptidoglycan to CD14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE LPS; SOLUBLE CD14; STAPHYLOCOCCUS-AUREUS; LIPOTEICHOIC ACIDS; LIPID-A; 70-KDA PEPTIDOGLYCAN; SIGNAL-TRANSDUCTION; MEMBRANE CD14; CROSS-LINKING; TNF-ALPHA	The hypothesis that soluble peptidoglycan (sPGN, a macrophage-activator from Gram-positive bacteria) binds to CD14 (a lipopolysaccharide (LPS) receptor) was tested. sPGN specifically bound to CD14 in the following three assays: binding of soluble P-32-CD14 (sCD14) to agarose-immobilized sPGN, enzyme-linked immunosorbent assay, and photoaffinity cross-linking. sCD14 also specifically bound to agarose-immobilized muramyl dipeptide or GlcNAc-muramyl dipeptide but not to PGN pentapeptide. Binding of sCD14 to both sPGN and ReLPS (where ReLPS is LPS from Salmonella minnesota Re 595) was competitively inhibited by unlabeled sCD14, 1-152 N-terminal fragment of sCD14, sPGN, smooth LPS, ReLPS, lipid A, and lipoteichoic acid but not by dextran, dextran sulfate, heparin, ribitol teichoic acid, or soluble low molecular weight PGN fragments. Binding of sCD14 to sPGN was slower than to ReLPS but of higher affinity (K-D = 25 nM versus 41 nM). LPS-binding protein (LBP) increased the binding of sCD14 to sPGN by adding another lower affinity K-D and another higher B-max, but for ReLPS, LBP increased the affinity of binding by yielding two K-D with significantly higher affinity (7.1 and 27 nM). LBP also enhanced inhibition of sCD14 binding by LPS, ReLPS, and lipid A. Binding of sCD14 to both sPGN and ReLPS was inhibited by anti-CD14 MEM-18 mAb, but other anti-CD14 mAbs showed differential inhibition, suggesting conformational binding sites on CD14 for sPGN and LPS, that are partially identical and partially different.	Indiana Univ, Sch Med, NW Ctr Med Educ, Gary, IN 46408 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Indiana University System; Indiana University Northwest; Scripps Research Institute	Dziarski, R (corresponding author), Indiana Univ, Sch Med, NW Ctr Med Educ, 3400 Broadway, Gary, IN 46408 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL023584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032021, R01AI028797] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL23584] Funding Source: Medline; NIAID NIH HHS [AI32021, AI28797] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cavaillon JM, 1996, J ENDOTOXIN RES, V3, P471, DOI 10.1177/096805199600300605; Cleveland MG, 1996, INFECT IMMUN, V64, P1906, DOI 10.1128/IAI.64.6.1906-1912.1996; COURTNEY HS, 1986, INFECT IMMUN, V51, P414, DOI 10.1128/IAI.51.2.414-418.1986; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DELUDE RL, 1995, P NATL ACAD SCI USA, V92, P9288, DOI 10.1073/pnas.92.20.9288; DZIARSKI R, 1991, J BIOL CHEM, V266, P4713; DZIARSKI R, 1994, J BIOL CHEM, V269, P2100; DZIARSKI R, 1991, J BIOL CHEM, V266, P4719; DZIARSKI R, 1994, J BIOL CHEM, V269, P20431; DZIARSKI R, 1986, BIOL PROPERTIES PEPT, P229; ESPEVIK T, 1993, EUR J IMMUNOL, V23, P255, DOI 10.1002/eji.1830230140; FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; GUPTA D, 1995, J IMMUNOL, V155, P2620; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Heymer B., 1985, IMMUNOLOGY BACTERIAL, P11; JAHR TG, 1995, SCAND J IMMUNOL, V42, P119, DOI 10.1111/j.1365-3083.1995.tb03634.x; JUAN TSC, 1995, J BIOL CHEM, V270, P1382, DOI 10.1074/jbc.270.3.1382; JUAN TSC, 1995, J BIOL CHEM, V270, P17237, DOI 10.1074/jbc.270.29.17237; JUAN TSC, 1995, J BIOL CHEM, V270, P5219, DOI 10.1074/jbc.270.10.5219; KIRIKAE T, 1994, FEMS IMMUNOL MED MIC, V8, P13; KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818; Kusunoki T, 1996, J IMMUNOL, V157, P5112; KUSUNOKI T, 1995, J EXP MED, V182, P1673, DOI 10.1084/jem.182.6.1673; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; ROSENTHAL RS, 1994, METHOD ENZYMOL, V235, P253; Savedra R, 1996, J IMMUNOL, V157, P2549; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Shapiro RA, 1997, INFECT IMMUN, V65, P293, DOI 10.1128/IAI.65.1.293-297.1997; SOELL M, 1995, J IMMUNOL, V154, P851; Stelter F, 1997, EUR J BIOCHEM, V243, P100, DOI 10.1111/j.1432-1033.1997.00100.x; Tapping RI, 1997, J BIOL CHEM, V272, P23157, DOI 10.1074/jbc.272.37.23157; THEOFAN G, 1994, J IMMUNOL, V152, P3623; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; ULEVITCH RJ, 1994, CURR OPIN IMMUNOL, V6, P125, DOI 10.1016/0952-7915(94)90043-4; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; Viriyakosol S, 1996, INFECT IMMUN, V64, P653, DOI 10.1128/IAI.64.2.653-656.1996; WEIDEMANN B, 1994, INFECT IMMUN, V62, P4709, DOI 10.1128/IAI.62.11.4709-4715.1994; Weidemann B, 1997, INFECT IMMUN, V65, P858, DOI 10.1128/IAI.65.3.858-864.1997; WRIGHT SD, 1995, J IMMUNOL, V155, P6; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu B, 1996, J BIOL CHEM, V271, P4100	49	226	231	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8680	8690		10.1074/jbc.273.15.8680	http://dx.doi.org/10.1074/jbc.273.15.8680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535844	hybrid			2022-12-27	WOS:000072990800021
J	Grazioli, L; Germain, V; Weiss, A; Acuto, O				Grazioli, L; Germain, V; Weiss, A; Acuto, O			Anti-peptide antibodies detect conformational changes of the inter-SH2 domain of ZAP-70 due to binding to the zeta chain and to intramolecular interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; JURKAT T-CELLS; SH2 DOMAINS; ACTIVATION MOTIFS; RECEPTOR; PHOSPHORYLATION; STIMULATION; OCCUPANCY; 3-KINASE; P72(SYK)	T cell receptor (TCR) triggering induces association of the protein tyrosine kinase ZAP-70, via its two src-homology 2 (SH2) domains, to di-phosphorylated Immunoreceptor Tyrosine-based Activation Motifs (2pY-ITAMs) present in the intracellular tail of the TCR-zeta chain. The crystal structure of the SH2 domains complexed with a 2pY-ITAM peptide suggests that the 60-amino acid-long inter-SH2 spacer helps the SH2 domains to interact with each other to create the binding site for the 2pY-ITAM, To investigate whether the inter-SH2 spacer has additional roles in the whole ZAP-70, we raised antibodies against two peptides of this region and probed ZAP-70 structure under various conditions. We show that the reactivity of antibodies directed at both sequences was dramatically augmented toward the tandem SH2 domains alone compared with that of the entire ZAP-70. This indicates that the conformation of the inter-SH2 spacer is not maintained autonomously but is controlled by sequences C-terminal to the SH2 domains, namely, the linker region and/or the kinase domain, Moreover, antibody binding to the same two determinants was also inhibited when ZAP-70 or the SH2 domains bound to the zeta chain or to a 2pY-ITAM. Together, these two observations suggest a model in which intramolecular contacts keep ZAP-70 in a closed configuration with the two SH2 domains near to each other.	Inst Pasteur, Mol Immunol Unit, Dept Immunol, F-75724 Paris 15, France; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Acuto, O (corresponding author), Inst Pasteur, Mol Immunol Unit, Dept Immunol, 25 Rue Dr Roux, F-75724 Paris 15, France.	oacuto@pasteur.fr						Brunati AM, 1996, EUR J BIOCHEM, V240, P400, DOI 10.1111/j.1432-1033.1996.0400h.x; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; COHEN C, 1994, SCIENCE, V263, P488, DOI 10.1126/science.8290957; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; DYSON HJ, 1988, ANNU REV BIOPHYS BIO, V17, P305; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; GARIEPY J, 1986, P NATL ACAD SCI USA, V83, P8888, DOI 10.1073/pnas.83.23.8888; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Huby RDJ, 1995, J BIOL CHEM, V270, P30241, DOI 10.1074/jbc.270.51.30241; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kimura T, 1996, MOL CELL BIOL, V16, P1471; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; Kohn WD, 1997, J BIOL CHEM, V272, P2583, DOI 10.1074/jbc.272.5.2583; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; LoGrasso PV, 1996, P NATL ACAD SCI USA, V93, P12165, DOI 10.1073/pnas.93.22.12165; Mege D, 1996, J BIOL CHEM, V271, P32644, DOI 10.1074/jbc.271.51.32644; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; PUSKEY S, 1995, J BIOL CHEM, V270, P2897; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; SHIUE L, 1995, J BIOL CHEM, V270, P10498, DOI 10.1074/jbc.270.18.10498; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WATTS JD, 1994, J BIOL CHEM, V269, P29520; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887	36	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					8916	8921		10.1074/jbc.273.15.8916	http://dx.doi.org/10.1074/jbc.273.15.8916			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535874	hybrid			2022-12-27	WOS:000072990800051
J	Hazan, RB; Norton, L				Hazan, RB; Norton, L			The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; CELL-CELL-ADHESION; HUMAN CARCINOMA-CELLS; BETA-CATENIN; ALPHA-CATENIN; TYROSINE PHOSPHORYLATION; EPITHELIAL-CELLS; MEDIATED ADHESION; PROTEIN INTERACTIONS; SIGNAL-TRANSDUCTION	Alterations in the expression or function of molecules that affect cellular adhesion and proliferation are thought to be critical events for tumor progression, Loss of expression of the cell adhesion molecule E cadherin and increased expression of the epidermal growth factor receptor are two prominent molecular events that are associated with tumorigenesis, The regulation of E-cadherin-dependent cell adhesion by epidermal growth factor (EGF) was therefore examined in the human breast cancer cell line, MDA-MB-468. In this study, changes were observed in the subcellular distribution of components that mediate the cytoplasmic connection between E-cadherin and the actin-based cytoskeleton in response to activation of the EGF receptor, Serum withdrawal activated E-cadherin dependent cell-cell aggregation in MDA-MB-468 cells, and this treatment stimulated the interaction of actin, alpha-actinin, and vinculin with E cadherin complexes, despite the absence of alpha-catenin in these cells, By contrast, the co-precipitation of actin with E cadherin was not detected in several alpha-catenin positive epithelial cell lines, Treatment with EGF inhibited cellular aggregation but did not affect either the levels of E-cadherin or catenin expression nor the association of catenins (beta-catenin, plakoglobin/gamma-catenin, or p120(cas)) with E cadherin. However, EGF treatment of the MDA-MB-468 cell line dissociated actin, alpha-actinin, and vinculin from the E cadherin catenin complex, and this coincided with a robust phosphorylation of beta-catenin, plakoglobin/gamma-catenin, and p120(cas) on tyrosine residues, Furthermore, inactivation of the EGF receptor in serum-treated MDA-MB-468 cells with either a function-blocking antibody or EGF receptor kinase inhibitors mimicked the effects of serum starvation by stimulating both cellular aggregation and assembly of E-cadherin complexes with vinculin and actin, These results demonstrate that the EGF receptor directly regulates cell-cell adhesion through modulation of the interaction of E cadherin with the actin cytoskeleton and thus substantiates the coordinate role of both of these molecules in tumor progression and metastasis.	Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Hazan, RB (corresponding author), Mt Sinai Med Ctr, Derald H Ruttenberg Canc Ctr, 1 Gustave Levy Pl,Box 1130, New York, NY 10029 USA.	rhazan@smtplink.mssm.edu			NCI NIH HHS [1P50CA68425] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA068425] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; BASELGA J, 1994, BREAST CANCER RES TR, V29, P127, DOI 10.1007/BF00666188; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; BOONSTRA J, 1995, CELL BIOL INT, V19, P413, DOI 10.1006/cbir.1995.1086; BRIGGES AJ, 1996, J MED CHEM, V39, P267; CHRYSOGELOS SA, 1994, BREAST CANCER RES TR, V31, P227, DOI 10.1007/BF00666156; CHRYSOGELOS SA, 1994, BREAST CANCER RES TR, V29, P29, DOI 10.1007/BF00666179; DERYNCK R, 1987, CANCER RES, V47, P565; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DSOUZA B, 1994, P NATL ACAD SCI USA, V91, P7202, DOI 10.1073/pnas.91.15.7202; FAN Z, 1993, CANCER RES, V53, P4322; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujii K, 1996, EXP CELL RES, V223, P50, DOI 10.1006/excr.1996.0057; GUMBINER BM, 1993, NEURON, V11, P551, DOI 10.1016/0896-6273(93)90068-3; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Hazan RB, 1996, CELL ADHES COMMUN, V4, P399, DOI 10.3109/15419069709004457; HERRENKNECHT K, 1991, P NATL ACAD SCI USA, V88, P9156, DOI 10.1073/pnas.88.20.9156; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Islam S, 1996, J CELL BIOL, V135, P1643, DOI 10.1083/jcb.135.6.1643; ITO S, 1983, J BIOL CHEM, V258, P4626; Jockusch BM, 1996, TRENDS CELL BIOL, V6, P311, DOI 10.1016/0962-8924(96)10022-2; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Kandikonda S, 1996, CELL ADHES COMMUN, V4, P13, DOI 10.3109/15419069609010760; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; Machesky LM, 1996, TRENDS CELL BIOL, V6, P304, DOI 10.1016/0962-8924(96)10026-X; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; MCNEILL H, 1993, J CELL BIOL, V120, P1217, DOI 10.1083/jcb.120.5.1217; MENKEL AR, 1994, J CELL BIOL, V126, P1231, DOI 10.1083/jcb.126.5.1231; MORTON RA, 1993, CANCER RES, V53, P3585; Nagafuchi A, 1993, Semin Cell Biol, V4, P175, DOI 10.1006/scel.1993.1021; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; OCHIAI A, 1994, BIOCHEM BIOPH RES CO, V205, P73, DOI 10.1006/bbrc.1994.2631; OKA H, 1993, CANCER RES, V53, P1696; OYAMA T, 1994, CANCER RES, V54, P6282; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; OZAWA M, 1980, P NATL ACAD SCI USA, V87, P849; PIERCEALL WE, 1995, ONCOGENE, V11, P1319; PIGNATELLI M, 1994, HUM PATHOL, V25, P849, DOI 10.1016/0046-8177(94)90002-7; POLLARD TD, 1982, METHOD ENZYMOL, V85, P211; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; RAJKUMAR T, 1994, BREAST CANCER RES TR, V29, P3, DOI 10.1007/BF00666177; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIEDEL H, 1988, P NATL ACAD SCI USA, V85, P1477, DOI 10.1073/pnas.85.5.1477; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; ROE S, 1998, IN PRESS CELL ADH CO; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Shibata T, 1996, ONCOGENE, V13, P883; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; SHIOZAKI H, 1995, BRIT J CANCER, V71, P250, DOI 10.1038/bjc.1995.52; SHORE EM, 1991, J BIOL CHEM, V266, P19672; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Takeda H, 1995, J CELL BIOL, V131, P1839, DOI 10.1083/jcb.131.6.1839; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; TODARO GJ, 1980, P NATL ACAD SCI-BIOL, V77, P5258, DOI 10.1073/pnas.77.9.5258; Tokman MG, 1997, CANCER RES, V57, P1785; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Wilding J, 1996, CANCER RES, V56, P5285	73	214	224	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9078	9084		10.1074/jbc.273.15.9078	http://dx.doi.org/10.1074/jbc.273.15.9078			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535896	hybrid			2022-12-27	WOS:000072990800073
J	Lipsky, BP; Beals, CR; Staunton, DE				Lipsky, BP; Beals, CR; Staunton, DE			Leupaxin is a novel LIM domain protein that forms a complex with PYK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE KINASE; CELL-ADHESION; EXTRACELLULAR-MATRIX; PAXILLIN; BINDING; PHOSPHORYLATION; IDENTIFICATION; VINCULIN; CYTOSKELETAL	We have identified a novel cytoplasmic protein, leupaxin, that is preferentially expressed in hematopoietic cells and is most homologous to the focal adhesion protein, paxillin, Leupaxin possesses two types of protein interaction domains. There are four carboxyl-terminal LIM domains in leupaxin that share 70% amino acid identity and 80% similarity with those in paxillin. Paxillin LIM domains mediate localization to focal contacts. In the amino-terminal region of leupaxin there are three short stretches of approximately 13 amino acids that share 70-90% similarity with paxillin LD motifs. Paxillin LD motifs have been implicated in focal adhesion kinase (FAK) and vinculin binding resulting in the localization of FAK to focal adhesions. Leupaxin is expressed in cell types, such as macrophage, that lack FAK, We demonstrate here that leupaxin associates with a second FAK family member, PYK2. As leupaxin and PYK2 are both preferentially expressed in leukocytes they may therefore form a cell type-specific signaling complex. We also demonstrate that leupaxin is a substrate for a tyrosine kinase in lymphoid cells and thus may function in and be regulated by tyrosine kinase activity. Leupaxin is thus a phosphotyrosine protein with LD and LIM binding motifs most homologous to paxillin that may assemble and regulate PYK2 signaling complexes in leukocytes.	ICOS Corp, Bothell, WA 98021 USA	Icos Corporation	Staunton, DE (corresponding author), ICOS Corp, 22021 20th Ave SE, Bothell, WA 98021 USA.		Lipsky, Benjamin A/B-4645-2013					Astier A, 1997, J BIOL CHEM, V272, P228; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Berg NN, 1997, J IMMUNOL, V159, P1753; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CHOI KG, 1993, P NATL ACAD SCI USA, V90, P5747, DOI 10.1073/pnas.90.12.5747; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; DeNichilo MO, 1996, J BIOL CHEM, V271, P11016, DOI 10.1074/jbc.271.18.11016; FUORTES M, 1994, J CELL BIOL, V127, P1477, DOI 10.1083/jcb.127.5.1477; Ganju RK, 1997, J EXP MED, V185, P1055, DOI 10.1084/jem.185.6.1055; Ganju RK, 1998, BLOOD, V91, P791, DOI 10.1182/blood.V91.3.791.791_791_797; Gismondi A, 1997, J IMMUNOL, V159, P4729; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Herzog H, 1996, GENOMICS, V32, P484, DOI 10.1006/geno.1996.0149; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; KOLEGA J, 1982, J CELL SCI, V54, P23; KOSA JL, 1994, BIOCHEMISTRY-US, V33, P468, DOI 10.1021/bi00168a011; Lee Juliet, 1993, Trends in Cell Biology, V3, P366, DOI 10.1016/0962-8924(93)90084-E; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; MICHELSEN JW, 1994, J BIOL CHEM, V269, P11108; MINOGUCHI K, 1994, MOL IMMUNOL, V31, P519; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; PEREZALVARADO GC, 1994, NAT STRUCT BIOL, V1, P388, DOI 10.1038/nsb0694-388; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; SADHU C, 1998, IN PRESS J IMMUNOL; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER CE, 1994, J CELL SCI, V107, P1583; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; Wu RY, 1996, J BIOL CHEM, V271, P15934, DOI 10.1074/jbc.271.27.15934; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; ZACHARY I, 1993, J BIOL CHEM, V268, P22060	42	79	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11709	11713		10.1074/jbc.273.19.11709	http://dx.doi.org/10.1074/jbc.273.19.11709			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565592	hybrid			2022-12-27	WOS:000073536700046
J	Mori, H; Cline, K				Mori, H; Cline, K			Communication - A signal peptide that directs non-Sec transport in bacteria also directs efficient and exclusive transport on the thylakoid Delta pH pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; MEMBRANE; EXPORT	Signal peptides that specifically direct precursor proteins to the thylakoid Delta pH pathway possess an N domain RR motif. Signal peptides that direct transport of bacterial proteins across a non Sec export pathway possess an N domain RRXFLK consensus motif. Recent genetic studies suggest an evolutionary link between these two protein translocation pathways. To further explore this relationship, we examined the thylakoid targeting capability of the signal peptide for Escherichia coli hydrogenase 1 small subunit (HyaA) by linking it to plastocyanin and assaying the chimeric protein in an in vitro thylakoid transport assay. The chimeric precursor was transported across thylakoids with high efficiency. Transport was characteristic of the Delta pH but not the Sec pathway, i.e. it was eliminated by ionophores that dissipate the Delta pH but occurred in the absence of stromal extract or ATP. This result was confirmed by competition with chemical quantities of a Delta pH pathway precursor. This indicates that the HyaA signal peptide has the necessary elements for efficient and exclusive targeting to the Delta pH pathway and further supports the notion that the alternate targeting pathways in prokaryotes and plant thylakoids are analogous.	Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cline, K (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	KCC@nervm.nerdc.ufl.edu	Cline, Kenneth/J-6238-2013		NIGMS NIH HHS [R01 GM46951] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046951] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bogsch E, 1997, EMBO J, V16, P3851, DOI 10.1093/emboj/16.13.3851; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1986, J BIOL CHEM, V261, P4804; Cline K, 1996, ANNU REV CELL DEV BI, V12, P1, DOI 10.1146/annurev.cellbio.12.1.1; Dreusch A, 1997, BBA-BIOENERGETICS, V1319, P311, DOI 10.1016/S0005-2728(96)00174-0; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HULFORD A, 1994, J BIOL CHEM, V269, P3251; MENON NK, 1991, J BACTERIOL, V173, P4851, DOI 10.1128/jb.173.15.4851-4861.1991; NIVIERE V, 1992, J GEN MICROBIOL, V138, P2173, DOI 10.1099/00221287-138-10-2173; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535	17	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11405	11408		10.1074/jbc.273.19.11405	http://dx.doi.org/10.1074/jbc.273.19.11405			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565548	hybrid			2022-12-27	WOS:000073536700002
J	Xie, B; Laouar, A; Huberman, E				Xie, B; Laouar, A; Huberman, E			Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-alpha via alpha(5)beta(1) integrin in HL-60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; COLONY-STIMULATING FACTOR; HUMAN MONONUCLEAR PHAGOCYTES; COLLAGENASE GENE-EXPRESSION; IV COLLAGENASE; MATRIX METALLOPROTEINASE-9; TNF-ALPHA; MECHANISM; PROLIFERATION; LEUKOCYTES	Tumor necrosis factor-alpha (TNF-alpha) gene is one of the early response genes induced by phorbol la-myristate 13-acetate (PMA) in human HL-60 myeloid leukemia cells. In the present study, we examined the role of the TNF-alpha autocrine loop in PMA-induced macrophage differentiation and gene expression of 92- and 72-kDa gelatinases (MMP-9 and MMP-2). In HL-60 cells, PMA inhibited cell proliferation and induced cell adhesion and spreading, expression of surface maturation marker OKM1 and phagocytic activity, as well as the expression of both gelatinases, which all characterize the macrophage phenotype. In contrast, TNF-alpha alone was only effective in inhibiting cell proliferation. Blocking the endogenous TNF-alpha activity with neutralizing anti-TNF-alpha antibodies abolished all these PMA-induced events with the exception of MMP-2 gene expression. Since fibronectin (FN)-mediated cell adhesion and spreading are prerequisite for both macrophage differentiation and MMP-9 gene expression in HL-60 cells, we hypothesized that TNF-alpha might be involved in modulating the expression of either the FN or its integrin receptor genes. Whereas PMA substantially enhanced the steady state mRNA and protein levels of both FN and alpha(5) beta(1) integrins, TNF-alpha alone had little effect on the expression of these genes. However, anti-TNF-alpha antibodies blocked PMA-induced augmentation of both alpha(5) and beta(1) integrin gene expression without affecting the expression of the FN gene. Our results suggest that TNF-alpha may regulate macrophage differentiation and critical matrix-degrading activities of myeloid progenitor cells in an autocrine manner by augmenting surface levels of the alpha(5) beta(1) integrin, thus promoting interactions with the extracellular matrix, a key event for maturation and migration of these cells during inflammation.	Argonne Natl Lab, Ctr Mechanist Biol & Biotechnol, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Huberman, E (corresponding author), Argonne Natl Lab, Ctr Mechanist Biol & Biotechnol, 9700 S Cass Ave, Argonne, IL 60439 USA.							BAUVOIS B, 1992, J IMMUNOL, V148, P3912; BLAIR OC, 1986, CYTOMETRY, V7, P171, DOI 10.1002/cyto.990070208; BRANCH DR, 1989, BLOOD, V73, P307; Callaghan MM, 1996, J LEUKOCYTE BIOL, V59, P125, DOI 10.1002/jlb.59.1.125; CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; COLLINS SJ, 1987, BLOOD, V70, P1233; FOON KA, 1982, BLOOD, V60, P1; GLESNE DA, 1991, MOL CELL BIOL, V11, P5417, DOI 10.1128/MCB.11.11.5417; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HIBBS MS, 1987, J CLIN INVEST, V80, P1644, DOI 10.1172/JCI113253; HORIGUCHI J, 1989, MOL CELL BIOL, V9, P252, DOI 10.1128/MCB.9.1.252; HUBERMAN E, 1979, P NATL ACAD SCI USA, V76, P1293, DOI 10.1073/pnas.76.3.1293; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; HUHTALA P, 1991, J BIOL CHEM, V266, P16485; LOTEM J, 1979, P NATL ACAD SCI USA, V76, P5158, DOI 10.1073/pnas.76.10.5158; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; MURPHY G, 1989, BIOCHEM J, V258, P463, DOI 10.1042/bj2580463; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; RUSTEN LS, 1994, J CLIN INVEST, V94, P165, DOI 10.1172/JCI117303; SANTIAGOSCHWARZ F, 1993, BLOOD, V82, P3019; Saren P, 1996, J IMMUNOL, V157, P4159; SATO H, 1993, ONCOGENE, V8, P395; SHIMA M, 1995, P NATL ACAD SCI USA, V92, P5179, DOI 10.1073/pnas.92.11.5179; STETLERSTEVENSON WG, 1990, CANCER METAST REV, V9, P289, DOI 10.1007/BF00049520; TAKEDA K, 1986, NATURE, V323, P338, DOI 10.1038/323338a0; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; WATANABE H, 1993, J CELL SCI, V104, P991; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WITSELL AL, 1991, P NATL ACAD SCI USA, V88, P1963, DOI 10.1073/pnas.88.5.1963; WITSELL AL, 1992, P NATL ACAD SCI USA, V89, P4754, DOI 10.1073/pnas.89.10.4754; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576	34	56	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 8	1998	273	19					11583	11588		10.1074/jbc.273.19.11583	http://dx.doi.org/10.1074/jbc.273.19.11583			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZM408	9565575	hybrid			2022-12-27	WOS:000073536700029
J	Davies, SJ; Shoemaker, CB; Pearce, EJ				Davies, SJ; Shoemaker, CB; Pearce, EJ			A divergent member of the transforming growth factor beta receptor family from Schistosoma mansoni is expressed on the parasite surface membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAUER LARVA DEVELOPMENT; PROTEIN-KINASE; FEMALE WORMS; MUTATIONS; COMPLEX; ENCODES; ADULT	To optimize reproductive success under the limitations determined by conditions within an individual host, parasitic helminths have evolved mechanisms that allow them to detect and respond to host factors such as species, age, sex, reproductive condition, and immune status. Using the model helminth Schistosoma mansoni, we have explored the possibility that parasitic helminths express signal-transducing receptor molecules on their surfaces. Here, we present the identification of a schistosome member of the transforming growth factor beta receptor family of cell-surface receptors, the first member of this family to be identified in a platyhelminth, The putative protein kinase domain of the schistosome receptor displays up to 58% amino acid identity to kinase domains of other type I receptor serine-threonine kinases, and contains a potential "GS domain," suggesting it is a divergent member of the type I receptor subfamily. This receptor is expressed on the surface of the parasite's syncytial tegument and expression of receptor messenger RNA and protein is up-regulated following infection of the mammalian host. The receptor protein can be isolated in a phosphorylated form from adult parasites, which together with its surface location, suggests that it functions in transducing signals across the parasite surface membrane.	Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Cornell University; Harvard University; Harvard T.H. Chan School of Public Health	Pearce, EJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.				PHS HHS [R0139085] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; BASCH PF, 1983, J PARASITOL, V69, P567, DOI 10.2307/3281371; BASCH PF, 1988, COMP BIOCHEM PHYS B, V90, P389, DOI 10.1016/0305-0491(88)90093-4; BROWNLEE DJA, 1995, PARASITOLOGY, V110, P143, DOI 10.1017/S0031182000063903; DAVIES SJ, 1995, MOL BIOCHEM PARASIT, V70, P33, DOI 10.1016/0166-6851(95)00002-I; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GEARNER GW, 1994, J PARASITOL, V80, P275, DOI 10.2307/3283758; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; GUPTA BC, 1987, J PARASITOL, V73, P481, DOI 10.2307/3282125; Hockley D.J., 1973, Advances Parasit, V11, P233, DOI 10.1016/S0065-308X(08)60188-8; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAZDINS JK, 1982, EXP PARASITOL, V53, P39, DOI 10.1016/0014-4894(82)90090-X; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; LOVERDE PT, 1991, PARASITOL TODAY, V7, P303, DOI 10.1016/0169-4758(91)90263-N; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Poulin R, 1996, ADV PARASIT, V37, P107, DOI 10.1016/S0065-308X(08)60220-1; RAM D, 1989, MOL BIOCHEM PARASIT, V34, P167, DOI 10.1016/0166-6851(89)90008-X; SHOEMAKER CB, 1992, MOL BIOCHEM PARASIT, V53, P17, DOI 10.1016/0166-6851(92)90003-3; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; SOGANDARESBERNAL F, 1976, J PARASITOL, V62, P222, DOI 10.2307/3279272; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; *WHO, 1993, 830 WHO; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	31	96	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11234	11240		10.1074/jbc.273.18.11234	http://dx.doi.org/10.1074/jbc.273.18.11234			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556614	hybrid			2022-12-27	WOS:000073395200066
J	Kraner, SD; Rich, MM; Kallen, RG; Barchi, RL				Kraner, SD; Rich, MM; Kallen, RG; Barchi, RL			Two E-boxes are the focal point of muscle-specific skeletal muscle type 1 Na+ channel gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-SUBUNIT GENE; HELIX-LOOP-HELIX; SODIUM-CHANNEL; ELECTRICAL-ACTIVITY; TRANSCRIPTION; PROTEIN; BINDING; PLASTICITY; ACTIVATION; MUTATIONS	We have characterized a group of cis-regulatory elements that control muscle-specific expression of the rat skeletal muscle type 1 sodium channel (SkM1) gene. These elements are located within a 3.1-kilobase fragment that encompasses the 5'-flanking region, first exon, and part of the first intron of SkM1. We sequenced the region between -1062 and +311 and determined the start sites of transcription; multiple sites were identified between +1 and +30. The basal promoter (-65/+11) lacks cell-type specificity, while an upstream repressor (-179/-65) confers muscle-specific expression. A positive element (+49/+254) increases muscle-specific expression, Within these broad elements, two E boxes play a pivotal role. One E box at -31/-26 within the promoter, acting in part through its ability to bind the myogenic basic helix-loop-helix proteins, recruits additional factor(s) that bind elsewhere within the SkM1 sequence to control positive expression of the gene. A second E box at -90/-85 within the repressor controls negative regulation of the gene and acts through a different complex of proteins. Several of these cis-regulatory elements share both sequence and functional similarities with cis-regulatory elements of the acetylcholine receptor delta-subunit; the different arrangement of these elements may contribute to unique expression patterns for the two genes.	Univ Penn, Med Ctr, Dept Neurosci, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Kraner, SD (corresponding author), Univ Penn, Med Ctr, Dept Neurosci, Sch Med, 223 Stemmler Hall, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001852, R01NS034954] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-01852, NS-34954] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barchi RL, 1997, NEUROBIOL DIS, V4, P254, DOI 10.1006/nbdi.1997.0158; BASSELDUBY R, 1994, MOL CELL BIOL, V14, P4596, DOI 10.1128/MCB.14.7.4596; BASSELDUBY RS, 1992, MOL CELL BIOL, V1, P5025; Buonanno A, 1996, DEV GENET, V19, P95, DOI 10.1002/(SICI)1520-6408(1996)19:2<95::AID-DVG1>3.0.CO;2-V; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; CHAHINE KG, 1992, DEVELOPMENT, V115, P213; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DIAS P, 1994, SEMIN DIAGN PATHOL, V11, P3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; Garry DJ, 1996, DEV GENET, V19, P146, DOI 10.1002/(SICI)1520-6408(1996)19:2<146::AID-DVG6>3.0.CO;2-9; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; GEORGE AL, 1993, GENOMICS, V15, P598, DOI 10.1006/geno.1993.1113; HAIMOVICH B, 1987, J NEUROSCI, V7, P2957; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; KOIKE S, 1995, P NATL ACAD SCI USA, V92, P10625; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LUPA MT, 1993, J NEUROSCI, V13, P1326; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Sambrook J., 2002, MOL CLONING LAB MANU; SHENG ZH, 1994, DNA CELL BIOL, V13, P9, DOI 10.1089/dna.1994.13.9; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; YANG JS, 1993, NEURON, V11, P915, DOI 10.1016/0896-6273(93)90121-7; YANG JS, 1991, NEURON, V7, P412; ZHOU JH, 1994, J BIOL CHEM, V269, P18563	33	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11327	11334		10.1074/jbc.273.18.11327	http://dx.doi.org/10.1074/jbc.273.18.11327			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556626	hybrid			2022-12-27	WOS:000073395200078
J	Zhou, A; Martin, S; Lipkind, G; LaMendola, J; Steiner, DF				Zhou, A; Martin, S; Lipkind, G; LaMendola, J; Steiner, DF			Regulatory roles of the P domain of the subtilisin-like prohormone convertases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASES; ENZYMATIC CHARACTERIZATION; NEUROENDOCRINE PEPTIDES; PROCESSING PROTEASES; CELL-LINE; PC2; FURIN; PURIFICATION; CALCIUM; FAMILY	A unique feature of the eukaryotic subtilisin-like pro-protein convertases (SPCs) is the presence of an additional highly conserved sequence of approximately 150 residues (P domain) located immediately downstream of the catalytic domain. To study the function of this region, which is required for the production of enzymatically active convertases, we have expressed and characterized various P domain-related mutants and chimeras in HEK293 cells and alpha-TC1-6 cells. In a series of C-terminal truncations of PC3 (also known as PC1 or SPC3), PC3-Thr(594) was identified as the shortest active form, thereby defining the functional C-terminal boundary of the P domain. Substitutions at Thr(594) and nearby sites indicated that residues 592-594 are crucial for activity. Chimeric SPC proteins with interchanged P domains demonstrated dramatic changes in several properties. Compared with truncated wild-type PC3 (pC3-Asp(616)), both PC3/PC2Pd and PC3/FurPd had elevated activity on several synthetic substrates as well as reduced calcium ion dependence, whereas Fur/PC2Pd was only slightly decreased in activity as compared with truncated furin (Fur-Glu(583)). Of th, three active SPC chimeras tested, all had more alkaline pH optima. When PC3/PC2Pd was expressed in alpha-TC1-6 cells, it accelerated the processing of proglucagon into glicentin and major proglucagon fragment and cleaved major proglucagon fragment to release GLP-1 and tGLP-1, similar to wild-type PC3, Thus, P domain exchanges generated fully active chimeric proteases in several instances but not in all (e.g. PC2/PC3Pd was inactive). The observed property changes indicate a role for the P domain in regulating the stability, calcium dependence, and pH dependence of the convertases.	Univ Chicago, Howard Hughes Med Inst, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Steiner, DF (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Biochem & Mol Biol, 5841 S Maryland Ave,MC 1028,N101, Chicago, IL 60637 USA.	dfsteine@midway.uckicago.edu		Zhou, An/0000-0002-9358-8012	NIDDK NIH HHS [DK-13914] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK013914, R01DK013914] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; AZARYAN AV, 1995, J BIOL CHEM, V270, P8201, DOI 10.1074/jbc.270.14.8201; BAILYES EM, 1992, BIOCHEM J, V286, P223, DOI 10.1042/bj2860223; BENJANNET S, 1995, J NEUROCHEM, V64, P2303; Bruzzaniti A, 1996, BIOCHEM J, V314, P727, DOI 10.1042/bj3140727; CHAN SJ, 1992, P NATL ACAD SCI USA, V89, P6678, DOI 10.1073/pnas.89.15.6678; Coates LC, 1997, J NEUROCHEM, V68, P828; Creemers JWM, 1996, J BIOL CHEM, V271, P25284, DOI 10.1074/jbc.271.41.25284; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; FULLER RS, 1991, ADV LIF SCI, P205; GALLAGHER T, 1993, PROTEINS, V16, P205, DOI 10.1002/prot.340160207; GLUSCHANKOF P, 1994, EMBO J, V13, P2280, DOI 10.1002/j.1460-2075.1994.tb06510.x; GROS P, 1991, J BIOL CHEM, V266, P2953; Guest PC, 1997, BIOCHEM J, V323, P445, DOI 10.1042/bj3230445; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; HATSUZAWA K, 1991, J BIOCHEM-TOKYO, V111, P296; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Jutras I, 1997, J BIOL CHEM, V272, P15184, DOI 10.1074/jbc.272.24.15184; Lamango NS, 1996, ARCH BIOCHEM BIOPHYS, V330, P238, DOI 10.1006/abbi.1996.0249; LIPKIND G, 1995, J BIOL CHEM, V270, P13277, DOI 10.1074/jbc.270.22.13277; MELNICK J, 1992, J BIOL CHEM, V267, P21303; MILGRAM SL, 1994, J CELL SCI, V107, P737; MIZUNO K, 1988, BIOCHEM BIOPH RES CO, V156, P246, DOI 10.1016/S0006-291X(88)80832-5; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; PANTOLIANO MW, 1988, BIOCHEMISTRY-US, V27, P8311, DOI 10.1021/bi00422a004; ROTHENBERG ME, 1995, J BIOL CHEM, V270, P10136, DOI 10.1074/jbc.270.17.10136; Rouille Y, 1997, FEBS LETT, V413, P119, DOI 10.1016/S0014-5793(97)00892-2; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; ROUILLE Y, 1995, J BIOL CHEM, V270, P26488, DOI 10.1074/jbc.270.44.26488; RUFAUT NW, 1993, J BIOL CHEM, V268, P20291; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; SHENNAN KIJ, 1994, J BIOL CHEM, V269, P18646; SHENNAN KIJ, 1995, J BIOL CHEM, V270, P1402, DOI 10.1074/jbc.270.3.1402; SIEZEN RJ, 1994, EUR J BIOCHEM, V222, P255, DOI 10.1111/j.1432-1033.1994.tb18864.x; SMEEKENS SP, 1992, PROG BRAIN RES, V92, P235, DOI 10.1016/S0079-6123(08)61179-6; SMEEKENS SP, 1993, BIO-TECHNOL, V11, P182, DOI 10.1038/nbt0293-182; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; TSUJI A, 1994, BIOCHEM BIOPH RES CO, V202, P1452, DOI 10.1006/bbrc.1994.2094; VINDROLA O, 1993, NEUROPEPTIDES, V25, P151, DOI 10.1016/0143-4179(93)90096-S; VOS P, 1991, PROTEIN ENG, V4, P479, DOI 10.1093/protein/4.4.479; WELLS JA, 1983, NUCLEIC ACIDS RES, V11, P7911, DOI 10.1093/nar/11.22.7911; YI Z, 1993, J BIOL CHEM, V268, P5615; ZHOU A, 1994, J BIOL CHEM, V269, P17440; ZHOU A, 1993, J BIOL CHEM, V268, P1763; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509; ZHOU Y, 1994, J BIOL CHEM, V269, P18408; ZHOU Y, 1995, J BIOL CHEM, V270, P24702, DOI 10.1074/jbc.270.42.24702	56	85	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	1998	273	18					11107	11114		10.1074/jbc.273.18.11107	http://dx.doi.org/10.1074/jbc.273.18.11107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZL064	9556596	hybrid			2022-12-27	WOS:000073395200048
J	Benov, L; Fridovich, I				Benov, L; Fridovich, I			Growth in iron-enriched medium partially compensates Escherichia coli for the lack of manganese and iron superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							6-PHOSPHOGLUCONATE DEHYDRATASE; ENZYME; ACONITASE; INACTIVATION; FUMARASE; CLUSTER; STRESS; PURIFICATION; SENSITIVITY; COMPLEXES	Enrichment of the growth medium with iron partially relieves the phenotypic deficits imposed on Escherichia coli by lack of both manganese and iron superoxide dismutases. Thus iron supplementation increased the aerobic growth rate, decreased the leakage of sulfite, and diminished sensitivity toward paraquat. Iron supplementation increased the activities of several [4Fe-4S]-containing dehydratases, and this was seen even in the presence of 50 mu g/ml of rifampicin, an amount which completely inhibited growth. Assessing the O-2(radical anion) scavenging activity by means of lucigenin luminescence indicated that the iron-enriched sodAsodB cells had gained some means of eliminating O-2(radical anion) which was not detectable as superoxide dismutase activity in cell extracts. It is noteworthy that iron-enriched cells were not more sensitive toward the lethality of H2O2 despite having the usual amount of catalase activity. This indicates that iron taken into the cells from the medium is not available for Fenton chemistry, but is available for reconstitution of iron-sulfur clusters. We suppose that oxidation of the [4Fe-4S] clusters of dehydratases by O-2(radical anion) and their subsequent reductive reconstitution provides a mechanism for scavenging O-2(radical anion), and that speeding this reductive reconstitution by iron enrichment both spared other targets from O-2(radical anion) attack and maintained adequate levels of these enzymes to meet the metabolic needs of the cells.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Fridovich, I (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.		Benov, Ludmil/AAD-3714-2020	Benov, Ludmil/0000-0002-0205-0146				ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; BEERS RF, 1952, J BIOL CHEM, V195, P133; BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; Benov L, 1996, J BIOL CHEM, V271, P21037, DOI 10.1074/jbc.271.35.21037; Benov L, 1997, ARCH BIOCHEM BIOPHYS, V347, P271, DOI 10.1006/abbi.1997.0343; BRALET J, 1992, BIOCHEM PHARMACOL, V43, P979, DOI 10.1016/0006-2952(92)90602-F; BROWN OR, 1995, ARCH BIOCHEM BIOPHYS, V319, P10, DOI 10.1006/abbi.1995.1262; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CHANG EC, 1989, J BIOL CHEM, V264, P12172; CHETON PLB, 1988, FREE RADICAL BIO MED, V5, P325, DOI 10.1016/0891-5849(88)90104-9; FARIDOON KY, 1991, J CHEM SOC CHEM COMM, P1141, DOI 10.1039/c39910001141; FLINT DH, 1992, BIOCHEMISTRY-US, V31, P10331, DOI 10.1021/bi00157a022; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; GRANT WM, 1947, ANAL CHEM, V19, P345, DOI 10.1021/ac60005a023; GUTTERIDGE JMC, 1986, BIOCHEM J, V234, P225, DOI 10.1042/bj2340225; Hill RL, 1969, METHOD ENZYMOL, V8, P91, DOI 10.1016/0076-6879(69)13021-9; IMLAY JA, 1987, J BACTERIOL, V169, P2967, DOI 10.1128/jb.169.7.2967-2976.1987; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; KONO Y, 1976, ARCH BIOCHEM BIOPHYS, V174, P454, DOI 10.1016/0003-9861(76)90373-8; KUNERT J, 1973, Z ALLG MIKROBIOL, V13, P489, DOI 10.1002/jobm.3630130606; KUO CF, 1987, J BIOL CHEM, V262, P4724; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Liochev SI, 1997, P NATL ACAD SCI USA, V94, P2891, DOI 10.1073/pnas.94.7.2891; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; Liochev SI, 1997, ARCH BIOCHEM BIOPHYS, V337, P115, DOI 10.1006/abbi.1997.9766; Maniatis T, 1982, MOL CLONING LABORATO, P68; PIRRUNG MC, 1989, J ORG CHEM, V54, P1543, DOI 10.1021/jo00268a014; Rodriguez M, 1996, BIOCHEM MOL BIOL INT, V38, P783; ROSE IA, 1967, J BIOL CHEM, V242, P1870; VasquezVivar J, 1997, FEBS LETT, V403, P127, DOI 10.1016/S0014-5793(97)00036-7; WOODS SA, 1988, BIOCHIM BIOPHYS ACTA, V954, P14, DOI 10.1016/0167-4838(88)90050-7	38	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10313	10316		10.1074/jbc.273.17.10313	http://dx.doi.org/10.1074/jbc.273.17.10313			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553085	hybrid			2022-12-27	WOS:000073224200034
J	Gatto, C; Wang, AX; Kaplan, JH				Gatto, C; Wang, AX; Kaplan, JH			The M4M5 cytoplasmic loop of the Na,K-ATPase, overexpressed in Escherichia coli, binds nucleoside triphosphates with the same selectivity as the intact native protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT ADENOSINE-TRIPHOSPHATASE; AMINO-ACID-SEQUENCE; CONFORMATIONAL-CHANGES; ACTIVE-SITE; ATP; SODIUM; FLUORESCEIN; BACTERIOPHAGE-T4; 5'-TRIPHOSPHATE; NA+,K+-ATPASE	Escherichia coli was used to overexpress the large cytoplasmic loop of the rat Na,K-ATPase. A 1260-base DNA segment encoding Lys(354)-Lys(774) of the rat alpha 1fsub unit was constructed via polymerase chain reaction. The polymerase chain reaction product was successfully subcloned into the expression vector pET-28 (Novagen), which produces an N-terminal 6-histidine-tagged fusion protein. The pET-28 vector containing rat alpha-loop, i.e. pAN, was used to transform calcium-competent E. coli BL21(DE3) cells, and positive clones mere selected by kanamycin resistance. Bacterial cultures were grown, and protein synthesis was induced with isopropyl beta-D-thiogalactoside. Cells were harvested and lysed, revealing production of the His-tagged fusion protein (similar to 46 kDa). The fusion protein was affinity-purified from other soluble cellular proteins via a Ni-NTA column, which routinely yielded similar to 20 mg of soluble His(6)-alpha-loop/L cell culture. The His(6)-alpha-loop retained significant native structure, as evidenced by the ability of ATP and ADP (but not AMP, CTP, GTP, or UTP) to protect against chemical modification by either fluorescein isothiocyanate or maleimidylanilinonapthalene sulfonic acid. More specifically, circular dichroism spectroscopy was used to estimate the secondary structure of the His, loop, revealing an ordered folding composed of 23% alpha-helix, 23% antiparallel beta-sheet, 4% parallel beta-sheet, 19% beta-turn, and 32% random coil. The 6-histidine loop bound the fluorescent ATP analog trinitrophenyl-ATP with high affinity, as determined by measuring the fluorescence changes associated with binding. Affinities for ATP (similar to 350 mu M) and ADP (similar to 550 mu M) were determined by their ability to compete with and displace 2',3'-O-[2,4,6,-trinitrophenyl]-ATP. These nucleotide affinities are similar to those observed for the E(2) conformation of the intact Na,K-ATPase.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Kaplan, JH (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, L224,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	kaplan@ohsu.edu		Kaplan, Jack/0000-0002-7048-6574	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030315] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30315] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPIEAUX E, 1993, J BIOL CHEM, V268, P21895; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P212; COMPTON LA, 1987, J BIOL CHEM, V262, P13039; DUPONT Y, 1982, BIOCHEM BIOPH RES CO, V106, P1272, DOI 10.1016/0006-291X(82)91250-5; ELLISDAVIES GCR, 1990, J BIOL CHEM, V265, P20570; FARLEY RA, 1984, J BIOL CHEM, V259, P9532; FORBUSH B, 1987, J BIOL CHEM, V262, P11104; Gatto C, 1997, ARCH BIOCHEM BIOPHYS, V340, P90, DOI 10.1006/abbi.1997.9879; GLYNN IM, 1971, J PHYSIOL-LONDON, V218, P239, DOI 10.1113/jphysiol.1971.sp009612; HEGYVARY C, 1971, J BIOL CHEM, V246, P5234; Hellen EH, 1997, ANN NY ACAD SCI, V834, P439, DOI 10.1111/j.1749-6632.1997.tb52293.x; JENSEN J, 1971, BIOCHIM BIOPHYS ACTA, V233, P395, DOI 10.1016/0005-2736(71)90336-1; JOHNSON CL, 1995, BIOCHEM J, V309, P187, DOI 10.1042/bj3090187; KAPLAN JH, 1982, ANN NY ACAD SCI, V402, P292, DOI 10.1111/j.1749-6632.1982.tb25750.x; Kaplan JH, 1997, ANN NY ACAD SCI, V834, P45, DOI 10.1111/j.1749-6632.1997.tb52224.x; KAPLAN JH, 1991, SOC GEN PHY, V46, P117; KAPLAN JH, 1998, IN PRESS ACTA SCAND; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KIRLEY TL, 1984, BIOCHEM BIOPH RES CO, V125, P767, DOI 10.1016/0006-291X(84)90605-3; KO YH, 1993, J BIOL CHEM, V268, P24330; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Maniatis T., 1982, MOL CLONING LAB MANU; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2346; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2357; MOUTIN MJ, 1994, J BIOL CHEM, V269, P11147; NORBY JG, 1971, BIOCHIM BIOPHYS ACTA, V233, P104, DOI 10.1016/0005-2736(71)90362-2; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; PEDEMONTE CH, 1990, AM J PHYSIOL, V258, pC1, DOI 10.1152/ajpcell.1990.258.1.C1; PEDEMONTE CH, 1988, BIOCHEMISTRY-US, V27, P7966, DOI 10.1021/bi00420a056; Pedersen PA, 1996, J BIOL CHEM, V271, P2514, DOI 10.1074/jbc.271.5.2514; POST RL, 1972, J BIOL CHEM, V247, P6530; TAYLOR WR, 1989, EUR J BIOCHEM, V179, P241, DOI 10.1111/j.1432-1033.1989.tb14547.x; Tran C. M., 1996, Biophysical Journal, V70, pA329	36	60	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 24	1998	273	17					10578	10585		10.1074/jbc.273.17.10578	http://dx.doi.org/10.1074/jbc.273.17.10578			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZJ519	9553118	hybrid			2022-12-27	WOS:000073224200067
J	Schwemmle, M; Salvatore, M; Shi, LC; Richt, J; Lee, CH; Lipkin, WI				Schwemmle, M; Salvatore, M; Shi, LC; Richt, J; Lee, CH; Lipkin, WI			Interactions of the Borna disease virus P, N, and X proteins and their functional implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; CASEIN KINASE-II; STRAND RNA VIRUSES; INFECTED-CELLS; PHOSPHOPROTEIN; SYSTEM; ORGANIZATION; EXPRESSION; SEQUENCE; ANTIGENS	Borna disease virus (BDV) causes persistent central nervous system infection and behavioral disturbances in warm-blooded animals. Protein interaction studies were pursued to gain insight into the functions of the putative nucleoprotein (N), phosphoprotein (P), atypical glycoprotein (gp18), and X protein (X) of BDV, Coimmunoprecipitation experiments indicated that N and P, and P and X, form complexes in infected cells, Two-hybrid analyses confirmed interactions between P and P, P and X and P and N, but not between P and gp18, N and gp18, X and gp18, or X and N, Analysis of P truncation mutants identified three nonoverlapping regions important for oligomerization (amino acids (aa) 135-172), and binding to X (aa 33-115) or N (aa 197-201), Coexpression of X stimulated oligomerization of P but decreased N-P complex formation, Immunocytochemistry of transfected noninfected CHO cells demonstrated that the distribution of X is dependent upon the presence of P-X expressed alone was found predominantly in the cytoplasm whereas coexpression of X and P resulted in nuclear localization Immunocytochemistry of infected cells revealed nuclear colocalization of P and X, Interactions of P, N, and X may have implications for regulation of BDV transcription/replication and ribonucleoprotein assembly.	Univ Calif Irvine, Lab Neurovirol & Microbial Pathogenesis, Dept Neurol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Anat, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Mol Genet, Irvine, CA 92697 USA; Inst Virol, D-35392 Giessen, Germany	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Lipkin, WI (corresponding author), Univ Calif Irvine, Lab Neurovirol & Microbial Pathogenesis, Dept Neurol, 3rd Fl,Gillespie Bldg, Irvine, CA 92697 USA.	ilipkin@uci.edu	Lipkin, W. Ian/ABE-6216-2020; Salvatore, Mirella/K-6691-2016; Richt, Juergen/AAL-3632-2020	Lipkin, W. Ian/0000-0002-8768-9386; Salvatore, Mirella/0000-0002-8296-0376; 	NINDS NIH HHS [NS-29425] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029425] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANERJEE AK, 1991, PHARMACOL THERAPEUT, V51, P47, DOI 10.1016/0163-7258(91)90041-J; BAUSENIEDRIG I, 1991, VET IMMUNOL IMMUNOP, V27, P293, DOI 10.1016/0165-2427(91)90027-A; BAUSENIEDRIG I, 1992, VET IMMUNOL IMMUNOP, V31, P361, DOI 10.1016/0165-2427(92)90022-I; BRIESE T, 1994, P NATL ACAD SCI USA, V91, P4362, DOI 10.1073/pnas.91.10.4362; BRIESE T, 1995, J CLIN MICROBIOL, V33, P348, DOI 10.1128/JCM.33.2.348-351.1995; BRIESE T, 1992, P NATL ACAD SCI USA, V89, P11486, DOI 10.1073/pnas.89.23.11486; CUBITT B, 1994, J VIROL, V68, P1382, DOI 10.1128/JVI.68.3.1382-1396.1994; CUBITT B, 1994, J VIROL, V68, P1371, DOI 10.1128/JVI.68.3.1371-1381.1994; CURRAN J, 1995, VIROLOGY, V214, P139, DOI 10.1006/viro.1995.9946; DAS T, 1995, J BIOL CHEM, V270, P24100, DOI 10.1074/jbc.270.41.24100; DAS T, 1995, VIROLOGY, V211, P218, DOI 10.1006/viro.1995.1394; DELATORRE JC, 1994, J VIROL, V68, P7669, DOI 10.1128/JVI.68.12.7669-7675.1994; GAO Y, 1995, EMBO J, V14, P1240, DOI 10.1002/j.1460-2075.1995.tb07107.x; HSU TA, 1994, VIROLOGY, V204, P854, DOI 10.1006/viro.1994.1608; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kliche S, 1996, J VIROL, V70, P8133, DOI 10.1128/JVI.70.11.8133-8137.1996; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LUDWIG H, 1988, PROG MED VIROL, V35, P107; NARAYAN O, 1983, SCIENCE, V220, P1401, DOI 10.1126/science.6602380; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Prieve MG, 1996, J BIOL CHEM, V271, P7654, DOI 10.1074/jbc.271.13.7654; Pyper JM, 1997, J VIROL, V71, P5133, DOI 10.1128/JVI.71.7.5133-5139.1997; SALVATORE M, 1997, 10 INT C NEG STRAND, P175; SCHNEEMANN A, 1995, VIROLOGY, V210, P1, DOI 10.1006/viro.1995.1311; Schneider PA, 1997, J VIROL, V71, P5614, DOI 10.1128/JVI.71.7.5614-5619.1997; SCHNEIDER PA, 1994, J VIROL, V68, P5007, DOI 10.1128/JVI.68.8.5007-5012.1994; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Schwemmle M, 1997, J BIOL CHEM, V272, P21818, DOI 10.1074/jbc.272.35.21818; SLACK MS, 1997, 10 INT C NEG STRAND, P84; SOLBRIG MV, 1995, CURR TOP MICROBIOL, V190, P93; TAKACS AM, 1993, P NATL ACAD SCI USA, V90, P10375, DOI 10.1073/pnas.90.21.10375; THIEDEMANN N, 1992, J GEN VIROL, V73, P1057, DOI 10.1099/0022-1317-73-5-1057; THIERER J, 1992, J GEN VIROL, V73, P413, DOI 10.1099/0022-1317-73-2-413; Wehner T, 1997, J GEN VIROL, V78, P2459, DOI 10.1099/0022-1317-78-10-2459	35	68	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 10	1998	273	15					9007	9012		10.1074/jbc.273.15.9007	http://dx.doi.org/10.1074/jbc.273.15.9007			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZG331	9535888	hybrid			2022-12-27	WOS:000072990800065
